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Orals
Clinical Nutrition Symposium
CN01
WHEY PROTEIN ISOLATE SUPPLEMENTATION IMPROVES BODY
COMPOSITION, MUSCLE STRENGTH AND TREATMENT TOLERANCE
IN MALNOURISHED ADVANCED CANCER PATIENTS UNDERGOING
CHEMOTHERAPY
E. Cereda1*, A. Turri1, C. Klersy2, S. Cappello1, A. Ferrari3, A.R. Filippi4,
S. Brugnatelli3, M. Caraccia1, S. Chiellino3, V. Borioli1, T. Monaco3,
G.M. Stella5, L. Arcaini6, M. Benazzo7, G. Grugnetti8, P. Pedrazzoli3,
R. Caccialanza1. 1Clinical Nutrition and Dietetics Unit, 2Biometry and
Clinical Epidemiology Service, 3Medical Oncology Unit, 4Radiation
Oncology Unit, 5Unit of Respiratory System Diseases, 6Division of
Hematology, Fondazione Irccs Policlinico San Matteo, 7Department of
Otolaryngology, University of Pavia and Head Neck Surgery Fondazione
IRCCS Policlinico San Matteo, 8Nursing Technical and Rehabilitation
Service, Fondazione Irccs Policlinico San Matteo, Pavia, Italy
* Corresponding author.
Rationale:WP represents the soluble class of dairy proteins which are
known immune-enhancing constituents linked to a range of bioactive
functions, such as prebiotic effects, promotion of tissue repair,
maintenance of intestinal integrity, destruction of pathogens and
elimination of toxins. WPs are rich in substrates for glutathione
synthesis and could play a major role in cell protection against free
radicals, ionizing radiation, reactive oxygen species and carcinogens.
Furthermore, supplementationwithWPmay also inducemoremuscle
protein synthesis than other protein sources, due to their higher
anabolic potential. We evaluated the benefit of whey protein isolate
(WPI) supplementation in addition to nutritional counseling in
malnourished advanced cancer patients undergoing chemotherapy
(CT).
Methods: In a single-center, randomized, pragmatic, parallel-group
controlled trial (ClinicalTrials.gov: NCT02065726; February 2014–
June 2018), 166 malnourished advanced cancer patients with mixed
tumor entities candidate to or undergoing CT, were randomly assigned
to receive nutritional counselingwith (N = 82) orwithout (N = 84)WPI
supplementation (20 grams/daily) for 3 months. Primary endpoint
was the change in phase angle (PhA). Secondary endpoints included
changes in standardized PhA (SPA), fat-free mass index (FFMI), body
weight, muscle strength, quality of life and CT toxicity (CTCAE 4.0
events).
Results: In patients with the primary endpoint assessed (modified
intention-to-treat population), counseling plus WPI (N = 66) resulted
in improved PhA compared to nutritional counseling alone (N = 69):
mean difference, 0.48° [95%CI, 0.05 to 0.90] (P = 0.027). Imputation of
missing outcomes yielded consistent findings. WPI supplementation
resulted also in improved SPA (P = 0.021), FFMI (P = 0.041), body
weight (P = 0.023), muscle strength (P < 0.001) and in a reduced risk of
CT toxicity (risk difference, −9.8% [95%CI, −16.9 to −2.6]; P = 0.009),
particularly of severe (grade≥3) events (risk difference,−30.4% [95%CI,
−44.4 to −16.5]; P = 0.001).
Conclusions: In malnourished advanced cancer patients undergoing
CT and receiving nutritional counseling, a 3-month supplementation
with WPI resulted in improved body composition, muscle strength,
body weight and reduced CT toxicity. Further trials, aimed at verifying
the efficacy of this nutritional intervention on mid and long-term
primary clinical endpoints in newly diagnosed specific cancer types,
are warranted.
Disclosure of Interest: None declared.
CN02
β-HYDROXY-β-METHYLBUTYRATE (HMB), ARGININE AND
GLUTAMINE COMPLEX ON MUSCLE VOLUME LOSS IN CRITICALLY
ILL PATIENTS: A RANDOMIZED CONTROL TRIAL
K. Nakamura1*, T. Sonoo1, H. Naraba1, H. Nakano1, A. Shimada1,
N. Tomizawa1, D. Takai1, Y. Takahashi1, H. Hashimoto1. 1Emergency
and Critical Care Medicine, Hitachi General Hospital, Ibaraki, Japan
* Corresponding author.
Rationale: β-hydroxy-β-methylbutyrate (HMB), a metabolite of
leucine, can strongly induce muscle protein synthesis. We evaluated
the efficacy of HMB complex on muscle volume loss during critical
care.
Methods: For this prospective, single-center, randomized control trial,
we created control and HMB groups by random assignment of
critically ill intensive care unit (ICU) patients for whom enteral
nutrition could be performed. From day 2 after admission, HMB group
participants were administered 3 g HMB, 14 g arginine, and 14 g
glutamine daily in addition to standard nutrition therapy. Early
rehabilitation with electrical muscle stimulation was started from
day 2 in both groups. As a primary outcome, we evaluated femoral
muscle volumeusing computed tomographyon days 1 and 10 after ICU
admission.
Results: From 164 ICU patients, 88 severely ill patients were included
and assigned: 43 to control and 45 to HMB. Day 1 and day 10 femoral
muscle volumes of 24 control and 26 HMB group participants were
analyzed as per protocol. Volumes decreased significantly during days
1–10 (p < 0.0001). Volume loss rates were 14.4 ± 7.1% for control
participants and 11.4 ± 8.1% for HMB participants (p = 0.18). In a
subgroup of the sequential organ failure assessment scores <10,
femoral muscle volume loss was 14.0 ± 6.9% for control participants
and 8.7 ± 6.4% for HMB (p = 0.0474). Results of intention-to-treat
analysis of the two groups showed no differences in basic character-
istics or outcomes.
Conclusions: For critically ill patients, HMB complex supplementation
from the acute phase of intensive care does not inhibit muscle volume
loss. Only moderately severe patients received a benefit.
Disclosure of Interest: None declared.
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CN03
TICACOS INTERNATIONAL: A MULTI-CENTER, RANDOMIZED,
PROSPECTIVE CONTROLLED STUDY COMPARING TIGHT CALORIE
CONTROLVERSUS LIBERAL CALORIE ADMINISTRATION STUDY
P. Singer1*, E. De Waele2, C. Sanchez3, S. Ruiz-Santana4, J.C. Montejo5,
P. Laterre6, A. Soroksky7, L. Moscovici1, I. Kagan1. 1Department of General
Intensive Care and Institute for Nutrition Research, Rabin Medical Center,
Tel Aviv, Israel, 2Department of Surgical ICU, UZ Brussel, Brussels, Belgium,
3Intensive Care, Hospital General Reina Sofía, Maaga, 4Inteisve Care,
Hospital Universitario Dr Negrín., Las Palmas de Gran Canaria, 5Inteisive
Care, Hospital Universitario 12 Octubre, Madrid, Spain, 6Intensive Care,
UCL St Luc, Leuven, Belgium, 7Inteisive Care, Wolfson Hospital, Holon,
Israel
* Corresponding author.
Rationale: Following TICACOS pilot study (1), a multicenter prospect-
ive, randomized, controlled non blinded study assessed the advantage
of guiding nutritional support in critically patients by daily measured
resting energy expenditure (REE).
Methods: From580 adult ventilated ICUpatients planned to staymore
than 48 hours, nutritional support was aimed to meet 100% of energy
requirementmeasured by indirect calorimetryor by 25 kcal/kg IBW/d)
in the Control Group. Parenteral Nutrition (PN) was added if enteral
nutrition (EN) caloric supply <90% calculated needs. Enteral and
parenteral formulas enriched in protein were used. Indirect calorim-
etry was performed using Deltatrac II, COVX (GE) or Quark (Cosmed,
Italy). Statistics used T test for equalityofmeans (independent samples
test) and correlations with the Pearson correlation test. A p level <0.05
was considered as significant. Cross tabs procedure used Chi-square
test for testing differences in complication rates, length of stay and
length of ventilation. Kaplan Meir curves assessed the proportion of
surviving patients in the 2 groups.
Results: Seven centers recruited 417 ITT patients from 4737 screened
(339 per protocol). Study was stopped due to slow recruitment. No
baseline differences between control and study groups in age, sex BMI,
SOFA (7.1 ± 3.1 vs 7.4 ± 3.3) and APACHE II (22.4 ± 7.9 vs 22.2 ± 7.4).
Measured REE was similar in the 2 groups. Study group received more
total energy (1747 ± 467 vs 1305 ± 418 kcal/d, p < 0.02), more propofol
(137 ± 37 vs 40 ± 28 kcal/d, p < 0.02) and protein (79 ± 20 vs 62 ± 7 g/d,
p < 0.001) and was in a lower negative energy balance (−357 ± 1091 vs
−875 ± 270 kcal/d, p < 0.001). When administered, calories from PN
were larger in the study group (1477 vs 958 kcal/d, p < 0.02). Rate of
infections (40 vs 31), including VAP, rate of pressure ulcers, surgeryand
dialysis requirement, length of ventilation, LOS ICU and hospital were
similar. ICU Mortality (30 in the control vs 21 in the study group) was
not different according to Kaplan Meir curve. None of these
parameters reached significant difference. However, the decreased
mortalityobserved in the studygroup added to the previous studymay
have a positive effect on a meta-analysis.
Conclusions: Tight Calorie Control guided by indirect calorimetry
decreased rate of infection and mortality but not significantly in this
study stopped prematurely. Compared to the pilot study, less over-
feeding andmore proteinwere associatedwith less complications. The
trend in decrease mortality may reinforce the results of the meta-
analysis exploring the effects of IC guided nutrition on mortality.
Reference
1. Singer P, Anbar R, Cohen J, Shapiro H, Shalita-Chesner M, Lev S
et al. The tight calorie control study (TICACOS): a prospective,
randomized, controlled pilot study of nutritional support in
critically ill. Intensive Care Med 2011.
Disclosure of Interest: None declared.
CN04
EFFECTS OF A BLENDED HOME-BASED EXERCISE PROGRAM AND
PROTEINCOUNSELLING INCOMMUNITYDWELLINGOLDERADULTS:
RESULTS OF THE VITAMIN RCT
J. van den Helder1,2*, S. Mehra3, M. Tieland1, B. Visser2, B.J. Kröse3,4,
R.H. Engelbert2,5, P.J. Weijs1,6 on Behalf of Vitamin Research Group.
1Faculty of Sports and Nutrition, 2Faculty of Health, 3Faculty of Digital
Media and Creative Industries, Amsterdam University of Applied Sciences,
4Informatics Institute, University of Amsterdam, 5Department of
Rehabilitation, Amsterdam University Medical Centers, AMC,
6Department of Nutrition and Dietetics, Amsterdam University Medical
Centers, VUmc, Amsterdam, Netherlands
* Corresponding author.
Rationale:With the ageing population, there is an increasing demand
for strategies to optimise muscle mass, strength and physical
performance in community dwelling older adults. We designed a
new innovative e-health intervention “VITAMIN” to improve physical
performance in older adults. The blended home-based exercise
intervention contains digital support to improve personalised coach-
ing as well as dietary protein counselling. This study evaluates the 6
months effectiveness of the intervention.
Methods: The cluster RCT included 245 community dwelling older
adults (age≥ 55 y) randomised to control, exercise, and exercise +
dietary protein counselling group. Data was collected at baseline and
after 6months of intervention. The primaryoutcomewas themodified
Physical Performance test (mPPT) with an emphasis on daily
functioning. Secondary measures were gait speed (GS; m/s), physical
activity level (PAL), protein intake (g/kg/d), appendicular skeletal
muscle mass by DXA (ASMM; kg), hand grip strength (HGS; kg). For
statistical analysis SPSSv24.0 was used. A mixed models analysis was
performed, with group, time and group*time interaction as fixed
factors, subject and cluster as random factors, and additional posthoc
Bonferroni test.
Results: Mean age of the 224 evaluated participants was 72.0 ± 6.5 y,
71% were females and 44% low educated. No significant intervention
effect was found for mPPT (p = 0.889). Secondary outcomes showed a
significant intervention effect: GS (p = 0.002), PAL (p = 0.014), protein
intake (p < 0.001), ASSM (p = 0.029), HGS (p < 0.001). Posthoc
Bonferroni showed that exercise+protein group had statistical
improved outcome compared to control for these secondary outcomes
(p < 0.001; p = 0.003; p < 0.001; p = 0.009; p < 0.001). Control group
showed declined values at 6 months compared to baseline for GS
(Δ−0.23 m/s), PAL (Δ−0.03), ASSM (Δ−0.32 kg) and HGS (Δ−0.96 kg).
Conclusions: Older adults had already very high scores for physical
performance (mPPT). However, the blended home-based exercise
interventionwith protein counselling was still effective for gait speed,
physical activity level, dietary protein intake, muscle mass and
strength. This personalised innovative e-health intervention showed
to be a promising strategy for community dwelling older adults for
maintenance instead of declining physical function.
Disclosure of Interest: None declared.
CN05
PROSPECTIVE ASSOCIATIONS OF POOR DIET QUALITY WITH
INCIDENT FRAILTY IN COMMUNITY-DWELLING OLDER ADULTS:
THE HEALTH ABC STUDY
L.M. Hengeveld1*, H.A.H. Wijnhoven1, M.R. Olthof1, I.A. Brouwer1,
E.M. Simonsick2, S.B. Kritchevsky3, D.K. Houston3, A.B. Newman4,
M. Visser1. 1Department of Health Sciences, Vrije Universiteit,
Amsterdam, Netherlands, 2Intramural Research Program, National
S2 Abstracts / Clinical Nutrition 38 (2019) S1–S32
Institute on Aging, Baltimore, 3Department of Internal Medicine, Wake
Forest School of Medicine, Winston-Salem, 4Department of Epidemiology,
Graduate School of Public Health, University of Pittsburgh, Pittsburgh,
United States
* Corresponding author.
Rationale: Poor diet is considered an important determinant of the
development of frailty. None of the studies on associations between
dietary components and frailty considered time to onset of frailty nor
potential competing risks. This studyaimed to examine associations of
diet quality indicators relevant in old age with 4-year incidence of
frailty (accounting for competing risks of death) in community-
dwelling older adults.
Methods:Datawere from2154 community-dwellingmen andwomen
aged 70–81 y in 1998–1999 (present study’s baseline) from the Health
ABC Study. In 1998–1999, dietary intake over the preceding year was
assessedwith a food frequency questionnaire. Indicators of diet quality
include overall diet quality as estimatedwith the Healthy Eating Index
(HEI; categorized as poor, medium, and good), energy intake, and
protein intake (a priori adjusted for energy intake using the nutrient
residual model). Frailty status was determined using Fried’s five-
component frailty phenotype and categorized into “robust” (0
components present), “pre-frail” (1–2), or “frail” (3–5). Cox propor-
tional hazards analysis was used to examine associations of the diet
quality indicators with 4-year incidence of 1) frailty and 2) pre-frailty
or frailty. Competing risks analysis was used to examine associations
with incidence of frailty by accounting for competing risks of death.
Results: During the 4-year follow-up, 277 of the 2154 participants,
robust or pre-frail at baseline, developed frailty, and 629 of the 1020
participants, robust at baseline, developed pre-frailty or frailty. Among
the robust and pre-frail, after adjustment for confounders including
energy intake, those consuming poor- andmedium-quality diets had a
higher frailty incidence than those consuming good-quality diets (HR:
1.92, 95% CI: 1.17–3.17 and 1.40, 0.99–1.98, respectively). No associa-
tions for energy or protein intake were observed. Competing risks
analysis yielded similar results. Among the robust, those with lower
vegetable protein intake had a higher “pre-frailty or frailty” incidence
(per −10 g/d: 1.20, 1.04–1.39). No other associations were observed.
Conclusions: Better overall diet quality and lower vegetable but not
animal protein intake may increase the risk of becoming frail in old
age. Although some prospective studies showed that higher total
protein intake may lower frailty risk, our study indicates that the
quality of the overall diet may be more important than protein intake
for reducing the development of frailty in old age.
Disclosure of Interest: None declared.
CN06
IMPROVING REHABILITATION IN SARCOPENIA (IRIS) BY MUSCLE-
TARGETED NUTRITIONAL SUPPORT: A RANDOMIZED, DOUBLE-
BLIND, PLACEBO-CONTROLLED TRIAL
M. Rondanelli1, E. Cereda2*, C. Klersy3, M.A. Faliva4, G. Peroni4,
M. Nichetti4, C. Gasparri4, D. Spadaccini4, V. Infantino4, S. Perna5.
1Department of Public Health, Experimental and Forensic Medicine, Unit
of Human and Clinical Nutrition, University of Pavia, 2Clinical Nutrition
and Dietetics Unit, 3Biometry and Clinical Epidemiology Service,
Fondazione Irccs Policlinico San Matteo, 4Azienda di Servizi alla Persona
(ASP) di Pavia, University of Pavia, Pavia, Italy, 5Department of Biology,
College of Science, University of Bahrain, Sakhir Campus, Bahrain
* Corresponding author.
Rationale: Sarcopenia is a negative prognostic condition of aging. A
combined intervention with physical exercise and nutritional support
should be considered. We evaluated the efficacy of a muscle-targeted
nutritional support on the outcome of a physical exercise rehabilita-
tion program in old adults with sarcopenia.
Methods: A single-site, double-blind, randomized (1:1), placebo-
controlled trial (NCT03120026) in sarcopenic old adults (≥65 years)
without severe cognitive impairment (Mini Mental State Examination
≥18) and admitted to an in-patient rehabilitation facility for a physical
rehabilitation program. In addition to a standard hospital diet, patients
(n = 140) were randomized to receive until discharge (for at least
4 weeks and up to 8 weeks) a whey protein-based nutritional
supplement enriched with leucine and vitamin D or an iso-caloric
placebo twice daily. The primary efficacy endpoint was the change in
4-meter gait speed per month. Key secondary endpoints were change
inphysical performance outcomemeasures: chair-stand test, Timedup
and go test, Short Physical Performance Battery. Other secondary
outcome variables were change in: Tinetti scale, handgrip strength,
Barthel Index, activitiesofdaily living (ADL),bodyweight, appendicular
muscle mass (AMM), skeletal muscle mass index (SMMI), cognitive
status (Trailmaking test,MMSE)andqualityof life (12-itemShort-Form
health Survey). The overall economic benefits (surrogate measures:
length of stay and duration of rehabilitation) were also evaluated.
Results: Intention-to-treat analyses were based on patients re-
assessed at discharge (n = 127). Supplementation with the experi-
mental formula (n = 64) resulted in greater increase in gait speed than
placebo (n = 63): mean difference, 0.063 meters/sec/month [95%CI,
0.043 to 0.082] (P < 0.001). A significant effect was also found for all
physical performance, functional and cognitive function endpoints
(P < 0.001 for all), AMM (P = 0.011) and SMMI (P = 0.023). No difference
was observed in qualityof life. Supplementation resulted also in higher
proportion of patients improving their rehabilitation intensity profile
(P = 0.003) and being discharged at home (P = 0.002) and in shorter
rehabilitation (P < 0.001) and hospital stay (p < 0.001).
Conclusions: In old adults with sarcopenia admitted to hospital for
rehabilitation the consumption of a whey protein-based nutritional
formula enriched with leucine and vitamin D improved physical
performance and function,musclemass and reduced the intensity and
costs of care.
Disclosure of Interest: None declared.
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COMPARISON OF ESPEN 2015 AND GLIM CRITERIA FOR ASSESSING
MALNUTRITION IN SYSTEMIC SCLEROSIS
A. Gigante1, M.L. Gasperini1, A. Iacolare1, A. Molfino1, L. Proietti1,
E. Rosato1, M. Muscaritoli1*. 1Department of Translational and Precision
Medicine, Sapienza University of Rome, Rome, Italy
* Corresponding author.
Rationale: Systemic sclerosis (SSc) is a rare, chronic autoimmune
disease characterized by fibrosis of the skin and internal organs.
Gastrointestinal involvement may lead to malnutrition which can in
turn negatively affect morbidity, mortality and quality of life. The aim
of the study was to assess the prevalence of malnutrition in SSc
patients with both the ESPEN 2015 and the recently published GLIM
criteria and to assess whether it relates with disease activity and
severity.
Methods: Adults patients with diagnosis of SSc admitted to our
Scleroderma Unit were included in the study. Biochemical analyses,
disease activity index (DAI), disease severity scale (DSS), anthropo-
metric data and body composition from bioelectrical impedance (BIA)
were recorded at the time of enrollment. Group comparisons were
made by Student’s unpaired two-tailed t-test or Kruskal–Wallis test.
Pearson or Spearman correlation coefficients (r) were used as
appropriate.
Results:One hundred and two SSc patients were enrolled (86 females;
mean age 55 ± 14 years). Fifty-seven patients had limited cutaneous
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SSc and forty-five had diffuse cutaneous SSc. The prevalence of
malnutrition was 8.8% (9/102) according to ESPEN 2015 criteria and
16.6% (17/102) according to GLIM criteria. GLIM severity grading of
malnutrition was moderate in 13 patients (12.7%), severe in 4 patients
(3.9%). In SSc patients with malnutrition according to GLIM criteria,
DAI and DSS were significantly higher than in SSc patients without
malnutrition (p < 0.0001), while no associationwas observed between
malnutrition and DAI or DSS when using the ESPEN 2015 criteria.
Conclusions: In our study the prevalence of malnutrition is higher
using GLIM criteria with respect to ESPEN 2015 criteria. In SSc, GLIM
criteria appear to better discriminate for the presence of malnutrition
associated with higher degree of disease severity and activity.
Disclosure of Interest: None declared.
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VALIDATION OF GLIMMALNUTRITION CRITERIA FOR DIAGNOSIS OF
MALNUTRITION IN ICU PATIENTS
M. Theilla1*, S. Rattanachaiwong2, I. Kagan3, M. Rigler4, I. Bendavid4,
P. Singer4. 1Nursing Department, Steyer School of Health Professions,
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 2Division of
Clinical Nutrition, Department of Medicine, Faculty of Medicine, Khon
Kaen University, Khon Kaen, Thailand, 3Department of General Intensive
Care and Institute for Nutrition Research, Nutrition Department,
4Department of General Intensive Care and Institute for Nutrition
Research, Nutrition Department, Rabin Medical Center, Beilinson
Hospital, Petah Tikva, Israel
* Corresponding author.
Rationale: Patients in ICU are at high risk of malnutrition. Global
Leadership Initiative on Malnutrition (GLIM) is a new malnutrition-
screening tool.1 The present study compares the nutrition-related
parameters of the following tools: GLIM tool, Patient- And Nutrition-
Derived Outcome Risk Assessment (PANDORA) score, and low FFMI (Fat
Free Mass Index) to the gold standard SGA (Subjective Global
Assessment) regarding their values on predicting malnutrition in
severely ill patients.
Methods: 84 ICU patients included. The tools mentioned above were
assessed for diagnosis of malnutrition. All patients were defined as
suffering from acute disease and received medical nutrition therapy.
Statistical analysis was based on Stepwise regression to demonstrate
correlation between proposed parameters. In addition, T-Test and
Pearson correlation was used between variances.
Results: Mean age was 50 ± 20 years, BMI 25.3 ± 5.1 kg/m2, APACHE II
20.5 ± 7.7, PANDORA score 32 ± 8.5. GLIM malnutrition criteria was
significantly correlatedwith low FFMI, with PA (Phase Angle) andwith
PANDORA score (R = 0.778, p≤ 0.00; R =−0.307, p≤ 0.005; R = 0.215,
p≤ 0.05 respectively). SGA assessment was correlated with GLIM
malnutrition criteria and PANDORA score (R = 0.518, p≤ 0.00; R = 0.517,
p≤ 0.00 respectively). According to the stepwise regression, the
measurement of low FFMI and SGA predicts 77% of the GLIM score
(R2 = 0.620; P < 0.00; R2 = 0.770; P < 0.00 respectively).
Conclusions: There is a high correlation between PA, and PANDORA
score with GLIM criteria in ICU patients. A low FFMI and SGA predict
the GLIM malnutrition criteria with a high level of precision. GLIM
malnutrition assessment seems to be acceptable in the ICU setting.
Reference
1. Cederholm T., Cederholm T., Jensen G.L., Jensen G.L., Correia M.I.T.
D., Correia M.I.T.D.,…, Fuchs V. (2019). GLIM criteria for the
diagnosis of malnutrition – A consensus report from the global
clinical nutrition community. Clinical Nutrition, 38(1), 1–9.
Disclosure of Interest: None declared.
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COMBINATION OF ENTERAL AND PARENTERAL NUTRITION IN
COMPARISON TO ENTERAL NUTRITION ALONE– DOES
COMBINATION TIMING MATTER?
A. Hill1,2*, C. Benstoem1,2, D.K. Heyland3, C. Stoppe1,2. 1Department of
Intensive Care, 23CARE, Cardiovascular Critical Care & Anesthesia
Evaluation and Research, Medical Faculty RWTH Aachen, Aachen,
Germany, 3Clinical Evaluation Research Unit, Kingston General Hospital,
Kingston, Canada
* Corresponding author.
Rationale: A combination of enteral nutrition (EN) and parenteral
nutrition (PN) may avoid large nutrition debts in critically ill patients.
One strategy is the combined use of EN and PN (EN + PN) starting early
after admission to the intensive care unit. Another possibility is the
early initiation of EN with delayed start of supplemental PN if the
nutritional targets cannot be reached (SPN).
In our recent meta-analysis (under submission) evaluating influence
of the route of administration EN alone vs. a combination of EN and PN,
heterogeneity was observed with regards to publication date and
supplementation strategies. This subgroup analysis investigates the
influences of a) publication year (before or after 2000) and b) the
supplementation strategy (EN + PN or SPN) on 30-day mortality and
hospital length-of-stay (LOS).
Methods: The detailed methodology was previously published
(www.criticalcarenutrition.com). In short, randomized controlled
trials (RCTs) targeting the effect of EN alone vs. a combination of EN
and PN in critically ill and mechanically ventilated patients were
systematically identified and pooled in a meta-analysis.
Of the 10 RCTs meeting the inclusion criteria, 5 were published before
2000 and 5 afterwards, 8 RCTs compared EN + PN to EN alone and 2
RCTs compared SPN to EN alone. Dichotomous variables are presented
as risk ratio (RR), continuous variables as weighted mean difference
(WMD) with 95% confidence intervals (CI).
Results: Detailed results are displayed in the table 1. Including all
studies, on average, there was no treatment effect on 30-day mortality
with a combination of EN and PN (RR 1.00, CI 0.70, 1.41, 10 studies,
n = 880, p = 0.98, heterogeneity I2 = 41%) compared to EN alone. A
combination of EN and PN compared to EN alone was, on average,
associated with a trend towards a reduced LOS (WMD− 3.14, 95% CI
−6.46, 0.18, 6 studies, n = 771, p = 0.06, heterogeneity I2 = 38%. In the
subgroup of EN+PN vs. EN, the overall mean difference was significant
(−4.38 [−8.53,−0.24], p = 0.04), whereas in the SPN vs. EN subgroup no
influence was observed.
Outcome Group Studies RR or WMD [95% CI] p-Value Interpretation
30-day
mortality
EN+PN vs. EN 8 1.01 [0.64, 1.60] 0.96 RR values >1
favor EN
alone
SPN vs. EN 2 0.96 [0.50, 1.82] 0.89
Before 2000 5 1.27 [0.82, 1.94] 0.28
After 2000 5 0.77 [0.47, 1.27] 0.31
All trials
included
10 1.00 [0.70, 1.14] 0.98
Hospital-LOS EN+PN vs. EN 4 −4.38 [−8.53, −0.24] 0.04
SPN vs. EN 2 −1.00 [−5.25, 3.25] 0.64
All trials
included
6 −3.14 [−6.46, 0.18] 0.06
Conclusions: Regarding mortality, a combination of enteral and
parenteral nutrition is non-inferior to enteral nutrition alone. An
early combination of EN+PN might be more effective than SPN to
reduce hospital-LOS.
Disclosure of Interest: None declared.
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A NEW PROGNOSTIC INDICATOR IN SEPTIC SHOCK: MUSCLE MASS
MEASURED BY THE THICKNESS OF QUADRICEPS IN ULTRASOUND
C. Lemaitre1,2*, M. Selim3, L. Lagache4, G. Le Bouar5, D. Boyer2,M. Grall6,
T. Clavier7, E. Demarest-Durand5, E. Surlemont7, S. Grange2,
D. Carpentier2, G. Beduneau2, C. Girault2, G. Savoye1, P. Michel1,
C. Savoye-Collet8, P. Dechelotte9, M. Coeffier9, F. Tamion2. 1Hepatology
and Gastroenterology Unit, 2Intensive Care, Rouen University Hospital,
Rouen, 3Anesthesiology Unit, Bayonne Hospital, Bayonne, 4Intesnive Care,
Jacques Monod Le havre Hospital, Montivilliers, 5Intensive Care, Evreux
Hospital, Evreux, 6InternalMedicine Unit, 7Cardiac Surgery Intensive Care
Unit, 8Radiology Unit, 9Nutrition Unit, Rouen University Hospital, Rouen,
France
* Corresponding author.
Rationale: Low skeletal muscle mass in critically ill patients has been
independently associated with prolonged mechanical ventilation,
prolonged ICU and hospital length of stay and mortality Assessing
body composition remains challenging in ICU. Ultrasonography (US)
has recently been suggested to measure muscle volume and
architecture and may monitor acute muscle wasting in critically ill
patients.
Methods: It was an observational, prospective study, in Medical
Intensive Care of Rouen University Hospital. Patients were included
between April and October 2017. The primary aim was to evaluate
relationship between D1–D4 thickness delta of quadricepsmuscle and
D28 mortality. Bioelectrical impedance was also evaluate in this
population.
Results: A total of Thirty four patients were included. The median of
D1–D4 delta thickness was −6.77% and was defined as cut off.
Mortality was increased when the loss of thickness was more than
6.77% (p = 0.02; IC [0.0015; 0.7157]), with 88% of Sensibility (IC
[50;99]), 64% of Specificity (IC[42;82]). Higher average loss of
thickness was associated of D28 mortality (13% for dead-patients,
1.8% for alive-patients, p = 0.02). Bioelectrical impedance was not
correlated with mortality.
Conclusions:An earlier loss of quadricepsmuscle thicknessmore than
6.77% is associated with mortality in septic shock. The assessment by
ultrasonography of the quadriceps muscle thickness may constitute a
promising tool to evaluate acute muscle wasting and the effect of
nutritional-based interventions on muscle wasting in critically ill
patients.
Disclosure of Interest: None declared.
OR03
NUTRITIONDAY ICU: ANNULAR CHANGE IN ONSET OF PARENTERAL
NUTRITION
C. Veraar1*. 1Medical University of Vienna, Wien, Austria
* Corresponding author.
Rationale: The timing of parenteral nutrition (PN) was considerably
earlier in Europe based on ESPEN guidelines and North America based
on ASPEN guidelines. A large European RCT (EPANIC) published in
2011 appeared to confirm a delayed start of PN. The controversy
persists and a recent French trial appears to allow early start of full PN
and more side-effects with early full enteral nutrition.
We investigated in the nutritionDay cohort whether the start of PN or
EN was changed after 2011 in Europe.
Methods: 8829 of 13043 patients from the 2007–2015 nutritionDay
ICU cohort were admitted in Europe. General linear modeling (R 3.3.1)
of the starting day for PN and EN was used and adjusted for countries,
age, gender, SOFA Score reason for ICU dependency and duration since
admission. Data are given as mean with 95% confidence intervals.
Results:OnnutritionDay nutritionwas enteral for 3283 (37%) patients,
parenteral for 1230 (14%) and combined for 1093 (12%). Age was 65
years and proportion of women was 35–40% over the years. 52–71%
were ventilated and 31–35% needed vasoactive drugs. Predicted
mortality was 41% with enteral, 35% with parenteral and 37% with
combined nutrition. Observed mortality was 33%, 32% and 38%. 60
days after nutritionDay 34% of patients on artificial nutrition had died
and 15% were still hospitalised.
Start of PN was similar between 2007 and 2010. In 2011 PN start was
delayed by 5.86 (CI95 3.49;8.23) days (P < 0.0001), in 2012 4.72 (CI95
2.18;7.26) and in 2013 3.15 (CI95 0.47; 5.83) and decreased to 2.29 and
1.12 days in 2014 and 2015. A similar time profile was found for
combined nutrition but not for enteral nutrition.
Conclusions: Published research may have triggered an abrupt delay
of parenteral and combined enteral and parenteral nutrition in Europe
that was reversed within 4 years.
Reference
Literature: Casaer NEJM 2011; Reignier Lancet 2017.
Disclosure of Interest: None declared.
OR04
ASSESSING THE APPROPRIATE ENERGY EXPENDITURE
REQUIREMENT USING INDIRECT CALORIMETRY FOR LIVER
TRANSPLANT RECIPIENTS
J.-K. Baek1*, S.-J. Lee2, H.-J. Lee1, Y.-J. Jung1, S.-K. Hong1. 1Division of
Acute Care Surgery, Department of Surgery, AsanMedical Center, 2College
of Medicine, University of Ulsan, Seoul, Republic of Korea
* Corresponding author.
Rationale: The aim of this study was to compare predictive
equations with indirect calorimetry and identify the appropriate
energy expenditure requirement of liver transplant recipients in
South Korea.
Methods: This prospective observational study was conducted in a
surgical intensive care unit (ICU) in an academic tertiary hospital.
Fifty mechanically ventilated patients who had received LTs and
were expected to stay in the ICU more than 2 days were studied.
Resting energy expenditure (REE) was measured 48 hours after ICU
admission using open-circuit indirect calorimetry. Theoretical REE
was estimated using three predictive equations: Harris-Benedict
methods, lreton-Jones ventilated, and Penn state 1988. The REEs
derived from each predictive equation were compared with the
measured REE using an intraclass correlation coefficient (ICC) and a
Bland-Altman plot.
Results: Except for 4 patients whowere extubatedwithin 36 hours, 46
patients were enrolled (n = 46). Penn-state 1988 equation showed 65%
agreement (ICC 0.65) and Harris-Benedict method showed 56%
agreement (ICC 0.56) with indirect calorimetry measurement which
was statistically significant (p < 0.001), while the other predictive
equation showed poor agreement. The mean difference between the
measured and predicted REE for each method was as follows: Harris
Benedict method, 148.50 ± 247.67 kcal; Ireton-Jones ventilated,
−105.30 ± 284.72 kcal; and Penn state 1988, −52.49 ± 249.86 kcal
(Table 1) All three predictive equations seemed to have fixed bias,
but Penn state 1988 method seemed to have the least. Harris Benedict
method tended to underestimate REE, while Ireton-Jones ventilated
and Penn state 1988 tended to overestimate REE.
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Table 1
Intraclass correlation coefficients and mean difference between measured and
predicted REE.
Predictive
equation
Intraclass
correlation
coefficient
between predicted
and measured REE
P-value Mean difference
between predicted
and measured REE
(Kcal)
Harris-Benedict
method
0.56 <0.001 148.50 ± 247.67
Ireton-Jones
(ventilated)
0.39 0.004 −105.30 ± 284.72
Penn State 1988 0.65 <0.001 −52.49 ± 249.86
Conclusions: All three predictive equations showed unsatisfactory
agreement with measured REE, which all had a fixed bias and
appeared to be inaccurate for predicting REE for LT recipients.
Therefore, precise measurements using indirect calorimetry may be
helpful when treating critically ill patients to avoid underestimating or
overestimating their metabolic needs.
Disclosure of Interest: J.-K. Baek Grant/Research Support from: GE
healthcare for indirect calorimetry, S.-J. Lee Grant/Research Support
from: GE healthcare for indirect calorimetry, H.-J. Lee Grant/Research
Support from: GE healthcare for indirect calorimetry, Y.-J. Jung Grant/
Research Support from: GE healthcare for indirect calorimetry, S.-K.
Hong Grant/Research Support from: GE healthcare for indirect
calorimetry.
OR05
EFFECT OF CONTINUOUS VENO-VENOUS HEMOFILTRATION ON
MEASUREMENT OF RESTING ENERGY EXPENDITURE BY INDIRECT
CALORIMETRY. RESULTS FROM THE MECCIAS TRIAL
J. Jonckheer1*, J. Demol2, R. Jacobs1, K. Lanckmans3, H. Spapen1,
M.L. Malbrain1, E. Dewaele1. 1Intensive Care, 2Nutrition, 3Clinical
Laboratory, University hospital of Brussels, Jette, Belgium
* Corresponding author.
Rationale: Measuring resting energy expenditure (REE) in patients
undergoing continuous renal replacement therapy (CRRT) is challen-
ging. Indeed, indirect calorimetry (IC) fails to capture CO2 removal over
the filter, CRRT induces immunologic changes that activate metabol-
ism, and CRRT-induced heat loss and citrate anticoagulation may have
a significant metabolic impact.
Methods: The trial was registered at clinicaltrial.gov (NCT03314363).
REEwasmeasuredwith IC in 10 ventilated critically ill adult patients in
4 different settings: standard continuous veno-venous hemofiltration
(CVVH), high-dose CVVH (50 ml/kg/h of effluent), standard CVVHwith
citrate replaced by NaCl 0.9%, and no CVVH. Gas flow was measured at
different sample points within the CRRT circuit using blood gas
analysis. Loss of CO2 and O2 into the effluent was added to calculation
of REE.
REEtotal ¼ REEIC þ REEeffluent ¼ ð3:94 VO2 þ 1:1 VCO2ÞIC
þð3:94 VO2 þ 1:1 VCO2Þeffluent:
Results: REE without CVVH was 1706 ± 702 Kcal/day. Wilcoxon
matched paired rank test showed statistically significant difference
between standard and high dose (p = 0,037), standard vs no-citrate
(p = 0,020), and standard vs no CVVH (p = 0,049).
Table 1
(Values are means ± standard deviation).
Standard
CVVH
High-dose
CVVH
CVVH
without
citrate
CO2 loss in effluent (ml/min) 23 ± 5 34 ± 16 22 ± 4
REE change due to CO2 loss
in effluent (%)
+2.3 ± 0.9 +4.0 ± 2.0 +2.5 ± 1.1
REE (Kcal/day) 1970 ± 907 1766 ± 745 1643 ± 635
Conclusions: Measuring REE during CVVH underestimates the true
value by 2 to 4%. Metabolism is lower in the absence of CVVH. REE is
lower in high-dose CVVH than in standard CVVH,whichmay be due to
heat loss and lower body temperature. Replacing citrate by NaCl 0.9%
diminishes REE which suggests citrate-induced metabolic alterations.
Disclosure of Interest: J. Jonckheer Grant/Research Support from:
Baxter®, J. Demol: None declared, R. Jacobs: None declared,
K. Lanckmans: None declared, H. Spapen: None declared,
M. Malbrain: None declared, E. Dewaele: None declared.
OR06
THE USE OF PROBIOTICS AS A PREVENTATIVE MEASURE AGAINST
SURGICAL SITE INFECTIONS IN MULTIPLE TRAUMA ICU PATIENTS: A
PRELIMINARY STUDY
G. Thoma1, G. Stavrou1, P. Malliou1, E. Giamarellos-Bourboulis2,
K. Kotzampassi1*. 1Department of Surgery, Aristotle University of
Thessaloniki, Thessaloniki, 24th Department of Internal
Medicine, National and Kapodistrian Univeristy fo Athens, Medical
School, Athens, Greece
* Corresponding author.
Rationale: Probiotics have been proposed as an adjunct means of
reducing infections in highly susceptible patients, such as multiple-
trauma, surgical and/or ICU patients. Their efficacy on reducing
surgical site infections [SSIs] has not been fully demonstrated. The
purpose of our study was to elucidate the role of probiotics for
prevention of SSIs in a high-risk patient population, namely multiple
trauma ICU patients.
Methods: This randomized, placebo-controlled study included 58
multiple trauma patients that required surgical intervention and
subsequently ICU treatment with or without mechanical ventilation
for≥10 days. Patientswere randomlyallocated to the probiotic [n = 28]
or placebo group [n = 30]. A commercially available, 4 probiotic
combinationwas used. Patients received two capsules of the probiotic
or placebo from days 1–15 of their ICU stay through a nasogastric tube.
Patients were followed up for the incidence of SSIs, total length of ICU
stay and mortality for 30 days.
Results: The probiotics group demonstrated a significant decrease in
the incidence of SSIs [10.7% vs 26.6%, p = 0.014, RR placebo = 5.4 (95% CI
2.4–11.9)] compared to the placebo group. In addition, the need for
prolonged ICU stay [>30 days] was also significantly decreased [7.1% vs
40%; p = 0.002; RR placebo = 2.8 (95%CI 1.7–4.1)] in the probiotics
group compared to placebo. 30-day mortality remained unaffected
between the two groups [10.7% probiotics vs 6.7% placebo].
Conclusions: In the present study, probiotic appeared able to reduce
the incidence of SSIs and total ICU stay in a subgroup of surgical,
multiple-trauma, ICU patients that are traditionally prone to septic
complications.
Disclosure of Interest: None declared.
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OR07
PROGNOSTIC FACTORS FOR CLINICAL AND NUTRITIONAL
OUTCOMES IN CRITICALLY ILL PATIENTS WITH ENTERAL FEEDING
INTOLERANCE: FOLLOW-ON ANALYSES FROM THE PROMOTE TRIAL
M.S. Harris1*, A.R. van Zanten2, T. Grau-Carmona3, D. Evans4,
A. Beishuizen5, M.-A. Garcia-Martinez6, A. Perez7, D.J. Klein8,
D.K. Heyland9 on behalf of Investigators of the PROMOTE Trial. 1Lyric
Pharmaceuticals, South San Francisco, United States, 2Intensive Care,
Gelderse Vallei Hospital, Ede, Netherlands, 3Intensive Care, Hospital
Universitario Doce de Octubre, Madrid, Spain, 4Intensive Care, Ohio State
University, Columbus, United States, 5Intensive Care, Medisch Spectrum
Twente, Enschede, Netherlands, 6Intensive Care, Hospital Universitario de
Torrevieja, Torrevieja, 7Pivotal SL, Madrid, Spain, 8Intensive Care,
University of Toronto, Toronto, 9Intensive Care, Queen’s University,
Kingston, Canada
* Corresponding author.
Rationale: The optimal definition of enteral feeding intolerance (EFI)
in clinical practice remains uncertain. In PROMOTE (Heyland, Intens
CareMed 2019), a randomized, controlled, 5-day studyof ulimorelin or
metoclopramide in critically ill patients with EFI (one or more
episodes of gastric residual volume (GRV) ≥500 mL), nearly 70% of
patients who received volume-based feeding achieved feeding
success; rates of vomiting and aspiration were low. The aim of the
current study was to explore more predictive factors of clinical
outcomes in EFI.
Methods: Pooled data from PROMOTE were analyzed to assess the
impact of various factors (BMI, weight, concomitant medications,
reason for ICU admission, vomiting, APACHE II, SOFA and NUTRIC
scores, days in ICU andmechanical ventilation, repeatedGRVepisodes)
on nutritional intake and outcomes. Associations were explored
between % daily protein prescription (%DPP) achieved, feeding
success (80% DPP) and safety outcomes in subgroup and regression
models. A safetyeventwas defined as death, severe adverse event (AE),
or serious AE with 3 days of study completion.
Results: In the final model, among pre-treatment factors, only
persistent EFI (2 or more episodes of GRV≥ 500) (p = 0.01) and use
of sedatives (p = 0.03) were significantly associated with lower %DPP.
Two ormore episodeswithin 24 h post-treatment also predicted lower
%DPP (61.8% vs. 87.3%, p < 0.0001), lower rates of feeding success
(42.1% vs. 74%, p < 0.0001) and higher rates of safety events (57.1% vs
36.8%, p = 0.03). No differences in ventilator-free days, ICU or hospital
length of stay (LOS), or 30-day mortality were observed.
Conclusions: Repetitive episodes of GRV ≥500 mL better predicted
worse nutrition delivery andmore safety events than a single episode,
but the frequency of episodeswas not associatedwith VFD, LOS, or 30-
day mortality.
Disclosure of Interest: M. S. Harris Shareholder of: Lyric
Pharmaceuticals, A. van Zanten Consultant for: Lyric Pharmaceuticals,
T. Grau-Carmona Consultant for: Lyric Pharmaceuticals, D. Evans
Consultant for: Lyric Pharmaceuticals, A. Beishuizen: None declared,
M.-A. Garcia-Martinez: None declared, A. Perez Other: Pivotal SL,
D. Klein Consultant for: Lyric Pharmaceuticals, D. Heyland Consultant
for: Lyric Pharmaceuticals.
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SURVIVAL ADVANTAGE BY HIGHER LEVELS OF MUSCLE MASS
COMPARED TO HIGHER BMI IN CRITICALLY ILL PATIENTS
P.J. Weijs1,2*. 1Nutrition and Dietetics, Amsterdam University of Applied
Sciences, 2Nutrition and Dietetics, Amsterdam University Medical
Centers, Amsterdam, Netherlands
* Corresponding author.
Rationale: A high BMI is associated with lower mortality, however a
low muscle mass (based on L3 CT-scan analysis) is associated with
highermortality (1). It is unclear how independently these risk factors
affect survival in critically ill.
Methods: 739 critically ill with L3 based CT-scan analysis of muscle
mass (muscle area) were included. Low muscle mass was categories
according to sex-specific prespecified cutoffs (Normal muscle n = 294
40%, Low muscle n = 445 60%). WHO classification of BMI categories
was used (UW= underweight n = 27 4%, NW= normal weight n = 385
52%, OW= overweight n = 253 34%, OB = obese n = 74 10%). Cox
regression analysis for 6 months mortality was used for muscle mass
(per 100 cm2) and BMI category, adjusted for APACHE II score and age
(sex was not a confounder). One-way anova and KM survival analysis
were applied.
Results:Mean age was 58 (SD 18) y, BMI was 25.3 (SD 4.4), APACHE II
score 23 (SD 8). The table shows that with increasing BMI category the
6 m mortality decreased, even in the low muscle mass subgroup.
Hazard ratios for muscle (HR 0.51, 95%CI 0.34–0.77, p = 0.001) and BMI
category (HR 0.78, 95%CI 0.65–0.95, p = 0.011) were independently
associated with 6 m mortality. KM analysis showed different survival
for 7 subgroups (as in table; p < 0.001) between muscle groups, but
less between BMI categories. Long stay obese patientswith lowmuscle
mass appear to have slight survival advantage. Muscle mass (cm2) was
105 (SD 27) for UW,138 (SD 39) for NW,152 (SD 42) for OW,150 (SD 41)
for OB; one-way anova (p < 0.001), post-hoc Bonferroni showed no
difference between OWand OB.
UW NW OW OB
NORMAL MUSCLE 20,1% 13,0% 22,9%
LOW MUSCLE 48,0% 41,0% 41,5% 28,2%
ALL 44,4% 33,8% 27,7% 25,7%
Conclusions: Survival improvedwith BMI category in critically ill, also
in patients with low muscle mass. This is partly explained by an
increase in muscle mass. Survival is more dependent on the level of
muscle mass than BMI category. Long stay obese patients with low
muscle mass appear to have a survival advantage over low muscle
mass patients in other BMI categories.
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ANALYSIS OF THE BODY COMPOSITION ON 3RD LUMBAR
VERTEBRA (L3)-TARGETED COMPUTED TOMOGRAPHY (CT)-SCAN
IN THE INTENSIVE CARE UNIT (ICU): PROGNOSTIC VALUE,
INTEROBSERVER REPRODUCIBILITY, AND PREVALENCE OF MUSCLE
MASS IMPAIRMENT
E. Jali1, A. Mulliez2, L. Lacaze1, E. Lascouts1, N. Rotovnik Kozjek3,
A.-M. Makhlouf4, I. Ceniceros Rozalen5, J.-C. Preiser6, Z. Krznaric7,
K. Kupczyk8, N. Cano9, C. Pichard4, R. Thibault1* on behalf of Phase
angle Project investigators. 1Nutrition Unit, Univ Rennes, CHU Rennes,
Rennes, 2DRCI, CHU Clermont-Ferrand, Clermont-Ferrand, France,
3Clinical Nutrition Unit, Institute of Oncology, Ljubljana, Slovenia,
4Nutrition Unit, HUG, Geneva, Switzerland, 5Department of Intensive
Care, Clinic USP Palmaplanas, Palma de Majorque, Spain, 6Department of
Intensive Care, Erasme Hospital, Brussels, Belgium, 7Department of
Internal Medicine, University Hospital Center, Zagreb, Croatia,
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8Department of Anesthesiology and Intensive Care, University Hospital
no 1 CM NCU, Bydgoszcz, Poland, 9CRNH, CHU Clermont-Ferrand,
Clermont-Ferrand, France
* Corresponding author.
Rationale: Low fat-free mass at admission to ICU, as measured by
phase angle (1) or psoas area index (2), predicts mortality at 28 days
(D28). Objectives: to evaluate if: i) the body composition: areas of total
muscle (main objective), psoas, subcutaneous (SAT), visceral (VAT),
intra-muscular (IMAT), intra-psoas (PAT) and total (TAT) adipose
tissues (secondary objectives), assessed on a L3-targeted CT scan,
predicted D28 mortality; ii) interobserver reproducibility; iii) preva-
lence of muscle mass impairment.
Methods: Ancillary study of the multicentric international PHASE
ANGLE PROJECT (n = 931) (1). Inclusion criteria: routine abdominal CT
scan within 9 days of admission. Body composition analysis using
ImageJ software (NIH, USA). Statistics: Area under the curve (AUC)
ROC. Multivariate logistic regression: variables associated with
mortality at D28. Analysis of 33 blind scanners. Impaired muscle
mass defined by: total muscle area/height (m)2 <38.9 (female) or
<55.4 cm2/m2 (male).
Results: 210 included patients: 55% males, 62 ± 17 years, APACHE II
20 ± 9, 50/50% medical/surgical patients. In females, high IMAT, VAT
and TAT indexeswere associatedwithD28mortality (p = 0.03, p = 0.02,
p = 0.02, respectively). In males, low total muscle area and psoas
indexes, total muscle and psoas areas were associated with D28
mortality (p = 0.01, p = 0.003, p = 0.003, p < 0.001, respectively). Total
muscle areawas predictive of mortality with better reliability in males
(AUC = 0.74) than in females (AUC = 0.61). Multivariate analysis: 1st
quartile of total muscle area (<96 (F) or <118 (H) cm2) (odds ratio = 2.5
[95% CI, 1.0–6.1], p = 0.04), age > 65 years (2.8 [1.1–7.3], p = 0.03), and
phase angle at admission (2.71 [1.1–6.6], p = 0.03) were associated
with D28 mortality. Inter-observer reproducibility was good with
visceral and total adipose tissues (correlation coefficient r = 0.99), total
muscle area (r = 0.72), and psoas area (r = 0.90). Prevalence of impaired
muscle mass: 57% (total); 35% (females); 74% (males).
Conclusions: The total muscle area expressed in cm2 is associated
with D28 mortality. There is good interobserver reproducibility of
body composition parametersmeasured by L3-targeted CT-scan.More
than half of the ICU patients had impaired muscle mass. This study
confirms the importance of lean mass measurement in assessing the
prognosis of the ICU patient.
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GUT MICROBIOTA DEPLETION AFFECTS METABOLIC AND
BEHAVIORAL RESPONSES DURING ACTIVITY-BASED ANOREXIA
P. Tirelle1*, J. Breton1, W. Bahlouli1, C. L’huillier1, E. Salameh1,
A. Amamou1, M. Jarbeau1, C. Guérin1, A. Goichon1, J.C. do Rego2,
P. Déchelotte1,3, D. Ribet1, M. Coëffier1,3. 1UNIROUEN, INSERM UMR
1073, 2UNIROUEN, Animal Behavior Platform SCAC, 3Nutrition
Department, Rouen University Hospital, Rouen, France
* Corresponding author.
Rationale: The role of the gut-brain axis in eating behavior and
anxiety-depressive disorders has gained increasing attention.
Although gut microbiota dysbiosis has been reported in anorectic
patients, its pathophysiological role remains poorly understood. Thus,
we aimed to characterize the potential role of gut microbiota by
evaluating the effects of its depletion in the Activity-Based Anorexia
(ABA) mouse model.
Methods:Male C57Bl/6 (n = 16/group) were submitted (ABA group) or
not (CT group) to the ABA protocol, which combines access to a
running wheel with a progressive limited food access. Gut microbiota
was previously depleted or not by antibiotics (ATB) gavages. Body
composition, anxiety-like behavior, plasmatic levels of leptin and
adiponectin, hypothalamic and hippocampal mRNA levels for neuro-
peptides, dopamine receptors (DRD) and inflammatory factors were
assessed. Data were compared by two-way ANOVA followed by
Bonferroni post-tests.
Results: Body weight loss was less pronounced in ABA+ATB
(10.0 ± 6.5%) compared to ABA (15.1 ± 6.0%, p < 0.01). An increased fat
mass and a decreased leanmass were observed in ABA+ATB compared
toABA (p < 0.001), whichwas linkedwith increased levels in plasmatic
adiponectin (p < 0.05). In contrast, plasmatic leptin levels were
decreased in both ABA and ABA + ATB mice (p < 0.05). ABA + ATB
mice showed decreased physical activity compared to ABA (p < 0.05).
During open field test, only ABA+ATB mice exhibited lower travelled
distance, increased immobility time and lower vertical activity,
suggesting increased anxiety. In the hypothalamus, CRH
(Corticotropin Releasing Hormone) mRNA upregulation observed in
ABAwas blunted in ABA+ATB (p < 0.05). Similarly, in the hippocampus,
DRD1, DRD2 and TNF-αmRNAwere increased in ABA compared to CT,
but not in ABA+ATB.
Conclusions: Gut microbiota depletion triggers alterations of meta-
bolic and behavioral responses in the ABA murine model of anorexia.
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THE IMPACT OF PRETRANSPLANT SARCOPENIA AND
PERIOPERATIVE REHABILITATION WITH NUTRITIONAL THERAPY
ON OUTCOMES AFTER LIVING DONOR LIVER TRANSPLANTATION: A
PROSPECTIVE STUDY
S. Iwamura1*, T. Kaido1, Y.Miyachi1, S. Yao1, H. Shirai1, N. Kamo1, S. Yagi1,
S. Uemoto1. 1Hepato-Biliary-Pancreatic and Transplant Surgery, Graduate
School of Medicine, Kyoto University, 54, Shogoin Kawaracho, Sakyo-ku,
Kyoto City, Japan
* Corresponding author.
Rationale: There has been no prospective study to examine the impact
of pretransplant sarcopenia nor the effect of perioperative rehabilita-
tion with nutritional therapy on outcomes after LT. Therefore, we
prospectively investigated the impact of pretransplant sarcopenia and
perioperative rehabilitation with nutritional therapy on outcomes
after adult living donor LT (LDLT).
Methods: This prospective study included 44 consecutive patients (22
males and 22 females) who underwent adult LDLT from November
2015 to June 2018 except acute liver failure. Median age was 55 (44–
61). Pretransplant sarcopenia was defined as follows: low skeletal
muscle mass index (SMI) (<40.31 cm2/m2 for men and <30.88 cm2/m2
for women) and decreasedmuscle strength (handgrip strength <26 kg
for men and <18 kg for women) or impaired physical performance
(gait speed <0.8 m/s). Firstly, patients were categorized into three
groups as follows: sarcopenia group (low SMI, low handgrip strength
and/or low gait speed) (n = 3), normal group (normal SMI, normal
handgrip strength and normal gait speed) (n = 28) and presarcopenia
group (the others) (n = 13). Secondly, patients were categorized into
two groups as follows, because the number of the sarcopenia group
was small: normal group (n = 28) and abnormal group (presarcopenia
group + sarcopenia group) (n = 16). Patient demographics, peritrans-
plant outcomes and posttransplant 1-year patient survival rate were
compared among the groups. All patients received perioperative
nutritional treatment and rehabilitation.
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Results: Experiment 1: Among the three groups, significant differ-
ences were seen in BMI (p = 0.036), MELD score (p = 0.039), graft-to-
weight ratio (GRWR) (p = 0.025), and SMI (p < 0.001). No significant
differencewas seen in the posttransplant complications. Postoperative
hospital stay was the longest in the sarcopenia group among the three
groups. Posttransplant patient survival rates were comparable among
the three groups. Experiment 2: Patients in the abnormal group had
significantly higher GRWR (p = 0.022), lower SMI (p = 0.005), higher
intramuscular adipose tissue content (p = 0.047) compared with the
normal group. Operative blood loss in the abnormal group was
significantly larger than the normal group (p = 0.028). No significant
difference was seen in the posttransplant complications and the
postoperative hospital stay between the two groups. The period from
LDLT to the first walk in the abnormal group was longer than the
normal group (p = 0.085).
Conclusions: Patients with pretransplant sarcopenia or presarcopenia
had larger operative blood loss and later recovery after LDLT than
normal group. However, posttransplant survival rates were compar-
able among the three groups probably due to our perioperative
rehabilitation and nutritional therapy.
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CHANGE OF GUT BARRIER MARKERS FOLLOWING THE
MEDITERRANEAN DIET IN THE LIFESTYLE INTERVENTION STUDY
IN WOMEN AT RISK FOR HEREDITARY BREAST CANCER (LIBRE)
B. Seethaler1*, M. Kogel1, J. Beutel1, M. Basrai1, A. Neyrinck2, J. Walter3,
M. Laville4, N.M. Delzenne2, M. Kiechle5, S.C. Bischoff1. 1Institute of
Nutritional Medicine, University of Hohenheim, Stuttgart, Germany,
2Metabolism and Nutrition Research Group, Louvain Drug Research
Institute, Université catholique de Louvain, Brussels, Belgium,
3Department of Agricultural, Food & Nutritional Science and
Department of Biological Sciences, University of Alberta, Edmonton,
Canada, 4Rhône-Alpes Research Center for Human Nutrition, Lyon,
France, 5Technical University Munich (TUM) and Comprehensive Cancer
Center Munich (CCCM), Munich, Germany
* Corresponding author.
Rationale: A number of small intervention studies suggested that the
Mediterranean diet (MedD) and physical activity can lower the risk for
breast cancer. LIBRE is the first large multicenter RCT to test the effect
of these lifestyle factors on the incidence of breast cancer inwomen at
risk because of BRCA mutations [1]. LIBRE also offers to unravel
underlying mechanisms such as the role of the intestinal barrier for
beneficial effects of such lifestyle interventions.
Methods:We examined the effect of lifestyle intervention on the gut
barrier markers albumin, calprotectin and zonulin, all measured in
feces, as well as lipopolysaccharide-binding protein (LBP) measured in
plasma. From the ongoing LIBRE trial we included all complete
datasets (259 women; mean age 44.4 ± 11 years). The participants
were randomized into an intervention group (IG) trained for MedD
and physical activity, and a usual care control group (CG). Adherence to
the MedD was assessed at baseline and after 3 months (V1) using the
validated Mediterranean Diet Adherence Screener (MEDAS).
Results: At baseline there was no difference between the groups
regarding the barrier markers. Albumin levels did neither alter during
intervention nor between groups. At V1 the CG showed higher levels of
calprotectin (p < 0.05) and lower levels of zonulin (p < 0.05) compared
to the IG. The level of LBP decreased in both groups (p < 0.05). The level
of zonulin correlated inversely with the MEDAS score (p < 0.001).
Conclusions: There were positive changes in the gut barrier markers
in the course of the study. Higher adherence to the MedD seems to
positively influence gut barrier function, which might be protective
against breast cancer outbreak.
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OCCURRENCE OF REFEEDING SYNDROME IN SARCOPENIC PATIENTS
SUBMITTED BY DIGESTIVE TRACT SURGERY IN HOSPITAL DO
SERVIDOR PÚBLICO DE ESTADUAL DE SÃO PAULO, BRAZIL
L.S. Figueredo1*, L.M. Nadal2, M.A. Souza1, P.P. Fernandes1, K.S. Teles1,
N.L. Barros1.1Nutrologia, 2CirurgiaGeral, Instituto deAssistênciaMédica ao
Servidor Público Estadual de São Paulo, São Paulo/Vila Clementino, Brazil
* Corresponding author.
Rationale: Sarcopenia can be a predictive factor for the occurrence of
refeeding syndrome (RS). Therefore, new methods of diagnostic
analysis of sarcopenia should be explored to prevent this syndrome.
Methods: A cross-sectional, retrospective study was carried out in the
second half of 2018 at Hospital do Servidor Público Estadual de São
Paulo (Brazil) in patients undergoing digestive surgery. The psoas
muscle area and its index (psoas muscle area by squared height) were
evaluated by computed tomography, for the diagnosis of sarcopenia
and review of charts for the analysis of the occurrence of RS.
Results: Fifty-two patients were evaluated, of which 13.4% presented
RS at some time during the surgical hospitalization, of which 57.1% had
psoa index equivalent to sarcopenia. Regarding the occurrence of RS in
the Sarcopenic group (SG), this represents 16% of the group, and the
incidence of RS in the non-sarcopenic group (NSG), is equivalent to
11.5%. It was not statistically significant the occurrence of SR in the SG
and NSG.
Conclusions: There is no way to state that sarcopenia is an isolated
factor for the occurrence of RS in the studied group, but it is possible to
infer that this syndrome has a range that goes beyond the nutritional
state. Thus, even groups of patients who do not present sarcopenia
may evolvewith RS. Further studies with larger samples are needed to
confirm these findings and their statistical significance, although the
SG has a non-statistical trend of higher RS incidence.
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EFFECTS OF FOOD AND GASTROINTESTINAL SECRETIONS ON
INTESTINAL INTEGRITY IN AN EXPERIMENTAL RAT MODEL
Ö. Cennet1*, A. Hajıyev2, C. Sökmensüer2, F. Akbıyık3, B. Şener4,
O. Abbasoğlu1. 1General Surgery, 2Pathology, 3Biochemistry,
4Microbiology, Hacettepe Univercity, Ankara, Turkey
* Corresponding author.
Rationale: Paracelluler intestinal permeability is mediated mainly by
tight junction (TJ) proteins. Deterioration of TJ proteins and morpho-
logical structure of intestinal epitheliummay result in translocation of
bacterial end-products. The aim of this study was to investigate effect
of biliopancreatic secretions and food on intestinal morphology and
microbial flora of rat intestine.
Methods: Thirty Sprague-Dawley male rats were randomly divided
into three groups. (10 per groups): Control, biliopancreatic (BP) and
jejunal by-pass (JP) groups. With these procedures biliopancreatic
juice deficient (bile(-)), food deficient (food(-)) and both of them
deficient (bile(-)/food(-)) jejunal segments and corresponding control
intestinal segments were obtained. Animals were sacrificed at the end
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of week 3. Lipopolysaccharides (LPS) and citrulline levels were studied
in venous blood samples. Jejunal segments were cultured quantita-
tively (log10(cfu/mg)). We observed the changes in the intestinal
morphology (villus/crypt ratio, intraepithelial lymphocytes) and
expression and distribution of tight junction proteins (occludin,
claudin-1, Zonula Occludens-3) by using immunohistochemistry.
Results: Villus height to crypt depth ratio was lower in the bile and
food deficient segment compared to other groups (p: 0.007).
Intraepithelial lymphocytes were significantly high in the bile and
food deficient segment (p: <0.001). Immunohistochemical staining
pattern of claudin-1 was weaker when there was no food (p: 0.035).
Occludin expression increased if the segment contained food (0.016).
Jejunal aeorobic bacterial count decreased in bile and food deficient
segment (log 10(CFU/mg):−1.32 ± 0.61) and increased in bile deficient
segment (log 10(CFU/mg):0.1 ± 1.08) when compared with control
group (log 10(CFU/mg):−0.3 ± 0.6)(p:0.043). There were no statistic-
ally significant difference in plasma lipopolysaccharides and citrulline
levels between groups.
Conclusions: In our study; the presence or absence of bile and
pancreatic secretions altered jejunum morphology, the number of
intraepithelial lymphocytes, and the expression of some TJ proteins
(occludin, claudin-1). These effects were more prominent in the
presence or absence of food. The microbiological environment also
affected by these changes. Our results implicate the importance of oral
food on the structure and integrity of the gastrointestinal tract
compared to gastrointestinal secretions.
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DOES THE LOW-CALORIE DIET AND PROBIOTIC SUPPLEMENTATION
INFLUENCED ON INTESTINAL BARRIER AND MICROBIOME IN
OVERWEIGHT AND OBESE SUBJECTS?
A. Janczy1*, Z. Kochan1, S. Małgorzewicz2. 1Department of Nutritional
Biochemistry, 2Department of Clinical Nutrition and Dietetics, Medical
University of Gdansk, Gdansk, Poland
* Corresponding author.
Rationale: The gut microbiota composition is an important factor of
maintaining intestinal barrier in overweight and obese subjects.
Zonulin affects the integrity of intercellular tight junction and can be an
indicator of the intestinal permeability. The aim of the study was to
find the relationships between low-calorie diet, probiotic supplemen-
tation, zonulin levels, and microbiome in faecal samples.
Methods: It was a randomized, double-blinded placebo controlled
trial. The study involved 56 overweight or obese volunteers, divided in
two groups: Placebo (n = 20) and Probiotic (n = 36). They were on low-
calorie diet (acc. to European Clinical Practice Guidelines) and were
supplemented with Sanprobi SF for 3 months. Gut microbiome was
tested using KyberKompact. Zonulin levels in faces were assessed
using ELISA method.
Results: Significantly higher zonulin levelswere found inpatientswho
lose more than 5.5 kg of weight in the Placebo group before the study
(P = 0.0426) and lower in Probiotic group, after diet (P = 0.0464). A
negative correlation in Probiotic group was found between zonulin
levels and the number of Bifidobacterium spp. (R =−0.47) and
Enterococcus spp. (R =−0.36) before the study and a negative
correlation was found between zonulin levels and E. coli (R =−0.49)
and Enterococcus spp. (R =−0.47) in the end. Significant negative
correlation between zonulin levels and bacteria performing protective
functions (R =−0.78) in Placebo group after diet was found.
Conclusions: Our findings indicate that diet therapy and probiotic
supplementation influenced the intestinal permeability. Correlation
between zonulin levels and bacteria from immunostimulatory and
protective groups suggests that the dysbiosis in gut microbiome is
probably associated with the intestinal permeability and that weight
lose can be helpful in intestinal barrier repair.
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IMPACT OF CHOLECYSTECTOMYON THE FECAL BILE ACIDS PROFILE
BEFORE AND AFTER ROUX EN-Y GASTRIC BYPASS
C.D.S. Cardinelli1, R.S. Torrinhas1, P. Sala2, N. Machado3, G. Ravacci2,
G. Canuto4, M. Tavares4, D. Waitzberg2*. 1Gastroenterology, University of
São Paulo – School of Medicine, 2Gastroenterology, University of São
Paulo, School of Medicine, 3Gastroenterology, University of São Paulo,
School of Medicine, 4Chemistry, University of São Paulo, São Paulo, Brazil
* Corresponding author.
Rationale: Changes in bile acids (BA) type and profile have been
considered as a potential effector of glucose homeostasis after bariatric
surgery. We here evaluated whether cholecystectomy, a common
procedure in bariatric patients, can impact the fecal BA profile before
and after Roux-en-Y gastric by-pass (RYGB).
Methods: Fecal samples were collected before surgery and 3 and 12
months after RYGB from diabetic obese women who underwent
cholecystectomy (COLE; n = 7) or not (NOCOLE; n = 13). Fecal BA profile
was accessed by liquid chromatography coupled to tandem mass
spectrometry in a targeted approach.
Results: COLE andNOCOLE patients exhibited different fecal BA profile
at preoperative period, whith higher levels of cholic, chenodeoxy-
cholic, glycochenodeoxycholic, and taurochenodeoxycholic acids in
COLE than in NOCOLE (Mann Whitney, p < 0.05). This BA profile was
sensitive to RYGB: after surgery at both 3 (Anova, p = 0.006) and 12
months (Anova, p = 0.047), deoxycholic acid decreased in NOCOLE and
increased in COLE, compared to the preoperative period.
Conclusions: Cholecystectomy affects fecal BA profile and its answer
to RYGB in diabetic obese women and should be considered as a
potential bias in studies assessing the influence of BA in regulating the
glycemic homeostasis after the procedure. Furthermore, the effect of
cholecystectomyon themetabolic response of RYGB should be studied.
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BARIATRIC SURGERY AMELIORATES THE METABOLIC PHENOTYPE
AND IMPROVES THE GUT MICROBIOTA IN PATIENTS WITH OBESITY
R. Gao1, X. Jiang1, H. Qin1*. 1Shanghai Tenth People’s Hospital, Shanghai,
China
* Corresponding author.
Rationale:Obesity is a commonmetabolic chronic disease, whichwas
associated with gut microbiota dysbiosis. Bariatric surgery is a
promising and effective method for weight loss. This study aims to
investigate the effect of bariatric surgery on clinical metabolic
parameters and gut microbiota alteration in morbidly obese patients.
Methods: Forty eight patients were enrolled and glucose and lipid
parameters were evaluated before and after surgery. Twelve patients
provided fresh stool sample before and after surgery, which was then
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applied for 16S rRNA sequencing and the data were analyzed to
decipher the gut microbiota architecture alteration.
Results: Themean age of the patients was 34.00 ± 10.62 years old. The
average BMI was 39.82 ± 6.20 and 29.55 ± 5.16 Kg/m2 before and after
surgery (average 7 months), respectively. Blood pressure, glucose and
lipid metabolic parameters and inflammatory markers were signifi-
cant improved after bariatric surgery (P < 0.01). The circulation
concentration of testosterone was also improved both in male and
female. The gut microbiota composition was improved significantly
before and after surgery (P = 0.004). The relative abundance of
Actinobacteria (0.33% vs.2.62%, P = 0.02) increased significantly after
the surgery. At the genus level, Escherichia-Shigella (21.87% vs. 2.49%,
P = 0.035) decreased while Streptococcus (1.28% vs.10.85%, P < 0.001)
and Collinsella (0.23% vs.2.07%, P = 0.02) increased significantly.
Microbial function alteration and network were also revealed due to
the bariatric surgery.
Conclusions: Bariatric surgerywas an effectivemethod to improve the
inordinate glucose and lipid metabolism, as well as the gut microbiota
in morbidly obese patients.
Disclosure of Interest: None declared.
OR18
THE CLINICAL EFFECT OF PREOPERATIVE LEVELOF 25-OH-VITAMIN
D3 ON THE LIVER TRANSPLANT RECIPIENTS
M. Park1*, H.-J. Lee2, S. Lee2, S.-Y. Yoon1, S.-K. Hong2. 1Dietetics and
Nutrition Services Team, ASAN Medical Center, 2Division of Acute Care
Surgery, Department of Surgery, University of Ulsan College of Medicine,
Asan Medical Center, Seoul, Republic of Korea
* Corresponding author.
Rationale: Vitamin D deficiency is common in patients of chronic liver
disease and has been associated with infection and mortality. The aim
of this study is to determine whether preoperative vitamin D levels
affect clinical outcomes after liver transplantation.
Methods: This was a single-center retrospective study. Between
August and October 2017, a total of 110 patients underwent liver
transplantation. The primary outcome was the relationship between
serum25-OH-vitamin D3 (25(OH)D3) level before liver transplantation
and length of stay (LOS) in the intensive care unit (ICU). Secondary
outcomes included the duration of normalization of inflammatory
marker, such as white blood cell count (WBC) & C-reactive protein
(CRP) after liver transplantation, new infection rates, rejection rates,
hospital LOS and mortality among 25(OH)D3 level.
Results: Among 110 liver transplant recipients, 45.5% of patients were
malnourished. The mean 25(OH)D3 level was 16.7 ± 12.1 ng/ml (range
2∼50) and 42 (38.2%) patients had low levels of <10 ng/ml. The mean
ICU LOS was 6.4 ± 14.9 days, and the mean hospital LOS was 35.0 ± 31.6
days. Based on the mean 25(OH)D3 level, ICU LOS (9.0 ± 18.3 vs
1.9 ± 1.5, p = 0.002) and hospital LOS (41.1 ± 37.8 vs 24.7 ± 11.5, p =
0.001) were significantly longer in the lower group. The incidence of
new infections tended to increase in the low 25(OH)D3 level group
(29.0% vs 12.2%, p = 0.072). The higher NRS2002 score (Odds ratio 3.69,
95% confidence interval 1.30− 10.45, p = 0.014) and low 25(OH)D3
levels (Odds ratio 0.74, 95% confidence interval 0.58–0.95, p = 0.018)
were statistically significant as a risk factor for the poor outcome group
who had been in the ICU more than one week.
Conclusions: The low 25(OH)D3 levels and malnutrition before liver
transplantation showed an increase in the length of stay in ICU and
hospital. Our study showed that low 25(OH)D3 levels were an
independent risk factor for poor outcome after liver transplantation.
It is necessary to prospectively analyze the effect of vitamin D
supplements on clinical outcomes in liver transplant recipients.
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STRIATAL ACTIVITY DECREASES FOLLOWING THE INTRAGASTRIC
INFUSION OF GLUCOSE AND LIPIDS IN LEAN HUMANS
K.A. Van Galen1*, K.W. ter Horst1, A.G. Schrantee2, S.E. la Fleur1,3,
J. Booij4, M.J. Serlie1. 1Endocrinology and Metabolism, 2Radiology,
3Clinical Chemistry, 4Nucleair Medicine, Amsterdam UMC, AMC,
Amsterdam, Netherlands
* Corresponding author.
Rationale: Striatal dopamine signaling is involved in reward and the
motivation to eat. Animal studies showed that nutritional signals that
arise following the ingestion of nutrients induce striatal dopamine
release. These post-ingestion nutritional signals may therefore play an
important role in the rewarding aspects of food consumption and the
regulation of feeding behavior. To study this in humans, we assessed
the taste- and preference-independent effects of glucose and lipids on
striatal activity in lean humans.
Methods: In 15 lean humans, we assessed the effects of direct
intragastric infusions of glucose 50% (250 ml, 500 kcal), Intralipid®
(250 ml, 500 kcal) and water (250 ml) on the BOLD signal of striatal
subregions (the nucleus accumbens, the caudate nucleus and the
putamen), using functional MRI.
Results: Relative to the infusion of water, intragastric glucose infusion
induced a significant decrease in BOLD signal in the nucleus
accumbens (p < 0.001), caudate nucleus (p = 0.049) and putamen
(p = 0.006). The intragastric Intralipid® infusion induced a significant
decrease in the nucleus accumbens (p = 0.025) and putamen (p =
0.025). There was no difference between the effects of glucose and
Intralipid® infusion on neuronal activity in these striatal regions.
Conclusions: These findings show that, in lean individuals, striatal
neuronal acitivity is reduced following intragastric infusion of
macronutrients in a taste- and preference independent manner.
These data suggest an important role for post-ingestion nutritional
signals in the regulation of hedonic eating behavior. We are currently
assessing these post-ingestion nutritional effects in obese individuals
before and after weight loss.
Disclosure of Interest: None declared.
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FOUR WEEKS INTAKE OF GALACTO-OLIGOSACCHARIDES DID NOT
AFFECT IMMUNE MARKERS IN HEALTHY ADULTS AND PREFRAIL
ELDERLY
E. Wilms1*, R. An2, A. Masclee1, H. Smidt2, E. Zoetendal2, D. Jonkers1.
1Division Gastroenterology-Hepatology, Department of Internal
Medicine, NUTRIM School of Nutrition and Translational Research in
Metabolism, Maastricht University Medical Center+, Maastricht,
2Laboratory of Microbiology, Wageningen University & Research,
Wageningen, Netherlands
* Corresponding author.
Rationale: Ageing is associated with a decline of physiological
function, including immunosenescence, contributing to frailty and
comorbidity. Prebiotics may improve immune function, e.g. by
bacterial production of short-chain fatty acids. Our aim was to
compare immune markers in healthy adults and prefrail elderly and
to study the impact of galacto-oligosaccharides (GOS) in both groups.
Methods: In this double-blind, randomized, placebo-controlled, cross-
over trial, 24 healthy adults (33.3% male, age 38.1 ± 7.8 yrs) and 20
prefrail elderly (Fried criteria; 55.0% male, age 74.3 ± 3.7 yrs) received
21.6 g/day GOS and placebo for 4 weeks. CRP by immunoturbidimetry,
and cytokine production after 24 h stimulation by 10 µg/ml LPS or PHA
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were assessed pre- and post-intervention. IL-1β, IL-6, IL-8, TNF-α, IL-
10, IL-12p70, IL-13, IFN-α and IFN-γ were measured using CBA and
FACS analyses. Gastrointestinal SymptomRating Scale and Bristol Stool
Scale were completed weekly to monitor tolerance of GOS. Healthy
adults and prefrail elderly were compared by independent-samples T-
tests, the effects of GOS by linear mixed model analyses.
Results: Stimulated cytokine levels and serum CRP did not differ
between age groups (all P≥ 0.255), nor between GOS and placebo
interventions (all P≥ 0.130). Mean change betweenpre- and post GOS-
intervention on stimulated cytokine levels ranged from −8.5 9.5% in
prefrail elderly and from −12.5 to 16.5% in adults. GI symptom scores
and stool characteristics did not differ between GOS and placebo
intervention in adults, nor in prefrail elderly (all P≥ 0.058).
Conclusions: Immune markers did not differ between prefrail elderly
and adults. Four weeks GOS intake did not affect immune markers in
prefrail elderly, nor in adults. GOS was tolerated well by both groups.
Analysis of microbiota composition is underway.
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EFFECTS OF N-CARBAMOYL-PUTRESCINE ON MUSCLE PROTEIN
METABOLISM IN MALNOURISHED OLD RATS
P. Jegatheesan1*, M. Lhuillier1, N. Akir1, N. El-Hafaia1, R. Ramassamy1,
M. Aboubacar1, S. Nakib1, N. Neveux2, C. Loï3, L. Cynober1,2,
J.-P. De Bandt1,2. 1EA4466 Prevention and Treatment of Resistance to
Muscle Anabolism, Faculty of Pharmacy, Paris Descartes University,
2Clinical Chemistry Department, Hôpital Cochin, AP-HP, Paris, 3Citrage,
Créteil, France
* Corresponding author.
Rationale: The prevalence of sarcopenia-related dependency
increases with the population of elderly people. The efficiency of
available treatments being limited, it becomes amajor health problem.
We showed in healthy young rats that N-carbamoyl-putrescine (NCP),
a decarboxylation derivative of citrulline metabolically close to
polyamines increases soleus (Sol) muscle protein content. The aim of
the present study was to evaluate the effects of NCP onmuscle protein
content in malnourished old rats and to investigate the underlying
signaling pathways involved in the balance between protein anabol-
ism and catabolism.
Methods:Malnutrition was induced in 18 month-old rats by a dietary
restriction at 50% of their spontaneous intakes for 6 weeks. The
animals were then randomized into four groups: 8 malnourished rats
(n = 7, MAL group) were sacrificed immediately while the animals of
the other groups were housed individually in metabolic cage and
received for 4 days their standard diet at 100% of their spontaneous
intake, alone (n = 7, REN group) or associated with NCP 1 (n = 7, NCP1
group) or 10 mg/kg/d (n = 7, NCP10 groups). We measured plasma and
muscle amino acids (AA), nitrogen balance, muscle protein catabolism
(3-methylhistidine (3MH)) and synthesis (MPS, measured by SunSet
method in EDL, Sol and tibialis (Tib)) and expression/activation of
proteins involved in anabolism (4EBP1, S6K) and catabolism (MuRF1)).
Statistics: ANOVA and Fisher’s PLSD.
Results: The gain and rate of weight gain during refeeding were
similar. Refeeding was associated with an increase in triglycerides
(p < 0.05) and, in NCP groups, in glycemia (p < 0.05). Whatever the
dose, NCP promoted muscle gain in Tib (p < 0.05 vs MAL) but not in
EDL or Sol and increased EDL protein content (ANOVA p = 0.07, NCP10
vs. DEN, p = 0.05) with no effect on other muscles. Phosphorylation of
4EBP1 increased in the REN (p < 0.05), NCP1 (p = 0.06) and NCP10
groups (p < 0.05) compared to the DEN group in the EDL and in REN vs
NCP1 (p = 0.07) in Tib. S6K1 increased in Tib (NCP vs REN, p = 0.007)
and EDL (+24%NCP vs REN andMAL, NS). However, the rate of MPS did
not differ. NCP decreased MuRF1 expression in Tib (NCP vs REN,
p < 0.05) but not in Sol and EDL. NCP did not alter plasma AA profile,
nitrogen balance, plasma Phe/Tyr ratio, urinary excretion of 3MH,
creatinine, and urea.
Conclusions: During refeeding, NCP supply may help to preserve lean
mass. NCP effects are muscle-type dependent and appeared to be
limited either by refeeding-associated insulin resistance or by the
availability of AA for MPS.
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SHORT TERM EFFECT OF OMEGA FATTY ACIDS ON INTESTINAL
SATIETY HORMONES AND c-FOS PROTEIN LEVELS IN
HYPOTHALAMUS
H. Hizli Guldemir1*, N. Büyükuslu1, Ç. Çakıcı2, P. Yiğit3, P. Dilsiz4,
E.M. Özdemir5. 1Department of Nutrition and Dietetics, 2Department of
Biochemistry, 3Department of Biostatistics and Medical Informatics,
4Remer, 5Meditam, Istanbul Medipol University, Istanbul, Turkey
* Corresponding author.
Rationale: A better understanding of the effect of dietary fats on food
intake and satiety metabolism has an important role in combating
obesity. In this study, we aimed to research the effects of omega fatty
acids on plasma glucose levels, responses of some intestinal hormones
related to satiety on short-term effects.
Methods: Sixty Sprague-Dawley female rats were used in the study.
The rats were randomly divided into 6 groups and the groups were
determined as baseline (BA), serum physiologic given group (SF),
linoleic acid (LA), α-linolenic acid (ALA), eicosapentaenoic acid (EPA)
and docosahexaenoic acid (DHA). Except for the BA, SF and fatty acids
were administered by oral gavage at a dose of 400 mg/kg and 1 mL of
blood was taken at the end of 15 min, 30 min, 60 min and 120 min. At
the end of the second hour, the rats were sacrificed by cardiac
perfusion and brain tissues were removed. Plasma glucose levels were
measured with a glucometer. Cholecystokinin, GLP-1 and peptide YY
hormones were analyzed by ELISA. Activation of c-Fos protein in the
hypothalamus was determined by immunohistochemical staining.
Data were evaluated with SPSS 18.0 program and interpreted at 5%
significance level.
Results: Cholecystokinin hormone levels increased in omega-3 groups
in the first hour and decreased in LA. Compared with the linoleic acid
group, the hormone levels of cholecystokinin, GLP-1 and peptide YYof
omega-3 fatty acids were found to be significantly higher at 60 min
and 120 min (p < 0.05). The highest level in cholecystokinin and GLP-1
hormones was determined in the ALA group and in the peptide YY in
the DHA group. When compared between groups, GLP-1 levels are
significantly higher in ALA group than in LA group only in 15 minutes.
No significant difference was found between the other groups in
30–120 min (p > 0.05).When the neuron activities demonstrated by c-
Fos expression in the hypothalamus at the end of two hours were
compared, it was seen that the highest activationwas in the EPA group.
Conclusions: Omega-3 fatty acids have been shown to be effective in
short-term satiety. Evidences show that fats stimulate secretion of the
gut peptides, which are reported to have satisfactory effects, but have a
limited effect on long-term energy intake.
Disclosure of Interest: None declared.
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INSULIN RESISTANCE AND IMPARIED LIVER GLYCOGEN SYNTHESIS
ARE RESPONSIBLE FOR GLYCOMETABOLIC DISORDER IN TOTAL
PARENTERAL NUTRITION
H. Sun1*, X. Wang1. 1Jinling Hospital Institute of General Surgery, Nanjing
University, School of Medicine, Nanjing, China
* Corresponding author.
Rationale: Hyper- and hypoglycemia are common during total
parenteral nutrition (TPN) support. Traditionally, glycometabolic
disorder in TPN is thought to be caused by direct intravenous infusion
of glucose, but there is a lack of study on the mechanism. We aimed to
explore the mechanism underlying TPN related glycometabolic
disorder.
Methods: 1) Patients with chronic intestinal failure (CIF) requiring
long-term parenteral nutrition (PN) from August 2013 to August 2018
were included in clinical research. We assessed insulin resistance by
using homeostaticmodel assessment for insulin resistance (HOMA-IR)
weekly. The correlation between HOMA-IR and PN proportion,
nosocomial complications, leanmass ratewas analyzed in CIF patients.
2) We detected insulin sensitivity, hepatic insulin signaling pathway
and liver glycogen deposition in TPN mouse model.
Results: In clinical research, 256 CIF patients were analyzed. The
average PN calorie proportionwas positively correlatedwith HOMA-IR
value. Moreover, higher HOMA-IR was associated with nosocomial
complications, including ICU transfer, liver injury, renal insufficiency,
infection, pneumonia and fever (all P < 0.05). HOMA-IR was the third
significant independent risk factor after BMI and gender for protein
mass rate, fat freemass rate and skeletalmusclemass rate (all P < 0.05).
Accordingly, in mice model, TPN induced systemic insulin resistance,
blocked insulin-derived glycogen synthesis pathway and decreased
glycogen deposition in liver compared to enteral feeding mice.
Conclusions: Insulin resistance and impaired liver glycogen depos-
ition may accelerate and exacerbate the occurrence of hyper- and
hypoglycemia, respectively. We added to the current knowledge about
the mechanism of PN-related hyper- and hypoglycemia and recom-
mended monitoring insulin resistance in CIF patients with long-term
PN dependence.
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EFFECT OF THE PRESENCE OF THE POLYMORPHISM OF BCAT2
RS11548193 ON PLASMA BRANCHED-CHAIN AMINO ACIDS
CONCENTRATION AFTER A DIETARY INTERVENTION IN SUBJECTS
WITH OBESITY AND INSULIN RESISTANCE
L.E. González-Salazar1,2*, E. Pichardo-Ontiveros1, A. Vigil-Martínez1,
O. Granados-Portillo1, M.D.R. Guizar-Heredia1, B. Palacios-González3,
L.G. Noriega1, A. Flores-López1, N. Torres1, C.G. Castelan-Licona4,
P.K. Heredia G.-Cantón1, G. Ordaz-Nava1, J.G. Reyes-Garcia2,
L. Arteaga-Sanchez1, A. Avila-Nava5, C. Zerrweck-López4, A.R. Tovar1,
M. Guevara-Cruz1. 1Fisiologia de la Nutrición, Instituto Nacional de
Ciencias Médicas y Nutrición Salvador Zubirán, 2Instituto Politécnico
Nacional. Escuela Superior de Medicina, 3Unidad de Vinculación
Científica, Instituto Nacional de Medicina Genómica, 4The Obesity
Clinic, Hospital General de Tlahuac, México, 5Hospital Regional de Alta
Especialidad de la Península de Yucatán., Merida, Mexico
* Corresponding author.
Rationale: Branched-chain amino acids (BCAAs) are referred as
markers of insulin resistance (IR) in subjects with obesity. In this
study, we assessed whether the presence of the single nucleotide
polymorphism (SNP) of the branched-chain aminotransferase 2
(BCAT2), that has been previously associated with a decrease in
BCAAs concentration, can modify the effect of a dietary intervention
(DI) on the plasma concentration of BCAAs in subject with obesity
and IR.
Methods: A before and after study was performed in adult subjects
with a BMI≥ 30 kg/m2, IR (HOMA-IR≥ 2.5) and no diagnosed chronic
diseases. They were given a DI based on calorie restriction and
nutritional education for a month. Anthropometric measurements,
body composition, blood pressure, resting energy expenditure (REE),
oral glucose tolerance test (OGTT), serumbiochemical parameters, and
plasma amino acid profile were evaluated, before and after DI. The
presence of SNP was by TaqMan® SNP Genotyping Assay. Statistical
analysis was performed by multivariate analysis to compare the effect
of both groups (with and without SNP).
Results: Sixty subjects with obesity (BMI 38.3 ± 6.01 Kg/m2) and IR
(HOMA-IR 6.13 ± 2.37) participated in the study. A weight loss of
3.22 ± 1.82 kg was observed with the DI. SNP frequency corresponded
to 20%. The DI decreased the area under curve of glucose and insulin.
Interestingly, the effect of DI on BCAAs, glutamine and methionine
concentration, as well as on fat mass, lean mass, systolic blood
pressure, LDL cholesterol, liver function tests, REE and area under the
curve during OGTT was modified by the presence of SNP on BCAT2.
Conclusions: The presence of the SNP of BCAT2 modifies the effect of
DI on BCAAs concentration in subjects with obesity and IR.
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DISTURBED BRANCHED-CHAIN AMINOACID METABOLISM IN COPD
WITH ABDOMINAL OBESITY IS MORE PRONOUNCED IN WOMEN
BUT NOT ASSOCIATED WITH MORE IMPAIRED FUNCTIONAL
PERFORMANCE
C.L. Cruthirds1*, N.E. Deutz1, R. Harrykissoon2, A. Zachria2,
M.P. Engelen1. 1Health and Kinesiology, Texas A&M University,
2Pulmonary and Critical Care, Scott and White Memorial Hospital,
College Station, United States
* Corresponding author.
Rationale: Abdominal obesity is widely accepted as the most
hazardous fat deposit in the body, with links to inflammation and
disturbed branched-chain amino acids (BCAA) metabolism, and is
becoming more prevalent in Chronic Obstructive Pulmonary Disease
(COPD). It remains unclear if abdominal obesity produces different
metabolic and functional phenotypes in COPD patients in a gender
specific manner.
Methods: 27 COPD (GOLD II-IV) and 27 control subjects, all
abdominally obese (AO) based on published cut offs for android/
gynoid ratio, were studied. Body composition (Fat mass (FM), Fat-free
mass (FFM) and visceral adipose tissue (VAT)) was measured by DEXA,
and mood and cognition by questionnaires and assessments (stroop
and trail making tests). Whole body rate of appearance (Ra) of leucine
(LEU) and plasma BCAA concentrationwere assessed by pulse IV tracer
infusion and LC-MS/MS. Statistics (SE; p < 0.05) by two-way ANOVA.
Results: AO-COPD patients were characterized by higher VAT
(1063 ± 76 vs 834 ± 50 g, p < 0.01) and FM/FFM ratio (0.67 ± 0.04 vs
0.58 ± 0.04, p < 0.05), lower cognitive performance (p < 0.05), and
higher depression and anxiety (p < 0.05) than AO-controls.
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Furthermore, cardiometabolic profile was impaired as reflected by
higher plasma hs-CRP (6.5 ± 1.6 vs 1.6 ± 0.3 mg/L, p < 0.01) and glucose
(5.97 ± 0.20 vs 5.57 ± 0.09 mmol/L, p = 0.07).Womenhad higher values
for FM/FFM (p < 0.001) than men due to higher FM (34.2 ± 2.1 vs.
28.8 ± 1.8 kg, p = 0.07) and lower lean mass (60.2 ± 1.4 vs 44.9 ± 1.7 kg,
p < 0.001) and daily protein intake (p < 0.05). BCAA metabolism was
more impaired in women (higher Ra LEU and lower plasma BCAA
concentration (p < 0.01)), despite comparable lung function and BMI.
Significant AO x gender interactionwas found for Ra LEU with highest
values in AO-COPD females (p < 0.05). Although women tended to
have less comorbidities (1.00 ± 0.20 vs 1.23 ± 0.38, p = 0.07), no gender
effect was observed for mood and cognitive function, CRP or plasma
glucose values.
Conclusions: BCAA metabolism is more disturbed in women with
COPD and concomitant abdominal obesity but is not linked to reduced
functional performance.
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OMEGA 3 FATTY ACID SUPPLEMENTATION ATTENUATES MUSCLE
DISUSE ATROPHY DURING TWO WEEKS OF UNILATERAL LEG
IMMOBILIZATION IN YOUNG WOMEN
C. Mcglory1*, P. Miotto2, S. Gorissen1, M. Kamal1, R. Bahniwal1,
A. Hector1, A. Chabowski3, G. Holloway2, S. Phillips1. 1Kinesiology,
McMaster University, Hamilton, 2HumanHealth and Nutritional Sciences,
University of Guelph, Guelph, Canada, 3Physiology, Medical University of
Bialystok, Bialystok, Poland
* Corresponding author.
Rationale: Omega-3 fatty acid supplementation enhances rates of
myofibrillar protein synthesis (MPS), muscle size, and ADP sensitivity
in otherwise healthy adults. Whether omega-3 fatty acid supplemen-
tation attenuates human muscle disuse-atrophy and the associated
decline in MPS, muscle size, and readouts of mitochondrial function
remains unknown.
Methods: Twenty women (BMI = 23.062.3 kg/m2, age = 22 6 3 yr)
underwent 2 wk of unilateral limb immobilization followed by 2 wk of
return to normal physical activity. Commencing 4 wk prior to
immobilization, participants consumed either 5 g/d of omega-3 fatty
acids or an isoenergetic quantity of sunflower oil as a control. Muscle
size and mass were measured pre-and post immobilization as well as
after 2 wk of recovery. Serial skeletal muscle biopsies were obtained
throughout the protocol to assess changes in integrated rates of MPS,
mitochondrial function as well as alterations in myogenic gene and
protein expression.
Results: Following immobilization, the decline in muscle volume was
greater in the control group compared to the omega-3 fatty acid group
(14 vs. 8%, P < 0.05) and was not different from pre immobilization at
recovery in the omega-3 fatty acid group; however, it was still lower in
the control group (P < 0.05). Muscle mass was reduced in the control
group only (P < 0.05). MPSwas higher in the omega-3 group compared
with the control group at all times (P < 0.05). In response to
immobilization, there was a significant reduction (∼20%, P < 0.05) in
ADP-stimulation mitochondrial respiration in the control group but
not the omega-3 group.
Conclusions: These data suggest that 4 wk of omega-3 fatty acid
supplementation protects against muscle disuse-atrophy during 2 wk
of unilateral leg immobilization in young women that could be
mediated by the preservation of mitochondrial function, and attenu-
ation of declines in rates of MPS.
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BARIATRIC SURGERY AFFECTS OBESITY-RELATED PROTEIN
REQUIREMENTS
C. Guillet1*, A. Masgrau1, A. Mishellany-Dutour1, A. Blot2, A. Caille2,
N. Lyon2, B. Pereira3, K. Slim4, M. Robert5, E. Disse6, N. Feugier6,
P. Leruyet7, C. Louvet8, M. Miolanne8, N. Farigon8, J. Goudable6,
M. Laville6, Y. Boirie8. 1Human Nutrition Unit, Medicine Faculty,
2Auvergne Human Nutrition Research Center, Clermont Auvergne
University, 3DRCI, Biostatistics Unit, 4Service de chirurgie digestive, CHU
Clermont-Ferrand, Clermont-Ferrand, 5Service de Chirurgie Digestive, CH
Edouard Herriot, Hospices Civils de Lyon, 6Service d’Endocrinologie
Diabétologie et Nutrition, CH Lyon Sud, Hospices Civils de Lyon, Lyon,
7Research and Development, Lactalis, Retiers, 8Service de Nutrition
Clinique, CHU Clermont-Ferrand, Clermont-Ferrand, France
* Corresponding author.
Rationale: Following bariatric surgery, protein deficiency intakes are
reported in morbidly obese patients, whereas post-bariatric protein
requirements are not specifically defined with validated method in
this population. The objective of the study was to assess average
protein requirement (APR) in obese subjects, before, 3 months and 12
months after bariatric surgery using the validated method of nitrogen
balance.
Methods: Prospective longitudinal study conducted in 21 morbidly
obese patients (BMI 43.9 ± 1.4 kg/m2) before (M0), 3 months (M3) and
12 months (M12) after sleeve gastrectomy or Roux-en-Y gastric by-
pass. An additional larger cross-sectional study was performed to
validate APR before surgery in non-operated matched obese patients
(n = 106). APR was evaluated at M0, M3, M12 by measuring 3 days
dietary intakes together with losses of nitrogen in urine and stools.
APR was defined as the mean value of protein intake required to
achieve balance nitrogen equilibrium.
Results: Before surgery, APR in morbidly obese patients was 0.76 [95%
CI, 0.66–0.92] g/kg Body Weight (BW)/d in the experimental group,
and 0.74 [0.70–0.80] g/kg BW/d in the validation group. APR was 0.62
[0.51–0.75] g/kg/d at M3 and 0.87 [0.75–0.98] g/kg/d at M12, with no
difference between surgical procedures. Spontaneous protein intakes
were respectively 0.80 ± 0.05, 0.43 ± 0.03 and 0.71 ± 0.04 g/kg BW/d
respectively at M0, M3 and M12.
Conclusions: This study demonstrated a temporal change in protein
requirement after bariatric surgery whatever the type of surgery.
Spontaneous protein intakes following bariatric surgery did not cover
protein requirements for most patients, suggesting that specific
dietary protein recommandations have to be adapted in obese patients
with bariatric surgery.
Disclosure of Interest: None declared.
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INDIVIDUAL NUTRITIONAL INTERVENTION DURING 4 WEEKS
FOR THE PREVENTION OF RE-ADMISSIONS AMONG GERIATRIC
PATIENTS – RCT
M.O. Cramon1,2*, I. Raben1,2, A.M. Beck3, J.R. Andersen1. 1Department of
Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen,
2Department ofMedicine, ZealandUniversity Hospital, Køge, 3Institute for
Nursing and Nutrition, Faculty of Health, University College Copenhagen,
Copenhagen, Denmark
* Corresponding author.
Rationale: Malnutrition is common in geriatric patients discharged
from hospital, resulting in risk of decreased muscle strength,
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functional capacity, quality of life and increased risk of re-/admission.
Primary objective: To investigate if an individualized nutritional
intervention in geriatric patients reduced re/-admission rate at 30
days. Secondary objectives: Re-/admission rate at 60 days, nutritional
status (weight, energy- and protein intake), functional status (ADL),
muscle strength (chair stand, handgrip strength) and quality of life.
Methods: 4 weeks RCT in Zealand University Hospital with 30/60 days
follow-up. Geriatric patients (65+ years) randomized to hospital
standard treatment (CG n = 19) or individualized nutritional interven-
tion (IG n = 21) consisting of dietary counselling and a nutrition plan at
discharge combined with 2 home visits. Statistical analysis: Non-
parametric statistical tests, ITT for re-/admission and PP for secondary
outcomes.
Results: 100% compliance to intervention. No significant differences
between IG and IC in re-/admission rate at 30 days (29% vs 11%) and 60
days (29% vs 25%). 93% in the IG achieved their required energy intake
compared to 47% in the CG (p = 0.014). No other differences between
IG and CG. Baseline to 30 days: In the IG an increased percentage
achieved ≥75% of their required energy- (53% vs. 93%, p = 0.035) and
protein intake (20% vs 73%, p = 0.009). Baseline to 60 days: In the IG
median ADL increased (79 vs. 82, p = 0.016) and in the CG handgrip
strength increased (19 vs. 22 kg, p = 0.049) and so did self-evaluated
quality of life (60 vs. 75 VAS, p = 0.032).
Conclusions: Four weeks individualized nutritional intervention at
discharge did not reduce re-/admission in geriatric patients 30/60 days
after discharge, despite an increased number of geriatric patients
achieved their required energy intake at 30 days.
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COMPARISON OF THE 2010 AND 2018 DIAGNOSTIC CRITERIA FOR
SARCOPENIA BY THE EUROPEAN WORKING GROUP ON
SARCOPENIA IN OLDER PEOPLE (EWGSOP) IN SWEDISH ELDERLY
O. Wallengren1*, I. Bosaeus1, K. Frändin2, E. Rothenberg2,3, I. Skoog2.
1Clinical Nutrition Unit, Sahlgrenska University Hospital, 2Department of
Psychiatry and Neurochemistry, University of Gothenburg, Gothenburg,
3Kristianstad University, Kristianstad, Sweden
* Corresponding author.
Rationale: The updated diagnostic criteria for sarcopenia (EWGSOP2)
focus less on performance. Therefore, it is of interest to compare the
sarcopenia prevalence between the 2010 (EWGSOP1) and 2018
(EWGSOP2) criteria.
Methods: Two birth cohorts, 70 and 85 years old (n = 887 and n = 156,
respectively) were assessed (BMI 26 ± 4, 16.5–46.2 kg/m2, 57%
women). Low grip strength (Martin Vigorimeter) and slow self-
selectedwalking speed (30/10 m.)were defined as below−2.5 SD from
a young reference population (T-score) (♂ 60, ♀ 69 kPa and ♂ 1.0, ♀
0.9 m/s, respectively). Low muscle mass was defined as appendicular
lean soft tissue index (DXA) T-score below −2 (♂ 7.0, ♀ 5.7 kg/m2). The
EWGSOP1 and EWGSOP2 were applied and compared with Chi2 and
McNemar tests.
Results: Prevalence of low grip strength was 11 and 77% in the 70 and
85 year olds (p < 0.001) and slow self-selected walking speed was
found in 3 and 58%, respectively (p < 0.001). Prevalence of low muscle
mass was 18 and 67% in the 70 and 85 year cohorts (p < 0.001).
Sarcopenia prevalence was higher in the 85 compared to 70 year olds,
both according to EWGSOP1 (60 and 4%) and EWGSOP2 (54 and 3%),
with no difference between sexes (ns). Comparing the EWGSOP1 and
2, there was a significant difference in sarcopenia classification
(p < 0.001), stratified by cohort and sex there was a difference only
in 85 year old women (7 out of 99 was discordant, p = 0.02).
Conclusions: This study shows a clear increase in prevalence of
sarcopenia between 70 and 85 years, irrespective of definition. Overall,
the differences between the EWGSOP1 and EWGSOP2 classifications
are small. However, there may be clinically important differences in
classification between the two criteria in populations with high
sarcopenia prevalence, particularly in women.
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THE GERIATRIC NUTRITIONAL RISK INDEX PREDICTS OVERALL
SURVIVAL IN GERIATRIC PATIENTS WITH METASTATIC LUNG
ADENOCARCINOMA
M. Tang1*, L. Li1, P. Zhang1, X. Wu1, H. Wang1. 1Medical Oncology, Beijing
Hospital, National Center of Gerontology, Beijing, China
* Corresponding author.
Rationale: Geriatric nutritional risk index (GNRI) is a simplified,
objective screening assessment for nutrition risk in geriatric patients.
However, the role of GNRI in predicting prognosis of geriatric patients
with metastatic lung adenocarcinoma (MLA) has not been investi-
gated. This study aimed to assess the prognostic value of the
pretreatment GNRI in geriatric patients with MLA.
Methods: The clinicopathological characteristics of 144 consecutive
geriatric patients withMLA between January 2011 andMay 2017 were
retrospectivelyanalyzed to calculateGNRI. The pretreatmentGNRIwas
calculated as follows: GNRI = 1.489 × pretreatment serum albumin
concentration (g/L) + 41.7 × pretreatment body weight (kg)/ideal body
weight (kg); ideal body weight (kg) = Height (cm)-100–[(Height
(cm)–150)/4](for men) or Height (cm)-100–[(Height (cm)–150)/2.5]
(for women); when pretreatment body weight exceeded ideal body
weight, pretreatment body weight/ideal body weight was set to 1. The
receiver operating characteristic (ROC) curve was used to determine
the best cutoff value of the GNRI for predicting overall survival (OS).
The Kaplan–Meier method was used to estimate survival curves.
Univariate and multivariate Cox regression were used to identify
variables associated with OS in the whole cohort, the non-sensitizing
epidermal growth factor receptor (EGFR)mutation subgroup (including
EGFR wildtype and non-sensitizing mutations), and the sensitizing
EGFR mutation subgroup.
Results: The best cutoff value of the GNRI was 97. The patients were
divided into the malnutrition risk group (MNRG) (GNRI≤ 97, N = 75)
and the normal nutrition group (NNG) (GNRI > 97, N = 69). Low GNRI
values were significantly associated with older age (p = 0.002), a high
Eastern Cooperative Oncology Group (ECOG) (p = 0.037), low body
mass index (BMI) (p = 0.003), low serum albumin concentrations
(p < 0.001), and a high neutrophil/lymphocyte ratio (p = 0.004). In
Kaplan-Meier analysis of OS, NNG had significantly longer OS
compared to the MNRG (1-year OS, 85.6%vs.54.7%, p < 0.001) in the
whole cohort. In non-sensitizing EGFRmutation subgroup (N = 84), the
normal nutrition patients had significantly longer OS compared to the
malnutrition risk patients (1-year OS, 77.5%vs.36.4%, p < 0.001). In
EGFR sensitizing mutation subgroup (N = 60), there was no significant
differences in OS between the NNG and MNRG patients (1-year OS,
96.6%vs.80.6%, P = 0.099). Low GNRI values (p = 0.019), liver metasta-
ses (p < 0.001), and EGFR mutation status (p < 0.001) were independ-
ent prognostic factors of OS. Furthermore, lowGNRI values (p = 0.025),
liver metastases (p < 0.001), and ECOG score (p = 0.008) were
independent prognostic factors of OS in the non-sensitizing EGFR
mutation subgroup, and sex (p = 0.007) was an independent prog-
nostic factor for OS in the sensitizing EGFR mutation subgroup.
Conclusions: This study firstly shows the importance of the
pretreatment GNRI in predicting OS in geriatric patients with MLA,
especially in patients not harboring sensitizing EGFR mutations.
Disclosure of Interest: None declared.
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LOSS OF SUBCUTANEOUS ADIPOSE TISSUE DURING PALLIATIVE
CHEMOTHERAPY PREDICTS REDUCED SURVIVAL IN PATIENTSWITH
INCURABLE COLORECTAL CANCER
E.S. Sullivan1*, L.E. Daly1, É.B. Ní Bhuachalla1, S.J. Cushen1, D.G. Power2,
A.M. Ryan1. 1School of Food & Nutritional Sciences, University College
Cork, 2Departments of Medical Oncology, Cork & Mercy University
Hospitals, Cork, Ireland
* Corresponding author.
Rationale: Obesity is an established risk factor for colorectal cancer
(CRC), however little is known about the impact on survival of changes
in body composition during chemotherapy.
Methods: A prospective study of adult CRC patients undergoing
chemotherapy between 2012 and 2016 was conducted. Baseline body
composition and longitudinal changes were examined using com-
puted tomography (CT) images at two timepoints (interval 7 months,
IQR: 5–9 months) using paired t-tests. Sarcopenia and low muscle
attenuation (MA) were defined using published cut-offs. Cox models
were used to estimate mortality hazard ratios, adjusted for known
prognostic covariates –age, sex, performance status & systemic
inflammation.
Results: In total, 268 patients were recruited (66% male, mean age 63
years) and 51% were undergoing chemotherapy with a palliative
intent. At baseline, 4% had BMI <20 kg/m2 & 58% had BMI≥ 25 kg/m2.
However, 38%, 34% & 43% had cachexia, sarcopenia & low MA,
respectively. Over 100 days, 68% were muscle stable (±1 kg), while
25% lost >1 kg and 7% gained >1 kg. Fat mass remained stable ±1 kg in
49%, while 28% lost >1 kg and 23% gained >1 kg. On multivariate
analysis, baseline BMI and subcutaneous fat (SAT) loss predicted
survival in patients treated with palliative intent. Normal BMI (20–
25 kg/m2) predicted reduced survival compared to overweight (25–
30 kg/m2) [HR:1.80 (95% CI:1.04–3.14), p = 0.037]. Loss of >6.4% SAT
over 100 days was predictive of poor survival versus gain/<6.4% loss,
independent of changes in muscle mass [HR:2.2 (95% CI:1.07–4.62),
p = 0.033].
Conclusions: Patients with CRC experience significant losses in
muscle and fat mass during chemotherapy. Loss of SAT mass during
palliative chemotherapy is prognostic of poor survival, independent of
changes inmuscle mass. Baseline BMI in the overweight range confers
a survival advantage. Nutritional strategies to prevent or attenuate
weight loss during chemotherapy are advisable especially in the
context of advanced CRC.
Disclosure of Interest: None declared.
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POSTOPERATIVE SKELETAL MUSCLE LOSS NEGATIVELY IMPACT
SURVIVAL OF COLORECTAL CANCER
G. Wu1, S. Tan1*, Y. Jiang1, Q. Xi1, Q. Meng1, Q. Zhuang1, Y. Han1, X. Sui1.
1Department of General Surgery/Shanghai Clinical Nutrition Research
Center, Zhongshan Hospital, Fudan University, Shanghai, China
* Corresponding author.
Rationale: Loss of skeletal muscle is common in patients with
surgically treated colorectal cancer and it may be associated with
poor survival, but previous studies including ours mainly focused on
the preoperative skeletal muscle loss. The aim of this study was
therefore to evaluate the prognostic impact of postoperative skeletal
muscle loss on survival in patients after surgery for colorectal cancer.
Methods: Three hundred and seventy-five consecutive patients who
underwent surgery for colorectal cancer were prospectively included.
The changes in skeletal muscle index were calculated to assess
postoperative skeletal muscle loss using computed tomography scan
before and after cancer surgery. The survival data was recorded, and
univariate and multivariate analyses were performed.
Results: The mean reduction in skeletal muscle index was more
significant in patients with recurrence than in those without
recurrence (P < 0.05). Patients with a >12% reduction in skeletal
muscle index showed poorer overall survival and disease-free survival
than those without a <12% reduction in skeletal muscle index
(P < 0.05). On multivariate analysis, a >12% postoperative reduction
in skeletal muscle index was identified as a risk factor of overall
survival and disease-free survival (P < 0.05).
Conclusions: Postoperative skeletal muscle loss negatively impacted
survival in patients with colorectal cancer. Identiﬁcation of post-
operative skeletal muscle loss in surgery for colorectal cancer and
targeted approaches may improve its negative survival.
Disclosure of Interest: None declared.
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PRESERVATION OF LEAN MASS UPON COMBINED LIFESTYLE
INTERVENTION IN OLDER ADULTS WITH OBESITY AND TYPE 2
DIABETES DURING 6-MONTHS FOLLOW-UP AFTER RCT (PROBE
STUDY)
R.G. Memelink1*, A. Bongers2, W.J. Pasman3, M.J. van Rijmenam1,
S. Wopereis3, G. Verlaan4, J. De Vogel-Van Den Bosch2, P.J.M. Weijs1,4.
1Faculty of Sports and Nutrition, Department of Nutrition and Dietetics,
Amsterdam University of Applied Sciences, Amsterdam, 2Nutricia
Advanced Medical Nutrition, Danone Nutricia Research, Utrecht,
3Netherlands Organisation for Applied Scientific Research (TNO), Zeist,
4Department of Nutrition and Dietetics, Amsterdam University Medical
Centers, VU University, Amsterdam, Netherlands
* Corresponding author.
Rationale:Weight loss is a keyelement in the treatment of obesity and
type 2 diabetes (T2D), but also a risk factor for lean mass (LM) loss in
older adults. We evaluated whether a whey protein drink enriched
with leucine and vitamin D preserved LM during 3-month lifestyle
intervention andwhethereffects sustained during 6months follow-up
after intervention (FU).
Methods: 123 older adults (66 ± 6 y) with obesity (BMI 34 ± 4 kg/m2)
and T2D participated in a 3-month lifestyle intervention with dietary
advice (−600 kcal/d) and resistance exercise (3×/wk). In this double-
blind RCT (PROBE) subjects were randomised to receive 10×/wk a test
(21 g protein) or isocaloric control (0 g protein) drink. LM, appendicu-
lar muscle mass (AMM), leg muscle mass (LMM), and fat mass (FM)
were assessed with DXA. Mixed linear model analysis was used with
baseline value in the outcome vector and adjustment for stratification
factors sex and SU-derivate use. Data represent EMM±SE (within
group) or 95% CI (between groups).
Results: 105 subjects completed intervention and 76 subjects
participated in FU. At 3 months, body weight (−2.2 ± 0.4 kg, p < 0.001,
for test; −2.9 ± 0.4 kg, p < 0.001, for control) and FM (−2.6 ± 0.4 kg,
p < 0.001, for test; −2.5 ± 0.4 kg, p < 0.001, for control) were reduced
without differences between groups. LM and AMM were increased in
test (+0.57 ± 0.27 kg, p = 0.03; +0.39 ± 0.13, p < 0.01) and unchanged in
control (−0.35 ± 0.26 kg, p = 0.18; +0.03 ± 0.12 kg, p = 0.80), with
significant difference between groups (+0.92 kg, 95%CI 0.19–1.65,
p = 0.015; +0.36 kg, 95%CI 0.01–0.71, p = 0.047). At FU (without test or
control drink), the difference in LM and AMM between groups had
disappeared while both groups still had significantly improved body
composition compared to baseline, as reflected by decreased FM and
increased or preserved LM and AMM (see table).
S16 Abstracts / Clinical Nutrition 38 (2019) S1–S32
FU compared
to baseline
Test
EMM±SE; p
Control
EMM±SE; p
Test vs. Control
EMM; 95%CI
FM −2.4 ± 0.4 kg; <0.001 −2.6 ± 0.4 kg; <0.001 +0.24; −0.94–1.41
LM +0.88 ± 0.32 kg; 0.007 +0.54 ± 0.32 kg; 0.09 +0.34; −0.56–1.24
AMM +0.46 ± 0.15 kg; 0.002 +0.31 ± 0.15 kg; 0.03 +0.15; −0.26–0.56
Conclusions: Use of a whey protein drink enriched with leucine and
vitamin D during a combined lifestyle intervention showed beneficial
effects on lean mass in older adults with obesity and type 2 diabetes.
Preservation of lean mass was sustained after 6 months follow-up,
without differences between treatment groups.
Disclosure of Interest: R. G. Memelink Grant/Research Support from:
Danone Nutricia Research provided financial support for the conduct
of the study, A. Bongers Other: Employee Danone Nutricia Research,
W. J. Pasman: None declared, M. J. van Rijmenam: None declared,
S. Wopereis: None declared, G. Verlaan: None declared, J. de Vogel-van
den Bosch Other: Employee Danone Nutricia Research, P. J. M. Weijs:
None declared.
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EFFECTS OF PROBIOTICS AND SYNBIOTIC ON LIPID PROFILES IN
ADULTS AT RISK OF TYPE 2 DIABETES: A DOUBLE-BLIND
RANDOMIZED CONTROLLED CLINICAL TRIAL
N. Kassaian1*, A. Feizi2, A. Aminorroaya2, M. Amini2, B. Ataei2,
S. Rostami2. 1Endocrine and Metabolism Research Center, 2Isfahan
University of Medical Sciences, Isfahan, Islamic Republic of Iran
* Corresponding author.
Rationale & Background: The use of probiotics and/or prebiotics as
the effective means of regulating gut microbiota may have a beneficial
effect on metabolic disorders.
Aims: This study was designed to assess the ability of probiotics and
synbiotic to modify lipid profiles in subjects with prediabetes who are
at risk of diabetes and cardiovascular diseases.
Methods: In a randomized double-blind placebo-controlled clinical
trial, 120 prediabetic adults aged 35–70 years from the first degree
family of type 2 diabetic patients were recruited and randomly equally
assigned to consume 6 g/d either probiotics or synbiotic or placebo
supplements for 6 months. Food record, physical activity, anthropo-
metric measures, and lipid profiles were assessed repeatedly at
baseline, and 3 and 6-month supplementation.
Results: Demographic and anthropometric measures, dietary intakes
and physical activity were comparable at the baseline between the
three groups and remained unchanged during the study. Probiotics
and synbiotic were significantly effective in reduction of serum
triglycerides after 6 months of intervention (SMD =−10.6 and −9.4
respectively). Compared with the placebo, synbiotic resulted in a
significant reduction in serum triglyceride levels (mean±SE: −9.4 ±
6.6 mg/dl vs. +13.2 ± 6.8 mg/dl, p = 0.02). Serum total-, LDL-, and HDL-
cholesterol were unaffected by probiotic or synbiotic.
Conclusions: The results of this study demonstrated that supplemen-
tation with probiotic and especially synbiotic could decrease the
concentration of triglyceride in prediabetic adults. This finding could
warrant future studies to determine the therapeutic and preventive
effects of these supplements in individuals at risk of diabetes and
cardiovascular diseases.
Disclosure of Interest: None declared.
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AUTOMATED BODY COMPOSITION ANALYSIS OF COMPUTED
TOMOGRAPHY SCANS USING NEURAL NETWORKS
M.T. Paris1*, D.K. Heyland2,3, P. Tandon4, H.F. Furberg5, T. Premji1,
M. Mourtzakis1. 1Kinesiology, University of Waterloo, Waterloo, 2Critical
Care, Kingston General Hospital, 3Clinical Evaluation Research Unit,
Queens University, Kingston, 4Gastroenterology, University of Alberta,
Edmonton, Canada, 5Epidemiology and Biostatistics, Memorial Sloan
Kettering Cancer Center, New York, United States
* Corresponding author.
Rationale: The quantity and quality of skeletal muscle and adipose
tissue is associated with clinical outcomes across several illnesses.
Computed tomography (CT) scans can be retrospectively analyzed for
body composition, but manual analysis is laborious and costly. An
open-source automated analysis framework would enable high-
throughput quantification of body composition for clinical research.
Methods: CT scans at the 3rd lumbar vertebrae from critically ill and
clearcell renal cell carcinomapatients, aswell as renal and liverdonors,
were retrospectively analyzed for body composition. These scans were
then used to train a neural network for the automated segmentation of
skeletal muscle, intermuscular adipose tissue (IMAT), visceral adipose
tissue (VAT), and subcutaneous adipose tissue (SAT). Network accuracy
was evaluated using the Dice similarity coefficient (DSC), which
quantifies the overlap between human and network-predicted
segmentation maps (0 = no overlap, 1 = perfect overlap). The network
wasdevelopedusing90%of the scans (80% trainingand10%validation),
with the remaining 10% used for testing network performance.
Results: Analysis included 708 patients (44% female; 300 critically ill,
155 clear cell renal cell carcinoma, and 253 donors) who were
(mean±standard deviation) 52.0 ± 16.6 years old and had a body mass
index of 28.3 ± 6.1 kg/m2. In the testing cohort (n = 72), DSC scores
indicated excellent agreement between human and network-
predicted segmentations for skeletal muscle (0.978 ± 0.032), IMAT
(0.923 ± 0.032), VAT (0.974 ± 0.043), and SAT (0.986 ± 0.033). Network
segmentation took approximately 25 seconds (n = 72) using modern
computing hardware versus up to 18 hours of human analysis (15
minutes/scan).
Conclusions: Our network displayed excellent segmentation accuracy
and speed across a wide range of body composition phenotypes and
clinical cohorts, whichmayaid larger-scale exploration of the complex
relationships between body composition and clinical outcomes.
Disclosure of Interest: None declared.
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THE ANALYSIS OF MYOSTEATOSIS FROM COMPUTED TOMOGRAPHY
IMAGES –WHICH SKELETAL MUSCLE GROUP?
K. Rollins1*, A. Gopinath2, A. Awwad3, I. Macdonald4, D.N. Lobo5.
1Gastrointestinal Surgery, Nottingham Digestive Diseases Centre,
2University of Nottingham Medical School, 3Sir Peter Mansfield Imaging
Centre (SPMIC), 4School of Life Sciences, 5Gastrointestinal Surgery,
University of Nottingham, Nottingham, United Kingdom
* Corresponding author.
Rationale: Attenuated skeletal muscle Hounsfield Unit (HU) radio-
density which can be measured on computed tomography (CT)
imaging at the third lumbar vertebral (L3) level, is associated with
increased systemic inflammation and adverse clinical outcomes in
patients with a number of types of cancer. The validated technique for
the measurement of skeletal muscle density uses the combined
density of all skeletal muscle groups at L3. However, there is increasing
interest in the use of psoas muscle HU density at the same level. This
technique has not been thoroughly investigated as a potential
surrogate for muscle density when compared with the gold standard.
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Methods: A total of 150 Portovenous phase CT images at the L3 level
were retrospectively identified in patients who had non-emergency
scans at a single institution and analysed by a single trained assessor
using SliceOmatic software v5.0 (TomoVision, Canada). Manual
segmentation based upon validated HU thresholds for skeletal
muscle density was performed of all skeletal muscle at the L3 level,
aswell as the psoas, paravertebral and anterior abdominalwall skeletal
muscle. The software then automatically calculates the mean HU
density of each muscle group and all were compared with the gold
standard which is whole L3 skeletal muscle density. The presence of
myosteatosis was calculated from a previously validated definition.
Results: The paravertebral muscle groupmean HU density was closest
to the validated measure of whole L3 slice skeletal muscle HU density
(34.5 ± 10.8 HU versus 32.3 ± 9.5 HU, p < 0.0001). The mean ± SD
density of the psoas muscle (42 ± 8.4 HU) was significantly higher
than that of the whole slice skeletal muscle (p < 0.0001). Anterior
abdominal wall skeletal muscle HU density was significantly lower
than that of the whiole L3 slice (27.1 ± 9.9 HU versus 32.3 ± 9.5 HU,
p < 0.0001). There was a significant difference in the prevalence of
myosteatosiswhen the densitymeasured from the psoas andwhole L3
skeletal muscle were compared (28.5% vs. 63.1%, p < 0.0001).
Conclusions: Psoas skeletalmuscleHUdensitywas significantly greater
than whole L3 slice density and is likely to underestimate the true
prevalence of myosteatosis, making this an unreliable sentinel for the
gold standard analysis of whole skeletal muscle density at L3.
Paravertebral HU radiodensity is likely to represent a better sentinel for
whole slice values, however given the simplicity of the already validated
techniquewewould advocate that this remains the gold standard.
Disclosure of Interest: None declared.
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PSOAS VERSUS WHOLE L3 SKELETAL MUSCLE CROSS-SECTIONAL
AREA: HOW DO THEY RELATE?
K. Rollins1*, A. Gopinath2, A. Awwad3, I. Macdonald4, D.N. Lobo5.
1Gastrointestinal Surgery, Nottingham Digestive Diseases Centre,
2University of Nottingham Medical School, 3Sir Peter Mansfield Imaging
Centre (SPMIC), 4School of Life Sciences, 5Gastrointestinal Surgery,
University of Nottingham, Nottingham, United Kingdom
* Corresponding author.
Rationale: Assessment of skeletal muscle cross-sectional area using
computed tomography (CT) has been used to evaluatre the presence of
sarcopenia in patients with a variety of different cancer types. Studies
have established a link between sarcopenia, and particularly sarcope-
nia in combination with being overweight or obese and negative
treatment outcomes and overall survival. The validated methodology
for this analysis utilises whole skeletal muscle cross-sectional area
(CSA) at the third lumbar vertebral level (L3). However, an increasing
body of evidence has focused upon CSA of the psoas muscle alone at
the L3 level as a surrogate for whole slice area, a technique which has
not been validated. The aim of this studywas to investigate the validity
of using the psoas muscle as a sentinel for calculated CSA at the L3
level.
Methods: A total of 150 CT scan images in portovenous phase at
L3 were retrospectively identified retrospectively in patients who
underwent non-emergency scans at Nottingham University Hospitals
NHS Trust and were analysed by a single trained assessor using
SliceOmatic software v5.0 (TomoVision, Canada). Cross-sectional area
(CSA) was calculated for psoas, paravertebral and anterior abdominal
wall skeletal muscle groups and compared with values for the whole
L3 skeletal muscle CSA, representing the gold standard.
Results:When compared with whole L3 skeletal muscle CSA, anterior
abdominal wall CSA had the strongest correlation (r = 0.9315, p <
0.0001) followed by paravertebral (r = 0.9508, p < 0.0001), with psoas
muscle CSA having the lowest correlation, although this remained
statistically significant (r = 0.7041, p < 0.0001). CSA was maximal for
paravertebral muscles and least for psoas muscles, with abdominal
wall muscles being inbetween.
Conclusions:Whole L3 skeletal muscle CSA correlated positively with
psoas muscle CSA, although the correlation was stronger for both
anterior abdominal wall and paravertebral muscle groups. Given the
simplicity of the gold standard formeasurement ofmuscle CSA and the
validated thresholds for the diagnosis of sarcopenia, we recommend
that whole L3 skeletalmuscle rather than individualmuscle CSA should
remain the gold standard for this method of body composition analysis.
Disclosure of Interest: None declared.
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NUTRITION-RELATED FACTORS ASSOCIATED WITH LENGTH OF
HOSPITAL STAY FOLLOWING NUTRITIONDAY
N. Kiss1*, I. Sulz2,3, P. Bauer2, J. Simon1, M. Mouhieddine3,4,
M. Hiesmayr3,4 on behalf of nutritionDay. 1Department of Health
Economics, Center for Public Health, 2Center for Medical Statistics,
Informatics, and Intelligent Systems, Medical University of Vienna,
3NutritionDay Worldwide, 4Division Cardiac-, Thoracic-, Vascular
Anaesthesia and Intensive Care, Medical University of Vienna, Vienna,
Austria
* Corresponding author.
Rationale: Length of stay (LOS) is often used to assess hospital
nutrition care outcomes. This study examines the continuum of
nutrition-related hospital care and its association with LOS in the
general hospitalized population, accounting for commonly known
determinants of LOS. The objective was to identify nutrition-related
determinants of LOS from nutritionDay in the general hospitalized
population.
Methods: The analysis was based on the 10 year cross-sectional multi-
national nutritionDay dataset (n = 155,524). Fine and Gray competing
risk model was used to examine LOS factors from nutritionDay to 30-
day follow-up for three outcomes: discharge, transfer, and in-hospital
mortality. Variables included known determinants of LOS and
nutrition care factors relevant during a patient’s hospital stay.
Results: The main analysis focuses on 104,540 patients of which
76,524 were discharged home within 30 days after nutrition Day. The
median LOS before nutritionDay was 5 (IQR 2–11) and after
nutritionDay 5 (IQR 2–10) for patients with the outcome discharged
home. Nutrition-related factors associated with longer LOS [sub-
distribution hazard (sH) <1] and shorter LOS (sH >1) fromnutritionDay
in these patients were: parenteral therapy (sH 0.88; 95%CI 0.84–0.94),
enteral therapy (0.72; 0.69–0.76), both enteral and parenteral therapy
(0.69; 0.62–0.76), ONS (0.87; 0.84–0.90), BMI [ei. underweight (0.89;
0.86–0.92) and overweight (1.04; 1.03–1.06) vs. normal], not having
eaten all of the main meal [ei. only having eaten a quarter of the meal
(0.89; 0.87–0.91) vs. eating the whole meal]. Other, non-nutrition
factors were also relevant: mobility, age, sex, being in a region with
lack of secondary care or cultural tendency towards hospital being the
main care institution, being over the age of 70, being in the geriatric
department or psychiatry department, infection, and brain, lung, bone,
blood, liver, or skin as affected organs. Factors associated with longer
and shorter LOS for patients who died in the hospital or were
transferred will also be presented.
Conclusions: This study confirms the role of known determinants of
LOS, but also found nutrition-related factors which have an associ-
ation: the type of nutrition therapy, the amount of food eaten on
nutritionDay, having lost weight, and not having a dietician.
Disclosure of Interest: None declared.
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GASTRIC BYPASS DECREASES POSTPRANDIAL EXOGENOUS AND
ENDOGENOUS TRIGLYCERIDE RESPONSES
K. Seyssel1*, P. Jegatheesan1, N. Stefanoni1, V. Rey1, P. Schneiter1,
V. Giusti2, L. Tappy1,3. 1Physiology, Lausanne University Faculty of Biology
andMedicine, 2Centre médico-chirurgical de l’obésité, Clinique La Source,
Lausanne, 3Cardio-metabolic Center, Hopital Intercantonal de la Broye,
Estavayer-le-lac, Switzerland
* Corresponding author.
Rationale: Obesity is associated with increased postprandial trigly-
ceride (TG) concentration, which is reverted to normal after gastric
bypass (GB). Decreased intestinal chylomicron secretion and/or
increased clearance from the blood may be involved.
Methods: Seven GB patients (GB: 2M/5F, mean BMI 30 ± 2 kg/m2), 6
overweight non operated subjects (OW: 1M/5F, mean BMI 31 ± 3 kg/
m2) and 8 normal weight healthy subjects ((NW: 4M/4F, mean BMI
22 ± 1 kg/m2)were studied over 7 hours after ingestion of a liquidmeal
containing 18 g fat labelled with 250 mg 13C6 palmitate, 22 g protein,
36 g fructose and 36 g glucose. Chylomicrons TG (chylo-TG) and 13C
palmitate (chylo-13Cpalm) concentrations were measured hourly in
Sf>400 lipoprotein sub-fractions. Exogenous-(chylo-TGexo) and
endogenous-(chylo-TGendo) TG in chylomicrons were calculated
from chylo-TG and meal 13C palmitate enrichments. Incremental
areas under the curve 0–420 min (iAUC) were compared with ANOVA
and Bonferronni’s correction.
Results:
Mean (SEM) GB OW NW
iAUC chylo-TG (mmol/l*7 h) 8.9 (11.5)* 96.5 (23.1)# 28.8 (11.8)
iAUC chylo-13Cpalm (umol/l*7 h) 133 (28)*§ 341 (37) 314 (78)
iAUC chylo-13C TGexo (mmol/l*7 h) 6.0(1.4)* 16.3(1.5) 14.7(3.7)
iAUC chylo-TGendo (mmol/l*7 h) 0.6(11.2)* 80.3(23.6)# 14.1(10.3)
Conclusions: Exogenous, 13C-labelled lipids kinetics was not different
in NWandOW. In OW, however, postprandial TGwere increased due to
unlabeled, endogenous TG, suggesting increased secretion of pre-
stored TG from enterocytes and/or hepatic secretion of low density
VLDLTG inOW. Compared toOW, GB patients had 1)markedly reduced
chylo-13C TG exo and 13Cpalm but no sign of severe fat malabsorption,
suggesting that their postprandial exogenous TG clearance was
increased; 2) lower postprandial endogenous TG responses indicating
that their secretion of pre-stored TG from enterocytes or from the liver
was normalized independently of body weight.
Disclosure of Interest:K. Seyssel: None declared, P. jegatheesan: None
declared, N. Stefanoni: None declared, V. Rey: None declared,
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GUT BACTERIAL CLPB GENE FUNCTION IS ASSOCIATED WITH
DIETARY FIBER INTAKE AND DECREASED BODY WEIGHT
M. Arnoriaga Rodríguez1,2,3,4*, G. Blasco5,6, A. Burokas7,8, C. Biarnes9,
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* Corresponding author.
Rationale: Growing evidence sustains the role of the microbiota-
gut-brain axis in the pathophysiology of obesity. The chaperone ClpB,
a gut bacterial protein, identified as a conformational antigen mimetic
of α-melanocyte-stimulating hormone, has been implicated in body-
weight regulation in mice studies. Here we investigated the associa-
tions of ClpBwith bodymass index, dietary pattern and gutmicrobiota
composition in humans.
Methods: Cross-sectional case-control study which included 113
subjects (64 with obesity), aged 27.2–66.6 years. Body composition
was assessed bydual energy x-rayabsorptiometry. Dietary patternwas
collected in a personal interview using a validated food-frequency
questionnaire. Metagenomic and metabolomic analyses were carried
out by shotgun sequencing and mass spectrometry-based techniques
(ultra-high pressure liquid chromatography (UHPLC)), respectively.
Mice experiment: 22 mice were orally gavaged with fecal material
from healthy volunteers previous treatment with a cocktail of
antibiotics. Mice were weighted every week during 6 weeks.
Statistical analysis: χ2, Student’s t-test and Mann-Whitney U test
were used to determine differences between groups, correlationswere
performed by Spearman analyses using MetaboAnalyst®.
Results: The bacterial ClpB was linked to a common gut microbiota
ecosystem andmetabolites (plasma hippuric acid), increased with the
energy-adjusted fiber intake (r = 0.294, FDR = 0.009), and decreased
with the body mass index (r =−0.283, FDR = 0.006). The relative
abundance of several phyla and families directly associated with ClpB
was decreased in subjects with obesity. Furthermore, mice which
received microbiota from donors with high ClpB expression gained
lessweight than thosewhich receivedmicrobiota fromdonorwith low
ClpB detection.
Conclusions: The present study suggest that the intake of dietary fiber
is associated with a bacterial ecosystem enriched in ClpB bacterial
function, that could lead to increased satiety and decreased fat mass in
long-term.
Disclosure of Interest: M. Arnoriaga Rodríguez Grant/Research
Support from: María Arnoriaga Rodríguez is funded by a predoctoral
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SERUM MAGNESIUM DEFICIENCIES IN PATIENTS WITH INTESTINAL
FAILURE: PERIOD PREVALENCE AND RISK FACTORS FOR
OCCURRENCE
G. Van Der Werf1*, C. Jonkers1, I. van Arum2, R. Lindeboom3,
M. Boermeester4, M. Serlie2. 1Departement of Nutrition & Dietetics,
2Department of Endocrinology and Metabolism, Amsterdam University
Medical Centers, AMC, 3Department of Clinical Epidemiology, Biostatistics
and Bioinformatics, Medical Faculty, Amsterdam University Medical
Centers, AMC and University of Amsterdam, 4Department of Surgery,
Amsterdam University Medical Centers, AMC, Amsterdam, Netherlands
* Corresponding author.
Rationale: Magnesium deficiency is a common finding in intestinal
failure (IF) patients. A clinical prediction rule to identify patients at risk
for low plasma magnesium may result in early treatment and
prevention of complications and hospital admissions.
Methods: We conducted a diagnostic retrospective cohort study.
Patients treated between September 2015 until February 2018 were
included. Primary outcome was the occurrence of a plasma magne-
sium level below 0.75 mmol/L, or being dependent on magnesium
supplementation for more than one month. The following predictors
were studied: presence of jejunostomy, jejuno-colonic anastomosis,
jejuno-ileo-colonic anastomosis and preservation of the ileocecal
junction, proton pump inhibitor (PPI) use, time after last abdominal
surgery, stoma or fistula output, administration of magnesium in
standard parenteral nutrition (PN) in mmol/week, daily mean of the
total volume fluids infused per week inml, daily mean of the total kcal
infused per week in kcal/kg body weight, use of alcohol and use of
diuretics. Reliable data on stoma and fistula output were missing in
27% and 42% respectively, alcohol intake and use of diuretics were also
excluded from analysis. Administration of magnesium in standard PN
and daily mean of the total volume fluids infused per week were
excluded because of high correlation. A multivariable logistic
regression analysis was used to estimate regression coefficients. For
updating the model the predictors age and short bowel pathophysi-
ology were examined by calculating net reclassification.
Results: 213 patients were analysed (41% men, median age 61(48–70)
years). 113(53%) patients were classified as hypomagnesaemia cases.
20% of all patients had a jejunostomy, 15% a jejuno-colonic anasto-
mosis (21% cases vs 7% non-cases, p.002) and 11(6%) patients had a
jejuno-ileo-colonic-anastomosis. 67% used a PPI. 133 patients used
intravenous administration of fluids and/or PN (76% in non-cases vs
50% in cases, p < 0.001). More cases had a short bowel (49% vs 23% in
non-cases p < 0.001). Four prespecified predictorswere included in the
model. The model discriminated with an AUC of 0.76 (95% CI;0.70–
0.83). Adding age and the presence of a short bowel resulted in a 0.53
re-classification (95% CI;0.27–0.79, p < 0.001).
Conclusions: Low plasma magnesium or the need for magnesium
supplementation was present in 53% of the IF patients. Only daily
mean of the total kcal infused per week in kcal/kg body weight, age
and the presence of a short bowel remained significant predictors for
hypomagnesaemia.
Disclosure of Interest: None declared.
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VALIDITY OF BIOIMPEDANCE EQUATIONS TO EVALUATE BODY
COMPOSITION IN PATIENTS WITH SEVERE ANOREXIA NERVOSA
M. Coëffier1,2*, M. Gaté1, A. Rimbert1,2, A. Petit1,2, V. Folope1,2,
S. Grigioni1,2, P. Déchelotte1,2, N. Achamrah1,2. 1Department of
Nutrition, CIC1404, Rouen University Hospital, 2INSERM unit 1073,
Rouen Normandy University, Rouen, France
* Corresponding author.
Rationale: Bioimpedancemetry (BIA) is a simple and rapid technique
tomeasure body composition. However, validityof BIA inpatientswith
low BMI remains controversial. Thus, we aimed to evaluate the validity
of several BIA equations in patients with severe anorexia nervosa (AN)
by using dual X ray absorptiometry (DXA) as reference.
Methods: Eight BIA equations (Deuremberg et al, Kyle et al, Sun et al,
Bedogni et al, Roubenoff et al, Scalfi-1 et al, Scalfi-2 et al, Kushner et al)
have been retrospectively applied on electrical data measured by BIA
in ANpatientswith BMI < 16 kg/m2. BIA (Bodystat Quadscan 4000) and
DXA (Lunar Prodigy Advance) were done the same day after an
overnight fasting. Results were compared with Bland-Altmanmethod,
Pearson correlation and Lin concordance test.
Results: Data from 115 AN patients (32.3 ± 14.5 y; 14.6 ± 1.2 kg.m−2)
were included. Fat mass and fat-free mass assessed by DXA were,
respectively, 4.2 ± 2.4 kg and 35.4 ± 3.8 kg. The best results were
obtained with Sun’s Equation: respectively for FM and FFM, Bland
Altman bias at 0.548 and 0.706 kg, Pearson correlation r at 0.86 and
0.86 and Lin concordance coefficient at 0.81 and 0.84. However, 95%
confidence intervals (CI 95%) were high (from −2,73 to 3,83 kg for FM;
from −4.55 to 3.13 kg for FFM). Other equations also showed high CI
95% (Table 1).
Conclusions: In severe AN patients with BMI < 16 kg/m2, all tested BIA
equations are not adapted to evaluate body composition at the
individual level.
Disclosure of Interest: None declared.
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CREATININE TO CYSTATIN C RATIO AND BIA FOR THE ASSESSEMENT
OF LOW LEAN BODY MASS IN CANCER PATIENT: COMPARAISON TO
L3 CT-SCAN
G. Ulmann1,2*, J. Kaï1, J.-P. Durand2,3, N. Neveux1,2, A. Jouinot3,
J.-P. De Bandt1,2, F. Goldwasser2,3, L. Cynober1,2. 1Clinical Chemistry,
Hôpital Cochin-HUPC-APHP, 2EA 4466, Faculty of Pharmacy, Paris
Descartes University, 3Medical Oncology, Hôpital Cochin-HUPC-APHP,
Paris, France
* Corresponding author.
Rationale: Lean body mass (LBM) is an important prognosis factor in
cancer patients. Although the L3 CT-scan is the most widely used
method for the assessment of their body composition, it has some
limitations particularly in terms of longitudinal follow-up. As the
accuracy of BIA is discussed by some, the plasma creatinine-to-cystatin
Table 1 (abstract: OR42).
(kg) Deuremberg Kyle Bedogni Roubenoff Scalfi-1 Scalfi-2 Kushner
CI 95% FFM −2.589/6.831 −2.447/5.534 −5.972/6.671 −2.069/5.918 −1.394/7.633 −6.594/5.547 −7.032/1.608
Bias FFM 2.121 1.543 0.349 1.925 3.119 −0.523 −2.712
CI 95% FM −6.511/1.954 −5.189/1.787 −6.596/5.582 −5.611/1.446 −7.141/0.587 −5.522/6.254 −1.367/6.476
Bias FM −2.278 −1.701 −0.507 −2.082 −3.277 0.366 2.555
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ratio (CCR) could be an attractive alternative: while both cystatin C and
creatinine are markers of renal function, cystatin C is independent of
muscle mass unlike creatinine. The aim of this study was to evaluate
the CCR and BIA for the measurement of muscle mass and their ability
to detect low muscularity in cancer patients compared to the CT-scan
use as a standard.
Methods: Patients with any kind of cancer who had a L3 CT-scan 6
weeks or less before inclusion were recruited during their one-day
multidisciplinaryevaluation. Skeletalmuscle area (SMA) on L3 CT-scan
was measured on 2 consecutive slices with ImageJ software for the
calculation of LBM (0.3 × SMA + 6.06).1 Skeletal muscle index (SMA/
height2, cm2/m2) thresholds for lowmuscularity on CT-scanwere 55.4
for men and 38.4 for women1. Multifrequency BIA was performed
following the manufacturer instructions with the patient fasted and
lying on his back. Fasting blood samples were used for creatinine and
cystatin C levels determination. Correlation tests and Bland-Altman
concordance analysis were carried out and ROC curve analysis were
done to assess the capacity of BIA and CCR to detect low muscularity.
Results: 30 men and 14 womenwere included. Among the 17 primary
localization of cancer, lung, bladder and prostate accounted for 54% of
cases. 84% of patients had metastatic disease. Both BIA and CCR were
well correlated with CT-scan (r = 0.763 and 0.648 respectively) but
concordance analysis revealed a +3 kg constant bias towards BIA
compared to CT-scan. Results for ROC curve analysis are presented in
the table:
Conclusions: This study shows that LBM assessed by the CCR or BIA is
well correlated with that determined by L3 CT-scan. The CCR capacity
to detect lowmuscularity is similar to that of BIA. For the first time, we
show that CCR, without further dedicated apparatus, can be used in
cancer patient as a very convenient biomarker of muscularity.
Reference
1. Mourtzakis et al. Appl Physiol Nutr Metab, 2008.
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THE SELF-EVALUATION OF FOOD INTAKE (SEFI®) AS A SCREENING
TEST FOR MALNUTRITION IN GENERAL PRACTICE: PROSPECTIVE
NON-INTERVENTIONAL MULTICENTER STUDY
G. Bouëtté1, M. Esvan2, K. Apel1, R. Thibault3*. 1Department of General
Medicine, Univ Rennes, 2DRCI, CHU RENNES, 3Nutrition Unit, Univ
Rennes, CHU Rennes, NuMeCan, INRA, INSERM, Rennes, France
* Corresponding author.
Rationale:Malnutrition prevalence is 35% at hospital, 30% in nursing
homes and 5% in outpatients. Its diagnosis is often delayed. SEFI® is a
quick and simple tool of assessment of food intake, and consists in a
visual analogue scale (0 to 10), or evaluation of consumed portions. It
allows the early identification ofmalnutrition riskwhen the sore is <7/
10 (1). In nursing homes, SEFI® detects malnutrition if the portions
consumed are≤50% of themain course (2). Main objective: to evaluate
the reliability of SEFI® for the detection of malnutrition in adults in
general practice. Secondary objectives: to assess the feasibility of SEFI®
and the risk factors for malnutrition.
Methods: Non-interventional prospective 3 month study in consecu-
tive patients seen in general practice in two French practices. Inclusion
criteria: adult consulting in general medicine to the principal
investigator, not opposed to participating in the study. Exclusion
criteria: pregnancy, diuretics, surgery for obesity, cognitive disorders,
impossibility toweigh or collect information. Primary endpoint: SEFI®
<7/10 compared to the presence of malnutrition defined by: weight
loss in 6 months ≥10% and/or 1 month ≥5% and/or body mass index
(BMI)≤18.5 or <21 if≥70 years of age. Secondary endpoint: proportion
of patients forwhoma SEFI® scorewas collected.Multivariate analysis:
threshold α = 0.20 during univariate analyzes, step by step logistic
regression.
Results: Among 747 patients meeting the inclusion criteria, 505
patients were included: mean age (±SD), 56 ± 19 years, 23% ≥70 years,
61% women, 31% living alone, 49% consulting for acute medical
problems and 37% for refilling prescriptions. 80 patients had SEFI® <7/
10 (15.8%) and 32 patients (6.3%)weremalnourished. The sensitivityof
the SEFI® <7 for the diagnosis of malnutrition was 34.4% (95%
confidence interval (CI) 17.9–50.8), the specificity of 85.4% (82.2–
88.6), the positive predictive value of 13.4% (7.7–19.2), and the
negative predictive value of 96.2% (93.7–97.7). SEFI® was feasible in
all patients. In multivariate analysis, the risk factors for malnutrition
were: age 45 to 70 years (odds ratio, 0.34 [95% CI, 0.13, 0.87]), female
gender (4.72 [1.63; 13.66]), cancer (5.66 [1.58, 20.29]), and chronic
alcoholism (8.60 [1.46, 50.81]), P < 0.05.
Conclusions: The high specificity and NPV, as well as the feasibility of
the test, makes it a reliable tool for screening for malnutrition in
general practice. A negative score could in particular rule out the
diagnosis of undernutrition by the general practitioner in situations
where recent weight loss or BMI are indeterminate.
References
1. Thibault et al. Clin Nutr 2009;28:134–140.
2. Mesbah et al. Clin Nutr 2018;37 (Suppl 1):S6.
Disclosure of Interest: G. Bouëtté: None declared, M. Esvan: None
declared, K. Apel: None declared, R. Thibault Other: Ronan Thibault is
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5-YEAR MORTALITY OF 384 SEVERELY MALNOURISHED ANOREXIA
NERVOSA (AN) ADULT PATIENTS AFTER ADMISSION IN A CLINICAL-
NUTRITION-UNIT
M. Guinhut1*, J.-C. Melchior1, M.A. Benadjaoud2, N. Godart3,
M. Hanachi1. 1Clinical Nutrition Unit, Raymond Poincaré Hospital,
Garches, 2Institut de Radioprotection et de Sûreté Nucléaire, Institut de
Radioprotection et de Sûreté Nucléaire, Fontenay-aux-Roses, 3Université
Versailles Saint Quentin en Yvelines, Fondation Santé des Étudiants de
France, Paris, France
* Corresponding author.
Rationale: AN is associated with the highest mortality rate of any
psychiatric disorder. The clinical-nutrition-unit in Raymond Poincaré
University hospital is specialized in the management of severe
undernutrition and its somatic complications in AN patients.
Intensive medical care is provided to stabilize the patients prior
Eating Disorders Programs in psychiatric unit. We aimed in this study
to estimate Standardized Mortality Ratio (SMR) and to investigate
potential predictive factors ofmortalityamong this specific population
Table (abstract: OR43).
Men Women
AUC Threshold Sensitivity Specificity AUC Threshold Sensitivity Specificity
BIA 0.715 19.0 kg/m2 75% 67% 0.646 15.8 kg/m2 38% 100%
CCR 0.750 95.0 µmol/g 96% 50% 0.604 65.3 µmol/g 37.5% 100%
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to improve detection and management of AN patients most at risk of
death.
Methods: All adult AN patients (DSM IV criteria), admitted for the first
time in the unit of Raymond Poincaré hospital between November
1997 and January 2014 were included. For each patient, socio-
demographic, anamnesis and clinical data were collected from the
patient’s medical record. Patient vital status was provided by the
French National Death Register. Univariate and multivariate Cox
regression analysis were performed to identify mortality predictors.
Results:Vital statuswas determined for 384 patients (21male and 363
female). At admission: mean age was 29.4 years (SD = 12), mean BMI
was 12.7 kg/m2 (SD = 2.2), mean AN duration was 9.8 years (SD = 9.3).
301 patients (78%) had previously been hospitalized in other hospitals
for AN before their first admission in Raymond Poincaré hospital. 44
deaths were reported over an average post in-patient treatment
follow-up of 5.7 years. Crude mortality rate was 11.5%. Standardized
mortality ratio was 15.92 [CI 95% (11.56–21.37)].
Predictors factors of mortality were: having at least one child, history
of discharge against medical advice, diuretic use, and cardiovascular
and/or endocrine comorbidities. During the hospitalization in the unit,
predictors of mortality were compulsory treatment, MICU transfer,
hematologic complications (anemia with hemoglobin level < 9 g/dl
and/ or thrombopenia), dysnatremia.
Conclusions: In a population of severely malnourished AN adult
patients, hospitalized inmedicine unit because of somatic severity, the
mortality is higher than the mortality of patients with a less severe
somatic status hospitalized in psychiatric unit. This study highlights
new somatic predictive factors of mortality. It brings new insights to
help in recognizing and managing patients at risk of death.
Disclosure of Interest: None declared.
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HANDGRIP STRENGTH AND DIETARY INTAKE IN AN ELDERLY
POPULATION: RESULTS FROM THE ISRAELI NATIONAL HEALTH
AND NUTRITION SURVEY, 2014–16
R. Doyev1, R. Axelrod2, T. Shimony2, L. Nitzan2, R. Goldsmith3,
L. Keinan-Boker2,4, T. Sinai1,2*. 1School of Nutritional Sciences, The
Hebrew University of Jerusalem, Rehovot, 2Israel Center for Disease
Control, Ministry of Health, Ramat Gan, 3Nutrition Division, Ministry of
Health, Jerusalem, 4School of Public Health, University of Haifa, Haifa,
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Rationale: Hand Grip Strength (HGS) is a means to assess muscle
strength, which is one of the most decisive indicators of health status
in older adults. This study evaluated the association between HGS and
dietary intake in free-living older adults using a large-scale nationally
representative dataset.
Methods: Data for this research was taken from the 2014–2016 Israeli
Health and Nutrition Survey carried out in the elderly population. The
cross-sectional survey included 1029 adults, ≥65 years of age (44%
male). Trained personnel performed interviews focusing on health and
nutrition status, performed anthropometric measurements and
examinations. HGS was measured in both hands three times using a
digital grip strength dynamometer and the highest result was
reported. Cut-off values for low HGS were 30 kg for men and 20 kg
for women. Dietary intake data were collected using the 24-h recall
method.
Results: Of the survey participants, 937 aged 74.3 ± 0.3 years
completed both the nutritional interview and HGS measurements. In
a univariate analysis, total energy, protein, carbohydrate and fat
intakeswere significantlyassociatedwith HGS. Increments of 100 kcal,
and 10 grams of each macronutrient a day, were associated with
decreased prevalence of lower HGS, with odds ratios (OR) of 0.90, 0.90,
0.95, and 0.84, respectively (p < 0.05 for all). In multivariate analysis
adjusted for age, sex, household income, ethnic group and morbidity,
the linear association between HGS and energy intake remained.
However, only the association of HGS with fat intake remained
significant (OR = 0.86, 95%CI: 0.74–0.99) in a similar model which also
controlled for energy intake and body mass index.
Conclusions: Better nutrient intake appears to be associatedwith HGS
in the Israeli elderly. However, further cohort or case-control studies
are necessary to determine the causal relationship of these factors.
Disclosure of Interest: None declared.
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MATCHED WEIGHT LOSS THROUGH INTERMITTENT OR
CONTINUOUS ENERGY RESTRICTION DOES NOT RESULT IN
COMPENSATORY ADAPTATIONS IN APPETITE: A PROOF OF
CONCEPT RCT
K. Beaulieu1*, N. Casanova2, P. Oustric1, C. Gibbons1, M. Hopkins2,
K. Varady3, J. Blundell1, G. Finlayson1. 1School of Psychology, 2School of
Food Science and Nutrition, University of Leeds, Leeds, United Kingdom,
3Department of Kinesiology and Nutrition, University of Illinois at
Chicago, Chicago, United States
* Corresponding author.
Rationale: Continuous energy restriction (CER) may be problematic
due to compensatory adaptations promoting poor weight loss (WL).
Intermittent energy restriction (IER) is an alternative WL strategy that
may mitigate some of these adaptations. The aim of this pilot study
was to compare the effects of CER and IERon appetitewhen the degree
of WL is matched.
Methods: Women with overweight/obesity were recruited for a
controlled feeding RCT to ≥5% WL (within 12 weeks) via CER (25%
daily energy restriction with all foods provided) or IER (alternating ad
libitum days and 75% energy restriction dayswith LighterLife total diet
replacement products provided). Probe days were conducted by
blinded investigators at baseline and post-WL. Following baseline
measurements, 46 participants (BMI = 29.2 ± 2.4 kg/m2; age = 34.7 ±
10.7 y) were allocated to IER (n = 24) and CER (n = 22). Participantsmet
with a dietitian each week to collect foods and track WL.
Results: 37 participants completed the intervention and 30 reached
≥5% WL [CER (n = 18): 6.3 ± 0.8% in 57 ± 16 days vs. IER (n = 12):
6.6 ± 1.1% in 67 ± 13 days; p = 0.43 and p = 0.10, respectively]. Body
composition changed to a similar extent between groups after
WL (p < 0.001), but no changes in RMR were observed. Hunger
after a fixed meal decreased similarly between groups after WL
(p < 0.05), but satiety quotient remained unchanged. Self-selected
meal size decreased in CER only (p = 0.03). Both interventions
improved dietary restraint, craving control, susceptibility to hunger
and binge eating (p < 0.001).
Conclusions: CER or IER to ≥5% WL similarly reduced hunger and
improved eating behaviours that promote overconsumption. This
suggests that clinically significant diet-induced WL via CER or IER did
not induce detrimental compensatory adaptations in appetite.
Trial registration: Clinicaltrials.gov as NCT03447600.
Funding: This work was funded by a Research Fellowship awarded to
Kristine Beaulieu by the European Society for Clinical Nutrition and
Metabolism (ESPEN). We are grateful for in-kind support from
LighterLife UK Ltd.
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METABOLOMIC STUDY SUGGEST PRESERVED KIDNEY FUNCTION AS
REQUIREMENT FOR TYPE 2 DIABETES REMISSION AFTER ROUX EN-
Y GASTRIC BYPASS
N. Mendonça Machado1, R.S. Torrinhas1, P. Sala1, C. de Siqueira
Cardinelli1, G. Ravacci1, M.A. Santo1, D. Linetzky Waitzberg1*.
1Gastroenterology, School of Medicine, University of São Paulo, São
Paulo, Brazil
* Corresponding author.
Rationale: About 60% obese of patients experience type 2 diabetes
(T2D) remission after Roux-en-Ygastric bypass (RYGB), but the precise
mechanisms are not yet fully understood. We developed a prospective
clinical study to investigate the molecular basis of this metabolic
outcome.
Methods: Plasma and urine samples were collected from 23 obese
women with T2D, before and 3 months after RYGB. Samples were
analyzed by liquid and gas chromatography-mass spectrometry.
Wilcoxon test and fold change were applied to display altered
metabolites.
Results: RYGB deeply changed plasma and urine metabolomic profile,
mainly altering bile acids, uremic toxins, dicarboxylic acids, and
different lipid classes (p < 0.05). By comparing patients according to
T2D remission, a discriminatory pattern of alterations was observed:
succinic, aloxanoic, glycochenodeoxycholic, taurochenodeoxycolic
and hidroxybutiric acids, along with transcrotobetaine and trimethy-
lamine n-oxide (TMAO)were discriminatory in T2D remission patients
(n = 13); while litocholic and uric acids, piperidone and urobilin were
distinct in T2D non-remission patients (n = 10). Particularly, increased
plasma TMAO was observed in all patients after RYGB, but this
metabolite was only equally increased in urine of T2D remission
patients, as an excretory route.
Conclusions: RYGB changed the metabolomic profile of obese
patients, suggesting shifts in flux and use of key metabolites that
could trigger T2D improvement. The metabolomic signature of T2D
remission patients partially rely on a preserved kidney function and its
local enzymes, while metabolites changed in T2D non-remission
patients were previously associated with kidney disorders. Thus, our
data raises the question of whether a kidney subclinical dysfunction
could interfere in the metabolic state and consequently impair RYGB
role on T2D remission.
Disclosure of Interest: None declared.
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IMPACT OF MEAL COMPOSITIONANDWALKING ON POSTPRANDIAL
ATTENTION, MOOD, AND SATIETY IN OLDER ADULTS
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H.-G. Predel6, B. Stoffel-Wagner7, R. Fimmers8, P. Stehle1, S. Egert1,9.
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Epidemiology, University Hospital Bonn, Bonn, 9Institute of Nutritional
Medicine, University of Hohenheim, Stuttgart, Germany
* Corresponding author.
Rationale: Research suggests that attention, mood, and satiety can be
influenced bymeal composition and postprandial activity. The present
studyexaminedwhether this hypothesis applies to personswith a risk
phenotype for cardiovascular/neurodegenerative diseases.
Methods: A randomized crossover trial was conducted in 26 subjects
with metabolic syndrome traits (age 70 ± 5 y; female: 8). Each subject
participated in four controlled interventions: isoenergetic (4300 kJ)
meals (Western diet high-fat meal, WD, and Mediterranean-type diet
meal, MD) followed by either 30 min moderate walking (4.6 ± 0.1 km/
h) or rest. Attention (Frankfurter Attention Inventory 2), mood
(Multidimensional Mood Questionnaire), and the feeling of hunger
and satiety (Visual Analogue Scales) were measured at fasting and 1.5,
3.0, and 4.5 h postprandially. Data were analyzed by linear mixed
models.
Results: In all four interventions attention increased continuously in
the postprandial period (time effect, P < 0.001). After the WD,
attentionwas lower after walking compared to resting (meal x activity
effect, P < 0.05). Postprandial mood was generally “good” with no
treatment effects (meal x activity effect, P = 0.819). Postprandial
hunger decreased reaching minimum at 1.5 h after meal (time effect,
P < 0.001) with no treatment effects. Postprandial satiety increased
reaching maximum at 1.5 h after meal (time effect, P < 0.001) and was
higher after MD compared to WD (meal effect, P < 0.001).
Conclusions: Meal composition had no relevant impact on attention
and mood in older subjects. After a typical WD resting instead of
walking seems to have a more beneficial effect on postprandial
attention. The MD leads to a strong and long lasting feeling of satiety,
possibly resulting in a reduced energy intake in the further course of
the day and, thus, a long-term effect on weight control.
Disclosure of Interest: None declared.
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BIOIMPEDANCE ANALYSIS TO PREDICT MAJOR MORBIDITY IN
PANCREATIC RESECTION. THE KEY ROLE OF PERIOPERATIVE
INTERSTITIAL FLUID SHIFT
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Monza, 2Unit of General and Pancreatic Surgery, University of Verona
Hospital Trust, Verona, 3Pancreatic Surgery, Humanitas Research Hopsital,
Milan, 4Unit of General and Pancreatic Surgery, University of Verona
Hospital Trust, Verona, 5Clinical Nutrition and Dietetics Unit, Fondazione
IRCCS Policlinico SanMatteo, Pavia, 6Dept. of Surgery, 7Pancreatic Surgery,
Humanitas University, Milan, Italy
* Corresponding author.
Rationale: Perioperative over and under fluid infusion are associated
with adverse outcome after pancreatic surgery (1). Aim of this study
was to evaluate whether perioperative anthropometric and hydration
parameters derived from bioimpedance vector analysis (BIVA) predicts
the occurrence of major morbidity.
Methods: We prospectively measured BIVA of patients undergoing
resection for pancreatic cancer on the day prior to surgery and on
postoperative day (POD) 1. Intraoperative fluid infusions were
provided according to goal-directed fluid therapy algorithms and
postoperative fluid balance calculated by the difference between in
and out estimates. Postoperative morbidity was scored by Clavien-
Dindo Classification (CDC). Nonrandom association was tested using
the Fisher exact test for categorical variables and the Mann-Whitney
U test for continuous data. The Hotelling T2 test was used for
multivariate hypothesis testing. Correlations between continuous
variables were assessed with the Spearman σ test
Results: 249 patients were analyzed. 42 patients (16.5%) had a major
morbidity (CDC≥ 3). The amount of preoperative extracellular water
(ECW) was significantly higher in patients who experienced CDC≥ 3
[19.4 L (17.5–22.0) vs 18.2 L (15.6–20.6) in uncomplicated; p = 0.009].
Also the hydration status on POD1 was significantly higher in patients
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who experienced major complications [23.9 L (20.6–22.5) vs 19.7 L
(17.3–23.1), p = 0.020]. No correlation between ECW and the fluid
balance on POD1 was detected (p = 0.215). Similar results were
obtained for hydration status. Age (p = 0.035), female gender (p <
0.001), high BMI (p < 0.001) and malnutrition (p = 0.037) were
independent preoperative predictors of ECW retention.
Conclusions: Excessive extracellular fluid retention significantly
predicted major morbidity. Fluid balance is inaccurate in estimating
hydration status as it disregarded the fluid shift into the interstitial
space. Specific preoperative characteristics of the patient can predict
the risk of interstitial fluid retention.
Reference
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ASSESSMENT OF NUTRITIONAL STATUS AND NUTRITIONAL RISK IN
HOSPITALIZED TURKISH CHILDREN
Z. Caferoglu1*, D. Gunes2, E. Celik3. 1Department of Nutrition and
Dietetics, Erciyes University Faculty of Health Sciences, Kayseri, 2Nutrition
and Diet Unit, 3Department of General Pediatrics, Adnan Menderes
University Research and Application Hospital, Aydin, Turkey
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Rationale: Although all hospitalized patients need to be screened for
malnutrition risk, no universal nutritional risk screening tool have yet
existed for paediatric patients. This study aimed to define the
nutritional state of children admitted to a tertiary paediatric hospital
and to evaluate nutritional risk score tools in these children.
Methods: We performed a cross-sectional study comparing three
published malnutrition risk screening tools (STRONGkids, PYMS and
STAMP), applying them to children admitted to a paediatric ward for at
least 24 hours. The total scores were calculated for each child, and
children were then classified into high, medium and low-risk groups,
as per published cut-offs. Weight and height or recumbent length
were measured and recorded for all inpatient children within the first
24 h of admission. BMIwas calculated and z-scoreswere derived for all
measurements. Malnutrition was defined according to the WHO
guidelines plotted on the national growth charts with <−3 SD of
weight-for-height (WFH) or height-for-age (HFA) (representing severe
malnutrition) and <−2 SD of WFH or HFA (representing moderate
malnutrition) as the cut-off point. When WFH z-score was not
available, BMI z-score was used. The relationships between anthropo-
metric data and nutritional risk screening tool results was assessed
by Pearson correlation.
Results: Of the 276 eligible children, aged 1 month to 17 years (mean
age 5.9 years), 269 (44.2% girls and 55.8% boys) participated. The
prevalence ofmoderate and severemalnutrition in the inpatientswere
11.9% and 14.1%, respectively. The moderately and severely malnour-
ished patients were predominantly aged <5 years (65.6% and 71.1%
respectively). The STRONGkids, PYMS and STAMP tools identified 77.1%,
86.7% and 80% of the moderately and severely malnourished patients
in the medium- and high-risk groups. The PYMS tool classified the
most (36.3%) and STRONGkids the least (8.2%) children as having a high
risk for malnutrition. The PYMS tool correlated more strongly with
anthropometric measurements (r = 0.366) than the STAMP (r = 0.337)
and STRONGkids (r = 0.140) tools (p < 0.05).
Conclusions: PYMSwas themost accurate screening tool for detecting
malnutrition and may be useful as the screening method in our
hospital. Routine screening for the risk of malnutrition is important in
detecting at-risk inpatient children who would otherwise be left
without dietary intervention.
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FOOD HABITS AND DIETARY INTAKE IN ITALIAN CHILDREN WITH
SPINAL MUSCULAR ATROPHY TYPE 1 AND 2
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Nutrition Center, Auslromagna, Cesena, 2International Center for the
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3SAPRE, Parents Hearly Habilitation Service. Fondazione IRCSS Cà Granda,
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Rationale: Spinal Muscular Atrophy (SMA) is an autosomal recessive
neurodegenerative disease characterized by degeneration of spinal
cord motor neurons. SMA patients suffer from swallowing and
gastrointestinal problems that could reduce energy and nutrients
intake. This study aimed to compare the dietary intake of Italian
children affected by SMA type 1 (SMAI) and 2 (SMAII) with national
recommendation.
Methods: 188 SMAI (94M, 63 ± 40 months) and 177 SMAII patients
(88M, 51 ± 37 months) were enrolled. 3-days food dietary records was
used to investigate feeding behavior and type of food used. Dietary
records were analyzed using WinFood version 3.0. Italian recom-
mended daily allowances of energy and nutrients (LARN, 2014) were
used as reference. Nutrients intakes are expressed as mean and
standard deviation (SD) of adequacy indexes calculated.
Results: 60.1% of SMAI children was fed per os, 36.2% via gastrostomy
and 3.7% used nasogastric tube. 100% of SMAII was fed per os. SMAI
consume 85.7 ± 27.5 kcal/kg bodyweight (BW), SMAII 65.3 ± 24.2 kcal/
kg BW. Carbohydrates were 70% of recommendation. Protein were
2.7 ± 1.1 g/kg BW in SMAI and 2.6 ± 1.0 g/kg BW in SMAII. Fibers were
68% of recommendation. Fat and sugar intakes agreed with recom-
mendations. Concerning micronutrients, SMAI and SMAII introduced,
respectively, 72.8 ± 57.5% and 54.6 ± 44.5% of vitC; 26 ± 18.5% and
25.5 ± 15.1% of vitB9, 39.9 ± 50.9% and 14.4 ± 14.7% of vitD, 46.8 ± 31.4%
and 39.4 ± 21% of vitE, 64.6 ± 29.2% and 54.4 ± 23.7% of calcium,
87.5 ± 42.2% and 44.9 ± 21.5% of iron, and 23 ± 16.3% and 30.8 ± 13.4%
of magnesium. All micronutrients intake resulted statistically different
from recommendation (p < 0.05).
Conclusions: Both SMAI and SMAII children has an adequate daily, but
consume more proteins than recommendations, and micronutrients’
intake results 50% lower than recommendations. Therefore, specific
dietary reference intakes for SMA children are needed to enhance
nutritional management.
Disclosure of Interest: None declared.
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NEIGHBORHOOD ENVIRONMENT MEDIATES THE RELATIONSHIP
BETWEEN SOCIOECONOMIC STATUS AND FAT MASS IN CHILDREN
AND ADOLESCENTS
I. Gätjens1*, M. Hasler2, J. Richter1, A. Bosy-Westphal1, M.J. Müller1,
S. Plachta-Danielzik3. 1Human Nutrition, Human Nutrition and Food
Science, Christian-Albrechts University Kiel, 2Applied Statistic,
Agricultural and Food Economics Faculty, Christian-Albrechts University
Kiel, 3Komeptenznetz Darmerkrankungen e.V., Kiel, Germany
* Corresponding author.
Rationale: To investigate the possible mediating effects of neighbor-
hood environment on the inverse association between socioeconomic
status (SES) and percentage fat mass (FM%) in children and
adolescents.
Methods: Study population: 506 boys and 539 girls aged 9–15 y from
the Kiel Obesity Prevention Study (KOPS). FM was measured by
bioelectrical impedance analysis. Socioeconomic status (parental
income/education) was obtained by validated questionnaires.
Statistical data of built and social environment (e.g. traffic density,
parks and public playgrounds, food outlets, percentage of foreigners,
density of welfare) were reported by local authorities. Product-of-
coefficients method was conducted to examine mediator effects
(indirect effects) on the relationship between SES and FM% > standard
deviation score (SDS) (c = total effects/c0 = direct effects) and their ratio
to total effects, adjusted for age, sex and nationality.
Results: Income (c1 =−0.21, p < 0.001/c01 =−0.13, p < 0.01) and educa-
tion (c2 =−0.28, p < 0.001/c02 =−0.20, p < 0.01) were inversely related
to FM%>SDS. The relationship between income and FM%>SDS was
partially mediated by density of welfare (54%), playground distance to
residential address (2%) and traffic density (−15%, inverse effect)
resulting in a total mediating effect of 41%. The relationship between
education and FM%>SDS was partially mediated by density of welfare
(32%) and traffic density (−5%, inverse effect) resulting in a total
mediating effect of 27%.
Conclusions: There are significant mediator effects of neighborhood
environment on the relationship between SES and fat mass. Thus,
successful obesity prevention strategies should address living condi-
tions of built and social environment.
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THEREVE STUDY, PRELIMINARY RESULTS. AMONOCENTRIC SINGLE-
ARM STUDY TO CHARACTERIZE THE LONG-TERM SAFETY AND
EFFICACY OF GLP-2 ANALOG (TEDUGLUTIDE) IN THE
MANAGEMENT OF SHORT BOWEL SYNDROME IN PEDIATRIC
PATIENTS ON HOME-PARENTERAL NUTRITION
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Rationale: GLP2-analog treatment has been demonstrated to be
efficient in adult and children with short bowel syndrome (SBS). This
study was designed to evaluate the efficacy and the safety of
Teduglutide during one year in children with long-term intestinal
failure due to SBS.
Methods: Children with SBS followed in our center with more than
two years of home parenteral nutrition (HPN), small bowel length <
80 cm and stable on long-term PN (no decrease of PN in the past
6 months) were consecutively included in the study. At baseline
they underwent a 4 days hospitalisation to perform a stool balance
analysis with the duplicate meal technique, blood tests, abdominal
ultra-sound, densitometry, coloscopy if age >12 years old and to
initiate the treatment. Teduglutide was administered sub-cutaneously
at the dose of 0.05 mg/kg/day. Visits were every 2 weeks for 8 weeks,
then every 4 weeks, then every 12 weeks fromweek 12 until week 48.
At week 48, a second hospitalisationwill take place to repeat the stool
balance analysis. This study was registered on clinical trials
NCT03562130.
Results: Nine months after the first inclusion, 17 children had been
enrolled. Mean age was 10 years old (range 5–16). Four children had
SBS type 1, seven had type 2, and six type 3. The results of their stool
balance analysis at baseline are shown in table 1.
Table 1
Food intake* 1500 kcal/day
Stools 1200 g/day
Lipid absorption 44%
Nitrogen absorption 50%
Carbo-hydrates absorption 67%
Total energy absorption 58%
Results are expressed in mean.
*Two patients received tube feeding on top of oral feeding.
At week 12, fifteen children (100% children who reached the week 12
endpoint) experienced a decrease >20% of PN requirements in calories
and in volume, 29% and 28% respectively (mean). Six children reached
week 24 with a further decrease of PN intake at a mean of 39% from
baseline. Two children could be evaluated at the week 36 endpoint:
one was weaned from PN, the other one had decreased his PN
dependency by 50% in calories and by 66% in volume from baseline,
and could experience one night aweek without a PN infusion. Z-score
in weight and height remained stable.
All the children experienced a reduction in stool frequency or a reduc-
tion of the ostomy flow and an improvement of the stool consistency.
Citrulline plasma levels increased from 14 µmol/l to 24 µmol/l (mean)
at week 12.
Six children suffered from mild abdominal pain in the first month of
treatment. Only one severe adverse event was reported with an
increased ostoma output and abdominal pain which led to a hospital
admission for 3 days at week 17; no direct link was made with the
treatment which was maintained.
Conclusions: All the children included in the study had severe
malabsorption as shown by the stool balance analysis. The first results
are encouraging on the safety and the efficacy of the treatment. PN
reduction still occurred after week 36. The results of the second stool
analysis at week 48 should confirm the intestinal absorption
improvement that is observed clinically.
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INFLUENCE OF PROTEIN INTAKE IN THE FIRST YEAR OF LIFE ON
BODY SIZE AND IGF-I LEVELS
I. Tincu1*. 1Emergency Department, “Grigore Alexandrescu” Emergency
Children’s Hospital, Bucharest, Romania
* Corresponding author.
Rationale: Rapid weight gain during infancy is associated with
increased risk of obesity, but the undergoing mechanisms of these
processes are still to be fully revealed. Itwas stipulated that insulin-like
growth factor-I (IGF-I) might be associated with rapid linear growth.
This paper examines whether protein intake from complementary
feeding is associated with IGF-I levels and greater growth rates in
children of 1 year of age.
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Methods: This was a prospective observational study. The eligible
populationwas formed of 75 healthy infants examined at their check–
up visits at 6 and 12 months. All participants were assessed with
anthropometry, 3 days food record and blood analysis of IGF-I and
serum urea at the age of 1 year. The subjects were assessed either to
the groupwith lowprotein (<2.5 g/kc/day) or to the high protein group
(>2.5 g/kc/day).
Results: At 6months of age, therewas no difference between girls and
boys regarding growth parameters, while at 12 months, the boys were
larger. Girls had considerable higher values for IGF-I than boys (78.3
[51.3; 114.2]) vs 72.5 [49.3; 92.1]. Protein intake was significantly
correlated with serum urea and IGF-I. The infants receiving <2.5 g
protein/kg of body weight hadmedian values for IGF-I with 35% lower
than the ones receiving higher amounts.
Conclusions: The introduction of solid food in children diet provides
increasing amount of protein, sometimes exceeding real needs. Our
results, although observational, provide evidence that higher amount
of protein during complementary feeding promotes further higher
rates of growth.
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PREGNANCY EXPOSURE TO MATERNAL SMOKING AND HIGH
CAFFEINE INTAKE IS ASSOCIATED WITH INCREASED CHILDHOOD
ASTHMA RISK: EVIDENCE FROM A BIRTH COHORT
F.C. Mendes1*, I. Paciência1,2,3, C. Lopes3,4, A.C. Santos3,4, H. Barros3,5,
A. Moreira1,3,6, P. Moreira3,61 Faculdade de Medicina Universidade do
Porto, 2Institute of Science and Innovation in Mechanical Engineering
and Industrial Management, 3EPIUnit – Instituto de Saúde Pública,
Universidade do Porto, 4Departamento de Ciências da Saúde Pública e
Forenses e Educação Médica, Faculdade de Medicina, 5Departamento de
Epidemiologia Clínica, Medicina Preditiva e Saúde Pública da Faculdade
de Medicina da Universidade do Porto, 6Faculdade de Ciências da
Nutrição e Alimentação Universidade do Porto, Porto, Portugal
* Corresponding author.
Rationale: During pregnancy, the caffeine crosses the placenta barrier
and its elimination half-life rises in late gestation, exposing the fetus.
Although several observational surveys proposed that higher intake of
caffeine may be associated with growth restriction, reduced birth
weight and preterm birth, its association with asthma during
childhood has not yet been explored. Moreover, there are conflicting
data about the fetal safety of maternal dietary caffeine consumption,
particularly at levels of 300 mg/day or greater. Therefore, we aimed to
evaluate the association between high levels of caffeine consumption
in pregnancy and asthma at 10 years of age.
Methods: We studied 1451 mothers and children enrolled in the
population-based birth cohort – Generation XXI in Porto, Portugal.
Portion sizes and frequency from coffee, decaffeinated, black and green
tea and cola throughout pregnancy, including first, second and third
trimester, were collected during the face-to-face interviews with
structured questionnaires at 24 to 72 hours after birth. Overall caffeine
estimation throughout pregnancy was made multiplying the portion
size by the multiple/fraction of daily frequency intake for each food
item. Asthma was defined based on caregiver self-reported diagnosis
at 10 years of age. Logistic regression models were performed to
evaluate the association between pregnancy consumption levels of
caffeine and asthma.
Results: After adjustments for maternal diagnosis of asthma, educa-
tion and body mass index (BMI), gestational age, type of birth, and
children’s sex and BMI z-scores, smoking mothers with caffeine
consumption levels of 300 mg/day or greater had 3.58 times higher
risk of having a child with asthma than smokers with levels inferior to
300 (OR = 3.58; CI 95% 1.16 to 11.0).
Conclusions: In conclusion, childrenwhose mothers smoked and had
consumption levels of caffeine equal or above 300 mg/day, were at
higher risk to develop asthma. Recommendations should be provided
to avoid smoking and reduce caffeine intake throughout pregnancy.
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INTRAVENOUS IRON SUPPLEMENTATION IN CHILDREN WITH
INTESTINAL FAILURE ON HOME PARENTERAL NUTRITION
M. Danko1*, A. Żyła-Pawlak1, K. Popin´ska1, M. Sibilska1, K. Olszewska1,
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Rationale: The intravenous trace elements formulations available for
children in Poland are Peditrace (Fresenius-Kabi®) which does not
contain iron and Addamel (Fresenius-Kabi®) which contains 2 µg Fe/
ml but is registered for children with body weight >15 kg. The aim of
the study was to assess the prevalence of anemia and efficacy of
intravenous iron supplementation in children on home parenteral
nutrition.
Methods: 54 children (age 5–184 months, median 48,5 months) on
home parenteral nutrition were included into the study. 18 patients
were additionally supplemented with intravenous iron sucrose
formula (3 mg/kg of Venofer – Vifor France®) during control visits
(last dose 2–3months before the study). All patients received Peditrace
as an intravenous trace elements formulation. Laboratory parameters
of RBC, haemoglobin, ferritin and iron concentration, MCV, MCH,
MCHC and TIBC, were analyzed using Mann-Whitney test and
Spearman correlation.
Results: The prevalence of anemia in thewhole groupwas 37% (20 out
of 54). The median iron and ferritin concentration was very low in the
whole group of patients – 45 µg/dl (range 14–195) and 29,7 ng/ml
(range 3–273) respectively. Iron concentration was significantly
correlated with ferritin, haemoglobin, MCV, MCH, MCHC and RBC
(p < 0,05). Patients with ileostomy had lower iron concentration, MCV
and RBC then others (p < 0,05). Haemoglobin concentrationwas lower
in group of patients who recived i.v. iron supplementation then in
others (10,6 vs 11,8 g/dl; p < 0,05).
Conclusions: Iron deficiency anemia is common in children on long
term parenteral nutrition. Every 2–3 months i.v. supplementation of
iron sucrose is not sufficient in these patients.
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IS BOWEL LENGTHENING A STEP TOWARDS ENTERAL AUTONOMY?
E. Cernat1*, J. Steele1, V. Zamvar1, J. Puntis1, I. Sugarman2. 1Department
of Paediatric Gastroenterology, 2Department of Paediatric Surgery, Leeds
Children’s Hospital, Leeds, United Kingdom
* Corresponding author.
Rationale: Bowel lengthening procedures (longitudinal intestinal
lengthening and tailoring – LILT procedure and serial transverse
enteroplasty procedure – STEP) are one of the treatment options for
children with short bowel syndrome but precise indications, timing
and outcomes are still the subject of debate.
The aim of the study was to review our centre experience in terms of
decreasing the proportion of Estimated Average Requirement (EAR)
given by PN/nights on PN post-bowel lengthening surgery (LILT and
STEP procedures).
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Methods:We collected data retrospectively from electronic and paper
case notes of paediatric patients on home PN that underwent a bowel
lengthening procedure over a 17 year period (2001–2018). The timing
of different procedures was documented and we calculated the
proportion of EAR delivered by PN/nights on PN pre-bowel lengthen-
ing, 1-year post procedure and at the present time.
Results: 10 children (7 males) with a median (range) age of 10.3 years
(3.7–17) underwent a bowel lengthening procedure. Theywere born at
a median (range) gestational age of 34+2 weeks (27.2–40). The cause
for short bowel was gastroschisis in 7/10 with 1 case of NEC and 2 of
bowel atresia. The median (range) initial bowel length was 17.5 cm
(10–30); none had ICV or full colon although 9/10 had a partial colon.
The PN was started at a median (range) of 2 days of of life (1–29). The
general approach to bowel lengthening was to consider when further
adaptation seemed unlikely and therewas no progress with advancing
enteral feeds (some patients were also symptomatic, e.g. abdominal
pain, bloating). 3 patients underwent a LILT procedure (2 of whom also
had later STEP), 9 underwent a first STEP procedure at a median
(range) age of 2.6 years (0–11.5), 3 patients underwent a second STEP
(1 had a LILT previously) and one patient underwent a third (duodenal)
STEP at the age of 10.7 years. Themedian (range) bowel length pre first
STEP was 27 cm (17–60), after the first procedure the median (range)
was 55 cm (26–90) and for the ones who had a second procedure
108 cm (85–125). Only one patient came off PN (6 months after a STEP
procedure); his % EAR derived from PN before procedurewas 80%, with
7 nights PN per week; however, before surgery hewas off PN for a total
of 14.7 months over 5 different periods between 2002 and 2006 and
always restarted due to poor weight gain. One patient underwent a
combined liver and small bowel transplant, due to end stage liver
disease and one patient had isolated small bowel transplant due to loss
of venous access at 7 and 9.3 years of age respectively; both are off PN,
one still on IV fluids. One patient died age 7 months from end stage
liver disease having had a STEP aged 6 days and was on full PN at the
time of death. The median (range) % EAR derived from PN before
surgery was 82.8% (34%>105%; n = 8), and the median (range) days of
PNwere 7 days/week (2–7). 1 year post last procedure undertaken, the
PN % EAR decreased to 48.8% (median of 3.5 nights/week; n = 8) and
currently the EAR given by PN (excluding the transplanted and death
patient) is 42.5% (4 nights/week; n = 7). In one patient the symptoms
improved post lengthening but this was confounded by social issues.
Conclusions: Only 1/10 child who had bowel lengthening came off PN
after surgery in our centre and he had good enteral tolerance at the
time of surgery but could not grow when PN was stopped. The rest of
the patients that are alive and have not undergone small bowel
transplant (n = 6) are still PN dependant although the % EAR from PN/
nights on PNhave slightly reduced. It is difficult to know if thiswas due
to the surgery or further bowel adaptation.
The precise indications, benefits and long term complications of bowel
lengthening procedures remain unclear. It is possible that only
patients who are close to full enteral autonomy should be considered
for this surgery.
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ERYTHROCYTE SELENIUM AND SELENOPROTEIN P ARE
INDEPENDENTLY ASSOCIATED WITH THE ENDOTHELIAL
ADAPTATIVE RESPONSE IN CHILDREN WITH SYSTEMIC
INFLAMMATION
H.P. Leite1*, E. Lopes Junior1, T. Konstantyner1, M.D.C.P. Franco2.
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Rationale: Experimental studies have demonstrated a relationship
between adhesion molecules as biomarkers of endothelial function
and selenium status under different conditions (1). However, there are
few clinical studies to support the hypothesis that selenium has an
active role in endothelial function. Unlike plasma selenium, erythro-
cyte selenium is a reliablemarker of selenium status in the presence of
systemic inflammation, as it is unaffected by the acute phase response
(2). We tested the hypothesis that selenium nutritional status, as
measured by erythrocyte selenium and selenoprotein P, is associated
with endothelial adaptative response during the acute phase of
systemic inflammation in children.
Methods: A prospective study of 109 children (median age of 22.4
months) admitted with circulatory shock, 22% of them malnourished
according to the WHO standards. Patients were evaluated for plasma
concentrations of the adhesionmolecules ICAM-1, VCAM-1, P-Selectin,
and EndoCAM at days 1, 2 and 3 of the ICU stay. Erythrocyte selenium
and Selenoprotein P concentrations were assessed on admission. We
performed multivariable repeated measures analysis of variance
controlling for the Pediatric Index of Mortality 2, C-reactive protein,
procalcitonin and serum lactate concentrations, and anthropometric
nutritional status.
Results:Mean (SD) erythrocyte selenium concentrationwas 75.8 (3.7)
µg/L, plasma selenium: 60.4 (28.1) µg/L and Selenoprotein P: 83.8
(44.5) nmol/L. There was no association between anthropometric
indices and erythrocyte or plasma selenium. There were positive,
independent associations between erythrocyte selenium and P-
selectin and EndoCAM plasma concentrations, and between
Selenoprotein and P-Selectin plasma concentration. The increase of
1.0 µmol/L in erythrocyte selenium resulted in increases of 4.7 nmol/L
(95% CI: 2.6;6.9, p < 0.001) in P-Selectin and of 0.004 ng/mL (95% CI:
0.001;0.006, p = 0.02) in EndoCAM. The increase of 1.0 nmol/L in
Selenoprotein P resulted in the increase of 1.7 nmol/L (95% CI: 0.50;3.0,
p = 0.006) in P-Selectin. There was no association between selenium
status and ICAM-1 or VCAM-1. Plasma selenium concentrationwas not
associated with any of the adhesion molecules.
Conclusions: Selenium nutritional status is associated with the
endothelial adaptative response during acute systemic inflammation
in children. This association is independent of the degree of
inflammatory response and clinical severity.
References
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EVALUATION OF SERUM SELENIUM, ZINC AND COPPER IN AN
INTENSIVE CARE UNIT. THEIR RELATIONSHIP TO THE PROGNOSIS
AND EVOLUTION OF PATIENTS
A.M. Gonçalves1*, A.D. Messias1, M.L. Cravo2. 1Intensive Care Unit,
2Gastroenterology, Hospital Beatriz Angelo, Lisboa, Portugal
* Corresponding author.
Rationale: Zinc,1 selenium2 and copper are essential trace elements
in critical care patients.3,4 Our aim was to correlate their serum
concentrationswith severity, clinical evolution and patients prognosis.
Methods: We designed a prospective study, with four months
duration, in a Polivalent Intensive Care Unit in Portugal.
We evaluated serum zinc (Zn), selenium (Se) and copper (Cu) levels at
admission to ICU and correlated them with organ failure indicators
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(defined based on SOFA), acute phase markers, clinical evolution (ICU
length of stay, days on ventilator, vasopressor needs, infectious
complications and renal function substitution needs) and hospital
prognosis.
Results: A total of 200 consecutive patients (59% males, 41% females;
median age 65,8 years; age range 22–90 years) were included. Their
median SAPS II and APACHE II scores were 42,96 + 21,05 and
19,46 + 10,4, respectively. 69,5% of the patients had two or more
organ failures at admission. On admission low zinc levels were present
in 74% of patients, 20% had low selenium levels whereas serum copper
was elevated in 8% of the patients.
Patients with respiratory failure had lower Zn (p = 0,005) and Cu
(p = 0,047) levels whereas those with hemodynamic failure had lower
Zn (p = 0,000) and Se (p = 0,002) levels. Lower levels of Se were also
observed in patients with renal failure (p = 0,002) and hematological
failure (p = 0,028). Lower zinc and selenium levels on admission were
associatedwith longer periods of ventilation (r (Zn) =−0,175, p = 0,014,
and r (Se) = − 0,149, p = 0,037).
Patients who developed infectious complications during ICU stay had
higher levels of Cu on admission (p = 0,007).
Finally, on admission, patients with multiple organ failure had
significant lower zinc (p = 0,004) and selenium (p = 0,005) levels.
We didn’t find any relationship between trace elements levels and ICU
length of stay, ICU mortality or hospital mortality.
Conclusions: Patients with worst prognosis had significantly lower
zinc and selenium levels on ICU admission, whereas higher copper
levels were also observed on patients who developed infectious
complications during their ICU stay.
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SKELETAL MUSCLE AS A MAJOR SOURCE OF ACUTE-PHASE
REACTANTS (APR) DURING CANCER CACHEXIA
I. Massart1, G. Paulissen2, L. Bindels3, N. Delzenne3, M.-A. Meuwis2,
E. Louis2, J.-P. Thissen1*. 1Endocrinology, Diabetes & Nutrition, University
of Louvain, Brussels, 2Translational Gastroenterology, University of Liege,
Liege, 3Louvain Drug Research Institute, University of Louvain, Brussels,
Belgium
* Corresponding author.
Rationale: Reliable parameters for early diagnosis of cancer cachexia
are still lacking and molecular mechanisms of muscle atrophy are
incompletely unraveled. The goal of this study is to identify new
pathways and potential biomarkers of muscle atrophy during cancer
cachexia using proteomic analysis.
Methods: Ten days after C26 carcinoma cells SC injection, a classical
model of cancer cachexia in mouse, gastrocnemius samples were
collected for protein extraction and fractionation into sarcoplasmic
(SF) and myofibrillar fractions (MF). Differential label free proteomics
was used to compare muscle extracts from cachectic and control mice
(n = 6/group) on a 2Dnano-UPLC coupled to a QExactive Plus Hybrid
Quadrupole-Orbitrap mass spectrometer. Protein identifications and
relative quantitations were obtained using MaxQuant and the
differential analysis was performed using Perseus. Different softwares
were used to identify the pathways dysregulated and the proteins
potentially secreted.
Results: Cachexia was confirmed by decreased muscle mass and
induction of several atrogenes. By label-free mass spectrometry, 960
proteins were obtained in SF and 935 in MF, with 228 differentially
abundant between control and cachectic mice in SF and 198 in MF.
Among the most down regulated proteins are the respiratory chain
proteins (five complexes) and ribosomal proteins (40S and 60S) aswell
as the main myosin heavy chains (Myh7,1,4). These observations
suggest an impairment in protein synthesis and energy generating
processes, which may contribute to muscle atrophy and weakness
observed in cancer cachexia. Among the most significant upregulated
and potentially secreted proteins during cancer cachexia are several
acute phase reactants (APR): Haptoglobin (Hp), Serum Amyloid A
(SAA), Alpha-1-acid glycoprotein 1 (Orm1), C3 complement (C3) and
Serpina3n. These changes were confirmed byWestern Blot (P < 0.001)
and RTq-PCR (increase from 2- to 23-fold; P <0.001) indicating a local
muscle production. Similar changes were also observed in two
different murine models of cancer cachexia. Induction of APR
expression did not result from decreased food intake. Administration
of an anti-IL-6 antibody in C26 mice was able to counteract the
induction of Hp, SAA1 and Serpina3n but not C3 and Orm1. However,
the role of IL-6was indirect as IL-6 failed to stimulate the expression of
these APR in C2C12myotubes. In contrast, myotube atrophy caused by
glucocorticoids or proinflammatory cytokines (TNF-alpha/IFN-
gamma) was associated with increased mRNA for most of these APR,
confirming their increased production by muscle cells and indicating
the role of glucocorticoids and proinflammatory cytokines in this
induction.
Conclusions: Our study identifies some major pathways potentially
involved in muscle atrophy and demonstrates the marked increased
production of APR by skeletal muscle during cancer cachexia. Further
studies are required to unravel the roles of these proteins in muscle
atrophy and their interest as potential biomarkers of cancer cachexia.
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UNACYLATED GHRELIN PLASMA CONCENTRATION DECREASES
WITH AGE AND INDEPENDENTLY PREDICTS 5-YEAR MUSCLE MASS
AND STRENGTH IN NON OBESE HUMANS
G. Gortan Cappellari1*, P. Vinci1, A. Semolic1, G. Cremasco1, A. Tolin1,
M. Zanetti1, R. Barazzoni1. 1Dept. of Medical Sciences, University of
Trieste, Trieste, Italy
* Corresponding author.
Rationale: Unacylated ghrelin (UnAG) is an emerging modulator of
skeletal muscle metabolic pathways with reported anti-oxidative,
anti-inflammatory, insulin-sensitizing and anabolic actions in rodent
healthy and disease models. Aging is associated with multiple
alterations of systemic and skeletal muscle metabolism which
contribute to muscle loss, leading to frailty and increased morbidity
andmortality. Potential associations between aging, UnAG andmuscle
mass and whether ghrelin forms predict future muscle mass and
strength in lean humans remain currently undefined.
Methods: We investigated associations between age and ghrelin
profile [total (TG), acylated (AG) and unacylated hormone (UnAG)] in
580 lean (BMI<25 kg/m2) individuals from the North-East Italy MoMa
population study (Age:47 ± 14 y;M/F:266/314).Moreover,153 subjects
(baseline age:47 ± 16 y; M/F:72/81) were investigated after 5 years for
musclemass by bioelectrical impedence andmuscle strength by hand-
grip assessment.
Results: Both TG and UnAG were negatively associated with age
(P < 0.01) in the study cohort. In multiple regression analysis, these
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results were also independent of gender, BMI and plasma markers of
metabolic disease. In the follow-up subgroup, TG andUnAG but not AG
positively predicted 5-year muscle mass and muscle strength, also
after multiple adjustments for confounding variables.
Conclusions: In lean subjects from a North-East Italy general
population cohort, UnAG decreases with aging. In addition, UnAG
but not AG selectively and independently predicts 5-year musclemass
and strength. These results suggest UnAG should be further investi-
gated as a potential modulator of aging related muscle wasting.
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A PHASE 1, SINGLE-BLIND, PLACEBO-CONTROLLED, 3-ARM CROSS-
OVER TRIAL OF FOOD-GRADE PEPTIDES WITH OREXIGENIC
PROPERTIES IN MURINE MODELS
E.S. Sullivan1,2*, T. Kelly1,2, S.J. Cushen1,2, L.E. Daly1,2, É.B. Ní
Bhuachalla1,2, K. Howick2,3,4, H. Schellekens2,3, J.F. Cryan3,5, B.
T. Griffin2,4, D. Dahly6,7, A.M. Ryan1,2. 1School of Food & Nutritional
Sciences, 2Food for Health Ireland, 3Department of Anatomy and
Neuroscience, 4School of Pharmacy, 5Alimentary Pharmabiotic Centre
(APC) Microbiome Ireland, 6HRB Clinical Research Facility, 7School of
Public Health, University College Cork, Cork, Ireland
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Rationale:Methods to stimulate appetite in the sick or elderly remains
a challenge with few safe therapeutic options. Ghrelin has received
considerable attention as a therapeutic target to stimulate food intake
in patients with anorexia.
Methods:A single-blind, 3-arm (placebo, casein bioactiveMF1145 and
whey bioactive UL-2-141) cross-over trial was conducted in healthy
male volunteers. Participants received 26 mg/kg of both bioactives and
placebo. Outcome measures were energy & protein intake from an ad
libitum lunch and subjective appetite sensations as assessed by visual
analogue scale (VAS). Basal and postprandial levels of active ghrelin
(AG) were measured.
Results: Overall, 22 male participants (mean age 27 years) were
included, average BMI was 24.6 kg/m2. Mean energy and protein
intakes at lunch when treated with placebo were 1343 kcal (95% CI:
1215–1471 kcal) and 74 g (95% CI: 66–81 g), respectively. Energy and
protein intakes were not significantly different from placebo for either
treatment (p = 0.918, p = 0.319 for UL-2-141 and p = 0.889, p = 0.959
for MF1145, respectively). Similarly, appetite, hunger and satiety
responses on VAS were not significantly different from placebo for
either treatment. AG peak after lunch on placebo was 653 pg/ml (95%
CI: 511–794 pg/ml). Treatment with UL-2-141 and MF1145 resulted in
139 pg/ml, p = 0.021 and 114 pg/ml, p = 0.045 reduction in post-
prandial AG compared to placebo, respectively. However, when
controlling for fasting AG, the pattern was no longer significant
(p = 0.590 and p = 0.877 respectively). Pre-prandial AG peaks were not
significantly different across treatments.
Conclusions: While these peptides have previously demonstrated
ghrelinergic effects in rats, no effect on appetite or food intake in
humans was identified by this study. This may be attributable to the
small sample size or low dose. Repeating the study in subjects with
established anorexia may be prudent in order to target an abnormal
ghrelinergic response.
Disclosure of Interest: None declared.
OR64
A GREEN-MEDITERRANEAN WEIGHT LOSS DIET, SUPPLEMENTED
WITH MANKAI DUCKWEED, PRESERVES IRON-HOMEOSTASIS IN
HUMANS AND IS EFFICIENT IN REVERSAL OF ANEMIA IN RATS
A. Yaskolka Meir1* on behalf of DIRECT Plus team. 1Epidemiology, Ben
Gurion University, Beer Sheva, Israel
* Corresponding author.
Rationale: Decreased dietary meat may deplete iron stores, as plant-
derived iron bioavailability is typically limited. We aim to explore the
effect of a low-meat Mediterranean (green-MED) diet, supplemented
withWolffia-globosa duckweed (Mankai: rich in protein and iron) as a
food source for humans, on iron-status. We further examined the
specific iron bioavailability of Mankai in rats.
Methods: 294 abdominally-obese/dyslipidemic (mean age = 51.1 yrs;
mean body-mass-index = 31.3 kg/m2; mean waist circumference
111 cm for men and 103 cm for women; 88% men, non-anemic
participantswere randomized to physical activity (PA), PA+MEDdiet or
PA+green-MED diet. Both iso-caloric MED groups consumed 28 g/day
walnuts and the low-meat Green-MED further consumed green tea
(800 mL/day) and Mankai (100 g/green-shake/day). In a complemen-
tary animal experiment, following 44-days of an iron-deficient
anemia-inducing diet, 50 female rats (age = 3 weeks; Sprague-
Dawley strain) were randomized into: iron-deficient diet (vehicle),
or vehicle+iso-iron: ferrous-gluconate (FG)14,Mankai-50 andMankai-
80 versions (1.7 mg · kg−1 · day−1 elemental iron), or FG9.5 and
Mankai50-C version (1.15 mg · kg−1 · day−1 elemental iron). The spe-
cific primary aim for both studies was changes of iron homeostasis
parameters.
Results: After 6 months of intervention and significant weight loss
across all intervention groups, iron-status trajectory did not differ
between PA and PA+MED groups. Hemoglobin modestly increased in
the PA+green-MED group (0.23 g/dL) as compared to PA (−0.1 g/dL;
p < 0.001) and PA+MED (−0.1 g/dL;p < 0.001). Serum-iron and serum-
transferrin saturation increased in the PA+green-MED group as
compared to the PA-group (8.21 µg/dL vs. −5.23 µg/dL and 2.39% vs.
−1.15%; p < 0.05 for both comparisons), as did folic acid (p = 0.011). In
rats, hemoglobin decreased from15.7 mg/dL to 9.4 mg/dL after 44 days
of diet-induced anemia. Following the post-depletion treatment,
the vehicle-treated group had a further decrease of 1.3 mg/dL,
whereas both FG and Mankai iso-iron treatments similarly rebounded
hemoglobin levels (FG14:+10.8 mg/dL, Mankai50:+6.4 mg/dL,
Mankai80:+7.3 mg/dL; FG9.5:+5.1 mg/dL, Mankai50-C:+7.1 mg/dL;
p < 0.05 for all vs. vehicle group).
Conclusions: In humans, green-MED, low-meat, diet does not impair
iron-homeostasis. In rats, iron derived from Mankai (green-plant
protein source) is bioavailable and efficient in reversal of anemia.
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DOES THE RISK VARIANT OF THE OBESITY-ASSOCIATED GENE FTO
RS9939609 AFFECT INSULIN SENSITIVITY IN ADULTSWITH OBESITY
CLASS 2 AND 3?
A.K. De Soysa1*, V. Grill2, I. Løvold Mostad2. 1Department of Clinical
Nutrition and Speech-Language Therapy, Clinic of Clinical Services,
St. Olavs Hospital, Trondheim University Hospital, 2Norwegian
University of Science and Technology, Trondheim, Norway
* Corresponding author.
Rationale: Metabolic effects of FTO related to its effects on BMI have
been proposed; however, they have been only sparsely investigated in
obese individuals. We investigated whether the FTO risk allele SNP
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rs9939609 is associated with insulin resistance (IR) and in particular
with hepatic IR.
Methods: In 79 participants (68% women) with BMI obesity class 2-3,
hepatic IR was measured with a 2h hyperinsulinaemic euglycaemic
clamp (0.3 i.u./kg/min) including a stable tracer infusion of [6,6-2H2]
glucose. The sample of study participants, recruited froman outpatient
obesity clinic, was double blindly enriched to achieve a study
population of 1/3 with double risk (A/A-genotype), 1/3 with single
risk (A/T) and 1/3 with the non-risk allele (T/T). We calculated glucose
infusion rate (GIR), rate of appearance and disappearance (Ra and Rd)
as tracer variables, and metabolic clearance rate (MCR).
Results: Although we did not detect genotype effects on the tracer
variables we found a significant negative effect of FTO risk on MCR
(p = 0.026). For thewhole study populationwomenwere more insulin
sensitive than men, indicated by higher GIR (p < 0.002), lower Ra
response (p < 0.02) and higher MCR (p < 0.07).
Conclusions: Using an euglycemic clamp protocol in obesity class 2
and 3 revealed an effect of the A allele (risk allele) of FTO SNP
rs9939609 on the MCR of glucose, indicating a link to insulin
resistance.
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MICRONUTRIENTS DEFICIENCIES IN 374 SEVERELYMALNOURISHED
ANOREXIA NERVOSA INPATIENTS
M. Hanachi1*, M. Dicembre2, C. Rives-Langes3, P. Bemer4, J. Poupon5,
A. Dauvergne6, J.-F. Zazzo4, J. Ropers7, J.-C. Melchior1. 1Clinical Nutrition
Unit, Raymond Poincare University Hospital, Garches, France, 2Clinical
Nutrition Unit, Raymond Poincaré University Hospital, Garches, 3Nutrition
Unit, Georges Pompidou University Hospital, Pris, 4Clinical Research Unit,
Raymond Poincare University Hospital, Garches – France, 5Laboratory of
Biological Toxicology, Saint Louis–Lariboisiere, University Hospital, Paris,
6Laboratory of Biochemistry, Beaujon University Hospital, Clichy, 7Clinical
Research Unit, Pitié-Salpêtrière University Hospital, Paris, France
* Corresponding author.
Rationale: Anorexia nervosa (AN) is a psychiatric disorder, which can
lead to somatic complications. Undernourished AN patients could
have micronutrients deficiencies. We aimed to determinate the
prevalence and the associated factors of micronutrients deficiencies
in the two subtypes of AN (restricting type (AN-R) and binge-eating/
purging type (AN-BP)).
Methods: A retrospective study of all consecutive malnourished AN
adult patients, hospitalized in clinical nutritional unit of Raymond
Poincaré University hospital, between 2011 and 2017, was conducted.
Results: In all, 374 ANpatients (351 (94%)W,13 (6%)M), age: 31.3 ± 12.9
years, BodyMass Index (BMI): 12.5 ± 1.7 kg/m2were included; 121 (32%)
patients had AN-BP while 253 (68%) had AN-R subtype. Zinc had the
highest deficiency prevalence 64.3%, followed by vitamin D (54.2%),
copper (37.1%), selenium (20.5%), vitamin B1 (15%), vitamin B12 (4.7%)
and vitamin B9 (8.9%). Patients with AN-BP type had longer disease
duration history, were older, and had a lower left ventricular ejection
fraction (LVEF) (p < 0.001, p = 0.029, p = 0.009), when compared with
AN-R type patients who, instead, had significantly higher Alanine
Aminotransferase (ALT) and Brain Natriuretic Peptide (BNP) levels
(p < 0.001, p < 0.021). In AN-BP subgroup, as compared to AN-R, lower
selenium (p < 0.001) and vitamin B12 plasma concentration (p < 0.036)
were observed; whereas lower copper plasma concentration was
observed in patients with AN-R type (p < 0.022). No significant
differences were observed for zinc, vitamin B9, vitamin D, and vitamin
B1 concentrations between the two types of AN patients.
Conclusions: Malnourished AN patients have many micronutrient
deficiencies. Differences between AN subtypes are identified.
Micronutrients status should be monitored and supplemented to
prevent deficiency related complications and to improve nutritional
status. Prospective studies are needed to explore the symptoms and
consequences of each deficiency, which can aggravate the prognosis
during recovery.
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TOTAL LYMPHOCYTE COUNT IN CANCER PATIENTS WITH
LYMPHOPENIA TREATED WITH INTRAVENOUS VITAMIN C: RESULTS
OF AN OBSERVATIONAL STUDY
M.B. Andrade Hernandez1*, D. Rodriguez2, M. Guerrero2,
B.M. Maldonado2, C. Vollbracht3, S.A. Herrera2. 1Research, ASENPE,
2Clinical Nutrition, SOLCA, Guayaquil, Ecuador, 3Research, University of
Applied Sciences, Idstein, Germany
* Corresponding author.
Rationale: Lymphopenia commonly occurs in cancer patients and
predicts poor prognosis. It is caused by radioand chemotherapy, with
malnutrition and treatment-related oxidative stress playing key roles
in its pathogenesis. Tumour-related morbidity is reported to be
associatedwith reduced plasma ascorbate,which is a key physiological
antioxidant and essential factor in immune function.
Methods: A prospective observational study was conducted on 48
cancer patients with lymphopenia (<1500/μL) to investigate the total
lymphocyte count (TLC) during four weeks of elective adjuvant
treatment with intravenous (iv) vitamin C 7.5 g (Pascorbin®7.5 g) once
a week. TLC values at baseline ( just prior to start of treatment) and
after 4 weeks treatment were compared using descriptive statistics.
Results: Obesity Grade 1 n = 4.
After 4 weeks iv vitamin C 7.5 g, TLC increased by a mean of 211/μL
(p = 0.0018). Subgroup analyses showed that, in patients with severe
lymphopenia (n = 25) (TLC <1000/μL), the increase in TLC was greater
with a mean rise of 368/μL (p = 0.0004), than in patients (n = 23) with
an initial TLC of 1000–1500 (mean rise of 40/μL) (p = 0.6105). TLC
increased by at least 240/μL in half of the patients with severe
lymphopenia and by more than 610/μL in 25% of patient.
Table 1 (abstract: OR65): Participants and hepatic insulin resistance by genotype, mean values (SD)
Risk allele Age, years BMI, kg/m2 GIR, µmol/kg/
min
Ra, µmol/
min/kg
Rd, µmol/
min/kg
MCR, ml/
min/kg
T/T 38.8 (9.5) 43.1 (5.7) 6.56 (2.74) 2.88 (1.09) 10.00 (2.02) 2.04 (0.39)
A/T 43.7 (10.1) 41.8 (4.7) 7.44 (3.63) 2.81 (1.33) 10.74 (2.44) 2.14 (0.61)
A/A 43.9 (13.3) 44.3 (4.7) 6.12 (2.16) 2.64 (0.93) 9.32 (1.55) 1.82 (0.32)
Linear reg, Coef. (p-value) (A/T) 4.9 (0.075) −1.32 (0.370) 0.88 (0.325) −0.07 (0.856) 0.73 (0.180) 0.09 (0.504)
Linear reg, Coef. (p-value) (A/A) 5.1 (0.116) 1.26 (0.389) −0.43 (0.533) −0.24 (0.386) −0.68 (0.180) −0.22 (0.026)
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Nutrition status Lymphocytes
before therapy
mean [cells/μL]
Lymphocytes
after therapy
mean [cells/μL]
Difference in
Lymphocytes
mean [cells/μL]
Normal = 0 — — —
Risk of
malnutrition
n = 10
1046.9 1334.0 287.1
Mild
malnutrition
n = 3
1270.0 1096.7 −173.3a
Moderate
malnutrition
n = 17
846.5 1013.5 167.1
Severe
malnutrition
n = 12
774.2 1013.3 239.2
Overweight n = 2 615.0 1620.0 1005.0
Obesity Grade 1
n = 4
1025.0 1035.0 10.0
Valid data 48 48 48
Missing data 0 0.0 0
Conclusions: Our data indicate that iv high-dose vitamin C treatment
increases TLC, which strongly implies improvement of immune
function, especially in patients with severe lymphopenia.
Appropriately-powered, randomized, placebo-controlled trials of iv
high-dose vitamin C are now needed to define more precisely its role
in the treatment of cancer-related lymphopenia and how this impacts
on the patients’ clinical prognosis.
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EFFECTS OF A MICRONUTRIENT PACKON MICRONUTRIENT STATUS,
HOMOCYSTEINE LEVEL, OXIDATIVE STRESS BIOMARKERS AND
FUNCTIONS IN INSTITUTIONAL OLDER ADULTS: A MULTICENTER
RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
Q. Ren1, H. Xie1, Y. Chen1, C. Wu2, H. Li2, Y. Lu2, N. Lin3, X. Li3, W. Yuan4,
Y. Yang5, H. Jin5, J. Sun1*. 1Huadong Hospital Affiliated to Fudan
University, 2Shanghai Yinyuan Hospital, 3Shanghai Donghai Geriatric
Nursing Hospital, 4Jingan District Center Hospital, 5Social Welfare
Institute of Minhang District, Shanghai, China
* Corresponding author.
Rationale: Institutional older adults are at increased risk of micronu-
trient deficiency (MND) which may lead to serious health burdens.
This study aimed to investigate the effects of a micronutrient pack on
micronutrient status and functions in institutional older adults.
Methods: In this randomized, placebo-controlled trial, 98 older adults
aged 65∼100 years were enrolled and assigned to either intervention
group or control group (n = 49 each), with either a package of
micronutrient pack or placebo daily, for three months. Fasting blood
samples were collected both at baseline and the end of study to detect
the concentrations of micronutrients, homocysteine (Hcy), malon-
dialdehyde (MDA), glutathione peroxidase (GSH-Px) and superoxide
dismutase (SOD). The nutritional status, self-care ability, and cognitive
function of the subjects were also evaluated by mini-nutritional
assessment short-form (MNA-SF), activities of daily living (ADL) and
mini-mental state examination (MMSE), respectively. The difference
(before and after intervention) between the two groupswas compared
by independent sample t test or non-parametric test.
Results: Compared to the control group, concentrations of serum
folate (21.1 ± 1.6 vs 0.6 ± 0.5 nmol/L), vitamin B1(3.4 ± 0.4 vs −0.2 ± 0.3
nmol/L), vitamin B2(11.5 ± 3.3 vs 2.3 ± 1.4 nmol/L), vitamin
B12(128.8 ± 34.8 vs 13.3 ± 16.0 pmol/L), 25-hydroxyvitamin D
(17.8 ± 1.3 vs −0.8 ± 0.5 ng/mL) and plasma zinc (0.6 ± 1.8 vs
−9.6 ± 1.9 μmol/L) significantly increased in the intervention group
over 3-month supplementation (all P < 0.05). Moreover, plasma Hcy
(−4.9 ± 6.9 vs 3.2 ± 6.2 μmol/L, P < 0.001) and serumMDA (−1.3 ± 2.7 vs
0.6 ± 2.3 nmol/mL, P = 0.001) levels were remarkably reduced, and the
activities of serum GSH-Px (1.4 ± 1.8 vs 0.3 ± 1.0 ng/mL, P = 0.003) and
plasma SOD (30.0 ± 35.6 vs −0.8 ± 26.6 U/mL, P < 0.001) were both
increased in the intervention group than that of the control group.
Further, improvements in MNA-SF (1.1 ± 2.1 vs 2.1 ± 1.7), ADL
(−3.8 ± 12.6 vs 2.6 ± 10.4) and MMSE (−0.2 ± 2.5 vs 1.2 ± 3.0) scores in
intervention group were also observed (all P < 0.05).
Conclusions: The 3-month supplementation of the micronutrient
pack ameliorated MND, enhanced antioxidative capacities, and may
confer advantageous effect on ADLs and global cognitive function in
institutional older adults.
Disclosure of Interest: None declared.
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Critical care/Liver and gastrointestinal
tract/Perioperative care
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THE EFFECTS OF APPLYING GASTRIC RESIDUAL VOLUME
MANAGEMENT PROTOCOL(GRVMP) IN CRITICALLY ILL PATIENTS
C.H. Lee1*, S.K. Peak1, K.H. Park1, Y.S. Jang2, C.S. Shin3, J.H. Cho4, S.H. Na3,
Y.S. Choi1, S.N. Kim1, J.E. Lee1, D.W. Lee1, P.R. Choi1, S.J. Kim5, S.K. Lee6,
S.M. Lee6, N.K. Park1. 1Department of Nursing, Gangnam Severance
Hospital, Yonsei University Health System, 2College of Nursing, Yonsei
University, 3Anesthesiology and Pain Medicine, 4Internal Medicine,
5Department of Nutrition, 6Department of Pharmacy, Gangnam
Severance Hospital, Yonsei University Health System, Seoul, Korea,
Republic of
* Corresponding author.
Rationale: Earlyenteral nutrition (EN) has a positive effect onprogress
and prognosis by increasing the nutritional supply of critically ill
patients. Gastric residual volume (GRV) is a frequently used in nursing
practice because it is relatively easy and cost effective to evaluate
gastrointestinal (GI) dysfunction at the early stage of EN in critically ill
patients.
The purpose of this study was to develop the Residual Gastric Volume
Management Protocol (GRVMP) for improving GI function and to
evaluate the effects of GRVMP in patients with critical illness.
Methods: This study was conducted in two stages. The first stage was
to develop GRVMP based on the Manual for Guideline Adaptation
version 2.0 by the National Evidence-based Healthcare Collaborating
Agency.
The second stage was designed as a quasi-experimental study, which
only pretest was practiced to control group and after The GRVMP only
posttest was practiced to experimental group.
The subjects were patients admitted to the ICU of G hospital in Seoul
and were eligible for inclusion criteria. A total of 75 participants were
enrolled in the study, of which 45were received enteral nutrition. Data
were collected from July 2016 to September 2017. EN performance, EN
start date, Achievement Rate of Target Nutritional Requirement
(ARTNR), GI dysfunction, and aspiration pneumonia were measured.
Datawere analyzed using the independent t test, theMann-Whitney U
test, and the χ2 test through the R 4.3.2 statistical program.
Results: GRVMP included the maximum capacity of GRV, assessment
frequency and the treatment method of GRV, and included specific
nursing intervention when GRV limit was exceeded.
GRV assessment frequencywasmeasured every 4 hours for the first 48
hours and then every 6 hours thereafter.
The maximum capacity of GRV was 250 ml and less than 250 ml of
volumewas returned using the aseptic technique and over 250 mlwas
discarded. In other words, if the GRV exceeded 250 ml, the nursing
intervention was carried out according to the four specific steps.
The results of the GRVMPapplication showed that the EN Performance
was 17(40%) in the control group and 28(85%) in the experimental
group (p = 0.0001). EN was started within 72 hours in 9(21%) of the
control group and 19(58%) of the experimental group (p = 0.00003).
On the 7th day, ARTNR was 0% [0.0, 46.5] in the control group and 54%
[31.0, 80.0] in the experimental group (p = 0.0001), which was
significantly improved.
There was no significant difference of vomiting, reflux, diarrhea,
constipation and abdominal distension.
The incidence of aspiration pneumonia was 2(11.8%) in the control
group and 0(0%) in the experimental group, but it was not significantly
different.
Conclusions: The application of GRVMP significantly improved the
early EN and ARTNR of the critically ill patients and there was not
found a negative effect in this study. Rather, it seems that GRVMPmay
be the way to detect early and prevent the negative effects of EN in
patients with critical illness.
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ZP7570: A NOVEL GLP-1/GLP-2 DUAL ACTING PEPTIDE WITH
POTENTIAL AS THE NEXT GENERATION THERAPY FOR SHORT
BOWEL SYNDROME
J. Skarbaliene1*, W. Russell1, J. Griffin1, P.-O. Eriksson1. 1Zealand Pharma
A/S, Glostrup, Denmark
* Corresponding author.
Rationale: The GLP-2 analog teduglutide is approved for use in adult
short bowel syndrome (SBS), whilst GLP-1 analogs exendin-4 and
liraglutide have shown positive effects in clinical studies in SBS
patients. We are developing a long-acting dual GLP-1/GLP-2 agonist
peptide ZP7570, with the potential to improve the current standard
treatment for SBS.
Methods: C57BL/6 mice (n = 6) were dosed SC once daily (QD) with
vehicle, ZP7570 (6 and 250 nmol/kg, QD), liraglutide (50 nmol/kg, BID)
or teduglutide (250 nmol/kg, BID) for 3 days. An oral glucose tolerance
test was performed on day 1 and at sacrifice (day 4), the intestinal tract
was weighed. Wistar rats (n = 4–6/ group) were dosed SC (QD) with
vehicle or ZP7570 (0.1–225 nmol/kg, QD) for 14 days. Gastric emptying
(GI) and intestinal transit (IT) were determined using a barium sulfate
assay, and small and large intestines weighed.
Results: Inmice, acute dosingwith ZP7570 significantly reduced blood
glucose levels at all time-points prior to and after glucose adminis-
tration, with similar effects to liraglutide. Moreover, ZP7570 signifi-
cantly increased total intestinal weight vs vehicle group. After 14 days
of dosing in rats, ZP7570 dose-dependently inhibited IT, but had no
effect on GE. In addition, ZP7570 significantly increased small
intestinal mass and intestinal length, but only induced a slight
increase in large intestinal mass.
Conclusions: ZP7570has potent intestinotrophic and intestinal transit
effects in rodents, effects expected to result in increased absorption of
fluid and nutrients in SBS patients. Furthermore, due to its GLP-1
agonist activity ZP7570 is also expected to protect against hypergly-
cemia and liver injury, which are both frequently associated with
parenteral support. These findings warrant clinical evaluation of
ZP7570 as a future treatment for SBS.
Disclosure of Interest: J. Skarbaliene Shareholder of: Zealand Pharma
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PT01.3
SHORT-TERM PREOPERATIVE SMOKING CESSATION WITHIN AN
ENHANCED-RECOVERY PROGRAMME REDUCES PERIOPERATIVE
RISKS TO BASELINE: A STUDY IN 1,517 CONSECUTIVE PATIENTS
K. Schalling1*, J. Nygren1, M. Soop1. 1Department of Surgery, Ersta
Hospital, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden
* Corresponding author.
Rationale: Randomised trials have demonstrated that smoking
cessation in the weeks before elective major orthopaedic and general
surgery reduces postoperative morbidity. We hypothesised that
smoking cessation before colorectal surgery reduces morbidity to a
level similar to that of non-smokers.
Methods: Consecutive patients undergoing elective major colorectal
surgery in an enhanced-recovery programme 2011–2018 were
prospectively studied using an international perioperative registry.
Patients with unknown smoking status were excluded. The enhanced-
recovery programme incorporated limited smoking cessation support.
The effect of smoking cessation on postoperative outcomes was
assessed using univariable and multivariable regression. Medians
(range) reported.
Results: 1517 patients were included, 1348 non-smokers, 117 smokers
and 52 who had stopped smoking within 2–8 weeks before surgery.
The proportions of patients with a complication (Clavien-Dindo I-IV)
within 30 days differed between groups, 27.2 vs 40.2 vs 23.1%
(P 0.0083) These differences persisted (P 0.032) when correcting for
confounders (body mass index, surgical approach, duration of surgery
and fluid administration). Length of hospital stayalso differed between
groups at 6 (4–9) vs 7 (5–12) vs 6.5 (4–10) days (P = 0.0322), with
differences persisting when correcting for confounders.
Conclusions: In this large, consecutive single-centre series, patients
who stopped smoking before surgery had not only improved out-
comes compared to smokers, but outcomes comparable to those of
non-smokers. These findings strengthen the case for preoperative
intensive smoking cessation support.
Disclosure of Interest: None declared.
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EFFICIENCY OF EARLY ENTERAL NUTRITION WITH AUGMENTED
PROTEIN-CALORIC VALUE IN THE COMPLEX OF INTENSIVE CARE
THERAPY OF POLYTRAUMA PATIENTS
N. Matolinets1*, F. Kettl1. 1Anesthesiology and Intensive Care, Danylo
Halytsky Lviv National Medical University, Lviv, Ukraine
* Corresponding author.
Rationale: Protein-energy homeostasis along with proper oxygen-
ation forms the basis of combating a critical state.
Our goal was to evaluate the effectiveness of early enteral nutrition
(EEN) with use of the PEP uP protocol (Enhanced Protein-Energy
Provision via the Enteral Route in Critical ill Patients) in the complex of
intensive care therapy for polytrauma patients.
Methods: The study included 40 adult polytauma-patients, treated in
the Lviv Emergency Hospital with moderate (60%) and severe (40%)
polytrauma according to the ISS (Injury severity score). The patients
arrived at the hospital within 30 min after the accident, the average
agewas 42,1 ± 2,3 years. The levels of total proteinwere determined on
admission, on the 5th day of treatment and throughout the days of
artificial ventilation. These indicators were compared between an
experimental group of 20 patients who were put early on EEN
according to the PEP uP protocol and a control group in which
nutritional support was conducted according to the European guide-
lines for clinical nutrition, using standard mixtures.
Results: The experimental group received a specialized protein-
saturated semi-elemental peptide-based mixture, that contains
1,5 kcal per 1 ml with an initial feeding rate from 60 ml/h to 80 ml/h.
The maximum residual volume of the stomach was 250 ml with
systematic usage of prokinetics. After 5–7 days the nutritional therapy
was switched to a standard regimen. The stabilization of hemodynam-
ics and oxygenation was achieved within 12–24 hours by Intensive
care therapy and early surgical intervention. The blood protein level in
the experimental group on admission was 58.0 ± 1.0 g/l, in the control
group 58.2 ± 1.6 g/l (p > 0.5), on the 5th day – 60.0 ± 1.0 and 51.5 ± 0.8 g/l
(p <0.001) respectively. The total duration of artificial ventilation in
the experimental group was on average shorter by 3.4 days and
amounted to 8.7 ± 2.0 days as opposed to the control group 12.1 ± 1.8
days (p > 0.2).
Conclusions: In comparison with the control group, the usage of
enhanced protein-caloric provision according to the PEP uP protocol
achieved a normalization in the protein levels on the 5th day of
treatment and reduced the total days of mechanical ventilation by an
average of 3.4 days. The protein-energy deficit of patients switched to
standard, balanced mixtures for enteral nutrition was associated with
an exacerbation of hypoproteinaemia and longer durations of
mechanical ventilation.
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ASSOCIATION BETWEEN HAEMODYNAMIC PARAMETERS AND
ENTERAL NUTRITION OUTCOMES IN SEPTIC SHOCK PATIENTS:
PRELIMINARY RESULTS
O.S. Franzosi1, D.S.L. Nunes1, T.M. Klanovicz1, S.H. Loss2*, É. Batassini2,
E.E. Turra2, C. Teixeira3, S.R.R. Vieira1. 1Postgraduate Medical Sciences
Program, Federal University of Rio Grande do Sul, 2Intensive Care
Department, Hospital de Clínicas de Porto Alegre, 3Medicine School,
Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil
* Corresponding author.
Rationale: Provide enteral nutrition (EN) to patients who are
haemodynamically compromised still an issue up to debate. The aim
of this study was to evaluate the association between haemodynamic
parameters and nutrition therapy (NT) outcomes in septic shock
patients.
Methods: Prospective study carried out in a tertiary teaching hospital.
Consecutive adult patients with septic shock admitted to ICU were
included. Mean arterial pressure (MAP), heart rate (HR), urine output
(UO), lactate, skin mottling (mottling score from 0–5), capillary refill
time (CRT), central-to-toe temperature gradient (TG) were evaluated
in bedside in the admission (H0), 12-hours (H1), 24-hours (H2) and
48-hours (H3). Patientswere stratified into twogroups according toNT
outcomes [NTS (success): start EN≤ 48-hours and achieve≥20 Kcal/kg
or 11 kcal/kg body weight when obese in the first ICU week; or NTF
(failure) when those parameters were not achieved). Statistical
analysis for independent samples, generalized linear model and
generalized estimation equations model were performed.
Results: During a 12-month period, 106 septic shock patients were
included, 23 were excluded (death in <48-hours) and 83 were
analyzed. At H0, SAPS 3 was 74 ± 11, SOFA score 8(6–10) and age 64
(55–71) years. Regarding NT groups, 53(63.8%) achieved NT success
and 30(36.2%) NT failure. At H1, NTF showedmore severemottling (MS
4–5) while NTS more absence or modest mottling (MS 0–1) [4(13.3%)
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vs 1(1(1.9%); (18(60.0%) vs 43(81.1%), p = 0.045], and higher lactate
levels [(3.15(1.77–6.77) vs 1.40(1.0–2.32), p = 0.005]. At H1 more TG
was observed in NTF [22(73.3%) vs 21(39.6%), p = 0.03] and CRT
threshold ≥3 seconds [21(70.0%) vs 22(41.5%), p = 0.013] than in NTS.
No differences for MAP, HR, UO at H1 between groups were found. At
H1, hiperlactatemia [RR 2.8 95%CI (1.5,5.3), p < 0.001], TG [RR 2.6 95%CI
(1.3,5.2), p = 0.006], CRT threshold ≥3 seconds [RR 2.2 95%CI (1.1,4.3),
p = 0.016], MS [0–1 RR 1; 4–5 RR 2.75 95%CI (1.53–4.95), p = 0.001]
were associatedwith NT failure. Lower MSwas observed in NT success
group in H1, H2 andH3while no reductions inMSwere observed in NT
failure group.
Conclusions: Preliminary results suggest association between early
improvement in haemodynamic parameters and success in NT. This
could support the recommendation to start NT after hemodynamic
and perfusion goals are achieved. An enlargement of the study
population is needed to clarify this results.
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SKETETAL MUSCLE INDEX AT ICU (INTENSIVE CARE UNIT)
ADMISSION IS VALID FOR PREDICTING THE PROGRESSION OF
ICU-ACQUIREDWEAKNESS (ICU-AW) FOR SEPTIC PATIENTS
Y. Mitobe1*, Y. Koyama2, S. Sakai2, M. Uchiyama2, H. Abeywickrama2,
E. Yamada2, K. Ohashi2, Y. Kikuchi2, M. Nitta3, T. Honda4, H. Endoh4.
1Department of Nursing, Teikyo University, Tokyo, 2Niigata University
Graduate School of Health Sciences, 3Advanced Emergency and Critical
Care Center, Niigata University Medical and Dental Hospital, 4Division of
Emergency & Critical Care Medicine, Niigata University Graduate School
of Medical and Dental Science, Niigata, Japan
* Corresponding author.
Rationale: Early detection of intensive care unit-acquired weakness
(ICU-AW) is necessary for preventingmuscleweakness in ICUpatients.
Medical research council (MRC) score < 48 has been generally used
for ICU-AW diagnosis. On the other hand, skeletal muscle index (SMI,
cm2/m2) calculated by height and skeletal muscle area at the level of
the third lumbar vertebra, measured by computed tomography, is
recently used for the assessment of sarcopenia. In this study, we
examined whether SMIat ICU admission is valid for predicting ICU-
AWfor septic ICU patients.
Methods: We examined septic ICU patients who admitted Niigata
University Hospital ICU during 2012–2017 under mechanical ventila-
tion. Patients were retrospectively divided into two groups by the
MRCscore at ICU discharge: Group AW contained the patients of ICU-
AW diagnosed by MRC <48, and Group N the contained patients of
non-ICU-AW. Clinicopathological factors at ICU admission such as age,
gender, underlying disease, body mass index (BMI), APACHE II score,
Barthel index, and SMI, were compared between the two groups. The
statistical analyses were performed by Mann-Whitney U test, Fisher’s
exact test, ROC analysis and multivariate analysis. The statistical
significance was defined as P < 0.05.
Results: A total of 31 septic patients were examined; 23 patients in
Group Aw and 8 patients in Group N. There was no significant
difference between the two groups in age, BMI, APACHE II score and
Barthel index, however, female patients were significantly frequent in
Group Aw (P < 0.05). SMI was significantly low in in Group Aw
compared with Group N (P < 0.05). ROC analysis revealed that the cut-
off value of SMI for predicting ICU-AW was 44.1, and multivariate
analysis showed that low SMI was a significant factors predicting ICU-
AW (rerative risk 2.262, 95% confidence interval 1.451–63.5000,
P < 0.05).
Conclusions:Our results show that SMImeasurement at ICUadmission
might be valid for predicting ICU-AW progression for septic patients.
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PT02.1
POORER MEMORY IS RELATED TO POORER ODOR DISCRIMINATION
AND IDENTIFICATION IN MILD COGNITIVE IMPAIRMENT AND
ALZHEIMER’S DISEASE: THE NUDAD PROJECT
A. Doorduijn1*, O. Van de Rest2, F. De Leeuw3, M. Kester3, C. Teunissen4,
P. Scheltens3, W. van der Flier3, M. Visser5, M. de van der Schueren1,
S. Boesveldt2. 1Nutrition and Dietetics, Amsterdam UMC, Vrije
Universiteit Amsterdam, Amsterdam, 2Division of Human Nutrition and
Health, Wageningen University & Research, Wageningen, 3Alzheimer
Center Amsterdam, 4Department of Clinical Chemistry, Amsterdam UMC,
Vrije Universiteit Amsterdam, 5Department of Health Sciences, Faculty of
Science, Vrije Universiteit Amsterdam, Amsterdam, Netherlands
* Corresponding author.
Rationale: Lower olfactory scores, especially on identification, is
reported in patients with mild cognitive impairment (MCI) and
Alzheimer’s disease (AD). It is not clear whether this is associatedwith
poorer cognition or AD pathology. We compared olfactory function of
patients with MCI and AD with controls, and studied associations of
cognitive domains and AD biomarkers with olfactory function.
Methods:We included 22 patientswithMCI (age 70 ± 7 y, 27%Female),
30 with AD (70 ± 8 y, 53%F) and 40 controls (63 ± 7 y, 55%F). We
assessed olfactory threshold, discrimination and identification. Age,
gender and education adjustedANOVAs, and linear regression analyses
of cognitive domains (memory, attention, executive function, language
and visuospatial ability) or AD biomarkers (Aβ42, tau and p-tau) with
olfactory function were used.
Results: Patients withMCI and AD scored lower on discrimination and
identification than controls (9.0 and 9.5 vs 11.6; 9.5 and 9.2 vs 11.6),
but not on threshold (6.9 and 5.9 vs 7.1). Poorer memory, but no other
domain, was associated with poorer discrimination and identification
(Table 1). There were no associations between AD biomarkers and
olfactory function.
Table 1
Associations of cognitive domains with olfactory function.
Threshold Discrimination Identification
Memory 0.62 (−0.16; 1.39) 1.19 (0.57; 1.82) 1.29 (0.60; 2.01)
Attention −0.42 (−1.10; 0.26) 0.14 (−0.46; 0.74) 0.10 (−0.60; 0.80)
Executive function −0.43 (−1.60; 0.74) 0.20 (−0.78; 1.18) 0.86 (−0.21; 1.92)
Language −0.31 (−1.31; 0.69) 0.31 (−0.57; 1.19) 0.55 (−0.45; 1.55)
Visuospatial ability −0.17 (−1.03; 0.67) −0.50 (−1.22; 0.22) −0.24 (−1.02; 0.53)
Data presented as β (95% CI).
Conclusions: Patients with patients with MCI and AD do not have a
lower sensitivity for detecting odors but difficulties in discriminating
and identifying odors, which is likelya consequence of poorermemory
rather than a direct result of AD pathology.
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EFFECT OF AGE, STRESS AND PROTEIN SUPPLY ON PLASMA AMINO
ACID KINETICS DURING CONTINOUS ENTERAL NUTRITION
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Rationale: As life expectancy rises, an increasingly older population
may require surgery with perioperative nutritional management.
Little is known about the combined effect of age and stress on the
metabolism of amino acids (AA) provided by enteral nutrition (EN). In
addition, the respective advantages of whole proteins and protein
hydrolysates in EN can be questioned in the context of intestinal
ageing. These questions were addressed in aged and adult rats
subjected to continuous EN before and after a standardized surgical
stress.
Methods: Thirty-two 5-month or 21-month-old male SD rats were
used. After a gastrostomy and the insertion of a jugular vein catheter
and a one-week recovery, the animals were enterally fed (317 kJ/24 h
and 4.15 g protein/24 h) whole proteins or a protein hydrolysate
(Sondalis HP or Peptamen HN, Nestle Health Science respectively) for
24 hours before (healthy state) and 18 hours after a standardized
laparotomy (surgical stress). Blood samples were repeatedly collected
for the measurement of plasma AA and calculation of enrichment and
incremental area under the curve (iAUC) during each EN period.
Statistical analysis: three factor (protein source, age, and stress)
ANOVA; significance: p < 0.05.
Results:Whatever the conditions, ENwas associatedwith a significant
plasma enrichment (50 to 150 µmol/l; p < 0.001) in Ala, Thr, Lys and
Pro, and a decrease (−80 µmol/l) in Gly (p < 0.01). Individual AA iAUCs
were strongly affected by the AA composition of the protein supplied
(increased AA utilisation with protein hydrolysate) and by surgical
stress (increased utilisation ofmost AAs but decreased branched-chain
AA utilisation). Aging was only associated with higher Tyr and Thr
iAUC (p < 0.001), and lower Gln iAUC (p < 0.01). There was no
interaction between age and surgical stress.
Conclusions: Plasma AA availability during EN is determined by the
nature of the protein supply and the existence of stress. The effects of
aging appear to be very limited. Aging does not appear to negatively
affect postoperative AA availability whether from a protein hydolysate
or whole proteins.
Disclosure of Interest: J. P. De Bandt Grant/Research Support from:
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PROTEIN INTAKE IN CANCEROLOGY: DOES IT LIMIT MALNUTRITION
OR PROMOTE TUMOR GROWTH?
M. Boutiere1*, K. Couturier1, C. Moinard1, C. Breuillard1. 1LBFA, INSERM
U1055, Grenoble, France
* Corresponding author.
Rationale: The amount of protein intake in cancer is a controversial
issue. Indeed, a too high protein intake could promote tumor growth,
whereas a hypo protein intake would promote malnutrition and
cachexia (1,2). To date, the majority of the data are in a cancer-only
model, but there are no clinical or experimental studies to resolve this
issue in a model of tumor-bearing rats receiving chemotherapy. The
objective was to evaluate the influence of different protein intakes in
an animal model of cancer associated of chemotherapy.
Methods: Seventy-eight female rats (Fisher 344, 12 weeks old) were
divided into 6 groups: a control group (C, n = 8) of healthy rats with a
standard diet (100% of protein requirements) and 5 groups (K, n = 14)
with a dietwith different amounts of protein (50%, 75%,100%,150% and
200% of protein requirements), which received a cancer (Ward colon
tumour injected subcutaneously) and chemotherapy included two
cycles, one week apart, each consisting of one injection of irinotecan
(CPT-11, 50 mg/kg) and one of 5-Fluorouracil (5-FU, 50 mg/kg) the day
after (3). Food intake, animal body weight and tumour size were
measured daily. The day after the last injection of chemotherapy, rats
were killed, the organs were weighed and body composition
determined. Protein synthesis and content were evaluated in the
muscles (EDL, tibialis, soleus) and tumor. The protocol has been
validated by the ethics committee (APAFIS#11492).
Results: Cancer led to a weight loss of the animals (C = 171.5 ± 2.6 g vs
K = 150.8 ± 2.4 g (p < 0.005)). Similarly at the tissue level, cancer
induced atrophy of the liver (p < 0.005), thymus (p < 0.005), lean
body mass (p < 0.005) and fat mass (p < 0.005). Surprisingly, these
alterations inbodycompositionarenotaffectedbyeitherhyper-protein
or hypo-protein intakes. In addition, protein synthesis and protein
content in the muscles and tumor were not different between the
groups. Tumor growth was not affected by the level of protein intake.
Conclusions: Initial data suggest surprisingly that neither nutritional
status or tumour growth appears to be modulated by the level of
protein intake. Such results may to be confirmed in humans.
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ASSESSING SKELETAL MUSCLE MASS WITH ULTRASOUND IN
PATIENTS WITH SYSTEMIC SCLEROSIS
A. Sarı1, M. Eşme2*, G. Şengül Ayçiçek2, M. Halil2, A. Akdoğan1. 1Internal
Medicine, Division of Rheumatology, 2Internal Medicine, Division of
Geriatrics, Hacettepe University, Ankara, Turkey
* Corresponding author.
Rationale: Patients with systemic sclerosis (SSc) have increased risk
for decreased skeletal musclemass due to inflammation, malnutrition,
low physical activity status andmusculoskeletal involvement. The role
of ultrasonography (USG), which is increasingly used in rheumatology
practice, in evaluating muscle mass in this patient group is unknown.
The aim of this study is determine to assess of the utility of USG in the
evaluation of muscle mass in SSc
Methods: 93 SSc patients who were admitted to rheumatology
outpatient clinic were included. Appendicular skeletal muscle mass
indices (ASMI) of patients was calculated using bioelectric impedance
analysis (BIA)1. Decreased muscle mass was defined as an ASMI below
7.26 kg/m2 for men and 5.50 kg/m2 for women. The severity of the
gastrointestinal involvement was assessed by the UCLA GIT 2.0 scale
and the physical activity status by the International Physical Activity
Questionnaire (IPAQ). The presence of malnutrition was determined
ESPEN criteria was used to determine the presence of malnutrition.
Thicknesses of gastrocnemius, rectus femoris, rectus abdominis,
external oblique, internal oblique and transverse abdominis muscles
was assessed byUSG. Pearson analysiswas used to evaluate correlation
between ASMI and each muscle thickness. Sensitivity, specificity and
predictive values of ultrasonographic cut-off values in predicting
decreased muscle mass were determined by ROC analysis.
Results: Reducedmusclemass was present in 13 (13.9%) of 93 patients
(F/M: 86/7). Demographic and clinical features of patients are
summarized in Table 1. Diffuse subset, flexion contracture of hands,
history of digital ulcer and malnutrition were more frequently
observed in patients with decreased muscle mass (p < 0,05 for all).
Ultrasonographic thickness of gastrocnemius, rectus abdominis and
internal oblique muscles were also significantly low in this group
(Table 2)]. Gastroknemius thickness showed the highest correlation
with ASMI (r = 0.513, p <0.001). The cut-off value of 1.47 cm for the
thickness of gastrocnemius had 92.3% sensitivity, 58.7% specificity and
97.9% negative predictive value in predicting decreased muscle mass
(AUC: 0.846).
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Table 1
Demographic. clinical and anthropometric features of SSc patients.
Normal muscle
mass (n = 80)
Decreased
muscle mass
(n = 13)
p
Female 73 (91.3%) 13 (100.0%) 0.588
Age. years 52.5 (42.6–58.8) 54.1 (35.2–58.7) 0.991
Disease duration. years 10.5 (5.7–15.7) 21.8 (3.3–26.8) 0.148
Diffuse disease 14 (17.5%) 7 (53.8%) 0.004
Interstitial lung disease 41 (51.2%) 10 (76.9%) 0.085
Digital ulcer history 39 (48.8%) 10 (76.9%) 0.059
Flexion contracture of hands 16 (20.0%) 9 (69.2%) <0.001
CRP. mg/dL 0.40 (0.24–0.70) 0.81 (0.20–1.51) 0.279
Body mass index 25.5 (22.2–29.0) 18.8 (17.6–20.8) <0.001
ASMI. kg/m2 6.9 (6.2–7.8) 4.9 (4.7–5.3) <0.001
UCLA GIT 2.0 score 0.19 (0.04–0.36) 0.08 (0.05–0.27) 0.526
Malnutrition 7 (8.8%) 8 (61.5%) <0.001
Physical activity
Low/moderate 65 (81.2%) 13 (100.0%)
High 15 (18.7%) – 0.118
Glucocorticosteroids
No/ low dose (<7.5 mg/day) 76 (95.0%) 12 (92.3%) 0.537
Moderate/high dose
(≥7.5 mg/day)
4 (5.0%) 1 (7.7%)
CRP; C-reactive protein, ASMI; appendicular skeletal muscle mass index.
Conclusions:Measurement of gastrocnemius thickness by USG can be
used as screening test due to its high sensitivity and negative
predictive value for detecting decreased muscle mass in SSc patients.
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Rationale: The updated analysis and stratification of patients on home
parenteral nutrition (HPN) is presented with the aim to demonstrate
the trends in occurrence of complications among patients on total HPN
in recent years.
Methods: Retrospective data from HPN National Registry was analysed
for the time period 2007–2018. Time-to-event analyseswere performed
for catheter related sepsis (CRS), catheter occlusion, and thrombotic
complications using the competing-risks regression (Fine and Gray)
model and expressed as hazard ratio (HR). Other data is presented as
median or meanwith 95% CI (p <0.05 was considered significant).
Results: Out of 1008 records, short bowel syndromewas present in 349
patients (35.2%), intestinal obstruction in 201 patients (20.3%), and
malabsorption in 114 patients (11.4%). The rest of 344 patients (34.1%)
was split among fistulas, anorexia, dysphagia, or unspecified. The
majority of SBS were type I (53.1%) and II (18.8%), mean length of
residual bowelwas 88.1 cm (0–400 cm). 78.3%HPNpatiensweremobile
for a substantial part of the day, and 148 (14.7%) out of 549 economically
potentoneswereeconomicallyactive.A tunnelledHickmancatheterwas
used in 527 patients (52.3%). More than 50% patients received
commercially prepared bags. 2/3 of patiens were administered one bag
per day, seven days a week. The sepsis ratio per 1000 catheter days
decreased from 0.79 in 2013 to 0.20 in 2018. In 2018, the catheter
occlusions ratio was 0.134 per 1000 catheter days, and thrombotic
complications ratio was 0.119. 44.6% of all patients terminated HPN
(weaning or death)within the first year.14.2% of patients are categorised
as life-long HPN dependent. Prevalence of metabolic bone disease is
16.9%, and prevalence of liver disease (PNALD) is 33.1%.
Conclusions: Prevalence of HPN patients in the Czech Republic has
been stable in the past five years. Majority of patients are expected to
terminate HPN within the first year. Risk of CRS decreased in the past
five years and remains very low, while catheter occlusion and
thrombotic complications show the opposite trend.
Disclosure of Interest: None declared.
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THE ASSOCIATION OF PROTEIN INTAKE AND LIKELIHOOD OF
FUNCTIONAL LIMITATIONS 14 YEARS LATER IN OLDER MEN
S.S. Jonnalagadda1*, L. Langsetmo2, S.L. Harrison3, J. Cauley4,
J.T. Schousboe5, J.M.S.M. Shikany6, S.L.P.L. Pereira7, P.M. Cawthon8.
1Nutrition Science, Abbott, Columbus, 2Division of Epidemiology and
Community Health, University of Minnesota, Minneapolis, 3Research
Institute, California Pacific Medical Center, San Francisco, 4Graduate
School of Public Health, University of Pittsburgh, Pittsburgh, 5Park Nicollet
Institute for Research and Education, Park Nicollet Health Services,
St. Louis Park, 6Preventive Medicine, School of Medicine, University of
Alabama at Birmingham, Birmingham, 7Research and Development,
Abbott, Columbus, 8San Francisco Coordinating Center, University of
California San Francisco, San Francisco, United States
* Corresponding author.
Rationale: Low protein intake has been linked to worse functional
status, but the long-term association between daily protein intake and
development of functional limitations in older adults is not described.
Methods: At the baseline visit in Osteoporotic Fractures in Men
(MrOS) Study (2000–2), men completed a food frequency question-
naire, from which low protein intake (analyzed as <0.8 grams
/kilogram body weight/day) and energy intake were estimated. At
baseline and via questionnaires 14–16 years later, men were asked
about any difficulty with activities of daily living (ADL, tasks: bathe,
transfer, toilet, dress, eat), instrumental ADLs (IADL, tasks: prepare
meals, manage medications, manage money, shop, drive, housework)
andmobility (tasks: walk 2–3 blocks, climb 10 stairs). Inmen free from
limitation at baseline, we used logistic regression models to estimate
the likelihood of limitation at follow-up by protein intake (low vs.
high) and energy intake (tertiles: low (referent), medium, high).
Multivariatemodels were first adjusted for age, education, alcohol use,
smoking, marital status, activity and race, and protein models then
further adjusted for energy intake. Due to long-term follow-upwe also
assessed likelihood of survival.
Results: In multivariate models without consideration of energy
intake, there was no evidence of an association between low protein
intake and likelihood of limitation (Table). However, after adjustment
for energy intake, men with lower protein intake were more likely to
report ADL or mobility limitation at follow-up. There was no
significant association of energy intake at baseline and subsequent
limitations (p > 0.05 for all outcomes in multivariate models). Those
with lower protein intake at baseline were also less likely to survive
through follow-up 14–16 years later.
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Table
Low protein intake (<0.8 grams /kilogram body weight/day) and its association
(odds ratio, 95% CI) limitations in ADLs, IADLs and mobility tasks 14–16 years
later in older men.
Multivariate
model
Multivariate
plus energy
intake
ADL limitation (N = 306 of 1006 at risk) 1.24 (0.93, 1.65) 1.88 (1.29, 2.74)
IADL limitation (N = 401 of 939 at risk) 0.87 (0.66, 1.16) 1.22 (0.85, 1.75)
Mobility limitation (N = 362 of 958 at risk) 1.12 (0.85, 1.48) 1.62 (1.12, 2.34)
Conclusions: Amongst men with similar energy intake, those with
lower protein intake are more likely to report ADL or mobility
limitationsmany years later thanweremenwith higher protein intake.
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PATIENT SOURCES OF DIETARY AND NUTRITIONAL INFORMATION
AFTER A CANCER DIAGNOSIS
P. Ui Dhuibhir1, D.U. Burke2, V. Mc Sharry3, A. Mullee4, M. Barrett1,
L. Casey5, Y. Donnelly6, J. Gallagher7, K. Higgins8, J. McCaffrey9,
N. O’Donoghue10, A.O. Donoghue10*, C. Corish11, D. Walsh12.
1Academic Department of Palliative Medicine, Our Lady’s Hospice &
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3Dietetics Department, Mater Misericordiae, 4University College Dublin,
Dublin, 5Dietetics Department, University Hospital Limerick, Limerick,
6Dietetics Department, St Luke’s Hospital, 7Dietetics Department, Tallagh
University Hospital, 8Dietetics Department, Tallaght University Hospital,
9Oncology Medicine, Mater Misericordiae University Hospital, 10School of
Medicine, Trinity College Dublin, 11School of Public health, Physiotherapy
& Sport Science, University College Dublin, Dublin, Ireland, 12Department
of Supportive Oncology, Levine Cancer Institute, Charlotte, United States
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Rationale:Nutrition-related problems in cancer are under-recognised
and under-treated. Few healthcare professionals discuss nutrition/diet
with cancer patients. Consequently, patients may seek information
from other sources. Information sources and types of advice accessed
are unknown. This study aimed to determine the source and type of
nutritional/dietary information accessed by cancer patients prior to
first dietetic assessment and the degree towhich advicewas followed.
Methods: This prospective, multi-center, cross-sectional observa-
tional study recruited consecutive cancer patients at seven tertiary
centers. During initial dietetic assessment, a dietitian determined all
nutritional/dietary information accessed since cancer diagnosis.
Results: 74 participants (50% female) with amedian age 60 (range 23–
80) were recruited. Forty percent reported weight loss of 5% or greater.
The median time from diagnosis to initial dietetic assessment was 3
months (range 0–242). Patients obtained advice from a variety of
sources (average 1.6 sources per patient) prior to dietetic referral. In
rank order these were; 1) family or friend (n = 31), 2) health
professional (n = 24), 3) online forums or websites (n = 16) and 4)
media (n = 14). Twenty-one (28%) received no dietary advice prior to
referral. The most frequent advice related to avoidance of certain
foods; particularly sugar, dairy and meat. The consumption of fruit,
vegetables, protein, juices and wholegrain was commonly advised.
Fifty-one percent followed advice and 4% partially followed it. Many
expressed disappointment at not having a dietetics referral earlier and
identified the need for “good information early.”
Conclusions:
1. The majority of dietary and nutritional advice prior to dietetic
referral came from friends, family, media and online forums and
websites.
2. In a minority, dietary advicewas provided by health professionals
prior to dietetic referral.
3. Most advice related to the avoidance and/or promotion of
particular foods.
4. Cancer patientswant dietaryadvice fromdietitians at diagnosis to
prevent unnecessary avoidance of certain foods and to reduce the
risk of unintentional weight loss.
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DOES MALNUTRITION INFLUENCE HOSPITAL REIMBURSEMENT? A
CALL FOR DIAGNOSIS AND CODING
A. Fernandes1, A. Pessoa2*, M.A. Vigário3, H. Jager-Wittenaar4,5,
J. Pinho6. 1Instituto de Saúde Pública da Universidade do Porto, Porto,
2Serviço de Medicina, Centro Hospitalar do Médio Ave, Vila Nova de
Famalicão, 3Serviço de Nutrição, Centro Hospitalar do Médio Ave, Santo
Tirso, Portugal, 4Research Group Healthy Ageing, Allied Health Care and
Nursing, Hanze University of Applied Sciences, 5Department of
Maxillofacial Surgery, University of Groningen, University Medical
Center Groningen, Groningen, Netherlands, 6Serviço de Nutrição, Centro
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Rationale: In the hospital setting, malnutrition is highly prevalent and
entails significant morbidity and mortality, but it is frequently
undiagnosed and underreported. Since malnutrition contributes to a
poorer prognosis, its diagnosis and documentation are essential not
only to improve patient care but also to correctly report associated
hospitalization costs (HC), allowing hospitals to obtain the appropriate
reimbursement. Therefore, we aimed to determine how malnutrition
diagnosis in an internal medicine ward setting influences potential
hospital reimbursement.
Methods: Patients admitted to the internal medicine ward of CHMA,
EPEwere screened byNutritional Risk Screening 2002 (NRS 2002), and
patients classified as at “risk for malnutrition” were assessed by the
Patient-Generated Subjective Global Assessment (PG-SGA). For each
patient, medical coders simulated coding taking into account the
malnutrition diagnosis by PG–SGA, and compared it to the real
coding as retrieved from the medical records. For the coding, the
Diagnosis-Related Group and Severity of Illness (SOI) were deter-
mined, allowing the calculation of HC according to Portuguese
Ministerial Directive number 207/2017. The increase of HC in this
subsample was extrapolated to the number of patients admitted
during 2018 to obtain the estimated unreported annual HC.
Results: Of the participants having malnutrition risk according to NRS
2002 (92/129, 71%), 86% were malnourished. Including malnutrition
diagnosis in the coding ofmalnourished patients increased the level of
SOI in 39% of cases, and increased HC for this subsample in €52 K.
Extrapolating for the annual HC, total HC reached € 1.3M.
Conclusions: Identifying, coding, and recording malnutrition allows
inclusion of this highly prevalent diagnosis in medical records, which
increases HC. This can improve the potential hospital reimbursement,
which could contribute to the economic sustainability of hospitals
and, consequently, to the quality of patient care.
Disclosure of Interest: A. Fernandes: None declared, A. Pessoa: None
declared, M. Vigário: None declared, H. Jager-Wittenaar Other: Harriët
Jager-Wittenaar was co-developer of the PG SGA based Pt-Global app,
J. Pinho: None declared.
S38 Abstracts / Clinical Nutrition 38 (2019) S33–S58
PT03.03
PERIPHERAL PARENTERAL NUTRITION AND OCCURENCE OF
THROMBOPHLEBITIS
Z. Rosseel1, G.Meers2*, J. Demol3, C. Verhelst3, H. Collier2, M.Malbrain4,
J. Pen5, H. Spapen4, E. De Waele4. 1University, Vrije Universiteit Brussel,
2Pharmacy, 3Dietics, 4Intensive Care, 5Endocrinology, UZ Brussel, Brussel,
Belgium
* Corresponding author.
Rationale: Parenteral nutrition (PN) is used to supplement or replace
inadequate oral or enteral feeding in hospitalized patients. In nearly
half of the patients, peripheral PN (PPN) is associated with thrombo-
phlebitis according literture review.(1)
The duration and incidence of trombophlebitis with patients who
receive peripheral parenteral nutrition at the University Hospital
Brussel is unclear. Knowledge of complications and use is important
for the optimalisation of the nutritional therapy.
Methods: A observational retrospective study in a tertiary care center
covering a period of 3 years (2015–2018) was conducted. All patients
on peripheral parenteral nutrition are included (n = 343), the osmo-
larity of the parenteral nutrition deaty-to-use bag is 760 mosm/l. A
database is developed and the medical records are thorough analysed.
Treatment duration, age, occurrence of thrombophlebitis, flow rate,
osmolarity and important co-medications were recorded. Data are
given as means ± SD.
Results: 343 patients with peripheral parenteral nutrition PPN were
studied, aged 63 ± 22 years, who received 367 PN therapies via the
peripheral route. A PPN therapy was administered for 5.7 ± 6.1 days.
Thrombophlebitis (TP) occurred in 5% of the therapies on PPN. Patients
who developed thrombophlebitis received a peripheral PN therapy
for 11 ± 6.2 days. Under 18 years there was an incidence of 5% for TP
and PPN. Between 18–50 years there was no TP for 48 therapies.
Between 51 and 97 years there was an incidence 5.3% TP with a
treatment duration of 11 ± 6 days.
Conclusions: A substantial proportion of our hospitalized patients
receive PN via a peripheral vein. In contrast with data from the
literature, peripheral PN-associated incidence of thrombophlebitis
was low. The risk to develop thrombophlebitis increased with
prolonged treatment. TP occurred more in patients older than 50
years, and PPN duration was longer than in other age categories.
Reference
1. Sugrue D., Jarrell A.S., Kruer R., Davis S., Johnson D., Tsui E.,
Snyder S. and Crow J. (2018) Appropriateness of peripheral
parenteral nutrition use in adult patients at an academic medical
center, Clinical Nutrition ESPEN. Elsevier, 23, pp. 117–121. doi:
10.1016/J.CLNESP.2017.11.004.
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AN ENHANCED NUTRITIONAL SUPPORT PATHWAY INCLUDING
EXTENDED PREOPERATIVE AND HOME ENTERAL NUTRITION IS
SAFE, FEASIBLE AND MAY BENEFIT PATIENTS UNDERGOING
ENHANCED RECOVERY AFTER ESOPHAGECTOMY: A PILOT
RANDOMIZED CLINICAL TRIAL
K. Liu1*, J. Luo1, C. Shao2, S. Ji2, Y. Xu2, L. Hu1, Y. Qiang1, Y. Shen1.
1Department of Cardiothoracic Surgery, Jinling Hospital, Medical School
of Nanjing University, 2Department of Cardiothoracic Surgery, Jinling
Hospital, Nanjing, China
* Corresponding author.
Rationale: Perioperative malnutrition is common seen in esophageal
cancer patients. This pilot RCT aims to evaluate the safety, feasibility,
and effect of an enhanced nutritional support pathway for enhanced
recovery after esophagectomy.
Methods: Patients who would undergoing enhanced recovery after
esophagectomy and met the inclusion criteria were randomly divided
intoconventionalnutritionsupportgrouporenhancednutritionsupport
group, a week before surgery. Both groups underwent the same ERAS
program of esophagectomy basing on the guidelines[1,2], except the
nutrition support program. Standard nutritional support basing on the
guidelines[3,4]was implemented for the conventional nutrition group. In
addition, extendedpreoperative nutrition support and onemonthhome
enteral nutrition (HEN) were implemented for the enhanced nutrition
group. The safety, feasibility and compliance of the enhanced nutrition
support were evaluated and the perioperative outcomes, nutritional
status, and quality of life (QoL) were assessed at preoperative day, POD7
and POD30. This study was registered (ChiCTR1800015951) and
approved by the ethics committee of Jinling Hospital.
Results: The nutrition schedule compliance was 90.63% (29/32) and
87.10% (27/31) in the enhanced nutrition group and conventional
nutrition group respectively, exclusive of five patients lost to follow-
up. No severe nutrition-related complications occurred. The intention-
to-treat analysis of the 63 randomized patients showed that therewas
no significant difference in baseline characteristics. The weight and
BMI loss of patients in the enhanced nutrition group were obviously
decreased and the LBM, ASMI was significantly higher at POD30.
EORTC QLQ-C30 scores revealed that the enhanced nutrition support
improved QoL in physical function (75.96 ± 9.32 vs. 68.46 ± 7.18,
P < 0.01) and fatigue symptom (41.86 ± 9.64 vs. 49.19 ± 10.72,
P < 0.01) compared to the conventional nutrition support.
Table 1
Nutritional outcomes.
Conventional nutritional
support group (n = 31)
Enhanced nutrional
support group (n = 32)
P
value
Weight (kg) Mean ± SD Mean ± SD
POD7-Preop −0.61 ± 1.73 −0.67 ± 1.58 0.886
POD30-Preop −4.19 ± 3.01 −2.11 ± 2.19 0.003
BMI (kg/m2)
POD7-Preop −0.19 ± 0.62 −0.20 ± 0.53 0.945
POD30-Preop −1.52 ± 1.03 −0.71 ± 0.75 0.001
LBM (kg) n Mean ± SD n Mean ± SD
Preop 28 48.83 ± 10.16 29 51.05 ± 9.58 0.400
POD7 28 48.11 ± 10.75 28 50.09 ± 9.94 0.477
POD30 25 41.57 ± 9.12 26 48.36 ± 9.51 0.012
ASMI (kg/m2)
Preop 28 8.56 ± 1.18 29 8.63 ± 1.02 0.881
POD7 28 7.82 ± 1.15 28 8.09 ± 0.93 0.338
POD30 25 6.43 ± 0.95 26 7.61 ± 1.02 <0.001
Abbreviations: Preop, preoperative; POD7, postoperative day 7; POD30,
postoperative day 30; BMI, body mass index; LBM, lean body mass; ASMI,
appendicular skeletal muscle mass. AMSI = appendicular skeletal muscle mass
(kg)/height2 (m2).
Conclusions: This pilot RCT showed that an enhanced nutritional
support pathway was feasible, safe and might beneficial to enhanced
recovery after esophagectomy.
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VALIDATION OF GLIM MALNUTRITION CRITERIA WITH SGA AND
FFMI MEASUREMENT IN 150 HOSPITALIZED PATIENTS
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Rationale: Subjective Global Assessment (SGA) is a recognized and
validated method for malnutrition diagnosis. However, recently a
global consensus of numerous clinical nutrition societies has proposed
the Global Leadership Initiative on Malnutrition (GLIM) criteria for
diagnosis and identification of malnutrition in clinical settings. The
aim of this study was to compare SGA assessment and GLIM
malnutrition criteria and to evaluate the measurement of FFMI (Fat
Free Mass Index) alone as a useful tool for malnutrition diagnosis
Methods: 150 (74 male and 76 female) hospitalized patients were
assessed for SGA, and GLIM criteria including FFMI, using BodyStat
4000, UK (N = 117 from the 150). Phase Angle (PA) was also obtained.
Statistical analysis used Pearson correlation and Stepwise multiple
Regression. The study was approved by local IRB.
Results: Mean age was 58 ± 18 years, mean BMI was 27.8 ± 6.7 kg/m2.
Diagnosis included 69.8% Mild and moderate malnutrition (SGA A and
B) and severe malnutrition was found in 30.2% patients. GLIM
malnutrition criteria was correlated with SGA assessment (R = 0.353,
p≤ 0.001). GLIM was better correlated with low FFMI alone (R = 0.566
p≤ 0.001), but not with PA (R =−0.316, p < 0.44). SGA had a poor
correlation with PA (R =−0.315, p = 0.45). A stepwise multiple regres-
sionwas conducted to evaluate whether SGA, low FFMI scores and Dry
Lean Body Mass (DLBM) are necessary to predict GLIM malnutrition
criteria. Themultiple correlationcoefficientwasR2 = 0.782, (p < 0.0001)
indicating approximately that most of the variance (78.2%,) could be
accounted by low FFMI (R2 = 0.591, p≤ 0.001), scores SGA (R2 = 0.742,
p≤ 0.00), and DLBM (R2 = 0.782, p≤ 0.01).
Conclusions: In hospitalizedpatients, theGLIMmalnutrition criteria are
significantly correlated to SGA, low FFMI, and DLBM. GLIMmalnutrition
criteria can assess malnutrition. GLIM is highly correlated to FFMI.
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MALNUTRITION IN CHILDREN AND ADOLESCENTS WITH
MALIGNANT NEOPLASMS: A NEW PARAMETER FOR
CLASSIFICATION AND EARLY IDENTIFICATION?
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* Corresponding author.
Rationale:Malnutrition in cancer is a frequent finding, occurring both
by the biochemistry of malignant tumor cells and by treatment
toxicity. To date, no simple instrument has been proposed worldwide
that best identifies the state of malnutrition in this population, since
BMI has several limitations. The main objective of this work was to
identify cutoff values of calf circumference (CC) for malnutrition in
children and adolescents with malignant neoplasms.
Methods: A cross-sectional study that assessed patients from 0 to 19
years old at a Pediatric Oncology Specialized Institute between
October 2015 and April 2017. Measurements of weight (kg), height
(cm), CC (cm) were evaluated, and BMI were calculated. ROC curves
were performed, with sensitivity and specificity analysis, considering
the gold standard BMI z-score, to identify cutoff points of CC for
malnutrition. Statistical significance was p < 0.05.
Results: Among the 1794 assessments, 56,3% (n = 1011) were male.
Taking into consideration the best sensibility and specificity, area
under the curve, and confidence interval 95% (CI95%) the cutoff values
of CC, in centimeters to identify undernutrition, according to the age
range, in years (y), for males, were: 0–1 y: ≤17,2 cm; 2–5 y: ≤18,8 cm;
6–9 y: ≤23,9 cm; 10–12 y: ≤25,3 cm; 13–15 y:≤28,2 cm; 16–19 y:
≤32,0 cm; and for females:0–1 y: ≤15,4 cm; 2–5 y: ≤18,9 cm; 6–9 y:
≤24,1 cm; 10–12 y: ≤24,4 cm; 13–15 y: ≤29,1 cm; 16–19 y: ≤30,2 cm;
(p < 0,001). Malnutrition was observed in 30.14% of the sample,
considering the classification by CC, and in 13.3%, considering the BMI
z-score.
Conclusions: It is concluded that CC is a good parameter of
malnutrition in children and adolescents with malignant neoplasms,
better than BMI, besides being simple and easy to apply.
Disclosure of Interest: None declared.
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EVALUATION OF SYNERGIC POTENTIAL EFFECTS BETWEEN INULIN
AND VOLUNTARY EXERCISE DURING OBESITY
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P. Cani1, J.P. Thissen2, A. Neyrinck1, N. Delzenne1. 1Louvain Drug
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Catholique de Louvain, Bruxelles, Belgium
* Corresponding author.
Rationale: The gut microbiota can be influenced by dietary prebiotics,
which have been proposed as modulators of behavior andmetabolism
in obesity. Here we tested the hypothesis of the interest to combine
physical exercise and prebiotics in a model of diet-induced obesity.
Methods: 45 male C57BL/6J mice were randomized in: 1) Control diet;
2) High-fat diet (HFD, 45% kcal from fat); 3) HFD + Inulin (0.2 g/day/
mice) (HFD+ I); 4) HFD + exercise using a voluntary running wheel
(HFD + Ex); 5) HFD+ Inulin + Exercise (HFD + I + Ex). Mice were indi-
vidually housed (n = 9 per group), a lockedwheelwas placed in the cage
of sedentarymice and the experiment lasted for eightweeks. Behavioral
testing using a light/dark box and an oral glucose tolerance test (OGTT)
were performed respectively during the 6th and the 7th week.
Results: Aftereightweeks, physical activitywas similar between the two
groups of mice submitted to running wheel. All mice gained a similar
bodyweight upon HFD. Only voluntary exercise limited the increased of
subcutaneous adipose tissue weight (p < 0.05). Interestingly, inulin
supplementation improved the glucose tolerance and this effect was
higherwhencombinedwith voluntaryexercise.Moreover,we found that
only inulin reduced the anxiety-like behavior, associated with a lower
level of plasmacorticosterone (p < 0.05 for inulin treatment). In addition,
the increase of cecal content – signing gut fermentation- was found in
inulin groups but the fermentation seems to be higher in active mice.
Finally, inulin increasedBifidobacterium species independentonexercise,
but furtherexpandedRoseburiaandLactobacillus specieswhencombined
with exercise.
Conclusions: Our work highlighted a synergic effect of inulin
supplementation and physical activity on glucose tolerance, both
treatment exerting differential effect on adiposity and anxiety. Future
efforts will focus on correlations existing between the changes in gut
microbiota and the beneficial consequences of both inulin and exercise
during obesity.
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THE INFLUENCE OF PREOPERATIVE WEIGHT LOSS ON GASTRIC
CANCER PATIENTS’ PROGNOSIS
L. Jiang1*, J. Yu1. 1General Surgery, Peking UnionMedical College Hospital,
Beijing, China
* Corresponding author.
Rationale: To investigate the influence of preoperative weight loss on
gastric cancer patients’ prognosis.
Methods: We conducted a retrospective study which included 363
gastric cancer patients. These patients underwent gastrectomydirectly
after being diagnosed from January 2002 to September 2006. These
patients were divided into three groups according to the percentage of
weight loss which happened during 6 months before their diagnoses:
no weight loss group (0%), mild weight loss group (<10%) and severe
weight loss group (310%). We compared the clinicopathological
characteristics and analyzed the influence of preoperative weight
loss onpatients’ survival prognosis.We used Kaplan-Meiermethods to
calculate the survival rates. Univariate analysis and multivariate
analysis were both proceeded by Cox regression model.
Results: Among the 363 gastric cancer patients, no weight loss group
had 163 patients, mild weight loss group had 128 patients and severe
weight loss group had 72 patients. The 5-year overall survivals of the
three groups were 63.2%, 53.1% and 42.5% respectively. Three survivals
were statistically significant (c2 = 78.482, P < 0.01). Univariate analysis
showed that age (95% CI: 0.282–0.527, P < 0.01), weight loss before
surgery (95% CI: 0.142–0.462, P < 0.01), tumor location (95% CI: 0.679–
0.913, P < 0.05), depth invasion (95% CI: 0.276–0.580, P = 0.000) and
lymphatic metastasis (95% CI: 0.379–0.628, P = 0.000) were all
associated with survivals of these patients. In multivariate analysis,
age (HR = 1.536, 95% CI: 1.262–1.897, P < 0.01), weight loss before
surgery (HR = 1.632, 95% CI: 1.479–1.963, P < 0.01), depth invasion
(HR = 1.926, 95% CI: 1.653–2.112, P = 0.000) and lymphatic metastasis
(HR = 1.647, 95% CI: 1.514–1.709, P = 0.000) were independent prog-
nostic factors for gastric cancer patients’ survival.
Conclusions: Gastric cancer patients with weight loss 310% before
surgery had the worst outcomes. Preoperative weight loss may be a
poor independent prognostic factor for gastric cancer patients.
Perioperative nutrition support should be implemented for improving
the prognosis of gastric cancer patients.
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PROGNOSTIC SIGNIFICANCE OF MUSCLE DEPLETION IN END-STAGE
CANCER PATIENTS
N.Mori1*, K.Maeda1, T. Nonogaki2, Y. Ishida3, T. Kimura3. 1Palliative Care
Center, 2Department of pharmacy, 3Department of Nutrition, Aichi
Medical University, Nagakute, Japan
* Corresponding author.
Rationale: Although muscle depletion is associated with adverse
outcomes in cancer patients, change of mass, quality, and strength of
muscle in end-stage cancer remains unclear. We investigated their
potential as prognostic factors in end-stage cancer.
Methods: A retrospective study of all adult solid cancer patients
referred to our palliative care team from July 2017 to April 2018 was
conducted. We analyzed associations between survival time and;
muscle mass (psoas muscle index [PMI]); muscle density of psoas
muscle; pinch grip strength (PGS); edema and inflammation (C-
reactive protein [CRP]), at first consultation. Cox’s proportional hazards
model was used to estimate the median mortality hazard ratio (HR) of
each muscle variable.
Results: Of 78 solid cancer patients (45% male, median age 67 years),
median survival was 91 (range 50–186, 95% CI) days. After adjustment
for age, gender, edema and CRP as potential confounders, loss of PMI
(HR 0.998, range 0.995–0.999, 95% CI, p = 0.01), muscle density (0.999
0.998–0.999, 95% CI, p = 0.019) and PGS (0.699, 0.502–0.974, 95% CI,
p = 0.034), independently predicted overall survival time.
Conclusions: Depletion of muscle mass and strength were independ-
ent predictors of survival in end-stage cancer patients. PMI, muscle
density and PGS are feasible prognostic factors in end-stage cancer.
Disclosure of Interest: None declared.
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TOLL-LIKE RECEPTOR 9 PLAYS AN IMPORTANT ROLE IN
ANGIOTENSIN II-INDUCED ATHEROSCLEROSIS
S. Nishimoto1,2*, D. Fukuda2,3, M. Usami1, M. Sata2. 1Clinical Nutrition
and Dietetics, Konan Women’s University, Kobe, 2Cardiovascular
Medicine, 3Cardio-Diabetes Medicine, Tokushima University Graduate
School, Tokushima, Japan
* Corresponding author.
Rationale: Chronic vascular inflammation causes atherosclerosis. Toll-
like receptor (TLR) 9 recognizes bacterial unmethylated DNA and plays
a role in innate defense, whereas it can also provoke inflammation in
response to fragmented DNA released from damaged mammalian
cells. However, the role of TLR9 in the development of atherosclerosis
remains unknown. Here, we investigated whether genetic deletion of
TLR9 attenuates atherosclerosis in apolipoprotein E knockout (ApoE
KO) mice.
Methods: TLR9/ApoE double knockout (dKO) mice were generated by
crossing ApoE KO mice and TLR9 KO mice, and infused angiotensin II
(Ang II) (1000 ng/kg/min) subcutaneously for 28 days using osmotic
pump. The concentrations of double-stranded DNA (dsDNA) and
single-strand DNA (ssDNA) in plasmawere measured using a Quant-iT
PicoGreen dsDNA Assay Kit and QuantiFluor ssDNA System, respect-
ively. The gene expression of inflammatory molecules in vascular
tissue and macrophages was evaluated by immunohistochemical
analysis and real-time qPCR. We used peritoneal macrophages for in
vitro experiments.
Results: There were no differences in blood pressure and plasma lipid
levels between two strains of mice. Ang II infusion increased plasma
levelsof ssDNAanddsDNA,endogenous ligandsofTLR9, inbothstrainsof
mice (P < 0.001, respectively). TLR9/ApoE dKO mice showed less
atherosclerotic lesion progression in the aortic arch and less lipid
accumulation in atherosclerotic plaques in the aortic root comparedwith
ApoE KOmice (P < 0.05, respectively). TLR9/ApoE dKOmice also showed
less gene expression of inflammatory molecules (e.g., ICAM-1 and MCP-
1) in the abdominal aorta. The result of cell sorting experiment using
atherosclerotic aorta obtained from Ang II-infused ApoE KO mice
demonstrated that macrophage population mainly expressed TLR9 in
this tissue. Similarly, pharmacological blockade of TLR9 attenuated
vascular inflammation and atherogenesis in Ang II-infused ApoE KO
mice. ATLR9 agonistmarkedly promoted pro-inflammatoryactivation of
Apoe-/- macrophages. We, therefore, performed in vitro experiments
using thioglycolate-stimulated peritoneal macrophages. CpG ODN,
agonistic oligonucleotide for TLR9, markedly promoted the expression
of inflammatory molecules (e.g., ICAM-1 and MCP-1) in ApoE KO
macrophages but not in TLR9/ApoE dKOmacrophages.
Conclusions: Our results suggested that Ang II infusion stimulates the
TLR9 signaling in macrophages, leading to the promotion of vascular
inflammation and atherosclerosis. TLR9 may serve as a potential
therapeutic target for atherosclerotic diseases.
Disclosure of Interest: None declared.
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REDUCED POSTPRANDIAL SERUM TRIGLYCERIDE AFTER A MEAL
PREPARED USING HOT AIR FRYING: A RANDOMIZED CROSSOVER
TRIAL
S. Ge1*, X. Feng1, M. Li2, H. Liu3, P.B. Higgins2, Y. Tang3, Y. Cao3, J. Shen3,
S. Jin3. 1Clinical Nutrition, Shanghai Jiaotong University Affiliated Sixth
People’s Hospital, 2Personal Health, Philips Research, 3Shanghai Jiaotong
University Affiliated Sixth People’s Hospital, Shanghai, China
* Corresponding author.
Rationale: Elevated circulating non-fasting triglyceride (TG) or post-
prandial triglyceride (ppTG) is as an independent contributor to risk for
coronary heart disease. We hypothesized that a commonly consumed
friedmeal (including French fries and chickennuggets) preparedbyahot
air frying technique (airfrying) would result in lower ppTG responses
than the same meal prepared by conventional deep fat frying.
Methods:We conducted a randomized crossover meal test trial with a
7 day washout and standardized pre-test evening meals to evaluate
the effects of hot air frying compared to deep fat frying in young
healthy male (n = 10) and female subjects (n = 6). Serial blood samples
(baseline, 30, 60, 90, 120, 150, 180, 240, 300, 360, 420 mins) were
collected for biochemical analysis before and after administration of
both meals. Participants were blinded to the meal type and detailed
dietary intake assessments were performed throughout the trial.
Results: The subjects’habitual dietswere similar before each of themeal
tests. Hot air frying led to a large reduction (74%, 95%CI 70–78%) in the
total fat content of the meal and intake of the meal produced a lower
ppTG response (67%, 95% CI 52–82%) compared to deep fat frying
(P < 0.01). No differences in glucose (P = 0.34), insulin (P = 0.62), or GLP-1
(P = 0.35) responses were found. Satiety was not affected by meal type.
Conclusions: Hot air frying of a common meal results in lower ppTG
excursions. Hot air frying technologies are effective for lowering
mealtime fat intakes and have demonstrable beneficial effects on an
established cardiovascular risk factor.
Disclosure of Interest: S. Ge Grant/Research Support from: Research
Supported by Philips, X. Feng: None declared,M. Li Other: employee of
philips, H. Liu: None declared, P. Higgins Other: employee of philips,
Y. Tang: None declared, Y. Cao: None declared, J. Shen: None declared,
S. Jin: None declared.
PT04.6
CYTOTOXIC POTENTIAL OF LIPOSOMES CONTAINING N-3
POLYUNSATURATED FATTY ACIDS IN THE LIPID BILAYER AND 5-
FLUOROURACIL IN THE AQUEOUS CORE (LIPUFU) ON TWO
DIFFERENT HUMAN COLORECTAL ADENOCARCINOMACELL LINES
Y.M. Dupertuis1*, A. Viglione1, N. Boulens2, F. Delie2, E. Allémann2,
C. Pichard1. 1Clinical Nutrition, Geneva University Hospital, Geneva,
2School of Pharmaceutical Sciences, University of Geneva, University of
Lausanne, 1211 Geneva, Switzerland
* Corresponding author.
Rationale: Previous studies have shown a potential synergy between
n-3 polyunsaturated fatty acids (n-3 PUFAs) and 5-fluorouracil (5-FU),
the commonly used chemotherapeutic agent in colorectal cancer
treatment1. This studyaims at evaluatingwhether the incorporation of
n-3 PUFAs into the lipid bilayer of liposomes loaded with 5-FU
(LIPUFU) is more efficient than n-3 PUFAs or 5-FU administration
alone.
Methods: Liposomal formulations containing docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA) in the lipid bilayer and 5-FU in
the aqueous core (LIPUFU) were obtained by the classic thin film
hydration method followed by sonication and ultracentrifugation
cycles. Control liposomes (LIP)with only n-3 PUFAs (LIPU) or only 5-FU
(LIFU)were produced in a similarway. Characterization of the different
liposomal formulations was performed with zetasizer and transmis-
sion electron microscopy. The incorporation rates of n-3 PUFAs and 5-
FU were determined by gas chromatography and high performance
liquid chromatography, respectively. The effects of these different
liposomal formulations on the cell cycle, apoptosis and viability were
evaluated by fluorescence activated cell sorting analyses in twohuman
colorectal adenocarcinoma cell lines differing in 5-FU sensitivity,
LS174T (p53+/+, bax−/−) being less sensitive thanHT-29 (p53−/0, bax+/+).
Results: Liposomal formulation gave stable LIPUFU at 4°C for at least 3
months with uniform size of 166 ± 12 nm, polydispersity index of 0.12
andzetapotential between−56.5and−36.9 mV.The incorporationrate
of DHA, EPA and 5-FUwas 66.4 ± 15.8, 91.4 ± 19.1 and 13.8 ± 0.7 µg/mL,
respectively. LIPUFU were more cytotoxic than LIP, LIFU and LIPU
on both HT-29 and LS174T cells. Similar to LIFU, LIPUFU increased
the percentage of cells in S-phase of the cell cycle, in apoptosis and
necrosis.
HT-29 LS174T
Viable cells
(%)
S-phase
cells (%)
Viable cells
(%)
S-phase
cells (%)
Controls 100.0 ± 0.9* 10.8 ± 1.2* 100.0 ± 0.5* 12.5 ± 0.7*
LIP 100.3 ± 0.9* 12.3 ± 0.8* 99.2 + 1.0* 13.1 ± 0.6*
LIFU 98.5 ± 0.5* 27.6 ± 2.2* 98.8 ± 0.8* 16.0 ± 2.1
LIPU 99.4 ± 2.0* 9.5 ± 1.9* 87.8 ± 2.7 6.8 ± 1.0*
LIPUFU 86.4 ± 9.6 20.6 ± 1.3 86.0 ± 6.8 15.1 ± 1.0
*Means ± SD significantly different from LIPUFU (t-test, P≤ 0.05); n = 4/
condition.
Conclusions: These preliminary results show that the LIPUFU
formulation is stable and the combination of n-3 PUFAs and 5-FU in
a single stealth liposome can decrease the viability of cancer cell lines
through a possible additive or synergistic effect.
Reference
1. Volpato M and Hull MA. Cancer Metastasis Rev. 2018 Sep;37
(2–3):545–555. doi: 10.1007/s10555–018-9744-y.
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SERUM N-6 POLYUNSATURATED FATTY ACIDS AND RISK OF ATRIAL
FIBRILLATION IN MEN
B. Tajik1*, T.-P. Tuomainen1, J.K. Virtanen1. 1Public Health and Clinical
Nutrition, University of Eastern Finland, Kuopio, Finland
* Corresponding author.
Rationale: n-6 polyunsaturated fatty acids (PUFA) have been asso-
ciated with lower risk of cardiovascular disease, but little is known
about their antiarrhythmic properties. We investigated the associa-
tions of the serum n-6 PUFAs with the risk of atrial fibrillation (AF).
Methods: 2450 men free of AF at baseline from the prospective,
population-based Kuopio Ischaemic Heart Disease Risk Factor Study
(KIHD) aged 42–60 years in 1984–1989 were included. The n-6 PUFAs
included linoleic acid (LA), arachidonic acid (AA), γ-linolenic acid (GLA)
and dihomo-γ-linolenic acid (DGLA). In the analyses, the n-6 PUFAs
were expressed as the proportion of all serum fatty acids. All AF events
that occurred between study entry and December 31, 2014, were
S42 Abstracts / Clinical Nutrition 38 (2019) S33–S58
included. Cox proportional hazards regression were used to estimate
hazard ratio (HR) of incident events.
Results: The mean±SD serum concentrations were 26.4 ± 4.7% for LA,
4.8 ± 1.1% for AA, 0.3 ± 0.1 for GLA and 1.3 ± 0.3 for DGLA. During the
mean 22.4-y follow-up, 337 men were diagnosed with AF.
In the analysis adjusted for multiple potential confounders, the HR for
incident AF in the highest vs. the lowest serum LA quartile was 0.76
(95% CI 0.58–1.00, P = 0.07). In contrast, the other n-6 PUFAs were not
associated with the risk (AA: extreme-quartile HR 0.98, 95% CI 0.74–
1.30, P = 0.52; GLA: extreme-quartile HR 1.04, 95% CI 0.80–1.35,
P = 0.78; and DGLA: extreme-quartile HR 1.12, 95% CI 0.85–1.46,
P = 0.70).
Conclusions: Higher serum concentration of the major n-6 PUFA, LA,
but not the other n-6 PUFAs, was associated with lower risk of AF
among middle-aged and older men.
Disclosure of Interest: None declared.
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METABOLIC DISBALANCE AFTER ACUTE PESTICIDE
EXPOSURE – EXPERIMENTAL STUDY
C. Cobilinschi1*, R.C. Tincu2, A. Totan3, C.O. Cobilinschi4, I.F. Tincu5,
R.A. Macovei2. 1Anesthesiology and Intensive Care, 2Anesthesiology and
Intensive Care – Toxicology, Clinical Emergency Hospital Bucharest,
3Biochemistry Departement, Carol Davila University of Medicine and
Pharmacy, 4Rheumatology and Internal Medicine, Saint Mary Hospital,
5Pediatrics, Grigore Alexandrescu Clinical EMergency Hospital for
children, Bucharest, Romania
* Corresponding author.
Rationale: In order to fulfill the continuous growth of food demand,
pesticide use rose uncontrollably, becoming an important environ-
mental risk factor. Despite their efficiency in crop protection and
vector-borne disease control, organophosphate compounds are
associated with severe toxic effects, including metabolic disturbances.
Methods: In order to evaluate the acute changes of metabolic status
after organophosphate poisoning we performed an experimental
study on 13 Wistar rats. They were distributed in two groups – study
group A and control group B. Firstly, 0.1 mg/kg chlorpyrifos was
administered by oral gavage in group A and six hours later blood
samples were taken to determine the level of cholinesterase, blood
sugar, insulin, IGF-1 and cortisol. In group B an equivalent quantity of
normal saline was administered through the same method and blood
samples were collected in order to determine the above mentioned
parameters. Blood drawing procedures and organophosphate admin-
istration were performed under general anesthesia according to
international guidelines. The statistical analysis was performed using
the SPSS statistical software, setting a standardized significant P value
at 0.05.
Results: Levels of cholinesterase were significantly decreased after
exposure to chlorpyrifos and the difference between the two groups
was of 1458 U/L (p < 0.001). Glucose level was significantly higher in
group A (103 mg/dl ± 5.8 vs 117 mg/dl ± 9.7) (p = 0.015). Insulin and
IGF-1 levels were also significantly increased in the poisoned group.
Cortisol levels were significantly higher after clorpyrifos administra-
tion (358.75 ± 43 vs 241.2 ± 35) with p = 0.0004.
Conclusions: In this study we demonstrate that acute exposure to
organophosphates may cause important metabolic disturbances, even
at relatively low doses. Moreover, the identified changes on glucose
profile sustain the trending published data that continuous pesticide
exposure is a risk factor for further metabolic diseases.
Disclosure of Interest: None declared.
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ALUMINIUM BLOOD LEVELS IN INPATIENTS WITH PARENTERAL
NUTRITION: COMPOUNDED VERSUS MULTICHAMBER-BAG
PARENTERAL NUTRITION
D. Berlana1*, S. Garcia Garcia1, C. Puiggros2, I. Cardona Pascual1,
R. Albertos Martell3, L. Gomez Ganda1, R. Burgos Pelaez4, J.B. Montoro
Ronsano1. 1Pharmacy, Vall Hebron Barcelona Hospital Campus,
Barcelona, 2Nutrition Suport Unit, Vall Hebron Barcelona Hospital
Campus, Barceloan, 3Critical Care Unit, 4Nutrition Suport Unit, Vall
Hebron Barcelona Hospital Campus, Barcelona, Spain
* Corresponding author.
Rationale: Aluminum (Al) is a known contaminant of pediatric
parenteral nutrition (PN). Despite this fact, few studies have been
performed in adult patients, and to our knowledge none with multi-
chamber-bags (MCBs). The objective is to assess blood Al levels (BLAIs)
in adult inpatients with PN, regarding the type of PN (MCB or
compounded), PN days, liver and renal parameters.
Methods:We conducted a retrospective study from prospective data.
Adult inpatients with PN from november 2018 to March 2019 with
BLAl data were included and placed into two groups (MCB or
compounded PN). Plasma Al concentration was retrospectively
gathered from the patient charts of all inpatients receiving PN. BLAl
obtained were compared depending on the type of PN, lenght of PN
therapy, and renal and liver blood parameters. Linear regression
models were performed with BLAl as dependent variable, and type of
PN, length of PN, and liver and renal parameters as independent
modifiers variables.
Results: A total of 80 samples from 55 patients were included. Mean
BLAl value was 2.8 ± 2.0 µg/L for samples collected after a mean of
23.6 ± 40.9 days of PN. A total of 47 samples (58.8%) were collected
during the administration of MCB PN and 33 samples (41.2%) during
the administration of compounded PN. Mean liver parameter values
were: GGT 330.6 ± 372.8 U/L, alcaline phosphatase 241.8 ± 166.4 U/L;
the % of patients with hyperbilirubinemia (bilirubin >1.2 mg/dL) was
37.5%. Data were compared regarding the variables mentioned. Mean
BLAl was higher in the compounded group, 3.0 ± 2.0 µg/L versus
2.7 ± 2.0 µg/L in the MCB group. However, no significant differences in
mean BLAl were found regarding the type of PN (MCB or com-
pounded), length of PN, use of renal replacement therapy, renal
function, or liver parameters (GGT, alkanine phosphatase). However,
linear regression models showed a positive association between BLAl
and hyperbilirubinemia; beta coefficient 1.42 (95%CI 0.56–2.28)
p < 0.01.
Conclusions: The BLAl could not be influenced by the type of PN (MCB
or compounded). However the study found difference in BLAl in
patients with hyperbilirubinemia. Monitor the BLAI and limit Al
exposure in patients with hyperbilirubinemia should be done to avoid
adverse effects related to Al.
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SCREENING TESTS FOR DYSPHAGIA IN MOTOR NEURON DISEASE
E. Romero1,2*, M.N. Virgili1,2, M.A. Barceló2,3, R. Dominguez2,4,
M. Povedano2,4, V. Herrera1, A. Prats1 on behalf of Functional Unit of
Motor Neuron Disease (FUMND), Bellvitge University Hospital (HUB).
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Rationale: Deglutition disorders are common in patients with motor
neuron disease (MND). Oropharyngeal dysphagia (OD) can occur in
80% of patients. OD contributes negatively in the evolution of MND.
An early diagnosis of OD would allow a better nutritional approach,
which in turn would improve the quality of life of the patient.
Currently, there are no specific clinical tests for the diagnosis of
dysphagia in MND. In this study, we aimed to asses specificity and
sensitivity of the dysphagia screening tests available for other diseases
(EAT-10), as well as to compare the specific swallow assessment scale
for ALS (ALS-SS) results with videofluoroscopy (gold standard
technique for the diagnosis of dysphagia).
Methods: From 154 patients visited in the Functional Unit of MND of
the “Hospital de Bellvitge,” between September 2017 and July 2018,
with different disease status progression, and who met inclusion
criteria, 46 agreed to participate in our study. 52.17% were women;
bulbar affection was in 78.3% patients which 30.6% with bulbar onset
and 69.4% in later stages of evolution. OD was assessed in all patients
with videofluoroscopy and dysphagia screening tests: EAT10 and
subscale ALS-SS. Participants were also asked to fill out a quality of life
questionnaire (SwalQoL), from which a selection was made of the 6
items that were considered of greatest interest for the assessment of
dysphagia.
Results: Compared with videofluoroscopy, ALS-SS subscale showed a
better specificity (87.5%) and sensitivity (72.9%) than EAT10, which
specificity and sensitivity were 70.3% and 75.0% respectively. SwalQoL
6 items selection showed a specificity of 100% and a sensitivity of 50%.
Conclusions: ALS-SS gives similar results to those of videofluoroscopy.
The EAT-10 test is not specific enough to discriminate dysphagia in
MND patients, although it is the most widely used by dieticians as
screening for dysphagia. In contrast, Swal QoL 6 items selection can
perform an interesting test of discrimination of patients who do not
really have OD in patients with MND. In order to describe the severity
of the dysphagia and adjust the diet to the patient’s needs, it will be
necessary to perform a videofluoroscopy.
Disclosure of Interest: None declared.
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CLINICAL APPLICATION OF RAW CORN STARCH-BASED DIET IN
PATIENTS WITH INSULINOMA: A BEFORE-AFTER PROSPECTIVE
STUDY
R. Li1*, W. Chen1. 1Clinical Nutrition, Peking Union Medical College
Hospital, Beijing, China
* Corresponding author.
Rationale: Insulinoma, a rare insulin-secreting tumor, may cause
severe hypoglycemia and subsequent hyperphagia as well as weight
gain. The nutritional interventions play a role in its adjuvant
management. This is the first study that tried to stabilize blood
glucose and weight in unoperated insulinoma patients by using raw
corn starch (RCS)-based diet.
Methods: 28 consecutive patients with unoperated insulinoma were
offered a structured diet with 60%∼70% from carbohydrate. RCS
constituted 30%∼50% of daily carbohydrate, and was administered as
snacks between meals or every 4 hours at night.
Results: The 28 patients (8 males) were at age of 47.6 ± 14 years (range
21∼75 years). Among them, 20 patients underwent the dietary
therapy during an average waiting time of 36.9 ± 41.9 days (range
4∼192 days) before curative surgery, while 8 patients with unresect-
able insulinoma relied primarily on long-term RCS-based intervention
for an average time of 95.6 ± 92.8 days (range 20∼267 days). Before the
dietary intervention, the mean fasting blood glucose (FBG) was
2.27 ± 0.64 mmol/L (range 0.9∼3.6 mmol/L), with onset of hypogly-
cemia (BG < 2.8 mmol/L) occurring more than 3 times/week in all
subjects. The median BMI was 27.87 ± 5.07 kg/m2 (range
17.06∼40.06 kg/m2), with 14 (50.0%) patients complicated with
obesity, and 8 (28.6%) with overweight. After nutritional therapy for
over 1 week, the mean FBG was significantly elevated to 3.30 ± 0.91
mmol/L (range 1.8–5.7 mmol/L) (P < 0.001), and frequency of hypo-
glycemiawas decreased to less than twice/week in 75% of subjects (21
cases). Of 13 patients having RCS-based diet for over 4 weeks, weight
remained stable in 10. Besides, 2 cases of mild diarrhea, and 1 case of
flatulence were reported among patients, but relieved when RCS was
slightly reduced.
Conclusions: RCS-based diet constitute a feasible and safe adjuvant
therapy to alleviate hypoglycemia and weight gain for unoperated
insulinoma patients.
Disclosure of Interest: None declared.
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OPTIMAL CUTOFF VALUE OF THE GERIATRIC NUTRITIONAL RISK
INDEX AS A NUTRITIONAL SCREENING TOOL
Y. Ishida1,2*, K. Maeda2, T. Nonogaki3, N. Mori2. 1Department of
Nutrition, Aichi Medical University Hospital, 2Palliative Care Center,
Aichi Medical University, 3Department of Pharmacy, Aichi Medical
University Hospital, Nagakute, Japan
* Corresponding author.
Rationale: The Geriatric Nutritional Risk Index (GNRI) predicts
nutritional risk and poor outcomes in geriatric patients. However,
little is known about its optimal cutoff value for nutritional screening
in older adults. This study aimed to identify the GNRI’s optimal cutoff
value to screen older patients with malnutrition.
Methods: A cross-sectional study of 5,873 consecutive patients aged
≥65 years admitted to an academic hospital was conducted. The
GNRI was calculated using actual and ideal body weight, body
height, and albumin level. Receiver-operating characteristic (ROC)
curve analyses were performed to obtain the GNRI’s optimal cutoff
value against values of validated screening tools: Mini Nutritional
Assessment Short Form (MNA-SF) ≤11 points and Malnutrition
Universal Screening Tool (MUST) ≥1 point. The validation of the
obtained cutoff values was examined per the concordance rate of
malnutrition diagnosis based on the European Society of Clinical
Nutrition and Metabolism (ESPEN) criteria between GNRI-, MNA-SF-,
and MUST-based diagnoses.
Results: The mean age was 76.0 ± 7.0 years. Approximately 45.6% and
39.7% of patients were at risk of malnutrition based on their MNA-SF
and MUST scores, respectively. ESPEN-defined malnutrition was
diagnosed in 16.8% and 17.3% of patients who completed the MNA-
SFandMUSTas the first-step tool, respectively. The ROC curve analyses
showed that the GNRI’s optimal cutoff value forMNA-SF≤11was 95.92
(area under the curve [AUC]: 0.827 [0.817–0.838], p < 0.001) and that
for MUST ≥1 was 95.95 (AUC: 0.788 [0.776–0.799], p < 0.001). In
adapting GNRI <96 as the first screening step in diagnosing
malnutrition, the concordance rates of the comparisons were 98.5%
for both MNA-SF- and MUST-based diagnoses.
Conclusions: The GNRI, with an optimal cutoff value of <96, might be
easy to use for nutrition screening andmalnutrition diagnosis in older
adults.
Disclosure of Interest: None declared.
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EFFECTSOFKRILLOILONOMEGA-3 INDEXANDCARDIOMETABOLIC
RISK FACTORS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER
DISEASE (NAFLD): PILOT RANDOMIZED DOUBLE-BLIND TRIAL
D. Vranesic Bender1*, M. Zupcic2, M. Hok3, I. Delas4, A. Barisic1,
D. Ljubas Kelecic1, I. Karas1, M. Premuzic5, Z. Krznaric1. 1Unit of Clinical
Nutrition, University Hospital Centre Zagreb, 2Vitaminoteka, 3Faculty of
Food Technology and Biotechnology, 4Department of Chemistry and
Biochemistry, Zagreb School of Medicine, 5Department of
Gastroenterology and Hepatology, University Hospital Centre Zagreb,
Zagreb, Croatia
* Corresponding author.
Rationale: NAFLD is considered a liver manifestation of metabolic
syndrome and the key role in its pathogenesis plays insulin resistance.
There is currently no standardized pharmacological treatment and the
only proven therapeutic strategy is lifestyle modification. Omega-3
fatty acid treatment may have beneficial effects in regulating hepatic
lipid metabolism, adipose tissue function, and inflammation.
Considering that NAFLD patients have a higher risk of developing
cardiovascular disease, the aim of this study was to examine the
influence of omega-3 fatty acids from krill oil on various risk factors in
NAFLD patients.
Methods: The study was randomized, double blind and placebo
controlled, and lasted for 6 months. It included 14 NAFLD patients,
ages 39 to 64, divided into two groups. In the intervention group,
subjects consumed krill oil capsules (1500 mg krill oil, 36 mg vitamin
E,165 mcg selenium daily), while in placebo group subjects consumed
soybean oil capsules (1500 mg soybean oil daily). The patients were
diagnosed with NAFLD by the standard diagnostic algorithm proced-
ure and tools including ultrasound. Methods included standard
anthropometric measurements, biochemical tests: serum lipids, liver
enzymes, calculation of value of fatty liver index (FLI) as well as
measurement of omega-3 index (level of EPA and DHA in red blood
cells) according to method by Rose and Oklander and ISO method
5509.
Results: The results of the study showed that there was a statistically
significant reduction in body mass (p = 0.028), BMI (p = 0.043) and
waist circumference (p = 0.041) in the intervention group compared to
the placebo group where the change was not statistically significant.
None of the groups showed statistically significant changes in serum
lipids and liver enzymes. Fatty liver index decreased in intervention
study in 75% patients with NAFLD, while in placebo group, FLI
increased in 66% of the subjects.
Results of assessment of cardiovascular risk before the intervention
are indicating insufficient cardio-protection in both groups because of
low omega-3 index: 3,25 ± 1,14% in females and 3,74 ± 0,97% in males.
After the intervention, there was a 7,7% increase in omega-3 index in
the intervention group, while therewas 6% decrease in omega-3 index
in placebo group.
Conclusions: Improvements in waist circumference, omega-3 index
and fatty liver index in the intervention group indicate the potential of
use of krill oil in the population of NAFLD patients. Considering that
this is the first research on this subject, further studies should involve a
larger number of subjects that would establish the dose of krill oil
omega-3 fatty acids as a treatment and determine the preferable
duration of therapy.
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OBESE INDIVIDUALS: PRELIMINARY RESULTS OF A RANDOMIZED-
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Rationale: Physical activity (PA) and dietary modifications are
cornerstones in the treatment of obesity and related cardiometabolic
risk factors. However, many obese adults do not achieve the
recommended PA-levels (150 min/week) and lack of time is among
the reasons most commonly cited for insufficient PA. High-intensity
interval training (HIIT) has emerged as a time-efficient exercise
strategy to improve various health outcomes. However, it was also
argued that HIIT might be inappropriate for sedentary individuals
because it is too strenuous and potentially unsafe for patient
collectives. This study compared the effects of two extremely time-
efficient training regimens (15 min/session), either performed as high-
(HIIT) or moderate-intensity interval training (MIIT), on cardiometa-
bolic health in obese individuals.
Methods: 44 obese subjects (BMI: 37.6 ± 5.5 kg/m2, body fat: 44 ± 7%)
with ≥2 further risk factors were randomized to HIIT, MIIT or a control
group (CON). All groups received nutritional counselling (aim: –
500 kcal/day). HIIT and MIIT were performed on cycle ergometers (2×
weekly for 12 weeks) consisting of 5 × 1 min at 85–95% and 70–80%
maximum heart rate, respectively. Primary endpoints were the
metabolic syndrome z-score (MetS, determined from fasting blood
glucose, HDL-cholesterol, triglycerides, waist circumference and blood
pressure) and maximum oxygen uptake (VO2max).
Results: HIIT andMIITwere both well tolerated and no adverse events
occurred. All groups significantly reduced body weight (P < 0.05,
average: 2.9 kg) but only the exercise groups improved MetS and
VO2max. HIIT improved MetS (–1.5 units, P < 0.01) and VO2max
(+2.9 ml/kg/min, P < 0.001) to a greater magnitude than MIIT (MetS: –
1.2 units, P < 0.05; VO2max: +1.8 ml/kg/min, P < 0.05).
Conclusions: The preliminary results of this study indicate that
extremely time-efficient interval trainingmay significantly improve in
cardiometabolic health in obese individuals in an intensity-dependent
manner. Clinically relevant health benefits can also be achieved with
moderate-intensity intervals. Moreover, these findings underpin the
crucial role of exercise in improving health outcomes that goes far
above simple weight loss.
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PURIFIED EGG PROTEIN SUPPLEMENTATION HAS BENEFICIAL
EFFECTS ON BODY COMPOSITION, METABOLISM AND EATING
BEHAVIOR AND RESULTS IN A MORE SUSTAINED WEIGHT LOSS
THAN LOW FAT DIET
J.-F.R. Brun1*, L. Hammoudi1, C. Chevalier1, E. Raynaud de Mauverger1.
1Clinical Physiology, U1046 INSERM, UMR9214 CNRS, Université de
Montpellier, Département de Physiologie Clinique, Unité D’Explorations
Métaboliques (CERAMM), Service Central de Physiologie Clinique, Hôpital
Lapeyronie Chu Montpellier, France, Montpellier, France
* Corresponding author.
Rationale: An increasing body of literature emphasizes the interest of
moderate enrichment in protein for treating obesity and its metabolic
consequences. However, egg proteins that are known to have the
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highest biological value have not been studied in this context.
We investigated in self-restricted obese individuals with low
protein intake (PI) (<0,7 g · kg−1 · d−1) the effects of increasing PI up
to 1.5 · −1 · d–1 on body weight, body composition, eating behavior,
resting metabolic rate (RMR) and kidney function.
Methods: Randomized controlled trial over 2 months. Twelve
subjects were given daily supplements of a formula of purified high
biological value egg protein (PEP) (Ovamine(R) Nuvia laboratories,
Paris) to achieve this level of of PI while ten matched controls were
given a simple low fat high protein diet (LFHPD). Subjects were tested
before and after 2 months. Controlled follow-up trial over 18
months: 337 subjects divided into three matched groups followed
over 18 months: no change in diet or lifestyle (n = 69); LFD (n = 171),
and PEP (n = 97) targetting 1.2 · −1 · d−1 proteinwith the same purified
egg protein preparation of high biological value.
Results: Randomized controlled trial over 2months. PEP resulted in
a lowerpercentageof lipids (−13,6%p < 0,01) indiet. Appetite increased
under LFHPD and decreased under PEP (p = 0.006) with a feeling of
eating less (p < 0.01), yet in both groups, total calculated energy intake
was not decreased. Under PEP (but not LFHPD) therewas a decrease in
fat mass (−3.2 ± 1,3 kg p < 0,05). Creatinine clearance increased by 10%
under PEP (before: 149 ± 19; after: 162 ± 22 ml · min−1 p = 0.05) but not
under LFHPD. Microalbuminuria was unchanged.
Controlled follow-up trial over 18 months: In the group of control
subjects (n = 58) there was a gradual weight increase up to
+8.58 ± 0.56% of initial weight on the 18th month, while subjects on
low fat diet had lost −5.55 ± 1.31 and those receiving moderate
enrichment in protein had lost −8.07 ± 1.58. During the first 6 months
the curves of low fat diet and protein supplementation are almost
overlapped but after 8 months the difference becomes significant. At
18 mo, subjects on low fat diet have lost −5.95 ± 1.82 and those
receiving moderate enrichment in protein have lost −8.05 ± 1.87
(p = 0.023). On the whole moderate enrichment in protein induces a
weight loss >10% in 18% of the subjects and aweight loss >5–10 in 22%
of them. Visual analogic scales evidence in receiving egg protein a
decrease in appetite (p < 0.01) and nibbling (p < 0.01) and an increase
in satiety (p < 0.01). The effect on body weight is more pronounced in
three categories of subjects: those with marked excess calorie intake,
those with initial low protein intake, and those whose phase 2 insulin
response is higher.
Conclusions: PEP supplements are an easymeans for increasing PI and
reducing fat intake. They induce a slight loss in body fat, with
preservation of lean mass, and only marginal changes in glomerular
filtration.Weight loss is more pronounced (+38%) and continues over a
longer period under PEP compared to LFD. Since egg proteins are the
variety of proteins that possess the greatest biological value and have
additional biological properties beneficial for cardiovascular and
metabolic health, they are likely to represent a new promising tool
for the management of obesity and metabolic syndrome. Further
controlled studies are in progress to better assess this issue.
Disclosure of Interest: None declared.
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PRESCRIPTION TRENDS AND EFFECTS OF SODIUM–GLUCOSE
COTRANSPORTER TYPE 2 INHIBITORS ON WEIGHT AND GLYCEMIC
CONTROL IN OBESE PATIENTS WITH TYPE 2 DIABETES: A SINGLE-
CENTRE REALWORLD EXPERIENCE
C. García-Figueras-Mateos1, M. Cayón-Blanco2*. 1Internal Medicine,
2Endocrinology and Nutrition Unit, Universitary Hospital Jerez de la
Frontera, Jerez de la Frontera, Spain
* Corresponding author.
Rationale: Sodium-glucose cotransporter type 2 inhibitors (SGLT2is)
are recommended for a large spectrumof patientswith type 2 diabetes
(T2DM), because of favorable effects on glycemic control and weight.
With a view to identifying patient profile that could influence
physicians’ prescription of SGLT2is, we carried out this observational
study in routine clinical practice conditions. Outcomes after add-on
these drugs were described as well.
Methods: The study was based on a retrospective design and the
following variables were collected to identify potential influencing
factors in patient profile at baseline: gender, age, time of evolution of
T2DM, body mass index (BMI), HbA1c level and treatment with
insulin. To measure outcomes, changes in HbA1c and BMI at 6 months
after add-on, were assessed.
Results: 75 poorly controlled patients with T2DM who received any
SGLT2is as add-on therapy were analysed. There was a homogeneus
distribution according to the drugs evaluated (empagliflozin, dapagli-
flozin and canagliflozin). At baseline: age: 59.4 ± 11 years; HbA1c:
8.8 ± 1.4% duration of T2DM: 11.9 ± 8 years; 69.3% men. Macrovascular
diseasewas in 34.7%. 78.7% were on insulin. BMI at time of add-onwas
33.7 ± 6 Kg/m2. At 6months, significant reductions (p < 0.001 for every
parameter) onweight (−3 ± 0.9 Kg), BMI (−1.1 ± 0.4 Kg/m2) and HbA1c
(−1.8 ± 0.6%) were observed. There was a nonsignificant trend to
prescribe empagliflozin to patients withmacrovascular complications.
No significant changes in HbA1c, weight and BMI reductions were
detected among drugs.
Conclusions: Our experience shows SGLT2is, are mainly prescribed
in T2DM patients with high level of HbA1c, long duration of T2DM
and frequently, on insulin. There is a trend to prescribe empagliflozin
in the presence of macrovascular disease. HbA1c, weight and
BMI reductions are equivalent among different SGLT2is in our
routine clinical practice.
Disclosure of Interest: None declared.
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THE LOSS OF FAT-FREE MASS: AN EARLY EVENT IN PATIENTS WITH
MORBID OBESITY UNDERGOING BARIATRIC SURGERY
M. Comas Martínez1*, M. Sánchez1, D. Romero1, E.M. Fidilio1,
A.M. Ortiz1, R. Burgos2, A. Ciudin1. 1Endocrinology and Nutrition,
2Nutritional Suport Unit, Vall Hebron Hospital, Barcelona, Spain
* Corresponding author.
Rationale: Bariatric surgery (BS) induces a significant and sustained
weight loss in time, but apart from the reduction of body fat, patients
can lose muscle mass. The existing data in the literature on the
evolution of fat-free mass (FFM) after BS is controversial. The analysis
of body composition by bioimpedance (BIA) is a widely used method
to evaluate FFM.
Methods: To evaluate, through BIA, the evolution of FFM in patients
with morbid obesity undergoing BS.
Prospective study of patients undergoing BS in our center between
April-September 2018. All patients underwent a 1-month post-BS
study: physical examination, biochemical analysis, dietary interview
and BIA. The BIA evaluated: fat free mass index (FFMI), fat mass (FM)
and fat free mass (FFM).
Results: 44 patients were evaluated: 70.5% women, age 45.57 ± 10.6
years, BMI 44.7 ± 5.31 kg/m2. 56.8% of patients underwent Roux-en-Y
gastric bypass (RYGB) and 43.8% had vertical gastrectomy (VG).
Average FFMI prior to the intervention was 24.16 ± 3.22 kg/m2. Average
weight loss per month was 12.74 ± 1.82 kg. Patients undergoing RYGB
had significantly lower levels of post-BS transthyretin than with VG
(p = 0.029). However, the FFMI was 22.7 ± 2.9 kg/m2 (p = 0.01), without
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significant differences between RYGB and VG (p = 0.712). The reduction
of the FFM at 6 months compared to the initial was 7.1 ± 1.46 kg.
The multivariate analysis discarded age, sex, surgical technique, BMI,
FFMI, transthyretin levels, dietary questionnaire, as independent
predictors of FFM loss at the post-BS month.
Conclusions: The study has demonstrated that the FFM lost is an early
event in patients with morbid obesity undergoing BS. However, this
reduction has not been relatedwith proteinmetabolic parameters, this
suggests an independent mechanism.
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POSTPRANDIAL EFFECTS OF DIFFERENTLY COMPOSED MEALS ON
METABOLIC MARKERS POSTPRANDIAL EVENTS IN OLDER ADULTS
WITH METABOLIC SYNDROME TRAITS – APOE GENOTYPE
POLYMORPHISM AS INFLUENCING FACTOR?
Y.B. Schönknecht1*, S. Crommen1, B. Stoffel-Wagner2, M. Coenen3,
R. Fimmers4, P. Stehle1, A. Ramirez5, S. Egert6. 1Department of Nutrition
and Food Sciences, University of Bonn, 2Institute of Clinical Chemistry and
Clinical Pharmacology, 3Clinical Study Core Unit, Study Center Bonn,
4Institute of Medical Biometry, Informatics and Epidemiology, University
Hospital Bonn, Bonn, 5Molecular Neuropsychiatry, University Hospital
Cologne, Cologne, 6Department of Nutritional Science, University of
Hohenheim, Stuttgart, Germany
* Corresponding author.
Rationale: The apoE polymorphism has been shown to chronically
impact blood levels of lipids and biomarkers of oxidation and
inflammation, thereby contributing to graded risks for developing
degenerative diseases. We hypothesize that apoE polymorphism may
also effect (acute) postprandial metabolic responses.
Methods: Following a randomized crossover design, subjects with
metabolic syndrome traits (apoE3, n = 39; apoE4, n = 10; mean age
70 ± 5 y) consumed a Western diet high-fat meal (WD-HF) rich in
saturated fatty acids, a WD high carbohydrate meal (WD-CH) rich in
refined carbohydrates or a Mediterranean meal (MD) rich in
monounsaturated fatty acids, dietary fiber and antioxidants. Blood
samples were collected at fasting and 1, 2, 3, 4, and 5 h postprandially
and analyzed for concentrations of triglycerides, glucose, insulin,
interleukin-6 (IL-6), and oxidized LDL. Differences in postprandial
responses (area under the curve, iAUC) between apoE3 and apoE4
genotype were calculated using linear mixed models.
Results: Magnitude of IL-6 release after the WD-HF meal was
significantly higher in apoE4 carriers than in apoE3 subjects
(P = 0.002; iAUC: apoE4 = 24.7 vs. apoE3 = 15.2 h*pg/mL). In addition,
time to detect significant plasma IL-6 increase was shorter in apoE4
than in apoE3 subjects (P = 0.008). In all groups, no significant change
in plasma oxidized LDL was observed after meal intake All three meals
produced postprandial hyperglycemia, hyperinsulinemia, hyperlipid-
emiawithout any differences for apoE3 and apoE4 subjects, as seen in
values for iAUC and postprandial graphics.
Conclusions: As hypothesized, apoE polymorphism affects postpran-
dial metabolic responses influencing the individual CVD risk.
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RELATION BETWEEN MALNUTRITION AND THE PRESENCE OF
SYMPTOMS OF ANXIETY AND DEPRESSION IN PATIENTS WITH
CANCER
F.J. Sanchez-Torralvo1, V. Contreras Bolivar1, M. Ruiz Vico2, J. Abuín
Fernández1, I. Gonzalez Almendros3, M. Barrios García4, R. Vallejo
Mora1, A. Cantero Gonzalez2, G. Olveira1*. 1UGC Endocrinología y
Nutrición, 2UGC Oncología Médica, 3UGC Radiodiagnóstico, 4UGC
Hematología, Hospital Regional Universitario de Malaga, Malaga, Spain
* Corresponding author.
Rationale: Our objective was to estimate the prevalence of symptoms
of anxiety and depression in oncological inpatients, as well as its
relationship with malnutrition.
Methods: Prospective study in patients hospitalized in Medical
Oncology and Hematology wards. Subjective Global assessment
(SGA) was done and data regarding anxious-depression symptom-
atology was obtained with the Hospital Anxiety and Depression Scale
(HADS).
Results: 282 inpatients were assessed, 55.7% male and 44.3% female,
with an average age of 60.2 ± 12.6 years and a BMI of 24.6 ± 4.9 kg/m2.
SGA found 18.6% ofwell-nourished, 25.3%withmoderatemalnutrition
and 56.1% with severe malnutrition.
HADS presented an average score of 8.3 ± 4.4 points in respect to
anxiety (8.0 ± 4.5 points in male vs 8.7 ± 4.3 points in female) and an
average score of 7.7 ± 4.6 in respect to depression (7.5 ± 4.8 points in
male vs 7.8 ± 4.3 points in female).With these data, 54% of our patients
showed a risk of anxiety and 45.3% showed a risk of depression.
Inmalnourished patients according to GSA, average score tended to be
higher in respect to anxiety (8.5 ± 4.3 points in malnourished vs
7.1 ± 4.6 in well-nourished; p = 0.06) and was significantly higher in
respect to depression (8.2 ± 4.6 points in malnourished vs 5.3 ± 4.0
points in well-nourished; p < 0.001).
Inmalnourished patients according to SGA the odds ratio of presenting
anxious symptomatologywas 2.4 times greater than inwell-nourished
[95% CI 1.2–4.9; p = 0.016] and the odds ratio of presenting depression
symptomatology in these patients was 3.5 times greater than in well-
nourished [95% CI 1.6–7.8; p = 0.002].
Conclusions: Anxious-depression symptomatology in oncological
inpatients is high. There is a clear association between presenting
anxious-depression symptomatology andmalnutrition in hospitalized
oncologic patients.
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A CRITICAL ASSESSMENT OF CT AS A VALID MEANS OF SKELETAL
MUSCLE ANALYSIS AND MUSCULAR BODY COMPOSITION ANALYSIS
IN CANCER CACHEXIA
M.I. Ramage1*, J. Miller1, C.D.A. Deans1, K.C.H. Fearon1, S. Wigmore1,
C. Jacobi2, R. Skipworth1. 1Clinical Surgery, University of Edinburgh,
Edinburgh, United Kingdom, 2Novartis, Basel, Switzerland
* Corresponding author.
Rationale: Recently, CT body composition analysis (BCA) as a means
to assess skeletal muscle index (and thus sarcopenia) has been
increasingly used in the diagnosis of cancer cachexia, and has been
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proposed as an outcome measure in randomised trials. However, the
validity of CT-BCA for these functions, and the relationship between
CT-BCA variables, skeletal muscle protein content, and patient-
reported outcome measures are largely unknown.
Methods: Patientswere recruited fromupper GI cancer (UGIC) (n = 89;
M:F = 62:27), vascular (AAA) (52, 44:8), and live kidney donor (LDN)
(53, 24:29) populations. CT-BCA was carried out at L3 level using
validated semi-automated planimetry. Muscle biopsies were obtained
intra-operatively and protein content analysed using the Pierce BCA
method. Immunohistochemistry was performed to determine muscle
fibre cross-sectional area. Quality of life was assessed using the EORTC
QLQ-C30+OG25.
Results: In this body of work, salient findings include:
1. Unanticipated high incidence of sarcopenia in both AAA (>UGIC)
and healthy control (LDN) populations.
2. Sarcopenia and cachexia can exist independent of reductions in
patient functional status or quality of life.
3. Systemic inflammation, a key component of cancer cachexia, is
associated with increases in tissue volume and reductions in
tissue density due to oedema, thus making CT-BCA difficult to
interpret.
4. Skeletal muscle protein content varies widely in UGIC, and only
weakly correlates with muscle density.
5. Muscle fibre diameter appears maintained in slow fibres, and
reflect underlying disease in fast twitch fibres
Conclusions: Although CT-BCA has been shown previously to be
associatedwith cancer patientmorbidity andmortality, there are clear
areas inwhich the interpretation and applicabilityof thismethodology
are incompletely understood and potentially limited. Further work is
required to assess whether CT-BCA is a valid and sensitive measure of
alterations in patient body composition and protein levels during
therapeutic intervention for cancer cachexia.
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CLINICAL EFFECTS OF A PECTIN-CONTAINING OLIGOMERIC
FORMULA IN TUBE FEEDING PATIENTS: A MULTICENTER
RANDOMIZED CLINICAL TRIAL
M. Maruyama1*, S. Goshi2, Y. Kashima3, A. Mizuhara4, T. Higashiguchi5
on behalf of Clinical Study Committee, Japanese Society of Parenteral
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3Surgery, Tochigi Medical Center, Tochigi, 4Surgery, Higashiwasinomiya
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* Corresponding author.
Rationale: A pectin-containing oligomeric formula (POF) is a unique
type of enteral formula that transforms from a liquid to a gel after
reacting with gastric acid. Reports on its clinical effects have been
limited. The present study was conducted to examine and verify the
clinical effects of POF.
Methods: The study subjects were 201 stable patients on intragastric
tube feeding. They were randomized into two groups to receive either
POF or a standard polymeric formula (SPF) as a control. The duration of
observationwas 1 week. Analyses were conducted for the incidence of
predefined composite events, including diarrhea, defecation treat-
ments, and other enteral nutrition management-related events.
Results: Composite events occurred in 15 of 98 patients in the POF
group and 30 of 100 patients in the SPF group, with a significantly
lower incidence in the POF group compared with the SPF group
(P = 0.011). In particular, diarrhea occurred in 2 patients in the POF
group and 13 patients in the SPF group, with a significantly lower
incidence in the POF group compared with the SPF group (P = 0.003).
Conclusions: The results of this study suggest that POF is less likely to
cause enteral nutrition-related events, especially diarrhea, than SPF.
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ASSOCIATION BETWEEN THE BODY MASS INDEX ANDTHE RELAPSE
RATE IN PATIENTS WITH B-CELL PRECURSOR ACUTE
LYMPHOBLASTIC LEUKEMIA
C.O. Ramos-Peñafiel1, A. Martínez-Tovar1, E. Rozen-Fuller1,
M.P. Bejarano-Rosales2*, K. Alvarez-Altamirano2, V. Fuchs-Tarlovsky2,
E.A. Rosas-Gonzalez3, I. Olarte-Carrillo1. 1Hematolgy, 2Clinical Nutrition,
Hospital General de Mexico “Dr Eduardo Liceaga”, 3Instituto Politécnico
Nacional, Mexico City, Mexico
* Corresponding author.
Rationale: To identify the association between body mass index and
the risk of relapse in adult patients with acute lymphoblastic leukemia
of phenotype B.
Methods: Retrospective, observational study in patients with acute
lymphoblastic leukemia of lineage B Ph + (-). The diagnosis was made
with the presence of more than 20% of Blasts in the bone marrow and
confirmed by flow cytometry. Relapsewere considered if the patient at
any time of their treatment increased 10% of blasts in the bonemarrow.
The BMI was calculated at the time of diagnosis. The Cox regression
analysis was used to assess the associations between BMI and risk of
relapse.
Results: A total of 128 patients were analyzed. According to BMI 37.5%
were classified with a normal weight, 34.4% overweight, 18.8% obesity
grade I, and 3.9% obesity grade III. The frequency of relapse to bone
marrow was 43.8% (n = 56) and mortality was 42.2% (n = 54)
throughout the follow-up. BMI ≥30 kg/m2 did not behave as a risk
factor for failure (OR: 0.888 (0.4074–1.9378), p = 0.766, 95% CI), even
considering individually caseswith a BMI greater than 30 kg/m2 it was
not considered as a risk factor associated with relapse (OR: 0.615
(0.1755–2.1588, p = 0.448, 95% CI).
Conclusions: Obesity defined as a BMI ≥30 kg/m2 was not associated
as an independent risk factor of relapse of mortality in adults patients
with acute lymphoblastic leukemia. BMI should be considered a rough
guide because it may not correspond to the same degree of fatness in
different individuals.
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CHANGES IN FTO AND IRX3 GENE EXPRESSION IN OBESE AND
OVERWEIGHT MALE ADOLESCENTS UNDERGOING AN INTENSIVE
LIFESTYLE INTERVENTION AND THE ROLE OF FTO GENOTYPE IN
THIS INTERACTION
S. Doaei1,2*, M. Gholamalizadeh2 on behalf of Saeid Doaei, Naser
Kalantari, Pantea Izadi, Tuire Salonurmi, Alireza Mosavi Jarrahi,
Shahram Rafieifar, Ghasem Azizi Tabesh, Ghazaleh Rahimzadeh,
Maryam Gholamalizadeh, Mark O. Goodarzi. 1Health Education, Health
School, Guilan University of Medical Sciences, Rasht, 2Cancer Research
Center, Shahid BeheshtiMedical University, Tehran, Iran, Islamic Republic of
* Corresponding author.
Rationale: Lifestyle intervention may have a critical effect on the
association between genetics and obesity. This study aimed to
investigate the effects of lifestyle intervention on obesity-related
genes in obese adolescents with different genotypes.
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Methods: This study was a field trial of 62 adolescents from boys’ high
schools in Tehran, Iran. Two schools were randomly allocated as the
intervention (n = 30) and control (n = 32) schools. The rs9930506 SNP
in FTO was genotyped at baseline and the level of FTO and IRX3
expression in PBMCs. Anthropometricmeasurementswere assessed at
baseline and after 18 weeks of intensive lifestyle intervention.
Results: Our results showed that IRX3 expression in the intervention
group was significantly up-regulated compared to baseline (P = 0.007)
and compared to the control group (P = 0.011). The intervention group
had significantly up-regulated transcripts of IRX3 only in rs9930506
risk allele carriers of the intevention group compared to risk allele
carriers of the control group (P = 0.017). Moreover, our data showed
that the FTO expressionwas up-regulated in AA genotype carriers and
down-regulated in AG/GG genotype carriers. (P = 0.017).
Conclusions: Lifestyle modification may exert its effects on obesity
through changes in the expression level of the FTO and IRX3 genes.
However, FTO genotype plays a role in the extent of the effect of
lifestyle changes on gene expression. Further studies are crucial to
have a better understanding of the interaction between lifestyle,
genetics and anthropometric measurements.
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VALIDATION OF INDUCTIVELY COUPLED PLASMA METHOD TO
DETERMINE IRON TRACE LEVELS IN SOLUTIONS TO PREPARE
NUTRITION PARENTERAL MIXTURES
A.M. Menendez1*, S.S. Farías2, R.M. Pontiggia3, R.E. Servant4,
P. Libenson3, O.V. Cereseto1, P.N. Mandrini3, M.L. Pita Martín de
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Rationale: A wide range of iron (Fe) levels have been found as
impurities in the individual components (solutions) used to prepare
Parenteral Nutrition (PN). This contamination must be taken into
account due to the lipids possible destabilization, oxidation reactions
on certain amino acids and vitamins and the Fe patient’s requirements.
However, no limits have been established.
Objective: Validate an optimized method in order to accurately
determine iron traces using Optical Emission Spectroscopy –
Inductively Coupled Plasma (ICP-OES) in several matrices used to
prepare PN solutions.
Methods: Optical emission spectrometer (OPTIMA 8000, Perkin
Elmer) was used to accurately determine Fe. Method was optimized
and validated evaluating selectivity/ specificity, linearity (normality
test, ANOVA test), repeatability, intermediate precision and bias.
Referencematerials andmatrix certified referencematerial were used.
Results: Selected wavelengh 239.562 nm allowed to discriminate
spectral interferences the potentially present (as Cu, Zn, Co, Ni, Cr).
Linearity was demonstrated by homogeneity of variances and
normality test as by r2 = 0,998; Intermediate precision raised to 5%.
Obtained quantification limit was 10 microgramos/L and recovery was
100,7%. Uncertainties associated to anaytical determinations ranged
between 10 to 20% depending on Fe levels present in the studied
solutions.
Conclusions: Validation has demonstrated that the proposed method
was selective, provides adequate uncertainties and it is useful to
quantify quickly and accurately iron traces in matrices that can be
converted to aqueous acid solutions. This would allow to suggest a
limit for Fe used to prepare parenteral nutrition mixtures.
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DIETARY IODINE INTAKE ANDURINARY IODINE CONCENTRATION IN
NORWEGIAN HOME-DWELLING OLDER ADULTS
I. Ottestad1*, S.M.Ulven1,M.H. Carlsen1, T.E.Gundersen2, G.O.Gjevestad3,
L.F. Andersen1, K.B. Holven1,4. 1Department of Nutrition, Institute of Basic
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Rationale: To describe the iodine status (the urinary iodine concen-
tration (UIC) and the iodine intake from food) and dietary sources of
iodine among adults (≥70 years). Further, to investigate the effect of
daily intake of milk on iodine status (UIC).
Methods: Subjects from a cross-sectional study (n 434) and a
randomized controlled trial (RCT) (n 36) among Norwegian older
home-dwelling adults (≥70 years) were included. Iodine was
quantified in spot urine and 24-h urine samples, and from 2 × 24-h
dietary recall method.
Results: Women had significantly lower median (p25, p75) UIC than
men (79 (53–129) µg/L v. 108 (74–155) µg/L, respectively, P < 0.001).
Additionally, UIC lower than 50 µg/L was observed among 23% of
women and 10% of men. Median (p25, p75) iodine intake was
significantly lower inwomen compared tomen (117 (79, 229) mcg/d v.
133 (94, 234) mcg/d, respectively, P = 0.033). Dietary sources of iodine
and changes in the UIC from increased milk intake in the RCT will be
presented at the poster at the ESPEN conference.
Conclusions: According to WHO, Norwegian older women in the
present study are defined as iodine insufficient (median <100 µg/L,
and > 20% had UIC < 50 µg/L) and men are defined iodine sufficient.
According to the Nordic Nutrition Recommendations, both women
and men had lower iodine intake than the recommended daily intake
(150 µg/day).
Disclosure of Interest: I. Ottestad: None declared, S. Ulven: None
declared, M. Carlsen: None declared, T. Gundersen Other: is CEO and
owner in Vitas AS, that perform iodinemeasurements on a commercial
basis, G. Gjevestad Grant/Research Support from: TINE SA, Oslo,
Norway, where G O Gjevestad is employed, L. Andersen: None
declared, K. Holven: None declared.
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PT08.3
THE EVALUATION OF THIAMINE DEFICIENCY IN PATIENTS WİTH
HYPERVOLEMIA UNDER THE FUROSEMIDE TREATMENT
I. Bicer1, O.S. Dizdar1, K. Gundogan2*, A.I. Gunal1, H. Bicer3,
E. Dondurmaci4, A. Tok4. 1İnternal Medicine, Kayseri City Training
and Research Hospital, 2İnternal Medicine, Erciyes University, 3Urology,
4Cardiology, Kayseri City Training and Research Hospital, Kayseri, Turkey
* Corresponding author.
Rationale: Reportedly, thiamine deficiency, resulting from long-term
diuretic therapy, is observed in patients with heart failure (HF).
However, the effect of furosemide treatment on thiamine concentra-
tion is not clear in hypervolemic patients with chronic renal failure
(CRF). The aim of this study was to assess thiamine deficiency in
patients with hypervolemia (HF and/or CRF) under the furosemide
treatment.
Methods: 61 hypervolemic patients with HF or CRF who treated with
diüretics for the control of fluid overload in Kayseri City Training and
Research Hospital, Nephrology, Cardiology and Internal Medicine
department were included in this study. Hypervolemiawas diagnosed
according to echocardiography and physical examination findings
(crepitant rales, acid, pretibial edema, pleural effusion). Whole blood
sample was taken for the measurement of thiamine levels before
treatment in patients who were planned to receive IV furosemide
treatment (40–200 mg/day). While the patients continued to receive
their treatment, bloodwas taken on the 2nd and 4th days for the control
of thiamine levels. The normal range of thiamine concentration
was regarded as 35–99 ng/mL. thyamine deficiency was defined as
<35 ng/mL.We evaluated the association between the change of blood
thiamine concentrations and other clinical and demographic
parameters.
Results: Themean agewas 69.00 ± 10.39 years. This study included 32
patients with HF (%52.5) and 47 patients with CRF (%77). In 12 patients
(19.7%), blood thiamine concentration was lower than the lower limit
of normal (35 ng/mL; dotted line) at the time of the hospitalization. On
the 4th day of treatment, thiamine deficiency was found in 44.3%
(n = 27) patients. The mean thiamine levels in the blood samples
was 51.71 ± 20.66 ng/mL at the time of the hospitalization, 47.64 ±
15.43 ng/mL at 2nd day after diuretic treatment and 43.78 ± 16.20 μg/
ml at 4th day after diuretic treatment (p < 0.001). The change of
thiamine levels with diuretic therapy was found statistically signifi-
cantly differ in repeated measures variance analysis (p = 0.029). The
change of thiamine levels in patients with HF was statistically
significant between day 0 and 2th day and between day 0 and
4th day (p = 0.047 and p = 0.020). Thiamine levels in patients wih CRF
before treatment were observed to decrease from 52.02 ± 21.19 ng/mL
to 43.76 ± 15.79 ng/mL on the 4th dayand itwas statistically significant
(p = 0.036).
Conclusions: Our findings suggest that the furosemide treatment
decreases the blood thiamine concentrations in patients with
hypervolemia. When diuretic treatment is started for these patients,
blood thiamine levels should be checked and thiamine support should
be kept in mind for thiamine deficiency.
Disclosure of Interest: None declared.
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EFFECTS OF DIET-INDUCED REPETITIVE SPIKES IN PLASMA
PHOSPHORUS ON VASCULAR CALCIFICATIONS IN RATS WITH MILD
KIDNEY DYSFUNCTIONS
M. Tani1*, K. Takamiya1, S. Tanaka1, M. Sakaue1, M. Ito1. 1Graduated
School of Human Science and Environment, University of Hyogo, Himeji,
Japan
* Corresponding author.
Rationale: Since hyperphosphatemia induced by excess phosphorus
(Pi) intake causes vascular calcifications, it is thought hyperpho-
sphatemia is a major risk factor for cardiovascular disease in patients
with chronic kidney disease. It was reported that repetition of short-
term excessive Pi diet intakes caused transient plasma Pi elevations,
we called Pi spikes, which resulted in vascular endothelial dysfunction
in normal rats. The purpose of this study was to investigate whether
repetitive plasma Pi spikes exacerbated vascular calcifications in rats
with mild kidney dysfunctions.
Methods: As a mild kidney dysfunction model, rats receiving
unilateral nephrectomies were used. The rats were divided into 3
groups; the CP group fed control Pi (0.6%) diet, theHP group fed high Pi
(1.2%) diet, and the Pi spike group fed low Pi (0.02%) and high Pi
diet alternatelyevery 2 days. During the experiment period for 36 days,
blood, urine and feces were collected, and Pi and calcium (Ca)
concentrations were measured. At the end of the experiment,
calcifications of the thoracoabdominal aortae were visualized by von
Kossa staining, and then Ca contents of the aortae were evaluated.
Results: In the Pi spike group, plasma Pi levels fluctuated with
alternative intakes of Pi diets. Although total amount of Pi intake of the
Pi spike group (6.33 ± 0.16 g) was the same as the CP group (6.43 ±
0.09 g), the vascular calcifications of the Pi spike group had more
severely progressed than those of the CP group, which were similar to
those observed in the HP group. The Ca contents of the aortae in the Pi
spike group were also significantly higher than those of the CP group
(42.94 ± 3.64 μg/g tissue weight vs 19.65 ± 2.21 μg/g tissue weight,
p < 0.05), which were nearly equal to those in the HP group (42.55 ±
9.26 μg/g tissue weight).
Conclusions: In the rats with mild kidney dysfunction, the vascular
calcifications were exacerbated by repetitive plasma Pi spikes, despite
the same amount of total Pi intake with those of the control group. It
was suggested that diet of avoiding transient hyperphosphatemia (Pi
spike) was important for prevention of vascular calcifications with
mild kidney dysfunctions.
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PT08.5
EFFECT OF ANTIOXIDANT SUPPLEMENTATION DURING
ONCOLOGICAL TREATMENT ON SERUM HEMOGLOBIN LEVELS IN
CERVICAL CANCER PATIENTS
M.D. Arias-Soberon1, M.P. Bejarano-Rosales1, K. Alvarez-Altamirano1,
V. Fuchs-Tarlovsky1*. 1Clinical Nutrition, Hospital General de Mexico,
Mexico City, Mexico
* Corresponding author.
Rationale: Cervical cancer is the 4th most common type of cancer in
women worldwide. In Mexico it is the second cause of death because
of cancer among women. As much as 68% of cervical cancer patients
experiment anemia and it is considered a poor prognosis factor.
Antioxidant therapy in cancer is a controversial topic. It showed
benefits in hemoglobin levels maintenance in cervical cancer during
antineoplastic therapy. The research questionwas: ¿What is the effect
of antioxidant supplementation at different doses on serum hemo-
globin in cervical cancer patients during onoclogy treatment?
Methods: A randomized, controlled, single-blinded clinical trial was
conducted in women with cervical cancer treated with radiotherapy
and chemotherapy with cisplatin. Participants were divided into 3
groups (SP = single dosis, SS = double dosis and PP = placebo) to receive
during antineoplastic treatment different dosages of antioxidants
with: beta-carotene 4.8 mg; vitamin C 200 mg; vitamin E 200 UI; zinc
15 mg; selenium 50 mcg. A complete blood count and food frequency
questionnaires were performed before and after the oncology
treatment. A paired student-t test and ANOVA analysis were used to
determine the differences between groups. To calculated sample size
we used a power of 80% and a 95% of significancewith a p-value <0.05.
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Results: We included 82 patients: 26 received SS (31.7%), 29 received
SP (35.4%) and 27 received PP (32.9%). The SS group maintained
significantly more stable their hemoglobin levels when compared
with the PP (Table 1). All study groups showed a lower food intake at
the end of oncological treatment.
Table 1
Serum Hemoglobin levels (g/dl) before and after the oncological treatment.
Initial
g/dl
Final
g/dl
δ
g/dl
p-Values p-Values
SS 12.07 ± 2.3 11.51 ± 1.7 0.55 ± 1.39 .053* 0.041
SP 13.15 ± 1.5 12.01 ± 1.1 1.13 ± 1.14 .000*
PP 13.16 ± 1.9 11.72 ± 2.61.8 1.44 ± 1.26 .000*
Reference value: 12–16 g/dL.
*p-values <0.05 for t student test.
**p-values <0.05 for ANOVA.
Conclusions: Antioxidant supplementation helped to maintain
hemoglobin levels during oncology treatment in cervical cancer
patients. Food intake decreases during treatment. Both, vitamin E
and selenium intake are lower than RDI (Recommended daily intake),
therefore, patients need further supplementation to avoid negative
side effects.
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DIAGNOSIS OF ELECTROLYTE AND MICROELEMENT IMBALANCE IN
PATIENTS WITH ACUTE PANCREATITIS
V. Kochergin1,2*, S. Sviridov1. 1Department of anesthesiology and
intensive care, Pirogov Russian National Research Medical University,
2The Loginov Moscow State Clinical Scientific Center., Moscow, Russian
Federation
* Corresponding author.
Rationale: Themain purpose of our study was to investigate the levels
of electrolytes and microelements in patients with acute pancreatitis
in parallel with markers of systemic inflammatory response and
protein-energy malnutrition.
Methods: We have analyzed 137 clinical cases of patients with acute
pancreatitis, among them 86 men (62,8%) and 51 women (37,2%). The
maximal age of enrollee was 55 years, the minimal age – 18 years (the
mean age 38,7 ± 5,6 years). In all patients we estimated the severity of
their condition using APACHE-II score and SOFA, moreover biochem-
ical analysis were performed, the levels of electrolytes (K, Na, Cl) and
microelements (Zn++ и Cu++) were measured, acide-base balance
analysed.
Results: Initially, disease severity in all patientswith acute pancreatitis
was determined as severe. The severity score obtained using APACHE-
II was 12,25 ± 1,63, and using SOFA – 2.33 ± 0,78. All patients had
profound leukocytosis 11,58 ± 3,03 × 10^9/l, increased levels of CRP
with mean levels up to 208,56 ± 53,63 mg/l (norm 0–6 mg/l). Notably,
the level of CRP exceeded 150 mg/l in 93,7% of patients. The mean
levels of Zn in plasma were about 4436,0 ± 857,1 mсg/l, Cu++ –
786,0 ± 237,2 mсg/l. Reliable correlation (r = 0,56, p = 0,047) was
found between the levels of Zn++ and treatment outcomes in patients
with acute pancreonecrosis. In cases when the level of zinc exceeded
4500 mcg/l, the risk of death was approaching 100%. While analyzing
the levels of electrolytes in plasma the following tendency was
established: prognosis worsened in patients with hyponatremia (level
of sodium lower than 130 mmol/l).
Conclusions: Hyperzincemia can be taken under consideration as a
biochemical marker that reflects the severity of patients condition in
case of acute pancreatitis. The prognostic value of hyperzincemia in
the evaluation of the treatment prognosis in patients with pancreo-
necrosis needs to be investigatedmore thoroughly. Hyponatremia is an
another marker of disease severity in patients with acute pancreatitis,
so infusion therapy in such patients should be thoroughly planned and
controlled.
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GUT MICROBIOTA PATTERN IN PATIENTS WITH INFLAMMATORY
BOWEL DISEASE (RELATED TO DIET, ACTIVITY DEGREE AND
MALNUTRITION)
I.M. Cornejo-Pareja1*, B.M. García-Muñoz2, E. Romero-Pérez2,
E. García-Fuentes2, S. Tapia-Paniagua3, M.A. Moriñigo-Gutiérrez3,
G. Alcaín-Martínez2, J.M. García-Almeida1. 1Endocrinology and
Nutrition Department, 2Gastroenterology Department, Virgen de la
Victoria Hospital, 3Microbiology Department, Faculty of Science,
University of Malaga, Malaga, Spain
* Corresponding author.
Rationale: Modifications of gut microbiota have been described in
relation to inflammatory bowel disease (IBD), dietary habits and
nutritional status. We related gut microbial pattern of patients with
IBD compared to healthy individuals; and link gut microbial pattern
with activity of the disease, nutritional status and dietary habit.
Methods: Observational study of 56 subjects (44 with IBD and 12
controls). We collected clinical and analytical data (nutritional and
inflammatory profile), anthropometric, dietary habits (record of 3
days) and microbial study (grouped by a dendrogram for Lactobacillus
and the clusters were amplified by PCR).
Results: Mean age 44.7 ± 2.07 years (54.5% males). The disease ratio
Crohn’s disease (CD)/ulcerative colitis (UC) was 23/21. 38.6% presented
remission of the disease and the rest hadmild (27.3%), moderate (27.3%),
severe activity (11.4%). 37%with activity hadmalnutrition and 76.9% had
moderate or severe vitamin D deficiency (p = 0.025, 11.61 ± 5.42 vs
21.99 ± 1.81). In theanalysis of gutmicrobiotawe foundgreater similarity
between controls and those patient in remission (M1pattern). The other
microbial pattern (M2) showed lower bacterial diversity (patients with
higher use of corticosteroid therapy).
However, M1 had a higher vitamin D deficiency (75% vs 52.4%) and
malnutrition (37.5% vs 22.7%). M2 was associated with the highest
protein and carbohydrate intake: meat (p = 0.003, 60.63 ± 32.55 vs.
128.73 ± 10.26); dairy products (p = 0.040, 137.13 ± 64.43 vs
285.36 ± 34.28) and pasta (p = 0.049, 15.88 ± 8.62 vs 40.82 ± 8.23).
However, malnourished patients took more vegetables (p = 0.024,
161.25 ± 43.1) and less fat products (p = 0.032, 74.84 ± 6.34 vs
92.93 ± 4.24).
Conclusions:
• Gut microbiota pattern changes according to diet. M2 (more
Firmicutes and Proteobacteria and less Bacteroidetes).
• Active IBD (M2) is associated with a Western diet.
• The dietary influence on gut microbiota is greater than inflamma-
tory pattern.
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PT09.2
RISK FACTORS FOR NEPHROLITHIASIS IN ADULT PATIENTS WITH
SHORT BOWEL SYNDROME
J. Yang1*, H. Sun1, S. Wang1, G. Mamtawla1, X. Gao1, L. Zhang1, X.Wang1,
J. Li1. 1Department of General Surgery, Medical School of Nanjing
University, Nanjing, China
* Corresponding author.
Rationale: Patients with short bowel syndrome (SBS) were known to
have an increased frequency of nephrolithiasis. However, few studies
focusing on nephrolithiasis in SBS patients have been insufficiently
studied.We aimed to identify potential risk factors for the formation of
nephrolithiasis in adult patients with SBS.
Methods: All eligible adults diagnosed with SBS admitted to a tertiary
referral center from December 2008 to December 2018 were retro-
spectively identified fromaprospectivelymaintaineddatabase. SBSwas
defined as the length of the remaining small bowel less than 200 cm.
Patients’ demographic and clinical valuables were analyzed using
univariate and multivariate analysis to identify potential risk factors.
Results: Of 231 adults with SBS, 42 (18.2%) patients developed
nephrolithiasis. The main age was 46.4 ± 17.8 years, the main BMI
was 18.2 ± 3.8 kg/m2 and the median duration of SBS was 11 months
(range, 2–324). Multivariate binary logistic regression analysis
revealed that patients with jejuno-ileal anastomosis and colon in
continuity (odd’s ratio [OR], 4.335; 95% confidence interval [CI], 1.175–
16.002; p = 0.028), prolonged duration of SBS (OR,1.008; 95% CI,1.002–
1.014; p = 0.010) and increased serum creatinine concentration (OR,
1.005; 95% CI, 1.001–1.009; p = 0.012) were independent risk factors
associated with nephrolithiasis in adult SBS patients.
Conclusions: Nephrolithiasis remain a common complication in adult
SBS patients. As nephrolithiasis can developed into adverse clinical
consequence, closely monitoring and possible prophylactic interven-
tions should be conducted in patients with SBS.
Disclosure of Interest: None declared.
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LONG-TERM EFFECT OF COLD PRESSED COCONUT OIL SUPPLEMENT
ON LIPID PROFILES AMONG DYSLIPIDEMIA PATIENTS RECEIVING
MODERATE INTENSITY STATINS, 6 MONTHS
M. Chuansangeam1*, S. Wichansawakun1. 1Internal Medicine,
Thammasat University, Bangkok, Thailand
* Corresponding author.
Rationale: Dyslipidemia is an important factor of atherosclerosis
especially in coronary artery and cerebral artery. Guideline for
dyslipidemia management recommends lifestyle modification and/
or lipid lowering medications. However, many supplements being
claimed for lipid reduction are wildly use by patients. Nowadays, the
results are still controversial and there was no study of cold pressed
coconut oil capsule (CO) on dyslipidemia patients taking lipid lowering
drugs. The aims of this study is to investigate the efficacy and safety of
CO supplement in this group of patients.
Methods: This study is a non-blinded randomized control trial study.
Participants were 82 dyslipidemia patients taking moderate-intensity
statin. 42 were control group and the others took CO 1000 mg per day
for 6 months. The lipid profiles, renal and liver function tests were
measured at week 0, 12 and 24.
Results: No significant reduction of LDL level in study group
compared to control group (95% CI− 18.985 to 5.719 p = 0.211),
cholesterol level (95% CI− 12.967 to 16.477, p = 0.109), triglyceride
level (95% CI− 16.087 to 46.561, p = 0.198) and HDL level (95% CI 0.331
to 12.822, p = 0.120). Aspartate aminotransferase (95% CI− 2.035 to
6.889, p = 0.213) and alanine aminotransferase (95% CI− 3.201 to
10.628, p = 0.450) were no significant different among two groups.
Also no significant in kidney function was seen between the groups
(95% CI− 0.1 to 0.154, p = 0.723).
Conclusions: There were no positive effect of CO supplement on
reduced serum lipid in dyslipidemia patients taking lipid lowering.
Nevertheless CO supplement do not effect liver and kidney function.
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HPN PATIENTS WITH SEVERE GASTROINTESTINAL DYSMOTILITY
HAVE SIMILAR CLINICAL OUTCOMES TO PATIENTS WITH SHORT
BOWEL SYNDROME: A CANADIAN’S PERSPECTIVE
N.M. Clermont Dejean1*, E. Salazar1, K. Schwenger2, J. Noelting3,
J. Allard4 on behalf of Canadian Home Parenteral Nutrition Registry.
1University of Toronto, 2University Health Network, Toronto, 3Queen’s
University, Kingston, 4University of Toronto – University Health Network,
Toronto, Canada
* Corresponding author.
Rationale: Severe gastrointestinal dysmotlity (GID) makes up less
than 20% of chronic intestinal failure requiring home parenteral
nutrition (HPN) versus 75% in short bowel syndrome (SBS). Patients
with GID have systemic consequences of their disease linked to
negative clinical outcomes. The aim of our study is to characterize and
compare the outcomes of these two populations using the Canadian
HPN registry.
Methods: Using the password protected internet-based Canadian
HomeParenteral Nutrition Registry, a prospectively recorded database,
patients with GID and SBS were identified. The retrospective data of
patients from 2003 to November 1st 2018 was considered. A total of
830 patients were recruited in the registry. Sixty-eight patients (22
male, 46 female) with a clear GID diagnosis and 218 patients (67male,
151 female) with SBS were included in the final analysis. Parameters
were compared between groups using Kruskal-Wallis test followed by
Wilcoxon ranked sum or chi-square and Fisher’s exact test as
necessary. Kaplan-Meier was used to determine survival probability.
To avoid left-truncation, only patients who started HPN after 2003
were included for survival analysis (n = 271). Statistical significance
was determined when p-value<0.05 and results were expressed as
median (3rd quartile; 1st quartile).
Results: When compared GID patients were younger with a median
age of 47.0(60.0;33.0) vs 53(63.0;44.0) years p < 0.05. They had a
smaller BMI 20.9 kg/m2(22.2;18.0) vs 21.0 kg/m2(24.2;19.2) p < 0.05
and required PN for a longer amount of time 7.1(10.8;3.47) vs 2.5
(5.6;1.0) years p < 0.05. There were no differences in line sepsis
per 1000 catheter days 0.0(0.5;0.0) vs 0.0(0.8;0.0), total number
of hospitalizations 1.0(3.0;0.0) vs 2.0(3.0;0.0) or total number of
HPN-related admission days 0.0(1.0;0.0) vs 0.0(5.0;0.0) between GID
and SBS patients. Actuarial survival probability forGID and SBS patients
was similar with 72.3% vs 78.8% at 5 years and 61.8% vs 64.2% at 10
years. The overall population had amedian age of 52.0(62.0;42.0) years
and a median BMI of 21.0(23.3;19.0) kg/m2. The median PN duration
was 3.2(7.2;1.3) years with 0.0(0.8;0.0) line sepsis per 1000 catheter
days, 2.0(3.0;0.0) hospitalizations, 0.0(1.0;0.0) admissions related
to HPN and a median number of HPN related admission days
of 0.0(4.0;0.0). Overall actuarial survival was 76.8% and 63.2% at 5
and 10 years.
Conclusions: In this large Canadian national study of HPN patients
therewas no difference in 5 and 10 year survival between GID and SBS
despite SBS patients being older. SBS patients had a shorter PN
duration likely due to the use of surgical andmedical options enabling
them to gain enteral autonomy. Overall survival was similar to other
HPN centers.
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EVALUATION AND PREDICTION AND OF RESTING ENERGY
EXPENDITURE IN ADULT CROHN DISEASE
I. Cioffi1, R. Sammarco1*, D. Morlino1, E. Speranza1, L. Santarpia1,
L. Alfonsi1, N. Imperatore1, F. Castiglione1, M. Marra1, F. Pasanisi1.
1Department of Clinical Medicine and Surgery, University Federico II,
Naples, Italy, Naples, Italy
* Corresponding author.
Rationale: The aim of this study was to compare resting energy
expenditure (REE) measured (MREE) by indirect calorimetry (IC) and
REE predicted (PREE) from established predictive equations in a cohort
of adult patients with Crohn diseases.
Methods: We evaluated 198 Crohn patients (males 119, females 79)
aged between 18 and 65 years (M: age 36.8 ± 12.9 y, weight 66.5 ±
10.3 kg, BMI 22.4 ± 3.4 kg/m2, REE 1673 ± 218 kcal, QR 0,81 ± 0.07; F:
age 38.8 ± 14.2 y, weight 56.0 ± 9.4 kg, BMI 22.0 ± 3.7 kg/m2, REE
1351 ± 171 kcal, QR 0.81 ± 0.08). Data were obtained by comparing
MREE with PREE, derived from different equations, within and
between normal weight and obese groups. The mean differences
between PREE and MREE as well as the accuracy prediction within
±10% level were investigated in the whole sample.
Results:We observed that in men Schofield, FAO, andMarra equations
provided good mean PREE-MREE (bias −0.2, −0.4 and 1.8%; root mean
standard error (RMSE) 139, 138 and 132 kcal per day, respectively); in
women, HB, Schofield, FAO equations provided good mean PREE-
MREE (bias −1.3, −2.9 and 1.9%; root mean standard error (RMSE) 109,
123 and 120 kcal per day, respectively);
in men, prediction accuracy individually was low (∼70%) for all
predictive equations; only FAO, Schofield and Mifflin was over 60%
(68%, 65% and 62%).
inwomen, overall, prediction accuracywas low (∼55%) individually for
all predictive equations considered; only Harris and Benedict equation
reached the 68%.
Conclusions: Different established equations can be used for
estimating REE at the population level in both sexes. However, the
accuracy was very low for all predictive equations used, particularly
among females limiting their use in clinical practice. Our findings
suggest that the validation of new predictive equationswould improve
the accuracy of REE prediction in Crohn’ diseases and it could be useful
for nutritional monitoring
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VITAMIN K1 STATUS IN PATIENTS UNDERGOING MAINTENANCE
HEMODIALYSIS
S.Małgorzewicz1*, M. Kaczkan1, E. Puchalska-Reglinska2, P. Rutkowski3,
L. Konieczna4, T. Bac̜zek4, K. Krzanowska5, A. De˛bska-Slizien6. 1Clinical
Nutrition, Medical University of Gdansk, 2Dialysis Unit, 7 Gdansk Navy
Hospital, 3General Nursing Department, 4Department of Pharmaceutical
Chemistry, Medical University of Gdansk, Gdansk, 5Department of
Nephrology, Jagiellonian University Medical College, Kraków,
6Department of Nephrology, Transplantology and Internal Disease,
Medical University of Gdansk, Gdansk, Poland
* Corresponding author.
Rationale: Vascular calcification is a serious complication in hemodi-
alysis patients associated with high risk of cardiovascular events. A
preventive role for vitamin K against vascular calcification progression
has been proposed on the basis of its role in activating matrix gla
protein (MGP), which is a calcification inhibitor in vascular tissue.
The aim of the studywas an assessment of serum level of vitamin K1 in
correlation to matrix Gla proteins level and nutritional status.
Methods: 143 people (62 F, 81 M) aged 64.7 ± 15.5 years underwent
chronic hemodialysis were examined. Nutritional status was assessed
according to SGA, s-albumin and BMI. The status of vitamin K1 was
assessed by measurement of serum concentration of phylloquinone −
vitamin K1 (LC MS method) and MGP, ucMGP (ELISA methods). The
other biochemical parameters were measured by routine laboratory
methods. n PCR was calculated.
Results: The mean BMI was 25.1 ± 6.4 kg/m2. Underweight was
diagnosed in 5.2% of patients, and normal body weight in 23,3%.
According to SGA, 24.6% of the subjects were mild/moderate
malnourished. Low level of vitamin K1 (median = 0.56 ng/ml) was
noticed in 46.1% HD patients and it was associated with higher CRP
(p < 0.01). The concentration of vitamin K1 correlated with MGP
(R = 0.4; p < 0.05), time of dialysis treatment (R =−0.35; p < 0.05) and
no correlated to nutritional indices.
Conclusions: Haemodialysis patients have subclinical vitamin K
deficiency, as indicated by reduced serum K1, it was associated with
the duration of dialysis and the presence of inflammation.
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SARCOPENIA AND INFLAMMATION IN CANCER PATIENTS AT
DIAGNOSIS
A. Casirati1*, G. Vandoni1, S. Della Valle1, S. Colatruglio1, G. Greco2,
M. Platania3, L. Mariani4, C. Gavazzi1. 1Clinical Nutrition Unit,
2Department of Radiology, Interventional Radiology, Nuclear Medicine
and Radiotherapy, 3Medical Oncology and Hematology Department,
4Clinical Epidemiology and Trials Organization Unit, Fondazione Irccs
Istituto Nazionale Dei Tumori, Milano, Italy
* Corresponding author.
Rationale: Sarcopenia is associated with poor oncological outcomes
and inflammation plays an important role in prognosis worsening. The
aim of our study was to evaluate the nutritional status in newly
diagnosed cancer patients (pts) and detect both sarcopenia and
inflammation.
Methods:We prospectively enrolled pts with advanced solid tumours
candidate to first-line chemotherapy. Before starting any treatments,
we assessed nutritional status by anthropometric, body composition
and systemic inflammationmeasurement collection: weight loss (WL)
in the previous 6 months, body mass index (BMI), skeletal muscle
index (SMI) using analysed images of computed tomography (CT)
and neutrophil-to-lymphocyte ratio (NLR). WL > 10% was chosen as
malnutrition criteria; SMI<38.5–52.4 cm2/m2 for female and male pts
respectively as cut-off point of sarcopenia; NLR≥ 4 to define high
inflammation. Statistical analysis was performed with Fisher’s exact
test and t-Test. Data are given as means±SD.
Results: 68 pts were assessed: 40M/28F; average age 59 ± 13 years
and BMI 23 ± 4 kg/m2; 41 (60%) upper gastrointestinal, 11 lung, 9
colorectal, 1 breast and 6 other cancers. According to selected criteria,
49 pts (72%) were sarcopenic and 19 (28%) non sarcopenic. 35 (71%)
sarcopenic pts had WL > 10% and 20 (57%) of those had NLR≥ 4.
WL > 10% was reported in 10 (53%) non sarcopenic pts and 2 (20%) of
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those had high NLR. Overall, 29 (43%) pts were both sarcopenic and
inflamed. Sarcopenic pts presented BMI lower than non sarcopenic pts
(p = 0.001) and NLR higher (p < 0.05).
Conclusions: Our results suggest that body composition and systemic
inflammation measurements, derived from existing routine exams for
diagnostic purposes, can bring an added value to the nutritional
assessment of oncological pts. Cancer-related malnutrition is well
known but further studies are required to define an adequate
nutritional intervention reversing sarcopenia and inflammation effects.
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DEVELOPMENTOFTOOLS TOASSESSDIETARY FIBER INTAKETAKING
INTO ACCOUNT PREBIOTIC (OLIGO)SACCHARIDES
A.M. Neyrinck1*, J.-A. Nazare2,3, M. Sothier2,3, L. Vandenbergue2,3,
C. Amadieu1, J. Rodriguez1, M. Alligier2,3, M. Laville2,3, N.M. Delzenne1.
1Louvain Drug Research Institute, Université catholique de Louvain,
Brussels, Belgium, 2Centre de Recherche en Nutrition Humaine Rhône-
Alpes, 3CarMeN Laboratory, Université Claude Bernard Lyon1, Hospices
Civils de Lyon, CENS, FCRIN/FORCE Network, Lyon, France
* Corresponding author.
Rationale: The scientific rationale for the recommendation in dietary
fiber (DF) intake comes from the recognition of their health benefits.
Gut microbiota related health benefits are not yet included in the
current dietary recommendations. Quantitative and qualitative ana-
lysis of DF are missing in food composition tables. The FiberTAG1
project aimed to develop a database and a food frequency question-
naire (FFQ) allowing DF intake estimation including prebiotic (oligo)
saccharides.
Methods: A database of total, soluble and insoluble DF in food
products consumed in Europe has been established based on the
Souci-Fachmann-Kraut database, completed for soluble versus insol-
uble DF and for prebiotic (oligo)saccharide levels following published
data. The FiberTAG FFQ was submitted to healthy volunteers (n = 15)
and DF intakes were calculated using the new FiberTAG database.
Results: The new FiberTAG database detailed DF in 400 food items
allocated into 4 categories (fruits, vegetables, cereal products and
others) and 15 subcategories. The new fiberTAG FFQ presents 280
items regrouped in 4 high DF-containing food groups (vegetables,
fruits, cereal products and others) using frequency scale (6 categories),
photographs for portion size and taking into account the seasonal
occurrence for some vegetables or fruits. Mean DF intakewas 36.44 g/
day when applying the FiberTAG FFQ and the new database. This
reveals a higher DF intake compared to previously reported intake for
adults in Europe ranging from 16 to 24 g/d based on 24 h-recall or 3–7
days records2. This difference might be explained by a more adequate
inclusion of fruits and vegetables intake in FFQ than with other
methods, as previously reported3. Estimation for fructan, inulin and
fructo-oligosaccharides intakes were 4.18, 2.95 and 1.00 g/day,
respectively whereas galacto-oligosaccharides intake was 0.28 g/d.
Conclusions: The new FiberTAG database and FFQ are tools to evaluate
prebiotic (oligo)saccharides intakes togetherwithDF intake byhealthy
volunteers. The FiberTAG project generates scientific knowledge that
helps to take into account nutrients interacting with gut microbiota to
establish DF intake recommendations.
References
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NUTRITIONAL STATUS ASSESSMENT IN OLDER PATIENTS WITH
CANCER: A NATIONAL CROSS-SECTIONAL SURVEY
(NUTRIAGECANCER)
E. Paillaud1,2*, C. Martinez-Tapia3, R. Boulahssass4, A.-L. Couderc5,
R. Guess6, E. Liuu7, F. Pamoukdjian8, L. De Decker9, A. Aregui10,
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Epidemiology and Ageing Unit, University Paris EST Creteil, Creteil, 4UCOG
PACA Est, Hôpital de Cimiez, Nice, 5UCOG PACA OUEST, Hopital Sainte
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Hopital Broca, Paris, 15UCOG PACA OUEST, Centre Hospitalier
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Rationale: Weight loss is common in older cancer patients and
strongly associated with poor outcomes. We aim to assess weight loss
(WL) in this population and identify associated factors.
Methods: A national cross-sectional survey (59 geriatric oncology
clinics, France) of older cancer patients, ≥70 years (inclusion periods:
November-December, 2017 and 2018). Demographic and clinical data
were collected; a geriatrician performed nutritional assessment.
Primary outcome: WL within the last six months precedent cancer
treatment: minimal (≤5%); moderate (>5% and <10%); severe (≥10%).
Factors studied included age, gender, family situation, in/out patients,
cancer site, metastatic status, previous anticancer treatment (<12
months), performance status (ECOG-PS), Timed Up and Go test (TUG),
Activities of Daily Living (ADL), sarcopenia (SARC-F score1), hand grip
strength test, dental health, dysgeusia, upper arm circumference, body
mass index (BMI), food intake, comorbidities (updated Charlson
index), number of medications, Mini Mental State Examination
(MMSE) and mini-Geriatric Depression Scale (GDS 4 items).
Results: A total of 1105 patients were included (median age 83 yrs.
[interquartile range, IQR 79–87]; males, 49%; metastasis, 41%; main
cancer sites: digestive (27%), breast (16%)). In total, 225 patients (20%,
IQR 18–23) had moderate WL and 288 (26%, 23–29), severe WL. In
multivariate analysis, female (p < 0.004), overweight (p < 0.05), obese
(p < 0.008), and patients with breast (p < 0.03), urologic (p < 0.006)
and hematologic cancers (p < 0.04) (compared with colorectal), were
less likely to have moderate or severe WL. Patients with poor
performance status (PS≥ 2), low body mass index (BMI <22.5 kg/m2),
low food intake (≤2/3 of last meal), low mobility (TUG test) (all
p < 0.001) or depression risk (p = 0.02), were more likely to have
moderate or severe WL. Patients with congestive heart failure (CHF)
were more likely to have moderate WL (p = 0.01); those with upper
gastro-intestinal (GI) tract cancers (liver and pancreas included) or
previously treated for their cancer, weremore likely to have severeWL
(p < 0.03). In sensitivity analysis, when replacing the TUG test and/or
PS with the SARC-F score, sarcopenia was only associated with severe
WL (p < 0.026).
Conclusions: Near half of older cancer patients managed in geriatric
oncology clinics had lost more than 5% of body weight in the last six
months. Male gender, upper GI tract cancer, poor PS, poor mobility,
depression risk, CHF, low BMI and low food intake were associated
with weight loss.
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PT10.4
ASSOCIATION OF HANDGRIP STRENGTH WITH MALNUTRITION
INFLAMMATION SCORE INMAINTENANCEHEMODIALYSIS PATIENTS
H. Bakkal1, O.S. Dizdar1*, K. Uludag2. 1Internal medicine department,
2Nephrology department, Kayseri City hospital, Kayseri, Turkey
* Corresponding author.
Rationale: Protein-energy wasting (PEW) is common in patients with
end-stage renal disease on maintenance hemodialysis (HD) patients
and is associated with increased morbidity, −+ mortality and poor
quality of life. Anthropometry assessment, nutritional screenings,
biochemical parameters and body composition measurement
methods are used for early diagnosis of malnutrition. Handgrip
strength (HGS) is related to nutritional assessment with
Malnutrition inflammation score (MIS) and biochemical parameters;
we investigated toverify best cut-off point of the HGS,which predicted
the value of MIS > 5, which determines survival in both sexes
Methods: This was a cross-sectional study including 132maintanance
hemodialysis patients (73male, age 56 ± 13,7) in the hemodialysis unit
of Kayseri Education Research Hospital. Biochemical parameters
including albumin, protein, creatinine, blood urea nitrogen, total
cholesterol, CRP ve ferritin of the last 3 months were respectively
collected. A physician performed the MIS test and modified Charlson
comorbidity index (CCI) questionnaire. Handgrip strength was
measured on the nonfistula side before dialysis session using a hand
dynamometer (Takei 5401).
Results: HGS differs between male and women (p < 0,001). Thus,
patients were divided into low and high HGS according to the gender-
specific median HGS values. It was revealed that there was significant
relationship between age, CCI, MIS and gender-specific median HGS
values (respectively p = 0,001, p = 0,001 and p < 0,001). A correlation
analysis revealed that HGS values were positively correlated with
weight (r = 0,190; p < 0,001), height (r = 0,348; p < 0,001), albumin
(r = 0,349; p < 0,001), creatinine (r = 0,374; p < 0,001) and in negative
correlation with age (r =−0,352; p < 0,001), ferritin (r =−0,199; p <
0,022), CCI scores (r =−0,350 p < 0,001) ve MİS value (r =−0,619,
p < 0,001). In multivariate regressions, adjustment for age, weight,
height, creatinine, albumine, ferritin levels did notmaterially diminish
these relationships. The optimized cutoff point of HGS for MIS >5 was
29,1 kg formen (sensitivity = 72,5%; specificity = 63,6%) and 20,1 kg for
women (sensitivity = 63,5%; specificity = 57,1%).
Conclusions: Lower HGS values were independently associated with
higherMIS among patients onmaintananceHD.We recommend using
it for early diagnosis and follow-up of PEW because HGS is a
noninvasive, cheap, radiation-free, simple and objective
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POSITIVE EFFECTS OF BREAD ENRICHED WITH Β-GLUCANS OR
RESISTANT STARCH ON POSTPRANDIAL GLUCOSE, INSULIN AND
GHRELIN RESPONSES OF HEALTHY SUBJECTS
P. Binou1* on behalf of Athena Stergiou, Amalia Yanni, Vaios
Karathanos, Panagiotis Konstantopoulos, Despina Perrea, Nikolaos
Tentolouris, Konstantinos Karavasilis. 1Nutrition and Dietetics,
Harokopio University of Athens, Athens, Greece
* Corresponding author.
Rationale: Efforts regarding the amelioration of postprandial glucose
and insulin responses to bread remain a priority in nutrition research
since they can result to significant beneficial effects for health. Beta-
glucans and resistant starch are known for their effects on improve-
ment of glucose tolerance and enhancement of insulin sensitivity.
Enrichment of bread with two different types of dietary fibers was
performed to examine potential postprandial benefits.
Methods: Ten healthy normoglycemic adults participated in the study
andwere providedwith either a solution of glucose (reference food) or
bread enriched with beta-glucans (BG) or bread enriched with
resistant starch (RS), with 1-week intervals in amounts that yielded
50 g of available carbohydrates. Venous blood samples were collected
before consumption and at 15, 30, 45, 60, 90, 120 and 180 min
postprandially. Glucose, insulin and ghrelin responses as well as
glycemic index (GI) and subjective appetite ratings were evaluated.
Results: Ingestion of BG and RS elicited lower incremental area under
the curve (iAUC) for 120-min glycemic response compared to the
solution of glucose (P < 0.05). Both breads demonstrated a low GI. A
significantly lower desire to eat and higher fullness were detected 30
minutes after BG and RS consumption and until 180 minutes (P < 0.05
compared to glucose). There were no significant differences in insulin
response or ghrelin suppression among the two breads.
Conclusions: Enrichment of bread with beta-glucans or resistant
starch induces similar effects on glucose, insulin and ghrelin responses
and offers a lower desire for the next meal. The development of bread
products which cause improved metabolic effects is of great
importance for the promotion of public health.
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IMPAIRED AMINO ACID AVAILABILITY AND MUSCLE PROTEIN
SYNTHESIS RATES AFTER MEAL INGESTION IN MAINTENANCE
HEMODIALYSIS PATIENTS
S. van Vliet1*, S.K. Skinner1, J.W. Beals1, B. Pagni1, H.-Y. Fang1,
A.V. Ulanov1, Z. Li1, S.A. Paluska1, M. Mazzulla2, D.W. West2,
D.R. Moore2, K.R. Wilund1, N.A. Burd1. 1University of Illinois, Champaign
– Urbana, Champaign – Urbana, United States, 2University of Toronto,
Toronto, Canada
* Corresponding author.
Rationale: Skeletal muscle loss is common in patients with renal
failure receiving maintenance hemodialysis (MHD) therapy. Regular
ingestion of protein-rich meals are recommended to help offset
muscle protein loss in MHD patients, but little is known about the
anabolic potential of this strategy.
Methods: Eight MHD patients (age: 56 ± 5 y: BMI: 32 ± 2) and eight
non-uremic controls (age: 50 ± 2 y: BMI: 31 ± 1) received primed
continuous L-[ring-2H5]phenylalanine and L-[1-
13C]leucine infusions
with blood and muscle biopsy sampling on a non-dialysis day.
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Participants consumed a mixed meal (546 kcal; 20 g protein, 59 g
carbohydrates, 26 g fat) with protein provided as L-[5,5,5-2H3]leucine
labeled eggs.
Results: Circulating dietary-amino acid availability was reduced in
MHD patients (41 ± 5%) vs. controls (61 ± 4%; P = 0.03). Basal muscle
caspase-3 protein content was elevated (P = 0.03) and LAT1 protein
content was reduced (P = 0.02) in MHD patients vs. controls. Basal
muscle protein synthesis (MPS) was ∼2-fold higher in MHD patients
(0.030 ± 0.005% · h−1) vs. controls (0.014 ± 0.003% · h−1) (P = 0.01). Meal
ingestion failed to increase MPS in MHD patients (absolute change
from basal: 0.0003 ± 0.007% · h−1), but stimulated MPS in controls
(0.009 ± 0.002% · h−1; P = 0.004).
Conclusions: MHD patients demonstrate muscle anabolic resistance
to meal ingestion. This blunted postprandial MPS response in MHD
patients may relate to high basal MPS resulting in a stimulatory
“ceiling effect” and/or reduced plasma dietary amino acid availability
after mixed meal ingestion.
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ASSOCIATION BETWEEN GROWTH AND DIFFERENTIATION FACTOR
(GDF)-15 SERUM LEVELS, ANOREXIA AND SARCOPENIA IN
GASTROINTESTINAL AND LUNG CANCER PATIENTS
A. Molfino1*, M.I. Amabile1, C. Ramaccini1, R. Belli1, A. Di Renzo1,
G. Imbimbo1, P. Costelli2, M. Muscaritoli1. 1Sapienza University of Rome,
Rome, 2Interuniversity Institute of Myology, University of Turin, Turin,
Italy
* Corresponding author.
Rationale: The pathophysiology of cancer anorexia and sarcopenia is
not completely clarified. Different serum biomarkers, including some
growth and differentiation factors, may be modulated during cancer
and likely associated with an anorexic and sarcopenic phenotype.
The aim of our study was to explore the potential association(s)
between the serum levels of GDF-15, anorexia and sarcopenia in
patients with gastro-intestinal (GI) and lung cancer.
Methods: We considered patients with GI (gastric, pancreatic and
colorectal) and lung cancer, at their first diagnosis, with or without
anorexia and sarcopenia, and healthy matched controls. Radiological
evaluation of skeletal muscle mass by computed tomography scan (L3
SMI) was used to diagnose sarcopenia in cancer patients and GDF-15
serum levels were assessed by ELISA in all the participants. The
Functional Assessment of Anorexia/Cachexia Therapy (FAACT) ques-
tionnaire was administered to all patients to detect the presence of
anorexia. Parametric and non-parametric tests were performed,
appropriate.
Results: 38 cancer patients and 19 controls were enrolled. GDF-15
serum levels were significantly higher in cancer patients with respect
to controls (P = 0.007). Anorexic patients (34%, by FAACT score ≤21)
showed higher GDF-15 levels with respect to non-anorexic (P = 0.03).
The prevalence of sarcopenia was 52.6%. Sarcopenic patients showed
higher GDF-15 levels compared to non-sarcopenic cancer patients
(P = 0.02). Moreover, GI cancer patients showed higher GDF-15 levels
compared to lung cancer patients (P = 0.009).
Conclusions: Our data suggest an involvement of GDF-15 in the
pathogenesis of cancer-associated anorexia and sarcopenia, in par-
ticular in GI tract cancer, with mechanisms to be further elucidated.
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AN IRISH PATIENT SURVEY OF NUTRITION ATTITUDES & ACCESS TO
DIETETIC CARE THROUGHOUT THE CANCER JOURNEY
E.S. Sullivan1*, N. Rice2, A. Kelly1, E. Kingston1, L.E. Daly1, D.G. Power3,
J.V. Reynolds4, A.M. Ryan1. 1School of Food & Nutritional Sciences,
University College Cork, Cork, 2Irish Society for Clinical Nutrition &
Metabolism (IrSPEN), Dublin, 3Departments of Medical Oncology, Cork &
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Rationale: The attitudes of cancer patients towards nutrition and
nutrition care has never been captured in Ireland. An awareness of the
nutritional needs and attitudes of cancer patients along with a review
of their experiences would help inform service planning.
Methods: In September 2018, a national survey was conducted to
examine patient attitudes towards nutrition and access to dietetic
services during their cancer journey. Patients diagnosed or treated in
Ireland since 2015 were asked to complete a 25-item survey (available
online and at 20 hospitals across Ireland).
Results: In total, 1085 valid responses were received (63% female,
mean age 58 years). All major cancer groups were represented & 33%
had metastatic disease. Overall, 45% reported suffering from a diet-
related problem and 44% reported weight loss since diagnosis. Muscle
loss was noted by 52%. Amongst weight losers, 42% were “unhappy/
worried” while 27% reported being “delighted/happy.” Although 80%
are “always/usually” weighed in clinic, just 43% reported that they are
“always/usually” asked about diet. Nutrition was rated “very/
extremely” important by 89% of respondents. Only 39% had received
dietary advice from a dietitian and 74% rated this advice as “very/
extremely” helpful. Overall, 57% of those who did not see an RD said
they would have liked more support with diet. While 58% reported
trying general healthyeating as a result of their diagnosis, 38% and 32%
admitted trying at least one alternative dietary strategy or avoiding a
specific food due to their diagnosis, respectively.
Conclusions: While nutrition is highly important to Irish cancer
patients, fewer than half surveyed had accessed a dietitian.Weight and
muscle loss are common,but their significance isnot alwaysunderstood
by patients. Almost half used alternative dietary strategies, highlighting
the need to screen oncology patients for potentially restrictive diet or
supplement use to guide appropriate referrals and education.
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PREOPERATIVE IMMUNONUTRITION COMPARED TO STANDARD
NUTRITIONAL SUPPORT AFFECTS THE INFLAMMATORY RESPONSE
WITHIN THE COLORECTAL CANCER TISSUE – RANDOMIZED
CONTROLLED TRIAL
M.Wierdak1*, M. Surmiak2, M. Rubinkiewicz1, M. Wysocki1, K. Milian-
Ciesielska3, P. Major1, A. Rzepa1, M. Pedziwiatr1. 12nd Department of
Surgery, 2Department of Internal Medicine, 3Department of Pathology,
Jagiellonian University Medical College, Krakow, Poland
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Rationale: The first choice of treatment in colorectal cancer is surgery.
Nutritional support in form of oral nutritional supplements (ONS) in
the preoperative period is widely accepted in reducing the amount of
S56 Abstracts / Clinical Nutrition 38 (2019) S33–S58
perioperative complications and immunonutrition is generally recom-
mended. However, there is little clinical data regarding the impact of
such treatment on a tumor biology. Therefore we designed a study
comparing the effect of immunonutritional and standard ONS
treatment on altering the expression of inflammatory response
cytokines in colorectal cancer tissue.
Methods: 26 patients who underwent laparoscopic colonrectal
resection due to cancer were included into the study. None of
them underwent preoperative radiochemotherapy. In all patients,
tumor samples were collected during colonoscopy at the time of
diagnosis (samples A). Next, randomization to 2 groups was
performed. The group 1 consisted of patients who, as part of
standard preparation, used standard ONS (3 × Nutricia Nutridrink per
day) for 2 weeks before surgery. In group 2 ImmunoONS (2× Nestle
Impact Oral) was administered. Tumor tissue (samples B) was than
retrieved after resection. The material was analyzed in luminex
method for proteins expression (TNF-α, CXCL8, SDF-1a, CXCL6,
CXCL2, MPO, CXCL1).
Results: Pre-operatively, the groups did not differ in terms of
demographic parameters and tumor staging. There were no differ-
ences in the expression of any of the analyzed proteins in the pre-
operative period (samples A). A statistically significant change in the
deference of expression of TNF-α was observed between the groups
[group 1 (35.68 vs 21.54); group 2(27.79 vs 31.63) p = 0.049] and CXCL1
[group 1 (2144.59 vs 953.75); group 2 (1902.86 vs 2698.27) p = 0.032].
The levels of remining cytokines did not differ.
Conclusions: Immunonutrition in preoperative period compared to
standard nutritional support may influence inflammatory cytokine
expression in the tumor tissue in patients with colorectal cancer.
Farther studies are needed to establish real influence of immunonu-
trition in colorectal cancer tissue.
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MALNUTRITION IN CANCER PATIENTS: CAN PATIENTS BE
IDENTIFIED SOONER?
N.F. Devlin1*, D. Mcgeough1, S. Stone1. 1HSE, Drogheda, Ireland
* Corresponding author.
Rationale: Malnutrition is a predictor of outcome in patients’ with
cancer diagnosis1. Preventing malnutrition aims to maintain skeletal
muscle mass, reduce interruptions in treatment, and improve quality
of life. The aim of this study was to compare the Malnutrition
Screening Tool (MST)2 with an amended form of the screening tool to
investigate if cancer patients at risk of malnutrition could be identified
sooner.
Methods: Participants were screened for malnutrition using both the
MST and an amended form of this screening tool. Eligible participants
(≥18 years, and undergoing chemotherapy treatment: newly diag-
nosed and those with established malignancy were accepted –
irrespective of cancer type) were recruited from an outpatient
oncology day ward. A scoring system was used to highlight those at
risk of malnutrition. The MST was scored on weight loss and reduced
appetite, while the amended MST was scored on weight loss, reduced
appetite and the common side effects of cancer treatment (nausea,
taste changes, dysphagia, xerostomia, diarrhoea, constipation and
vomiting). The amended screening tool was validated against the MST
using the statistical values of sensitivity, specificity, positive predictive
values (PPV), and negative predictive values (NPV).
Results: A total of 151 oncology outpatients were included in this
research (median age: 52 years; mean weight: 74 kg; mean BMI:
26.9 kg/m2). Using the MST 24% of participants were deemed at risk of
malnutrition. Using the amended MST 42% of participants were
deemed at risk of malnutrition. Reduced appetite (73%) and weight
loss (67%) were the main risk factors, followed by taste changes (33%),
nausea and vomiting (26%). The amended MST had a 100% sensitivity
against the MST and 100% NPV.
Conclusions: Side effects of cancer treatments may be a precursor of
malnutrition. Using the amended MST, an additional 18% of patients
were highlighted to be at risk ofmalnutritionwhen comparedwith the
MST. The excellent sensitivity and NPV of the amended screening tool
supports the tool in its ability to detect malnutrition and correctly
highlight those not to be at risk of malnutrition.
References
1. Arends, et al. ESPEN expert group recommendations for action
against cancer-related malnutrition. Clinical Nutrition 2017.
2. Ferguson M., et al.Development of a valid and reliablemalnutrition
screening tool for adult acute hospital patients.Nutrition.1999 June;
15(6): 458–64.
Disclosure of Interest: None declared.
PT11.05
BODY MASS INDEX AND INVASIVE BREAST CANCER PROGNOSIS:
STUDY OF 1,638 LOCALLY BREAST CANCERS
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Rationale: Breast cancer (BC) is the first cause of death by cancer in
women. Overweight and obesity, evaluated by the body mass index
(BMI), are associated with an increased risk of postmenopausal BC,
especially hormone receptor-positive cancers. BMI is associatedwith a
more aggressive or advanced BC regardless of menopausal status but
the linkwith classical BC prognosis factors is unknown. The aims of our
studywere: i) to compare the invasive BC initial prognostic factors and
evolution in women according to BMI and menopausal status, ii) to
study the survival according to the BMI, iii) to search the factors
associated to BC recurrence.
Methods:We included all women with locally invasive BC diagnosed
between 2004 and 2013 at the University Hospital Center of Limoges.
Menopausal status, BMI at the time of diagnosis, tumor characteristics
(histological type, urokinase plasminogen activator and plasminogen
activator inhibitor-1, estrogen receptor, progesterone receptor-posi-
tive), treatment, and evolution of patients were collected. We
compared two BMI groups (>25 and <25 kg/m2) and two menopausal
statuses (pre and post-menopausal). Statistical tests used were
Student’s t-test, chi-square test, multivariate regression analysis
using logistic regression and Kaplan-Meier analysis.
Results: In total, 1,638 women were included. More tumors of
premenopausal women with BMI≥ 25 kg/m2 were urokinase plas-
minogen activator and plasminogen activator inhibitor-1-positive
(77.8% vs. 47.1%, p = 0.009) and the percentage of metastatic recur-
rences was greater (93.3% vs. 53.6%, p = 0.008) compared to patients
with BMI < 25 kg/m2. Tumors of postmenopausal women with BMI 3
25 kg/m2 were more estrogen receptor-positive (87.9% vs. 82.2%,
p = 0.008), progesterone receptor-positive (61.3% vs 49.2%, p = 0.0003),
and more luminal A subtypes (69.5% vs. 66.5%, p = 0.04). According to
the BMI the overall survival was not significantly different. The
multivariate analysis did not find factors associated to BC recurrence.
Conclusions: Biomarker results may explain different prognoses
in patients with invasive BC according to BMI and menopausal
status. The nutritional status of women is an important parameter to
consider in BC. Excessweightmust be screened at diagnosis andduring
S57Abstracts / Clinical Nutrition 38 (2019) S33–S58
follow-upto allow appropriate nutritional care in addition to the usual
BC treatments.
Disclosure of Interest: None declared.
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IS HOME PARENTERAL NUTRITION BURDENSOME IN ADVANCED
CANCER PATIENTS WITH MALIGNANT BOWEL OBSTRUCTION? A
RETROSPECTIVE ANALYSIS IN AN UK INTESTINAL FAILURE CENTRE
P.S. Patel1, K. Fragkos2, N. Keane1, K. Cauldwell3, F. O’hanlon2, J. Rogers2,
S. Obbard2, J. Barragry2, G. Sebepos-Rogers2, S. Mehta2, F. Rahman2,
S. Di Caro2*. 1Department of Nutrition and Dietetics, 2Intestinal Failure
Unit, University College London Hospital, 3Palliative Care, Central and
North West London NHS Trust, London, United Kingdom
* Corresponding author.
Rationale: Use of home parenteral nutrition (HPN) in advanced
cancer patients with malignant bowel obstruction (MBO) who have
lost their nutritional autonomy and developed intestinal failure (IF), is
controversial. Controversies relate to financial, cultural, and ethical
issues, including the risk that HPN is burdensome for the patient and
their carer. We examined what burdens are placed when HPN is
initiated.
Methods: Retrospective cohort study of adults admitted to University
College London Hospital with MBO and started on HPN between 1.1.16
and 31.12.16with readmissions until 31.12.17. Datawere analysed using
mean (SD), median (min-max) and proportions (%). Survival was
examined using Kaplan Meier curves.
Results:We identified 10 patients with 20 MBO admissions whowere
commenced on HPN (mean±SD age: 55.3 ± 13.9 yrs, 80% female).
Primary malignancies were 50% gynaecological and 50% lower GI
cancers with metastases (70% in lower- and 30% upper-lower-
diaphragm area). Median weight and BMI on admission were normal
(54.8 kg, 42–87 kg; 19.1 kg/m2, 15–33), though, patients presented
with significant weight loss (9.1%, 3.8–21.1%). Weight at 0–3- and 3–6-
month follow-up was 54 kg and 55.4 kg. HPN was more likely to be
set-up on the 2nd admissionwith BO (HPN set up on: 1st n = 3; 2nd n = 5
and 3rd admission n = 2). HPN delayed inpatient discharge bymedian 2
days (0–6 d) due to lack of communication within and between
Oncology and Nutrition teams. Median duration of HPN was 196 days
(1–351 d). Patients were on PN 7 days/wk (4–7 d/wk), with n = 8/10
utilizing nursing input for PN (dis)connection. For those who were
nursed this meant 8–14 visits/wk by homecare nurses for PN (dis)
connection. HPN was stopped and restarted in 2 patients due to BO
resolving and line infection. Reasons for stopping HPN completely
included: patients had died (n = 5), were end of life (n = 2) oreating (i.e.
BO resolved), suggesting that there was flexibility to stop HPN to
patients’ circumstances. In addition, decision to stop HPN was not
contentious in none of the cases. Post discharge on HPN, median
readmissions were 3, of which 0 due to HPN. Follow-up appointments
were mostly in oncology than nutrition clinics (5.5 vs 3 follow-ups)
whilst on HPN. There was a 3 month longer survival in those on HPN
versus not on HP (median survival: 9 months for HPN patients, 4
months in patients not on HPN).
Conclusions:HPN is more likely to be set up during the 2nd admission
for MBO. HPN did not place a substantial burden on the patient with
regards to readmissions and follow-up visits to hospital or discharge
delays. Nursing visits, in addition to other service visits (e.g. GP,
palliative care) could be perceived as burdensome by patients. All
these factors should be weighed against survival which was longer in
HPN patients. Further research in larger settings and quality of life
factors is required.
Disclosure of Interest: P. Patel Grant/Research Support from: Research
post is funded by Calea, Fresenius Kabi., K. Fragkos: None declared,
N. Keane: None declared, K. Cauldwell: None declared, F. O’Hanlon:
None declared, J. Rogers: None declared, S. Obbard: None declared,
J. Barragry: None declared, G. Sebepos-Rogers: None declared,
S. Mehta: None declared, F. Rahman: None declared, S. Di Caro: None
declared.
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SUN-PO001
COMPARATIVE STUDY BETWEEN CONVENTIONAL FASTING VERSUS
OVERNIGHT INFUSION OF LIPID OR CARBOHYDRATE ON INSULIN
AND FREE FATTYACIDS IN OBESE PATIENTS UNDERGOING ELECTIVE
ON-PUMP CORONARY ARTERY BYPASS GRAFTING. A PROSPECTIVE
RANDOMIZED TRIAL
A. Abdelmonem1*, Hisham Hosny, MD, DESAn,†,1, Mohamed Ibrahim,
MDn, Wael El-Siory, MDn. 1Anaesthesia and Surgical Intensive Care,
Faculty of Medicine, Cairo University, Giza, Egypt
* Corresponding author.
Rationale: Postoperative insulin resistance represents a major
component of postoperative metabolic disorder. The authors com-
pared the effects of preoperative infusion of lipid emulsion or
carbohydrate to conventional preoperative fasting on postoperative
insulin and free fatty acid (FFA) levels.
Methods: Design: A prospective randomized double-blinded study.
Settings: Tertiary university hospital.
Participants: Sixty-three patients undergoing coronary artery bypass
grafting.
Intervention: Participants were randomized into 3 equal groups.
Group G received 500 mL of glucose 10% (50 g glucose). Group L
received 100 mL of 2% lipid emulsion (soybean 30%, medium chain
triglycerides (TG) 30%, olive oil 25%, fish oil 15%, and 20 mg
vitamin E). Group C fasted overnight except for clear fluids
allowed until 4 hours preoperatively. Serum insulin at the start
of infusion (T1), 1-hour preinduction (T2), on admission to the
intensive care unit (T3), after 24 hours of admission (T4), and after
48 hours of admission (T5), and FFA at T1 and T2 were measured.
Serum very-low-density lipoprotein (VLDL), serum TG, and blood
sugar were all measured (T1-T4). Bypass time, ischemic time, need
for inotropic support, and length of intensive care unit stay also
were measured.
Results:Measurements and Main Results: At the end of infusion FFAs
were significantly lower in the L group (1.1 7 0.76 mg/dL) compared
with G (1.64 7 0.85 mg/dL) and C groups (1.48 7 0.76 mg/dL). Insulin
levels were significantly lower in the L group compared with levels in
the G and C groups at T2, T3, and T4. Also, TG, VLDL, and random blood
sugar levels decreased significantly at T2, T3, and T4 in the L group
compared with the other 2 groups and compared with baseline value
within the same group.
Conclusions: Preoperative lipid infusion lowered postoperative FFA,
insulin, TG, VLDL, and random blood sugar in obese patients
undergoing coronary artery bypass grafting surgeries. & 2017
Elsevier Inc. All rights reserved.
Disclosure of Interest: None declared.
SUN-PO002
DYNAMICS OF POLYUNSTURATED FATTY ACID PROFILE IN PLASMA,
LIVER AND BLOOD LEUKOCYTES AFTER ENDING PARENTERAL
INFUSION OF FISH OIL LIPID EMULSION
M.D.S. Antunes1, D. Waitzberg1*, A. Tesser1, R. Oliveira1, F.G. Aprobato1,
E. Tamanaha1, P. Garla1, G.R. Sampaio2, E. Torres2, P. Calder3,
R. Torrinhas1. 1Gastroenterology, 2Public Health, University of São
Paulo, São Paulo, Brazil, 3Faculty of Medicine, University of
Southampton, Southamp, United Kingdom
* Corresponding author.
Rationale: Aiming to contribute to the design of protocols on
specialized nutrition, we evaluated the profile of polyunsaturated
fatty acids (PUFA) in different biological samples and periods after the
end of a fish oil-containing parenteral lipid emulsion (FOLE) infusion.
Methods: After 5-day adaptation in metabolic cages, 78 male Lewis
rats (300–450 g) feeding AIN-93M ad libitumwere sacrificed (BC basal)
or had only central venous catheterization (SC Sugery) or also received
72-hour infusion of a commercial lipid emulsionwithout fish oil (MCT/
LCT – EC, LP control) or FOLE (MCT/LCT/FO). After the period
corresponding to the end of infusion, these rats were sacrificed at 0
(T0), 2 (T2), 6 (T6) and 12 (T12) h. Gas chromatography was used to
determine levels of eicosapentaenoic (EPA), docosahexaenoic (DHA)
and arachidonic (ARA) acids, and w-3:w-6 ratio in liver, plasma and a
pool of peripheral mononuclear and polymorphonuclear leukocytes.
Data were compared by Kruskal Wallis and Wilcoxon tests.
Results: Leukocytes, plasma and liver from BC group had undetectable
EPA and DHA and high ARA levels. Immediately after FOLE infusion
(T0) these PUFAs changed in all samples, showing a higher w-3:w-6
ratio compared to rats with no FOLE (p < 0.05). These changes
remained until T6 in plasma and T12 in liver, but were not longer
observed in leukocytes after T2.
Conclusions: Our data suggest that leukocytes clear PUFA early after
the end of FOLE infusion. When FOLE is applied for immunomodu-
latory purposes this should be considered.
Disclosure of Interest: None declared.
SUN-PO003
DYNAMICS OF POLYUNSATURATED FATTYACID UPTAKE IN PLASMA,
LIVER AND BLOOD LEUKOCYTES AFTER PARENTERAL INFUSION OF
FISH OIL LIPID EMULSION
A. Tesser1, R.S. Torrinhas1, F.G.G. Aprobato1, E.M. Tamanaha1,
R.S. Oliveira-Filho1, M.S. Antunes1, G.R. Sampaio2, E. Torres2,
P.C. Garla1, P.C. Calder3, D.L. Waitzberg1*. 1University of São Paulo
Medical School, 2University of São Paulo School of Public Health, São
Paulo, Brazil, 3University of Southampton Faculty of Medicine,
Southampton, United Kingdom
* Corresponding author.
Rationale: Medium chain triglycerides (MCTs) have been considered
useful to promote uptake of n-3 polyunsaturated fatty acids (n-3
PUFAs). We assessed the uptake of n-/3 PUFAs in different biological
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samples and periods after infusion of a fish oil-containing parenteral
lipid emulsion (FOLE) with or without MCT.
Methods: After 5-day adaptation in metabolic cages, 42 male Lewis
rats (≈350 g) fed with AIN-93M were sacrificed (BC, baseline control)
or were submitted to central venous catheterization and distributed
into: Surgical control group (SC) – no infusion; MCT/LCT/FO group –
infusion for 48 and 72 hours of a commercial lipid emulsion (LE)
containing 50% MCTs, 40% long chain triglycerides (LCTs) and 10% fish
oil (FO) and LCT/FO group-infusion for 48 h and 72 h of an
experimental LE containing 80% LCTs and 20% FO. The n-6:n-3 ratio
were comparable between both LEs (LCT/FO = 2.7:1; MCT/LCT/
FO = 2.3:1). Gas chromatography was used to determine n-3 and n-6
PUFA levels in liver, plasma and blood mononuclear and polymorpho-
nuclear leukocytes. Data were compared by Kruskal Wallis and
Wilcoxon tests.
Results: There was no difference in the n-3 PUFA uptake, between LEs
(p > 0.05). In relation to BC and SC groups, leukocyte incorporation of
n-3 PUFAs peaked after 48 h infusion and decreased after 72 h in both
LE groups. After 48 h infusion, the plasma n-3:n-6 ratio was higher in
MCT/LCT/FO group than in the LCT/FO group (p < 0.05).
Conclusions: Despite promoting an early clearance of plasma n-3
PUFAs, there was no clear benefit of adding MCTs in their uptake in
leukocytes and liver.
Disclosure of Interest: None declared.
SUN-PO004
NUTRACEUTICAL INTERVENTION WITH BERBERINE, CHLOROGENIC
ACID AND TOCOTRIENOLS FOR MENOPAUSE-ASSOCIATED
DYSLIPIDEMIA: A PILOT, SINGLE-ARM TRIAL
E. Cereda1*, S. Cappello1, M. Caraccia1, A. Turri1, S. Masi1, R. Nappi2,
R. Caccialanza1. 1Clinical Nutrition and Dietetics Unit, Fondazione Irccs
Policlinico San Matteo, 2Research Center for Reproductive Medicine,
Gynecological Endocrinology and Menopause, Fondazione Irccs
Policlinico San Matteo, University of Pavia, Pavia, Italy
* Corresponding author.
Rationale: Dyslipidemia is a frequent feature of menopause, which is
associated with increased cardiovascular risk and often requires
pharmacological intervention with statins. The aim of this pilot
study was to evaluate the potential role of the combination of some
compounds of vegetal origin, such as berberine, chlorogenic acid
and tocotrienols, in the management of menopause-associated
dyslipidemia.
Methods: Post-menopause women with menopause-associated dys-
lipidemia (low-density lipoprotein [LDL] cholesterol >100 mg/dL)
were enrolled in a single-arm pilot trial and received a nutraceutical
(Trixy®) containing berberine, chlorogenic acid and tocotrienols (1
pill/day) for 3 months. The primary endpoint was the change in
measured LDL cholesterol at 3 months. Secondary endpoints included
the change in total and HDL cholesterol, triglycerides, blood glucose,
insulin, insulin resistance, body weight, waist circumference, body
composition by bioimpedance vectorial analysis, Greene Climacteric
Scale and quality of life (36-Item Short Form Health Survey).
Results: Thirty-one patients were enrolled and 27 (87.1%) completed
the study. At 3 months, the intervention was associated with a
reduction in LDL (−12.3 mg/dL [95%CI, −22.1 to −2.4]; p = 0.016) and
total cholesterol (−14.0 mg/dL [95%CI, −22.3 to −5.6]; p = 0.002) and
an improvement in Greene Climacteric Scale (−8.7 points [95%CI,
−12.9 to−4.6]; p<0.001). No significant changes in the other endpoints
were observed and no complications occurred.
Conclusions: The combination of berberine, chlorogenic acid and
tocotrienols could be a useful adjuvant therapy for menopause-
associated hypercholesterolemia and climacteric symptoms. Further
randomized-controlled trials with adequate samples and observation
periods are needed to confirm this hypothesis.
Disclosure of Interest: None declared.
SUN-PO005
SOLEUS MUSCLE CONTAINS HIGHER LIPID MEDIATORS THAN
EXTENSOR DIGITORUM LONGUS: SLOW/FAST FIBER-SPECIFIC
ANALYSIS IN ENDOTOXEMIA USING LC-MS/MS
M. Miyoshi1*, Y. Nishiyama1, M. Kai1, N. Maeshige1, M. Shinohara2,3,
Y. Fueda4, M. Usami1,5. 1Kobe University Graduate School of Health
Sciences, 2Division of Integrated Medical Education, 3Division of
Epidemiology, Kobe University Graduate School of Medicine, Kobe,
4Faculty of Health Sciences, Morinomiya University of Medical Sciences,
Osaka, 5Faculty of Clinical Nutrition and Dietetics, Konan Women’s
University, Kobe, Japan
* Corresponding author.
Rationale: We have reported that lipopolysaccharide (LPS) injection
induced skeletal muscle atrophy on early phase (ESPEN 2015);
however, detailed analysis of fatty acid-derived lipid mediators in
skeletal muscle has not been reported yet. The purpose of this study
was to evaluate fiber-specific analysis of muscular lipid mediators
using liquid chromatography/tandemmass spectrometry (LC-MS/MS)
in endotoxemic rats.
Methods: Male Wistar rats were treated with 10 mg/kg LPS i.p.
injection. Soleus (slow) muscles and extensor digitorum longus (EDL,
fast muscle) were harvested at 0, 6, and 24 h after LPS injection. Lipid
mediators were profiled using LC-MS/MS, and free fatty acids (FFA)
composition of phospholipid fractions was analyzed by gas chroma-
tography-mass spectrometry (GC-MS).
Results: Before LPS injection, all FFA, including arachidonic acid,
eicosapentaenoic acid, and docosahexaenoic acid (DHA), and all lipid
mediators measured were higher in soleus muscles than in EDL,
especially pro-inflammatory prostaglandin (PG) E2 and anti-inflam-
matory resolvin (Rv) E3 (p < 0.01–0.05). The anti-inflammatory lipid
mediators from DHA, RvD5 and protectin D1, were only detected in
soleus muscles. Because FFAs are the main source of energy in soleus
muscles, their metabolites lipid mediator might be higher than EDL.
LPS injection changed lipidmediators, PGE2were increased at 6 h after
LPS injection in bothmuscles (p < 0.01). The increased PGE2mayaffect
muscle atrophy.
Conclusions: Free fatty acids and lipidmediatorswere higher in soleus
muscle and LPS increased pro-inflammatory lipid mediators at very
early phase.
Disclosure of Interest: None declared.
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EVALUATING LONG-TERM USE OF SOYBEAN OIL, MEDIUM-CHAIN
TRIGLYCERIDE, OLIVE OIL AND FISH OIL (SMOFLIPID®) IN ADULTS
WITH INTESTINAL FAILURE
T. Khatib1*, S. Burden1, S. Lal2, S. Tyson1. 1The University of Manchester,
Manchester, United Kingdom, 2Salford Royal NHS Foundation Trust, The
University of Manchester, Manchester, United Kingdom
* Corresponding author.
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Rationale: To determinewhether SMOFlipid® is associated with more
effective or less favourable outcomes compared to alternative lipids in
patients needing home parenteral nutrition (HPN).
Methods: A single-centre, retrospective cohort study was completed
on those receiving HPN between 1st April 2011 to 31st March 2015.
Individuals were stratified into two groups based on lipid received
over 12 consecutive months. SMOFlipid® (SL) was compared with
soybean oil, or olive oil combined with soybean oil (SO). Outcomes
included liver dysfunction, tolerability and clinical signs of essential
fatty acid deficiency. Statistical analysis was completed on SPSS (IBM
version 23).
Results: 179 patients (mean age 55 years, 58.1% female)were included.
There were no differences in gender, age, diagnosis, type of Intestinal
Failure, chronic cholestasis or liver function in SL (n = 37) and SO
(n = 62). At 12 months, groups did not differ in chronic cholestasis
prevalence (SL n = 5 (17.9%), SO n = 13 (25.0%) p = 0.466) or incidence
(SL n = 5 (17.9%), SO n = 12 (23.1%) p > 0.999), mean liver function (ALP
SL 165.06 (SD 98.14), SO 165.26 (SD 81.27) p = 0.912; GGT SL 121.59 (SD
146.21), SO 123.85 (SD 142.12) p = 0.953; bilirubin SL 9.00 (SD 6.38), SO
9.24 (SD 11.06) p = 0.916; ALT SL 47.70 (SD 37.76), SO 36.29 (SD 22.62)
p = 0.141); mean change in liver function (ALP SL− 20.84 (SD 85.92),
SO 4.93 (SD 112.25) p = 0.273); GGT SL 9.50 (SD 14.85), SO− 14.00 (SD
31.22) p = 0.373; SL bilirubin− 1.81 (SD 7.36), SO 1.18 (SD 12.76)
p = 0.280; SL ALT− 15.67 (SD 52.96), SO− 3.88 (SD 30.42) p = 0.273);
catheter sepsis (SL n = 4 (10.8%), SO n = 2 (3.3%) p = 0.195) and change
in body mass index (SL 1.72 (SD 2.75), SO 1.69 (SD 3.17) p = 0.971).
There was no group difference in chronic cholestasis or liver
dysfunction after adjusting for confounding variables. Essential fatty
acid deficiency was not observed in either group.
Conclusions: Noclinically relevant differences were noted between
the SMOFlipid® and comparator in the outcomes analysed. Additional
studies are required to investigate the optimal lipid formulae to
manage liver dysfunctionwhile avoiding essential fattyacid deficiency.
Disclosure of Interest: T. Khatib Grant/Research Support from: MPhil
research sponsored by Fresenius Kabi, S. Burden: None declared, S. Lal:
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EFFECT OF RESVERATROL, CAPSAICINE AND PIPERIN ON LIPID
METABOLISM IN 3T3L1 CELLS
C. Kono1, T. Matsushima2*. 1Human Life Science, Jissen Women’s
University, Hino, 2Human Life Science, Jissen Women’s University, Tokyo,
Japan
* Corresponding author.
Rationale: Several food ingredients have been suggested to have
preferable effects on lipid metabolism and obesity, evidences are
rarely available and their mechanisms are not well known. In order to
confirm the effects and to elucidate the mechanisms, resveratrol,
capsaicinandpiperinwereanalyzed foreffectsonthe lipidaccumulation
and gene expression relevant to lipid metabolism using adipocytes.
Methods: Preadipocytes 3T3-L1 were cultured in Dulbecco’s Modified
Eagle Medium including 10% Fetal Calf Serum under 5% CO2. At the
second day after confluence, cells were differentiated by adding
isobutyl methyl xanthin, dexamethazon and insulin to the medium.
Food ingredients were added to the adipocytes with or without
epinephrin. At the 7th day, the cells were quantified lipid content by
enzymatic method and Oil Red O staining. Total RNA was prepared
from the cells and gene expressions of relevant genes to lipid
metabolism were analysed using real-time PCR.
Results: Compared to control, triglyceride content accumulated in cells
was significantlydecreasedup to54.3%by the additionof capsaicin and
up to 21.3% by resveratrol dose-dependently. Capsaicin when added
with epinephrin enhanced the suppressive effect of epinephrin 143%.
Secretion of leptin into themediawas decreased to 24.9% by resveratrol
and increased ti 171% by capsaicin. Adiponectin was increased to 110%
by resveratrol. Gene expression of PPAR-gammawas incresed to 340%
by resveratrol and to 633% by capsaicin. That of insulin receptor was
incresed 15.5 times and adrenergic beta-3 receptor genewas increased
8.7 times by capsaicin. Piperin itself did not have consistent effect on
lipid accumulation, but it enhanced 2.1 fold the effect of epinephrin
which decreased the lipid content of cells to 60.7%. Piperin increased
the gene expression of adrenergic beta-3 receptor to 354%, perilipin to
173% and hormon-sensitive lipase to 185%.
Conclusions: It is suggested that resveratrol decreases triglyceride
content of adipocytes by cell differentiation through gene expression
of PPAR-gamma. Capsaicin is suggested to enhance the lipid
degradation by incresasing the sensitivity to epinephrin. Piperin
enhanced the degradation of the triglyceride by epinephrin through
multiple mechanisms relevant to the triglyceride degradation. These
food ingredientsmay be beneficial to obesityandmetabolic syndrome.
Disclosure of Interest: None declared.
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D-GLUCOSAMINE ACTS AS A CALORIE RESTRICTION MIMETIC AND
EXTENDS NEMATODE LIFESPAN VIA AUTOPHAGY INDUCTION
T. Shintani1*, Y. Kosuge2, H. Shintani3, M. Sato4, H. Ashida5. 1United
Graduate School of Agricultural Science, Ehime University, Matsuyama,
2Graduate School of Biostudy, Kyoto University, Kyoto, 3Internal Medicine,
Saiseikai Izuo Hospital, Osaka, 4Faculty of Agriculture, Kagawa University,
Kagawa, 5Faculty of Biology-Oriented Science and Technology, Kindai
University, Wakayama, Japan
* Corresponding author.
Rationale: D-Glucosamine (GlcN) has been used for promoting joint
health; however, recently, it was reported that its efficiency is limited.
In an epidemiologic study, mortality significantly reduced in people
who consistently took GlcN [1]. Screening variousmonosaccharides in
mammalian cells revealed that GlcN induced autophagy and might
influence lifespan [2]. In this study, we examined autophagy induction
and lifespan extension in C. elegans by GlcN [3].
Methods: Autophagy induction in transgenic nematodes upon
administering GlcN and expression of GFP-fused LGG-1, a marker of
autophagy, was analyzed by western blotting. Dots in cells, represent-
ing autophagosomeweremeasured bymicroscopy. Using 100 primary
larvae, lifespan extension of nematodes was measured when treated
with or without GlcN. Survival curves were obtained and analyzed by
log-rank test. To identify the lifespan extensionmechanism, wild-type
strain N2 and three lifespan signal mutant strains, daf-16 (insulin
signal-related gene), sir-2.1 (sirtuin gene), and atg-16 (autophagy
related gene), were examined.
Results: Autophagy induction by GlcN was demonstrated by western
blotting for LGG-1 and bydetecting autophagosomal dots in seam cells
by fluorescence microscopy. Administration of GlcN induced autop-
hagy in nematodes and prolonged lifespan by 20%. It increased the
lifespan of daf-16 and sir-2.1 mutants, but not of atg-16 mutant.
Conclusions: We conclude that the lifespan extension is autophagy
dependent [3]. GlcN was recently reported as a calorie restriction
mimetic with autophagy-inducing activity [4]. Although this study
had some experimental limitations, the autophagy-inducing activity
of GlcN could partly explain its role in epidemiological research.
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NUTRITIONAL SUPPORT IN SEPSIS
A. Lapitsky1*, V. Luft1, P. Dubikaitis1, A. Sergeeva1. 1Saint-Petersburg I.I.
Dzhanelidze Research Institute of Emergency Medicin, Санкт-Петербург
Russian Federation
* Corresponding author.
Rationale: To date, the debate continues regarding the substrate
maintenance of patients with sepsis.
The purpose of the study is to study the severity of metabolic
dysfunction and determine the parameters of the optimal substrate
maintenance of patients with sepsis.
Methods: The study included 166 patients with sepsis (106 men, 60
women, average age – 52.8 ± 17.0 years). According to the source of
sepsis: abdominal – 51.2%, pulmonary – 30.8%, soft tissue infection –
9%, neurosepsis – 9%. In 77.7% of patients, BMI corresponded to
eutrophy, 15.1% – hypotrophy, 7.2% – to obesity. The severity of organ
dysfunction on the SOFA scale during diagnosis was 4.44 ± 2.4 points,
consciousness on the Glasgow scale – 11.7 ± 3.1 points. The average
duration of stay in the ICU is 25.4 ± 11 days, the average duration of
MV – 17.5 ± 16.1 days. The overall mortality rate is 39.2%.
Resting metabolic rate (RMR) was determined by the method of
indirect calorimetry (IC), the severity of the catabolic reaction by
determining the daily loss of nitrogen.
Results: The average RMR in sepsis according to IC for the entire
observation period was 30.1 ± 1.1 kcal/kg/day. The average RMR in the
initial period of sepsis was 27.1 ± 1.5 kcal/kg/day, reaching a peak by 5
days of illness (33.1 ± 1.7 kcal/kg/day) and, further, stabilized at the
level of 30.0 ± 2.2 kcal/kg/day.
The average daily loss of nitrogen over the entire observation period
was 18.8 ± 0.6 g/day (0.27 ± 0.01 g/kg/day), which corresponded to
1.68 ± 0.06 g/kg/day of protein. Protein losses reached a maximum by
the 5 days of illness (1.93 ± 0.12 g/kg/day) and subsequently amounted
to 1.56 ± 0.13 g/kg/day.
The ratio of lost nitrogen to RMRaccording to ICdepends on the severity
of the catabolic reaction.With nitrogen losses of less than 20 g/day, this
ratiowas 1:120, from 20 to 30 g/day – 1:95, more than 30 g/day – 1:68.
Conclusions: The amount of nutritional support for patients with
sepsis should be adjusted to the severity of systemic metabolic
dysfunction.
Disclosure of Interest: None declared.
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NUTRITIONAL SUPPORT WITH IMMUNE-ENHANCING FORMULA IN
THE PATIENTS WITH CLOSED HEAD INJURY
N. Arikan1, A. Shestopalov2*, A. Mitichkin3, on behalf of O. Varnavin,
V. Vasin, M. Fokina, A. Spitsin, O. Neudakhina. 1ICU department,
Inozemtsev City Clinical Hospital, 2Russian Medical Academy of
Postgraduate Education, 3Hospital Administrator, Inozemtsev City
Clinical Hospital, Moscow, Russian Federation
* Corresponding author.
Rationale: Early enteral nutrition is the most widespread way of
nutrients delivery in the patients with closed head injury. The aim of
this study is to assess immunological benefits of early enteral
immunomodulating nutrition in the patients closed head injury.
Methods: 64 consecutive patients with closed head injury (after
decompressive craniotomy) were randomly divided into 2 groups. In
the 1st group (n = 32) standard enteral formula was used (from
0.5 kcal/ml on 1th day to 1–1.5 kcal/ml on 7th day). In the 2nd group
(n = 32):1st day –using supplementary nutrition (enteral glutamine
30 g/day), from 2nd to 7th days- enteral immune-enhancing formula
(1 kcal/ml, with gradual icreasing in a volume fraction). Nutrition was
guided by indirect calorimetry. Data are shown as mean±SD.
Parameters were analysed by SPSS.
Results: Dynamics of cell-mediated immunity indices in both groups
has shown that all patients had propensity to an immune deficiency.
1st day after operation 1st/2nd groups (respectively): CD3 lymph
(%):58.7 ± 3.4/58.1 ± 3.7; CD4 lymph (%): 38.8 ± 1.5/37.4 ± 2.8; CD8
lymph (%): 29.6 ± 1.3/30.4 ± 2.1; CD4/CD8: 1.31 ± 0.02/1.26 ± 0.05 (p <
0.05;Wilcoxon’s ranksum test). The peripheral Tcell fraction on
peripheral lymphocytes, CD3, CD4, CD8 in 1st groupwere significantly
lower than those in 2nd group. On 7th day 1st/2nd groups
(respectively): CD3 lymph (%): 54.4 ± 3.5/59.5 ± 2.8; CD4 lymph (%):
25.4 ± 3.3/34.7 ± 3.4; CD8 lymph (%): 29.0 ± 2.1/22.3 ± 2.7; CD4/CD8:
0.87 ± 0.05/1.55 ± 0.06 (p < 0.05;Wilcoxon’s ranksumtest). Antibody
deficiency was detected in both groups (no significant difference
during follow-up period).
Conclusions: Enteral nutritional support with an immune-enhancing
formula has potential immunological benefits on cell-mediated
immunity indices predominantly.
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SUN-PO013
REFEEDING SYNDROME IN A CRITICAL CARE UNIT
A.P.C. Alves1*, B.C. Lourenço2, E. Pinto3. 1Clinical Nutritionist, 2Intensive
Care Unit, Centro Hospitalar e Universitário do Algarve, 3Centro de
Desenvolvimento de Estudos, Universidade do Algarve, Portimão, Portugal
* Corresponding author.
Rationale: Refeeding syndrome (RS) is a likely fatal condition in
critical ill patients, caracterized by metabolic and clinical complica-
tions. This syndrome is associated with hypophosphatemia and
changes in blood electrolytes such hypomagnesemia and hypocalce-
mia.We conducted a study to analysed the prevalence of RS in the unit
of Portimão in the intensive care of Teaching Algarve Hospital.
Methods:We conducted a observational retrospective study in all the
patients that have full artificial nutrition for a periodmore than 4 days.
We collected data between 1st Abril 2016 since 31 March 2018. We
colleted biochemichal parametrs such phosphorus, calcium, magne-
sium, albumin, C- reactive protein, total proteins. We also analyse
nutritional intake value (initial and final with and without additives),
initial and final protein intake and the Simplified Acute Physiology
Score (SAPS II). Data were analysed using SPSS stastical program
version 22. Mann-Whitney, Kruskall-wallis and Wilcoxon tests were
used, stastical significance accepted at p < 0,05.
Results: Our study assessed 93 patients under artificial nutrition, 26%
of patients (n = 24) had hypophosphatemia and 67% of those (n = 16)
had hypocalcemia. None of the patients had hypomagnesemia.
Patients with hypophosphatemia had a mean age of 67.3 years
(sd = 14.5), mean of BMI of 25.5 Kg/m2 (sd = 3.5), and mean lenght of
hospital stay of 12.5 days (sd = 8.8). Their mean initial caloric intake
with adittives was 1425.4 kcal (sd = 1114.6), significantly higher
(p = 0.01) than the one in patients without hypophosphatemia
(mean = 1341.1 kcal, sd = 722.1). The SAPSII for the patients with
hypophosphatemia was 44 (sd = 18.3) and the patients without
hypophosphatemia 52 (sd = 17.3).
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Patientswith hypophosphatemia had a 40%mortality rate during their
UCI stay and a mortality rate of 40% 28 days after admission. The
mortality rates for the patientswithout hypophosphatemiawere 18,3%
and 36,6%. The mortality rate during ICU stay of patients with
hypophosphatemia was significantly higher (p = 0.04).
Conclusions: In our study we found a prevalence of 26% of hypopho-
sphatemia in the ICU patients. From this 26%, 67% had hypocalcemia.
The mortality of patients with hypophosphatemia was significantly
higher. These results prompted a clinical meeting with the purpose of
providing training to the ICU team and protocols of enteral and
parenteral nutrition were reviewed.
References
Singer P, Blaser A, Berger M et al. ESPEN guideline on clinical nutrition
on the intensive care unit. Clinical Nutrition. 2018.
Friedly N., Stanga Z., Sobotka L. et al.Revising the refeeding syndrome.
2017, 151–160.
Disclosure of Interest: None declared.
SUN-PO014
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Rationale: Body composition is known to be a prognostic factor in
cirrhotic patients. However, the link between this and the prognosis of
patients in intensive care unit (ICU) is unknown. The Computed
tomography offer accurate estimations of muscle mass by analysing a
cross-section usually going through the third lumbar vertebrae.
This retrospective study aimed to assess the feasibility of body
composition (BC) analysis in cirrhotic patients with septic shock,
using Computed Tomography (CT) and evaluate the impact of BC
(muscle mass, subcutaneous and visceral fat) on outcome.
Methods: This retrospective study included 36 cirrhotic patients with
septic shock hospitalized in ICU who underwent an abdomino pelvic
CTscanwithin 48 hours of admission.We collected the surface areas of
musclemass and adipose tissue on the CT scans.We compared BC data
with mortality and with the number of organ failures.
Results: The average age was 60 years (42–73). The average Child and
MELD scores were respectively 10,8 (8–14) and 28,7 (15–54). The
prevalence of sarcopenia was 50%. It was not associated with a higher
mortality rate at day 28 (p = 0.31) or with a higher number of organ
failures at day 28 (p = 0.55). We observed a higher subcutaneous
adiposity index in patients who died at day 28 (p = 0.03) and in
patients with renal insufficiency at admission (p = 0.019). There was a
trend (p = 0.057) towardsmore visceral fat in patients who died in ICU.
Conclusions: The assessment by CT of body composition reveal
Evaluation of BC using CT is feasible and reproducible and may
constitute a promising tool to evaluate in cirrhosis critically ill patients.
Visceral fat mass seem associated with poor outcome in cirrhotic
patients with septic shock.
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RETROSPECTIVE EVALUATION OF TREATMENT OF GLUTAMIN RICH
ENTERAL NUTRITION IN THE INTENSIVE CARE UNIT
D. Ebiloglu1, C. Kaymak2*, H. Basar1, A. Ozcan1, N. Ozcan1,
M. Kotanoglu1, B. Baltacı1. 1Health Science University, Ankara Training
and Research Hospital, Ankara, Turkey, 2Department of Anaesthesiology
and Reanimation, Intensive Care Unit, Health Science University, Ankara
Training and Research Hospital, Ankara, Turkey
* Corresponding author.
Rationale: Glutamine plays an important role to maintenance of renal
acid base balance, regulation of immune system cells and proin-
flammatory cytokines, protein and nucleotide synthesis, glutathione
synthesis and heat shock protein production. The aim of this studywas
to evaluate the effects of glutamine-rich enteral nutrition support
therapy on morbidity in the intensive care unit.
Methods: After the approval of the ethics committee, 40 patients
between the ages of 18–92 were enrolled in the first 24–48 hours of
enteral nutrition. The patients were randomized into two groups as
standart isocaloric glutamine-free enteral nutrition and glutamine-
supplemented enteral formula groups. In Glutamine group 0.3 g/kg/
day enteral L-glutamine was given within 24 hours. The standart
enteral formulawas also administered during 24 hours. APACHE II and
SOFA scores of the patients in the first 24 hours, 7, 14, 21 and 28 days,
mechanical ventilator durations and culture results were compared.
Plasma samples and urine laboratory parameters were collected at the
24th hour and after 7, 14, 21 and 28 days. Demographics of patients,
types of nutritional therapy and complications were recorded.
Results: The demographic data and hospitalization diagnoses of the
patientswere similar.When the first 24 hours and 7,14, 21, 28. APACHE
II and SOFA scores, blood and urine laboratory results were evaluated,
there was no difference between the two groups and the time of
measurement. Plasma ammonia and urea levels were similar. The
duration of mechanical ventilation was similar between two groups.
Conclusions: As a result, When the factors affecting the morbidity
were examined, Although lower rates of blood and urinary infection
rates were observed in patients receiving glutamine-containing
enteral nutrition compared to patients undergoing standard isocaloric
enteral nutrition, there were no no statistical significant differences
were found.
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VITAMIN D IN CRITICALLY ILL PATIENTS WITH PARENTERAL
NUTRITION: A COHORT STUDY
D. Berlana1,1*, S. Garcia Garcia1, C. Puiggros2, I. Cardona Pascual1,
R. Albertos Martell3, R. Burgos Pelaez4, P. Sanchez-Sancho1,
D. Gonzalez Vaquero1, J.B. Montoro Ronsano1. 1Pharmacy, Vall Hebron
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Rationale: Low serum levels of vitamin D have been found in
observational studies conducted on patients in the intensive care
unit (ICU). This deficiency may be associated with comorbidities and
poor prognosis. The purpose of this study was to evaluate if vitamin D
deficiency is associated with poor prognosis measured as longer ICU
and hospital stay.
Methods: We conducted a retrospective study with critically ill
patients with parenteral nutrition (PN) between January 2017 and
March 2019. Vitamin D blood levels were retrospectively gathered
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from the patients charts of all critically ill patients receiving PN; aswell
as demographics, ICU and hospital stay, and laboratory data. Linear
regression models were performed with ICU stay and hospital lenght
of stay (days) as dependent variables, and vitamin D blood levels and
APACHE II score as independent modifiers variables.
Results: A total of 64 vitamin D blood values from 50 critically ill
patients with PN were included. Mean vitamin D level was 12.1 ± 6.6
ng/mL. Sixty percent of the patients assessed showed severe deficiency
(vitamin D < 12 ng/mL). A total of 43 samples were obtained prior to
PN start, and 21 during a mean of 6.5 ± 33.6 days of PN therapy. No
differenceswere found inmean vitamin D obtained prior or during the
PN (11.5 ± 5.2 vs 13.2 ± 8.8 ng/mL respectively); nor in percentage of
samples with severe deficiency 60.5 vs 61.9% respectively. In this
retrospective cohort, vitamin D level during or prior the PN therapy
was not significantly associated with length of stay in ICU, nor in
hospital. Overall mortality was 16% (8 of 50 patients), being slighty
associated with severe deficiency (23.3% [7 patients] in severe
deficiency patients vs 5% [1 patient] non severe deficiency; p = 0.12).
Only 6 patients (16.7%) showed normal serum values of vitamin D
(≥20 ng/mL), none of these patients died during the hospital stay.
Conclusions: Vitamin D deficiency was not associated with persistent
critical illness leading to longer hospital or ICU stay. However patients
with severe deficiency showed higher rates of mortality. Standard
supplementationwithmultivitaminsproducts inPNwere insufficient to
reach normal values of vitamin D level. Supplementation with vitamin
D should be perfomed to achieve normal values in severe deficiency.
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RELATIONSHIP BETWEEN CALORIC-PROTEIN ADEQUACY AND
NUTRITIONAL RISK BY NUTRIC SCORE
E. Suiter1*, A.N. Severine1, F. Ruotolo1, I.R. França2, R.D.C.D.S. Fernandes2,
P.C. Ribeiro1, I.A.O. Souza1, I. De Castro1, S.R. Machado1. 1Hospital Sirio
Libanes, Sociedade Beneficente de Senhoras, 2Universidade Presbiteriana
Mackenzie, Sao Paulo, Brazil
* Corresponding author.
Rationale: Daily monitoring of nutritional therapy adequacy is
essential in the evaluation of the quality of care. The aim this study
is to evaluate the relationship between the caloric-protein adequacy in
ICU patients and Nutritional Risk (RN) by Nutric Score (RS)
Methods: Retrospective cohort in an ICU of a private hospital (n = 79),
adults, under enteral and parenteral nutrition, for at least 6 days, being
included from the 4th to the 9th day to calculate the caloric-protein
adequacy until 30 days. The data were represented by medians and
percentiles and theMann-Whitney testwasapplied. Categoricaldatan (%)
were analyzed by theX2 test, or Fisher’s Exact. The accuracywas analyzed
by the ROC curve. A logistic regressionwas performed, and α≤ 0.05.
Results: 92.9% of patients in the High Nutritional Risk Group (HNRG)
reached the Caloric Goal (CG) at the first week of hospitalization
compared to 66.7% of the patients in the Low Nutritional Risk Group
(LNRG); p = 0.003. 73.2% of HMRG reached >80% in the first week vs
4.2% of LNRG; p < 0.001. Among thosewho achieved CG in both groups,
the median NS was 6.0 vs 5.0; p = 0.016, APACHE II median was 19 vs
13.5; p = 0.054; SAPS3 median of 54.5 vs 47; p = 0.018. 95.3% of the
HLRG reached the Protein Target (PT) vs 73% of the LNRG; p = 0.005.
Themedian APACHE II was 21 in vs 16 LNRG, p = 0.0017, SAPS3median
of 56 vs 4; p = 0.042 andmedian NS of 6.0 vs 5.0 p = 0.073. Themedian
frailty score was 7 for HNRG vs 5 for LNRG, p = 0.003. SAPS3 had low
prognostic accuracy for PT, ROC curve 0.67 ± 0.07 p = 0.017. APACHE II
and SOFA did not present good accuracy and are predictive factors for
NS with odds ratio of 2.7 (1,1–6,6) p = 0,026
Conclusions: NS presented better performance when associated with
other scores. The fact that the goals were more easily reached in the
most severe group suggests that the nutritional risk assessment
arouses greater attention from the multiprofessional team.
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MULTIPROFESSIONAL TEAM ENGAGEMENT TO REDUCE
PREVALENCE OF PRESSURE INJURY IN A CARDIOLOGICAL ICU
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J. Bolognesi1, A.N. Severine1, F.M.C. Paulon1, A.S.D.A. Freitas1,
A. Pedroso2. 1Nutrition Department, 2Nurse Department, Sociedade
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* Corresponding author.
Rationale: During the analysis of prevalence of Pressure Injury (PI) an
opportunity for improvements was identified in the Cardiology
Intensive Care Unit (ICU), which presented a median prevalence of
50% in the six months prior to the start of the project.
Methods: A descriptive study conducted in a highly complex
Cardiology ICU o from March to September 2018, using the science
of improvement. The project team together with the ICU have set a
series of interventions focused on the prevalence reduction, building a
directing diagram with four pillars of change: best practice-based
assistance, standardization of prevention actions through the devel-
opment of a care bundle, multi professional team engagement, and
both patient and family involvement in the process.
Results: The bundle of prevention elaborated includes: evaluation and
skin care, choice of support surface, early and effective movement,
moisture management and nutrition/hydration. Regarding the nutri-
tionist’s performance, a retrospective survey was performed on the
nutritional support of the patients, according to the nutritional
demands. So it was possible to observe that most of patients were
not reaching nutritional goals, especially due to hemodynamic
instability and the severity of the clinical case. Based on that, among
the project actions the issue of pressure injury is included in the daily
multi professional visitation, discussing the patient’s nutritional
status, early start of the diet, and the establishment of nutritional
goals to ensure that a prescribed diet is being correctly followed. The
realization of the project and the implementation of all interventions
from the bundle contribute to a reduction of 80% on the prevalence of
PI in the cardiology ICU (from 50% to 10%).
Conclusions: The project has shown the importance of engagement as
part of a multi professional team, and how well structured interven-
tions can contribute to the quality of service, reducing the occurrence
of PI.
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WHICH HAS MORE IMPACT ON MORBIDITY AND MORTALITY IN
INTENSIVE CARE PATIENTS; PROTEINS OR CALORIES?
E. Cankaya1*, M. Kangalgil2, H. Ulusoy3. 1Anesthesiology and
Reanimation, Trabzon Surmene State Hospital, 2Nutrition and Dietetics,
3Intensive Care Unit, Karadeniz Technical University, Trabzon, Turkey
* Corresponding author.
Rationale: Optimal energy and protein values in the catabolic process
that begins with the admission of patients to the intensive care unit
has been studied for many years (1). The aimwas to compare different
levels of protein and calorie intake in terms ofmorbidity andmortality
in intensive care patients given nutritional support.
Methods: This study has been designed as a retrospective study in the
Intensive Care Unit of Karadeniz Technical University, and 321 patients
who were followed up and received enteral nutrition in the Intensive
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Care Unit between January 1, 2008 –March 1, 2019 were examined for
14 days commencing from the initial date of hospitalization. The
patients were divided into two main groups based on protein intake
(≤1.2 g/kg/day, n = 142; >1.2 g/kg/day, n = 179) and the groups were
divided into sub-groups based on calorie intake (≤25 kcal/kg/day and
>25 kcal/kg/day [n = 107 and n = 35 in the high protein group; n = 73
and n = 106 in the low protein group, respectively]). The patients’
demographics and morbidity and mortality factors were compared.
Results: When the demographics, biochemical parameters, septic
shock development, presence of decubitus ulcer, PaO2/FiO2 ratios, the
types of enteral products used, vasopressor drug use, and the rates of
rehospitalization in the intensive care unit were compared between
the patients included in the study, no significant difference was seen
between the groups (p > 0.05). Nosocomial infection (NCI),mechanical
ventilation, and length of stay in the intensive care unit (ICU) of the
patients who had a low protein diet were found to be longer compared
to thosewho had a high protein diet, without any difference in calorie
intake (p < 0.05). When the patients who had a high protein intake
were evaluated, NCI, ICU mortality and reintubation rates were
detected to be lower in the patients with a hypocaloric diet compared
with those with a normocaloric diet (p: 0.001, 0.039, and 0.012,
respectively). The seventh day APACHE II (Acute Physiology
Assessment and Chronic Health Evaluation) score of the patients
with a hypocaloric high protein diet was found to be significantly
lower than that of the other three groups (p < 0.05). The seventh and
14th day SOFA (The Sequential Organ Failure Assessment) scores of the
patients with high protein intake were detected to be significantly
lower regardless of calorie intake (p < 0.05).
Conclusions: It was concluded that high protein intakewas associated
with better clinical outcomes and that clinical conditionmarkers were
better particularly in the case of a hypocaloric high protein diet.
Reference
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HYPERGLYCEMIA ASSOCIATED WITH NUTRITIONAL RISK PREDICTS
MORTALITYAND LONGER INTENSIVEUNITCARE STAY IN CRITICALLY
ILL PATIENTS: A MULTICENTER LONGITUDINAL STUDY
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Rationale: The nutritional risk in critically ill patients is considered a
predictor of mortality, as well as the presence of hyperglycemia.
Probably, critically ill patients with nutritional risk and with
hyperglycemia have a worse prognosis. So, the aim of this study was
to evaluate the frequency of death and length of stay at the intensive
care unit (ICU) in critically ill patients grouped according to the
presence of nutritional risk and hyperglycemia.
Methods: A longitudinal study was performed in two ICUs of two
Brazilian states with critically ill adult patients, whose nutritional risk
(NR)was assessed from themodifiedNUTRIC score in the first 24hours
after admission to the ICU. From the fasting blood glucose values, the
patients were grouped for the presence of hyperglycemia (fasting
glycemia >180 mg/dL). The RN and the presence of hyperglycemia
were grouped and the patients were divided into four categories:
0. without hyperglycemia and without NR; 1. without hyperglycemia
and with NR; 2. with hyperglycemia and without NR and 3. with
hyperglycemia andwith NR. Outcomes of interest weremortality at 28
days and length of ICU stay (categorized from the median). The ethical
committee of the two hospital approved the protocol.
Results: A total of 320 patients (62.0 ± 17.4 years, 54.4%males, 63.4% in
ventilatory support) were evaluated. RN was identified in 49.2% of the
studied sample and hyperglycemia in 26.6% of the patients. More than
half of thepatients remained in the ICU formore thaneightdays (54.6%)
and 34.5% died in 28 days. Patients with hyperglycemia had a higher
frequency of death compared to patients without hyperglycemia
(44.9% versus 32.1%, p = 0.043), while the frequency of ICU stay >8 days
did not differ between groups (62.8% versus 55.7%, p = 0.287). Patients
with NR had a higher frequency of death and hospitalization in the
prolonged ICU when compared to patients without NR (p < 0.001 for
both analysis). When considered the variable ‘hyperglycemia asso-
ciated with NR’, the frequency of death was significantly higher in
patients with hyperglycemia and NR (0. 25.5%, 1. 42.4%, 2. 19.0%,
3. 60.8%, p <0.001), as well as the frequency of patients with saty at
ICU > 8 days: 0. 49.1%; 1. 69.6%; 2. 57.1%; 3. 68.6% (p = 0.014).
Conclusions: The assessment of hyperglycemia combined with
nutritional risk screening appears to be a good predictor of clinical
outcomes in critically ill adult patients.
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THE ROLE OF OBESITY IN THE OCCURRENCE OF INFECTIONS
DURING INSERTION AND CARE OF CENTRAL VENOUS CATHETERS.
A PROSPECTIVE OBSERVATIONAL STUDY IN GREECE
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Rationale: CLABSIs are infections that are associated with the
insertion and the care of central venous catheters (CVCs). The aim of
this study was to investigate the incidence and the role of the obesity
in the development of CLABSI.
Methods: This is a prospective observational study, which took place
in three ICUs in Greece. We excluded all patients who died within 48
hours of their admission to ICU (n = 106), patients who for any reason
could not measure an obesity assessment parameter (n = 8), and
patients who had not been classified by a severity-of-disease
classification system (n = 5). One-way Anova analysis and non-
parametric tests were used for the statistical analysis of the data.
Results: The study sample consisted of 372 patients aged 63.6 ± 16.6
years with APACHE II 23.3 ± 6.9 and MODS 7.5 ± 3.8. A total of 174
(46.8%) patients were normal weight, 128 (34.4%) overweight, 36
(9.7%) obese, 26 (7%) underweight and 8 (2.2%) severe obese. Totally,
5426 catheter days were studied. The incidence of CLABSI was 2,248%
or 22,48 cases per 1000 catheterization days. Patients with CLABSI
were significantlymore overweight (59% vs. 35.3%, p < 0.05) and obese
(19.7% vs. 13.7%, p < 0.05) than non CLABSI. Obese and severe obese
patients compared to normal weight had significantly longer duration
of catheterization (p < 0.05) and more catheterization days (p < 0.05),
developed CLABSI earlier (p < 0.05), had significantly longer hospital-
ization in ICU (p < 0.05), and lower percentage of survival (p < 0.05).
Also, doctors attempted significantlymore times to insert CVC in obese
and severe obese patients (p < 0.05). BMI was found to be a prognostic
factor for CLABSI (β = 0.201, OR = 1.223, 95% CI: 1.107–1.351).
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Conclusions: Obese patients are more likely to be catheterized in the
femoral vein and doctors were unable to easily place the CVC.
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Rationale: Obesity has been demonstrated to increase the risk of out-
of-hospital cardiac arrest (OHCA) and may influence the quality and
effectiveness of cardiopulmonary resuscitation. The aim of the study
was to investigate the association between bodymass index (BMI) and
the outcome of OHCAvictims.
Methods: This was a prospective observational study. The patients
were categorized according to BMI into four groups: the normal BMI
group, the overweight group, the obese group and the severe obese
group. We included all patients who were transferred to the
emergency department of a large hospital in Greece after OHCA.
One-way Anova analysis and non-parametric tests were used for the
statistical analysis of the data.
Results: The study sample consisted of 84 patients aged 59.3 ± 12.4
years. The patient’s BMI was 29.8 kg/m2. Totally, 16 (19.3%) patients
had normal weight, 30 (36.1%) patients were overweight, and 38
(44.6%) patients were obese and severe obese. The transfer time for
patients from the site to ED was 9.7 ± 7.5 min. Severe obese patients
had significantly longer transfer time than normal weight (22.8 ±
21.3 min versus 7.8 ± 4.1 min, p < 0.05), and overweight patients
(22.8 ± 21.3 min vs. 8.9 ± 3.5 min, p < 0.05). Thirteen (15.5%) patients
achieved ROSC and were admitted to the ICU. Survival to ICU
admission and ICU discharge were higher in the obese and severe
obese patient’s group than normal weight (17.6% vs. 6.25%, p < 0.05
and 10.3% vs. 6.25%, p < 0.05, respectively) and overweight patients
(17.6% vs. 9.11%, p < 0.05 and 10.3% vs. 7.41%, p < 0.05, respectively).
Conclusions: Obese and severe obese patients had higher survival to
ICU admission rates and ICU discharge rates than normal weight and
overweight patients. Obesity had a protective role in patients with
cardiac arrest.
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LONG-STAYER PATIENTS IN THE ICU: WERE THEY SPECIAL FROM
START?
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Rationale: The intensive care (ICU) patient population has changed
during the last 2 decades, with an increasing number of very long ICU
stays, lasting up to several months. Long-stayers are usually defined as
requiring more than 1 weeks of mechanical ventilation (MV) and of
ICU therapy. Nothing is known about their nutritional characteristics.
In an attempt to better coordinate their treatment and reduce their
length of stay (LICU), the service instituted a dedicated program
enrolling patients requiring more than 2 weeks of ICU treatment. The
study aimed at investigating the demographic, nutritional and
metabolic aspects of their stay.
Methods: Retrospective analysis of 150 consecutive patients admitted
to the long-stayer program of themultidisciplinary ICU. Data extracted
from the computerized system: age, weight, NRS score, severity of
disease, admission for sepsis, requirement of renal replacement
therapy (RRT), daily energy, protein, glucose, insulin, discharge MRC
score, length ofMVand ICU stay, outcome. Separate analysis of the first
days (D1–D5 and D1–D7), and rest of ICU stay (D8–D30). Data as
median [IQR 25/75], and standard deviation for glucose.
Results: Cohort characteristics were: age 62 years [52/71], NRS 5 [3/7],
SAPSII score 51[39/66]; 73 (51%) patients were admitted for septic
conditions; 74 (48.7%) required RRT. LICU was 28 days [22/42] with
mortality 18.7%: NRS was significantly higher in those dying (p =
0.007). The nutrition intakes were extremely variable during the first
week with variable delay of initiation and multiple interruptions,
stabilizing thereafter at values inferior to the protocol recommenda-
tion. Median protein intakes and energy balances from D1–D7 were
0.92 g/kg [0.79–1.15] and −380 kcal/d [−1170/19] respectively, and
from D8–D30 were 0.97 g/kg [0.82–1.11], and −7 kcal [−259/78]
respectively. Patients had higher median blood glucose from D1–D5
(7.67 vs 7.49 mmol/l). During D1-D5, blood glucose was correlated
insulin intake (r2 = 0.41, p < 0.001), but only weakly with glucose
intake, and not with C-Reactive-Protein, without difference in septic
and non-septic patients.
Conclusions: The long-stayers were characterized by a high NRS-
score, highest in those dying. Variability of nutritional variables
compared to the protocol was a striking charactersitic. The energy and
protein intakes were very variable during the first week resulting in
moderate negative balances: protein intakes were below the ICU
recommendation. Blood glucose exhibited highest variability during
the first 5 days, without any clear association with glucose intake nor
with inflammatory status.
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EVALUATIONOF NORADRENALINE EFFECTON ENERGY DEFICITAND
MORTALITY OF CRITICAL PATIENTS IN ENTERAL NUTRITIONAL
THERAPY
A.G.C. Custódio1, A.B.M. de Oliveira2, M.B. de Lima1, R.D.S.F. Pequeno2,
V.S. Mendonça2, G.D. Ceniccola1*, T.P. Holanda3. 1Instituto Hospital de
Base do Distrito Federal, 2Instituto Brasileiro de Nutrologia, 3Hospital da
Criança de Brasília José de Alencar, Brasília, Brazil
* Corresponding author.
Rationale: Early enteral nutrition is indicated in the critical patient
since hemodynamically stable. However, on patients who demands
the use of vasopressor drugs and still hemodynamically unstable, it’s
recommended to postpone enteral nutrition start. There are few
evidences that support the safety and tolerance of enteral nutrition
(EN) in this group of patients. This studymain goals are to evaluate the
effect of noradrenaline (NORA) use on mortality after 60 days of
Intensive Care Unit (ICU) stay and energy deficit in the first week of
hospitalization of critically ill patients in exclusive EN.
Methods: A two years (2014–2016) prospective observational study,
performed in ICU and emergencies of a tertiary hospital, with 327
patients. Were excluded patients with ICU stay <48 h, absence of data
and age <18 years. Energy deficit was estimated from the period that
the patient remained on fasting in the first week of hospitalization.
Logistic regression model and Mann-Whitney U test were performed
to assess statistical associations and significances.
Results: There were 327 admissions with an exclusion of 72 patients
(255 subjects recruited). 62,3% of the patients were male, with age 52
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and 53 for the group NORA and the group that didn’t use nora (non-
NORA), respectively. 51,8% used NORA in first week of hospitalization.
TheNORA group had significantly higher values of SOFA and APACHE II
than the non-NORA group (p: 0.000). There was no significant
difference in caloric intake between the NORA group and the non-
NORA group (p: 0.350). NORA patients had 84% higher risk of
mortality (OR: 1.844; IC 95% 1.00–3.37; p: 0.047) compared to the
the non-NORA group. As a main result, each increase of 25% in the
amount of calories received, results in 36.4% chance of reduction in the
mortality risk, regardless whether noradrenalinewas used or not (OR:
0.636; IC 95% 0.49–0.82 p: 0.001).
Conclusions: The use of noradrenaline didn’t withhold the initiation
of EN in critical patients in the first week of hospitalization in this
sample. The amount of EN received acted as a protective factor in this
group of patients, regardless whether noradrenaline was used or not.
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THE EFFECT OF NUTRITIONAL STATUS AND ENERGY TARGET ON
MORTALITY: A PROSPECTIVE COHORT STUDY
A.C. Santos DeDeus1, A. Bassetto Okamura1, J. Da Silva SepúlvedaNeta1,
F. Lima Cintra1, R. Batista de Sousa1, A.L. Ribeiro de Lima1, I. De Brito-
Ashurst2, G. Duprat Ceniccola1*. 1Instituto Hospital de Base, Brasília,
Brazil, 2The Royal Marsden NHS Foundation Trust, London, United
Kingdom
* Corresponding author.
Rationale: Trauma is one of the most prevalent causes of death and
admission to Intensive care units (ICU) worldwide. These patients are
catabolic, have increased nutritional requirements and are at risk of
malnutrition and higher mortality. Malnutrition screening and
diagnosis are paramount for appropriate dietary intervention. This
study main goals are to identify malnourished patients and provide
adequate nutrition. We postulate that reaching nutritional targets will
have a protective effect on mortality risk.
Methods: A two year (04/2015–02/2017) prospective observational
study of 478 trauma ICU patients. Excluded were: ICU < 48 h,
pregnancy, suspicion of brain death and not tube fed. Malnutrition
screening and diagnosis were through the AND-ASPEN tool within
48 h admission. Energy intake were recorded for the first week.
Logistic regression model was performed to assess mortality as main
outcome with independent variables: sex, weight and malnutrition.
Results: There were 478 trauma patients admission with an exclusion
of 150; 328 subjects recruited. Patients weremale (84.1% vs 84.9%) and
with median age of 44 and 33 y for the malnourished and non-
malnourished group respectively. Malnourished subjects were 29.1%
and achieved a higher energy intake (17.1 kcal/kg/d × 14.4 kcal/kg/d;
p: 0.001) compared to the non-malnourished group. For the mortality
outcome, the protective effect of nutritionwas 70% (OR: 0.290; IC 95%
0.09–0.97; p: 0.044) and 65% (OR: 0.35; IC 95% 0.18–0.67; p: 0.001)
respectively for malnourished and non-malnourished group when
achieving ≥75% of nutrition target.
Conclusions: It is important to identify at-risk patients who are
already malnourished to initiate early intervention. A higher energy
intake has a protective effect on mortality in trauma ICU patients.
Understanding the impact of nutrition is an important part of
evaluating this evolving therapyand essential for an effective nutrition
plan.
Disclosure of Interest: None declared.
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PREVALENCE OF REFEEDING HYPOPHOSPHATEMIA IN PATIENTS
FEEDED BY ENTERAL NUTRITION IN THE INTENSIVE CARE UNIT:
SEVEN-DAY FOLLOW-UP RESULTS AFTER NUTRITION
N. Savas ̧1, N.T. Özer2, S. Onuk1, S. Şahin2, G. Günes ̧ Şahin2*,
H. Sipahioğlu1, M. Sungur1, K. Gündoğan1. 1Department of Medicine,
Division of Medical Intensive Care, Erciyes University, School of Medicine,
2Division of Clinical Nutrition, Erciyes University Health Sciences Institute,
Kayseri, Turkey
* Corresponding author.
Rationale: Refeeding Hypophosphatemia (RH) is common in critically
ill patients and is associatedwith highmorbidity/mortality. The aim of
this studywas to determine the frequencyof RH in critically ill patients
fed enterally in the acute phase.
Methods: This study was performed prospectively in Erciyes
University Medical Intensive Care Unit. Started to feed within 72
hours after hospitalization, patients aged 18 years and over, 48 hours
or more enteral fed were included in the study. If phosphorus was
below 2.4 mg/dl, hypophosphatemia was considered.
Results: Study was performed with 100 patients. The mean age was
57 ± 20 years. The mean APACHE II scorewas 22 ± 8. The mean NUTRIC
score of the patients was 5 ± 2. The number of 71% patients were
nasoduodenal and 17% patients were fed via nasogastric route. The
target caloric requirement of the patients was 1835 ± 303 kcal/day.
Patients received calories were 888 ± 362, 1254 ± 674, 1383 ± 660 and
1462 ± 580 kcal/day on 1, 3, 4 and 7 days respectively. The average
phosphorus levels of patients and the incidence of hypophosphatemia
during the follow-up period are shown in Table 1. Themean K value of
the patients on the first day was 4.3 ± 0.96 mmol/L, Mg value was
0.9 ± 0.18 mg/dL and Ca valuewas 9.0 ± 0.8 mg/dL. The incidence of RH
in any day during the seven-day follow-up of the patients was 52%.
Table 1.
The mean phosphorus levels of patients and the frequency of
hypophosphatemia during the follow-up period
Day Phosphorus
(mg/dL)
Frequency
of RH (%)
Day 1, ±SD 3.6 ± 1.53 20
Day 3, ±SD 3.2 ± 1.52 32
Day 4, ±SD 3.3 ± 1.05 21
Day 7, ±SD 3.9 ± 1.53 12
Conclusions:As a result of this study, the frequencyof RHwas found to
be high in critically ill patients fed enterally. The highest rate was
detected on the third day. More studies are needed on this subject.
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PROTEIN TARGET IN CRITICALLY ILL PATIENTS. IS IT POSSIBLE TO
ACHIEVE?
I.H. Mazucatto1*, F. Totti1, S. Longhi1, F. Rodrigues1, L. Magalhães1,
L. Mendonça1, C. Nascimento1, M. Jordão1, M. Bailer1. 1Hospital
Samaritano, São Paulo/SP, Brazil
* Corresponding author.
Rationale: Demonstrate if it is possible to administer the protein
requirement of critical patients and themain reasons that prevent this
offer in a hospital with multidisciplinary team of active nutritional
therapy.
Methods: Retrospective, quantitative study with data collected
between October/2018 and March/2019 of 107 adult and elderly
patients admitted to the ICU of a private hospital in the city of São
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Paulo/Brazil. To calculate protein target, the ESPEN referencewas used
for critical patients, considering 80% of the target as a minimum
supply. Data were analyzed in Excel spreadsheet.
Results: In October, November and December 2018, the offer of at least
80% of the target was possible to 88%, 87% and 91%, respectively. In
January, February and MarchIn 2019, the offer was 81%, 71% and 91%,
respectively. Of the 107 patients,15 (14%) did not receive theminimum
goal, the main causes being: abdominal distension (40%), diarrhea
(27%), failure to progress in volume (26.5%) and recurrence of fasting to
the center (6.5%). The main diagnoses involved respiratory tract
infection (49%) and the mean length of ICU stay was 10.7 days.
Conclusions: The results show that about 85% of critically ill patients
received adequate protein supply and that the main causes for
inadequate intake are related to gastrointestinal symptoms. It is
important to emphasize that adequate protein supply improves
clinical outcomes and that a well-established multidisciplinary team
with established protocols is fundamental to act in the face of
nutritional therapy management.
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PARENTERAL NUTRITION IS ONE OF THE MOST SIGNIFICANT RISK
FACTORS FOR NOSOCOMIAL INFECTIONS IN ADULT PATIENTS WITH
INTESTINAL FAILURE
J. Yang1*, H. Sun1, S. Wan1, G. Mamtawla1, X. Gao1, L. Zhang1, X. Wang1,
J. Li1. 1Department of General Surgery, Medical School of Nanjing
University, Nanjing, China
* Corresponding author.
Rationale: Intestinal failure (IF), the condition itself, and its manage-
ment were associated with increased infection complications and
impair patients’ quality of life. This study was aimed to evaluate the
prevalence and potential risk factors of nosocomial infections (NIs) in
hospitalized adult patients with intestinal failure.
Methods: Two hundreds and fifty-nine eligible adult patients with IF
admitted to a single clinical nutrition center in a tertiary referral
hospital from January 1, 2012 to December 31, 2018 were retrospect-
ively identified from a prospectively maintained database. NIs was
defined according the definition from the 2008 Centers for Disease
Control and Prevention criteria. The prevalence and independent risk
factor of NIs were analyzed.
Results: The prevalence of NIs was 25.5%, with 113 episodes of NIs
occurred in 66 patients. The most common NIs were pneumonia
(14.3%), followed by bacteremia of unknown origin (13.5%), catheter-
related bloodstream infection (5.0%), lower respiratory tract infection
(5.0%), surgical site infection (3.9%) and urinary tract infection (1.9%).
Multivariate analysis revealed that decreased serum albumin in
admission, presence of gallbladder stone or cholestasis and prolonged
duration of PN were independent predictors of NIs, while older age,
decreased serum albumin in admission and prolonged duration of PN
were significantly associated with pneumonia.
Conclusions: NIs was significantly prevalent in adult hospitalized
patients with IF. The prolonged duration of PN was one of the most
significant predictors for NIs.
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PARENTERAL NUTRITION INDUCED THERMOGENESIS DOES NOT
INFLUENCE MEASURED RESTING ENERGY EXPENDITURE DURING
CVVH
J. Jonckheer1*, J. Demol2, R. Jacobs1, K. Lanckmans3, H. Spapen1,
M.L. Malbrain1, E. Dewaele1. 1Intensive Care, 2Nutrition, 3Clinical
Laboratory, University Hospital of Brussels, Jette, Belgium
* Corresponding author.
Rationale: Indirect calorimetry (IC)-guided caloric delivery and
adequate protein provision is correlated with increased survival in
critically ill adult patients. Parenteral nutrition (PN) induces thermo-
genesis which may increase REE by 7%., suggesting that IC best should
be performed in unfed patients. We investigated whether PN-based
nutrition influenced REE in the particular setting of continuous veno-
venous hemofiltration (CVVH).
Methods: Retrospective analysis of data from the prospective
MECCIAS trial (NCT03314363) which investigated the effect of CVVH
on gas exchange and validated IC use during CVVH. During this trial,
patients daily received a 1L ready-to-usemultichamber PN bag (Olimel
N9 Baxter®) containing a double-dose vitamins and triple-dose trace-
elements during IC measurements.
Results: Eight mechanically ventilated critically ill adult patients
undergoing CVVH were studied. CVVH was performed with
Prismocitrate 18/0 (Baxter®) in predilution at a median flow of 1600
(range 1463–1838) ml/h andmedian blood flow of 9000 (range 9000–
9000) ml/h. Measured median REE values were 1208 (range 1037–
2275) and 1163 (range 864–2229) Kcal/day, respectively without and
with PN (p = 0.19).
Conclusions: Measured REE is not significantly altered by PN in
mechanically ventilated adult critically ill patients receiving CVVH. IC
remains a reliable tool to assess caloric needs in these patients.
Disclosure of Interest: J. Jonckheer Grant/Research Support from:
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THE PROCESSED POWDER OF JERUSALEM ARTICHOKE
(HELIANTHUS TUBEROSUS L.) TUBER MIXING IN HOSPITAL
ENTERAL FEEDING FORMULA FOR DIARRHEA PATIENT IN
SURGICAL INTENSIVE CARE UNIT: PREPARATION METHOD AND
CLINICAL PILOT STUDY
K. Chittawatanarat1*, Y. Polbhakdee2, S. Surawang3, P. Simapaisan3,
K. Judprasong4. 1Department of Surgery, 2Nutrition division, Faculty of
Medicine, Chiang Mai University, 3Department of Product Development
Technology, Faculty of Agro-Industry, Chiang Mai University, Chiang Mai,
4Institute of Nutrition, Mahidol University at Salaya, Nakhon Pathom,
Thailand
* Corresponding author.
Rationale: The Jerusalem artichoke (Helianthus tuberosus L.) is a
tuber crop and has the components of soluble fiber especially the
fructans (Inulin and oligofructose). Our previous reports using mixed
fiber on commercial formula in surgical critically ill patient
demonstrated reducing of diarrhea score. The objective of this
study was to find the processed method of Jerusalem artichoke fiber
into powder and tested the physical properties and dietary fiber
components as well as the pilot clinical use in diarrhea patient in
surgical intensive care unit (ICU).
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Methods: The Jerusalem artichoke tuber was processed by rotary
vacuummicrowave, hot dry air blower, and then blender-hammermill
machine into 600micrometers in size. The dietary fiber components of
processed powder were analyzed. Regarding the clinical pilot, the
selected diarrhea patient in surgical ICUwas received of 2 gram in each
100 mL of hospital enteral feeding formula for 5 days. The daily
diarrhea score was recorded. The diarrhea was defined when the
King’s stool chart score ≥12.
Results: The swelling artichoke powder particle was very low. The
mixing of hospital blenderized diet formula increased the viscosity
only 0.6–0.7 RVU. The component of dietary fiber was comprised of
20.8–21.6% and fructans (inulin and oligofrustose) 66.0–71.5%. After
mixing this power into the hospital enteral formula in 11 patients who
suffering from diarrhea [median of score (interquartile range) 18 (12–
26)], the diarrhea was improve (diarrhea score <12) in 7/11 patient
(63.6%) at the 5th day. The effect of improving was begin at 2nd day
[diarrhea score: 15 (8–32); p = 0.03] and significant improve at 4th and
5th day [9(5–24); p < 0.01 and 8(5–24); p < 0.01 respectively]. There
were no report of vomiting and tube clogging between the study
period. Three patients had the high gastric residual volume (>200 mL)
in the study period.
Conclusions: The processed powder of Jerusalem artichoke tuber
mixing in hospital enteral feeding formula might be improve the
diarrhea score. However, the future randomized control trial should be
performed for demonstrate the more valid results.
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SUN-PO032
DOES THE INTAKE OF NUTRIENTS ASSOCIATED WITH
CARDIOMETABOLIC RISK DIFFER ACCORDING TO OCCUPATIONAL
STATUS IN 60–65-YEAR-OLD SUBJECTS? PRELIMINARY RESULTS
A. Guligowska1*, B.K. Soltysik1, K. Karolczak2, T. Kostka1. 1Geriatry,
2Haemostatic Disorders, Medical University of Lodz, Lodz, Poland
* Corresponding author.
Rationale: The aim of the study was to compare the intake of those
nutrients which are associated with cardiometabolic risk in pre-
elderly subjects.
Methods: We recruited 300 subjects aged 60–65 and divided into
three equal groups of white-collar, blue-collar workers and
unemployed subjects; 50% were women. Anthropometric measure-
ments and clinical interview were conducted, metabolic syndrome
was assessed according to International Diabetes Federation. The
pattern of consumption of various nutrients was analyzed in detail.
Results: Themost beneficial intake of nutrients was in thewhite collar
women: vitamin C [103 mg (68–159)],% energy from saturated fats
(SFA) [10,8 (7,1–13,7)], the amount of kilocalories per 1 gram of fiber
[78 kcal (5—103)], sodium [2761 mg (1922–4108)]. Metabolic syn-
drome occurred in 72% of subjects in this group.
Among men, the highest sodium intake [4216 mg (3142–5660)], the
highest % SFA energy [14,5 (10,6–17,6)] and the least favorable index of
kcal per 1 g of fiber (106 kcal (91–149) occurred in the group of blue-
collar workers. The incidence ofmetabolic syndrome in this groupwas
78% of the subjects.
Conclusions: Occupational status differentiated the level of consump-
tion of the assessed nutrients. The most convergent with recommen-
dations diet occurred in white collar workers group, the least
beneficial in blue collar workers. Multifactor analyzes can determine
to what extent the diet as compared to other factors, eg lifestyle,
smoking determines the risk of metabolic syndrome.
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INFLUENCE OF PHYSICAL EXERCISE AND PROTEIN
SUPPLEMENTATION IN QUALITY OF LIFE (SF36) IN SENIORS TO
LIVE IN THE COMMUNITY
H. Loureiro1, M. Pocinho2, M. Lages3, M. Silva4, R. Martins4,
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Rationale:Ageing is characterized bya gradual loss of functions, being
a natural and physiological process and markedly heterogeneous.
However it is possible to modify the trajectories of functional decline
and promote successful ageing; physical exercise and nutrition have
shown benefits in the promotion of better quality of life. The objective
of this study to verify the influence of protein supplementation
associated with the practice of physical exercise in Quality of life (QoL)
in Seniors living in the community.
Methods: A clinical, prospective, double-blind, randomized, placebo-
controlled study was developed. Sample was probabilistic and
randomly assigned. Subjects were distributed through the 4 arms of
the study with 19 participants each: 1-physical exercise (strength and
resistance)+protein supplement (20 g); 2-physical exercise (strength
and resistance)+placebo; 3-only protein supplement (20 g); 4-control
group, without intervention. Each of the 4 groups was assessed at
baseline and after 12 weeks.
QoL was assessed through SF36 questionnaire, before and after
intervention. Descriptive and inferential statistics were used.
Results: The sample consisted of 79 individuals, 55 women and 25
men,with amean age of 68.54 ± 5.72 years, mean height 1.57 ± 0.09 m,
mean weight 72.7 ± 14.3 kg, being homogeneous with respect to age,
sex and the anthropometric characteristics (BMI, arm and leg
circumference). Groups 1 and 2 significantly improved their QoL
(p < 0.05) during the study. QoL improvement was greater in groups 1
and 3 than 2 and 4 (p < 0.05).
Subjects in group 4 worsened their outcomes in all domains of QoL
assessed.
Conclusions: Protein supplementation revealed a positive influence
on QoL, especially when associated with exercise. In fact, seniors who
were not supplemented and did not performed a prescribed exercise
(control group) showed aworsening of their QoL throughout the study.
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PREVALENCE OF OBESE OLDER MALNOURISHED ADULTS AND
COVERAGE OF THEIR PROTEIN NEEDS IN A TERTIARY CENTER
A. Kouadio1*, E. Guex2, M. Barigou1, P. Coti Bertrand3. 1NUTD, 2NUT1, C H
U V, Lausanne, 3CYOCB, eHnv, Yverdon-les-Bains, Switzerland
* Corresponding author.
Rationale: Meeting appropriate coverage of protein needs is a major
challenge in older adults (OA). This study aimed at evaluating the
prevalence of obese malnourished older adults and the coverage of
protein needs in a geriatric population, comparing obese/malnour-
ished (OM) to obese/well-nourished (OW), non-obese/malnourished
(NOM), and non-obese/well-nourished (NOWN) individuals.
Methods: This retrospective study included 1936 subjects followed at
the University of Lausanne during 2013–2015. 870 fulfilled the
inclusion criteria (≥70 years). Malnutrition was assessed according
to the GLIM (Global Leadership Initiative on Malnutrition) criteria.
Obesity was defined as a BMI≥ 30 kg/m2. Protein needs were
estimated to be 1.1 g/kg for the obese patients based on established
recommendations. Amount of food consumption was assessed by a
dietitian.
Results: Mean age was 81 ± 7 years and mean BMI was 24 ± 5 kg/m2.
Eighty (9%)were obese, and among them20 (25%)weremalnourished,
corresponding to 2.3% of the 870 OA. The protein coverage was
42%±25 g for OM, 45%±25 g for OW, 51%±25 g for NOM, and 55%±24 g
for the NOWN group, with a statistical difference between the OM and
NOWN groups (p = 0.029). Only 1 patient among the OM group
received nutritional support.
Conclusions: A large fraction (25%) of older and obese patients were
found to be malnourished. The protein coverage was found to be very
lowwith 42% of the actual needs. Although an adequate protein intake
is particularly important for this vulnerable population in order to
maintain lean body mass, only 1/20 patients received nutritional
support. The findings suggest 1) an inappropriate coverage of protein
needs in this cohort followed at a tertiary center and 2) emphasize the
need for implementing structured guidance for the care of OA, a
particularly vulnerable high-risk population.
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NUTRITIONAL STATUS IN INSTITUTIONALIZED OLDER ADULTSWITH
COGNITIVE IMPAIRMENT
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* Corresponding author.
Rationale: Older people with cognitive impairment are more
vulnerable to malnutrition. Our study aimed to assess the nutritional
status in a group of institutionalized Lebanese elderly with cognitive
impairment, and the factors associated with malnutrition.
Methods: It was a cross-sectional observational study. Candidates aged
65 and above with cognitive impairment were recruited from 7
Lebanese institutions. Data were collected from medical records,
questionnaires and clinical examination. Sociodemographic character-
istics, type and route of feeding, presence of chronic diseases, drug
intakeandresultsofbiologicalexaminationsperformedduring the last3
months were collected. Patient independence was assessed using the
Activity of Daily Living questionnaire (ADL). The anthropometric
measurements assessing the nutritional status of patients were BMI
(Kg/m2), upper arm circumference (cm), calf circumference (cm)
and triceps skinfold (cm). The examination of the number of
functional dental units (FU) and the clinical evaluation of pressure
ulcers were performed. Univariate analyses followed by multiple
regression analyses were performed to assess the factors associated
with malnutrition.
Results: One hundred and three participants (27 men and 76 women)
with a mean age of 83.90 ± 8.74 years were recruited. 64.1% had
severe dementia, 48.5% needed feeding assistance, 53.4% were
bedridden and 4.3% had pressure ulcers. The mean values of the
upper arm circumference, the calf circumference, the triceps skinfold
and the albumin level were 22.73 ± 3.14 cm, 27.14 ± 4.96 cm, 3.94 ±
2.29 cm, and 3.60 ± 0.46 g/dL, respectively. Gender, ADL score, dyspha-
gia, FU number and enteral feeding were associated with malnutrition
(p-value <0.05).
Conclusions: The assessment of nutritional status of elderly patients
with cognitive impairment should be periodic and integrate several
clinical and biological parameters, in order to avoid the complications
of malnutrition.
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EVALUATION OF DYNAMIC SERUM THIOL/DISULFIDE HOMEOSTASIS
IN SARCOPENIC &NON-SARCOPENIC ELDERY
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B.B. Yavuz1,M. Cankurtaran1, M.G. Halil1*. 1InternalMedicine/Division of
Geriatrics, Hacettepe University Medical Faculty, 2Biochemistry
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Rationale: Sarcopenia is a syndrome characterized by progressive and
generalized loss of skeletal muscle mass and chronic inflammatory
conditions are in the pathogenesis. As an indicator of antioxidant
capacity, thiol/disulfide homeostasis regulates detoxification and
antioxidant defense mechanisms. In this study, we aimed to evaluate
the thiol/disulfide homeostasis and ischemic modified albumin levels
in elderly patients.
Methods: Totally 95 patients who were admitted to a geriatric
outpatient clinic were included. Sarcopenia diagnosed according to
EWGSOP2 criterion (1). Serum samples for the thiol-disulphide test
and albumin levels obtained at the time of sarcopenia evaluation
and measured according to clinical and laboratory features (2, 3).
Patients were divided into two groups according to their sarcopenia
presence as normal and dyno-sarcopenia (dynopenia+sarcopenia
+severe sarcopenia).
Results: Overall, 95 patients were included in this study. Median age
was 76 (IQR: 13) years and female patients were 73.3% of all study
population. Forty-two patients (44.2%) were normal, 39 patients
(41.1%) were diagnosed as pre-sarcopenia (dynopenia), three patients
(3.2%) were sarcopenic and 11 patients (11.6%) were severe sarcopenic.
Demographic characteristics and laboratory findings of the study
populationwere in the Table 1. The levels of native thiol and total thiol
were lower while the disulphide level and disulphide/native thiol,
native thiol/total thiol and disulphide/total thiol ratios were similar in
patients with sarcopenia when compared with those in the control
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group. In addition, there were no difference between albumin and
ischemia modified albumin levels. Positive correlation detected
between handgrip strength, 4 meter walking speed and native thiol
&total thiol, disulphide levels. In addition, there was a negative
correlation between age and native thiol &total thiol levels.
Table 1
Demographic characteristics and laboratory findings of the study population
Normal (n:42) Dyno-Sarcopenia
(n:53)
P
value
Median (IQR) Median (IQR)
Age (years) 71 (10) 79 (11) <0.001
Female Gender (%) 48.6% 51.4% 0.152
Diabetes Mellitus (%) 39% 25% 0.16
Hypertension (%) 80.5% 62.7% 0.06
Hyperlipidemia (%) 29.3% 21.6% 0.39
Coronary artery disease (%) 17.1% 9.8% 0.30
BMI (kg/m2) 28.8 (9.3) 26.6 (7) 0.023
Waist circumference (cm)
(mean±SD)
104 ± 16 96 ± 18 0.047
Hip circumference (cm) 113 (14) 108 (18) 0.045
Albumin 4.14 (0.15) 4.11 (0.17) 0.65
Ischemia modified albumin 0.78 (0.15) 0.77 (0.11) 0.75
Native thiol (μmol/l) 400.5 (94.4) 376.0 (102.4) 0.019
Total thiol (μmol/l) 440.6 (120.7) 406.1 (112.1) 0.023
Disulphide (μmol/l) 18.7 (10.6) 13.7 (15) 0.109
Conclusions:Derangements of thiol/disulfide homeostasismay have a
role in sarcopenia pathogenesis and the lower levels of anti-oxidative
may relate to sarcopenia. The diagnostic and prognostic values of thiol/
disulfide products and ischemia modified albumin need to identify
with further studies.
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EATING CHALLENGES ASSOCIATED WITH ENERGY INTAKE OF LONG
TERM CARE RESIDENTS WITH COGNITIVE IMPAIRMENT: MAKING
THE MOST OF MEALTIMES (M3)
C.O. Lengyel1*, K. Mann1, S. Slaughter2, N. Carrier3, H. Keller4. 1Food and
HumanNutritional Sciences, University of Manitoba, Winnipeg, 2Nursing,
University of Alberta, Edmonton, 3École des Sciences des Aliments, de
Nutrition et d’études Familiales, Université de Moncton, Moncton,
4Schlegel-University of Waterloo Research Institute for Aging, University
of Waterloo, Waterloo, Canada
* Corresponding author.
Rationale: Long term care (LTC) residents with cognitive impairment
(CI) are at an increased risk for malnutrition, which is further
complicated by their eating challenges (i.e., refusing to eat, spitting
out food, etc.). The objective of this study was to examine the
association between diverse eating challenges and energy intake of
LTC residents with CI.
Methods: Secondary data analysis was conducted from the M3
study; a cross sectional research project that examined the
determinants of food and fluid intake of older adults in 32 LTC
homes in four Canadian provinces (Alberta, Manitoba, Ontario and
New Brunswick), using data of participants with CI (n = 353; ≥3
Cognitive Performance Scale). Eating challenges were assessed
using: Relational Behavioural Scale, Edinburgh Feeding Evaluation
in Dementia (Ed-FED), nine additional eating challenges, and
Mealtime Relational Care Checklist. Univariate linear regression
was used at a significance level of <0.05.
Results: Requiring close supervision (t (347) = 3.77, p < 0.001) and
physical assistance (t (347) = 4.51, p < 0.001), leaving food on the plate
(t (347) = 5.64, p < 0.001), refusing to eat (t (347) = 4.13, p < 0.001) and
turning head away while eating (t (347) = 2.05, p = 0.041) were
associated with poor energy intake. Adjusting for age and sex, partial
eating assistance and total Ed-FED score were also associated with
poor intake, while dysphagia risk and ‘often’ receiving assistancewere
associated with better intake.
Conclusions: Eating challenges and eating assistance factors are
important predictors of food intake for residents residing in LTC, but
their effect is dependent on the factor. Interventions that support and
promote eating independence, quality of life and address specific
eating challenges are needed to improve food intake of older persons
with CI in LTC.
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IMPACT OF MALNUTRITION ON QUALITY OF LIFE AND CLINICAL
OUTCOMES IN OLDER PEOPLE IN THE COMMUNITY
C.E. Weekes1,2*, M. Hickson3, A. Julian4, P.W. Emery2. 1Nutrition and
Dietetics, Guy’s & St Thomas’ NHS Foundation Trust, 2Nutritional Sciences
Division, King’s College, London, 3Institute of Health and Community,
Plymouth University, Plymouth, 4Nutrition and Dietetics Research Group,
Imperial College, London, United Kingdom
* Corresponding author.
Rationale: Prior to designing and testing novel nutritional interven-
tions, it is necessary to establish the impact of malnutrition on
outcomes that are important to patients and healthcare funders, and
sensitive to changes in nutritional status. The aim of this study was to
measure the impact of unplanned weight loss and reduced dietary
intake on quality of life and clinical outcomes.
Methods: 570 community-based participants (≥60 years) were
recruited for a 12-month observational study if they had been in
contact with healthcare or voluntary services in the previous 3months
(180 from general practice, 171 at hospital discharge, 168 from
intermediate care and 51 from voluntary services). Parameters
assessed at baseline: nutritional status, quality of life (EQ-5D Visual
Analogue Scale (EQ-5D VAS)) and patient-reported clinical outcomes
(falls, antibiotic prescriptions, A&E visits and presence of pressure
sores). Data were analysed using SPSS (IBM) v25.
Results: 352 (62%) participants were female; mean age 77.5 (±9.4)
years and BMI 25.6 (±5.9) kg/m2. At baseline, BMI was <20 kg/m2
in 135 (24%) participants. It was not possible to assign a reliable
MUST score to 140 (25%) participants since they were unable to
recall their weight in the previous 3–6 months and there was no
documented evidence of a previous weight, however 213 (37%)
participants reported unplanned weight loss in the previous 3–6
months and 178 (31%) reported reduced dietary intake in the same
time period. Participants with unplanned weight loss and reduced
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dietary intake reported significantly poorer quality of life and an
increased incidence of unfavourable clinical outcomes i.e. falls,
antibiotic prescriptions, visits to accident and emergency (A&E) and
pressure ulcers (see Table).
Reduced
intake
(n = 178)
Adequate
intake
(n = 392)
p
EQ-5D VAS scores 59.8 (24.6) 70.9 (23.7) <0.001
Falls 129 (73%) 165 (42%) <0.001
Received antibiotics 102 (58%) 157 (40%) <0.001
A&E visits 135 (77%) 184 (47%) <0.001
Pressure ulcers present 24 (14%) 25 (6%) 0.045
Weight loss
(n = 213)
No weight loss
(n = 357)
EQ-5D VAS scores 60.0 (24.5) 71.7 (23.5) <0.001
Falls 154 (73%) 140 (39%) <0.001
Received antibiotics 119 (57%) 141 (40%) <0.001
A&E visits 163 (78%) 156 (44%) <0.001
Pressure ulcers present 30 (14%) 19 (5%) 0.002
Values are means (SD) for EQ-5D VAS; higher EQ-5D scores indicate
better quality of life; p values are for t-test for EQ-5D VAS scores and
Chi2 test for other outcomes.
Conclusions: In this population, reported reduced dietary intake and
unplanned weight loss were associated with significantly poorer
quality of life and clinical outcomes. Participants are being followed up
for oneyear to determine if changes in nutritional status are associated
with changes in outcomes, and to quantify any changes. The data
generated by this study will be used to calculate sample sizes for
testing community-based nutritional interventions in older people
identified as at risk of malnutrition.
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DRUG-INDUCED DYSPHAGIA IN ELDERLY NURSING HOME
RESIDENTS
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R. Basile1, D. Sparvoli1, D. Fagnani1. 1Clinical Nutrition Department –
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Rationale: Oropharyngeal dysphagia may affect negatively both
the efficacy of deglutition (leading to malnutrition and/or dehy-
dration) and its safety (causing aspiration pneumonia). It is very
frequent in elderly Nursing Home residents (NHRs) also as a side-
effect of some drugs and medications (Drug-Induced Dysphagia).
This study was performed in a population of Italian NHRs to
evaluate how often drugs which may induce Dysphagia are
prescribed to them.
Methods: Data on overall clinical conditions of 140 NHRs were
gathered togetherwith their therapies. Dysphagia riskwas assessed by
I-EAT 10, malnutrition by ESPEN Consensus Definition 2015. Drug
therapies were analyzed and classified according tomechanismwhich
may induce Dysphagia, following Balzer’s classifications.
Results: NHRs (mean age 86,32 ± 9,11 years) were prevalently affected
by neurologic diseases (70%), 92% had comorbidities. Malnutritionwas
diagnosed in 27,9%, dysphagia risk in 27,5%. Polypharmacy (>5 drugs)
was registered in 77,9%, mean number of drugs taken daily by NHRs is
8 (min 1 – max 19). 14.7% of drugs prescribed belonging to the group
whichmay induce dysphagia by different mechanisms: as a side effect
(37,8%), as a complication of therapeutic action (31,7%), by inducing
esophageal injury (29,3%) or miscellaneous agents leading to
dysphagia (1,2%). 72.7% of subjects at risk of dysphagia according to
I-EAT 10 and 67.8% of subjects with previous diagnosis of dysphagia
were assuming at least one drugwhichmay induce dysphagia (min 1–
max 4).
Conclusions: Elderly NHRs frequently assume drugs which may cause
dysphagia and interferewith their nutritional status: in our population
122 patients (86,7%). To prevent Drug-Induced Dysphagia it is
necessary to obtain an accurate medication history from each patient
and, when it is feasible, the offending agent has to be discontinued or
replaced with a less harmful medication.
Reference
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MALNUTRITION RISK AND IN-HOSPITAL FALLS IN OLDER PATIENTS
D. Eglseer1*. 1Institute of Nursing Science, Medizinische Universität Graz,
Institut für Pflegewissenschaft, Graz, Austria
* Corresponding author.
Rationale: Falls and fall-related injuries are major causes for
functional impairment and lowered quality of life among older
persons. Malnutrition often comes along with reduced muscle mass
and may be associated with fall incidents. This study investigates the
association of malnutrition and in-hospital falls in older patients.
Methods: A cross-sectional, multi-centre study was conducted in 44
Austrian hospitals. Two nurses collected demographic data, data on
malnutrition risk and the number of falls within the last 30 days using
a standardized questionnaire.Malnutrition riskwas assessed using the
Malnutrition Universal Screening Tool (MUST). Non-fallers were
compared to fallers with chi-square tests. Univariate and multivariate
logistic regression was performed to assess the association between
malnutrition risk, other predictive factors and falls.
Results: 3702 patients aged ≥65 years participated in the study. The
overall prevalence of in-hospital falls within the last 30 days was 5.2%
(n = 193). 24.3% of the patients were at risk of malnutrition according
toMUST.Malnutrition risk patients fell significantlymore often during
their hospital stay than patients without malnutrition risk (p < 0.05).
Univariate regression analysis confirmed the relationship between in-
hospitals falls andmalnutrition risk (p < 0.05). Significant associations
of falls with female sex, dementia, diseases of the nervous system, the
musculoskeletal system and connective tissue, high care dependency,
psychotropic medication and age were observed.
Conclusions:Older hospitalized patients at risk of malnutrition have a
higher risk of in-hospital falls than older hospitalized patients without
malnutrition risk. Fall prevention programs must consider the
screening and assessment of nutritional status as well as nutritional
interventions for the prevention/treatment of malnutrition risk as one
important factor to achieve success.
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UNACYLATED GHRELIN PLASMA LEVELS DECREASE WITH
OBESITY AND PREDICT 5-YEAR LOW MUSCLE MASS IN THE
ELDERLY
G. Gortan Cappellari1*, P. Vinci1, A. Semolic1, G. Cremasco1, A. Tolin1,
M. Zanetti1, R. Barazzoni1. 1Department ofMedical Sciences, University of
Trieste, Trieste, Italy
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Rationale:Aging is associatedwith skeletal muscle loss, whichmay be
paralleled by increased fat mass, both contributing to frailty and
related healthcare and social costs. Unacylated ghrelin (UnAG) is an
emerging modulator of skeletal muscle metabolism with potential
muscle-anabolic actions, and plasma UnAG decreases with over-
weight-obesity [body mass index (BMI)>25 kg/m2] in general popu-
lation cohorts. Potential associations between UnAG, overweight-
obesity and muscle mass (MM) in elderly humans are currently
unknown.
Methods: We investigated associations between body mass index
(BMI) and ghrelin profile [total (TG), acylated (AG) and unacylated
hormone (UnAG)] in 450 elderly individuals (age >65 y) from the
North-East Italy MoMa population study (M/F: 179/271). After 5 years
theMM index (MM/m2) wasmeasured in 133 subjects (M/F: 72/81) by
bioelectrical impedence analysis. Low MM-index was defined as 2
standard deviations lower than average MM-index in young (18–39)
reference subjects from the same population study.
Results: In elderly subjects, UnAG was reduced (p < 0.01) in over-
weight-obese compared to lean. In multiple regression analysis, UnAG
was associated (P < 0.01) with BMI independently of potential
confounders, including gender, metabolic and inflammatory
markers. In logistic regression analysis, lower basal UnAG predicted
(p < 0.05) lowMM-index independently of BMI, gender andmetabolic
confounders.
Conclusions: In elderly subjects from a North-East Italy general
population cohort, unacylated ghrelin is lower in overweight-obese
compared to lean individuals and it predicts 5-year muscle mass
independently from BMI. The current results suggest that lower UnAG
may contribute to lower muscle mass in obese elderly individuals.
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REGIONAL PARTNERSHIPAND INTEGRATION ON DYSPHAGEAL DIET
IN JAPAN, LITERATURE SURVEY IN THE JAPANESE LANGUAGE
H. Mochizuki1*, K. Irikedamoto2. 1Nutritional Management, Sagami
Women’s University, Sagamihara, 2Food Service, Tsurumaki Onsenn
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* Corresponding author.
Rationale: As getting super-aged society, disturbance of swallowing is
one of big medical issue in Japan. At many hospitals and care facilities
dysphagia diet is served as to the ability of swallowing, but there is a
broad variation in modified textures and that’s name. Recently, many
attempts are reported about regional partnership and integration on
dysphagia diet in JAPAN. But, most of them arewritten in the Japanese
language.
Methods: The literature survey was done on the April 1st 2019, in the
Japanese language on three Japanesemedical database; JapanMedical
Abstracts Society, JDreamIII and MEDLINE. The search term was
selected which means ‘dysphagia diet’ and ‘region’ or ‘partnership’ or
‘integration’ in English.
Results: Since 2000 to 2018, 765 literatures were found. Among them
293(38%) were about trial within one institution, 274(36%) regional
(multi institutions or City area) partnership, 39(14%) broad area (one
or two prefectures and rest are review papers. At first ‘the dysphagia
diet pyramid’ was used as the criteria of dysphagia diet, after
publication of ‘The Japanese Dysphagia diet 2013’ most of the
literatures were based on it. Recently visual expression of dysphagia
diet using color photo, ‘dysphagia diet map’ is developed and is
spreading calmly. The difference among each prefecture was very
large: 0∼over100, three prefectures had over 50 literatures, Tokyo,
Kanagawa and Aichi, but, four had one or less.
Conclusions: Regional partnership and integration on dysphagia diet
is spreading in Japan, but the difference among each prefecture is still
very large. Tomake up the community-based integrated care system to
overcome super-aged society, countermeasure against dysphagia is
essential. In 2017 the International Dysphagia Diet Standardisation
Initiative (IDDSI) was published. Taking this opportunity, we should
develop further regional partnership and integration on dysphagia
using new standardization.
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EFFECTS OF ORAL NUTRITIONAL SUPPLEMENT ON NUTRITIONAL
STATUS AND MUSCLE FUNCTION: A RANDOMIZED, CONTROLLED
TRIAL IN COMMUNITY-DWELL ELDERLY
H. Xie1*, H. Bai1, Y.Wang1, Y. Zhao2, T. Ye2, L. Qiao3, J. Yu3, S. Li1, M. Zong1,
Y. Chen1, J. Sun1. 1Nutrition Department, Huadong Hospital Affiliated to
Fudan university, 2Xianxia Community Health Service Center, 3Changning
Community Health Service Center, Shanghai, China
* Corresponding author.
Rationale: To evaluate the benefits of health counseling with or
without oral nutrition supplementation (ONS) in community elderly
with malnutrition risk.
Methods: Design: Randomized controlled intervention trial (ChiCTR-
IOR-17012959).
Setting: Two Community Health Service Centers in Shanghai.
Participants: Two hundred and one older people.
Intervention: Weekly health consultation and receiving ONS (2
serving Ensure Complete®, 460 kcal, 17 g protein per day) for 3
months. Control: weekly health counseling.
Method: 201 community based Chinese elderly ages ≥60 years with
risk ofmalnutritionwere randomized into 2 groups: health counseling
with ONS (N = 101) or without ONS (N = 100). Nutritional (MNA-SF,
weight, body mass index [BMI], calf circumferences), functional
parameters (handgrip strength, gait speed, Activity of Daily Living
[ADL]) and experimental index (transferrin, prealbumin, hemoglobin)
were measured at baseline and after 12 weeks (T2). ONS intake was
registered daily and compliance calculated.
Results: A total of 182 community-dwell older people (75.48 ± 7.47
years) completed this study. Median compliance was 81.9% (95%
confidence interval (CI) = 77.8%>85.9%), median intake of 353 kcal
(95% confidence interval (CI) = 336–371) per day. There was
significant difference in change in MNA-SF score between supple-
ment and control groups (p = 0.023). Compared to the control group,
body weight, handgrip strength increased significantly in the
supplement group (p = 0.003, 0.005). There were no significant
between-group differences in calf circumferences, gait speed and
ADL. In addition, between baseline and 12 weeks in the two groups,
the change of blood levels of transferrin, (p = 0.031,), prealbumin
(p = 0.018) had increased and plasma hemoglobin had no difference
(p = 0.986).
Conclusions: ONS was well accepted among undernourished older
people in community-dwell, which resulted in significant improve-
ments of nutritional status. ONS might be a good strategy to improve
nutrition status and long-lasting strength in elderly.
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NUTRITIONAL EVALUATION IN A GERIATRIC CLINIC
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* Corresponding author.
Rationale: The frail geriatric population (+65 years) has specificities
and needs only met by a multidisciplinary approach. The Geriatric
assessment is multidimensional and nutrition is an essential compo-
nent, interacting with body composition and other geriatric syn-
dromes (including dementia falls and frailty). Nutrition wise, this
population faces precise challenges, mostly undernutrition, sarcope-
nia and cachexia, and more recently obesity.
The aim of this work is to assess the nutritional evaluation of the first 6
months of patients followed in our Geriatric Clinic that gathers nurses,
dietitians, pharmacists, physicians, and social workers.
Methods: Patients at the clinic were assessed in terms of nutrition by
the MNA score, BMI, and handgrip. Geriatric assessment including
functional status (Katz and Lawton & Brody scores), falls evaluation
(Holden score), depression evaluation (Yesavage), frailty (PRISMA7),
comorbidities and polypharmacy was made.
Results: Data from 34 patients attending the Geriatrics clinic was
analyzed, yielding a female preponderance (65%). Mean age was 79,7,
with 23,5% young old, 53% middle old and 23,5% very old. On average,
each patient had 7,4 diseases and was medicated with 8,4 drugs.
Patients were mostly independent (85% by Katz and 50% by
Lowton&Brody), however only 28,6% had an effective gait and time
up and gowas over 10 seconds in 72,7%. Also relevant, frailty screening
was positive in 32,3% of patients. Depression screening recorded only
slight depression in 32,3%.
Nutrition wise, average BMI was 25,4 ± 4,6, with the majority of
patients in the normal or overweight categories – 35% each, 18% were
moderately obese and only 12% had underweight. MNA screening
showed that 25% of patients were at risk, and 1 of them was actually
malnourished. Considering handgrip, both right and left were lower
than predicted: 41,4%±24 (right) and 42,5%±29,6 (left) of calculated
handgrip strength.
No association was established between the demographic and
geriatric assessment scores data and nutritional status.
Conclusions:Our data shows a normal age distribution through all age
categories, with a female preponderance according to literature.
Comorbidities and polypharmacy even though important, are not
overwhelming. The autonomy degree for daily activities in this sample
is a selection bias of this specific clinic, which aims independency
gains in the frail elderly patients. The nutrition data is distressing as
25% are at nutritional risk by the MNA. The handgrip used as a
prognostic factor also shows that patients are at risk.
The small sample from our Geriatric Clinic (of a highly selected elderly
population), limits the establishment of associations and the devel-
opment of risk and prognostic factors.
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STUDY OF PROBLEMS ENCOUNTERED DURING 390 MENU
COMMISSIONS IN 60 NURSING HOMES IN THE FRENCH LIMOUSIN
TERRITORY
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P. Fayemendy1,2,3,4, P. Jésus1,2,3,4. 1Nutrition Unit, University Hospital of
Limoges, 2INSERM, U1094, Tropical Neuroepidemiology, School of
Medicine of Limoges, 3Institute of Neurological Epidemiology and
Tropical Neurology, CNRS FR 3503 GEIST, University of Limoges,
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Rationale: The menu commissions (MC) of nursing homes (NH)
control and guide the nutritional policy of these institutions.We know
how they work [1], but not the problems raised. The objective of the
study was to identify the problems reported during MCs in NH in
Limousin territory.
Methods: The MCs operated according to procedures described
elsewhere [2], with the systematic participation of a dietician from
the health network ARS Limousin Nutrition (LINUT) who also took
over the reporting of results. Difficulties encountered were noted for
the following criteria: accompaniments (vegetables or starches),
beverages, entries, desserts, suppliers, fruit, waste, links between
cooking and care, menus, bread, replacement dishes, service, protein
dishes, soups, dairy products, pastry preparations, diets, sauces,
textures. The results are only descriptive.
Results: 390 CM from 60 different EHPAD were analysed in 2016 and
2017, covering 4 French departments. Table 1 shows the prevalence of
the 10 most reported problems, in decreasing %. Perception of waste,
links with suppliers or between kitchens and health care sectors,
breadwere the least problematic (12.3,10.0, 8.2 and 6.7% respectively).
For the feed itself, these were quality problems in 21.2 ± 8.0% of cases,
poorly adapted textures in 19.1 ± 9.8% of cases, defective grammages in
14.0 ± 8.3% of cases, variety, cooking or seasoning concerns were less
frequent (respectively 7.1 ± 7.2, 6.7 ± 5.4 and 5.5 ± 4.1% of cases).
Difficulties related to service were organizational (41.0% of cases),
including inadequate durations and hours of service, dishwasher non-
compliances (35.6% of cases), including equipment defects or hygiene
problems, presentations deemed to be poor (16.7% of cases), and they
occurred mostly in the evening (46.1% of cases). Mixed and chopped
textures had the most problems (55.4% and 31.0% of cases respect-
ively). Regimens caused difficulties in 23.9% of cases, and 46.2% of
these difficulties were related to diabetic regimens.
Conclusions: Quality of food is still a major issue raised during the NH
MCs. It may be linked to unappetizing or monotonous preparations,
but also to insufficient resources allocated to the food or the
pathologies of residents. The issue of textures is a concern, probably
linked with the high number of swallowing disorders in residents, but
also with the difficulties of staff in apprehending and managing these
disorders, all themore so since from one institution to another a single
name may correspond to different textures. Difficulties with the
service are noted in almost 60% of cases, which are of organisational
origin or due to the equipment and thereforemore easily soluble. Food
waste is very little perceived as a problem in MCs. These results point
towards many ways to improve the provision of food in EHPAD.
Table 1 (abstract: SUN-PO045): Prevalence of Top 10 problems encountered.
Protein
dishes
Accompaniments Service Textures Entries Soups Sauces Fruits Dairy
products
Desserts
87.4% 72.5% 59.1% 49.6% 46.3% 45.0% 40.1% 38.6% 33.9% 35.6%
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NUTRITIONAL STATUS IN PATIENTS OVER 65 AND ITS INFLUENCE ON
THE QUANTITYAND TYPE OF COMPLICATIONS OCCURRING 3, 6 AND
12 MONTHS AFTER HOSPITALIZATION
J. Ostrowska1*, D. Szostak-Węgierek1, A. Jeznach-Steinhagen1.
1Department of Clinical Dietetics, Medical University of Warsaw,
Warsaw, Poland
* Corresponding author.
Rationale: Malnutrition in hospitalized patients is associated with
frequent complications and increased mortality. Numerous studies
indicate that the results obtained during reliable nutritional assess-
ment may be predictors of an increased complication rate.
The objectivewas to determine the prevalence of abnormal nutritional
status in patients over 65with the diagnosis of cardiovascular diseases
and also to check its relationship with the duration of hospitalization
and the incidence of complications over 3, 6 and 12 months of
observation.
Methods: 76 patients over 65 years of age with cardiovascular
conditions were involved in the study. Abnormal nutritional status
was identified on the basis of MNA-SF test results, laboratory tests and
ESPEN nutritional status assessment criteria. During 3, 6 and 12
months of observation data were collected which concerned the
number of re-hospitalizations and the presence of complications.
Results: Abnormal nutritional status was reported in 78% of
participants. It was noted that malnutrition diagnosed on the basis
of laboratory findings and also on the basis of ESPEN criteria
comprising the value of FFMI had a significant predictive value for
prolonged hospitalization and an increased complication rate. The
results of MNA-SF test performed at baseline revealed no relationship
with the incidence of complications during the first stage of the study.
MNA-SF results performed during each subsequent stage of the study
revealed a significant association with an increased frequency of
hospitalizations and complications mainly with those which had
occurred within 3 months prior to the test.
Conclusions: The set of criteria to assess the nutritional status which
has the highest predictive value as regards the duration of hospital-
ization and the incidence of complications includes laboratory tests
and ESPEN criteria comprising the value of FFMI.
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HOW TO INCREASE REFERRALS IN AN RCT AMONG FRAIL OLD
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Rationale: Nurses play a significant role, in including patients in
intervention studies. The aim of the present observation study was to
evaluate the efficacy of different initiatives to increase inclusion rate in
an ongoing RCT1.
Methods: A three-step approach were used. 1) Prior initiation of the
study, posters were developed, and introduction meetings were
performed to inform nursing staff of their role in the recruitment
process. 2) In this period a reward cake arrangement was introduced,
and the research dietitians attended staff meetings and identified
possible participants. 3) In addition to initiative 2) systematic weekly
nutritional screening was performed by the research dieticians, based
on the nurse’s identification of potential participants in oneward. The
first period consisted of 15 weeks, the second period consisted of 21
weeks, and the third period consisted of 10 weeks.
Results: In the first period, the average of referrals was 1.7/week
(n = 25). We found a 74% increase (p = 0.03) in referrals to 2.9/week
(n = 61) when comparing the first period with the second period. In
the third period, an average of 3.1 referrals per week was seen (n = 28).
This was a significant increase (p = 0.02) of 87% compared with the
first period. Specifically, the systematic screening at one ward
increased referrals with 112% (P = 0.009).
Conclusions: It is possible to increase the inclusion of participants, by
close cooperation between research dieticians and nurses.
Reference
1. Clinical trial ID: NCT03488329
Disclosure of Interest: None declared.
SUN-PO048
SENSORY ACCEPTANCE OF FOOD DEVELOPED FOR FRAIL OLDER
ADULTS
J.A. Svendsen1*, A.W. Knudsen1, D.M. Konglevoll1, A.M. Beck1,2,
T. Munk1. 1The Dietetic and Nutritional Research Unit, Herlev-Gentofte
Hospital, Herlev, 2University College Copenhagen, Institute of Nutrition
and Nursing, Copenhagen, Denmark
* Corresponding author.
Rationale: Older frail adults are at high risk of undernutrition both in
the hospital and in themunicipality setting. The acceptance of the food
served in these settings are therefore of high importance to counteract
this risk.
The aim of this study was to test the acceptance of sensory optimized,
protein and energy-rich dishes specifically developed for older frail
adults1.
Methods: Participants were recruited from the main hall at Herlev
Hospital andwere served food samples from one of 25 dishes. Datawere
obtained using a sensory questionnaire consisting of 5 questions about
current appetite as well as flavor, appearance, smell, and texture of the
dish.A5-point scalewasused, from1=dislikea lot to5 = likea lot. Further,
data on age, gender, and if they were patients or visitors were collected.
Results: Each dish was on average tasted 23 times, in total 585 adults
completed a taste session. 54% were patients and 46% visitors, 61%
women. Mean age 69 ± 13 years, 70% 65+ years. Appetite was not a
confounder for acceptance of flavor. The dishes were overall ranked
4.3 ± 0.8 for flavor. No difference in scores on flavor compared with
appearance was found. However, a difference in scores on flavor
compared with texture 4.2 ± 0.8 (p = 0.03), and smell 4.0 ± 0.7 (p <
0.0001) was found. No difference was found in acceptance between
age groups.
Conclusions: We found a high acceptance of all the dishes, but more
studies are needed to investigate if a high acceptance equals a high
consumption.
Reference
1. Clinical trial ID: NCT03133364
Disclosure of Interest: None declared.
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SUN-PO049
IMPACT OF NUTRITIONAL STATUS ON DISCHARGE DESTINATION IN
OLDER HOSPITALIZED PATIENTS
K. Miyakoshi1*, K. Sato1, Y. Ueta2. 1Department of Rehabilitation Medicine,
2Department of Nutrition, Kameda General Hospital, Chiba, Japan
* Corresponding author.
Rationale: Prediction of discharge destination is important to provide
effective treatment plan. But the prediction is sometimes difficult
because various factors can affect the outcome. Malnutrition is
considered to be one of important factors affecting the outcome. We
report the relationship between the nutritional status and discharge
destination by retrospective chart review.
Methods: The subjectswere consecutive patientswhowere admitted to
ourhospital, fromApril 2017 tomarch2018. Study inclusion criteriawere
age 65 years or older. Our hospital is an 857-bed acute care community
hospital accredited by Joint Commission International. We collected the
following variables from the medical records retrospectively. The
candidates for prognostic factors were age, gender, hospitalized ward
(medical or surgical), diagnosis (cancer or others), and mini nutritional
assessment short-form (MNA-SF) on admission. The outcome measure
was discharge destination (home or nursing facilities).
Results: The participants were 8315 patients. The mean age was 76.4
years,meanMNA-SFwas 9.9 andmean length of hospital staywas 14.6
days. A total of 86.6% of patients were discharged home. All variables
were statistically significant in univariate analysis. In the logistic
regression analysis, following factors were statistically significant:
diagnosis (non-cancer) (OR6.800, 95%CI 5.801–7.972), hospitalized
ward (OR2.951, 95%CI 2.512–3.467), neuropsychological problems
(OR1.996, 95%CI 1.734–2.297), food intake decline (OR1.442, 95%CI
1.291–1.611) and body mass index (OR1.122, 95%CI 1.050–1.1.198).
Conclusions: Statistically significant correlation exists between MNA-
SF and discharge destination. Nutritional status should be taken into
consideration in order to provide an effective treatment plan.
Disclosure of Interest: None declared.
SUN-PO050
TWO FEASIBILITY STUDIES AMONG GERIATRIC PATIENTS: (FS1)
PHOTO DOCUMENTATION OF FOOD AND FLUID TO ASSESS ENERGY
& PROTEIN INTAKE – (FS2) CONTENT OF REFRIGERATOR AS
PREDICTOR FOR READMISSION
M.O. Cramon1,2*, I. Raben1,2, A.M. Beck3, J.R. Andersen1,1. 1Department
of Nutrition, Exercise and Sports, University of Copenhagen, Copenhagen,
2Department ofMedicine, ZealandUniversity Hospital, Køge, 3Institute for
Nursing and Nutrition, Faculty of Health, University College Copenhagen,
Copenhagen, Denmark
* Corresponding author.
Rationale: (FS1) It can be a challenge for patients to register diet and
fluid. Geriatric patients are particularly challenged due to low
functional ability. Objectives: To investigate if geriatric patients had
the desire and ability to take photos and if photo could be used to
assess energy and protein intake. (FS2) An older study showed an
empty refrigerator increased the risk of readmission1. Objective: To
investigate, by means of photo, if refrigerator contents 3 days after
discharge were predictive for readmission.
Methods: (FS1) In a RCT the intervention group of geriatric patients
(n = 21) were asked if they would take photos prior to and after food
and fluid intake 2 × 2 days and SMS/mail the photos prior to home
visits. Control: a 48-hour diet interview conducted on visiting day.
(FS2) Permission to take photos of the refrigerator contents was asked
at the first home visit. The contentswere evaluated adequatelywith≥3
perishable durable food items. Statistical analysis (FS1): Bland-
Altmann plot, median.
Results: (FS1) 15(71%) had a smartphone, 11(73%) took photos and 7
(33%) sent photos. Bland-Altman plot and percentage median
difference indicated a tendency to underestimate when using the
photo method compared to dietary interviews with 14%(−25%>6%)
energy intake and 13% protein intake (−31%>8%). Probably due to
missing photos of snacks/drinks. (FS2) 17 photos of refrigerator
contents, all evaluated adequate and not predictive of readmission.
Conclusions: (FS1) Geriatric patients with smartphone seem to have
the desire, but in some cases lack the ability to take/send photos. Photo
documentation seems to underestimate energy and protein intake
compared to diet interviews. (FS2) The refrigerator content 3 days after
discharge was not predictive of readmission.
Reference
1. Boumendjel (2000)
Disclosure of Interest: None declared.
SUN-PO051
BODY COMPOSITION, ENERGY AND PROTEIN INTAKE IN
INSTITUTIONALIZED PORTUGUESE OLDER ADULTS
M.A. Marques1,2*, A. Faria3, M. Cebola4. 1Faculdade de Medicina
da Universidade de Lisboa, Lisboa, 2Santa Casa da Misericórdia de
Alvaiázere, Alvaiázere, 3Nutrition and Dietetics, Escola Superior de
Tecnologia da Saúde de Coimbra, Instituto Politécnico de Coimbra,
Coimbra, 4(H&TRC) – Centro de Investigação em Saúde e Tecnologia;
(ESTeSL) – Dietética e Nutrição, Escola Superior Tecnologia da Saúde de
Lisboa; (IPL) – Instituto Politécnico de Lisboa, Lisboa, Portugal
* Corresponding author.
Rationale: Adequate nutritional intake (particularly energy and
protein) in older adults is crucial to maintain and prevent loss of
musclemass and further deterioration of nutritional and health status.
This investigation aimed to assess body composition and its
relationship with energy and protein intake in institutionalized older
adults.
Methods: Sociodemographic and anthropometric data was collected.
Body composition was assessed through bioimpedance analysis
(BodyStat 1500). Energy and protein intake was estimated through a
food frequency questionnaire validated in the Portuguese population.
Results: One-hundred and forty-six older adults were included (63.3%
female), with a mean age of 83 years old. Mean Body Mass Index was
25.2 ± 4.8 kg/m2 (min 14.6; max 37.5). Mean Free Fat Mass Index was
15.4 ± 3.2 kg/m2 (min 8.2; max 22.2). Food intake was estimated,
obtaining a mean energy intake of 2011.9 ± 275.7 kcal (32.4 ± 6.9 kcal/
kg Body Weight (BW)). As for protein, a mean daily intake of
76.1 ± 18.8 g (1.2 ± 0.3 g/kg BW). A strong positive correlation was
found between BMI and FFMI (r = 0.670; p = 0.000). A moderate
positive correlation was found between BMI and daily energy intake
(r = 0.217; p = 0.037) and between BMI and daily protein intake
(r = 0.363; p = 0.000). Protein intake below 1.5 g/kg BW and below
1.0 g/kg was found in 89.2% and 28.4% of the sample, respectively.
Conclusions: In this sample, a strong positive correlation was found
between BMI and FFMI, meaning that a free fat mass height adjusted
index is a better indicator of nutritional status and body composition,
than percentage of free fat mass. Free fat mass declines with age, and
even when a higher BMI is detected, nutritional intervention is still
needed to optimize energy and protein intake, preventing further
decline of nutritional and functional status of older adults.
Disclosure of Interest: None declared.
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SUN-PO052
PREVALENCE AND CHARACTERISTICS OF ADULT INTESTINAL
FAILURE IN FINLAND
A. Pohju1,2*, M.P. Pakarinen3,4, P. Bergman5,6, T. Sipponen2,7. 1Clinical
Nutrition Unit, Helsinki University Hospital, 2University of Helsinki,
3Section of Pediatric Surgery, Children’s Hospital, 4Pediatric Liver and Gut
Research Group, 5Biostatistics Consulting, Department of Public Health,
University of Helsinki, 6Helsinki University Hospital, Helsinki, Finland,
7Gastroenterology, Abdominal Center, Helsinki University Hospital,
Helsinki, Finland
* Corresponding author.
Rationale: Details of intestinal failure (IF) in the Finnish adult
population are unknown. The aim of this study was to investigate
the prevalence and characteristics of adult IF in Finland.
Methods: An internet-based survey was emailed to all Finnish
hospitals and hospital-at-home services (n = 111) with the potential
to provide parenteral support (PS) for adult IF. The participants were
asked whether their unit had provided long-term PS to any patient(s)
aged≥18 years during the preceding year. If no responsewas obtained,
the unit was phoned. Data were analysed using descriptive statistics.
Results: In total, 105 different health care providers responded,
resulting in an overall response rate of 95%. 29 units (28%) had
provided long-term PS during the preceding year. 71 cases were
reported, out of which 19 cases were excluded (16 cases were
reported multiple times, 3 cases didn’t have IF). This left an adult IF
population of 52 individual patients and a period prevalence of 12/
million for the year 2017. 31% (n = 16) of the patients had started PS
during 2017. The mean patient age was 57.6 ± 17.2 years and 67% were
women. Short bowel syndrome was the most frequently reported
underlying pathophysiology of IF (46% of cases), and majority of cases
(64%) had a stoma. The mean duration for PS was 41.9 ± 53.1 months
(median 23, range 3–287). Almost half of the patients (48%) received
parenterally both nutrition and fluids and electrolytes. Majority (54%)
received PS on a daily basis. 12 patients (23%) weaned off PS during
the year 2017 after receiving PS for 24.9 ± 24.9 months. Successful
weaning off was the most frequent reason for termination of PS, one
patient (8.3%) died.
Conclusions: The prevalence and disease characteristics of adult IF in
Finland are comparable to other Western countries. Short bowel
syndrome was the most common reason for adult IF.
Disclosure of Interest: None declared.
SUN-PO053
PEDIATRIC ACHALASIA: NUTRITIONAL STATUS BEFORE AND AFTER
TREATMENT
A.D. Widodo1*, E.J. Soelaeman1, I. Bramantyo2, C.F. Adhiwidjaja3,
B. Purnomo1, on behalf of Harapan Kita. 1Department of Pediatrics,
Pediatric Gastrohepatology Division, 2Department of Radiology,
3Department of Pediatric Surgery, Harapan Kita Women and Children
Hospital, Jakarta, Indonesia
* Corresponding author.
Rationale: Achalasia is an esophageal motor disorder that leads to
swallowing dysfunction, which compromise feeding tolerance in
children. The prevalence is about 1 out of 1,000,000 children. There
are, however, very limited studies assessing nutritional status of
patients with achalasia before and after treatment. This study focuses
on the nutritional status of children with achalasia before and after
treatment.
Methods: Children 0–18 years old with confirmed achalasia between
January 2016–March 2019 were analyzed for Z-scores of height-for-
age (HAZ), weight-for-age (WAZ), body mass index for age (BMIZ)
before and after achalasia treatment.WHOgrowth chartwere used as a
reference.
Results: Therewere five childrenwith confirmed achalasia referred to
our tertiary center. Upon diagnosis, WAZ <−1 was observed in all
patients, and similarly BMIZ <−1 in the five patients. HAZ <−1 was
observed in all five patients, and two of them even had HAZ<−2. Four
childrenwent to pneumatic dilation, only one childrenwent to surgery
due to esophageal diverticulum. After corrective treatment, WAZ and
BMIZ significantly improved. HAZ did not show significant improve-
ments in all subjects.
Table 1
Comparison of height for age, weight for age, and BMI for age at diagnosis and
after therapy
Case 1 Case 2 Case 3 Case 4 Case 5
Before After Before After Before After Before After Before After
Weight for Age −3 −1 −3,2 1,2 −1,4 2,8 −1,6 2,6 −3 −1
Height for Age −2,7 −3,3 −1,5 −1,6 −1,1 −1,9 −1 −1,6 −2,9 −2,8
BMI for Age −5,1 0,1 −3,7 3,1 −1,2 6,7 −1,4 6,1 −4,5 1
All in standard deviation (SD)/Z-score.
Conclusions: This study focuses on the nutritional status of children
with achalasia before and after treatment. Our data shows that at
diagnosis all the children have poor nutritional status. Significant
nutritional status improvement occured in all patients who have
received treatment, regardless the type of their treatment. Long-term
follow-up might be needed to see improvement in HAZ.
Disclosure of Interest: None declared.
SUN-PO054
CASE SERIES OF SEVERE GASTROINTESTINAL DYSMOTILITY IN
EHLERS-DANLOS SYNDROME (EDS). DISCUSSION OF NUTRITIONAL
MANAGEMENT ROADMAP
A. B-Nejad1*, T. Tremain-Hill2, K. So3, M. Ballal4, C.B. Pearce2. 1Dietetics,
2Gastroenterology, Fiona Stanley Hospital, Murdoch, 3Gastroenterology,
Royal Perth Hospital, Perth, 4Upper GI Surgery, Fiona Stanley Hospital,
Murdoch, Australia
* Corresponding author.
Rationale: There is increased recognition of gastrointestinal (GI)
problems such as abdominal pain, gastroparesis and intestinal
dysmotility in adults with EDS. The literature on EDS and severe GI
symptoms is sparse and produces unique diagnostic andmanagement
challenges. We present a case series of 11 patients and discuss their
characteristics and nutritional management including the challenges
and learnings in developing a management algorithm.
Methods: Retrospective review of 11 cases from Fiona Stanley and
Royal Perth Hospitals over the last 4 years.
Results: Six patients had clinical diagnosis of EDS, with a further 5
patients who had characteristics in linewith diagnosis included. All 11
patients required nutritional support via tube feeding or intravenous
nutrition. Ten patients were female with a mean age of 27 years. Four
were diagnosed with Postural Orthostatic Tachycardia Syndrome
(POTS), 2 patients had Mast Cell Activation Syndrome (MCAS).
Treatment varied; 10 patients required tube feeding, 8 received
gastric pacing, to varying effects, while 3 were unable to tolerate any
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form of enteral feeding and required home parenteral nutrition. All
patients presented with significant loss of weight andweight gainwas
arduous.
Conclusions: GI dysmotility in patients with EDS is not uncommon
and likely under-diagnosed, particularly as EDS itself is often under
diagnosed. It must be taken into account when treating EDS patients
with GI symptoms, especially in the presence of autonomic dysfunc-
tion features (including POTS) and failure to maintain weight. There is
very little evidence available on the most successful strategies to treat
GI dysmotility in EDS and further sharing of information and studies
would be beneficial. Subsequently a management algorithm has been
developed to trial in this patient cohort.
Disclosure of Interest:A. B-Nejad Grant/Research Support from: Shire
Australia Pty Ltd, T. Tremain-Hill: None declared, K. So: None declared,
M. Ballal: None declared, C. Pearce: None declared.
SUN-PO055
THE EFFECT OF MASTIHA SUPPLEMENT IN MICROBIOTA
COMPOSITION IN PATIENTS WITH IBD; PRELIMINARY RESULTS
C. Amerikanou1*, E. Papada1, A. Tanaini2, N. Jiménez-Hernández2,
G. D’auria2, E. Mitsou1, I. Smyrnioudis3, A. Kyriakou1, A. Forbes4,
M.P. Francino2, A.C. Kaliora1. 1Harokopio University of Athens, Athens,
Greece, 2Fundació per al Foment de la Investigació Sanitària i Biomèdica
de la Comunitat Valenciana, Valencia, Spain, 3Chios Mastic Gum Growers
Association, Chios, Greece, 4Norwich Medical School, University of East
Anglia, Norwich, United Kingdom
* Corresponding author.
Rationale: The purpose of this study was to explore the effect of
mastiha supplement, rich in bioactive nutraceuticals, in microbiota of
patients with active Crohn’s disease (CD) and ulcerative colitis (UC).
Methods: We employed 16S rRNA sequencing to investigate the
composition of faecal microbiota in stool samples derived from 27
participants in a randomised, placebo-controlled clinical trial
(Clinicaltrials.gov ID: NCT02796339).
Results: Relative abundances of Bifidobacteriales (p = 0.01),
Corynebacteriales (p = 0.002), and Coriobacteriales (p = 0.02) were
higher in UC, while Bacteroidales (p = 0.02), Desulfovibrionales (p =
0.05) andEnterobacteriales (p = 0.006)werehigher inCD. InCD treated
with mastiha, relative abundance of Tyzzerella (Lachnospiraceae)
decreased (p = 0.05). Also, in CD patients relative abundance of
Terrisporobacter (Peptostreptococcaceae) was higher (p = 0.04),
while Saccharimonadaceae was lower in mastiha vs placebo at follow
up (p = 0.02). In UC, relative abundance of Alistipes (Rikenellaceae)
(p = 0.03), Streptococcus (Streptococcaceae) (p = 0.04), Anaerostipes
(Lachnospiraceae) (p = 0.04), Papillibacter (Ruminococcaceae) (p =
0.03) and Lachnospiraceae (p = 0.04) were lower in mastiha vs
placebo at follow up. Also, relative abundances of Clostridiales vadin
BB60 group (p = 0.05), Eubacterium coprostanoligenes group
(Ruminococcaceae) (p = 0.05) and Lachnospiraceae CHKCI001 (p =
0.02) decreased in UC treated with mastiha. Our results showed no
significant differences in diversity or global microbiota composition.
Conclusions: Although no significant differences in diversity were
reported however some differences in relative abundances of bacterial
taxa were observed.
Disclosure of Interest: None declared.
SUN-PO056
EFFECT OF DIRECT-ACTING ANTIVIRALS ON SERUM LIPID PROFILES
AND BODY COMPOSITION OF CHRONIC HEPATITIS C PATIENTS: A
RETROSPECTIVE STUDY
D. Uehara1*, A. Naganuma2,3, T. Hoshino2, T. Taira2, T. Murakami2,
N. Sohara2, Y. Ogawa3, M. Inagawa3, T. Tanaka3, T. Ogawa3, K. Sato1,
S. Kakizaki1, T. Uraoka1. 1Department of Gastroenterology and
Hepatology, Gunma University Graduate School of Medicine, Maebashi-
shi, 2Department of Gastroenterology, 3Nutrition Support Team, Takasaki
General Medical Center, National Hospital Organization, Takasaki-shi,
Japan
* Corresponding author.
Rationale: Sustained virologic response (SVR) improves anorexia and
general fatigue in chronic hepatitis C. However, nonalcoholic fatty liver
disease (NAFLD) may occur because of excessive energy intake and
lack of exercise in some patients. We conducted a retrospective study
on changes in serum lipid profiles and body composition before and
after treatment in chronic hepatitis C patients achieving SVR with
direct-acting antivirals (DAAs).
Methods: From 121 chronic hepatitis C patients achieving SVR with
DAAs in our hospital from December 2015 to October 2018, we
enrolled 23 cases whose serum lipid and body composition data were
obtained before and after treatment. Serum lipid profiles (total
cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-
density lipoprotein cholesterol (HDL-C), triglycerides (TGs)) and body
composition data from bioelectrical impedance analysis using
InBodyS10TMwere collected before and 24weeks after DAA treatment.
We compared following parameters from body composition data:
bodymass index (BMI), skeletal mass index (SMI), body fat percentage
(BFP), extracellular water/total body water (ECW/TBW) ratio, phase
angle (PA), body cell mass (BCM) before and after DAA treatment.
Changes in hepatic fibrosis markers were compared before and after
DAA treatment using fibrosis-4 (FIB4) and serum mac-2-binding
protein glycosylation isomer (M2BPGi).
Results: The mean age of patients was 63.9 ± 13.6 (1SD) years; eight
were men. Mean values of data before and after DAA treatment were :
TC (183 ± 43 → 209 ± 45 mg/dL, p < 0.0001), LDL-C (109 ± 35 → 129 ±
39 mg/dL, p < 0.0001), HDL-C (57 ± 16→ 62 ± 19 mg/dL, p < 0.0001), TG
(114 ± 40→ 116 ± 52 mg/dL, p = 0.003), BMI (23.5 ± 2.3→ 23.6 ± 2.3 kg/
m2, p = 0.543), SMI (6.52 ± 0.94 → 6.49 ± 0.88 kg/m2, p = 0.605), BFP
(32.5 ± 6.6 → 32.7 ± 6.7%, p = 0.852), ECW/TBW ratio (0.392 ± 0.086 →
0.386 ± 0.023, p = 0.179), PA (5.16 ± 0.83→ 5.15 ± 0.85, p = 0.785), BCM
(25.8 ± 4.7 → 26.0 ± 4.5 kg, p = 0.582), FIB4 (2.43 ± 1.40 → 1.89 ± 0.73,
p < 0.0001), M2BPGi (1.68 ± 1.29 → 0.92 ± 0.45 COI, p = 0.002).
Conclusions: DAA treatment significantly increased liver fibrosis
markers and affected lipid metabolism. There were no significant
changes in the patient’s body composition before and after DAA
treatment as it was a short-term observational study. However, life-
style-related diseases may cause changes in body composition in the
long term, increasing the chances of NAFLD. Hence, a careful follow-up
is needed.
Disclosure of Interest: None declared.
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ADHERENCE TO MEDITERRANEAN DIET IN CROHN’S DISEASE
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Rationale: We aimed at assessing the adherence to Mediterranean
diet (MD) in patients with Crohn’s disease (CD).
Methods: Outpatients with CD were enrolled in the protocol. Medical
history, disease activity, Inflammatory Bowel Disease Questionnaire
(IBDQ), habitual Mediterranean Diet (MedDiet) score, dietary intake
and anthropometric characteristics were assessed. Biochemical and
inflammatory indices were quantified in blood.
Results: A total of 86 patients with CD participated in the protocol [41
in relapse (5≤Harvey Bradshaw Index ≤14) and 45 in remission
(Harvey Bradshaw Index ≤4)]. Patients with inactive disease adhered
more to MD. Regression models were developed to analyze the
relationship between MedDiet score and CRP or HBI or IBDQ adjusted
for age, sex, BMI and smoking (model 1) or for sex, age, BMI, smoking,
disease duration and use of anti-inflammatory agents (model 2) as
covariates. After adjustment for age, sex, BMI and smoking (model 1),
HBI showed a highly significant negative linear association with the
MedDiet score (p < 0.001) and IBDQ showed a positive linear
association with MedDiet score (p = 0.008). These associations
remained significant even when disease duration and anti-inflamma-
tory medication entered the model (model 2).
Conclusions: Adherence to MD is associated with improved quality of
life in CD patients. Higher adherence to MD could be of importance in
patients with CD to improve quality of life and reduce disease activity.
Disclosure of Interest: None declared.
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NUTRITIONAL MODULATION OF POSTPRANDIAL FGF19 PLASMA
LEVELS IN HUMANS
E.C. Meessen1*, E.M. Kemper2, S.W. Olde Damink3, J.A. Romijn4, J.
J. Jensen5, F.G. Schaap3, M.R. Soeters6. 1Department of Endocrinology
and Metabolism, Amsterdam University Medical Centers, location AMC,
2Hospital Pharmacy, Amsterdam University Medical Centers Location
AMC, Amsterdam, 3Department of Surgery, NUTRIM School of Nutrition
and Translational Research in Metabolism Maastricht University,
Maastricht, 4Department of Internal Medicine, Amsterdam University
Medical Centers, location AMC, Amsterdam, Netherlands, 5Department of
Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway,
6Endocrinology & Metabolism, Amsterdam University Medical Centers,
location AMC, Amsterdam, Netherlands
* Corresponding author.
Rationale: Fibroblast growth factor 19 (FGF19) inhibits bile acid
synthesis and improves energy metabolism. Therefore, FGF19 gained
interest in metabolic research, but the exact role of FGF19 in
postprandial nutrientmetabolism remains enigmatic. We investigated
the plasma FGF19 levels in response to different mixed meal test
(MMT) models in healthy lean subjects in a metabolic-endocrine
framework including glucose, insulin, glucagon-like peptide 1 and bile
acids (BAs).
Methods: We assessed inter- and intra-individual variability of
postprandial FGF19 excursion (Nutridrink, Nutricia). Additionally, we
investigated the responses to short-term starvation and eucaloric
reduced meal frequency as physiological interventions. Hereafter we
examined enteral tube vs. intravenous feeding (Periolimel, Baxter).
Finally, we assessed FGF19 responses to a single dose (10 mg/kg) of
glycine-conjugated deoxycholic acid (gDCA) during a MMT.
Results: The postprandial FGF19 course showed high inter- and intra-
individual variability. Short-term starvation increased fasted FGF19
levels (0.10 [0.07] vs. 0.22 [0.40] ng/mL, after 14 and 40 hrs fasting
resp.; P < 0.05) and postprandial FGF19 levels (58.6 [44.3] ng/ml × min
vs.123.8 [124.1] ng/ml ×min; P < 0.05). A reducedmeal frequency (one
vs. threemeals per day) hadno effect onpostprandial FGF19 responses.
Postprandial FGF19 levels after an intravenous MMTwere much lower
(42.3 [31.0] ng/ml × min), but tube feeding increased the postprandial
FGF19 response (152.6 [98.8] ng/ml × min). Finally, gDCA supplemen-
tation did not affect FGF19 levels, but augmented GLP-1 release.
Conclusions: Postprandial FGF19 levels vary considerablyandmight be
theoretically driven by intestinal BAs flux. Paradoxically, both starvation
and enteral tube feeding increase FGF19 levels which may also be
explainedby intestinal BAs, or in thecaseof tube feeding, componentsof
Periolimel. Apparently, eucaloric meal reduction does not modulate
FGF19 during themeal itself despite effects on daily glucose levels. Lack
of FGF19 elevation following intravenous nutrition supports the
importance of enterohepatic cycling of BAs as trigger for intestinal
FGF19 production. gDCA may have intrinsically low FGF19 secreting
potential, possibly due to its conjugated status. Postprandial FGF19
secretion is modifiable to specific stimuli that need to be elucidated.
Disclosure of Interest: None declared.
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CONSUMPTION OF LOW PROTEIN DIET IN COMBINATION WITH
INDOMETHACIN INDUCED GROWTH FAILURE AND GUT BARRIER
DYSFUNCTION IN MICE
E. Salameh1,2*, M. Jarbeau1, F. Morel2, M. Zeilani2, P. Déchelotte3,
R. Marion-Letellier1. 1INSERM Unit 1073, Normandie Université, Rouen,
2Nutrition Department, Nutriset SAS, Malaunay, 3Nutrition Department,
Rouen University Hospital, Rouen, France
* Corresponding author.
Rationale: Severe acute malnutrition (SAM) is often associated with
an environmental enteropathy (EE). As mechanisms leading to growth
failure in EE included increased intestinal permeability ant gut
inflammation, we aimed to develop a novel murine SAM model with
these features.
Methods: Sixty C57BL/6 mice were fed with low protein (LP-5%
protein) or control diet for 3 weeks. From D14 to D21, mice daily
received Indomethacin (1 or 2.5 mg.kg−1) to induce enteropathy. Body
weight and linear growth were recorded. Gut barrier function
(intestinal permeability, jejunal tight junction proteins (occludin,
claudin-2) and inflammation (fecal calprotectin, TNFα, MCP-1)) were
assessed. Data were compared by 2-way ANOVA (LP-indomethacin)
and statistical difference between two treatment groups was calcu-
lated by using t-test or Mann-Whitney.
Results: LP diet or indomethacin treatment led to significant decreases
in body weight, linear growth, occludin mRNA levels while LP diet or
indomethacin treatment increasedMCP-1mRNA levels (P < 0.05 forall).
Combination of indomethacin at 2.5 mg.kg−1 and LP diet led to a (i)
decreased body weight (P < 0.0001), (ii) decreased linear growth
(P < 0.0001), (iii) increased gut inflammation (increased fecal calpro-
tectin level (P = 0.0012); increased jejunal MCP-1 mRNA levels
(P = 0.02), (iv) intestinal hyperpermeability (P = 0.0627 vs CT,
P = 0.0448vsLP), (v)decreased jejunal claudin-2mRNAlevels (P < 0.05).
Conclusions: This murine model exhibits (i) wasting, (ii) stunting and
(iii) enteropathy such as an increased intestinal permeability and gut
inflammation. This model may contribute to a better understanding of
the mechanisms behind the role of environmental enteropathy in
stunting.
Disclosure of Interest: E. Salameh Grant/Research Support from:
Nutriset SAS, Other: Nutriset SAS employee, M. Jarbeau: None
declared, F. Morel Other: Nutriset SAS employee, M. Zeilani Other:
Nutriset SAS employee, P. Déchelotte: None declared, R. Marion-
Letellier: None declared.
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DISEASE TREATED WITH INFLIXIMAB: PRELIMINARY RESULTS
E.I. Rabito1*, M.M.S. Cruz2, G.T.D. Silva1, P.D. Fontana3, O. Ramos Junior4.
1Nutrition, 2Posgraduate Program ata Food and Nutrition, 3Posgraduate
Program of Internal Medicine and Health Science, 4Medicine, Federal
University of Parana, Curitiba, Brazil
* Corresponding author.
Rationale: Crohn’s disease (CD) impairs nutritional status, however
the process of nutritional transition with increasing prevalence of
obesity is a worldwide reality. Very likely to affects this patients. The
aim of this studywas to identify the body composition of patients with
Crohn’s disease (CD) using Infliximab (IFX).
Methods: This is a preliminary, cross-sectional study conducted in a
tertiary hospital on patients with CD in remission phase treated with
IFX. The body composition was evaluated using anthropometric
measurements: waist circumference (WC), weight and height to
calculate the Body Mass Index (BMI). Fat mass was assessed by means
of bioimpedance, compared to the reference proposed by Lohman.
Statistical analyses were performed using SPSS® software. The t-test
was used to compare groups. The values of p≤ 0.05 indicate statistical
significance.
Results: Fourteen patients were evaluated: 8 women, age 39.3 ± 12.4
years, diagnosedwithCDfor14 ± 6.6yearsand IFX for4.7 ± 3.1years. The
BMI was 24 (19.2–29.7) kg/m2 for the whole group, while 25.2 ± 3.4 vs
23.2 ± 3.5 kg/m2 (p = 0.293) for males and female respectively. WC:
81.9 ± 12.6 cm. A high percentage of body fat was observed, with
32.3 ± 6.9% for women and 26.5 ± 5.2% for men (p = 0.111).
Conclusions: Preliminary results indicate the risk of overweight and
high percentage of fat in the sample studied is higher in relation to the
risk of malnutrition, indicating that nutritional transition process
seems also affects these patients.
Reference
Lohman TG. Advances in body composition assessment. Champaign:
Human Kinetics, 1992.
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EVALUATION OF CARNITINE FRACTION DURING LONG-TERM LATE
EVENING SNACK ADMINISTRATION IN CIRRHOTIC PATIENTS
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3Department of Statistics and Computer Science, College of Nursing Art
and Science, University of Hyogo, Hyogo, 4Department of Central
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Rationale: Our previous study suggested that Fischer ratio at
fasting in the next morning was improved by administering LES
with BCAA in patients with Cirrhosis. Carnitine is used to improve
metabolic disorder in cirrhotic patients. However, there are few
reports on carnitine fraction. Therefore, we evaluated serum
carnitine fraction during long-term LES with BCAA in patients
with liver cirrhosis.
Methods: Ten outpatients with cirrhosis were enrolled in this study.
They were outpatients without LES. The patient’s characteristics
were age, 73.1 ± 8.9 years; Male/Female, 5/5; and BMI, 23.3 ± 2.4 kg/
m2. The etiology was eight HCV and two alcoholics. Five protocols
were tested: (i) no LES (control); (ii) branched-chain amino acid
enriched enteral nutrition (LES) containing 6.1 g branched-chain
amino acid as LES each day; (iii) branched-chain amino acid
enriched granule product containing 4 g branched-chain amino
acid twice a day, and branched-chain amino acid enriched EN
containing 14.1 g branched-chain amino acid taken throughout each
day until dinner (GP without LES); and (iv) branched-chain amino
acid enriched granule product containing 4 g branched-chain amino
acids twice a day, and branched-chain amino acid enriched EN
containing 14.1 g branched-chain amino acid taken as LES each day
(GP with LES 1M); and (v) After GP with LES-1M this protocol
continued for 3 months more. (GP with LES 3M) After each protocol
(i)∼(iv) had been used for 1 month and for 3 months (v), we
measured serum carnitine fraction.
Results: Short chain carnitine tended to be higher especially in C3, C4
and C5 than the Japanese average in all periods. Medium-chain
carnitines were in the usual range. Long-chain fatty acids tended to be
low especially in C16, C18, C18: 1, however C12, C14: 1 and C18: 1-OH
tended to be high. C 0 free carnitine tended to be low. Beta oxidation
tended to increase in the period of LES, however no significant
differences were observed.
Conclusions: In patients with liver cirrhosis, changes in blood
amino acid concentrations were observed by administration of
BCAA-containing LES, but no change in serum carnitine fraction was
found.
Disclosure of Interest: None declared.
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CHANGES IN BLOOD AMINO ACID CONCENTRATIONS SPECIFIC TO
THE PERIOPERATIVE PERIOD OF HEPATIC RESECTION
H. Yamanaka-Okumura1*, S. Ueta1, M. Ishihara1, T. Katayama2,
Y. Morine3, S. Imura3, M. Shimada3. 1Department of Clinical Nutrition
and Food Management, Tokushima University, Tokushima, 2Department
of Statistics and Computer Science, College of Nursing Art and Science,
Hygo University, 3Department of Digestive and Pediatric Surgery,
Tokushima University, Tokushima, Japan
* Corresponding author.
Rationale: Hepatic resection is a curative treatment for patients with
liver cancer. Because the liver plays a central role in nutrient
metabolism in the body, it is essential to determine patients’ disease
conditions and perform nutritional management during the peri-
operative period to reduce post-hepatic resection risks. We have
previously reported that patients exhibit malnutrition following
hepatic resection compared with those before the surgery; however,
there are only a few reports on the changes in amino acid metabolism
in the body during the perioperative period of hepatic resection.
Therefore, the present study compared the changes in blood amino
acid concentrations during the perioperative period of liver, stomach,
and colon cancer resections to clarify whether the changes in amino
acid metabolism following hepatic resection are reactions specific to
hepatic resection.
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Methods:Overall, 37 patientswhohad undergone resection—13 in the
hepatic resection group, 14 in the gastrectomy group, and 10 in the
colectomy group—were included. Fasting blood samples were col-
lected the morning of the day of surgery (pre), postoperative day 3
(PO3), and postoperative day 7 (PO7), and blood tests were performed.
In addition, amino acid concentrations were measured using plasma,
whereas insulin (IRI), acylcarnitine concentrations were measured
using serum.
Results: In the hepatic resection group, isoleucine (Ile) and leucine
(Leu), which are branched-chain amino acids (BCAAs), were
significantly lower than those in the colectomy group on POD3.
Moreover, in the hepatic resection group, the aromatic amino acid
(AAA) phenylalanine (Phe) significantly increased on POD3 and
POD7 compared with the pre concentrations, whereas tyrosine
(Tyr) was significantly higher than that in the gastrectomy and
colectomy groups on POD3. Fischer’s ratio (BCAA/AAA) of the
hepatic resection group significantly decreased on POD3 and POD7
compared with the pre concentrations and was significantly lower
than that of the gastrectomy and colectomy groups on POD3 and
POD7. Propionyl carnitine (C3), the catabolic intermediate of valine
(Val) and Ile, showed no temporal and intergroup differences. In
the hepatic resection and colectomy groups, isovaleryl carnitine
(C5), the catabolic intermediate of Ile and Leu, significantly
decreased on POD7 compared with that on POD3 and C5 in the
gastrectomy group significantly increased on POD3 compared with
the pre concentration.
Conclusions: Postoperative Fisher ratio in the hepatic resection group,
suggesting a possible increase in the need for BCAA. Therefore, BCAA
administration as a late evening snack (LES) from the early
postoperative period in patients who have undergone hepatic
resection was considered desirable.
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CONSUMPTION OF HIGH ENERGY PHOSPHATE AND EFFECTS OF
NUTRITIONAL THERAPY ON LIVER REGENERATION AFTER PATIAL
HEPATECTOMY
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National Taiwan University Hospital, Taipei, 2Center for Surgical
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Rationale: Energy charge in mitochondria decreased markedly after
partial hepatectomy (PH). This study evaluates the variations of high
energy phosphate, both adenosine triphosphate (ATP), creatine
phosphate (CP); and the effects of nutritional therapy on liver
regeneration (LR) after PH.
Methods:MaleWistar ratsweighed around 200 gwere used. A 67% PH
was performed on control (C), high glucose (HG), high fat (HF), high
balanced amino acid (HA), and high branched-chain amino acid (HB)
groups rats. The intravenously (iv) nutrition solution given 2 days prior
to PH. All rats were killed at 6, 24, 48, 72 h after PH. ATP, CP, were
measured. Remnant liver weight/body weight (RLW/BW) ratio, DNA
synthetic rate, DNA content, and Mitotic index (MI) were chosen as
indicators of LR.
Results: ATP and CP in remnant liver decreased sharply after PH. DNA
synthetic rate was significantly higher in HG, HB than HF, HA, and C
groups rats 24 h after PH. RLW/BW ratio and DNA content were
significantly higher in HG, HB than HF, HA, and C groups rats 72 h after
PH. MI was higher in HG, HB than HF, HA, C groups rats 48 h after PH.
Table 1
Variations of ATP, CP, and DNA Synthetic Rate during LR after PH
Item\Time Before (C) 6 h 24 h 48 h 72 h
ATP (mmole/kg dw) 27.1 ± 3.2 12.6 ± 2.2# 15.2 ± 1.9# 19.8 ± 2.7# 25.6 ± 3.0
CP (mmole/kg dw) 14.2 ± 2.2 3.8 ± 0.8# 7.2 ± 1.0# 8.8 ± 1.1# 13.4 ± 2.0
DNA Synthetic Rate
(DPM/ug DNA)§
HG 0 r 80.1 ± 8.1* 18.2 ± 2.2 r
HF 0 r 48.3 ± 5.0# 10.5 ± 1.7 r
HA 0 r 56.2 ± 7.1 12.4 ± 1.8 r
HB 0 r 78.8 ± 8.0* 18.0 ± 2.4 r
C 0 r 64.1 ± 6.4 12.3 ± 1.8 r
§[3H]-Thymidine incorporation;
*higher than C, p < 0.05;
#lower than C, p < 0.05; r: rare.
Conclusions: Energy substrate in remnant liver including ATP, CP
decreased immediately after PH. Nutritional therapy by high glucose
and high BCAA (but not high fat, high balanced amino acid) iv solution
can increase the LR after PH.
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EFFECT OF APRAGLUTIDE, A GLUCAGON-LIKE PEPTIDE-2 ANALOG,
ON PATIENTS WITH SHORT BOWEL SYNDROME: PRELIMINARY
RESULTS FROM AN OPEN-LABEL STUDY
J. Eliasson1*, M. Hvistendahl1, R.M. Naimi1, K.A. Fuglsang1,
F. Bolognani2, C. Meyer2, P.B. Jeppesen1. 1Department of
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Rationale: Treatment with glucagon-like peptide (GLP)-2 and its
analogs have been shown to improve intestinal function in patients
with short bowel syndrome (SBS). This study investigates the safety
and efficacy of weekly dosing of apraglutide, a novel long-acting GLP-2
analog, in development for the treatment of SBS.
Methods:A total of 8 patientswill be enrolled in an open-label phase II
trial with a 5 mg once-weekly subcutaneous injection of apraglutide
for 4 weeks. Main inclusion criteria include an average fecal output
≥1500 g/day and a urine volume <2000 ml/day. We present prelim-
inary results from 3 patients. Safety was the primary endpoint. As
secondary endpoints, we examined changes from baseline in stoma
wet weight output and intestinal absorption of wet weight and energy
measured by metabolic balance studies.
Results: Common adverse events (AEs) were peripheral edema,
polyuria and stoma nipple enlargement. AEs were transient with a
mild to moderate severity. No safety concerns were observed with
laboratory values, vital signs or ECGs.We observed a decrease in stoma
wet weight output and an increase in intestinal absorption of wet
weight and energy (Table 1). Initial pharmacokinetic analysis supports
once-weekly dosing.
Table 1
Results from 3-day metabolic balance studies: Change from baseline after 4
weeks of apraglutide treatment. SBL = short bowel length.
3-day average 63-year old
female with
jejunostomy
SBL = 150 cm
61-year old
male with
jejunostomy
SBL = 140 cm
65-year old
female with
jejunostomy
SBL = 230 cm
Stoma wet weight output, g/day (%) −1533 (−28%) −1632 (−33%) −280 (−15%)
Wet weight absorption, g/day (%) 1607 (+98%) 1732 (+83%) 95 (+4%)
Energy absorption, kJ/day (%) 2164 (+34%) 3038 (+37%) 388 (+5%)
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Conclusions: Preliminary results from this open-label phase II study
showed that weekly dosing of apraglutide was safe and well tolerated
and improved intestinal absorption in patients with SBS.
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GENETIC CONDITIONS IN THE ALTERATION OF LIVER FUNCTION
TESTS IN ADULT HOSPITALIZED PATIENTS TREATED WITH
PARENTERAL NUTRITION WITH LIPIDS OF VEGETAL ORIGIN
J. Llop-Talaveron1*, E. Leiva-Badosa1, T. Lozano-Andreu1, P. Alia-Ramos2,
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Rationale: Lipid emulsions (LE) phytosterols (PS) are relevant in liver
function test (LFT) alterations. Higher phytosterolemia for T carriers of
rs41360247 from ABCG5 and C of rs4245791 from ABCG8 have been
demonstrated. Objective: determine if LFT alterations in adult
hospitalized patients were associated with phytosterolemia and
these polymorphisms.
Methods: The population included in the EudraCT N°: 2014-003597-17
clinical trial. Patients received at least 7 days of 0.8 g lipid/Kg/day of
olive/soybean LE followed by 7 days of 0.4 g/kg/day olive/soybean or
100% fish oil (omega-3 fatty acids, PS-free). Multivariate analysis was
made to study LFT variations and PS association, and its fractions, as
well as polymorphisms and their interactions (PS*SNP). The stepwise
linear regression model uses the inclusion criteria of p <0.2.
Results: 19 patients, 73.7% male, the median age of 68 years (IQR, 16)
and weight 76 kg (IQR, 8.7). 73.7% of the patients had the rs41360247-
TT genotype and 52.6% rs4245791-TT genotype.
GGT variation
B [95% CI]
AP variation
B [95% CI]
ALT variation
B [95% CI]
Betasitosterol
rs41360247
0.473 [0.074–0.873]
—
0.278 [−0.092 to 0.648]
0.533 [0.161–0.905]
0.737 [0.171–1.302]
—
Lanosterol
rs41360247
rs4245791*
lnLanosterol
0.266 [0.115–0.417]
—
—
0.150 [−0.003 to 0.304]
0.531 [0.176–0.886]
-
—
—
0.206 [0.006–
0.346]
Stigmasterol
rs41360247
rs41360247*
lnStigmasterol
rs4245791*
lnStigmasterol
—
0.151 [0.050–0.252]
—
0.589 [0.214 to 0.964]
—
0.082 [−0.020 to 0.184]
—
—
0.210 [0.060–
0.361]
CI: confidence interval; GGT: Gamma-glutamyl transferase; AP: Alkaline
phosphatase; ALT: Alanine aminotransferase; Bold indicates significance.
Conclusions: rs41360247 and rs4245791 genotype could influence in
some LFTalteration associatedwith PS in adult patients with short PN.
Studies in larger series are needed to determine the conditions in
which polymorphisms act.
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COMPARISON OF THE DEFINITION OF SARCOPENIA ON CIRRHOTIC
PATIENTS REGARDING THE EUROPEAN CONSENSUS VALUES 2010
AND 2019
J. Traub1*, I. Bergheim2, V. Stadlbauer3. 1Nutrition Department,
University Hospital Graz, Graz, 2Departement of Nutritional Sciences, RF
Molecular Nutritional Science, University Vienna, Vienna, 3Departement
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Rationale: In 2010, the European Working group on Sarcopenia in
Older People published a practical clinical definition and consensus
diagnostic criteria to identify sarcopenia. In 2019, a revised consensus
with modified criteria was published. We aimed to compare the two
definitions in a cohort of patients with liver cirrhosis. (1,2)
Methods: Over a period of 2 years, 99 cirrhotic patients were
prospectively studied. Sarcopeniawas determined bymuscle strength,
assessed by hand grip strength, muscle mass estimated by L3 psoas
muscle area from CT/MRI scans and muscle performance assessed by
gait speed. Furthermore, midarmmuscle circumferences (MAMC) was
measured. Patients were divided into 3 groups: non-sarcopenia, pre-
sarcopenia and sarcopenia using both 2010 and 2019 definitions.
Results: Based on the 2010 definition, 35/99 patient had no
sarcopenia, 29/99 were defined as pre-sarcopenia and in 35/99
sarcopenia were diagnosed. With the 2019 definition, significantly
more patients were diagnosed as non-sarcopenic (88/99), whereas
only 4/99 were diagnosed as pre-sarcopenic and 15/99 as sarcopenic
(p < 0.0001). With the 2010 definition, significantly more men were
diagnosed as pre-sarcopenic (p = 0,008) and BMI was significantly
higher in the non-sarcopenic group compared to the pre-sarcopenic
and sarcopenic group, whereaswith the 2019 definition no differences
in gender and BMI were found between the groups. Liver function did
not differ between the groups when applying either definition. MAMC
decreased significantly with increasing degree of sarcopenia in the
2010 definition (p < 0.0001), but therewas no difference betweennon-
sarcopenia and pre-sarcopenia using the 2019 definition.
Conclusions:Using the 2019 definition, it appears that pre-sarcopenia
is underestimated in liver cirrhosis. Possible reasons could be different
starting points (2010 muscle strength, 2019 muscle mass) and cut-off
values (muscle strength) of the diagnose process. To evaluate, whether
the 2010 or 2019 diagnose criteria are valid for diagnosing sarcopenia
in liver cirrhosis patients, further outcome data needs to be compared.
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M. Kontogianni1. 1Department of Nutrition & Dietetics, School of
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2Department of Gastroenterology, Medical School of National and
Kapodistrian University of Athens, Laiko General Hospital of Athens,
32nd Department of Internal Medicine, Medical School of National and
Kapodistrian University of Athens, Hippokration General Hospital
of Athens, 41st Department of Internal Medicine, 5Department of
Gastroenterology, Army Share Fund Hospital of Athens, 6Department of
Nutrition & Dietetics, Laiko General Hospital of Athens, Athens, Greece
* Corresponding author.
Rationale: In 2018, the Global Leadership Initiative on Malnutrition
(GLIM) developed diagnostic criteria for malnutrition and the
European Working Group on Sarcopenia in Older People revised the
criteria of sarcopenia diagnosis. We applied both new criteria in a
sample of cirrhotics to explore the prevalence of these conditions, as
well as potential associations with 1-year survival.
Methods: 197 cirrhotics of various etiologies and disease stages (50.8%
compensated cirrhosis, 58.9% males, age 60 ± 10.8 years) were
enrolled. For the assessment according to the GLIM criteria, non-
volitional weight loss during the past year was recorded and Body
Mass Index was computed based on dry weight. Muscle mass was
assessed with DEXA and expressed with the Appendicular Skeletal
Mass Index, and muscle strength with handgrip strength. For 109
patients, data on 1-year survival were also available.
Results: According to the GLIM criteria, 22.3% (n = 44) of the patients
were classified as malnourished. According to the sarcopenia
definition, 4.6% (n = 9) of the patients were classified as sarcopenic,
among which only 1 patient was sarcopenic obese (0.5%). There were
no statistically significant differences regarding malnutrition and
sarcopenia prevalence between the subgroup of patients with survival
data and the whole study sample. After adjusting for age, sex, disease
etiology and decompensation, malnutrition was significantly asso-
ciated with 83% lower odds of survival (OR = 0.17, 95% CI 0.05–0.67,
p = 0.011), whereas sarcopenia was marginally associated with 75.6%
lower odds of survival (OR = 0.224, 95% CI 0.05–1.24, p = 0.089).
Conclusions: In cirrhotics of different etiologies, malnutrition as
assessed by the GLIM criteria is more prevalent, compared to sarco-
penia, and is associated with reduced likelihood of 1-year survival.
Disclosure of Interest: None declared.
SUN-PO068
THE FUNCTION OF ARACHIDONIC ACID (AA)IN CHRONIC
CONSTIPATION DURING SYNBIOTICS TREATMENT
L. Huang1*, H. Qin1. 1Shanghai Tenth People Hospital, Shanghai, China
* Corresponding author.
Rationale: Clinical trial was performed to identify the changes in gut
microbial and metabolic composition during the treatment with
synbiotics in patients with functional constipation and then animal
experiment was done to verify the function of characteristic
metabolin.
Methods:
1. The clinical trial included 53 patients diagnosed with chronic
functional constipation and 53 healthy community volunteers, all
constipated patients received synbiotics treatment for 1 month.
Fecal samples were collected from all participants and analyzed
by 16S-rRNA sequencing metagenome analysis and targeted
metabonomics analysis. In additional, patients should received
the questionnaire survey (Bristol Stool Chart, Wexner scale).
2. 40 adult C57BL/6 female mice (8 weeks of age) were treated with
antibiotics and received the FMT (fecal microbiota transplant-
ation) with the faeces from the healthy (H) and constipated
individuals (C) for 8 weeks, and then C group were divided into 3
groups, one group were received the arachidonic acid treatment
for 4 weeks. in the end, whole gut transport test were performed,
intestinal and brain tissue, gut faeces were collected from the
mice.
Results:
1. Clinical effects The defecation frequency per-week was increased
after synbiotics treatment (1.98 ± 0.15 vs.7.08 ± 0.36 p < 0.001), but
it had no improvement in fecal consistency and reducing toilet
time (p > 0.05).
2. Microbial improvement: genus of Prevotella_9 was the charac-
teristic bacteria that riched in healthy individuals but decreased
in the constipation group and increased in the treatment group, [
5.66%(H) vs. 1.20% (C) vs. 3.23%(T), P = 0.69, FDR = 0.82], while
Escherichia-Shigella was riched in the constipation group and
decreased in the treatment group [(3.66%(H) vs. 5.06%(C) vs.
0.22%(T) P < 0.001, FDR = 0.004].
3. The abundance of arachidonic acid was lower in constipation
group (p = 0.04) and increased after synbiotics treatment (p =
0.03) in the clinical trial. In the mice experiment, whole gut
transit time were longer in C group after FMT in 8 weeks
(75.0 ± 9.2 vs 150.2 ± 32.2 min, p = 0.032) and arachidonic acid
treatment can decreased the whole gut transit time (150.2 ± 32.2
vs 87.2 ± 6.7 min, p = 0.041) and increased the 5-HT abundance
(p = 0.024) in intestinal tissue (ELISA test)
Conclusions: Synbiotic treatment can achieve clinical remission in
defecation frequency, and improve the microbiota and metabolic
environment in constipated patients. the supplement of arachidonic
acid may be a great way in the treatment of constipation.
Disclosure of Interest: None declared.
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A CROSS-SECTIONAL STUDY OF FACTORS ASSOCIATED WITH
ACTIVITIES OF DAILY LIVING IN DIGESTIVE CANCER INPATIENTS
A. Matsumoto1,2*, H. Nishi1,2, S. Maruyama2, Y. Kume2, H. Ueta2,
T. Enishi1. 1Department of Rehabilitation Medicine, 2Nutrition Support
Team, Tokushima Municipal Hospital, Tokushima, Japan
* Corresponding author.
Rationale: The mortality in digestive cancer patient decreased,
according to annual statistics reporting from national survey of
Japan, due to advances in early detection and treatment. With
increased digestive cancer survivor, the quality of life and activities
of daily living (ADL) has become a priority issue. The purpose of this
study is to examine the factors associated with ADL at discharge in
digestive cancer patients.
Methods: In total, 221 patients who underwent surgery due to
digestive cancer between 2015 and 2017 were analyzed. All patients
were measured with modified controlling nutritional status (CONUT)
score at admission and Barthel Index (BI) at admission and discharge
as an ADL index. We examined the relationship between BI at
discharge and characteristics, nutritional index, antibiotic use period,
and hospitalization period. Multiple regression analysis was
performed.
Results: Multiple regression analysis showed that modified CONUT
score (r =−0.73, p < 0.01), age (r = 0.58, p < 0.01), BI at admission
(r =−0.28, p < 0.01), and antibiotic use period (r = 0.41, p < 0.05) were
independent contributors to BI at discharge.
Conclusions: Malnutrition, increased age, low ADL at admission, and
infection were associated with low ADL at discharge in digestive
cancer patients. Based on these findings, improvement of nutrition
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status before admission and infection control after surgery could lead
to better ADL.
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DO PATIENTS UNDERGOING INTESTINAL CANCER SURGERY BENEFIT
FROM AN APPROPRIATE NUTRITIONAL REGIMEN IN TERMS OF
LESSENING OF POSTOPERATIVE LEAN MASS LOSS?
A. Nikolič1, D. Mlakar-Mastnak2*, B. Geršak1, N. Rotovnik Kozjek2.
1Ljubljana University Medical Center, 2Institute of Oncology, Ljubljana,
Slovenia
* Corresponding author.
Rationale: Research has shown that cancer patients undergoing
surgical treatment suffer from chronic low-grade inflammation and
are therefore at risk of malnutrition. To counteract this, individually
adapted nutritional support is used. The purpose of this study was to
evaluate the relationship between the level of chronic inflammation
before surgery and during the perioperative period, and the
development of loss of lean mass 1 month after operation in patients
with an early start of nutritional support.
Methods: Between november 2018 and april 2019, we enrolled 62
cancer patients who underwent intestinal surgery at the Institute of
Oncology Ljubljana, Slovenia.
As a marker for preoperative chronic inflammation, absolute CRP
values were used. As an estimate of the inflammatory state during the
entire perioperative period, the mean between preoperative and
postoperative absolute CRP values was used. Relative change in the
FFMI was used to evaluate the progress of lean mass loss.
FFMI was measured using bioelectrical impedance analysis shortly
before the procedure, and 1 month after the procedure, while CRP
values were concurrently obtained.
Patients at nutritional risk received preoperative and postoperative
nutritional care, provided by a nutritional support team as part of
routine clinical practice.
Results: Between preoperative CRP values (stdev = 22.795, shapiro-
wilk p-value = 9.359 × 10−12, 79.032% of values in lowest 1/6 of
observed range) and the relative change in FFMI (stdev = 0.0719), we
observed a Pearson correlation of 0.359 (p-value = 0.004).
Between mean perioperative CRP values (stdev = 26.357, shapiro-wilk
p-value = 3.134 × 10−11, 77.419% of values in lowest 1/6 of observed
range) and the relative change in FFMI, we observed a Pearson
correlation of 0.393 (p-value = 0.002).
Conclusions: The data shows that patients with low inflammatory
states, both preoperativelyand in the entire perioperative period, show
some degree of lean mass loss, as is already known, in spite of an
individually planned nutritional regimen.
Interestingly, in patients with higher inflammatory states, the degree
of lean mass loss seems to be lower. This may be due to malnourished
patients in a higher catabolic state receivingmore intensive nutritional
support. It may also simply be the result of a considerably lower
sample size in this patient group.
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EFFECTSOFORALDHASUPPLEMENTATION INMODULATINGSERUM
EPOXYDOCOSAPENTAENOIC ACID LEVELS IN BREAST CANCER
PATIENTS
A. Molfino1*, M.I. Amabile1, C. Ramaccini1, L. Lionetto1, A. De Luca1,
A. Spagnoli1, M. Simmaco1, M. Monti1, M. Muscaritoli1. 1Sapienza
University of Rome, Rome, Italy
* Corresponding author.
Rationale: The omega-3 polyunsaturated fatty acids, as docosahex-
aenoic acid (DHA), are considered mediators for resolution of
inflammation during cancer and possibly associated with better
outcomes. Metabolites of the DHA, as the epoxydocosapentaenoic
acids (EDPs), are hypothesized to be responsible for some of DHA
beneficial effects. We aimed to assess the circulating 19,20-EDP levels
in breast cancer (BC) patients and in healthy controls before and after
oral DHA supplementation and the potential differences in the DHA
conversion in 19,20-EDPs between patients with different BC
presentations.
Methods: BC patients and healthy controls were supplemented with
DHA in form of algal oil for 10 days (2 g/day). Blood samples were
collected at baseline (T0) and after supplementation (T1) to assess
19,20-EDP serum levels by liquid chromatography spectrometry.
Results: 33 BC patients and 10 healthy controls were studied. EDP
values at T0 were not different between patients and controls. At T1,
we found an increase in 19,20-EDP levels in BC patients (P < 0 00001)
and in controls (P < 0 001), whereas no differences in 19,20-EDPs were
present between the two groups; when considering the type of BC
presentation, patients with BRCA1/2 mutation showed lower 19,20-
EDPs levels with respect to BC patients without the mutation (P = 0
03). According to immunohistochemical subtype, luminal A-like BC
patients showed at T1 higher 19,20-EDP levels compared to non-
luminal A (P = 0 02).
Conclusions: Oral DHA supplementation was associated with
increased 19,20-EDP serum levels in BC patients, independent of the
type of BC presentation, and in controls. Patients carrier of BRCA1/2
mutation seemed to possess lower ability of DHA epoxidation,
whereas luminal A-like BC patients showed higher EDP conversion.
This pattern should be further investigated in a larger population.
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EFFECTS OF NUTRITIONAL INTERVENTION ON SURVIVAL IN
ONCOLOGY PATIENTS
A. Hernández-Moreno1*, A. Vidal-Casariego1, B. Pintor-De la Maza1,
C. Guindel-Jiménez2, A. Calleja-Fernández1, M. Pedraza-Lorenzo3,
A. Rodríguez-García3, I. Cano-Rodríguez1, M.D. Ballesteros-Pomar1.
1Endocrinology&Nutrition, 2Hospital Pharmacy, 3Medical Oncology,
Complejo Asistencial Universitario de León, León, Spain
* Corresponding author.
Rationale:Malnutrition can reduce survival of oncology patients. The
aim of this study was to detect the effect of early detection of
malnutrition and early nutritional intervention on survival.
Methods: Patients with solid tumors undergoing chemotherapy
treatment and with Malnutrition Screening Tool≥ 2 were referred to
the Nutrition Unit (NU) from February 2013 to June 2016 (intervention
group, IG). We compared survival of this group of patients with those
with solid tumors treated with chemotherapy before implementing
the nutritional screening (control group, CG), referred or not to the NU.
Nutritional counseling was given to all the patients and nutritional
treatment was prescribed according guidelines. Survival was assessed
with Kaplan-Meier analysis and Cox regression.
Results: 106 patients were included in the IG and 167 patients were
included in the CG (43 submitted to the NU without nutritional
screening). Therewere no significant differences in age, gender, weight
and weight loss before chemotherapy treatment, primary tumor
location and tumor stage between groups.
Mortality was higher in the CG (63.5% vs 58.5%; p = 0.044). Comparing
survival between groups stratifying in CG by submission or not to the
NU we found that survival was: 28 (SE 6.1) months in IG, 42 (SE 6.6)
months in CG not referred and 17 (SE 3.5) months in CG referred to the
NU (HR = 1.00, 95%CI 0.85–1.19; p = 0.971).
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Finally, we compared survival between IG and patients in CG that were
not submitted to the NU, andwe found amedian survival of 28 (SE 8.6)
months in IG and 39 (SE 5.6) months in these patients of the CG
(HR = 1.02, 95%CI 0.72–1.45; p = 0.925).
Conclusions: Early nutritional intervention increases survival in
oncology patients, although a higher simple size is needed to
determine if the differences are statistically significant.
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MUSCLE MASS AND MUSCLE STRENGTH IN ONCOLOGY PATIENTS
AFTER NUTRITIONAL INTERVENTION
A. Hernández-Moreno1*, B. Pintor-De la Maza1, C. Guindel-Jiménez2,
A. Vidal-Casariego1, A. Calleja-Fernández1, M. Pedraza-Lorenzo3,
A. Rodríguez-García3, I. Cano-Rodríguez1, M.D. Ballesteros-Pomar1.
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* Corresponding author.
Rationale: Malnutrition is highly prevalent in oncology patients and
its etiology is multifactorial. The aim of this study was to detect the
impact of nutritional intervention on body composition (BC) and
muscle strength in oncology patients.
Methods: Patients with solid tumors undergoing chemotherapy
treatment and with Malnutrition Screening Tool≥ 2 were referred to
the Nutrition Unit from February 2013 to June 2016. A BC analysis,
hand-grip strength test and 24-h dietary recall were performed.
Nutritional counseling was given to all patients in the first visit (V1)
and nutritional treatment was prescribedwhen needed.We compared
changes in BC and muscle strength between the first and second visit
(V2), as well as dietary intake.
V1 V2 p
value
Muscle mass (kg) 49.9(10.3)* 48.7(8.7)* 0.234
Muscle mass index (kg/m2) 18.2(2.3)* 18.4(2.3)* 0.156
Hand-grip strength (kg) 26.0(14.8)** 26.5(12.35)** 0.017
Intake (kcal) 1755.5(573.1)* 2175.8(750.8)* <0.001
Carbohydrates (g) 199.2(372)** 228.9(541.8)** <0.001
Carbohydrates (%) 47.5(10.0)* 44.9(9.0)* 0.034
Protein (g) 71.7(171.4)** 88.6(167.7)** <0.001
Protein (%) 17.0(4.2)* 16.5(3.9)* 0.345
Protein (g/kg) 1.11(0.62)** 1.37(0.58)** <0.001
Fat (g) 69.5(29.4)* 93.3(40.1)* <0.001
Fat (%) 35.5(8.4)* 38.6(8.4)* 0.003
*mean (SD);
**median (IQR).
Results: 106 patients were included. Median agewas 68.5 (15.3) years
and 60.4% were male. Their weight loss before chemotherapy
treatment was 8.2 (SD 6.0) kg [11.0% (SD 7.5%)]. Colorectal tumors
were the most frequent (43.4%). 24.5% patients received radiotherapy
treatment and in 63.2% surgery was also performed. Median time
between V1 and V2 was 8 (IQR 11) weeks.
No statistically differences were found between V1 and V2 on weight
[63.6 (SD 11.8) vs 64.4 (SD 11.2) kg; p = 0.425], BMI [23.8 (SD 4.4) vs
24.5 (SD 4.2) kg/m2; p = 0.139] and fat mass [16.2 (SD 8.0) vs 15.9 (SD
7.2) kg; p = 0.797].
Therewere no differences in BC, dietary intake and hand-grip strength
according to primary tumor location or tumor stage.
Conclusions: Nutritional intervention increases energy and protein
intake, which has a positive effect on hand-grip strength.
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NUTRITIONAL STATUS AND MUSCLE FUNCTION IN PRE-
CHEMOTHERAPY PATIENTS
C.A. Santos1*, A.T. Barata1, C. Ferreira2, G. Nunes1, J. Fonseca1,
H. Mansinho3. 1GENE – Enteral Nutrition Group, Hospital Garcia de
Orta, 2Health Economics, Nova School of Business and Economics, 3Head
of Oncology, Hospital Garcia de Orta, Lisboa, Portugal
* Corresponding author.
Rationale: Malnutrition in cancer patients is multifactorial, encom-
passing tumor/host interactions, anorexia, systemic inflammatory
responses, and changes in nutrient metabolism with increase in
energy expenditure. These factors contribute to weight loss, sarcope-
nia and cachexia. Malnutrition prevalence is estimated to be between
45 and 60%, being associated to increase in complications, impaired
treatment tolerance and response, decreased quality of life and
increased mortality. In this context, loss in muscle function poses
grave consequences in loss of functions and increased morbimortality.
Our aim is to describe and assess the relationship between nutritional
status and muscle function in pre-chemotherapy patients.
Methods: Cross-sectional observational study conducted in neoplasia
patients followed in Hospital Garcia de Orta, before chemotherapy.
Nutritional status was assessed with Patient Generated Subjective
Global Assessment (PG-SGA) and BodyMass Index (BMI). To determine
muscle function, Handgrip Dynamometry was employed (HGD).
Results: Fifty (50) patients were evaluated. According to BMI, 16%
presented low weight; with HGD, 18% presented low handgrip
strength. In PG-SGA classes, most patients (60%) were malnourished.
Mean PG-SGA score was 8, pointing to need for nutritional
intervention. Nutritional status was defined by BMI and PG-SGA was
not significantly correlated to muscle function (p = 0,66; p = 0,07).
Conclusions: According to PG-SGA, 60% of patients were malnour-
ished. No statistically significant correlation between PG-SGA, BMI and
muscle function was found. The present study reinforces the
importance of early nutritional assessment through adequate tools,
so as to revert or mitigate the negative impact of malnutrition.
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NUTRITIONAL MANAGEMENT IN PATIENTS WITH SUGARBAKER’S
PROCEDURE
A. Gutierrez Lizarazu1*, P. Yarnoz Esquiróz2, C. Silva Froján3, M. Riestra
Vázquez2, C. Lacasa Arregui1. 1Pharmacy, 2Area of Nutrition,
3Endocrinology, Clinica Universidad de Navarra, Pamplona, Spain
* Corresponding author.
Rationale: Peritoneal carcinomatosis (PC) is associated with high
morbidity and there is a direct relationship between nutritional status
and the presence of complications in the Sugarbaker’s procedure
(SBP).
Methods: A retrospective study from 2012 to 2019 of the nutritional
management of SBP patients was done. Anthropometric and analytic
parameters (albumin, prealbumin, limphocytes, …), chemotherapy
and tumor type prior to the interventionwere used for the diagnosis of
protein malnutrition following the spanish consensus.
In the postoperative follow-up, parenteral nutrition (PN) composition,
days in intensive care unit (ICU), total hospitalization days and
postoperative complications were studied. Statistical analysis was
done with Stata®12.0.
Results: Fifty-four patients received PN with a mean age of 60.1
(SD = 11.3) years and mean body mass index (BMI) of 25.2 (SD = 4.0)
kg/m2. Colorectal (n = 27) and gastric (n = 13) were the most common
cancer types. Protein malnutrition was observed in a total of 35
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patients, 13 (72.2%) of those had a BMI >25 kg/m2. Complications were
recorded in 61% of the total patients.
No statistically significant differences were found between malnutri-
tion and hospitalization days or complications.
The average composition formula per kilogram daywas 1.7 g of Amino
acids, 3.6 g of carbohydrates and 1 g of lipids. The median duration of
the PN and of the total hospitalization and ICU dayswere 8 (4–47); 21.8
(4–80) and 17 (2–54), respectively.
When the NP was stopped, the oral intake was at least 60% of the
calculated total energy requirements (TER) in 46% of the patients.
Conclusions: Protein malnutrition has high prevalence 72.2% in
patients with PC despite BMI >25 kg/m2.
The relationship between malnourished patients and worse clinical
outcomes could not be found.
The macronutrient composition of PN is similar to the nutritional
requirements in critically ill patients.
The transition between PN and oral intake should be donewhen the 2/
3 of TER are tolerated.
Disclosure of Interest: A. Gutierrez Lizarazu Other: Nothing to
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THE IMPACT OF PREOPERATIVE NUTRITIONAL SUPPORT IN
PATIENTS WITH GASTROINTESTINAL CANCER QUALIFIED FOR
SURGERY FOR EARLY TREATMENT RESULTS
M. Lewicka1, M. Nartowicz1, A. Sobańska1*, K. Gruszecka1,
M. Jankowski1, K. Tkaczyński1, D. Wisńiewski1, W. Zegarski1.
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Copernicus University, Bydgoszcz, Poland
* Corresponding author.
Rationale:Malnutrition affects more than half of patients at the time
of diagnosis, before any therapy is started. It is one of the causes of a
weaker response to the anti-cancer treatment and more frequent
occurrence of adverse effects and serious complications of anti-cancer
therapy, which force medical team to prematurely terminate it. The
aim of the study was to evaluate the effect of 14-days preoperative
supplementation using high protein diet before surgery for selected
biochemical parameters and treatment outcomes (number and type of
postoperative complications), as well as duration of hospitalization in
patients undergoing cancer resection.
Methods: 14 days prior the admission to the Clinic patients recived
high protein diet, Novasource GI Advance in addition to normal diet.
Nutritional assessment was done based on biochemical and anthropo-
metric measurements and NRS, SGA questionnaires. After recruitment
to the research group, the patients from complementary groups who
did not receive pre-operative nutritional supplementation were
analyzed. Groups were not significantly different in demography,
surgery type or diagnosis.
Results: 62 patients were qualified to the research group. The size of
the control group was 60. Both the total hospitalization time (13.7 vs
16.9 days) and the time of hospitalization after surgery (8.8 vs 12.9) in
the research group were lower (p < 0.05). There was also a decrease in
number of septic complications in the group consuming supplement
(8 vs 16). There were no significant differences in the results of NRS/
SGA questionnaires, the duration of ICU stays and the duration of
antibiotic therapy.
Conclusions: The study shows benefits of preoperative nutritional
support in patients with gastrointestinal cancer qualified for surgery
for early treatment results, however, more research is still needed.
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PATIENTS UNDERGOING ALLOGENIC STEM CELLTRANSPLANTATION
SUFFER FROM POOR NUTRITIONAL STATE DESPITE
SUPPLEMENTATION
A. Hendricks1*, K. Treiber1, P. Dreger2, P. Nawroth1, T. Luft2, U. Zech1.
1Department of Endocrinology and Metabolism, 2Department of
Hematology, Oncology and Rheumatology, Heidelberg Univeristy
Hospital, Heidelberg, Germany
* Corresponding author.
Rationale: Inadequate food intake, muscle wasting, chemotherapy,
and multiple complications are common in hematologic oncologic
patients undergoing allogenic stem cell transplantation (SCT), lead to
poor nutritional state and decrease overall survival. We studied in
patients listed for SCT, whether despite nutritional routine care the
nutritional state continued to decrease.
Methods: The interim analysis of a prospective observational study
included 61 patients with AML, ALL, or MDS and indication for SCT.
Patients were recruited before SCT with a one-year follow-up. Body
weight, weight loss, hand grip strength, nutritional intake, and enteral
(ONS)/parenteral (PN) supplementation has been obtained before, 30,
90, and 365 days after SCT.
Results: Mean age at time of enrollment was 55.4 ± 12.7 years, the
average BMI was 26.7 ± 5.4 kg/m2. During follow-up, 15 patients (25%)
died and 8 (13%) dropped out. Body weight decreased from 84.1 ±
19.1 kg 6 month before to 73.3 ± 14 kg one year after SCT (p < 0.001).
Hand grip strength decreased after 30, 90 (both 30.5±kg; p < 0.001),
and 365 days (31.6 ± 11.8 kg; p = 0.009) compared to data before SCT
(34.4 ± 12.5 kg). The severity of weight loss before SCT correlated with
a decrease in handgrip strength in all study visits after SCT (p < 0.001).
20 patients (33%) before SCT, 37 patients (71%) around the time of SCT,
and 24 patients (50%) after SCT indicated to eat less than 75% of their
normal portion size, although 14 patients (23%) before SCT and 31
patients (60%) after SCT received nutritional supplements. Around
hospitalization for SCT, 11 patients (20%) received ONS, 12 patients
(22%) PN, and 18 patients (33%) received both.
Conclusions: Although hematologic SCT patients receive nutritional
supplements, results show poor nutritional state and high mortality.
Routine nutritional care is not sufficient. An intervention study
comparing routine with individualized care is needed.
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HOME PARENTERAL NUTRITION IN ADVANCED OVARIAN CANCER:
MAKING AND IMPLEMENTING THE DECISION
A.M. Sowerbutts1*, S. Lal2, J. Sremanakova1, A.R. Clamp3, G.C. Jayson3,
A. Teubner2, L. Hardy4, C. Todd1, A.-M. Raftery3, E. Sutton5, S. Burden1.
1Division Nursing, Midwifery and Social Work, School of Health Sciences,
University of Manchester, Manchester, 2Salford Royal Hospital, Salford,
3The Christie NHS Trust, 4Manchester University NHS Foundation Trust,
Manchester, 5University of Bristol, Bristol, United Kingdom
* Corresponding author.
Rationale: Increasingly, patients with advanced ovarian cancer in
bowel obstruction are receiving home parenteral nutrition (HPN). HPN
is contentious in this sitution as it may increase the burden onpatients
with palliative needs and little is known about the decision making
process. The aimof this studywas to explore howdecisions forHPNare
taken and to investigate barriers and facilitators to implementation.
Methods: This was a qualitative study underpinned by phenomen-
ology. Ninety-three longitudinal in-depth interviewswere undertaken
with 20 patients with advanced ovarian cancer in bowel obstruction
receiving parenteral nutrition, their relatives and healthcare profes-
sionals over 14 months. Participants were interviewed a maximum of
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four times. Interview transcriptswere analysed thematically guided by
the techniques of Van Manen [1].
Results: We found variance between oncologists and patients
regarding ownership of the decision for HPN. The oncologists believed
they were engaging in shared decision making, whereas patients felt
that the decisionwas driven by the oncologist. Nevertheless they were
content to have the treatment as they viewed the choice as HPN or
death.
The principalmutable barrierwas difficulties in communication across
professional disciplines and organisations. Facilitators to a timely
discharge included developing single point of contact between
organisations, improving communication and implementing standar-
dised clinical and operational processes.
Conclusions: Oncologists and patients differ in their perceptions of
how treatment decisions are made. Although patients are satisfied
with the process, it may be beneficial for healthcare professionals to
ratify patients’ understanding of treatment.
Reference
1. Van Manen M. (1990). Researching lived experience: Human science
for an action sensitive pedagogy. Ont.: Althouse Press.
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ANXIETY LEVEL, DIETARY INTAKE, AND NUTRITIONAL STATUS OF
PEDIATRIC CANCER PATIENTS UNDERGOING CHEMOTHERAPY IN
YOGYAKARTA, INDONESIA
A. Ermamilia1*, B. Aulia1, S. Mulatsih2. 1Department of Nutrition and
Health, Universitas Gadjah Mada, 2Department of Pediatrics, Sardjito
Central General Hospital, Yogyakarta, Indonesia
* Corresponding author.
Rationale: Cancer treatment may trigger the feeling of worry and fear
in childrenwhich can result in decreased dietary intake. As nutritional
status plays a pivotal role in determining the prognosis of cancer,
factors such as anxietyand dietary intake that contribute to nutritional
status need to be identified.
Methods: Anthropometric data were collected from a total of 85
pediatric cancer patients undergoing chemotherapy at Dr. Sardjito
Hospital, Indonesia. Dietary intakes were assessed using 2 × 24 hour
recall questionnaire and data were compared to individual needs to
determine nutritional adequacy. Supporting data associated with
treatment and food intake were collected from medical records or by
interviewing patients using questionnaire. Assessment of anxiety was
performed using Indonesian translated version of PROMIS Parent
Proxy Short-Form v2.0 for Anxiety questionnaire that had been
validated prior to the study.
Results: Around sixty percent of the children had normal nutritional
status according to BMI for age, while 23.6% others were underweight
and 16.5% others fell into overweight or obese category. Inadequate
energy, fat, and carbohydrate intakes were found in approximately a
third of the patients (29.4–37.6%). No statistically significant correl-
ation between nutritional status and dietary intake were found
(p > 0.05). Anxiety level was not correlated with nutritional status
(p > 0.05), even though moderate to severe anxiety levels were
observed in 33.3% of patients. A small negative correlation was found
between anxiety level and carbohydrate intake (r =−0.23, p = 0.04).
Patients with nausea or vomiting were found to present more with
inadequate energy intake than those with no such symptoms (χ2
[n = 73] = 6.68, p = 0.035).
Conclusions: In this study, anxiety level was not correlated with
dietary intake of patients except for carbohydrate. Nausea or vomiting
was associated with energy adequacy which signified the need to
address this problem in nutrition intervention.
Disclosure of Interest: None declared.
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WHEY PROTEIN WORSENS SURVIVAL OF MICE WITH
CARCINOMATOUS PERITONITIS BY ENHANCING PD-1 RECEPTOR
EXPRESSION ON CD8+T CELL
A. Watkins1*, K. Fukatsu1,2, M. Noguchi2, K. Higashizono1,3,
S. Murakoshi1. 1Surgical Nutrition and Metabolism, Graduate School of
Medicine, The University of Tokyo, 2Surgical Center, The University of
Tokyo Hospital, 3Gastrointestinal Surgery, The University of Tokyo Surgical
Cente, Tokyo, Japan
* Corresponding author.
Rationale: Whey protein (WP) is now expected to improve host
response against various surgical stress. However, its effects on cancer
progression remain unclear. Here, we investigated a WP rich diet on
cancer immunity using a murine Panc02 induced carcinomatous
peritonitis model.
Methods: Exp. 1 Male C57BL/6J mice (8 weeks old, n = 32) were fed a
casein diet (CD, n = 16), or whey protein diet (WPD, n = 16). On day 7,
Panc02 cancer cells (1 × 106/body) were inoculated i.p. Survival was
monitored for 46 days.
Exp. 2: Mice (CD; n = 13, WPD; n = 13) subject to the same protocol as
in Exp.1 were killed on day 35. All peritoneal cancer nodules were
harvested and weighed. Immune cells in the peritoneal cavity and
tumor nodules were analyzed by flow cytometry to detect CD8
positive T cells and Natural Killer (NK) cells as anti-tumor immune
cells, then regulatory T cells (Treg) and the expression of programmed
cell death 1(PD-1) on CD8 positive T cells as key components of
immune evasion of cancer cells.
Results:WPworsened survival and increased PD-1 expression on CD8
positive T cells in cancer nodules as compared with CD.
WPworsened survival and increased PD-1 expression on CD8 positive
T cells in cancer nodules as compared with CD.
CD WPD
Survival (days) 38.2 ± 0.8 35.3 ± 0.9*
Tumor (g/body) 1.46 ± 0.1 1.59 ± 0.1
Peritoneal washing CD8+ T cell (×106) 3.4 ± 1.1 4.0 ± 1.2
NK cells (×105) 7.5 ± 2.7 4.2 ± 1.1
Treg (×105) 4.7 ± 1.6 5.3 ± 2.0
PD-1+ CD8 T cells (%) 3.0 ± 0.7 2.9 ± 0.5
Cancer nodules CD8 T cells (×105) 7.9 ± 1.4 6.6 ± 1.1
NK cells (×106) 1.1 ± 0.2 1.1 ± 0.2
Treg (×105) 1.0+0.2 1.1 ± 0.1
PD-1+ CD8 T cells (%) 3.6 ± 0.4 5.1 ± 0.5†
Mean±SE
*p < 0.05 vs. ND, log-rank test, †p < 0.05 vs. ND, t-test
Conclusions: Use of WP in cancer patients might worsen prognosis
through PD-1 expression on CD8 positive T cells.
Disclosure of Interest: None declared.
S88 Abstracts / Clinical Nutrition 38 (2019) S59–S296
SUN-PO081
EFFECTS OF DIFFERENT TYPES OF LOW-CARBOHYDRATE HIGH-FAT
DIETS ON CANCER IMMUNE EVASION THROUGH PD-1 EXPRESSION
A. Watkins1*, K. Fukatsu1,2, M. Noguchi2, K. Higashizono1,3,
S. Murakoshi1,2. 1Surgical Nutrition and Metabolism, Graduate School
of Medicine, University of Tokyo, 2Surgical Center, 3Gastrointestinal
Surgery, University of Tokyo Hospital, Tokyo, Japan
* Corresponding author.
Rationale: In patients with advanced cancer, nutritional management
is recommended to control carbohydrates and increase the ratio of
lipids (ESPEN guidelines on nutrition in cancer patients, 2016).
However, we previously found a lard-based low-carbohydrate high-
fat diet (LCHFD) to worsen anti-cancer immunity and survival
compared to a normal diet (ND) in a murine Panc02 pancreatic
cancer peritonitis (CP) model. Continued research showed that LCHFD
rich in soy oil produced an even worse outcome, while fish oil
supplemented LCHFD (ω6/ω3 = 2.1) maintained cancer immunity and
improved survival. In recent years, immune checkpointmolecules such
as programmed cell death protein 1 (PD-1) has been shown potent
immunomodulatory effects on cancer treatment. Since PD-1 receptor
expression on CD8+ T cell has been demonstrated to cause cancer
immune evasion, we examined influences of an ND and three types of
LCHFD (lard, soybean oil, fish oil) on its expression in the CP model.
Methods:Male C57BL/6J mice (8 weeks old, n = 46) were fed a normal
diet (ND), fish oil-containing LCHFD (HF-F), soy oil-based LCHFD (HF-
S) or lard-based LCHFD (HF-L). Each LCHFD contained 60% energy from
fat, 20% from protein and 20% from carbohydrate. On day 7, Panc02
cancer cells (1 × 106/body)were inoculated i.p. Themicewere killed on
day 35. Peritoneal washings and visible tumor nodules were collected
from eachmouse. The PD-1 receptor expression ratio in CD8 positive T
cells in the peritoneal washing and tumor were evaluated by flow
cytometry.
Results: The PD-1 receptor expression was higher in the peritoneal
washing in the HF-S group and lower in the tumor infiltrating CD8
positive T cells in the HF-F group than in the ND group. The HF-F group
maintained CD8+ Tcell number in the tumor compared to theHF-S and
HF-L groups.
Peritoneal
washing
Tumor
CD8+ T cells
(×105)
PD1+ CD8+
Tcells (%)
CD8+ T cells
(×105)
PD1+CD8+
Tcells (%)
ND 2.0 ± 0.7 59.1 ± 4.6 6.2 ± 1.6 86.2 ± 1.7
HF-F 3.7 ± 0.7 59.9 ± 2.6 7.1 ± 0.8 78.5 ± 3.8*
HF-S 2.9 ± 0.6 74.4 ± 1.7* † 4.2 ± 0.3† 87.9 ± 1.6
HF-L 2.3 ± 0.5 65.4 ± 4.8 4.2 ± 0.5† 84.4 ± 1.4
Mean ± SE, *p < 0.05 vs. ND, †p < 0.05 vs. HF-F
Conclusions: It appears that influences of the soybean or fish oil rich
diet on cancer immunity are mediated by modulation of PD-1
expression. The present data may suggest that, when administering
LCHFD to cancer patients, we should pay attention to the impact of the
type of fat on cancer immunity.
Disclosure of Interest: None declared.
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FEASIBILITY, SAFETYAND PROGNOSTIC FACTORS IN PATIENTSWITH
ESOPHAGEAL CANCER UNDERGOING ENDOSCOPIC GASTROSTOMY
C.A. Santos1*, A. Laranjo1, M. Brito1, G. Nunes1, J. Fonseca1. 1GENE –
Enteral Nutrition Group, Hospital Garcia de Orta, Lisboa, Portugal
* Corresponding author.
Rationale: Esophageal cancer (EC) is an important health problem
worldwide with high morbidity and mortality. Patients with EC are
likely to develop malnutrition. Nutritional support plays an important
role on the disease management. The aim of this study was to assess
the feasibility and safety of endoscopic gastrostomy (PEG) feeding in
EC cancers and to identify risk factors associated with poor prognosis.
Methods: A retrospective observational study was performed using
records from EC patients referred to gastrostomy. Age, gender,
histologic subtype cancer, indication for gastrostomy and mortality
data were recorded. NRS 2002, body mass index (BMI), hemoglobin,
serum albumin, transferrin and total cholesterol were collected at the
day of PEG.
Results: Data from 41 EC patients (36 men and 5 women) aged 39–88
years (mean 62 years). 37 patients were diagnosedwith squamous cell
carcinoma (6 of themwith hypopharynx invasion) and 4 patients with
adenocarcinoma. Gastrostomy was possible in all patients referred to
PEG (27 patients selected for curative treatment and 14 patients for
palliative nutrition). No major complications occurred. Mean survival
after PEG was 18.1 months and mortality rate at 3 months was 31.7%.
The majority of the patients (34; 82.9%) died with PEG. In 7 patients
(17.1%), PEG tubewas removed due to adequate oral intake. Mean BMI
was 21.3 Kg/m2 and 34.1% patients displayed low BMI. Anemia in 17
patients (41.5%). Serum albumin, transferrin and total cholesterol were
low in 10 (24.4%), 20 (48.8%) and 18 (43.9%) patients, respectively.
Higher BMI (R = 0.30), serum albumin (R = 0.41) and transferrin
(R = 0.47) tend to be positively correlated with survival (p < 0.05).
Conclusions: PEG is a feasible and safe technique for enteral feeding in
EC patients. Higher BMI, serum albumin and transferrin levels at
admission predict a better outcome. Enteral feeding through PEG
should be early considered in EC patients due to higher risk of
malnutrition, which is associated with shorter survival.
Disclosure of Interest: None declared.
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NUTRITIONAL STATUS, FUNCTIONAL STATUS ANDQUALITYOF LIFE –
WHAT IS THE IMPACT ON CANCER PATIENTS?
C.A. Santos1*, I. Santos2, L. Mendes3, C. Ferreira4, H.Mansinho5. 1GENE –
Enteral Nutrition Group, 2Hospital Garcia de Orta, 3ESTeSL, ESTeSL,
4Health Economics, Nova School of Business and Economics, 5Head of
Oncology, Hospital Garcia de Orta, Lisboa, Portugal
* Corresponding author.
Rationale: Malnutrition is common in cancer patients and multifac-
torial, combining the systemic inflammatory process with decreased
food intake, loss of muscle and bone mass, and decreased functional
status. Failure to identify malnutrition leads to poor prognosis with
increased morbimortality, length of stay and health care costs as well
as decreased response and tolerance to treatments, functional status,
and quality of life. Our aims was track and evaluate the nutritional
status of cancer patients. Associate results between hospitalization
and Day Hospital (DH). Associate nutritional status and symptoms
with nutritional impact. Associate nutritional status with tumour
location and functional status.
Methods: Cross-sectional observational study in hospitalized patients
or DH from Hospital Garcia de Orta, over 18 years old. Nutritional
status was monitored through NRS-2002 and evaluated through the
Patient-Generated Subjective Global Assessment (PG-SGA) and
anthropometric and biochemical parameters. Body Mass Index (BMI)
was used for weight classification. Functional status was assessed
using the Eastern Cooperative Oncology Group (ECOG), Karnofsky
Performance Scale Index scales and handgrip dynamometer. The
tumour type/location was also identified by TNM classification to
verify the prevalence associated with malnutrition.
Results: We included 170 patients (65 hospitalized and 105 in DH),
mean age of 65,6 ± 12,9 years [29–90]. 32% of hospitalized patients and
S89Abstracts / Clinical Nutrition 38 (2019) S59–S296
14% in DH had low BMI. From the NRS-2002, 88% and 36% of the
patients were respectively at nutritional risk, and by PG-SGA, 92% and
41%, respectively, were malnourished. In the malnourished patients’
tumours located in the lymph nodes, lungs, colon, bone marrow and
stomach prevailed. NRS-2002 and PG-SGA score were positively
correlated with ECOG score (p < 0.01 for DH; p < 0.05 for hospitalized)
and negatively correlated with Karnofsky score (p < 0.01). PG SGA
correlation was stronger than NRS-2002.
Conclusions: PG-SGA, as well as functional status scales, have proven
to be the appropriate and validated tools for early identification of
malnutrition and functional status in cancer patients. In addition,
handgrip dynamometer can be a useful tool for assessing functional
and nutritional status.
Disclosure of Interest: None declared.
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EFFECTS OF RADIOTHERAPY-RELATED SYMPTOMS ON THE
NUTRITIONAL STATUS OF HEAD AND NECK CANCER PATIENTS
C.A. Gottschall1*, A.P. Kropidlofscky2, J.L. Ricardi3, E.I. Rabito4.
1Graduate Program in Nutrition Sciences, Federal University of Health
Sciences of Porto Alegre, 2Nutrition, Moinhos de Vento Hospital,
3Nutrition, Federal University of Health Sciences of Porto Alegre, Porto
Alegre, 4Nutrition, Federal University of Paraná, Curitiba, Brazil
* Corresponding author.
Rationale: Cancer of head and neck has a high mortality rate,
undernutrition is considered as one of the most serious problems
among cancer patients. increased morbimortality. The aim of this
study was to evaluate symptoms, dietary intake, and nutritional and
functional status of head and neck cancer patients undergoing
radiotherapy.
Methods: This was a qualitative, longitudinal study on adult patients
with head and neck cancer in a tertiary hospital at Porto Alegre (Rio
Grande do Sul, Brazil), whowere assessed at three time points: at first,
third, and last (sixth) week of radiotherapy. Patients answered
questionnaires addressing food intake (24-hour dietary recall)
symptoms (xerostomia, odynophagia, dysphagia, stomatitis, dysgeu-
sia, nausea and vomiting), therapy (concomitant chemotherapy), and
nutritional status (antropometry and Subjective Global Assessment).
We also performed the anthropometric assessment (body weight,
height, arm circumference, tricipital skinfold thickness) and functional
assessment (thickness of the adductor pollicis muscle and hand grip
strength) of patients. The protocol was approved by the Ethical
Commitee of the hospital. Data were tested for normality using the
Kolmogorov-Smirnov and Bartlett tests. Pearson and Spearman tests
were used to test correlations between number of symptoms, food
intake, and nutritional and functional status.
Results: Fifty-four patients (81% men) completed the study. At the
onset of treatment, the mean age was 60 ± 10 years. During the six
weeks of radiotherapy, values of muscle arm circumference, arm
muscle area and adductor pollicis muscle thickness decreased
(p < 0,05), while all other outcome measures decreased during the
first half of treatment (p < 0,05) and 76% of patients lost weight. The
intake of protein, energy and carbohydrate decreased in the beginning
of therapy. The prevalence of undernourished patients increased from
27% to 47%. All symptoms were significantly associated with Global
Subjective Assessment scores and muscle arm area.
Conclusions: The increase in the number of reported symptoms was
related with impairment of nutritional status and decrease of lean
body mass of patients at first, second, and last (sixth) week of
radiotherapy. Changes observed in the first half of treatment indicate
the importance of an early nutritional intervention.
Reference
Kang WX, Li W, Huang SG, Dang Y and Gao H. Effects of nutritional
intervention in head and neck cancer patients undergoing radio-
therapy: A prospective randomized clinical trial. Mol Clin Oncol.
2016 Sep; 5(3): 279–282.
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THE EFFECT OF PREOPERATIVE NUTRITIONAL SUPPORT ON LUNG
CANCER PATIENTS
C.E. Kalafat1*, S. Kalafat2, C.I. Kocaturk3, C.B. Sezen4, Z.K. Ozerson5.
1Department of Thoracic Surgery, 2Department of Nutrition and Dietetics,
Mardin State Hospital, Mardin, 3Department of Thoracic Surgery, Istinye
UniversityMedical Faculity, 4Department of Thoracic Surgery, Universiy of
Health Sciences Yedikule Chest Diseases and Chest Surgery Hospital,
5Department of Nutrition and Dietetics, Halic University Institute of
Health Sicence, Istanbul, Turkey
* Corresponding author.
Rationale: Aim of the study was to investigate the effect of
preoperative nutritional support on postoperative morbidity, mortal-
ity and length of stay in patients with non-small cell lung cancer.
Methods: This study was carried out retrospectively on 181 patients
between January and December 2017 in a single center. Descriptive
statistics, chi-square, Mann-Whitney u and regression analysis were
used.
Results: 81.2% of the patients were male and 18.8% were female. The
mean age was 59.74. The mean body mass index was 25,33 ± 3,87
kg/m2. 52.5% of the patients had NRS 2002 score 2; 30.4% of 3, 12.7% of
4, 4.4% of 5. While 38.1% of the patients developed complications; the
rate of major complications was 18.8%. Mean hospitalization timewas
7.67 days. Complications were observed in 62.5% (n = 5) of the patients
whose NRS 2002 scoringwas 5, while this ratiowas 39.1% (n = 9), 21.8%
(n = 9) 12) and 45.3% (n = 43) in patients with NRS scoring 4, 3 and 2
respectively (p = 0.016). It was found that overall complication
development increased 7.2 times by diabetes; 5,1 times by chest wall
resections; 2,7 times by taking NRS 2002 score 2 thus not receiving
nutritional support; 8,7 times by taking NRS 2002 score
5. Pneumonectomy, chest wall resections and not receiving nutritional
support were increased major complication rate by 4,6; 7,8 and 10,1
times respectively.
Conclusions: In patients receiving nutritional support, the incidence
of complications were significantly decreased, hospitalization time
was shortened and albumin loss was less in the postoperative one
month. Pneumonectomy, chest wall resection and not receiving
nutritional support were factors that increased major complication
rate. We recommend patients with extended lung resection should be
given nutritional support treatment even though the level of nutrition
is adequate with pre-evaluation tests. Surgical resections of NRS 2002
score 5 patients should be delayed.
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EARLY TUBAL JEJUNOSTOMY FEEDING IN PATIENTS WITH GASTRIC
CANCER UNDERGOING CURATIVE GASTRECTOMY
C.-J. Ma1,2,3*, L.-C. Sun3,4, Y.-L. Shih3,4, J.-Y. Wang2,3,5. 1Division of
Digestive and General Surgery, 2Division of Colorectal Surgery, 3Nutrition
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Rationale: Early enteral nutrition (EEN) within 24 hours after
gastrointestinal (GI) surgery is recommended to improve not only
quality of life (QOL) but also nutritional status and clinical outcomes,
especially in patients undergoing colon resection. However, the timing
of EN after upper GI surgery is not clearly defined. Considering
impaired postoperative gastric emptying and subsequent vomiting
after diet intake, EEN was achieved in 52% patients undergoing total
gastrectomy for gastric cancer (GC) and in 63% patients undergoing
pancreaticoduodenectomy. Tubal jejunostomy feeding is one of the
strategies to ensure EEN possible. The aim of the present study is to
compare early tubal jejunostomy feeding with no jejunostomy made
after curative resection for GC.
Methods: One hundred and ninety six patients with GC undergoing
curative resection were enrolled. Early tubal jejunostomy feeding
within post-operative 48 hours was conducted in 119 patients and the
rest 77 patients were fed by mouth or naso-gastric tube that might or
might not after first bowel movement.
Results: Longer post-operative hospital stay was observed in early
jejunostomy feeding group (16.62 ± 13.04 vs. 10.51 ± 4.83 days; p <
0.001). There were significantly more post-operative complications in
early tubal jejunostomy feeding group than in no jejunostomy group
(32.8% vs. 19.5%; p = 0.042). Period of post-operative antibiotics
administration was as well significantly longer in the tubal jejunost-
omy feeding group (10.30 ± 11.65 vs. 7.22 ± 5.16 days; p = 0.03).
Conclusions: Although EEN is recommended GI surgery, it is still
doubtful for patients with GC after curative gastrectomy in consider-
ation of short post-operative time.
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VALUE OF NUTRITIONAL PARAMETERS AS PREDICTORS OF
MORTALITY WITHIN 2 YEARS AFTER ALLOGENEIC
HEMATOPOIETIC STEM CELL TRANSPLANTATION
J.-Y. Taine1, D. Beauvais2, C. Dendoncker1, L. Magro2, V. Coiteux2,
I. Yakoub-Agha2, D. Seguy1*. 1Nutrition Unit, 2Department of
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* Corresponding author.
Rationale: Limited data are available on the prognostic value of
nutritional parameters in patients undergoing allogeneic stem cell
transplantation (allo-SCT). We aimed to evaluate the prognostic value
of various nutritional parameters and to determine which were
predictors of mortality within 2 years after allo-SCT.
Methods: A retrospective, single-center study was performed in
patients who received allo-SCT between 1 January 2013 to 30 June
2016. Their data on weight loss compared to usual body weight (WL),
BMI, mid-arm circumference (MAC), hand-grip strength (HG) and
albumin (Alb) were collected at 3 times: the day of admission (before
the chemotherapy/radiotherapy conditioning regimen, d-7), the day
following allo-SCT (d1) and 3 months later (d100). Parameters related
to the patient, transplantation, complications and outcome within 2
years after allo-SCT were also collected. Univariate analysis (Kaplan-
Meier curves and logrank test) and multivariate adjustment (Cox
proportional hazards model) were used to determine which factors
were associated with overall survival within 2 years after allo-SCT.
Results: Among the 276 patients included (113 F, 163 M) aged 49 ± 15
years, 53% underwent allo-SCT for acute leukemia, 17% for myelodys-
plastic syndrome, 12% for lymphoma, 5% for myeloproliferative
syndrome, 5% for multiple myeloma, 4% for aplastic anemia, and 4%
for other causes. The WL increased between d1 and d100 (−3.9 ± 8.2%
and −9.4 ± 10.2%, p < 0.0001, paired t-test). The prevalence of malnu-
trition doubled between admission (32%) and d100 (68%), according to
the following anthropometric criteria:WL≥ 5% or BMI <18.5 kg/m2. In
univariate analysis, some nutritional parameters were associated with
shorter survival within 2 years: WL≥ 5% (p = 0.005) and Alb≤ 35 g/L
(p = 0.015) at d-7; WL≥ 5% (p = 0.005), WL≥ 10% (p = 0.0035),
MAC≤ 27 cm (p = 0.045) and Alb≤ 30 g/L (p = 0.0001) at d1;
WL≥ 5% (p = 0.017), WL≥ 10% (p = 0.0008), IMC < 18.5 kg/m2 (p =
0.0076) and HG≤ 25 kg (p = 0.0009) at d100. In multivariate analysis,
the best predictors ofmortalitywithin 2 yearswere: Alb≤ 35 g/L at d-7
(HR = 2.02 [1.12–3.66], p = 0.02), Alb≤ 30 g/L at d1 (HR = 2.19 [1.29–
3.71], p = 0.004) and HG≤ 25 kg at d100 (HR = 2.58 [1.3–5.1], p =
0.0063). For each of the 3 times considered, nutritional parameters
outweighed other usual prognostic criteria (severe acute graft versus
host disease, myeloablative conditioning, peripheral blood stem cell
transplant, donor with a positive cytomegalovirus status and infec-
tion). Regardless of the parameter and time considered, a HG≤ 25 kg
at d100 appeared to be the best independent predictor of mortality
within 2 years after allo-SCT.
Conclusions: This study confirms that malnutrition is an independent
factorofmortality inpatients undergoing allo-SCT. It also reveals that 3
months after the transplantation, an alteration of the hand-grip
strength represents a major prognostic marker to be taken into
account when monitoring these patients. In the future, it would be
interesting to see whether the early management of sarcopenia
induced by the allo-SCT procedure improves the survival of these
patients.
Disclosure of Interest: None declared.
SUN-PO088
ONCOLOGY TREATMENT-RELATED AND PATIENT-RELATED FACTORS
THAT INFLUENCE FAT LOSS IN BREAST CANCER PATIENTS
D. Artene1*, A. Blidaru2. 1Oncology Nutrition, Carol Davila Medicine
University, 2Surgical Oncology, Alexandru Trestioreanu Oncology
Institute, Bucharest, Romania
* Corresponding author.
Rationale: Breast cancer patients frequently present sarcopenic
obesity – type of obesity that can affect both normal weight and
overweight or obese patients that is not necessarily generated by an
excessive food intake, but by sarcopenia indirectly generated by
chemotherapy and antiestrogenic treatment. Sarcopenic obesity
associates increased mortality, recurence and metastases risks in
breast cancer patients.
Methods: To counteract it, we proposed an at-home oncology
nutrition intervention based on foods naturally high in proteins,
omega-3 fatty acids, high-quality carbohydrates, calcium, probiotics
and prebiotics to 614 ER+/PR±/HER2- breast cancer patients under
antiestrogenic treatment (AET). 331 patients were randomly assigned
to the Control Group (CG), with no nutrition advice besides physicians’
recommendation to avoid weight gain. 283 patients were randomly
assigned to the Intervention Group (IG) and asked to follow the
proposed diet. We measured weight and body composition and we
compared results at 24 months between groups using the Mann-
Whitney and the Wilcoxon tests. Then we analyzed results based on
the type of oncology treatment administred and on patients’ age,
lifestyle and comorbidities.
Results: Results were modest, but IG Patients obtained statistically
significant weight loss and fat loss lost weight with no muscle mass
loss while CG patients maintained weight, increased fat and lost
muscle.
The only oncology treatment-related factor that influenced efficacy
was the type of AET: patients onAromatase Inhibitors lostmoreweight
and visceral fat than patients on Tamoxifen. Efficacy was not
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influenced by: chemotherapy and radiotherapy administration, by the
type of breast surgery or by salpingo-oophorectomy.
About the patient-related factors, efficacy was not influenced by the
dieting history of the patients before the diagnosis, and it was
influenced by: de novo thyroid disease and sleep disturbances which
accentuated sarcopenia; by statins coadministration in patients on
Anastrozole or Exemestane and by depression which decreased fat
loss; and by the age of the patients – younger breast cancer patients
had the lowest compliances and the worse results.
Conclusions: This oncology nutrition intervention can counteract
sarcopenic obesity, but its efficacy can be influenced by the type of AET
and by factors related to patients’ age, sleep disturbances and
comorbidities.
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WEIGHT LOSS AND BMI AS PROGNOSTIC FACTORS IN CANCER
PATIENTS
E. Madureira1*, L. Teixeira1, B.M.P.M. Oliveira2, F. Correia1, S. Silva1.
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Rationale: Identifying prognostic factors in oncologic patients is
essential to define strategies. The aim of this study was to determine
the association between the grading system using weight loss (WL)
and Body Mass Index (BMI) and the prognosis of patients undergoing
chemo and/or radiotherapy.
Methods: Prospective study of adult cancer patients, at Nutrition-
Oncology consultation, between April 2012 and January 2014. Clinical
data (location, staging, surgery, ECOG-PS); anthropometric data
(weight, height, BMI, WL in 6 months, grading system using WL and
BMI (L. Martin, 2015) in 5 grades (0–4); biochemical data (albumin, C-
reactive protein (CRP), modified Glasgow Prognostic Score (mGPS);
symptoms using Cancer Appetite and Symptoms Questionnaire
(CASQ) and with worst prognosis (53.3% grade 3 and 4). Patients
were followed until March 2019. The survival time was calculated as
the difference, in months, between the date of diagnosis and the date
of death. Kaplan-Meier curves were used to study the effect of risk
factors on survival time.
Results: 330 patients were included, mostly men (69.1%), with
colorrectal cancer (35.5%), advanced stage (40.6%), previously submit-
ted to surgery (59.7%), good performance status (57,6% ECOG 0/1),
systemic inflammation (48,8% mGPS 1/2), proposed for adjuvant
(34.5%) or palliative (34.5%) treatment. The median age was 62 years,
BMIwas 25.1 kg/m2,WLwas 7.7%, CASQ score 18, albumin 39.1 g/L and
CRP 13.1 g/L. Of these, 223 patients died. Median survival was 20.9
months.
The Kaplan-Meier curves show that patients with higher weight loss
and worst classification in the BMI/WL grading system had higher
mortality rates. Themedian survival time for grade 0was 35.2months,
decreasing to 14.1 months for grade 4.
Conclusions: In addition to the clinical data, factors related to patient
nutritional status, like weight loss and gradient system (BMI/WL) may
be useful in predicting mortality.
Reference
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ESTIMATING THE INCIDENCE AND PREVALENCE OF CANCER-
RELATED WEIGHT LOSS AND SARCOPENIA IN THE REPUBLIC OF
IRELAND AND THE UNITED KINGDOM
E.S. Sullivan1*, L.E. Daly1, D.G. Power2, A.M. Ryan1. 1School of Food &
Nutritional Sciences, University College Cork, 2Departments of Medical
Oncology, Cork & Mercy University Hospitals, Cork, Ireland
* Corresponding author.
Rationale:Weight loss (WL) and sarcopenia are common in oncology
populations and are associated with negative clinical outcomes
including poor tolerance to treatment, decreased quality of life and
reduced survival. The numbers of patients with cancer affected by
sarcopenia and WL in Ireland and the UK are currently unknown.
Methods: A literature search was undertaken to identify reports of the
prevalence of WL > 5% and CT-diagnosed sarcopenia. Median rates of
sarcopenia and WL > 5% were identified for 14 cancer sites. Incidence
and prevalence of each cancer were obtained from national cancer
registries of the Republic of Ireland (ROI); Northern Ireland, England,
Scotland and Wales (UK). Rates of WL > 5% and sarcopenia in the
population were extrapolated from these data.
Results: The 14 cancer sites with reported rates of WL >5% and
sarcopenia accounted for 93% of ROI and UK incident cases combined
for this period. These sites accounted for 82% of ROI and UK prevalent
cases combined for this period. We estimated that across the ROI and
UK, at least 86,827 cancer patients are affected by WL > 5% annually
and that there are 475,885 cancer survivorswho have sufferedWL > 5%
at somepoint in their disease trajectory. Furthermore,we estimate that
there are at least 162,071 annual cases of cancer patients with
sarcopenia in the ROI and the UK. We estimate that there are 892,929
cancer survivors alive who have been affected by sarcopenia during
their disease trajectory.
Conclusions: This is the first report estimating the burden of WL and
sarcopenia across the UK and Ireland. These figures are conservative
estimates limited by gaps in the literature. Given the impact of
malnutrition on cancer outcomes during treatment, and the long-term
impact of sarcopenia on frailty amongst survivors, urgent attention is
required to address gaps in access to nutrition care available to cancer
patients.
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NUTRITIONIST DELIVERED QUALITY IMPROVEMENT PROGRAM
RESULTS IN SIGNIFICANT REDUCTION IN UNPLANNED HOSPITAL
ADMISSIONS AMONG CANCER PATIENTS UNDERGOING
CHEMOTHERAPY AND/OR RADIOTHERAPY
E. Sathiaraj1*, S. Chakraborthy1, K. Priya1, K. Kulkarni2. 1Onco-Nutrition,
2Quality and Accreditation, Cytecare Cancer Hospitals, Bengaluru, India
* Corresponding author.
Rationale: Chemotherapy and radiation therapy have been associated
with increased risk of malnutrition in cancer patients and addressing
nutrition needs can result in improved health outcomes. This study
aimed to analyze the effects of a nutritionist delivered quality
improvement program (QIP) among Indian out-patients undergoing
cancer treatment on unplanned hospital admissions.
Methods: Data was collected for 80 QIP patients and 70 historical
controls. QIP included screening for malnutrition risk on start of
treatment, regular consultations with the nutritionists, monitoring
and education involving patient and care-giver and initiation of oral
nutrition supplements (ONS) for patients who are undernourished or
at risk of malnutrition with follow up for 3 months.
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The primary outcome measure was the 3-month unplanned hospital
admissions during treatment of chemotherapy and/or radiation
therapy. The secondary outcome included weight changes from the
beginning of the treatment (baseline) to 3 months after starting
treatment.
Results: 3-months unplanned hospital admission rates were signifi-
cantly reduced in the QIP group when compared to the control group
(37.5% vs 65.7%, p < 0.001). Average bodyweight of QIP patients did not
significantly decline from the start of the treatment to 3 months of
follow up when compared to statistical decline of body weight in the
control group (QIP: Baseline, 60.98 kg; 1 month, 60.68 kg; 3 months,
61.53 kg; p = 0.08; Controls: Baseline, 68.23 kg; 1 month, 66.64 kg; 3
months, 65.11 kg; p < 0.001). SGA done at baseline revealed that 25%
(n = 17) of the patients were malnourished and 60% (n = 48) were
nutritionallyat risk. ONSwas initiated to 81% (n = 65) of patients on the
start of the cancer treatment. Compliance of patients on ONS was
monitored during the review sessions andwas found to be 89% (n = 59)
in the first month and 77% (n = 50) in the third month.
Conclusions: Three months unplanned hospital admissions were
significantly lowered for out-patients undergoing cancer treatment by
the nutritionist-delivered quality improvement program.
Disclosure of Interest: None declared.
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ONCOLOGIC PATIENTS, UNDER OR OVER NUTRITION
F. Morgado1*, R. César1, R. Carvalho1. 1Endocrinology and Nutrition
Service, Divino Espirito Santo Hospital, Ponta Delgada, Portugal
* Corresponding author.
Rationale: Depending on the etiology of the disease, several forms of
malnutrition are present in oncology patients.
Nutritional risk assessment is an effective tool to early diagnose
nutritional imbalances associated with the disease and with the
anticancer treatments.
The aim of the study was to assess nutrition risk in cancer patients
using various methodologies.
Methods: The study included 57 (22 females, 35males,mean age 57 y)
cancer patients in chemotherapy (QT) treatment. 57% of male patiens
had head and neck or pulmonary cancer and 50% of woman had breast
or ovary cancer. The nutritional risk was determined by Body Mass
Index (BMI), categorized by World Health Organization criteria,
Malnutrition Universal Screening Tool (MUST) and Patient Generated
Subjective Global Assessment (PG-SGA).
Results: According to BMI, 14% of the patients were malnurished and
37% obese. Using MUST score 19% of the patients had high
malnutrition risk and by PG-SGA 47% needed nutrition intervention.
In females, by BMI therewas notmalnurished cases, byMUST 5% score
high risk of malnutrition and by PG-SGA 64% needed nutrition
intervention. 63.6% of the woman were overweight or obese. In males
by BMI 17% were malnurished, by MUST 29% scored high risk of
malnutrition and by PG-SGA 37% needed nutrition intervention. 45.7%
of the male patients were overweight or obese. There was a positive
association with head and neck cancer and high malnutrition
(p < 0.001) and a non statistical significant positive association with
breast cancer with overweight p < 0.1).
Conclusions: In our sample we obeserved a considerable high
prevalence of high malnutritional risk, especially when using the
PG-SGA, and was not positively correlated with BMI criteria of
malnurished. Head and neck cancer was associated with higher
malnutrition risk and breast cancer, although without statistical
significance, with overweight and obesity.
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GLIM MALNUTRITION CRITERIA APPLYING DYNAMOMETRY AS A
PREDICTING TOOLOF LENGTH OF STAYAND 6-MONTHSMORTALITY
IN ONCOLOGICAL INPATIENTS
V. Contreras Bolivar1, F.J. Sanchez-Torralvo1, J. Abuín Fernández1,
M. Ruiz Vico2, I. Gonzalez Almendros3, M. Barrios García4,
M. Gonzalo Marín1, G. Olveira1*. 1UGC Endocrinología y Nutrición,
2UGC Oncología Médica, 3UGC Radiodiagnóstico, 4UGC Hematología,
Hospital Regional Universitario de Malaga, Malaga, Spain
* Corresponding author.
Rationale: Malnutrition is a very common issue in oncological
patients and it is linked to an increased morbimortality. GLIM criteria
have been recently proposed to the diagnosis of malnutrition, they
must be validated in prospective studies.
Our objective is to determine the prevalence of malnutrition in
oncological inpatients with different malnutrition diagnostic tools, as
well as to assess its ability to predict length of stay and 6-months
mortality.
Methods: Prospective study in patients hospitalized in Medical
Oncology ward. Subjective Global assessment (SGA) was done and
anthropometrical datawas gathered.We used two options to assess fat
free mass determinants in order to classify patients according to GLIM
criteria: 1. Fat free mass index (FFMI), which was calculated by the
formulae of Durnin and Siri, and 2. Handgrip strength (HGS) by
dynamometry (Jamar).
Results: 282 inpatients were assessed, 55.7% male and 44.3% female,
with an average age of 60.2 ± 12.6 years and a BMI of 24.6 ± 4.9 kg/m2.
Average score on HGS was 26.2 ± 8.6 kg in male and 16.5 ± 6.7 kg in
female. Average FFMI was 17.5 ± 2.4 kg/m2 in male and 15.9 ± 2.5 kg/
m2 in female.
According to SGA, 81.4% of the patients were malnourished and
applying GLIM criteria malnutrition was detected in 77.6% of the
patients.
Average hospital length of stay was 10.3 ± 8.3 days. In patients with
severe malnutrition according to SGA, average stay was 12.1 ± 8.1 days
vs 8.2 ± 9.8 days in well-nourished (p < 0.001); according to GLIM
criteria with FFMI, 11.0 ± 7.7 days in malnourished vs 8.4 ± 9.9 in well-
nourished (p < 0.05); and according to GLIM criteria with HGS,
11.1 ± 8.1 days inmalnourished vs 7.7 ± 9.1 inwell-nourished (p < 0.01).
6-months mortality was 47.9% (135 deaths). In malnourished patients
according to SGA, mortality risk was 2.23 times greater than in well-
nourished [95% CI 1.14–4.38; p = 0.009]. Using GLIM criteriawith FFMI,
mortality risk was 1.87 times greater than in well-nourished [95% CI
1.01–3.5; p = 0.047]. Using GLIM criteria with HGS, mortality risk was
2.72 times greater than inwell-nourished [95% CI 1.37–5.4; p = 0.004].
Conclusions: Both GLIM criteria and SGA are good predictors of
hospital length of stay and 6-months mortality in oncological
inpatients.
Dynamometry and FFMI (calculated by anthropometrical measure-
ments) are presented as interesting tools to estimate fat free mass
when applying GLIM criteria.
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THE ROLE OF NUTRITIONAL INTERVENTIONS IN SURGICALLY
TREATED PANCREATIC CANCER PATIENTS: COMPARATIVE EFFICACY
IN A NETWORK META-ANALYSIS (NMA)
D. Basile1,2, G. Pelizzari1,2, C. Corvaja1,2, C. Lisanti1,2, M. Bartoletti1,2,
S. Buriolla1,2, S.K. Garattini1,2, L. Gerratana1,2, L. Bortot1,2, F. Cortiula1,3,
A. Parnofiello1,3, E. Ongaro2, M. Borghi4, G. Miolo2, G.G. Cardellino3,
R. Giaretta5, G. Schiavo5, A. Buonadonna2, F. Puglisi1,2, G. Aprile6*.
1Department of Medicine (DAME), University of Udine, 33100, Udine,
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Aviano (CRO), IRCCS, 33081, Aviano, 3Department of Oncology, ASUIUD
University Hospital of Udine, Udine, 4Intensive Care Unit, Centro di
Riferimento Oncologico di Aviano (CRO), IRCCS, 33081, Aviano, 5San
Bortolo General Hospital, Vicenza, Italy, 6Department of Oncology, San
Bortolo General Hospital, Vicenza, Italy
* Corresponding author.
Rationale: Surgery increases the risk of weight loss and sarcopenia in
pancreatic cancer (PC) patients. Peri-operative nutritional support
may improve recovery and reduce postoperative complications.
Methods: A systematic literature review of randomized clinical trials
(RCTs) was performed to evaluate the impact of immunomodulating
enteral nutrition (IMEN), standard enteral nutrition (EN), parenteral
nutrition (PN) or control in reducing postoperative complications in
surgical PC patients. Overall, 33 studies were considered. Only studies
evaluating nutritional intervention and complications in the peri-
operative setting were included. Outcomes of interest were infectious
and non-infectious complications. A Bayesian model was applied to
conduct NMA comparing the probability of post-operative complica-
tions for each treatment and to rank the best intervention arm.
Results: Seven RCTs (1,041 patients) were analyzed. In the pairwise
meta-analysis, nutritional interventions did not show a significant
difference in reducing complications. Odds ratios (OR) for post-
operative complications and 95% Credible Interval (CrI) of selected
NMA comparisons are reported in the table. Nevertheless, IMEN was
ranked as the best intervention in decreasing the rate of post-operative
complications. Probabilities of being the best treatment for each arm
are reported.
NMA
Comparisons
OR (95% CrI) Intervention Probability of being
the best nutritional
intervention
IMEN vs Control 0.37, 95% CI 0.06–2.2 IMEN 51%
PN vs Control 0.43, 95% CI 0.04–4.7 PN 32%
EN vs Control 0.49, 95% CI 0.05–3.9 EN 9%
Conclusions: In these indirect comparisons, complications after
pancreatic surgery were not significantly reduced by any nutritional
intervention. However, we estimated that IMEN might be the most
beneficial treatment in surgical PC patients.
Disclosure of Interest: D. Basile Grant/Research Support from: No,
Consultant for: No, Speakers Bureau of: No, Shareholder of: No, Paid
Instructor at: No, Other: No, G. Pelizzari Grant/Research Support from:
No, Consultant for: No, Speakers Bureau of: No, Shareholder of: No,
Paid Instructor at: No, Other: No, C. Corvaja Grant/Research Support
from: No, Consultant for: No, Speakers Bureau of: No, Shareholder of:
No, Paid Instructor at: No, Other: No, C. Lisanti Grant/Research Support
from: No, Consultant for: No, Speakers Bureau of: No, Shareholder of:
No, Paid Instructor at: No, Other: No, M. Bartoletti Grant/Research
Support from: No, Consultant for: No, Speakers Bureau of: No,
Shareholder of: No, Paid Instructor at: No, Other: No, S. Buriolla
Grant/Research Support from: No, Consultant for: No, Speakers Bureau
of: No, Shareholderof: No, Paid Instructor at: No, Other: No, S. Garattini
Grant/Research Support from: No, Consultant for: No, Speakers Bureau
of: No, Shareholder of: No, Paid Instructor at: No, Other: No,
L. Gerratana Grant/Research Support from: No, Consultant for: No,
Speakers Bureau of: No, Shareholder of: No, Paid Instructor at:
No, Other: No, L. Bortot Grant/Research Support from: No,
Consultant for: No, Speakers Bureau of: No, Shareholder of: No, Paid
Instructor at: No, Other: No, F. Cortiula Grant/Research Support from:
No, Consultant for: No, Speakers Bureau of: No, Shareholder of: No,
Paid Instructor at: No, Other: No, A. Parnofiello Grant/Research
Support from: No, Consultant for: No, Speakers Bureau of: No,
Shareholder of: No, Paid Instructor at: No, Other: No, E. Ongaro
Grant/Research Support from: No, Consultant for: No, Speakers Bureau
of: No, Shareholder of: No, Paid Instructor at: No, Other: No, M. Borghi
Grant/Research Support from: No, Consultant for: No, Speakers Bureau
of: No, Shareholder of: No, Paid Instructor at: No, Other: No, G. Miolo
Grant/Research Support from: No, Consultant for: No, Speakers Bureau
of: No, Shareholder of: No, Paid Instructor at: No, Other: No,
G. Cardellino Grant/Research Support from: No, Consultant for: No,
Speakers Bureau of: No, Shareholder of: No, Paid Instructor at:
No, Other: No, R. Giaretta Grant/Research Support from: No,
Consultant for: No, Speakers Bureau of: No, Shareholder of: No, Paid
Instructor at: No, Other: No, G. Schiavo Grant/Research Support from:
No, Consultant for: No, Speakers Bureau of: No, Shareholder of: No,
Paid Instructor at: No, Other: No, A. Buonadonna Grant/Research
Support from: No, Consultant for: No, Speakers Bureau of: No,
Shareholder of: No, Paid Instructor at: No, Other: No, F. Puglisi Grant/
Research Support from: No, Consultant for: No, Speakers Bureau of:
No, Shareholder of: No, Paid Instructor at: No, Other: No, G. Aprile
Grant/Research Support from: No, Consultant for: Yes, advisory board
for celgene and baxter, Speakers Bureau of: Yes, advisory board for
celgene and baxter, Shareholder of: No, Paid Instructor at: No, Other:
No.
SUN-PO095
EVALUATION OF PREOPERATIVE SARCOPENIA IN PATIENTS
UNDERGOING SURGERY FOR GASTROINTESTINAL SYSTEM CANCER
G. Şengül Ayçiçek1*, T. Erol2, O. Abbasoğlu2, M. Halil1. 1Geriatrics,
2General Surgery, Hacettepe University, Ankara, Turkey
* Corresponding author.
Rationale: It has been shown that the incidence of sarcopenia
increases in cancer patients and associated with chemotherapy
toxicity, postoperative complications and decreased survival.
Therefore, evaluation of body composition is becoming increasingly
important in these patients. The aim of this study was to evaluate
sarcopenia in patients who underwent surgery for gastrointestinal
system (GIS) surgery.
Methods: Twenty-four patients aged 65 years and older who were
admitted to the general surgery outpatient clinic were included in the
study. After preoperative comprehensive geriatric assessment, the
patients were evaluated with bioelectrical impedance analysis (BIA)
and ultrasound (USG). Skeletal muscle mass (SMI) was measured by
BIA and gastrocinemius (GK), rectus femoris (RF), rectus abdominis
(RA), external oblique (EO), internal oblique (IO) and transversus
abdominis (TA) muscle thickness were measured by USG. The cross-
sectional areawas also evaluated for RFmuscle (RF CSA). The diagnosis
of sarcopenia was made according to the EWGSOP2 criteria.
Results: The median age of the patients was 71.5 (65–87) and 58.3%
were female. Thirty seven point five percent of the patients had upper
GIS, 54.2% had lower GIS and 8.3% had hepatobiliary system
malignancy. The mean SMI value was determined as 10.1 ± 1.9 kg/m2.
Sarcopenia incidencewas 50% in these patients. It was found that 37.5%
of these cases had possible and 12.5% had severe sarcopenia. MNA SF
scores were similar between sarcopenic and non sarcopenic patients.
Handgrip strength of sarcopenic patients was lower than non
sarcopenic patients (p = 0.002). Skeletal muscle mass index and 4 m
walking speeds were similar between groups. Between measured
muscles, RF thickness and RF CSAwere found to be thinner in patients
with sarcopenia (p = 0.02, p = 0.04, respectively).
Conclusions: Sarcopenia is a common health problem in older
patients who are planned to undergo cancer surgery. Considering
the relationship between possible complications and mortality,
precautions should be taken for the management of sarcopenia in
these patients.
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ACCEPTANCE AND COMPLIANCE OF A NEW ORAL NUTRITIONAL
SUPPLEMENT INCANCERPATIENTS –APILOT STUDY INCROSS-OVER
DESIGN
H.J. Herrmann1*, D. Reljic1, M.F. Neurath2, Y. Zopf1. 1Department of
Medicine 1, Hector-Center for Nutrition, Exercise and Sports, 2Department
of Medicine 1, Gastroenterology, Pneumology and Endocrinology,
University Hospital Erlangen, Erlangen, Germany
* Corresponding author.
Rationale: Often, cancer patients cannot meet their nutritional needs
through a normal diet. Oral nutritional therapy given as oral
nutritional supplements (ONS) is an effective way to stabilize
nutritional status in this situation. For better compliance, the offer of
different flavors and preparations is crucial. Innovative forms of
application of ONS could help to improve compliance and acceptance
and avoid invasive nutritional measures. The aim of the present study
was to compare the acceptance and compliance of a commercial liquid
ONS (LO) and a newly developed, protein-rich, gelled, semi-solid
product based on fruit gums (FG) in oncological patients with an
increased risk of malnutrition.
Methods: Cancer patients with indication for oral nutritional therapy
were randomly assigned to LO and FG in cross-over design for 4 weeks
(group 1: LO-FG, group 2: FG-LO) with a 1-week wash-out phase.
Compliance and acceptancewere recorded by ONS diary, MARS-D and
sensory questionnaire. Safety monitoring was performed by recording
nutrient intake (3-day nutritional protocol), nutritional status (mBCA,
seca), performance status (Karnofsky Index, ECOG) and quality of life
(EORTC QLQ-C30).
Results: Forty patients (45% f, 85% UICC III/IV, Karnofsky Index/ECOG
70/1) were randomized to the study groups. Both the ONS diary
(p = 0.003) and the MARS-D (p = 0.005) showed significantly higher
compliance for the LO compared to FG. The differences were 26.7% and
15.6% respectively. UICC stage, gender, duration of previous oncologic
therapy, andrecommendedamountofONSappear tohaveno impacton
compliance. Taste, smell and enjoyment of the LO were rated
significantly better. Energy and nutrient intake, nutrition and perform-
ance status and quality of life remained stable throughout the study.
Conclusions: The protein-rich, gelled, semi-solid, fruit gum-based
ONS is an innovative formulation that stabilizes energy and protein
delivery in cancer patients and can be used to supplement conven-
tional liquid ONS. In order to increase compliance and acceptance, the
sensory properties must be further improved.
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EXAMINATION OF POLYPHARMACY AND NUTRITIONAL STATUS IN
CANCER PATIENTS
H. Takemoto1*, S. Mizuno2, C. Katsuura2, A. Kado3, M. Furukawa4,
H. Kitani4, K. Yoshifuku4, H. Saito5, K. Takachi1. 1Surgery, 2Pharmacy,
3Nutritional Management, 4Nursing, 5Internal Medicine, Kinki Central
Hospital, Itami, Japan
* Corresponding author.
Rationale: Recently, the state of taking 6 ormoremedications is called
polypharmacy. Cancer patients often take multiple medications to
alleviate various symptoms as the disease progression. We analyzed
the data of cancer patients collected on nutritionDay at our hospital,
and examined the polypharmacy and nutritional status.
Methods: We conducted a questionnaire survey on 908 patients on
nutritionDay for three years from 2013 to 2015. Of these, 188 patients
have cancer, so they are t divided into P group with more than 6 drugs
andNgroupwith 5 drugs or less. Therewere 58 in P group and 130 inN
group. We compared and examined the treatment situation and
nutrition management method between two groups.
Results: Average age is 73.14 years in P group, 69.72 years in N group.
The average value of BMI was 21.96 kg/m2 in P group and 20.63 kg/m2
in N group. There was no difference in the serum albumin level
between P group 3.12 and N group 3.08. Regarding nutrition
management, parenteral nutrition was administered in 35.7% of P
group and 45.0% of N group. Oral intakewas 59.0% in P group and 52.0%
in N group. Of 53 patients of stage 4, 15 (28.3%) in P group and 38
(71.7%) in N group. According to the purpose of treatment,12 (23.1%) of
52 curative treatments, 31 (32.6%) of 95 palliative treatments, and 12
(38.7%) of 31 termainal care were in the P group. The average number
of oral medications was 3.0 in the curative tratmennt patients, 4.1 in
the palliative, and 5.4 in the terminal.
Conclusions: From the results of this study, the proportion of patients
with polypharmacy increased with the progression of cancer.
Disclosure of Interest: None declared.
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EFFECT OF NRS2002 ON IDENTIFYING MALNUTRITION IN CANCER
PATIENTS UNDERGOING RADIOTHERAPY
H. Wan1*. 1Shanghai Proton and Heavy Ion Center, Shanghai, China
* Corresponding author.
Rationale:Nutrition Risk Screening Scale (NRS2002) is recommended
as a nutrition screening tools by ESPEN. However, we find thatmanyof
the low-risk patients with radiotherapy based on NRS 2002 may still
have develop malnutrition. This study aims to evaluate the effect of
NRS2002 on identifying malnutrition in cancer patients undergoing
radiotherapy based on Patient-Generated Subjective Global
Assessment (PG-SGA).
Methods: The nutritional status of cancer patients before radiotherapy
in two tertiary hospitals in Shanghai and Zhejiang province were
screened and evaluated by NRS2002 and PG-SGA. The Sensitivity,
Specificity, Yoden index, Kappa value and area under ROC curve of
NRS2002 were calculated using PG-SGA as a gold standard.
Results: A total of 368 cancer patients were enrolled in this study.
Among them, 27.1% of the cancer patients had NRS2002≥ 3 points at
admission and 35.9% had PG-SGA≥ 4 points. The Sensitivity,
Specificity, Accuracy and Yoden index of NRS2002 for screening
malnutrition (PG-SGA≥ 4) were 37.87%, 87.28%, 69.56% and 25.16%,
respectively. The Sensitivity, Specificity, Accuracy and Yoden index of
NRS2002 for screening severemalnutrition (PG-SGA≥ 9) were 62.06%,
96.18%, 80.16% and 58.35%.
Conclusions: NRS2002 has a low sensitivity but a high specificity for
malnutrition screening in cancer patients with radiotherapy.
Therefore, it is still necessary to carry out nutritional assessment for
low nutrition risk cancer patients with radiotherapy, and further
nutritional support should be given to those who are in nutrition risk.
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PREDICTIVE FACTORS OF CATHETER-RELATED BLOODSTREAM
INFECTION IN ADVANCED CANCER PATIENTS RECEIVING HOME
PARENTERAL NUTRITION
H.-L. Tsai1*, L.-C. Sun2, Y.-L. Shih2, J.-Y. Wang1. 1Surgery, 2Nursing,
Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan, Province
of China
* Corresponding author.
Rationale:Home parenteral nutrition (HPN) is a lifesaving therapy for
patients with intestinal failure or dysgunction, long-term
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administration of HPN allows patients to survive for prolonged periods
of time, improves patient quality, and reduces health care costs.
Catheter-related bloodstream infections (CRBSIs) are normally defined
clinically as symptomswith a positive blood culture from a central and
peripheral catheter, with no other apparent source of infection, while
receiving HPN. CRBSIs is a common and serve complication of long-
term HPN. CRBSIs may cause significant morbidity and mortality. The
aim of this study was to determine the predictive factors of CRBSIs
acquired through a central venous catheter for delivery of HPT therapy
among the advanced cancer patients in single medical center.
Methods: This retrospective study was conducted with advanced
cancer patients with intestinal failure or dysfunction who received
HPN from April 2002 to December 2018. A total of four-hundred and
sixty-three patients was enrolled. Multivariate analysis was used by
Logistic regression method.
Results: Therewere 270males (53.8%) and 193 females (41.7%), with a
mean age of 61.93 ± 13.23 years. Of 463 patients, 160 patients (34.6%)
were with stage III disease and 303 patients (65.4%) were stage IV
disease. Median HPN administration period was 43.0 days (range, 4–
728 days). Therewere 449 patients (97%) to receive venous-port access
and 14 patients (3%) were peripherally inserted central catheter.
Compounding formulation was 98 patients (21.2%) and 365 patients
(78.8%) with commercial formulation. Among these 463 patients, 133
patients (28.7%) have CRBSIs. After univariate and multivariate
analyses, the duration of HPN administration (>110 days), cancer
stage (stage IV), type of HPN (compounding HPN) and chemotherapy
combined with radiotherapy were the predictive factors of CRBSIs
[duration of HPN administration (>110 days vs. ≦ 110 days: odds ratio
(OR), 3.944; 95% confidence interval (CI), 2.157–7.211; P < 0.001;
cancer stage (stage III vs. stage IV): OR, 2.163; 95%CI, 1.252–3.734;
P = 0.006; type of HPN (compounding vs. commercial): OR, 2.300; 95%
CI, 1.250–4.234; P = 0.007; chemotherapy combined radiotherapy (yes
vs. no): OR, 11.898; 95%CI, 2.125–66.608; P = 0.005].
Conclusions: CRBSI is a significant complication in patients receiving
long-term HPN. Individualized therapy with a multidisciplinary team
in centers with HPN management expertise is required. Careful
selection of the catheter type and HPN formulation for each patient
is necessary to best meet patient requirements and minimize HPN-
related complications. Strict compliance by patients and caregivers
with evidence-based instructions together with supervision by well-
trained HPN providers is the most effective strategy to prevent CRBISs.
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HOME PARENTERAL NUTRITION THERAPY FOR MALNOURISHED
UNRESECTABLE/METASTATIC GASTRIC CANCER WITH SALVAGE
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of Colorectal Surgery, Kaohsiung Medical University Hospital, Kaohsiung
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Rationale: Gastric cancer (GC) is the seventh major cause of cancer-
related death in Taiwan. Although significant advances have been
made in the surgical techniques and the treatment, salvage chemo-
therapy remains the major treatment strategy for unresectable/
metastatic gastric cancer (GC) patients. Practical and technical
advances have simplified safe and convenient use of home parenteral
nutrition (HPN). This study aims to clarify the role of HPN in patients
with incurable GC undergoing salvage chemotherapy.
Methods: Twenty-five GC patients administrated with HPN were
enrolled. A total caloric supplement of 910–1800 kcal/day parenteral
nutrition, including 33–60 gm amino acid/day, 120–240 gm glucose/
day, 30–60 gm lipid/day and electrolyte, micro-element and vitamin
according to the nutritional status of subjects, of which was infused
continuously daily in an infusion time ranged between 18 and 24
hours. The nutritional status and laboratory data before the admin-
istration of HPN and after HPN at 0.5, 1, 2, 3 months were analyzed.
Results: Of 25 patients, there were 15 (60%) males and 10 (40%)
females, with a median age of 68 (range, 35–88) years. Median HPN
administration period was 135 (range, 16–569) days. 11 (44%) patients
and 14 (56%) patients were categorized to ECOG status 1 and 2,
respectively. There was a significant improvement of total protein
(P = 0.008), prealbulmin level (P < 0.001) and total cholesterol
(P = 0.023) after 0.5 month of HPN administration. After 1 month,
there was a significant improvement of nitrogen balance (P = 0.004)
and prealbulmin level (P < 0.012). After 2 months, there was a
significant improvement of triglyceride (P = 0.018), but inflamma-
tion-related cytokines were not significantly altered (all P > 0.05).
Conclusions: HPN therapy for malnourished unresectable/metastatic
GC patients with salvage chemotherapy was feasible and revealed the
markedly improvement in nutritional status after 0.5 month of
administration without significant alterations of inflammatory cyto-
kines. It is mandatory that early intervention in home parenteral
nutrition (HPN) formalnourished unresectable/metastatic GC patients
with salvage chemotherapy.
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DYSGEUSIA IN NON-SMALL CELL LUNG CANCER PATIENTS WITH
ANOREXIA
J.G. Turcott1*, P.A. Barragán1, Z.L. Zatarain1, O. Arrieta1. 1Thoracic
Oncology Unit, National Cancer Institute of Mexico, Mexico city, Tlalpan,
Mexico
* Corresponding author.
Rationale: Dysgeusia (taste alteration) is a very common symptom
reported by patients with lung cancer, and when presented together
with anorexia (lack of appetite) are the main reasons to promote the
reduction of food consumption and in turn promote the Weight loss
and the development of cachexia. Dysgeusia and anorexia can
contribute to increase the nutritional risk and increase the toxicity of
the treatments. Identifying them opportunely and attending them in a
timely manner could have an impact on the improvement of
nutritional status, tolerance of the treatments and quality of life.
Methods: We evaluated taste alterations with an spanish adapted
version of the Taste and Smell Survey in 20 patients with Non-Small
Cell Lung Cancer (NSCLC) diagnosed with anorexia and under
chemotherapy treatment. In addition, the patients answered a 24-
hour recall of food intake. Moreover, we associate the energy intake
according with the intensity of taste alterations. This is a preliminary
analysis, expecting to collect 84 patients to the final report.
Results: Dysgeusia was reported by 85% of NSCLC patients with
anorexia. The 60% of the patients reported amoderate intensityof taste
alterations. Salt taste change (65%) was the main abnormal taste
experiencing by the patients, followed by sweet (45), bitter (30%) and
sour (20%). The change in each tastewas reportedmostly stronger than
before.
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Variable Abnormal sense of taste: (n = 20) p*
Insignificant
n = 3
Mild n = 2 Moderate
n = 12
Severe n = 3
Energy Intake 1255 ± 176 1152 ± 201 1128 ± 301 863.1 ± 358 0.372
%energy
requirement
96.1 ± 14 85.7 ± 24.1 77.6 ± 15.3 56.9 ± 24.05 0.064
Protein intake (gr)/
kg weight
1.3 ± 0.3 1 ± 0.8 0.9 ± 0.2 0.6 ± 0.25 0.076
Conclusions: Patients with Non-Small Cell Lung Cancer (NSCLC) with
anorexia showed a high prevalence of dysgeusia, manifesting mostly
with a strong tastes. The energy intake in this sample of patients seems
to show a pattern according with the intensity of dysgeusia, between
greater intensity of taste alteration lower energy consumption.
Complete the sample size is required to draw strong conclusions.
References: Patients with non-small cell lung cancer (NSCLC) with
anorexia showed a high prevalence of dysgeusia, manifested mainly
with an increase in sensitivity to basic tastes. The energy intake in this
sample of patients seems to show a pattern of energy consumption
according to the intensity of dysgeusia; the greater intensity of taste
alteration, lower energy consumption.
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Rationale: The aim of this study was to assess nutritional status and
dietary intake of cancer patients undergoing chemotherapy.
Methods: This analytical cross-sectional observational study was
carried out between April and June 2018. Included cancer patients
undergoing chemotherapy above 18 years. Nutritional status was
assessed with the Patient Generated-Subjective Global Assessment
(PG-SGA®) and dietary intake was assessed with a 3-day food diary.
Results: This study included 42 cancer patients. 38.1% were moder-
ately malnourished and 4.8% were severely malnourished. Dietary
intake was characterized by low energy (64,3%), low protein (52,4%),
carbohydrates (83,3%), lipids (47,6%), fiber (71,4%), potassium (88,1%),
calcium (81%), magnesium (76,2%), iron (52,4%), folic acid (95,2%),
vitamin B1 (52,4%), vitamin E (95,2%), vitamin D (100%) and vitamin A
(81%). Although, it was verified a high ingestion of mono-disacchar-
ides (76,2%) and saturated fatty-acids (45,2%). It was verified a low
inverted correlation between macro and micronutrients intake and
nutritional status. However, this correlation was significant between
phosphorus intake and nutritional status, i.e., the lower phosphorus
intake the worst nutritional status (p < 0.05).
Conclusions: The aim of nutritional intervention is to guarantee that
nutritional intake supply nutritional requirements of cancer patients,
control symptoms with nutritional impact, improve nutritional status
and promote quality of life. In this study, 57.1% of patients were well
nourished but the majority was lower intake of energy and nutrients.
Thus, it’s important to have a personalized nutritional intervention
during cancer treatment. This study allowed to know the reality of
cancer outpatients in a Portuguese Private Hospital, in nutritional
status and dietary intake.
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NUTRITIONAL INTERVENTION IN POSTOPERATIVE BREAST CANCER
PATIENTS
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Rationale: We investigated the effectiveness of nutritional interven-
tion using smartphones in Korean female patients with postoperative
breast cancer and assessed the possible difference between using
smartphones or not.
Methods: We conducted a prospective study of 58 female patients
who underwent surgery for breast cancer between November 2017
and June 2018 at the Department of Surgery in Gangnam Severance
Hospital. Physical examination included bioelectrical impedance
measurement, dietary changes were checked using the self-food
intake record, and quality of life (QoL) was measured with calibrated
survey items of QoL.
Results: Thirty patients (51.7%, mean age 46.8 ± 5.24 years) were
classified as the nutritional intervention group using smartphones and
28 patients (48.3%, mean age 48.39 ± 7.81 years) as the control group
not using smartphones. Significant changes were observed in weight,
body mass index (BMI), waist–hip ratio, and QoL after 8 weeks
compared to the baseline in the nutritional intervention group using
smartphones. Weight (1.62 ± 1.74 vs. 1.37 ± 2.36 kg, p < 0.001), BMI
(0.64 ± 0.67 vs. 0.54 ± 0.92 kg/m2, p < 0.001), and waist–hip ratio
(0.02 ± 0.02 vs. 0.01 ± 0.04, p < 0.001) were significantly reduced
compared to those in the control group. However, QoL (14.27 ± 18.25
vs. 20.11 ± 20.28, p < 0.001) was higher in the control group.
Conclusions: These results suggest that nutritional intervention using
smartphones seems to be effective in improving risk factors of breast
cancer: weight, BMI, and waist–hip ratio.
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EVALUATION OF ENERGY EXPENDITURE BY INDIRECT
CALORIMETRY IN A HEMATOPOIETIC STEM CELL
TRANSPLANTATION CENTER IN BRAZIL
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Rationale: Treatment with hematopoietic stem cell transplantation
(HSCT) is often the only therapeutic alternative for myelodysplastic,
autoimmune or hemoglobinopathic diseases. During treatment,
variations in basal metabolism associated with variations in weight
loss such as loss of lean mass are associated with complications and
variations in clinical outcome. Aims: To characterize the service
sample describing the baseline expenditure measured by indirect
calorimetry (IC).
Methods: Retrospective study performed at the HSCT clinic of the
Clinical Hospital, Medical School, Ribeirão Preto, USP. At the first
outpatient appointment with the dietitian, the IC was evaluated, the
weight and height data were checked, and the serum C-reactive
protein (CRP) was obtained through the electronic medical record; the
predicted expenditure estimate datawere calculated from the Harris &
Benedict equation. Associations between variables were analyzed by
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analysis of variance (ANOVA) Pearson’s nonparametric correlation test,
with p < 0.05.
Results: 11 patients of both sexes were evaluated in a one-year period,
with avarage body mass index (BMI) of 22.1 kg/m2, avarage baseline
measured in 1545 Kcal ICs (an average of 27 kcal/kg) and PCRof 3.36 g/
dL. A significant difference (p = 0.036) was observed between the CRP
and diagnostic values, with the median being higher in aplastic
anemia (6.13 g/dl) and lower in multiple sclerosis (CR = 0.04) positive
with calorimetry findings (p = 0.02) and negatively with energy
expenditure kg/body weight (p = 0.05 R =−0.76) with weight and
BMI (p = 0.05).
Conclusions: The findings of this study are preliminary because of
sample size limitation, but seem to point to metabolic variations
caused by changes in body composition, mainly caused by myotoxic
drugs used in pre-transplantation conditioning and serum CRP
variations.
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Rationale: With the progression of cancer and difficulties in
preserving food intake during treatment, it is observed in the patients
expressive weight loss, often characterized by loss of muscle mass,
often accompanied by complaints of fatigue and loss of quality of life.
The aims of this study was to characterize the ponderal evolution,
associated to the measure of functionality and fatigue.
Methods: a control case study: 22 healthy participants and 21
participants diagnosed with gastrointestinal tract cancer of both
sexes between the ages of 18 and 60 formed the control and study
groups (CG and SG) respectively and were evaluated with nutritional
assessment (weight and height), handgrip stregth and fatigue
pictogram in 2 moments: before starting treatment (T0) and after 2
cycles of chemotherapy with platinum derivatives (T1). Statistical
analysis was performed with mixed model ANOVA, level of signifi-
cance p≤ 0.05.
Results: The initial avarage values (T0) of body mass index (BMI),
handgrip strenght, fatigue pictogram and fatigue impact in daily
activities for participants of the CG, were: 26.9 kg/m2, 33.5 kg, 2.4 and
1.7, respectively, and for SG: 27.2 kg/m2; 22.6 kg, 2.2 and 2.9. At T1 the
avarage values in the CGwere: 26.8 kg/m2; 31.5 kg, 2.18 and 1.15 and in
the SG: 26.5 kg/m2; 21 kg; 2.5 and 2.4. BMI, handgrip strength and
fatigue impact on the performance of daily activities presented a
significant difference between the times (p = 0.008, 0.009 and 0.006,
respectively).
Conclusions: Changes in body weight and muscular function showed
association in this study with the impact of fatigue, which may
influence the quality of life and outcome of the treatment of patients
on chemotherapy with platinum derivatives.
Disclosure of Interest: None declared.
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C. Turco4, L. Chanut1, C. Prothe1, C. Borg2, C. D’engremont1. 1Department
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Rationale: Pancreatic ductal adenocarcinoma (PDAC) is a highly
aggressive cancer and surgical resection with adjuvant chemotherapy
is the only treatment that can providing long term survival. However,
relapse occure in most patients and a better stratification of
preoperative therapies is required. Lymphopenia and sarcopenia are
two prognostic factors for PDAC.
The aim of this study was to investigate preoperative immunological
and nutritional factors including sarcopenia to predict relapse-free
survival (RFS) in patients with localized PDAC (LPDAC).
Methods: All consecutive LPDAC patients treated with surgical
resection at Besancon University Hospital, France, between January
2006 and December 2014 were included. Biological and nutritional
parameters were recorded before and after surgery. The association of
24 baseline parameters with RFS was evaluated using univariate and
multivariate Cox analyses. Then, a prognostic score was developed.
Results: Lymphocyte count and body composition calculation were
available for 94 patients.
In multivariate analysis, preoperative lymphopenia and sarcopenia
were identified as independent prognostic factors for RFS. We
determined three groups with median RFS of 5.6 months (95%
CI = 4.3 to 9.6 months) for high risk group, corresponding to patients
with lymphopenia; 11.5 months (95%CI = 9.8 to 13.9 months), and 21.2
months (95%CI = 9.9 to 55.3 months), for intermediate-(patient with
sarcopenia without lymphopenia), and low-risk groups (no risk
factor), respectively (P < 0.001).
A new threshold of sarcopenia of 36.1 cm2/m2 for women and
45.7 cm2/m2 for men was established to identify two risk groups
with a RFS of 11.4 months (95%CI = 8.4 to 13.1) and 28.3 months (95%
CI = 3.2 to NA), respectively (p < 0.0001).
Preoperative sarcopenia predict the occurrence of postoperative
lymphopenia in patients with a preoperative lymphocyte count
above 1,000/mm3 (77.8% versus 22.2%, p = 0.0029).
Conclusions: Preoperative sarcopenia and lymphopenia are pejorative
prognostic factors in LPDAC.
Furthermore, preoperative sarcopenia predicts postoperative lympho-
penia, and we actually know that patients with postoperative
lymphocyte count <1000/mm2 have the worst prognostic and none
of them had long term survival (1).
Sarcopenia is a promising nutritional tool and should be considered in
the preoperative evaluation to stratify death risk in patients with
LPDAC.
Reference
1. D’Engremont C, Vernerey D, Pointet A-L, Simone G, Fein F, Heyd B,
et al. Additive value of pre-operative and one-month post-operative
lymphocyte count for death-risk stratification in patients with
resectable pancreatic cancer: amulticentric study. BMCCancer. 2016
26;16:823.
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NUTRITIONAL STATUS AND INFLAMMATION MARKERS IN PATIENTS
WITH PANCREATIC CANCER UNDER CHEMOTHERAPY
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A. Zampelas4, M. Karamouzis3,5. 1Department of Nutrition and Dietetics,
2Oncology Clinic, Laiko General Hospital of Athens, 3Laboratory of
Biological Chemistry, Medical School, National and Kapodistrian
University of Athens, 4Laboratory of Food Chemistry and Human
Nutrition, Department of Food Science and Human Nutrition,
Agricultural University of Athens, 5First Department of Internal
Medicine, Laiko General Hospital of Athens, Athens, Greece
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Rationale: The study of the correlation of nutritional status with
inflammation markers in patients with pancreatic cancer receiving
chemotherapy.
Methods: In a sample of 52 patients (27 men) with mean age
68,27 ± 9,45 years with pancreatic cancer nutritional risk was
evaluated with Mini Nutritional Assessment Screening Form (MNA-
SF) and muscle functionality was evaluated with hand grip dynamo-
metry prior to the initiation of their treatment. Moreover, cytokine
levels, namely (IL-6, IL-10, IL-8 and TNFa were measured at the
beginning and after 3 months of treatment.
Results: According to the nutritional screening, 32.1% of the patients
were found to be malnourished, 42,9% at high risk of malnutrition and
only 12,5%were found to be at a normal nutritional status.15.4% of the
patients had normal muscle power while 84,6% of the patients were
dynamopaenic. Nutritional status at the beginning of chemotherapy
was strongly negatively associated (r =−0,747, p = 0,009) the increase
of the levels of IL-8, while body mass index (BMI) was negatively
associatedwith the increase in the levels of IL-10 (r =−0,837, p = 0,001)
and IL-6 (−0,707, p = 0,001) in the first trimester of the treatments.
Conclusions:Malnutrition in patients with pancreatic cancer is highly
prevalent. Nutritional status malnutrition risk and BMI seems to be
associated with an increase in inflammation markers during
chemotherapy.
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Rationale: The aim of the study was the evaluation of nutritional risk,
the quality of life and the nutritional intervention in patients with
pancreatic cancer before the initiation of chemotherapy.
Methods: In a sample of 52 patients (27 men) with mean age
68,27 ± 9,45 years with pancreatic cancer nutritional risk was
evaluated with Mini Nutritional Assessment Screening Form (MNA-
SF) and muscle functionality was evaluated with hand grip
dynamometry prior to the initiation of their treatment. Moreover,
the provision of nutritional advice or artificial nutritional support in
the past twelve months – enteral or parenteral – was also reported
and quality of life (QoL) was evaluated with EORTC-QLQ-C30
questionnaire
Results: According to the nutritional screening 32,1% of the patients
were found to be malnourished, 42,9% at high risk of malnutrition
and only 12.5% at good nutritional status prior tto the initiation of
chemotherapy. The percentage of weight loss in the past 3 and 6
months was 23,2 ± 7,0% και 30,0 ± 11,9% accordingly. Only 15.4% of the
patients were found to have normal muscle functionality, where
84,6% were found to be dynamopaenic. From the patients found at
high risk of malnutrition or were categorized as malnourished 54,7%
received nutritional advice in the past year, 2% (1/49) received enteral
nutrition and 6% (3/49) parenteral nutrition. The mean QoL score was
55,38 (range 0–100), and it was found to have a trend of positive
correlation with the nutritional risk as evaluated MNA – SF (r = 0,267,
p = 0,087).
Conclusions:Malnutrition in pancreatic cancer patients was found to
be non identified and not treated early enough, something that had a
negative impact in the quality of life of the patients. Manysteps should
be taken in order to raise awareness in oncologists in order to take
early measures against malnutrition in these patients
Disclosure of Interest: None declared.
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INSULIN RESISTANCE MARKERS IN FEMALE BRCA1/2 MUTATION
CARRIERS (LIBRE STUDY)
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2Department of Gynecologyand Center for Hereditary Breast and Ovarian
Cancer, Klinikum rechts der Isar, Technical University Munich (TUM),
Munich, Germany
* Corresponding author.
Rationale: Mediterranean diet (MedD) appears to have protective
effects against sporadic breast cancer (BC). The ongoing randomized
LIBRE studyexamines the impact of a lifestyle intervention comprising
MedD on hereditary BC, with the intervention already shown to
increase adherence toMedD in LIBRE-1 [1]. In this interim analysis we
investigate the possibility that some positive effects may be due to an
improved insulin sensitivity.
Methods: The intervention group (IG) receives a 1-year program
including physical exercise and group sessions on MedD, the control
group (CG) only two lessons on healthy lifestyle. Homeostasis model
assessment index of insulin resistance (HOMA2-IR) and different
clinical composite measures including BMI or waist circumference,
blood pressure, fasting glucose and serum lipids are calculated at study
entry (SE) and after 12 months (V2) in hitherto n = 422 subjects.
Nutrition habits and adherence to MedD are assessed by question-
naires. Statistics: paired t-test, Kendall’s tau-b, Mann-Whitney-U.
Results:At SE, themean BMI in the study populationwas 25.3 ± 5.2 kg/
m2, age 43.4 ± 10.3 years and HOMA2-IR 1.0 ± 0.73. There were no
changes from SE to V2 in fasting insulin, HOMA2-IR, Standl/Biermann,
ATP III or IRIS II scores in either study arm. In subjects with
BMI≥ 25 kg/m2, negative correlations between adherence to MedD
and fasting insulin (r =−0.128, p = 0.036) and HOMA2-IR (r =−0.134,
p = 0.036) were found at SE. In this subgroup, subjects consuming ≥3
portions of nuts per week and those who limit their consumption
of red and processed meat to <1 portion per day had lower fasting
insulin (p = 0.025 and p = 0.015) and HOMA2-IR (p = 0.026 and
p = 0.025) at SE.
Conclusions: No clear effects of the intervention on glucose
metabolism are evident in either study arm in this interim analysis
of a rather healthy study population. However, overweight subjects
appear to benefit from following the MedD by presenting more
favorable glucose metabolism parameters. The multiple feedback
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interaction between glucose, insulin, glucagon, body fat, blood lipids,
nutrition or lifestyle habits and other variables is nevertheless worth
to be addressed after study completion. Different risk calculators of
insulin resistance, especially in a subgroup of BMI≥ 25 kg/m2, will be
compared.
Reference
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ELEMENTAL DIET ELENTAL® IN ORAL CANCER TREATMENT
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Rationale: We have reported the effectiveness of elemental diet (ED)
Elental® against oralmucositis due to oral cancer treatment (Support Care
Cancer 2016, Mol Clin Oncol 2018). However, enough nutrition admin-
istrationtopatientswithoral cancermayprovidegoodnutritionforcancer
cells, which results in cancer development. At present, it is still unclear
whether ED canexert a beneficial effect than above sacrifice in oral cancer
treatment. In the present study, we investigated themechanisms of onset
of ED as well as effectiveness of ED in oral cancer treatment.
Methods:We evaluated the efficacy of ED on growth ability, migration
ability, expression of pro-inflammatory cytokines including tumor
TNF-α, IL-1β and IL-6, and nuclear factor-κB (NF-κB) in human
keratinocytes (HOK and HaCaT) and human oral squamous cell
carcinoma cell (HSC2) by MTT assay, Western blotting and ELISA. In
addition, we examined the ED-mediated inhibitory mechanisms of
oral mucositis by microarray analysis and network analysis.
Results: Our results indicated that ED promoted the growth and
migration of malnutrition HOK. In addition, ED inhibited the nuclear
transition of p65 NF-κB is known to regulate inflammatory cytokine
expression in the keratinocytes. Moreover, ED reduced the expression
or production of TNF-α, IL-1β and IL-6 significantly (P < 0.01).
Furthermore, ED was implicated in the proliferation and survival of
HOK through the integrin-mediated activation of ERK, and that ED
induced apoptosis of HSC2 through the induction heat shock protein
via the activation of unfolded protein response.
Conclusions: These findings suggested that ED might add stress to
cancer cells, and give growth stimulation to normal cells. It was also
suggested that the inhibitory mechanisms of mucositis aggravation by
ED might be involved in the promotion of proliferation and migration
of oral mucosal cells, the suppression of pro-inflammatory cytokine’s
expression through inhibition of NF-κB, and the maintenance of
proliferation and survival of oral mucosal cells through the integrin-
mediated activation of ERK.
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Rationale: Chemo-radiotherapy is the standard treatment in locally
advanced stages. The treatment effects are observed in clinical
manifestation as anorexia, nausea, vomiting, weight loss, alterations
in immune function, and body composition. Accelerate loss of fat-free
mass and skeletal muscle are independent predictor of severe toxicity
cancer treatment and associated with a worse prognosis.
Methods: Longitudinal studywas performed in 91womenwith locally
advanced cervical cancer IB2-IVA older than 18 years old were
included. Chronic kidney disease, lupus, HIV was excluded. Body
composition was evaluated with bioelectrical impedance. A repeated
measure ANOVAwas performed to evaluate body composition changes
before, baseline, during the treatment at week 3, and at week 9 after
treatment.
Results: The mean age was 48.7 ± 14.4, and mean weight 63.2 ± 11.7.
During the follow-upwe observed a statistics significance decreased in
body weight (64.72 ± 11.76, 63.75 ± 11.23, 61.8 ± 11.4, 59.01 ± 11.58,
p < 0.001); Body Mass Index (27.93 ± 4.83, 25.92 ± 8.06, 23.15 ± 10.48,
17.41 ± 12.80, p < 0.001); Body Cell Mass (23.5 ± 3.4, 23.0 ± 3.5,
22.4 ± 3.4, 22.3 ± 4.2, p = 0.043); phase angle (5.51 ± 0.79, 5.6 ± 0.78,
5.4 ± 0.78, 5.0 ± 0.93, p < 0.001); hand grip strength (20.83 ± 4.83,
20.62 ± 5.27, 20.9 ± 4.99, 19.0 ± 5.1, p < 0.001). However not difference
were observed in muscular mass index and fat-free mass. Also quality
of life score decreased (66.5 ± 28.7, 51.05 ± 39.41, 36.63 ± 47.11,
33.03 ± 49.36, p < 0.001).
Conclusions: Women with cervical cancer had a deteriorated body
composition and quality of life due to chemoradiotherapy treatment.
Which could have negative implications in prognosis.
Disclosure of Interest: None declared.
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NUTRITIONAL AND BODY COMPOSITION CHANGES DURING
RADICAL TREATMENT FOR LOCALLY ADVANCED HEAD AND NECK
CANCER (LA-HNC) PATIENTS
L. Arribas1,2,3, A. Sabaté4, M. Taberna1,2,5,6, L. Hurtós3*, A.R. González-
Tampán2, I. Peiró2,3, M. Sospedra2, E. Vilajosana1,6, A. Lozano1,7,
N. Virgili8, R. Mesia1,9,10, V. Baracos11. 1Head and Neck Cancer Unit,
Bellvitge University Hospital-Catalan Institute of Oncology (ICO),
2Bellvitge Biomedical Research Institute (IDIBELL), 3Clinical Nutrition
Unit, Catalan Institute of Oncology (ICO), 4Department of Nuclear
Medicine, PET Unit-IDI, Bellvitge University Hospital, 5Cancer
Epidemiology Research Program, 6Medical Oncology Department,
7Radiation Oncology Department, Catalan Institute of Oncology (ICO),
8Nutrition and Dietetics Unit, Nutrition and Endocrinology Department,
Bellvitge University Hospital, L’Hospitalet de Llobregat, Barcelona,
9Applied Research Group in Oncology (B-ARGO Group), 10Medical
Oncology Department, Catalan Institute of Oncology (ICO), Badalona,
Barcelona, Spain, 11Palliative Care Medicine, Department of Oncology,
University of Alberta, Cross Cancer Institute, Edmonton, Canada
* Corresponding author.
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Rationale:We aim to evaluate body composition (BC) and nutritional
changes that occur throughout radical treatment for LA-HNC patients.
We also aim to compare these changes in patients undergoing
chemoradiotherapy (CRT) vs bioradiotherapy (BRT).
Methods: This is a longitudinal retrospective single center study of a
cohort of patients diagnosed with LA-HNC that underwent treatment
with induction chemotherapy (iCT) followed by CTR or BRT. At
diagnosis BC was measured by analyzing a single slice at the level of
L3 of a PET/CT scan. This technique was repeated 3 months after
finishing the treatment. All patients received nutritional assessment at
diagnosis and nutritional support throughout the treatment as needed.
Results: A total of 40 patients were included. Patients were mainly
men (38, 95%) with amean age of 56.8 years (SD 7.92) and oropharynx
as the primary tumor (19; 47.5%) diagnosed in advanced stages (IVb:
21, 52.5%). At diagnosis 45% (18) showed symptoms that interferewith
oral feeding: anorexia 12.5% (5), dysphagia 32.5% (13) and odynopha-
gia 37.5% (15). Baseline malnutrition was 37.5% (n = 15) with 7 (17.5%)
severely malnourished. All patients received dietetic counseling by an
oncology dietitian, 10 patients (25%) added nutritional supplements
and 5 patients (12.5%) needed nasogastric tube due to dysphagia G3.
The cut-points for skeletal muscle index (SMI) classified 7 (17.5%)
patients as sarcopenic before starting the iCT but only 2 were
malnourished. Sarcopenic obesity (BMI≥ 25 kg/m2) was shown in 2/
16 obese patients. Sarcopenia also increased from 17% to 40%
(p = 0.001) decreasing the SMI from 51.5 cm2/m2 to 47.3 cm2/m2
(p < 0.001; 95% CI 2.52; 5.85). During the oncoespecific treatment,
total adipose tissue (TAT) was significantly reduced (p < 0.001; 95% CI
30.85; 103.38) at expenses of visceral adipose tissue (VAT) mainly
(P < 0.001; 95% CI 25.25; 73.75). There was no significant difference
between patients undergoing CRT or BRT (p = 0.506).
Conclusions:
• Significant nutritional and BC changes occur during radical
treatment for LA- HNC patients
• Malnutrition and sarcopenia increase along with the treatment
• There are no significant changes in BC between patients undergo-
ing CRT and BRT
Disclosure of Interest: None declared.
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INVESTIGATION OF THE GUT MICROBIOTA COMPOSITION AND
ACTIVITY IN ACUTE MYELOID LEUKEMIC PATIENTS: FIRST
CLINICAL RESULTS OF THE MICROAML STUDY
S.A. Pötgens1, F. Bindels1, V. Havelange1, J.-B. Demoulin1, I. Moors2,
T. Kerre2, J. Maertens3, H. Schoemans3, N. Delzenne1, L. Bindels1*.
1Université catholique de Louvain, Bruxelles, 2Ghent University Hospital,
Ghent, 3Leuven University Hospitals, Leuven, Belgium
* Corresponding author.
Rationale: The gut microbiota, a key regulator of host metabolism and
immunity, is affected in preclinical models of leukemia and cachexia.
Reversing these changes in the gut microbiota can provide benefits in
terms of muscle mass loss and quality of life, among others. However,
the translational value of this work is unclear.
Methods: The MicroAML study is a multi-centric, prospective,
observational study. Its primary objective is to assess the composition
and activity of the gut microbiota in patients diagnosed with acute
myeloid leukemia (AML) (n = 30) in relationship with the patients’
food habits and cachectic hallmarks (e.g. appetite, muscle strength,
body composition). Biological samples and clinical data are collected
before any therapeutic intervention, after the first cycle of chemo-
therapy and 4 weeks later.
Results: Currently, 20 patients have completed the study. Compared to
BMI-, sex- and age-matched control subjects, AML patients do not
show at diagnostic significant difference in body composition, quality
of theirdiet andmuscle strength. In thesepatients, bloodparameters (i.
e. CRP, glycemia and albumin) are altered, as an early sign of metabolic
alterations. After the first cycle of the chemotherapy, AML patients
displayadecrease inBMI (due tomusclemass loss) aswell an increased
occurrence of anorexia and diarrhea. Gut microbiota composition and
activity will be analyzed, once the recruitment is completed, using
shotgun metagenomics and 1H-NMR metabolomics, respectively.
Conclusions: Our first results show early signs of metabolic alterations
in AML patients at diagnostic, with the development of overt cachexia
after the first cycle of chemotherapy. Whether these signs are related to
changes in gutmicrobiota composition and activity will be investigated.
ClinicalTrials.gov Identifier: NCT03881826
Disclosure of Interest: None declared.
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VISCERAL FAT ASSESSED BY THIRD LUMBAR VERTEBRA (L3)-
TARGETED CT AFFECTS SURVIVAL AND RECURRENCE AFTER
CURATIVE LIVER RESECTION FOR INTRA HEPATIC
CHOLANGIOCARCINOMA (ICC)
L. Lacaze1,2*, D. Bergeat1,3, C. Rousseau4, L. Sulpice1,3, D. Val-Laillet1,
K. Boudjema1,3, R. Thibault1,2. 1INRA, INSERM, Univ Rennes, Nutrition
Metabolisms and Cancer, NuMeCan, 2Nutrition Unit, 3Digestive and
Hepatobiliary Department, Univ Rennes, Chu Pontchaillou, 4Biostatistics
Unit, Chu Pontchaillou, Rennes, France
* Corresponding author.
Rationale: Body composition (BC) was identified to be independently
associated with poor prognosis in hepatocellular carcinoma.
Measuring visceral fat (VFA), subcutaneous fat (SCFA), intramuscular
fat (IMFA) and muscle mass areas (MMA) on computed tomography
(CT) is a simple tool to evaluate body composition.
Aim: To evaluate the impact of body composition in patients who
underwent liver resection for ICC and to assess the prognostic impact
on patients’ survival and recurrence.
Methods: All consecutive patients who underwent liver resection for
ICC between 2004 and 2016 and who had available preoperative CT
scanwere included. BCmeasurementwas performed at the transversal
level of the L3 by one single non-radiologist operator with the ImageJ
softwarewith a threshold range between−29 and +150 corresponding
to muscle density and between −190 and −30 corresponding to fat
density. Low MMA was defined as less than 38.5 cm2/m2 in females
and 52.4 cm2/m2 in males. Univariate and multivariate analysis for
overall survival (OS) and disease-free survival (DFS) were realized
using the Cox model.
Results: 102 patients were included. 74% men, median age 67 yrs, 82%
ASA score ³2. 61% had low MMA. Median IMFAwas 2030,19 mm2, VFA
was 14890,19 mm2, SCFAwas 14278,7 mm2. On multivariate analysis,
VFA was found to be an independent predictor of OS (Hazard ratio
(HR) = 1.02 [95% confidence interval (CI), 1.01–1.02], p < 0.0001) and
DFS (HR = 1.02 [1.01–1.03], p = 0.0003). Pulmonary complications
(HR = 16.63[4.30–64.33], p < 0.0001), sepsis (HR = 2.46 [1.30–4.63],
p = 0.0055), per operative transfusion (HR = 2.07 [1.14–3.73], p =
0.0161), more than one tumor (HR = 2.29 [1.23–4.24], p = 0.0086)
were also found to be associated with a poor OS. Perinervous invasion
(HR = 3.29 [1.75–6.19], p = 0.0002), sepsis (HR = 3.75 [1.81–7.74], p =
0.0003),more than one tumor (HR = 2.42 [1.28–4.60], p = 0.0068)were
also found to be associated with a poor DFS.
Conclusions: VFA is an independent prognostic factor of poor OS and
DFS in European patients with resectable ICC. Low MMA, IMFA and
SCFAwere not found to be prognostic factors.
Disclosure of Interest: None declared.
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ANALYSIS OF SURVIVAL AND PREDICT FACTORS OF SURVIVAL IN
PATIENTS ON HOME PARENTERAL NUTRITION
L.C. Sun1,2*, Y.L. Shih1,2, H.L. Tsai2,3,4, J.Y. Wang2,3,4. 1Division of Nursing,
2Nutrition Therapy Team, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, 3Department of Surgery, Faculty of
Medicine, College of Medicine, Kaohsiung Medical University, 4Division
of Colorectal Surgery, Kaohsiung Medical University Hospital, Kaohsiung
Medical University, Kaohsiung, Taiwan, Province of China
* Corresponding author.
Rationale:Home parenteral nutrition (HPN)might prolong survival in
incurable cancer patients beyond the usually expected time span;
moreover, HPN is themainstay of treatment for patientswith intestinal
failure. The aim of this study was to investigate the predict factors of
survival for patients undergoing HPN.
Methods: Five-hundred and twenty-seven patients receiving HPN
were enrolled between April 2004 and December 2018. The study
endpoint was either the end of weaned-off HPN or death on HPN.
Multivariate Cox regression analysis and Kaplan Meier survival curves
was used for the statistical analysis.
Results: Therewere 305 (57.9%) males and 222 (42.1%) females, with a
mean age of 60.98 ± 15.11 years. Of 527 patients, 475 (90.1%) patients
were with malignancy and 52 (9.9%) patients were non-malignant
disease. Median HPN administration period was 97.25 (range, 1–3782)
days, with the median overall survival (OS) of 2.0 months (1.66–2.33
months). Low serum albumin level (<3.5 g/dl) was significantly
correlated with a shorter OS than normal serum albumin level (1.0
vs. 3.0 months, p = 0.002). High serum C-reactive protein (CRP) level
had an inverse correlation with OS (1.0 vs. 2.0 months, p < 0.001).
Moreover, Non-cancer patients associated with better OS (5.0 vs. 2.0
months, p < 0.001). Kaplan-Meier survival plots depicted a worse
prognosis of HPN if the low serum albumin level (p = 0.002),
malignancy (p < 0.001) and high serum CRP level (P = 0.002).
Conclusions: The use HPN in clinical care is trend of treatment.
Individualized therapy with a multidisciplinary team in hospital with
HPN expertise is mandatory. Low serum albumin level and high serum
CRP level may assist to predict thosewho are likely to have aworse OS
on HPN.
Disclosure of Interest: None declared.
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FAT QUALITY CORRELATES WITH PROGNOSIS OF ESOPHAGEAL
CANCER
M. Anciaux1*, A. Van Gossum2, C. Wenglinski3, L. Ameye4, T. Guiot5,
P. Flamen5, P. Demetter6, A. Deleporte3, M. Paesmans4, V. Donckier7,
A. Hendlisz3, C. Vandeputte1. 1Gastro-Oncology Laboratory, Institut Jules
Bordet, 2Department of Gastroenterology and Nutritional Support,
Hôpital Erasme and Institut Jules Bordet, 3Department of Medical
Oncology, 4Data Centre, 5Department of Nuclear Medicine, 6Department
of Pathology, 7Department of Surgery, Institut Jules Bordet, Bruxelles,
Belgium
* Corresponding author.
Rationale: Sarcopenia and weight loss carry a bad prognosis in
esophageal cancer (EC). We studied retrospectively the impact of body
mass composition (BMC) on the patient’ outcome in EC.
Methods: CT-based BMC was evaluated at diagnosis in 152 locally
advanced EC. For 50 patients (33%) having undergone a neoadjuvant
treatment (chemo- or chemoradiotherapy), a second preoperative CT
scan was analyzed. The index (area/height2) of skeletal muscle (SMI),
subcutaneous (SFI) and visceral fat (VFI) was delineated on two
adjacent slides at the third lumbar vertebra level by two independent
investigators using PLANET ONCO® software (DOSIsoft, France). Tissue
quality was measured by assessing the mean density of each area.
Survival was calculated from date of baseline CT-scan.
The difference between the two timepoints were calculated for the
indexes and the densities as delta (Δ).
The sex-specific median of each BMC parameter was used as a
threshold to separate patients into high and low group.
Sarcopenia was defined following the criteria of Prado et al. (Lancet
Oncol, 2008), while high and low BMI were defined based on the
median.
Results: Interobserver correlation was excellent for all BMC para-
meters measured (r = 0.94 to 0.99). We confirmed that patients with
sarcopenia had a poorer prognosis (HR 1,72 [95% CI 1,11–2,65],
p = 0.01). At baseline, patients with low VFI showed worse prognosis
compared to patients with high VFI (HR 1,56 [95% CI 1,01–2,40],
p = 0.04). Remarkably, high subcutaneous fat density (SFD) (HR 2,22
[95% CI 1,43–3,42], p = 0.0003), as well as high visceral fat density
(VFD) (HR 1,73 [95% CI 1,12–2,66], p = 0.01), also distinguished patients
with poor outcome. In contrast, low BMI was not correlated with
patient prognosis (HR 1,2 [95% CI 0,78–1,9], p = 0.4).
SMI (p = 0,0006), SFI and VFI (p < 0,0001) decreased along time and
treatment. Interestingly, a gain in VFI did not affect patient prognosis
(HR 1,6 [95% CI 0,77–3,5], p = 0.19), while patients who gained in SFI
showed a better outcome (HR 0,43 [95% CI 0,22–0,85], p = 0.01). In
contrast, ΔSFD showed no prognostic value (HR 1,6 [95% CI 0,8–3],
p = 0.16), while patients who gained in VFD displayed a poor outcome
(HR 2,38 [95% CI 1,22–4,64], p = 0.007).
Conclusions: These results confirm the prognostic value of BMC
assessment, although the cohort needs to be extended to study the
impact of treatment on BMC parameters. This study questions the
fundamental mechanism of density variation in adipose tissue in EC
but also in other cancers.
Reference
Prado CMM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical
implications of sarcopenic obesity in patients with solid tumours of
the respiratory and gastrointestinal tracts: a population-based
study. The Lancet Oncology. 2008;9:629–635.
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EVALUATION OF BODY MASS AND BODY COMPOSITION AMONG
WOMEN TREATED FOR BREAST CANCER DURING TREATMENT
M. Maciejewska-Cebulak1*. 1Department of Oncology and Radiotherapy,
Medical University of Gdansk, Gdańsk, Poland
* Corresponding author.
Rationale: Breast cancer is themost frequent type of cancer inwomen
and the second leading cause of death. The risk of breast cancer
depends onmany factors including physical exercise and eating habits.
Obesity is a known risk factor for breast cancer and many other types
of neoplasms. The correlation between body weight (bw) and
treatment efficacy measured by the patients’ outcomes has also been
proven. Proper nutrition and physical activity determine normal bw
and the appropriate level of body fat.
Methods: This prospective study aimed to evaluate the impact of
oncological diagnosis and therapy on bw, body mass index (BMI), and
body composition inwomen treated for breast cancer. The study group
included 60 consecutive patients aged 34–81 years (median 57.5)
treated in two oncological centers. In all patients, after obtaining the
informed signed consent, bw and composition were analyzed with
bioelectrical impedance (body composition analyzer Tanita BC
420MA). The waist-hip ratio (WHR) was calculated using a standard
mathematical formula. The measurements were conducted at four
time points: at baseline – before oncological treatment (chemotherapy
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and radiotherapy), during treatment (two to fourmonths after the first
measurement), during the follow-up (two and six months after
finishing therapy).
Results: At baseline, excessive body weight (BMI > 25 kg/m2) was
found in 33 patients (55%), the average BMI was 27.4 (range 16.4–
48.2; median 25.9. Body fat ≥30% (mean 34.6%) was found in 45
patients (75%). The healthy body fat was found in 26 patients
(normal range 21–33% age 20–39; 23–34% age 40–59; 24–36% age
60–79). The mean WHR for the whole group was 0.86, while in
women with excessive body fat the median WHR was 0.89. There
were significant differences in bw and body fat between the first and
the fourth measurements, but not in WHR. The increase in bw
correlated with increased body fat. There were no correlations
between any of the analyzed factors and the stages or histopatho-
logical differentiation of cancer.
Conclusions: Excessive body weight, increased levels of total fat,
increased WHR confirm that overweight and obesity are prevalent in
breast cancer patients. Moreover, body weight and body fat signifi-
cantly increase after the oncological treatment. Dietary intervention is
a must to protect women treated for breast cancer against excessive
body fat/weight and maintain a healthy weight.
Disclosure of Interest: None declared.
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INFLUENCE OF NUTRITIONAL STATUS INDEXES ON OUTCOMES IN
PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL
TRANSPLANTATION
M. Cayón-Blanco1*, C. García-Figueras-Mateos2. 1Endocrinology and
Nutrition Unit, 2Internal Medicine, Universitary Hospital Jerez de la
Frontera, Jerez De La Frontera, Spain
* Corresponding author.
Rationale: Several analysis have assesed that both underweight and
very obese adults patients subjected to hematopoietic stem cell
transplantation (HSCT) have worse outcomes but few studies are
focussed on other nutricional parameters. We aimed to assess the
value of anthropometric indexes and serum albumin as predictors for
one-year follow-up outcomes in HSCT patients in a cohort without
extreme values of body mass index (BMI).
Methods: A retrospective analysis was conducted. Data from patients
with hematological malignancies subjected to HSCTand who received
specialized nutricional support during their first transplantationwere
taken from the electronic medical record. Nutritional status was
categorized based on BMI, percentage of weight loss (PWL) and
albumin level. Endpoints included in-hospital mortality, overall
mortality and need for assistance in an emergency ward or
hospitalization from day 0 after discharge to +180 and from day +181
to +360.
Results: 33 patients were evaluated. 39.4% had hypoalbuminemia
(albumin <3.1 g/dL). All patients received nutricional support.
Mortality rate during hospital stay was 51.5%. PWL >5% was linked to
a higher rate of mortality during HSCT (81.8% vs 35%; p = 0.04).
Hypoalbuminemia was more frequently found among patients who
died during hospitalization as well as in thosewho required assistance
in emergency wards in period day 0 after discharge to +180, but only
the second finding reached statistical significance (p = 0.8 and p = 0.02,
respectively). No other differences were found according to any
nutritional index in outcomes at days +180 to +360.
Conclusions:Weight loss higher than 5% influences on earlymortality
rather than BMI or albumin levels in adult patients undergoing HSCT
without extreme values of BMI. Albumin is postulated as a good
predictor for short-term clinical outcomes. Further studies with a
larger number of patients are ongoing in our centre to clarify this term.
Disclosure of Interest: None declared.
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IMPACT OF NUTRITIONAL SUPPORT AND COUNSELING DURING
CHEMOTHERAPY ON THE QUALITY OF LIFE OF OVARIAN CANCER
PATIENTS. PRELIMINARY RESULTS FROM A PROSPECTIVE STUDY
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Gastroenterology – Gastroenterology Area, Fondazione Policlinico ‘A.
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* Corresponding author.
Rationale: Quality of life is an emergent topic in cancer therapy. To
evaluate the impact of nutritional support and counseling delivered
during chemotherapy session on the quality of life of patients affected
by ovarian cancer.
Methods: A prospective, observational pilot study was performed
from September 2017 to June 2018, in women affected by ovarian
cancer during the first cycle of chemotherapy with platin and taxol-
based drugs. Enrolled patients received, during each chemotherapy
session, a bag containing 50 g of sugar free candied ginger, a sandwich
and a cracker made with ancient Italian Sicilian, stone ground wheat
(Timiliadurum organic wheat), organic olive oil, organic vegetables,
sugar free vegan yeast, sunflower seeds and untreated lemon peel, 5
organic almonds from the ‘AltaMurgia National Park (Italy)’ or almond
from Avola (Italy), and 50 g of organic Peruvian fresh ginger root.
Clinical Nutritionists and Dietitians organized two meetings per
month for six months offering nutritional counseling during chemo-
therapy sessions. At the first visit, both the EORT Quality of Life
Questionnaire (QLQ-C30) and the ‘Quality of Life and Nutrition
Questionnaire’ (QoL-NQ) were administered to all patients enrolled.
Both questionnaires were repeated at the end of the study period. Data
collected were evaluated with a paired t-test. A p < 0.05 was
considered statistically significant.
Results: 82 patients were enrolled, and 75 patients completed the
study. Mean agewas 59 ± 17 years. Each patient accepted to participate
at least in one meeting a month and at least in three meetings in total.
QLQ-C30 increased from 60.9 ± 21.1 to 64.7 ± 19.9 (p = 0.04);moreover,
both the emotional function score and nausea and vomiting score
improved. The QoL-NQ increased from 128.2 ± 22.0 to 135.1 ± 19.4
(p = 0.03).
Conclusions: Nutritional support during chemotherapy may enhance
the quality of life in ovarian cancer patients. Structured planning to
ameliorate the hospital’s food and nutritional counseling should be
advisable.
Disclosure of Interest: None declared.
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PATIENT PREFERENCE AND ACCEPTABILITY FOR READY TO DRINK
VERSUS POWDERED ORAL NUTRITIONAL SUPPLEMENTS
A.L. Cawood1*, E.R. Walters2, T.R. Smith3, R.J. Stratton1. 1Faculty of
Medicine, 2Faculty of Health Sciences, University of Southampton,
3Department of Gastroenterology, University Hospital Southampton
NHS Foundation Trust, Southampton, United Kingdom
* Corresponding author.
Rationale: Oral nutritional supplements (ONS) are an evidence-based
strategy to manage malnutrition1, however little is known about
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patient preferences to the types of ONS available. This survey, in older
patients who had recently been prescribed both ready to drink ONS
and powdered ONS were asked to rate both products.
Methods: Fifty patients (50–73 y, 58% male, mean BMI 22 ± 3 kg/m2),
with a range of diseases including GI, COPD, Stroke and Cancer,
residing in their own home, whose prescriptions were recently
changed either from a ready to drink, energy dense, low volume
(125 ml) ONS (variety of manufacturers), to a powdered ONS
(reconstituted to >230 ml; variety of manufacturers) or vice versa,
rated both products (convenience, consistency, mouth feel, thickness,
taste, ease of use, compliance and overall preference) on a Likert scale
(1 very poor – 5 excellent) via electronic questionnaire. Statistical
analysis was undertaken using SPSS v23, including binomial (compli-
ance), paired t-test (preference) and Wilcoxon signed rank tests,
results reported as mean±SD.
Results: Patients significantly preferred the ready to drink ONS (70%),
to the powdered ONS (30%) (p = 0.007) and reported a significantly
greater compliancewith the ready to drink ONS (73% v 67%; p = 0.031).
Patients reported the ready to drink ONS was significantly more
convenient (4.4 ± 0.79 v 3.6 ± 0.99; p = 0.000); with a better consist-
ency (4.0 ± 1.0 v 3.6 ± 0.95; p = 0.017) andwas easier to use (4.4 ± 0.92 v
3.7 ± 1.15; p = 0.001) and prepare (4.4 ± 0.86 v 3.4 ± 0.97; p = 0.000).
There were no differences between the types of ONS in terms of
thickness, mouth feel, and taste.
Conclusions: This survey suggests that patients prefer ready to drink
ONS to powdered ONS and compliance is significantly better. A larger
survey with an assessment of outcomes is required. Patient prefer-
ences and ability to use ONS should be considered when making
evidence-based decisions on nutrition support.
Reference
1. Stratton RJ, Smith TR, Gabe S (2018) Managing Malnutrition to
improve lives and save money https://www.bapen.org.uk/pdfs/
reports/mag/managing-malnutrition.pdf
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ADHERENCE TO THE MEDITERRANEAN DIETARY PATTERN IN
RELATION TO CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A
CASE CONTROL STUDY
S. Kakavas1, D. Karagiannis2, A. Papanikolaou1*, A. Almperti2,
A. Baschali2, Z. Mastora3, G. Boulbasakos1. 1Pulmonary Department,
2Clinical Nutrition and Dietetics, 3First Department of Critical Care
Medicine and Pulmonary Services, Medical School of Athens University,
Evangelismos District General Hospital of Athens, Athens, Greece
* Corresponding author.
Rationale: Recent evidence suggests there is an association between
dietary patterns and lung function.1 The purpose of this study was to
examine the adherence to the Mediterranean Dietary Pattern among
COPD patients in comparison to subjects without COPD.
Methods: A case control study constituting 32 COPD patients
consecutively hospitalized with acute exacerbation and 40 patients
without COPD. To estimate habitual food and alcohol intake all
participants filled out a validated for the Greek population food-
frequency questionnaire (FFQ), which included 75 items (foods and
beverages commonly consumed in Greece and dietary habits)2
Adherence to the Mediterranean diet was assessed using a
Mediterranean diet score, the MedDietScore, and subjects were
classified into tertiles according to individual adherence scoring.
Weight, height, mid-upper arm circumference (MUAC), waist circum-
ference (WC), handgrip strength and body compositionmeasurements
were taken by a trained dietitian.
Results: The mean age of participants was 52.3 years. There was a
negative correlation between WC and MedDietScore (r = 0.336, p <
0.001). Average smoking in the COPD groupwas about 33.5 pack-years.
Significant differences were found for MedDietScore score between
patients with COPD and control subjects (30.8 ± 3.6 vs 33.4 ± 3.8,
p = 0.02). Mean fruit, vegetable, whole wheat cereals (serving/
1000 kcal/day) and dietary fiber (gr/day) intakewere lower in patients
with COPD compared to control subjects (2.1 vs 2.9, 2.2 vs 2.7, 1,3 vs
2,2, and 11.1 vs 17.2, all p < 0.05, respectively).
Conclusions:We observed that adherence to a Mediterranean dietary
pattern among patients with COPD was significantly lower compared
to the control group.
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SUN-PO122
ANTIOXIDANT EFFECTS OF HERBAL MIXTURE INFUSION
(HORCHATA) ON CIGARETTE SMOKERS: EX VIVO STUDY
A.M. Chisaguano1*, M.M. Guevara2, S. Valencia1, P. Beltrán3, J.
M. Alvarez-Suarez2. 1Escuela de Salud Pública. Nutrición y Dietética,
Universidad San Francisco de Quito, 2Grupo de Biotecnología Aplicada a
Biomedicina (BIOMED), Universidad de Las Américas, 3Facultad de
Economía, Universidad San Francisco de Quito, Quito, Ecuador
* Corresponding author.
Rationale: The Horchata drink is a popular herbal tea infusion,
normally ranging from 16 to 32 locally-produced plants, has been
consumed in the province of Loja, located in the southern inter-
Andean region of Ecuador, since colonial times. However, there are few
studies that analyze the chemical composition and biological effects.
Thus, in this study we determine the phytochemical composition and
the protective effect of the horchata infusion against oxidative damage
in smokers.
Methods: The characterization of phenolic acids, flavonoid and
anthocyanins were performed by HPLC-DAD/ESI-MSn. This study
was carried on erythrocytes and plasma from 20 smokers and 20 non-
smokers. The lipid profile and the enzymatic activity of catalase and
GSHwas determined in plasma, while the spontaneous hemolysis was
determined in erythrocytes. Statistical analysis was performed using
SPSS 22.0.
Results: Caffeoylquinic acids, flavones and flavonols (mostly quercetin
glycosides) were prominent in the extract. On the other hand, no
significant differenceswere observed in the lipid between the smokers
and non-smokers. The spontaneous hemolysis was significantly
higher (P < 0.05) in smokers compared to non-smokers after 5 h.
Furthermore, when erythrocytes were incubated with the horchata
extract in the smokers group, the spontaneous hemolysis was
significantly lower (P < 0.05) compared to the not-treated group. The
catalase and GSH activity was improved in both groups after
incubation with horchata extract.
Conclusions: The horchata extract reduce the oxidative damage in the
smokers erythrocytes, improving the spontaneous hemolysis as well
as improve the activity of the antioxidant enzymes in plasma.
Disclosure of Interest: None declared.
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SUN-PO123
PLASMA BAIBA LEVELS IN HEMODIALYSIS AND ITS ASSOCIATION
WITH BODY COMPOSITION AND PHYSICAL ACTIVITY CHANGE: A
LONGITUDINAL STUDY
A. Molfino1*, M.I. Amabile1, S. Lai1, L. Lionetto1, T. Amman2, A. Grosso2,
A. Spagnoli1, M. Simmaco1, M.G. Chiappini2, A. Laviano1,
M. Muscaritoli1. 1Sapienza University of Rome, 2Fatebenefratelli
Hospital, Isola Tiberina, Rome, Italy
* Corresponding author.
Rationale: Low physical activity is frequent in end stage renal disease.
We evaluated the longitudinal change in physical activity and its
barriers in hemodialysis (HD) patients and the association between
the patterns of physical activity change, body composition, and beta-
aminoisobutyric acid (BAIBA), as circulating myokine.
Methods: HD patients were considered in a 24-month follow-up.
We assessed overtime the change of physical inactivity and its barriers,
bodycomposition,muscle strength andplasmaBAIBA levels. Parametric
and non-parametric analyses were performed, as appropriate.
Results: 49 patients were studied at baseline, 39 completed the first-
year follow-up, and 29 completed the second year. The barrier
‘reduced walking ability’ was more frequent in inactive patients with
respect to active at month 12 (P = 0.003) and at month 24 (P = 0.05). At
month 12, active patients had higher intracellular water (ICW)
(P = 0.001) and cellular mass (P < 0.001), as well as at month 24
(P = 0.012, P = 0.002; respectively). A significant reduction in ICW was
shown at month 12 (P = 0.011) and 24 (P = 0.014) in all patients. At
month 24, a correlation was seen between muscle strength and ICW
(r = 0.51, P = 0.005) and plasma BAIBA levels were higher among active
patients with respect to inactive (P = 0.043). Normalizing BAIBA per
body mass index, we found it lower with respect to baseline
(P = 0.004), as well as after correcting per ICW (P = 0.001), as marker
of muscle mass.
Conclusions: A high prevalence of physical inactivity persisted during
a 24-month follow-up in this cohort, associated with a decline in
markers of muscularity and with reduced plasma BAIBA levels.
Disclosure of Interest: None declared.
SUN-PO124
STUDY OF ADHERENCE TO TREATMENT WITH COMMERCIAL
THICKENER IN A POPULATION WITH LIQUIDS DYSPHAGIA
A. Peñalva Arigita1, A. Sansano1*, M. Lecha1, R. Prats1, L. Vila1. 1Nutrition
and Dietetics, Hospital Moisses Broggi, Barcelona, Spain
* Corresponding author.
Rationale: There are not many published data on adherence to
treatment with commercial thickener in patients with dysphagia.
Methods: A year descriptive-prospective study (2018). Randomized
patients were chosen from our database of delivering thickener (875)
and called every 3months. General variables: age, residence, diagnosis
and information obtained from a telephone questionnaire related to
adherence: Appropriate thickener use (ATU) (according to indicated
treatment) and compliance (overall intake). Diet and liquid intake
were included.
Results: Sample of 202 patients. Median age 84.9 [22.8–103.4] years;
58.4% female. Residence: 43.10% home, 56.9% nursery homes (NH).
Main base diagnosis: Neurology 92%. A correct ATUwasmade in 41.6%,
22.3% had a completelymisused and 32,2% amoderate ATU. Changes in
ATU occurred in 12.41%(32), with improvement in 40.6%(13/32) and
worsening in 59.4%(19/32). Regarding compliance, 47.5% did it well/
correctly, 25.7% had poor compliance and 26.2% moderate. Changes in
compliance occurred in 14.8%(30) patients, with improvement in 50%
(15). There were no differences among residence, education or the
length of thickener use for both parameters. Themain reasons for non-
compliancewere: dislike of product 58.5%, perception of improvement
13% or no specific reasons 28%. Type of diet: pureed (P) 66.3%; soft diet
(SD) 3%, mixed (P&SD) 21.3% and normal 9.4%. Only 7.4% changed their
diet. At home 35,6% had P&SD diet vs 10,4% at NH, p < 0,05. At NH 85%
of diets were P. Inadequate water intake in 50%.
Conclusions:Half of population studied does not fulfill with thickener
treatment. Urge to develop new strategies to improve adherence to
thickener treatment and be aware of diets and water intake in
dysphagia.
Disclosure of Interest: None declared.
SUN-PO125
HOME PARENTERAL NUTRITION IN PATIENTS WITH TYPE III
INTESTINAL FAILURE. PATAGONIAN EXPERIENCE
A.L.N. Martinuzzi1*, F. Cascaron1, A. Nuñez1, M. Bogado1, C. Betancurt1,
P. Roel1, M. Tonnelier1, L.R. Ocampo1, C. Carcamo1, M. Traverso1,
N. Maldonado1. 1Nutrihome-SA, Neuquen, Argentina
* Corresponding author.
Rationale: Home parenteral nutrition (HPN) is a safe and effective
treatment for type III intestinal failure (CIF). Experiences accumulated
in the US and the European Union has been published over the last
years. However, HPN experience for CIF has not been properly
documented in South America. This work shows the results achieved
by a multidisciplinary team in the administration and management of
HPN for CIF in the southern region of Argentina.
INITIAL ACTUAL
AGE 54 ± 19 56 ± 13
CHARLSON COMORBIDITY INDEX 2,89 ± 2,3 NA
INITIAL SGA A 0%.
B 31,25%.
C 68,75%
A 28,1%.
B 62,5%.
C 9,4%
BMI 21,8 ± 6,1 23,9 ± 5,5
WEIGHT 60,2 ± 21,3 67±,20,1
KARNOFSKY 55 ± 10 75 ± 15
TOTAL PARENTERAL CALORIES PER WEEK 11300 ± 3666 8611 ± 4509
TOTAL PARENTERALVOLUME PER WEEK IN LITERS 13,63 ± 5,09 12,39 ± 5,98
ALBUMINmg/dl 2.96 ± 1.9 3.68 ± 1.8
HEMATOCRIT 30.4 ± 12 35.6 ± 11
HEMOGLOBINgr/dl 9.9 ± 3.2 11.7 ± 2.1
COLESTEROLmg/dl 121 ± 41 182 ± 37
Total Lymphocyte Count 1470 ± 780 1390 ± 240
BMI, serum albumin, total cholesterol, hemoglobin, Karnofsky and SGA
improved during the study. A non-significant reduction in TLC was seen during
the same period.
Methods: The Patagonian team of Nutritional Support carried out this
cases series study. Patients admitted to theHPN teamwith diagnosis of
CIF during the period 2011–2018 were included for analysis. The
information collected was stored in an electronic database and the
results are expressed in average, standard deviation and percentage,
according to the type of variable analyzed. All statistical analyzes were
performed in the SPSS-IBM® 24 program.
Results: During the study period, a total of 32 patients diagnosticated
with CIF and requiring HPN were assisted by the team. Table 1 shows
baseline characteristics of the patients, along with the results of the
latest medical check-up. 53% of the patients were women with an
average age at CIF diagnosis of 55 ± 19 years. CIF causes distributed as
follows: Extensive intestinal resection due to surgical complication
(44%); Postsurgery fistula (17%); Extensive intestinal resection due to
intestinal ischemia (13%); Mechanical obstruction due to extrinsic
compression (13%); Extensive mucosal disease (10%); and Pseudo
intestinal chronic obstruction (3%).
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Intestinal anatomy of the patients with SBS was distributed as: Type I:
40%; Type II: 30%; and Type III: 30%; respectively. According to the
ESPEN CIF Clinical Classification ESPEN, patients were assigned on
admission to categories D3:40%; D2:40%; D1:7%; and C3:7%; respect-
ively. The remaining 6% of the patients was scattered among other
groups.
Weekly average parenteral calories did not vary during the study:
Admission: 11,300 ± 3,666 calories vs. Actual: 8,611 ± 4,509 (D =−2,689
calories; p > 0.05).
HPN outcomes were as follows: Intestinal sufficiency with discon-
tinuation of HPN: 40,6% of the patients; Persistent CIF with prolonged
HPN: 40,6%; and Death from the underlying disease while on HPN:
18,7%; respectively.
Average HPN duration was 468 ± 440(range 2–2635) days. HPN
duration differed regarding HPN outcome: Intestinal sufficiency:
332 ± 240 days; Prolonged HPN: 489 ± 400 days; and Death while on
HPN: 148 ± 145 days.
Catheter-related bloodstream infection incidence (CRBSI) was 0.88
cases/1000 catheter-days, venous thrombosis 0.25 cases/1000 cath-
eter-days and catheter rupture 0.25 cases/1000 catheter-days. The
number of catheter replacements was 0.94 per patient, and average
catheter time of useful life was 467 ± 280 days.
Conclusions: In the present study series extensive intestinal resection
due to surgical complication was the most common cause of CIF. HPN
improved selected nutritional markers. HPN also improved the patient
´s self-sufficiency and quality of life. Patients required lower caloric
loads: a sign of better intestinal absorption probably related to
rehabilitation of the gut. Almost half of the patients achieved intestinal
sufficiency after almost a year on HPN. The 18.75% of mortality was in
patientswith amalignant cause of CIF. Finally the incidence of catheter
related complications were according to international recommenda-
tions. All these results demonstrate the safety and feasibility of HPN
treatment in our region.
Disclosure of Interest: None declared.
SUN-PO126
PHYSICAL DEVELOPMENT, NUTRITIONAL STATUS AND
GASTROENTEROLOGICAL PROBLEMS IN CHILDREN WITH
CEREBRAL PALSY
A.N. Zavyalova1*, A.V. Gostimskii1, A.A. Afanasyeva1. 1The Ministry of
Healthcare of the Russian Federation, Federal State Budgetary Educational
Institution of Higher Education ‘ST. Petersburg State Pediatric Medical
University,’ Saint Petersburg, Russian Federation
* Corresponding author.
Rationale: In children with severe neurological pathologies, cerebral
palsy defect of eating behavior was observed in 40% of cases, and in
90% in childrenwith the 5th level ofmotor activity according to GMFCS
scale. Special position being required, such children should be often
fed in a lying position which leads to developing of serious violations
in the gastrointestinal tract.
Methods: 30 children with cerebral palsy of the 4th and 5th activity
levels according to GMFCS scale were examined. Food history was
evaluated. Anthropometry and body composition assessment were
performed. Life history and medical records as well as the data of
hospital admissions were analyzed.
Results: Of the 30 children, 2 were on the probe nutrition, the
remaining patients were fed through gastrostomy. Prior to Installing
the patients suffered from constant reflux-esophagitis, gastroduode-
nitis, because of being fed in a lying position. Aspiration bronchitis,
pneumonia, requiring hospitalization had all of them. Everyone had
constipation, bowel emptying occurred every three days after applying
a suppository with glycerin. Their food had low fiber. Physical
examination was revealed signs of malnutrition. Severe malnutrition
had more than 30% impaired children, mild 10% and moderate 20%. In
gastrostomy patients began to receive enteral nutrition. Cases of
aspiration, bronchitis and pneumoniawere reduced. Only twopatients
had a relapse of gastritis with further hospitalization. The anthropo-
metric data of the patients changed, the children gained weight.
According to the analysis of medical records, the incidence of illness
decreased by 50%.
Conclusions: Determining of physical development in children with
cerebral palsy should be carried out depending on the level of motor
activity using specialized Growth Charts GMFCS. In children with
bulbar and pseudobulbar disorders, swallowing disorders and regur-
gitation, it is necessary to install a gastrostomy. Children should be fed
with special nutritional products in accordance with their biological
age and depending on their motor activity. Adequately selected
nutrition prevents reflux, aspiration, and as a result bronchitis and
pneumonia in children which reduces the drug (antibiotics) load on
the patient.
Disclosure of Interest: None declared.
SUN-PO127
CARDIOVASCULAR RISK FACTORS ARE HIGHER IN MALNOURISHED
PATIENTS WITH SYSTEMIC SCLEROSIS
A. Wojteczek1*, M. Ziętkiewicz1, S. Małgorzewicz2, Z. Zdrojewski1.
1Department of Internal Medicine, Connective Tissue Diseases and
Geriatrics, 2Department of Clinical Nutrition, Medical University of
Gdańsk, Gdańsk, Poland
* Corresponding author.
Rationale: Cardiovascular disease (CVD) is awell known complication
in rheumatoid arthritis and systemic lupus erythematosus.
Atherosclerosis (ATS) and its impact on CVD in patients with systemic
sclerosis (SSc) still remains unclear. Most of studies are suggesting
higher frequency of CVD in SSc in comparison to healthy controls. CVD
is a leading cause of death inmost developed countries, whereas in SSc
population it ranges from 20 to 30%. The etiology of ATS in SSc is
unknown. Traditional risk factors, endothelial dysfunction and
inflammation can contribute to ATS in SSc population. However,
there is lack of data about the impact of the nutritional status on CVD
factors in SSc patients.
Methods: In 55 patients with SSc (72,7% well-nourished, 18,1%
malnourished, 9,1% pre-cachexia) and 49 healthy controls we
measured markers of endothelial dysfunction (asymmetric dimethy-
larginine – ADMA), inflammation (C-reactive protein – CRP, high
sensitivity C-reactive protein – hsCRP, interleukin 6 – IL-6) and
dyslipoproteinemia (oxidized low-density lipoprotein – ox-LDL, high-
density lipoprotein- HDL, low-density lipoprotein – LDL and total
cholesterol). Nutritional status was determined with subjective global
assessment (SGA), body mass index (BMI), bioelectrical impedance
analysis (BIA) and anthropometric measurements.
Results: Well-nourished SSc patients had significantly higher level of
IL-6 (6,4 ± 10,1 vs. 2,8 ± 3,6 pg/ml; p = 0,002) and lower HDL choles-
terol (49,9 ± 11,6 vs. 57 ± 13,6 mg/dl; p = 0,011) in comparison to
healthy control. In malnourished SSc patients there was higher
concentration of ADMA (1,68 ± 0,53 vs. 1,24 ± 0,34 μmol/l; p = 0.003),
CRP (18 ± 28,8 vs. 2,4 ± 2,5 mg/l; p = 0.04), IL-6 (21,6 ± 34,9 vs. 2,8 ±
3,6 pg/ml; p = 0.004) and lower HDL cholesterol (42,5 ± 18,3 vs.
57 ± 13,6 mg/dl; p = 0.01) in comparison to healthy control. Pre-
cachexia SSc group had significantly lower total cholesterol
(166,8 ± 28,5 vs. 219,3 ± 40,9 mg/dl; p = 0.008) and LDL cholesterol
(96,8 ± 21,6 vs. 139,6 ± 36 mg/dl; p = 0.007). There were no differences
in concentration of oxLDL and hsCRP in those groups.
Conclusions: Nutritional status may play role in risk of CVD in SSc
patients. Although its contribution to morbidity and mortality rates in
CVD in SSc is yet to be established.
Disclosure of Interest: None declared.
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SUN-PO128
DETERMINING VITAMIN D STATUS IN CHRONIC INFLAMMATORY
CONDITIONS
A. Aksan1,2*, K. Boettger1,3, N. Hein4, Y. Caicedo-Zea4, I. Diehl4,
C. Schumann4, F.-P. Armbruster4, J. Stein1,2,3. 1Interdisciplinary Crohn-
Colitis Centre Rhein-Main, 2Department of Pharmaceutical Chemistry, J.
W. Goethe University, 3Gastroenterology and Clinical Nutrition, DGD
Clinics Sachsenhausen, Teaching Hospital of the J. W. Goethe University,
Frankfurt, 4Immundiagnostik AG, Bensheim, Germany
* Corresponding author.
Rationale: While vitamin D deficiency has been implicated in
the pathophysiology of inflammatory diseases, evidence that supple-
mentation may cure or prevent chronic disease is inconsistent. Since
25OH-vitamin D (25OHD) is thought to be an acute-phase protein, its
utility as a vitamin D status marker in the presence of inflammation is
questionable. This study explored interactions of vitamin D and
inflammation in patients with Inflammatory Bowel Disease (IBD).
Methods: Blood count, transferrin, albumin and CRPwere determined
by routine assays. Presence of inflammation was defined as CRP levels
≥5 mg/dL. 25OHD and vitamin D-binding protein (VDBP) levels were
determined by ELISA, 1,25OHD and 24,25OHD by LC-MS/MS. Free (Df),
bioavailable (Db), and albumin-bound (Da) vitamin D levels were
calculated with Bikle’s validated formula1 and correlations with
Spearman correlation coefficients.
Results: 188 patients with IBD (88 male/100 female; 111 CD/77 UC)
aged 18–65 (mean 44.75 ± 14.30y), participated in the study. CRP
correlated positively with 1,25OHD (0.207; p = 0.006) and VDBP
(0.240; p = 0.002) but negatively with Df (−0.179; p = 0.019), Db
(−0.224; p = 0.003), and Da (−0.223; p = 0.003). Serum transferrin
correlated only (positively) with VDBP (0.160, p = 0.037). VDBP was
significantly lower in the noninflammatory group (p < 0.05), while
1,25OHD, VDBP, Df, Db, and Da levels were influenced by inflammation.
25OHD tended to be (insignificantly) lower in inflammatory condi-
tions (Bikle formula). However, since albumin is affected by inflam-
mation, this result may be illusory.
Conclusions: While 25OHD may not accurately reflect vitamin D
status, all other vitamin D parameters including free vitamin D(Df)
were affected by inflammation. Thus, 25OHD still appears the best
vitamin D status marker in chronic inflammatory conditions. We
suggest that direct measurement of free vitamin D metabolites might
be a promising topic for future research.
Reference
1. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG.
Assessment of the free fraction of 25-hydroxyvitamin D in serum
and its regulation by albumin and the vitamin D-binding protein. J
Clin Endocrinol Metab. 1986;63:954–959..
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SUN-PO129
THE EFFECTOFNUTRITIONCOMPLEMENTS ONHEALTH CARE COSTS
BEFORE ANDAFTER THE INCORPORATION OF PATIENTS TOA HOME
HOSPITAL UNIT
B.R. Blanco1*, T. Mora2, M. Trapero-Bertran2. 1Unidad de Hospitalización
a Domicilio y Cuidados Paliativos, Hospital Universitario de Elda, Alicante,
2Research Institute for Evaluation and Public Policies, Universitat
Internacional de Catalunya, Barcelona, Spain
* Corresponding author.
Rationale: There is a need for evidence for the difference on
healthcare resources consumed at a home unit compared to classic
hospital conditioned to the nutritional status of the patient.
Methods: The sample considered in this study consists of 100 patients
of the Hospital Universitario de Elda, Spain, who have gone through
two stages of care, hospital care and home care. All these patients
might have severe or moderate nutritional problems or not have
nutritional problems. Descriptive analysis was carried out. Mean
difference test for paired samples was performed and for cases in
which the assumption of normality was not met logarithm trans-
formation of the variables have been carried out. These assumptions
are verified by the non-parametric normality test of Shapiro-Wilk.
Costs are expressed in € 2019 and for a one-year time horizon.
Results: Comparing the average healthcare cost of hospital care
(5,501.02€) with home care (4,857.21€) moving patients to home units
seems to save money to the National Health System. The subgroup of
patients that most benefit from this were those ones who were in a
severe or moderate malnutrition state and started taking supplemen-
tal complements. Under the log transformation of the variables, the
Shapiro-Wilk test results in showing significance of the average costs
differences at 5% level for those who have severe and moderate
malnutrition level. The average numberof hospital stays onceyou have
moved to the home unit and initiated the nutrition supplements was
reduced from 7.76 to 0.44 (−94.3%) whereas the hospitalization and
urgencies were reduced from 1.10 to 0.10 (−90.9%) and 1.99 to 0.45
(77.4%), respectively.
Conclusions: Patients with severe and moderate malnutrition state
saved money to the system when they start taking nutritional
complements and were moved from an hospital unit to a home care
unit.
Disclosure of Interest: None declared.
Table (abstract: SUN-PO129):
Variable Hospital care (€ 2019) Home care (€ 2019)
Without malnutrition
problems
(n = 22)
Mean (sd)
With severe or moderate
malnutrition problems
(n = 78)
Mean (sd)
Without malnutrition
problems
(n = 22)
Mean (sd)
With severe or moderate
malnutrition problems
(n = 78)
Mean (sd)
Procedures 542.98 (993.19) 368.32 (689.55) 83.04 (251.20) 18.20 (99.50)
Medication 1,460.96 (2941.54) 820.17 (724.96) 1,870.34 (3231.57) 846.12 (737.03)
Nutritional supplementation – – 3,581.75 (975.70) 3,397.22 (1097.03)
Hospital stays 2,711.43 (3121.59) 3,444.14 (3942.05) 173.07 (499.87) 189.83 (677.20)
Hospitalization 423.06 (488.51) 477.30 (448.96) 57.69 (148.60) 37.97 (121.70)
Urgencies 501.03 (428.93) 352.05 (323.50) 123.06 (152.68) 76.85 (137.06)
Total cost 5,639.47 (5233.69) 5,461.98 (4956.08) 5,888.96 (3249.76) 4,566.20 (1358.61)
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SUN-PO130
NUTRITIONAL ASSESMENT IN PERITONEAL DIALYSIS PATIENTS
SHOW LOWER PROTEIN AND ENERGY INTAKE THAN
RECOMMENDED
B.J. Knap1*. 1Dialysis, University Clinical Center Ljubljana, Ljubljana,
Slovenia
* Corresponding author.
Rationale: Protein malnutrition is common in peritoneal dialysis
patients and depends on many factors. The aim of this clinical study
was to analyze dietary intake of dialysis patients and to determine if it
meets their nutritional needs.
Methods:A clinical studywas carried out on 25 dialysis patients in the
Peritoneal Dialysis Unit of University Clinical Center of Ljubljana.
Nutritional interview was conducted unannounced three times over a
period of one month with the 24 hour recall method. Results were
analyzed with the Prodi 6.7 Expert software. Body composition has
been measured with bio impedance spectroscopy.
Results: Average caloric intake of 25 patients is 22,74 ± 6,54 kcal/kg
body weight per day, average protein intake is 0.86 ± 0.30 g/kg body
weight per day. Average values of body weights are 73,33 ± 13,76 kg,
BMI (body mass index) is 24,26 ± 2,53 kg/m2, average LTI -lean tissue
index 13,67 ± 3,21 kg/m2 and values of Phase angle are 5,08 ± 1,17.
Caloric (kcal), protein, fat (0.82 ± 0.35 g/kg BW per day), carbohydrate
(CHO)(2.68 ± 1.08 g/kg BWper day), sodium (Na+)(3.39 ± 6.69 g per
day), potassium (K+)(2.01 ± 0.55 g per day), and phosphorus (P)
(0.87 ± 0.29 g per day) intake in 24 hours was monitored. 25 patients
were analyzed. Caloric and protein intake values were lower than
recommended for dialysis patients.
Conclusions: Successful collaboration between patient and dietitian is
crucial for objective results of nutritional assessment. Protein and
energy intake were found to be lower in peritoneal dialysis patients
than recommended.
Disclosure of Interest: None declared.
SUN-PO131
BODY COMPOSITION AMONG NON-FRAIL AND FRAIL PATIENTS
UNDERGOING HEMODIALYSIS
B.W. Marinos Cotrina1*, C.A. Galindo2, F.S. Rodriguez-Brown3,
D. Mendez3. 1Intensive Care Unit, Hospital Guillermo Kaelin de la
Fuente, Lima, Peru, 2Clinical nutrition, Hospital San Ángel Inn
Universidad, Mexico DF, Mexico, 3Student, Universidad Federico
Villarreal, Lima, Peru
* Corresponding author.
Rationale: There is growing evidence suggesting that frailty is
associated with adverse outcomes among patients suffering from
end stage renal disease. In addition, it seems that every 1 of 2 patients
undergoing hemodialysis (HD) is frail. Moreover, it seems that affects
not only the elderly but also young adults through an increased
catabolism pathway that leads to poor nutritional status.
Methods: This descriptive study has the aim to determine the
relationship between body composition and frailty status in patients
undergoing hemodialysis (n = 130). Body composition (BC) was
measured by a segmental multifrecuency bioelectrical impedance
analysis after HD session and frailty status (FS) was obtained according
to Fried Frailty Phenotype, before. In order to find differences between
groups we performed T Student or U Mann Whitney. Furthermore,
correlations between measures of BC and functional tests (FT), such as
gait speed and grip strength, according to FSwere found using Pearson
or Spearman.
Results: A total of 76 patients were included in the final analysis,
where 40.8% were determined to be fragile. It’s important to mention
the collinearity that exists between FT and the detection of FS. Non-
frail showed higher numbers of skeletalmusclemass, total bodywater,
torso mass, left arm mass, left leg mass and lower numbers of
extracellular/intracellular water ratio (p < 0.05). We also found
Pearson and Spearman correlations in the bioelectrical impedance
and functional tests.
Conclusions: From the results presented, we conclude that phase
angle shows persistent correlation in both groups of FS and FT. Muscle
mass is correlated to grip strength in the non-frail; however, isn’t
correlated to FT in frail patients. Then, ratio ECW/ICW is negatively
correlated to grip strength in both groups. Also, frail patients show less
muscle mass than non-frail. We need to study these variables in a
larger population; notwithstanding, these results demand creation of
intervention strategies in order to lessen frailty, therefore enhance
quality of living. Finally, is important to be aware that to manage this
situation is mandatory an interdisciplinary approach.
Reference
Takeuchi H., Uchida H.A., Kakio Y., Okuyama Y., Okuyama M.,
Umebayashi R., Wada J. 2018. The Prevalence of Frailty and its
Associated Factors in Japanese Hemodialysis Patients. Aging and
disease, 9(2), 192–207. doi:10.14336/AD.2017.0429
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Table 1 (abstract: SUN-PO131): Descriptive data, body compostion and functional tests
Pre-frail Frail Total
Male 25 (55.6) 12 (38.7) 37 (48.7)
Female 20 (44.4) 19 (61.3) 39 (51.3)
Age 65 (60–72) 66 (62–73) 66 (60–72)
Muscle mass (kg) 24.7 (20.7–28.4)* 22.3 (17.1–14.9)* 23.2 (19.6–27.0)
TBW (L) 37.52 (7.38)* 33.87 (6.98)* 36.03 (7.39)
ICW (L) 21.19 (5.54)* 18.66 (4.20)* 20.16 (4.55)
Ratio ECW/ICW 0.8 (0.7–0.8)* 0.8 (0.8–1.0)* 0.8 (0.7–0.9)
Phase angle (°) 6.38 (1.26) 5.90 (1.36) 6.19 (1.32)
Torso muscle mass (kg) 11.73 (2.59)* 10.01 (2.41)* 11.03 (2.65)
Left arm muscle mass (kg) 1.54 (1.11–1.74)* 1.19 (0.96–1.39)* 1.31 (1.01–1.70)
Left leg muscle mass (kg) 4.98 (1.19)* 4.29 (1.33)* 4.70 (1.29)
Gait speed (m/s) 0.8 (0.7–1.0)* 0.66 (0.50–0.80)* 0.78 (0.60–1.00)
Grip strength (kg) 21.23 (6.53)* 16.03 (6.49)* 18.96 (6.97)
FTI: Fat Tissue Index, LTI: Lean Tissue Index, TBW: Total Body Water, ECW: Extracellular water, ICW: Intracellular water. *:p < 0.05, difference between frail vs Non-frail
group.
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SUN-PO132
ANEMIA AND HEMATOLOGICAL FEATURES OF DYSPHAGIC PATIENTS
THAT UNDERWENT ENDOSCOPIC GASTROSTOMY: A 9 YEARS AND
472 PATIENTS STUDY
C.A. Santos1*, M. Brito1, A. Laranjo1, G. Nunes1, J. Fonseca1. 1GENE –
Enteral Nutrition Group, Hospital Garcia de Orta, Lisboa, Portugal
* Corresponding author.
Rationale: Patients undergoing endoscopic gastrostomy (PEG) may
present protein-energy malnutrition, anemia and deficiencies of hem-
atopoietic factors: iron, folate and vitamin B12. There are no compre-
hensive studies on anemia or other hematological changes in PEG-
patients. Our aimwas to evaluate the hematological status of dysphagic
patients that underwent PEG and its associationwith clinical outcome
Methods: Retrospective study of patients followed by our Artificial
Feeding Team, submitted to PEG from 2010 to 2018. Patients were
divided into two etiological groups: neurological dysphagia (ND) and
head/neck or esophageal disorders (HNE). Laboratory data included
serum albumin, hemoglobin, mean corpuscular volume, ferritin,
transferrin, iron, vitamin B12 and folate. Survival after PEG was
recorded in months, until death or December 2018
Results:Weevaluated 472 patients, 250 (53%) presented anemia at the
time of gastrostomy, mostly normocytic (n = 219), with laboratory data
suggestive of anemia of chronic disease (ACD). Six patients (1.3%)
presented vitamin B12 deficiency and 57 (12.1%) presented folate
deficit. No statistically significant difference in hemoglobin between
the two groups (p = 0.230) were found. Folate and vitamin B12 levels
were lower in the HNE group (p < 0.01). A positive correlation between
hemoglobin and survival was present (p < 0.01, r = 0.289) and levels
were lower in the deceased population (p < 0.01).
Conclusions: Anemia is highly frequent in PEG-patients, mostly with
the features of ACD or multifactorial. Deficiencies in hematopoietic
factors are frequent and should be corrected. Anemia is associated
with significant decrease in survival and may be looked as a marker of
severe metabolic distress, signaling poor outcome.
Disclosure of Interest: None declared.
SUN-PO133
ASSESSMENT OF RENAL FUNCTION IN HOME PARENTERAL
NUTRITION PATIENTS FOR INTESTINAL FAILURE
M. Lauverjat1, S. Ait1, C. Bergoin1, L. Koppe2, D. Barnoud1, L. Dubourg3,
C. Chambrier1*. 1Nutrition, 2Nephrology, Hospices Civils de Lyon, Pierre-
Benite, 3Nephrology, Hospices Civils de Lyon, Lyon, France
* Corresponding author.
Rationale: Home parenteral nutrition (HPN) patients have risks
factors for chronic kidney disease (CKD). Many formulas are used to
estimate glomerular filtration rate (GFR). The aim of this study was to
compare the performance of estimates of GFR using several equations
with measured GFR in HPN patients.
Methods: 15-years retrospective study. Collected data: age, BMI,
parenteral nutrition (PN) duration, creatininemia. Measured GFR by
inulin or iohexol clearance, estimated GFR by CKD-EPI, MDRD,
Schwartz 2009 (S09). Relative bias, 30% accuracy (P30), paired T test,
Pearson correlation were used to determinate equations reliability.
Results were expressed in mean ± SD.
Results: 115 patients, 47.8% men, age: 53.9 ± 17.5 years, BMI: 21.6 ± 4.7,
73.9% of short bowel, PN duration: 80.7 ± 77.7 months. Mean measured
GFRwas67.3 ± 26.9mL/min/1.73m²andwasabove90mL/min/1.73m² in
21.7%, between60and 90 in34.8%,30 to60 in35.7%andbelow30 in7.8%.
CKD-EPI MDRD Schwartz
2009
Estimated GFR (mL/min/1.73m²) 86.4 ± 33.6** 91.9 ± 44.6** 86.3 ± 36.3**
Relative bias (mL) 19.5 ± 20.1 25.8 ± 30.7 19.2 ± 25.0
P30 (%) 52.2 49.6 46.1
**<0.0001.
The bias was negatively correlated with age and creatininemia for CKD-EPI and
MDRD and with only creatininemia for S09.
With CKD-EPI, MDRD and S09, stages of renal disease were correctly estimated
in 51.3%, 54.8% and 51.3% (S09) and the severity of CKD was underestimated in
47.0, 41.7 and 42.6%, mainly for stages 1 and 2.
Conclusions: 43.5% of HPN patients had a moderate to severe
chronic kidney disease. Equations present a low precision and
overestimate GFR notably for patients with an estimated GFR above
60 mL/min/1.73 m² and for young patients. So, measured GFR should
be recommended as possible to assess renal function in these patients.
Disclosure of Interest: None declared.
SUN-PO134
OMEGA-3 POLYUNSATURATED FATTY ACIDS REDUCE INTESTINAL
MUCOSAL BARRIER DAMAGE VIA ACTIVATION OF
CHOLECYSTOKININ IN CHRONIC KIDNEY DISEASE
C. Yu1*, S. Tan2, Z. Wang3, S. Zhuang1. 1Department of Nephrology,
Shanghai East Hospital, Tongji University School of Medicine,
2Department of General Surgery/Shanghai Clinical Nutrition Research
Center, Zhongshan Hospital, Fudan University, 3Department of
Nephrology & Rheumatology, Shanghai Tenth People’s Hospital, Tongji
University School of Medicine, Shanghai, China
* Corresponding author.
Rationale: Previous studies including ours have shown that chronic
kidney disease (CKD) could lead to intestinal mucosal barrier damage
followed by many complications. Increasing evidence suggests that
omega-3 polyunsaturated fatty acids can reduce intestinal injury and
improve intestinal function inmanydiseases. In this study,we therefore
investigated the effect of omega-3 polyunsaturated fatty acids on
intestinal mucosal barrier in CKD and the underlying mechanism.
Methods: CKD was induced by the 5/6 kidney resection, and omega-3
polyunsaturated fatty acids was administrated for six weeks. To assess
the intestinal mucosal barrier changes, blood samples were collected
for measuring the serum D-lactate level, and terminal ileum tissue
samples were used for analyses of intestinal permeability and
histopathology. The intestinal malondialdehyde (MDA) level and
superoxide dismutase (SOD) activity were also assessed.
Results: CKD increased serum D-lactate level, intestinal permeability,
intestinal mucosal and submucosal edema and inflammation, and the
Chiu’s scores assessed for intestinal mucosal injury (P < 0.05).
However, compared to the control, omega-3 polyunsaturated fatty
acids treatment markedly reversed these adverse parameter changes
(P < 0.05). In addition, the intestinal MDA level was reduced and the
intestinal SOD activity was increased after omega-3 polyunsaturated
fatty acids treatment (P < 0.05).
Conclusions: Omega-3 polyunsaturated fatty acids could reduce
intestinal mucosal barrier damage induced by CKD, which is most
likely due to its anti-oxidative activity.
Disclosure of Interest: None declared.
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SUN-PO135
MEALBOX FOR DIALYSIS PATIENTS
A. Wentink-Koopman1, H. Norbart1, R. Duivenvoorden2, D.V. Laar1*.
1Dianet, Amsterdam, 2Radboud University Medical Center, Nijmegen,
Netherlands
* Corresponding author.
Rationale: The aimwas to investigatewhethera specifically developed
mealbox canprovide support to dialysis patients inpreparing a healthy
and balanced meal while simultaneously complying with their diet
requirements.
Methods: The development of the mealbox consisted of the
creation of recipes, setting up logistics and performing a pilot.
Dieticians have drawn up conditions for the recipes. The price and
preparation were involved. Two pilots were done on a select group
of patients. The last pilot contained all hemodialysis patients of our
centre. An evaluation form with five questions about the taste,
portion size, clarity of the recipe, level of difficulty of preparation
and the price, were used for evaluation. Answers could be given on
a 10-points scale.
Results: Ten recipes were developed and contained 470–790 kilo-
calories, >24 g proteins (max 41 g), 455–635 mg phosphate, 990–
1250 mg potassium and 0,2–1,2 g salt per portion. We observed a
clear interest by dialysis patients for the mealbox concept, as attested
by the high participation rate: 59 patients participated out of 130
patients who were approached (45%). Evaluation form respons was
40%. The meals were rated (mean and sd) taste 7.6 (SD 1.8), portion
size 7.6 (SD 2.2), clarity 8.0 (1.9), difficulty 8.4 (SD 1.1), and price 7.0
(SD 2.7).
Conclusions: Our mealbox concept, aimed at preparing a balanced
meal that complies with the diet requirements for dialysis patients,
was positively evaluated by patients. Furthermore, it was technically
and logistically feasible to execute the concept in our center.
Disclosure of Interest: None declared.
SUN-PO136
WHY DOES ADMINISTRATION OF OMEGA-3 FATTY ACIDS IN
CHRONIC DISEASES ONLY SOMETIMES SHOW BENEFIT?
D. Smith1*. 1Pharmacology, University of Oxford, Oxford, United Kingdom
* Corresponding author.
Rationale: Trials of omega-3 fatty acids (w3-FAs) in cardiovascular
disease, depression and cognitive impairment have given inconsistent
results. One possible reason might be that the biological effect of w3-
FAs is dependent on other, interacting, factors that are either unknown
or not measured in the trials.
Methods: Literature review of trials.
Results: Several potential interacting factors were identified.
1. Baseline level of w3-FAs. If the baseline level is too low, then
even after administration of w3-FAs the concentration might not
reach the threshold for biological effect. (Carney 2016). 2. Genetic
polymorphism. The beneficial effect of w3-FAs in cognitive impair-
ment and in risk of dementia is influenced by the e4-allele of ApoE,
with most studies showing a protective effect only in those who carry
this allele. (Yassine 2017). 3. Oxidative stress. The beneficial effect of a
high w3-FAs index in depression is largely found only in subjects with
high levels of markers for oxidative stress (Bigornia 2016) and a
beneficial interaction between w3-FAs and anti-oxidant vitamins in
cognitive decline has been reported (Assmann 2018). 4. B vitamin
status. The protective effect of B vitamins on brain atrophy and on
cognitive decline in people with Mild Cognitive Impairment was only
found in those with a good w3-FA status at baseline (Jerneren 2015;
Oulhaj 2016). Likewise, the protective effect of w3-FA status on brain
atrophy was only found in those with a good B vitamin status. A trial
of w3-FAs in patients with Alzheimer’s disease only slowed cognitive
decline in those with a good baseline B vitamin status. (Jerneren
2019).
Conclusions: The effects of w3-FA may only be found in certain
subgroups of the population. It is important to identify these
subgroups so that effective use can be made of w3-FA supplements.
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SUN-PO138
EDEMA INDEX ESTABLISHED BY A MULTIFREQUENCY
BIOELECTRICAL IMPEDANCE ANALYSIS IN PATIENTS ON KIDNEY
TRANSPLANT WAITING LIST
D. Sukackiene1,2*, A. Laucyte-Cibulskiene1,2, J. Brauklyte1, A. Aleksaite1,
M. Miglinas1,2. 1Faculty of Medicine, Vilnius University, 2Center of
Nephrology, Vilnius University Hospital Santaros klinikos, Vilnius,
Lithuania
* Corresponding author.
Rationale: A multifrequency bioelectrical impedance analysis (BIA)
is a noninvasive and reproducible modality for estimating the fluid
state. Regarding differences in body size and hypervolemic status,
the edema index as an independent indicator is obtained by
calculating the ECF/TBF ratio. Therefore, the edema index measured
by BIA may be a useful marker for defining volume status, and it
may be associated with mortality in end stage renal disease (ESRD)
patients.
The aim of this study was to test the BIA-derived edema index
and to evaluate the association between this index and anthropo-
metric measurements in dialysis patients on kidney transplant
waiting.
Methods: Prospective study was conducted in a tertiary reference
hospital. BIA and anthropometric measurements (weight, height,
waist and hip circumferences), handgrip strength of 86 adult patients
were measured and Geriatric Nutritional Risk Index (GNRI) was
calculated. Following body subunits were evaluated: fat free mass
(FFM), fat mass (FM), muscle mass (MM), total body water (TBW),
intracellular (ICW) and extracellular water (ECW). The edema index
was defined as the ratio of extracellular fluid to total body fluid.
Statistical analysis was performed using R version 3.4.3, p values <0.05
were considered as statistical significant.
Results: There were 43 (50%) female and 43 (50%) male patients with
an average age of 44.9 (range 20–69) years. On the basis of a cutoff
value of edema index of 0.390, patients were separated into two
groups: edema index more than 0.390 (n = 37) and edema index of
0.390 or less (n = 49). Compared with patients with edema index
0.390 or less, those with edema index of more than 0.390 were anuric
(p < 0.01), older (p < 0.02), had lower muscle mass (p < 0.003), lower
handgrip strength (p < 0.004). and significantly lower GNRI (p < 0.02).
There were no significant differences between groups in sex, weight,
FM, FFM.
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Conclusions: Edema index was found to be associated with older age,
lower muscle mass and handgrip strength. Hence, the edema index
determined by BIA measurements should be used to closely monitor
ESRD patients.
Disclosure of Interest: None declared.
SUN-PO139
CORRELATION OF SERUM LEPTIN AND NUTRITIONAL PARAMETERS
IN ESRD PATIENTS
D. Sukackiene1,2*, A. Laucyte_Cibulskiene1,2, J. Brauklyte1, A. Aleksaite1,
V. Banys1,3, D. Vitkus1,3, M. Miglinas1. 1Faculty of Medicine, Vilnius
University, 2Center of Nephrology, 3Center of laboratory medicine, Vilnius
University Hospital Santaros klinikos, Vilnius, Lithuania
* Corresponding author.
Rationale: Malnutrition has very complex patterns in patients with
end-stage renal disease (ESRD) and is associated with poor prognosis.
Leptin is a small peptide hormone which is produced mainly, but not
exclusively byadipocytes. It plays a key role in regulating energy intake
and expenditure, including appetite and hunger, metabolism and
behavior.
The aim of this study was to evaluate the volume, nutritional status by
bioelectrical impedance analysis (BIA), biochemical markers and to
investigate the correlation between serum leptin and the nutritional
parameters in ESRDpatients, who are on the kidney transplantwaiting
list.
Methods: Prospective study was conducted in a tertiary reference
hospital. We enrolled a total of 64 ESRD patients. Routine serum
markers including albumin and the appetite regulating hormone,
serum leptin, were measured. Multi-frequency BIA was used for the
assessment of extracellular water (ECW), intracellular (ICW), fat (FM),
lean mass (LM), body cell mass (BCM) and phase angle (PhA). The
following anthropometric measurements were determined: body
mass (kg), waist circumference (cm) and hip circumference (cm).
Bodymass index (BMI), estimated according to the post-dialysis mass/
height2 (kg/m2). The nutritional status was estimated with the use of
the 7-point Subjective Global Assessment (SGA). Statistical analysis
was performed using R version 3.4.3, p values <0.05 were considered
as statistical significant.
Results: Mean age of patients was 44.9 ± 12.5 (range 22–69) years.33
(51.5%) were male. The average of values of BCM was 38.1 [22.3;60.6]
kg, FFM 60.4 (±14.2) kg, leptin 24.5 [0.2;103.9] ng/mL, BMI 25.6
[17.6;43] kg/m2, CRP 3.9 [0.32;21.6] mg/L. Mean PhA and ECW were
significantly higher in males (6.2[0.9;13.1]°, 20[14.7;35.9]L) than in
females (5.1[2.3;13.1]°,13.9[10.1;22.4]L)(P < 0.05). SGA- defined mod-
erate malnutrition was present in 27 (42.1%) patients. PhA and
albumin were significantly higher in normal nutritional group (SGA
A) in malnourished (SGA B) group 6.2 [3.9;13.1°] vs 5.1 [2.3;7.71°],
albumin 43.1(±4.6) g/L vs 40.6 (±4.7) g/L. Other variables (BMI, ECW,
CRB, LM, BCM, leptin, waist and hip circumferences) were not sig-
nificantly different between the groups. Leptinwas positively associated
with fat mass (r = 0.63, P < 0.0001) and BMI (r = 0.45, P = 0.0002) and
negatively associated with extracellular water (r = -0.35, P = 0.0045) in
the studied population.
Conclusions: This study demonstrated significantly higher albumin
and PhA in well-nourished group. The positive correlation between
body fat and serum leptin is probably explained primarily by the
increased release of leptin from large fat cells. In fact, some studies
have proposed that leptin can serve as an indicator of fat content and
that its levels increase exponentially with increasing body fat
percentage.
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DURING LOW-GRADE INTESTINAL INFLAMMATION, INGESTION OF
STREPTOCOCCUS THERMOPHILUS CNRZ160 LIMITED THE LEAN
BODY MASS LOSS IN OLDER ADULTS
I. Savary-Auzeloux1,M. Jarzaguet1, J. David1, C.Migné1,M. De Azevedo2,
J.-M. Chatel2, D. Dardevet1*. 1Unité de Nutrition Humaine, INRA, Ceyrat,
2Micalis, INRA, Jouy en Josas, France
* Corresponding author.
Rationale:Aging is reflected, at the systemic level, by the development
of low-grade inflammation, which is one of the explanatory factors for
the development sarcopenia by preventing post prandial muscle
anabolism. The origin of this ‘inflammaging’ is still not clearly defined.
An increase in intestinal permeability, a microbiota dysbiosis and
subsequent generation of a micro- and then generalized inflammation
has been hypothesized. The objective of our study is to test in vivo
during aging, if 1) a chronic lowgrade intestinal inflammation can lead
to anabolic resistance and muscle loss and 2) if a bacterial strain with
anti-inflammatory properties in vitro could prevent these adverse
effects.
Methods: To generate low grade intestinal inflammation, elderly rats
(18 m) were treated with Dextran Sodium Sulfate (DSS) (4% w/v in
drinking water) for 28 days with (CNRZ group) or without (DSS group)
S. Thermophilus CNRZ160 (109 CFU / day) previously shown to have
anti-inflammatory potential in vitro (Junjua.2016). They were com-
pared to pair fed control rats (PF). Body weight and food intake were
monitored daily, lean mass and body fat measured by EchoMRI at day
0, 14 and 28, and muscle and colon weights measured at day 28 at
slaughter.Muscle protein synthesiswasmeasured in the post-prandial
state using the flooding dose method with 13C Valine. Groups were
compared using ANOVA and Fisher posthoc test (significance: p < 0.05;
P > 0.05: NS)
Results: Bodyweight, leanmass and fat loss at day 28was significantly
greater in DSS compared to PF controls (−110 vs −86 g, −51 vs −36 g
and −65 vs −47 g, respectively, p < 0.05). Similarly, gastrocnemius and
tibialis muscles were smaller by 12% and 10% vs PF respectively
(p < 0.05). In contrast, colon weight was increased by 13% with DSS
(P < 0.05 vs PF). CNRZ160 allowed to: 1) maintain normal colonweight
(2.09 for CNRZ vs 2.14 g for PF, NS) 2) limit the loss of lean body mass
(−38 g for CNRZ vs −36 g for PF, NS), 3) limit to 4 and 5% the loss of
muscle mass (CNRZ intermediate between PF and DSS, P > 0.05 vs DSS
and PF) explained by a better maintenance of post prandial muscle
protein synthesis (p < 0.05).
Conclusions: In the elderly, the loss of lean and muscle mass
associated with low-grade inflammation of intestinal origin can be
reduced by the ingestion of S. Thermophilus. It could therefore be
considered as an efficient probiotic to modulate frailty and sarcopenia
during aging.
Disclosure of Interest: None declared.
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RIGHT HEART FAILURE AS A RISK FACTOR FOR CARDIAC CACHEXIA
IN HEART FAILURE PATIENTS: PROSPECTIVE COHORT STUDY
D. González-Islas1*, A. Orea-Tejeda1, A. Jimenez-Valentín1, R. Dávila-
Ramos1, F. Salgado-Fernández1, A. Flores-Vargas1, A. Ibarra-Fernández1,
L. Flores-Cisneros2, L. Jaramillo-Arellano1, J. Mancilla-Galindo1,
J. Pérez-Lara-Arbisua1. 1Instituto Nacional de Enfermedades
Respiratorias ‘Ismael Cosio Villegas’, 2Instituto Nacional de
Cancerología, Mexico City, Mexico
* Corresponding author.
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Rationale: Cardiac cachexia (CC) is a common complication in patients
with advanced heart failure (HF) and a significant risk factor for poor
prognosis. Several factors are involved in the development of CC.
However, there are no longitudinal studies to assess RHFas a risk factor
for the development of CC in HF patients.
Methods: Objective: to investigate whether RHF is a risk factor for CC
in HF patients.
A prospective cohort study. Subjects with confirmed diagnoses of HF
were included. Patients with congenital heart disease, cancer, HIV,
drug use and end-stage renal disease were excluded. CC was definite
according to bioelectrical impedance vectorial analysis criteria.
Follow-up at 42 months.
Results: From 282without CC at the initial evaluation, after 42months
follow-up 65 subjects had developed CC. They were older (63.7 ± 16.8
vs. 54.7 ± 16.5 years, p < 0.001) with less handgrip strength (20.5 ± 8.5
vs. 25.8 ± 11.2 kg, p < 0.001) and smaller phase angle (5.0 ± 1.2 vs.
5.7 ± 1.1°, p < 0.001) than those who did not develop CC. RHF was an
independent predictor of CC (HR: 2.91, 95%CI; 1.61 to 5.26, p < 0.001)
Conclusions: RHF was an independent predictor for the development
of CC in HF
Disclosure of Interest: None declared.
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SCREENING FOR MALNUTRITION IN RENAL WARDS: AN AUDIT
COMPARING THREE MALNUTRITION SCREENING TOOLS TO
INFORM SERVICE QUALITY IMPROVEMENT
E. Tsompanaki1*, S. Hayes1, T. Dassanayake1. 1Nutrition and Dietetics,
Imperial College Healthcare NHS Trust, London, United Kingdom
* Corresponding author.
Rationale: People with chronic conditions like renal disease are more
likely to bemalnourished, due to the impact of uraemia, inflammation,
comorbidities, metabolic changes and dialysis. It is estimated that
around half of the patients admitted to a renal ward are malnourished
(1). Malnutrition screening tools are essential in identifying patients
who require further dietetic input (2). This audit was conducted to
help establish an appropriate malnutrition screening tool for patients
with CKD at Imperial College Healthcare Trust.
Methods: This pre-implementation audit compared the Renal iNUT
(renal specific, validated) (3), MUST (used widely in UK hospitals) and
ESPEN (currently used across all wards in the Trust) tools (2) against
individualised dietetic screening, on all tertiary renal wards of
Hammersmith Hospital. 43 patients out of 72 inpatient beds (60%)
from 4 renal wards were screened using all three tools by student
dietitians. Each tool was then compared against dietetic screening and
assessment. The audit was registered with the Quality and Safety
Therapies team.
Results: Dietetic screening identified 25 patients at risk of malnutri-
tion plus 8 patients for diet education only. ESPEN identified 12
patients at risk of malnutrition and had the lowest sensitivity (23.3%)
and specificity of 34.4%, MUST identified 16 patients and had 32.6%
sensitivity and 34.9% specificity and iNUT identified 34 patients at risk
and had the highest sensitivity of 55.8% and lowest specificity of 16.3%.
Conclusions: This audit demonstrated that iNUT was more sensitive
than the other tools and is more likely to trigger the most referrals to
dietitians. Changing to iNUT from ESPEN in our wards would be
beneficial in reserving dietetic time from screening, however may
trigger some referrals for patients who do not require dietetic input.
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AGGRESSIVE WEIGHT LOSS PROGRAM WITH A KETOGENIC
INDUCTION PHASE FOR THE TREATMENT OF CHRONIC PLAQUE
PSORIASIS
G. Castaldo1, L. Rastrelli2, G. Galdo3, P. Molettieri1, F. Rotondi Aufiero4,
E. Cereda5*. 1Nutriketo Lab, A.O.R.N. ‘San Giuseppe Moscati,’ Avellino,
2Department of Pharmacy, Faculty of Pharmacy, University of Salerno,
Fisciano – Salerno, 3Oncologic Dermatology Unit, IRCCS-CROB, Rionero in
Vulture – Potenza, 4Dermatology and Dermatosurgery Unit, A.O.R.N. ‘San
Giuseppe Moscati,’ Avellino, 5Clinical Nutrition and Dietetics Unit,
Fondazione Irccs Policlinico San Matteo, Pavia, Italy
* Corresponding author.
Rationale: Chronic plaque psoriasis is an inflammatory skin disease
associated with obesity, a condition characterized by low-grade
inflammation. Weight loss (WL) has been demonstrated to reduce
psoriasis severity and inflammation. Very low-calorie ketogenic diet
(VLCKD) has been associated with a significant reduction in visceral
adipose tissue and keton bodies likely have anti-inflammatory
proprieties. We evaluate the efficacy of an aggressive WL program
with a ketogenic induction phase as first-line treatment of chronic
plaque psoriasis.
Methods:We conducted a single-arm trial conducted (NCT03531528).
Adult overweight/obese patients (N = 37) with stable chronic plaque
psoriasis underwent a 10-week two-phaseWL program consisting in a
4-week protein-sparing, VLCKD (<500 kcal/day; 1.2 grams of protein/
kg of ideal body weight/day) and a 6-week balanced, hypocaloric (25–
30 kcal/kg of ideal body weight/day), low glycemic index,
Mediterranean-like diet. The primary endpoint was the reduction in
the Psoriasis Area and Severity Index (PASI) at week 10. Major
secondary endpoints included: improvement of PASI ≥50% and ≥75%,
reduction in body surface area (BSA) involved, improvement of itch
severity (visual-analogue scale) and Dermatology Life Quality Index
(DLQI) at week 10.
Results: With a mean body weight reduction of 12.0%, dietary
intervention resulted in a significant reduction in PASI (mean ±
standard deviation baseline score, 13.8 ± 6.9 [range, 7–32]): mean
change, −10.6 [95%CI, −12.8 to −8.4] (P < 0.001). A reduction in PASI
≥50% and ≥75% was recorded in 36 (97.3%) and 24 (64.9%) patients,
respectively. Treatment resulted also in a significant reduction of
BSA involved and an improvement in itch severity and DLQI (P < 0.001
for all).
Conclusions: In adult overweight patients with stable chronic plaque
psoriasis an aggressive dietary WL program consisting in a ketogenic
regimen followed by a balanced, hypocaloric Mediterranean-like diet
appeared an efficacious first-line strategy for improving disease
severity. Comparative studies with other dietary regimens and long-
term efficacy data are warranted.
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USEFULNESS OF BIO-IMPEDANCE MEASUREMENT IN
RHEUMATOLOGIC PATIENTS MONITORING
E. Scarpellini1*, C. Rasetti1, P. Santori1, M. basilico1, N. Giostra1,
M.V. Valeri1, N. clementi1. 1Ospedale Madonna Del Soccorso, san
benedetto del tronto, Italy
* Corresponding author.
Rationale: Rheumatologic diseases such as systemic sclerosis (SS)
need continuousmonitoring for their follow-up/treatment. SS patients
suffer very often from malnutrition (1). Only a few reports from
literature showhow the nutritional status (NS) assessment can be used
for these aims (1). Bio-impedance (BI) is the gold standard for NS
assessment in humans.
Thus, we aimed to assess NS of rheumatologic patients and its possible
correlation with disease stage.
Methods: From March 2018 to March 2019, we consecutively
enrolled rheumatologic patients admitted to the Internal Medicine
Unit of San Benedetto del Tronto General Hospital. All the patients
underwent a complete NS assessment before and after iloprost
infusion.
Results: We consecutively enrolled 16 patients (10 with SS, 4 with
undifferentiated connectivity’s and 2 rheumatic polymyalgia; mean
age 68 ± 1.1 years, F 10, BMI 26.2 ± 0.8 Kg/m2, phase angle 4.5 ± 0.6°).
According to PA values, 90.9 ± 1.5% of patients had a reduced free fat
mass indicative of malnutrition. In agreement with literature, there
was no significant correlation between BMI values and disease stage
(1). However, a significantly lower PA, higher extra-cellular water
content correlated with a higher disease activity (r = 0.6 and r = 0.61,
respectively). Moreover, these two items significantly correlated with
higher inflammatory biochemical parameters (e.g. PCR) (r = 0.5 and
0.48, respectively).
More interestingly, we observed a significant PA increase and extra-
cellular water content decrease after iloprost infusion in all patients
(3.1 ± 0.6 vs. 4.0 ± 0.4°and 70.5 ± 8.7 vs. 48.7 ± 9.1%, both p < 0.05)
Conclusions: This prospective single-center study showed for the first
time the significant correlation between BI parameters and disease
gravity in a small cohort of rheumatologic patients. These preliminary
results suggest the possible use of BI in patients staging, follow-up and
assessment of treatment response.
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SUN-PO145
INTRAMUSCULAR FAT IS PREDICTIVE OF HYPOGLYCEMIA
INCIDENCE IRRESPECTIVE OF MALNUTRITION RISK. RESULTS
FROM THE MENU-STUDY
E. Leibovitz1*, T. Perluk2, I. Khanimov3, M. Shimonov2. 1Internal
medicine, Yoseftal Hospital, Eilat, 2Wolfson Medical Center, Holon,
3Sackler school of Medicine, Tel Aviv, Israel
* Corresponding author.
Rationale:Malnutrition risk was found to be associated with incident
hypoglycemia among hospitalized patients in internal medicine units.
We wanted to analyze body composition among patients with high
risk of malnutrition, with and without hypoglycemia.
Methods: Included were patients enrolled in the MENU study that
underwent CT scanning during their hospitalization. The NRS2002
was used for nutritional screening. Body compositionwas analyzed at
the level of L3 using SliceOmatic software (TomoVision, Montreal,
Canada). Body composition surface area of each tissue was corrected
for height squared. Patients were categorized as hypoglycemic if they
had at least one documented hypoglycemic event during the
hospitalization period (glucose ≤70 mg/dL). Regression analysis was
used to examine the association of body composition with incident
hypoglycemia.
Results: Included were 155 patients (mean age 69.7 ± 15.7, 51.6%
were males, 52.9% had diabetes mellitus). Rate of positive NRS2002
was 57.8%, and 26 patients (16.7%) had at least one documented
hypoglycemic event. Patients at risk of malnutrition had lower
muscle mass (44.9 ± 12.5 vs. 49.3 ± 13.6 cm2/m2, p = 0.045), and
lower subcutaneous fat (59.4 ± 40.7 vs. 86.8 ± 49.7 cm2/m2, p <
0.001) and visceral fat (64.3 ± 40.2 vs. 93.4 ± 58.1 cm2/m2, p =
0.001). Regression analysis showed that the NRS2002 (OR 4.986,
95% CI 1.052–23.632, p = 0.043) and insulin treatment (OR 7.769,
955 CI 1.529–39.461, p = 0.013) were predictive of hypoglycemia in
this patient population. Furthermore, intramuscular fat was also
indicative of hypoglycemia incidence (OR 1.091, 95% CI 1.002–1.187,
p = 0.044). Muscle mass, subcutaneous and visceral fat mass as well
as sex, albumin and diabetes mellitus status did not affect incident
hypoglycemia.
Conclusions: Our data suggests that intramuscular fat is predictive of
hypoglycemia incidence among patients admitted to internal medi-
cine units, irrespective of malnutrition risk.
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SUN-PO146
ALS, GASTROSTOMYAND SURVIVAL: TRYING TO CLARIFYOBSTACLES
TO OPTIMIZE OBJECTIVES
F. Palmas1*, M. Salvador2, G. Cárdenas1, M. Giribes1, V. Avilés1,
L. Andurell1, C. Puiggros1, M. Guerrero1, J. Gamez2, R. Burgos1.
1Nutrition Unit, 2Neurology department, University Hospital of Vall
D’Hebron, Barcelona, Spain
* Corresponding author.
Rationale:Malnutrition in amyotrophic lateral sclerosis (ALS) is a risk
factor for mortality. On the other hand, to date it has not been possible
to demonstrate that nutritional treatment increases survival.
Our aimwas to analyze the influence of gastrostomy placement in the
mortality of ALS patients in our cohort.
Methods: Retrospective analysis of the patients evaluated in the
multidisciplinary unit of ALS in our centre between 2013 and 2017.
Table 1
Descriptive data of the sample.
Population N = 88 (%)
Sex
Women 48 (54,5)
Age at onset 64,98 ± 12,44
Type of ALS
Spinal 56 (63,7)
Bulbar 31 (35,2)
Respiratory 1 (1,1)
Dysphagia 77 (87,5)
Non-invasive ventilation 38 (50)
Tracheostomy 5 (5.7)
Weight loss >10% 20 (31,7)
Initial BMI 25,9 ±4,2
Survival
Inmediatelly accepted 1118 ± 705
Delayed 1198 ± 692
Rejected 1004 ± 635
Exitus 71 (80,7)
Results: 88 ALS patientswere assessed and followed in our unit during
the afore mentioned period. 71 patients (80.6%) met criteria for PEG
placement, 29 (41%) immediately accepted and 12 (16.9%) delayed the
PEG because of initial rejection. PEG was refused in 30 patients (42%).
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The mean of forced vital capacity was 47 ± 18.17%. The overall survival
was 1141 ± 808 days, with no significant differences between imme-
diate acceptance or rejection. Weight loss occurred from the onset to
the insertion of the PEG correlated statistical significantly with a
higher overall mortality with a moderate-high correlation of Pearson
(R = 0.511, p < 0.001), mainly among patients who rejected PEG
(R = 0.681, p < 0.0001).
Conclusions:
• Reject or the delay in the placement of the PEG has not led to a
lower global survival in this first assessment. Detailed analysis of
the sample is necessary to clarify possible factors that interfere in
survival, as atypical forms of ALS.
• Malnutrition is confirmed as a significant prognostic factor
regarding mortality in patients with ALS, so efforts to prevent it
should be increased.
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SUN-PO147
LIFE QUALITY OF PATIENTS WITH IRRITABLE BOWEL SYNDROME
B. Yilmaz1, G. Akbulut1, G. Yurtdas ̧1*. 1Nutrition and Dietetics, Gazi
University, Ankara, Turkey
* Corresponding author.
Rationale: Irritable bowel syndrome (IBS) is a functional disorder
characterized by chronic recurrent abdominal pain and alteration of
intestinal habits regardless of known organic cause. Irritable bowel
syndrome, which is a frequently encountered disease in stress, does
not affect mortality and morbidity, but adversely affects the quality of
life.
Methods: This study was conducted with seventy individuals (18
males, 52 females) between 20 and 55 years with IBS. The data of the
study were gathered by the researcher using face-to-face interviews
with the patients using the ‘survey method’. Short Form 36 (SF-36)
was used for evaluation of the quality of life.
Results: The mean age of the patients is 37.8 ± 10.03 years and 40% of
them is in the subgroup of IBS-mixed. While the scores of physical
function, role physical and role emotional of male subjects were
higher than female subjects, pain scores of female subjects were
higher than male subjects (p < 0.05). Statistically, significant differ-
ences were found between genders in terms of physical function
(Z =−4.276; p < 0.05), role limitations due to physical health
(Z =−4.107; p < 0.05), pain (Z =−2.259; p < 0.05) and role limitations
due to emotional problems (Z =−4.361; p < 0.05). Male individuals
have higher scores on physical function, role limitations due to
physical health and role limitations due to emotional problems than
female subjects, while female subjects have higher pain scores than
male subjects. The pain scores of those with comorbid disease are
significantly higher than those without comorbid disease
(Z =−2.533; p < 0.05).
Conclusions: Patients with IBS have a generally low quality of life
when compared to a healthy population. Especially female patients
have lower scores than males. IBS patients should be trained in stress
management, as well as, psychological support should be recom-
mended to the patients who are considered necessary.
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SUN-PO148
THE EFFECT OF CONTINUOUS AND INTERVAL NUTRITION
EDUCATION ON DIABETES STATUS AND BODY COMPOSITION OF
TYPE 2 DIABETES
G. Kaner1, B. Önder Pamuk2, D. Ongan1, G. Pamuk3, E. Bellikci Koyu1,
G. Çalık1*, S. Öksüz3. 1Department of Nutrition and Dietetics, Iżmir Katip
Çelebi University, Faculty of Health Sciences, 2Department of
Endocrinology, 3Department of Family Medicine, Iżmir Katip Çelebi
University, Faculty of Medicine, Iżmir, Turkey
* Corresponding author.
Rationale: Nutrition education is considered the cornerstone of
diabetic management. This study was conducted in order to analyze
the effect of continuous and interval nutritional education on the clinic
and anthropometric measurements in type 2 diabetic patients
(Type2DM).
Methods: This study was carried out in 2 phases. The first part of the
study examined the lifestyle and eating habits of 135 people with
diabetes. In the second part, 47 individuals were divided into two
groups, nutrition training was given at different intervals. Individuals
who reside in Izmir has received 20 nutritional educations in total, for
10 months at intervals of 15 days. This education was named
continuous nutritional education (CNE). Individuals who come from
the towns of Izmir has received 5 nutritional educations in total, for
10 months at intervals of 2 months. This was named interval
nutritional education (INE). The education which was given to both
groups was designed in the form of 5 modules. The datawas collected
via questionnaire form. Body mass index (BMI) was calculated and
their waist and hip circumferences was measured. Individuals’ body
compositions was determined by an impedance analyzer. This study
was supported by Iżmir Katip Çelebi University Scientific Research
Project Coordinator (2016-GAP-SABF-0014).
Results: Body weight (kg), BMI (kg/m2), fat mass (%), fat mass (kg),
muscle mass (kg), waist circumference (cm), waist-hip ratio, neck
circumference (cm), and wrist circumference (cm) were similar in
groups before nutrition education. After CNE, body weight, BMI, fat
mass (%), fat mass (kg), muscle mass, waist circumference, hip
circumference, waist-hip ratio, neck circumference, and wrist circum-
ference were not significantly changed. After INE, body weight and
BMI changes were found to be statistically significant (p = 0.006 and
p = 0.008). The fat mass (%), fat mass (kg), muscle mass, waist
circumference, hip circumference, waist-hip ratio, neck circumference,
and wrist circumference were not significantly changed after INE.
Fasting blood glucose, total cholesterol, triglyceride, HDL and
LDL cholesterol, HbA1c levels did not change significantly after CNE
and INE.
Conclusions: It is thought that it is important to prepare structured
and individualized educational contents by considering the socio-
economic status of patients in future studies.
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THE RELATIONSHIP BETWEEN WAIST CIRCUMFERENCE AND
DIETARY I˙NTAKE AND FUNCTIONAL CONSTIPATION IN WOMEN
G. Yurtdas ̧1*, G. Akbulut1, N. Acar Tek1. 1Nutrition and Dietetic, Gazi
University, Ankara, Turkey
* Corresponding author.
Rationale: The aim of this study was to evaulate the relationship
between anthropometric measurements and dietary intake and
fuctional constipation in women.
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Methods: The study was carried out on a total of 445 women aged
18–65 years who were selected by random sampling method. Data
were collected by questionnaires prepared by the researchers using
face-to-face interview technique. The constipation status of the
women was evaluated according to the Roman IV criteria. Dietary
intakewas obtained from food frequency questionnaire (FFQ). In order
to determine the severity of constipation the ‘Constipation Severity
Scale’was used. Anthropometric measurements (height, body weight,
waist circumference) were measured. ‘International Physical Activity
Questionnaire Short Form’ (IPAQ-SF) was used for the evaluation of
physical activity status.
Results: The mean age of the participants was 28.8 ± 10.38 years.
The prevelance of functional constipation was 25.4%. Obese women
had a higher prevalence of constipation compared with the ones who
were overweight and normal (39.2%, 28.7%, 22.3% respectively). The
prevalence of constipation in women with moderate active was 21.1%,
while in women with inactive was 26.4%. Women with functional
constipation were found to have lower dietary fiber and fluid intake
compared to women without constipation. However, the difference
was not statistically significant. A positive significant correlation was
found between waist circumference and constipation severity (r =
0.156, p = 0.001). Logistic regression analysis showed that advancing
age, increasing body weight, higher body mass index (BMI), higher
waist circumference was significantly associated with a higher
prevalence of functional constipation. Total fiber intake, fluid intake
and physical activity level was not associated with constipation
(p > 0.05).
Conclusions: Functional constipation is common among women.
Advancing age, having high body weight, higher BMI and higher waist
circumference was associated with higher risk of functional conspa-
tion. Therefore, ensuring control of body weight and increasing
physical activity may help in the prevention and management of
functional constipation.
Disclosure of Interest: None declared.
SUN-PO150
EVALUATION OF DIETARY FIBER INTAKE AND GASTROINTESTINAL
SYMPTOMS OF PATIENTS WITH IRRITABLE BOWEL SYNDROME
B. Yilmaz1, G. Akbulut1, G. Yurtdas ̧1*. 1Nutrition and Dietetics, Gazi
University, Ankara, Turkey
* Corresponding author.
Rationale: Irritable bowel syndrome (IBS) is a chronic functional
bowel disease with no known etiology, characterized by lower and
upper gastrointestinal symptoms such as changes in bowel habits
(constipation/diarrhea), abdominal pain, dyspeptic complaints.
Although there is no clear information about the type and amount of
fiber in IBS, it is reported that soluble fiber may have positive effects in
studies. In a systematic review of 17 clinical trials, it was stated that the
effect of fiber in IBS is variable and insoluble fiber may worsen
symptoms.
Methods: Seventy individuals (18 males, 52 females) between 20 and
55 years of age were included in the study. The research data were
gathered by the researcher using face-to-face interviews with the
patients using the ‘survey method’. The fiber intake was determined
using a 3-day dietary recording method. The ‘Gastrointestinal
Symptom Rating Scale’ (GSRS) was used to assess the gastrointestinal
symptoms.
Results: The mean age of the patients was 37,8 ± 10,03 years. Mean
body mass index of male patients was 27,1 ± 2,97 kg/m2, while the
mean BMI of female patients was 26.6 ± 5.81 kg/m2. The fiber intake
was calculated as 21.8 ± 10.7 g in males and 14.6 ± 5.39 g in females.
Most of the patients (72% ofmales and 73% of females) had insufficient
fiber intake according to Dietary Reference Intakes. There was no
statistically significant relationship between dietary fiber and GSRS
scores (Table 1).
Table 1
Examination of the GSRS scores with dietary fiber intake
Fiber intake
status
GSRS scores
Abdominal
pain
Reflux Diarrhea Indigestion Constipation
Inadequate r = 0,082 r = 0,005 r = −0,045 r = 0,019 r = 0,024
Adequate p = 0,434 p = 0,963 p = 0,665 p = 0,852 p = 0,812
Conclusions: There is no specific fiber recommendation for patients
with IBS. The amounts determined by DRI also apply to IBS patients
(38 g/day for an adult male, 25 g/day for female). In the studies, it was
determined that IBS patients had dietary fiber intake lower than
recommended. Because each fiber type does not affect symptoms of
patients, a detailed nutrition history should be taken from individuals.
As well as, fiber types that do not affect their symptoms should be
included in their diet.
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SUN-PO151
NUTRITION-INFLAMMATIONMARKERS AND SURVIVAL IN PATIENTS
WITH CHRONIC ADVANCED KIDNEY DISEASE (ACKD)
G. Barril1*, A. Nogueira1, G. Alvarez1, A. Nuñez1, C. Sanchez1,
J.A.S. Tomero1. 1Nephrology, Hospital Universitario de la Princesa,
Madrid, Spain
* Corresponding author.
Rationale: Objective.- To assess the influence on the survival of ACKD
patients according to nutrition-inflammation markers.
Methods: We have evaluated 214 patients with ACKD with xage
71.22 ± 12.84 years, 145 men (67.8%), 41.2% diabetics.
We divided into 4 groups according to Albumin 3.7 and PCR 1: G1
albumin <3.7 and PCR <1, G2 albumin>3.7 and PCR <1, G3 albumin <3.7
and PCR>1, G4 albumin >3.7 and PCR>1.
We compared inter-groups: malnutrition-inflammation score, vis-
ceral proteins, Hb, lymphocytes, CRP, body composition by BIA
monofrecuency AKERN. HD.01 and hand grip strenght (baseline)..
Likewise we established survival curves according to the established
groups.
Results: We didnt föund a difference between interoperability xage,
xweight, xBMI, basal xmetabolisms, % TBW% fat mass, % lean mass, %
muscle mass, BCMI or anthropometric parameters, xCKD-EPI and
subjective global assessment.
We found significant intergroup differences in: MIS and VGO (0.000),
nPNA (0.05), albumin and prealbumin (0.000), transferred (0.001),
lymphocytes (0.046), Hb and CRP (0.000), phase angle, Na / K, AIC and
AEC (0.000). Hand grip strech right 0.021 and left0,047.
In the survival study with Kaplan-Meier curves, considering the 4
groups, we found greater survival in G2 (Albumin>3.7 and CRP <1)
compared to the rest of the groups, G3 being the lowest in survival
(Albumin <3.7 and PCR>1). (long rank 0.005). Grouping the 4 groups
into 2 according to PCR>1 and <1 and according to albumin> or <3.7,
significant differences are maintained with long Rank of 0.028 for PCR
and 0.001 for albumin.
S115Abstracts / Clinical Nutrition 38 (2019) S59–S296
Conclusions:
1. There are significant differences between the scales of nutritional
assessment, visceral proteins, biochemical and inflammation
parameters, body composition and hand grip strech between
the groups studied.
2. Albumin as amarker of nutritionmodulated by inflammation and
CRP as inflammation parameter appear as mortality markers
alone or in combination in patients with CKD.
Disclosure of Interest: None declared.
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WHAT IS MORE IMPORTANT IN THE DIAGNOSIS OF SARCOPENIA
STRENGTH, MUSCLE MASS OR FUNCTIONALITY?
G. Barril1*, A. Nogueira1, G. Alvarez1, D. Sapiencia1, N. Andres1,
A. Nuñez1, C. Sanchez1, J.A. Sanchez Tomero1. 1Nephrology, Hospital
Universitario de la Princesa, Madrid, Spain
* Corresponding author.
Rationale: The criteria for the definition of sarcopenia have changed
according to the European group of sarcopenia since 2018, considering
muscle strength as the first tool to be assessed for the diagnosis of
sarcopenia.
AIM.- Establish the prevalence of presarcopenia, sarcopenia and severe
sarcopenia in a sample of 108 patients with advanced CKD.
Methods: To establish the diagnosis of presarcopenia if there is a
decrease in muscle strength or Dinapenia less than 16 kg in
women and 27 in men with a baseline dynamometer. Decrease in
muscle mass if SMM / height2 <6.57 in women and 8.83 in men
(BIA Bodygramplus, and increase in pace with 6mwtest if it
is>0.8 m/sec.
Results: We evaluated 108 patients with advanced CKD (CKD-EPI
<30 mil/min/1.73 m2, Xage 70.55±11.60 (33–94), 72males and
36females. We found the difference between them, We found 42
patients with presarcopenia 38.8% 24 males and 18 females. Of them
had Sarcopenia = SMM/size2 low 24 patients, 6males and 18 females.
Finally, with gait speed>0.8 m/sec of the sarcopenic 5 patients, 4.62%,
which would constitute the group of severe sarcopenia.
Conclusions:
1. The ERC prospects metabolic alterations that can diminish the
strength and/or muscle mass
2. Preserved muscle mass does not always imply good muscular
strength.
3. The hand grip strength appears as the main tool to measure
sarcopenia.
4. The loss of functionality with lengthening of the gait speedwould
give us severity or functional repercussion of sarcopenia.
5. Muscle strength decreases with age but it improves with physical
exercise what should be considered in these patients.
Disclosure of Interest: G. Barril Speakers Bureau of: Abbot, Nutricia,
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THE CLINICAL VALUE OF SITAGLIPTIN, A DIPEPTIDYL PEPTIDASE-4
INHIBITOR, IN PATIENTS WITH SHORT BOWEL SYNDROME AND
COLON IN CONTINUITY: AN OPEN-LABEL PILOT STUDY
H. Skaraas Johnsen1*, R.M. Naimi1, L.M. Wangen1, M. Hvistendahl1,
P.B. Jeppesen1. 1Department of Gastroenterology and Hepatology,
Rigshospitalet, Copenhagen, Denmark
* Corresponding author.
Rationale: Patients with short bowel syndrome (SBS) and colon in
continuity have better potential for intestinal adaptation compared to
patients with jejunostomies due to enhanced endogenous responses
of glucagon-like peptide (GLP)-1, GLP-2, and peptide YY which are
normally degraded by dipeptidyl peptidase-4 (DPP-4). Treatmentwith
GLP-2 has been shown to improve intestinal absorption in a small
number of these patients who suffer from high-volume fecal output.
We aimed to evaluate the efficacy of sitagliptin, a DPP-4 inhibitor, on
fecal wet weight in this patient group.
Methods: In an open-label, proof-of-concept pilot study, 100 mg oral
sitagliptin was given twice daily for 8 weeks to patients with SBS and
≥50% of colon in continuity with intestinal insufficiency (II) or failure
(IF). To assess intestinal function, metabolic balance studies were
performed at baseline and at the end of treatment.
Results: Of the eight patients treated with sitagliptin seven patients
(SBS-II: n = 3; SBS-IF: n = 4) completed the trial. Although postprandial
endogenous GLP-2 concentrations increased in all patients by a
median (range) of 49 h×pmol/L (39 to 105), sitagliptin did not
significantly reduce median fecal wet weight (−174 g/day (−1510 to
675)) or increase intestinal wet weight absorption (223 g/day (−514 to
847)) (Table 1). However, heterogeneity in the treatment effect was
observed: six out of seven patients reduced their absolute fecal wet
weight ranging from −1510 to −10 g/day. Intestinal wet weight
absorption increased in all patients with SBS-IF. One patient achieved
a reduction in parenteral support of 500 ml per administration day.
Table 1
Results from metabolic balance studies. AWilcoxon signed-rank test was used
for the statistical analyses. P < 0.05 was considered statistically significant. Data
are presented as median (min, max).
Baseline Treatment Change P-value
Dietary wet weight
intake (g/day)
Fecal wet weight
(g/day)
Intestinal wet weight
absorption
(g/day)
3022 (1737, 4353)
1087 (383, 3480)
1523 (−360, 3267)
3183 (1730, 4208)
1135 (153, 3183)
1747 (90, 3132)
−7 (−663, 276)
−174 (−1510, 675)
223 −514, 847)
0.672
0.176
0.398
Conclusions: Larger placebo-controlled studies are needed to estab-
lish the role of DPP-4 inhibitors in the treatment of patients with SBS.
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SUN-PO154
IMPROVEMENT IN FRAILTY STATUS AFTER PULMONARY
REHABILITATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE
PULMONARY DISEASE
J. Plas1, L. ter Beek1,2, H. van der Vaart3, H. Jager-Wittenaar2,4*.
1Department of Pulmonary Diseases and Tuberculosis, Center for
Rehabilitation, University Medical Center Groningen, 2Research Group
Healthy Ageing, Allied Health Care and Nursing, Hanze University of
Applied Sciences, 3Department of Pulmonary Diseases and Tuberculosis,
Center for Rehabilitation, 4Department of Maxillofacial Surgery,
University of Groningen, University Medical Center Groningen,
Groningen, Netherlands
* Corresponding author.
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Rationale: Prevalence of frailty in outpatients with Chronic
Obstructive Pulmonary Disease (COPD) is high, i.e., 22–58%. Frailty
has a multidimensional character with physical, psychological, and
social domains. Since pulmonary rehabilitation (PR) includes nutri-
tional, exercise, and psychosocial interventions, PRmay improve frailty
status. In this study, we aimed to assess the change in prevalence and
frailty score during PR in patients with COPD.
Methods: Before and after a 9-week PR program, frailty was assessed
by the multidimensional Evaluative Frailty Index for Physical Activity
(EFIP), which includes the physical, psychological, and social domains.
A patient was considered frail if EFIP score >0.25. The Wilcoxon sign
test was used for not normally distributed data and for ordinal data.
The McNemar test was used for binary data.
Results: Longitudinal data on the EFIP were complete in 59 patients
(72%) (60.9 ± 9 years; 48%male; Forced Expiratory Volume in 1 second
39% predicted). EFIP score decreased from 0.34 pre-PR to 0.28 post-PR
(p < 0.001). Score on the physical domain decreased from 0.27 to 0.22
(p = 0.021), on the psychological domain from 0.26 to 0.22 (p = 0.011),
on the social domain from 0.34 to 0.28 (p = 0.011), and on the health
domain from 0.46 to 0.38 (p < 0.001). Also, the prevalence of frailty
decreased from 85% to 61% (p < 0.001).
Conclusions: After PR, prevalence of frailty in this group of COPD
patients is substantially lower than at the start of PR. Improvements in
frailty status are visible in the physical, psychological, and social
domains. The findings of our study underscore the dynamic character
of frailty.
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ENTERAL NUTRITION CONTAINING COLLAGEN PEPTIDE
PROMOTES SKIN WOUND HEALING BY ENHANCING COLLAGEN
SYNTHESIS
H. Yamashita1*, S. Miki1, G. Ebisu1. 1Medical Foods Research Institute, OS-
1 Division, Otsuka Pharmaceutical Factory, Inc., Naruto, Tokushima, Japan
* Corresponding author.
Rationale: Collagen peptide intake has been shown to promote the
healing of pressure ulcers. We developed a liquid enteral nutrition
product that contains collagen peptide (CP-EN). We performed two
separate studies to investigate the effects of CP-EN on skin wound
healing in diabetic model rats and to assess the effects of CP, which
is the collagen peptide used in CP-EN, on collagen synthesis in
vitro.
Methods: Male Sprague-Dawley rats were intravenously injected
with streptozotocin (50 mg/kg body weight) to induce diabetes.
Two weeks later, two full-thickness skin wounds were created on
the back of each rat, and they were fed either CP-EN or NCP-EN
(general commercial enteral nutrition product not containing
collagen peptide) for 14 days. We measured the epithelial gap
and neutral salt-soluble type I collagen (NSC) levels in the wound
area on days 7 and 14 post-wounding. Additionally, we performed
an in vitro study to assess the effects of CP on human dermal
fibroblasts. For this, normal human dermal fibroblasts (NHDF) were
incubated with CP for 48 hours and procollagen type I C-peptide
(PIP) levels were measured in the cultured medium after
incubation.
Results: Skin NSC levels were significantly increased in the CP-EN
group compared to the NCP-EN group on day 7. Therewas a significant
decrease in the size of the epithelial gap in the CP-EN group versus the
NCP-EN group on day 14. Furthermore, therewas a significant increase
in PIP content in the NHDF after treatment with CP.
Conclusions: Our data suggest that CP-EN intake might enhance skin
wound healing compared with general enteral nutrition products that
don’t contain collagen peptide. Furthermore, collagen peptide sup-
plementation via CP-EN intake might positively affect dermal
fibroblast collagen synthesis.
Disclosure of Interest: H. Yamashita Other: Employed by Otsuka
Pharmaceutical Factory, Inc., S. Miki Other: Employed by
Otsuka Pharmaceutical Factory, Inc., G. Ebisu Other: Employed by
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DOES THE PRO-INFLAMMATORY DIETARY PATTERN STOKE UP THE
INFLAMMATION FIRE IN TYPE 2 DIABETES MELLITUS AS IMPOSING
UNDESIRABLE VITAMIN D STATUS?
H. Ozcaliskan Ilkay1*, G. Samur2. 1Nutrition and Dietetics, Erciyes
University, Faculty of Health Sciences, Kayseri, 2Nutrition and Dietetics,
Hacettepe University, Faculty of Health Sciences, Ankara, Turkey
* Corresponding author.
Rationale: Low-grade systemic inflammation which provides the
substrate for many chronic diseases such as obesity, cardiovascular
disease, and type 2 diabetes (T2DM) is also influenced by environ-
mental factors and genetic background. Though it is now well
recognized that vitamin D deficiency is associated with T2DM, the
possible relationship between diet-related inflammation and the risk
of diabetes has been investigated recently. In the present study, the
linkage between vitamin D status and inflammatory potential of diet
was examined in type 2 diabetic participants.
Methods: The study consisted of 119 type 2 diabetics (93 female,
mean age 54.7 ± 8.4 years) who were admitted to a university
endocrinology department in Turkey. Serum 25(OH)D level was
measured by high performance liquid chromatography (available for
112 patients). Vitamin D deficiency was defined as a 25(OH)D level
<20 ng/ml (50 nmol/L). The dietary inflammatory index (DII) was
computed using two days of 24-hour recall data. Lower DII scores
indicate a lower inflammatory potential of the diet1. The study
population was divided into three subgroups according to their DII
tertiles (Tertile 1: <0.54, Tertile 2: 0.54–2.02, Tertile 3: >2.02).
Pearson’s chi-squared test and Mann-Whitney U test were used to
describe the relationships between variables. Statistical significance
was accepted as p < 0.05.
Results: Significant increasing trends across the tertiles of DII were
observed for prevalence of vitamin D deficiency. For instance,
vitamin D deficiency has been reported to occur in 48.6% of Tertile
1, 57.9% of Tertile 2 whereas it was identified in 78.4% of Tertile 3
(p = 0.027). The mean DII score was 0.42 ± 1.14 (min: – 2.48, max:
3.06) among patients who have vitamin D deficiency (n = 69),
whereas the mean DII score was – 0.12 ± 1.04 (min: – 2.01, max:
1.90) among patients (n = 43) with adequate vitamin D levels
(p = 0.011).
Conclusions: Further investigations are needed to explain how this
relationship between dietary pattern and vitamin D status contributes
to the inflammatory mechanism of T2DM.
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EFFECT OF A SPECIALIZED NUTRITION FORMULATION IN AN
ANIMAL MODEL OF ALZHEIMER’S DISEASE
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Rationale: Nutritional factors influence the risk of developing
Alzheimer’s disease (AD) and its rate of clinical progression. In
rodents, models mimicking AD, can be used to study whether
nutrition can improve cognitive alterations. One of these models, the
applying of intracerebroventricular (ICV) streptozotocin (STZ), cul-
minate in a neuroinflammatory picture with cognitive alteration.
Methods: Rats were randomly divided into two groups: sham and STZ.
STZ group received a single bilateral ICV injection of STZ (1 mg/kg total
dose) dissolved in sterile 0.9% saline. Sham group received a single
bilateral ICV injection of 0.9% saline. Treatment with an antioxidant
and anti-inflammatory nutritional formulation (AZ) (1 g/kg, per os) or
its vehicle (0.9% saline) was performed over 30 days, once a day (n = 6–
10 per group). The animalswere assessed in the open field test (OFT) to
evaluate locomotor activity (day 27). Cognitive performance was
evaluated (day 28), in the object recognition test (ORT) and in the
spatial version of the Y maze. On day 30, they were deeply
anesthetized and intracardially perfused for the immunohistochem-
ical of doublecortin (DCX; marker of newborn and migrating neurons)
and Iba-1 (microglial activation marker). Group differences were
analyzed using one way analysis of variance (ANOVA) with
Bonferroni’s post-hoc test, with p < 0.05 (significant).
Results: Locomotor activity in the OFT did not reveal any changes in
the locomotion parameters in all of the groups. STZ-lesioned rats
showed a reduction in memory process in both ORT and Y maze.
Besides, an increase in IBA-1 in the CA1 and CA3 (region of
hippocampus). Most importantly, the treatment with AZ formulation
was able to reverse thememory impairment observed in theORTandY
maze and also reduced IBA-1 in the CA-1 and gyrus dentatus region of
hippocampus.
Conclusions: STZ-lesioned rats present amemory impairment besides
the increase inmicroglial activation. The prolonged treatment with AZ
formulation was able to counteract these changes.
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Rationale: In our Unit of practice integrated in Intestinal Failure
working in collaboration with the Latin American Federation of
Parenteral and Enteral Nutrition (FELANPE) we designed a database
of this adverse event with the objective of knowing the results in the
medical-nutritional and surgical therapy in a prospective multicenter-
multinational, descriptive and analytical study with a 60-day follow-
up.
Methods: The first cohort of hospitalized patients with a diagnosis of
leak and/or postoperative fistula of the gastrointestinal tract was
performed on May 9, 2018. The follow-up of these patients was 2
months. Patient care was not intervened in any way. The informed
consent of the participating hospitals was obtained.
Results: The postoperative fistulawas presented after elective surgery
in 68.9% of the cases while 31.1% was after emergency surgery.
In 176 patients who completed the follow-up at 2 months, we found a
mortality of 21.46% (38 patients), of these, 48% (18 patients) presented
symptoms of anastomotic leak during the first 5 days.
The location of the fistula with the highest mortality was Small
Intestine.
Of the 38 patients who died, 15 cases developed FEAT.
Conclusions: The prevalence of this adverse event in the postoperative
period of gastro-intestinal surgery continues to be high and as a
clinical entity with different stages, diagnosis is difficult and
treatments are of wide variability.. It is urgent the standardization of
clinical scenarios, the creation of integrated practice units in intestinal
failure for the attention of this high cost adverse event.
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Rationale: Weight loss (WL) is a often under-recognised and under-
diagnosed complication in Parkinson`s disease (PD), which is
surprising given the clinical characteristics and a variety of symptoms
thatmayaffect nutrition status. The aim of this studywas to determine
the frequency, evolution and risk factors of WL in a representative
incident PD cohort.
Methods: In this prospective population-based study, we followed 185
incident and initially drug-naïve PD patients and 172 age- and sex-
matched controls with repetitiveweight examinations at baseline and
1, 3, 5, 7 and 9 years of follow-up. We used Andersen-Gill model to
identify risk factors of short-term WL (>10% WL in two years) and
multivariable Cox proportional hazards model in the long-term
perspective (>10% WL during the entire study period).
Results: Mean % weight change during the study period was −3.8
(±11.0) in patients and −1.3 (±7.9) in controls (p = 0.015). Long-term
WL was more common in PD than controls (25.9% vs. 10.1%, relative
risk 2.56; p < 0.001). Predictive risk factor for both short-and long-
term WL adjusted for demographics were dyskinesias (hazard ratios
(HRs) 2.25 [95% confidence interval 1.15–4.42] and 2.94 [1.45–5.93]
p = 0.02 and <0.01), age (1.04 [1.01–1.07] and 1.06 [1.03–1.10] both
p < 0.01) and cognitive impairment (0.94 [0.89–0.99] and 0.89 [0.81–
0.97] p = 0.03 and 0.01). In addition, short-term WL was predicted by
Unified Parkinson’s disease rating scale motor score (1.02 [1.00–1.05]
p = 0.04), while olfactory impairment predicted long-term WL (2.52
[1.19–5.31] p = 0.02).
Conclusions: WL is frequent in the general PD population and
associated with both disease-related features and drug-related
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complications. This suggests a complex nature of WL in PD, which is
important to take into consideration in clinical practice.
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Rationale: Primary Sjogren’s Syndrome (pSS) is a systemic auto-
immune disease characterized by the presence of sicca symptoms.
Mouth dryness is associated with change on the flora, and infections,
and teeth disease and loss. This, as well as the disease symptoms, have
a vast impact on the patients eating habits. As far as we know, no one
has attempted to evaluate its influence on nutritional risk.
The aim of this work is to evaluate the impact of drymouth, on dietary
habits and nutritional risk on pSS patients.
Methods: Questionnaires were developed to assess the patient’s
severity of dry mouth and oral disease, as well as their dietary habits
change due to the disease. Data regarding disease characteristics and
nutritional risk using the MUST scale were also collected.
Results: Data from 25 patients attending the Sjogren’s clinic were
analyzed, yielding a female preponderance (88%), with a mean age
of 60 years old. pSS disease duration was on average 10,7 years,
antibody positivity of 40% and 36% for anti-Ro and anti-La,
respectively. As for disease scores, ESSDAI mean was 2,7 ± 5,2 and
ESSPRI 5,7 ± 2,7.
Concerning oral dryness, 68% experienced dryness, with 44%
causing dysphagia, and 36% required moistening of the food and/
or artificial saliva use, but only 8% using pilocarpine. As for oral
health, 32% had experienced oral infections, 28% dental loss and
28% taste changes in food. The majority (60%) was using fluoride
products to protect the teeth decay, but 40% had already prosthesis.
There was no relationship between this and disease characteristics
or demographics.
Regarding the patient eating habits: 32% related reduced food intake
due to pSS. The most avoided types of food were acidic (87,5%), spicy
(75%), sugary (62,5%) and sticky (50%). Pasta andmeat/fish intakewere
reduced in 25% and vegetables in 12,5% of patients. There was a
marginal relationship (not statistically significant) between reduced
food intake and age and Anti-Ro.
As for the nutritional status of this sample. BMI average was 28,
with 70% overweight and above. MUST stratification identified 18% as
at risk.
Conclusions:Oral dryness and disease are very important in pSS. Its
impact on food intake has never been addressed, however, our
questionnaire reveals that some patients avoid eating certain types
of food. These relate to foods that worsen dryness or have negative
effects on dental health. The relationship to age is probably due to
the overall effects of aging on the reduction of food taste or eating
pleasure. The not statistically significant association with anti-Ro
antibody requires a bigger sample size to understand.
Even though the nutritional risk wasn’t alarming, it was still relevant
with an 18% incidence, therefore raising the importance of screening
patients. Further studies may help to find risk and prognostic factors.
More importantly, the high prevalence (70%) of overweight. These
patients are at increased cardiovascular risk due to its inflammatory
condition and drugs.
The main bias are the small sample size, and the lack of a matched
control group to infer if the features are exclusive to pSS. Future work
will involve more patients, but also a more extensive food diary.
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Rationale: We investigated the association between muscle and
visceral fat mass with prognosis of patients hospitalized with acute
pancreatitis (AP).
Methods: Included in this retrospective analysis were patients
admitted with AP between 2008 and 2014. Body composition analysis
(Sliceomatic, Tomovision, CA) was performed on CT images at the L3
level. Regression analysis was used to examine the effect of body
composition on 1-year mortality as well as 1-year readmission rates.
Results: A total of 158 patients were enrolled in our study (age
63.7 ± 17.4 years, 57.6% male predominance). Fat was the most
abundant tissue (408 ± 180 cm2 surface area). Age was the only
prognostic factor that had a tendency to affect 1-year mortality rates
(HR 1.051, 95% CI 0.993–1.112, p = 0.087). Low muscle mass and low
visceral fat were associated with significant increase in re-admissions
rate (1.7 vs. 1.1, p = 0.018; 1.6 vs. 1.1, p = 0.087, respectively). Regression
analysis showed that high visceral fat was associated with reduced
1-year re-admission rates (OR 0.995, 95% CI 0.991–1.000, p = 0.034).
Visceral fat mass was also associated with reverse correlationwith the
number of 1-year re-admissions (HR −0.004, 95% CI −0.008–000,
p = 0.070).
Conclusions: High visceral and muscle mass were good prognostic
criteria for patients admitted with acute pancreatitis. These results
suggest the importance of nutritional rehabilitation in patients after
admission due to AP.
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Rationale: To examine the difference between males and females
regarding association between malnutrition risk and hypoglycemia.
Methods: The study design is a subgroup analysis of a cross-sectional
analysis of newly admitted patients to internal medicine departments
at Wolfson Medical Center in Israel.
Malnutrition risk, assessed with Nutritional Risk Screening 2002
(NRS2002), and serum albumin were measured upon admission.
Logistic regression was applied to men and women separately, to test
the effect of malnutrition and hypoalbuminemia on incidence of
hypoglycemia.
Results: Included were 1185 patients (50.4% males, 39.2% with
positive NRS2002). Rate of high malnutrition risk was similar across
sexes (37.4% vs. 41.2% in males and females respectively, p = 0.186).
Within NRS2002 negative males, rate of hypoglycemia was 7.1%,
compared to 9.2% in NRS2002 positive males (p = 0.520). However,
within NRS2002 negative females, rate of hypoglycemia was 2.4%
compared to 9.5% in NRS2002 positive females (p < 0.001). NRS
component analysis found that the weight loss/decreased food
intake criterion was significantly higher in the hypoglycemic group
within females (p = 0.03). Logistic regression showed that serum
albumin level was inversely associated with hypoglycemia in both
female (OR 0.491, 95% CI 0.264–0.914) and male populations (OR
0.385, 95% CI 0.234–0.633). However, increased malnutrition risk
was significantly associated with hypoglycemia only among females
(OR 3.915, 95% CI 1.592–9.627). Diabetes status was associated with
hypoglycemia (OR 2.784, 95% CI 1.417–5.469) only in males; this
association did not occur in females.
Conclusions: Malnutrition risk, as measured by the NRS2002, is
associated with significantly increased incidence of hypoglycemia in
women alone. Females who lose weight prior to hospitalization have
an increased risk to develop hypoglycemia.
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Rationale: Chronic haemodialysis (HD) patients with a high body
mass index (BMI) have been shown to have a survival advantage, and
strong predictive correlation to decreased all-cause mortality. The
paradoxical observation, named the obesity survival paradox was first
reported in the 1970’s; the benefitmechanismhas eluded scientists for
over four decades. The objective of this study was to assess whether
there is a significant difference in the 3rd water space between the
subjects with a higher body fat percentage and bodymass index (BMI)
compared with their leaner counterparts.
Methods: A prospective, non-randomized observational study was
conducted. Repeated measures of 24 bioelectrical impedance analysis
pre- and post-HD measurements were conducted over three months
on 23 chronic HD subjects (50% male; ages 21–63 years) at the King
Edward VIII Hospital HD unit.
Results: Patients with a body fat percentage of ≥30% and a BMI
≥28 kg/m2 had a negative 3rd water space, compared to those with
lower body fat percentage and BMI. The difference between the two
groups was statistically significant (p = 0.000*).
Conclusions: Previous studies have shown persistent excess fluid in
the 3rd water space causes progressive soft tissue damage, cardiac
failure and brain cell damage in chronic HD patients. This study
findings suggest there is a potential benefit (lower 3rd water space) of
a higher body fat percentage and BMI in patients on chronic HD, in
contrast to the conventional perception of a healthy BMI and body fat,
namely, a BMI between 19 and 25 kg/m2, and body fat percentage
between 15 and 20%. The results of such a study may be pivotal in
changing the dietary management of chronic HD patients. Current
practice of aiming for a ‘healthy’ body fat percentage and BMI maybe
deleterious, as it has a direct impact on the risk formortality, and long-
term survival in chronic HD patients.
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POLYUNSATURATED FATTY ACID STATUS IN INDIVIDUALS WITH
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Rationale: Polycystic ovarian syndrome (PCOS) is a leading cause of
female infertility. PCOS patients are more susceptible to develop
insulin resistance, with hyperinsulinemia known to aggravate repro-
ductive dysfunction. Polyunsaturated fatty acids (PUFAs), have been
shown to improvemetabolic parameters. The purpose of the studywas
to investigate the PUFA status in women with PCOS.
Methods:A cross-sectional case-control studywas conducted (n = 77).
The study group (n = 39) was women with PCOS and infertility, and a
control group (n = 38). Demographic information, anthropometric
parameters, medical-, supplement-, and fertility history, three-day
food intake records and plasma and red blood cell membrane
phospholipid fatty acid composition were compared between
groups. Independent t-tests, Levene’s test and analysis of variance
were used to analyse the data.
Results: Dietary intake was significantly higher in the control group
for docosahexaenoic acid (C22:6n3 DHA; p = 0.043) and docosapen-
taenoic acid (C22:5n3DPA; p = 0.029), and higher for eicosapentaenoic
acid (C20:5n3 EPA; p = 0.062). The plasma phospholipid omega-6:
omega-3 ratio (n-6:n-3) was higher in women with PCOS as was the
plasma phospholipid n-6:n-3 long-chain PUFAs (LC-PUFAs) ratio
compared to the control group when adjusted for possible confound-
ing of PUFA supplementation (p = 0.039) and PUFA supplementation
with endometriosis (p = 0.048). Plasma phospholipid n-3 fatty acids
were higher in the control compared to the study group for DHA
(p = 0.029), total n-3 PUFAs (p = 0.036) and n-3 LC-PUFAs (p = 0.036).
Plasma phospholipid fatty acids with a significantly higher concen-
tration in the study group were stearic-, elaidic-, mead- and dihomo-
gamma-linolenic acid.
Conclusions: Women with PCOS and infertility presented with
significantly lower plasma phospholipid n-3 PUFAs (in particular
DHA), and consequently a higher n-6:n-3 PUFA ratio compared to
controls. These results probably reflect the dietary intakes of DHA,
DPA and EPA that was lower in women with PCOS. Plasma
phospholipid fatty acid profiles differed between women with
PCOS and controls, and may provide a complementary approach to
the treatment of PCOS.
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LONG TERM PARENTERAL NUTRITION IMPAIRS LUNG BARRIER
FUNCTION, DISTURBS PULMONARY MICROBIOTA AND INDUCES
BACTERIAL TRANSLOCATION IN A MOUSE MODEL OF TOTAL
PARENTERAL NUTRITION
J. Yang1*, X.Wang1, J. Li1. 1Department of General Surgery, Medical School
of Nanjing UNIVERSITY, Nanjing, China
* Corresponding author.
Rationale: Long term parenteral nutrition (PN) is always associated
with increased incidence of pulmonary complications including
pneumonia and pulmonary thromboembolism, which limited its
clinical application. However, few studies have focused on parenteral
nutrition associated lung injury, and the impact of parenteral nutrition
on lung barrier function impairment remains unclear.
Methods: Cannulated male C57BL/6 mice at the age of 10–12 weeks
were randomized to chow or PN group. Mice in PN group were
given continuous total parenteral nutrition for 7 and 14 days,
respectively. Severity of lung injury, lung barrier function, pulmon-
ary microbiota in bronchoalveolar lavage and bacterial translocation
were measured.
Results: Compared with mice in the chow group, total parenteral
nutrition significantly increased the severity of lung injury and
impaired the lung barrier function. The expression of tight junction
protein (ZO1 and Occludin) was significantly decreased and ultra-
structure damaged with the prolonged usage of PN. The pulmonary
microbiota analysis revealed that the number of actinomycetes and
firmicutes phylum significantly increased, and bacteroidetes phylum
decreased, as well as subordinate categories (p < 0.01). Bacterial
translocations in lung were observed by fluorescence in situ
hybridization. The longer parenteral nutrition was used, the more
serious impairment of lung barrier was observed.
Conclusions: Long term parenteral nutrition had a damaged effect
on lung barrier function, pulmonary microbiota homeostasis and
bacterial translocation in a mouse model of total parenteral
nutrition.
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AUTOPHAGY PROTECT AGAINST THE IMPAIRMENT OF LUNG
BARRIER FUNCTION IN A MOUSE MODEL OF TOTAL PARENTERAL
NUTRITION
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Rationale: Parenteral nutrition is an important life-saving strategy in
clinical practice for patients with intestinal failure. However, the long
term usage of parenteral nutrition is always associated with increased
incidence of pulmonary complications including pneumonia and
pulmonary thromboembolism, which limited its clinical application.
Previous studies have pointed out that autophagy suppression may be
an important mechanism for parenteral nutrition associated compli-
cations, but its role in parenteral nutrition associated lung injury is still
unclear.
Methods: Cannulated male C57BL/6 mice at the age of 10–12 weeks
were randomized to chow, PN, PN+ rapamycin (PN+RA), or chow+
rapamycin (chow+ RA) for 7 days. Severity of lung injury, lung barrier
function, level of autophagy, reactive oxygen species (ROS), lung
apoptosis, and inflammatory signaling pathway were measured.
Results: Parenteral nutrition caused increased severity of lung
injury and autophagy suppression, which demonstrated by the
decreased light chain 3 fluorescence (LC3) II/I ratio and increased
p62 protein accumulation. Fewer autophagosomes and intact
mitochondria in lung were observed by transmission electron
microscopy detection. Long term parenteral nutrition can also
activated the apoptosis level and inflammatory HMGB1/RAGE/NF-kB
signaling pathway. The intervention of exogenous rapamycin can
reduce the impairment of lung barrier, lower the level of ROS,
reduce apoptosis and inhibit inflammatory signaling by upregula-
tion of autophagy.
Conclusions: Autophagy suppression induced by parenteral nutrition
was an important mechanism in inducing the impairment of lung
barrier. Clinically, drugs that aimed to up-regulate autophagymay be a
potential mechanism for alleviating parenteral nutrition associated
complications.
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MODIFICATION IN THE PHASE ANGLE AND BODY COMPOSITION IN
MALNOURISHED PATIENTS: EFFECT OF SUPPLEMENTATION WITH
SPECIFIC, ENRICHED IN Β-HYDROXY Β-METHYL BUTYRATE
CALCIUM
J.M. Garcia-Almeida1*, I. Vegas-Aguilar1, I. Cornejo-pareja1, R. Rioja-
Vázquez1, I. Damas-Fuentes1, B. Fernández-Medina1, F. Tinahones-
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Rationale: Caloric protein malnutrition associates changes in body
composition and function that are related to an increase in morbidity
and mortality. The nutritional intervention tries to recover this
parameter in the malnourished patient.
The phase angle (FA) is considered a global prognostic factor that
informs about cellular functionalism and therefore in relation to body
composition.
OBJECTIVES: To assess the clinical response (FA, Standardized FA,
nutrition and hydration and body composition in a group of
malnourished patients) subjected to a nutritional intervention
during a period of 3-6M. We treat patients with a nutritional
supplement. enriched in β-hydroxy β -methyl butyrate calcium (HMB).
Methods: Prospective study of nutritional intervention n = 31, where
analytical determinations (albumin, prealbumin, RCP), nutritional
(anthropometric parameters, FA, standardized FA) are performed.
Intake and nutritional support records, during a follow-up period of 3–
6 Months.
Results: 31 patients, 59.6 ± 13.8 years, 45% males.
There is an improvement in the FA of 0.83° with maintenance of the
degree of hydration (TBW/FFM) and increase in the nutritional status
78.8 (mg 24 h/htm)
The mean weight was 69.3 ± 12.7. There is an increase in weight of
3.3 kg in 6 Months of intervention with improvement in the body cell
mass (BCM) and muscle function (dynamometry)
There is an improvement in protein parameters with recovery of
albumin and prealbumin and decrease in inflammatory pattern
(CRP),
Conclusions: A significant improvement was observed in the para-
meters of function and cellular composition associated with the
nutritional intervention enriched in β-hydroxy β-methyl butyrate
calcium (HMB). Weight gain and recovery of the nutritional and
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inflammatory analytical parameters are important for the nutritional
evolution and global prognosis of patients.
Table 1
PARAMETER BASAL FINAL
WEIGHT (Kg) 60,5 ± 10,8 63,9 ± 11,6*
BMI (Kg/m2) 22,0 ± 3,2 23,2 ± 3,5*
FA Estandardized (°) −0,9 ± 1,1 −0,7 ± 0,9*
TBW(L) 36,6 ± 6,6 36,5 ± 6,6
ECW(L) 18,0 ± 3,2 16,7 ± 3,1*
ICW(L) 18,3 ± 4,7 19,8 ± 4,4*
FFM(Kg) 49,0 ± 8,8 49,5 ± 9,5
FM(Kg) 11,4 ± 5,5 13,1 ± 6,5*
BCM(Kg) 24,2 ± 6,8 26,8 ± 6,0*
ASMM(Kg) 18,3 ± 4,2 18,7 ± 4,0
SMI(Kg/m2) 8,7 ± 1,7 8,5 ± 1,7
DYNAMOMETRY)(Kg) 24,7 ± 11,2 30,0 ± 11,0*
ALBUMIN(g/dl) 3,2 ± 0,6 4,0 ± 0,6*
PREALBUMIN(mg/dl) 19,4 ± 5,5 24,9 ± 6,9*
CRP(mg/l) 9,2 ± 13,5 3,2 ± 0,7*
(TBW total body water, ECW extracelular water, ICW intracelular water, FFM fat
freemass, FM fatmass, BCM body cell mass, ASMMappendicular skeletalmuscle
mass, SMI skeletal muscle mass index, CRP protein C reactive.
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SUN-PO169
WAIST-TO-HIP RATIO IS REFLECTION OF HIGHER FAT CONTENTAND
CORRELATED WITH CARDIOVASCULAR RISK FACTORS IN RENAL
TRANSPLANT RECIPIENTS
J. Radic1́*, H. Raos2, M. Vučkovic2́, D. Bucán Nenadic1́, Ž. Puljiz3.
1Nephrology and dialysis, University hospital Centre Split, 2Medical
School Split, Split, 3Faculty of Food Technology and Biotechnology at the
University of Zagreb, Zagreb, Croatia
* Corresponding author.
Rationale: Previous studies in adults revealed that the waist-to-hip
ratio (WHR) is equivalent to or slightly better than waist
circumference (WC) and superior to body mass index (BMI) in
predicting higher cardiometabolic risk. The aim of this cross-
sectional study was to analyse correlations between WHR and
other anthropometric parameters, blood pressure and laboratory
parameters and other clinical parameters among Dalmatian renal
transplant recipients (RTRs).
Methods: 89 RTRs, 48 (53.93%) men and 41 (46.07%) women, aged
59.31 years were included. For each RTRs patient data about
number and type of antihypertensive drugs, age, gender, weight
and height were collected. Also, serum urea, creatinine, glucose,
triglyceride, total cholesterol and low density cholesterol level, were
measured and body mass index (BMI) and glomerular filtration (GF)
was calculated. The Agedio B900 device was used to measure
arterial pressure (peripheral and central systolic as well as
peripheral and central diastolic arterial pressure) and parameters
of arterial stiffness (pulse wave velocity (PWV) and augmentation
Index (AIx). Furthermore, Tanita MC780 Multi Frequency segmental
body composition analyser was used to measure content of body
fat, muscle mass and visceral fat.
Results: Statistically positive correlations betweenWHR, BMI, glucose
and triglyceride level were found (p = 0.005), (p = <0.001), (p = 0.027),
(p = 0.005), respectively. Also, statistically positive correlation
between fat mass (kg), fat mas (%) and visceral fat (kg) was found
(p = <0.001), (p = <0.001), (p = <0.001), respectively. Furthermore,
those patients with higher WHR had statistically lower muscle mass
(%) (p = <0.001), higher systolic blood pressure (p = 0.038) and higher
PWV (p = 0.038). RTRs with diabetes (p = 0.05) and resistant hyper-
tension (p = 0.032) had statistically higher WHR.
Conclusions: These correlations suggested that WHR is reflection of
fat content and correlated with cardiovascular risk factors (BMI,
systolic blood pressure, PWV, glucose and triglyceride level). WHR
could be screening tool for obesity and related cardiometabolic risks
for RTRs in everyday clinical practice.
Disclosure of Interest: None declared.
SUN-PO170
IMPACT OF PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) ON
THE EVOLUTION OF THE DISEASE IN PATIENTSWITH AMIOTROPHIC
LATERAL SCLEROSIS (ALS)
J.J. López-Gómez1*, M.D. Ballesteros-Pomar2, B. Torres-Torres1,
B. Pintor de la Maza2, M.Á. Penacho-Lázaro3, J.M. Palacio-Mures4,
C. Abreu-Padín5, I. Sanz-Gallego6, D.A. De Luis-Román1, on behalf of
Grupo Nutrición Scledyn. 1Servicio de Endocrinología y Nutrición,
Hospital Clinico Universitario Valladolid, Valladolid, 2Servicio de
Endocrinología y Nutrición, Complejo Asistencial Universitario de León,
León, 3Servicio de Endocrinología y Nutrición, Hospital de El Bierzo,
Ponferrada, 4Servicio de Endocrinología y Nutrición, Hospital
Universitario Rio Hortega, Valladolid, 5Servicio de Endocrinología y
Nutrición, Complejo Asistencial de Segovia, Segovia, 6Servicio de
Neurología, Complejo Asistencial de Ávila, Ávila, Spain
* Corresponding author.
Rationale: Patients with Amyotrophic Lateral Sclerosis (ALS) has high
risk of dysphagia and they may need gastrostomy in its evolution. The
aims of this studywere: a) To describe anthropometryat the beginning
of the nutritional follow-up. b) Rate of complications between patients
with and without PEG and the influence of the moment of
implantation on them. c) Evaluate survival based on the implantation
of PEG.
Methods: An interhospital registry was created for the eleven
hospitals of Castilla y León through a web platform. They were
evaluated on data on disease evolution, nutritional history and
subjective global assessment (VGS). We compared the data of those
inwhich PEGwas implanted and those that did not and between those
in which PEG was implanted before (less than 10 months after
diagnosis) with respect to those that were implanted later.
Results: A total of 93 patients from 6 hospitals in Castilla y León were
analyzed. In 38 patients (38.8%), PEG was implanted. The nutritional
assessment at the start according to VGS was PEG (A: 25%, B: 25%, C:
50%); NoPEG (A: 28.6%; B: 51%; C: 20.4%); p < 0.01). Those inwhich PEG
was implanted had a higher rate of admissions (26.3% vs. 8.3%,
p < 0.01). In those who were implanted earlier, they had less income
associated with complications of this (>10 m: 27.5%, <10 m: 0,
p = 0.01). Among the deceased patients 38 (40.4%) those who had
PEG implanted (20 patients (52.6%) had a longer survival time (30.21
(5.15) months vs. 15.31 (3.47)) months, p = 0.01).
Conclusions: Patients with PEG present a worse nutritional situation
at onset. PEG implanted early produced a reduction in admission
associated with complications derived from it. PEG could show a
survival benefit among patients with ALS.
Disclosure of Interest: None declared.
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SUN-PO171
NUTRITIONAL STATUS AND RELATED COMPLICATIONS IN
HOSPITALIZED ONCOLOGICAL PATIENT
J.J. López-Gómez1*, J.M. Cerezo-Martín2, B. Torres-Torres1, E. Gómez-
Hoyos1, A. Ortolá-Buigues1, E. Delgado-García1, S. García-Calvo1,
C. Serrano-Valles1, L. De Marcos-White1, Á. Castro-Lozano1, D.A. De
Luis-Román1, on behalf of Instituto de Investigación en Endocrinología
y Nutrición (IENVA). 1Servicio de Endocrinología y Nutrición, Hospital
Clinico Universitario Valladolid, 2Facultad de Medicina, Valladolid, Spain
* Corresponding author.
Rationale: Malnutrition is a disease with a high prevalence in the
oncologic patient. The aims of this study were: (a) To assess the
nutritional status of the oncological hospitalized patient. (b) Evaluate
the relationship of the nutritional situation of the patient with the
development of complications.
Methods: An observational, longitudinal and retrospective study was
designed in 168 patients admitted to the Oncology Department of a
tertiary hospital in which nutritional support was requested between
January 2014 and June 2017. They were collected epidemiological,
anthropometric and nutritional data. The nutritional status was
evaluated with the Mini Nutritional Assessment (MNA) and the
Malnutrition Universal Screening Tool (MUST).
Results:Of the 168 patients, 29.9%werewomen and 70.1%men,with a
median age of 63 (56–71) years. Most of the patients were in an
advanced stage of the disease (Stage III: 15.3%, Stage IV: 66.7%). The
median stay of the patients was 11.5 (7–19) days. The median weight
loss before admission was 12.50 (6.67–18.29) %. The median
consumption of the diets was 50 (30–75) %. The adjustment of the
diet consumed to the requirements had a median of −34.98 (−7.80–
59.38) %. Among the patients analyzed, artificial oral supplementation
was prescribed in 138 (82.1%), enteral nutrition by tube in 18 (10.7%)
and parenteral nutrition in 4 (2.4%). According to the MUST scale,
62.3% had a high nutritional risk and 12.3% would have a mild
nutritional risk. According to their MNA score, 47.2% of Oncology
patients had a poor nutritional status (MNA <17.5). The multivariate
analysis by logistic regression showed that the poor nutritional
situation (MNA <17.5) is related to an increase in the probability of
death independently of the stage of the disease and the age of the
patient OR: 3.74 IC95% (1.37–10.21) p-value = 0.01.
Conclusions:Malnutrition among oncological patients hospitalized in
the HCUV is a frequent comorbidity and with a prevalence like
previous studies. The poor nutritional status acts as an independent
risk factor in the mortality of cancer patients.
Disclosure of Interest: None declared.
SUN-PO172
ALLERGY STATUS OF HOSPITALIZED PATIENTS AND REDUCED
ERRORS IN PROVIDING MEALS THROUGH THE DEVELOPMENT OF
A COMPUTERIZED SYSTEM
J.-M. Mo1*, M.-J. Sung1, E.-M. Kim1, M.-Y. Rha1. 1Dietetics, Samsung
Medical Center, seoul, Republic of Korea
* Corresponding author.
Rationale: Patients are likely to incur allergic food-related accidents
because it is difficult to know about allergenic foods on their meal
plate.
Methods: We collected patient’s food allergy cases who admitted to
SamsungMedical Center in December 2018, to grasp the allergy status.
Before the automated system was developed, recipe for allergenic
foods were identified by manually entering data and matching with
existing text. With the developed system, the user can automatically
match allergy foods and recipes using the allergy food database and
display them on the menu information sheet. We compared the error
reports of food provision before and after development.
Results: Of the 8,501 patients admitted to the hospital in December
2018, 338 patients(4.0%) reported food allergies, of which 41(12%)
were children(≤18 years). In children, food allergies included milk
(11%), crab(11%), peanuts(10%), eggs(10%), and shrimp(10%). In adults,
the allergies were peach(16%), mackerel(11%), pork(10%), shrimp(10%),
and crab(10%). Children had a significantly higher incidence of
allergies to milk(p = 0.004), eggs(p = 0.002), peanuts(p = 0.014), and
sesame(p = 0.017). The analysis of the error rate of the meals before
and after the development of the system showed that there were 18
errors(3 operating errors, 7 input errors, and 8 preparing meal errors)
in providing allergy meals during the period(2013∼2014) before the
development of the system. After its development(2017∼2018), the
number of errors in the provision of meals totaled 4 cases, all of which
were errors in preparing meals, and the error rate was 78% lower than
before.
Conclusions: It is necessary to plan andmanage alternativemenus for
allergic foods of patients who are admitted to the hospital, in advance,
and to reduce errors in providing meals, as well as provide safe meals,
by building an automated system.
Disclosure of Interest: None declared.
SUN-PO173
EFFECTS OF A WEIGHT-LOSS MEDITERRANEAN LIFESTYLE
INTERVENTION ON SYMPTOMS AND QUALITY OF LIFE OF
PATIENTS WITH OBSTRUCTIVE SLEEP APNEA: A RANDOMIZED
CONTROLLED CLINICAL TRIAL
M. Georgoulis1, N. Yiannakouris1, I. Kechribari1, Z. Karapetsa1, K.-
A. Poulia1*, K. Lamprou2, E. Vagiakis2, A. Kokkinos3, M.D. Kontogianni1.
1Department of Nutrition and Dietetics, School of Health Sciences and
Education, Harokopio University, 2Center of Sleep Disorders, 1st
Department of Critical Care, ‘Evangelismos’ General Hospital, 31st
Department of Propaedeutic Internal Medicine, Medical School, ‘Laiko’
General Hospital, National and Kapodistrian University, Athens, Greece
* Corresponding author.
Rationale: Obstructive sleep apnea (OSA) patients suffer from
insomnia, sleepiness and low quality of life. Our aim was to explore
the effect of a weight-loss Mediterranean lifestyle intervention (MLI)
combined with continuous positive airway pressure (CPAP) on OSA
symptoms and quality of life, compared to patient standard care (SC) (i.
e. CPAP alone).
Methods: 117 adult overweight/obese patients (77% men, mean age:
47 ± 10 years) with polysomnography-diagnosed OSA were rando-
mized to either a SC group (SCG, n = 59) or a MLI group (MLIG, n = 58).
Patients in SCG received CPAP and general lifestyle advice, while those
inMLIG participated in an intensive 6-month intervention, in addition
to CPAP, aiming at 5–10% weight loss and promoting adherence to the
Mediterranean lifestyle. Patients were evaluated pre- and post-
intervention regarding OSA symptoms, quality of life, anthropometric
indices and lifestyle habits.
Results: The two groups did not differ in anthropometric, lifestyle or
clinical parameters at baseline. Drop-out rate was 24.1% for MLIG and
35.6% for SCG.Meanweight losswas−11.3 kg forMLIG and− 0.5 kg for
SCG (P < 0.001). Both groups had significant reductions in daytime
sleepiness and degree of insomnia, however improvements were
greater in MLIG after adjusting for baseline values, weight loss and
adherence to CPAP (both P < 0.001). At 6 months, % of patients with
excessive daytime sleepiness and insomnia was 2.3 and 11.4 in MLIG
compared to 63.2 and 31.6 in SCG (P = 0.02 and 0.001, respectively).
Physical and mental health improved only in MLIG (both P < 0.001),
and the difference between groups was significant for mental health
(P = 0.02).
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Conclusions: Aweight-loss MLI combined with CPAP offers additional
improvements in OSA symptomatology and patients’ quality of life,
compared to CPAP alone.
Disclosure of Interest: None declared.
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THE NUTRITIONAL ADEQUACY OF A GLUTEN-FREE DIET IN ADULTS
WITH CELIAC DISEASE
K. Gładys´ 1,2*, M. Guzek3, K. Adrych3, S. Małgorzewicz2, Z. Kochan1.
1Nutritional Biochemistry, 2Clinical Nutrition and Dietetics,
3Gastroenterology and Hepatology, Medical University of Gdansk,
Gdańsk, Poland
* Corresponding author.
Rationale: Since gluten-containing whole grains contain fiber and
nutrients, such as B vitamins, calcium and iron, it is important to
compensate for these missing nutrients in gluten-free diet (GFD) in
patients with celiac disease (CD). Our aim was to determine the
nutritional adequacy of GFD.
Methods: The study population included 66 adults (average age: 41
years old) with CD diagnosed by the serological and histopathological
tests. All participants completed a 3-day diet diary, additionally a
qualified dietician carried out a 24-hour diet recall during the
consultation. GFD adherence was also evaluated by validated tests:
Celiac Dietary Adherence Test (CDAT) and Standardized Dietitian
Evaluation (SDE). Assessment of nutritional status was carried out
using anthropometric measurements and bioimpedance. Statistical
evaluation of medical data were performed with STATISTICA program.
Results: Among CD patients, 15% were malnourished, 13% were
overweight, and 2% were obese. Moreover, the majority of patients
had altered body composition: 59% had excessive fat mass. Only 21% of
patients had remission of CD, while 44% had partial remission and 35%
still had symptoms of CD. In the group with remission, almost 80%
consumed too much fat (especially cholesterol) and not enough
calcium; more than 50% did not eat appropriate amount of iron and
potassium. In contrary, in the group of active CD only 35% of patient’s
diets contained too much fat, but consumption of calcium and other
nutrients was comparable.
Conclusions: Diet of patients with active CD contains less fat than diet
of people with remission, however, in both groups nutritional
deficiencies are still an important problem. This can lead to an
abnormal nutritional status and CD complications. Therefore, balan-
cing a GFD, in consultation with a dietitian, plays a crucial role in the
therapy of this disease.
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NUTRITIONAL STATUS IN OLD PATIENTS WITH WOUND HEALING
DISORDERS AT HOSPITAL ADMISSION
K. Franz1*, L. Otten1, C. Herpich2, U. Haß2, V. Aykac3, U. Müller-
Werdan1,3, K. Norman1,2. 1 Nutrition and Body Composition – Research
Group on Geriatrics (FGG), Charité – Universitätsmedizin Berlin, Berlin,
2Dept. of Nutrition and Gerontology, Institute of Human Nutrition
Potsdam-Rehbrücke, Nuthetal, 3Evangelical Geriatric Center Berlin
(EGZB), Berlin, Germany
* Corresponding author.
Rationale:Wound healing disorders (WHD) are common in old adults
and are usually associated with negative clinical outcomes and higher
mortality (1). In this prospective cross-sectional study, we evaluate the
number and type of WHD and the nutritional status in old patients at
admission in an acute geriatric clinic.
Methods:We assessed all study participants forWHD (pressure ulcer,
leg ulcers caused by venous insufficiencyor peripheral arteryocclusive
disease, diabetic foot and chronic non-healing surgical wounds) at
hospital admission. Involuntary loss of weight in the last 3 and 6
months was recorded. We used 4 categories of BMI according toWHO
(<18.5 kg/m², 18.5–24.9 kg/m², 25–29.9 kg/m², ≥30 kg/m²) and loss of
appetite was estimated with the CNAQ questionnaire.
Results: Of 215 recruited old patients (78.2 ± 7.1 years, 60% female), 45
(20.9%) patients hadWHDat admission,with amean numberofWHD/
person of 2.4 ± 2.2 (min – max: 1–10). Pressure ulcer (n = 21) was the
most commonWHD followed by chronic non-healing surgical wound
(n = 18), leg ulcers caused by peripheral artery occlusive (n = 5), leg
ulcers caused by venous insufficiency (n = 3), diabetic foot (n = 1), and
otherWHD (n = 5). Although patients withWHD had lost moreweight
in the last 3 (6.2 ± 6.8% vs. 2.7 ± 4.4%, p = 0.002) and 6 months
(8.6 ± 9.5% vs. 3.4 ± 4.8%, p = 0.001), WHD were most frequently
present in obese patients (<18.5 kg/m²; 18.5–24.9 kg/m²; 25–
29.9 kg/m²; ≥30 kg/m²: 6.7%; 33.3%; 20%; 40%, chi² p = 0.028). The
ANOVA also showed a significant difference in number ofWHD/person
between BMI categories (global p = 0.031) with the highest number of
WHD/person present in obese patients compared to overweight
patients (0.9 ± 1.9 number of WHD/person vs. 0.3 ± 0.9 number of
WHD/person, p = 0.040). Patients with WHD did not suffer more
frequently from loss of appetite compared to other patients (48.9% vs.
patients without WHD 56.4%, p = 0.367).
Conclusions: Our results showed that although involuntary weight
loss is higher in patients with chronic wounds, an obese BMI is
associatedwith the highest number ofWHD/person. This might partly
be explained by inflammatory processes, which are related to obesity.
Reference
1. Zarchi et al. 2015
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DO FAT-SOLUBLE VITAMIN REQUIREMENTS IN ADULT CYSTIC
FIBROSIS PATIENTS CHANGE FOLLOWING BIPULMONARY
TRANSPLANTATION?
L. Andurell1*, G. Cárdenas1, M. Giribes1, V. Aviles1, N. Garcia1,
A. Álvarez2, A. Roman2, F. Palmas1, H. Segurola1, R. Burgos1.
1Nutritional Support Unit, 2Pneumology Service, Vall d’Hebron Hospital,
Barcelona, Spain
* Corresponding author.
Rationale: Is well known that cystic fibrosis (CF) adult patients who
have exocrine pancreatic insufficiency (EPI) require supplementation
with fat-soluble vitamins (FSV). An increase in FSV levels after BPT has
been described, even reaching in the long termpotentially toxic levels.
There are no clear recommendations on the dose of vitamins needed
by patients after BPT.
Aim: to evaluate the FSV blood changes in CF patients and EPI,
previous and after to BPT.
Methods: Observational study in CF patients with EPI undergoing/
following a BPT. We compared FSV serum levels (A, D, E and
protrombine time) before BPT and 3 month later, analyzing separately
the patients who continued taking the usual vitamin supplementation
and thosewhowithdrow it after the transplantation. All patients prior
to BPT were supplemented with specific FSV. In case of a punctual
deficiency, it was necessary an extra FSV supplementation. Other
parameters studied: gender, Diabetes mellitus related to CF, BMI and
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FSV supplementation. All patients received immunosuppressive
treatment after BPT.
Results: 22 CF adult patients following/undergoing to TBP (12
women), age 29.5 (±7). All presented EPI, additionally 10 presented
endocrine pancreatic insufficiency (45%). The FSV compliance was
adequate. Three months after BPT half of them keep a good FSV
compliance (table 1). After BPT, patients who didn’t follow FSV
supplementation, showed adequate FSV blood levels, in some cases
above the maximum levels recommended.
Parameters Previous –
transplantation
After –
transplantation
(3 months)
p
Weight 46.7(±10.85) 47.5(±9.76) n.s
BMI 17.9(±2.8) 18.2(±2.54) n.s
AVit (1.55–2.5 mmol/l) 1.22(±0.32) 2.2(±0.68) p < 0.0001
E Vit (18–46 mmol/l) 20.4(±6.4) 26.8(±8.3) p = 0.006
D Vit (>20 mmol/l) 23.8(±11.5) 27.1(±11.9) n.s
Protrombine time (%) 83.1(±12.7) 96.0(±14) p = 0.003
Conclusions: FSV blood levels increase after BPT in CF adult patients.
The FSV doses after BPT should be re-evaluated, especially vitamin A
levels, because of their potential long-term toxicity.
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CAN MUSCLE MASS BE PRESERVED DURING ADMISSION? BEYOND
NUTRITION DAY
L. Andurell1*, V. Avilés1, G. Cárdenas1, N. Garcia1, M. Sevillano2,
C. Puiggros1, M. Guerrero1, F. Palmas1, H. Segurola1, R. Burgos1.
1Nutritional Support Unit, 2Pneumology Service, Vall d’Hebron Hospital,
Barcelona, Spain
* Corresponding author.
Rationale: The pulmonary patient has a high nutritional risk. During
admission, respiratory infections and immobility, among other causes,
favours malnutrition and loss of muscle mass, being associated with
worse prognosis.
The aim of the study was to assess muscle mass(MM) evolution and
function(FM) in patients with respiratory pathology admitted in our
hospital.
Methods: Descriptive prospective study in hospitalized patients
included in NutritionDay 2018 at the Pneumology Service. Body
composition measurement: Tetrapolar Bodystat QuadScan 4000
Bioelectrical Impedance (BIA). FM measurement: hand hydraulic
dynamometer (HG-JAMAR). Other Variables: hospital diet compli-
ance, length of stay (LOS). All data were collected weekly during 3
weeks. Diet was adapted and supplemented individually according to
nutritional needs.
Results: 23 patients (age 62.4 ± 13.5),13women, LOS: 21.8 ± 15.8.With
the individualyzed nutritional treatment and dietary enrichment we
observed an improvement in the adherence of the assigned energyand
protein intake (Table 1); in the third week 75% of the patients fulfilled
100% of the intake. After the nutritional intervention, FM and MM
were preserved (table 1). Fat free mass index(FFMI) correlates slightly
with FM (R = 0.498, p = 0.015). The MM correlates with the FM
(R = 0.656, p = 0.001).
Variables 1st Week
(n:23)
2n Week
(n:12)
3th Week
(n:4)
FFMI 17.2 ± 3.5 17.7 ± 2.8 20.3 ± 2
MM (kg) 46.3 ± 13.7 49.2 ± 11.5 54.2 ± 5.8
FM(kg) 21.39 ± 7.2 22.23 ± 9.5 24.8 ± 8.5*
Diet compliance
over 100%
52.2% 66.6% 75%
*P < 0.05 between the 1st and 3th week
Conclusions: With an adapted dietary treatment and a regular
monitoring, we can preserve the FM and the MM in the patient
admitted to the Pneumology Service. The significant correlation
observed between MM measured by BIA and FM measured by HG,
show that HG could be an alternative to BIA in clinical practice due to
its simplicity, reproducibility and lower cost.
Disclosure of Interest: None declared.
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NUTRITIONAL STATUS IN CHILDREN WITH INFLAMMATORY BOWEL
DISEASE
A. Kamalova1*, E. Kirshina1. 1Paediatrics, Kazan State Medical University,
Kazan, Russian Federation
* Corresponding author.
Rationale: Childrenwith inflammatory bowel disease (IBD) often have
nutritional status disorders associated with both reduced meal intake,
increased loss of nutrients with stool, chronic catabolic status,
increased nutritional requirement and therapy.
Methods: We assessed anthropometry and body composition in 60
children (22 girls and 38 boys) aged 4–17 yearswith IBD. 25 (42%) subj.
have ulcerative colitis (UC), 17 (28%) have Crohn’s disease (CD) and 18
(30%) subj. have IBD unclassified. The WHO AnthroPlus program and
bioelectrical impedance analysis (BIA) were used to assess the
parameters of the nutritional status.
Results: According to the anthropometry 36 (60%) subj. have
malnutrition (UC – 23 (92%), CD – 13 (77%), p < 0,05). 9 (25%) of
them have mild (UC – 2 (8%), CD – 7 (41%)), 20 (56%) subj. have
moderate (UC – 12 (48%), CD – 8 (47%)) and 7 (19%) subj. have severe
malnutrition (UC – 5 (20%), CD – 2 (12%)). 4 (7%) children were
overweight (UC – 3 (12%), CD – 1 (6%)). According to the results of BIA
50 (89%) subj. have body composition disorders (UC – 24 (96%), CD – 15
(88%)). The active cell mass was decreased in 31 (52%) subj. with
malnutrition (UC – 18 (72%), CD – 13 (77%)). An increase of the fatmass
proportion was found in 30 (14%) childrenwith malnutrition (UC – 18
(72%), CD – 12 (71%)). Decreased phase angle values which may
indicate a low level of functional capabilities and disease exacerbation
were observed in 18 (72%) childrenwith UC and 10 (59%) patients with
CD (p < 0,05).
Conclusions: According to our preliminary data nutritional status
disorders were detected in a majority of children with IBD. Patients
with UC have malnutrition and altered body composition more often
than in CD. This may be due to the high frequency of total and severe
form of the UC among our patients. Our results require amore detailed
study of the nutritional status of children with IBD for targeted
correction of nutrition.
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VALIDITY OF THE NUTRITION SCREENING TOOL CIPA IN SURGICAL
INPATIENTSANDDIFFERENCES IN CLINICALOUTCOMESACCORDING
THE RESULT
A.MoraMendoza1*, J.P. Suárez Llanos1, A. SánchezMorales1, C. Lorenzo
González1, Y. Zambrano Huerta1, I.L. Gómez de Segura1. 1Endocrinology
and Clinical Nutrition, HUNSC, S/C Tenerife, Spain
* Corresponding author.
Rationale: The nutritional screening CIPA (Control of Intakes, Proteins,
Anthropometry) is positive if one of the following ismet: 48–72 h food
intake control <50%, serum albumin <3 g/dL, body mass index (BMI)
<18.5 kg/m2 or mid-upper arm circumference ≤22.5 cm. After validity
in hospitalized non-surgical inpatients*,**, the CIPA method is valid
when compared with Subjective Global Assessment (SGA) in surgical
pathologies.
Methods: Prospective study of prevalence of malnutrition on 226
adults patients admitted to surgical departments, through CIPA and
SGA screening. The data of SGA, CIPA, epidemiological and clinical
outcomes were collected. Concordance between the two methods
(Kappa index), sensitivity (S) and specificity (E) of CIPAwere studied.
Analysis of hospital malnutrition according to CIPA screening and
association of positive results with length of stay (LOS), mortality and
rate of early readmission. Checking normal distribution by
Kolmogorov-Smirnov test, bivariate analysis with Student´s or
Mann-Whitney U test and categorical variables Chi-square test.
Quantitative variables are expressed as mean±standard deviation or
as median and interquartile range (IQR), and qualitative as frequencies
(%). Level of significance: 5%.
Results: The prevalence or risk of malnutrition by CIPA was 35.40%
(95%CI: 29.12–41.68) and 30.08% (95%CI: 24.06–36.11) by SGA. S and E
of CIPA taking SGA as a reference: 70.59% and 79.75% respectively. K-
index evaluating concordance between CIPA and SGA was 0.479
(p < 0.001). CIPA is able to detect patients with higher risk of hospital
death (5.00% vs 0%, p = 0.006) which contrasted with SGA (2.94% vs
1.27%, p = 0.385). CIPA detected mortality in the first three months
after discharge, 8.75% vs 0.68%, p = 0.002, also SGA 8.82% vs 1.27%,
p = 0.005. Patients with CIPA screening positive had an increased
median LOS compared with negative, (21; 14–34 days vs 14.5; 9–27
days, p = 0.002) and SGA too (23; 14.25–37.25 vs 15; 9–25, p < 0.001).
CIPA screening is also able to detect higher rate of early readmissions
vs CIPA negative (25.32% vs 8.22%, p < 0.001 as well as SGA (23.53% vs
10.13%, p = 0.008).
Conclusions: The prevalence of malnutrition in surgical patients is
high. The nutritional screening CIPA is able to detect the surgical
patient with worse clinical outcomes, being a simple and applicable
tool in the hospital. CIPA proved valid for use in surgical patients.
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OF MALNUTRITION DEPENDING OF DIFFERENT FORMULAE
A. Sanz-Paris1*, B. Calvera-Supervia2, N. Díaz-Laguardia2, F. Losfablos-
Callau2, J. Perez-Nogueras3, E. Torres-Anoro4, M. Blasco-Solana5,
M. Gonzalez-Fernandez2, A. Sanz-Arque6, J.-M. Arbones-Mainar7.
1Nutrition Unit, Instituto Aragones de Ciencias de la Salud, 2Nutrition
Unit, Miguel Servet Hospital, 3Geriatric, Residencia Elias Martinez,
4Geriatric, Residencia Romareda, 5Geriatric, Residencia Casa Amparo,
Zaragoza, 6Primare Care, Centro de Salud Santa Ana, Tudela, 7IASS,
Instituto Aragones de Ciencias de la Salud, Zaragoza, Spain
* Corresponding author.
Rationale: Recently, a new nutritional assessment tool has been
proposed: GLIM criteria for the diagnosis of malnutrition. It includes
three phenotypic criteria (non-volitional weight loss, low body mass
index, and reduced muscle mass) and two etiologic criteria (reduced
food intake or assimilation, and inflammation or disease burden).
Reducedmusclemass can be defined formen andwomen according to
ASMI <7.26 and <5.25 or according to FFMI <17 and <15 respectively.
The objective of the present study is to compare the results of applying
both formulas in a defined population
Methods: A cross-sectional study was performed in 132 patients
hospitalized with basal diet (20.18% from the total hospitalized
patients) (57.6% men, mean age 66.9 +15, range 19–97 years). We
determine BIA and calculate the lowmusclemass according to ASMMI
and FFMI for malnutrition (GLIM). The prevalence of malnutrition is
compared with the two formulas. Informed consent was obtained.
Results: 1) The first step is a screening test. We used MNA-SF with
64.4% normal, 33.3% risk and 2.3% malnourished. 2) Regarding weight
loss: 82.6% lose only <5%, 13.6% lose 5–10% (moderate) and 3.8% lose>
10% (severe). 3) Normal BMI in 90.2%, moderate affectation 7.6% and
severe 2.3%. 4) FFMI low at 23.5% and ASMI low at 33.3%. 5) Reduced
food intake only 3%. 6) The etiological criterion of inflammation was
applied to all patients due to presenting an acute situation that
motivated their hospital admission. 7) GLIM: moderate malnutrition
26.5% and severe 6.1%. 8) Only 58.3% of patients agree that ASMI and
FFMI are normal and 15.2% agree that both are low. The 18.2% ASMI is
low but FFMI is normal and 8.3% is the opposite. These differences did
not alter the GLIM results for the other phenotypic and etiologic
criteria.
Conclusions: In hospitalized patients reduced muscle mass is the
phenotypic criterion more frequently affected and it depends of the
formula used.
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Rationale:Recently, consensus has beenpublished for the diagnosis of
sarcopenia (EWGSOP2) and malnutrition (GLIM). In both the muscle
mass has a fundamental role that can be measured with BIA
(bioelectrical impedance analysis). To standardize the results, they
recommend formulas based on the electrical data of Resistance and
Reactance. But each consensus recommends different formulas with
their cut-off points.We propose to compare the results of musclemass
with both formulas in a group of institutionalized elderly.
Methods: A cross-sectional multicenter study was carried out in 187
institutionalized elderly people (64.7%women, average age 83.27 + 7.2
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(63–96) years). We determined BIA and calculated ASMMI for the
diagnosis of sarcopenia (EWGSOP2) and FFMI for malnutrition (GLIM).
Linear regression analysis was performed between ASMMI and FFMI.
The elderly were determined with muscle mass (MM) decreased
according to the cut points of each parameter and Chi squarewas used
to determine the concordance of both tests. The study was evaluated
by the local ethics committee.
Results: There is a high relationship between the two determinations
(R2 = 0.993, ASMMI = 1.91 + 2.33 × FFMI).
From the 187 elderly, in 129 (68.9%) the muscle mass was normal and
in 34 (18.8%) decreased with both But in 24 (12.8%) ASMMI of the
EWGSOP2 was decreased with FFMI of the normal GLIM and none of
those that had the FFMI of the GLIM low had the ASMMI of the
EWGSOP2 was normal.
Conclusions: The assessment of the muscle mass of the institutiona-
lized elderly studied according to the use of formulas for the diagnosis
of sarcopenia or malnutrition may vary, being the criterion of the
EWGSOP2 more sensitive than that of GLIM.
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Rationale: Malnutrition in oncological patients results from cachexia
and anorexia. Bioelectrical impedance analysis (BIA) establishes the
composition of the body, which seems to be an effective tool to assess
the stage of cachexia.
Methods: The study group consisted of 107 patients (M = 46; F = 61,
mean age 66 ±12) including patients with colorectal cancer (56) and
healthy individuals (51). BIAwas carried out using the seca mBCA 525
device (seca GmbH & Co. KG.). Nutritional status was assessed using;
NRS 2002, SGA, BMI, total protein, albumin and others.
Statistical datawere analyzed by the Student’s T test using Statistica 13
software. Statistical significance was defined using a two-sided value
of P < 0.05. Receiver-operator characteristic (ROC) curve analysis was
used to compare the ability of BMI, skeletal muscle mass (SMM), fat
mass index (FMI), and other to identify the presence of cancer
cachexia.
Results: Therewere significant differences (p < 0.05) in the division of
patients into the group with cancer and control, in terms of: SMM,
extracellular water/total bodywater (ECW/TBW) and phase angle (PA).
Applying the sex division, the differences (p < 0.05) between cancer
patients and control patients included; in women SMM, TBW, ECW/
TBW, and in men fat free mass (FFM), SMM, TBW, ECW/TBW.
Overweight was found among patients with cancer and also in the
control group, according to BIA (63%) and by Lorenz’s (92%).
Conclusions: Screening methods for assessing nutritional status do
not take into account changes in body composition. BIA provides
valuable information on the composition of the body, which can be an
important complement to thesemethods in the context of the Fearon’s
definition of cachexia. Evaluation of BIA results requires their reference
to the results of the same-sex control group.
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Rationale: Systemic sclerosis (SSc) may be associated with malnutri-
tion. We previously found that left ventricular mass (LVM) reflects
poor nutritional status in SSc patients; no data are available on LVM as
surrogate of muscularity in SSc. We aimed to evaluate the association
between muscle mass indices in SSc patients and LVM, as a novel
indicator of muscularity in this setting.
Methods: Patients and gender- and body mass index (BMI)-matched
healthy controls (HCs) underwent echocardiography to assess left
ventricular mass (LVM) and LVM normalized by body surface area
(LVMI). Body composition, including fat free mass index (FFMI), phase
angle (PhA) and body cell mass index (BMCI), was assessed by
bioelectrical impedance analysis (BIA). We recorded Disease Activity
Index (DAI), Disease Severity Scale (DSS), Modified Rodnan skin score
(mRSS).
Results: 64 SSc patients (55 women; mean age 50 ± 13 y) and 30 HCs
were enrolled. Mean DAI, DSS and mRSS were 3.9 ± 3, 5 ± 4 and 12 ± 7
respectively. BMI (kg/m2) in patients was not different from HCs
(22 ± 3.1 vs 22.3 ± 3.6). BCMI and PhA were significantly lower in
SSc patients with respect to HCs [10.38 ± 1.24 vs 18 ± 1.4 and 4.6 ± 0.8
vs 5.6± 0.4, respectively] (p < 0.001). Absolute and normalized LVM in
SSc patients and HCs were respectively 110.8 ± 36.7 g vs 108 ± 19 g
(p = 0.068) and 66.8 ± 19.8 g/m2 vs 65.8 ±8 g/m2 (p = 0.140). In
multiple regression analysis we found a positive correlation between
LVMI and FFMI (r = 0.52 p < 0.01). No correlation was found between
LVMI and FFMI in the HCs, as well as between LVMI and other BIA
parameters and severity and activity indices.
Conclusions: A correlation between LVMI and indices of muscularity
exists in patientswith SSc. If further confirmed, the cardiacmassmight
be use as a surrogate of nutritional status.
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MYOGRAPHY AND THEIR RELATIONSHIP WITH QUALITY OF LIFE
AND THE HEALTHY EATING INDEX
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Rationale: Whether electrical impedance myography or Bioelectrical
impedance analysis is a stronger predictor of sarcopenic-obesity
considering muscle strength and quality of life.
Methods: Body composition was obtained by Electrical Impedance
Myography (EIM) and Bioelectrical impedance analysis (BIA), infor-
mation was used to determinate body composition percentages.
Muscle strength was determined by dynamometry. Quality of life was
obtained by EuroQol-5D. Fitness Test Battery y Eurofit Testing Battery
was determinate. Information of the dietary intake was obtained by
24-hour recall. The Healthy Eating Index (HEI) was used to score the
diet component. Statistical analysis included a paired t test, to
determinate the differences between the intake amount and the
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suggested; and linear regression analysis to determinate the effect of
Muscle Quality on quality of life (QoL).
Results: Forty-six adults (33%males and 67% females) were evaluated.
According to the BMI 54.3% (25/46) of the patients were overweight,
obesity grade I was 15.2% (7/46), obesity grade II was 2.1% (1/46),
Obesity grade III was 2.1% (1/46). According to thewaist circumference
80% (n = 36) of the patients had an increased cardiovascular risk.
Subjectswere classified as sarcopenic 6.5% and sarcopenic-obese 17.3%
with EIM, with BIAwas 3.4% lower, Muscle Quality was ‘good’ in 36%.
The amount of EQ-5D as 0.82 (SD = 0.15). The MQwas entered into the
linear regression model as a continuous variable, the QoL were
significant (p = 0.031). The mean amount of energy, fat, protein, and
carbohydrateswere 2200.1 kcal/d (SD = 500), 65 gr/d (SD = 25), 71 gr/d
(SD = 13) and 233 gr/d (SD = 60), respectively.
Distribution by categories and levels of the EuroQol.
Category Level 1 Level 2 Level 3
Mobility 72% 28% 0%
Personal care 91% 89% 0%
Everyday activity 82% 17% 0%
Pain/Upset 54% 42% 4.34%
Anxiety/Depression 65% 35% 0%
Conclusions: Electrical impedance myography has a potent facility to
measure the fat- mass andmuscle quality. The incidence of sarcopenic
obesity using EIM and BIA was different between the two method-
ologies. The risk of sarcopenia should be considered in thosewith low
protein intake. Further research must be done in order to link the
muscle quality and functionality to quality of life.
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Rationale: About 32% of portuguese children are overweighted (1).
This study aims to evaluate the prevalence of overweight and obesity
in five grade children of primary education.
Methods: A cross-sectional study conducted in five grade students of
primary school, held in October 2016. Weight and Body Mass Index
(BMI) were measured using Omron BF511® scale and height with a
stadiometer. Data collected was classified according to the growth
curves of the World Health Organization (2) and then analysed with
Excel®.
Results: 140 children were evaluated, of whom 51.4% were female
(n = 72); with a mean of 10.6 years±0.85. Prevalence of overweight
(P85≤ BMI < P95) and obesity (BMI≥ P95)were 15% (n = 21) and 23.6%
(n = 33), respectively. Overweight prevalencewas higher amongmales
(16%; n = 11), whereas obesity prevalence was higher in females
(26.4%; n = 19).
Conclusions: The present study showed a high prevalence of
overweight and obesity (38,6%). According to this reality it is essential
to carry out more interventions in order to promote healthy eating
habits among the school community and to prevent future
comorbidities.
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Rationale:Mucopolysaccharidosis (MPS) patients may be at risk of to
malnutrition due to disease progression, and/or inadequate food
habits. This study aimed to assess nutritional status of MPS patients.
Methods: A cross-sectional study including patients from 4 national
centres was developed. Anthropometric, body composition, laborator-
ial data and usual food intake data were collected.
Results: 31 patients (5MPS I; 4MPS II; 9MPS III; 3 MPS IV; 9MPS VI; 1
MPS VII; 17 males), aged between 1.7 and 32.7 years, were included.
The lowest weight, height and BMI z-score values were observed in
MPS VI, MPS IV and MPS I groups, respectively. Mean phase angle
varied from 3.9° to 5.0°, in MPS I and MPS VI groups, respectively.
Pre-albumin, retinol binding protein (RBP), creatinine and HDL-
cholesterol were low in 59.3%, 75%, 77.4% and 48.4%, of the patients,
respectively. Vitamin D insufficiency was present in 38.7% and
deficiency in 48.4%. MPS III group showed significantly higher
plasma pre-albumin RBP and vitamin A levels and MPS VI group
exhibited lower RBP, vitamin A and vitamin E than the other groups.
Energy, protein, carbohydrate and fiber intake were lower than
requirements in 56.0%, 32.0%, 64.0% and 76.0% of the subjects,
respectively. The intake of vitamins and minerals was high in most
patients.
Conclusions:MPS patients usually showhigh inability associatedwith
elevated disease severity. In this sample, a substantial number of
patients (namely MPS VI and the oldest ones), nutritional status was
also found to be impaired. The degenerative character of MPS, as well
as an unhealthy pattern of living may lead to nutritional deficits.
Nutritional status monitoring and improvement, by correction of
deficits, may contribute to a better prognosis and, possibly, to a better
quality of health during the reminiscent years of life.
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Rationale: Low muscle mass predicts morbidity and mortality in
hospitalization patients either in surgical and medical ill patients.
Recently, previous study showed that muscle area derived from CT-
scans and muscle mass from Bio-impedance analysis (BIA) are related
tomortality. Bothmethods have their limitations. The aim of this study
was to determine the correlation between CT- and BIA- derivedmuscle
mass.
Methods: This cross-sectional study included adult medical ill
patients who underwent abdominal CT scans in purpose for
diagnostic. BIA was performed in the same day when CT-scan was
performed. CT-scans was analyzed using special software. BIA was
performed using standing-posture 4-electrode BIA device BC-418 (BIA,
Tanita Corp, Tokyo, Japan). Height adjusted Appendicular skeletal
muscle mass (ASM) was calculated from BIA. Height adjusted skeletal
muscle Index (SMI) was performed from a single cross-sectional CT
image (slice) at third lumbar (L3) for abdominal skeletal muscle area.
We calculated Pearson’s r correlation coefficient between two
parameters.
Results: A total of 39 patients were included (28 female), mean age
was 46.54 ± 14.87 years old. Mean height adjusted BIA-derived ASM
was 6.17 ± 0.77 kg/m2 in female and 7.81 ± 1.29 kg/m2 in male. Mean
height adjusted Skeletal muscle area was 257.84 ± 59.67 cm2/m2 in
female and 387.39 ± 114.48 cm2/m2 in male. BIA derived muscle mass
and CT-derived muscle were moderately correlated (r = 0.630,
p < 0.001).
Conclusions: This study showed that BIA- and CT – derived muscle
masswasmoderately correlated. Further research is needed to confirm
this result. However, our findings indicate BIA is a promising method
to assess muscle mass without practical and safety issues of CT-scan
using.
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Rationale: Bioelectrical impedance analysis (BIA) is a simple and
practical method for the assessment of body composition. BIA has
important applications in the evaluation of nutritional status. From the
AsianWorking Group on Sarcopenia (AWGS) consensus recommended
that reference value of cutoff low muscle mass based on a young
reference group in each population. Until now, there is no reference
cutoff ofmusclemass for Indonesia population. The aim of this study is
to identify cutoff of lowmusclemass in healthy Indonesianpopulation.
Methods: Healthy young adult between 18 and 25 years old with no
known chronic disease or chronic drug usewere included in our study
as reference population for assessing low muscle mass. Muscle mass
was assessed using standing-posture 4-electrode BIA device BC-418
(BIA, Tanita Corp, Tokyo, Japan).Mean of height adjusted Appendicular
skeletal muscle mass (ASM) was calculated. Young reference of sex-
specific cutoff was determined by lowest quintile of study population
(Mean- 2SD). When conducting measurements, the subjects stood on
the base with both feet contact with electrode plates and low voltage
current passed through the body. The subjects were instructed not
exercised in previous 30 minutes, not drinking caffeine-contained
drinks, and keep hydrated.
Results: The young reference included a total of 232 participant
consist of 145 females and 87 males. The mean age was 19.55 ± 1.28
years old. Themean of height adjusted ASMwas 6.17 ± 0.66 kg/m(2) in
female and 8.79+1.06 kg/m(2) in male. Cutoff thresholds of height
adjusted ASM based on mean – 2SD were 5.52 kg/m(2) in female and
7.71 kg/m(2) in male.
Conclusions: The mean of cutoff of low muscle mass in Indonesian
population were 5.52 kg/m(2) in female and 7.71 kg/m(2) in male.
Further study with bigger sample size need to confirm this result.
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Rationale: Surgical resection offers the only chance of cure for
pancreatic cancer, but only 15 to 20 percent of cases can be treated
surgically. Malnutrition and lack of implementation of nutritional
therapy increases the risk of postoperative complications and
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mortality. There are several methods of assessing nutritional status,
but not all of them have the same sensitivity. We assessed whether
BMI could be an indicator of nutritional status in this group.
Methods: The prospective analysis included 82 patients with
pancreatic tumors qualified for surgical treatment. An assessment of
the nutritional status wasmade based on NRS 2002, SGA. The albumin
level was evaluated. We calculated BMI at the time of the study and
before the disease. Body fat tissue (FAT%) was assessed by electrical
bioimpedance (BIA).
Results:Malnutritionwas detected in 84.1% (n = 68) by NRS and 79.3%
(n = 64) by SGA. The average albumin value was 3.9 g/l.
Hypoalbuminemia <3.5 g/l occurred in 22.2%. The average BMI value
at the time of the study was 25.4 kg/m2 (range 15.4–36.7). FAT% level
was 38.5% in women and 26.1% in men. There was a significant
correlation between the level of malnutrition and albumin (p = 0.00),
also between BMI and albumin (p = 0.03). We evaluated associations
between BMI before the disease and degree ofmalnutrition at the time
of the study (p = 0.048).
Conclusions: Based on BMI, most of patients were overweight.
However, most of them presented malnutrition or high risk of
malnutrition. Despite significant weight loss, FAT% indicates excessive
fatness, whichmay contribute to increase perioperative complications.
More than 20% of the patients had hypoalbuminemia. Higher BMI
before the disease affected the worse state of nutrition and increased
weight loss.
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Rationale: Bioimpedance is a simple, rapid and non-invasive
technique to evaluate the body composition of patients with CKD.
It’s based on the conductive response of the human body to an
electrical current, taking advantage of the different electrical proper-
ties of different tissues.
The segmental bioimpedance allows interpreting the human bodyas 5
cylinders, being able to study the hydration status of each member
separately.
Aim: evaluate changes in the body composition of the arms according
to vascular access in HD patients.
Methods: 111 patients with CKD IN HD from the university hospital of
La Princesa in Madrid, were evaluated, and distributed according to
presented fistula or catheter. The measurement was made using the
S10 inbody segmental multifrequency bioimpedance, analyzing the
data using the SPSS software 23.
Results: In the study sample, 36 patients presented catheter and 75
fistula, 64 in left arm and 11 in right arm. The TBW in patients whit
fistula was 34.19 ± 6.53, whit catheter was 32.86 ± 6.28 L.
The TBW of arm right was 1.96 ± 0.42 L, and TBW of left arm was
2.16 ± 0.49L (p = 0,000).
We found significant differences between TBW of right and left arm
(p = 0.000), as well as between TBW of left arm of patients whith
catheter (p = 0.000) but not in TBW of right arm of patients whith
catheter (p = 0.280)
Conclusions: segmental bioimpedance allows not only to evaluate the
body composition, but also to evaluate the differences between the
different body segments.
It allows to monitor the variations and evolution of the fistula as
vascular access in the segment of the fistula.
Disclosure of Interest: None declared.
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NUTRITIONAL RISK AT HOSPITAL: WHAT ARE THE DIFFERENCES
BETWEEN THOSE WHO ENTER AT RISK AND THOSE WHO DEVELOP
IT DURING HOSPITALIZATION?
Á.P. Morales Cerchiaro1,2,3*, C. Cuerda Compés3, C. Velasco Gimeno3, M.
L. Carrascal Fabián2,3, L. Frías Soriano3, L. Arhip1,2,3, I. Bretón Lesmes3,
M.L. Motilla de la Cámara1,2,3, M. Camblor Álvarez3, P. Garcia Peris3.
1Universidad Complutense de Madrid, 2Instituto de Investigación
Sanitaria Gregorio Marañón, 3Unidad De Nutrición Clínica Y Dietética,
Hospital General Universitario Gregorio Marañón, Madrid, Spain
* Corresponding author.
Rationale: In Spain the prevalence of hospital malnutrition is high.
Because of the impact of disease related malnutrition in hospitals on
the morbidity and mortality, it is important to identify patients at risk
at admission. The objective was to study the differences between
patients who are at nutritional risk at admission and those who
develop it during hospitalization.
Methods: Patients admitted in Cardiology, Neurology and Digestive
wards (01/25/17 to 03/03/17) with an expected stay of >48 h were
included in the study. Nutritional screening (NRS-2002) was per-
formed at admission and was repeated at least once during the
hospitalization. Patients were grouped into 3 groups: risk at admission
(RA), no risk during hospitalization (NR) and risk developed during
hospitalization (RD). The results are expressed in percentages and
mean ± SD. Chi-Square and ANOVA test of IBM-SPSS Sttistics21® were
used.
Results: We included 105 patients, 52.4% men, aged 65.6 ± 18.6, of
whom 67.6% were at risk at admission, 23.8%NR and 8.6%RD. No
significant differences were found between groups in mortality,
infectious complications rate and readmissions after 30 and 60 days.
The following table summarises the statistically significant results
(p-value < 0,05):
Conclusions: Patients who become malnourished during hospitaliza-
tion are those who have a longer length of stay. These data agree with
those obtained in the Spanish PREDYCES study. Therefore, we
recommend to re-evaluate the nutritional risk during the hospital
stay in order to adequately treat malnutrition.
RA RD NR
Age (years) 73.6 ± 15.3 65.6 ± 12 43.4 ± 23.1
Length of Stay (days) 10.9 ± 7.7 25.9 ± 14.6 9.8 ± 4.2
BMI at admission (kg/m2) 24.1 ± 4.8 29.1 ± 4.9 25.8 ± 5
Weight loss (%) 12.7 ± 7.6 5.3 ± 4.2 3.3 ± 1.2
Charlson Index at
admission
3.2 ± 2.7 3.4 ± 2 1 ± 2
Reference
León-Sanz M, Brosa M, Planas M, García-de-Lorenzo A, Celaya-Pérez
S, Hernández JÁ; Predyces Group Researchers. PREDyCES study: The
cost of hospital malnutrition in Spain. Nutrition. 2015 Sep; 31
(9):1096–102.
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CHANGES IN RESTING ENERGYMETABOLISM IN PATIENTS ON TOTAL
PARENTERAL NUTRITION VERSUS ENERGY SUPPLY
A. Ukleja1*, M. Ławiński2, W. Cebulski2, M. Cybula1, D. Kot1,
M.K. Skroński2, M. Słodkowski2. 1Department of Clinical Dietetics,
2General, Gastroenterological and Oncological Surgery, Medical
University of Warsaw, Warsaw, Poland
* Corresponding author.
Rationale: Knowledge of the real demand for energy is the basis for
planning the proportion of nutrients adapted to the current needs and
is an extremely important element in the assessment of nutritional
status. The most accurate method of estimating the resting metabolic
rate is indirect calorimetry (IC), however, due to the costs of equipment
in general-clinical practice, the prediction equations are most often
used. People qualified for total parenteral nutrition (TPN) are a group
of patients in severe general condition, inwhom the estimatesmay not
coincide with the actual demand of energy.
Methods:Measurements of resting energy expenditure (REE)using IC
were performed in 31 patients [average (Av) age: 51.06 ± 16.40 years
Min: 18 y.o. Max: 79 y.o., males (M) – 67.74%, females (F) 32.26%]
qualified for nutritional treatment on first day of starting TPN and on
the 7th day of its application. The results of REE were compared to the
energy value of commercial food bags.. The T-test and the Wilcoxon
signed rank test were used for statistical analysis.
Results: The average value of REEwas forM: 1605,29 ± 457,46 kcal and
for F: 1178,30 ± 317,62 kcal p = 0.01284, and after 7 days M: 1490,29
± 406,11 kcal, F: 1289,10 ± 227,85 kcal p > 0.05. Energy supply with
TPNwas significantly different in the first day in the group ofmen– the
difference of 268.67 ± 467.85 kcal (1336,62 ± 114,31 kcal) in the group
of women and after a week of using TPN there were no statistically
significant differences.
Conclusions: The application of IC in patients qualified for TPN as a
determinant of resting energy demand is justified due to the very
different clinical condition and large dispersion of compliance with
the predictive equations. During the seven-day TPN, no significant
changes in the resting metabolic rate of patients undergoing
nutritional treatment were observed.
Disclosure of Interest: None declared.
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RATE AND CORRELATES OF A POSITIVE SCREEN FOR EATING
DISORDERS: A CROSS-SECTIONAL STUDY AMONG CHILDREN AND
YOUNG ADOLESCENTS IN LEBANESE SCHOOLS
J. Dib1, N. El Gerges1, S. Moukarzel1,2, L. El Osta3, S. Hlais3, A. Wehbe3,
P. Dechelotte4, A. Aoun1*. 1Notre Dame University – Louaize, Zouk
Mosbeh, Lebanon, 2University of California San Diego, California, United
States, 3Saint Joseph University, Beirut, Lebanon, 4CHU de Rouen, Rouen,
France
* Corresponding author.
Rationale: Eating disorders (ED) are one of the most common
psychiatric illnesses that may lead to physical and psychosocial
morbidity in children and young adolescents. The aim of this study
was to assess the prevalence and correlates of a positive screen for ED
among children and young adolescents in several Lebanese schools.
Methods: This cross-sectional study included a convenience sample of
253 students (54.5%males and 45.5% females), aged between 8 and 13
years, recruited from private schools located in Mount Lebanon
between February and June 2018. Every student was interviewed to
collect information about sociodemographic factors and health
characteristics. SCOFF questionnaire was used to examine the
prevalence of positive screens for ED. Logistic regression analyses
were conducted with the use of the screening of ED as the dependent
variable.
Results: SCOFF was positive in almost one third (36.4%) of the
students. Logistic regression analyses showed that being between 8
and 9 years (p = 0.029), obesity (p = 0.01), and the symptom of fatigue
(p = 0.017) were associated with a positive screen for ED.
Conclusions: The high prevalence of positive screens for ED among
children and young adolescents points out the urgent need for earlier
diagnosis and intervention.
Disclosure of Interest: None declared.
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ARE THEUSERSOFWEIGHT LOSS SUPPLEMENTSATHIGHERRISKOF
HAVING A POSITIVE SCREEN FOR EATING DISORDERS?
A. Aoun1*, S. Bteich1. 1Notre Dame University – Louaize, Zouk Mosbeh,
Lebanon
* Corresponding author.
Rationale: Weight loss supplements may be used as means for
compensating binge eating by providing a liberating effect from diet
control. Thus, eating disorders (ED) may be associated with the
harmful use of weight loss supplements. The objective of this study
was to explore the association between the use of weight loss
supplements and a positive screen for ED.
Methods: This observational cross-sectional study was carried out
between March and July 2018. A convenience sample of 200 adults,
recruited from the clients of a pharmacy in Mount Lebanon, was
equally divided into a group of users of weight loss supplements and a
control group of non-users. Data on socio-demographic, lifestyle and
health characteristics were collected. SCOFF questionnairewas used to
examine the prevalence of positive screens for ED. Logistic regression
analyses were conducted with the use of weight loss supplement as
the dependent variable.
Results: The use of weight loss supplements was significantly
associated with a positive SCOFF (p = 0.019), and users had a 1.7
times higher risk of having a positive screen for ED. Moreover, users of
weight loss supplements were more likely to have attempted and
failed many weight loss diets (p < 0.001) and were more likely to have
used Orlistat (p = 0.004) for weight management.
Conclusions: Our results revealed a significant association between
the use of weight loss supplements and a positive screen for ED.
Disclosure of Interest: None declared.
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COMPARISON OF SIX NUTRITIONAL SCREENING TOOLS IN PATIENTS
WITH HEMATOLOGIC MALIGNANCIES IN THE ERA OF THE GLOBAL
LEADERSHIP INITIATIVE ON MALNUTRITION (GLIM) CRITERIA
A. Karachaliou1, A. Kouka1*, N. Biniaris1, K. Sideris1,
N. Giannakopoulou1, M. Arapaki2, E. Bazani3, V. Pappa3, N.-A. Viniou1,
L. Poulia4, P. Diamantopoulos1. 1Hematology Unit, First Department of
Internal Medicine, Laikon General Hospital, National and Kapodistrian
University of Athens, Greece, 2Hematology Department, Laikon General
Hospital, National and Kapodistrian University of Athens, Greece,
3Hematology Department, Attikon General Hospital, National and
Kapodistrian University of Athens, Greece, 4Clinical Nutrition
Department, Laikon General Hospital, Athens, Greece
* Corresponding author.
Rationale: Poor nutritional status is a significant negative prognostic
factor for patients with hematologic malignancies as it adversely
affects prognosis. In light of the newly developed criteria of the Global
Leadership Initiative on Malnutrition, we compared the performance
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of six malnutrition screening tools in patients with hematologic
malignancies to determine the most efficient.
Methods:We conducted a questionnaire-based studyonpatientswith
hematologic malignancies (outpatient and hospitalized). We then
calculated the following scores: MNA-SF, MUST, SNAQ, NRI, NRS-2002,
and MST and compared their positive predictive value, LR, sensitivity
and specificity.
Results: In total, 131 patients were included. Among the inpatients
(n = 58), MNA-SF had the highest sensitivity (100%) but the lowest
positive predictive value and LR+ (36.36% and 2.032 respectively),
whereas SNAQ was the most specific tool (78.9%) and had the highest
LR+ (3.869). MUST had a sensitivity of 95% and LR+ 2.96. In the
outpatient group (n = 73) apart from MST and NRI all the other tools
had a sensitivity of 100% and SNAQ again had the highest specificity
and LR+ (78.8% and 4.717 respectively). Moreover, inpatients scored
significantly less in the MNA-SF (40% inpatients and 62.5% outpatients
had a score of 12–14/normal nutritional status, p = 0.03).
Conclusions: All things considered, SNAQ seems ideal due to its
simplicity and efficacy. Among inpatients SNAQ and MUST appear
superior due to their high LR+ and sensitivity, while SNAQ performed
better among outpatients. This could be explained by the cutoffs used
in the parameters of these two scores, which are sensitive enough but
still do not allow false positive results. The study is still ongoing with
the inclusion of more patients.
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VALIDITY OF THE PG-SGA AND PG-SGA SF AGAINST GLIM CRITERIA
TO IDENTIFY MALNUTRITION IN CANCER OUTPATIENTS
B.S. Van Der Meij1,2,3*, L.M. De Groot1,2, G. Lee3, A. Ackerie2. 1Mater
Research Institute, University of Queensland, 2Dietetics and Foodservices,
Mater Health, Brisbane, 3Bond University Nutrition and Dietetics
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* Corresponding author.
Rationale: In cancer centres, a valid malnutrition assessment tool is
important for early identification and nutrition intervention. The aim
of this study was to identify malnutrition prevalence in cancer
outpatients and test the validity of the Patient-Generated Subjective
Global Assessment (PG-SGA) and Short Form (PG-SGA SF) against the
criteria by the Global Leadership Initiative on Malnutrition (GLIM).
Methods: In a 2-week cross-sectional study in adult cancer out-
patients receiving intravenous treatment, we assessed: 1) PG-SGA SF
(cut off score ≥6); and 2) PG-SGA against GLIM criteria (6-month
weight loss>5%, BMI<age-specific reference, handgrip strength <25th
percentile of age- and gender specific normative values1). Sensitivity
of ≥80% and specificity of ≥60% were deemed acceptable.
Results: Out of 275 outpatients, 246 consented to participate in the
study (74.0% females, age 61.9 ± 13.1). The prevalence of moderate or
severemalnutritionwas 21.5% via PG-SGA and 20% via GLIM+handgrip
strength. Compared to GLIM+handgrip strength, the 1) PG-SGA SF had
a sensitivity of 68.8%, specificity of 82.5% and kappa = 0.15; and 2) PG-
SGA had a sensitivity of 44.9%, specificity of 89.3% and kappa = 0.37.
Conclusions: Approximately 1 in 5 outpatients with cancer were
malnourished. PG-SGA and PG-SGA SF were not sensitive or specific
enough to identify malnutrition and had low agreement with GLIM.
Reference
1. Dodds RM et al.Grip strength across the life course: normative data
from twelve British studies. PLoS One. 2014 Dec 4;9(12):e113637.
doi: 10.1371/journal.pone.0113637. eCollection 2014. PubMed
PMID: 25474696; PubMed Central PMCID: PMC4256164.
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Rationale: In cancer centres, a valid malnutrition assessment tool is
important for early identification and nutrition intervention. The aim
of this study was to identify malnutrition prevalence in cancer
outpatients and test the validity of the Patient-Generated Subjective
Global Assessment (PG-SGA) and Short Form (PG SGA SF) against the
criteria by the Global Leadership Initiative on Malnutrition (GLIM).
Methods: In 246 adult cancer outpatients receiving intravenous
treatment, we assessed: 1) PG-SGA SF (cut off score ≥6); and 2) PG-
SGA against GLIM combined with low handgrip strength (25th
percentile of age- and gender specific normative values1). Sensitivity
of 80% and specificity of 60% were deemed acceptable.
Results: The prevalence of moderate or severe malnutrition was
21.5% via PG SGA and 20% via GLIM+handgrip strength. Compared to
GLIM + handgrip strength, the 1) PG-SGA SF had a sensitivity of 68.8%,
specificity of 82.5% and kappa = 0.15; and 2) PG SGA had a sensitivity of
44.9%, specificity of 89.3% and kappa = 0.37.
Conclusions: Approximately 1 in 5 outpatients with cancer were
malnourished. PG-SGA and PG-SGA SF were not sensitive or specific
enough to identify malnutrition and had low agreement with GLIM.
Reference
1. Dodds RM et al.Grip strength across the life course: normative data
from twelve British studies. PLoS One. 2014 Dec 4;9(12):e113637.
doi: 10.1371/journal.pone.0113637. eCollection 2014.
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THE PREVALENCE OF MALNUTRITION ACCORDING TO THE NEW
GLIM DEFINITION IN CHRONIC SMALL AND LARGE INTESTINAL
DISEASES
B. Knappe-Drzikova1*, S. Maasberg2, D. Vonderbeck1, S. Knüppel3,
A. Schirbel1, P.C. Grunert4, S. Pevny1, K. Norman3, U.-F. Pape2.
1Department of Hepatology and Gastroenterology, Charité, University
Medicine Berlin, Berlin, 2Department of Internal Medicine and
Gastroenterology, Asklepios Klinik St. Georg, Hamburg, Germany,
Hamburg, 3Department of Nutrition and Gerontology, German Institute
of Human Nutrition, Potsdam-Rehbrücke, 4Department of Internal
Medicine IV, Jena University Hospital, Jena Germany, Jena, Germany
* Corresponding author.
Rationale: In chronic small and large intestinal diseases (inflamma-
tory bowels disease IBD or short bowel syndrome SBS) malabsorption
often causes malnutrition (MN) and its diagnosis is a challenge due to
complexityof both inherent disease aswell asmalnutrition symptoms.
Recently, the European Society for Clinical Nutrition and Metabolism
ESPEN presented new GLIM (Global Leadership Initiative on
Malnutrition) criteria for the diagnosis of MN1. The aim of this
prospective pilot study was to evaluate the association between MN
according to GLIM as well as other nutritional assessment criteria in
patients with IBD and SBS.
Methods: Nutritional status was prospectively assessed in 20 pts with
IBD or SBS by NRS and SGA, mid-upper arm circumference (MUAC),
triceps skinfold thickness (TST), serum albumin and BIA. MN was
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classified according to novel GLIM criteria. Prospective follow-up was
performed in 6-month.
Results: Screening at baseline showed an increased risk of MN in 65%
of pts by NRS >3 and SGA B+C. According to GLIM criteria 85% of this
group were malnourished but no correlation between severity of
malnutrition acc. toGLIMand grades of screening scoreswas observed.
Pts with no risk ofmalnutrition (score NRS 0–2, SGA A) account to 35%.
According to GLIM criteria were 85% of this pts without MN. MN
according to GLIM criteria was strongly associated with poorer results
for BMI (19.4 ± 3.0 vs. 25.8 ± 3.3; p < 0.001), TST (7.5 ± 3.9 vs 15.8 ± 6.0;
p = 0.006), MUAC (23.9 ± 3.4 vs. 30.9 ± 3.5; p < 0.001), BCM (19.2 ± 6.2
vs. 25.7 ± 6.3; p = 0.037), FFM (42.6 ± 9.4 vs. 55.3 ± 12.4; p = 0.016) and
serum albumin (40.4 ± 7.7 vs. 47.7 ± 1.1) while no differences were
found in ‘etiologic criteria’: ‘reduced food intake’ and ‘inflammation
condition’ between theMNgroup and the groupwithoutMN. 6month
follow-up showed comparable results for the diagnosis of MN
according to the GLIM criteria. An increased risk of malnutrition was
found in 58% pts according to SGA andNRS; 85% of pts from thesewere
also malnourished by GLIM-criteria but again no statistical correlation
between MN acc. to GLIM or NRS/SGAwas detected.
Conclusions: Our study confirms that the new GLIM definition for the
diagnosis of MN is reliable for patients with IBD and SBS. Further
studies with larger patient numbers and specific subgroups group are
needed to assess the validity of this new MN criteria. However, strong
association between ‘GLIM malnutrition,’ BIA results, anthropometry
and serum surrogates were observed. Careful monitoring of these risk
factors as well as meticulous management of complications are thus
mandatory for improvement of malnutrition in these challenging pts.
Reference
1. Cederholm T. et al.: GLIM criteria for the diagnosis of malnutrition –
A consensus report from the global clinical nutrition community,
Clin Nutr, 2019. 38 (1): p. 1–9.
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ANTHROPOMETRY AS PREDICTIVE FACTOR OF FFMI IN THE
ASSESSMENT OF MALNUTRITION IN ELDERLY NURSING HOME
RESIDENTS
B. Lardiés-Sánchez1*, A. Sanz-Paris2, J. Arbones-Mainar3, J. Pérez-
Nogueras4, A. Serrano-Oliver5, E. Torres-Anoro6. 1Endocrinology and
Nutrition, Hospital Obispo Polanco, Teruel, 2Translational Research Unit,
3Endocrinology and Nutrition, Hospital Universitario Miguel Servet,
4Geriatric Unit, Elias Martinez, 5Geriatric Unit, Casa Amparo, 6Geriatric
Unit, Romareda, Zaragoza, Spain
* Corresponding author.
Rationale: The objectives of the study were to assess the prevalence
of malnutrition in institutionalized elderly people, to investigate the
relationship between fat free mass index(FFMI) and malnutrition, and
to assess if several anthropometric parameters could be good
predictors of FFMI.
Methods: In this cross-sectional study we enrolled 327 elderly people
living in five public nursing homes. For the assessment of nutritional
status we used MNA and the new ESPEN criteria of malnutrition.
Relationships between anthropometric parameters and FFMI were
explored using Pearsońs correlation coefficient(r). Multiple linear
regression analysis was performed to determine functional predictor
variables for FFMI that could be easily measured by clinicians.
Results: mean age of was 84.3 years (±8.1) and 66.1% were females.
Prevalence of malnutrition according toMNAwas 24.7% and according
to the ESPEN definition of malnutrition was 16.6%. FFMI was
significantly correlated with all measured circumferences (arm, arm
muscle, calf), with body mass index and with handgrip strength
(table 1). Multiple linear regression analysis confirmed some
anthropometric parameters as predictive factors of FFMI.
Table 1
Pearson correlation analysis: correlations between FFMI and measured
anthropometric parameters and handgrip strength
Total Females Males
r p r p r p
BMI 0.706 0.0001 0.688 0.0001 0.732 0.0001
AC 0.453 0.003 0.360 0.004 0.716 0.0001
CC 0.529 0.0001 0.484 0.003 0.725 0.001
AMC 0.495 0.003 0.247 0.004 0.789 0.0001
Handgrip
strength
0.516 0.001 0.243 0.003 0.384 0.002
NC 0.608 0.001 0.498 0.004 0.712 0.002
Conclusions: There is a high prevalence of malnutrition in elderly
nursing homes residents. Anthropometric parameters and FFMI have
a good correlation. Neck circumference could be a good alternative
anthropometric parameter to assess nutritional status especially in
elderly women.
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USE OF A MOBILE MEXICAN DIETARY ASSESSMENT APP TO
EVALUATE DIFFERENCES IN DIETARY INTAKE AMONG SUBJECTS
WITH ANDWITHOUT TYPE 2 DIABETES
B. Palacios-Gonzalez1*, M. Razo-Azamar1, A.B. Perez-Lizaur2. 1National
Institute of Genomic Medicine, National Institute of Genomic Medicine,
2Dirección de Posgrado, Universidad Iberoamericana, Mexico City, Mexico
* Corresponding author.
Rationale: The use of Information and Communication Technologies
(ITCs) as a strategy to use the data collected from a mobile app for
dietary assessment; in order to understand the relationship between
diet and health outcomes, in an accurate assessment of dietary intake
in people with and without type 2 diabetes (T2D).
Methods: We retrieved dietary and demographic information from a
mobile app for dietary assessment called SMAE in diabetic and non-
diabetic Mexican population (n = 44,428). Only 10% had complete
dietary and demographic data and met T2D criteria, while 90% had
complete demographic and dietary records. The groups were
composed primarily of females and had overweight. T2D group had
a mean age of 37 years old while the healthy subjects had a mean age
of 30 years. Multivariate analyses were performed in order to assess
the variability and differences between these two study groups
Results: Using PCA, we identified two major components that
accounted for the 48.5% variance among the study groups. These
components were characterized mainly by beans, cereals & bread,
sugars, fat and meat & poultry on the T2D study group. Moreover, the
dietary group’s assessment of the healthy study group was character-
ized by fruits, vegetables, beans, sugar, and milk. The differences
between study groups were identified by LDA where the main
variables discriminating both study groups were carbohydrate
content, age, protein, fiber, and lipid content.
Conclusions: The data retrieved from this mobile app was used to
evaluate the dietary composition among patients with T2D compared
to a healthy group. The usage of ITCs in nutrition to self-monitor
dietary intake is now a practical alternative to paper-based systems.
Moreover, the data retrieved from these dietary assessment mobile
apps can be used to generate further studies to evaluate dietary
composition on different chronic diseases.
Disclosure of Interest: None declared.
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CLINICAL NUTRITION TREATMENT
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Rationale:While providing nutrition treatment recording the process
by nutrition support team (NST) becomes important to monitor and
make changes in the plan when needed. Knowing the current
nutrition treatment processes is important for institutions also to
develop protocols.
The aim of the study was to evaluate the demographic data and
treatment course of the patients whowere followed up by the NST in a
university hospital in respect to reaching the energy goals.
Methods:All patients whowere admitted to the hospital and followed
up by NST in 2018 a in the study. Patient’s data (demographic,
laboratory findings, etc.) were prospectively recorded by NST and
analyzed retrospectively after the follow-up period. The analyses were
performed by SPSSversion23.
Results: A total of 681 patients were included in the study. Of the
patients, 411 (60.4%) received parenteral (PN), 246 (36.1%) enteral (EN)
and 24 (3.5%) supplemental parenteral nutrition (SPN) treatment. The
median age of the patients was 63 (18–96), the median time to
nutritional therapy was 0 days (0–15 days) and the median follow-up
period was 10 days (1–144 days). The most common access route was
the nasogastric (166, 61.5%) route for EN and the peripheral route for
the PN (266, 61.1%). Only 54.3% of all patients reached 80–100% of the
energy goal. It was found that 61.3% of the patients who received PN
treatment and reached the energy goals have central access route
(p < 0.001). Reaching targets according to the access route is given in
the Table.
Table 1
Level of targets EN
treatment
PN
treatment
SPN
treatment
Reaching 80–100% of target 175(71.1) 175(42.6) 22(91.66)
Reaching 60–79% of target 26(10.6) 109(26.5) 0(0)
Reaching 50–59% of target 14(5.7) 57(13.9) 2(8.34)
Reaching 49 or less of target 31(12.6) 70(17.0) 0(0)
Total 246(100) 411(100) 24(100)
Conclusions: Nearly half of the patients could not reach their energy
goals. In patients who received PN treatment, the goals are less
achievable through aperipheral route. With the SPN, the rate of
reaching nutritional goals increases.
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PREDICTING MORTALITY IN HOSPITALIZED OLDER ADULTS: 2-
YEAR PROSPECTIVE STUDY
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Rationale: There are numerous screening tools to assess nutritional
status of the patients, but it is unclear whether these screening tools
can successfully predict worse outcomes. This study aimed to
determine which nutritional assessment method had the highest
prognostic significance for predicting long-term mortality in hospita-
lized older adults.
Methods: This prospective study included 231 hospitalized patients
from December 2013 to March 2014. Nutritional status of the patients
was evaluated using The Malnutrition Universal Screening Tool
(MUST), the Subjective Global Assessment (SGA), and the Nutritional
Risk Screening-2002 (NRS-2002) within 48 hours of the admission.
Patients were followed-up for 2 years. The primary endpoint was all-
cause mortality.
Results: In total, 231 patients were included in the cohort, mean age
was 58.8 ± 16.1 years and 131 (56.7%) of them were female.
Malnutrition or malnutrition risk was identified in 38.1% of the
patients with NRS-2002, in 37.2% of the patients with SGA, and in
34.2% of the patients with MUST. The crude death rate at 2 years was
24.2%. Age, gender, Charlson co-morbidity index and fat-free mass
index (FFMI) adjusted cox regression analyses revealed that all
nutritional screening tools were significantly related to survival(SGA
(hazard ratio[HR] = 4.7; 95% CI = 2.1–10.8, p < 0.001, NRS-2002(hazard
ratio[HR] = 3.4; 95% CI = 1.6–7.4, p = 0.002, MUST (hazard ratio
[HR] = 3.3; 95% CI = 1.6–6.9, p = 0.001).
Conclusions: In this study, three different nutritional screening tools
were evaluated for long-term mortality prediction. All screening
instruments were able to predict long-term mortality, but SGA seems
to provide a best yield.
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FUNCTIONAL FOOD CONSUMPTION AND ADHERENCE TO
MEDITERRANEAN DIET IN ADULT POPULATION
E. Inan-Eroglu1, C. Cetin1*, A. Akyol1, A. Ayaz1, G. Samur1. 1Nutrition and
Dietetics Department, Hacettepe University, Ankara, Turkey
* Corresponding author.
Rationale: The Mediterranean region provides countless functional
foods (FF) due to its great richness and diversity of plants. FF, such as
olive oil, yoghurt, garlic, tomato, wine, condiments, herbs, spices and
nuts, improve health and provide a decrease in the risk of some
diseases. It is well known that the Mediterranean Diet (MD), which is
considered as a good example of a functional diet, is rich in functional
dietary components including phenols, flavonoids, isoflavonoids,
phytosterols, phytic acid and n-3 fatty acids. The aim of this study
was to assess the relationship betweenMediterranean Diet Adherence
Screener (MEDAS) scores and functional FF consumption.
Methods: This cross-sectional studywas conductedwith 1650 healthy
adults, with themean age 28.19 ± 9.42 years.MEDASwas administered
the participants. Consumption of functional foods was questioned.
Dietary intake of participantswas assessed using 24-h dietary recall by
intern dietitians. Data were analysed using the Statistical Package for
the Social Sciences (SPSS), version 22.0.
Results: More than half of the participants (59.0%) were women. The
mean MEDAS score of FF consumers and FF non-consumers were
5.83 ± 2.11 and 5.39 ± 2.23, respectively (p < 0.01). In addition, there
were significant differences in the intake of some functional food
components (namely fibre, calcium, magnesium and folic acid)
between FF consumers and FF non-consumers (p < 0.05). Moreover,
binomial logistic regression analysis demonstrated that adherence to
Mediterranean diet was a significant predictor of FF consumption (OR:
0.911; 95% CI: 0.870–0.953: p < 0.05).
Conclusions: Consumption of FF is an important part of MD which is
linked to significant reduction in overall mortality and morbidity,
inspiring a beneficial dietary approach in the management of CVD,
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type 2 diabetes, obesity, inflammatory diseases, degenerative diseases
and cancer.
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NUTRITIONAL STATUS OF HOSPITALIZED SURGICAL PATIENTS
ACCORDING TO THE RISKOF SARCOPENIA
C.A. Gottschall1*, M.D.S. Tarnowski1, A.A. Dariva2, I.C. Marques2,
L.P. Alves2, F.M. Silva1. 1Graduate Program in Nutrition Sciences,
2undergraduate nutrition courses, Federal University of Health Sciences
of Porto Alegre, Porto Alegre, Brazil
* Corresponding author.
Rationale:Currently the risk of sarcopenia can be evaluated through of
the SARC-CalF questionnaire (1). Considering that, the association
between nutritional status and the risk of sarcopenia has been still
scarcely investigated, this studyaimed to investigate this association in
hospitalized surgical patients.
Methods: A cross-sectional study was carried out with surgical
patients admitted in a hospital at Porto Alegre (Rio Grande do Sul,
Brazil). The nutrition assessment was performed in the first 48 hours
and comprised anthropometry (current weight, mid-arm circumfer-
ence, body mass index, and adductor pollicis muscle thickness), hand
muscle strength bydynamometry,malnutrition diagnosis according to
Subjective Global Assessment (SGA), and risk of sarcopenia by SARC-
CalF questionnaire (composed by five questions and themeasurement
of calf circumference). Student, Mann-Whitney, Chi-square tests and
logistic regression was performed for statistical analysis. The protocol
was approved by the Ethical Committee.
Results: A total of 153 patients were included (58.14 ± 14.6 years;
50.4% women). The main medical specialties were oncology (24.4%),
general surgery (23.5%) and nephrology (20.2%). The main surgical
prupose was curative (83.9%). The risk of sarcopenia was identified in
20.6% of the sample and 30.5% was diagnosed as malnourished (23.1%
asmoderate and7.4%as severemalnutrition). All indicators of nutrition
status were significantly lower in patients with risk of sarcopenia
compared to those without risk of sarcopenia (p < 0.05). In multiple
logistic regression (adjusted for gender and age), patients with risk of
sarcopeniapresentedhigheroddsofmalnutritioncompared topatients
without risk sarcopenia (OR = 6.28; CI95% 2.03–19.45).
Conclusions: Patients with risk of sarcopenia presented worse
nutritional status assessed by different parameters and 6.3 times
higher odds of malnutrition compared to patients without risk of
sarcopenia.
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IS NUTRITION SCREENING IN THE COMMUNITY WITH COMMONLY
USED SCREENING TOOLS REALISTIC AND PRACTICABLE?
C.E. Weekes1,2*, M. Hickson3. 1Nutritional Sciences Division, King’s
College, 2Nutrition and Dietetics, Guy’s & St Thomas’ NHS Foundation
Trust, London, 3Institute of Health and Community, Plymouth University,
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* Corresponding author.
Rationale: Nutrition screening is recommended to identify people
who are at risk ofmalnutrition andwhomight benefit fromnutritional
intervention. However, there is anecdotal evidence that it is not always
carried out. The aim of this studywas to identify issues associatedwith
obtaining data required for nutrition screening in the community.
Methods: 231 participants (aged ≥60 years) who had accessed GP or
community-based voluntary services in the previous three months
were recruited as part of an observational study. Participants were
assessed at baseline in their own homes to determine nutrition risk
status using two screening tools, MUST (Elia, 2003) and NRS-2002
(Kondrup et al., 2003). Data were collected on weight, height, weight
change and change in dietary intake. Where participants were unable
to provide data on height or previous weight, medical records were
searched by the principle investigator (CEW) for the relevant data, and
the time taken to undertake the searches was recorded.
Results: 150 (65%) participants were female; mean age 73.8 (±8.5)
years, weight 72.6 (±15.9) kg and BMI 26.2 (±5.2) kg/m2. Four (2%)
participants could not be weighed because they were unsafe to stand
on the portable weighing scales. Data regarding height were obtained
for all participants. 195 (85%) participants provided a recalled height.
In 24 (10%) participants height was measured using a portable
stadiometer, and in 12 (5%) a search in the medical records was
required. Obtaining information on previous weight was more
problematic (see Table). In this population, only 91 (39%) participants
could provide aweight within the time period used by both screening
tools i.e. previous 3–6 months, and 45 (19%) could only provide a
weight thatwas frommore than oneyear ago. Ofmore concernwas the
fact that 75 (32%) participants were unable to provide any information
on their previous weight. However, 25 (11%) participants were able to
report that they had observed weight loss in the previous 3–6 months
(even if they could not quantify the amount lost) and 30 (13%)
participants reported reduced dietary intake in the same time period.
Table 1
Time period in which the
person could recall their
weight
Number (%) able to
provide weight data
3–6 months 91 (39%)
6–12 months 20 (9%)
>12 months 45 (19%)
No idea of previous weight 75 (32%)
The medical records of 148 (64%) participants were searched for data
on height or previous weight and the researcher was required to
search up to four different local IT systems to obtain the information.
The mean time to undertake the searches was 8 (±11) minutes per
participant.
Conclusions: This study shows there are practical issues involved in
obtaining timely and accurate data required for nutrition screening in
the community, with implications for staff time and resources. This
might partially explain reported poor rates of nutrition screening in
the community.
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OSTEOPOROSIS IS ASSOCIATED WITH CHEMOTHERAPY TOXICITY
ANDRELAPSE AMONGNONMETASTATIC BREAST CANCER PATIENTS.
EXPERIENCE FROM A SINGLE MEXICAN INSTITUTION
C. Arce Salinas1*, V. Calvo-Sanchez1, M.T. Nieto-Coronel2, C. Rosiles-
Monroy3, J. Santamaria Galicia1, A. Peña-Ruiz4. 1Medical oncology,
Instituto Nacional de Cancerologia, Mexico City, Mexico, 2Medical
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3Universidad Anahuac, 4Instituto Nacional de Cancerologia, Mexico City,
Mexico
* Corresponding author.
Rationale: Among premenopausal women, osteoporosis is related to
lowmuscle mass, postmenoausal osteoporosis which is mainly driven
by the low estrogen levels. Sarcopenic is associated with worse
prognosis
Methods: Stage I-III of breast cancer were included and treated with
chemotherapy (neo)adjuvant. bone mineral density were assessed by
bone densitometry of the spine and hip (dual energy x-ray [DXA]),
score T -2.5 SD was used to define osteoporosis
Results: 221 patients were included. Median age at diagnosis were 49
years-old (23–81), 19% (n = 43) has osteoporosis. chemotherapy
toxicity grade 3/5, were 65.1% and 39.7% for osteoporosis vs normal
bone density p = 0.019. Breast cancer relapses were 14% vs 1.3%
respectively p = 0.006. There were no differences in mortality.
Conclusions:Osteoporosis is present in 19% of patients. It is associated
with higher incidence of chemotherapy toxicity as well as more
disease relapses. Understanding the mechanisms of the osteoporosis
along with obesity and low muscle mass is important to initiate
preventive strategies
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ARE THE NUTRITIONAL MINI NUTRITIONAL ASSESSMENT (MNA)
SCALE USED IN OUR HOSPITAL AS PART OF THE NUTRITIONAL
SCREENING RISK PROTOCOL (NRSP), GOOD PREDICTOR OF
MALNUTRITION ACCORDING TO THE GLIM CRITERIA?
C. herranz fernandez1*, A. segovia campo1, G. simats oriol1,
C. fernandez chavez1, G. monroy rodriguez1, G. saenz de navarrete
ribera1. 1Parc Sanitari Sant Joan De Deu, Sant boi de llobregat, Spain
* Corresponding author.
Rationale: There is evidence supporting the use of nutritional
screening methods at hospital admission for early detection and
treatment of malnutrition (MN). Our hospital developed a NRSP using
a validated screening tool Nutritional Risk Screening 2002 (NRS-2002)
and a combination of evaluation tests (MNA, subjective global
assessment -SGV) and complementary data to obtain a nutritional
diagnosis.
Methods: Once developed and established the NRSP we intended to
evaluate whether MNA is effective and correctly oriented toward the
complete nutritional diagnosis according to new GLIM criteria. We
established a NRSP in which nursing complete first part of NRS-2002
scale at hospital admission in medical services patients older than 65
years. If any of the questions are affirmative a full nutritional
assessment is performed using MNA scale and complementary data.
Finally, it is carried out a nutritional diagnosis by GLIM criteria. Once
the data was collected statistical study is conducted to evaluate the
current operation of the NRSP and propose improvement initiatives.
Results: 94 patients were finally included of which 50% (n = 47) were
men. The middle age was 80.2 years and the average length of stay of
12.39 days. Of these patients 50% (n = 47) had moderate to severe
malnutrition and the other half were well-nourished according to
GLIM criteria. The combinedMNA (CombinedMNA =MNA part 1/12) *
30) was calculated to obtain a comparable approximation to the
complete MNA. The mean MNA showed a score of 19.38 indicative of
risk of malnutrition. It had also been assessed the MNA is a good
predictor of nutritional status according to GLIM criteria.
Conclusions: According to data we can conclude that higher
punctuations of NRS-2002 and lower punctuations of MNA are
statistically significant related to moderate-severe malnutrition.
However, a large number of malnourished patients would not have
been detected with MNA due to the score of the scale. It could be as a
result as the weight loss factor, underestimated in MNA or over-
estimated in the GLIM criteria but we need more data to draw
conclusions. Taking into account the results, we set ourselves the
objective of continuing the research recording one by one MNA scale
items to study the relation between them and GLIM diagnosis criteria
and also try to assess the concordance between NRS-2002, MNA and
GLIM diagnosis criteria.
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COMPARISON OF PREDICTED VERSUS MEASURED RESTING ENERGY
EXPENDITURE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER
DISEASE (NAFLD)
D. Vranesic Bender1*, P. Polancec2, D. Ljubas Kelecic1, I. Karas1,
V. Domislovic1, Z. Krznaric1. 1Unit of Clinical Nutrition, University
Hospital Centre Zagreb, 2Faculty of Food Technology and Biotechnology,
Zagreb, Croatia
* Corresponding author.
Rationale: Non-alcoholic fatty liver disease (NAFLD) with prevalence
of 25% is a major global health problem. There is currently no
standardized pharmacological treatment and the only proven effective
therapeutic strategy is based on a weight reduction, an adequate diet
and a regular physical activity. The aim of this study was to assess
nutritional status, diet quality and determine the concordance
between measured resting energy expenditure (REE) with calculated
values, using 5 different equations.
Methods: We enrolled 13 patients with mean age of 53,77 ± 9,34,
diagnosed with NAFLD by the standard diagnostic algorithm proced-
ure and tools including ultrasound. Anthropometric parameters were
measured, intake of energy and nutrients were assessed by 3-day food
diary, resting energy expenditure was measured by indirect calorim-
etry (Cosmed Quark CPET) and compared to the resting energy
expenditure calculated using 5 different equations (Harris-Benedict,
Mifflin-St. Jeor, Schofield, Ikeda, Huang). In order to determine the
most predictive equation, we calculated the mean difference (BIAS)
and Root Mean Squared Error (RMSE) for each calculated value with
regard to measured REE.
Results: The average BMI of the patients was in obese category
(31,15 ± 4,28 kg/m2), the everage waist circumference was 103,80 ±
10,30 cm and everage body fat percentage was 35,32 ± 8,49%. The
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average energy intake of patients was 1734,50 ± 497,86 kcal, signifi-
cantly less than their measured energy needs (2403,65 ± 498,10 kcal)
(p = 0,0002) that implies patients were following a reduction diet or
they underestimated their food intake. The results show that the
patients had high intake of fats, especially saturated fatty acids, and
that the intake of dietary fibers, vitamins A, D and E, as well as
magnesium was insufficient. The lowest BIAS and RMSE (97,86 and
194,80, respectively) were calculated for the Schofield equation, while
the same valueswere highest in case of the Ikeda equation (279,69 and
336,47, respectively).Most of predictive equations underestimatedREE
in NAFLD patients in the present study.
Conclusions: Nutrition status and diet quality indicate the features of
metabolic syndrome, while diet quality is characterized by high
saturated fat intake and insufficient intake of micronutrients and fiber.
By comparing measured with calculated resting energy expenditure it
was found that the Schofield equation is the most appropriate
equation for calculating energy needs among patients with NAFLD.
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HOW NUTRITION SUPPORT TEAMS DEALWITH ETHICAL ISSUES?
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pública, Facultad de Medicina, Universidad Pontificia Bolivarian,
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* Corresponding author.
Rationale: Nutrition support teams (NSTs) frequently face ethical
issues in clinical practice. Clinical ethics can help nutrition support
professionals (NSP) to identify, understand and solve common ethical
issues related to patient care (1). The purpose of this survey was to
investigate how NSTs dealt with ethical issues in Colombia.
Methods:A cross-sectional studywas performed inMay 2018 through
the administration of an online questionnaire to all the Colombian
NSTs registered in a national database. Descriptive measures were
obtained.
Results:A total of 54NSTswere surveyed, and 30% of thembelonged to
public hospital. Their main activities were nutritional care (100%),
education (92%), research (75%) and administrative (83%). Clinical
practical guidelines on clinical nutritionwere used by 87% of the NSTs.
The NSTs were integrated by physicians (91%), dieticians (96%), nurses
(89%) and pharmacists (85%).
The majority of the NSTs considered nutritional therapy as a medical
intervention as well as a basic support (74%), as amedical intervention
(13%), as a basic support (5%), and none (8%). The ethical dilemmas and
issues were faced mainly by the NSTs with the patient and/or family
(42%), by the institutional Committee on Ethics (24%), by the NSTs
themselves (15%) and by the NSPs by themselveswith the patient and/
or family (11%). It is noteworthy that 8% of the NTSs affirmed that they
hadńt faced the ethical issues and dilemma. Even if themajority of the
NSTs claimed that they had dealt with ethical issues and dilemma
(92%) all of the NSTs claimed that they hadńt used anymethodology to
solve them.
Conclusions: Theway theNSTs dealtwith ethical dilemmas and issues
in Colombia was heterogeneous. Special efforts should be aimed at
education and sensitizing the NSPs in clinical ethics.
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NUTRITIONAL ASSESSMENT OF HOSPITALIZED PATIENTS WITH
CANCER WITH TWO TOOLS: PGSGA & NRS 2002
D. Gunes1*, S. Dag1, D. Ongan2. 1Adnan Menderes University Faculty of
Medicine Nutrition and Diet Unit, Aydin, 2Katip Celebi Universty Health
Science Faculty Nutrition and Dietetic Department, Izmir, Turkey
* Corresponding author.
Rationale: Nutritional assessment of patients with cancer is strongly
recommended in order to take precautions againstmalnutritionwhich
may decrease the efficacy and tolerance of the treatment and may
cause prolonged hospitalization. ESPEN recommends identifying the
patients at risk of malnutrition by validated tools for treating
accordingly. Therefore this study was conducted to determine the
nutritional risk of hospitalized patients with cancer with two scales:
PGSGA & NRS 2002.
Methods: This cross-sectional and descriptive study was conducted
between the dates of November 2018 – March 2019 at Aydın Adnan
Menderes University Faculty of Medicine Hospital with patients
hospitalized in the oncology unit. Data were collected with a
structured questionnaire form, and two nutritional screening &
assessment tools: Patient Generated Subjective Global Assessment
(PGSGA) Scale and Nutritional Risk Screening (NRS 2002) with a face-
to-face interview after obtaining oral consent from the patients. Data
were analyzed with SPSS 16.0.
Results: Nutritional screening was performed in 167 hospitalized
patients with cancer (65.9% were men, 34.1% were women, and the
mean age was 61.7 ± 12.5 years). Gastrointestinal system (GIS) cancers
were seen in 43.1% of the patients. Chemotherapy (38.9%), chemo +
surgery (35.3%), chemo+radiotherapy (12.0%) were applied. Total
mean PGSGA score in men and women were 5.5 ± 2.5 and 6.5 ± 2.8,
respectively (p = 0.024). Total mean NRS 2002 score in men and
womenwere 2.3 ± 1.0 and 2.2 ± 1.0, respectively (p = 0.324). According
to PGSGA; 44.9% of the patients were well nourished, 29.9% had
moderate/suspected malnutrition and 25.1% were severely malnour-
ished. NRS 2002 results showed that 39.5% of the patients had
nutritional risk (NRS 2002 score ≥3) which meant that a nutritional
plan should be started, while 60.5% of the patients should be regularly
screened once aweek during hospitalization. It was found that the two
scales were correlated (p < 0.001).
Conclusions: It was concluded that concurrently performed multi-
tools for nutritional screeningmay help not miss any patient who is at
risk of malnutrition and/or malnourished. It was thought to be
important because patientswith cancer are at high risk ofmalnutrition
due to the disease and its treatment.
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EVALUATION OF ATHELETES’ FOOD CHOICES IN SCOPE OF THEIR
BODY IMAGE AND EATING BEHAVIOR
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Rationale: Disordered eating attitude and/or body image dissatisfac-
tion is a problem that can be seen among athletes. The aimof this study
is to determine the factors that affect food choice behaviour of athletes
according to their sex, eating behaviour and body image perception.
Methods: A total of 224 professional athletes between the age of 16–
25 and from different branches participated in this study. Themajority
of athletes were males with 57.1%. Athletes general behaviour, eating
habits, perception towards their body and their attitudes towards food
choice were evaluated by face to face questionnaire. Their eating
behaviours, body images and food choice attitude were assessed by
‘Eating Attitude Test (EAT-40),’ ‘Body Shape Questionnaire (BSQ),’ and
‘Food Choice Questionnaire (FCQ)’ respectively. The FCQ consisted of
36 items in 9 factors (health, mood, convenience, sensory appeal,
natural content, price, weight control, familiarity and ethical concern).
Results: Health, body weight control, and sensory appeal were the
most important factors in food selection of athletes. While women
tended to mostly pay attention to ‘health’ and ‘weight control’ factor
when choosing food, menpaidmore attention to the ‘sensorial appeal’
and ‘health’ factor. It was determined that 14.7% of the athletes had
eating disorder and 30.8% had body image dissatisfaction in different
levels. When choosing food, athletes with the dissatisfaction of body
image and/or eating disorder tended to pay more attention to ‘body
weight control’ factor (p < 0.05).
Conclusions: This study informs the readers about the importance
that the athletes give to food selection and also it shows that there
could be various changes in the food selection when gender
differences are considered. ‘Weight control’ factor comes first to
argue in the selection of food for athletes who have an eating disorder
and/or body image dissatisfaction.
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PROGNOSTIC IMPACT OF HAND GRIP STRENGTH COMPARED TO
CALF CIRCUMFERENCE FOR PREDICTING 6 MONTH MORTALITY IN
PATIENTS UNDERGOING ABDOMINAL SURGERY
D. Karagiannis1*, Z. Bouloubasi1, S. Kakavas2, A. Almperti1,
D. Constantinou3, A. Baschali1, Z. Mastora2, G. Stylianidis3. 1Clinical
Nutrition and Dietetics, 2First Department of Critical Care Medicine and
Pulmonary Services, Medical School of Athens University, 3Second
Department of Surgery, Evangelismos District General Hospital of
Athens,, Athens, Greece
* Corresponding author.
Rationale:Muscle weakness before major abdominal surgery is a risk
factor for postoperative complications, prolonged hospitalization and
increasedmorbidity andmortality. The aim of the present studywas to
evaluate the predictive power of muscle strength assessment tools
along with established medical and surgical parameters in terms of
mortality in a sample of Greek surgical patients.
Methods: This was a single center, prospective observational study of
115 adult patients (56,7% female; mean age 65.2 ± 15.3 years) who
underwent abdominal surgery from July 2014 to October 2016.
Patients were followed-up until June 2017. Nutritional assessment
was performed using hand grip strength, calf circumference and
serum albumin. We also evaluated anthropometric and hematological
indices, recent weight loss, surgery severity, comorbidity, in hospital
and 6-month mortality, length of hospital stay and postoperative
complications. Statistical analysis was performed using non paramet-
ric analysis and Receiver Operating Characteristic (ROC curve).
Results: Overall, during the follow up period, 26 (23.1%) of patients
died. As compared with calf circumference and serum albumin,
HGS had the largest area under the ROC curve (AUC) for predicting
6 month mortality after adjusting for age, smoking, comorbidities,
and malignancy presence. The AUCs (95% CIs) for Calf circumference,
serum albumin and HGS were 0.293 (0.251–0.332), 0.398
(0.352–0.410) and 0.431 (0.375–0.498), respectively. The cut-off of
HGS able to predict mortality was 20.6 kg for men and 14.2 kg for
women. Using this cut-off to fit the Kaplan-Meier survival curve, the
association of HGS with all-cause mortality for both genders was
confirmed. Finally, in the multivariate analysis adjusted for demo-
graphic, clinical and nutritional variables, HGS remained significant
predictor of mortality, independent of surgical complications.
Conclusions: In a group of patients undergoing abdominal surgery,
hand grip strength represented higher discriminating accuracy
compared to calf circumference on predicting 6-month post-operative
mortality.
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CLINICAL PRACTICE GUIDELINES FOR MALNUTRITION AND USE OF
NUTRITIONAL INTERVENTIONS: CHANGES OVER 6 YEARS
D. Eglseer1*, V. Blanar2̌, C. Lohrmann1, M. Hoedl1. 1Medizinische
Universität Graz, Institut Für Pflegewissenschaft, Graz, Austria,
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* Corresponding author.
Rationale: Clinical practice guidelines (CPG) support healthcare
professionals in conducting evidence-basedmanagement of malnour-
ished patients. The aim of this study was to evaluate the availability of
guidelines for malnutrition and interventions based on these guide-
lines in hospitals, specifically the change from 2012 to 2017.
Methods: This cross-sectional multicentre study was part of the
Prevalence Measurement of Care Problems (LPZ) andwas conducted in 6
consecutive years (2012–2017). 15 Austrian hospitals with a total of
5650 patients participated in the study. Data were collected with a
standardized questionnaire by nurse directors (organizational level)
and nurses (patient level). Data were analysed with SPSS 25 using
descriptive statistics and statistical tests, e.g. X2 test, McNemar’s test,
Mann-Whitney U test.
Results: The availability of CPGs formalnutrition increased from6.7% in
2012 to 100% in 2017 (p < 0.001). Interventions conducted to treat
malnutrition increased accordingly during the study period. The
availability of a guideline was associated with a higher frequency of
nutritional interventions. The most frequently conducted interventions
were the referral to a dietician, diet enrichment and food consistency
adjustment.Thenumberofpatientswhodidnot receiveany intervention
decreased from 70.0% in 2012 to 55.6% in 2017 (p < 0.001).
Conclusions: The availability of guidelines on malnutrition increased
considerably in the participating hospitals over the six-year study
period. This highlights the rising awareness regarding this topic in
Austrian hospitals. The frequency of CPG-based nutritional interven-
tions for patients at risk of malnutrition rose concurrently with the
increased use of guidelines. Therefore, stakeholders and hospital
managers but also healthcare staff working in clinical practice should
promote the implementation of CPGs for the management of
malnourished patients to support the provision of evidence-based
nutritional care in hospitals.
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Rationale: Early diagnosis ofmalnutrition is thought to be important in
hospitalized children to prevent the complications. Therefore, the need
for early detection of malnutrition has lead to the development of
various nutritional screening tools. Today, seven screening tools are
available fordetecting themalnutrition inchildrenadmitted tohospital.
Methods: In this cross-sectional study, the risk of malnutrition was
determined by PYMS ans STRONGkids in 222 patients aged from 1 to
16 years old. Demographic data, clinical information and anthropo-
metric measurements were recorded. The results of the anthropo-
metric measurements and the screening tools were compared.
Results: According to the BMI values of the patients, 84.7% were
normal and 15.3% were acute malnourished. Severe and moderate
stunting was detected in 8.1% and in 11.3% of chronic malnourished
patients respectively. In patientswithout acutemalnutrition, the lower
malnutrition risk was found in 55.0% of the patients with PYMS
whereas in 42.9% with STRONGkids. The detection rate of the
moderate risk with STRONGkids (47.1%) was higher than PYMS
(22.2%). The detection rate of high malnutrition risk with PYMS
(22.8%) was higher than STRONGkids (10.1%). In patients with acute
malnutrition, PYMS could not detect low and moderate malnutrition
risk. The detection rateswith STRONGkids were 6.1% for lowand 36.4%
for moderate risk. STRONGkids’ ability to detect patients with high
malnutrition risk was lower (58.3%) than that of PMYS (100%).
Significant changes were determined between the patients with low,
moderate and high malnutrition risk regarding anthropometric
measurements by STRONGkids (p < 0.001).
Conclusions: According to anthropometric measurements, PYMS was
superior for detecting acute malnutrition while STRONGkids was
superior for detecting chronic malnutrition.
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E. Inan-Eroglu1*, B. Madali1, C. Ozsin-Ozler2, S. Karahan3, M. Uzamis-
Tekcicek2, Z. Buyuktuncer1. 1Nutrition and Dietetics Department,
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Rationale: Nutritional counseling is increasing in the field of
paediatric dentistry. There is an inevitable need for practical tools
that assess dietary intake in the epidemiological and interventional
oral health studies. This study aimed to determine the reliability and
validity of the Food Frequency Questionnaire (FFQ) which was
developed to examine the consumption of 40 food items related to
oral health in children.
Methods: A sample of 120 healthy children (59 girls, 61 boys), aged 2–
9 years, who consulted to Department of Pediatric Dentistry,
Hacettepe University, were included in this cross-sectional study. A
total of 2 FFQ (at the beginning and end of the study) and three 24-h
dietary recalls were conducted to the caregivers of children. The
prevalence and severity of dental caries were measured using the
decayed, missing or filled teeth (dmft) index. Multiple statistical
methods were used to evaluate the validation of the questionnaire.
Spearman correlation coefficient, weighted kappa, and intra class
correlation (ICC) values were calculated.
Results: Spearman correlation coefficient was >0.5 for lactose, calcium
and phosphorus. Weighted k was >0.4 for only lactose, calcium and
phosphorus (0.613, 0.463 and 0.538, respectively). Spearman correl-
ation coefficient was >0.5 for energy, fat, carbohydrate, pulp, starch,
lactose, glucose, polysaccharide, calcium, phosphorus, iron and zinc
when it was calculated for reliability. ICC values showed that the FFQ
has reproducibility for lactose and calcium (0.722 and 0.63,
respectively). Although carbohydrate, starch, polysaccharide and
sucrose levels showed a positive correlation with DMFT, no significant
difference was found (p < 0.05).
Conclusions: The validation of FFQ for paediatric dentistry gives
promising insight to the field of oral health but the results should be
repeated in larger group.
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WEIGHT CHANGES RELATED TO DYSPHAGIA AND BULBAR
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Rationale: Oropharyngeal dysphagia (OD) occurs in 80% of patients
with Motor Neuron Disease (MND). When it appears, OD contributes
negatively in the evolution ofMNDpatients, because is one of principal
causes of weight loss, malnutrition and aspiration pneumonia. The
influence of weight loss and BMI on survival time has recently been
reported. In this study we want to know how the appearance of
dysphagia and bulbar symptoms influences weight loss in patients
Methods: A total of 48 patients with MND were recruited from a
SpanishMultidisciplinaryMNDUnit. A final cohort of 46 patients with
different phenotypes ofMNDand in different stages of evolution of the
disease was selected for a transversal study. These patients were
classified according to the presence of dysphagia and bulbar
involvement. Parameters relative to their weight variation were
evaluated. Data before the diagnosis was based on patients’ records
and from the diagnosis ofMND, all subsequent datawould be recorded
in their clinical history. A clinical evaluation and a videofluoroscopy
was also carried out in all patients. To facilitate the interpretation of
the data, the patients were grouped into 4 groups according to their
evolution of MND from diagnosis: 1) those of with a recent diagnosis
(<12months) (n = 21), 2) with 1–2 years of disease evolution (n = 9), 3)
2–5 years (n = 10), and 4) slow progression forms of MND (>5 years)
(n = 3). Weight variation was evaluated from patients’ weight before
the appearance of MND symptoms until their current weight
Results: In group 1,16 patients presented bulbar symptoms, though 18
patients had dysphagia. The median weight loss in this group was
4.94%. For group 2, 6 patients presented dysphagia with a median
weight loss of 3.98%. Group 3 was more heterogeneous, since weight
gain was 12.50% and weight loss 14.84%, 8 patients had dysphagia,
with a median weight loss of 1.38%. Group 4 comprised 3 spinal
patients, with dysphagia symptoms and without significative weight
loss. Differences in weight change according to the onset of bulbar
symptoms, can be significantly found. In the case of bulbar symptoms
onset prior to diagnosis (3–12 months), the median weight loss is
5.13%. When bulbar symptoms appear at the time of diagnosis (0–3
months), weight loss is 7.14% (median) and if it is 4–12 months after
diagnosis, weight loss is only a 3.73% of median
Conclusions:Weight loss due to dysphagia is present in the cohort. As
well, the time of onset of the bulbar symptoms in the progression of
the disease determine their weight loss. In some cases, dysphagia can
be found in MND patients without bulbar symptoms. A more accurate
diagnosis of bulbar affectation, would contribute to an early treatment
of dysphagia, preventing weight loss and malnutrition
Disclosure of Interest: None declared.
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PARAMETER IN CANCER PATIENTS
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Rationale: During the last decades, there has been growing interest in
the assessment of body composition in daily clinical practice. In this
perspective, the necessity of bedside, safe (non-invasive), cheap, rapid,
easily interpretable and reproducible techniques has made bioelec-
trical impedance analysis (BIA) a valuable tool. Estimation errors
associated with bioelectric impedance evaluation may affect the
accuracy of body composition and its prognostic value. We evaluated
the prognostic value of a new body composition parameter (creatinine
height index [CHI]) obtained from bioimpedance vectorial analysis-
derived body cell mass and its association with nutritional and
functional status.
Methods: Data of Italian and German cancer patients observed
prospectively until death were used (N = 1084). Multivariable models
(adjusted for age, gender, hydration status, performance status, and
disease’s stage) were built in both cohorts to assess the association
between body composition outcome parameters (low fat-free mass
[FFM], <15 [females] and <17 [males] kg/m2; low standardized phase
angle [SPA], <−1.65; low CHI, <510 [females] and <660 [males] mg/
24 h/m) and 1-yearall-causemortality, lowbodymass index (BMI; <20
[<70 years] and <22 [≥70 years] kg/m2), clinically significant weight
loss (WL; ≥10% in 6 months) and low handgrip strength (HG; <20
[females] and <30 [males] kg).
Results: Low CHIwas independently associatedwithmortality in both
Italian (HR = 1.84 [95%CI, 1.18–2.86]; P = 0.007) and German cohorts
(HR = 1.52 [95%CI,1.17–2.07]; P = 0.008). Low FFMI and low SPA did not
predict survival in the German cohort. In patients with low CHI, worse
nutritional and functional status were observed in both study
populations. Performance of models addressing the study endpoints
showed substantial consistency with both cohorts, particularly of
those including low CHI.
Conclusions: We validated a new prognostic body composition
parameter, which is easier to interpret than standard nutritional
parameters and may be useful for identifying cancer patients at
nutritional risk, requiring early nutritional support. Its prognostic value
should be confirmed in other patient populations and its sensitivity in
detecting changes in protein-calorie intake is still to be investigated.
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Rationale: Anorexia nervosa outcomes without clinical follow-up
have not been thoroughly investigated to date. This study aimed to
assess long-term outcome indicators in a group of women with
restrictive anorexia nervosa AN (AN-R) living in southern Italy.
Methods: A cohort of 117 women (mean age at the first visit 20.0 ± 5.2
years, body mass index 16.1 ±1.5 kg/m2) with AN-R who were treated
from January 2000 to December 2005 and who did not undergo any
regular clinical observation in our outpatient unit in the last 10 years
were asked to complete a questionnaire on their present living and
clinical conditions (at least 10 years after their last observation at our
outpatient unit).
Results: Forty-four (37.6%) out of 117 patients completed the
questionnaire, forty-two (35.8%) could not be reached (i.e., changed
address and phone number), and 30 (25.6%) denied participation.
A total of 41% (n = 21) of respondents were married or cohabiting, 55%
(n = 24) obtained a university degree, and 55% (n = 24)were employed,
while 6.8% (n = 3) were unemployed. Moreover, 68.2% (n = 30) of
patients reported a good remission of disease symptoms. During the
10-year period without clinical follow-up, three patients required
hospitalization in a psychiatric ward. The total mortality rate was
3.72%, corresponding to a standardized mortality ratio (SMR) of 6.9.
Conclusions: although the results of our study cannot be fully
generalized, women with a history of AN-R may experience a variety
of long-term outcomes: achieving expected goals in life goals or
maintaining some pathological traits requiring qualified long-term
nutritional and psychological support. Lastly, although the AN-related
mortality rate in this study was lower than those observed in past
literature, it remains the AN-related mortality rate, regarding the
entire studied cohort, was lower than that in our past studies but is still
considerably higher than that of the age-matched population.
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EVALUATION OF NUTRITIONAL STATUS WITH NUTRITIONAL RISK
SCREENING 2002 AND SUBJECTIVE GLOBAL ASSESSMENT, ESPEN
CRITERIA, AND BODY COMPOSITION AT ADMISSION IN A HOSPITAL
WARD
E. Speranza1, O. Di Vincenzo1, L. Santarpia1, M. Naccarato1, C. De
Caprio1, R. Sammarco1*, M. Marra1, F. Contaldo1, F. Pasanisi1.
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Rationale: Nutritional risk and malnutrition are highly prevalent
among hospitalized patients. Therefore, assessing patients’ nutritional
status may be useful in identifying patients with increased risk for
morbidity and mortality. The first aim of the study was to evaluate the
efficacy of two test NRS 2002 and SGA to assess the nutritional status
and the malnutrition’s prevalence with ESPEN criteria; secondly to
show the relation with the other nutritional risk parameters: phase
angle (PA) and Handgrip strength (HG).
Methods: This study was conducted since September 2016 to
December 2017 and included 214 patients, 115 male and 99 female
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(age 65.2 ± 15.4 y, 59.1 ± 17.9y; body weight 74.7 ± 15.9 kg, 67.9 ± 16.3
kg; BMI 25.5 ± 4.6 kg/m2, 26.6 ± 6.3 kg/m2) admitted to the Hospital
wards coming from the Emergency Unit. The SGA and NRS 2002 were
administered to all patients within 72 h of admission and bioimpe-
dance analysis (BIA) and muscle strength. were performed.
Results: According to SGA, 45.2% of male patients are considered well
nourished (score a), 49.6% moderately malnourished (score b), and
5.2% severely malnourished (score c), whereas with NRS, 89.6%
considered well-moderately nourished (score < 3), and 10.4% severely
malnourished (score ≥ 3). About female patients according to SGA,
44.4% are considered well nourished (score a), 51.5% moderately
malnourished (score b), and 4.0% severely malnourished (score c),
whereas with NRS, 94.9% considered well-moderately nourished
(score < 3), and 5.1% severelymalnourished (score≥ 3). The prevalence
of malnutrition according to the new ESPEN definitions was : 9.1% in
female and 3,5 in male (BMI ≤ 18 kg/m2), and 6.1% for each (fat free
mass index < 15 kg/m2 for female and < 17 kg/m2 for male combined
with an unintentional weight loss > 10% independent in the last three
months), Therefore we also observed a strong correlation between AF
and HG (r = 0.666; p < 0.05).
Conclusions: SGA and NRS appear to are useful tests to identify
patients at risk for malnutrition at hospital admission from the
Emergency Unit in addition to other important parameters, andwith a
similar prevalence to Espen criteria use. Furthermore our study
confirms that both AF and muscle strength are the useful markers of
nutritional status.
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AND PHYSICAL ACTIVITY WITH VITAMIN D STATUS AMONG
INDONESIAN ADOLESCENTS: URBAN SETTING
E. Prafiantini1*, M.J. Thia1, on behalf of corresponding author,
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Rationale: The prevalence of vitamin D deficiency has increased
rapidly worldwide in both children and adults, including country with
abundant sun exposure as well as Indonesia. The objective of the
present study was to determine the prevalence of vitamin D and its’
association with behavioral factors like physical activity and exposure
to sun light among healthy group of Indonesian adolescents in urban
setting.
Methods: A total of 64 adolescents aged 15–18 years (28 boys and 36
girls) from four different senior high schools in Depok-West Java were
included in this cross-sectional study. Sun exposure score, vitamin D
intakes, and physical activity were determined using a standard
questionnaire, and serumconcentration of 25-hydroxyvitamin-Dwere
measured using Direct Competitive Chemiluminescence Immunoassay
(CLIA).
Results: The prevalence of vitaminD deficiency (25-hydroxyvitaminD
serum <37.5 nmol/L) was 62.5%. This recent study found that sun
exposure score (U = 196.5, p = 0.000) and vitamin D intakes (U = 257,
p = 0.025)were significantly different in adolescents’ serumof Vitamin
D. However, there was no significant different found in physical
activity (t (62) = 0.458, p = 0.648) in adolescents’ serum of Vitamin
D. Adolescents with vitamin D deficiency had a lower sun exposure
score, but they had higher vitamin D intakes compared to adolescents
with vitamin D sufficiency.
Conclusions: Vitamin D deficiency in Indonesian urban adolescents is
very prevalent. Furthermore, status of vitamin D appears to have
associationwith sun exposure, vitamin D intakes, and physical activity.
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PHASE ANGLE IN PATIENTS WITH CONGESTIVE HEART FAILURE
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Rationale: Congestive heart failure (CHF) is a complex clinical
syndrome manifested by cardiac muscle dysfunction and its develop-
ment is closely related to nutritional status and body composition. The
use of phase angle (PA), measured by bioelectrical impedance (BIA), is
described as valid, even in situations with oscillations in the hydration
state, and has been related to the success, survival and evolution of the
disease.
Methods: Patients accompanied by the ICC protocol of a general
hospital in São Paulo – Brazil, were included. Individuals who were
unable to apply BIA (pacemaker patients and extensive metal
prostheses) were excluded from the sample. Sociodemographic data
(sex and age) and anthropometric data (weight, height and BodyMass
Index – BMI) were obtained with the help of Toledo scale, capacity
150 Kg and sensitivity 100 g, of a portable X-ray stadiometer. The
functional class (FC) of CHFwas established according to the New York
Heart Association criteria, described in the Brazilian Guideline for CHF
(2018). To obtain PA and muscle mass, the results of the BIA test
performed with the BCM-Fresenius instrument were used.
Results: The study included 24 subjects with a mean age of 81,4 (±
10,58) years. The sample was composed of 19 (79.2%) men and 5
(20.8%) women, with mean PA of 3,79° (±0.98). In relation to the
functional class and PA 2 (8.3%) patients were FC II with mean PA
of 5.22° (±1,35°); 13 (54.2%)were FC III withmean PA of 3.95° (± 0.90°);
9 (37.5%) were FC IV with mean PA of 3.25° (±0.66°). As for muscle
mass, 11 (45.8%) patients presented reduced values with mean PA of
3.36° (±0.69) while 13 (54.2%) presented normal values with mean PA
of 4.16°(±1.06).
Conclusions: The present study shows that patients with higher
functional class or lower muscle mass presented a lower phase angle,
suggesting that PA can be a good indicator of the nutritional status and
prognosis of congestive heart failure.
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Rationale: Hospital malnutrition has a high prevalence and is often
underdiagnosed. It leads to increased morbidity and mortality and
length of hospital stay. Due to this, the main global societies of clinical
nutrition were summoned to the Global Leadership Initiative on
Malnutrition (GLIM), aiming to create a tool for the diagnosis of
malnutrition in hospital environments.
Methods: A discussion group composed by nutritionists has adjusted
existing tool, which is applied since 2006 for the diagnosis and
nutritional monitoring of patients to the standard proposed by GLIM
consensus.
Results: The tool called ‘Nutritional Risk Tree’ evaluates: food intake,
chewing, swallowing, digestion, absorption, intestinal function,
metabolism alteration, treatments, renal function, large surgeries,
burn, pressure injury, mass index weight loss, decompensated
systemic arterial hypertension, congestive heart failure, dyslipidemia
and feeding pathway. After the patient is classified into: with or
without nutritional risk. The instrument was effective in evaluating
the phenotypic and etiological criteria, but did not classify the etiology
ofmalnutrition. After the readaptationwas established: reallocation of
the criteria already evaluated in 2 groups: 1. Phenotypic: weight loss,
reduced BMI, depletion of muscle mass and functionality and
2. Etiological: reduction of intake/absorption and inflammation.
From this it will be defined whether the patient is malnourished or
not, as well as the etiology of malnutrition. For nutritional screening,
the NRS2002 will be adopted.
Conclusions: The tool used by the hospital already met the main
criteria proposed by the GLIM consensus, but adjustments were
necessary in order for the nutritional status classification to meet the
most recent nutritional assessment recommendations, more efficient
and individualized nutrition.
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Rationale: Calf circumference (CC) is indicatorof musclemass and low
muscle mass is one criteria applied in different tools for malnutrition
diagnosis. Cut-off point ≤33 cm for women and ≤34 cm for menwere
recently determined for South Brazilian population to identify low
muscle mass. However, it was not tested regarding its accuracy for
malnutrition diagnosis. The aim of this study was to evaluate the
accuracy of CC for diagnosis of malnutrition in hospitalized patients.
Methods: Cross-sectional study included Brazilian hospitalized
patients from two hospitals (Porto Alegre-RS and Curitiba-PR). The
protocol was approved by the Ethical Committee of the hospitals. The
sample was consecutively selected from all patients admitted to the
hospitals within 48 hours of hospitalization. The inclusion criteria
were patients with age ≥18 years that were conscious, able to move,
and without oedema. Malnutrition was diagnosed according to
Subjective Global Assessment (SGA). The CC was measured using an
inelastic tape at the point of greatest circumference. Area under ROC
curve was calculated to evaluate the performance of CC to identify
malnutrition considering the Brazilian cut-off points and CC as a
continuous variable to established the most accurate cut-off (high
specificity with an acceptable sensibility – at least 50%). The statistical
analysis were performed in SPSS 20.0 and p values <0.05 were
considered significant.
Results: 509 patients (50.3 ± 14.7 years old; 51.5% females; 66.4%
white ethnicity) were included in this study (52.3% from Curitiba). The
majority of patients had cancer (25.9%), followed by cardiovascular
disease (19.6%) and gastrointestinal disorder (14.5%). Malnutritionwas
identified in 33.2% to patients according to SGA. The Brazilian CC cut-
off point didn’t present a good performance for identify malnutrition
(AUC ROC = 0.370; CI 95% 0.312–0.428). When CC was considered as
continue variable the AUC of ROC curve was equal to 0.784 (CI 95%
0.718–0.850) for men and 0.678 (CI 95% 0.602–0.753) for women. For
men the cut-off point established was 34.4 cm (sensitivity = 53.7%;
specificity = 82.7%) and for women it was 34.1 cm (sensitivity = 52.0%;
specificity = 75.2%).
Conclusions: CC ≤34.4 cm presented an accuracy of 71.8% to identify
malnutrition in men. For women, the performance of CC as
malnutrition marker was less satisfactory. These results suggest that
CC could be adopted as an indicator of malnutrition in men
hospitalized, considering that, the measurement of CC is simple,
non-invasive and cheap.
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PREVALENCEOFMALNUTRITION INACOHORTOF CROHN’S DISEASE
PATIENTS ACCORDING TO THE NEW GLIM CRITERIA
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Rationale: Crohn’s disease (CD) is a chronic inflammatory bowel
disease that may alter ingestion and/or assimilation of nutrients. It is
well known that CD patients may develop malnutrition and/or
nutritional deficiencies. The objective of this study was to assess the
prevalence ofmalnutrition using theGLIM criteria in CDpatients at the
era of new therapies such as the biologics.
Methods: This is a prospective study including ambulatory CD
patients. The study included demographics data (age, gender), CD
characteristics (duration of CD, location, degree of activity (Bradshaw
index, HBI), surgical resection, current therapies). Nutrition status was
assessed by SGA and the GLIM criteria (weight loss (WL), BMI, muscle
function (handgrip tests), food intake and inflammation).
Results: 92 CD patients (47 females and 45 males) were enrolled in
this studywith amean age of 46 years and amean duration of CD of 16
years (1–62 years). 37% of the patients had undergone previous
intestinal resection and 63% of the patients received immunosuppres-
sion or biologics at the time of evaluation. According to HBI, 43,48%
patients had a clinical active CD.
Based on the GLIM criteria, the prevalence of malnutrition was 32,6%
with 18,5% and 14,1% being moderately or severely malnourished.
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Malnutrition was significantly correlated with HBI (p < 0,002), CRP
(p < 0,032) and presence of inflammation at the endoscopy (p < 0,05).
Amongst the 5 GLIM criteria, % of WL, low BMI, strength diminution,
decreased oral intake and active inflammationwere defined as positive
in 43,33%, 23,3%, 76,7%, 56,7% and 83,3% of cases respectively. SGA and
GLIM criteria were positively correlated in 63% of the patients.
Conclusions: Based on the GLIM criteria, the prevalence of malnutri-
tion was 32,6% in a cohort of ambulatory CD patients. Amongst the 5
criteria, strength, decreased oral intake and the inflammationwere the
most frequently altered. Malnutrition was correlated with the clinical,
the biological and the endoscopic activity of the disease.
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QUANTITATIVE ANALYSIS OF NUTRITIONAL RISK SCREENING TOOLS
NRS 2002 AND PG-SGA IN ONCOLOGY OUTPATIENTS
E. Justin1*, D. Mlakar Mastnak1, N. Rotovnik Kozjek1. 1Unit of Clinical
Nutrition and Diet Therapy, Institute of Oncology Ljubljana, Ljubljana,
Slovenia
* Corresponding author.
Rationale: In the clinical pathway of nutritional care for hospitalized
patients at the Institute of Oncology Ljubljana Nutrition Risk Screening
NRS 2002 (NRS 2002) has already been implemented. Now, choosing
an effective tool for nutritional screening for patients treated in our
outpatients department also becomes a key objective. The purpose of
the study was to evaluate the use of NRS 2002 and Patient-Generated
Subjective Global Assessment (PG-SGA) in outpatient department. The
goal was to determine the differences in the prevalence of patients at
nutritional risk (NR) and the usefulness of the two tools.
Methods: In one week in the 2013, 144 patients were included. The
patients were interviewed by a dietitian using NRS 2002 and PG-SGA.
In terms of the number of points acquired, patients were classified into
three categories: not at NR (PG-SGA: 0–3; NRS 2002: 0); at moderate
NR (PG-SGA: 4–8; NRS 2002: 1–2); at highNR (PG-SGA:≥9; NRS 2002:
≥3). The datawere analyzedwith the statistical program SPSS 22.0, we
used the t-test.
Results: The difference in prevalence of patients at NR was 9,6%
(p < 0,05). The prevalence by using PG-SGA was 56,2% and by NRS
2002 46,6%. PG-SGA detected 6,9% more patient at moderate NR than
NRS 2002 (PG-SGA: 24,3%, NRS 2002: 17,4%). Patients at high NR were
about one third, the difference between tools was smaller (PG-SGA:
31,9%, NRS 2002: 29,2%).
Conclusions: Although PG-SGA detected more patients at NR and
included nutritional assessment and triage for nutritional support,
NRS 2002was less time-consuming and easyer to perform as suchwas
more suitable for use in our outpatient clinics. On the basis of the
obtained results, we suggest the use of NRS 2002, but we recommend
that nutritional support should be performed as soon as patient is at
nutritional risk (NRS 2002 1-2 points).
Disclosure of Interest: None declared.
SUN-PO226
NUTRITIONAL RISK SCREENING IN ONCOLOGY OUTPATIENTS: SF
PG-SGAVERSUS PG-SGA AND NRS 2002
E. Justin1*, D. Mlakar Mastnak1, N. Rotovnik Kozjek1. 1Unit of Clinical
Nutrition and Diet Therapy, Institute of Oncology Ljubljana, Ljubljana,
Slovenia
* Corresponding author.
Rationale: Short Form Patient-Generated Subjective Global
Assessment (SF PG-SGA) is a validated tool for nutritional risk
screening (NRS). Beside being shorter than PG-SGA, it can be filled
by the patient himself. This is particularly important in situatonwith a
large number of patients in our outpatient department and lack of
medical staff. The purpose of the study was to evaluate the use of (SF
PG-SGA), Patient-Generated Substantive Global Assessment (PG-SGA)
and Nutritional Risk Screening 2002 (NRS 2002) in the outpatient
department of the Institute of Oncology Ljubljana. The goal was to
determine the differences in the prevalence of patients with
nutritional risk (NR) using all three tools.
Methods: In one week in the 2013, 144 patients were included. In
terms of the number of points acquired in NRS with all three tools,
patientswere classified into three categories: not at NR (SF PG-SGA: 0–
2, PG-SGA: 0–3, NRS 2002: 0), at moderate NR (SF PG-SGA: 3–5, PG-
SGA: 4–8, NRS 2002: 1–2) and at high NR (SF PG-SGA:≥6, PG-SGA: ≥9,
NRS 2002: ≥3).
Results: The prevalence of NR patients using SF PG-SGAwas 49,3% (at
moderate NR 18,0%, at high NR: 31,3%), using the PG-SGA 56,2% (at
moderate NR: 24,3%, at high NR: 31,9%), using the NRS 2002 46,6% (at
moderate NR: 17,4%, at high NR: 29,2%). Not at NR patients were 50,7%
using the SF PG-SGA, 43,8% using the PG-SGA and 53,4% using the NRS
2002. Between SF PG-SGA and PG-SGA, the difference in prevalence
was 6,9%, and between SF PG-SGA and NRS 2002 it was 2,7%.
Conclusions: The difference in the prevalence of NR patients between
SF PG-SGA and NRS 2002 was 2,7% especially it was small in the
moderate NR category (0,6%). But SF PG-SGA and NRS 2002 compared
with PG-SGA detected fewer all at NR patients and not included
nutritional assessment. However, SF PG-SGA in comparison with NRS
2002 may have an advantage over NRS 2002 because it includes the
assessment of patients nutritional symptoms and their physical
condition.
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CONCORDANCE OF DIFFERENT TOOLS FOR DIAGNOSIS OF
MALNUTRITION IN HOSPITALIZED PATIENTS
F.M. Silva1*, C.F. Burgel1, B.E. De Araújo1, P. Teixeira1, F.W. Rodrigues1,
V. Chites1, G.D. Carvalho2, C.B. Saragiotto3, P.V.G. Modanesi4, E. Rabito5.
1nutrition, Universidade Federal De Ciencias Da Saude De Porto Alegre,
Porto Alegre, 2nutrition, Universidade Federal do Paraná, 3nutrition, UFPR,
4Hospital of Clinics – UFPR – EBSERH, 5UFPR, Curitiba, Brazil
* Corresponding author.
Rationale: There is no international consensus on a single ‘best tool’
for malnutrition diagnosis, and new tools were proposed by different
international society of clinical nutrition recently (1–3). Considering
that the concordance of these tools with Subjective Global Assessment
(SGA) has been scarcely investigated until this moment, the aim of this
study was to evaluate the concordance of different tools for diagnosis
of malnutrition in hospitalized patients with SGA.
Methods: Cross-sectional study including Brazilian patients from two
hospitals (Porto Alegre-RS and Curitiba-PR). The inclusion criteria
were age ≥18 years, conscious and able tomove patients. Malnutrition
was diagnosed within 48 hours of hospitalization by SGA, Academy of
Nutrition and Dietetics/American Society for Parenteral and Enteral
Nutrition (AND/ASPEN), European Society for Clinical Nutrition and
Metabolism (ESPEN), and Global Leadership International
Malnutrition (GLIM) criteria. The kappa coefficient was calculated
and interpreted as follow: 0.41–0.60 moderate; 0.61–0.80 substantial;
0.81–1.0 almost perfect.
Results: 509 patients (50.3 ± 14.7 years old; 51.5% females; 52.3% from
Curitiba) were studied. The majority of patients had cancer (25.9%),
cardiovascular disease (19.6%) and gastrointestinal disorder (14.5%).
Malnutrition was identified in 33.2% of patients by SGA, 36.4% by
AND/ASPEN, 16.1% by ESPEN and 37.5% by GLIM. The concordance
between SGA and AND/ASPEN (k = 0.66; p < 0.001) and GLIM (k = 0.69;
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p < 0.001) was substantial while the concordance between SGA and
ESPEN criteria was moderate (k = 0.42; p < 0,001).
Conclusions: AND/ASPEN and GLIM criteria for malnutrition diagno-
sis had a satisfactory concordance with SGA and could be applied for
nutrition assessment of hospitalized patients.
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RISK OF SARCOPENIA AND CLINICAL OUTCOMES IN HOSPITALIZED
PATIENTS: A PROSPECTIVE STUDY
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Rationale: The risk of sarcopenia can be assessed by SARC-CalF (1), but
little is known about the prognostic value of SARC-CalF among
hospitalized patients. So, the aim of the current study was to evaluate
the association between risk of sarcopenia and clinical outcomes in
hospitalized patients.
Methods: Prospective cohort study including hospitalized patients
from five hospitals at Porto Alegre-RS. The Ethical Committee of the
hospital approved the protocol. The inclusion criteria were age ≥18
years, conscious, able to move and without oedema patients. The
sarcopenia risk was evaluated within 48 hours of hospitalization by
SARC-CalF, considering the components strength, assistance in
walking, rise from a chair, climb stairs and falls, and calf circumference
(measured using an inelastic tape at the point of greatest point).
Outcomes of interestwere admission at intensive unit care (IUC), death
and length of hospital stay (LHS) higher than nine days (categorized by
median). Chi-square and Fisher tests, and Cox regression was
performed for statistical analysis.
Results: A sample of 237 patients (54.6 ± 15.1 years; 54.8% females)
was studied. The majority of patients had cancer (51.6%), and
cardiovascular disease (18.4%). The risk of sarcopenia was observed
in 18.4% of sample. The frequency of admission at IUC (12.5% × 18.6%;
p = 0.356) and LHS≥9 (45.0% × 50.8%; p = 0.504) did not differ between
groups. The incidence of death was higher in patients with risk of
sarcopenia in comparison to patients without risk of sarcopenia
(7.5% × 1.1%; p = 0.045). In the multivariate analysis (adjusted for age,
comorbidities and stress of disease) a positive SARC-Calf increased the
risk of death in 12.78 times (CI 95% 1.29–127.11).
Conclusions: Risk of sarcopenia was associated to mortality in
hospitalized patients. The prognostic value of SARC-CaF in hospita-
lized patients requires future confirmation.
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IS THE SCREENING TOOL FOR CONTROLLING NUTRITIONAL STATUS
(CONUT) ADEQUATE FOR NUTRITIONAL SCREENING AT HOSPITAL
ADMISSION?
F.J. Vílchez-López1*, M.D.M. Roca-Rodríguez1, M. González-Pacheco2,
D. González-Duarte1, L. Larrán-Escandón1, Á. Bailén-García3,
M. Aguilar-Diosdado1. 1Endocrinology and Nutrition Department,
2Investigation Department, 3Clinical Analysis Department, Hospital
Puerta del Mar, Cádiz, Spain
* Corresponding author.
Rationale: Evaluate the prevalence of undernutrition at admission and
analyse the utility of nutritional screening system (CONUT) compared
with the nutritional assessment at admission at Hospital Puerta del
Mar (Cádiz).
Methods: Prospective cohort study including patients older than 18,
admitted to hospital for more than 3 days in 2018. A systematic
analysis of CONUT was undertaken in general blood tests analysed
during the first 3 days’ admission. Positive risk was defined by CONUT
>4. Nutritional assessment was evaluated by subjective global
assessment (SGA), dynamometry and biochemical parameters. The
relationship between CONUT result and clinical variables, and its
validity as a diagnostic test were evaluated.
Results: 468 patients included, 56.0% men, mean age 69.3 (±15.4).
95.7% admitted from Emergency, 59.2% multimedicated (taking ≥6
drugs) and 35,5% with diabetes. 65,7% presented with undernutrition
(35,1% energy, 2,8% protein and 27,8% energy-protein undernutrition):
31,7%mild, 27,0%moderate and 7,1% severe. CONUT toolwas positive in
30,2% and negative in 69.7%. Patients with CONUT positive were older.
Levels of albuminwere lower (3,1 vs 3,9 g/dl; p < 0,001) and CRPhigher
(132,3 vs 51,9 mg/l) in CONUT positive than CONUT negative. Length of
stay (LOS) was longer in CONUT positive (14.3 vs 9.9 days, p < 0.001).
5,3% of patients studied died during their admission (12,8% CONUT
positive vs 2,1% negative, p < 0.05). Linear regressionmodel confirmed
the association between CONUT positive and LOS and mortality.
Comparing with Nutritional Assessment, CONUT presented sensitivity
54,6%, specificity 91,2%, positive predictive value 84,4%, negative
predictive value 69,6% and Kappa index 0,47
Conclusions: The prevalence of undernutrition at admission is high in
our center. In our experience, although CONUT tool at admission is not
well correlated to nutritional assessment (sensitivity 54,6%, Kappa
index 0,47), it is a factor independently related to LOS and mortality
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EVALUATION OF THE PROTEIN TARGET IN DIETARY PRESCRIPTION
IN PATIENTS WITH PRESSURE ULCERS
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Rationale: Inadequate nutritional Therapy(NT) has a negative impact,
inducing weight and muscle mass loss and undernutrition. It
negatively acts on the pathogenesis and wound healing. The objective
was to evaluated the dietary prescription and protein target in patients
with pressure ulcers(PU).
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Methods: Retrospective cross-sectional data collected done by
quarterly, with adults and elderly patients admitted into a private
hospital in São Paulo, Brazil. Two audits were performed, in electronic
records among the variables were: name, age, risk of and/or presence
of PU, location and stage. In relation to PU risk, Braden Scale was
considered and, regarding the presence of PU, nursing records was
considered.
Results: This study evaluated 855 patients(47%men and 53% woman),
of which 74% were notified with nutritional risk. Audited patients and
Braden Scale, see below:
Oct/2018 Feb/2019
Risk of PU 171(42%) 181(41%)
Ulcer-free 214(52%) 257(58%)
No nursing records 26(6%) 6(1%)
High Risk 56(31%) 56(31%)
Severe Risk 27(16%) 26(15%)
There was no prescription of oral nutritional supplements(ONS) in
patients with high and severe risk of PU in the first(35%) and second
(43%) audits. The prescribed and TN infusion was 81% and 89%. It was
observed that protein prescription was adequate 57% and 65%. In
patients with NT the energy and protein goals ware reached, 72% and
74%, on the first(71%) and second(75%) audit.
Conclusions: In patients with PU, the adequacy in the protein
prescribed there was improvement in 8%, the factors that prevented
the adequacy: renal failure, gastric feeding intolerance and medical
circumstances. In patient with high and severe risk of PUs, provision of
ONS can be considered, in cases of fasting a regular evaluation to
ensure effective and early TN must be performed. An effective NT and
continuous management of indicators are relevant to insure a proper
TN, recovery and best outcome.
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DIFFERENCES IN BODY COMPOSITION BY SEGMENTAL
MULTIFREQUENCY BIOIMPEDANCE BETWEEN PATIENTS IN
ADVANCED CKD AND HEMODIALYSIS
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Rationale: The study of body composition by bioimpedance is part of
the routine routine in the area of nephro-nutrition.
The segmental bioimpedance provides us in a simple and reproducible
way the possibility of obtaining not only globalmeasurements but also
divided into 5 segments for better detection of problems.
Methods: We analyzed 276 patients with CKD × 71.64 ± 12.16, 105 in
ERCA (64 men) and 171 122 men) in HD with no difference in age
between the two groups.
Differences in body composition are established by INDBODY S10
multifrequency bioimpedance between the two groups.
Results: We found sig difference with higher value in ERCA in: ACT
(0.040), AIC (0.033), AEC (0.05), proteins (0.033), Minerals (0.020), fat-
free mass (0.003), SMM (0.034), BMI (0.05), SMI (0.048), cell mass
(0.03), basal metabolism (0.003). Analyzing by segments, therewas no
difference in the% of lean mass in the arms and legs between patients
with ACKD and in HD,% fat mass in the trunk, or in AEC/ACT between
the two groups. If we find in some segments difference in the ACT and
its distribution.
The evolution of the values at 3, 6, 9 and 12months is also analyzed. In
the SMI no significant differences are observed over time in paired
samples, if in the total bodywaterat 6 and 12months, in the case of the
cell mass, a decrease is observed in the year measurement. With this
we can both global and segmental monitor the changes in body
composition and its relationship with the binomial nutrition inflam-
mation over time.
Conclusions:
1. There are differences in some parameters of body composition
between patients in ACKD and HD.
2. The segmental distribution allows us to see the changes in
hydration in the different body segments and monitor their
resolution.
3. The monitoring over time of body composition with bioimpe-
dance allows us to detect early alterations can stop their evolution
and detecting their recovery with appropriate treatment.
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THE ASSESSMENT OF NUTRITION CARE PRACTICE BY NURSES AND
DOCTORS OF NORTH ESTONIA MEDICAL CENTRE
H.-L. Lepp1*, K. Eiche2. 1General and Oncologic Surgery, North-Estonia
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Rationale: Timely noticing of malnutrition depends on the awareness
of doctors and nurses, but nutrition care practice also relies on how it is
governed by the hospital. In order to evaluate the obstacles of
implementing recommended clinical nutrition practices in hospital
setting, the views of local medical practitioners need to be studied and
heard.
Methods: An online survey with multiple-choice questionnaire
among all doctors and nurses working in inpatient clinics in North
Estonia Medical Centre (NEMC) was carried out to evaluate their
opinions towards nutrition care practice ideal and reality in their unit
and assess their compliance with the ESPEN guidelines. Nurses and
doctors answers were compared.
The questionnaire used was composed by Danish researches group in
2004 and it is based on the recommendations in the guidelines of the
European Society for Clinical Nutrition andMetabolism (ESPEN). It has
been previously used in studies in multiple Scandinavian countries.
The translation and use of the questionnaire was approved by main
original author.
Results: 156 doctors and 607 nurses received the questionnaire via e-
mail with several reminders to respond during March and April 2017.
The total sample of responders was 93 (12.2%), of whom 26 were
doctors and 67 nurses. Most responses were received from surgical
clinic. All returned questionnaires were included to the analyses.
A difference appeared in participants’ expectations to and assessment
of current nutritional care practice in the hospital: doctors and nurses
equally (p = 0,1–0,7) complied in their opinions of appropriate
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nutrition carewith ESPEN guidelines (61–95%), but the concordance of
practices with guidelines was assessed to be very low (5,4–39,8%).
The main obstacle for compliance to nutrition care practices according
to the participants was insufficient knowledge and skills- 66% of the
participants admitted that they lack knowledge to make decisions
about clinical nutrition support. Other reasons for poor pratice were
the fear of increase in workload and of inconvenience to the patients.
One clear obstacle in implementing knowledge to practicewas also the
uncertainty of the responsibilities and role of doctors and nurses in the
process of nutrition care.
Conclusions: Although with limited value to the general overview of
the hospital medical pratitioners ́ opinions, the results of this study
clearly demonstrated the necessity to better define the responsibilities
among personnel in surgical clinic and further implement protocols
and organize trainings in nutrition care.
As the study participants, doctors and nurses equally have positive
attitudes towards ESPEN guidelines it is possible to overcome the few
obstacles that prevent best practice of nutritional care in our hospital.
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VALIDATION OF A MALNUTRITION SCREENING TOOLS FOR
HOSPITALIZED CHILDREN
H. Pars1*, A. Açıkgöz2, B. Doğanay Eroğan3. 1Nursing Faculty,
2Department of nutrition and dietetics, Hacettepe University, 3The
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Rationale: Use of malnutrition screening tools (MSTs) among
hospitalized pediatric patients is an easy method to property identify
children at risk of malnutrition. There are different tools developed in
the English language, but there are limited data available on their
validity when translated into other languages. The aim of this study
was to construct a version of the Pediatric Yorkhill malnutrition score
(PYMS), STRONG-kids, and STAMP in the Turkish language and
determine the validity and reliability of the adaptation in a pediatric
population.
Methods: The study was conducted in two stages. First, it was
developed the process of translation of the MST PYMS, STRONG-kids,
and STAMP to Turkish language. In the second stage the validity,
reliability was evaluated in the new version of the tools.
Anthropometric assessment was used as the reference standard to
evaluate the criterion validity of the MSTs. Reliability was observed
through inter-rater and intra-rater agreement. The study was
conducted by a nurse and a dietitian.
Results: A total 202 children were included in the study, 42 of whom
took part in reliability phase. The interrater agreement between one
dietitian and one nursewas kappa (κ) = 0.955 (95% CI 0.904–1.000) for
PYMS, 0.901 (95% CI 0.828–0.974) for STONG-kids, and 0.963 (95% CI
0.912–1.000) for STAMP (almost perfect agreement). Sensivity of the
PYMS, STRONG-kids, and STAMP were 96.8%,38.7%, and 77.4%,
respectively. Specificity of the PYMS, STRONG-kids, and STAMP were
63.7%, 88.9%, and 93.4%, respectively.
Conclusions: The interrater reliability of theMST PYMS, STRONG-kids,
and STAMP was one dietitian and one nurse is high. While PYMS is
more sensitivity to detect malnutrition risk than the STRONG-kids and
STAMP, STAMP is more specificity than the STRONG-kids and PYMS
according to agreement between tool results and anthropometric
assessment.
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THE EFFECT OF MNUTRI˙C SCORE AND NRS- 2002 ON PREDICTING
INTENSI˙VE CARE UNIT MORTALI˙TY IN PATIENTS WITH
HAEMATOLOGICAL CANCER
I. Ileri1, C. Ozsürekçi1, M.G. Halil1*, K. Gundogan2. 1Internal Medicine/
Geriatric Medicine, Hacettepe University, Ankara, 2Internal Medicine/
Medical Intensive Care, Erciyes University, Kayseri, Turkey
* Corresponding author.
Rationale: Haematological cancers are one of the most common
types of cancer in Turkey.. Intensive care unit follow-up and treatment
are needed in these patients who develop treatment-related
complications. The aim of this study was to investigate the effect of
mNUTRIĊ (modified Nutric score) and NRS 2002 score (Nutritional
Risk Screening-2002) on intensive care unit mortality and long-term
mortality of patients with haematological cancer aged ≥18 years.
Methods: This retrospective study was performed at the Department
of Medical Intensive Care of Erciyes University Medical Faculty. A total
of 112 patients admitted to the Medical Intensive Care Unit for 1 year
were evaluated retrospectively from their medical records. Patients
stayed less than 24 hours in ICU were not included in the study
analysis. Statistical analysiswas performed on a total of 81 records. The
endpoint of the study was intensive care unit mortality and long-term
mortality. Categorical variables were compared using the chi-square
test orMcNemar test and continuous variables using Student’s t-test or
the Wilcoxon–Mann–Whitney test. All other statistical analysis was
conducted using SPSS software (version 21.0; SPSS Inc., Chicago, IL,
USA). All significance tests were two-sided; a p-value <0.05 was
considered significant.
Results: A total of 81 people with a median age value of 56 (28) were
included in the study. The medianmNutric score of our patients was 6
(3), while the median value of NRS 2002 was 4 (1). According to the
mNutric score, the risk of malnutrition was present in 56 (69%) of our
patients, and 43 (77%) of dead patients had a risk of malnutrition and
this was statistically significant (p < 0.001). According to NRS 2002, 66
(82%) of our patients were at risk of malnutrition, and 46 (70%) of dead
patients were at risk of malnutrition and this was statistically
significant (p = 0.03).While 19 (29%) of living patients had an infection
source, 47 (71%) of dead patients had an infection source and this was
statistically significant (p = 0.006). The mNutric score (p < 0.001) and
the presence of infection source (p = 0.003)were found asmultivariate
risk factors effecting intensive care unit mortality.
MULTIV̇ARIȦTE RIṠK FACTORS
OR p CI
mNutric Score 8,1 <0,001 2–30
Infection Source 7,7 0,003 2.6–25.5
Conclusions: In our study, high mNutric score and presence of
infection sourcewere found as independent risk factors for predicting
the intensive care unit mortality of patients with haematological
cancer.
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PREVALENCE OF CANCER CACHEXIA AND MALNUTRITION IN
ONCOLOGY PATIENTS PRIOR TO TREATMENT INITIATION
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Harokopio University, Athens, 5Department of Anatomy, University of
Thessaly, Larissa, Greece
* Corresponding author.
Rationale: Cancer associated malnutrition/cachexia is a syndrome
related with increased morbidity, decreased quality of life and poor
survival. In 2018, the Global Leadership Initiative on Malnutrition
(GLIM) developed diagnostic criteria for malnutrition. Our aim was to
apply and compare the GLIM criteria with the standard international
consensus definition criteria (ICDC) as published by Fearon et al. in a
sample of newly diagnosed cancer patients.
Methods: Patients with locally advanced head and neck tumors or
metastatic primaries of any site, referred for induction/first line
therapy were eligible. Medical, dietary and weight status history were
recorded. Muscle mass was assessed by bioelectrical impedance
analysis and was also determined from the Lumbar (L3) skeletal
muscle index (SMI) by computed tomography imaging.
Results: In total 40 patients (62.5% men) with mean age 73.6 (range,
47–92) were evaluated. According to GLIM criteria 80% were
malnourished whereas according to the ICDC 77.5% were categorized
as cachectic and 7.5% as precachectic. GLIM criteria detected cachectic
patients with 96.8% sensitivity and 77.8% specificity and good strength
of agreement (SoA) (k = 0.776, p = 0.001) and also detected both
precachectic and cachectic patients with 90.9% sensitivity and 71.4%
specificity and moderate strength of agreement (SoA) (k = 0.590,
p = 0.001).
Conclusions: New GLIM criteria for malnutrition showed acceptable
ability in detecting both cancer cachexia and precachexia in this
sample of oncology patients and could be implemented in routine
clinical practice for the timely identification of malnutrition/cachexia
in cancer patients.
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EVALUATION OF MUSCLE MASS LOSS RELATED TO THE TIME OF
MECHANICAL VENTILATION, DIAGNOSIS AND AGE. IS THERE A
RELATIONSHIP?
I.H. Mazucatto1*, S. Longhi1, F. Totti1, G. Lazo1, F. Alves1, L. Lins1,
L. Sanches1. 1Hospital Samaritano, São Paulo/SP, Brazil
* Corresponding author.
Rationale: To evaluate if there is a relationship between loss of muscle
mass assessed by quadriceps ultrasound related to factors such as:
mechanical ventilation time (MV), diagnosis and age of patients in
critical units.
Methods: This is a descriptive, retrospective, quantitative and
observational study with data collected between June and August
2018 of 5 patients with orotracheal intubation (OTI) (1 female and 4
male), adults and elderly (mean age 68.2 years) hospitalized in ICU of
medium complexity of a private hospital in the city of São Paulo/Brazil.
The quadriceps thickness measurement was evaluated in 4 moments,
the first measurement being measured in up to 48 hours after OTI
and the results 3, 7 and 10 days after the initial evaluation. The
thickness measurements were measured using Campbell’s validated
ultrasound instrument and the measurement of the reference points
(1/2 and 2/3 of the iliac crest to the top of the patella) with non-
extensible measuring tape. All patients received enteral nutritional
therapy, started within 48 hours of OTI. Data were analyzed in Excel
spreadsheet.
Results: Of the 5 patients, 3 (60%) had a diagnosis related to the
respiratory system on arrival at the ICU. The mean OTI time for all
patients was 11 days, with elderly patients (mean age 77.3 years)
remaining longer on mechanical ventilation (MV) (12.7 days), all of
whomprogressed to tracheostomy. The analysis of musclemass loss in
the elderly groupwas also higher, with amean loss of 38%, beingmore
intense in patients who stayed longer in IOT (loss of 50%), while in
young patients, this mean was 10.6%.
Conclusions: The findings of this study corroboratewith research that
shows that the longer the duration of MV, the more intense is
catabolism, especially in the elderly population that has greater
anabolic resistance. The loss of muscle mass in the elderly population
and more exposed to MV demands more attention, mainly, on the
adequate protein supply in order to reduce the catabolism improving
the outcomes
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NUTRIC SCORE X NRS NUTRITIONAL RISK SCREENING. IS THERE
DIFFERENCE IN RESULTS IN THE SAME POPULATION?
I.H. Mazucatto1*, S. Longhi1, F. Totti1, F. Alves1, L. Lins1, C. Nascimento1,
A. Arrais1, T. Paiva1, L. Sanches1. 1Hospital Samaritano, SÃO PAULO/SP,
Brazil
* Corresponding author.
Rationale: NUTRIC SCORE X NRS 2002 nutritional risk screening. Is
there difference in results in the same population?
Methods: Descriptive, retrospective, quantitative, and observational
study with data from October to November 2018 of 50 patients (29
female and 21 male), adult and elderly (mean age 67 years) admitted
to the medium complexity ICU of a private hospital in the city of São
Paulo Brazil. For comparison, it was established: low nutritional risk:
NUTRIC SCORE ≤4 points and NRS ≤1 point; High nutritional risk:
NUTRIC ≥5 points and NRS ≥2 points. Data were analyzed in Excel
spreadsheet and treated statisticall
Results: The results of NUTRIC SCORE and NRS 2002 tools applied to
50 patients were compared at the same time. The primary diagnoses
involved the nervous (30%) and respiratory systems (20%). The results
showed that 23 patients (46%) were classified as low nutritional
risk, whereas NUTRIC represented 84% of the patients. In the
classification of high nutritional risk, the result was inversely
proportional, with NRS high nutritional risk 27 patients (54%) and
NUTRIC only 8 patients (16%).
Conclusions: The results showed that NRS 2002 screening was more
sensitive when compared to NUTRIC SCORE, in this population. This
result may be related to the patient profile (low and medium
complexity), being the most suitable for this institution, being easier
to apply than NUTRIC SCORE. It is important to emphasize that
nutritional risk screening, regardless of the tool used, should be
applied in order to identify the need for nutritional intervention as
early as possible in order to improve the outcomes of critical patients.
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PREVALENCE AND DETERMINANTS OF UNDERNUTRITION IN A
SAMPLE OF DUTCH COMMUNITY-DWELLING OLDER ADULTS:
RESULTS FROM TWO ONLINE SCREENING TOOLS
J. Borkent1,2*, E. Naumann1,2, E. Vasse2,3, E. van der Heijden2, M. De van
der Schueren1,2. 1Hogeschool Arnhem en Nijmegen, 2Stuurgroep
ondervoeding, Nijmegen, 3Ziekenhuis Gelderse Vallei, Ede, Netherlands
* Corresponding author.
Rationale: To increase awareness of undernutrition and to stimulate
screening for risk factors (early determinants) and risk of under-
nutrition (late symptoms) among Dutch community dwelling older
adults, a website was developed that includes information about
nutrition and healthy ageing and two self-tests. In this study the
prevalence and determinants of undernutrition in different age groups
of Dutch community dwelling older adults were studied based on
these self-tests.
Methods: SCREEN II (n = 2470) was used to asses nutritional risk
factors. This tool consists of 16 items regarding nutritional intake,
perception of bodyweight, appetite, oral health and meal
preparation. A score <54 (out of 64) indicates nutritional risk. An
adjusted SNAQ65+(n = 687) was used to assess risk of undernutrition.
This four-item tool contains questions on weight loss, appetite,
walking stairs and BMI. Differences between age-groups (65–74, 75–
84, ≥85) were tested by logistic regression.
Results: Overall prevalence of nutritional risk factors was 84.1%.
Most frequent problems were perception of own weight (62.2%), a
low intake of fruit and vegetables (67.5%)/meat(replacements)
(55.4%)/dairy products (55.3%), eating meals alone (40.7%), problems
with preparing meals (39.5%), or changes in bodyweight (38.7%).
Participants aged ≥85 scored significantlyworse on almost all items of
SCREEN II. An increased risk of undernutrition was seen in 56.8% of
older adults, whichwas higher in age-group≥85 compared to younger
age groups (p < 0.05).
Conclusions: A large proportion of older adults reported early
determinants for undernutrition, while a smaller, yet remarkable
proportion scored positive on undernutrition risk. Online self-screen-
ing is a useful, contemporary and easy accessible way to reach older
adults who are at nutritional risk. It may contribute to early
identification and prevention of undernutrition.
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FOUR CLASSICAL MALNUTRITION SCREENINIG TEST AND ESPEN
NEW DIAGNOSTIC CRITERIA OF MALNUTRITION AT HOSPITAL
ADMISSION AS PREDICTORS OF LONG-TERM (3 YEARS) SURVIVAL
J. Olivares1,2*, P. Sanchis1,2, L. Ayala2, R. Fortuny2, L. Masmiquel1,2.
1Institut d’Investigació Sanitària de les Illes Balears – IdISBa,
2Endocrinology and Nutrition, Hospital Universitari Son Llatzer, Palma
de Mallorca, Spain
* Corresponding author.
Rationale:Malnutrition is frequent at admission and increases morbi
and mortality.
Methods: We conducted a prospective study at 24 h of hospital
admission in order to assess four classical malnutrition screening test
performance (mini-nutritional assessment short form (MNA-SF),
nutritional risk screening 2002 (NRS2002), malnutrition universal
screening tool (MUST), subjective global assessment (SGA)), and
ESPEN new diagnostic criteria of malnutrition (being ‘at risk’ of
malnutrition and 1) BMI<18.5 kg/m2) or 2)weight loss >5% and BMI<20
if <70yo or weight loss >5% and IMC<22 if >70) as predictors of long
term (3years) survival.
Results:Westudied 522 patients (56.4%males, n = 294)withmean age
of 61.43 ± 17.62yo, weight 73.89 ± 15.80 kg, height 164.41 ± 9.92 cm,
BMI 27.31± 5.34 kg/m2 and recent weight loss 1.24 ± 7.08%. The overall
rate of malnutrition was 47.3% and 54.2% in patients >65yo vs 40.7% in
patients <65yo (p = 0.002). Specific rates were 29.8, 21.3, 19.5, and
18.8% for MNA-SF, NRS2002, SGA, and MUST respectively. Only 20
subjects (3.8%) were malnourished according to ESPEN criteria. In-
hospital mortality was not significantly increased in any test group.
However, there was a significantly increased mortality at 3y for
undernourished patients detected by any test 24.08% vs 9.06%
(p < 0.000) and ESPEN criteria 35% vs 15.37% (p = 0.029). The baseline
variables associated to survival at 3-years were: mean age (HR = 1.02
p = 0.001), age >65y (HR = 1.94 p = 0.004), diabetes (HR = 1.76 p =
0.017), lung disease (HR = 2.77 p = 0.001), heart disease (HR = 1.67
p = 0.001), readmissions within 1year (HR 2.77 p < 0,001), recent
weight loss >5% and BMI<20 if <70yo or weight loss >5% and IMC<22 if
>70(HR = 5.75 p = 0.003), NRS2002 (HR = 2.20 p < 0.001), SGA
(HR = 3.10 p < 0.001) and MUST (HR = 1.72 p = 0.027), any classical
test (HR = 2.90 p < 0.001) and ESPEN criteria (HR = 2.60 p = 0.016). In
multivariate analysis, SGA (HR = 1.98 p = 0.005) and recent weight loss
>5% and BMI<20 if <70yo or weight loss >5% and IMC<22 if >70
(HR = 5.32 p = 0.008) were associated with 3 years survival.
Conclusions: Malnutrition at admission is frequent. SGA and recent
weight loss combined with low BMI at hospital admission were
independently related to 3 years mortality in our cohort.
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BODYCOMPOSITIONCHANGES AFFECT RUNNING PERFORMANCE IN
A PROSPECTIVE STUDY
J.Mareschal1*,M. Delsoglio1, V.L. Karsegard1, N. Achamrah1, C. Pichard1,
C. Graf2, F.R. Herrmann3, L. Genton1. 1Clinical Nutrition, 2Rehabilitation
and palliative care, 3Rehabilitation and geriatrics, Geneva University
Hospitals, Geneva, Switzerland
* Corresponding author.
Rationale: A previous cross sectional study demonstrated that
running performance is negatively associated with fat mass index
(FMI) in both sexes and positively associated with fat-free mass index
(FFMI) in women only (1). This study aims to investigate the effect of
body composition changes on running performance.
Methods:We included runners participating to a yearly timed city run
(‘Course de l’Escalade’), older than 16 years old, who had ≥2 body
composition assessments by bioelectrical impedance analysis at this
event between 1999 and 2016. Body compositionwas calculated by the
Geneva formula (2) and converted to FFMI and FMI by dividing fat and
fat-free masses by height (m)2. Running speed (km/h) was deter-
mined, based on running distances (women: 4.8 km; men: 7.2 km)
and times. Results are shown as mean±SD. Multivariate linear mixed
regression models, adjusted for categories of age, year of measure-
ment, temperature and relative humidity, evaluated the impact of
body mass index (BMI), FMI or FFMI changes on the evolution of
running performance.
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Results: This study included 377women and 509men, totalizing 1419
and 2161 body composition measurements, respectively. At baseline,
age, BMI and running speed were: 41.1 ± 12.2 yrs, 22.1 ± 2.5 kg/m2,
10.9 km/h in women, and 42.0 ± 11.9 yrs, 24.0 ± 2.1 kg/m2, 12.9 km/h
in men.
Conclusions: Evolution of running performance over years is mainly
affected by a gain in BMI and FMI in both sexes. Runners who want to
maintain or improve their performance should avoid gaining weight
and fat mass.
Table 1
Multivariate mixed linear regression to evaluate changes in running
performance
Women (n = 377) β;
(95%CI), p
Men (n = 509) β;
(95%CI), p
BMI (kg/m2) −0.21; (−0.24, −0.17), <0.001 −0.35; (−0.38, −0.31), <0.001
FMI (kg/m2) −0.31; (−0.35, −0.27), <0.001 −0.42; (−0.47, −.38), <0.001
FFMI (kg/m2) −0.05; (−0.12, 0.02), 0.163 −0.16; (−0.22, −0.10), <0.001
Running performancewas negativelyassociatedwith an increase of BMI and FMI
in both sexes and FFMI in men.
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PREVALENCE OF MALNUTRITION IN HOSPITALIZED CHILDREN AT
ADMISSION AND DURING HOSPITALIZATION: A NATIONWIDE
MULTICENTER STUDY IN SOUTH KOREA
J.Y. Joo1*, H.R. Yang1,2. 1Pediatrics, Seoul National University Bundang
Hospital, Seongnam, 2Pediatrics, Seoul National University College of
Medicine, Seoul, Korea, Republic Of
* Corresponding author.
Rationale:Malnutrition in hospitalized children can have detrimental
effects on clinical outcomes and growth, and hospitalized patients are
at risk of malnutrition at admission and can be more malnourished
during hospitalization. The aim of the study was to investigate the
prevalence of malnutrition in hospitalized children at admission and
during hospital stay in South Korea.
Methods: Nationwide multicenter study was conducted in a total of
872 children (504 boys, 368 girls) admitted to general and tertiary
hospitals. The Pediatric Yorkhill Malnutrition Scorewas used to screen
pediatric patients at risk for malnutrition, and weight-for-height and
height-for–age z scores were used as indicators for acute and chronic
malnutrition.
Results: According to thePediatric YorkhillMalnutritionScore, pediatric
patientsathighrisks formalnutritionwere299 (34.4%)of872childrenat
the time of admission and 262 (30.9%) during hospitalization. At
admission, the prevalence of wasting (weight-for-height z score ≤1.0)
was 176 (20.3%) and stunting (height-for–age z score≤1.0)was noted in
151(17.5%). At admission, 33.4%of pediatric patients admittedatmedical
departments showed poor oral intake, compared to 15.6% in surgical
patients (p < 0.001). Pediatric patients showing poor oral intake were
significantly higher in the ICU group than in generalward andH-Oward
at admission and during hospital stay (both P < 0.001). During
hospitalization, weight loss was noted in 94 (11.2%).
Conclusions: Malnutrition was commonly observed at the time of
admission and even during hospitalization in pediatric patients. A
significant portion of hospitalized children showed poor oral intake
(medical > surgical & ICU > general ward) and weight loss during
hospital stay. Therefore, it might be crucial to screen and identify all
children at risk ofmalnutrition so that nutritional interventions can be
initiated in malnourished children.
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HAND GRIP STRENGTH AND ITS RELATIONSHIP WITH DIETARY
INTAKE FROM THE MALAYSIAN HEALTH AND ADOLESCENTS
LONGITUDINAL RESEARCH TEAM STUDY (THE MYHEART)
H.A. Majid1, A.K. Ng1*, N.N. Hairi1, M.Y. Jalaludin2, on behalf of
MyHeART study group. 1Social Preventive Medicine, 2Department of
Paediatrics, University of Malaya, Kuala Lumpur, Malaysia
* Corresponding author.
Rationale: The relationship between hand grip strength and dietary
intake in adolescents is not well understood. No cohort study
investigating the longitudinal relationship of dietary intakes and
physical activity on muscles strength among adolescents up to date.
Often, these cohort studies were analysed cross-sectionally. Therefore,
this will be the first in Asia looks into longitudinal relationship
between hand grip strength and dietary intakes (energy and
macronutrients).
Methods: A cohort study design involved 923 secondary school
children who have given consent and participated in 2012 and
returned in 2014 and 2016 data collection periods of the MyHeART
study. Hand grip strength was measured by using a calibrated JAMAR
hand grip dynamometer. Dietary intakewas collected using seven-day
diet history and was analysed by using the database from Nutrient
Composition of Malaysian Food (4th edition) and Nutritionist ProTM
software. The analyses were performed separately by gender. Linear
regression was used to examine the association between hand grip
strength and dietary intake.
Results: In this study, dietary intakes changes over the time did not
impacts on the hand grip strength for both genders. Although it was
not part of the study objectives, it was found that the changes in hand
span was found to be associated with hand grip strength for both
genders (Male: R2 = 0.389; female: R2 = 0.313). At later age (between 15
and 17-year-old), changes in hand span and % body fat were found to
be associated with changes in male’s hand grip strength (R2 = 0.326)
whereas changes in BMI and hand span were found to be associated
with changes in female’s hand grip strength (R2 = 0.206).
Conclusions: Although there was no relationship found between
dietary intakes and hand grip strength, it is important to focus on
improve the provision of nutrition strategies for adolescent muscular
skeletal health.
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RESULTS OF A SURVEY ON THE QUALITY OF THE BASAL DIET IN
HOSPITALIZED PATIENTS AND THEIR RELATIONSHIP WITH THEIR
NUTRITIONAL STATUS
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Rationale: One of the indicators of quality of the diet offered to hospi-
talized patients is conducting a survey of the patients themselves. The
answers can be influenced by multiple factors. We explore the
influence of the patient’s nutritional status on some of the responses.
Methods: A satisfaction survey of the diet is offered to hospitalized
patients who are on a regulardiet. These patients are selected because
it is a non-therapeutic diet and therefore its quality does not depend
on the underlying pathology. General assessment, presentation,
variety, quantity and temperature are requested. In addition, nutri-
tional assessment was performed with MNA-SF, calf circumference,
triceps skinfold, arm circumference, weight loss, hand strength and
bioelectrical impedance. Chi square and ANOVA are assessed.
Informed consent is requested.
Results: 1) Of the 654 hospitalized patients, 132 patients (20.18%)
(57.6% men, mean age 66.9 +15 years) were on a regular diet. 56.8%
are from medical areas and 43.2% from surgical areas. The average
number of days admitted was 10.93 ± 12.9. 2) The good or very good
valuation in general is 71.4%, presentation 85.7%, variety 81.7%,
temperature 84%, but consider that the amount was too much 50%. 3)
They recognize that 35.4% eat half or less of the ration and according
to MNA-SF, 2.4% are malnourished and 29.7% are at risk of
malnutrition. 4) Patients who reported that the quantity offered
was too much, 40.8% are at risk of malnutrition and 5.3% are
malnourished. 5) Comparison between those who consider that the
amount of food is too much compared to those who consider it
adequate, those who report that it is too much are older (p: 0.0001),
lower calf circumference (p: 0.01), worse score in MNA (p: 0.01) and
lower strength of the hand (p: 0.0001). 6) The muscle mass
measured by bioimpedance was lower in the group that considered
that the quantity of the food offered was too much but without
statistical significance.
Conclusions: The regular diet is well considered in the hospital and a
high percentage of hospitalized patients consider that the quantity
offered is excessive, but they are the oldest and worst nourished so it
should not consider reducing the food rations offered.
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SERUM LEPTIN LEVELS IN HEALTHY VEGETARIAN AND MEAT-
EATING WOMEN
P. Gogga1, A. S ́liwińska2*, N. Szupryczyńska1, P. Jabłońska3,
S. Małgorzewicz2, Z. Kochan1. 1Department of Nutritional
Biochemistry, 2Department of Clinical Nutrition, 3Department of
Biochemistry, Medical University of Gdańsk, Gdańsk, Poland
* Corresponding author.
Rationale: Appropriately planned vegetarian diet is not only con-
sidered as nutritionally adequate, but also healthful – its positive role
in prevention and treatment of overweight and obesity has been
proven widely. Leptin, hormone secreted from the adipose tissue,
regulates appetite and is deeply involved in the maintenance of
energetic homeostasis – too high levels of the adipokine result in
excessive body fat. Leptin concentrations correlate positively with the
number and size of the adipocytes, but certain diet components
presumably also play a role. It is well established that people whose
diet is meat-free have lower BMI and body fat. In this study we aimed
to evaluate serum leptin concentrations in healthy lacto-ovo-vegetar-
ians, vegans and control subjects with normal BMI.
Methods: Leptin levels were investigated in 105 female volunteers –
39 vegans, 42 lacto-ovo-vegetarians and 24 omnivores. All women
had – on average – the same BMI, andWHR. For examination of serum
leptin levels immunoenzymatic test (ELISA) was used. Calculations
weremade in Statistica 12 (Statsoft). Serum leptin concentrationswere
compared using Kruskal-Wallis test.
Results: Statistically significant differences in medians have been
observed between omnivores and both plant-based diet groups –
meat-eating subjects had higher serum levels of the hormone
(H = 13.22, p = 0.001).
Conclusions: These results show benefits from adopting diets
excluding meat. The further step of the study encompasses analysis
of 24-h diet recalls and dietary records made by participants, in order
to identify potential diet factors responsible forobserved differences in
leptin levels.
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CROATIAN NUTRITIONAL SCREENING OF COPD PATIENTS
I. Markelic1́, T. Jalušic ́ Glunčic1́, S. Škrinjaric-́Cincar2, G. Petrovic2́,
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Dugac1,7. 1Clinical department for respiratory diseases, University
Hospital Centre Zagreb, Zagreb, 2Clinical department for respiratory
diseases, University Hospital Centre Osijek, Osijek, 3Department for
respiratory diseases, Special Hospital for Lung diseases, Zagreb,
4Department for respiratory diseases, General Hospital Zadar, Zadar,
5Department of Pulmonology and Immunology, General Hospital
Dubrovnik, Dubrovnik, 6Department of biophysics, Faculty of Pharmacy
and Biochemistry, University of zagreb, 7University of zagreb, School of
medicine, Zagreb, Croatia
* Corresponding author.
Rationale: The aim of this study was nutritional screening of COPD
patients as well as their demographic characteristics. We have
evaluated relationship between body mass indeks (BMI), pulmonary
function results, six minute walk test (6MWT) and Bioelectrical
impedance analysis (BIA) variables – fat free mass (FFM), sarcopenic
indices (SI), phase angel (PA) and fat free mass index (FFMI).
Methods: This was a population-based epidemiologic study con-
ducted in three Croatian cities. The study sample included COPD
patients. Weight and body composition were measured barefoot in
lightweight indoor clothing; PA, SI, FFM were determined using a BIA.
Results:We have analysed data of 151 COPD patients, 93 male (61.6%)
and 58 female (38.4%), mean ± SD baseline age 65.68 ± 8.5. Mean ± SD
percentage of FEV1, men vs women, was 50.5% ± 20.41 vs 59.56% ±
24.91. Mean ± SD 6MWT,men vs women, was 383.6 ± 113.5 mvs 399 ±
107.4 m. Mean ± SD BMI was 26.64 ± 5.508 kg/m2, mean ± SD FFM,
men vs women, was 63.62 ± 10.53 kg vs 46.91 ± 8.22 kg, mean ± SD PA,
men vs women, was 5.89 ± 1.52 vs 5.88 ± 1.96 and mean ± SD for FFMI,
men vs women, was 20.87 kg/m2 ± 3.043 vs 17.85 kg/m2 ± 3.103. Mean
SI for both man and womanwas 7.77 ± 1.428. Further analysis showed
no significant correlation of BMI with FEV1(r = 0.066, p = 0.427) but it
showed significant negative correlation with 6MWT (r =−0.186,
p = 0.023). FFMI showed no significant correlationwith FEV1 (r = 0.132,
p = 0.112) and 6MWT (r =−0.083, P = 0.311). There was also no
significant correlation between PA and SI with FEV1 (r = 0.103,
p = 0.217, r = 0.121, p = 0.147) and with 6MWT (r =−0.003, p = 0967,
r =−0.103, p = 0.21).
Conclusions: We have presented first evaluation of nutritional status
on national level of COPD patients in Croatia. These preliminary results
point towards the importance of an interdisciplinary approach while
assessing COPD patients. Including more patients of various nutri-
tional status is necessary to confirm these findings.
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PREVALENCES OF BULIMIANERVOSA ANDBINGE EATINGDISORDER
AMONG A SAMPLE OF LEBANESE CHILDREN AND YOUNG
ADOLESCENTS
A. Aoun1*, J. Dib1. 1Notre Dame University – Louaize, Zouk Mosbeh,
Lebanon
* Corresponding author.
Rationale: Childhood and adolescence are critical periods of neural
development and physical growth. Malnutrition and other complica-
tions resulting from eating disorders (ED) may have severe conse-
quences on health. The objective of our study was to examine the
prevalences of bulimia nervosa (BN) and binge eating disorder (BED)
among children and young adolescents in several Lebanese schools.
Methods: Our study was conducted on a convenience sample of 253
students (54.5% males and 45.5% females), aged between 8 and 13
years, recruited from private Lebanese schools between February and
June 2018. Every student was interviewed to collect information about
sociodemographic factors and health characteristics. The DSM-5
criteria were used to examine the prevalences of BN and BED.
Results: The prevalences of BN and BED were 1.18% and 4.74%
respectively. The prevalences of overweight and obesity were 13.83%
and 10.67% respectively. Around 55.3% of the participants bought fast
food more than 3 times/week from school cafeterias. Almost the third
(32.06%) of students spent between 2 and 5 hours/day in front of a
digital device.
Conclusions: Many children and young adolescents suffer from ED
that can lead to serious future health problems.
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CHILDHOOD OBESITY RISK AND ITS ASSOCIATION WITH EATING
AWAY-FROM-HOME
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H. Nogueira1, V. Rosado-Marques5, C. Padez1. 1Research Centre for
Anthropology and Health, University of Coimbra, Coimbra, Portugal,
2Department of Pediatrics, Federal University of Paraná, Curitiba, Brazil,
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Rationale: Considered the epidemic of the XXI century, childhood
obesity, is a serious public health problem. Among other biological and
behavioural factors, paediatric obesity has become increasingly related
to eating away-from-home. This study examined the association
between childhood obesity, children’s meals and eating out in three
types of restaurants (traditional Portuguese food restaurant, fast food
restaurant and snack bar).
Methods: A representative sample of Portuguese children (5706 boys
and 5950 girls aged 6–11 years) was used for this analysis and an
ethnographic studywith 233 interviews of the owners of snack bars in
a Portuguese city (Coimbra). Weight and height were measured, and
the body mass index was consequently calculated; the obesity was
defined using the International Obesity Task Force cut-offs. A question-
naire was filled out by their parents to survey on their family
characteristics and the children’s nutritional behaviours. Logistic
regression analyses were performed, adjusted for age, the fathers’
and mothers’ levels of education and obesity of the fathers and
mothers.
Results: Overweight/obesity values were higher in children whose
father or mother is obese than in children whose parents are not
overweight/obese. Findings revealed a statistically significant
association between obesity and eating out at snack bars in boys
(Odds Ratio = 1.21; 95% Confidence Interval = 1.03–1.43; p = 0.03).
Conclusions: The present study shows that eating out at snack bars
may be a risk for children’s health because those who eat out at these
food establishments have a 21% higher risk of being obese than those
peers who do not eat out at snack bars. The results indicate the need
for designing public health strategies directed toward this type of food
establishment with the purpose of providing healthier meals.
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IMPLEMENTING AND PILOT TESTING OF A CUSTOMIZED
INTERVENTION TO INCREASE PHYSICAL ACTIVITY AND HEALTHY
EATING AMONG PRESCHOOL CHILDREN: A RANDOMIZED
CONTROLLED TRIAL
A. Mehdizadeh Hakkak1*, M. Nematy2, M. Khadem-Rezaiyan3,
A. Norouzy1, M.A. Sardar4, H. Vatanparast5. 1Nutrition, 2Metabolic
Syndrome Research Center, 3 Community Medicine and Public Health,
4General Courses, Mashhad University of Medical Sciences, Mashhad,
Iran, Republic of Islamic, 5College of Pharmacyand Nutrition, University of
Saskatchewan, Saskatoon, Canada
* Corresponding author.
Rationale: The World Health Organization has introduced non-
communicable diseases (NCDs) as the major health challenge in 21st
century and emphasizes the need for urgent action to prevent and
control NCDs. The main objective of this study was to customize and
implement a multi-level multi-componemt intervention program and
to evaluate its effects on nutrition- and physical activity-related
outcomes in preschool children.
Methods: In a pilot randomized controlled trial, 202 preschool aged
children (4–6 years) in four cluster randomized preschools from high
and middle socioeconomic levels in Mashhad, Iran, were enrolled and
entered into two groups of intervention and control. A customized
intervention program, consisting of six interlinked components
(resources for children, implementation guide, training and monitor-
ing, parent engagement, building partnership, communication and
knowledge exchange)was conducted in the intervention group for five
months. Quality of life, anthropometric indices, nutrition risk, healthy
eating index, subjective and objective physical activity level and
children attraction to physical activity, as well as feasibility of the
intervention program were evaluated.
Results: A total of 193 children (95 in intervention and 98 in control
group) remained for analysis. The BMI z-score increased in under-
weight children (ANCOVA, p = 0.01), and remained unchanged in
overweight children of intervention group compared to control group
(ANCOVA, p = 0.84). Nutrition risk score insignificantly decreased
among intervention group (Paired T-test, p = 0.72) and increased
among control group (Paired T-test, p = 0.29), and was not significant
in between-group analysis (ANCOVA, p = 0.43), while healthy eating
index significantly increased in underweight (ANCOVA, p = 0.04).
Objective physical activity level increased significantly in physical
activity level among intervention group (ANCOVA, p < 0.001). No
improvements were detected in quality of life.
Conclusions: This program is feasible and effective in promotion of
healthy eating and physical activity among preschool children in a
nutrition transition context. Further surveys with qualitative
approaches as well as studies with longer intervention and short-
term and long-term follow-up period is highly recommended.
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HOW THE NUTRITIONAL RISK IN HOSPITALIZED PATIENTS
DETERMINES THE CUSTOMIZATION DIET AND LENGTH OF STAY: A
RETROSPECTIVE STUDY
C.A. Santos1*, A. Fonseca2, A. Almeida2, C. Lopes2, F. Oliveira2, M. Coito2.
1GENE – Enteral Nutrition Group, 2Hospital Garcia de Orta, Lisboa,
Portugal
* Corresponding author.
Rationale:Malnutrition is common in hospitalized patients as a cause
and/or consequence of disease. It is associated with morbidity and
mortality, length of stay, and associated health costs. The prevalence
still high, 20–50%, depending on assessment criteria, malnutrition
definition, and screening tools used. Hospitalized patients should be
screened for nutritional risk and according to the ESPEN recommen-
dations the NRS-2002 must be used in all hospitalized patients.
Our aimwas to compare the nutritional risk at the beginning and end
of hospitalization period (discharge or death); compare NRS-2002
initial score with underlying disease, length of stay, proposed diet and
clinical outcome; correlate NRS-2002 score at the moment of
discharge with length of stay and proposed diet.
Methods: Observational retrospective analytic study. Included hospi-
talized patients from every ward in Garcia de Orta Hospital (except
ICU, pediatrics and pregnant patients), age ≥ 18 years and admitted
during 2018
Results: 2838 patients, 1525 male, age 65.7 ± 17.2 years [18–101] and
length of stay 16.9 ± 18.9 days [1–278]. Causes to hospitalizations:
cancer, pneumonia, stroke and decompensated heart failure. Proposed
diet at admission: general meal (28%) and modified soft meal (14%).
Proposed diet at discharge: customization diet (39%) and EN/PN
(26.6%). For initial scores ≥3 (1413 patients) we found a positive,
statistically significant correlation with customization of diet during
hospitalization and length of stay until themoment of death (p < 0.01).
Conclusions: NRS 2002 assessment upon hospital admission is
fundamental for early identification of nutritional risk, with implica-
tions in length of stay and clinical outcome, allowing for appropriate
nutritional support with diet customization, decreasing hospital stay
and improving nutritional status and clinical outcome.
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HEALTH AND NUTRITIONAL MANAGEMENT IN THE UNEXPECTED
DISASTER THROUGH THE CONCEPT OF NST
C. Mihara1*, H. Sato1, A. Sukekane2, N. Yuhki3. 1Neurosurgery,
2Rehabilitation, 3Nutrition, Hibino Hospital, Hiroshima, Japan
* Corresponding author.
Rationale: A small town, where the author lives, was hit by the debris
flow disaster caused by a local heavy rainfall in the summer of 2018.
Fortunately, therewas no personal injury such as death ormissing, but
the residential area was surrounded by much amount of mud and
isolated from the near towns for 6 days. As the town’s ViceMayer, I had
to manage the health of the residents with removing soil and so on.
Methods: Using the concept of NST, we decided role allotment
according to occupation of the residents. As for, medical care workers
managed nutrition and support to the elderly. City office workers
responded to government administration, teachers responded to the
children, civil engineers worked to remove soil, etc. After that, we
carried out a questionnaire to the residents and conducted an
interview survey about their diet and health condition.
Results: Responseswere obtained from54 people in 17 households. 20
males and 34 females, with an average age of 46.3 years old. About
nutrition, 70% answered ‘Yes’ for cooking. In addition, 76% answered
‘Yes’ as to whether they have consumed a sufficient amount of food.
About the contents of meals, 41% of retorts and frozen foods, 18% of
lunch boxes,13% of instant foods,15% of not havingmuch appetite and
not eating very much, and 13% of people who had regular meals.
Nutritionally, it was rich in carbohydrates, and only 30% of people
could eat vegetables and meat each. On health, there were no direct
effects (such as injuries) from the disaster, but thereweremanymental
stresses such as anxiety and sleeplessness, and back pain due to work
without heavy equipment.
Conclusions: In the disaster site, the concept of ‘multi-professional
nutritional assessment, nutritional management plan, implementa-
tion, re-planning’ cultivated by NST activities should be ‘conduct
assessment, health and living environment improvement planning,
implementation, by carrying out the ‘plan’ flow. It was very useful for
keeping the government’s response in a small but isolated situation
without causing a major accident or illness. At any disaster sites, it is
important to share information and unify policies regardless of the
scale.
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EAT TO DEATH – FEEDING THE PATIENT AT THE END OF LIFE – A
HOLOCAUST PERSPECTIVE
D. Weiner1*. 1Sheba Medical Center, Ramat Gan, Israel
* Corresponding author.
Rationale: The issue of artificial feeding at the end of life is complex
and sensitive. The Dying Patient Act, Israel 2005 established the legal
arrangement on this issue, however the dilemmas of how to treat the
feeding of the dying patient, still preoccupies doctors, nurses,
dietitians, social workers as well as patients and their families. The
question arises whether the Dying Patient Act in Israel was influenced
by the Holocaust, andwhether the difficulty of caregivers in the field is
based on the national memory of the Holocaust.
Methods: In this presentation, I will address the physiologically and
nutritionally relevant information and clarify the provisions of the law
on the subject of feeding at the end of life and the rationale behind it,
while addressing similar aspects and dilemmas during the Holocaust.
Results: The ethical approach to this issue in Israel is highly influenced
by the Holocaust memory of starvation and consequence death. The
famous images of malnourished survivors after the war is almost
genetically imprinted in the Jewish memory. Together with Jewish
perspectives on end-of-life care, feeding at the end of life becomes a
major dilemma in Israel.
Conclusions: While Jewish tradition maintains that human life is of
infinite value and that its preservation and extension overrides every
other religious imperative, relieving pain and allowing for the soul’s
peaceful departure are also valueswell-established in Jewish tradition.
Of course, there is a moral distinction between hastening death and
removing obstacles to its natural progression, but in practice, the
difference is not always easy to discern. Artificial feeding is a treatment
designed to provide the patientwith the basic needs of food and fluids,
which without it is impossible to exist, and as such, preserves life as
long as it lasts naturally. Nevertheless, providing these needs through
feeding tubes is perceived as an artificial means of prolonging life and
some see it as a medical treatment like any other treatment. Most
Orthodox authorities generally consider nutrition and hydration, even
if artificially provided by a feeding tube, to constitute essential human
needs that should never be discontinued as long as they are effective.
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SWISSHPN-II STUDY: LONG TERM CHALLENGES AND
COMPLICATIONSHOME PARENTERAL NUTRITION
E. Reber1*, S. Mühlebach2, Z. Stanga1. 1Departement for diabetes,
endocrinology, nutritional medicine and metabolism, Bern University
Hospital, Bern, 2Department of Clinical Pharmacy and Epidemiology,
University of Basel, Basel, Switzerland
* Corresponding author.
Rationale: The incidence of home parenteral nutrition (HPN) for
adults in Switzerland is about 4 per 1 million inhabitants per year1.
Although necessary, no representative national registry exists to date
to compare and evaluate HPN treatments with other countries and
healthcare systems. The prospective SwissHPN-II study implements a
first study from 2013/20141.
The study aimed to characterize adult Swiss HPN-patients, their
underlying diseases, HPN indications and complications, and living
conditions. This preliminary study evaluation after two years focused
on PN catheters-related complications and PN regimens used.
Methods: Data from a structured questionnaire filled every 6 months
over two years by the patient and the treating physician of 70 HPN-
patients (50% women) were analyzed.
Results: The proportion of central venous accesses were: Hickmann
(54%), Port-a-Cath (29%), and PICC (17%). Except two, all patients were
infused with commercial multi-chamber all-in-one PN admixtures.
Most patients (56%) manage HPN administration themselves or with
help of family members. Most prevalent underlying diseases are
cancer (30%), bariatric surgery (11%), and Crohn’s disease (10%).
Mechanical and infectious catheter-related complications were
experienced by 66% and 36% of the patients, respectively. Catheter
thrombosis occurred in 14% of the patients.
Conclusions: The larger HPN-patient number compared to SwissHPN-
I (+112%) gives a representative picture of the adult Swiss HPN cohort.
Oncologic patients account for only one third. Mechanical complica-
tions affected every third patients while infectious complicationswere
seen in two thirds of the patients. Venous thrombosis occurred in
every sixth patient. More comprehensive data will be presented after
completion of the data analysis.
Reference
1. Aeberhard C et al. Ann Nutr Metab 2015; 67: 210–217.
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IMPORTANCE OF SMI AS A PARAMETER OF MUSCLE MASS IN
PATIENTS WITH CKD
G. Barril1*, A. Nogueira1, G. Alvarez1, B. Santos1, J.A. Schez Tometo1.
1Nephrology, Hospital Universitario de la Princesa, Madrid, Spain
* Corresponding author.
Rationale: Chronic kidney disease produces changes in the skeletal
muscle that can lead to sarcopenia, which increases in advanced ages.
It is difficult to agree on the method of assessing the loss of muscle
mass and SMI appears by BIA as a muscle marker.
Methods: We studied 200 patients with CKD, 74 with ERCA in one
center and 125 with HD in 2 different units. 71.9% men, total age
71.5 + 12.3 years.
We evaluated the skeletal SMI value by bioimpedance and correlated it
with strength, muscle, fat mass, lean mass and total muscle and
segmental by INDHODY S10 multifrequency bioinpedance as well
as visceral proteins, PCR, Hb and muscle strength by Hand grip
strenght.
Results:xSMI in thepatients analyzedwas7.39 ± 1.19 inmenand6.54±
3.90 in women. xSMI ACKD 7.64±3.46 and in HD 6.86 ± 1.15 (p0.023).
We found significant direct correlation in men between SMI and left
dynamometry (0.02), right (0.08), lean mass in arms and legs (0.000),
skeletal muscle (0.000), BMI (0.000), inverse with age (0.000)). Not
significant with albumin, prealbumin, PCR and B2microglobulin, MIS,
VGS or Hb, ratio ECW/TBWA in arms.
We found significant direct correlation in women between SMI and
skeletal musclemass, leanmass in arms and BMI (0.000), inversewith
age, rest of non-significant parameters.
Analyzing according to the ERCA and HD groups, we observed the
same result in ACKD as in the global group ofwomen,with a significant
direct correlation between SMI between right and left (0.000) and
indirect MIS (0.000).
Conclusions:
1. SMI appears as a good marker of both overall and segmental
muscle mass.
2. It correlates with parameters of skeletal muscle mass and muscle
strength.
3. There are differences between the group of Advanced CKD andHD
as well as between men and women
Disclosure of Interest: G. Barril Speakers Bureau of: ABBOT, Nutricia,
Viphor Fresenius, A. Nogueira: None declared, G. Alvarez: None
declared, B. Santos: None declared, J. A. Schez Tometo: None declared.
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PREVALENCE OF NUTRITION-RELATED ORAL HEALTH PROBLEMS IN
THE DENTAL CARE PRACTICE
H. Kuiper1, M. Appels1, T. Nijman1, G.H. Van den Berg1*. 1Department of
Nutrition and Health, Han University of Applied Science, Nijmegen,
Netherlands
* Corresponding author.
Rationale: In this cross-sectional study, we aimed to evaluate
the prevalence of nutrition-related oral health problems (NR-OHP)
in general dental care practice. Oral health problems related to
nutritional intake is a risk for chronic diseases like obesity, heart
disease, cancer and diabetes. Also, dietary imbalance is a risk factor
for tooth decay and periodontal diseases. Collaboration between
dietitians and dentists may improve quality of care for patients with
NR-OHP. Nutritional assessment and diet treatment is essential in
case of noncompliance, readmission or comorbidities. Knowledge
about the prevalence of NR-OHP in dental care practice is the first
step to collaborate in nutritional and dental care.
Methods: All 1181 visitors (aged 42,4 ± 21,1 years) of the general
dental care practice Stichting Tandartsen Centrum Deventer, The
Netherlands, were screened on six NR-OHP from November 19 to 30
November 2018. Ten dentists performed clinical examination using a
checklist developed by the researchers following DPSI criteria. Before
data collection, the dentists were educated how to use this checklist.
Data collected were age, active dental caries, tooth erosion, gingivitis,
periodontitis, oral ulcers and xerostomia.
Results: According to the diagnostic criteria of six NR-OHP, 75,7% of
the visitorswere classifiedwithNR-OHPand 24,3% did not have an oral
health problem. 49,3% of all visitors had gingivitis, 23,4% active dental
caries and 18,8% periodontitis. Xerostomia, tooth erosion and oral
ulcers had a prevalence of 3,7, 3,2 and 0,9%. 54,1% had one of the six
NR-OHP, 19,6% had two and 1,9% multiple problems.
Conclusions: Three-quarter of dental care practice visitors have NR-
OHP and one out of five visitors have multiple OHP related to dietary
intake. Gingivitis, dental caries and periodontitis are the most
common oral health problems that may need nutritional care next to
dental care.
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DIETARY PROTEIN INTAKE AND HAND GRIP STRENGTH AMONG
ADOLESCENTS: FINDING FROM MALAYSIAN HEALTH AND
ADOLESCENTS LONGITUDINAL RESEARCH TEAM STUDY (MYHEART)
H.A. Majid1*, A.K. Ng1, N.N. Hairi1, M.Y. Jalaludin2, on behalf of
MyHeART study group. 1Social Preventive Medicine, 2Department of
Paediatrics, University of Malaya, Kuala Lumpur, Malaysia
* Corresponding author.
Rationale: Efforts to understand the dietary especially protein
influence hand grip strength in adolescents could help develop early
strategies to prevent adverse health-related outcomes such as
cardiovascular diseases. Therefore, this study attempt to examine the
high biological value protein intake and hand grip strength among
adolescent.
Methods: The data was analysed cross-sectionally based on 973
adolescents, aged 17-year-old on-going secondary schooler (male =
333; female = 640) who have participated in the MyHeART. The
details of the protocol of the study was published previously (1).
Hand grip strength was measured with calibrated JAMAR hand
dynamometer. Dietary intake was collected using seven-day diet
history and was analysed by using the database from Nutrient
Composition of Malaysian Food (4th edition) and Nutritionist ProTM
software. The analyses were performed separately by gender. Hand
grip strength was categorised into tertile and ANOVA was used to
examine the association between hand grip strength and dietary
protein intake.
Results: Male in all tertiles consumed approximately 55% of high
biological value protein (T1:37 g; T2:41 g; T3:40 g). Similar finding
was found for female (T1:32 g; T2:34 g; T3:33 g).
Conclusions: This study suggest no relationship between high
biological value protein intake and hand grip strength for both gender.
Reference
1. Hazreen MA, Su TT, Jalaludin MY, Dahlui M, Chinna K, Ismail M,
et al. An exploratory study on risk factors for chronic non-
communicable diseases among adolescents in Malaysia: overview
of the Malaysian Health and Adolescents Longitudinal Research
Team study (TheMyHeARTstudy). BMCPublic Health. 2014;14 Suppl
3:S6.
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THE EFFECT OF WOLFFIA GLOBOSA DUCKWEED, A GREEN AQUATIC
PLANT, ON POSTPRANDIAL GLYCEMIC RESPONSE; A RANDOMIZED
CROSSOVER CONTROLLED TRIAL
H. Zelicha1*, on behalf of DIRECT PLUS Team. 1Department of
Epidemiology Faculty of Health Sciences, Ben Gurion University, Beer
Sheva, Israel
* Corresponding author.
Rationale: We aimed to compare the postprandial and overnight
glycemic response using a novel green aquatic plant thought to
provide a dietary source for high-quality protein, with a dairy shake.
Methods: This is a randomized controlled crossover trial among
twenty abdominally-obese participants (age = 51.4years; fasting-
plasma-glucose = 110.9 mg/dL), who were allocated to replace dinner
with either, first, a green shake containing Wolffia globosa duckweed
(Mankai:specific-strain), or an iso-carbohydrate/protein/calorie yogurt
shake. A two-week flash-glucose-monitoring-system was used to
assess post-meal glucose dynamics. We further obtained from each
participant dietary/daily-activity/satiety-scale/sleep logs.
Results: Wolffia globosa elicited a lower postprandial glucose peak
compared to yogurt (Δpeak = 13.4 mg/dL vs. 19.3 mg/dL; p = 0.044),
which occurred later (77.5 min vs. 59.2 min; p = 0.037) and returned
faster to baseline glucose levels (135.8 ± 53.1 min vs. 197.5 ± 70.2 min;
p = 0.012). The mean post net-incremental-area-under-the glucose
curve (netAUC) was lower with Wolffia globosa up to 60 and 180
minutes (netAUC60min:185.1 ± 340.1 mg/dL*min vs. 441.4 ± 336.5
mg/dL*min; p = 0.005; netAUC180min:707.9 ± 1428.5 mg/dL*min
vs.1576.6 ± 1810.1 mg/dL*min; p = 0.037). Wolffia globosa based shake
replacing dinner resulted in lower next-morning fasting glucose levels
(83.2 ± 0.8 mg/dL vs. 86.6 ± 13 mg/dL; p = 0.041). Overall, postprandial
glucose levels from the shake administration until the next morning
were lower in theWolffia globosa green shake compared to the yogurt
shake (p < 0.001).
Conclusions:Wolffia globosa duckweed, naturally rich in dietary fibers
and polyphenols, may serve as an emerging alternative plant protein
source with potential beneficial postprandial glycemic effects.
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PREVALENCE OF THE SARCOPENIA AMONG UNDERNOURISHED
PATIENTS WITH CACHEXIA AND DISEASE-RELATED MALNUTRITION
I. Khoroshilov1*, S. Ivanov2. 1Clinical Nutrition, North-Western state
medical university named after I.I.Mechnikov, 2Gastroenterology, Pavlov
First Saint Petersburg State Medical University, Saint-Petersburg, Russian
Federation
* Corresponding author.
Rationale: Estimate of the sarcopenia prevalence among patients with
cachexia and disease-related malnutrition
Methods: 64 patients (30 men, 34 women) with undernutrition
(BMI less than 18.5 kg/m2) held the treating in 2012–2018 were
included into retrospective analyze. Sarcopenia was identified by
criteria suggested G. Biolo et al. (2014): fat-free mass index (FFMI) less
than 17 kg/m2 for men and FFMI less than 15 kg/m2 for women.
Bioelectrical impedance analysis (BIA) and dual energy X-ray
absorptiometry (DXA) were used for FFMI evaluating. Cachexia was
determined in patients with systemic inflammation (C-reactive
protein etc.) and body mass index (BMI) less than 17 kg/m2 and
weight loss greater than 10%, in patients with BMI between 17 and
18.5 kg/m2, precachexia established.
Results: It has been found that FFMI in the patients with cachexia and
precachexia with inflammation (cancer, Crohn’s disease, ulcerative
colitis, sepsis etc.) were 13.96 ± 1.4 kg/m2, particularly 13.5 ± 0.47 kg/
m2 in 12 women and 14.3 ± 0.49 kg/m2 in 10 men. Sarcopenia was
found at all of 22 patients with cachexia and precachexia (100%). At 42
patients with chronic and acute disease-relatedmalnutrition (without
inflammation) FFMI were 13.7 ± 0.4 kg/m2, particularly 13.7 ± 0.46 kg/
m2 in 23 women and 13.7 ± 1.2 kg/m2 in 19 men. In patients with
malnutrition (without inflammation) sarcopenia had been observed
in 30 persons (71%). Significant differences in FFMI were found
between patients with sarcopenia but without inflammation (FFMI
was 12.68 ± 0.49 kg/m2) and patients with sarcopenia combined with
cachexia (P < 0.05).
Conclusions: Sarcopenia is observed at all of patients with cachexia
and precachexia. Among patients with undernutrition without
inflammation the sarcopenia was observed at 71% of them.
Reference
Biolo G., Cederholm T., Muscaritoli M. Muscle contractile and
metabolic dysfunction is a common feature of sarcopenia of aging
and chronic diseases: from sarcopenic obesity to cachexia. Clin. Nutr.
2014; 33 (5): 737–748.
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CENTRAL VENOUS CATHETERS INFECTIONS RELATED TO
PARENTERAL NUTRITION PROVISION
A. Hernández-Moreno1*, L. González-Roza1, B. Pintor-De la Maza1,
I. Cano-Rodríquez1, M.D. Ballesteros-Pomar1. 1Endocrinology &
Nutrition, Complejo Asistencial Universitario de León, León, Spain
* Corresponding author.
Rationale: Infections are one of the most common complications of
central venous catheters (CVC) used to provide parenteral nutrition.
Methods: We review all CVC used for parenteral nutrition supply in
our Hospital during 2014 and 2018 in order to compare the causes of
CVC removal, the rate of blood culture and catheter tip culture
requested, the frequency of CVC infections (defined as positive blood
and/or catheter tip cultures), the pathogenic microorganisms involved
in case of infection and the duration of parenteral nutrition. Moreover,
we look for factors conditioning a higher risk of CVC infection.
Results: We analyzed 332 CVC used for parenteral nutrition in 2014
and 248 used in 2018. There were no significant differences on
patients’ baseline characteristics among 2014 and 2018, except for
nutritional status: rate of malnutrition was higher in 2014 (91.6% vs
79.0%; p < 0.001). Mean duration of parenteral nutrition was 11 (IQR
93) days on 2014 and 10 (IQR 136) days on 2018 (p = 0,049).
In 2014, the proportion of CVC removed because of the presence of
fever was higher than in 2018 (21.8% vs 18.6%), and also the rate of
catheter tip cultures requested (40.7% vs 20.85; p < 0.001).
Confirmed Infection related to CVC used for parenteral nutrition
supply was more prevalent in 2014 than in 2018 (34.0% vs 20.6%;
p < 0.001). Incidence rate of CVC infection decreased from 21.6/1000
days of parenteral nutrition (CI95% 17.8–25.9) in 2014 to 13.9/1000
days of parenteral nutrition (CI95% 10.4–18.4) in 2018 [RR 1.54 (CI95%
1.10–2.19); p = 0.009].
Onmultivariate analysis, we did not find any factor thatmight increase
the risk of CVC infections.
Conclusions: The prevalence of CVC infections related to parenteral
nutrition in our Hospital is high although it has decreased in the last 4
years, as it happens with the incidence rate of CVC infections.
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MACHINE LEARNING MODEL PERFORMANCE IN PRESCRIPTION OF
NUTRITION Therapy
H.F.R. Cunha1, L.S. Monteiro da Silva1, A.P. Carreiro1*. 1Clinical Nutrition,
Hospital Das Américas, RIO DE JANEIRO, Brazil
* Corresponding author.
Rationale: A machine learning model (MLM) was created, tested for
caloric & protein prescription
Models of Machine Learning (ML) and Artificial Intelligence have their
increasing application in several
specialties of health care. Nutritional Therapy is a field of potential
application of the methodology.
Investigations in the area are still scarce
Machine learning model was created & tested for caloric & protein
prescription
Methods: A nutritional therapy specialist performed simulations of
caloric and protein targeting for 100 clinical scenarios created from the
random combination of the following variables: Age, Weight, Height,
Glycemia, Creatinine, PCR-T, Chance of evolution for dialysis. A neural
network residing on a cloud platform computing (Amazon Web
Services (R)) was fed with this data, in steps of 10 simulations to
the 100 entries. At each step, a new ML model was created, pushing
against the increasing number of
Appetizer. The model created was tested in the scenarios proposed to
the examiner. The accuracy of bothmodels was compared bymeans of
themean square error. The performancewas considered better in favor
of the minor mean square error.
Specialist made simulations of cal & prot goals for scenarios created by
Age, Wt, Ht, Glyc, Creat, CRP, dialysis chance. A neural network was
trained in steps of 10, total = 100, and new ML models were created.
Performancewas compared with specialist by mean square root error.
A specialist performed simulations for CAL and PROT in 100 clinical
scenarios randomly created (Age, Wt, Ht, Glycemia, Creatinine, CRP,
dialysis. A neural network was trained in steps of 10. New MLM were
generated and compared to specialists’s by mean square root error.
Results:
C20 C40 C60 C80 C100 P20 P40 P60 P80 P100
MOD 5.32 FAIL 6.44 4.83 6.37 0.59 0.79 0.597 0.357 0.39
spec 6.21 7.63 5.80 7.61 0.43 0.45 0.41 0.39 0.31
DIF 0.90 1.19 0.97 1.25 0.16 0.34 0.18 0.05 0.08
Res y y y y n N N y N
Conclusions:ML returned prescriptions with lower MSQE than those
provided by experts
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SENSITIVITY OF DIFFERENTIAL TIME TO POSITIVITY COMPARED TO
POUR PLATES FOR DIAGNOSING CATHETER-RELATED BLOOD
STREAM INFECTION: AN EVALUATION IN PATIENTS WITH CHRONIC
INTESTINAL FAILURE
P. Chadwick1, A. Abraham2*, K. Ryan1, A. Teubner2, A. Bond2, S. Lal2,3.
1Microbiology Department, 2Intestinal Failure Unit, Salford Royal NHS
Foundation Trust, Salford, 3School of Medical Science, University of
Manchester, Manchester, United Kingdom
* Corresponding author.
Rationale: Clinical findings are unreliable for establishing the
diagnosis of central venous catheter-related bloodstream infection
(CRBSI) because of their poor sensitivity and specificity. Therefore, in
order to establish a diagnosis of CRBSI,when this is clinically suspected
and the central venous catheter (CVC) is to be preserved, ESPEN
recommend that paired quantitative blood cultures (pour plates) or
paired qualitative blood cultures from a peripheral vein and from the
catheter are recommended, with continuous monitoring of the
differential time to positivity (DTP). However, it is unclear whether
quantitative or qualitative cultures provide the optimal method for
diagnosing CRBSI in patientswith intestinal failure (IF). A retrospective
evaluationwas undertaken in intestinal failure patientswith long term
CVCs to evaluate DTP against pour plates for the diagnosis of CRBSI.
Methods: A list of patients with a diagnosis of CRBSI was obtained
from the intestinal failure (IF) unit database for a five year period, 2013
to 2017. Microbiology records were reviewed to obtain further
information about blood culture and pour plate examinations.
Organisms and times of collection, loading and positivity were
recorded. Patients with a contemporaneous set of central and
peripheral pour plates and blood cultures were included in an analysis
of the sensitivity of DTP compared to pour plates.
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Results: There were 61 (45.5%) episodes in 56 patients where
complete sets of central and peripheral blood cultures and pour
plates were received. All 61 episodes had positive central blood
cultures, 59 (96.7%) had positive central line pour plates and 17 (27.9%)
had positive peripheral pour plates. Using pour plates as the gold
standard, DTP sensitivity was 96.0% for 50 episodes where pour plates
were consistent with CRBSI. The sensitivity increased to 100% for 17
episodes where there were no delays in either collection or loading of
blood cultures.
Conclusions: This is the first evaluation to support the use of DTP as a
sensitive test in diagnosing CRBSI in IF patients and provides
confidence to IF centres where pour plate cultures are not available.
DTP can be used as a primary diagnostic test for CRBSI in patients with
IF; however, in order for this to be ofmaximumvalue to clinicians, time
to positivity needs to be routinely reported with blood culture results.
Disclosure of Interest: None declared.
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ARE FEMORAL TUNNELLED CENTRALVENOUS CATHETERS SAFE TO
USE FOR HPN?
A. Abraham1*, D. Sawbridge1, A. Cloutier1, A. Teubner1, M. Taylor1,
S. Lal1,2. 1Intestinal Failure Unit, Salford Royal NHS Foundation Trust,
Salford, 2School of Medical Science, University of Manchester, Manchester,
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Rationale: Patients with Intestinal Failure (IF) require reliable
intravenous access for the provision of Parenteral Nutrition. Venous
access for Home Parenteral Nutrition (HPN) patientswith Type 3 IF can
be compromised due to thrombosis of deep veins. The preferred
choice of veins for central venous catheter are the supra cardiac veins.
Femoral tunnelled CVC are avoided due to concerns of catheter-related
bloodstream infection (CRBSI) and are considered as a last resort when
all other thoracic CVC access is exhausted. We assess the outcomes of
tunnelled femoral catheters in our cohort of HPN patients.
Methods:We did a retrospective analysis of a prospectively collected
data of all HPN patients and venous access from January 2013 to
December 2018managed at a National HPNUnit. The details of venous
access, complications of CVC, sex and details of stoma extracted from
the database.
Results: In a cohort of 9 HPN patients with tunnelled femoral CVC, 6
were females and 3weremales leading to a total of 8418 days. A total of
3 episodes of CRBSI were recorded in 1 patient. All of the 3 episodes
(methicillin-sensitive Staphylococcus aureus (MSSA), Escherichia Coli
and CNS) were successfully salvaged. The average no of days for
femoral CVC was 935 days. The rate of CRBSI was 0.35 per 1000
catheter days. 8 patients had a stoma or open abdominalwound. There
were no episodes of ipsilateral femoral DVT. The CVCwas replaced for 2
patients due to fracture of CVC
Conclusions: Tunnelled femoral CVC CRBSI rate (0.35) is comparable
to thoracic veins CVC CRBSI rate(0.31) in our unit. Furthermore,
femoral access could be considered as reliable access to provide HPN. It
may be considered as an option if more than 2 thoracic deep veins are
occluded to prevent complete occlusion of SVC. We feel tunnelled
femoral CVC is a safe option to consider for HPN
Reference
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Rationale: Malnutrition is a common feature in patients with
Alzheimer’s disease (AD) and mild cognitive impairment (MCI), and
might be caused by a reduced energy intake and/or a higher energy
expenditure. Resting energy expenditure (REE) covers up to 70% of
daily energy expenditure andmight be elevated in patients with AD or
MCI. We compared REE of patients with AD and MCI with controls
and explored associations of AD biomarkers in cerebrospinal fluid
with REE.
Methods:We included 29 patients with AD (age 70 ± 9y, 55%Female),
22 with MCI (70 ± 7y, 27%F) and 40 controls (63 ± 7y, 55%F). We
assessed REE (kcal/d) by indirect calorimetry and fat-free mass
(FFM, kg) by bio-electrical impedance analysis. Age, gender and FFM
adjusted ANOVA was performed to compare the groups. Age, gender
and FFM adjusted linear regression analyses were used to study
associations of AD biomarkers (Aβ42, tau and p-tau) with REE.
Results: Adjusted for age, gender and FFM, groups did not differ in REE
(patients with AD 1696 ± 43, with MCI 1762 ± 52, controls 1625 ± 36
kcal/d, p = 0.11). Therewere no associations of AD biomarkerswith REE
(Table 1).
Table 1
Associations of AD biomarkers in CSF with REE (kcal/d)
Aβ42 (pg/ml) −0.11 (−0.35; 0.13)
Tau (pg/ml) 0.02 (−0.17; 0.21)
P-tau (pg/ml) 0.30 (−1.63; 2.24)
Data presented as β (95% CI). AD = Alzheimer’s disease; CSF = cerebrospinal fluid;
Aβ42 = β-amyloid 42; p-tau = phosphorylated tau; age, gender and fat-free mass
adjusted linear regression analyses
Conclusions: Groups did not differ in REE, which is further supported
by not finding associations of AD biomarkers with REE. The groups did
not differ in FFM, i.e. nutritional status, however, we cannot exclude
that groups were too small to observe differences. Other mechanisms,
such as increased physical activity level or altered nutrient uptake,
need to be studied as possible mechanism explaining malnutrition in
patients with AD.
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Rationale: Percutaneous transesophageal gastro-tubing (PTEG) is a
technique used in Japan to provide enteral nutrition and intestinal
decompression in cases where percutaneous endoscopic gastrostomy
(PEG) is impossible; this procedure was introduced in our hospital in
June 2018. In order to clarify the outcomes of PTEG treatment at our
hospital, a retrospective observational study was conducted.
Methods: Eight patients who switched from nasogastric tube to PTEG
in our hospital from June 2018 to January 2019 were enrolled. The
surveyed variables were age, sex, body mass index (BMI), serum
albumin level (ALB) at the time of PTEG construction, baseline disease,
reasons for PEG failure, complications at the time of PTEG construc-
tion, quality of life (QOL), body weight change following PTEG
treatment, and 6-month survival rate.
Results: Six of the enrolled patients (75%) were men; the median age
was 79.5 years; the median BMI was 17.4 kg/m2; and the median
serum ALB was 3.2 g/dL. The reasons for PEG failure across the
different cases were as follows: unsuitable stomach location, two
cases; total gastrectomy, two cases; cancer invasion in the stomach,
three cases; and abdominal radiotherapy effects, one case. There were
no complications at the time of PTEG construction. In terms of QOL, all
patients considered PTEG to be less painful and more cosmetically
acceptable than a nasogastric tube. After PTEG, weight gain was
observed in 50% of patients. The 6-month survival rate was 70%.
Conclusions: PTEG was safely constructed in all cases. It was a useful
and well tolerated alternative to PEG for providing enteral nutrition.
Awareness regarding PTEG as an alternative technique to PEG is not yet
widespread, and it is important to disseminate the value of PTEG to
medical professionals worldwide.
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Rationale: The aim of this study was to assess the effects of a enriched
fish oil lipid emulsion on recovering liver indicators (LI) and control of
triglyceridemia (TG) in critically ill adult patients with parenteral
nutrition (PN).
Methods: From July 2017 to March 2019 critically ill adult patients
with PN were enrolled. Demographics, nutrients supplied, PN
duration, surgery, ICU stay and laboratory data were collected.
Patients were included after at least 4 days of PN and an increase of
total bilirubin [TB] or gammaglutamyl transferase [GGT] frombaseline
levels at the start of PN greater than 40%. Patients were classified as
standard-care (SC) group if no change in the content of the standard
lipid emulsions was performed; or fish-oil (FO) group if they received
≥5 days of FO enriched emulsion, containing at least 90% (range 84–
90%) of FO olive soybean emulsion (Smoflipd®) and at least 10% (range
10–16%) FO of based emulsion (Omegaven®). Evolution of LI (alanine
aminostransferase, aspartate aminotransferase, TB, GGT, and alcaline
phosphatase [AF] and TG) were compared in two points: switching to
FO formula and back to standard lipid emulsion and end of PN.
Results: A total of 80 patients were included: 44 in SC and 36 in FO
group, 43.8% female (n = 35)mean age 55.7 ± 13.8 years. No differences
were found in mean baseline values such as TB, GGT, AF, albumin, age
and TG. Mean values of GGT, TG and AF at switching point time were
greater in the FO group. No differences were found during the study
period in mean PN days (16.7 ± 15.7 vs 16.3 ± 12.2), mean energy
(24.2 ± 4.0 kcal/kg/d vs 24.9 ± 3.5 kcal/kg/d) and mean lipid intake
(0.75 ± 0.25 g/kg/d vs 0.83 ± 0.20 g/kg/d) for SC and FO respectively. T-
paired tests showed a higher and significant decrease (p < 0.05) in FO
patients in final GGT, AF and TG compared to SC patients. The % of
patients lowering≥30% of LIwas signifcant greater in FO group (44.4 vs
15.9% for GGT; 18.2 vs 9.8% for TB).
Conclusions: FO enriched lipid emulsion formulations might help to
recover liver impairment, aswell as control of TG related to PN therapy.
Protocols and strategies should be performed to identify patients that
might get profit from this therapy.
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Rationale: Phytosterols in lipid emulsions used in parenteral nutrition
(PN) has been associated with alterations of liver parameters and
hypertrygliceridemia. However content of phytosterols are currently
undeclared in lipid emulsions. Althought content in commercial lipid
emulsions has been studied, there are not available data related to the
content of phytosterols in commercial multichamberbags (MCBs).
Therefore the determination of phytosterols in MCBs would allow the
development of strategies to prevent or treat alterations related to
phytosterols.
Methods: Batches of 5 MCBs commercially available in Europe from
3 different providers (Olimel N9 (lipid content: LCT + olive) with
electrolytes; Smofkabiven (lipid content: LCT+MCT+olive+ fish oil)
with and without electrolytes; Smofkabiven extra nitrogen with
electrolytes; Nutriflex Lipid Special (lipid content: MCT+LCT) with
and without electrolytes; and Nutriflex Omega (lipid content: MCT +
LCT + fish oil) were analyzed. Differences in total phytosterol assay
between MCBs and batches were statistically studied by a one-way
ANOVA and Kruskal-Wallis non-parametric approximation and
Bonferoni test.
Table 1
Phytosterols
(mg)/bag
Phytosterols
(mg)/100 g
SmofKabiven (n = 13) 47.7 ± 3.4 3.2 ± 0.2
With electrolytes (n = 7) 47.0 ± 3.9 3.2 ± 0.3
Without electrolytes (n = 6) 45.6 ± 3.1 3.1 ± 0.2
Nutriflex-Lipid-Special 1250 mL (n = 8) 59.0 ± 3.2 4.7 ± 0.3
With electrolytes (n = 4) 60.1 ± 1.9 4.8 ± 0.2
Without electrolytes (n = 4) 57.9 ± 4.2 4.6 ± 0.4
Olimel-N9 (n = 9) 4.8 ± 0.2
1000mL (n = 4) 51.3 ± 9.2 5.1 ± 1.0
1500mL (n = 5) 71.9 ± 3.3 4.8 ± 0.2
Smofkabiven Extra Nitrogen (n = 3) 2.3 ± 0.2
Nutriflex Omega 1250 mL (n = 3) 53.0 ± 3.7 4.2 ± 0.3
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Results: A total of 36 batches from 5 different MCBs were analyzed.
The highest content in phytosterols per bag (73.6 ± 1.6 mg) was found
in the Olimel N9 MCB with highest proportion of LCT. Statistically
significant differences of phytosterol content were observed among
the different MCBs studied and MCBs containing Smolflipid
(Smofkabiven and Smofkabiven extra nitrogen; F = 20.16; p = 0.000;
Table). However the ratio and amount of the differents types of
phytosterols did no show the same results. Among the differents
phytosterols (sitosterol, campesterol and stigmasterol): beta-sitosterol
amount in Olimel MCB was statistically higher compared to the rest of
the MCBs studied (60.5 ± 1.7 for Olimel vs 31.7 ± 2.5; 34.0 ± 2.1 and
29.9 ± 1.9 mg/bag for Smofkabiven 1250 mL, Nutriflex Lipid Special
1250 mL and Nutriflex Omega 1250 mL, respectively; F = 69.5 p <
0.001). Meanwhile the content per bag of stigmasterol were higher in
the MCBs containing LCT + MCT mixture (11.3 ± 0.6 and 10.5 ± 0.8 mg
for Nutriflex Lipid Special and Nutriflex Omega) compared to the rest
of MCBs: 4.1 ± 0.7 mg and 6.5 ± 0.5 mg for Olimel 1500 mL and
SmofKabiven, respectively (F = 149.8; p = 000).
Conclusions: MCBs commercially availabe on the European market
contain variable quantities of phytosterols dependent on commercial
brand and batch. MCBs with lipids containing fish oil showed
signifcantly lower amount of phytosterols.
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HOW TO ADMINISTRATE HOME ENTERAL NUTRITION (HEN) MORE
PRECISELY AMONG ADULT PATIENTS: A SYSTEMATIC REVIEW AND
META-ANALYSIS
D.Mu1*, J. Gong1, L. Shi2, J. Yu3, W. Hu2. 1Sichuan University, 2West China
Hospital, 3Chinese Evidence-Based Medicine Center, Chengdu, China
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Rationale: Adults, especially elders need a long time, averagely 17.5
times the length of hospital stay, to recover from malnutrition or the
state of having nutritional risks. Therefore, just providing nutritional
support (NS) during hospitalized period is not sufficient, which
makes it reasonable to offer NS after discharge aswell. This sort of NS is
called Home Enteral Nutrition (HEN), a relatively mature healthcare
service in developed countries, generally including Oral Nutritional
Supplement (ONS) and Tube Feeding (TF). To figure out what
effectiveness dose HEN have for patients’ nutritional status and find
some suggestions for the precise administration of HEN in China.
Methods: A systematic review and meta-analysis was conducted of
randomized controlled trials (RCTs). We comprehensively searched 3
databases (PUBMED, OVID-CENTRAL and OVID-CDSR) for relevant
studies and duplicated assessment of inclusion, data extraction, valid
assessment and data tabulation.
Results: From 10167 studies obtained, 15 RCTs were included for the
systematic review and meta-analysis, disappointingly none were
judged at low risk of bias. 1 TF study and 4 ONS studies were
narratively described because of their heterogeneity. The rest of ONS
studies (n = 7) indicated small positive effects on nutritional status:
after receiving ONS (energy ≥ 200 kcal/d) for not less than 10 weeks,
BW (Mean: 1.23 kg, 95%CI: [0.50, 1.95]), BMI (Mean: 0.61 kg/m2, 95%
CI: [0.14, 1.09]), CC (Mean: 0.64 cm, 95%CI: [0.04, 1.24]) and MAC
(Mean: 0.56 cm, 95%CI: [0.01, 1.11]) had significantly increased.
However, there were no significant results observed in MAMC
(Mean: 0.29 cm, 95%CI: [−0.07, 0.66]), HG (Mean: 0.50 kg, 95%CI:
[−0.60,1.60]), MNA-SF (Mean: 0.97 score, 95%CI: [−0.23, 2.17]) and TSF
(Mean: 0.44 mm, 95%CI: [−0.71, 1.59]). The TF studies only revealed a
positive result in BW (Mean: 2.67 kg, 95%CI [0.27, 5.07]) but not in HG
(Mean 0.64 kg, 95%CI [−1.84, 3.12]) after receiving TF (energy = 10–50%
of basal energy requirement) for 6–8 weeks.
Conclusions: HEN could have a positive effect on nutritional status
for adult patients, but more studies were required to build a solid
confirmation on this. The results also indicated the dosage and
frequency of administration of ONS for generic patients requiring HEN.
It’d be a better option for them to gain additional energy of at least
200 kcal/d for at least 10 consecutive weeks. If some specific
parameters were demanded for the concerns of safety and effective-
ness of HEN, for example, tracing HG among sarcopenia patients, 2
more weeks of ONS should be considered as a possible solution. The
suggested duration and energy of HEN-TFwould be 6–8weeks and 10–
50% of basal energy requirement respectively.
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IMPACT OF NUTRITIONAL SUPPORT ON PRESSURE ULCERS: A
REVIEW OF CURRENT EVIDENCE
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Rationale: Pressure ulcers (PU) remain a vexing and distressingly
commonproblem inpatiens living in long term care. Research suggests
that malnutrition is an important risk factor for PU development. This
study was conducted in order to analyze the impact of nutrition on
pressure ulcers.
Methods: This study was designed based on the systematic review of
randomised controlled trials (RCTs). RCTs were identified by searching
Medline, ULAKBIṀ, Pubmed, Proquest, Web of Science between 2009
and 2019. Search terms included ‘pressure ulcers,’ ‘pressure wounds,’
‘pressure injury’ in combination with ‘nutrition’ and ‘supplements.’
Data were qualitatively described using standard methods of system-
atic review described by the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines. PRISMA improves
authors’ reporting of systematic reviews and meta-analyses via a 27-
item checklist with criteria for title, abstract, introduction, methods,
results, discussion, and funding, along with a flow diagram for article
selection. In order to summarize the data, a standard table was used.
Results: Of the 1195 articles identified, after applying inclusion and
exclusion criteria, 6 articles were selected for review. These studies
included a total of 620 participants (male and female), for a mean of
80,09 ± 7,82 participants with pressure ulcer stage II, III or IV. The
patients population was composed of malnourished patients (n = 1),
Table (abstract: SUN-PO266):
Start PN Switching point End switching End PN
FO SC FO SC FO SC FO SC
GGT (U/L) 83.8 ± 58.3 93.2 ± 61.7 559.4 ± 277.7 303.6 ± 142.8 555.9 ± 398.1 303.6 ± 142.8 505.4 ± 320.3 426.1 ± 452.0
FA (U/L) 94.8 ± 63.5 103.3 ± 50.6 289.1 ± 163.4 225.8 ± 216.6 316.7 ± 212.9 253.3 ± 163.3 306.6 ± 203.6 329.7 ± 452.5
TB (mg/dL) 1.05 ± 0.80 1.04 ± 0.91 1.38 ± 1.26 1.46 ± 1.27 1.49 ± 2.17 1.60 ± 1.69 1.30 ± 2.15 1.67 ± 2.19
TG (mg/dL) 127.9 ± 66.4 168.9 ± 129.5 265.2 ± 100.9 247.4 ± 112.1 217.4 ± 74.9 249.2 ± 123.6 245.1 ± 97.6 293.3 ± 147.5
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tube-fed patients (1), elderly patients (n = 2), non-malnourished
patients (n = 1), patients in long-term care/ home-care services
(n = 1). Intervention groups of these studies were used ‘A nutrition
formula enriched with protein, arginine, zinc, and vitamin C’; ‘An
energy-dense, protein-rich oral formula enriched with arginine, zinc,
and antioxidants (400 mL/d)’; ‘A nutrition formula contains protein
4.38 g, fat 2.23 g, and carbohydrate 15.62 g, all per 100 mL of product
(37.9 ± 6.5 kcal/kg/day)’; ‘Ornithine alpha-ketoglutarate once a day for
6 weeks’; ‘A specific oral nutrition supplement, which was a high
energy supplement enriched with arginine, antioxidants, and other
micronutrients (600 ml/d)’ and ‘Disease-specific oral nutritional
formula.’ In all studies, it has been found that the nutrition
intervention has improved PU healing, the size of ulcers and ulcer area.
Conclusions: The results suggest that nutrition intervention could
directly improve the healing process on patients with pressure ulcer
stage II, III or IV. The use of a various nutritional formula not only
results in better healing of PUs, but also reduces the costs of local PU
care from a local healthcare system perspective.
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TREATMENTOF HYPERGLYCEMIA IN NON-CRITICAL PATIENTSWITH
PARENTERAL NUTRITION
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Rationale: Hyperglycemia is frequent in hospitalized patients up to 32–
38%, the prevalence in patients with parenteral nutrition is higher. The
objetive of the studywas to determine the prevalence of hyperglycemia
in non-critically ill patients receiving parenteral nutrition and describe
the management and risk factors in these patients.
Methods: A retrospective cohort of non-critical hospitalized patients
>18 years who received parenteral nutrition frommedical and surgical
areas. Patientswith type 1 diabetesmellitus, pregnantwomen, transfers
toothercenters andvoluntarydischargeswereexcluded.Hyperglycemia
was defined with glucose levels ≥180 mg/dL. The glycemic protocols
were focused on guaranteeing glycaemia less than 180 mg/dL, by
administering rapid-acting insulin from glycemia ≥140 mg/dL.
Results:Westudied 96 patients, 56.3%women and 43.8%men,with an
mean age of 54 ±16.4 years, 35.4% presented hyperglycemia with a
mean of 255.8 ± 55.39 mg/dL. In the prescription review of energy
needs, ranges were reported of 25–35 cal/Kg/d and the glucose
infusion rate was <4 mg/Kg/min. Insulin in parenteral nutrition was
calculated considering the grams of carbohydrates provided, initially
at 0.05 IU/g carbohydrate up to a maximum of 0.2 IU/g, 7% of patients
required adding subcutaneous intermediate-acting insulin. The causes
associated with poor control and increased hyperglycemia were the
body mass index, the use of steroids and the presence of infection
p < 0.05.
Conclusions: Hyperglycemia in non-critical patients receiving paren-
teral nutrition is frequent; body mass index, use of steroids and the
presence of infection are associated with poor control. The optimiza-
tion of the contribution of carbohydrates and the use of insulin
contribute to the improvement of the glucose levels.
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USEFULNESS OF ABDOMINAL ULTRASOUND VS. CHEST X-RAY IN
NASOGASTRIC TUBE POSITIONING CHECK IN MALNOURISHED
PATIENTS
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Rationale: Chest CT-scan is the gold standard for naso-gastric tube
(NGT) position assessment (1). Chest x-ray (XR) is avalid alternative. In
absence of XR, abdominal ultrasound (AU) can be used (1).
Thus, we aimed to verify the agreement between XR and AU in the
assessment of NGT position in a secondary healthcare center.
Methods: From May 2018 to March 2019, we consecutively enrolled
patients requiring NGT positioning, admitted to the Internal Medicine
Unit of San Benedetto del Tronto General Hospital.
Before NGT placement, all the patients underwent a complete
nutritional (bio-impedance analysis) and speech-pathologist assess-
ment. After NGT placement, patients underwent XR and AU assess-
ments. AU protocol followed codified criteria (2) by the same operator.
Results: We consecutively enrolled 46 patients (mean age 50 ± 1.5, F
24, BMI 18 ± 0.8 Kg/m2, phase angle 5.9 ± 0.4°). All patients had a
significantly lower free fat mass content (65.5 ± 1.8%) indicative of
malnutrition.
Correct NGT positionwas found in 100% of patients according to XR vs.
84% by AU.
AU showed a sensitivity and a specificity of 84% and 100% respectively,
vs. XR.
Disagreement was found in 16% of patients (false negative due to
abdominal bloating). Interestingly, severity of malnutrition did not
predict AU assessment failure.
Conclusions: This prospective single-canter study confirmed a good
sensitvity and specificity of AU in bed-side in-patients NGT position
assessment. AU could be used also in outpatients if larger multicenter
prospective studies will confirm these preliminary results.
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PATIENTS PERCEPTION OF ORGANOLEPTIC CHARACTERISTCS OF
ORAL NUTRITIONAL SUPPLEMENTS
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Rationale: Patients present low acceptance of diet and supplements
during hospital stay and consequently worsening nutritional status. It
was taken under consideration that evaluating oral nutritional
supplements’ (ONS) perception, regarding organoleptic characteristics
by paciente, is very important.
Methods: Cross-sectional studywas performed patients in the tertiary
hospital. Patients with exclusive oral feeding with ONS were included.
The ONS formulae were classified as: high protein (>20% total energy
from protein), normal protein (<20% total energy from protein),
immune modulation and fiber containing (1.5 g/100 ml), distributed
in 11 differents flavors delivered during the hospital stay. The
organoleptic characteristics for each ONS was obtaind, with a
maximum score of 45 points by apparence, texture, odor, taste and
residual taste using a 9 points hedonic scale (1 = extremely dislike,
9 = extremely like). Statistical analyses ANOVA were performed using
SPSS. The protocol was approved by Ethical Commite of th Hospital.
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Results: 141 patients (54.6 ± 16.9 years, 50.4% male) were evaluated.
Different perceptions of organoleptic characteristics for adults and
elderly were observed (p < 0.05). However normal protein and
hiperenergetic ONS red fruits flavor (8.4 ± 1.1) was better than
strawberry (8.0 ± 1.0), chocolate (7.4 ± 2.1) (p < 0.05) flavors. The
better result for five characteristics (43.7 points) was strawberry
flavor for normal protein and hiperenergetic ONS. The lowest was
strawberry with fiber (27 points). The residual taste and odor were
disliked by the patients. Most ONS (68%) was higther than 35 points.
Conclusions: The organoleptic characteristics of ONS were well
evaluated. However, the ONS products strawberry with fiber had
worse residual taste and odor when compared to the others.
Reference
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HOW DOES THE USE OF SODIUM GLYCEROPHOSPHATE AFFECT
PERSONALIZED PARENTERAL NUTRITION ADMIXTURE STABILITY?
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Rationale: Personalized Parenteral Nutrition (PN) admixtures require
organic phosphate to ensure admixture stability especially in children
and prematures. Previously, we tested and used 1,6-fructose diphos-
phate, having low viscosity and sodium content. Unfortunately, it is no
longer available in the market and the only substitute is sodium
glycerophosphate. We aim to evaluate whether sodium glyceropho-
sphate ensures the same PN admixture stability according to European
Guidelines (droplet diameter maintained in the 0.4–1.0 micrometer
range of chylomicra).
Methods: Stability studies were carried out on five admixtures (1 PN
adult, 2 paediatric and 2 neonatal) with different calcium and
phosphate contents. Each admixture was compounded with five
different lipid emulsions with and without fish oil. The analyses were
performed at time 0 (t = 0) and 24, 48, 72, 96 (t = 96) hours after
compounding. Droplet diameters were determined by Light
Scattering-Reverse Fourier Optics Technique. Every sample was triple
tested for a total of 750 analyses. Statistical significancewas verified by
F-test.
Results: Physicochemical stability did not change between t = 0 and
t = 96. Droplet diameterswere in the expected range of 0.4–1.0micron,
apart from the admixtures containing fish-oil based emulsion and
calcium concentration above 4.5 mmol/L. In these last admixtures,12%
of droplet diameters were larger than 1.0 micron and 2% exceeded 5.0
micron immediately after compounding.
Conclusions: Sodium glycerophosphate, as previously observed when
1,6-fructose diphosphate was tested, assures PN personalized admix-
tures stability until 96 hours provided calcium content is lower than
4.5 mmol in admixture containing fish oil based emulsion. The
downside of sodium glycerophosphate is its high sodium content
which requires a careful consideration in clinical practice, especially
for paediatric and neonatal patients.
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VALIDATION PROCESS OF A NEW CALORIMETER: IMPORTANCE OFA
MIXING CHAMBER
G.E. Bagnoud1*, M. Charrière1, D. Favre1, O. Pantet1, C. Pichard2,
M.M. Berger1, on behalf of ICALIC group. 1Service de Médecine
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Rationale: Determination of the patients’ energy expenditure (EE) is
an important step to individualize energy prescription. Breath-
by-breath technology is unsatisfactory: a new device is available and
integrates a micro-mixing chamber technology and very rapid
detection of FiO2 and FeCO2 changes (Q-NRG, Cosmed). Its reliability
and precision have been validated in vitro against mass-spectrometry.
The clinical validation has been undertaken by the multicenter
international ICALIC study group; this sub-study reports the problems
encountered during the validation process by the local group.
Methods: Indirect calorimetry studies (IC) were undertaken in 70
patients on mechanical ventilation. The QuarkRMR2 (Cosmed), and
the Q-NRG (Cosmed) were connected in series using 3 different
ventilators (Maquet Servo-I and -U, HamiltonS1) without any filter or
humidifier on the inspiratory limb, with only one single HME (heat
moister exchange) filter close to the patient. Local primary endpoint
was the agreement between the devices. Secondary local endpoints
were clinical observations (practicality, airway and material handling,
cleaning) Data as mean±SD, Min-Max.
Results: Patients were aged 60 ± 17 yrs (19F, 51M). The calibration is
daily with QuarkRMR2 vs. monthly with Q-NRG. The warming-up
takes 20 min for both devices. The first 60 measurements were done
without inspiratory filter: a systematic difference was observed
between the two device measures. While the mean difference was
not significant, theminimal andmaximal values differed significantly:
respiratory quotient (QR): -0.42 to +2.02, VO2− 267 to +312 ml/min,
VCO2− 181 to +240 ml/min, resulting in large differences in derived
EE from− 1790 to +2135 kcal/d. The lowest QR and highest VO2 were
observed with the Q-NRG. Investigation enabled identification of the
cause of the differences: the very rapid response time of the oxygen
cell led to FiO2 variability with every respiratory cycle. Insertion of a
HME filter on the ventilator-outlet, i.e. insertion of a 30 ml additional
pseudo-mixing chamber that dampened the cyclic pressure variations,
resulted in agreement between devices (10 measures with ±5%
variation). Q-NRG with single use disposables was easier to handle
and clean: insertion of the Pneumotach device on the endotracheal
tube caused ventilatory instability in some patients, and required
training of the dieticians
Conclusions: The new device provides rapid stable VO2 and VCO2
values, close to those obtained with the QarkRMR, but is is more
practical; the battery offers a better autonomy. In our setting the Q-
NRG requires more single use material (1 pneumotach, 2 catheters, 2
filters per measure). The connection to the patient requires specific
skills in airway handling
Disclosure of Interest: None declared.
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ALTERATION OF BRAIN LIPIDS IN MURINE MODEL OF DIETARY
OBESITY
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1Department of Environmental Analysis, University of Gdańsk,
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Rationale: High-fat western diet contributes to the obesity epidemic,
which in turn is associated with increased risk of cancer, cardiovas-
cular disease or type 2 diabetes. This dietary pattern involves higher
saturated fatty acids (SFA) and n-6 polyunsaturated fatty acids (PUFA)
intake and concurrent reduction of n-3 PUFA content. Members of n-3
PUFA, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA),
exhibit beneficial, neuroprotective properties. The aim of this study
was evaluation of high-fat diet impact on brain PUFA.
Methods: Obesity was induced through administration of either high
fat diet (HFD) with 60% fat to C57BL/6 mice (n = 10) or standard diet
(SD), containing 10% fat – control mice (n = 10). After 19 weeks the
micewere euthanized, and brains sampled. Gas chromatography-mass
spectrometry was used to analyze total fatty acids (FA) content. Brain
lipids were fractionated using two solid phase extractionmethods and
FAwere profiled in each fraction. Parametric and nonparametric tests
were used to estimate differences between HFD and SD mice.
Results: Dietary treatment resulted in around 30% increase of body
mass of HFDmice, with similar to SDmice concentrations of total brain
SFA, n-3 and n-6 PUFA. Remarkably, despite comparable composition
of n-3 PUFA in SD and HFD chow, EPA content was halved in HFD
brains. In brains of all mice the most abundant PUFA was DHA.
Fractionation of brain extracts revealed changed percentage share of
different groups in HFDmice, with significant increase in acylglycerols
(AG) level. Moreover, separation showed significantly less glyco-
sphingolipids and more sphingomyelins in HFD mice. Across all PL
fractions level of EPAwas decreased in HFD mice.
Conclusions: Consumption of high-fat diet induces changes in brain
lipids composition. Increase of AG might induce resistance to leptin
and insulin, whereas alterations in n-3 PUFA can negatively impact
cognition and brain function.
Reference
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FACTORS, BELIEFS AND BEHAVIORS RELATED TO THE USE OF
WEIGHT LOSS SUPPLEMENTS
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Rationale: Increasing prevalence of overweight and obesity is a major
worldwide problem associated with many metabolic comorbidities.
Compliance with lifestyle modifications required for losing weight on
long-term is poor.Weight loss supplements arewidely used and easily
available without prescription. They do not require strict regulations
before being marketed and they are wrongly considered innocuous.
The objective of this study was to explore knowledge and behaviors
regarding weight loss supplements, and to assess socioeconomic,
health and lifestyle characteristics related to their use.
Methods: This observational cross-sectional study was carried out
between March and July 2018. A convenience sample of 200 adults,
recruited from the clients of a pharmacy in Mount Lebanon, was
equally divided into a group of users of weight loss supplements and a
control group. Data on socio-demographic, lifestyle and health
characteristics were collected. Logistic regression analyses were
conducted with the use of weight loss supplement as the dependent
variable.
Results: The use of weight loss supplements was significantly
associated with female gender (p = 0.016), age above 45 years
(p = 0.01), being married (p = 0.006), unemployment (p < 0.001), low
level of education (p = 0.012) and smoking (p < 0.001). Weight loss
supplements were mainly recommended by friends (45%) and
pharmacists (40%). Pharmacies were the most common sources
(87%) for obtaining weight loss supplements. Around two-thirds of
users reported experiencing side effects (59%), and considered that
weight loss supplements are not safe (61%), not efficient (60%) and
very expensive (67%).
Conclusions: Increased awareness should be provided to the com-
munity about the risks of using weight loss supplements.
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EFFECT OF MATERNAL CAFETERIA DIET AND TAURINE
SUPPLEMENTATION ON BODY WEIGHT CHANGE, BODY FAT RATIO
AND PLASMA LEPTIN LEVELS IN ADULT MALE AND FEMALE
OFFSPRING
A. Kabasakal Çetin1*, Y. Büyükdere1, A. Güleç1, A. Akyol Mutlu1.
1Nutrition and Dietetics, Hacettepe University Faculty of Health
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Rationale: Maternal overnutrition during gestation and lactation
affects the metabolic phenotype of the offspring. The efficacy of
maternal taurine supplementation as an intervention in the setting of
maternal overnutrition is notwell documented. The aim of the present
study was to evaluate the effect of maternal cafeteria diet and taurine
supplementation on body weight change, body fat ratio and plasma
leptin levels in adult male and female offspring.
Methods: Female Wistar rats were fed a control (CON) diet, CON
supplemented with 1.5% taurine in drinking water (CONT), cafeteria
diet (CAF) or CAF supplemented with taurine (CAFT) from weaning.
After 8 weeks all animals were mated and maintained on the same
diets during pregnancy and lactation. One male and female offspring
from every damweaned onto a control diet. Animals were culled and
plasma samples were taken at 20 weeks of age. Repeated mesures
analysis of variance and factorial analysis of variance (ANOVA) tests
were used for data analysis.
Results: Body weights did not differ between groups (p > 0.05) but
both male and female CAF rats presented greater body fat content at
the age of 20 weeks. (CONmale: 24.3 ± 1.44%, CONTmale:28.4 ± 1.61%,
CAF male:33.2 ± 1.44%, CAFT male:29.9 ± 1.22%; CON female:24.3 ±
1.32%, CONT female:27.4 ± 1.22%, CAF female:32.8 ± 1.44%, CAFT
female:26.2 ± 1.22%, p < 0.01). Plasma leptin concentrations of CAF
offspring were higher than CON offspring in both sexes (CON male:
80.14 ± 14.12 pg/mL, CONT male: 100.56 ± 15.47 pg/mL, CAF male:
129.61 ± 13.07 pg/mL, CAFT male:111.35 ± 13.07 pg/mL; CON
female:64.45 ± 14.12 pg/mL, CONT female:75.30 ± 12.23 pg/mL, CAF
female:98.71 ± 13.07 pg/mL, CAFT female:70.09 ± 13.07 pg/mL,
p < 0.01).
Conclusions: Maternal exposure to a cafeteria diet and taurine
supplementation had no effect on body weights but the offspring of
rats fed a cafeteria diet showed greater fat accumulation compared
with CON, CONT and CAFT groups. CAF group also displayed
hyperleptinemia versus CON group. Therefore, taurine may induce
anti-obesogenic effects when supplemented with CAF diet.
Disclosure of Interest: None declared.
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EFFECT OF MATERNAL CAFETERIA DIET AND TAURINE
SUPPLEMENTATION ON GENE EXPRESSION PROFILE OF ADULT
MALE AND FEMALE OFFSPRING’S LIVER
A. Kabasakal Çetin1*, A. Güleç1, A. Akyol Mutlu1. 1Nutrition and
Dietetics, Hacettepe University Faculty of Health Sciences, Ankara, Turkey
* Corresponding author.
Rationale:Maternal overnutrition during gestation and lactation leads
to disruption of pregnancy metabolism and affects both maternal and
offspring’s health. The effect of taurine supplementation on gene
expression changes induced by maternal overnutrition is not well
documented. This study aimed to evaluate the effect of maternal
cafeteria diet and taurine supplementation on gene expression profile
of adult male and female offspring’s liver.
Methods: Female Wistar rats were fed a control (CON) diet, CON
supplemented with 1.5% taurine in drinking water (CONT), cafeteria
diet (CAF) or CAF supplemented with taurine (CAFT) from weaning.
After 8 weeks all animals were mated and maintained on the same
diets during pregnancy and lactation. One male and female offspring
from every dam weaned onto a control diet. Animals were culled
and liver samples were taken at 20 weeks of age. Whole genome
microarray analysis was used to find out the effects of maternal
cafeteria diet and taurine supplementation on gene expression profile
of liver. Transcriptome analysis software was performed for statistical
analysis (Fold change ≥2 or ≤ −2, p < 0.05)
Results: Microarray results showed that maternal cafeteria diet
significantly upregulated 40 genes while significantly downregulated
78 genes (CAF vs CON) in adult male offspring’s liver. Maternal
cafeteria diet led to upregulation of 40 genes while downregulation of
80 genes (CAF vs CON) in adult female offspring’s liver. 69 genes were
upregulated whereas, 23 genes showed downregulation (CAFT vs CAF)
in adult male offspring’s liver in response to maternal taurine
supplementation. Exposure to maternal taurine supplementation
caused upregulation of 19 genes while downregulation of 11 genes
(CAFT vs CAF) in adult female offspring’s liver. When the gene
pathways were analysed, results indicated that mostly lipid metabol-
ism, oxidative stress, transcription factors and transmembrane
transporter activity levels were affected.
Conclusions: These results suggest that maternal cafeteria diet and
taurine supplementation leads to significant changes in liver gene
expression patterns.
Disclosure of Interest: None declared.
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HOW DOES BARIATRIC SURGERY AFFECT FOOD TOLERANCE,
PROTEIN INTAKE AND BODY COMPOSITION? COMPARISON OF
THREE DIFFERENT SURGICAL PROCEDURES
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Rationale: Reduced food tolerance is often associated to bariatric
surgery(BS) which might affect energy and protein intake. The
objective of this study was to assess the food tolerance, intake and
body composition in patients that underwent Sleeve gastrectomy(SG),
Biliopancreatic diversion(BPD) and Gastric Bypass(GB).
Methods:Retrospective observational study performed from July 2016
to February 2019. Patients that underwent BS with a follow up of 12
months were included. The food test tolerance, described by Suter
et al. was administered to all patients 12months after surgery. This test
included one question about the self-perception qualityof the intake,
food tolerance of 7 food groups and the presence or not of vomiting,
giving a global test score from 0 to 27 points(from worst to best food
tolerance). A 24-h intake record was analyzed bya Registered Dietitian
using Dietsource 3.0® software(Novartis Consumer Health-Cath Soft,
1997–2003). Body composition was assessed using bioelectrical
impedance analysis. The statistical analysis included ANOVA test.
Results: 47 patients were included (74.5% women). Mean age 45.21
(SD 9.29) years. 14 patients underwent BPD, 21 SG and 12 GB.
Full results of food tolerance test, energy and protein intake are shown
in table 1.
12 months after surgery
BPD(n = 14) SG(n = 21) GB(n = 12) p
Food
Tolerance
Score
26.0 (IQR 8.0) 23.00 (IQR 15.0) 22.0 (IQR 17.0) 0.007
Energy
(Kcal)
1339.9 (IQR 1033.0) 943.60 (IQR 1553.3) 906.1 (IQR 1348.2) 0.036
Protein (g) 81.3 (IQR 74.8) 55.20 (IQR 77.6) 65.0 (IQR 69.4) 0.050
Body weight was 84.4(IQR 62.3)kg in BDP, 74.4(IQR 40.9)kg in SG and
81.7(IQR 24.7)kg in GB(p = 0.016). Muscle mass was 56.6(IQR 46.3)kg
in BDP, 49.3(IQR 44.9)kg in SG and 51.8 (IQR 37.4)kg in GB. No
statistically differences were found in %WL and %MML.
Conclusions:Oneyear after surgery patients that underwent BPD have
a better food tolerance that is reflected in a better energy and protein
intake.
Reference
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RELATION OF BINGE EATING DISORDER, NUTRITIONAL STATUS AND
PRESENCE OF METABOLIC DISEASES IN OBESE PATIENTS
C.A. Gottschall1*, R.F. Mundstock1, F.M. Busnello1. 1Graduate Program in
Nutrition Sciences, Federal University of Health Sciences Of Porto Alegre,
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Rationale: Binge Eating Disorder (BED) is the most prevalent eating
disorders and it is an important risk factor for obesity and metabolic
syndrom1. The aimof this studywas to evaluate the relationship of BED
with nutritional status and the presence ofmetabolic diseases in obese
outpatients.
Methods: We included obese adult outpatients, according to BMI
classification, attended at a Nutrition Outpatient Clinic, in a general
hospital in the South of Brazil. Weight, height andwaist circumference
(WC) were evaluated. Structured questionnaires were applied to
obtain information on dietary habits. The presence of metabolic
diseases was verified in an electronic medical record. The Binge
Eating Scale was applied with the aim of diagnosing BED and its
severity (0–17 points: no disorder, 18–26: moderate disorder, >27:
severe disorder). The research was approved by the ethics committee
of the hospital. Chi-square and t-testswere used for statistical analysis.
Results: A total of 56 obese adult patients was included. The
prevalence of BED in the studied population was 28.6% (17.9%
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moderate disorder, 10.7% severe disorder), being more found in
women (35.7%, p = 0.047). Both weight, BMI (mean 38.07 ± 5.68) and
WC (mean 116.61 ± 13.74) were higher in patients with BED, but the
datawere not significant (p = 0.167 and 0.185). The daily consumption
of fruits and vegetables was higher in the groupwithout BED (65% and
67.5% × 56.2%). Among the patients with BED, 87.5% reported daily
consumption of processed meats, versus 60% of patients without BED.
The most frequent metabolic disease in the BED group was type 2
diabetes mellitus (75%), followed by hypertension (68.7%). In addition,
62.5% of the patients with BED reported restrictive diets.
Conclusions: The difference between nutrition status of obese
patients with and without BED was not statistically significant. The
prevalence of type 2 diabetes was high in the group with BED. Most of
the patients with BED have already performed restrictive diets.
Reference
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INCREASED PLASMA CONJUGATED CHENODEOXYCHOLIC ACID: A
POSSIBLE KEY-MEDIATOR OF TYPE 2 DIABETES IMPROVEMENT
AFTER ROUX-EN-Y GASTRIC BYPASS
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Rationale: Bile Acids (BAs) are key signaling and regulatory molecules
with systemic endocrine functions and can integrate metabolic
regulation by activating specific receptors. Roux-en-Y gastric bypass
(RYGB) is associated with increased plasma BAs levels, and this has
been suggested as a main factor of metabolic improvements observed
in the early postoperative response, specially type 2 diabetes (T2D)
control. We assessed the effect of RYGB on plasma BAs levels in obese
patients and its potential relationship with T2D remission.
Methods: Plasma samples were collected from obese women with
T2D (n = 21) before and 3-month after RYGB. Twenty-four plasma BAs
from primary and secondary biosynthesis were measured by liquid
chromatography – triple quadrupole mass spectrometer in a targeted
approach. Patients were classified as responsive and nonresponsive to
T2D remission, and BAs alterations were compared by Wilcoxon test
and fold change.
Results: By comparing patients according T2D remission, different
altered BAs profile were observed. Increased levels of a primary BA
conjugatedwith both glycine and taurine (glycochenodeoxycholic and
taurochenodeoxycholic acids) was observed in responsive patients,
while nonresponsive patients showed alterations in two secondary
BAs: increased glycodeoxycholic acid and a decreased lithocholic acid
(p £0.05).
Conclusions: RYGB changed BAs levels, showing a different pattern of
alterations according to T2D remission. This indicates triggering a
different metabolic route, once that chenodeoxycholic acid, altered in
responsive patients is more likely to activate farnesoid X receptor;
while altered BAs identified in nonresponsive patients are more likely
to activate Takeda G-protein receptor 5. This BAs could act at different
key points of glucose metabolism, conditioning T2D improvement
after RYGB.
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BENEFICIAL EFFECTS OF LOW-CALORIE DIET ON VISCERAL
ADIPOSITY AND ADIPOKINE PROFILE
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Rationale: Abdominal obesity is associated with dyslipidemia,
hypertension, insulin resistance, and metabolic syndrome. An excess
of visceral fat is related to the dysregulated secretion of adipokines
which influence the vascular function and overall inflammation and
may be involved in cardiovascular risk. The adipokines are used as
adjunctivemarkers of metabolic disorders. The purpose of our study is
to evaluate the effects of energy intake restriction on visceral fat and
adipokine status.
Methods: The study involved sixty middle-aged obese women
(mean body mass index 35.3 kg/m2). We collected the data of
anthropometry, body composition analysis (InBody 770, Biospace
Co., Ltd, Korea), and biochemical markers (Konelab Prime 60i, Thermo
Scientific, Wilmington, DE, USA) before and after 1-month dietary
intervention.
Results: Therewas a significant decrease in body weight, fat mass and
visceral fat area (4.15 kg, 3.1 kg, and 12.67 cm2, respectively; p < 0.05).
49 (81.7%) women had elevated leptin levels; 22 (36.7%) had elevated
adiponectin levels. The average values were 49.92 ng/ml and 11.26 μg/
ml, respectively. After the dietary intervention, a significant decrease
in leptin and adiponectin levels were observed; however, the leptin/
adiponectin ratio did not show marked changes. After 1 month, the
normal leptin level was reached in 23 (38.3%) patients, while normal
adiponectin level was found in most patients (91.7%). The initial
visceral fat area correlated with leptin (r2 0.53), insulin (r2 0.38), and
C-peptide (r2 0.42) values.
Conclusions: The restriction of the energy intake leads to significant
positive changes in fat mass, visceral fat area, and adipokine status
and provide another biological explanation for the beneficial effect of
weight loss on reducing cardiovascular and diabetes risks in obese
patients. Correlation analysis also confirmed the relationship
between visceral fat, leptin and insulin levels, which is consistent
with data on the dramatic metabolic activity of the visceral adipocyte
pool.
Funding: Research work carried out at the expense of subsidies for
public tasks in the framework of the Program of Basic Research of state
academies of science for 2013–2020 (topic No 0529-2015-0013; 0529-
2017-0055; 0529-2017-0058).
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IMPROVEMENT IN INFLAMMATORY POTENTIAL OF DIETARY
PATTERN COULD CONTRIBUTE TO BETTER CARDIOMETABOLIC
RISK PROFILE
H. Ozcaliskan Ilkay1*, B. Cicek1. 1Nutrition and Dietetics, Erciyes
University, Faculty of Health Sciences, Kayseri, Turkey
* Corresponding author.
Rationale: Dietary patterns such as Mediterranean Diet with their
anti-inflammatory properties are associated with a decreased cardi-
ometabolic risk profile. Our objective was to evaluate the association
between the inflammatory potential of the diet and some anthropo-
metric variables that are indicators of cardiometabolic risk.
Methods: Eligible participants (n = 833, 446 male, 387 female, mean
age 24.8 ± 5.2 years) were recruited from Erciyes University’s Main
Campus. All data were gathered through interviews and clinical
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measurements. The dietary inflammatory index (DII) was computed
using 24-hour recalls. Lower DII scores indicate a lower inflammatory
potential of the diet. It was also reported that the DII score could take
on values ranging +8 (maximally pro-inflammatory) to −9 (maximally
anti-inflammatory). A fourteen-item dietary screener was used to
assess adherence to the Mediterranean diet (MeDiet). Each item is
worth 0 or 1 point. Higher scores reflect higher adherence.
Anthropometric measurements, including height, body weight, waist
circumference (WC), hip circumference (HC) and neck circumference
were evaluated according to standardized protocols. Partial correlation
coefficient was used to assess the relationship between DII, adherence
to the MeDiet and some anthropometric variables controlling for
energy intake. Statistical significance was accepted as p < 0.05.
Results: The mean DII score was 1.24 ± 1.50 (min: −2.97, max: 4.75),
whereas score of adherence to the MeDiet was 6.04 ± 2.36 (min: 0.0,
max: 13.0). DII showed significant positive correlation with body
weight (r = 0.097, p = 0.005), WC (r = 0.082, p = 0.018) and waist-hip
ratio (r = 0.113, p = 0.001), while adherence to the MeDiet showed
significant negative correlation with body weight (r =−0.096, p =
0.005), waist-hip ratio (r =−0.081, p = 0.020) and neck circumference
(r =−0.172, p = 0.000). In addition, there was a significant negative
correlation between DII and adherence to the MeDiet (r =−0.100,
p = 0.004).
Conclusions: An enhancement of dietary inflammatory potential with
better adherence to a MeDiet would improve the cardiometabolic
profile by supporting obesity management.
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FREE MASS SIX MONTHS AFTER ROUX-EN-Y GASTRIC BYPASS: A
CROSS SECTIONAL STUDY
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* Corresponding author.
Rationale: Roux-en-Y gastric bypass (RYGB) is the most effective
treatment for morbid obesity. One of the side-effects of RYGB is loss of
fat free mass (FFM). The preservation of FFM during weight loss (WL)
can be stimulated by high protein intake combined with resistance
training. However, it remains unclear whether this also applies to
patients undergoing RYGB. The aim was to examine the association
between dietary protein intake (DPI) and FFM six months post-
operative in patients undergoing RYGB correcting for the potential
distorting effect of physical activity.
Methods: This cross-sectional study included patients who under-
went RYGB at the Maasstad Hospital. Data were collected at the
outpatient clinic five to seven months postoperative. Collected data
consisted of sociodemographic variables, three-day food diaries, body
composition measured by bio-electrical impedance analysis,
anthropometric variables and information regarding physical activity.
Multiple linear regression analysis was used to investigate the
association between DPI and percentage FFM (%FFM).
Results: 76 patients (80.3% women; mean age 46.1 ± 9.8 years) were
included. Only 44.7% of the patients met the general protein
recommendation of ≥60 grams per day. There was a significant
difference in %FFM between patients consuming <80 grams of protein
and patients consuming ≥80 grams of protein (67.4% vs. 72.4%;
p = 0.035). There was no difference between patients consuming <60
grams of protein compared to patients consuming ≥60 grams of
protein. DPI was not significantly associated with %FFM in linear
regression analysis six months after RYGB corrected for physical
activity, gender, % excess WL, energy intake and preoperative BMI
(β = 0.006; p = 0.872).
Conclusions: LowDPI after RYGBwas common in this study. Therewas
no significant association between DPI and %FFM six months after
RYGB after correction for confounding.
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IMPLICATION OF THE GUT MICROBIOTA IN PERSONALIZED
METABOLIC RESPONSE TO DIETARY INULIN IN OBESE PATIENTS
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Expérimentales et Cliniques IREC, Université Catholique de Louvain,
Bruxelles, Belgium
* Corresponding author.
Rationale: Dietary supplementation with inulin as a prebiotic has
been shown to lessen obesity and relatedmetabolic disorders in some
individuals. Using mice transferred with the fecal microbiota from
obese patients, we have addressed the following question: do the
characteristics of the gut microbiota in obese individuals explain the
different physiological response to prebiotics?
Methods: The gut microbiota of four-week old mice was depleted
using antibiotics. C57BL/6J Mice were then colonized with stools from
one of the four human obese patients (hum-ob) selected for different
gut microbiota composition. Conventional and hum-ob mice were
then fed with a high-fat diet (HFD) during four additional weeks,
supplemented or not with native inulin (Cosucra) (6–9 mice per
group).
Results: We demonstrated a different response to inulin supplemen-
tation in hum-ob mice upon a HFD. Inulin supplementation largely
reduced the body weight of hum-ob mice for only one donor
(p < 0.05). Inulin significantly reduced hepatic steatosis (lipids and
triglycerides content), as well as the increased adiposity induced by
HFD for two donors. Despite an increased cecal content – signing gut
fermentation – observed in all humanized mice, the regulation of the
gutmicrobiota by inulin differs between donors. Themodel of hum-ob
mice allowed us to point out new bacteria associated to the metabolic
response to inulin. In addition, some bacterial genera (Barnesiella,
Victivallis, Akkermansia…) are correlated with the observed metabolic
outcomes in hum-ob mice. Interestingly, most of these bacteria seems
to be involved in the differential response by inulin observed in a
clinical trial with obese patients (NCT03852069).
Conclusions: Our work using a model of gut microbiota transfer from
patients into mice highlighted the differential response of humanized
mice to dietary supplementation with inulin. We propose that the gut
microbiota is an important component to be taken into account for
personalized nutrition related to prebiotic dietary fibers in the future.
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Rationale: Bariatric surgery (BS) is the most effective treatment for
morbid obesity. However, data are scarce regarding long-term changes
in quality of life (QoL) of this procedure and regarding predictors for
the improvement in QoL. Thus, our aims were to describe the health
status, QoL 24months following BS and assess whether those changes
are linked to magnitude of weight loss.
Methods:Cross-sectional study. Using electronicmedical records from
patients who underwent BS two years befote study, data related to
weight, evolution of comorbidities and early or late complications
linked to BS were collected. Efficacy of surgery and changes in QoL
were evaluated by Bariatric Analysis and Reporting Outcome System
(BAROS) questionnaire.
Results: 43 patients (72.1% women, aged 38.2 ± 9.2 years) were
evaluated. Before BS, weight was 139.9 ± 19.4 Kg; body mass index
(BMI): 52.7 ± 7.3 Kg/m2. Major and metabolic comorbidities were
present in 83.7% and 58.1%, respectively. Early and late complications
linked to BSwere present in 11.7% and 21.2% of the cohort, respectively.
Two years after BS, mean BMI was 30.6 ± 4.6 Kg/m2, percentage of
weight loss 40.9 ± 9.7% and total or partial remission of comorbidities
was observed in 91.6% of patients. Score BAROS classified QoL as
‘excellent’ in 59.6% and as ‘good’ or ‘very good’ in 38.1%. Changes in QoL
were not significantly linked to magnitude of weight loss or
development of complications.
Conclusions: BS provided long-term improvement in QoL in a large
number of patients with morbid obesity that is not linked to weight
loss magnitude or early or late complications linked to surgical
procedure.
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BIOIMPEDANCE ANALYSIS OVERESTIMATES APPENDICULAR
SKELETAL MUSCLE MASS FOR SEVERELY OBESE PEOPLE BUT
MIGHT BE A GOOD ALTERNATIVE MEASUREMENT
M.D. Ballesteros-Pomar1*, B. Pintor de la Maza1, E. González Arnaiz1,
P. Fernández Martínez1, A. Urioste Fondo1, D. Ariadel Cobo1,
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Rationale: Although measurement of appendicular skeletal muscle
mass (ASM) using dual-energy X-ray absorptiometry (DXA) is the gold
standard for the diagnosis of low muscle mass, bioelectrical
impedance analysis (BIA) might be a cheaper and easily available
alternative to diagnose sarcopenic obesity
Methods: Cross-sectional observational study to compare measure-
ments of ASM and whole fat mass (FM) obtained using dual energy X-
ray absorptiometry (DXA, Lunar iDXA, GE Healthcare, USA) and
bioelectrical impedance analysis (BIA, MC-780A; TANITA, Tokyo,
Japan) performed in the same day in patients with morbid obesity
submitted to our Obesity Clinic. Exclusion criteria were weight over
150 kg, difficulty in maintaining an upright position or presence of
pacemakers. ASM (sum of lean mass in both legs and arms), ASM/
height2 and ASM/BMI are reported as median (interquartile range) as
Kolmogorov-Smirnov test confirmed a non-normal distribution; FM is
reported as mean (standard deviation) as it adjusted to a normal
distribution. Bland Altman method was used to compare BIA vs DXA
and reliability analysis was performed using intraclass correlation
coefficient (ICC)
Results: 72 patients with BMI >35 (mean 42.5 Kg/m2, SD 4.9) were
included, 73.6% were women, mean age 42.3 (SD 8.5). ASM measured
by BIAwas 26.2 (9.4) kg and by DXA 20.9 (5.9) kg; ASM/height2 by BIA
9.8 (2.1) and by DXA 7.8(1.5)kg/m2; ASM/BMI by BIA 0.58 (0.2) and by
DXA 0.46 (0.15). FM by BIAwas 56.4 (9.4) kg and by DXA 51.5 (5.9) kg
ICC (95% confidence
interval)
BIA-DXA Bias
(Limits of
agreement)
ASM (kg) 0.874 (0.796–0.922) +7.1 (−0.8,+15.1)
ASM/height2 (kg/m2) 0.730 (0.564–0.833) +2.5 (−0.0,+5.1)
ASM/BMI 0.902 (0.841–0,939) +0.16 (−0.01,+0.32)
FM (kg) 0.929 (0.886–0.956) −3.7 (−13.5,+6.2)
Conclusions: Although BIA overestimated ASM (and consequently
ASM/height2 and ASM/BMI) and underestimated FM compared with
DXA, reliability analysis showed an excellent intraclass correlation.
This differences must be taken into account to diagnose sarcopenic
obesity, so cut-off points for BIA should be defined
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LACK OF CONCORDANCE AMONG DIFFERENT DEFINITIONS OF
SARCOPENIC OBESITY IN PEOPLE WITH MORBID OBESITY
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Rationale: Low muscle mass and quality have a strong negative
prognostic impact in obese individuals. However, consensus on the
definition and diagnostic criteria of sarcopenic obesity is lacking
Methods: Cross-sectional observational study to assess the prevalence
of sarcopenic obesity in patients with morbid obesity. The study was
approved by the Ethical Research Committee of the CAULE (approval
no 1775/2017). Dual energy X-ray absorptiometry (DXA, Lunar iDXA,
GE Healthcare, USA) and bioelectrical impedance analysis (BIA, MC-
780A; TANITA, Japan) were performed in the same day. Hand grip
strength (HGS) was measured with DynxR (Akern, Italy) and physical
performance was assessed by timed up and go test (TUG), both are
expressed as median(interquartile range). Fat mass/free fat mass ratio
(FM/FFM) using BIA, appendicular skeletal muscle mass (ASM) by
DXA, ASM/height2 and ASM/BMI were used to assess SO by different
definitions (table 1). Concordance among different definitions was
assessed by Coheńs kappa test. Mann Whitney U- test was used to
assess relationship of different definitions with either hand grip
strength or TUG.
Table 1
Author Criteria Men 18–40
years old
Men 40–60
years old
Women
18–40
years
old
Women
40–60
years
old
Xiao CN
2018 (1)
FM/FFM (BIA)
>percentile 95
0% 27,3% 0% 3,2%
EWGSOP 2 (2)
and FNIH (3)
ASM (DXA)
<20 kg men/<15
women
0% 0% 4.8% 3,4%
EWGSOP2 (2) ASM/height2
(DXA) <7 kg/m2
men/<6 women
0% 0% 4.8% 3,4%
Masanes
2012 (4)
ASM/height2 (BIA)
<8.31 Kg/m2
men/<6.68
Kg/m2 women
25% 36,4% 19% 10,3%
Chiles
Shaffer (5)
ASM/BMI <0.725
<0.591
62,5% 81,8% 100% 100%
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Results: 72 patients with BMI >35 (mean 42.5 Kg/m2, SD 4.9) were
included, 73.6% were women, mean age 42.3 (SD 8.5, range 22–59).
HGS was 23,8 kg/13,4) and TUG 9,0 sec (2,15). Table 1 shows the
prevalence of sarcopenic obesity (%) according to different criteria.
Coheńs kappa tests were below 0.2 for all the combinations of criteria.
No differences were found in either hand grip strength or TUG, no
matter the definition of SO used.
Conclusions: Definition of sarcopenia in obese people is challenging
and concordance among current criteria is very poor in our patients
with morbid obesity. Further research is needed for a consensus
definition.
References
1. Xiao J, et al. Clin Nutr. 2018;37(6 Pt A):2284–2287.
2. Cruz-Jentoft AJ, et al. Age Ageing. 2019 Jan 1;48(1):16–31.
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Rationale: A high fat mass to fat-free mass ratio (FM/FFM) has been
postulated (1) as a marker of sarcopenic obesity (SO) and linked to
worse health outcomes. Diagnosing this condition might be
challenging
Methods: Cross-sectional observational study to assess FM/FFM in
patients with morbid obesity submitted to our Obesity Clinic. The
study was approved by the Ethical Research Committee of the CAULE
(approval no 1775/2017) and after written informed consent, patients
underwent dual energy X-ray absorptiometry (DXA, Lunar iDXA, GE
Healthcare, USA) and bioelectrical impedance analysis (BIA, MC-780A;
TANITA, Tokyo, Japan) performed in the same day. Exclusion criteria
were weight over 150 kg, difficulty in maintaining an upright position
or presence of pacemakers.
FM/FFM was calculated for DXA- and BIA-based measurements and
reference values using BIA published by Xiao were used to assess SO,
defined by a FM/FFM ratio greater than the 95th percentile of sex, BMI
and age. Bland Altman method was used to compare BIA vs DXA and
reliability analysis was performed using intraclass correlation coeffi-
cient (ICC).
Results: 72 patients with BMI >35 (mean 42.5 Kg/m2, SD 4.9) were
included, 73.6%werewomen,mean age 42.3 (SD 8.5, range 22–59). FM
by BIA was 56.4 (9.4) kg and by DXA 51.5 (5.9) kg. Table 1 shows
median and interquartile range for measurements, ICC and limits of
agreement. FM/FFM was higher for females in the range of 40–60
years-old. According to Xiao et al reference values, 4.2% of our patients
had a FM/FFM higher than P95
Table 1
BIA DXA ICC (95% confidence
interval)
BIA-DXA Bias
(Limits of
agreement)
FM (kg) 57.7 (48.2–63.0) 59.9 (54.0–67.6) 0.929 (0.886–0.956)−3.7 (−13.5,+6.2)
FFM (kg) 66.1 (60.5–76.0) 61.2(55.4–71.8) 0.955 (0.927–0.972) +3.6(−6.4,+13.6)
FM/FFM 0.82 (0.74–0.93) 0.96 (0.76–1.15) 0.755 (0.605–0.848)−0.23 (−0.54,+0.07)
Conclusions: FM/FFM ratio classified 4.2% of our patients as having
sarcopenic obesity. Although BIA infraestimates FM/FFM, a good ICC
makes it a suitable measurement vs DXA
Reference
1. Xiao J, Purcell SA, Prado CM, Gonzalez MC. Fat mass to fat-free
mass ratio reference values from NHANES III using bioelectrical
impedance analysis. Clin Nutr. 2018 Dec;37(6 Pt A):2284–2287. doi:
10.1016/j.clnu.2017.09.021. Epub 2017 Oct 6.
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RESTRICTION
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Rationale: Calcium is one of the responsible nutrients for bone health
and can only be obtained exogenously through food. Dairy is the
richest source of calcium in our diet. The aim of this study was to
determine whether children who do not consume dairy products
regularly show adequate bone mineral density.
Methods: Anthropometry (weight, height and abdominal circumfer-
ence) and body composition (DEXA) children aged 3 to 11 years
regularly restricting milk intake were evaluated. A questionnaire of
habits and feeding frequency was also applied.
Results: Seventeen children were included, with a mean age of 6.7
years old. Four childrenwere taking vitamin D supplementation; none
was taking calcium. All children showed adequate height Z Score (−2
to +1). Sixteen individuals were breastfed in the past with a mean
duration of exclusive breastfeeding of 5.6 months. Mean total time of
breastfeeding was 25.3 months.
Thirteen subjects do never consume dairy or do it less than once a
month. The remainder consumed it 1 to 3 times amonth. Two children
reported drink fortified vegetable beverages on a daily basis, 7 drink
once a week and the rest do it even less often.
About the consumption of dark green vegetables, 2 kids consume 4 to
5 servings per day, 7 consume2 to 3 servings per dayand 3 one per day.
The rest ingest once a week.
The parents of 6 children find that their descendants consume few
dark green vegetables and seaweed. Sixteen consume added sugar
food less than once a month.
Average BMD Z-Score was−1.05, with 6 children presenting BMD
Z-Score adequate (−1 to +1). The remaining 6 showed values
lower than−1.
Conclusions: Children submitted to dairy restriction do not seem to
accomplish calcium requirements. This may justify that low bone
mineral density was present in half of the sample.
The intake of 2 servings of calcium-fortified vegetable drinks per day
and the increase the intake of dark green vegetables is, thus, suggested.
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BREAST MILK FATTY ACIDS INFLUENCE INFANT GROWTH AND
COGNITION: THE PREOBE STUDY
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Rationale: Breast milk reflects the maternal nutritional status and is a
key source of polyunsaturated fatty acids (PUFAs), crucial in growth
and development, especially arachidonic (AA) and docosahexaenoic
acid (DHA). This study aimed to analyze the effect of colostrum fatty
acids (FAs) on infant outcomes to raise awareness about the
programming effect of maternal nutrition and promote a healthy
diet in women.
Methods: Mother-child pairs (n = 78) of the PREOBE cohort were
classified in normal-weight, overweight and obese mothers. PUFAs
and long-chain PUFAs (LCPUFAs) were determined in colostrum
collected 2–4 days and are presented in percentage of total FAs.
Infant bodymass index-for-age z-scores (BMIZ)weremeasured at 6,18
and 36months of age. Cognitionwas assessed at 18months of agewith
the Bayley-III Scale.Maternal pre-pregnancyweight and infant feeding
practice were considered for analysis.
Results: BMIZ at 6 months of age were inversely associated with
colostrum levels of AA (β−0.44, p 0.02), DHA (β−0.37, p 0.04),
PUFAn3 (β−0.38, p 0.04), LCPUFAn6 (β−0.38, p 0.04), LCPUFAn3 (β
−0.43, p 0.02), whereas n6:n3 ratio was positively associated with
it (β 0.42, p 0.03). Cognition of infants born to normal-weight
mothers was enhanced with colostrum linoleic acid (β 0.84,
p < 0.001) and PUFAn6 (β 0.81, p 0.002). Infant cognition of
overweight mothers was endorsed with DHA (β 0.88, p 0.04) and
LCPUFAn3 (β 1.01, p 0.004), while the n6:n3 ratio (β−0.97, p 0.02)
showed an inverse association.
Conclusions: The early supply of n6 and n3 impacts infant nutritional
status and cognition, at 6 and 18months of life, respectively. This study
endorses the need for preventive health care. Since breast milk
influences the early nutritional status of the child, which is related to
health conditions through life span, a healthy diet inwomen should be
encouraged to increase the quality of breast milk and promote
healthier future generations.
Disclosure of Interest: None declared.
SUN-PO292
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COMPOSITION IN THE OFFSPRING COMPARED TO ARTIFICIAL AND
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Rationale: Early life nutrition has a programming effect in the future
health of the child and, even when the World Health Organization
recommends exclusive breastfeeding up to 6 months of age with
continued breastfeeding up to 2 years of age or beyond, the rate of
breastfeeding is alarmingly low. Since polyunsaturated fatty acids
(PUFAs) and long-chain PUFAs (LCPUFAs) play a crucial role in survival,
growth and development of the child, the aim of this study was to
analyze the effect of infant feeding practices in their FA levels and to
discuss the implications in future health to promote breastfeeding in
the scientific community and citizens.
Methods: Children of the PREOBE study were included (n = 102). FAs
were analyzed from cheek cell samples collected at 6 months of age of
children that were 1) breastfed and 2) formula or mixed-fed during
their first 3months of life. Potential cofounders, such as pre-pregnancy
maternal weight status and infant gender, were considered to perform
the analysis.
Results: Infant linoleic acid (β = 0.37; p < 0.001), arachidonic acid
(β = 0.22; p = 0.026), PUFAn6 (β = 0.39; p < 0.001), LCPUFAn6 (β = 0.23;
p = 0.019), docosahexaenoic acid (β = 0.29; p = 0.003) and LCPUFAn3
(β = 0.22; p = 0.032) levels were positively associated with exclusive
breastfeeding. Instead, α-linolenic acid was negatively associated with
it (β =−0.41; p < 0.001), possibly due to an increased DHA conversion.
Conclusions: Exclusive breastfeeding is associated to a healthier
infant FA composition, known to enhance neurodevelopment and
growth and protect from conditions, such as cardiovascular diseases
and allergies. This information provides further evidence of the
positive programming impact of breastfeeding in future health.
Dissemination of these results can contribute to raise public awareness
and engage societyand health care providers to promote breastfeeding
beyond other feeding practices.
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Rationale: Although the diagnosis of malnutrition includes the
analysis of growth charts, most studies assessing the nutritional
status only consider nutritional indices. The aim of our study was to
analyze previous growth data in hospitalized children.
Methods: This observational study included hospitalized children
fromMarch 12 to 23, 2018 in the French participating centers. Children
from 0 to 18 years old were included, except premature infants. The
date, weight and height of the last known point of the health book
were recorded. Nutritional status was assessed at admission and
discharge from hospital. A growth faltering of 1 SD in 3 months and a
Waterlow index <−2 SD were compatible with malnutrition. Recent
follow-up was defined as <3 months for children under 2 years, <6
months for children between 2 and 5 years, and <1 year for children
older than 6 years. Data was recorded in the e-Pinut internet tool
(www.epinut.fr), allowing the calculation of indices according to
French standards.
Results: Among the 1385 children included in 48 centers, 671 children
(48%), had previous documented growth data. The frequency of
malnutrition was 6% at the last known point, 11% at admission
(p < 10−4). A recent follow-up was present in 76% of cases; 87% for
children under 2 years, 69% for children between 2 and 5 years and 64%
for children older than 6 years (p < 10−4), making 37% of the data
relevant. Children <2 years and ≥6 years of age with chronic diseases
were more likely to have recent follow-up than children without
chronic disease (90% vs. 81%, p < 0.05, 77% vs. 50%, p < 10−4) but not 2 to
5-year-old children. Twenty-eight percent of children had growth
faltering before hospitalization. They did not have a different
hospital length of stay than other children (4.0 ± 4.0j vs 4.0 ± 4.3j,
NS), nor a different frequency of nutritional treatment at admission
(14% vs. 16%, NS).
Conclusions: In hospitalized children, previous growth data are
relevant in only barely 1/3 of cases. Growth charts, a major part of
the nutritional assessment, are insufficiently available in hospitalized
children, particularly in children ≥6 years old without chronic
pathology. The higher frequency of malnutrition at admission than
at the last point of the health record and the high frequency of growth
faltering suggest an acute impact of the disease leading to
hospitalization.
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EVALUATION OF EATING HABITS OF ADOLESCENTS FROM HIGH-
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Pathophysiology, University of Medicine and Pharmacy ‘GR. T.POPA’,
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Biostatistics, University of Medicine and Pharmacy ‘GR. T.POPA’, 5Dr.
Ghelerter’ Centre, 6Discipline Public Health and Management, University
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* Corresponding author.
Rationale: The purpose of the study was to assess the eating habits of
some adolescents and, depending on the results, the necesity of an
educational program contributing to significant health benefits.
Methods: The study developed between January 2016 and December
2017 included 1320 adolescents from 4 high-schools. The adolescents
completed a questionnaire about nutritional status and eating habits.
The data were code and entered into the EXCEL® program and then
exported to the statistical application. The analyses were performed
using IBM SPSS version 18. Statistically values with a p-value <0.05
were considered significant, thus setting up a level of confidence of
95%.
Results: Only 9.07% of adolescents were overweight or obese.
Breakfast was the most skipped meal. The most adolescents (63.56%)
consuming 3–4 meals/day. 77.8% consumed a maximum of 3 servings
of whole grains/day, 4.6% consumed more than 6 servings/day of
refined cereals, but therewere no statistically significant differences in
the relationship between BMI and the number of portions of refined
cereals consumed. 39.31% consumed less than 2 servings of fruits/day,
and 32.90% consumed more than 3 servings of sweets daily. 9.77% did
not consume dairy at all or very rarely. The study of the relationship
between meat consumption and sweets revealed statistically signifi-
cant differences in the fact that both girls and boys who consumed
more meat consumed even more sweets (p = 0.00). 16% consumed
daily at least 3 servings of fat foods. 37.87% consumed caffeine
products at least once a week and 5.68% consumed over 2 daily
alcoholic beverages.
Conclusions: Taking into account the results obtained, it is necessary
to develop a nutritional education program to improve nutritional
knowledge and to make future healthy food choices.
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ACHIEVING ENTERAL AUTONOMY IN CHILDREN WITH INTESTINAL
FAILURE: LACK OF CORRELATION BETWEEN CLINICAL AND
MORPHOLOGICAL PRESENTATION
I. Averíanova1, D. Petrov2, S. Makarov3*, E. Zhelezoglo4, A. Ermolayeva5.
1Russian Childrens Clinical Hospital, Москва, 2Pediatric Surgery, Pirogov
Russian National Research Medical University, Moscow, 3Russian
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* Corresponding author.
Rationale: The aim is to demostrate the lack of correlation between
clinical and morphological presentation of intestinal adaptation and
the achievement of enteral autonomy
Methods: Short bowel syndrome (SBS) and gastrointestinal neuro-
muscular diseases (GINMDs) are the most frequent causes of chronic
intestinal failure (IF) in children.
58 patients with SBS and 44 children with GINMDs aged 1 months to
17 years have been treated in the department of Pediatric Surgery at
Russian Children’s Clinical Hospital. We have a wide range of non-
transplant treatment options: home parenteral nutrition (HPN)
program, autologous intestinal reconstructions, drug therapy enhan-
cing intestinal absorption (teduglutide). Enteral nutrition of children
of the first year of life is carried out with breast milk or oligomeric
nutrient formulas. In some SBS patients and children with CIPO, we
apply night feeding via gastrostomy tube. The introduction of
complementary foods begins at 4 months of age which prevents the
formation of eating disorders.
Evaluation of jejunal biopsies for morphological signs of intestinal
adaptation has been performed in all cases which included villi hight,
crypt depth and intracellular mitosis.
Results: Fourteen SBS children remain off PN 32 months after STEP
procedure; nineteen children after intestinal reconstractions continue
to receive reduced PN 2–4 nighta a week – all with reassuring growth
and nutritional status. Teduglutide therapy in 5 SBS patients allowed to
increase enteral tolerance and reduce in PN by 50% within 12 weeks.
23% patientswith GINMDs, (but not CIPO), achieved enteral autonomy.
Based on morphological evaluation we have not noted a correlation
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between the describedmorphological changes and clinical signs of the
degree of enteral tolerance.
Conclusions: Up to date the assessement of intestinal adaptation has
been based mainly on clinical signs such as volume and frequency of
stools, urine output and preservation of nutritional status during the
reduction of PN.Morphometric criteria of intestinal adaptation such as
villi lengthening and crypt deepening do not directly correlate with
the severity of enteral autonomy. More studies are needed to
investigate specific markers of intestinal adaptation to be able to
work out personolezed nutritional strategies.
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PAEDIATRIC PARENTERAL NUTRITION COMPLIANCE: A SIMULATED
COMPARISON BETWEEN THE OLD (2005) VERSUS THE NEW (2018)
ESPEN/ESPGHAN/ESPR/CSPEN GUIDELINES
N. Vercaigne1, G. Meers1*, H. Collier1, B. Hauser2, K. Vergaelen2, E. De
Waele3, P.-J. Cortoos1, S. Steurbaut1. 1Pharmacy, 2Pediatrics, 3Intensive
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* Corresponding author.
Rationale: With the advent of the new 2018 guidelines on pediatric
parenteral nutrition (PPN), there is an important shift towards infusing
less carbohydrates, with the aim of reducing related hyperglycemia,
hepatic problems and mortality. Therefore we decided to retrospect-
ively evaluate PPN policy in our hospital, to see how our local
nutritional policy and choice of needed PPN infusions should be
adapted accordingly.
Methods: Setting: 750-bed tertiairy care hospital in Belgium. All PPN
therapies between 2015 and 2018 from patients >6 months and <18y,
hospitalized on a pediatric unit were included in our study. For each
patient, optimal PPN therapy was retrospectively calculated (carbohy-
drates (CH), lipids, amino acids (AA) and total energy requirement
(TER) according both 2005 and 2018 guidelines and compared with
the actually administered PPN. TER was calculated according the
Schofield formula. A difference below 10% between theoretical and
prescribed values was considered compliant. For pharmacy com-
pounded mixtures (PCM), physicians used specific software
(Nutriscript®) to calculate required nutrients, accounting for most
recent recommendations. All other ready-to-use (RTU)mixtures could
be prescribed through the local CPOE system. In order to increase RTU
use instead of PCM, all therapies were finally compared against
formulations available on the hospital formulary (Olimel® N5+ N7,
Smofkabiven® 20GN) or specifically registered for pediatric use
(Numetzah® G16 + G19).
Results: 113 patients were included, comprising 1671 PPN days (913
PCM, 758 RTU, 658 without lipids). Median patient age was 6.0 years
(range 0.5–17.5y). Median PPN durationwas 9 days (range 1–69 days).
Overall, 52.5% of all patients were evaluated bya dietician. Compliance
rates are presented in Table 1. All differences between both guidelines
were highly significant (p < 0.001)
AA (%
compliance)
CH (%
compliance)
Lipids (%
compliance)
TER (%
compliance)
2005 2018 2005 2018 2005 & 2018 2005 2018
All 70% 58 86 58 75 34 71
RTU 65 44 86 61 83 43 71
PCM 73 67 86 56 69 27 73
Regarding CH, there is an important decrease in compliance if the new
guidelines are applied, resulting in 41% of all prescriptions being
overdosed on CH. Equally there is a decrease in AA compliance with
32% being overdosed, especially for the RTU (42% overdosed). In
contrast, TER compliance showed a high increasewith in total only 16%
exceeding calculated energy needs, although for PCM this still
amounted to 23% requiring some adjustments of the Nutriscript®
system. All For lipids, no changes were made between the 2005 and
2018 recommendations but overall compliance is good.
For the 0–2 year age group, AA and lipid needs are well covered by
Numetzah G16 if prescribed using TER, although CH are often
overdosed (3–104%) and volume is often too low (2–45%) necessitating
additional dilution with water. Above 2 years, Numetzah G19 showed
the highest compliance when body weight remained below 30 kg.
Above 30 kg, a better compliance is seen when Olimel N5 would be
used, although N7 is suitable in case of high AA need.
Conclusions: The introduction of new guidelines on PPN results in
significant changes regarding nutrient compliance and a thorough re-
evaluation of current practice is recommended. Based on our
observations, we have developed a new prescribing algorithm to
guide physicians towards more appropriate PPN prescribing.
References: ESPGHAN/ESPEN/ESPR/CSPEN Guidelines on pediatric
parenteral nutrition
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EFFECTIVENESS OF THE DISCHARGE EDUCATION PROGRAM FOR
CHILDREN WITH GASTROSTOMY TUBE ON CAREGIVING BURDEN,
KNOWLEDGE, AND ANXIETY LEVEL OF THE MOTHERS
H. Pars1*, T. Soyer2. 1Department of Pediatric Nursing, Hacettepe
University Faculty of Nursing, 2Department of Pediatric Surgery,
Hacettepe University Faculty of Medicine, Ankara, Turkey
* Corresponding author.
Rationale: The purpose of this pre- and post-training descriptive
evaluation study was to investigate the effects of a standardized
evidence-based discharge education program prepared for children
with gastrostomy tubes on caregivers’ knowledge, anxiety levels, and
caregiving burden.
Methods: This quasi-experimental study was conducted between
November 2017 and November 2018 and was carried out to examine
the improvement in caregivers and the patient after implementation
of standardized evidence-based discharge education. The study
employed a pre- and post-training descriptive evaluation. The
primary caregivers of children with a gastrostomy tube were (n = 30)
interviewed on the first day of the education, and a pretest, the Zarit
Caregiver Burden Scale, and the State and Trait Anxiety Inventory
(STAI) were applied. The designed training was subsequently imple-
mented. The primary caregivers were reinterviewed during the first
week and the third month after the education, and the posttest, Zarit
Caregiver Burden Scale, and STAI were reapplied. To evaluate the
effects of the education on the patient, complications of enteral
nutrition experienced during the process were followed in clinical
interviews.
Results: The study revealed that the knowledge levels of mothers
increased in the first week and third month after the training, and
their caregiving burden and state-trait anxiety levels decreased
significantly. Furthermore, although some complications were
observed depending on the enteral nutrition process, it was found
that the complications were fewer, and the difference was statistically
significant compared with the group that did not receive the
standardized evidence-based discharge education program.
Conclusions: Families be educated in the hospital environment
with the support of the clinical nurse and nutritional team so that
they can learn the steps of enteral nutrition and how to manage
complications. Standardized education program can be recommended
because caregivers manage home care process more successfully and
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that their stress, anxiety, and difficulties experienced during care will
decrease.
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REDUCED SALT CONTENT OF SCHOOL RESTAURANT LUNCHES
THROUGH COORDINATED INTERVENTIONS BY A HEALTH
NETWORK, WITH KITCHEN STAFF AND INDUSTRIAL FOOD
SUPPLIERS
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C. Soulefour1,M. Guitard1, S. DeMagalhaes1, V. Javerliat1, C. Bachelerie5,
C. Jalladeau5, A. Lecointre5, P. Fayemendy1,2,3,4, P. Jésus1,2,3,4. 1Limousin
Nutrition (LINUT) network, Isle, 2Institute of Neurological Epidemiology
and Tropical Neurology, CNRS FR 3503 GEIST, University of Limoges,
3INSERM, U1094, Tropical Neuroepidemiology, School of Medicine of
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* Corresponding author.
Rationale: Reduced salt consumption in children has a positive effect
on blood pressure, and can induce a decrease in sugary drinks, so can
affect weight. For French National Health Program, the average salt
consumption target is 6.5 g NaCl /d in child, i.e. 2.6 g for lunch. For
prevention purposes, the City of Limoges wanted with the support of
the Regional Health Agency (RHA) to test if a reduction of at least 20%
of the salt load of lunches of 3 school restaurants was possible.
Methods: 1st step: 3 restaurants representative of the city’s 17 school
restaurants were selected. The chosen effector was the network RHA
Limousin nutrition (LINUT), specialized in Nutrition and authorized to
carry out training and audits. For the 3 restaurants and 3 consecutive
days, the salt content of maternal and primary classes’ identical meals
was measured. Results were reported to values recommended by the
French Collective Restoration and Nutrition Market Review Group.
2ndstep: cooking and service staff of all restaurants had 28 h training,
and 10 points for possible improvement were identified with the
employees. Suppliers of the saltiest foodswere asked to reduce the salt
content of their products; the 10 measures were implemented.
3rdstep: The salt content of luncheswas againmeasured sevenmonths
after the initial tests.
Mann–Whitney and Kruskal-Wallis tests were used.
Results: Initial measures showed excess salt intake in all schools
(3.7 ± 0.2 for nurseries and 5.0 ± 0.2 g NaCl for primary schools, with
differences between the schools; p = 0.002). 82–88% of personnel
expected to attend training were present. Suppliers responded to
requests by delivering less salty foods in four cases on five of the most
initial salty ones (including bread) (p = 0.04 to 0.02 compared to initial
salt concentrations). At the final tests, salt content was close to the
recommended values (2.5 ± 0.4 for nurseries; reduction: 32.4%, and
3.4 ± 0.5 g NaCl for primary schools; reduction: 32.0%), and lower than
initial values (p = 0.0001).
Conclusions: This preventive action made possible to highly reduce
the salt content of lunch in the school restaurants studied beyond the
initial objective. This is the first time that such an action is described,
involving the kitchen staff and the food industrialists.
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IRISH DIETITIANS’ ATTITUDES AND EXPERIENCES OF BLENDED
TUBE FEEDING IN PAEDIATRICS
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Rationale: Blended tube feeding (BTF) describes the provision of
whole foods blended to a smooth puréed consistency for bolus (i.e.
non-pump driven) administration through a feeding tube.While there
is growing international data on BTF, Irish data is lacking. Anecdotal
evidence from Irish clinicians suggests that BTF is being used as an
alternative or to supplement commercial nutritional feeds among
some paediatric patients and their caregivers. This study examined; a)
the number of Irish registered dietitians (RDs) in both acute and
community settingswho currently support blended tube feeding (BTF)
in the home environment and what proportion of RDs current
caseloads patients using BTF account for; b) the attitudes and
experiences of RDs towards BTF use within the paediatric population;
c) recommendations on information and future resources required by
RDs to support patients choosing BTF.
Methods:An online surveywas conducted on eighty-two RDs through
relevant databases of Irish dietetic professional bodies and Health
Service Executive (HSE) working groups. Quantitative data was
collected over a four-week period and examined through cross-
tabulations and Mann-Whitney U tests. Qualitative analysis was used
to categorize free-text responses.
Results: Sixty-nine respondents were based in paediatric settings on a
full or part time basis and the remainder had an adult only caseload.
Over two thirds reported Home Enteral Nutrition (HEN) patients on
their caseloads (n = 48/69, 70%). Over half of RDs with HEN caseloads
managed patients choosing to use BTF (n = 27/48, 56%). The greatest
concentration of RDs with both BTF and commercially formula fed
patient groups were in tertiary hospitals (HEN; n = 20/48, 42%, BTF;
n = 12/27, 44%). Almost half of RDs were willing to support patients
choosing to use BTF in practice or on a patient case basis (n = 36/77,
47%). RDs reported that international guidelines were the most used
source of information to guide practice (n = 40/69, 58%). Professional
training and workshops were the preferred method of learning
(n = 60/73, 82%) for RDs.
Conclusions: The choice to use BTF appears to be commonwithin the
HEN paediatric patient cohort. Development of dietetic models of care
and resources as well as access to RDs for patients who choose to use
BTF are required. Professional guidelines, training and information in
the Irish setting are needed to support dietetic practice in this area.
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PARENTERAL NUTRITION INDICATIONS AND USE IN CHILDREN
WITH CANCER
K.H. McGrath*,1,2, J. Yap3. 1Gastroenterology and Clinical Nutrition, The
Royal Children’s Hospital, 2Intestinal Failure and Clinical Nutrition Group,
Murdoch Children’s Research Institute, 3Department of Paediatrics,
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Rationale: Children with cancer are a common referral group for
parenteral nutrition (PN) however patterns of use in this population
are poorly described and published indications for PN in childrenwith
cancer are generally non-specific.1–3We sought to describe patterns of
use, indications and frequency of PN use in children with cancer at a
tertiary referral paediatric hospital.
Methods: A retrospective chart review of all children with cancer
receiving inpatient PN in a tertiary referral paediatric hospital over 12
consecutive months was performed using electronic medical record
search and records. Data was summarised using descriptive statistics.
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Results: PN was prescribed to 88 patients (n = 47 haematological
cancer) in 111 episodes. Total PN days were 2377, representing 24% of
annual inpatient days in children with cancer (excluding day
admissions). Primary clinical indications were mucositis (n = 44,
40%), feed intolerance (n = 32, 29%), post-operative (n = 18, 16%) and
‘other’ (n = 17, 15%) [conservative surgical management (n = 7);
aspiration (n = 1); patient/parent refusing nasogastric tube (NGT) or
enteral nutrition (n = 7); NGT contraindicated (n = 2)]. Patients with
haematological cancer had longer median episodes (19 vs. 12.5 days)
and earlier commencement of PN after diagnosis (50 vs. 80 days) than
children with non-haematological cancer. Children with HSCT (n = 35,
40%) had longer median episodes than those without HSCT (24 vs. 11
days). 74% of PN episodes longer than 28 days were in children with
HSCT (17/23).
Conclusions: Inpatient PN use is common in childhood cancer.
Common indications are mucositis, feed intolerance, post-operative
and conservative surgical management. Patterns of use are influenced
by cancer type and treatment modality. Understanding PN demand
and use may assist development of specific nutrition support tools to
aid appropriate PN prescription, guide resource allocation and support
patient counselling.
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Rationale: The results of surgical treatment of invasive gastric cancer
are still not content. Adequative preoperative immunonutrition can
contribute to their improvement.
Methods: The study involved patients with invasive gastric cancer
prepared to surgery. They were fed a natural hospital diet. In addition,
each patient received a three-chamber nutritional bag with a capacity
of 1206 ml. Patients were randomly divided into three immunonutri-
tion groups. Group I was given an oral glutamine (Resource Glutamine)
2 × 5 g daily. Group II received an oral ω-3 fatty acids (Supportan) in the
amount of EPA andDHA2.8 g daily, andGroup III a solution of arginine,
ω-3 fatty acids and nucleotides (IMPACT) in the amount of 8.6 g
arginine, 2.37 g of ω-3 fatty acids, and 0.86 g of nucleotides per day.
Lean body mass, and muscle strength was measured and skeletal
muscle mass and index was calculated twice – before and after
immunonutrition.
Results: Forty-six patients was enrolled into the study. Eleven patients
lost above 10% body weight, on average 17.6%. The average duration of
immunonutrition was from 7 to 24 days–on average 12 days. In Group
with arginine, ω-3 fatty acids, and nucleotides supplementation the
muscle strength improved significantly (p < 0,05). Other parameters
did not changed relevantly. In patients with oral glutamine supple-
mentation and ω-3 fatty acids supplementation there was no
statistically significant changes in muscle parameters.
Conclusions: Immunonutrition based on different models protected
against loss of skeletal muscle mass, index, muscle strength and lean
body mass, but it did not improve these values. Immunonutrition
containing the supply of arginine, ω-3 fatty acids and nucleotides
improved muscle strength in patients with gastric cancer.
Disclosure of Interest: None declared.
SUN-PO302
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COMPLICATIONS AFTER CARDIAC SURGERY
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Rationale: Studies evaluating the fasting time and the occurrence of
post-cardiac complications are scarce. It is an area ofmultiprofessional
interest and the results can direct new research.
Methods: Observational and Longitudinal study, involving patients
submitted to cardiac surgery from a public institution specializing in
cardiology care in São Paulo.
Results: Sixty patients with a mean age of 62.3 ± 9.24 years of age
participated in the study. The mean preoperative fasting time (pre FT)
was 13.84 ± 2.08 hours and the perioperative fasting time (peri FT)was
42.49 ± 13.35 hours, patients remained on average in the intensive care
unit (ICU) for 74.5 ± 44.10 hours and 11.9 ± 5.26 hospitalized days.
There was no association between pre FT and postoperative complica-
tions. The peri FT was positively correlated with length of ICU stay
(p < 0.01), with orotracheal intubation time (OIT), which is associated
with hospitalization time (HT) (p < 0.01). Every 1 hour in fasting
increases the risk of chances of postoperative complications by
approximately 40% (p 0.008).
Conclusions: There is a higher risk of postoperative complications of
cardiac surgeries with increased perioperative fasting time, these
complications may influence the prolongation of ICU stay and
hospitalization.
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ENTERAL NUTRITION TUBE PLACEMENT ASSISTED BY
ULTRASONOGRAPHY IN PEDIATRIC PATIENTS AFTER MAJOR
ABDOMINAL SURGERY
D. Dmytriiev1*, K. Dmytriieva1. 1Vinnitsa National Medical University,
Vinnitsa, Ukraine
* Corresponding author.
Rationale: To evaluate the effect of a novel procedure using real-time
ultrasonography to assist nasojejunal tube placement at bedside in
pediatric patients after major abdominal surgery (MAS).
Methods: Single center, prospective descriptive study in a 12-bed
surgery intensive care unit of a Vinnitsa regional children hospital. 151
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MAS patients were enrolled. The whole procedure of placing
nasojejunal tube was performed by a single physician, who places
nasojejunal tube at the bedside and performs ultrasonography to
guide the tube positioning. The final nasojejunal tube position was
confirmed by abdominal radiograph. The successful rate of the
procedure as well as the time it took, the time from the decision of
enteral feeding to commencement of feeding, and complications were
recorded.
Results: 157 intubations were performed in 151 patients by using
ultrasonography-assisted method at bedside. Nasojejunal tubes were
successful placed in 129 of 151 patients (85.43%). The average time of
successful placement was 23.12±4.84 minutes. The median time
betweenphysician’s decision for tube placement and feeding initiation
was 6.2 (2, 04) hours. No adverse events occurred in all of patients.
Conclusions: This novel method of nasojejunal tube placement under
ultrasound guidance is practical, less time consuming and reliable.
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Rationale: Effects of preoperative one week enteral nutrition (EN)
support on the postoperative nutritional status, immune function and
inflammatory response of abdominal surgery pediatric patients were
investigated.
Methods: 202 cases of abdominal surgery pediatric patients were
randomly divided into preoperative one week EN group (trial group)
and early postoperative EN group (control group), which were
continuously treated with EN support until the postoperative 9th
day according to different treatment protocols. All the patients were
checked for their body weight, skin fold thickness, upper arm
circumference, white blood cell count (WBC), albumin (ALB),
prealbumin (PA), C-reactive protein (CRP), humoral immunity (IgA,
IgG), T cell subsets (CD4, CD8 and CD4/CD8), interleukin-6 (IL-6),
tumor necrosis factor-α (TNF-α), etc. on the preoperative and the
postoperative 1st and 10th day, respectively.
Results: PA and IgG levels of the experimental group were higher than
those of the control group on the postoperative 10th day, whereas IL-6
level of the experimental group was lower than that of the control
group.
Conclusions: EN support for preoperative abdominal surgery pediat-
ric patients will improve the postoperative nutritional status and
immune function, alleviate inflammatory response, and facilitate the
recovery of patients.
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A TRIAL ABOUT SHORT-TERM OUTCOMES OF UNCUT ROUX-EN-Y
RECONSTRUCTION FOR EARLY GASTRIC CANCER
H. Xu1*, J.K. Xu1, Y.F. Li1, J.L. Wang1, C.D. Zhang1, L. Yang1, K.Z. Xu1. 1The
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Rationale: We conducted a randomized controlled trial to compare
the safety and nutritional status between uncut and classic Roux-en-Y
reconstruction.
Methods: Patients with clinical T1 gastric cancer were prospectively
enrolled and underwent laparoscopic distal gastrectomy by either
the uncut Roux-en-Y reconstruction or classic Roux-en-Y recon-
struction. Nutritional status was measured by laboratory tests like
blood routine and blood chemistry examination and BMI change.
HRQOL was evaluated using the European Organization for Research
and Treatment of Cancer, Quality of Life Questionnaire -STO22.
Laboratory tests, BMI and questionnaires were completed at 3, 6, 9
and 12 months.
Results: A total of 89 patients (Uncut RY group, n = 49; RY group,
n = 40) were enrolled between June 2015 and December 2017 and
analyzed. These two approaches had no significant difference in
operating time, blood loss, and time to recovery. At each time point, no
statistically significant differences were observed regarding nutri-
tional status and quality of life (P < 0.05).
Conclusions: The study’s results were considered to be negative
because no benefit of the uncut approachwas observed. As a result, we
suggested much more conservative opinions on uncut Roux-en-Y
reconstruction. However, the number of patients in this study is small
and the observation time is short. Sowe need to carry outmulti-center
cooperation to include more patients and conduct long-term obser-
vation, so as to draw more convincing conclusions.
Disclosure of Interest: None declared.
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CAUSES AND OUTCOMES OF INTESTINAL FAILURE IN CROHN’S
DISEASE: AN 18-YEAR EXPERIENCE FROM A NATIONAL CENTRE
M. Soop1, H. Khan1*, E. Nixon1, A. Teubner1, A. Abraham1, G. Carlson2,
S. Lal1. 1Irving National Intestinal Failure Unit, The University of
Manchester, Manchester Academic Health Science Centre, Salford Royal
NHS Foundation Trust, 2Irving National Intestinal Failure Unit, The
University of Manchester, Manchester Academic Health Science Centre,
Salford Royal NHS Foundation Trust, Manchester, UK, Manchester, United
Kingdom
* Corresponding author.
Rationale: Although intestinal failure (IF) is a feared complication in
Crohn’s disease (CD), direct causes and outcomes of this complication
have not been well described.
Methods: Consecutive patients with CD and IF lasting >12months and
admitted 2000–2018 to a national IF centre were prospectively
followed. Data were censored on 31 Jan 2019. Medians (range) are
given. Longitudinal data were analysed by the Kaplan-Meier method.
Results: 121 patients (67women)were included. IFoccurred 14 (0–50)
yrs after CD diagnosis. IF occurred after an operation in 110 (94%)
patients, and directly due to disease activity in 11 (9%). Among the 110
patients with postoperative IF, the direct cause was an abdominal
septic complication in 60 (55%) (anastomotic dehiscence in 31, enteric
fistulation in 24 and intra-abdominal abscess in 5), uncomplicated
bowel resection in 37 (34%) and proximal diversion in 13 (12%). 75
(62%) patients did not have their colon in continuity. Of the 31 patients
with anastomotic dehiscence, the anastomosis had been formed
during an emergency procedure in 11 (35%) and during corticosteroid
therapy in 11/19 with data (58%). 29 of the 52 (56%) patients who
underwent restorative surgery regained nutritional autonomy, as did 8
of the 69 patients (12%) who did not. On Kaplan-Meier analysis, 42% of
all patients had regained nutritional autonomy after 11 years.
Conclusions: IF is a severe complication of CD, with less than half
referred to a national centre regaining nutritional autonomy. Themost
frequent cause was a postoperative septic complication following
abdominal surgery, in many cases following anastomosis in the
presence of risk factors. Preservation of the colon and improved
management of perioperative risk factors associated with abdominal
septic complications may reduce the incidence of IF in CD.
Disclosure of Interest: None declared.
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EFFECTOFHOMEENTERALNUTRITIONSUPPORT INPATIENTSWITH
REFRACTORY CONSTIPATION AFTER JINLING PROCEDURE
H. Tian1*, Q. Chen1, J. Jiang2, N. Li1. 1Intestinal Microenvironment
Treatment Center, Tenth People’s Hospital of Tongji University, ShangHai, 2
Department of General Surgery, Nanjing General Hospital, Nanjing, China
* Corresponding author.
Rationale: Constipation is a commonproblem. Surgery is indicated for
chronic constipation refractory to the conservative therapy. To
investigate the feasibility and effect of home enteral nutrition(HEN)
support in patients after Jinling procedure (subtotal colectomy and
side to side cecorectal anastomosis) for refractory constipation.
Methods: From July 2017 to December 2018, 107 patients with
refractory constipation after Jinling procedure and had nutritional risk
at discharge were collected and randomly subjected into HEN group
(n = 55) and control group (n = 52). After discharge, the intervention
group received whole-protein enteral nutrition by nasointestinal tube
placed in the proximal jejunum on the basis of regular diet, and the
control group took only regular diet. Body weight, laboratory serum
nutritional indicators, clinical indexes between two groups after
discharge were compared.
Results: As compared to control group, the levels of body weight(8
weeks 56.24 ± 3.48 vs. 52.46 ± 2.17), total plasma protein(8 weeks
72.03 ± 3.66 vs. 68.98 ± 3.9), albumin(8 weeks 41.75 ± 3.04 vs.
38.45 ± 2.37) and pre-albumin(8 weeks 199.20 ± 18.02 vs.
190.24 ± 13.65) were significantly higher in HEN group on the 2
weeks, 4weeks, 8 weeks after discharge(P < 0.05). HEN group also
showed significant elevation of stool consistency score(4.9 ± 1.3 vs.
5.6 ± 1.1) and fewer diarrhea(24.5% vs. 36.4%) and abdominal discom-
fort events (17.6% vs. 31.4%) included venting, nausea, abdominal pain,
etc.) (P < 0.05). However, there were no statistical significant differ-
ences in constipation clinical cure rate(96.7% vs. 95.3%) between the
two groups (P > 0.05). HEN group hadmore nasointestinal tube related
respiratory difficulty occurrence rate(65.0% vs. 0%).
Conclusions: HEN can improve nutritional status and gastrointestinal
function, and therefore accelerate the postoperative recovery in
patients undergoing Jinling procedure. Nasointestinal tube related
adverse events should be avoided.
Disclosure of Interest: None declared.
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CLINICAL IMPACT OF PREOPERATIVE SARCOPENIA ON
POSTOPERATIVE NUTRITIONAL STATUS IN PATIENTS WITH
HEPATOBILIARY AND PANCREAS MALIGNANCY
J.H. Park1*, Y. Ryu1, C.-S. Lim2, Y.C. Shin3,W. Jung4, J.S. Heo1, D.W. Choi1, I.
W. Han1. 1Devision of Hepatobiliary-Pancreatic Surgery, Department of
Surgery, Samsung Medical Centre, Sungkyunkwan University School of
Medicine, 2Department of Surgery, Seoul Metropolitan Government –
Seoul National University Boramae Medical Centre, Seoul National
University College of Medicine, Seoul, 3Department of Surgery, Ilsan
Paik Hospital, Inje University College ofMedicine, Goyang, 4Department of
Surgery, Ajou University School of Medicine, Suwon, Republic of Korea
* Corresponding author.
Rationale: Recently, several studies have reported that preoperative
sarcopenia could worsen postoperative complications in patients with
various types of periampullary malignancy. The purpose of this study
is to compare preoperative and postoperative changes between a
sarcopenia patient group and a normal patient group after pancrea-
toduodenectomy (PD).
Methods: From 2015 to 2016, a total of 434 patients who underwent
PD with periampullary malignancy at 4 centres was included and
analysed retrospectively. Sarcopenia was defined based on third
lumbar vertebra (L3) muscle index. The L3 muscle index was
calculated from cross-sectional visceral fat and muscle area on
preoperative CT imaging at the third lumbar vertebra level and
normalized for height by an automatic calculation program in Matlab
version R2010a (Mathworks Inc., Natick, MA, USA). The preoperative
patient data were compared to postoperative 6-month values.
Results: Preoperative sarcopeniawas present in 176 of the patients. In
the postoperative weight comparisons, the sarcopenia patient group
had a greater body weight change than the normal patient group, but
the difference was not statistically significant. There was no difference
in BMI change between the two groups. The differences in albumin
and cholesterol were greater in the normal patient group, but the
difference was not statistically significant.
Conclusions: There was no statistically significant difference in body
weight, BMI, or albumin and cholesterol levels between the normal
patient group and the sarcopenia patient group. Further evaluation is
needed in the future.
Disclosure of Interest: None declared.
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MALNUTRITION IN BILIOPANCREATIC MALIGNANCY: MULTIMODAL
SUPPORT (NUTRITIONAL-DIGESTIVE-METABOLIC)
M. Molina-Vega1, J.I. Martinez-Montoro1, A.M. Gómez-Pérez1,
Y. Eslava-Zea1, J. Roldan-de la Rua1, M.A. Suarez-Muñoz1, J.M. García-
Almeida1*. 1Virgen de la Victoria Hospital, Malaga, Spain
* Corresponding author.
Rationale: Patients undergoing pancreatectomy requires multimodal
support (nutritional-digestive-metabolic) to ensure proper approach,
because of their nutritional deterioration, development of exocrine
pancreatic insufficiency and diabetes.
The aim of this study is to evaluate the evolution of a group of patients
included in a medical-surgical protocol for patient care after
pancreatectomy.
Methods: Data from 56 patients with pancreatic surgery from 2013 to
2018 were evaluated. We analyzed demographic and clinical-analytic
data. Nutritional status between the preoperative period (M0) and the
immediate postoperative period (M1), M1 and 3–6 months after
surgery (M2) and M2 and a year after surgery (M3) was compared.
Results: 56 patients: 57.1% men, mean age 64.4 ± 8.5 years. Tobacco
and alcohol use: 50.9% no, 5.5% alcohol, 29% tobacco,14.5% alcohol and
tobacco. 26.8% type 2 diabetesmellitus. Other comorbidities: 61.8% no,
23.6% 2 comorbidities, 14.5% over 2 comorbidities.
M0 M1 p M2 p M3 p
BMI (kg/m2) 27.5 ± 4.21 24.6 ± 4.1 0.000 23.9 ± 3.9 0.894 23.7 ± 3.8 0.106
Fat free mass (%) – 75.7 ± 7.4 – 74.8 ± 8.1 0.359 74.2 ± 8.2 0.117
Albumin (g/dl) 3.2 ± 0.6 2.5 ± 0.7 0.000 3.6 ± 0.3 0.000 3.7 ± 0.3 0.295
Prealbumin
(mg/dl)
17.8 ± 6.7 13.5 ± 7.3 0.026 20.9 ± 6.6 0.000 21.7 ± 6.2 0.800
CRP (mg/dl) 25.1 ± 35.7 109.5 ± 108.4 0.000 9.1 ± 12.5 0.000 4.6 ± 3.8 0.230
SGA (%)
Well nourished
Risk of
malnutrition
Obvious signs
of
malnutrition
61.8
27.3
10.9
7.8
29.4
62.7
0.000
56.1
24.4
19.5
0.000
72.7
15.2
12.1
0.336
Histopathological diagnosis: 75% adenocarcinoma, 7.1% neuroendo-
crine tumors, 17.9% others. 36.4% presented post-operative complica-
tions, 12.5% required new surgery and 8.9% hospital readmission.
Nutritional status evolution (table 1): Patients lost weight significantly
in M1 and then they maintained it, preserving fat-free mass. Despite a
significant decline in albumin and prealbumin levels in M1, then
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they increased, being in M3 better than in M0. Consequently, the
prevalence of malnutrition, according to SGA (subjective global
assessment), increased significantly in M1, but then the situation
improved with a higher percentage of well-nourished in M3 vs M0.
Nutritional supplements use: inM017.9% of patients (925 ± 298.6 kcal;
50.6 ± 10.3 gr of proteins); in M1 67.9% (596 ± 157.5 kcal; 30.8 ± 9.2 gr
proteins); in M2 35.2% (588.8 ± 188.3 kcal; 33.5 ± 9.7 gr proteins); M3
39.4% (674.8 ± 161.5 kcal; 29.5 ± 15.7 gr proteins). All patients used
pancreatic enzymes replacement therapy (dose in gr): 165930.2 ±
44404.2 M1; 193382.3 ± 44085.3 M2 and 194482.7 ± 53674.7 M3.
Conclusions:
• Significant deterioration of nutritional status in patients after
pancreatectomy, with improvement in M2 regarding albumin and
prealbumin and maintenance in M3.
• Although weight is not recovered, fat-free mass is preserved.
• More than 1/2 of patients in M1 and more than 1/3 in M2 and M3
required nutritional supplements
• 100% of patients received pancreatic enzymes replacement, with
increasing dose.
Disclosure of Interest: None declared.
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A RANDOMIZED CONTROLLED CLINICAL TRIAL OF PRE- AND
POSTOPERATIVE SUPPLEMENTATION WITH ZINC, VITAMIN C,
ARGININE AND MULTIVITAMIN IN PATIENTS OPERATED FOR HEAD
AND NECK CANCER
K.M. Odgaard1*, N.B. Andersen1, C. Munk1, I. Wessel2, J.R. Andersen1.
1Department of Nutrition, Exercise and Sports, University of Copenhagen,
2Department of Ear, Nose and Throat Diseases, Section of Oncological
Surgery, Rigshospitalet, Copenhagen, Denmark
* Corresponding author.
Rationale: Nutritional supplementation may potentially have a
beneficial effect on wound healing after surgery, but evidence is
lacking.
We wanted to investigate the effect on wound healing of a combined
pre- and postoperative oral dietary supplement consisting of 14 g
arginine, 63 mg zinc and 1090 mg vitamin-C and two multivitamin
tablets daily, as a supplement to adequate nutrition in patients
operated on for head and neck cancer.
Methods: 42 patients operated for cancer or strong suspicion of cancer
in the head and neck region. Randomized to the intervention group
(n = 22) or control group (n = 20). Both groups were given supplemen-
tary protein drinks with 20 g protein /pcs. The patients were included
−7 to− 1 days preoperatively, and completed the trial 28 days
postoperatively. Evaluation of the scar was based on the Patient and
Observer Scar Assessment Scale (POSAS) on day 14 and 28.
Biochemical and clinical measurements were performed at baseline,
14 and 28 days postoperatively.
Results: The intervention group scored significantly lower than the
control group in question; 1 (p = 0,021), 2 (p = 0,026) and 7 (p = 0,033)
in POSAS. Significant differences were found between the groups for
p-cobalamin (p = 0,003), p-albumin (p = 0,035), p-creatinine (base-
line, p = 0,013) (day 28, p = 0,021) and p-carbamide (day 14, p = 0,008)
(day 28, p = 0,001).
Conclusions: It can be concluded that significant improvement is seen
in the intervention group in relation to pain, itching and overall
assessment of the scar during the intervention period. However, no
significant difference was found between the groups based on the
observers’ assessment. Significant differences were found in several
biomarkers, but it is unclear whether these findings are clinically
relevant.
References: MEDTRITION is acknowledged for providing ARGIMENT,
JEMOPHARM for providing VitaCare Multivitamins, and NATUR
DROGERIET for providing Zinc and Vitamine C tablets
Disclosure of Interest: None declared.
SUN-PO311
OUTCOMES IN SURGERY FOR INFLAMMATORY BOWEL DISEASE VS
ADENOCARCINOMA IN AN ENHANCED-RECOVERY PROGRAMME: A
STUDY IN 1,195 CONSECUTIVE PATIENTS
K. Schalling1*, J. Nygren1, M. Soop1. 1Department of Surgery, Ersta
Hospital, Karolinska Institutet at Danderyd Hospital, Stockholm, Sweden
* Corresponding author.
Rationale: Abdominal surgery for inflammatory bowel disease (IBD)
has been associated with more morbidity and slower recovery than
surgery for adenocarcinoma. We hypothesised that within enhanced
recoveryafter surgery (ERAS), outcomes are similar between these two
major diagnostic groups.
Methods: Consecutive patients undergoing elective major abdominal
surgery for IBD or primary colorectal adenocarcinomawithin an ERAS
programme 2011–2018 were prospectively studied using an inter-
national perioperative registry. Effects of diagnosis on ERAS compli-
ance, 30-day overall morbidity and length of stay (LOS) were assessed
using univariable and multivariable regression. Means (SEM) and
medians (range) reported.
Results: 186 patients underwent surgery for IBD and 1,009 for
adenocarcinoma. IBD patients were younger, 49.0 (0.9) vs 69.5 (0.4)
yrs (P < 0.0001); had more minimally invasive operations, 62.9 vs
46.3% (P < 0.0001); had less pelvic operations, 24.2 vs 37.0%
(P = 0.0006); and received less intravenous fluid on the day of
surgery, 44.8 (2.0) vs 54.4 (0.9) ml/kg (P < 0.0001). Overall ERAS
compliancewasmarginally higher, 69.4 (1.0) vs 67.2 (0.4) % (P = 0.045),
but morbidity, 22.6 vs 29.3% (P = 0.060), and LOS, 6 (2–42) vs 6 (1–53)
nights (P = 0.081) were similar between groups. On multivariable
analysis including confounders, diagnostic group was not associated
with morbidity and LOS (P = 0.34 and 0.90, respectively).
Conclusions: In this large, consecutive single-centre series, patients
with IBD had similar compliance and outcomes to patients with
adenocarcinoma.
Disclosure of Interest: None declared.
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CARBOHYDRATE LOADING: IMPACT ON SURGICAL PATIENTS
L.F.O. Figliolino1*, A. Bottoni2, S. Garnes2, K. Piza3, U. Fernandes3.
1UniversidadeMogi Das Cruzes, 2Funzionali, 3Hospital Rede D’Or São Luiz
Unidade Villa Lobos, São Paulo, Brazil
* Corresponding author.
Rationale: This study aims to analyze the effects of the carbohydrate
loading in surgical patients performed surgeries at the Hospital Rede
D’Or São Luiz Villa Lobos Unit – São Paulo.
Methods: A clear liquid with carbohydrate and proteinwas sent to the
patients: when the surgery takes place in the morning, a fat
supplement was delivered at 23 hours the previous day. Those who
had surgery in the afternoon were given a fat-free supplement up to
four hours before surgery.
Results: A total of 5319 patients hospitalized for elective surgery
(orthopedics, urology, general surgery, vascular, gynecology, neur-
ology, plastic surgery, otorhinolaryngology) were evaluated. The
fasting of 449 patients (8% of the total surgical patients) was
shortened. The total length of hospital stay in patients not fasting
(n = 4870) was 4,242 ± 20,10 days (CI95% 3,678–4,807) versus
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2,573 ± 1,578 days (CI95% 2,390–2,683) of those patients (n = 449)
whose protocol was applied (P < 0.0001). Regarding hospital costs, we
found a significant association between the shorter hospitalization
time (mean time of 4,095 ± 16,60) and lower hospital costs (mean of €
5.459) for the Spearman correlation (P < 0.0001). The mean hospital
costs among the group of fasting patients was € 3.484 ± 5.132 (CI95%
2.968–4.000) and mean length of stay of 2,629 ± 1,626 days (CI95%
2,466–2,793) versus € 5.658 ± 4.575 (CI95% 5.002–6.314) and the time
of permanence of 4,243 ± 17,41 days (CI95% 3,689–4,798) of the
patients that fasting was not abbreviated, showing reduction of
approximately 24% in the total costs of the surgeries and one day of
hospitalization. Patients with fasting≥11.5 hourswere 164 timesmore
likely to present nausea and/or vomiting.
Conclusions: Therefore, the abbreviation of fasting is safe, it is possible
to reduce length of stay in one day and hospital costs byapproximately
24%, to prevent nausea, vomiting and complications.
Reference
1. Ljungqvist O.; Scott M.; Kenneth C.; Fearon K.C. Enhanced
Recovery After Surgery: A Review. JAMA Surgery, v.152, n.3, p. 292–
298, 2017.
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ASSESSMENT OF EFFICIENCY OF IMMUNONUTRITIVE SUPPORT IN
CONTROL OF SYSTEMIC INFLAMMATION AFTER GASTRECTOMY
M. Evseev1*. 1Department of Surgery, Clinical Hospital 1 (Volyn) of the
office of the President of the Russian Federation, Moscow, Russian
Federation
* Corresponding author.
Rationale: High-volume oncosurgery is followed by development of
the systemic inflammatory response syndrome (SIRS) underlying local
and systemic complications. To assess the effect of fat emulsions with
Ʊ-3 fatty acids on the severity of postoperative systemic inflammation,
this study was undertaken.
Methods: The prospective comparative research included 53 patients
of both sexes (57.2 ± 6 years) after open or laparoscopic gastrectomy
D2+. Within 4 days after surgery in group A of 29 patients parenteral
administration of Nutriflex 70/240 in combination with a fatty
emulsion with Ʊ-3 fatty acids (Lipoplus 20), in group B of 24 patients
parenteral administration of Nutriflex Lipid 70/180were carried out. In
both groups cytokines TNF-α, IL-6 and IL-4 concentration in peripheral
blood was investigated in 2, 5 and 8 days after surgery. Comparison of
quantity of local and systemic postoperative complications between
both groups was carried out.
Results: In group ATNF-α, IL-6 and IL-4 level in all cases authentically
(р < 0.01) below, than at the patients group B on 2–5-8th day, pg/ml
(for TNF-α: 2.1 ± 0.5–1.8 ± 0.1–1.2 ± 0.3 vs. 3.9 ± 1.2–2.6 ± 1.3–2.1 ± 0.4;
for IL-6: 67.1 ± 4.2–44.1 ± 5.1–35.1 ± 4.6 vs. 109.2 ± 7.1–71.4 ± 8.3–
52.6 ± 1.2; for IL-4: 2.3 ± 0.9–2.5 ± 0.1–2.1 ± 0.3 vs. 4.9 ± 1.3–4.1 ± 0.6–
3.2 ± 1.1 respectively). The share of patients with local and system
complications in the group A was authentically below, than in the
group B: 5.2% vs. 7.2% (р < 0.05) and 5.2% vs. 14.2% (р < 0.01).
Conclusions: The decrease in plasma concentration of TNF-α, IL-6 and
IL-4 cytokines revealed in this study confirmed the fact of decrease in
expressiveness of SIRS in response to a surgical trauma. Clinical
confirmation of efficiency of Ʊ-3 fatty acids was the reduction of local
and systemic postoperative complications.
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SUN-PO314
INTESTINAL FAILURE (IF) AFTER BARIATRIC SURGERY, REPORT OF A
SERIES OF PATIENTS SEEN AT A SINGLE CENTER IN ARGENTINA
M. Doeyo1*, H. Solar1, S. Rubio1, A. Crivelli1, D. Ramish1, G. Gondolesi1.
1Unidad de soporte nutricional, rehabilitacion y transplante intestinal,
Hospital Universitario Fundacion Favaloro, Buenos Aires, Argentina
* Corresponding author.
Rationale: Bariatric surgery (BS) has become an established treatment
for severe obesity. Although, complications medical and surgical
complications have been reported, there is sub-registry and commu-
nication of the number of patients ending with IF after bariatric
surgery. Our aim is to report a case series of patients with IF as a result
of BS complication, seen at an IF, rehabilitation and intestinal
transplantation program.
Methods: A retrospective analysis of a prospective IF database was
done to determinate the type of BS, demographic data, type of
complications and outcomes
Results: From a database of 275 IF patients, 13 pts had IF after BS (8
females,mean age 43.8 years); 11 pts (84%) had IFas a result of surgical
complications (3 anastomotic leaks, 2 enterocutaneous fistulae; 2
Petersen’s Hernia, other: 4), and 2 pts (16%) developed chronic
malabsortive diarrhea as a medical complication. After anatomic and
functional evaluation, surgical treatment was proposed to 10 pts: 4
Received CRATGI, 1 received CRATGI with by-pass reversal, 5 other
surgical procedures and 2 medical therapy. The mean number of
surgical procedures needed to reestablish enteral continuity was: 1.82.
Nine pts (69%) recovered intestinal sufficiency (IS), 1 patient (7%)
remains in PN, 1 died early after BS with type II IF and 2 were lost of
follow-up. The subjective global assessment (SGA) at the time of PN
initiation was C in 6 pts (46%), B in 5 pts (38%) and A in 2 pts (15%).
Mean time on PNwas 270.58 days. The SGA at the last follow-up is: A in
10 pts (77%), B in 2 pts (15.4%) and C in 1 pt (7.7%). At a mean follow up
time of 8.29months, the overall survival of patients currently followed
at our center is 90%
Conclusions: As obesity is recognized and increasing global health
problem and BS has become an accepted and worldwide spread
treatment, its complications will appear and should be early
recognized in order to minimize the risk of evolving to IF. When IF
occurs, patients should be seen and evaluated by an experience
intestinal rehabilitation and transplant program in order to maximize
the chances to recover IS.
Disclosure of Interest: None declared.
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VALIDATION OF ULTRASOUNDMUSCLE THICKNESS IN COMPARISON
TO L3 MUSCLE AREA IN COMPUTED TOMOGRAPHY IN 119 NON-ICU
PATIENTS: THE PROSPECTIVE USVALID STUDY
A. Fischer1*, M. Pesta2, I. Timmermann2, T. Siebenrock2, K. Liebau2,
R. Hahn2, M. Anwar2, A. Hertwig2, D. Tamandl3, H. Ringl4,
M. Hiesmayr1. 1Anesthesia and Intensive Care Medicine, 2Medical
University of Vienna, Vienna, Austria, 3Radiology, Medical University of
Vienna, 4Radiology, Donauspital Vienna, Vienna, Austria
* Corresponding author.
Rationale: CTmuscle area at the level of the third lumbar vertebra is a
gold standard of musclemassmeasurement, because it correlates very
well with whole body muscle mass. Ultrasound muscle thickness
measurement has only shown a weak correlation (r2 = 0,2) with CT in
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ICU patients (1). The objective of the study was to validate ultrasound
muscle thickness in comparison to CT in non-ICU patients.
Methods: 119 non critically ill patients were recruited after routine
abdominal CT scanning. Ultrasoundmuscle thicknesswasmeasured at
2measuring points on each upper arm and 3measuring points on each
thigh. Mean of upper armmuscle thickness and mean of thigh muscle
thickness was calculated. Limb length was measured. Minimal
compression was applied during ultrasound measurement. The
ultrasound muscle thickness was compared to CT L3 muscle area by
regression model. Only statistically significant covariates were
retained in the model.
Results: 79 men and 40 womenwere recruited. Median (IQR) agewas
61 (47–69) years. Mean thigh and upper arm muscle thickness
accounted for 53% of the variation in CT L3 muscle area (r2 = 0,53).
When accounting for sex and weight the coefficient of determination
(r2) improved to 0,72 (see Table 1).
Table 1
Multivariable linear regression model for CT L3 muscle area (cm2):
Estimate of CT L3
muscle area (cm2)
95% CI of estimate P
constant 16,2 −1,0 to 33,3 0,06
mean thighmuscle
thickness (cm)
11,8 5,4 to 18,2 <0,001
mean upper arm
muscle
thickness (cm)
12,2 1,0 to 23,3 0,03
men 19,0 12,2 to 25,8 <0,001
women reference
weight (kg) 0,6 0,4 to 0,9 <0,001
Conclusions: The USVALID ultrasound technique applying minimal
compression showed a better correlation between ultrasound muscle
thickness and CT L3 muscle area (r2 = 0,53) than the ultrasound
technique of Paris et al. applying maximal compression (r2 = 0,2) (1).
The USVALID ultrasound technique may be used for clinical assess-
ment of muscle mass.
Reference
1. Paris M. et al.: Validation of Bedside Ultrasound of Muscle Layer
Thickness of the Quadriceps in the Critically Ill Patient (VALIDUM
Study): A Prospective Multicenter Study. Journal of Parenteral and
Enteral Nutrition, 2016.
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IMPACT OF PROTEIN INTAKE AND HIGH-FAT DIET ON MUSCLE
PROTEIN SYNTHESIS AND LIPID INFILTRATION IN RELATION TO
AGING IN RATS
E. Poggiogalle1,2*, F. Rossignon2, A. Carayon2, J. Salles2, C. Giraudet2,
J.-P. Rigaudière2, S. de Saint-Vincent2, F. Sanchez2, O. LeBacquer2,
F. Capel2, S. Walrand2, B. Yves2, C. Guillet2. 1Experimental Medicine-
Medical Pathophysiology, Food Science, and Endocrinology Section,
Sapienza University, Rome, Italy, 2Centre de Recherche en Nutrition
Humaine, Université de Clermont Ferrand, Clermont Ferrand, France
* Corresponding author.
Rationale: Ectopic lipid deposition impairs muscle anabolic response
especially during aging. We hypothesized that the anabolic efficiency
of dietary protein in skeletal musclemight be affected by high-fat diet.
The objective of the study was to investigate muscle protein synthesis
in response to two levels of protein intake combined to two levels of fat
intake.
Methods: Two groups of sixty adult and forty-nine old male Wistar
rats were randomly divided into four groups: isocaloric standard diet
(12% protein, 14% lipid, as STD12); isocaloric standard (high-protein)
diet (25% protein, 14% lipid, STD25); hypercaloric high-fat (normal-
protein) diet (12% protein, 45% lipid, HFD12); and hypercaloric high-
fat (high-protein) diet (25% protein, 45% lipid, HFD25). The nutritional
intervention lasted 10 weeks. The fractional synthesis (FSR) and
absolute synthesis rates (ASR) of mixed muscle proteins were
calculated using isotopically labelled 13C-Valine incorporation in
tibialis anterior (TA). Muscle lipid content was assessed using
chromatography method.
Results: Rats in the high-fat diet groups self-limited their food intake,
so that energy intake was not different among the groups. Regardless
of dietary intervention, TAweightwas lower in old groups compared to
their adult counterparts (all p values
Conclusions: Aging is characterized by reducedmuscleweight despite
increased FSR, suggesting specific alterations in the nutritional
regulation of muscle protein turnover. In isocaloric conditions, higher
protein intake modulates muscle lipid infiltration, without improving
age-related anabolic resistance in old rats fed a high-fat diet.
Disclosure of Interest: None declared.
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EFFECTS OF A BRANCHED-CHAIN AMINO ACIDS-ALANINE-
SUPPLEMENTATION INTAKE IN HIGH INTENSITY ENDURANCE
CYCLING TESTS
M. Gervasi1*, D. Sisti1, S. Amatori1, S. Donati Zeppa1, G. Annibalini1,
G. Piccoli1, L. Vallorani1, M.B.L. Rocchi1, E. Barbieri1, A.R. Calavalle1,
P. Benelli1, D. Agostini1, V. Stocchi1, P. Sestili1. 1Department of
Biomolecular Science, University Of Urbino Italy, Urbino, Italy
* Corresponding author.
Rationale: Sports nutritional supplements containing branched-chain
amino acids (BCAA) are reported to improve psychological and
biological aspects connected to central fatigue and performance in
endurance exercise. Here we sought to determine, in a randomized
double-blind placebo-controlled study, whether the intake of recom-
mended doses of a commercially available BCAA-based supplement
affects the rating of perceived exertion (RPE) and performance, at the
beginning (1d) and at the end of a 9-weeks (9w) scheduled high
intensity interval training.
Methods: To this endahigh intensityendurance cycling (HIEC) testwas
developed and used. In parallel with RPE, haematological values
(creatine kinase, alanine, BCAA, tryptophan and glucose levels), diet
habits, performance indexes (maximal oxygenconsumption–VO2max,
powerat lactate thresholds –WLT1,WLT2 and time to exhaustion –TTE)
and training load (Training Impulse – TRIMP), were assessed during the
HIEC tests and training period. Serum tryptophan:BCAA ratio, which is
considered as a determinant of RPE, was also calculated.
Results: Supplement (SU) intake significantly reduced RPE compared
to placebo (PL) at 1d and 9w; at 9w, prolonged supplement intake
improved also TTE and TRIMP. SU consumption promoted a rapid
increase (within 1 h) of BCAA serum blood levels and prevented the
post-HIEC tryptophan: BCAA ratio increase found in PL group, at both
1d and 9w. Diet habits of the participants neither differed between
groups nor changed over time; no difference in glycemia was found
between SU and PL. VO2max,WLT1 andWLT2 values ameliorated over
time, but were unaffected by supplement intake.
Conclusions: On the whole these results suggest that i) the intake of
the BCAA-based commercially available supplement used in this study
reduces RPE as a result of a better and favourable handling of serum
tryptophan:BCAA ratio; ii) over time, reduced RPE allows to sustain
higher workloads, leading to increased TRIMP and TTE; iii) HIEC test
may represent a valid and sensitive method to quantify the actual
efficacy of sports supplements to help training outcomes.
Disclosure of Interest: None declared.
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THE IMPACT OF AMINOACID KETOANALOGUES ON NUTRITIONAL
STATUS OF WASTED PERITONEAL DIALYSIS PATIENTS
P. Borek1,2*. 1Department of Onclogy and Radiotherapy, Medical
University of Gdańsk, Drewnica, 2Department of Physiotherapy and
Health Sciences, Higher School of Health, Gdańsk, Poland
* Corresponding author.
Rationale: Wasting constitutes a common and severe complication
among patients with end-stage renal disease. It is mainly caused by
decreased appetite due to uremic intoxication, catabolic processes and
dietary restrictions. In patients treated with peritoneal dialysis (PD)
protein losses with the dialysate constitute an additional culprit.
Supplementation of aminoacid ketoanalogues stands as one of the
potential therapeutic options. It helps to diminish the risk of wasting
and uremic toxicity without the need of increasing dialysis dose. The
aim of the study was to assess the impact of aminoacid ketoanalogues
on nutritional status of malnourished PD patients.
Methods: The study included 24 PD patients with diagnosed wasting.
They were allocated into the interventional or the control group. The
intervention was based on aminoacid ketoanalogue supplementation
with 9 tablets (Ketosteril®) daily for three months. A number of
laboratory and anthropometric indices were monitored. Nutritional
status and appetite were assessed with SGA (Subjective Global
Assessment), NRS 2002 (Nutritional Risk Score), and SNAQ (Short
Nutritional Assessment Questionnaire).
Results: In the intervention group, after three months of supplemen-
tation, increased values of normalized Protein Catabolic Ratio (nPCR)
were noted (0.93 vs 1.14 g/kg/day), while they decreased in the
controls (1.13 vs 0.98 g/kg/day). Protein ingestion did not change in
any of the groups. In the intervention group, contrary to the controls,
lean body mass (LBM) increased, whether expressed as LBM index
(14.6 ± 2.5 vs 16.2 ± 3.1 kg/m2), or as kilograms (40.6 ± 8.2 vs 44.7 ±
11.0 kg). Following the intervention, nutritional status, as assessed
with NRS-2002, significantly improved, as did the appetite. Six
patients (55%) failed to fulfil the SGA criteria of wasting, while in
controls it was only one subject.
Conclusions: Aminoacid ketoanalogue supplementationmay improve
nutritional status, appetite and LBM in wasted PD patients.
References
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NOVEL IONIC LIQUID CREATINE FORMULATION IMPROVES
SKELETAL MUSCLE CREATINE AND STRENGTH PERFORMANCE IN
HEALTHY MEN: A PILOT STUDY
S.M. Ostojic1*, M. Vranes1, V. Stajer1. 1Applied Bioenergetics Lab,
University of Novi Sad, Novi Sad, Serbia
* Corresponding author.
Rationale: While creatine monohydrate (CRM) is a well known ‘gold
standard’ among different creatine formulations, its large-scale use
remains somewhat limited due to poor solubility in water and limited
performance in specific medical conditions. Cholinium-creatinate
(CCR), a novel 100% water-soluble ionic liquid creatine formulation,
has recently shown superior blood bioavailability as compared to CRM,
yet no study so far evaluated its tissue uptake and performance-
enhancing effects after short-term supplementation.
Methods: Three apparently healthy men (age 24.3 ± 1.8 years; body
mass index 23.7 ± 1.2 kg/m2) voluntarily participated in this double
blind, randomized, cross-over pilot trial. All participants were
allocated to receive either 3 grams per day of CCR or CRM for 7 days,
with 4-week wash-out period between interventions.
Results: CCR intervention resulted in a more potent rise in muscle
creatine levels comparing to CRM at 7-day follow-up, as evaluated
with 1.5 TMR spectroscopy (5.8 ± 2.9% vs. 3.0 ± 3.7%; P < 0.05). CCRwas
similar to CRM to increase both upper and lower body strength, as
evaluated bymaximal number of repetitions until volitional fatigue for
bench press and leg press exercise. No subjective side effects were
reported during each intervention period.
Conclusions: CCR appears to be more superior alternative to CRM in
terms of tissue uptakewhile a new experimental treatment is safe and
not unacceptably less efficacious than CRM for exercise performance
improvement in a small cohort of young healthymen. Long-termwell-
sampled studies are highly warranted to confirm this preliminary
results in both athletic and clinical environment.
Disclosure of Interest: S. Ostojic Grant/Research Support from:
Serbian Ministry of Education, Science and Technological
Development (#175037) and Provincial Secretariat for Higher
Education and Scientific Research (# 114-451-710), Other: The
author filed a patent application: Sports Supplements Based oн
Liquid Creatine at International Bureau of WIPO, Application ID PCT/
IB2019/050832. February 13, 2019, M. Vranes Other: The author filed a
patent application: Sports Supplements Based oн Liquid Creatine at
International Bureau of WIPO, Application ID PCT/IB2019/050832.
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Hormones, mediators and immunity
MON-PO323
SUSTAINED ACYLATED GHRELIN TREATMENT LOWERS
MITOCHONDRIAL FUNCTION AND INSULIN SIGNALLING IN RAT
ADIPOSE TISSUE
A. Semolic1, G. Gortan Cappellari1*, R. Caporale1, F. Kharrat1, M. Zuanel1,
M. Zanetti1, R. Barazzoni1. 1Department ofMedical Sciences, University of
Trieste, Trieste, Italy
* Corresponding author.
Rationale: Acylated ghrelin (AG) is a gastric orexigenic hormone
which plays a relevant role in the regulation of intermediate
metabolism, with tissue specific effects. In skeletal muscle AG
reportedly enhances mitochondrial function and insulin signalling,
with variable effect in reducing tissue inflammation and redox
balance, both in vitro and in healthy and diseased rodent models. In
liver samples AG limits fat accumulation and reduces insulin signalling
with no changes in mitochondrial function while improving redox
state and gluconeogenesis. AG effects on adipose tissue metabolism
are currently largely undefined.
Methods: We investigated the impact of AG s.c. administration for four
days in12-week-oldmalehealthyWistar rats (AGT;n = 8)by twice-a-day
200 ng s.c. non orexigenic hormone injection compared tovehicle (Con;
n = 8) on retroperitoneal adipose tissue (AT) mitochondrial enzyme
activities (citrate synthase and cytochrome c oxidase), oxidized/total
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glutathione, cytokine levels (xMAP) and insulin sensitivity in terms of
AKTand GSK activating phosphorilation (western blot).
Results: No statistically significant differences were observed among
between groups in cumulative food intake or body weight. Compared
to Con, AGThad lower (p < 0.05)mitochondrial enzyme activities, with
similar (p = NS) inflammatory cytokine profile and redox state. Insulin
signalling activation was lower in AGT at AKT level (P < 0.05), with
similar trend at GSK (p = 0.08).
Conclusions: In rat adipose tissue, sustained acylated ghrelin
adiministration lowersmitochondrial function and insulin sensistivity.
These findings are consistent with reports suggesting a potential
adaptative role for AG during starvation, as decreased insulin
sensitivity and mitochondrial function both lower energy storage by
decreasing lipogenesis in adipose tissue.
Disclosure of Interest: None declared.
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MON-PO324
COMBATING HOSPITAL MALNUTRITION: DIETITIAN-LED QUALITY
IMPROVEMENT INITIATIVE II (DQII)
D. Lovesley1*, R. Parasuraman1. 1Dietetics, APOLLO HOSPITALS, Chennai,
India
* Corresponding author.
Rationale: Hospital malnutrition is estimated at least one third of
patients in developed countries are malnourished on admission to the
hospital, and if left untreated, approximately two thirds of those
patients will experience a further decline in their nutrition status
during their hospitalization. Hence, dietitian driven continuous
nutrition improvement initiative is vital. This study aimed to
understand the nutritional status of a large cohort of hospitalized
patients and to audit the effect of our previous phase 1 DQII.
Methods: Retrospective cohort study composed by secondary data-
base formed by patients included from January to April’18. Patient’s
data were retrieved from the new digital dietitian module as part of
electronic medical records. Patients’ demographics, baseline markers
of nutritional status – Subjective Global Assessment (SGA), body mass
index (BMI), details of nutritional intervention and clinical outcomes
were recorded. Data was analyzed using SPSS 20.0.
Results: A total of 4531 patients were included with the mean age of
55.1 ± 15.1y, comprising of 19% critically ill and the rest were non-
critical patients. Out of 4531 patients, 3681 of non-critical patients
were included for further analysis with the average BMI of 25.7 ± 11.1
kg/m2, 77% were well-nourished and 23% malnourished as per SGA.
Majority (98%) of patientswere on oral nutrition and 14% of thosewere
prescribed with oral nutritional supplements (ONS). Among the non-
critical cohort, 63% had a lesser (<4 days) length of stay (LOS) whereas
23% had LOS between 4–7 days and only 14% stayed >7 days. BMI of
<18.5 kg/m2 and >25 kg/m2were associatedwith increased LOS,which
proves both undernutrition and overnutrition are detrimental (p =
0.002). A significant decrease in the LOS (<4 days) was observed in 46%
of patients on ONS (p = 0.000). Likewise moderately malnourished
patients who were supplemented had an impact on LOS (p = 0.001).
ONS helped in lowering the LOS irrespective of the percentage weight
loss, which was statistically significant (p < 0.01). There was an
improvement in the nutritional intervention especially ONS prescrip-
tion and delivery in DQII-II and decreased length of stay of 3.75 ± 4.3d
from 6.04 ± 7.11d (Phase-1).
Conclusions: Continuous improvement initiatives like digitalization of
nutrition care process and regular audits helped improve and sustain
clinical nutrition practices.
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IBERO-LATIN AMERICAN JOURNALS DEDICATED TO FOOD AND
NUTRITION SCIENCES: ARE THEY REACHING AN IMPACT?
E. Frias1*, C. Almazán2, S. Santana3. 1Research Committee, SOLCA,
2Universidad de Guayaquil, Guayaquil, Ecuador, 3Laboratorio Clínico,
Hospital Pediátrico Juan Manuel Márquez, La Habana, Cuba
* Corresponding author.
Rationale: Publishing of the results of a conducted research is the final
step of the scientific activity. Choice of the literary container is
determinant for thevisibilityand the impactof scientific communication.
Aim: To describe the state of the Ibero-Latin-American (ILA) journals
devoted to publishing contents of the Food and Nutrition Sciences.
Methods: Study design: Descriptive. ILA journals specialized in
publishing contents of the Food and Nutrition Sciences that where
identified in selected literary repositories were described regarding
the host country, the Publisher, the number of issues comprising each
volume, the adherence to the ‘Open Access’ declaration, and the
‘Article Processing Charges’ (APC) canon. Performance of the ILA
journals was described using several metrics.
Results: There were identified twenty-seven medical journals in 8
different countries. Journals differed regarding the publisher, the
number of issues per volume, and adherence to the ‘Open Access’
declaration. All (but one) of the examined journals accepted original
contributions without charging the APC canon. Visibility of ILA
journals dedicated to Food and Nutrition Sciences is poor when
examined through different performance metrics.
Description Findings
CiteScore Issues:11
0.39
± 0.24
CiteScore ≥0.50: 5¶
SJR Issues: 12
0.22 ± 0.09
SJR ≥ 0.200: 7¶
h-index Issues: 12
14.8 ± 10.9
Índice H ≥ 10: 6 ¥
FI Issues:10 0.19 ± 0.20
FI ≥ 0.14: 6¥
h5-index Issues: 19
10.3 ± 6.9
SJR: Scopus Journal Rank. FI: Impact Factor.
¶Calculated by the authors.
¥Based oh the median from the findings.
Conclusions: Visibility of ILA journals specialized in publishing
contents of the Food, and Nutrition Sciences is weak, and that might
explain (at least in part) their insufficient impact. A change of
mentality and attitude towards the scientific publication is needed
to increase the visibility and, consequently, the impact of the journals
dedicated in the ILA area to Food and Nutrition Sciences.
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CONSTRUCTING STANDARDIZED NURSING PRACTICE ON KOREAN
NUTRITION SUPPORT NURSES
J.Y. Park1, J. Song2*, E. Seol3, M. Seok4, K. Song5. 1Department of Clinical
Nursing, University of Ulsan, 2Department of Nursing, Asan Medical
Center, 3Nutrition Support team, Seoul National University Hospital,
Seoul, 4Nutrition Support team, Keimyung University Dongsan Medical
Center, Daegu, 5Seoul National University, Seoul, Korea, Republic of
* Corresponding author.
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Rationale: At August 1st, 2014 Korea Ministry of Health and Welfare
(KMHW) launched legislation for reimbursement for Nutrition
Support Team (NST) activities which should be comprised of a
professional physician, an educated nurse, an educated pharmacist,
and a professional and experienced dietitian. Among NST members,
nurses play an important role, however, they are confused because
their roles are not established and standardized. The purpose of this
study was to construct a standardized nursing practice on Korean
nutrition support nurse (NSN) working in hospitals.
Methods: A descriptive study design was used. Structured question-
naire was developed by experienced nurses, MSNs, and professors
majoring in clinical nutrition. The final version included 6 domains
(advanced care, NST, advocate, collaboration, research, management)
and 38 activities. Validity of the instrument was tested by five
experienced NSNs and a doctor. To confirm nursing practice with 1–7
Likert scale of Korean nutrition support nurse, 101 NSNs were
recruited from December, 10 to December, 30, 2018. The collected
data were analyzed using SPSS/WIN 17.0.
Results: One hundred one Korean NSNs from 39 tertiary hospitals, 41
general hospitals with over 300 beds, and 11 general hospitals with
100–300 beds participated in this study. About 43.6% of the nurses had
BSNs and 34.7% had master’s degree. Years of nursing experience for
the nutrition support team had 2.5(SD: 2.4) years. The mean scores of
nursing practice in Korean NSNs were 5.3 (SD: 1.0) in advanced care,
4.8 (SD: 1.6) in NST, 3.7 (SD: 1.2) in advocate, 4.2 (SD: 1.4) in
collaboration, 3.8 (SDL 1.4) in research, and 5.0 (SD: 1.3) in
management, respectively.
Conclusions: The standardized nursing practices of Korean NSNs are
useful for the qualitative improvement of clinical nutrition services in
hospital. Korean NSNs are prepared to a clinical competence,
education of staff, and patients, team coordination, research and
quality improvement. NSNs could play a key role in improving the
patient outcome in NST. Further, it is needed to develop an education
program for nutrition nurse specialist which allows the nurse to be
certified with accreditation.
Disclosure of Interest: None declared.
MON-PO327
PROFESSIONALS’ PERSPECTIVE ON THE TREATMENT OF
MALNUTRITION IN OLDER ADULTS DURING HOSPITALISATION
AND POST-DISCHARGE
J. Verstappen1*, C. van Dronkelaar1, M. Tieland1, H. Kruizenga2,
P. Weijs1. 1Faculty of Sports and Nutrition, Amsterdam University of
Applied Sciences, 2Nutrition and Dietetics, Department of Internal
Medicine, Amsterdam University Medical Centers, VU, Amsterdam,
Netherlands
* Corresponding author.
Rationale: Many older adults in hospital and post-discharge are
malnourished. The treatment of malnutrition is a multidisciplinary
process inwhich dietary protein intake and physical activity play a key
role. To get a complete overview of the current treatment of
malnutrition, we performed a qualitative research.
Methods: Focus group sessions were organised with Dutch hospital
and community dietitians, physiotherapists and nurses. Beforehand an
interview guide was made focussing on four main topics in the
treatment of malnutrition: the current treatment practice versus the
most optimal treatment, multidisciplinary collaboration, patient
handovers, and the use of digital support. The sessions continued
until information saturation was reached. The focus groups were
transcribed verbatim, subsequently coded and analysed using
MAXQDA.
Results: Eight focus group sessions were held between May and
August 2018. The main results show: 1) professionals are unaware of
each other’s ongoing treatments. They desire more inter- and
multidisciplinary communication and collaboration; 2) patient hand-
overs are often incomplete or missing because of file access problems,
a lack of time or failing software; 3) more attention should be paid to
inactivity of older adults; 4) new digital support tools can help in the
communication between professionals and with patients. However,
patient contact remains the most valuable.
Conclusions: In the treatment of patients with malnutrition in
hospital and post-discharge setting, communication, collaboration,
patient handovers and physical inactivity should be improved
according to dietitians, physiotherapists and nurses.
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THE COGNITIVE, BEHAVIORALANDEMOTIONALASPECTSOF EATING
HABITS AND ITS ASSOCIATION WITH IMPULSIVITY, CHRONOTYPE,
ANXIETY AND DEPRESSION: A CROSS-SECTIONAL STUDY AMONG
UNIVERSITY STUDENTS
L. Rabbaa Khabbaz1*, on behalf of Carla Aoun, Lynn Nassar, Stéphanie
Soumi, Joelle Najem, Maroun Saber, Tatiana Papazian. 1faculty of
pharmacy, SAINT-JOSEPH UNIVERSITY, beyrouth, Lebanon
* Corresponding author.
Rationale:One of themost prevalent and often ignored form of public
health disorder, affecting both developed and developing countries, is
obesity. Understanding behavioral issues associatedwith eatingwould
provide important insight into obesity development and possibly
procure ways to prevent its occurrence or to treat it.
This study’s objectives were to examine links between cognitive,
behavioral and emotional aspects of eating habits and chronotype,
impulsivity, anxiety and depression among young adults (university
students). To the best of our knowledge, no previous study has
assessed these associations.
Methods:Our study was a cross-sectional questionnaire-based survey
conducted among Lebanese university students (Grand Beirut univer-
sities: USJ, Lebanese university, USEK, ALBA, NDU, LAU, SAGESSE), from
October 2017 till March 2018. Inclusion criteriawere: students aged 18
years and above, willing to participate in the study. Exclusion criteria
were the presence of any cognitive deficit or other chronic diseases.
Students were randomly selected within each university using a
random number table to ensure the representativeness of the sample.
This random selection was proportional to the number of students in
each university. Students selected were approached by two trained
research assistants at the end of their courses before leaving the
classroom. Out of 580 students approached, 400 agreed to participate.
Results: The results of this study showed significant associations
between the 3 dimensions of eating habits (cognitive restraint CR,
uncontrolled eating UE and emotional eating EE) and BMI. No
differences in CR or UE were observed in this study between males
and females; only EE was significantly higher among females. Our
results also showed that impulsivity was intimately associated to
eating habits. In particular, higher sensation seeking was associated to
lower CR. Furthermore, higher negative urgency was associated with
higher UE and EE. The last factor that remained significantly associated
to eating habits in the multivariate analysis was the chronotype; it
showed links with CR and UE:morning type individuals had higher CR
while evening type individual presented higher UE scores. Our results
showed that anxiety and depression scores were not significantly
correlated to any of the 3 factors of eating habits;
Conclusions: Further studies are needed to estimate how specific
facets of sensation seeking and negative urgency interact with
chronotype in relation to eating behaviors, and specifically CR and
UE. Finally, future studies should replicate findings in samples of
individuals with different aspects of eating disorders such as binge
eating disorder, bulimia nervosa or food addiction.
Disclosure of Interest: None declared.
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THE FRAGILITY INDEX IN RANDOMIZED CONTROLLED TRIALS IN
THE FIELD OF CLINICAL NUTRITION
M.Mizera1, M. Wysocki1, P. Małczak1, T. Stefura1, N. Gajewska2, J. Dros1́,
G. Torbicz1, A. Kacprzyk1, P. Major1, M. Bała3, S. Kłęk4*, M. Pędziwiatr1.
12nd Department of General Surgery, 22nd Deparment of General Surgery,
3Chair of Epidemiology and Preventive Medicine, Department of Hygiene
and Dietetics, Jagiellonian University, Kraków, 4General and Oncology
Surgery Unit, Stanley Dudrick’s Memorial Hospital, Skawina, Poland
* Corresponding author.
Rationale: Recently, a parameter called ‘Fragility index’ (FI) has been
proposed, which measures how many events the statistical signifi-
cance relies on. The lower the FI the more ‘fragile’ the results, and thus
more care should be taken when interpreting the results. Our aim in
this study was to check FI of nutritional trials.
Methods: We conducted a systematic review of human clinical
nutrition RCTs that report statistically significant dichotomous
primary outcomes. We searched the EMBASE, MEDLINE, and Scopus
databases. The FI of primary outcomes using the Fisher exact test was
calculated and checked the correlations of FI with the number of
randomised trials, the p-value of primary outcomes, the publication
date, the journal impact factor and the number of patients lost to
follow-up.
Results: The initial database search revealed 5790 articles, 45 of which
were included in qualitative synthesis. The median (IQR) FI for all
studieswas 1 (1–3). Thirty-two studies (71.1%) had an FI lower or equal
to 2, and in 18 articles (40.00%) the FI was lower than the number of
patients lost to follow-up. FI has a significant positive correlationwith
the number of randomised patients (p = 0.020) and a negative
correlation with p-value of primary outcomes (p = 0.016).
Conclusions: The results of RCTs in nutritional research often rely on a
small number of events or patients. The number of patients lost to
follow-up is frequently higher than the FI calculation.
Reference
1. Walsh M, Srinathan SK, McAuley DF, et al. (2014) The statistical
significance of randomized controlled trial results is frequently
fragile: A case for a Fragility Index. J Clin Epidemiol 67:622–628. doi:
10.1016/j.jclinepi.2013.10.019
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A LACKOFKNOWLEDGEANDA FEAROF FOODTRIGGERS SUFFERING
IN PATIENTS WITH A HISTORY OF ACUTE DIVERTICULITIS: AN
INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS
F. Eberhardt1, J. Jenkins2, R. Nucera2, P. Dalwood1, R. Canavan3,
S. Marshall1*. 1Bond University Nutrition & Dietetics Research Group,
Faculty of Health Sciences and Medicine, Bond University, 2Nutrition &
Dietetics, 3Department of Digestive Health, Gold Coast Hospital and
Health Service, Robina, Australia
* Corresponding author.
Rationale: The inpatient dietary management for diverticulitis
routinely includes dietary restrictions despite a lack of evidence for
this approach. There is also a dearth of qualitative research which
prevents understanding of the patient experience, a barrier to
providing patient-centred care. This study aims to understand the
impact of dietary restrictions for the management of acute diverticu-
litis on patient experience.
Methods: Three semi-structured in-depth face to face interviewswere
conducted with adult patients admitted to a public hospital in South
East Queensland, Australia for acute, uncomplicated diverticulitis
treatment. Interviews were analysed following the interpretive
phenomenological analysis (IPA) framework.
Results: Inter-related themes of knowledge, control, social stigmatisa-
tion, and vulnerability were found to sit within a broad experience
driven by fear of food and suffering. Theme interpretation guided the
development of a ‘diverticulitis fear and suffering framework’ which
explained a phenomenon experienced by the patients. Sitting in a
context of a lack of knowledge by patients, family, and health
professionals, food was used as a vehicle of blame and causality for
diverticulitis occurrence. ‘Fear of food’ was a trigger for a cycle, which
commences with dietary restrictions and leads to stigma, loss of
culture, failure, blame, guilt, vulnerability, and back to a fear of food.
With each cycle, fear of food, dietary restrictions, and patient suffering
worsen.
Conclusions: Considering patient experiences highlights the need for
a multidisciplinary collaborative approach to avoid unnecessary
dietary restrictions to prevent avoidable suffering by patients.
Increased research regarding the dietary management of acute
diverticulitis is essential to improve evidence-based practice to
improve the quality of life for diverticulitis patients.
Disclosure of Interest: None declared.
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MON-PO331
CHARACTERIZATION OF BODY COMPOSITION AND HYDRATION
STATUS ACCORDING TO AGE’S GROUP AND GENDER IN ELDERLY
PEOPLE LIVING IN NURSING HOMES
M.D.M. Ruperto Lopez1*, C. Iglesias1. 1Human Nutrition and Dietetics,
Universidad Alfonso X EL Sabio, Madrid, Spain
* Corresponding author.
Rationale: Body composition and hydration status are highlighted
predictors of functionality, nutritional status and adverse outcomes in
elderly population. This study aimed to analyse the potential
differences in body composition and hydration status according to
gender and Age’s ranges in older people living in nursing homes.
Methods: A multicenter cross-sectional observational study in 229
autonomous elder people (women: 84.4%; aged: 87.5 ± 6.84; time on
institutionalization:3 1.6 ± 28.37 months). Assessment of nutritional
status by Mini-nutritional assessment (MNA). Body composition and
hydration status was analysed by mono-frequency bioelectrical
impedance analysis. The sample was stratified according to recom-
mendations of world health organization (WHO) by gender and Age’s
ranges into 2 groups (Gn) (G1: aged,74–85 years) and, (G2:aged, >85
years). Statistical analysis by SPSS v.20.
Results: Of 250 elders evaluated, 229 (91.6%), were enrolled. The aged
distribution (%) was 32,3% (G1) and 67.3% (G2), women 74.3% and
75.5%, in both Age’s ranges groups (G1,G2), respectively. Age was
positively correlated with resistance (r = 0.19; p = 0.037) and inversely
with body cell mass (BCM, kg)(r = -0.24; p = 0.02) and intracellular
water (ICW,L) (r =−0.24; p = 0.02) in both groups. By comparing aged
and gender groups, mean differences were found with body weight
(BW), resistance, BCM, total body water, ICW, fat mass, lean bodymass
and fat-freemass (at least, p < 0.05). Themultivariate analysis adjusted
by age and gender showed significantly that BW, mid-arm upper
circumference, ICWand resistance (at least, p < 0.05) were associated.
Conclusions: The evaluation of body composition and hydration
status should be analysed by Age’s ranges and gender for identifying
the potential changes and to promote preventive and/or tailored
nutritional intervention in elder people as needed.
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ORAL NUTRITIONAL SUPPLEMENTS AND NUTRITIONAL STATUS
EVALUATION IN ELDERLY PATIENTS AFTER HIP FRACTURE: A ONE
YEAR RETROSPECTIVE STUDY
M. Ventosa1*, M.C. Terroba1, C. Crespo1, J.M. Palacio1, L. Cuéllar1,
M. Alejo1, M. García-Alonso2, A. Cerón3, F. Núñez1, F. Redondo1,
M. González-Carabias1. 1endocrinology, 2Traumatology, 3Geriatric
department, Hospital Rio Hortega, Valladolid, Spain
* Corresponding author.
Rationale: Hip fracture is associated with high mortality and
malnutrition risk. 2018 ESPEN guideline in geriatrics recommends
oral nutritional supplements (ONS) postoperatively. The aim of this
study was to evaluate the use of ONS and nutritional status evaluation
(NSE) after hip fracture surgery (HFS) at our institution.
Methods: Retrospective study of 261 patients >65 years undergoing
HFS at our hospital between Jan 2017 and Dec 2017. We collected data
of serum albumin (ALB), cholesterol (CHOL) and total protein (TP)
measured in the first 2 weeks after HFS. Statistical analysis: χ2 and
T-test.
Results: 59/202 (male/female) patients were included. Age; 84,6 ± 7,3
yrs (65–107). Mortality: Intrahospital 8,8%; 3 months 13% and 1 yrs
postHFS21,4% (malesvs females:37,2%vs16,8%;χ2p = 0,001).ONSwere
prescribed in 22,6% for 6,39 ± 7.6 months (45,7% hyperproteic, 42,4%
hyperoproteic+vit D, 1,7% hyperproteic+vit D +HMB; 10,2% others). 10
patients were using ONS previously, the rest started within the first
postHFS week. All patients had a subjetive NSE by a geriatrician and
12,3% had a NSE by endocrinologist, registered in their clinical history
(all initiated ONS). Biochemical data: TP (n = 124) 5,3 ± 0,6 g/dl; CHOL
(n = 99)146,9±43,7 mg/dl,ALB(n = 57)2,6±0,5 g/dl. In thesubgroups1)
ALB<3,5 g/dl ONS in 53,8% and NSE registered in 32,7%.2)
CHOL<150 mg/dl ONS in 43,6% and ENS in 32,7%.3)TP<6,5 g/dl: 36,2%
used ONS and 21,6% had registered NSE. Patients who used ONS were
older: 87,02 ± 6,3 vs. 83,8±4 yrs (p0,002). CHOLwas lower in thosewho
died within 3 months: 129,8 ± 48,4 vs 152,1 ± 42,6 mg (p < 0,05)
Conclusions: ONS were prescribed in a low proportion of patients
with HFS at our institution. The proportion increased in malnourished
patients acording to biochemical data. NSE was a routine nutritional
intervention but not registered in many cases.
Disclosure of Interest: None declared.
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ARE ADVANCED GLYCATION END PRODUCT (AGE) LEVELS
ASSOCIATED WITH FRAILTY IN DUTCH OLDER ADULTS?
M.J. Sealy1*, A. van Dinther1, J.S. Hobbelen1,2, C.P. van der Schans1,3,4,
H. Jager-Wittenaar1,5. 1Research Group Healthy Ageing, Allied Health
Care and Nursing, Hanze University of Applied Sciences Groningen,
2Department of General Practice and Elderly Care Medicine, 3Department
of Rehabilitation Medicine, 4Department of Health Psychology Research,
5Department of Maxillofacial Surgery, University of Groningen, University
Medical Center Groningen, Groningen, Netherlands
* Corresponding author.
Rationale: Levels of Advanced Glycation End products (AGEs) increase
with age andmay contribute to loss of muscle function. Loss of muscle
strength and mass are considered indicators of the multidimensional
construct of frailty. Until now, it is unclear if the level of AGEs is
associated with frailty in older adults. Therefore we studied the
association between levels of skin AGEs and frailty in older adults.
Methods: Frailty was identified with the Groningen Frailty Indicator
(GFI) in community dwelling adults aged ≥55y, who participated in
the Hanze Health and Ageing Study. GFI scores may range from 0–15
(cut off for frailty ≥4). The autofluorescence value (AU) of skin was
measured with an AGE reader (Diagnoptics). Univariate and multi-
variate binary logistic regression analyses were performed.
Multivariate analysis corrected for age, sex, Caucasian origin,
smoking, handgrip strength (handgrip dynamometer; kg) and lean
body mass (bio electrical impedance; kg). A p-level of <0.05 was
considered significant and Odds Ratios (OR; 95% CI) were presented.
Results: 111 participants (age 64.0 ± 5.5y; male 45.9%; autofluores-
cence 2.14 ± 0.54 AU; median GFI = 1 [min 0-max 6], frail: n = 21) were
included in the analysis. Both in the univariate analysis (p = 0.036,
OR = 2.55 [1.07–6.13]) and in the multivariate analysis (p = 0.046,
OR = 2.80 [1.02–7.71]), skin autofluorescence was significantly asso-
ciated with frailty. Other variables were not significantly associated
with GFI.
Conclusions: In this sample of older adults aged≥55y, the level of skin
AGEs shows a borderline significant association with frailty. Further
research that includes sub-analysis of AGE levels for the different
domains of frailty may provide more insight in this relationship.
Disclosure of Interest: None declared.
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ASSOCIATION BETWEEN (ABDOMINAL) OBESITY AND ADVANCED
GLYCATION END PRODUCTS IN DUTCH OLDER ADULTS
M.J. Sealy1*, A. van Dinther1, J.S. Hobbelen1,2, C.P. van der Schans1,3,4,
H. Jager-Wittenaar1,5. 1Research Group Healthy Ageing, Allied Health
Care and Nursing, Hanze University of Applied Sciences Groningen,
2Department of General Practice and Elderly Care Medicine, 3Department
of Rehabilitation Medicine, 4Department of Health Psychology Research,
5Department of Maxillofacial Surgery, University of Groningen, University
Medical Center Groningen, Groningen, Netherlands
* Corresponding author.
Rationale: (Abdominal) obesitymay contribute to the development of
insulin resistance. Insulin resistance may contribute to the develop-
ment of Advanced Glycation End products (AGEs), which may further
contribute to the pathogenesis of insulin resistance and of age-related
chronic diseases. However, until now it is unclear if abdominal obesity
contributes to increased AGE levels. Therefore, we studied the
association between measures of (abdominal) obesity and skin AGE
levels in older adults.
Methods: In this cross-sectional study, the skin autofluorescence value
(AU) was measured with an AGE reader (Diagnoptics) in Dutch
community dwelling adults aged ≥55y. Abdominal obesity was
measured by waist circumference (cm). BMI was calculated from body
weight and height (kg/m2). Data were corrected for outliers, and
univariate and multivariate linear regression analyses were performed.
Multivariate analysis corrected for age, sex, Caucasian origin, smoking,
diabetes type2, daily physical activity (3-axis accelerometer;METs/day),
and lean bodymass (bioelectrical impedance analysis; kg). Significance
was presumed at p < 0.05 and explained variance (r2) was reported.
Results: In total, 85 participants (age 64.8 ± 6.0y; male 48.2%; waist
male 97.9 ± 10.0 cm,waist female 89.2 ± 14.5 cm; BMI 26.1 ± 4.1 kg/m2;
AF 2.12 ± 0.47 AU) were included in the analyses. In the univariate
analysis, waist circumference was significantly associated with skin
autofluorescence (r2 = 0.05, p = 0.032), whereas BMIwas not (r2 = 0.02,
p = 0.205). In the multivariate analysis, waist circumference was not
significantly associatedwith skin autofluorescence (model r2 = 0.20, r2
change = 0.03, p = 0.096).
Conclusions: This study indicates that abdominal obesity only
explains about 3–5% of variance in skin AGE level. After correction
for co-variables, abdominal obesity was no longer significantly
associated with skin AGEs. The weak explained variance in our
sample may indicate that the impact of intra-abdominal fat stores on
AGE levels could be limited.
Disclosure of Interest: None declared.
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THE GERIATRIC APPROACH TO THE POTENTIAL RISKS OF COPD IN
THE ELDERLY PATIENTS WITH TYPE 2 DIABETES COMPARED WITH
THE NON-ELDERLY
M. Ishii1*, Y. Yamaguchi1, H. Hamaya1, S. Ogawa1, M. Imura2,
M. Akishita1. 1The Department of Geriatric Medicine, The University of
Tokyo, Tokyo, 2Okamoto Internal Medicine Clinic, Yaizu, Japan
* Corresponding author.
Rationale: Type 2 diabetes is considered a common comorbidity for
elderly patients with chronic obstructive pulmonary disease (COPD).
Both of COPD and type 2 diabetes are serious diseases requiring proper
diagnosis andmanagement in geriatricmedicine.However, there is little
evidence about the prevalence of COPD and the lung function in the
elderly patients with type 2 diabetes compared with the non-elderly.
Methods:We investigated 246 elderlyaged65 years over and 293non-
elderly patients aged 40–64 diagnosed with type 2 diabetes who had
not been diagnosed as respiratory diseases in a diabetes clinic in Japan.
They underwent the lung function test including predicted expiratory
volume at one second (%FEV1) and FEV1% for assessing the sevirity of
COPD.
Results: The prevalence of COPD in our survey was 37.0% in the elderly
and 3.1% in the non-elderly patients. In the multivariate analysis the
decrease of FEV1.0%was associatedwith BMI (p = 0.004), age (p = 0.01)
and the presence of insulin use (p = 0.003) in the elderly and BMI
(p = 0.04) and c-peptide (p = 0.03) in the no-elderly, respectively. BMI
is the common factor for the elderly, which was significantly
associated in male The decrease of %FEV1.0 was associated with the
presence of insulin use (p = 0.001) and pack year (p = 0.01) in the
elderly and c-peptide (p = 0.02) in the no-elderly, respectively.
Conclusions: Our results suggest that there is a potential risk of COPD
in elderly patients with type 2 diabetes compared to the non-elderly
and lung function test is important for the early detect of COPD in
patients with type 2 diabetes. In addition the treatment of type 2
diabetes including the management of low BMI may be effective,
especially in the male elderly patients with COPD.
Disclosure of Interest: None declared.
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A SYSTEMATIC REVIEW OF THE EFFECTIVENESS OF NUTRITIONAL
INTERVENTIONS PROVIDED BY NON-DIETITIANS ON NUTRITIONAL
OUTCOMES IN ADULTS AT RISKOF MALNUTRITION
M. Dabbous1*, C.E. Weekes2, C. Baldwin1. 1Nutritional Sciences, King’s
College London, 2Nutrition and Dietetics, Guy’s and St. Thomas’ NHS
Foundation Trust, London, United Kingdom
* Corresponding author.
Rationale: Whilst dietitians remain uniquely-qualified to provide
targeted nutritional interventions, the low numbers of dietitians in
relation to patients needing nutritional support means that innovative
ways of working are needed. This systematic review aims to describe
the nutritional interventions provided to adults at risk ofmalnutrition,
by non-dietetic healthcare professionals, caregivers or volunteers
according to setting and mode, and to synthesise their impact on
nutritional outcomes.
Methods: Seven electronic databases were searched for relevant
studies, supplemented by a ‘snowball’ search. All quantitative study
types evaluating the effectiveness of a nutritional intervention in
adults at risk of malnutrition across different settings and provided by
a non-dietitian were included. Risk of bias was assessed by the
Cochrane risk of bias or Robins-I tool.
Results: 20 studies met the inclusion criteria. Interventions were
provided by nurses (n = 9), lay volunteers (n = 9) andMDTs (n = 2), in a
variety of care settings. The majority were in people aged >65 years
(n = 17). Nutritional interventions included nutritional advice and
counselling (n = 10), mealtime feeding assistance (n = 9), and changes
to dietary intake (n = 1). Mixed results were found for changes in
energy, protein, and food intake (Table). Studies varied in outcomes
reported, measurement methods (e.g. screening tool used), duration
(one month-3 years) and study quality.
Energy
Intake
Protein
Intake
Food
Intake
Weight
change
Nutrition
Risk
Status
Nurses 2(1)a 2(1) 3(2) 1(1) 2(2)
Volunteers 3(0) 3(1) 0 0 1(1)
MDTs 1(1) 1(1) 0 0 1(0)
aNumbers represent the numberof studies (numberof studieswith a statistically
significant benefit in the intervention group).
Conclusions: These results suggest improvements in dietary intake,
weight change, and nutritional risk in some studies where nurses
delivered the intervention. Further research is needed to evaluate
which interventions are most effective and the impact of nursing
interventions on other patient outcomes e.g. quality of life and
functional outcomes. There are insufficient data to evaluate the
effectiveness of interventions delivered by volunteers or MDTs.
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MON-PO337
REVIEW OF NUTRITIONAL CARE PROVIDED TO OLDER ADULTS IN
THE COMMUNITY
M. Dabbous1*, C. Baldwin1, C.E. Weekes2. 1Nutritional Sciences, King’s
College London, 2Nutrition and Dietetics, Guy’s and St. Thomas’ NHS
Foundation Trust, London, United Kingdom
* Corresponding author.
Rationale: Nutritionally vulnerable patients are frequently not
recognised early. The number of routine healthcare interactions and
the amount and nature of nutritional information provided is not
known among these patients. This study aimed to explore interactions
between older people and healthcare professionals and to identify the
nature of any nutrition care provided.
Methods: 99 participants (mean age 74.5 ± 8.6) were recruited from
different GP settings and informationwas collected on nutritional risk
status. Data were collected from the electronic healthcare records
system of three hospitals within one NHS Trust in the UK on
participant contact with hospital departments and staff, and docu-
mentation of nutritional care for a one-year period. Data were
imported into SPSS and summarised using descriptive statistics.
Results: At baselinemean BMIwas 26.4 ± 6.0 kg/m2with seven (7%) of
the participants being underweight and ten (10%) reporting weight
loss. 71 (72%) had no comorbidities recorded and 11 (11%) were
described as frail. Among the 14 (14%) participants who were
underweight or reported weight loss (‘at risk’), 88% (n = 93) of visits
were outpatient and 12% (n = 13) were inpatient visits at any one of the
three hospitals. These participants were seen mainly by physicians
(n = 58 times), nurses (n = 18 times), and physiotherapists (n = 15
times). No dietitian contacts were recorded. Of those participants who
were at risk (n = 14), seven (50%) had no input regarding nutrition
documented, four (28%) had BMI recorded, of which majority were
during inpatient visits. One (7%) participant was screened using MUST
during an inpatient visit by a nurse, four (28%) were assessed
nutritionally by a physician and three (21%) were referred to a
dietitian. All documentation was provided by non-dietetic profes-
sionals (physician or nurse).
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Conclusions: Despite numerous healthcare contacts, malnutrition
remains undetected in the community with numerous missed
opportunities during routine healthcare appointments for timely
identification and management of malnutrition of at-risk patients.
Future research will review nutritional documentation during General
Practice visits.
Disclosure of Interest: None declared.
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CT-GUIDED PERCUTANEOUS GASTROSTOMY FOR ELDERLY
PATIENTS: A RETROSPECTIVE EVALUATION IN 75 PATIENTS
M. Sun1*, Z. Wang2, X. Lv1, F. Lin1. 1Department of Clinical nutrition,
Fujian Provincial Hospital, Fujian Institute of Clinical Geriatrics, Fujian
Provincial Center for Geriatrics, 2Department of Radiology, Fujian
Provincial Hospital, Fuzhou, China
* Corresponding author.
Rationale: Elderly patients often suffer from dysphagia, painful
swallowing, or cough caused by the age-related diseases such as
dementia, stroke, Parkinson’s syndrome and tumor. Although percu-
taneous endoscopic gastrostomy (PEG) is the most common method
for patients with long-term enteral feeding, it has obvious limitations
for patients with severe stenosis of the pharynx or esophagus, and for
elderly people at high risk for anesthesia. Then computed tomography
(CT)-guided percutaneous gastrostomy may be an safe and effective
alternative. The purpose of this study was to assess the effectiveness,
complications and quality of life associated with CT-guided percutan-
eous gastrostomy for elderly patients.
Methods: This retrospective study included elderly patients who had
undergone CT-guidedpercutaneous gastrostomy betweenMarch 2007
and December 2018. The elderly patients who underwent PEG during
the same period were selected as the control group. Information
regarding the patients’ backgrounds, NRS-2002 scores, Charlson
Comorbidity Index, CT-guided percutaneous gastrostomy techniques,
technical success rate, and complication were obtained from the
medical records. Thebodymass index (BMI) and laboratoryevaluations
including albumin and prealbuminwere determined before operation
and2monthsafteroperation. Thephysiological function,psychological
health and social function were compared between pre-operation
and post-operation using SF-36 quality of life scale.
Results: There were 75 elderly patients underwent CT-guided
percutaneous gastrostomy, and 86 elderly patients underwent PEG
with the success rate of 100% and 96.51%, respectively (P > 0.05). In the
CT-guided percutaneous gastrostomy group, the average age of
patients and Charlson Comorbidity Index were higher than PEG
group(P < 0.05). There were no significant differences based on BMI,
albumin, prealbumin and SF-36 scores between CT-guided percutan-
eous gastrostomy and PEG group. The overall mean procedure time of
CT-guided percutaneous gastrostomy was 40.3 min. No Major com-
plications were observed in those patients underwent CT-guided
percutaneous gastrostomy.Minor complications occurred in 5 patients
(6.7%), which included peristomal leakage (n = 2), irritation (n = 1),
inadvertent removal (n = 1), and peristomal hemorrhage (n = 1). BMI,
hemoglobin and albumin were significantly improved after operation
(P < 0.05). Physiological function, psychological health and social
function were also significantly improved after operation (P < 0.05).
Conclusions: Our study suggests that CT-guided percutaneous
gastrostomy is a feasible and safe alternative for elderly patients who
are unsuitable for PEG.
Disclosure of Interest: None declared.
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SKELETAL MUSCLE ULTRASONOGRAPHY: A NEW DIAGNOSTIC TOOL
FOR SARCOPENIC OBESITY?
O. Deniz1*, G. Sengul Aycicek1, P. Unsal1, M. Esme1, B. Balam Yavuz1,
M. Cankurtaran1, M. Halil1. 1Department of InternalMedicine, Division of
Geriatrics, Hacettepe University School of Medicine, Ankara, Turkey
* Corresponding author.
Rationale: Although different definitions have been proposed, there is
no definitive diagnosis of sarcopenic obesity yet. The aim of our study
is to evaluate sarcopenic obesity by different diagnostic tools.
Methods: Seventy six patients, aged over 65 years, whose body mass
index(BMI) was 30 and over were included in the study. All patients
underwent comprehensive geriatric assessment, including hand grip
strength(HGS) and bioimpedance analysis(BIA). In six different types of
muscle [gastrocinemius medialis(GM), rectus femoris(RF), rectus
abdominis(RA), external abdominal oblique(EAO), internal abdominal
oblique(IAO), transversus abdominis(TA)] ultra-sonographic evaluation
of the patients was carried out. The diagnosis of sarcopenic obesity was
based on functional sarcopenic obesity definition consisting of both low
HGS (Male<27 kg, Female<16 kg) and high BMI (≥30 kg/m2).
Results: The median age of the patients was 71 (65–85) years, 80.3%
was female and 26.3% (n = 20) of the patients were sarcopenic obese.
Gender rate was similar between sarcopenic obese and non-
sarcopenic obese groups. There was no difference in BIA-derived
skeletal muscle mass index(SMI) between two groups (p = 0.596). RF
and IAO muscle thickness was found to be lower, RF cross sectional
area (CSA) smaller and GM fascicle length shorter in sarcopenic obese
patients compared to non-sarcopenic obese group (p = 0.042, p =
0.019, p = 0.004, p = 0.039, respectively). Receiver operating character-
istic (ROC) analysis suggested that optimum cut-off point of RF CSA for
sarcopenic obesity was ≤4.22 cm2 with 76.92% sensitivity, 68.18%
specificity, 41.7% positive predictive value and 90.9% negative
predictive value (AUC: 0.734, p = 0.001).
Conclusions: This study demonstrated that ultra-sonographic evalu-
ation of skeletal musclemass, especially RF CSA, may bemore accurate
than BIA-derived SMI assessment for the diagnosis of sarcopenic
obesity.
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EFFECTOF EARLYGLUCOSE INFUSIONONPLASMAMINERAL LEVELS
IN VERY OLD PATIENTS
O. Sobotka1*, J. Fortunato2, P. Skorepa2,3, V. Blaha2, K. Havlova2,
L. Lejskova2, L. Sobotka2. 13rd Department of Medicine, Department of
Physiology, 23rd Department of Medicine, University Hospital and Faculty
of Medicine in Hradec Kralove, Charles University, Hradec Kralove,
3Department of Military Internal Medicine and Military Hygiene,
University of Defence, Hradec Králové, Czech Republic
* Corresponding author.
Rationale: An intake of carbohydrates can stimulate cellular anabol-
ism that leads to transport of electrolytes into the cells and decrease
plasma levels – refeeding syndrome. The aimof our studywas to assess
the glucose effect on plasma mineral changes in acutely ill geriatric
patients.
Methods: Forty patients (78+ years old) acutely accepted to hospital
were subsequently randomised into two groups. Control group
received standard rehydration crystalloid therapy, the second group
(GLUC) received intravenously 200 g of glucose per day together with
rehydration therapy. The patients were carefully monitored and
plasma mineral levels were measured during 72 hours. This project
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was approved by the local ethical committee and data were analysed
statistically.
Results: The groups were comparable regarding to number of chronic
diagnoses and age (86 ± 4 years). We observed significant drops in
plasma potassium and phosphate levels over first 72 hours of
rehydration:
Potassium [mmol/L] Phosphate [mmol/L] Magnesium [mmol/L]
Day Control Gluc Control Gluc Control Gluc
1 4.06 ± 0.45 4.12 ± 0.65 0.91 ± 0.14 0.98 ± 0.25 0.71 ± 0.11 0.83 ± 0.12
2 4.17 ± 0.29 3.86 ± 0.49 0.97 ± 0.13 0.86 ± 0.27 0.84 ± 0.11 0.85 ± 0.09
3 4.04 ± 0.46 3.81 ± 0.34 0.96 ± 0.27 0.79 ± 0.21 0.85 ± 0.07 0.89 ± 0.08
4 4.01 ± 0.41 3.8 ± 0.47 0.96 ± 0.38 0.72 ± 0.19 0.79 ± 0.09 0.86 ± 0.12
Conclusions: Administration of glucose can cause mineral changes
that are typical for refeeding syndrome in acutely ill very old patients
in early stage of disease. Careful re-alimentation with mineral
monitoring is important in this group of patients.
Acknowledgements: PROGRESS Q40/12
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FRAIL SCALEASANUTRITIONAL SCREENING TOOL INACOMMUNITY
PHARMACY CONTEXT
S. Barreirinhas1*, D. Ramos1, P. Araújo1, M. Mendes2, S. Maximiano2.
1HolonNutrition Service, 2Department of Projects and Services, Farmácias
Holon, Lisbon, Portugal
* Corresponding author.
Rationale: In Portugal, the life expectancy has increased over the
years, being nowadays higher than 80 years old. Older age is a risk
factor for malnutrition and the evidence also indicates that the
sarcopenia and fragility prevalences are higher in people over 65 y.o.
The nutritional status and frailty’s evaluation are essential to establish
preventive and therapeutic measures.
The present study aims to:
• Evaluate the prevalence of frailty risk in people over 65 y.o. who
participated in the nutritional screening, conducted in community
pharmacies;.
• Identify situations of pre-frailty and frailty.
Methods: A cross-sectional observational study was carried out for
elderly people (age≥65 yo) through a nutritional screening conducted
in 55 community pharmacies.
Weight and Body Mass Index (BMI) were measured using Omron
BF511® scale and registered with patient informed consent. The frailty
was evaluated with the FRAIL questionnaire screening tool that
consider 5 categories: fatigue, resistance, locomotion, illnesses and
weight loss.
Results: Between October and December 2018, 243 elderly people,
with a mean age of 75.1 ± 6.6 were evaluated, the majority of which
were female (75.3% (n = 183). The prevalences of low weight
(IMC < 22 Kg/m2) and overweight (IMC > 27 Kg/m2) were 10.7%
(n = 26) and 53.5% (n = 130) respectively. Both prevalences were
higher in women [80.8% (n = 21) presented underweight and 77.7%
(n = 101) were overweight].
Regarding the FRAIL questionnaire, 35,4% (n = 86) of participants
reported feeling fatigue, 29.6% (n = 72) were unable to climb a flight of
stairs and 17.7% (n = 43) were unable to walk a block. 24.3% (n = 59) of
the participants had more than 5 diseases diagnosed and 15.2%
(n = 37) showed a percentage ofweight loss higher than 5% in the last 6
months. In the final score, more that 50% of participants presented a
risk of pre-frailty and frailty [39.5%(n = 96);18.5%(n = 45), respectively].
Category Question Points Total
Fatigue Are you fatigue? 0 64,6%
1 35,4%
Resistance Cannot walk up 1 flight of
stairs.
0 70,4%
1 29,6%
Locomotion Cannot walk 1 block. 0 82,3%
1 17,7%
Illnesses Do you have more than 5
diseases?
0 75,7%
1 24,3%
Weight loss Had you lost more than 5% of
your weight in the past 6
months?
0 84,8%
1 15,2%
FINAL SCORE
Male Female Total
Pre-Frail (1–2
points)
740% (n = 71) 26,0%
(n = 25)
39,5%
Frail (≥3 points) 82,2% (n = 37) 17,8%
(n = 8)
18,5%
Conclusions: It was verified that more than half of the sample
presented a risk of pre-frailty and frailty, mainly affecting women.
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RELATION BETWEEN RAMADAN FASTI˙NG AND SARCOPENIA
S. Akin1*, F. Fırat Özer1, G. Günes ̧ Şahin2. 1Geriatrics, 2Clinical nutrition,
Erciyes University, Kayseri, Turkey
Rationale: Ramadan fasting is a unique model that is associated with
the restriction of food and fluid intake. The purpose of this studywas to
evaluate the physiological effects of Ramadan fasting on loss of muscle
mass in the elderly.
Methods:Healthyelderly aged 60 years and olderwere included in the
study. Measurements were taken both before and after Ramadan
fasting. Body mass index (BMI) was calculated by dividing weight (in
kilograms) by height. Walking speed was expressed in meters per
second (m/s). Muscle strength was assessed by hand grip strength
(HGS) with a dynamometer. A Bioelectrical impedance analysis (BIA)
device (BodystatQuadScan 1500, UK) was used for the evaluation of
body composition and muscle mass. Dietary data of the patients
during Ramadan were obtained by a 43-item Food Frequency
Questionnaire (FFQ).
Results: Thirty subjects fasted ≥30 days. The mean age (Standard
Deviation (SD)) of the elderly was 66.7(4.7) years of age and 50% were
females. Therewere no significant changes in bodyweight, sarcopenia,
or body composition in either the females ormales between, before, or
after Ramadan fasting. The mean SMI, mean (SD) kg/m2, values of
females andmaleswith adequatemilk and yogurt consumption before
and after Ramadan fasting were 8.03 (0.75) kg/m2 and 8.43(1.03) kg/
m2 for females (p = 0.133) and 10.11 (0.79) kg/m2 and 10.35 (0.93)
kg/m2 formales (p = 0.059), respectively. Themean SMI,mean (SD) kg/
m2, values of females and males with inadequate milk and yogurt
consumption before and after Ramadan fasting were 8.01(0.93) kg/m2
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and 7.79 (0.82) kg/m2 for females (p = 0.242) and 9.82 (1.16) kg/m2 and
9.29(0.76)kg/m2 for males (p = 0.105), respectively.
Conclusions: Ramadan fasting supplied no risk for loss ofmusclemass
and muscle strength in the elderly sample population. Elderly who
consumed enough milk and yoghurt in Ramadan, had no loss of
muscle mass.
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SARCOPENIA AND ITS ASSOCIATION WITH DYSPHAGIA: INSIGHTS
FROM THE VICIOUS CYCLE
G. Tanigör1, S. Eyigör1*. 1Physical Medicine and Rehabilitation, EGE
University School of Medicine, Bornova/Iżmir, Turkey
* Corresponding author.
Rationale: Nutritional deficits are known to cause sarcopenia (1).
There is also evidence that sarcopenia itself may cause dysphagia, and
swallowing problems are among the reasons for patients to have
nutritional deficits (2). This study aims to evaluate the prevalence of
nutritional deficits and dysphagia in patients with or without
sarcopenia.
Med (min-max) or n (%).
No
sarcopenia
(n:64)
Probable
sarcopenia
(n:42)
Sarkopenia
(n:22)
p
Dysphagia 10(%15,6) 10(%24,4) 9(%39,1) 0,026**
EAT-10 0(0–6) 0(0–13) 1(0–35) 0,0001*,**,***
SARCF 2(0–9) 8(4–10) 8(4–10) 0,0001*,**
Walking velocity
(m/sn)
5,4(0–12,1) 0(0–25,7) 0(0–8,1) 0,0001,**
Grip strength
(right)
18,9(0–46,3) 9,2(0–45,7) 0(0–25,4) 0,0001*,**
Grip strength (left) 15,5(0–41,1) 7(0–26,9) 5,6(0–24) 0,0001*,**
Beck depression
score
9,5(0–29) 14(0–31) 14(0–40) 0,104
MDA global score 4(2–5) 4(2–5) 4(2–5) 0,778
MDA physical score 36(5–40) 34(22–40) 32(17–40) 0,918
MDA functional
score
21(16–40) 21(18–25) 20(10–25) 0,532
MDA emotional
score
29(16–33) 26(19–32) 25(14–40) 0,026
MDA toplam skor 91(62–100) 85(65–100) 85(48–100) 0,399
Malnutrition
screening point
13(3–14) 10(3–14) 9(0–13) 0,0001*,**,***
Malnutrition index 26(8,5–29) 22,5(10–28,5) 19,5(10–26,5) 0,0001*,**,***
*Difference present between no sarcopenia and probable sarcopenia.
**Difference present between no sarcopenia and sarcopenia.
***Difference present between probable sarcopenia and sarcopenia.
Methods: 128 patients residing in a rehabilitational clinic are
evaluated with EAT10, MD Anderson Dysphagia Inventory,
Functional Oral Intake Status scale, Mini Nutritional Assessment and
Beck Depression Index. All patients were then classified according to
SARC-F scores as well as latest sarcopenia classification proposed by
EWGSOP in 2018 (3). Muscle strength and mass were assessed using a
hand dynamometer and measuring calf circumference, respectively.
Walking velocity was assessed using 4 meters walk test. Patients
belonging to sarcopenia, presarcopenia and non sarcopenia groups
were then compared using relevant statistical methods to show
whether there are differences in outcomes mentioned as well as
demographical and clinical status.
Results: Demographical and clinical properties of the patients from 3
groups.
Presence of orophageal dysphagia risk was only found between
sarcopenic and non sarcopenic individuals (p = 0,026) other compar-
isons being insignificant. EAT-10 scores seemed to be significantly
worse for presarcopenic and sarcopenic individuals, and their in
between comparison also showed sarcopenics were worse than
presarcopenics (p = 0,001). While gait velocity only differed between
individuals with sarcopenia and not sarcopenic ones, grip strength
were deteriorated for both sarcopenic and presarcopenic individuals
when compared to non-sarcopenics. MNA scores were still signifi-
cantly worse for presarcopenics and sarcopenics, latter being even
worse than the other two (p = 0,0001).
Conclusions: Dysphagia and nutritional impairments may be seen in
the course of sarcopenia, and this also applies for the condition of
presarcopenia. Further evidence from prospective studies utilizing
more objectiveways for assessing dysphagia or sarcopenia in different
sarcopenic patients with distinct comorbidities are required.
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DIFFERENTIAL EVOLUTION OF RESTING ENERGY EXPENDITURE IN
SARCOPENIC ALDERY SUBJECTS
S. Djaafar1*, L. Genton2, V.L.K. Karsegard3, C. Pichard4. 1Nutrition
Clinique, Service d’endocrinologie, diabétologie, hypertension et
nutrition, 21Clinical Nutrition, University Hospital of Geneva, 3Clinical
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* Corresponding author.
Rationale: Sarcopenia is a muscle disorder that is associated with
adverse outcome and mortality. The European Working Group on
Sarcopenia in Older People (EWGSOP) updated recently the algorithm
for sarcopenia diagnosis, defining new cut-off points for sarcopenia
tests. Based on the main cut-off points of the appendicular skeletal
muscle (ASM) and ASM adjusted for height squared (ASM/h2), we
assessed the evolution over three years of resting energy expenditure
(REE) adjusted for lean body mass (LBM) in aldery subjects.
Methods: Community subjects underwent measurements at baseline
(T0) of REE by indirect calorimetry and LBM by dual-energy x-ray
absorptiometry. Measurements were repeated 3 years later (T3) in
most subjects. Data were expressed as means±SD and statistical
comparisons were performed using t-tests.
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Results: During the follow-up, REE were significantly higher in non
sarcopenic than sarcopenic subjects in both genders (Table 1). The REE
values in women tended to decrease during the follow-up. When the
REE values were normalized to LBM, the REE/LBM values significantly
decreased in sarcopenic women during the follow-up. By contrast the
REE/LBM values did not change in both non sarcopenic and sacopenic
men subjects during the follow-up.
Conclusions: The decrease of REE with aging in sarcopenic women is
not related only to the decrease of the lean component. By contrast, the
REE seems to be directly related to lean component in aging men.
Disclosure of Interest: None declared.
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Rationale: Ultrasound (US) might be a useful appendicular skeletal
muscle mass (ASM) assessment tool in the sarcopenia context, but
neither normative data or prediction equations are currently available
for Latin Americans.We aimed to develop newASMpredictionmodels
from an elderly South American sample.
Methods: Cross-sectional evaluation of 190 community-dwelling
subjects ≥60 y from COMO VAI?, a population-based Brazilian study.
ASM was measured by dual-energy X-ray absorptiometry (DEXA). US
muscle thickness (MT) was assessed on the anterior aspect of both
upper and lower limbs from supine subjects, and, along with
anthropometric data, used to develop ASM prediction models
through backward stepwise regression analysis. The best performing
models were assessed for biases using Bland-Altman analysis, and
their simulated validity was assessed by bootstrap.
Results: The selected models were]:
Equation 1: ASM = (3.27*sex) + 16*h) + (0.2*AL) + (0.09*DAcirc) + (0.04*
DTcirc) + (1.25*DAMT) + (0.72*DTMT) – 24.9
Equation 2 (without circumferences, in the presence of edema):
ASM = (2.39*sex) + (15.14*h) +
(0.29*AL) + (1.93*DAMT) + (0.87*DTMT) – 23.78
[ASM (kg); sex: female 0, male 1; h: height (m); AL: arm length (cm);
DAcirc: dominant arm circumference (cm); DTcirc: dominant thigh
circumference (cm); DAMT: dominant arm MT (cm); DTMT: dominant
thigh MT (cm)]
Adjusted R2, root mean square error and limits of agreement for each
model were, respectively: 0.90, 1.23 kg, (–2.36, 2.36 kg); 0.89, 1.30 kg,
(–2.51, 2.51 kg). ASM estimates were unbiased and not significantly
different from DEXA measurements. Both models’ validity was
favorably suggested by bootstrap.
Conclusions: From only two US MT assessments and a few
anthropometric measurements – hence, two US sites + two lengths
(+ two circumferences, in the absence of edema) = four limbs’musclemass
– the proposed models represent a practical new approach for muscle
assessment in the elderly.
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FUNCTIONAL TEETH IMPROVE NUTRITIONAL STATUS AND SELF-
CARE ACTIVITY IN ELDERLY PEOPLE
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Tokushuen Geriatric Health Service Facility, Suita, 2Department of
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* Corresponding author.
Rationale: Good oral function is essential to live in a healthy life
especially for elderly people. The Japanese Ministry of Health, Labor
and Welfare advocates to keep more than twenty teeth even after
eighty years old (called 8020 Campaign). The significance of residual
teeth and denture in nutritional status and self-care activity was
investigated.
Methods: Eighty-nine elderly people (23males, 66 females,mean age,
84 ± 4 years) who are long-term admitted to a geriatric health care
services facility in a stable state were subjected. The association of
remaining teeth with nutritional status evaluated by serum albumin
and self-care activity evaluated by Barthel Index (BI) was investigated.
Then the significance of functional teeth supported by denture was
examined.
Results: The correlation coefficients of residual teeth with serum
albumin and BI were r = 0.053 (p = 0.607) and r =−0.048 (p = 0.657),
respectively. Those of functional teeth, were r = 0.189 (p = 0.080) and
r = 0.327 (p = 0.00175), respectively. The number of residual teeth was
not associated with serum albumin or BI at all, meanwhile that of
functional teeth was associated with BI. The correlation coefficients of
BI with serum albuminwas r = 0.399 (p = 0.00011), then the functional
teethmight be somehowassociatedwith serum albumin. The subjects
were classified into two groups, Group A and Group B according to the
number of residual teeth of 0 to 19 and 20–28. They were also divided
into groups C and D according to the number of functional teeth of 0–
19 and 20–28. Serum albumin was 3.45 ± 0.53 g/dl in Group A and
3.55 ± 0.55 g/dl in Group B (p = 0.24). BI was 49.3+29.5 in Group A and
45.0 ± 31.1 in Group B (p = 0.29). Serum albuminwas 3.35 ± 0.43 g/dl in
Group C and 3.53 ± 0.57 g/dl in Group D (p = 0.082). BI was 36.6+31.9
and 54.1 ± 27.2, respectively (p = 0.0042). In the comparison of Group C
and Group E of number of functional teeth 28, the serum albuminwas
3.59 ± 0.56 g/dl (p = 0.0398) and BI was 58.8 ± 24.9 (p = 0.0011) in
Table 1 (abstract: MON-PO344).
Women Men
Sarcopenic Non sarcopenic Sarcopenic Non sarcopenic
T0 n = 20 T3 n = 18 T0 n = 37 T3 n = 34 T0 n = 18 T3 n = 18 T0 n = 48 T3 n = 36
REE(Kcal) 1136.4 ± 61 1012.1 ± 90 1323.6 ± 164.7† 1249.2 ± 118† 1282.6 ± 92 1261 ± 135.4 1524.5 ± 141† 1489.2 ± 1†
REE/LBM (Kcal/kg) 30.2 ± 1.0 27.7 ± 1.6* 29.3 ± 2.2 28.2 ± 1.9 26.0 ± 1.5 25.6 ± 2.1 25.9 ± 2.1 25.3 ± 2.1
*p < 0.05 T3 vs T0.
†p < 0.05 Non sarcopenia vs sarcopenia.
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Group E. Therewere 34 peoplewith full denture and three peoplewith
residual teeth in Group E.
Conclusions: The residual teeth were not associated with serum
albumin or BI at all. However, the full denture was significantly
associatedwith serum albumin and BI. The full denture seems towork
well for better nutritional status and self-care activity. It is very
important to get foods orally by using full denture, if necessary, for
elderly people.
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A NUTRITIONAL TELECARE SYSTEM: THE CULTURAL IMPACT ON
STAFF
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Rationale: A new and specialist telecare system, eViSuS, has been in
use in the Clinical Nutrition Service of S. Lazzaro Hospital (Alba, Italy)
since August 2016, for the management of malnourished patients in
NursingHome (NH), through remote video-visits. FromAugust 2016 to
December 2018 386 video-visits were performed on 97 patients. The
target of the study is to assess healthcare staff satisfaction.
Methods: A validated survey was submitted anonymously to the
hospital and NH healthcare professionals who use eViSuS. Questions
covered different subjects, including ease of use, audio-video quality,
perceived quality of the relationship with the patient and overall
satisfaction.
Results: 26 surveys were completed. eViSuS was easy to use (92%
score) and made it possible to carry out a greater number of specialist
visits on NH patients (88% score). Despite the system being equipped
with high-performance cameras and microphones, the perceived
audio-video quality of the system was not always optimal due to its
reliance on the speed of the internet connection. Telecare fit well in the
staff work plans (77% score), allowing them to carry outmore activities
during the working day. eViSuS improved the relationship with the
patient (80% score) and increased the ability to communicate (100%
score). Staff confirmed to be able to respond to patient’s needs through
telecare (73% score). 93% of healthcare professionals were overall
satisfied with eViSuS, however only 19% preferred a video-visit to a
face-to-face visit.
Conclusions: The staff was satisfied and considered eViSuS a user-
friendly and valid tool, however the traditional face-to-face visit was
preferred over the video-visit. The cultural impact is still one of the
main barriers to the spread of telemedicine: despite its huge potential
in terms of efficiency and greater access to care, acceptance of this
assistance procedure is essential to enable its diffusion and
implementation.
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MON-PO348
PREVALENCE AND RISK FACTORS OF AGE-RELATED SARCOPENIA IN
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V. Therakomen1*, A. Petchlorlian2, N. Lakananurak3. 1Department of
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Medicine, Faculty of medicine, 3Faculty of medicine Chulalongkorn
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Thailand
* Corresponding author.
Rationale: Sarcopenia is one of the most important causes of
dependence and mortality in elderly. Few studies have investigated
prevalence and risk factors of age-related sarcopenia in Asian
community-dwelling elders.
Methods: This cross-sectional study was performed in 330 people
aged over 60 years in community-based setting from October 2017 to
July 2018. Participants were evaluated for muscle strength by
handheld dynamometer, muscle performance by 6-meter gait speed,
andmusclemass by bioelectrical impedance analysis (BIA). Sarcopenia
was diagnosed by Asian Working Group for Sarcopenia (AWGS)
criteria. The prevalence of sarcopenia was calculated. Risk factors
associated with sarcopenia were analyzed using univariable and
multivariablelogistic regression analysis.
Results: The prevalence of sarcopenia and sarcopenic obesity was 10%
and 3.3%, respectively. In multivariable logistic regression analysis, age
was an independent risk factorof sarcopenia, with an odds ratio of 6.87
(95% confidence interval (CI): 1.63− 28.88; p < 0.001) in middle old
group (age 70–79 years), and 13.71 (95% CI: 3.66–51.41; p = 0.009) in
very old group (age≥ 80 years). Prefrailty was a significant risk factor
of sarcopenia (odds ratio 4.75, 95% CI: 1.90–11.89; p < 0.001). Low
physical activity significantly increased risk ofsarcopenia,with an odds
ratio of 15.35 (95% CI: 1.69–139.47; p = 0.015) in themoderate physical
activity group (1401–2800 kcal/week) and an odds ratio of 17.99 (95%
CI: 1.95–165.73; p = 0.011) in the lowest physical activity group
(≤1400 kcal/week). Other factors, including gender, body mass
index, nutrition status, and protein intake, were not significantly
associated with sarcopenia.
Conclusions: Age-related sarcopenia was found in one-tenth of Thai
community-based elderly. Age, prefrailty, and low physical activity
were independent risk factors associated with sarcopenia.
Disclosure of Interest: None declared.
Liver and gastrointestinal tract II
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AGREEMENT BETWEEN BIOELECTRICAL IMPEDANCE AND DUAL-
ENERGY X-RAY ABSORPTIOMETRY FOR ASSESSING SKELETAL
MUSCLE MASS LOSS IN PATIENTS WITH CHRONIC HEPATITIS C
K.G.D. Diniz1, D.A. Vieira1, M.I.T.D. Correia2, E.A. Colosimo3, G.A. Rocha4,
L.D. Silva1,5*, on behalf of Grupo Interdisciplinar e Interprofissional em
Nutrição Clínica e Metabolismo (Nutriclim). 1Viral Hepatitis
Ambulatory, Instituto Alfa de Gastroenterologia, 2Surgery, Faculdade De
Medicina Da UFMG, 3Statistics, Instituto de Ciências Exatas da UFMG,
4Laboratory of Research in Bacteriology, 5Internal Medicine, Faculdade De
Medicina Da UFMG, Belo Horizonte, Brazil
* Corresponding author.
Rationale: Skeletal muscle mass loss (SMML) has been reported to
frequently occur in chronic liver diseases and can be identified in
30.0%–70.0% of cirrhotic patients.1 Given the potential relevance of
SMML inhepaticdiseases, apractical screening tool forearlierdetection
of SMML isofutmost significance.Weassessed thedegreeof agreement
between the two methods bioelectrical impedance analysis (BIA) and
energy X-ray absorptiometry (DXA) for SMML estimation.
Methods: Prospectively, we analysed DXA and BIA measures in 104
CHC patients followed in a viral hepatitis outpatients clinic. Body
composition was assessed under standardized conditions by DXA
(Hologic, Inc., Bedford, MA) and BIA (RJL Systems Quantum, Clinton
Township, MI). The cut‐off points for SMML, for women and men
assessed by BIA were <15.0 kg/m2 and <17.4 kg/m2 and by DXA were
<5.45 and <7.26 kg/m2, respectively.2 Agreement between the devices
was calculated by using the Kappa statistic.
Results: The baseline characteristics of the CHC patients were: mean
age, 50.5 ± 11.2 years; 25.0% females; 67.3% noncirrhotic and 32.7%
compensated cirrhotic patients; 43.3% hypertensive patients; 21.2%
diabetic patients. SMML, assessed by BIA and DXA, was observed in
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16.5% and 14.4% patients, respectively. For CHC patients, the Kappa
result [(All CHC patients, n = 104), Kappa = 0.87; P≤ 0.001; (female
CHC patients, n = 26), Kappa = 0.92; P≤0 .001; (male CHC patients,
n = 78), Kappa = 0.85; P≤0 .001].
Conclusions: BIA appears to have potential for assessing SMML in CHC
patients, as obtained using DXA. Overall, these findings reinforce the
potential of BIA to be widely applied by healthcare professionals in
caring for patients with CHC in clinical routine practice.
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IS THERE ANY CORRELATION BETWEEN CRITICAL AGGREGATION
NUMBER AND LIVER PARAMETERS IN PATIENTS ON LONG-TERM
PARENTERAL NUTRITION?
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Pharmacy, 2Clinical Nutrition and Surgery Deprtment, Prof. Orłowski
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Rationale: Critical Aggregation Number (CAN) is a parameter
describing the stability of lipid emulsions (LE) in parenteral nutrition
(PN) admixtures. It reflects the concentration of all cations in PN – the
higher the concentration of the cations the higher their destabilisation
force on the lipids which in turn is detrimental for the liver. Avalue of
600 is considered a cut-off: below that PN admixtures are safe.
However, this value is controversial and often a clinical situation
requires a higher content of cations, leading to a higher CAN. The aim
of the study was to compare liver parameters and relate the influence
of CAN below and above 600 on liver parameters of patients receiving
PN.
Methods: Fifty three PN regimes were enrolled into the observation:
23 PN regimes with CAN >600 and 30 with CAN≤ 600. The patients
received PN for average 23 months (range 3–60). Patients were aged
26–91 years and they did not have any concomitant liver problems.
Alanine aminotransferase (AlaAT), aspartate aminotransferase (AspAT)
and gamma glutamyl transpeptidase (GGTP) were measured during
thewhole observationperiod and the averageswere compared to CAN.
The values of liver enzymes between the two groups (CAN below and
above 600) were analysed using nonparametric Mann-Whitney U test.
Results: None of the liver enzymes differed betwen the two CAN
groups.
CAN AlaAT (U/L) AspAT (U/L) GGTP (U/L)
>600 67 (14–224) 44 (15–199) 112 (17–812)
≤600 73 (15–389) 44 (14–242) 112 (16–343)
p 0.779 0.865 0.293
Conclusions: Based on these observations, CAN should not be used as
a limiting factor while designing PN formulas. However, these results
must be considered preliminary; there is a need to a study with more
patients and using physical examination of the lipid particals in the PN
formulation.
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SPECIALISED INTESTINAL FAILURE UNIT: AN OBSERVATIONAL
COHORT STUDY
M.D. Eriksen1*, S.M.D. Jørgensen1, L.E. Lemming2, J.F. Dahlerup1, S. Lal3,
C.L. Hvas1. 1Department of Hepatology and Gastroenterology,
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Rationale: Intestinal failure (IF) is defined by a need for intravenous
(IV) supplementation. Patientsmay presentwithmultiplemorbidities,
and IV treatments carry a risk for catheter-related complications. Few
studies described patient characteristics and clinical outcomes
according to type of IF.
Methods:We consecutively included patients whowere admitted to a
newly established inpatient IF unit (IFU) from 2013 through 2017. We
evaluated patient characteristics and clinical outcomes of all patients’
first admission. Outcomes included IF classification, length of stay,
central line-associated blood stream infection (CLABSI), and discharge
on home parenteral support (HPS). Follow-up was conducted six
months after discharge for mortality and the continued need for HPS.
Results: A total of 236 patients were evaluated, including 39 (17%)
with type 1 IF, 123 (52%) with type 2 IF, and 74 (31%) with type 3 IF. Of
91 who had a central venous catheter (CVC) on admission, CLABSI was
present in 11 (12%). The CLABSI occurrence during admission was 2
(1%) of 173 patients with a CVC. Mean length of stay declined from
mean 33 days (95% confidence interval (CI): 26.2–42.5) in 2013 to 15
days (95% CI: 12.2–17.7) in 2017 (p < 0.0001). Undiagnosed comorbid-
ity was revealed in 165 patients (70%) with unchanged frequency
during the study period (p = 0.8). Sixty-seven (28%) patients were
discharged with HPS.
Conclusions: Inpatients with IF present with multiple morbidities.
CLABSI should be investigated on admission. A low inpatient CLABSI
rate may be achieved through the implementation of a specialised IFU.
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Rationale: To compare the effects of an organic durum wheat
variety (‘Senatore Cappelli,’ SC) pasta with standard commercial
wheat pasta in patients with diagnosed non-celiac gluten sensitivity
(NCGS).
Methods: A double-blind, randomized trial was performed Between
April 2018 and July 2018, at the Fondazione Policlinico Gemelli
IRCCS in Rome, on patients with NCGS. Patients were randomly
assigned to a two-week diet with SC wheat variety pasta or a two-
week diet with standard commercial pasta. After a two-week
washout period (gluten-free diet), each patient crossed over to the
other treatment group. Symptoms were assessed through a
modified version of the Gastrointestinal Symptom Rating Scale
(GSRS), tailored on NCGS. Wilcoxon signed-rank test was used to
compare nonparametric data. The Bonferroni correction for multiple
comparisons was applied. Two-tailed p values <0.05 were con-
sidered significant.
Results: Forty-two patients were enrolled. Patients reported lower
overall GSRS when in SC pasta group than standard pasta
(p = 0.03). Significantly lower scores were reported in several
specific gastrointestinal (bloating, abdominal distention, eructation,
flatus, and feeling of incomplete evacuation) (p < 0.05) and extra-
intestinal symptoms (dermatitis and limb numbness) (p < 0.05) in
SC group.
Conclusions: Patients with NCGS experienced lower gastrointestinal
and extra-intestinal symptom scores eating SC wheat variety pasta
compared to standard commercial wheat pasta. If confirmed in larger
studies, this evidence could pave the way to new alternative
approaches to NCGS.
Disclosure of Interest: None declared.
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EQUAL EFFICACYOF GASTRIC AND JEJUNALTUBE FEEDING IN LIVER
CIRRHOSIS AND/OR ALCOHOLIC HEPATITIS – A RANDOMISED
CONTROLLED TRIAL
P. Bager1, L.K. Olesen1, R.L. Baltzer1, M. Borre1*, N.K.M. Aagard2.
1Department of hepatology and gastroenterology, Aarhus University
Hospital, Aarhus N, 2Department of hepatology and gastroenterology,
Aarhus University Hospital, Aarhus, Denmark
* Corresponding author.
Rationale:Malnutrition is a frequent complication in decompensated
liver cirrhosis and alcoholic hepatitis.
Hospitalized patients who don’t meet nutritional requirements are
recommended to be enteral or parenteral fed. No guidelines
recommend a specific type of tube. We hypothesized that jejunal
tube feeding increases delivery of food in the intestine.
Methods: 40 inpatients with liver cirrhosis or alcoholic hepatitis
and a daily energy intake <75% of the calculated requirements were
included consecutively and randomised 1:1 to: 1) Nasogastric (NG)
feeding or 2) Nasojejunal (NJ) feeding. All received Peptamen AF®
as enteral supplement to their oral intake. Participants were fed for
7 days, or followed until discharge or death. The total amount of
calories and proteins delivered (tube feeding or eaten by the
patient) was calculated. Patients with hepatic encephalopathy grade
3 or 4 were excluded. Descriptive statistics were used in the
calculation.
Results: Of 146 patients screened, 40 were randomized (40% males,
mean age 58 years, 70% cirrhosis,10% alcoholic hepatitis, 20% both. 30%
were Child-Pugh (CP)-B, 70% CP-C. A total of 33 patients fulfilled 7
days.Meandailyenergy intake for 7 dayswere 6400 kJ (NG) vs. 5900 kJ
(NJ) (p = 0.53). CP-B & NG: 6100 kJ; CP-B & NJ: 5415 kJ; CP-C & NG:
5935 kJ; CP-C & NJ: 5520 kJ. Calculated caloric requirement was not
acquired in either group. Tubes were accidently removed by the
patients: once 36; twice 22; three times 10, no differences betweenNG
and NJ.
Conclusions: NJ feeding was not superior to NG feeding in alcoholic
hepatitis with or without cirrhosis. NG tube was more efficacious in
both Child-Pugh B and C patients. Nutritional needs remained unmeet
in both groups. The number of accidental tube displacements was not
related to the type of tube. Based on this study, the use of the more
difficult to install jejunal tube is not justified.
Disclosure of Interest: None declared.
MON-PO354
IMPACT OF POSTOPERATIVE ADMINISTRATION OF HMB-RICH
NUTRIENTS WITH REHABILITATION ON SARCOPENIA AND
OUTCOMES AFTER LIVER TRANSPLANTATION: A PILOT
RANDOMIZED CONTROLLED TRIAL
N. Kamo1*, T. Kaido1, Y. Hamaguchi2, S. Uemoto1. 1Division of Hepato-
Biliary-Pancreatic and Transplant Surgery, Department of Surgery,
Graduate School of Medicine, Kyoto University, Kyoto, 2Surgery,
Kishiwada City Hospital, Osaka, Japan
* Corresponding author.
Rationale: Most patients undergoing liver transplantation (LT) are
associated with low skeletal muscle mass, malnutrition, and low
activity. These comorbidities prevent early recovery after surgery
due to various causes including low activity and infection. Therefore,
we performed a pilot randomized controlled trial examining the
impact of -hydroxy- -methylbutyrate (HMB), leucine metabolite
with promoting synthesis and suppressing proteolysis, with post-
operative rehabilitation on sarcopenia and outcomes after adult
living donor LT (LDLT).
Methods: Between March 2017 and October 2018, patients who
underwent adult LDLT were randomly assigned to HMB group and
control group using pre-stratification allocation method according to
factors including sex, age, and preoperative muscle mass. Patients in
the HMB group were administered HMB-rich nutrients orally or
enterally from postoperative day (POD) 1–30 with postoperative
rehabilitation. Excluding some cases who could not undergo post-
operative rehabilitation enough, 12 patients in HMB group and 11 in
control group were assessed for the following (on treatment analysis);
1) background, 2) incidence of postoperative bacteremia, blood
biochemical data, and postoperative hospital stay, 3) ratio for
preoperative value of skeletal muscle mass index and grip strength
at 1 and 2 months after LDLT.
Results: Regarding patients and surgical characteristics, there were
no significant differences between 2 groups. In the HMB group,
incidence of postoperative bacteremia was significantly lower
(P = 0.043), WBC level at POD 21 was significantly lower
(P = 0.005), and postoperative hospital stay was significantly
shorter (P = 0.028) compared with the control group. Ratio for
preoperative value of skeletal muscle mass index showed higher
tendency in the HMB group. Grip strength was significantly higher
in the HMB group than the control group (1 month, P = 0.003; 2
month, P = 0.005).
Conclusions: Administration of HMB-rich nutrients with rehabilita-
tion after LDLT significantly increased grip strength, decreased
posttransplant bacteremia and shortened postoperative hospital stay.
Disclosure of Interest: None declared.
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MON-PO355
INTESTINAL PERMEABILITY MARKER ZONULIN IN SERUM
DECREASES WITH FATTY LIVER DISEASE DURING WEIGHT LOSS IN
OBESITY, WITH NO CORRELATION TO BODY COMPOSITION.
N. Chaudhry1, A. Schweinlin1*, M. Basrai1, S.C. Bischoff1. 1Institute of
Nutritional Medicine, UNIVERSITY OF HOHEHEIM, Stuttgart, Germany
* Corresponding author.
Rationale: Studies point to an altered intestinal permeability (IP) in
obesity and its role in non-alcoholic fatty liver disease (NAFLD). A
Western style diet might lead to increased IP with microbial
translocation, which in turn causes inflammation and thus may
contribute to NAFLD. Metabolic endotoxemia can initiate insulin
resistance (IR), a risk factor for NAFLD, but is also associated with
sarcopenic obesity (SO).
Methods: We retrospectively investigated whether weight loss (WL)
leads to an improvement in IP. We also analyzed connections between
altered IP, NAFLD and body composition (BodC). NAFLDwas estimated
by ultrasound and BodC by body impedance analysis. Zonulin in serum
(SZ), a modulator of tight junctions and marker of paracellular
permeability was measured by enzyme-linked immunosorbent
assay, the urinary lactulose/mannitol ratio (r-l/m) was used to
determine transcellular as well as paracellular permeability. Data of
25 subjects undergoing a structured 52-week multidisciplinary
weight loss intervention were analyzed by Wilcoxon test. Differences
between subgroups were analyzed by Mann-Whitney U test; correla-
tions by Spearman’s rho.
Results: A mean WL of 21.2 kg between baseline and week 52 leads
to a reduction in SZ (19.8 ± 5.7–16.3 ± 5.0 ng/ml, p = 0.015), r-l/m
(0.050 ± 0.010–0.017 ± 0.005, p = 0.001) and NAFLD prevalence (80%
to 40%, p = 0.006). Compared to obese subjects without NAFLD,
those with NAFLD showed a higher r-l/m (0.022 ± 0.013 vs.
0.033 ± 0.010, p = 0.005) and SZ (16.2 ± 4.7 vs. 18.70 ± 4.7 ng/ml,
p = 0.032). SZ and r-l/m also increased with severity of steatosis,
and were higher in patients with moderate to severe steatosis than
in those with mild steatosis (SZ: p < 0.05 and r-l/m: p < 0.001) or
without steatosis (SZ: p < 0.01 and r-l/m: p < 0.001). Obese subjects
with IR showed higher SZ levels than those without IR (18.8 ± 4.6
vs. 14.4 ± 5.0, p = 0.001). R-l/m was higher when metabolic syn-
drome (MetS) was present compared to no MetS (0.035 ± 0.018 vs.
0.024 ± 0.012, p = 0.009). There was neither a correlation between SZ
and BodC measures nor between SZ and r-l/m.
Conclusions: These results indicate that IP, both via tight junctions and
the transcellular path, improves with WL accompanied by an
improvement in NAFLD. The data suggest associations between
impaired IP and NAFLD, IR as well as MetS. No association was found
between SO and IP nor between NAFLD and BodC, yet it should be
subject of further research.
Disclosure of Interest: None declared.
MON-PO356
A HUMAN GUT BACTERIUM TRIGGERS OBESITY AND NON-
ALCOHOLIC FATTY LIVER DISEASE IN GERM-FREE MICE THROUGH
LPS-DEPENDENT MECHANISM
P. Gerard1*, N. Fei2, A. Bruneau2, L. Zhao3. 1MICALIS Institute, 2INRA,
Jouy-en-Josas, France, 3Shanghai Jiao Tong University, Shanghaï, China
* Corresponding author.
Rationale: Several lines of evidence suggest a link between the gut
microbiota and the etiology of obesity and NAFLD. Among the
potential mediators of this association, lipopolysaccharides from the
gut may play a key role in this pathogenesis. However, the causative
responsibility of endotoxin producers in human NAFLD remains to be
identified.
Methods: Germ-free mice were colonized by Enterobacter spp. B29,
a bacterialstrain isolated from a morbidly obese volunteer’s gut.
Mice were administered a control or a high-fat diet. Developement
of obesity, metabolic disorders and NAFLD was assessed and
compared with germ-free mice (not colonized) administered the
same diets.
Results: We first demonstrated that Enterobacter spp. B29 induced
obesity and NAFLD in germ-free (GF) mice. While GF mice did not
develop obesity or steatosis whatever the diet, massive adiposity and
hepatic steatosis were observed in mice mono-associated with B29 on
high-fat diet but not on normal chow diet. Moreover, mice associated
with B29 developed liver inflammation both on a high fat or a standard
diet. This was associated with an increased expression of genes
involved in lipogenesis and inflammation pathways in the liver of
these mice.
Then, we constructed a B29-mutant by deletion of the waaG
gene involved in LPS synthetic pathway. Markedly, the E. cloacae
B29 waaG mutant lost the capacity to trigger obesity, insulin
resistance, steatosis and liver inflammation in germ-free mice
suggesting that endotoxin is the main molecular mechanism
responsible for.
Conclusions: The approach described should be useful for defining the
critical mechanisms of gut bacteria for the development of obesity and
NAFLD and spawn new approaches of therapeutic interventions for
modifying the structure of gut microbiota to control the development
of metabolic diseases.
Disclosure of Interest: None declared.
MON-PO357
RESTING ENERGY EXPENDITURE MEASURED BY INDIRECT
CALORIMETRY AND ESTIMATED BY PREDITIVE EQUATIONS IN
GALLBLADDER DISEASE PATIENTS
P.S. Barcellos1,2*, A. Amorim1, M. Araujo1, N. Borges2, D.P. Torres2.
1Departamento de Ciências Fisiológicas, UFMA Universidade Federal do
Maranhão, São Luís, Brazil, 2FCNAUP Faculdade de Ciências da Nutrição e
Alimentação, Universidade do Porto, Porto, Portugal
* Corresponding author.
Rationale: Pathologic conditions that affect the gallbladder include
cholelithiasis and associated complications such as acute and chronic
cholecystitis, choledocholithiasis, gallstone pancreatitis, and cancer. In
this prospective study, we investigated the impact ill in resting energy
expenditure (REE) and to compare REE measured by indirect
calorimetry (IC) predicted by equation values.
Methods: Gallbladder disease patients (82) were evaluated from June
2015 to December 2016 during hospital stays at Surgery unit at
Hospitalar Center São João, Portugal. Indirect calorimeter was used to
measure REE (Cosmed k4 b2) and data was compared with energy
expenditure estimated byHarris-Benedict,Mifflin-St.Jeor, Ireton-Jones
and Schofield equations.
Results:
Conclusions: Resting energy expenditure measuared by indirect
calorimetry didnt’ shows correlation with estimated energy by
formulas (Harris-Benedict, Scholfied and Ireton-Jones). Accurate was
poor and most all equations tested underestimated energy expend-
iture values. It suggests the need to develop specific formulas for this
population.
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MON-PO358
Ω-3 FATTY ACID-BASED PARENTERAL NUTRITION SHORTENS
HOSPITAL STAY INACUTE VARICEAL BLEEDING CIRRHOTIC PATIENTS
S.-J. Kim1, J.-Y. Cho1*, I.A. Chun2, J. Lee1, Y.-D. Kim1, C.-G. Park1,
M.-W. Kim1. 1Department of Internal Medicine, Chosun University,
2Clinical Nutrition, Chosun University Hospital, Gwangju, Korea,
Republic of
* Corresponding author.
Rationale: Acute variceal bleeding, a crucial complication of liver
cirrhosis associated with high mortality, requires high energy
expenditures but gastrointestinal bleeding limits enteral feeding in
the acute stage. We investigated the safety and efficacy of ω− 3 fatty
acid-based parenteral nutrition in acute variceal bleeding patients
with cirrhosis.
Methods: A total of 208 cirrhotic patients with acute variceal bleeding
whounderwent parenteral nutrition in the absenceof enteral nutrition
between January 2013 and December 2017 were enrolled. Among the
patients, 86 patients had parenteral nutrition containing ω− 3 fatty-
acid while 122 patients had parenteral nutrition devoid of ω− 3 fatty-
acid. The primary endpoint was to evaluate the presence of clinical
complications of liver cirrhosis and the duration of hospital stay.
Results: The mean age of the patients enrolled was 54.9 years-old and
185 patients (88.9%) were male. The cause of liver cirrhosis, grade of
Child-Pugh score and comorbidities were statistically not different in
patients with or without ω− 3 fatty-acid in the parenteral nutrition.
Compared to the patientswithoutω− 3, patientswithω− 3 containing
parenteral nutrition had a significantly lower systolic blood pressure
(101.6 ± 23.3 vs. 93.5 ± 23.1 mm Hg, p = 0.013) and total bilirubin levels
(3.8 ± 5.4 vs. 2.4 ± 2.9 mg/dL, p = 0.023). The difference in the in-
hospital mortality (p = 0.813) or rate of complications (p = 0.880) was
not statistically significant between the two groups. The duration of
hospital stay was significantly shorter in the patients who underwent
ω− 3 fatty acid-based parenteral nutrition (10.7 ± 7.3 vs. 7.9 ± 4.2 days,
p = 0.001).
Conclusions: In liver cirrhosis patients with acute variceal bleeding,
ω− 3 fatty acid-based parenteral nutrition significantly decreased the
length of hospital stay.
Disclosure of Interest: None declared.
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INFLUENCE OF INPATIENT DIETARY RESTRICTION ON RECOVERY
FROM AND REOCCURRENCE OF ACUTE, UNCOMPLICATED
DIVERTICULITIS.
M. Crichton1, R. Nucera2, J. Jenkins2, R. Canavan3, S. Mahoney1,
F. Eberhardt1, P. Dalwood1, C. Dahl1, S. Marshall1*. 1Bond University
Nutrition and Dietetics Research Group, Faculty of Health Sciences and
Medicine, Bond University, 2Nutrition and Dietetics, Gold Coast Hospital
and Health Service, Robina, 3Digestive Health, Gold Coast Hospital and
Health Service, Southport, Australia
* Corresponding author.
Rationale: Recent literature suggests that a liberalised diet (i.e. no
dietary restrictions) is safe for the inpatient management of acute,
uncomplicated diverticulitis; however, physicians internationally
continue to prescribe restricted diets (i.e., nil per os or fluid-only
diets for >48 hours). This study aims to assess the impact of restricted
versus liberalised inpatient dietary prescription on recovery and
reoccurrence in adults with acute, uncomplicated diverticulitis.
Methods: Prospective observational study of adult patients admitted
to two metropolitan hospitals in Queensland, Australia from 2016 to
2019. Hierarchical multiple linear regression was used to determine
the impact of restricted versus liberalised diets on length of hospital
stay (i.e., time to recovery). Stepwise binomial logistic regression was
used to determine the impact of restricted versus liberalised diets on
30-day reoccurrence of diverticulitis.
Results: Of the 82 participants, 39 (64% female, mean age 57.6 ± 13.3
years, mean BMI 27.0 ± 4.3 kg/m2) were prescribed a restricted diet
and 41 (49% female, mean age 58.1 ± 14.6 years, mean BMI 28.7 ± 4.8
kg/m2) were prescribed a liberalised diet. In the adjusted models, a
liberalised diet decreased length of stay by 1.1 days (95%CI: −1.8 to
−0.4; p = 0.004). At 30-days post-discharge, there were no dietary,
gastrointestinal symptom, demographic, or medical characteristics
which predicted reoccurrence.
Conclusions: This study found that a liberalised diet for the
management of acute, uncomplicated diverticulitis was associated
with a shorter length of hospital stay compared to a restricted diet, and
was not associated with diverticulitis reoccurrence. This study
suggests a liberalised diet is safe, reduces burden on both the patient
and the health care system, and may promote recovery from acute,
uncomplicated diverticulitis.
Disclosure of Interest: None declared.
Table (abstract: MON-PO357):
REE Estimated
REE
Accurate
prediction1
Underprediction2 Overprediction3
Equations (kcal) (kcal/kg) (%) (%) (%)
REE-IC 1,734.7 ± 667.5 24.8 ± 9.7
Harris-
Benedict
1,413.6 ± 251.3a 20.1 ± 2.2a 26 54 21
Schofield 1,551.5 ± 277.9a 21.6 ± 3.2a 24 50 26
Ireton-Jones 1,541.1 ± 411.7a 22.0 ± 5.1a 20 46 34
Mifflin-St.Jeor 1,339.9 ± 251.9a 19.1 ± 2.5a 23 61 16
aWilcoxon signed-rank test p <0,05, compared with REE-IC (Resting energy expenditure measured by indirect calorimetry) distribution. 123The percentage of subjects
predicted by this predictive equation within10%, under and over respectively of the measured value.
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RESULTS OF A MULTICENTRIC RETROLECTIVE STUDY OF
TEDUGLUTIDE TREATMENT IN BENIGN SHORT BOWEL SYNDROME
IN GERMANY
S. Pevny1*, J. Wehkamp2, Y. Zopf3, I. Blumenstein4, M.W. von Websky5,
I. Schiefke6, J. Büttner1, S. Maasberg7, U.-F. Pape1,7. 1Department
of Gastroenterology, Hepatology and Endocrinology, Charité –
Universitätsmedizin Berlin, Berlin, 2Department of Gastroenterology,
Hepatology and Infectious Diseases, University Hospital Tübingen,
Tübingen, 3Department of Medicine 1, Hector-Center for Nutrition,
Exercise and Sports, Universitätsklinikum Erlangen, Erlangen,
4Department of Internal Medicine 1, University Hospital Frankfurt,
Frankfurt am Main, 5Department of Surgery, University Hospital of
Bonn, Bonn, 6Department for Gastroenterology, Hepatology, Diabetology
and Endocrinology, Klinikum St. Georg gGmbH, Leipzig, 7Department of
Internal Medicine and Gastroenterology, Asklepios Klinik St. Georg,
Hamburg, Germany
* Corresponding author.
Rationale: Teduglutide (TED) is a medical treatment for intestinal
functional rehabilitation of short bowel syndrome (SBS) patients with
chronic intestinal failure (cIF). Its application and effectivity is
routinely monitored in a structured home care service program by a
multicentric approach in Germany. From these prospectively docu-
mented data, a retrolective data base was generated in order to study
treatment characteristics and outcome parameters in a clinical routine
setting of TED-treated cIF-patients.
Methods: For the present interim analysis, prospectively collected
clinical data until December 2018 were retrolectively analyzed.
Statistical analyses were performed with SPSS using repeated
measures ANOVA and Friedman-Test with subsequent Bonferroni-
adjusted post-hoc analyses for TED treatment characteristics up to one
year.
Results: So far, 29 patients (f:17/m:12, median age 52 years) were
included in this interim analysis. Causes of SBS included vascular
(n = 12) and inflammatory diseases (n = 6), ileus (n = 4), injury (n = 4)
and others (n = 3). Median time on parenteral support (PS) before TED
was 30 months. At TED start, 72% of patients (21/29) received
individually compounded parenteral nutrition (PN); the remaining
28% received standardized PN. PS was administered by patients
themselves (n = 15), by relatives (n = 3), by nurses (n = 8) or others
(n = 3). TED treatment resulted in a significant reduction in PN calories
and volume requirements as well as reduced infusion days per week
and shortened infusion times (see Table 1). The reduction of infusion
time was positively correlated with the reduction of PN volume
(p < 0.001; r = 0.75) and calories (p = 0.003; r = 0.59) after one year of
TED treatment. After one year, 22 of 29 (76%) patients were considered
responders to TED treatment (with a minimum of 20% i.v.-volume
reduction).
Table 1
Changes in parenteral support characteristics on teduglutide treatment.
i.v. Volume
perWeek [L]
(±SD)
i.v Energy per
Week [kcal]
(±SD)
Infusion
Time [h]
(±SD)
PN days per
week (±SD)
Baseline 13.2 (±7.9) 7.450 (±4.232) 11.0 (±3.0) 5.3 (±2.2)
Week 12 ± 1 11.3 (±7.7)* 6.301 (±4.241) 10.8 (±3.0) 4.5 (±2.2)**
Week 23 ± 2 10.3 (±7.3)** 5.176 (±4.123)* 9.8 (±4.2) 3.8 (±2.4)***
Week 49 ± 5 8.4 (±6.7)** 4.611 (±4.311)*** 7.4 (±5.6)* 3.2 (±2.6)***
n = 24; p < 0.05, ** p < 0.01, *** p < 0.001 vs. baseline; PN = parenteral nutrition.
Conclusions: In this multicentric real-world analysis of severely PS-
dependent SBS/cIF-patients, TED displays effectivity with regards to
improvement of intestinal absorptive function as indicated by
significantly reduced weekly i.v.-volume and calorie requirements. In
addition, the findings demonstrate a reduction of effective infusion
days and times, which both importantly affect patients’ wellbeing.
These data indicate the effectivity of TED treatment in a national
routine treatment setting in concordance with clinical trial data and
guideline recommendations.
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MON-PO362
VITAMIN D AND LIVER STEATOSIS IN PATIENTS WITH CHRONIC
INTESTINAL FAILURE ON HOME PARENTERAL NUTRITION
T. Jordan1*, P. Popovič1, N. Rotovnik Kozjek2. 1Institute of radiology,
University Medical Center Ljubljana, 2Department for clinical nutriiton,
Institute of oncology, Ljubljana, Slovenia
* Corresponding author.
Rationale: The aim of the study was to determine the potential
correlation between the serumvitamin D levels and the degree of liver
steatosis in patients with chronic intestinal failure (CIF) on home
parenteral nutrition (HPN). According to cross-sectional studies
vitamin D deficiency seems to affect the development of non-alcoholic
steatohepatitis (NASH), suggesting the potential effect of vitamin D in
the development of non-alcoholic fatty liver disease (NAFLD) (1).
Methods: From January 2017 until December 2018 we were
prospectively collecting data from medical records of patients with
CIF (including serum vitamin D levels), who are on HPN therapy. Liver
steatosis was diagnosed with magnetic resonance imaging. The
association between vitamin D and liver steatosis was tested by
univariate logistic regression. P value < 0.05 was considered statistic-
ally significant.
Results:Wehave collected data from 63 patients, 29men (46%) and 34
women (54%), the median age was 65 years (min. 23 years, max. 81
years). The prevalence of liver steatosis was 28,6% (18 patients). Mean
(SD) value of vitamin D was 41.3 (13.9) nmol/L, 41.9 (15.4) in patients
with no liver steatosis and 39.8 (9.1) nmol/L in patients with liver
steatosis. The P-value was 0,586; therefore no statistically significant
association between vitamin D and liver steatosis was found.
Conclusions: We hypothesized that the presence of liver steatosis in
intestinal failure associated liver disease (IFALD) is associatedwith low
serum vitamin D levels through a similar pathophysiological mech-
anism as liver steatosis in NAFLD. In our group of CIF patients, no such
correlationwas found. However, mean vitamin D levels were relatively
low in both groups of patients, mainly due to insufficient intestinal
absorption. The limitation of our study is a relatively small sample size
since liver steatosis is a relatively rare complication of an already small
group of patients diagnosed with CIF and treated with HPN.
Reference
1. Eliades M. et al., ‘Meta-analysis: vitamin D and non-alcoholic fatty
liver disease,’ Aliment. Pharmacol. Ther., vol. 38, no. 3, pp. 246–254,
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BIOIMPEDANCE-DERIVED PHASE ANGLE ANDMORTALITY IN LIVER
DISEASES
V.L. Karsegard1*, L. Spahr2, C. Oropesa2,M. Dupuis2, L. Genton1. 1Clinical
Nutrition, 2Gastroenterology and Hepatology, University Hospitals of
Geneva, Geneva, Switzerland
* Corresponding author.
Rationale: Bioimpedance-derived phase angle was reported to reflect
cell membrane integrity, cell size and/or distribution of intra- vs.
extracellular water. It has been shown to predict outcomes, such as
mortality, functional status, quality of life and length of hospital in
several chronic diseases. This study aims to investigatewhether phase
angle predicts mortality in mixed liver diseases.
Methods:We considered all patients with alcoholic and non-alcoholic
liver disease, who participate in our cohort study. From our computer
database, we retrieved the last body composition assessment (50-kHz
bioelectrical impedance analysis (Nutriguard®, Data Input), and mid
arm muscle circumference (MAMC)), the MELD score (marker of liver
insufficiency) and themortality. Phase anglewas standardized (PhAst)
for sex, age, and body mass index (BMI),1 and categorized as < or
≥−2.12, themedian value. Univariate andmultivariate Cox regressions
evaluated whether PhAst predicted mortality.
Results: The analysis included 132 (26% women) participants among
whom42 died (29%women; 32 patients with a PhAst <median value).
Median time between measurement and death was 85 days (range 1–
707). A PhAst<the median value predicts mortality (HR :4.225, 95% CI
2.074–8.606, p < 0.001.) This prediction remains significant when
adjusting for MAMC (HR :3.2, 95% CI 1.457–7.011, p < 0.004), but not
when adjusting for MAMC and the MELD score (HR :2.144, 95% CI
0.946–4.862, p = 0.068), suggesting that the MELD score captures the
cell integrity measured with the PhAst.
Conclusions: This study demonstrated that 50 kHz phase angle is a
valuable prognostic indicator of mortality in liver diseases, independ-
ently of age, sex, BMI and anthropometric measurements but not of
MELD score.
Reference
1. Bosy-Westphal A., JPEN, 2006.
Disclosure of Interest: None declared.
MON-PO364
PROTEOME CHARACTERISTICS OF LIVER TISSUE IN PATIENTS WITH
LIVER DISEASE INDUCED BY LONG TERM TOTAL PARENTERAL
NUTRITION
G. Mamtawla1, F. Tian2, H. Sun3, L. Zhang4, X. Gao5, X. Wang3*. 1Jinling
Hospital, Nanjing University, Nanjing, Jiangsu Province, 2Shandong
Provincial Hospital, Jinan, Shandong Province, 3Jinling Hospital, Nanjing
University, Nanjing,Jiangsu Province, 4Jinling Hospital, Nanjing, Jiangsu
Province, 5Jinling Hospital, Nanjing University, Nanjing, Jinagsu Province,
China
* Corresponding author.
Rationale: Parenteral nutrition (PN) associated liver disease (PNALD)
is common and life-threating complication for patients receiving PN.
However, the definitive etiology of PNALD is not clear. We aimed to
investigate the potential molecular mechanism of PNALD.
Methods: Liver tissue was derived and comparied between selected
patients with (n = 3) /without (n = 4) PNALD via isobaric Tag for
Relative and Absolute Quantitation (iTRAQ)-based quantitative pro-
teomics. The key different proteins between two groupswere explored
and verified by Wertern-blot. Bioinformatics analysis was performed
using Gene Ontology (GO) and Kyoto Encyclopedia of Genes and
Genomes (KEGG) databases to explore the mechanisms of PNALD.
Results: A total of 112 proteins were found to be differentially
expressed. 73 proteinswere down-regulated, and 39 proteinswere up-
regulated in PNALD group. Bioinformatics analysis showed that the
differentially expressed proteins (DEPs) were associated with mito-
chondrion, and involved in mitochondrial electron transport, mito-
chondrial respiratory chain complex I assembly, oxidation reduction
process, response to oxidative stress and oxidative phosphorylation.
Conclusions: The results indicated that the energy metabolism
dysfunction initiated by abnormal oxidative phosphorylation was
one of the essential mechanisms of PNALD, and mitochondria-
initiated oxidative stress may play an important role in this process.
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INCLUDING BODY COMPOSITION IN MELD SCORES IMPROVES
MORTALITY PREDICTION AMONG PATIENTS AWAITING LIVER
TRANSPLANTATION
Y. Hamaguchi1*, T. Kaido2, N. Kamo2, S. Uemoto2. 1Departement of
Surgery, Kishiwada City Hospital, Osaka, 2Division of Hepato-Biliary-
Pancreatic Surgery and Transplantation, Departement of Surgery,
Graduate School of Medicine, Kyoto University, Kyoto, Japan
* Corresponding author.
Rationale: The Model for End-stage Liver Diseases (MELD) is widely
accepted for prioritizing candidates awaiting liver transplantation (LT).
However, MELD scores do not reflect the severity of the nutritional or
functional status of patients with cirrhosis.
Methods: This retrospective study analyzed data from 173 patients
who were waitlisted for LT at our institution between April 2006 and
December 2016. By including skeletalmusclemass,muscle quality and
visceral adiposity evaluated using plain computed tomography
imaging in MELD scores, we developed body composition-MELD
(BC-MELD), and investigated its impact on the prediction of mortality
among patients awaiting LT.
Results: The equation generated using Cox regression analysis was as
follows:
BC-MELD =MELD score + 3.59 × low SMI + 5.42 × high IMAC + 2.06 ×
high VSR. (IMAC, intramuscular adipose tissue content; SMI, skeletal
muscle mass index; VSR, visceral-to-subcutaneous adipose tissue area
ratio). Waitlist mortality in patients with high BC-MELD was
significantly higher in all tested cohorts (P < 0.001) and among
patients with lower conventional MELD scores (< 15) (P < 0.001). The
discriminatory powerwas significantly better for BC-MELD thanMELD
scores (P = 0.001 for 3-month, P = 0.002 for 6-month, P < 0.001 for 12-
month, P = 0.014 for overall mortality).
Conclusions: BC-MELD is the first to include not only muscularity but
also visceral adiposity. It predicted waitlist mortality more accurately
than the conventional MELD score. A new allocation system based on
BC-MELD might lead to better outcomes for patients with cirrhosis
awaiting LT.
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Nutrition and cancer II
MON-PO366
NUTRITIONAL SCREENING IN PATIENTS ADMITTED TO A
ONCOHEMATOLOGIC UNIT
M.C. Montalban Carrasco1*, F. Cruz T2, L. Ramos R3, A. Gonzalez D.-F3,
L. Vazquez S3, M.C. Garcia G3. 1S Endocrinology and Nutrition, 2Unit of
Nutrition and Dietetics, Hospital Valdecilla, 3S Endocrinology and
Nutrition, H Valdecilla, Santander, Spain
* Corresponding author.
Rationale: The PREDYCES study in Spain identified the impact of
malnutrition related to disease, with a prevalence of malnutrition of
36% in oncohematological patients. In our hospital, until the beginning
of this study, no nutritional screening had been performed in these
patients. Our Unit of Clinical Nutrition and Dietetics attended patients
on demand of their doctors when malnutrition was suspected. The
goal of our study was to identify patients with nutritional risk at
hospital admission in a Oncohematologic Unit and to assess the
benefit of universal screening in this group of patients.
Methods: Prospective, longitudinal study. All patients older than 16
years with oncohematological diagnosis who entered from July 2018
to February 2019 (8 months) in the Hematology Service Plant of the
M. Valdecilla Hospital were included in the study. Terminal patients
were excluded. The Malnutrition Screening Tool (MST) tool was used
for nutritional screening. In patients identified with nutritional risk, a
complete nutritional assessment was carried out.
Results: 152 patients were included in the study. The median age of
the patients was 61,49 years (range 16–96 y). 46.8% of the patients
were women and 53,2% were men. MST identified 71 patients at
nutritional risk (46.71%). A statistically significant difference was
found between the body mass index (BMI) of the patients with
nutritional risk (BMI 23,9 kg/m2) versus the patients without
nutritional risk (BMI 27,2 kg/m2) (p < 0,05). In the 8 months prior to
the implementation of screening, only 35 patients were attended by
our Nutritional Unit in the Hematology Service.
Hematologic malignancies in each group.
Leukemia Lymphoma Multiple
Myeloma
Others
NO RISK (81) 24 23 17 17
AT RISK (71) 19 26 11 15
Conclusions: Almost half of the patients admitted with onco-
hematological diseases were at nutritional risk using the MST as a
screening tool. The type of hematologicmalignancy did not predict the
nutritional risk. Systematical nutritional screening detects double
oncohematological patients at risk of malnutrition than on demand
and justifies the implementation of this program. Identification of
these patients allows an early nutritional intervention.
References
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MON-PO367
RELEVANCE OF BASELINE NUTRITIONAL STATUS ON THE EFFICACY
OF A FAST-TRACK NUTRITIONAL CIRCUIT IN HEAD AND NECK
CANCER PATIENTS UNDERGOING RADIOTHERAPY: THE SOONER
THE BETTER
M. Gonzalez1*, R. Villar1, A. Fernández1, M.A. Sifontes1, M. Pazos1,
M.Á. Martínez1, A. Cantón1. 1Endocrinology and Nutrition Service,
University Hospital Complex of Santiago de Compostela, Santiago de
Compostela, Spain
* Corresponding author.
Rationale: Head and neck cancer (HNC) patients undergoing
radiotherapy (RT) have a high risk of malnutrition. The aim of this
study was to evaluate the influence of baseline nutritional status on
the efficacy of the fast-track circuit.
Methods: HNC patients referred to the fast track circuit (before RT)
from 2014 to 2018 were included. Those with nasogastric tube
previous to RT were excluded.
Baseline nutritional status was evaluated following Spanish nutrition
society criteria (SENPE-SEDOM). Clinical evolution up to 3 months
after finishing RT was compared between well-nourished and
malnourished groups.
Results: 177patients (83%men),mean age 61.9 years. 68.4% of subjects
had advanced tumour state (IV) and 76.3% received concomitant
chemotherapy. Table 1 shows baseline characteristics and evolution of
both groups.
Well-
nourished
(n = 120)
Malnourished
(n = 57)
P
Baseline
BMI (kg/m2) 26.4 ± 5.0 23.6 ± 3.8 0.0001*
Anorexia (%) 12.5 49.1 0.0001*
Dysphagia (%) 39.2 68.4 0.0001*
Daily intake:
• Kcal:
• Protein (g):
2009
81
1629
66
0.0001*
0.004*
Oral supplements (%) 32.5 71.9 0.0001*
3-month follow up
BMI (kg/m2) 24.3 ± 4.2 22.4 ± 4.9 0.036*
Weight loss (%) −7.0 ± 8.6 −3.2 ± 9.0 0.018*
Oral supplements (%) 65.8 71.9 0.479
Nasogastric tube (%) 12.5 12.3 0.961
Death (%) 4.3 17.1 0.014*
*Statistical significance: p < 0.05.
The Hazard ratio of death is 3.937 (95% CI 1.319–11.750).
Conclusions: The well-nourished group had a better evolution
suggesting that malnutrition attenuates the benefits of the fast-track.
Despite receiving an early and intense nutritional support (with more
use of oral supplements at baseline and less weight loss during RT),
malnourished patients had almost 4 times more mortality. Nutritional
surveillance should be encouraged as soon as the HNC diagnose is
suspected, to ensure that all patients start RT in the best possible
nutritional status.
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NUTRITIONAL STATUS AND IMMUNONUTRITION IN PATIENTS
INTERVENED FOR TOTAL LARINGECTOMY FOR CANCER
A. Barrera1,2, M.R. Alhambra1,2, M.J. Molina1,2*, Á. Rebollo1,2,
M.D. Alcántara1,2, S. León1,2, P. Moreno1,2, C. Muñoz1,2, G. Manzano1,2,
J.C. Padillo1,2, A. Calañas1,2, J. Gutiérrez3, M.Á. Gálvez1,2. 1Maimonides
Institute of Biomedical Research, 2Endocrinology and Nutrition, 3Service of
Otorhinolaryngology, Hospital Universitario Reina Sofia, Cordoba, Spain
* Corresponding author.
Rationale: In addition to administering the necessary nutritional
requirements, immunonutrition aims to improve the immune status in
order to minimize the response to surgical aggression.
Objectives: To assess the nutritional status in the perioperative period
of laryngectomy in cancer patients and to analyze the possible
repercussion of the immunomodulatory enteral diet in postoperative
complications.
Methods: Retrospective study of patients undergoing total laryngect-
omy (2016–2018) in our hospital. Statistical analysis SPSS v.22.0.
Results: 40 subjects, 95% men, mean age 66.3 ± 11.48 years, 32.5%
diabetics. All the patients had total enteral nutrition by nasogastric
tube after surgery; 45% immunomodulatory formula.
Anthropometric-biochemical parameters before and after surgery:
weight 79.1 ± 19.2 vs 75.2 ± 15.4 kg (p = 0.033), BMI 28.9 ± 6.8 vs
27.5 ± 5.5 kg/m2 (p = 0.034), hemoglobin 14.0 ± 1.6 vs 11.3 ± 1.8 g/dl
(p < 0.001), lymphocytes 1835.6 ± 928.8 vs 1432.3 ± 756.6/mm3 (p <
0.001), proteins 7.1 ± 0.6 vs 6.1 ± 0.4 g/dl (p < 0.001), albumin 3.9 ± 0.4
vs 3.4 ± 0.7 g/dl, prealbumin 17.5 ± 12.0 vs 18.5 ±2.1 mg/dl and
transferrin 230 ± 50.4 vs 196 ± 30.4 mg/dl (p = NS in the last 3
parameters). The use of immunomodulatory formula is associated
with higher levels of post-surgery pre-albumin (25.8 ± 10.9 vs 17.9 ±
7.6 mg/dl, p = 0.012), without differences in the rest.
The most common complication after surgery is pharyngocutaneous
fistula (30%). The appearance of complications and mortality are not
associated with enteral nutrition formula. Hospital stay is greater in
cases with complications (31.2 ± 12.2 vs 17.7 ± 3.8 days, p < 0.001).
Conclusions: Aworsening of nutritional status is experienced bymost
patients after surgery. In our series, the use of the immunomodulatory
formula seems to be associated with higher levels of prealbumin
compared to the standard formula, without differences in other
parameters.
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THE EFFECT OF NUTRITIONAL COUNSELING ON MUSCLE MASS AND
TREATMENT OUTCOMES IN PATIENTS WITH METASTATIC
COLORECTAL CANCER UNDERGOING CHEMOTHERAPY: A
RANDOMIZED CONTROLLED TRIAL
A. van der Werf1, J. Langius1, A. Beeker2, A.J. ten Tije3, A. Vulink4,
A. Haringhuizen5, H. Berkhof6, H. van der Vliet7, H. Verheul7, M. de van
der Schueren1*. 1Nutrition and Dietetics, Amsterdam UMC/VRIJE
Universiteit, Amsterdam, 2Medical Oncology, Spaarne Gasthuis,
Hoofddorp, 3Medical Oncology, Amphia Ziekenhuis, Breda, 4Medical
Oncology, Reinier de Graaf Gasthuis, Delft, 5Medical Oncology,
Ziekenhuis Gelderse Vallei, Ede, 6Epidemiology, 7Medical Oncology,
Amsterdam UMC/VRIJE Universiteit, Amsterdam, Netherlands
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Rationale: A low muscle mass and loss of muscle mass during
chemotherapy is related to adverse outcomes in patients with cancer.
In this randomized controlled trial, the effect of nutritional counseling
on change in muscle mass and treatment outcomes in patients with
metastatic colorectal cancer during first-line chemotherapy was
studied.
Methods: Patients scheduled for first-line chemotherapy (n = 107)
were randomly assigned to individualized nutritional counseling by a
dietitian (NC) or usual care (UC). NC was aimed at sufficient protein-
and energy intake, supported byoral supplements orenteral feeding in
indicated. Furthermore, physical activity was encouraged. Outcomes
were assessed at baseline (T0) and the time of the first (T1) and second
(T2) regular follow-up computed tomography scans. The proportion of
patients with a clinically relevant decrease in skeletal muscle area of
≥6.0 cm2, measured by computed tomography, was the primary
outcome. Secondary outcomes included body weight, quality of life,
treatment toxicity and progression free and overall survival.
Results: Between 2013 and 2018,107 patientswere randomlyassigned
to NC (n = 52) or UC (n = 55). The proportion of patients with ≥6.0 cm2
decrease in skeletal muscle area of did not differ (NC 30% versus UC
31%, p = 0.467). NC compared with UC had a significant positive effect
on body weight (B coefficient 1.7, p = 0.045), progression free survival
(p = 0.039) and overall survival (p = 0.046).
Conclusions: NC of patients undergoing chemotherapy for metastatic
colorectal cancer did not have an effect on muscle mass. However, we
found that NCmay increase bodyweight andmay improve progression
free survival and overall survival compared to UC in this group of
patients. Future trials powered on survival should confirm the
beneficial effect of NC and will have to investigate the mechanism
whereby survival may be improved.
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PLASMA LEVEL CITRULLINE UNDERGOING HEMATOPOPOIETIC
STEM CELL TRANSPLANTATION
M.Motilla De La Cámara1,2*, C. Velasco Gimeno1,2, C. Cuerda Compes1,2,
I. Bretón Lesmes1,2, M. Camblor Alvarez1,2, A. Morales Cerchiaro1,2,
L. Arhip1,2, M. Carrascal Fabian1,2, N. Dorado Herrero2,3, M. Kwon2,3,
P. Garcia Peris1,2. 1Nutrition Unit, 2Instituto de Investigación Sanitaria
Gregorio Marañón, 3Bone Marrow Transplantation Unit, Hospital Gerenal
Universitario Gregorio Marañón, Madrid, Spain
* Corresponding author.
Rationale: Plasma citrulline has been proposed as a marker of
intestinal epithelial damage following myeloablative therapy
(≤20 μmol/L: intestinal insufficiency and ≤10 μmol/L: villus
atrophy).(1) Furthermore, levels ≤26 μmol/L before hematopoietic
stem cell transplantation (HCT) was associated with acute graft vs
host-disease and non-relapse mortality.(2)
Our objectivewas to analyse plasma citrulline levels during HCT in our
centre.
Methods: Prospective observational study of patients undergoing HCT
during 2015–2018. Data (age, gender, transplant type, diagnosis,
citrulline and blood samples) were collected at days (−7)(+7)(+14) and
2 weeks after discharge (AD) of the HCT. Patients received nutritional
treatment according to usual clinical practice of our centre. Plasma
citrulline levels were assessed using liquid chromatography combined
withmass spectrometry (normal levels 40 ± 10 μmol/L). The results are
expressed in median [interquartile range] and frequencies. Wilcoxon
test using IBM-SPSS21.0©
Results: We studied 39 patients (51% men; median age 52[42–63]
years) who underwent HCT (65.8% allogeneic). The median stay was:
32[28–39] days. Citrulline levels varied significantly during the study
(even adjusted by gender, transplant type, diagnosis, PCR and kidney
failure) (Table 1). At admission, 40.5% of the patients had citrulline
levels ≤26 μmol/L.
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Table 1
Plasma citrulline levels during the study.
−7 +7 +14 AD p
Median
[interquartile range]
26.7
[22.9–33.2]
10.3
[8.3–15.9]
12.4
[9.9–17.4]
18.1
[16.4–24]
<0.001
N° with Cit≤ 10 μmol/L (%) 2(5%) 15(43%) 9(26%) 0 0.001
N° with Cit≤ 20 μmol/L (%) 5(13%) 32(91%) 27(79%) 19(61%) <0.001
Conclusions: In our series, patients undergoing HCT had citrulline
levels at admission below normal range, and almost in half of them
citrulline levels were ≤26 μmol/L. This has been associated with an
increased risk of complications.
Minimum levels were reached one week after transplant (43% in the
range of villous atrophy) and remained low even after two weeks of
hospital discharge. These data should be considered when managing
patient’s nutritional treatment.
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ASSOCIATION BETWEEN FTO GENE POLYMORPHISMS AND BREAST
CANCER: A SYSTEMATIC REVIEW
S. Doaei1, M. Gholamalizadeh2*. 1Research Center of Health and
Environment, Guilan University of Medical Sciences, Rasht, Iran, Rasht,
2Cancer Research Center (CRC)., Shahid Beheshti University of Medical
Sciences, Tehran, Iran., Tehran, Iran, Islamic Republic of
* Corresponding author.
Rationale: It has recently been reported that the fat mass and obesity-
associated (FTO) gene is associated with cancer risk. The aim of the
current research is to systematically investigate the conducted
research studies on the association between FTO gene polymorphisms
and breast cancer.
Methods: In this study all of the case-control studies associated with
cancer and FTO gene polymorphisms were gathered from Pubmed,
Science Direct, Scopus, and Cochran databases and assessed inde-
pendently by 2 researchers. Key words such as breast cancer and/or
FTO and/or polymorphism were used in order to identify related
articles. Exclusion criteria included studies unrelated to the FTO gene
and unrelated to the outcome of breast cancer
Results: In accordance with our criteria, 12 studies were included into
this systematic review. Of these studies, 7 investigated the association
between rs99396096 polymorphism and breast cancer, 4 studies
investigated the association between rs1477196 polymorphism and
breast cancer, 3 studies investigated the association between
rs11075995 polymorphism and breast cancer, and 2 studies investi-
gated the association between rs17817449 polymorphism and breast
cancer. The association between FTO gene polymorphisms and cancer
were significantly different between different studies.
Conclusions: FTO genotype may play an important role in breast
cancer. The association between FTO gene polymorphisms and cancer
differs from one study to another, whichmay be due to the complexity
of the subject matter and the impact of various factors on it.
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THE EFFECTS OF GENE POLYMORPHISMS OF METABOLIC ENZYMES
ON THE ASSOCIATION BETWEEN RED AND PROCESSED MEAT
CONSUMPTION AND THE DEVELOPMENT OF COLON CANCER; A
LITERATURE REVIEW
S. Doaei1, M. Gholamalizadeh2*. 1Research Center of Health and
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University of Medical Sciences, Rasht, Iran, 2Cancer Research Center
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Rationale: The role of environmental factors and genetic susceptibility
in the development of colon cancer (CC) has been already proven, but
the role of gene polymorphisms in modifying the risk of environmen-
tal factors such as nutritional factors is still unknown
Methods: This review study was carried out using keywords such as
polymorphism and/or protein and/or red meat and/or processed meat
and/or colon cancerPubMed and Science Direct Databases were used
to collect all related articles published from 2001 to 2017.
Results: The presence of single-nucleotide polymorphisms in the coding
genes of proteins involved in metabolism of nutrients could play
significant roles in the extent of the effects of nutrition in the
development of CC. The effect of dietary proteins greatly depends on
the polymorphisms in the metabolizing genes of these substances.
Gene polymorphisms may have a role in CRC risk, especially in people
with high meat intake. and this leads to a difference in the effects of
meat consumption in different individuals.
Conclusions: Dietary recommendations for the prevention and
control of CC should be modified based on genotype in different
individuals. Increasing our knowledge on this field of nutritional
genomics can lead to personalized preventive and therapeutic
recommendations for CC patients
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ANOREXIA OVERCOMING IN PATIENTS WITH CYTOSTATIC THERAPY
AND HEMATOPOIETIC STEM CELL TRANSPLANTATION
I. Zhuk1,2, P. Sheveleva2, N. Saltykova2, M. Kucher2*, B. Afanasyev2.
1Saint-Petersburg State Pediatric Medical University, 2Raisa Gorbacheva
Memorial Institute for Children Oncology, Hematology and
Transplantation, First State Pavlov Medical University of Saint-
Petersburg, Saint-Petersburg, Russian Federation
* Corresponding author.
Rationale: Cytostatic therapy and hematopoietic stem cell transplant-
ation (HSCT) is often associated with gastrointestinal toxicity,
including anorexia, which leads to protein-energy malnutrition and
ultimately cachexia – factor associated with high mortality. We
evaluated clinical efficacy of existing appetite stimulants in cytostatic
therapy and HSCT.
Methods: Since 2014, 99 patients with malignancy (n = 83) and other
diseases (n = 16) treated with allogeneic HSCT (n = 75), cytostatic
therapy (n = 24) were enrolled to the prospective study. Median age
was 20.6 years (0.2–76 years). Appetite stimulant therapy was carried
out in 58 patients – megestrol acetate (Megace, Bristol-Myers Squibb,
USA) 40–320 mg/day (0.8–13.3 mg/kg) orally; 19 patients – levocar-
nitine (Elkar, PEAK-Pharma, Russia) – 0.3–0.9 g/day orally. Patients in
control group (n = 22) received prednisolone 1–2 mg/kg/day as part of
graft-versus-host disease (GvHD) therapy, for whom appetite eleva-
tion is a common side-effect. Clinical effectiveness was evaluated 1
month after therapy was started.
Results: Appetite stimulants had provoked appetite in 79.3%
(n = 46) patients in megestrol acetate group, р = 0.0001; 63.6%
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(n = 14) – prednisolone, р = 0.0001; 22.2% (n = 4) – levocarnitine. Body
mass increase was observed in 81% (n = 47) of patients with megestrol
acetate (p = 0.05) and in 50% (n = 11) with prednisolone (p = 0.05),
levocarnitine – 15.8% (n = 3). Initial nutritional status, GvHD didn’t
affect appetite stimulants effectiveness, р = 0.3, respectively.
Prednisolone treatment was associated with more frequent rate of
complications – 31.8% (n = 7), p = 0.0001; megestrol acetate (n = 1) and
levocarnitine (n = 1).
Conclusions: Low-dosemegestrol acetate is a safe and effective option
for anorexia treatment in patients after HSCT and cytostatic therapy.
Prednisolone was less effective, moreover it was accompanied with
metabolic alterations.
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A COMPARISON OF EARLY ENTERAL FEEDING VIA NASOJEJUNAL
VERSUS NASOGASTRIC TUBES IN ALLOGENEIC HEMATOPOIETIC
STEM CELL TRANSPLANTATION – RESULTS OF A TWO-CENTER
NUTRITIONAL INTERVENTION TRIAL
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Rationale: Allogeneic hematopoietic stem cell transplantation
(allo-HSCT) is associated with inadequate oral food intake. Enteral
nutrition (EN) is more appropriate in comparisonwith total parenteral
nutrition, but is difficult to provide due to gastrointestinal toxicity and
graft versus-host-disease. The aim of the study was to compare
nasojejunal (NJ) versus nasogastric (NG) tube feeding in recipients of
allo-HSCT.
Methods: Allo-HSCT recipients (n = 69) with myeloablative condition-
ing (MAC) were enrolled in a randomized controlled trial comparing
optimized energy and protein intake with routine hospital nutritional
support. A NJ tube (Flocare Bengmark Ch8, Nutricia or Freka
Endolumina 10 Fr, Fresenius Kabi) (Norwegian arm) and a NG tube
(Flocare Pure Ch8) (Russian arm) were inserted within 5 days after
allo-HSCT. A semi-elemental formula (Nutrison Advanced Peptisorb,
Nutricia) was started at 15 ml/h and increased to maximum 100 ml/h.
Results:
Tube type tolerance and outcome
Nasojejunal Nasogastric P-value
Variables (n = 55) (n = 14)
Days in position, median, range 7 (1–34) 5 (1–14) 0.05
Maximum infusion rate, ml/h 53 (20–100)* 27 (20–50) 0.001
Reduced infusion rate due to:
nausea 13 (27.1)* 2 (14.3) 0.48
diarrhea 6 (12.5)* 1 (7.1) 1.00
bloating 7 (14.6)* - -
Gastric residual volume, ml - 80 (31–187) -
Removed adequate oral energy
intake
7 (12.7) - -
Poorly tolerated 16 (29.1) 8 (44.4) 0.05
Vomited tube 19 (34.5) 2 (14.3) 0.20
Fall out 8 (14.5) - -
Others 5 (9.1) - -
Values are numbers (%) unless otherwise stated, *NJ feedingwas started in 48/55
(87.3%) patients.
Conclusions:NJ feeding was better tolerated compared to NG feeding,
but was associated with high risk of tube loss. Semi-elemental
formula was well-tolerated and could be recommended for patients
with high risk of gastrointestinal toxicity in allo-HSCT after MAC.
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THE RELATIONSHIP BETWEEN PARENTERAL NUTRITION AT HOME
AND QUALITY OF LIFE AND CATHETER INFECTIONS
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Rationale: Indications for treatmentof parenteral nutrition (PN) at
home remain contraversial. High rates of infection are reported in
patients receiving PN support at home. The aim of the present study
was to investigate the effect of home PN application on catheter-
related infection rateswith the support of an experienced home nurse.
Methods: The PN indication at homewas determined according to the
European Society for Clinical Nutrition and Metabolism guideline.
Patients >18 years old were included in the study. Before PN support
was given at home, complying with asepsis rules for 2–5 days, the
patients and their relatives were trained on the preparation and
insertion of the feeding bag, catheter care, complications that may
occur. The visits were made by an experienced nurse 2 days/week at
home. Short form Health Survey-36 abd Karnofsky quality of life tests
were applied to all patients and patients were evaluated for catheter
infection and other complications.
Results: Seventeen (nine male and eight female) patients were
included in the study. The median age of the patients was 61 (40–
80) years. Fourteen patients had PN support due to malignancy, and
two patients had short bowel syndrome. The median bodymass index
was 20.7 (13–30) kg/m2, whereas the median Nutritional Risk
Screening-2002 score was 4 (3–6). The median follow-up period was
47 (0–155) days. Of the 17 patients, 3 died after the first home visit
after being discharged from the hospital. One patient was excluded
from the study because she did not want to come home after her basal
evaluation was made. At the end of the study, 15 patients died. PN
support was discontinued in two patients who started to take it oraly.
One patient was hospitalized on day 63 of PN administration at home
due to catheter-related infection. One patient had port obstruction due
to PN support. In total, PN support with catheter was found as 811
days. The rate of catheter infection was 1.23 in 1000 catheter days.
Conclusions: In our study, the rate of infection was found to be
significantly low in patients whowere followed up with PN support at
home with the help of an experienced nurse.
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THEUSE OF BIOLOGICALLY-BASED COMPLEMENTARYMEDICINES IN
PATIENTS WITH NEUROENDOCRINE TUMOURS
M. Borre1*, G. Dam1, H. Grønbaek1. 1Department of hepatology and
gastroenterology, Aarhus University Hospital, Aarhus N, Denmark
* Corresponding author.
Rationale: Biologically-based complementary medicines (BB-CMs)
are popular in patients with cancer. However, there are only limited
data for BB-CMs in patients with neuroendocrine tumors (NET). We
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aimed to identify the prevalence and type of BB-CM use and the
association to the nutritional risk score (NRS-2002) in NET patients.
Methods:We performed a cross-sectional questionnaire study in NET
outpatients at the department of Hepatology and Gastroenterology at
Aarhus UniversityHospital. The nutritional riskwas determined by the
NRS-2002.
Results:We included 186 patients (51%women, median age 66 years).
Sixty-six percent were regular BB-CMusers. Forty-two percent used at
least two supplements. The most popular BB-CMs were vitamin and
mineral supplements (47%), calcium and vitamin D (34%). One-third
used non-vitamin non-mineral supplements like fish oil, herbs,
Ginger, Q-10, garlic and probiotics. The use of BB-CMs was associated
with female gender (48% vs 37%, p < 0.05). Intake was significantly
more frequent among patients with an NRS score ≥3, (60% vs 76%) and
in patients with impaired level of function (58% vs 76%), (p < 0.05, all).
Patients reporting dietary changes used BB-CMsmore frequently than
patients without dietary changes (61% vs 77%), (p < 0.05).
Conclusions: In our study, 66% percent of NET patients use BB-CM and
42% used two ormore supplements. Vitaminswith andwithout herbal
ingredients, minerals, calcium, vitamin D and fish oil were the most
popular supplements. The use of of BB-CMs was associated with an
NRS score ≥3, change in food intake, female gender and impaired level
of function.
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ARE BODY COMPOSITION PARAMETERS ASSOCIATED WITH THE
CLINICAL OUTCOME OF PATIENTS WITH ADVANCED PANCREATIC
CANCERRECEIVING FLUOROPYRIMIDINE-BASED CHEMOTHERAPY?
M. Som1*, C. Brac de la Perriere2, J. Viaud3, B. Campillo-gimenez2,
L. Lacaze1, J. Edeline2, R. Thibault1. 1Unité de nutrition, CHU de Rennes-
Site Pontchaillou, 2Oncologie, Centre Eugène Marquis, 3Oncologie, CH
Saint Malo, Rennes, France
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Rationale: Pancreatic cancer (PC) is one of the most aggressive cancer
with 80% metastatic disease at diagnosis and a high 5 year-mortality
rate (95%). Fluoropyrimidin based chemotherapy is one of standard
treatment with the best efficiency but also with more toxicity. Impact
of body composition (BC), including impaired muscle mass, specific-
ally in advanced PC is still debated. The aim of our study was to
determine impact of different BC parameters on PC prognosis and
Folfirinox toxicity.
Methods: All patients treated by Folfirinox as a metastatic first line for
advanced PC between 2007 and 2015 at a French Cancer Center were
retrospectively analysed. BC was assessed by CT scan at the third
lumbar level. Images from CTscanwere analysedwith ImageJ software
(National Institutes of Health, Bethesda, MD, USA). Impaired muscle
mass was defined using skeletal muscle index (SMI) (<52.4 cm²/m²
for males and 38.5 cm²/m² for females). Psoas muscle (PMI), visceral
adipose tissue (VAI), subcutaneous adipose tissue (SAI), intramuscular
fat index were collected. Kaplan Meier analyses and the cox
proportional hazard ratio were used to compare effect of BC on
overall survival (OS) and progression free survival (PFS). Chi-square or
Fisher exact test were used to compare chemotherapy toxicity.
Results: Data from 137 patients with PC were enrolled. Among them
91 had a baseline CT scan available and were included in analyses.
Mean agewas 60.7 ± 9.2 years old. Cancer was locally advanced in 42%
of cases and metastatic in 58%. Mean SMI was 48.6 ± 7.03) cm²/m² for
males and 36.9 ± 6.0 cm²/m² for females. Impaired muscle mass was
observed in 64% (n = 58) of patients. Neither impairedmusclemass nor
other BC parameters (except for intrapsoas fat index) were signifi-
cantly associated with OS or PFS. However, performance status
(HR = 0.42 [0.20;0.85], p = 0.015), first intent surgery (HR = 0.55
[0.32;0.93], p = 0.03), livermetastasis (HR = 2.62 [1.59; 4.32], p < 0.001)
and intrapsoas fat index (HR = 0.52 [0.29; 0.95], p = 0.03) were
independent predictive factors of mortality. The lower quartile of
SMIwas associatedwithmore vomiting: n = 12/22 (54.5%) vs n = 15/62
(24.2%), p = 0.016. Patients with the highest quartiles of SAI or VAI had
significantly more grade 3 haematological toxicity than the lowest
(35% vs 4.8%, p = 0.009; 34% vs 9%, p = 0.028, respectively).
Conclusions: In this study, there is no relation between BC parameters
includingmusclemass and prognosis in locally advanced ormetastatic
PC. Nevertheless, a low SMI, a high SAI or VAI is associated with more
severe toxicity of chemotherapy. Other studies should be performed to
evaluate whether a targeted nutritional care could improve tolerance
of chemotherapy.
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CARCINOMATOUS PERITONITIS?
M. Noguchi1*, K. Fukatsu1, A.Watkins1, T.Watanabe1, K. Higashizono1,2,
S. Murakoshi1. 1Surgical Center, 2Department of Gastrointestinalsurgery,
The University of Tokyo Hospital, Tokyo, Japan
* Corresponding author.
Rationale: Cancer causes systemic inflammation and malnutrition.
Particularly, at the end stage of cancer, the amount of oral food intake
may be markedly reduced. Although avoidance of malnutrition is
essential for the maintenance of host immunity against hostile
microbes and cancer cells, parenteral feeding under such condition
is not recommended in clinical guidelines. On the other hand, because
enteral nutrition may enhance host immunity, tube feeding might
improve outcome of animalswith advanced cancerwhen oral intake is
diminished.
Methods: Male C57BL/6 J mice (n = 21) underwent gastrostomy and
were inoculated PancO2 cancer cells (1 × 106/body) i.p. on day 8 after
the operation. Then, all mice were fed normal chow and water ad
libitum until day 29. Because our previous study showed body weight
loss and oral intake reduction from day 29, we randomly divided the
mice into 2 groups:{CHOW (n = 10) and SED (n = 11)} on day 29. The
CHOW group was allowed to take the chow and water ad libitum
throughout the study period, whereas the SED group received
continuous tube feeding of a standard enteral diet at the rate of
0.48 kcal/hwithoutoral food intake fromday29. Survivalwasobserved
until day 43 and survival timewas analyzed using log rank test.
Results: Autopsy of the dead mice revealed progression of cancer
peritonitis in the 2 groups. Obstruction of GI tract due to cancer
peritonitis was not observed. Survival timewas 33.2 ± 1.6 in the CHOW
and 28.3 ± 1.2 in the SED group (days, mean±SE group, p = 0.03).
Conclusions: Aggressive enteral feeding may be disadvantageous in
the advanced cancer peritonitis.
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Rationale: To identify the association of body mass index on survival
in adult patients with B Cell Precursor Acute Lymphoblastic Leukemia.
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Methods: A retrospective, observational study was performed in
patients with acute lymphoblastic leukemia of lineage B Ph + (-). All
cases with genetic alterations of poor prognosis or with adverse
phenotypic alterations (ALL-MyL) were excluded. BMI was calculated
at the time of diagnosis. We studied the association of the different
clinical risk factors (leukocyte count, age, risk) with BMI. Survival
curves were performed using the Kaplan-Meier method; the differ-
ences between the groups were identified by the log-rank test. The
impact of the variables on the forecast was identified by the Cox
regression analysis.
Results: A total of 128 patients with diagnosis of de novo lympho-
blastic leukemia who initiated induction chemotherapy protocol for
remission were studied. The mean age was 32 years (16–68 years),
being higher for females (36 years and 28 years), this difference being
statistically significant (p = 0.000, 95% CI). When classifying the cases
according to age, most of the patients were under 35 years old (n = 84,
65.6%), being mostly male cases (74.7% and 52.8%). BIM was obtained
at the diagnosis, they were classified with a normal weight 34.4%,
overweight, 18.8% obesity grade I, and 3.9% obesity grade III. The mean
follow-up was 393 days (10–1216 days), with an average survival of
57.8% at 600 days of follow-up. In the multivariate analysis of the
clinical variables (age, leukocytes and global risk), only age showed a
significant impact on both overall survival (p = 0.045, 95% CI) and for
disease-free survival (p = 0.054)., 95% CI). When analyzing the BMI,
overweight (25–29.9 kg/m2) and obesity (≥30 kg/m2) on overall
survival, we found no direct no association between this variable on
overall survival (p = 0.640, 95% CI) as in disease-free survival (p =
0.527.95% CI).
Conclusions: Body mass index was not associated on overall survival
and a disease-free survival in patients with b-cell precursor Acute
Lymphoblastic Leukemia. Further studies analyzing body composition
are recommended.
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Rationale: This cross-sectional study, aimed to determine nutritional
status among oncology outpatients, was conducted in collaboration
with Turkish Society of Radiation Oncology as an awareness-raising
project within the context of World Nutrition Day.
Methods: A total of 394 oncology outpatients were screened for
nutritional status via NRS 2002 during their admission to 12 radiation
oncology centers across Turkey in October 2018. Patients with NRS
2002 scores ≥3 were considered to be at risk of malnutrition
necessitating the provision of nutritional intervention.
Results: The most common diagnosis was head and neck carcinoma
(23.4%), as followed bygastrointestinal (20.8%), breast (14.0%), prostate
(12.4%) and lung (12.2%) cancer. Overall, 78.9% of patients were newly
diagnosed. NRS 2002 assessment (scores ≥3) revealed 133(33.8%)
patients to be at risk for malnutrition. Highest rates for malnutrition
risk were noted for patients with lung cancer (43.8%), head and neck
cancer (43.5%), gastrointestinal tumors (42.7%), and gynecologic
cancer (33.3%). Poor nutritional status was evident in 36.0% and
25.3% of newly diagnosed and formerly diagnosed patients,
respectively.
Conclusions: This screening study revealed malnutrition risk and
need for nutritional intervention in 33.8% of cancer patients, including
36.0% of newly diagnosed patients. Our findings emphasize that
nutritional intervention should be implemented in two out of every
five patients with newly diagnosed cancer, particularly for those with
lung cancer, head and neck cancer and gastrointestinal tumors.
Accordingly, screening for nutritional risk in every cancer patient
during the early treatment period seems crucial, given the likelihood
of being already at risk of malnutrition at the time of initial diagnosis
and the role of appropriate multimodal nutritional intervention prior
to anti-cancer therapy in the long-term success.
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Rationale: Malnutrition is very common for among the cancer
patients. Treatment modalities that are used to management of
disease can cause worsening of malnutrition. This can affect the
success of treatment. In this regard, it is very critical to assess
nutritional status of the patients properly and start early nutritional
support to high risk group for achievement of treatment. Nutritional
status can be evaluated by different tests. Still, there is no consensus
for that. However, subjective global assessment (SGA) and nutritional
risk scanning (NRS-2002) are generally preferred by most of the
physicians. We aimed to compare the effectiveness of SGA and NRS-
2002 to predict to malnutrition risk for lung cancer patients.
Methods: 37 patients were evaluated with both SGA and NRS-2002
tests by same physician before beginning of definitive treatment for
lung cancer or head and neck cancer in Radiation Oncology
Departments. Prediction values for malnutrition for both tests
statistically compared with chi-square test. Cohen’s kappa value is
used to assess compatibility of two tests.
Results: Median age was 58.5 years old. SGA test detected malnutri-
tion risk for 18 patients (%48.6), while NRS-2002 had detected for only
9 patients (%24.3) at same group. There is a statistically significant
difference between two tests for detection of malnutrition (p = 0.005).
Cohen’s kappavalue showed low level compatibility (0.397).Whenwe
assumed that SGA is the reference test, sensitivity and specificity ratios
for NRS-2002 calculated as %94 and %11 respectively. Negative
predictive value (NPV) was %50 and positive predictive value (PPD)
was %67 according to assumption.
Cohen’s kappa value calculated as 0.56, which means intermediate
level compatibility between two tests, when patients older than 65
years old evaluated among themselves. There is no statistically
significant difference for these two tests in patients that are older
than 65 years old (p = 0.25).
Conclusions: There is a statistically significant difference between
NRS2002 and SGA tests for detection of malnutrition. But there is no
statistically significant difference for these two tests in patients that
are older than 65 years old. Further attention should be given to detect
malnutrition in oncology group.
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Rationale: Due to the metabolic and pathophysiological changes that
accompany cancer, post-pancreatectomy cancer patients often exhibit
a high risk of malnutrition, mainly caused by weight loss and trouble
eating (decreased appetite, indigestion, or early satiety). This study
proposes a new postoperative diet strategy developed to address these
issues.
Methods:A retrospective analysis studywas conducted on 25 patients
who underwent pancreatectomy from November 2016 to May 2018 at
Severance Hospital in Seoul. Subjects were categorized into two
groups,15 individuals in the ‘Regular Diet Group’ and 10 individuals in
the ‘Experimental Diet Group.’
The ‘Regular Diet Group’ abstained from food or drink (NPO) prior to
surgery and followed a clear liquid diet (520 kcal/1300 ml), full liquid
diet (1200 kcal/1900 ml), then soft diet (1600 kcal/2600 ml) follow-
ing the procedure.
The ‘Experimental Diet Group’ followed a shortened NPO period by
consuming a carbohydrate-rich drink both before and after surgery.
Post-surgery, the period for patients following a low-calorie liquid diet
(350 kcal/710 ml), with which patients exhibit a lack of compliance,
was limited to a day or less. Instead, their soft diet was separated into
step 1 (1100 kcal/1300 ml) and step 2 (1600 kcal/2100 ml), with
caloric density increased using high calorie and high protein foods and
oral nutritional supplements. Furthermore, snacks were provided in
between meals a total of three times to promote frequent, light
consumption of calories.
Caloric intake was recorded everyday and weight data were collected
through EMR records. CAN.pro 4.0 was used for nutritional analysis
and SPSS ver.23 was used for statistical analysis.
Results: There were no significant differences in age, gender, weight
pre- or post-operation or pre-operation BMI between the two groups.
The ‘Regular Diet Group’ consumed 27% of the calories provided, while
the ‘Experimental Diet Group’ consumed 49%. The ‘Experimental Diet
Group’ showed a significant increase in caloric intake (p = .007). The
‘Regular Diet Group’ consumed 43% of the required calories per
patient, while the ‘Experimental Diet Group’ consumed 57%, but there
was no statistically scientific difference between the two groups
(p = .161). The ‘Regular Diet Group’ showed a significant (p = 004)
decrease of −3.2% in weight. The ‘Experimental Diet Group’ showed a
decrease of −2.8% in weight, which was not significant (p = .097).
Conclusions: The ‘Experimental Diet Group’ exhibited an increase in
caloric intake and a low rate of weight loss, which demonstrates
functional significance of this diet in improving the nutritional status
of post-pancreatectomy cancer patients.
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PROGRAM FOR PEOPLE WITH GASTROINTESTINAL CANCER
RECEIVING CHEMOTHERAPY
N. Harris1*, C. Sandsund2, C. Shaw1, C. McKeown3. 1Nutrition &
Dietetics, 2Rehabilitation Therapies, 3Patient representative, The Royal
Marsden Hospital, London, United Kingdom
* Corresponding author.
Rationale: Prehabilitation originates in surgery where its use can
reduce morbidity and improve health outcomes.1 It is now evolving as
an intervention to minimise the deconditioning experienced during
chemotherapy. Personalisation and patient experience are key factors
to adherence to interventions and its success. Improving experience
through co-design may be the key to designing an optimal service.2
Methods: A single-site service evaluation was undertaken using an
experience-based co-design approach.
Eligible participants:
• Adults with gastrointestinal cancer who received chemotherapy,
along with their carers, if they had seen one more therapists
(dietitian, occupational therapist, physiotherapist, psychological
support) between 01.04.16–31.03.17
• Staff with three months experience working in the service.
Objectives:
1. Explore staff and patient experiences of the current ad-hoc service
and their recommendations for improvement
2. Co-design a prehabilitation intervention to improve the experi-
ence of people starting chemotherapy.
Results: Eleven interviews were filmed and twelve interviews
transcribed. Thematic analysis was undertaken and a film and staff
experience presentation were shared at a joint event.
Experience of ad-hoc service:
Staffs’ specialist knowledge, friendliness and compassion was valued
but they struggled to remember their roles. It was important to have
time and space to ask questions. People wanted seamless care and an
opportunity to interact and share their experiences.
Supporting people to self-manage was a key priority. Staff wanted to
offer holistic care and address service inequalities, particularly access.
Therapists felt their roles were poorly understood.
The work was prioritised together and nutrition, physical activity and
emotional well-being co-design groups were formed.
Co-design recommendations for a new prehabiltation service:
• Ensure people understand its importance
• Use as non-medical environment as possible
• Offer groups for peer support and reciprocal learning
• A personalised plan is needed
• Critical points for support, especially emotionally, are diagnosis
and discharge
• Minimise hospital visits
Conclusions: Experience-based co-design is an innovative framework.
It facilitates the uncovering of experience and design of interventions
thatmeet the needs of peoplewith cancer and staff, thereby improving
quality. This prehabilitation model has been used for business
planning and the novel ideas, e.g. app use, for research for patient
benefit applications.
References
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Rationale: Given the bibliographic controversy regarding the use of
total parenteral nutrition (TPN) in end stage cancer patients, the aim of
the present retrospective study is to review the clinical practice in a
hospital clinic of internal medicine, where these patients were
admitted for supportive care.
Methods: Data concerning patients hospitalized during 2018, with a
diagnoses of end stage cancer, were analyzed anonymously by excel
and spss, and in total accordancewith current legislation derived from
General Data Protection Regulation (GDPR).
Results: 98 adult patients of an average age of 62 years old were
admitted in the hospital clinic for supportive care. The average length
of stay (ALOS) was 31 days, while death was the hospitalization’s
outcome in the majority of cases. 30 patients out of 98 were regularly
administered TPN,12with amalignancy located in the gastrointestinal
tract. 10 of these were already being administered TPN at the time of
their admission. Disconnection of TPN occurred in 3 cases due to
complications. Only 5 out of 30 patients under TPN, survived more
than 2 months.
Conclusions: Data analysis shows that there has not been an
exaggeration concerning TPN’s administration in that group of
patients, even if they were characterized by extremely limited
autonomy and physical activity. Once a decision for TPN administra-
tion has been made, a consequent disconnection is difficult to occur,
unless a severe clinical complication happens. No difference was
observed regarding the type of tumor and the need of TPN use.
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CAN PHASE ANGLE BE CONSIDERED A MARKER OF MUSCLE
STRENGTH IN COLORECTAL CANCER PATIENTS?
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Rationale: Phase angle (PA) is a well-known marker of muscle mass,
but only recently it has been also considered a marker of muscle
quality. Its applicability as a marker of muscle quality in patients with
cancer has not yet been investigated. Therefore, we aimed to
investigate the association between muscle function with measures
of skeletal muscle mass and muscle quality from computed tomog-
raphy (CT) and PA in colorectal cancer patients.
Methods: The skeletal muscle mass and quality were estimated as
skeletal muscle index (SMI) measured by CT at the third lumbar
vertebra and by muscle attenuation (MA), respectively. PA was
obtained from the raw measurements of resistance and reactance
from bioelectrical impedance analysis. Muscle strength was evaluated
as handgrip strength (HGS) using dynamometer. Body mass index
(BMI) and patient-generated subjective global assessment (PG-SGA)
were also assessed. Multiple linear regression models were con-
structed to investigate the association between HGS (log transform-
ation) andmeasures of skeletalmusclemass (SMI),muscle quality (MA
and PA), BMI, age and sex using backwards stepwise regression.
Results: This study included 190 colorectal cancer patients, with a
mean age of 60 ± 11 years, 62% were overweight∕obese and 69% were
well-nourished by the PG-SGA. Sex explained more than half of the
variability of HGS (R2 = 0.51), PA explained 25% (R2 = 0.25), SMI 22%
(R2 = 0.22), MA 17% (R2 = 0.17) and age 5% (R2 = 0.05) (P≤ 0.001).
Multivariate regression analysis revealed that, after adjustment for sex,
only PAwas independently associated with HGS and augments in 12%
the expected value of HGS (R2 = 0.62; P < 0.001).
Conclusions: After adjustment for sex, as a confounder variable, only
PA stayed independently associated with HGS. These results may
suggest that PA could be amarkerofmuscle qualityand strength in this
subset of patients.
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Rationale: Fish-oil, rich in n-3 LC PUFAs may in high doses inhibit the
development or progression of cancer cachexia. However, poor
compliance may limit positive effects and lead to inconsistent
results. We aimed to investigate acceptability and compliance to a
nutritional drink with fish-oil or an equivalent dose of fish-oil
administrated as capsules in patients receiving chemotherapy for GI
tract cancers. In addition, if one type of supplement was superior with
respect to nutritional status and side effects and, if n-3 LC PUFAs affect
leukocyte and platelet counts, markers of dose-limiting toxicities of
chemotherapy.
Methods: We consecutively included 41 patients with advanced
cancer in the controlled study. Patients were advised to take either 10
capsules/day for four weeks. 400 mL/day of a nutritional drink was
used for comparison. Compliancewas assessed by daily self-registered
product consumption and n-3 LC PUFAs in whole blood. Side effects
were assessed using 10 cm visual analogue scales.
Results: Compliance and daily consumption of n− 3 LC PUFAs were
96.4% (94.1–99.3) and 4.8 (4.7–4.9) g/day in the capsule group and 80.8
(55.4–93.6) % and 4.0 (2.8–4.7) g/day in the juice group, respectively
(p≤ 0.02). We found no differences between the groups with respect
to changes in weight, nutritional status, acceptability or side effects.
However, in the capsule group the whole blood n-3 LC PUFAs
correlated negatively with the increase in nausea (rs =−0.39, p = 0.05).
Nausea, reduced appetite and loose stools were of great importance in
deviations from recommended daily doses. Product evaluations
showed that the number of capsules had a negative impact on
acceptability and compliance, whereas this wasmainly related to taste
and consistency in the nutritional drink group. No changes in median
thrombocyte or leukocyte blood counts were observed.
Conclusions: Fish oil in capsules improves compliance compared to a
nutritional drink with an equivalent dose of n-3 LC PUFAs. Capsules,
however, were not superior to the drink with respect to the effect on
nutritional status or side effects. Our data did not suggest any effect of
n-3 LC PUFAs on leukocyte and platelet counts during chemotherapy.
References: Acknowledgements: Smartfish is acknowledged for
supplementing Nutrifriend Cachexia® and Orkla care Denmark for
capsules Möllers Omega 3 Ekstra Sterk®.
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Rationale: Prevalence of malnutrition in hospitalized cancer patients
is high. It is unclear whether in Brazil prevalence of malnutrition and
nutrition impact symptoms is higher in older patients with cancer. In
this study, we aimed to assess prevalence of malnutrition across
different age groups in Brazilian hospitalized patients with cancer, and
to identify associations with nutrition impact symptoms.
Methods: From August to November 2012, 4.783 patients with cancer
aged ≥20 years and admitted to 45 public hospitals in Brazil were
included in this observational, cross-sectional, multicenter study.
The Patient-Generated Subjective Global Assessment was used to
evaluate presence of nutrition impact symptoms and to categorize
patients according to nutritional status: Stage A =Well nourished,
Stage B =Moderate/suspected malnutrition, Stage C = Severely
malnourished.
Results: Of all participants, 26% were ≥65 years. Prevalence of
moderate/suspected malnutrition was 45.3% and severe malnutrition
11.8% %. In participants aged ≥65 years, the prevalence of moderate/
suspected and severe malnutrition was 55% in total, while 36% in
participants aged ≤50 years, and 45% in those aged 51–64 years.
Nutrition impact symptoms more frequently present in participants
aged ≥65 years (compared to those aged ≤50 years) were: no appetite
(OR 1.90, 95% CI: 1.62–2.22, p < 0.05) and dry mouth (OR 1.40, 95%CI:
1.18–1.67 p < 0.05). Nutrition impact symptoms more frequently
present in participants aged 51–64 years were: no appetite (OR 1.45,
95%CI 1.23–1.69 p < 0.05), dry mouth (OR 1.22 95% CI, 1.02–1.45
p < 0.05).
Conclusions: The prevalence of malnutrition and nutrition impact
symptoms is high in older (≥65 years) Brazilian hospitalized cancer
patients. The population aged over 50 years, chances of having at he
nutrition impact symptoms no appetite and dry mouth re higher.
Nutritional screening and assessment should be performed immedi-
ately after hospitalization, in order to enable early diagnosis and
multidisciplinary intervention.
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Rationale: Cancer is a leading cause of death for children, however,
appropriate nutritional status can positively affect the outcome of the
disease. The aim of this study was to determine whether intensified
nutrition support had an effect on the disease progression inpaediatric
patients with solid tumours.
Methods: Data of 148 patients with solid tumour, undergoing
chemotherapy and treated at Semmelweis University 2nd
Department of Paediatrics, was collected and analysed. The character-
istics and treatment scheme of the underlying disease were identical.
Two 3-year periods (2009–2011 and 2012–2014) were compared
regarding several factors, including total time elapsed from diagnosis
to completion of treatment, length of hospital stay, nutritional risk at
diagnosis, number of patients receiving nutrition therapy, length of
nutrition therapy and 2-year survival following the end of treatment.
In 2012 the nutritional team was established and our own screening
tool was used since no specialised tool for childhood cancer had been
available then. BMI, weight-for-height, height-for-age andweight-for-
age were interpreted using the Z-score classification system. For
statistical analysis logistic regression, Fischer test and general linear
model were used.
Results: Detected differences between the two groups (Group 1
without and Group 2 with intensified nutrition therapy): the number
of patients at risk of malnutrition at diagnosis (n = 6 vs. n = 47;
p < 0,005) and the number of nutrition therapy days (22 vs. 54 days)
have increased. Mortality rate decreased (from 58.5% to 23.5%) and the
survival rate improved significantly during the second period (2012–
2014: 54 patients (75%); 2009–2011: 44 patients (60%) survived
(p < 0,005). In addition, due to intensified nutrition support the time
elapsed from diagnosis to the completion of treatment also reduced
remarkably (512 ± 39 days; previously 788 ± 57 days (p < 0,001) in the
first period.
Conclusions: Our data suggests that survival was better in the second
period. The recognized nutritional risk, early nutrition therapy and
regular monitoring seem to have positive effects on patient survival
and the outcome of the disease.
Disclosure of Interest: None declared.
MON-PO390
HOME ENTERAL NUTRITION IN CANCER PATIENTS WITH
JEJUNAL ACCESS.
P. Kabata1*, M. Świerblewski2, J. Jasḱiewicz2. 1Department of
Surgical Oncology, Medical Univeristy of Gdańsk, 2Department of
Surgical Oncology, Medical University of Gdańsk, Gdańsk, Poland
* Corresponding author.
Rationale: Jejunal feeding is a treatment of choice for patients
requiring artificial nutrition, not feasible for gastric or oral route,
which is common in patients with upper gastrointestinal tract cancers
and history of surgical treatment in this region. It is said to be less
tolerated and connected with higher number of complications when
compared to gastrostomy, however literature data are limited and
often conflicting. The aim of this study was to assess the safety and
tolerance of jejunal feeding in cancer patients requiring home enteral
nutrition.
Methods:All consecutive patients qualified for home enteral nutrition
at a single center in Gdańsk, Polandwere later followed up by the same
surgical oncological team until exclusion or death. Follow up visits
were performed every 3 months, or earlier if needed or problems
occurred. Patients’ demographic and nutritional measures were
assessed on initiation of treatment. Body weight and BMI, tolerance
of enteral feeding and compliance, as well as complications’
occurrence were recorded on follow up visits.
Results: A total of 65 patients, 47 men (72.3%), comprising 11480
patient-days of enteral nutrition were included in the study. Most
patients (n = 50, 76.9%) suffered from esophageal and gastric cancer,
with initial body weight loss of 19% and palliative intent in 87,6%. The
mean time of home nutritionwas 177 days (min 8,max 594). Response
to the treatment was good, with 90% tolerance after 3 months and 89%
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compliance, howevermeanweight change at the end of treatmentwas
−2.4 kg. Complications were noted n = 18 times and were mainly
connectedwith the jejunal catheter (72.2%). Side effectswere recorded
n = 16 times.
Conclusions:Observations of our group prove, that jejunal feeding can
be safe and effectiveway of home enteral nutrition for cancer patients,
which stays in conflict with some literature results. Therefore, we see
the need for further multicenter studies on larger groups of patients.
Disclosure of Interest: None declared.
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IDENTIFICATION AND IMPACT OF SARCOPENIA IN OVERWEIGHT
AND OBESE PATIENTS WITH LOCALIZED RENAL CELL CARCINOMA
T. Darbas1, G. Forestier2, S. Léobon1, J. Pestre1, P. Jésus3,4,5*, D. Lachatre2,
A. Descazeaud6, N. Tubiana-Mathieu1, E. Deluche1. 1Department of
Medical Oncology, 2Department of Radiology, 3Nutrition Unit,
University Hospital of Limoges, 4INSERM, U1094, Tropical
Neuroepidemiology, School of Medicine of Limoges, 5UMR_S 1094,
Tropical Neuroepidemiology, Institute of Neuroepidemiology and
Tropical Neurology, CNRS FR 3503 GEIST, University of Limoges,
6Department of Urology, University Hospital of Limoges, Limoges, France
* Corresponding author.
Rationale: Sarcopenia is known in patient with normal weight and
localized renal cell cancer (RCC). It has been shown that sarcopenic
obesity may have a negative prognostic role in the management of
cancer. Weinvestigated sarcopenia at the initial diagnosis only in
patients with excess of body weight.
Methods: Patients with overweight (25 BMI 29.9 kg/m2) or obesity
(BMI ³30 kg/m2)and localized RCC were retrospectively included. The
total skeletal muscle and fat tissue areas were evaluated by CT-scan,
used for disease staging. Patients were assigned to either a sarcopenia
or non-sarcopenia group based on their skeletal muscle index (SMI)
(cut-off 41.0 cm2/m2 in females, 53.0 cm2/m2 in males). Skeletal
Muscle Density (SMD) was also studied. The association of these
parameters andprognosis were analyzed.
Results: Among 100 patients included 46% were obese and 42% were
sarcopenic before any treatment. Median follow-up was 24.9 months.
Patientswith sarcopeniawere inmore oftenmen,with overweight and
were older than the other patients (p < 0.05). SMI had no impact on
morbidity (infections, length of hospital stay), on overall survival (OS)
or progression free survival (PFS). In the overweight group, low SMD
(31Hounsfield Units) had a negative effect onOS (42.6months vs 111.3
months, HR = 4.3, 95% CI [1.01–18.0], p = 0.03).
Conclusions: Sarcopenia exists and is not insignificant in patientswith
excess of body weight and localized-RCC. Low SMD has a negative
impact on the OS of patients who are overweight. Their assessments,
quick and simple, can be done on baseline CT-scan and broader
evaluation of the findings may improve therapeutic care.
Disclosure of Interest: None declared.
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THE CONTRIBUTORY ROLE OF PROTEIN INTAKE ON MAINTAINING
MUSCLE MASS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
R. Tobberup1*, H.H. Rasmussen1, M. Holst1, N.A. Jensen2, U.G. Falkmer2,
A. Carus2. 1Department of Gastroenterology, 2Department of Oncology,
Aalborg University Hospital, Aalborg, Denmark
* Corresponding author.
Rationale:Muscle wasting in cancer patients is prevalent and the role
of protein intake inmusclemaintenance remains unknown. The aim of
the current study was to explore protein intake in relation to muscle
mass during anti-neoplastic treatment in patients with non-small cell
lung cancer (NSCLC).
Methods: A longitudinal observation study was conducted in 52
NSCLC patients during the first three cycles of anti-neoplastic
treatment. Nutrient intake was assessed by a 24-hour recall at the 1st
and 2nd cycle of treatment. Absolute changes in muscle mass were
calculated by routine thoraco-abdominal CT scans (baseline and after 3
cycles of treatment) at landmark lumbar 3rd vertebra (VikingSlice
software). Independent t-tests and chi-square test were conducted to
assess differences in protein intake in muscle maintainers (±5.9 cm2)
and muscle wasters (>6 cm2 loss). Univariate and multivariate linear
regression analyses were performed.
Results: Most patients had stage IV disease and received palliative
anti-neoplastic treatment. Twenty-seven out of 52 patients main-
tained muscle mass and had a significantly higher total protein intake
(1.2 vs. 1.0 g protein/kg body weight/d, p = 0.023) as well as a higher
protein intake per meal (1.1 vs. 0.7 g protein/kg body weight/meal,
p = 0.038) compared to muscle wasters (n = 25). The protein intake
explained 9.2% of the variation in muscle mass which increased to
14.4%when the inflammatory scorewas added in themodel (p < 0.05).
Conclusions: Total protein intake and protein quantity per meal was
higher in muscle maintainers compared to muscle wasters. Muscle
wasting occured frequently and early in the treatment trajectory.
Muscle wasting should be diagnosed and effective interventions need
to be identified.
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CLINICAL EFFECTS OF CURRENT PARENTERAL NUTRITION
TREATMENT IN PATIENTS WITH ADVANCED CANCER, A
SYSTEMATIC REVIEW
R. Tobberup1*, L. Thoresen2, U.G. Falkmer3,M.N. Yilmaz3, T.S. Solheim2, T.
R. Balstad4. 1Department of Gastroenterology, Aalborg University Hospital,
Aalborg, Denmark, 2Cancer Clinic, St. Olavs Hospital, Trondheim, Norway,
3Department of Oncology, Aalborg University Hospital, Aalborg, Denmark,
4Faculty of Medicine and Health Sciences, NTNU – Norwegian University
of Science and Technology, Trondheim, Norway
* Corresponding author.
Rationale: The aim of this reviewwas to evaluate the effects of current
parenteral nutrition (PN) treatment on health-related quality of life
(HRQoL), physical function, nutritional status, survival, tolerance to
antineoplastic treatment and adverse events exclusively in patients
with advanced cancer.
Methods: This review was conducted according to the PRIMSA
guidelines (PROSPERO ID: 4201707915).
Results: Two underpowered randomized controlled trials and six
observational studies were retrieved (n = 894). HRQoL and physical
function improved during anti-neoplastic treatment inpatients unable
to feed enterally (+4 to +24 score in overall QoL and +4 to +17 points in
physical function, EORTC QLQ-C30, p < 0.05); however, in patients able
to feed per os PN was not superior to dietary counselling. Nutritional
status improved in patients regardless of anti-neoplastic treatment
and gastrointestinal function (Δ6.4 kg fat free mass, p < 0.05; +1.5 to
+4.6 kg body weight, p < 0.05). PN treatment was neither superior
to fluid in terminal patients nor to dietary counselling in patients able
to feed enterally in regards to survival. The total incidence of adverse
events was low (3.6–9.0%; 0.33 per 1000 catheter days); however, a
lack of systematic reporting was observed.
Conclusions: Current PN treatment in patients with advanced cancer
is understudied and the evidence of the existing studies is weak.
Further RCTs with sufficient number of patients of clinically homo-
genous subgroups are urgently needed.
Disclosure of Interest: None declared.
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DEVELOPMENT OF A PROTOCOL FOR INSERTION OF NASOGASTRIC
TUBES IN AN OUTPATIENT SETTING FOR PATIENTS UNDERGOING
CHEMO ± RADIOTHERAPY TREATMENT FOR HEAD AND NECK
CANCER IN A TERTIARY CARE CENTRE: A DIETETIC LED CLINIC AND
PROTOCOL
R. Smith1*, C. Wardzynski1, L. Oxley2, S. Duff2. 1Nutrition and Dietetics,
2Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom
* Corresponding author.
Rationale: A protocol was developed for the insertion of naso gastric
tubes (NGTs) in an outpatient setting for patients with head and neck
cancer undergoing radiotherapy, ± chemotherapy. The aim of this
protocol was to reduce hospital admissions, increase patient safety,
prevent malnutrition and as a response to the increasing number of
patients requiring hospital admission for ‘reactively’ placed NGT’s
within this patient group.
Methods: Dietetic input into this patinet group was increased from
0.4 wte to 1.0 wte. If patients required a NGT after dietetic assessment
an outpatient appointment was arranged with a nutrition nurse/
qualified dietitian, for insertion of a NGT.
The dietitian underwent training to insert NGT’s and completed
competencies to be able to insert and train patients on NGTeducation.
The patient was educated on how to use the NGT and necessary
equipment themselves. The patient was providedwith a NGTcare plan
booklet containing trouble shooting advice, pH on placement and
measurement of the NGT at the nose. Position of the tube was
checked using a pH of less than 5. A chest x-raywas not required unless
the pH > 5.
Dietitians provided trouble shooting advice for patients at their
outpatient appointment or over the phone.
Data was collected over a year on the number of patients who had a
NGT inserted as an outpatient, compared with the number of patients
who were admitted to hospital for NGT placement the year before.
Length of hospital stay for patients admitted for NGT’s was taken into
consideration.
Results: This protocol prevented 24 hospital admissions and saved 168
bed days producing a cost saving of £30 912.
There was a 14.8% reduction inweight loss from a mean 8.1 kg–6.9 kg.
The number of x-rays required to check the placement of the NGTwere
significantly reduced.
Conclusions: A dietetic led protocol provides a safe and effective way
to insert NGT’s in an outpatient setting, prevents hospital admissions
and provides a cost saving to the NHS. There are plans to expand this to
other service users.
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NUTRITIONAL CHANGES IN BORDERLINE RESECTABLE PANCREATIC
CANCER PATIENTS ALONG THE ONCOLOGICAL TREATMENT
R. González-Tampán1*, M. Alonso2, L. Arribas3, L. Hurtós3, R. López-
Urdialez4, C. Sánchez5, B. Laquente5, E. Buxó5, L. Secanella6, D. Leiva7,
I. Peiró3. 1Bellvitge Biomedical Research Institute (IDIBELL), 2Oncology
Data Analytics Program, 3Clinical Nutrition Unit, Catalan Institute of
Oncology (ICO), 4Endocrinology and Nutrition Deparment, Bellvitge
Hospital (HUB), 5Medical Oncology Department, Catalan Institute of
Oncology (ICO), 6Surgery Department, 7Radiology Department, Bellvitge
Hospital (HUB), Hospitalet de Llobregat, Spain
* Corresponding author.
Rationale: Pancreatic ductal adenocarcinoma (PDAC) is a major cause
of death, with a high rate of malnutrition at diagnosis. Neoadjuvant
treatment (NAT) in borderline resectable (BR) PDAC is used to improve
resectability and outcomes, but just few patients could benefit due to
toxicity or disease progression. The aim of our study is to assess
pretreatment nutritional status and the changes that occur during NAT
for BR PDAC.
Methods: From 2010 to 2018 all consecutive BR PDAC patients
from our institution were included. All patients had an active
nutritional support along the NAT. Demographic, oncological, surgical
and nutritional parameters (body mass index (BMI), % weight (wt),
serum albumin level, exocrine pancreatic insufficiency (EPI), nutri-
tional assessment (PG-SGA) and nutritional intervention) were
recorded at baseline and during the treatment.
Results: 81 BR PDAC patients (pts). Baseline data: mean age: 67 y (42–
84), 64% men. Mean BMI: 24.8 kg/m2. EPI: 42% of pts. 93% pts had
moderate or severe malnutrition (B or C), 52% of them with ≥10% wt
loss for the last 6 m. Serum albumin was at normal ranges in all
patients.71% pts required oral nutrition supplementation. During NAT,
79% of pts needed to reduce dose of NAT due to toxicity. 46% of pts had
their weight stabilized and 12% of them improved their nutritional
status along de treatment. After NAT, surgery was performed in 44% of
pts. Patients with weight loss and with severe malnutrition (C) during
NAT were less operated (p = 0.05 and p = 0.044, respectively). Those
patients without wt loss and/or with ‘A’ nutritional status after NAT
had better overall survival (OR 3.03 p = 0.036) and progression free
survival (OR 3.17 p = 0.0006).
Conclusions: A high prevalence of malnutrition and exocrine
pancreatic insufficiency was observe at baseline and along the
treatment in borderline resectable pancreatic ductal adenocarcinoma
patients. Persistence of severe malnutrition and weight loss during
neoadjuvant treatment despite nutritional intervention has a negative
impact on clinical outcomes.
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BODY WEIGHT CHANGES AND HEPATOBILIARY EFFECTS
ASSOCIATED WITH PARENTERAL NUTRITION IN PATIENTS WITH
ACUTE MYELOID LEUKEMIA DURING REMISSION INDUCTION
TREATMENT
R. van Lieshout1*, L.W. Tick2, J. Dieleman3, S. Custers4, D. van der Lee1,
M.S. van Dongen5, A.R. Schaaphok6, M. Snellen6, H.C. Schouten7,
S. Beijer6. 1Department of Dietetics and Nutrition, 2Department of
Internal Medicine, 3Department of Research, Maxima Medical Center,
Veldhoven, 4Department of Dietetics and Nutrition, Maastricht University
Medical Center, Maastricht, 5Department of Dietetics and Nutrition,
Catharina Hospital, Eindhoven, 6Department of Research, Netherlands
Comprehensive Cancer Organisation, Utrecht, 7Department of Internal
Medicine, Maastricht University Medical Center, Maastricht, Netherlands
* Corresponding author.
Rationale: Malnutrition is an independent risk factor for adverse
outcomes in patients with acute myeloid leukemia (AML) and
parenteral nutrition (PN) is often used to prevent deterioration of
nutritional status. This study investigated the influence of PN versus no
or minimal intervention with PN on body weight changes and serum
liver test levels in AML patients during intensive remission induction
(RI) chemotherapy.
Methods: AML patients who underwent at least one RI chemotherapy
cycle in one of three Dutch hospitals between 2004 and 2015 were
included. Data on age, sex, chemotherapy regimen, dietary interven-
tions, complications, and length of hospital stay were retrieved from
medical records and from the Netherlands Cancer Registry. Body
weight and serum concentrations of total bilirubin (TBILI) and liver
enzymes (ALAT, ASAT, AP and GGT), expressed as ‘times upper limit of
normal’ (xULN), were registered weekly between start of RI cycles and
discharge. Body weight changes (%) were compared between patients
treated in one of two hospitals where PN is frequently administered
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(PN hospitals) and patients treated in the hospital where PN is only
used in exceptional cases (no-PN hospital) using a repeated-measures
mixed model analysis. Differences in severity of serum liver test
elevations, according to the CommonTerminology Criteria for Adverse
Events (CTCAE) version 4.0, were assessed in patients who received PN
(PN group) versus those who did not receive PN (no-PN group) using
logistic regression analysis.
Results: In total 213 AML patients (no-PN hospital n = 111; PN
hospitals n = 102), 46% female, with a mean (± SD) age of 57.4 ± 13.2
years were included. Patients of the no-PN hospital experienced more
bodyweight loss during RI treatment than patients of the PN hospitals
(between-group difference 7.7%, 95% CI: 4.1–11.2%). Among patients
who received only one RI cycle (n = 85), severe body weight loss of
>10% occurred in 7% of patients of the PN hospitals versus 39% of
patients of the no-PNhospital (P = 0.006). For patients receiving two RI
cycles (n = 128) this was 17% versus 70%, respectively (P < 0.0001).
Explorative analysis among the total study population with multivari-
ate linear regression models showed body weight loss to be
significantly associated with longer duration of hospitalization.
Median serum concentrations of TBILI remained below the ULN in
both the PN- and no-PN group. However, PN was associated with
transient mild elevations of serumALAT-, ASAT- and AP levels (median
values ≤2.0 × ULN), with moderately elevated GGT levels (median
values ≤4.0 × ULN), and with higher odds for CTCAE-grade 3–4 GGT
levels during the first RI cycle (OR: 3.4, 95% CI: 1.3–8.5).
Conclusions: Compared to no or minimal intervention with PN, the
nutrition support strategy, including frequent administration of PN,
better preserved body weight in AML patients during intensive RI
chemotherapy without severe adverse hepatobiliary effects of PN.
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MON-PO397
PARENTERAL NUTRITION THERAPY IN PATIENTS WITH INCURABLE
CANCER: A RETROSPECTIVE MEDICAL CHART REVIEW OF CURRENT
PRACTICE
R.F. Sande1,2*, L. Thoresen1, E.T. Løhre1,2, A.S. Nygard2,3, Ø. Paulsen4,
I. Ottestad5, T.S. Solheim1,2, T.R. Balstad1,2. 1Cancer Clinic, St. Olavs
Hospital, Trondheim University Hospital, 2Department of Clinical and
Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU –
Norwegian University of Science and Technology, Trondheim,
3Department of Oncology, Vestfold Hospital, Tønsberg, 4Palliative Care
Unit, Department of Medicine, Telemark Hospital Trust, Skien,
5Department of Nutrition, Institute for Basic Medical Sciences,
University of Oslo, Oslo, Norway
* Corresponding author.
Rationale: Indication for use, dose and duration of parenteral nutrition
(PN) in patients with incurable cancer is understudied. The aim of the
study was to describe current practice of PN treatment in adult
patients with incurable cancer at St. Olavs University Hospital,
Trondheim, Norway.
Methods: A retrospective medical chart review of patients with
incurable cancer receiving PN between 2011 and 2017 was conducted.
Of 271 identified patients, data from the first 78 patients was included
in this preliminary analysis. Medical information was collected from
start of PN until patients’ death.
Results: The mean (SD) age was 63.5 (12.9) years, 41 women and 37
men. All patients received PN concomitant with anti-cancer treatment
at some point in time. The most common indications for PN were
‘insufficient oral or enteral intake’ (n = 67) or ‘gastrointestinal
malfunction’ (n = 17). At start of PN, there were no differences
between subgroups in s-albumin, C-reactive protein level, metastatic
disease, or ascites. The main reason for discontinuation of PN was
imminently dying patient (n = 36), patient preferences (n = 19), and
complications (n = 12).
The table presents available data on PN treatment and survival in
subgroups defined by duration of PN treatment. Data presented as
number (n) or median (Q1–Q3).
Conclusions: To our knowledge, this is the first study describing
clinical practice with respect to dose, duration and termination of PN
in incurable cancer patients. Preliminary data suggest that the use of
PN was dynamic and differentiated. Termination of PN was based on
expected patient survival, patient preferences, and treatment
complications.
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EXAMINATION OF IMMUNE-NUTRITIONAL INDEX BEFORE AND
AFTER SURGERY AND PROGNOSIS FOR COLON CANCER PATIENTS:
POSSIBILITY TO NUTRITIONAL PRECISION MEDICINE
S. Furuya1*, N. Ashizawa1, Y. Nakata1, H. Shimizu1, H. Akaike1,
N. Hosomura1, Y. Kawaguchi1, H. Amemiya1, M. Sudo1, H. Kawaida1,
S. Inoue1, H. Kono1, D. Ichikawa1. 1First Department of Surgery, Faculty of
Medicine, University of Yamanashi, Chuo, Japan
* Corresponding author.
Rationale: National Comprehensive Cancer Network (NCCN) guide-
line for colon cancer indicated that adjuvant chemotherapy is not
recommended for Stage II and is recommended for Stage III for half an
year. In other words, it is possible that chemotherapy is not available
for Stage II patients who require it and chemotherapy is performed for
Stage III patients who don’t require it. In addition, it has been reported
that neutrophil lymphocyte ratio (NLR) are useful as prognostic factors
in various cancer types including colon cancer. We examined the
relationship between immune-nutritional indexes before and after
surgery and the outcome of colon cancer patients in our hospital.
Methods: We retrospectively analyzed 119 patients of Stage II and III
colon cancer who underwent curative surgery in our institution
Table (abstract: MON-PO397).
Variables <2 weeks 2 weeks -1
month
1 month - 2
months
>2 months P1 n
Patients (n) 14 20 16 16 66
PN treatment Highest received PN dose, kcal 1100
(612–1600)#,¤
1600
(1100–2200)#
1600
(1100–1600)
1750
(1450–2200)¤
0.001 62
Received dose (percentage of
estimated energy need)
73
(43–73)
78
(62–101)
69
(50–94)
97
(73–118)
0.03 52
Documented oral food intake, n 9 16 15 15 0.09 55
Survival From start of PN, days 19
(13–74)&
39
(26–384)
61
(43–115)
168
(88–295)&
0.001 66
From PN termination, days 10
(4–70)
16
(5–358)§
4.5
(1–70)
2
(1–7)§
0.016 66
1Kruskal-Wallis test, Dunn’s Post Hoc test; # P = 0.04, ¤ p = 0.003, & P = 0.001, § P = 0.02; n indicates number.
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between 2007 and 2013 (II:68, III:51). NLR and PLR were calculated
from the numbers of neutrophils and lymphocytes of peripheral blood
before surgery and in the postoperative stable period. As the Cut-off
value, a value calculated using ROC curve (NLR: 2.0) and values based
on literature (NLR: 4.0) were used. ΔNLR as the change rate
(preoperative NLR value/postoperative NLR value) was calculated.
And Then, we analyzed statistically the relationship these immune-
nutritional indexes, overall survival (OS) as prognosis, and clinico-
pathological findings.
Results: The median of preoperative NLR was 2.706 (2.068–3.810).
Assuming the cut-off value of NLR was 4.0, 92 cases in the low NLR
group and 27 cases in the high NLR group were obtained (no
differences in clinicopathological background), and the 5-year OS
showed significant difference in survival rate at 85.0/64.7% in the low
preoperative NLR/high preoperative NLR group respectively (p =
0.0004). The median value of ΔNLR was 1.306 (1.040–1851), and 90
patients (76.9%) had lower postoperative NLR than before surgery.
Assuming the cut-off value of NLR was 1.287 calculated from the ROC
curve, 56 cases in the low ΔNLR group and 61 cases in the high ΔNLR
group, and the 5-year OS showed a significant difference in survival
rate at 74.6/87.5% (p = 0.0374). In univariate analysis, gender, T factor,
preoperativeNLR, andΔNLR showed dominant differences betweenOS
and clinicopathological factors (P < 0.05). In multivariate analysis,
preoperative NLR and T factor became independent factors. Moreover,
low ΔNLR patients showed poor survival in high preoperative NLR
group.
Conclusions: It is suggested the higher the rate of decrease in NLR, the
better the prognosis in malnutrition patient. And it may be useful for
Nutritional precise medicine.
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NUTRITIONAL CARE PATHWAYS OF PATIENTS WITH MALIGNANT
BOWEL OBSTRUCTION: PRELIMINARY FINDINGS FROM 8 UK
CENTRES
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C. Swfit7, A. Forbes8, S. Mehta1, F. Rahman1, S. Di Caro1*. 1Intestinal
Failure Team, University College LondonHospital, London, 2Department of
Gastroenterology, Newcastle upon Tyne Hospitals, Newcastle, 3Intestinal
Failure Unit, St Mark’s and Northwick Park Hospital, 4Department of
Gastroenterology, St George’s University Hospitals, London, 5Translational
Gastroenterology Unit, Oxford University Hospitals, Oxford, 6Department
of Gastroenterology, St Bart’s Hospital, London, 7Intestinal Failure and
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* Corresponding author.
Rationale: Variations in access to parenteral nutrition (PN) in
advanced cancer patients with malignant bowel obstruction (MBO)
and intestinal failure exist due to differing practice, beliefs and
resource access. We aimed to examine nutritional care pathways of
MBO patients at 8 UK Tertiary-Referral Centres.
Methods: A retrospective cohort study of MBO adults admitted to
hospitals between 1.1.16–31.12.16 and any readmissions up to 31.12.17.
Demographic, nutritional and medical data were analysed by
comparing patients referred (R) or not referred (NR) for PN.
Differences between groups tested by Kruskal-Wallis and Chi-
Squared tests and survival by KaplanMeier Curves and Cox regression.
Results: 197 patients with 371 MBO admissions (median 66 yr,
(range32–97 yrs, 30% male), with 2 admissions/patient (1–8) were
identified. 56/197 patients were referred (R group). Gynaecological
and gastrointestinal cancers predominated (72%). 79% of patients had
metastases. 66% of admissions presented with subacute BO, 60% with
single-, 35% with multi-level BO in either complete (45%) or partial BO
(55%).
Admission malnutrition screening, MDT PN discussion and dietetic
contact were more likely to occur in the R group-103/371 admissions
(R vs. NR group: 96% vs. 84%, P < 0.01; 54% vs. 1%, P < 0.0001; 27% vs
17%, P < 0.0001). Median admission weight loss was 5.9% (-45% to
26.2%). Nodifferencewas observed inweight or BMI at start of PN (R vs.
NR: 56 vs. 58 kg, BMI 21.2 vs. 21.7 kg/m2) or weight at follow-up (0–3
months) (R vs. NR 54 vs. 57 kg). 44/103 R group admissions received
inpatient PN only, with 47 patients discharged or already established
on HPN.
Survival was 158 days (131–271) with no difference between PN
groups.
Conclusions: Nutritional screening and knowledge of potential
palliative HPN appear to significantly influence referral and outcomes,
but further comparison of disease severity and other prognostic
markers between groups would be required to determine this.
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A. Johnson2, M. Naghibi3, D. Chan3, B. Roberts3, P. Neild4, M.D. Yalcin4,
P. Allan5, M. Fitzpatrick5, M. Gomez5, S. Williams6, K. Kok6, L. Sharkey7,
C. Swfit7, A. Forbes8, S. Mehta1, F. Rahman1, S. Di Caro1*. 1Intestinal
Failure Team, University College LondonHospital, London, 2Department of
Gastroenterology, Newcastle upon Tyne Hospitals, Newcastle, 3Intestinal
Failure Unit, St Mark’s and Northwick park hospital, 4Department of
Gastroenterology, St George’s University Hospitals, London, 5Translational
Gastroenterology Unit, Oxford University Hospitals, Oxford, 6Department
of Gastroenterology, St Bart’s Hospital, London, 7Intestinal Failure and
Transplant Unit, Addenbrookes’ hospital, Cambridge, 8Department of
Gastroenterology, Norfolk & Norwich University Hospital, Nowrwich,
United Kingdom
* Corresponding author.
Rationale: There is variation in access to parenteral nutrition (PN) in
patients with malignant bowel obstruction (MBO) and intestinal
failure.We aimed to examine outcomes of patients withMBO, across 8
UK tertiary centres, who were not referred to the nutrition team that
may have required PN.
Methods: A retrospective cohort study of adults with MBO, admitted
to hospitals between 1.1.16–31.12.16 and any readmissions up to
31.12.17. Demographic, nutritional and medical data were analysed by
comparing patients who were not referred to the nutrition team
(n = 141) andwhowe speculate may have required PN (RPN) (based on
patients initial admission presenting with complete BO that was not
resolved on discharge from hospital) versus those discharged on HPN.
Differences between groups tested by Kruskal-Wallis and Chi-Squared
tests and survival by Kaplan Meier Curves and Cox regression.
Results: 141/197 patients were not referred to nutrition team (median
age: 67 yrs, range: 32–97, 72% female). Gynaecological and
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gastrointestinal cancers predominated (78%) and 82% presenting with
metastases, mostly subdiaphragmatically.
RPN (n = 18/141) vs HPN (n = 47) group were more likely to be
conservatively managed (100 vs 66%, P < 0.01), higher BMI (24.8 vs
21.7 kg/m2, P = 0.01 butwith higherweight loss (−20 vs.−6%, P = 0.02),
shorter median survival (34 vs 317 days, P < 0.0001), higher CRP (105
vs 26 mg/L, P = 0.01) and less likely to have dietetic input (33 vs 89%,
P < 0.0001), length of stay (8 vs 26 days, P = 0.003), and no. of
readmissions (1 vs 3, P < 0.01).
Conclusions:Within the limitations of the study, our findings suggest
that some patients may be missed for the initiation of PN. The HPN
group had a longer survival and lower weight loss (which is a function
of QoL), though it is associated with longer stay in hospital and
readmissions.
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NUTRITIONAL CARE PATHWAYS OF PATIENTS WITH MALIGNANT
BOWEL OBSTRUCTION: EXPERIENCE FROM A UK TERTIARY-
REFERRAL CENTRE
P.S. Patel1, K. Fragkos2, N. Keane1, K. Cauldwell3, F. O’Hanlon2, J. Rogers2,
S. Obbard2, J. Barragry2, G. Sebepos-Rogers2, S. Mehta2, F. Rahman2,
S. Di Caro2*. 1Department of Nutrition and Dietetics, 2Intestinal Failure
Unit, University College London Hospital, 3Palliative Care, Central and
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* Corresponding author.
Rationale: Emerging evidence is gathering for the use of parenteral
nutrition (PN) in patients with malignant bowel obstruction (MBO)
who have lost nutritional autonomy and developed Intestinal Failure
(IF). However, there is limited evidence describing the outcomes for
MBO patients who are not referred for PN. We aimed to examine
nutritional care pathways of MBO patients by referral for PN and
appropriateness of referral/non-referral for PN.
Methods: Retrospective cohort study of adults (≥18 yrs) admitted to
University College London Hospital, admitted with MBO between
1.1.16–31.12.16 with any readmissions up to 31.12.17. Data were
analysed by comparing patients who were referred (R) and not
referred (NR) for PN.
Results: We identified 72 patients with 117 MBO admissions (mean
±SD age: 63.1 ± 13.1 yrs, 79% female), with median no. of admissions/
patient as 1 (range: 1–6). 24/72 patients were in R group. Predominant
primary malignancies were gynaecological and gastrointestinal
cancers (76%). 83% of MBO patients had metastases and 61% were
located subdiaphragmatically. All patients were at high risk of
malnutrition using UCLH nutrition screening tool (score of 8, a score
of ≥7 indicates high risk of malnutrition) and mean weight loss on
admission was 7%. Discussion of PN at MDT (21% vs. 4%, P = 0.02) and
dietetic contact (94% vs 41%, P < 0.0001) were more likely to occur in
the R group. In 13/69 MBO admissions in NR group, the reasons for
non-referral to the Nutrition team are unclear. Conservative manage-
ment of cancer was more likely to occur in NR group (94% vs. 77%).
Chemotherapy and surgery for BO were more likely to occur in the R
group. There was no significant difference in modified Glasgow
Prognostic Score in the 2 groups. 20/24 referred patients received
inpatient PN (4 did not start: 1 declined, 3 were advised to optimise
enteral nutrition following assessment), and 10 patients went home
with PN. The remaining patients did not go home on PN as BO resolved
or they were approaching the end of life. There were no differences in
weight or BMI by PN referral groups. In all patients, medianweight on
admission was 55 kg (range: 38–100 kg), and 55–55.8 kg at 0-3- and
3-6- months follow-up. Overall survival was 4.7 (1.4–15.2) months,
with no differences by referral groups
Conclusions: All patients with MBO presented with high risk of
malnutrition on admission. Less than half were referred to the
Nutrition team. Interestingly, patients who received a dietetic review
andwhen PNwas discussed atMDTweremore likely to be referred for
PN. It was unclear in some caseswhy patientswere not referred for PN.
Timing of referral and integration of nutritional care, not only PN, into
clinical management discussion at MDT is crucial. Not all patients
referred to the Nutrition team were discharged on HPN based on
judicious review of each case.
Disclosure of Interest: P. Patel Grant/Research Support from: Pinal
Patel’s Research Post is funded by Calea, Fresenius Kabi., K. Fragkos:
None declared, N. Keane: None declared, K. Cauldwell: None declared,
F. O’Hanlon: None declared, J. Rogers: None declared, S. Obbard: None
declared, J. Barragry: None declared, G. Sebepos-Rogers: None
declared, S. Mehta: None declared, F. Rahman: None declared, S. Di
Caro: None declared.
MON-PO402
SYSTEMIC ANTI-CANCER THERAPIES IMPAIR THE NUTRITIONAL
STATUS OF NEUROENDOCRINE TUMOR PATIENTS – A PILOT STUDY
S. Pevny1*, S. Maasberg2, M. Karber3,4, B. Knappe-Drzikova1,
K.-H. Weylandt3, H. Jann1, M.E. Pavel5, B. Wiedenmann1, U.-F. Pape1,2.
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Universitätsmedizin Berlin, Berlin, 2Department of Internal Medicine
and Gastroenterology, Asklepios Klinik St. Georg, Hamburg, 3Medical
Department, Division of Gastroenterology, Oncology, Hematology,
Rheumatology and Diabetes, Ruppiner Kliniken, Neuruppin, 4Berlin
Institute of Health, Berlin, 5Department of Medicine 1, Division of
Endocrinology, Universitätsklinikum Erlangen, Erlangen, Germany
* Corresponding author.
Rationale: Neuroendocrine tumors (NETs) are rare tumors and
treatment plans comprise various treatment options. In NET-patients,
malnutrition is a clinically relevant problem independently influen-
cing overall survival, particularly in patients undergoing chemother-
apy (CTx).1 So far, therapy-related influence on comprehensive
nutritional status has not been studied prospectively.
Methods: Comprehensive nutritional assessment was performed,
including Subjective Global Assessment (SGA), anthropometry para-
meters, indirect calorimetry, bioelectrical impedance analysis and
food diary before and during therapy.
Results: Twenty-six NET patients were analyzed (CTx n = 6, targeted
therapies (tTx) n = 7, biotherapeutics n = 13). At baseline, 9/24 patients
were hypermetabolic and according to SGA, 9/25 patients were
moderately or severely malnourished (SGA-B: 6, SGA-C: 3), although
BMI was within or above the normal range in almost all patients
(BMI≥18.5: n = 25 pts, BMI<18.5: n = 1). Survival analysis showed
reduced survival in those graded SGA B+C at baseline (n = 25;
p = 0.003). After 38 ± 7 weeks of treatment (n = 14), bodyweight and
BMI were significantly reduced (−3 kg, p = 0.021 and− 1 kg/m2,
p = 0.028; resp.), appetitewas decreased (p = 0.035) and SGAworsened
in 5 patients. Subgroup analysis of patients on tTx (i.e. everolimus,
n = 5) showed a significant increase in energy expenditure (REE)
per metabolically active body cell mass (60.3 vs. 68.6 kcal/kg
BCM; p = 0.022), a trend towards body weight reduction (−5,7 kg,
n = 5, p = 0.068) despite at least constant oral intake (2818 vs.
3017 kcal; p = 0.336) and 2 of 5 patients became hypermetabolic.
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Conclusions: Anti-cancer therapies bear the risk of worsening
nutritional status (i.e. by increasing REE) in NET G1/G2 patients who
are already prone to malnutrition. Close nutritional monitoring –
beyond BMI examination – is advised.
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PREVALENCE OF SARCOPENIA IN OLD PATIENTS WITH A GASTRO-
INTESTINAL CANCER TREATED WITH ADJUVANT CHEMOTHERAPY
S. De Breucker1, S. Szklarzewska2*, J.-L. Van Laethem3. 1Geriatrics,
Hôpitalerasme, Brussels, 2Geriatrics, Hôpital Erasme, Brussels, 3Gastro-
Oncology, Hôpital Erasme, Brussels, Belgium
* Corresponding author.
Rationale: Loss of muscle mass is associated with poor survival and
loss of autonomy in gastro-intestinal cancers and might be influenced
by age, cancer treatment, nutritional status and presence of cachexia.
We aimed to assess the evolution of sarcopenia according to EWGSOP
criteria 2010 and 2018 in old patients with a gastro-intestinal cancer
treated with adjuvant chemotherapy.
Methods: 50 patients aged 65+with treatment-naïve gastro-intestinal
cancers were included. Muscle mass was assessed by L3-centered CT
scan, muscle strength by handgrip dynamometer and physical
performance by a 4-meter walking test. Sarcopenia was defined
according to EWGSOP criteria 2010 and 2018, frailty status according to
Fried criteria, nutritional status according to MNA-sf and cachexia
stages according to Vigano criteria. We analyzed data at baseline, and
after 6 months and 12 months. We also analyzed 1 year-mortality rate
and baseline factors associated with mortality.
Results: At 0, 6 and 12months, the prevalence of sarcopenia according
to EWGSOP-2010 was respectively 28%, 36% and 39%, and according to
EWGSOP-2018was 8%,19% and 32%.1 year-mortality ratewas 15(29%).
The only factor associated with mortality in multiple regression was
cachexia (OR 2.84 (CI95% 1.30–6.18 – p = 0.009). Age, cancer stage,
sarcopenia, frailty status, and nutritional status were not associated
with mortality in multiple regression.
Conclusions: The prevalence of sarcopenia in old digestive cancer
patients treated with adjuvant chemotherapy rises with time accord-
ing to both EWGSOP definitions. Cachexia is the only prognostic factor
of mortality. Further studies are needed to assess if adequate physical
activity and nutritional counseling before initiation of treatment could
improve outcomes of these patients.
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L-GLUTAMINE DOES NOT INFLUENCE THE SURVIVAL OUTCOMES IN
PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK CANCER
RECEIVING CHEMORADIOTHERAPY
T. Tsujimoto1,2*, M. Wasa3, H. Inohara4, T. Ito2. 1Department of Clinical
Pharmacy, Faculty of Pharmaceutical Sciences, Kobe Gakuin University,
Kobe, 2Department of Integrative Medicine, 3Department of Pediaric
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* Corresponding author.
Rationale: We have reported that L-glutamine decreases the severity
of chemoradiotherapy (CRT)-induced mucositis in patients with head
and neck cancer (HNC) in a double-blind, randomized, and placebo-
controlled study. However, whether glutamine promotes tumor
growth and interferes with anticancer effect of CRT remains
controversial. The present study aimed to investigate whether
L-glutamine negatively impacted survival outcomes in these patients.
Methods: Forty patients with squamous cell carcinoma of the
nasopharynx, oropharynx, hypopharynx, or larynx were enrolled in
the study. All patients received 66 or 70 Gy of total radiation at the rate
of 2 Gy per fraction daily and five fractions per week. Cisplatin
(20 mg/m2) and docetaxel (10 mg/m2) were intravenously co-admi-
nistered once a week for 6 weeks. Patients were randomized to orally
receive either glutamine (group G, n = 20) or placebo (group P, n = 20)
at a dose of 10 g three times a day throughout the CRT course, and the
severity of mucositis were compared between the 2 groups. After 10
weeks of treatment, tumor response was evaluated using PET-CT and
histopathological examination of biopsy specimens. We compared the
overall survival (OS) and the progression free survival (PFS) between
the two groups. The follow-up time was 5 years. QOL was evaluated
using the EuropeanOrganization for Research and Treatment of Cancer
Qualityof Life Questionnaire (EORTCQLQ-C30 ver3.0) andQOLModule
for Head and Neck Cancer (EORTC QLQ-H&N35 ver.3.0) for Japanese
patients.
Results: After 10 weeks of CRT completion, the tumor responses in
group Gwere as follows: complete response (CR) 65%, partial response
(PR) 25%, stable disease (SD) 10%, and progressive disease (PD) 0%.
Those in group P were as follows: CR 60%, PR 25%, SD 0%, PD 10%, and
unknown 5%. No significant difference in the response rate after 10
weeks of CRT completionwas observed between the groups (group G:
90%, group P: 85%; p = 0.390). Thirty patients (75%) were survived at
the 5-year follow-up (16 in group G vs. 14 in group P). There was no
significant difference in survival time between the groups (group G:
46.0 ± 2.3 months, group P: 31.8 ± 2.5 months; p = 0.434). Twenty-
seven patients were free of disease progression (14 in group G vs. 13 in
group P). There was no significant difference in progression free
survival time between the groups (group G: 49.8 ± 4.4 months, group
P: 14.3 ± 1.1 months; p = 0.620). There were no significant differences
in those QOL scores between group G and group P.
Conclusions: L-glutamine did not influence the survival outcomes in
patients with locally advanced head and neck cancer receiving CRT.
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PROLONGING FACTORS OF THE DURATION OF PARENTERAL
NUTRITION IN PATIENTS TREATED WITH HEMATOPOIETIC STEM
CELL TRANSPLANTATION
T. Kamiya1*, D. Hira2, N. Hoshino1, M. Kurihara3, M. Nakagawa3,
M. Sasaki3, T. Terada1. 1Department of Pharmacy, Shiga University of
Medical Science Hospital, 2College of Pharmaceutical Sciences,
Ritsumeikan University, 3Division of Clinical Nutrition, Shiga University
of Medical Science Hospital, Shiga, Japan
* Corresponding author.
Rationale: Nutritional management is strongly required to improve
the survival and QOL of the hematopoietic stem cell transplantation
(HSCT) patients. Although several guidelines indicate the strategy of
nutritional management of HSCT patients, we often encounter
complicated cases of nutrition management in clinical settings. In
this study, we investigated the relationship between patient factors
and the duration of both total parenteral nutrition (TPN) and
parenteral nutrition (PN).
Methods: Sixty-one patients who underwent HSCT in the Department
of Hematology in Shiga University of Medical Science Hospital
between April 2010 and December 2014 were enrolled. The
S208 Abstracts / Clinical Nutrition 38 (2019) S59–S296
relationship between patient factors and the duration of TPN and PN
were retrospectively analyzed based on the medical records. Multiple
linear regression analyses were performed to identify confounding
factors for the duration of TPN and PN.
Results: Forty-nine and 53 patients were received TPN and PN. The
mean duration of in-hospital TPN and PN was 20.1 ± 22.2 and
26.1 ± 23.2 days, respectively. Administration route was replaced
from oral intake to PN with decreasing oral intake. As protein intake
derived frommealwas insufficient, amino acid intakewas significantly
increased from injections. In multivariate analysis, body mass
index (BMI) was significantly correlated with the duration of TPN
(β = –2.733; p < 0.05) and PN (β = –2.260; p < 0.05). In addition, use of
the myeloablative conditioning regimen, including busulfan and
cyclophosphamide significantly prolonged the duration of PN,
compared with the reduced-intensity conditioning regimen
(β = 12.726; p < 0.05), generally including melphalan.
Conclusions: BMI at admission and the type of conditioning regimen
may affect the duration of TPN and PN.
Disclosure of Interest: None declared.
MON-PO406
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CHEMOTHERAPY-INDUCED ORAL MUCOSITIS AND DERMATITIS
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1Department of Oral and Maxillofacial Surgery, Yamaguchi University
Graduate School of Medicine, Ube, Japan
* Corresponding author.
Rationale: Elental®, an elemental diet (ED) with L-Glutamine has
been used in Japan as a treatment for malnourished patient. In
addition, Elental® has been reported to be useful in the management
of chemotherapy-induced mucositis in various cancer patients.
Recently, we have also reported that Elental® effectively reduced
chemotherapy-induced oral mucositis and dermatitis in oral squa-
mous cell carcinoma (OSCC) patients. However, it is still unclear
whether or not oral intake of ED can act directly on chemotherapy-
induced oral mucositis and/or dermatitis. In the present study, we
investigated the direct effect of ED on chemotherapy-induced oral
mucositis in OSCC patients.
Methods:We evaluated the direct effect of ED on the healing process
of 5-fluorouracil (5-FU)-induced dermatitis in nude mice by compar-
ing topical application and oral administration by a gastric tube.
Moreover, we examined the effect of ED on the proliferating ability,
wound healing ability and migration ability by MTT assay, wound
healing assay and migration assay respectively with immortalized
human keratinocyte cell line; HaCaT after 5-FU pre-treatment.
Results: Oral administration with a gastric tube as well as topical
application of ED reduced dermatitis more effectively than dextrin
administration of the same caloric value in the animal model. MTT
assay revealed the growth-promoting effect of ED on HaCaTafter 5-FU
pre-treatment. In addition, ED could enhance the wound healing
ability and migration ability of HaCaT as observed by wound healing
assay and migration assay respectively.
Conclusions: These findings suggest that topical application of ED is
effective in the treatment of dermatitis, and oral intake of EDmight act
directly on chemotherapy-induced oral mucositis in patients with
OSCC.
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RELATIONSHIP BETWEEN NUTRITIONAL STATUS AND HANDGRIP
STRENGHT IN THE ONCOLOGICAL PATIENT
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DESCOBERTAS (JMS), Lisboa, Portugal
* Corresponding author.
Rationale:Muscle protein depletion is a hallmark of cancer cachexia,
severely impinging quality of life and physical function and treatment
tolerance. The assessment of malnutrition is crucial for early
nutritional interventions in these cases. The handgrip strength is a
clinical method for assessing the muscle function and is indicated as a
fiability the nutritional status. A cross-sectional study was conducted
to evaluate the patient’s nutritional status through the application of
Patient-Generated Subjective Global Assessment PG-SGA©, with a
handgrip strength.
Methods: The nutritional status of 30 patients with cancer diagnosed
were assessed, using a Patient-Generated Subjective Global
Assessment (PG-SGA©) and handgrip strength, with 3 maximal
contractions of the left and right hands. The statistic relationship
between PG-SGA© and handgrip strength, was performed using SPSS
(Statistical Package for the Social Sciences)with Spearman Correlation.
Results: According to PG-SGA©, 16,7% (n = 5) of the patients were
moderately undernourished, and 10% (n = 3) were severely under-
nourished. A significant association between nutritional status
according to PG-SGA© and handgrip strength in the non-dominant
hand (r□−0.423; p□0.022) was gotten. On the other hand, in the
dominant hand a negative result was found, however with non-
significant association (r□−0.058; p□0.765).
Conclusions: There appears to be an inversely proportional relation-
ship between the nutritional status and the noun by the PG-SGA© and
the handgrip strength percentile. Handgrip dynamometry can be a
useful tool to evaluate the functional and nutritional status of the
patients with cancer diagnosis.
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EFFECT OF NUTRITION STATUS ON PATIENT ACTIVITIES OF DAILY
LIVING IN DIGESTIVE CANCER PATIENTS
T. Enishi1*, A. Matsumoto1. 1Department of Rehabilitation Medicine,
Tokushima Municipal Hospital, Tokushima, Japan
* Corresponding author.
Rationale: The incidence rate of digestive cancer is high and cancer
death have been increasing in Japan, based on the national survey of
the incidence and mortality data in 2013. However, little is known
about the relationship between nutrition status and activities of daily
living (ADL) for digestive cancer patients after surgery. The purpose of
this retrospective study is to investigate the relationship between
nutrias status and ADL in digestive cancer patients.
Methods: Ninety-one digestive cancer patient treated with surgery,
hospitalized from June 2016 toMay 2017, were included. The nutrition
status was evaluated based on modified controlling nutritional status
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score: albumin (g/dL), total number of lymphocytes (/ul), and
hemoglobin (g/dL).(1) Barthel index was used to measure the
performance in ADL and was examined at the time of hospital
discharge and admission. All patients were received rehabilitation
during hospitalization. Pearson’s correlation coefficient was applied.
Results: Correlation betweenmodified CONUTscore and Barthel index
was detected (r = 0.73, P < 0.05). The higher modified CONUT score
shows lower Barthel index score both at the time of hospital discharge
and admission. The higher modified CONUT score was significantly
associated with lower improvement of Barthel index score (r = 0.59,
P < 0.05).
Conclusions: This study shows that nutrition status is strongly
associated with ADL in digestive cancer patients. Patents with
malnutrition showed the lower improvement of ADL despite of
rehabilitation. Based on our findings, it might be preferable to
improve patients’ nutrition status before surgery.
Reference
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Rationale:Malnutrition or cachexia in the gastrointestinal (GI) cancer
patients is a major problem due to advance cancer stage related or GI
dysfunction. Home parenteral nutrition (HPN) is a nutrition-support-
ive therapy to fulfill the nutritional need for these patientswho cannot
acquire appropriate enteral nutrition. However, long-term use of HPN
may also cause various complications from minor central catheter-
related mechanical problems to major life-threating issues such as
electrolyte imbalance or catheter-related bloodstream infections
(CRBSIs). The aim of this study is to determine the clinical variables
of complications acquired from HPN therapy among the GI cancer
patients in a single medical center.
Methods: This retrospective study was conducted with GI cancer
patientswho receivedHPN fromApril 2004–December 2018. A total of
three-hundred and eighty-two patients was enrolled. Univariate
analysis and Kaplan Meier survival curves was used for the statistical
analysis
Results: Therewere 240 (62.8%) males and 142 (37.2%) females, with a
mean age of 62.16 ± 13.37 years. Of 382 patients, 240 (62.8%) patients
had colorectal cancer and 142 (37.2%) patients had gastric cancer.
Besides, 239 (62.6%) patients had stage IV disease. Median HPN
administration period was 43.5 days (range, 4–728 days). The most
frequent complicationwas hyperglycemia and followed by hyperbilir-
ubinemia, electrolyte imbalance, CRBSIs, catheter occlusion, catheter
slipping, hypoglycemia and catheter disconnection. When patients
having HPN-related complications, they had longer duration of HPN
(91.07 ± 103.07 days vs. 42.29 ± 49.29 days, P < 0.001). Besides there
was higher proportion of diabetic patients in complicated patients
(22.9% vs. 13.7%, P = 0.05). The median OS of patients with serum C-
reactive protein (CRP) level greater than 50 mg/L was shorter than
those not (1 month; 95%CI, 0.343–1.657 vs. 2 months; 95%CI, 1.447–
2.553; HR = 1.42; 95%CI, 1.039–1.946; P = 0.012).
Conclusions: The most frequent complication among the GI cancer
patients receiving HPN was hyperglycemia, of which hyperglycemia
occurred more frequently in patient may have a longer duration of
HPN.We should paymore attention to diabetic patients receiving HPN
therapy and patients having a serum CRP level greater than 50 mg/L.
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* Corresponding author.
Rationale: Head and neck cancer patients develop important
nutritional alterations due to cancer-cachexia that affect survival.
Omega-3 fatty acids, specifically EPA (eicosapentaenoic acid) has
shown to be a nutritional an option to maintain nutritional status.
Therefore, the research question was: ¿What is the effect of omega 3
fatty acids supplementation during treatment on 5-years survival in
head and neck cancer
Methods: This is an observational prospective study with a 5-years
follow up. We enrolled 64 patients who previously received either a
polymeric diet enriched with omega-3 (EPA) Supportan Drink® (2 g
per day) of a standard polymeric formulawith equal amount of energy
and protein, during their antineoplastic treatment.We followed up the
patients for five years to determine mortality or time of survival.
Differences between groups were analyzed with a chi-square test for
qualitative variables and student-t test for numerical variables.
Survival was calculated by Multivariate COX regression with Log
rank test
Results:We included a total of 50 patients: 25 (50%) weremale and 25
(50%) female. Average age of 59.9 ± 13.66 years old. From the whole
sample, 52% of them received the supplement containing 2 gr of EPA
(Supportan Drink®) and 48% of them the standard supplement.
Follow-up showed a mortality of 50% for the supplemented group (2 g
of EPA per day) and 58% for the control group (p = 0.380). Survival
between groups showed non significant differences. However, the
differences in survival time between group were 29 (experimental
group) versus 23 (control group) months.
Conclusions: Supplementation with an omega 3 enriched formula
during oncologý treatment had no effect in mortality. However, there
was a tendency in a longer survival time in the experimental group.
Further analysis will be made after 10 years to find out what happened
with a longer survival time.
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METASTATIC BREAST CANCER PATIENTS
V. Calvo-Sánchez1, C. Arce-Salinas1*, C. Rosiles-Monroy2, M.T. Nieto-
Coronel3, J. Santamaría-Galicia2, A. Peña-Ruíz2. 1Medical Oncology,
2Instituto Nacional de Cancerología,México,Mexico, 3Oncoservice, La Paz,
Bolivia, Plurinational State of
* Corresponding author.
Rationale: Breast cancer is the leading oncologic cause of incidence
and mortality among women in the world. Due to the higher
prevalence of obesity worldwide, combined with the muscular
catabolism, sarcopenic obesity has increased among patients with
cancer. The aimof this study is to evaluate the prevalence of sarcopenic
obsity in mexican patients with non metastatic breast cancer.
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Methods: We included non metastatic breast cancer patients
diagnosed between 2014–2018. All patients were treated whith
(neo) adjuvant chemotherapy. Before treatment, we assesed the
bioelectrical impedance analysis, height and weight. Obesity was
defined as fat mass index (FMI) >11.8 kg/m2 and sarcopenia was
defined as fat-free mass index (FFMI) <15.1 kg/m2.
Results: 237 patients were included. Median age at diagnosis were 49
years old, 20.3% (48) of patients had sarcopenic obesity with no
difference with their age (<50 years: 18 and >50 years: 30 patients).
Themedian of FMIwere 16.77 kg/m2. (4.74–42.32 kg/m2) and for FFMI
16.03 kg/m2 (5.6–22.29 kg/m2).
Conclusions: To our knowledge this is the first study that evaluates the
presence of sarcopenic obesity among mexican, non metastatic breast
cancer. The next step with this information and the growing cases of
sarcopenic obesitiy has to be evaluate the role of this condition in the
outcomes (survival and chemotherapy toxicity) for mexican non
metastatic breas cancer patients.
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PREOPERATIVE WEIGHT LOSS PREDICTS POSTOPERATIVE
INFECTIOUS COMPLICATIONS IN ELDERLY PATIENTS WITH
GASTRIC CANCER
X. Liu1*, J. Yu1. 1Peking Union Medical College Hospital, Beijing, China
* Corresponding author.
Rationale: To evaluate the postoperative complications and their risk
factors in elderly patients with gastric cancer.
Methods: 331 patients (≥70 years) who underwent curative gastrec-
tomy for gastric cancer were retrospectively analyzed. The infectious
complications included pulmonary infection, urinary tract infection,
pleural or abdominal effusion, wound complications and systemic
inflammation response syndrome, but not infections due to anasto-
mosis leakage. The severity of postoperative complications was
clarified according to the Clavien-Dindo classification.
Results:Of all the patients,male accounted for themajority (252 cases,
76.1%) and age ranged from 70 to 88 (average 74.7) years old. Operative
mortality was 1.2% (4 cases) and overall postoperative morbidity was
42.9% (142 cases). Clavien-Dindo class 3 andmorewas 38 cases (11.5%).
Therewere 65 cases of infectious complications.Multivariable analysis
revealed that preoperative weight loss ≥5% (hazard ratio 2.214, 95%
confidence interval 1.145–4.279, p = 0.018) and Charlson comorbidity
score ≥4 (hazard ratio 2.834, 95% confidence interval 1.303–6.163,
p = 0.009) were independent risk factors for infectious complications.
Conclusions: The elderly patients with preoperative weight loss and
many comorbidities have more risk of postoperative infectious
complications. So fully nutrition support and careful preoperative
assessment are needed for these patients.
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PREDICTION OF 1-YEAR SURVIVAL AFTER RADICAL GASTRECTOMY
IN GASTRIC CANCER BY CACHEXIA SCORE ASSESSED BY CT
D. Zhou1, Y. Zhang2, X. Wang2*. 1Research Institute of General Surgery,
Jinling Hospital, Southern Medical University, Guangzhou, China,
2Research Institute of General Surgery, Jinling Hospital, China, 305 East
Zhongshan Road, Nanjing, Jiangsu Province, China
* Corresponding author.
Rationale: The present study showed that the presence of adipopenia
and sarcopenia, as determined using baseline CT, can be used to
predict 1-year survival after surgery in patients with gastric cancer.
Hence, surgeons should pay more attention to the presence of
sarcopenia and adipopenia, as this would aid in preparing timely
individualized nutrition therapy.
Methods: We reviewed 187 patients with gastric cancer who
underwent radical gastrectomy. The patients were categorized into
three groups as having CS0 (no sarcopenia or adipopenia), CS1 (having
sarcopenia only and no adipopenia) and CS2 (having sarcopenia and
adipopenia) according to their third lumbar vertebra skeletal muscle
index and fat index calculated using abdominal computed tomog-
raphy. We compared clinicopathological factors, postoperative com-
plications,1-year survival after radical gastrectomy, and cause of death
among the three groups.
Results: Totally,140 patients (74.9%) had CS0, 38 (20.3%) had CS1 and 9
(4.8%) had CS2. The development of postoperative complications did
not differ significantly among the groups. Univariate and multivariate
analyses showed that no neoadjuvant chemotherapy (odds ratio [OR]:
3.9; 95% confidence interval [CI]: 1.4–11.1; P = 0.01), tumor stage III
(OR: 5.1; 95% CI: 1.2–21.9; P = 0.028), CS1 (OR: 10.8; 95% CI: 4.0–34.7;
P < 0.001), and CS2 (OR: 13.2; 95% CI: 2.1–85.1; P < 0.001) were
independent factors of 1-year mortality after radical gastrectomy. The
main cause of death was cancer-related.
Conclusions: CS1 and CS2were strongly associatedwith a poor 1-year
survival for patients with gastric cancer who underwent radical
gastrectomy, suggesting that special attention may be required for
nutritional support while determining therapeutic strategies.
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EFFECTOFN2-L-ALANYL-GLUTAMINE INPATIENTSWITHDIGESTIVE
CANCER UNDERGOING TO ONCOLOGICAL SURGERY
Y.L. Beltran Chaidez1*, M.V. Dominguez Garcia1, M.V. Flores Merino1,
V.Y. De Anda Torres2. 1UAEMEX, Toluca, 2UNAM, CDMX, Mexico
* Corresponding author.
Rationale: Cancer patients could present malnutrition. In these
patients it is important an adequate nutritional support. TPN improved
with glutamine could cover the nutritional requirements We eval-
uated the effect of N2-l-alanyl-glutamine in patients with digestive
cancer undergoing to oncological surgery
Methods: Prospective, interventional, longitudinal study. 40 patients
were included and allocated in two groups; supplemented with
glutamine (at a dose of 0.4 g per kg per day) and non-supplemented.
All patients were prescribed not less than 1.5 g per kg per day of amino
acids while receiving TPN. The measurements were performed at day
one and at day sevenwith the TPN. In both times the nutritional status
was evaluated, a blood sample was taken to analyze hematic
cytometry, protein metabolism and biochemical data.
Results:
Conclusions: The N2-l-alanyl-glutamine could have positive effects
after 7 days, improving lymphocytes, monocytes. Also the patients
present less complications and better nutritional status.
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POST-OPERATIVE WEIGHT REDUCTION WORSEN SURVIVAL AFTER
GASTRIC CANCER SURGERY
Y. Ikematsu1,2*, M. Ogiku2, T. Ogasawara3, Y. Okamoto4. 1Surgery,
Juzenkai Hospital, Nagasaki-city, 2Surgery, 3Respiratory Medicine,
Hamamatsu Medical Center, Hamamatsu-city, 4Nutritional Support,
Aichi Gakuden University, Nagoya-city, Japan
* Corresponding author.
Rationale: Body weight reduction is known to occur to some extent
after gastric cancer surgery, but little is known about the influence on
the prognosis. The degree of weight reduction after gastrectomy on
survival was checked and analyzed, retrospectively.
Methods: Three hundred and ninety-seven patients with resected
gastric cancer were enrolled in this study, who were operated in our
institute from June 2009 to December 2017. Bodyweightwas regularly
checked before and after surgery on 9 points (at admission, discharge,
3 months, 6 months, and annually up to 5-year after gastrectomy).
Then the weight reduction rates compared by pre-operative status
were calculated, and the relationship between the rates and the cancer
related survival curves were analyzed.
Results: Median weight reduction rates on discharge, at 3, 6 and 12
months after surgery were −6.6%, −10.3%, −11.3% and −11.9%,
respectively. As lower quantile of 3 months after surgery was −14.0%,
patients were divided into two groups as the lower reduction rate
group (Group L >− 13.9%, n = 253) and the higher reduction rate group
(GroupH <−14.0%, n = 85). Group L showed better 5-year survival rates
both in the relapse free and overall survival when compared to Group
H (p < 0.01, Wilcoxon). Weight reduction rates at 3 months after total
(n = 113) or non-total gastrectomy were− 12.4% and− 9.3%,
respectively (p < 0.01) and the curve lines were never come cross nor
close up to 5 years after surgery.
Conclusions: Almost all post-gastrectomy patients have lost their
weight around− 10% compared to pre-operative status within a year.
At 3 months after surgery, extreme body weight reduction rate (<
−14.0%) seemed to worse both 5-year relapse free and overall
survivals. Better peri-operative nutritional aids to sustain patients
body weight seem to be crucial.
Disclosure of Interest: None declared.
MON-PO416
EFFECTS OF PREOPERATIVE SKELETAL MUSCLE MASS AND
NEUTROPHIL LYMPHOCYTE RATIO ON THE PROGNOSIS OF STAGE
II AND III COLORECTAL CANCER
Y. Nakata1*, S. Furuya1, H. Shimizu1, H. Akaike1, N. Hosomura1,
Y. Kawaguchi1, H. Amemiya1, M. Sudo1, H. Kawaida1, S. Inoue1,
H. Kono1, D. Ichikawa1. 11st department of surgery, Faculty of Medicine,
University Of Yamanashi, Chuo, Japan
* Corresponding author.
Rationale: Some studies reported that the decrease of skeletal muscle
mass worsens the immune-nutritional status, and related to the poor
prognosis in colorectal cancer. We examined the relationship between
skeletal muscle mass and immune-nutritional parameters, and the
outcome of colorectal cancer patients at our hospital.
Methods: We retrospectively analyzed 196 patients of Stage II and III
colorectal cancer who underwent curative surgery in our institution
between 2007 and 2013. The cross-sectional area of the psoas muscle
at the level of the third lumbar vertebra on preoperative computed
tomography was assessed to calculate the psoas muscle index (PMI).
Patients are divided into high PMI group (H group) and low PMI group
(L group) with cut off value based on PMI value for Japanese adults’
average (6.36 cm2/m2 for males and 3.92 cm2/m2 for females).
Evaluation item were patient background, tumor factor, Onodera
nutritional index (PNI), as immunity and nutrition index, neutrophil/
lymphocyte ratio (NLR), lymphocyte/monocyte ratio (LMR), platelet/
lymphocyte ratio (PLR), overall survival (OS), disease free survival
(DFS). The immunity and nutrition index used the 25 percentile value
for cut-off.
Table 1 (abstract: MON-PO414): Treatment response on biochemical parametersa.
Group 1
(TPN)
n = 19
Group 2
(TPN + N2-l-alanyl-glutamine)
n = 21
Basal Final p Value Basal Final p Value
Lymphocytes
(X103/μL)
Monocytes
(X103/μL)
Neutrophils
(X103/μL)
1.0
(0.25–2.59)
0.69
(0.16–1.48)
8.51
(2.31–25.98)
0.67
(0.35–2.34)
0.74
(0.33–2.0)
6.63
(0.52–14.81)
0.240
0.055
0.314
0.67
(0.23–2.56)
0.57
(0.11–2.3)
8.14
(1.67–18.58)
0.90
(0.34–4.56)
0.72
(0.48–6.92)
6.04
(0.0–47.96)
0.023*
0.009*
0.601
Albumin
(g/dL)
Prealbumin
(mg/dL)
2.4
(1.2–3.5)
8.7
(6.5–13.2)
2.4
(1.3–3.10)
10.1
(6.5–29.8)
0.74
1.00
2.3
(1.4–3.6)
8.4
(4.3–15.6)
2.2
(1.8–3.4)
10.5
(5.3–38.2)
0.794
0.020
Glucose
(mg/dL)
Urea
(mg/dL)
Creatinine
(mg/dL)
BUN
(mg/dL)
140
(43–268)
44
(18–117)
0.80
(0.4–3.4)
21
(8–55)
125
(86–538)
42
(22–307)
0.60
(0.2–2.6)
19
(10–143)
0.629
0.629
0.005
0.794
106
(76–215)
28
(12–203)
0.5
(0.2–1.4)
13
(6–34)
117
(83–261)
35
(18–96)
0.5
(0.2–2.8)
16
(8–45)
0.068
0.225
0.139
0.091
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Results: There were 119 cases in H group and 77 cases in L group. In
patient factor, gender, age, serumAlbumin and BMI showed significant
differences between two groups. The 5-year survival was significantly
different 82.8% in H group and 70.3% in L group (p < 0.01). The 5-year
recurrence-free survival was 74.0% in the H group, and 68.3% in the L
group (p = 0.46). Univariate analysis showed that age (70≦), CEA
(0.51≦), depth of invasion (T4), lymph node metastasis (N1–3),
vascular infiltration (V1-3), preoperative low PMI, high NLR, low
LMR, and high PNI significantly related to decrease of OS. Multivariate
analysis showed that age, high CEA, deep invasion, lymph node
metastasis and L group were independent predictors of poor OS. The
immunity and nutrition index weren’t the candidate of independent
predictors. However, OS was decreased significantly at the high NLR in
L group, to examine by stratify immunity and nutrition index.
Conclusions: Preoperative PMI and NLR suggested to become
prognostic factors in stage II and III colorectal cancer.
Disclosure of Interest: None declared.
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RISK FACTORS FOR GLOMERULAR FILTRATION RATE IN PATIENTS
WITH SHORT BOWEL SYNDROME
P. Wang1, J. Yang1, J. Wang1, X. Gao1, L. Zhang1*, X. Wang1. 1General
Surgery, Jinling Hospital, Nanjing, China
* Corresponding author.
Rationale: Chronic renal failure (CRF) is a long-term complication in
patients with intestinal failure that is mostly caused by short bowel
syndrome (SBS) which seriously affects the patient’s quality of life.
However, risk factors for CRF in patients with SBS are not clear.
Methods: We retrospectively identified patients admitted to our
General Surgery department during 2007–2017 who were diagnosed
with SBS for more than 6 months. The patients’ creatinine, cystatin C,
hemoglobin, C-reactive protein, and electrolyte level; computed
tomography scans among those tested during their last hospitaliza-
tion; their surgery records and the doctors’ notes were collected.
Creatinine and cystatin C levels were used to calculate the glomerular
filtration rate (GFR) using the GFRscr-cys equation.
Results: Of 235 SBS patients meeting eligibility criteria, median
(minimum,maximum)GFR, age, and SBS durationwere 127.41 (41.45–
321.19) mL/min/1.73 m2, 46.37 (4–85) y, and 33.44 (1–324) m,
respectively. The age (P = 0.006), SBS duration (P = 0.024), whether
patients had the ileocecal value (P = 0.043), and existing kidney stones
(P = 0.001) were independent risk factors for low GFR. Moreover, the
SBS patients’ GFR had a linear relationship with the SBS duration
(Pearson r = 0.33; P = 0.0008).
Conclusions: Our study showed that the severity of renal function
depended on the duration that patients suffered from SBS. If the
ileocecal valve is removed, SBS patients are prone to has low GFR
Disclosure of Interest: None declared.
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NOTALL PATIENTSWITH SHORT BOWEL SYNDROME AND COLON IN
CONTINUITY HAVE ELEVATED FASTING AND POSTPRANDIAL
RESPONSES OF GLP-1 AND GLP-2: A POST HOC ANALYSIS.
L.M. Wangen1*, R.M. Naimi1, H. Skaraas Johnsen1, M. Hvistendahl1,
P.B. Jeppesen1. 1Department of Gastroenterology and Hepatology,
Rigshospitalet, Copenhagen, Denmark
* Corresponding author.
Rationale: Enhanced L-cell response has been reported in ileum-
resected short bowel syndrome (SBS) patients with colon in continuity
resulting in elevated fasting plasma concentrations and postprandial
responses of the enteroendocrine hormones glucagon-like peptide
(GLP) 1 and 2 compared to healthy controls.1 This study aimed to
evaluate the generalizability of this claim.
Methods: As part of a pilot study evaluating the therapeutic potential
of sitagliptin, a dipeptidyl peptidase-4 inhibitor, plasma GLP-1 and
GLP-2 were measured before treatment with sitagliptin in eight SBS
patients with ≥50% of colon in continuity. Blood samples were drawn
fasting and at fixed time points after a standardizedmeal. In a post hoc
analysis, fasting values and areas under the curves (AUC) for GLP-1 and
GLP-2 were compared to seven SBS patients and to seven healthy
controls from a study by Jeppesen et al.1
Results: In the sitagliptin study, no patient had preserved terminal
ileum or ileocecal valve (ICV) while two patients had partly preserved
ascending colon. In the Jeppesen study, four patients had terminal
ileumand ICVwhile six patients had partly preserved ascending colon.
Comparable fasting values and AUC of GLP-1 were observed between
the two patient cohorts (Table 1). When compared to the healthy
controls, both fasting values and AUC of GLP-1 were significantly
higher in the sitagliptin patients. The sitagliptin patients had
significantly lower fasting values and AUC of GLP-2 compared to
Jeppesen’s SBS patients. However, compared to healthy controls only
AUC of GLP-2 was significantly lower.
Conclusions: The preservation of the terminal ileum, ICV, and
ascending colon may be required for elevated L-cell activation and
could possibly explain the differences observed in this post hoc
analysis.
References
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Table 1 (abstract: MON-PO418): Fasting and postprandial hormone responses. A Mann-Whitney U test was used for the statistical analyses. P < 0.05 was considered
statistically significant. Data are presented as median (min, max).
Sitagliptin Jeppesen et al.1 SBS sitagliptin vs.
SBS Jeppesen et al.1
SBS sitagliptin vs. Healthy
controls1
SBS
patients
n = 8
SBS patients
n = 7
Healthy
controls
n = 7
Difference P-value Difference P-value
GLP-1 Fasting (pmol/L) 10 (4,25) 10 (5,21) 5 (2,9) 0 0.779 5 0.029
AUC (h × pmol/L) 61 (28,90) 51 (37,191) 38 (18,52) 10 0.779 23 0.029
GLP-2 Fasting (pmol/L) 16 (9,42) 72 (50,177) 23 (16,54) -56 <0.001 -7 0.054
AUC (h × pmol/L) 77 (47,118) 314 (178,711) 169 (78,236) -237 <0.001 -92 0.009
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BREASTFEEDING ASSOCIATED WITH EATING BEHAVIOR AND BODY
MASS INDEX IN CHILEAN SCHOOL CHILDREN
M. Valladares1*, C. Pino2, C. Canto3, A.M. Obregón4. 1Departamento de
Ciencias Químicas y Biológicas, 2Escuela de Nutrición y Dietética, 3Escuela
de Terapia Ocupacional, Universidad Bernardo ÓHiggins, Santiago,
4Escuela de Nutrición y Dietética, Universidad San Sebastián,
Concepción, Chile
* Corresponding author.
Rationale: Is there an association between breastfeeding and body
mass index and eating behavior in Chilean school children from 6 to 9
grades?
Methods: School children were recruited by convenience (n = 132,
mean of age 14,1 ± 1,1), were asked with their mothers how many
months they had breastfeeding when they were babies. Additionally,
they were evaluated current eating behavior through Three Factor
Eating Questionnaire (TFEQ-P19) and Child Eating Behavior
Questionnaire (CEBQ); also, current BMI was measured. To compare
between groups, Mann-Whitney test was used. The study was
developed following the Declaration of Helsinki and approved by the
Ethics Committee of the Bernardo ÓHiggins University.
Results: The children presented mean BMI z score of 1.13 ± 0.92 and
0.78 ± 1 for girls and boys, respectively. Girls who did not receive
breastfeeding had a higher BMI z score than those who received
(p = 0.05); in boyswe did not find significant differences. Boyswho did
receive breastfeeding showed lower scores on dimensions: food
responsiveness, enjoyment of food, desire to drink (p < 0.05) than
those who did not have breastfeeding and higher scores in satiety
responsiveness dimensions (p < 0.05). Girls did not show differences
on eating behavior dimensions according to breastfeeding.
Conclusions: There is a difference between current BMI and eating
behavior and having received breastfeeding in school children, it is
noted that this may be dependent on sexual dimorphism.
Interestingly, boys who had breastfeeding showed lower score on
food approach (pro intake) dimensions and higher on food avoidant
(anti intake) dimensions, where the first types of dimensions have
been constantly associatedwith higher BMI and the secondwith lower
BMI. More studies are necessary to deepen in those eating behavior
dimensions that we observed associated with breastfeeding.
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THE FREQUENCY OF PRESCRIPTION’S MODIFICATIONS DURING
HOME PARENTERAL NUTRITION (HPN)
M. Pietka1,1*, A. Olejko1, K. Sczepanek2, S. Klek2. 1Pharmacy, 2General
and Oncology Surgery Unit, Stanley Dudrick’s Memorial Hospital,
Skawina, Poland
* Corresponding author.
Rationale: Protocols for home parenteral nutrition (HPN) require
constant verifying of laboratory tests and patient’s status followed by
the revisions of the prescription if necessary. There are, however, no
studies to examine the frequency of modifications of HPN regimens.
The analysis of the latter was the goal of the study.
Methods:A retrospective studyof the clinical curse of 52 HPN patients
(31 female – 60%, 21male – 40%, mean age 56.1) treated between 2016
and 2018 at the Intestinal Failure Center in Skawinawas performed. All
patientswere supervised by the same physician for at least 6months. A
check-up with lab test were performed every 3 months or in any case
of complications. The frequency and type of changes to prescriptions,
HPN duration, underlining disease and re-admission to the hospital
were performed.
Results: The mean duration time of HPN was 72 months (min.7, max.
141, SD±34). Causes of chronic intestinal failure were: short bowel
syndrome (83%), motility disorders (8%), extensive parenchymal
disease (8%) and intestinal fistulas (2%). The mean number of HPN
prescriptions for the treatment period was 4.0 (median 4.5). Themean
number of changes to the prescription was 7.0 (median 7.2). Types of
modifications: change in quantity/ type of macronutrients (46%/18%),
change of the volume (43%), electrolytes (38%) and introduction of the
new ingredient (18%). No correlation between the frequency of
changes and the length of HPN or underlying disease was found.
Most modifications were done during hospitalization.
Conclusions: The need for the change of the HPN admixture’s
composition more depends on clinical and metabolic conditions
than on the length of therapy or underlying disease.
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DIAGNOSIS AND MANAGEMENT OF CATHETER-RELATED
BLOODSTREAM INFECTION (CRBSI) DURING HOME PARENTERAL
NUTRITION (HPN)
M. Pietka1*, M. Sumlet2, K. Sczepanek2, S. Klek2. 1Pharmacy, 2General
and Oncology Surgery Unit, Stanley Dudrick’s Memorial Hospital,
Skawina, Poland
* Corresponding author.
Rationale: According to the most common criteria, catheter-related
bloodstream infection (CRBSI) is diagnosed with the microbiological
confirmation of paired blood cultures. In home parenteral nutrition
(HPN), however, the approach is often different, because the successful
rescue therapy of a central venous catheter (CVC) is of the most
importance. Therefore, some centers would start antibiotic therapy
even in the case of a single positive culture from CVC. The aim of the
study was to analyzewhether that approach should be used in clinical
practice.
Methods: A retrospective study comparing results of CVC lumen and
peripheral blood cultures were performed. The group of 281 HPN
patients (F175 (62%), M 106 (38%), mean age 58,7 years) treated
between 2016 and 2018 were analyzed. All lab reports were analyzed
and matched with each other.
Results: Clinical symptoms of the infection were reported 89 times in
50 patients. In 56 cases microbiological confirmation followed. The
CRBSI’s criteria were fulfilled only in 61%. In 51 cases CVC’s infection
was diagnosed, while in only 36 of them positive peripheral blood
cultures for the same species were detected. 100% of CVC infection
caused by: C. albicans, E. faecalis, K. oxytoca, K. pneumonia,
P. agglomerans, P. mirabilis, S. aureus, S. capitis, S. haemoliyticus
were confirmed in peripheral bood sample and 88% of E. cloacae
complex; 67% of E. coli, 75% of S. hominis, 33% of S. warnerii.
Conclusions: This study illustrates themethodological challenges and
variability in diagnosis and management, as well as reporting, of
CRBSIs. Paired blood cultures should be performed in patients with
suspected CRBSI because CVC line cultures isolates are frequent and
useful for diagnosis of CRBSI even without positive blood culture and
should be calculated to CRBSI incidence factor.
Disclosure of Interest: None declared.
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ASSESSMENT OF EMPIRICAL ANTIBIOTIC THERAPY FOR CATHETER-
RELATED BLOODSTREAM INFECTION (CRBSI) DURING HOME
PARENTERAL NUTRITION (HPN)
M. Pietka1*, M. Sumlet2, K. Sczepanek2, S. Klek2. 1Pharmacy, 2General
and Oncology Surgery Unit, Stanley Dudrick’s Memorial Hospital,
Skawina, Poland
* Corresponding author.
Rationale: When CRBSI is suspected in HPN patients and blood
cultures results are awaited, empiric antibiotics or other antibacterial
lock therapywith a systemic antimicrobial agent should be introduced
to save long term central venous catheter (CVC). The purpose of this
study was to assess the appropriateness of empiric antibiotic
recommendations and to determine if initial empiric antibiotics
covered the spectrum of microbes.
Methods: A retrospective study assessing current empiric CRBSI
treatment at the Stanley Dudrick’s Memorial Hospital in Skawina,
Poland was performed. A group of 281 HPN patients (F175 (62%), M
106 (38%), mean age 58,7 years) treated from 2016 to 2018 was
analyzed. The standard of care for the clinical suspicion of CRBSI was a
catheter lock with gentamycin. All reports of blood cultures were
analyzed and matched against each other.
Results: 89 episodes of suspected CRBSI were diagnosed with clinical
symptoms, 82 blood cultures from the catheter and 89 from the
peripheral vein were performed. 51 of them came back positive. In 57
cases (70%) catheter antibiotic lock was applied, in 55 cases with
Gentamycin. In 30% of cases, the catheter was removed. In 20 cases
(35%) the empirical drug covered the real spectrum (18 (33%) for
Gentamycin). Regarding the peripheral cultures, 41 came back
positive. 31 episodes were empirically treated (15 with Gentamycin).
In 19 (61%) and 10 (67%) regarding Gentamycin) the spectrum was
covered correctly.
Conclusions: The study showed the urgent need for a change of the
first choice product for catheter lock used for empirical therapy for
CRBSI.
Disclosure of Interest: None declared.
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PREDICTIVE FACTORS FOR IMPROVEMENT OF SWALLOWING
FUNCTION IN PATIENTS WITH ASPIRATION PNEUMONIA
M. Sato1,2*, Y. Ogawa3, N. Atsushi2, I. Motoaki2, K. Masanori2,
M. Mitsuru2, O. Tetsushi2, I. Hiroshi4. 1National Hospital Organization
Takasaki General Medical Center, Respiratory, 2National Hospital
Organization Takasaki General Medical Center, Dr, 3National Hospital
OrganizationTakasaki GeneralMedical Center, Nutritionist, 4Dr, Takasaki-
city, Takamatsu-cho, Japan
* Corresponding author.
Rationale: Pneumonia-related mortality and especially, number of
elderly patients with aspiration pneumonia have been increasing in
Japan. Swallowing function evaluation, nutrition therapy, and rehabili-
tation by early intervention of the nutrition support team (NST) are
crucial for preventing aspiration pneumonia recurrence in acute phase
hospitals. We retrospectively investigated predictive factors for
improvement of swallowing function in patients with aspiration
pneumonia who underwent videoendoscopic examination of swal-
lowing (VE) at our hospital.
Methods: We studied 34 patients with aspiration pneumonia who
underwent VE on hospital admission during the one year from April
2018. Patients with food intake level scale (FILS) scores≥7 at discharge
were judged to havemild dysphagia (Group A, n = 17,13men),whereas
those with FILS scores ≤6 at discharge were judged to have moderate
or severe dysphagia (Group B, n = 17, 12 men). Age, sex, body mass
index (BMI), skeletal mass index (SMI), serum albumin level at
admission, number of days to first NST intervention, and degree of
independent living for elderly (DILE) were assessed. Mean values of
each item were compared between Groups A and B using the t test.
Results: Of the enrolled patients, 25 (74%) were men. Mean age, BMI,
and serum albumin level were 83 ± 9.4 years, 20.1 ± 4.4 kg/m2, and
3.0 ± 0.6 g/dL, respectively.Meanhospitalisation lengthwas 24.6 ± 18.1
days. Male SMI (Group A vs. Group B: 5 ± 0.5 vs. 5.9 ± 0.9 kg/m2,
p < 0.001), number of days to first NST intervention (5.5 ± 4.4 vs.
2.6 ± 1.6 days, p < 0.01), BMI (18.6 ± 4.4 vs. 21.5 ± 3.7 kg/m2, p = 0.03),
and DILE (2.4 ± 2.1 vs. 4.5 ± 2.1, p = 0.003) differed significantly
between Group A and Group B.
Conclusions: Patients with aspiration pneumonia with FILS scores ≥7
with enough oral intake have high SMI and DILE; these factors may be
related to swallowing function.
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Rationale: CCI, a scale that assesses comorbidity, is considered a
powerful predictor of mortality in patients on hemodialysis (HD). In
these, comorbidity intervenes in the development and progression of
the protein energy wasting syndrome (PEW), strongly associated with
all mortality causes, but there is little data on the relationship between
CCI and PEW. The aim of this studywas to determine the association of
CCI with PEWand the parameters linked to inflammation and thus to
comorbidity.
Methods: We evaluated 58 patients (38 men); mean age 69.1 (SD
13.2);median time on hemodialysis 28 (3.7–80.8)months, performing
anthropometry, bioimpedance, food survey and biochemistry that
included albumin, prealbumin, C-reactive protein (CRP) and vitamin
25-OH-D. The diagnosis of PEW was established according to the
International Society of Renal Nutrition and Metabolism (ISRNM)
criteria. The CCI was calculated applying amodified scale that does not
consider albumin and where HD assigns 2 points. Spearman
correlation and student-T were used in the bivariate analysis, with a
level of significance of p < 0.05.
Results:Out of the 58 patients, 39.7%were diagnosedwith PEW, 75.9%
had albumin <3.8 g/dl and 51.7% had prealbumin <30 mg/dl. Median
CCI: 7.15 points (5.4–9.15). Vitamin 25-OH-D levels (ng/ml) were <15
in 32.8%, between 15–30 in 31% and >30 in 13.8% of the patients. We
found significant negative association of CCI with albumin (p = 0.011)
and prealbumin (p = 0.002) but not with CRP (r = 0,202; p = 0.139),
PEW syndrome or vitamin D status.
Conclusions: The clinical relevance of the CCI in our patients is limited
since it is not associated with nutritional status and therefore not
useful to establish therapies that improve malnutrition and reduce
mortality. On the other hand, it correlates with simpler and available
markers as albumin, considered a strong predictor of mortality.
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Rationale: The phase angle (PA) has shown a good correlationwith the
nutritional parameters and survival in maintenance hemodialysis
(MHD) patients. On the other hand, for these patients, subjective
global assessment (SGA) is a method of nutritional evaluation
recommended by the guidelines, and Charlson comorbidity index
(CCI), is considered a powerful predictor of mortality. The aim of this
study was to determine the association of PAwith SGA and CCI.
Methods:We evaluated 107 patients (69.2% men) on MHD, mean age
68.4 ± 12.8, median time on hemodialysis 26.5 months (3.5–80.8),
performing anthropometry, bioimpedance, modified quantitative SGA
that rates 8 items and CCI.We consider the existence of nutritional risk
when SGA>8 points and the presence of severe malnutrition when
SGA>15 points. The CCI was calculated applying a modified scale that
does not consider albumin andwhere HD assigns 2 points. ANOVA and
Student-T tests were used in the bivariate analysis, with a level of
significance of p < 0.05.
Results: The mean PA at a frequency of 50 kHz was 4.5°±1.3; median
4.5 (3.4–5.3); 34.6% had a PA<4°; the meanwas significantly higher in
men than women (4.8°±1.3 vs 3.8°±0.8; p < 0.001) and in those
aged> = 70 than in those of age<70 (4.0°±1.0 vs 5.1°±1.3; p < 0.001). The
mean SGA was 12.5; median 11 (9–15); 17% of the patients had
SGA< = 8; 54.7% had SGA 9–14 and 28.3% SGA = >15. Themean CCI was
7.7;median 8 (6–9.6); 45.8% of the patients had CCI<8;17.8% had CCI 8–
9.6 and 17.8% CCI>9.6. We found a negative relationship between PA
and SGA and between PA and CCI with statistical inter-group
difference (p < 0.001).
Conclusions: In these patients on MHD, the PA, an easily available
parameter, presents a strong association with the more time-
consuming SGA and CCI. Although PA is considered an early marker
of malnutrition, in this study it showed a greater ability to identify
patients with severe malnutrition.
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Rationale: Vitamin D has extraosseous pleiotropic effects and its
deficit is associated with cardiovascular mortality, the main cause of
death in hemodialysis patients. The aim of this study was to analyze
the correlation between markers and pathologies linked to inflam-
mation and vitamin D status
Methods: We evaluated 52 patients (36 men), mean age 69 (SD 14),
median time on hemodialysis 39.9 months (10–84), performing
vitamin 25-OH-D, C-reactive protein (CRP), albumin and prealbumin
levels. We applied a combined criteria: diabetes and/or ischemic
cardiopathy (IC) and/or Ictus, and considered levels of vitamin
D < 15 ng/ml indicative of severe deficit, between 15 and 30 insuffi-
cient and >30 optimal.
Results: CRP (mg/L): median 4 (2–8); Albumin (g/dl): mean 3.5 (SD
0.4); Prealbumin (mg/dL): mean 29.8 (SD 8); Vitamin D (ng/ml):
median 17 (12–25.75); the levels were deficient in 42.3%, insufficient
in 40.4% and optimal in 17.3% of patients. We did not find vitamin D
association with albumin and prealbumin. A positive association with
CRPwas found (r = 0.298, p = 0.032) and itsmean tended to increase as
the status improved. The vitaminDmean in the 17 patientswith CRP<3
was 16.76 (SD 8.75) and in the 35 with CRP ³ 3 was 23.8 (SD 16.6)
(p = 0.108). The mean CRP in patients who did not meet the combined
criteria was 10.44 (SD 16.22) and in those who met it, 18.18 (SD 30.23)
(p = 0.203); 54.5% of patients with vitamin D levels<15 met the
combined criteria whereas those with levels>15, only 32% did
(p = 0.118).
Conclusions:Only 17.3% of patients showoptimal levels of vitamin 25-
OH-D and >50% have CRP ³ 3. Our results regarding association
between inflammatory situation and vitamin D status could be
justified by insufficient sample size, lack of sensitivity of the
methods used to detect inflammation and also because, given the
existence of vitamin D deficiency in most patients, it is not possible to
demonstrate anti-inflammatory action.
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Rationale: The aim of the study is to describe the functional and
nutritional status of subacute stroke patients at admission and at
discharge from the Brain Injury Unit of the HLP.
Methods: This is a descriptive study of a cohort of 198 patients
diagnosed with a subacute stroke that were admitted consecutively
during the period of May 2013 to May 2016.
The analysed parameters were the following:
• Sex and age.
• Risk of malnutrition via ‘Mini Nutritional Assessment’ (MNA).
• Nutritional analytic parameters (albumine, cholesterol,
lynphocytes).
• Nutritional anthropometric parameters (weigth, index bodymass).
• Score of Barthel Dependency Scale.
• Rankin Physical Disability Scale.
Statistical analysis was carried out using the SPSS 23.0 software
Results: There was a weight reduction and a BMI decrease after
discharge compared to the moment of admission. An increase on the
MNA malnutrition scale was observed from admission to discharge,
changing from a state of malnutrition to risk of malnutrition. The
average of functional dependence according to the Barthel scale
changed from total dependence upon admission to moderate
dependence upon discharge. The average disability according to the
Rankin scale at dischargewas alsomoderate disability, improving from
moderately severe disability upon admission.
The parameters presenting statistical significance between admission
and discharge are reflexed in Table 1.
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Parameter P value
BMI 0.001
Barthel <0.0005
MNA 0.02
Rankin <0.0005
Malnutrition lymphocytes <0.0005
Malnutrition albumin 0.016
Conclusions:At discharge, patients presented an improved nutritional
state in anthropometrical and analytical parameters, and in the risk of
malnutrition. There was also an improvement in functionality and
disability grade.More studies are necessary to observe the relationship
between a nutritional improvement and a functional improvement.
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Rationale: Extracellular mass-to-body cell mass ratio (ECM/BCM),
which reflects the proportions of intra and extracellular spaces, is
considered a sensitive index of being wasted-overloaded in dialysis
patients. This study aimed to explore the relationship between the
nutritional-hydration status measured by the ECM/BCM ratio and
survival in hemodialysis patients (HD)
Methods:A retrospective observational study in 56HDpatients (mean
age: 75.9; men: 29(51.8%);time on HD: 34.8) for 30-months of follow-
up. Demographic, clinical, biochemical data and assessment of
protein-energy wasting (PEW) by malnutrition-inflammation score
were performed. The ECM/BCM ratio was measured by bioimpedance
analysis (RJL-System-Bia 101) and the optimal cut-off point of 1.20 by
Receiver operating characteristic curve (ROC curve) as criterium for
diagnosing wasting-hyperhydration was applied. Log-rank test was
used to assess the differences between survival curves. Independent
predictors of survival were determined by Cox regression analysis.
Calculations were performed using SPSS v.21 and Stata softwares’.
Results: PEWwas identified in 67.9% of HD patients. The cut-off point
for screening PEWwas 1.20 by ROC curve (area under the curve) of 0.79
(p < 0.001). The cumulative observed survival of pts with enrollment
ECM/BCM ratio ≤1.20 was significantly better than those with >1.20
(p = 0.009). In the multivariate Cox proportional hazards model, after
adjusting for age, gender and time on HD, the ECM/BCM ratio remained
an independent predictor (HR = 8.9; p = 0.035) of mortality.
Conclusions: The ECM/BCM ratio a marker of being wasted-over-
hydrated was an independent predictor of long-term survival in HD
patients.
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Rationale: Currently, cardiovascular diseases (CVD) are the leading
cause of death worldwide. A risk factor for CVD is high blood pressure,
a condition that is associated with a high consumption of sodium in
the diet. According to the World Health Organization (WHO), the
current recommendation for sodium is 2000 mg of sodium per day.
Identify the main sources of sodium of the Ecuadorian diet and
determine the knowledge, attitudes and practices related to the use of
salt in young adults between 25 and 64 years of age in the city of Quito.
Methods: Cross-sectional study. There was a random sample for
convenience of 177 employees (men and women between 25 and 64
years old) of theHospital de los Valles and the San Francisco University
of Quito. The collection of sociodemographic, anthropometric data
(weight and height) and the taking of blood pressure in subjects was
perform. A questionnaire of frequency of consumption, a question-
naire of knowledge, attitudes and practices was use and a single
sample of urinary sodium excretion was collect in 24 hrs.
Results: Nearly 97% of participants had a misperception about their
sodium intake, 98.9% know that a diet high in salt causes health
problems, but only 38.4% do something systematically to regulate their
intake of salt. Moreover, there are no significant differences between
the means of sodium consumption (p = 0.870) of those subjects who
regulate their salt intake (2689 mg/day) compared to thosewhodo not
take any action (2681.74 mg/day)
Conclusions: There is a misperception about sodium consumption.
Only a small group of subjects takes actions that would help reduce
their consumption, not being effective. The foods most frequently
consumed were meat products and soft drinks.
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Rationale: The link between nutritional status and psychiatric
symptoms in malnourished AN patients is described since two
decades, but has not been described in an homogeneous sample of
very severely malnourished patients. The aim of this study was to
describe the evolution of anxio-depressive symptoms, and hyper
activity after nutritional care in a sample of very severe malnourished
AN patients.
Methods: All consecutive very severe malnourished AN adult patients
(DSM-5), hospitalized in a clinical nutritional unit between July 2018
and February 2019 were included. Psychiatric symptoms were
assessed by self-report questionnaires: anxio-depressive symptoms
by Beck Depression Inventory II (BDI II) and Hospital Anxiety and
Depression Scale (HADS), obsessive-compulsive symptoms by
Maudsley Obsessive-Compulsive Inventory (MOCI), social phobia
symptoms by using Liebowitz Social Phobia Scale (LSAS) and Godin
Leisure time exercise to assess physical activity. Patients were
evaluated at admission and at discharge.
Results: Thirty-nine patients (2 Men/37 Women), age: 30.2 ± 11.4
years, BMI: 12.6 ± 2.7 kg/m2, Albumin: 36.5 ± 9.1 g/L, TTR: 0.310 ±
0.110 mg/L were included; scores levels of psychiatric symptoms were
high: 51.2 ± 16.3 for BDI, 34.3± 2.9 for HAD, 43± 2.3 for MOCI,
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97.9 ± 29.5 for Liebowitz and level of physical activity was important
41.1 ± 60.8 for Godin time exercise. After 6 ± 4weeks of nutritional care
all patients improved their nutritional status (Delta-BMI 2 + 0.5,
p < 0.05) and decrease significantly their psychiatric symptoms.
Weight gain was not link to trends to be associated with the decrease
of depressive symptoms (BDI r =−0.5, p = 0.07) and with social phobia
(LSAS r =−0.41 p = 0.08).
Conclusions: In very severely malnourished AN patients following
enteral nutrition, a decrease of depressive symptoms and social phobia
has been observed along with an improvement of nutritional status.
This study suggest that nutritional care contributes not only to somatic
treatment of AN, but also to the treatment of at least a part of anxio-
depressive symptoms. Larger prospective studies are needed to
confirm these results.
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Rationale: Atherosclerosis is usually the result of a number of risk
factors. Some of them (e.g. total cholesterol level, bodymass index) are
modified in parenteral nutrition (PN) patients group. This could results
in changes of the cardiovascular risk. The cardiovascular risk could be
estimated using one of the risk estimation systems, eg.: Systemic
Coronary Risk Estimation (SCORE) or Framingham risk score. SCORE
calculates 10-year risk of CVD mortality and Framingham risk score –
10-year risk of hard coronary events. The aim of the study was to
estimate the cardiovascular risk for PN patients.
Methods: Forty eight patients without cardiovascular disease diag-
nosis were recruited into the study: 24 PN patients and 24 control –
healthy volunteers (HV).12women and 12men in the PN group and 13
women and 11 men in the control group participated in the study.
Patients in both groupswerematched for age (mean: PN – 62.25 ± 5.06
years; HV – 61.83 ± 5.82 years; p-0.79), body mass index (mean: PN –
22.77 ± 2.8; HV –24.01 ± 1.75; p-0.07) and smoking history (number of
smokers: PN -13, HV-11; p-0.56). Total cholesterol and its lipoprotein
fractions serum level were examined. Brachial systolic blood pressure
(SBP) was measured for each patient. The assessment of total
cardiovascular disease (CVD) risk was performed using SCORE chart
and Framingham risk score (10-year risk of CVD and ‘heart age’). All
subjects provided written informed consent. Characteristics of the
study population were recorded and compared using the Student’s t-
test, Mann–Whitney U test, Kendall’s tau-b test, Kolomogorov-
Smirnov test and Pearson’s chi-squared test.
Results: Total (mean: PN –136.04 ± 41.45; HV – 221.37 ± 40.81 mg/dl;
p < 0.05) andHDL (mean: PN –44.87 ± 13.03; HV– 77.04 ± 23.91 mg/dl;
p < 0.05) cholesterol were lower in the PN patients. Total CVD risk was
lower in the PN patients in SCORE chart, but not in the Framingham
risk score and in the ‘heart age’ (SCORE: PN – 3.79 ± 2.69% vs HV –
5.04 ± 4.88%, p < 0.05; Framingham: PN-17.9 ± 15.38% vs HV- 20.44 ±
14.19%, p-0.53; heart age: PN-66.42 ± 11.86 vs HV-72.21 ± 11.92 years,
p-0.42).
Conclusions: Parenteral nutrition patients have lower cardiovascular
risk than patients from the control group in SCORE chart. The further
studies are necessary to determine if it is confirmed by the incidence of
the CVD in parenteral nutrition patients.
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Rationale: To examine whether sodium reduction dietary consult-
ation in anuric hemodialysis (HD) patients, as a single tool, will lead to
reduced fluid Intra dialytic weight gain (IDWG) while preventing
nutritional deterioration.
Methods: Open-label prospective cohort study in which subjects are
compared to themselves. One medical center. 17 HD adults patients
with renal function of less than 200 ml per 24 hours, more than 3
months in HD with IDWG of more than 2.2 kilograms or 4% from the
dry body weight, in two mid-week sessions.
Subjects were evaluated in 3 periods: baseline before intervention
(time 0), after 4weeks of intervention and after 12weeks intervention,
accompanied by dietitian with specialization in the nephrology. In
each period, the following parameters were examined and evaluated:
IDWG, sodium intake, systolic and diastolic blood pressure along the
dialysis treatments, routine biochemical and hematological blood tests
nutritional status and dietary intake. The quality of life index was
measured by SF-36 at time 0 and end after 12 weeks. The IDWG was
based on the weight difference between two adjacent dialysis
treatments. Average of 6 adjacent treatments. The nutritional status
was carried out using the 7 points Subjective Global Assessment tool.
The assessment of dietary intakewas collected by 24-h recall for 3 days
per period. Sodium intake was also evaluated by blood sodium,
throughout the 3 study periods. Dietary intervention was a total of 4
weeks and included nutritional counseling to reduce salt from the diet
according to patient preferences and adjusted for hyperkalemia.
Results: There was a significant decrease in IDWG between treatment
after 4 weeks, but not after 12 weeks. The IDWG decreased from
3.48 ± 0.93 to 2.89 ± 0.89 (p < 0.001) after 4 weeks of intervention but
increased to 3.3 ± 0.99 at 12 weeks to 0 time. The decrease after 4
weeks was not attributed to the change in sodium intake alone
because there was no significant decrease in sodium intake. No
significant differences were found in the three study periods: systolic
and diastolic blood pressure at the beginning of dialysis, duration and
end of dialysis, biochemical and hematologic tests (except ferritin
decline), nutritional status, or dietary parameters.
Six of the 17 participants were able to reduce sodium and maintain
their low intake throughout the 12-week study period. Among the
‘successful’, the change in fluid accumulation after 12 weeks was
significant and decreased from 3.44% to 2.77% (change of 0.66%
p < 0.05). No nutritional status was found in calories, protein and
electrolytes consumed. In the group that did not change sodium
intake, there was a significant decrease in the accumulation rate only
after 4 weeks from 3.5% to 3.1%, but the decrease did not persist after
12 weeks and the fluid accumulation rate returned to 3.5%. There was
no significant change in blood pressure in nutritional status or in
dietary parameters that were significantly examined throughout the
study. The quality of life decreased significantly between the
beginning and end of the study at an average of 6.6 points with a
median decrease of 3 points (p < 0.05).
Conclusions: Dietary guidance for dietary sodium reduction in anuric
HD patients was found to help maintain IDWG reduction between
adjacent hemodialysis treatments for at least 12 weeks while
maintaining nutritional status. Adherence to treatment is not high
and requires close nutritional monitoring.
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Rationale: Quality of life (QOL) of HPN patients is a critical issue for
functioning and survival. A better evaluation of the factors influencing
this QOL can guide clinicians to provide significant advantages and
advices for better outcome. We aimed to investigate these factors by
evaluating the role of health perception, self-efficacy and use of social
media in QOL of HPN patients
Methods:We included 204 participants (148 from Poland and 55 from
Israel) that completed validated questionnaires for QOL, illness
perception, self-efficacy, and the use of social media. A z score was
used to equate means and variances for QOL questionnaire. Statistical
analysis was based on Stepwise Regression, T-Test, and Pearson
correlation between variances. The Helsinki committees of both
medical centers waived the requirement for informed consent and
approved the study.
Results: A significant higher positive QOL was recorded in polish
patients compared to israelis (−0.1723±.46 and.5131±.45, p < 0.001
respectively). However, israeli patients had a significant higher self-
efficacy score, meaning that their motivation and ability to overcome
hardships associated with their disease were high (4.3± 1.9 and 5.3±
2.2, p < 0.002 respectively). A stepwise regression equation showed
that QOL could be predicted by the variances of independent variables
(R2 = 0.439, p < 0.0001), self-evaluation physical health status
(R2 = 0.152, p < 0.0001), the use of social media (R2 = 0.189, p < 0.0001),
and the level of self-efficacy (R2 = 0.207, p < 0.0001).
Conclusions: Physical changes that affect health and daily function,
self-efficacy, and increase in social relationships by receiving emo-
tional support through social networks are important factors for QOL
improvement. These findings should guide health professionals in the
management of this population.
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D. Kot1, M. Ławiński1, M. Słodkowski1, I. Kagan2, M. Theilla3*.
1Department of General, Gastroenterological and Oncological Surgery,
Medical University of Warsaw, Warsaw, Poland, 2Department of General
Intensive Care and Institute for Nutrition Research, Rabin Medical Center,
Beilinson Hospital, Petah Tikva, Affiliated to the Sackler School of
Medicine, Tel Aviv, 3Nursing Department, Steyer School of Health
Professions, Sackler School of Medicine, Tel Aviv, Israel
* Corresponding author.
Rationale: Social support is one of the most widely used and studied
strategies for encouraging behavior change in social networks. Patients
that use social media as their source of information shown improved
health outcome and better chronical disease management. This study
aims to examine the correlation between the use of social media and
self-definition of self-efficacy for the physical and sexual functioning
of chronic patients receiving home parenteral nutrition (HPN).
Methods: The data were collected using self-administered question-
naire to HPN patients in 2 large centers. Statistical analysis was based
on T-Test and Pearson correlation between variances. The ethics
committees waived informed consent request
Results: 148 (Poland) and 55 (Israel) patients were included. Mean
HPN duration was 9.7 ± 7 years in Poland, and 12 ± 9.6 years in Israel.
Only 61 patients had a stoma (data was not available in15 patients).
20.6% were singles, 52% married, 12.2% divorced, 14.7% widows, and
0.5% missing. The younger HPN patients used more social media and
they were more sexually active (R = .462 p < 0.000), their self-efficacy
was higher (R = .224 p < 0.001), and they were rating their physical
condition higher (R = .405 p < 0.0001). Patients with a stoma were
significantly less sexually active rating without stoma (p < 0.0001).
Patients with stoma rated their self-efficacy lower than patients
without stoma (mean 4.1 ± 1.8 versus 4.8 ± 2.2, respectively, p < 0.004).
Israelis were more sexually active than Poland patients were (1.7±.8;
versus 1.5 ±. 7, p < 0.03 respectively). Patients that use social media
more often were more sexually active (R = .215 p < 0.003).
Conclusions: Younger patients that are more involved in social media
activity are also more physically and sexually active. Patients with
Stoma evaluate their self-efficacy as lower and are sexually less active.
Social media has a positive effect on the sexual life of HPN patients.
Disclosure of Interest: None declared.
MON-PO435
DISEASE RELATEDMALNUTRITION IN PATIENTSWITH PULMONARY
TUBERCULOSIS (TB), ATTENDING DISTRICT CHEST CLINICS (DCC) OF
COLOMBO AND GAMPAHA DISTRICTS.
R. Jayatissa1, N. Wijenayaka2, N. de Alwis1, A. Perera1, A. Munasinghe2,
P. Karunaratna3*, V. Fernando1. 1Nutrition department, Medical Research
Institute, Colombo, 2Medical Nutrition Clinic, Clombo North Teaching
Hospital, Ragama, 3Medical Nutrition Clinic, National Hospital Sri Lanka,
Colombo, Sri Lanka
* Corresponding author.
Rationale: TB is one of the most prevalent communicable diseases in
Sri Lanka. Even though the association betweenmalnutrition and TB is
well recognized, available data on the Sri Lankan situation of the above
relationship is inadequate.
The aim of this study was to reveal the prevalence of disease related
malnutrition among pulmonary TB patients in Sri Lanka.
Methods:Adescriptive cross sectional studywas carried out including
257 pulmonary TB patients. Sample calculated with 1.96 standard
normal deviate for 5% α error and desired level of precision of 5%. A
content validated and pretested interviewer administered question-
naire, 24 hour dietary recall, physical examination and anthropometry
were done. Data analysis done with SPSS version 22. Descriptive
statistics, cross tabulation, correlation and paired t test were carried
out to ascertain prevalence and relationships. Statistical significance
was taken as p > 0.05
Results: There were 72.8% males and 27.2% females. At the interview
56.4% of patients had BMI<18.5 kg m2 (56.2%males, 57.1% females) and
23.7% were severely thin. Mean BMI from 18.6 ± 3.9 kg m2 recorded at
initiation, showed improvement with treatment 18.8 ± 4.9 kg m2,
which was not statistically significant. Half of patients (47.8%)
experienced impairment of functional capacity. One third (33% and
29.1%) of patients were identified as having fat and muscle loss
respectively. Gender, ethnicity, level of education, smoking and
alcoholism significantly associated with presence of malnutrition,
whereas age, occupation, monthly income or presence of diabetes or
hypertension were not associated.
Conclusions:More than half of pulmonary TB patients had malnutri-
tion and one fourth of themwere severelymalnourished. Therewas no
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significant improvement of nutritional status with anti TB treatment.
There is a need of addressing malnutrition in TB patients.
Disclosure of Interest: None declared.
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RELATIONSHIP BETWEEN NUTRITIONAL SCREENING TESTS AND
BIOCHEMICAL PARAMETERS IN STROKE PATIENTS
N. Ongun1*. 1Neurology, Burdur State Hospital, Burdur, Turkey
* Corresponding author.
Rationale:Malnutrition is common in stroke patients and evaluation
and monitoring nutritional status with screening tests and laboratory
methods is very important. The aim of this study is to evaluate the
nutritional status of stroke patients and to determine the relationship
between nutritional screening tests and biochemical parameters.
Methods: This prospective study was conducted on 42 acute stroke
patients. Nutritional status were screened with Nutritional Risk
Screening 2002 (NRS-2002) and Mini Nutritional Assessment
(MNA). All patients were evaluated for routine biochemical analyses
including albumin, pre-albumin, complete blood count, iron, vitamin
B12 and lipid profile. Individualized nutritional support was provided
for patients with NRS-2002 score ≥3. Screening tests and biochemical
parameters were performed in first visit and after 4 weeks later.
Statistical analyzes were performed to determine the relation and
correlation between the data.
Results: The mean age of patients was 67.1 ± 16.9 years. The average
MNA score was 22,44 ± 3,13. While 15 patients were under malnutri-
tion risk, 7 patients were found to be malnourished at admission.
Serum albumin and prealbumin levels were significantly lower in
patients under the risk of malnutrition and malnourished group
(p < 0,05) but the other indexes of malnutrition were not different.
MNA scores were higher after nutritional intervention (p < 0,001), but
biochemical parameters did not differ significantly. No correlationwas
found between screening tests and biochemical parameters.
Conclusions: There is no ideal biochemical parameter to show the
nutritional status in stroke patients. Screening tests are more sensitive
in the diagnosis and short-term follow-up of the nutritional status.
Disclosure of Interest: None declared.
MON-PO437
CONSUMER KNOWLEDGE AND USE OF FOOD AND NUTRITION
LABELLING IN SOUTH AFRICA
N. Koen1*, E. Wentzel-Viljoen2, D. Nel3, R. Blaauw1. 1Division of Human
Nutrition, Department of Global Health, Stellenbosch University, Cape
Town, 2Centre of Excellence for Nutrition, Faculty of Health Sciences,
North-West University, Potchefstroom, 3Centre for Statistical Consultation,
Stellenbosch University, Stellenbosch, South Africa
* Corresponding author.
Rationale: The non-communicable disease burden can be addressed
through population-wide interventions, including the promotion of
healthy diets through the provision of adequate nutrition information
on food labels. This study aimed to determine consumer knowledge
and reading of nutrition information on food labels; the self-reported
impact of food and nutrition labelling on purchasing behaviour; and
barriers to and expectations of reading nutrition information.
Methods: In this cross-sectional descriptive study, an interviewer-
administered electronic survey was conducted on adult consumers
(N = 960) at 16 randomly selected grocery stores (from the four main
food retailers in South Africa) in four health districts of Cape Town,
Western Cape, South Africa. Data from the survey was exported from
SurveyMonkey® to Microsoft Excel and analysed using STATISTICA
Version 13. The relation between nominal variables was investigated
with contingency tables and likelihood ratio chi-squared tests.
Regression analysis of a continuous response variable versus ordinal
input was done and the strength of the relationship was measured
with Spearman correlation. A p-value of p < 0.05 represented statistical
significance.
Results: Only 36.0% of participants indicated that they frequently/
always read nutrition information on food labels. Older individuals
(p < 0.05), white participants (p < 0.001), those with a higher level of
education (p < 0.001) and income (p < 0.001) read nutrition informa-
tion more frequently. The main reasons for not reading nutrition
information included buying the same type of product all the time
(34.28%) and not being interested in the nutrition information
(31.44%). The mean food and nutrition label knowledge score was
44.4% (fair or below average) with those that often read the nutrition
information on labels having a significantly higher score (p < 0.01).
Main factors influencing food purchasing behaviour included price
(81.25%), sell-by date (89.16%) and products on special/promotion
(87.08%). Participants would prefer less complex terminology
(79.69%), more pictures/colours (71.15%), a single health endorsement
logo (73.33%) and bigger font sizes (69.17%) to be used on food labels.
Conclusions: Cape Town consumers have fair food and nutrition label
knowledge and do not regularly read nutrition information on labels.
This could explainwhy nutrition informationwas notmentioned as an
important determinant of food purchasing. More should be done to
educate consumers on utilizing the nutrition information on food
labels to make healthier food choices and to simplify food labels for
consumers.
Disclosure of Interest: None declared.
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THE DIABETES RISK EVALUATION WITH FINDRISK IN HEALTHY
ADULTS: KAYSERI/TURKEY
N. Inanc1*, E. Basm̧ısırlı1, A.G. Çapar1. 1Nutrition and Dietetic, Nuh Naci
Yazgan University, Kayseri, Turkey
* Corresponding author.
Rationale: Today, there are many tools for assessing the risk of
diabetes in adults. Especially for this purpose, the FINDRISK is a
screening tool that can be easily used in daily practice. The assessment
made with this survey determines the individual’s risk of having
diabetes within the next 10 years.
Methods: This study was conducted to evaluate the risk of diabetes
with FINDRISK screening on 1500 healthy subjects, aged 18 years and
older in Kayseri/Turkey. Demographic information of the participants
was recorded by face-to-face interviews with the questionnaire. Body
weight, height, waist and hip circumference were measured and Body
Mass Index (kg/m2) was calculated. Individuals were grouped
according to WHO BMI standards. Diabetes risk of participants had
been tried to be revealed by FINDRISK. FINDRISK score of 15 and above
was accepted as high risk in terms of Type 2 diabetes.
Results: Therewas a statistically significant relationship between total
FINDRISK score and gender (p <0.05). While 15.2% of thewomenwere
in high risk group, 12.4% of the men were in high risk group. The
percentage of the women in the low risk group (35.9%) is less than
the men with low risk of diabetes (38.5%). As the BMI increased, the
individuals were found to have a high risk compared to FINDRISK.
Conclusions: As a result of this study, it has been shown that the use of
FINDRISK screening tool can be a effective way to detect the risk of
diabetes in practice.
Disclosure of Interest: None declared.
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MON-PO439
IMPACT OF NUTRITION SUPPORT TEAM (NST) FUNDING FROM THE
BELGIAN NATIONAL HEALTH INSURANCE (NHI) ON THE QUALITYOF
CARE OF HOME PARENTERAL NUTRITION (HPN) IN ADULTS WITH
BENIGN DISEASES
N. Umbrain1, D. Hermans2, P. Schlesser3, M. Hiele4, M. Van Winckel5,
D. Ysebaert6, A. Van Gossum1*. 1Department of Intestinal Diseases and
Nutritional Support, Erasmus Hospital – Free University of Brussels,
2Department of Pediatrics, Saint Luc Hospital – Catholic University of
Louvain, Brussels, 3Department of pediatrics, Centre Hospitalier Chrétien-
Montagnée, Liège, 4Department of gastroenterology, University Hospital
Leuven – Catholic University of Leuven, Leuven, 5Department of pediatric
gastroenterology, Hepatology and Nutrition, Ghent University Hospital –
Ghent University, Ghent, 6Department of Transplant Surgery, University
Hospital Antwerp – University of Antwerp, Antwerp, Belgium
* Corresponding author.
Rationale: Six Belgian academic hospital NSTs received from 2011 to
2017 a funding from the NHI for the follow-up of adult HPN-patients
with benign diseases. We reviewed the NHI requested quality of care
annual reports aiming to analyse the impact of their funding on NST
performance while comparing it with existing data.1
Methods: Patient data were extracted from seven annual reports
(2011–2017) of six Belgian NST academic units involving only adults
HPN-patients with benign diseases. Reported data are: Age,
HPN-incidence and prevalence, HPN-related hospitalisation days/yr,
catheter-related blood stream infection/1000 HPN days (CRBSI),
number of catheter replacements/yr and patient autonomy.
Statistical analysis involves linear regression.
Results:Mean adult prevalencewas 14/million/yr, range[11–19].Mean
adult incidence was 4,7[3,2–6,2] adults per million/yr. Mean age: 55
[18–93]. Sex ratio F/M: 0,57[0,58–0,7]. This represented 634 catheter
yr during 7 yr. The main HPN indication was short bowel syndrome
59,6%. Mean rate of CRBSI was 0,6 [0,4–0,8]. The mean number of
catheter replacement/HPN/yr was 0,31[0,21–0,43]. The mean number
of HPN-related hospitalisation days/yr was 3,26 [1,97–5,00] with a
significant increase:1.97(2011)–5.00(2017)(p < 0,05) but this remains
a small number. 90% of adults are independent on daily medical aid
and have normal (26%), partially (45%) or no activity (19%).
Conclusions: This study demonstrates that the funding of NST in
academic hospitals has allowed to assess and ultimately to control the
number of new cases, to show a lower the HPN- complications than
data,1 and to favour patient autonomy.
Reference
1. Dreesen M et al. Clinical Nutrition. 2013;32:16–26.
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MON-PO440
IMPACT OF NUTRITION SUPPORT TEAM (NST) FUNDING FROM THE
BELGIAN NATIONAL HEALTH INSURANCE (BNHI) ON THE QUALITY
OF CARE OF HOME PARENTERAL NUTRITION (HPN) IN CHILDREN
WITH BENIGN DISEASES
N. Umbrain1, D. Hermans2, P. Schlesser3, M. Hiele4, M. Van Winckel5,
D. Ysebaert6, A. Van Gossum1*. 1Department of Intestinal Diseases and
Nutritional Support, Erasmus Hospital – Free University of Brussels,
2Department of Pediatrics, Saint Luc Hospital – Catholic University of
Louvain, Brussels, 3Department of Pediatrics, Centre Hospitalier Chrétien-
Montagnée, Liège, 4Department of gastroenterology, University Hospital
Leuven – Catholic University of Leuven, Leuven, 5Department of Pediatric
Gastroenterology, Hepatology and Nutrition, Ghent University Hospital
-Ghent University, Ghent, 6Department of Transplant Surgery, University
Hospital Antwerp – University of Antwerp, Antwerp, Belgium
* Corresponding author.
Rationale: Five Belgian academic hospital NST received from 2011 to
2017 a funding from the BNHI for the follow-up of children HPN-
patients with benign diseases. We reviewed the NHI requested quality
of care annual reports aiming to analyse the impact of their funding on
NST performance while comparing it with existing data.1
Methods: Patient data were extracted from seven annual reports
(2011–2017) of five Belgian NSTacademic units involving only children
HPN-patients with benign diseases. Reported data are: Age, HPN-
incidence and prevalence, HPN-related hospitalisation days/yr, cath-
eter-related blood stream infection/1000 HPN days (CRBSI), number of
catheter replacements/yr and patient autonomy. Statistical analysis
involves linear regression.
Results: Mean children prevalence was 12,4/million/yr, range [10–
14,8] and mean children incidence 2,6 patients/million/yr, range [0,8–
4]. Mean age: 6,8 yr range [7 months-17 yr]; gender ratio F/M-ratio
1,97. This represented 177 catheter yr over 7 yr. The main HPN
indication was short bowel syndrome 55%. Mean rate of CRBSI was
1,04/1000 HPN-days, range [0,6–1,6]. The mean number of catheter
replacement/yr HPN was 0,47 range [0,40–0,56]. The mean number of
HPN-related hospitalisation days/yr was 4,9 range [4,0–5,7]. Average
62% of children are able to go to school with parents continuing their
working activities.
Conclusions: This study demonstrates that the funding of NST in
academic hospitals has allowed to assess and ultimately to control the
number of new cases, to show lower HPN-complications than data,1
and to favour patient autonomy.
Reference
1. Dreesen M et al. Clinical Nutrition. 2013;32:16–26.
Disclosure of Interest:N. Umbrain: None declared, D. Hermans Grant/
Research Support from: Belgian National Health Insurance, P. Schlesser
Grant/Research Support from: Belgian National Health Insurance,
M. Hiele Grant/Research Support from: Belgian National Health
Insurance, M. Van Winckel Grant/Research Support from: Belgian
National Health Insurance, D. Ysebaert Grant/Research Support from:
Belgian National Health Insurance, A. Van Gossum Grant/Research
Support from: Belgian National Health Insurance.
MON-PO441
IMPACT OF DIETARY COUNSELING ON CONTROL OF
HYPERPHOSPHATEMIA AMONG HEMODIALYSIS PATIENTS
N.A. Shams1*, N.A. Elsayed2, A.H. Mohammed3, R.M. Elsharkawy4,
R.H. Emara5. 1Nutri Derm Clinic, Alexandria, 2High institute of Public
Health, Alexandria, 3Nephrology, 4chemical Pathology, Medical research
institute, 5Nutrition, High institute of Public Health, Alexandria, Egypt
* Corresponding author.
Rationale: The general objective of this study was to evaluate the
impact of dietary counseling on control of hyperphosphatemia among
HD patients. The specific objectives of the study were to design and
implement individualized renal diet plans for HD patients, determine
the effectiveness of dietary phosphorus restriction, assess the impact
of the renal diet plans on anthropometric indices, laboratory indices
and clinical parameters of protein energymalnutrition and hyperpho-
sphatemia of them.
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Methods: study design: one Pretest posttest intervention study.
targeted patients: patients above 18 years, both sexes anuric attending
hemodialysis unit
The study was conducted on 100 anuric HD patients with serum level
>5.5 mg/dl in the past six months prior to the study. The duration of
the study was 3 months. The studied patients were subjected to full
history taking (medical and dietary) using pre-designed questionnaire
and laboratory investigations. Also anthropometric assessment, SGA
tool for HD patients were used to evaluate their nutrition status. In
addition, they received standard phosphorus education and indivi-
dualizedmeal plans at baseline and at 6weeks after intervention. Then
the effect of the intervention on dietary phosphorus restriction and
serum phosphorus was evaluated 6 weeks after intervention and at
the end of the study.
Results: Phosphorus intake of the studied patients at baseline was
within the recommended level, then it was significantly decreased
from 819.0 ± 526.5 mg to 791.0 ± 529.2 mg during the study period. On
the other hand themean inorganic phosphorus intake frequency score
was high at baseline and it was significantly decreased after 6weeks of
intervention by 60.18 ± 21.89% then it decreased non-significantly by
47.86 ± 42.43% in comparison to baseline. A modest positive correl-
ation between dietary protein intake and dietary phosphorus intake
was found at baseline (r = 0.627*, P < 0.001*).
The mean serum phosphorus in the studied patients was 6.62 ± 0.90
mg/dl at baseline and it showedweak positive correlationwith dietary
phosphorus intake (r = 0.287*, P = 0.004*), then it was significantly
decreased to 5.83 ± 0.96 mg/dl at the end of the study. The mean
calcium × phosphorus product was significantly decreased during the
study period. The current study reported that there was a week to
modest positive correlation between different sources of inorganic
phosphorus intake and serum phosphorus level which strength was
decreased by time till it reached non-significance, except for fast food,
after 3 months.
The results of the current study showed that the most potent factors
which had affected serum phosphorus level as shown in the multi-
linear regression model were total protein intake and inorganic
phosphorus intake at 6weeks after intervention, then at the end of the
study total protein intake remained effective while inorganic phos-
phorus intake lost its effectiveness. At the same time, the total
phosphorus intake became significantly affecting serum phosphorus
level replacing inorganic phosphorus intake at the end of the study.
Conclusions: From this study we concluded that the effectiveness of
inorganic phosphorus intake became weaker at the end of the study
owing to the convenience and availability of fast food denoting that
dietary choices had an important role in phosphorus homeostasis in
HD patients. A significant increase in mean protein intake of the
studied patients occurred which was low at baseline denoting that
individual dietetic counseling may be useful in reducing phosphate
load and in limiting the phosphate burden related to an adequate
protein intake.
Disclosure of Interest: None declared.
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24-WEEK, LOW GI DIET DECREASES TRUNCAL FAT MASS IN SOUTH
INDIANS WITH TYPE 2 DIABETES: A RANDOMIZED STUDY
N. Pavithran1*, H. Kumar2, A. Menon2, P. Ragasudha1, M. Pillai3,
K. Sundaram4. 1Clinical Nutrition, 2Endocrinology, 3General Medicine,
4Biostatistics, Amrita Institute of Medical Sciences and Research Centre,
Amrita Vishwa Vidyapeetham, Kochi, India
* Corresponding author.
Rationale: The effect of low glycemic index (LGI) diet on glycemic
control in Western population has been reported, but its effect with
locally available ingredients of Kerala cuisine in South Indians has not
been examined previously. Hence the aim of the study was to evaluate
the effects of consuming LGI diet on glycemic control and body
composition, specifically truncal and visceral adipose fat mass.
Methods: A randomized, 24-week intervention with LGI diet or usual
diabetic dietwas assigned to subjects with type 2 diabeteswith HbA1c
between 7 and 10%. Anthropometric measurements (BMI, TSF and
waist circumference), biochemical tests like HbA1c and lipid profile
(total cholesterol, triglycerides, LDL,HDL) and body fat composition
(fat mass, fat free mass, truncal fat, android and gynoid fat%) were
measured using DXA and assessed at baseline and after 6months. Two
sample t-testwas applied for parametric test andMannWhitneyU test
was applied for non-parametric.
Results: Thirty patients (M = 16; F = 14) with a mean age of 52 ± 7.7
years (BMI 27 ± 4.3 kg/m2) and having a mean duration of diabetes of
10.6 ± 4.56 years completed the study. Twenty-four weeks of LGI diet
(n = 15) was compared with control group (n = 15). There was a
significant reduction in the study variables in the LGI group vs. control
group: BMI (kg/m2) (26.5 ± 5.34 to 25.7 ± 4.43 vs. 27.5 ± 2.90 to
27.6 ± 2.91; P = 0.013); total body fat%(37.85 ± 7.50 to 36.42 ± 8.21 vs.
34.85 ± 7.87 to 35.64 ± 7.51; P = 0.001); total fat mass (kg) (25.0 ± 8.78
to 23.6 ± 8.04 vs. 25.68 ± 8.27 to 26.34 ± 8.16; P < 0.0001); truncal fat
(kg) (14.5 ± 4.76 to 13.6 ± 4.67 vs. 15.19 ± 5.4 to 15.62 ± 5.13; P = 0.001).
There was a significant reduction between the groups in the android
fat%(46.77 ± 7.14 to 44.57 ± 8.20 vs. 44.54 ± 7.96 to 45.13 ± 7.48;
P = 0.031) and gynoid fat%(38.88 ± 9.72 to 38.30 ± 9.97 vs.
35.42 ± 9.60 to 36.60 ± 9.40; P = 0.026).This decrease in fat mass was
accompanied by a significant decrease in HbA1c % (8.12 ± 0.9 to
7.16 ± 0.72 vs. 8.15 ± 1.03 to 8.24 ± 1.14; P = 0.003) and total cholesterol
(mg/dL)(175.3 ± 39.8 to 157.6 ± 34.3 vs. 154.8 ± 35.5 to 161.7 ± 47.5;
P = 0.05). The fat-free mass did not change in the LGI group.
Conclusions: We concluded that a 24-week LGI diet prepared with
local recipes of Kerala cuisine significantly improved the glycemic
control and reduced the BMI as well as total body fat without affecting
the lean mass thereby promoting a healthy weight loss.
Disclosure of Interest: None declared.
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NUTRITIONAL STATUS AND PHYSICAL QUALITYOF LIFE IN PATIENTS
ABOVE THE 15 YEARS OF AGE SUFFERING FROM CYSTIC FIBROSIS.
O. Kijora-Jaroszewska1*, R. Dudkowiak1. 1Dietetics Division, Department
of Gastroenterology and Hepatology, Wroclaw Medical University,
Wroclaw, Poland
* Corresponding author.
Rationale: Malnutrition caused by cystic fibrosis (CF) remains in a
vicious circle mechanism, together with exacerbations of the disease,
bacterial infections of lower respiratory tract, decline in respiratory
efficiency and worsening of well-being. The aim of the study was to
analyze the nutritional status of patients suffering from CF in relation
to frequency of exacerbations of the disease, hospitalization, respira-
tory efficiency and well-being.
Methods: The study group consisted of 44 patients (20 women, 24
men) from theMedical Centers in Karpacz and Rabka. The patients’ age
range was between 15 and 43. The authorial questionnaire, anthropo-
metric measurements (weight, height), spirometry and laboratory
tests results served to assess the above-mentioned parameters.
Statistical analyses were based on: T-student and U Mann-Whitney’s
tests and correlation coefficients.
Results: Three key conclusions were drawn from the study:
1. Impaired glucose tolerance and diabetes were associated with
higher malnutrition risk (r = 0.488, p < 0,001)
2. Therewas a positive correlation betweenwell-being and ability to
be physically active with nutritional status (BMI) of patients with
CF (r = 0.421 p < 0.012 and r = 0.433, p < 0.009, respectively).
3. The respiratory efficiency (FVC%) was decreasing along with the
decrease in BMI index (r = 0.496, p < 0.002). There was a positive
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correlation between both: well-being and the possibility of
making physical effort, and nutritional status (BMI) of patients
with CF: r = 0.421 p < 0.012 and r = 0.433, p < 0.009, respectively.
Conclusions: In the analyzed group of patients with CF nutritional
status is strongly related to respiratory efficiency, physical activity,
carbohydratemetabolism andwell-being. However, BMI above normal
does not improve spirometry parameters.
Disclosure of Interest: None declared.
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EFFECTS OF DAILY CONSUMPTION OF YOGHURT ENRICHED WITH
VITAMINS B IN COMPARISON TO PLAIN YOGHURT ON TYPE 2
DIABETIC PATIENTS: A RANDOMIZED CLINICAL TRIAL
P. Binou1*, A. Yanni1, V. Karathanos1, K. Kartsioti1, A. Chatzigeorgiou2,
D. Perrea3, P. Konstantopoulos3, N. Tentolouris3, A. Kokkinos3. 1Nutrition
and Dietetics, Harokopio University of Athens, 2DELTA S.A, 3Medical School,
National and Kapodistrian University of Athens, Athens, Greece
* Corresponding author.
Rationale: Vitamins B exert multifunctional roles in energy metabol-
ism while in the state of Type 2 Diabetes (T2D) the requirements may
be higher. Yoghurt naturally contains vitamins of the B-complex and
enrichment with other members of this vitamin class could offer
additional health benefits. The study investigates the effects of
consumption of yoghurt enriched with vitamins B1, B5 and B6
compared to plain yoghurt, on T2D patients.
Methods: Twenty-eight (N = 28, men 75%, age 45–75) overweight/
obese T2D patients (BMI 27–36 kg/m2) were randomized to a 12 week
dietary intervention characterized by the consumption of two servings
per day (2 × 200 g) of non-fat yoghurt either strawberry flavored
enriched with vitamins B1, B5 and B6 in a minimum of 15% of the
recommended dietary intakes per 100 g (VY) or isocaloric plain
yoghurt (PY). Anthropometric characteristics, fasting plasma glucose
and insulin, glycosylated haemoglobin (HbA1C) and basal biochemical
parameters were measured. Concentrations of vitamins B and
homocysteine were also determined in VY group.
Results: At the end of the dietary intervention body weight and BMI
and were reduced in VY group (P = 0.04 and P = 0.04, respectively) and
there was a trend for reduction in HbA1C (P = 0.08), while they
remained unchanged in PY group compared to baseline values. In VY
group, concentrations of B2 and B6 were increased (P = 0.04 and
P = 0.006, respectively) and there was a trend for increase in B1 levels
(P = 0.09). A trend towards reduction in homocysteine levels was also
observed (P = 0.06).
Conclusions: Inclusion of a non-fat yoghurt enriched with vitamins B
in the daily dietary pattern facilitates body weight management,
increases vitamins B concentration and ameliorates homocysteine
levels of overweight/obese T2D patients.
Disclosure of Interest: None declared.
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IMPACT OF BODYMASS INDEX IN THE OCCURRENCE OF IDIOPATHIC
DEEP VEIN THROMBOSIS AND IN THE QUALITY OF LIFE OF GREEK
NURSES
P. Koskinas1, G. Intas2*, P. Stergiannis3, G. Panoutsopoulos4. 1Outpatient
Department, Panarcadiko Hospital, Tripoli, 2Medical Department, General
Hospital of Nikaia ‘Agios Panteleimon’, Nikaia, 3Administration Office,
Oncology Hospital of Agioi Anargyroi, Athens, 4Nursing, University of
Peloponese, Keratsini, Greece
* Corresponding author.
Rationale: Idiopathic deep vein thrombosis (DVT) is a common
disease with high prevalence and various risk factors. The aim of the
study was to investigate the role of body mass index (BMI) at the
incidence of DVT in nursing staff of Greek hospitals and the effect of
BMI at the quality of their life (QoL).
Methods: This is a multi-center descriptive correlation study,
including nurses of Greek hospitals. Estimation of deep vein
thrombosis was donewith the clinical criteria of Hicks or by diagnosis
by clinician. QoLwas assessed using the SF-36 questionnaire. One-way
Anova analysis was used for the statistical analysis of the data.
Results: The study sample consists of 3152 nurses. Totally, 896 (28.4%)
subjects had normal weight, 2143 (68%) were overweight and 113
(3.6%) were obese. Obese patients rather than normal and overweight
patients have lower level of exercise (4.5 ± 0.8 vs. 3.4 ± 1.1 vs. 3.8 ± 0.9,
p < 0.001), increased rate of diagnosis of DVT by physician (45.1% vs.
2.7% vs. 9.2%, p < 0,001) and 3 or more criteria of DVT (60.2% vs. 14.1%
vs. 25.3%, p < 0,001), and lower score of physical function (35.7 ± 38.8
vs. 85.1 ± 28.6 vs. 74.1 ± 35.3, p < 0,001), role limitations due to physical
health (38.9 ± 42.4 vs. 84.9 ± 31.4 vs. 73.6 ± 36.9, p < 0,001), role
limitations due to emotional problems (38.1 ± 41.8 vs. 83.1 ± 33.3 vs.
72.5 ± 38.5, p < 0,001), energy/fatigue (44.7 ± 22.1 vs. 57.9 ± 19.8 vs.
57.1 ± 20.2, p < 0,001), emotional well-being (53.6 ± 18.1 vs. 66.4 ± 18.9
vs. 66.1 ± 17.9, p < 0,001), social functioning (52.4 ± 37.2 vs. 87.7 ± 22.5
vs. 80.6 ± 31.1, p < 0,001), pain (39.8 ± 39.2 vs. 82.6 ± 29.1 vs. 74.7 ± 36.4,
p < 0,001) and general health (42.9 ± 22.9 vs. 65.7 ± 16.8 vs. 60.4 ± 19.1,
p < 0,001). The advanced BMI was found to be prognostic factor for
DVT (β =−0.323, OR = 1.381, 95% CI: 1.302–1.464).
Conclusions: Increased BMI is a risk factor for DVT in nurses and
negatively affects their QoL.
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Rationale: Oral nutritional supplements (ONS) are effective in
managing malnutrition when prescribed for the right patients.
Previous research indicates that inappropriate prescribing of ONS
occurs frequently in the community. Previous Irish research has
demonstrated low awareness of malnutrition and its management
among non-dietetic health care professionals. In Ireland, general
practitioners (GPs) are themain prescribers of ONS in primary care. On
many occasions GPs are the first point of contact for individuals in the
community at risk of malnutrition. GPs’ views can provide insight into
the complexities of managingmalnutrition and ONS prescribing in the
community.
Methods: Semi-structured interviews with nine GPs. Domains
explored; Barriers and facilitators managing malnutrition and ONS
prescribing. Data was transcribed and analysed using inductive
thematic analysis.
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Results: Preliminary themes identified; i) Malnutrition a secondary
concern ii) Resources and support for managing malnutrition are
needed iii) Reluctance to prescribe ONS.
Conclusions: GPs reported not screening for malnutrition, but viewed
it as a consequence of other conditions and social factors. GPs
expressed that they should not have sole responsibility for malnutri-
tion management and more dietitians and trained community nurses
would be desirable to support them. A preference to avoid supple-
mentation and implement dietary changes first was expressed by GPs.
GPs thought that they should receive further independent training on
the different ONS available in the market as currently they did not feel
confident prescribing a range of them. Awareness of ONS cost and its
misuse by certain patients were reported as reasons that made GPs
reluctant to prescribe them, potentially leading to under prescribing.
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Rationale: Malnutrition occurs in developed countries both in
hospitalized patients and in the community setting. Oral nutritional
supplements (ONS) are effective managing malnutrition when
prescribed for the right patients. Previous Irish research has demon-
strated low awareness of malnutrition and its management among
non-dietetic health care professionals. This qualitative study aims to
explore nurses’ and dietitians’ views on the management of
malnutrition and the prescription of ONS in the community in Ireland.
Methods: Four focus groups were conducted, three with dietitians
(n = 17) and one with nurses (n = 5). Domains explored; the term
malnutrition, barriers and facilitators in the management of malnu-
trition and ONS prescribing in the community. Data was transcribed
and analysed using inductive thematic analysis.
Results: Both professional groups showed similar perspectives,and
three preliminary main themes were identified; i) Malnutrition is a
misunderstood term, ii) Delayed treatment of malnutrition, iii)
Challenges with ONS prescription.
Conclusions: Both professionals agreed that the term malnutrition
had negative connotations for patients. Dietitians identified the need
for a multidisciplinary approach to manage malnutrition in the
community, and nurses agreed on their pivotal role identifying the
risk of malnutrition and providing first line advice. However, nurses
expressed the urgent need for training to provide first line advice to
patients to improve their nutritional status to prevent malnutrition.
Both groups also agreed on the need for access tomore dietitians in the
community, and suggested that giving dietitians prescribing rights
would improve appropriate ONS prescribing. Community nurses
identified the need to receive independent generic education on
nutritional supplements.
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Rationale: Anorexia nervosa (AN) is a psychiatric disorder with
potentially serious somatic consequences and high rate of mortality.
Reduced bone mineral density (BMD) is the most frequent chronic
complication. We aimed to study the prevalence of low BMD (Z-score
≤−2 SD) and fractures in severely malnourished inpatients with AN
and to describe their evolution during nutritional care.
Methods: We conducted a retrospective study including all consecu-
tive AN patients hospitalized in Nutritional Care Unit of Raymond
Poincare University Hospital over 2 years. Clinical and biological data
were collected. BMD was evaluated by dual energy X-ray
absorptiometry.
Results: One hundred and one patients were included (97 F/4 M), age
30.7 + 12.1, BMI 12.6 ± 1.6, 68% of patients had a restrictive type (DSM
IVr). At baseline, mean values of lumbar spine BMD Z-score was
−2.2 ± 1.2 SD and of femoral neckwas−1.9 ± 0.86 SD. The prevalence of
Z-score ≤−2 SD for the lumbar spine was 51% and 38% for the femoral
neck (p < 0,01). The prevalence of fractures was about 9.1%.
Associations of low BMD and BMI, restrictive type, onset of disease
and amenorrhea were found (p < 0.01, p < 0.05, p < 0.01, p < 0.001).
After 3 years mean evolution, the mean of BMD increased in 36% of
patients (p = 0.007) in association with improvement of their weight
about 11 ± 10.5 kg (p = 0.04) and vitamin D status (p = 0.002).
Conclusions: AN is associated with a high risk of low BMD and low
kinetics fractures at very young age. Improvement of BMD was
associated with weight gain. Further studies are needed to assess the
management of bone disease in patients with AN.
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Rationale: A gastrostomy is recommended in ALS patients when the
weight loss is over 10% as compared to usual weight, repeated
aspirations, a meal time durationmore than 45minutes. The impact of
gastrostomy on survival of ALS patients is still debated. The objectives
of our work were: i) to search at diagnosis, factors associated with the
indication of gastrostomy ii) to evaluate survival of ALS patients with
gastrostomy indication’s according to their acceptance of the feeding
tube placement.
Methods: ALS patients were followed in the referral ALS centre
between 2006 and 2017 and had from diagnosis to death prospective
evaluations of their neurological (onset form, ALS functional rating
scale revised, bulbar functional scale), nutritional (weight, percentage
of weight loss according to usual weight, body mass index and body
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composition by bioelectrical impedancemetry analysis) and respira-
tory status (forced vital capacity). Statistical analysis was done by
using Mann-Whitney test, Chi² tests, Cox model and multivariate
logistic regression.
Results: Two hundred and eighty-five patients were included. Among
the 63.9% for whom gastrostomy was indicated, 63.7% had accepted
the placement. The median delays diagnosis-indication and indica-
tion-placement were 7.3 months [3.2–15.0] and 2.7 months [0.9–5.8],
respectively. At diagnosis, bulbar onset, a loss of one point of body
mass index and of bulbar functional scale were positively associated
with indication of gastrostomy (aOR = 10.0; p = 0.002, aOR = 1.17;
p = 0.025 and aOR = 1.19; p = 0.002, respectively). Weight loss > 5%
significantly increased the risk of death by 17% (p < 0.0001). However,
gastrostomy placement did not have impact on the survival
(aHR = 1.25; p = 0.22).
Conclusions: Neurological and nutritional criteria were associated
with an indication of gastrostomy. The gastrostomy placement had no
impact on survival. The study of an earlier placement of gastrostomy
and on the impact of the level of enteral nutrition associated might be
of interest in further prospective studies.
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Rationale: TB on its own is associatedwithwasting, loss of weight and
fat free mass (FFM) and this may be a major contributing factor to
increased mortality in these individuals. Published data on body
composition analysis of pulmonary TB is very limited worldwide
including Sri Lanka
To investigate the usefulness of body composition of pulmonary TB
patients for specific treatment.
Methods: A cross sectional study was carried out including 195
pulmonary TB patients attending DCC, in central and one regional
clinic. All new recruits in these clinics were enrolled for the study
during 3 months period. Anthropometry and body composition
analysis was done.
Results: There were 77.9% males and 22.1% females, with mean age of
49.6 ± 13.9 and 42.6 ± 18.7 years respectively. 41.4% males and 48.8%
females were underweight (<18.5 of BMI). Males were having 20.0%
and 5.1% of total fat mass and visceral fat mass respectively, whereas
femaleswere having 21.6% and 5.0%.Males had skeletalmusclemass of
23.9 ± 4.2 kg and females had 24.3 ± 3.6 kg. Underweight males had
12% and 83.2% of fat mass and muscle mass respectively whereas
females had 17% and 80.9%. Underweightmales had visceral fat level of
2% and females had 1.5%.
Conclusions: Half of pulmonary TB patients were underweight.
Females were having low total fat mass and males were within
normal limits. Fat mass is affected than muscle mass in underweight
patients.
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Rationale: Magnesium serves as a cofactor in more than 300
enzymatic reactions and plays a key role in the body’s anti-oxidative
mechanisms. High magnesium intake has been associated with better
prognosis in patients with heart failure (1). However, this beneficial
effect is quite variable, suggesting other factors may interact with the
positive effect of high magnesium intake (2). Therefore, we sought to
determine if potassium intake (an important ion in cardiac function)
could interact with the beneficial effects of magnesium in patients
with heart failure (HF).
Methods: Patients were prospectively enrolled in this cross-sectional
study. We included patients with stable chronic HF and reduced left
ventricular ejection fraction (LVEF). The evaluation of dietary magne-
sium and potassium intake was obtained through a food processor
nutrition analysis software. NT-proBNP (main biomarker in heart
failure hence higher levels imply poor prognosis) was measured to
assess severity of HF. Dietary evaluation and NT-proBNP measure-
ments were done the same day. Multivariable linear regression and
partial correlations were used to assess association between magne-
sium and NT-proBNP.
Results: We included 60 patients (age 60 ± 14 years, male 78%). Only
31% of participants consumed the recommended magnesium daily
intake. In the whole population, magnesium intake showed a modest
correlation with NT-proBNP (rho −0.30, p = 0.020). However, after
comprehensive multivariable regression, a strong interaction was
noted betweenpotassium andmagnesium intake. The beneficial effect
ofmagnesium intake onNT-proBNPoccurred only in patientswith low
potassium intake (partial correlation −0.57, p = 0.002), whereas
magnesium intake was not correlated with NT-proBNP when
potassium intake was high (partial correlation 0.02, p = 0.938;
pinteraction = 0.048).
Conclusions: In patients with stable chronic heart failure and reduced
LVEF, high magnesium intake was associated with beneficial cardiac
effects only when potassium intake was low. Higher potassium intake
led to no cardiac benefits with high magnesium intake.
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Rationale: Heart failure (HF) is a pandemic disease with poor
prognosis. Amino-terminal pro-brain natriuretic peptide
(NT-proBNP) is associated with severity of HF and is a strong predictor
of mortality (1). Pyridoxal 50-phosphate (PLP), nicotinamide adenine
dinucleotide oxidized (NAD) and reduced (NADP) are the metabolic-
ally active forms of pyridoxine and niacin, respectively. These
micronutrients play key roles as cofactors in energy-producing
pathways; thus, potentially contributing to the progression of HF (2).
However, their role with the severity of HF is unclear. Therefore, we
sought to assess the association between thesemicronutrients andNT-
proBNP
Methods: Cross-sectional study. We included patients with stable
chronic HF and reduced left ventricular ejection fraction (LVEF). The
evaluation of dietary intake was obtained through a 24-hour dietary
recall. NT-proBNP was measured with a standardized technique. Both
were performed the same day. Simple and multivariable linear
stepwise backward regression analysis were used to assess association
between these micronutrients and NT-proBNP.
Results: We included 61 patients (age 60 ± 14 years, male 79%, LVEF
30 ± 7%). Median NT-proBNP was 940 pg/mL (interquartile range 376–
2666). Dietary intake of niacin was 22.9 mg±14.9, and pyridoxine
1.2 mg±0.6, respectively. Niacin and pyridoxine showed negative
correlations with NT-proBNP (p = 0.031; p = 0.012; respectively).
After comprehensive adjustment for covariates, only hypertension,
LVEF, and niacin were independently associated with NT-proBNP.
Pyridoxine was also independently associated with NT-proBNP in a
similar model.
Conclusions: Dietary intake of pyridoxine and niacin were independ-
ently associated with NT-proBNP. This suggests that these micronu-
trients could potentially affect the severity of HF.
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Rationale:Anemia is themost common complication of inflammatory
bowel disease (IBD). Iron deficiency, precedes the development of
anemia, can be one of the first manifestations of undernutrition.
Maldigestion and malabsorption associated with disease activity
(hypermetabolism), location of lesions, fear of eating and using
irrational diets significantly affect the risk of undernutrition and the
need for nutritional support in IBD patients.
Methods: Assessing how the composition of the diet used by IBD
patients affects the incidence and extent of latent iron deficiency and
anemia.
42 patients with Crohn’s disease (CD; 11 women, 31 men) and 34
patients with ulcerative colitis (UC; 13 women, 21 men) underwent
assessment of daily nutrition at the time of admission to the
gastroenterology ward. Data on food intake were collected using the
nutritional diary (information from the 3 days preceding
hospitalization).
All patient underwent blood investigation comprising hemoglobin
(HGB), ferritin, transferrin and serum iron. Anemia defined as a HGB
level of less than 12.0 g/dl in females and less than 13.0 g/dl in males
has been established in 10 patients with CD (24%) and 13 patients with
UC (38%).
Results: 59% patients had impaired iron homeostasis: 23 patients had
anemia (10 CD; 13 UC), and 22 iron deficiency (12 CD; 10 UC). The
occurrence of anemia was significantly statistically related to the
number of exacerbations of the IBD in the last year (p = 0.0454). There
was no relationship between the duration of the disease, the type of
treatment used and the stage of the disease to iron deficiency and
anemia.
47 patients (62%) of the patients had a correct BMI (25 CD; 22 UC). 50
patients (CD 22, UC 28) declared compliance with dietary recommen-
dations related to the disease. The average iron supplywas 13.7 mg (SD
±4.9 mg) for the whole group. Women supplied 12.5 mg (SD±4.7 mg)
of iron with food, while men supplied 14.2 mg (SD±5.0 mg). Patents
with CD consumed less in this microelement (12.6 mg; SD±4.4 mg),
compared with patients with UC (15.0 mg; SD±5.3 mg). It was shown
that statistically significantly lower supply of iron in the diet occurred
inwomen (p = 0,0109 – both types of IBD) and patients with ulcerative
colitis (p > 0,0001).
The disease statistically significantly affects the introduction of dietary
restrictions to the daily diet in UC patients (p = 0.0062). The diet used
by IBD patients showed a statistically significant effect on the
occurrence of iron deficiency (p = 0,0341) but not anemia (p = 0,1311).
Conclusions: It has been shown that in addition to activity of
inflammatory bowel disease, the diet is also important in the
development of the iron defiiciency and anemia. Based on the study
conducted, special attention should be paid to prevention in women
and patientswith ulcerative colitis. A properly balanced dietmay be an
important element that reduces the risk of developing the most
common parenteral manifestations of IBD = anemia.
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Rationale: Food Insecurity (FI) in Home Enteral Nutrition (HEN)
occurs when the Human Right to Adequate Food Intake is disre-
spected. Thus, the aim of this study was to verify the correlation
between nutritional formulae categories and FI in households of
patients in HEN, beneficiaries of the Programme of Nutritional
Attention to People with Special Feeding Needs (PAN).
Methods: A cross-sectional observational study within the households
of PAN patients over 18 years old was performed. Data was collected
between December 2015 and June 2018 in Curitiba/PR, Brazil.
Nutritional formulae were categorized as commercial, with food and
mixed (food + supplement). FI was evaluated by short-form version of
the Brazilian Scale of Food Insecurity (EBIA). Statistical analysis was
carried out bymeans of chi-squared test, with level of significance of 5%.
Results: 130 HEN patients were included (mean age: 64.6 ± 20.8
years), being 51.5% (n = 67) men, 72.3% (n = 94) with nervous system
diseases and 20.8% (n = 27) with cancer. The most frequent nutritional
formula category was mixed (53.1%, n = 69), followed by commercial
(34.6%, n = 45) and with food (12.3%, n = 16). FI was observed in 50.0%
(n = 65) of households. Nutritional formula category and diagnose did
not associate to FI (p = 0.163 and p = 0.492, respectively). Households
with male HEN patients presented higher FI frequency in comparison
to households with female HEN patients (66.1% e 33.8%, respectively,
p = 0.001). Male patients received mixed formula more frequently
compared to female patients, that received commercial formula more
frequently (p = 0.002).
Conclusions: Nutritional formula category could not be linked to FI in
households of HEN patients’ beneficiaries of PAN, but being male and
receiving mixed nutritional formula can influence presence of FI.
Disclosure of Interest: None declared.
MON-PO455
ACOMPLETE LINKAGEDISEQUILIBRIUM INAHAPLOTYPEOF THREE
SNPS IN FAT MASS AND OBESITY ASSOCIATED (FTO) GENE WAS
STRONGLY ASSOCIATED WITH ANTHROPOMETRIC INDICES AFTER
CONTROLLING FOR CALORIE INTAKE AND PHYSICAL ACTIVITY
S. Doaei1*, M. Gholamalizadeh2. 1Research Center of Health and
Environment, Guilan University of Medical Sciences, Rasht, Iran, Rasht,
2Cancer Research Center, Tehran, Iran, Islamic Republic of
* Corresponding author.
Rationale: The underlying mechanism of the effect of FTO genotype
on body mass index (BMI) and body composition is unknown. The
objective of the study was to investigate the association of FTO gene
polymorphisms with anthropometric indices in adolescent boys after
adjustments for dietary intake and physical activity.
The underlyingmechanismof the effect of FTO genotype on bodymass
index (BMI) and bodycomposition is unknown.
Methods: In this school-based study, we enrolled 123 male adoles-
cents without extra weight and 110 adolescents with BMI higher
than + 1 Z-score. The DNA samples were genotyped for the FTO gene
polymorphisms by DNA Sequencing. BMI and body composition were
assessed using BIA scale. Association of the FTO polymorphisms with
Weight, height, BMI, body fat percent and skeletal muscle percent
were investigated.
Results: Adolescents with higher BMI and body fat percent and lower
skeletal muscle percent were more likely tohave a newly found
haplotype of rs9930506, rs9930501 & rs9932754 (GGT) in the first
intron of the FTOwith completelinkage disequilibrium (LD) compared
with those with the lower BMI (6.15;2.28–16.63), body fat percent
(9.54;0.92–47.44) and higher skeletal muscle percent (9.26;1.85–
46.38).
Conclusions: haplotype in the first intron of the FTO gene had a strong
association with obesity indices in adolescentboys after adjustments
for calorie intake and physical activity. It’s suggested that the FTO
genotype exert its effects onadolescents’ anthropometric indices as
haplotype and through mechanisms other than changes in caloriein-
take and expenditure.
References: Haplotype in the first intron of the FTO gene had a strong
association with obesity indices in adolescent boys after adjustments
for calorie intake and physical activity. It’s suggested that the FTO
genotype exert its effects on adolescents’ anthropometric indices as
haplotype and through mechanisms other than changes in calorie
intake and expenditure.
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INVESTIGATION OF EXERCISE AND ACTIVITY LEVELS AMONG
PATIENTS ON HOME PARENTERAL NUTRITION WITHIN THE
REGIONAL INTESTINAL FAILURE SERVICE NORTHERN IRELAND.
L.A. Harrison1, S.-J. Hughes2*. 1School of Biomedical Sciences, University
of Ulster, Coleraine, 2Nutrition Support Team, BHSCT, Belfast, United
Kingdom
* Corresponding author.
Rationale: The aim of this investigation is to determinewhether home
parenteral nutrition (HPN) treatment effects exercise and activity
levels in patients. Intestinal failure is a ‘reduction in the functioning
gut mass below theminimal amount necessary for adequate digestion
and absorption of food’. Parenteral nutrition refers to the provision of
nutrients by the intravenous route and is a form of artificial nutrition
for intestinal failure (IF) patients. Over the past decades, considerable
knowledge has accumulated for the signiﬁcance of exercise in the
treatment of a number of diseases.1 Exercise is indicated in the
treatment of a large number of medical disorders.2,3
Methods: A survey of 17 patients on HPN; participants aged between
17–84; 7 male, 10 female. A survey was devised by creating a list of
questions and distributed by post to all HPN outpatients within the
Regional Intestinal Failure Service, Northern Ireland. The survey was
compiled of multiple choice and short answer questions, using
language that is appropriate and easy to read so that the patients
could understand. All relevant data for the current analysis were
collected from the survey.
Results: Since starting HPN 76% of respondents have been able to
exercise although these activities may not have been as high impact as
before starting HPN. There is a correlation in the hours and nights
infused per week and the frequency and duration of exercise. As the
hours and nights of infusion increased the frequency and duration of
exercise decreases. The most common barriers to exercise were
discomfort and pain and illness/fatigue.
Conclusions: These results support the hypothesis that HPN can have
a negative effect on exercise and activity levels in patients but it is not
the only contributing factor.
References
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MON-PO457
UNDERLYING CAUSES OF VITAMIN K DEFICIENCY IN PATIENTS
TREATEDWITH HEMODIALYSIS
S.Wikstrøm1*, K.A. Lentz1, D. Hansen2,3, L.M. Rasmussen4, J. Jakobsen5,
H.P. Hansen2,3, J.R. Andersen1. 1Department of Nutrition, Exercise and
Sports, University of Copenhagen, Copenhagen, 2Department of
Nephrology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev,
3Department of Clinical Medicine, University of Copenhagen,
Copenhagen, 4Department of Clinical Biochemistry and Pharmacology,
Odense University Hospital, Odense, 5National Food Institute, The
Technical University of Denmark, Lyngby, Denmark
* Corresponding author.
Rationale: A low vitamin K status is common in patients in
hemodialysis, and this is considered one of the reasons for the
accelerated atherosclerosis in these patients. The vitamin is essential
in activation of the protein MGP, and the inactive form, dp-ucMGP is
used to measure vitamin K status. The reason for the low vitamin K
status in these patients is not known. The purpose of the study was to
investigate possible underlying causes, which potentially can be low
intake, washout during dialysis or inhibited absorption capacity.
Moreover, the aimwas to asses if the biomarker dp-ucMGP is affected
in plasma and dialysate.
Methods: Vitamin K intake was assessed by FFQ (n = 16) and
absorption capacity by D-xylose-test (n = 7). P-dp-ucMGP was mea-
sured before and after dialysis, and phylloquinone and dp-ucMGP was
measured in the dialysate. Differences in p-dp-ucMGP were measured
after 14 days of protein supplementation (n = 16).
Results: All patients had p-dp-ucMGP above 750 pmol/L. 63% of the
women and 45% of the men met the recommended intake for vitamin
K, with a median of 1856 pmol/L. Difference in p-dp-ucMGP before
and after dialysis was −1022 pmol/L (p < 0,0001). Vitamin K (phyllo-
quinone) was not present in the dialysate, but dp-ucMGP was
measured in high concentration. The difference in p-dp-ucMGP
before and after protein supplementation was −165 pmol/L (−1690–
373) (p = 0,06). D-xylose tests were normal.
Conclusions: P-dp-ucMGP was increased in all patients meaning
vitamin K deficiency. The reason for the low vitamin K status is
probably not removal of phylloquinone during dialysis or decreased
absorption, but is probably due to low intake of vitamin K. The dp-
ucMGP is washed out during dialysis and thereby markedly affected.
The level of p-dp-ucMGP is not affected by protein intake.
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A CROSS-OVER TRIAL OF THE EFFECTS OF DIET RICH IN VITAMIN K
ANDVITAMIN K SUPPLEMENTATION IN TABLETS IN PATIENTSWITH
VITAMIN K DEFICIENCY IN HEMODIALYSIS. AND THE EFFECT OF
BOILING ON THE CONTENT OF VITAMIN K IN BROCCOLI
K.A. Lentz1, S.Wikstrøm1*, D. Hansen2,3, L.M. Rasmussen4, J. Jakobsen5,
H.P. Hansen2,3, J.R. Andersen1. 1Department of Nutrition, Exercise and
Sports, University of Copenhagen, Copenhagen, 2Department of
Nephrology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev,
3Department of Clinical Medicine, University of Copenhagen,
Copenhagen, 4Department of Clinical Biochemistry and Pharmacology,
Odense University Hospital, Odense, 5National Food Institute, The
Technical University of Denmark, Lyngby, Denmark
* Corresponding author.
Rationale: A low vitamin K status is common in patients in
hemodialysis. Because of potassium and phosphate restrictions in
their diet the amount of vitamin K-rich foods are often limited to a
minimum. The purposewas to investigate if a diet rich in vitamin Kor a
supplement with vitamin K could improve the vitamin K status in
these patients.
In addition it was examined if boiling of broccoli affected the
potassium and phylloquinone ratio.
Methods: 10 patients participated (9 completed both periods) in a 15
weeks long crossover study consisting of two 6-weeks interventions
interrupted by a three-weeks wash-out period. The diet-intervention
focused on a diet rich in menaquinones and phylloquinones and the
tablet intervention (MK-7) consisted of a daily supplement with
360 μg. P-dp-ucMGP (biomarker of vitamin K status) was measured
before, after 3 weeks and after 6 weeks of intervention. Vitamin D
(p-25-OH-Vitamin D) and coagulations factors (INR) was measured as
well.
Broccoli was boiled for 2 and 8minutes. Phylloquinone and potassium
koncentrations were measured before and after.
Results: P-dp-ucMGP differences in the diet-intervention were
26 pmol/L (−1335–2205) (p = 1) and −417pmol/L (−1257–44) (p =
0,007) in the MK-7-intervention. P-25-OH-Vitamin D differences in
the diet-intervention were −6 nmol/L (−38–46) (p = 0,374) and
−16 nmol/L (−61–154) (p = 0,066) in the MK-7-intervention. INR
differences were 0 (−0,1–0,0) (p = 0,083) in the diet-intervention
and 0 (−0,1–0,0) (p = 1) in the MK-7-intervention.
After 2 min of boiling, the potassium content was reduced by 24% (±1)
and phylloquinone content by 8% (±8). After 8 min of boiling,
potassium was reduced by 51% (±3) and phylloquinone 7% (±3).
Conclusions: MK-7-supplementation lowered p-dp-ucMGP signifi-
cantly more than menaquinone and phylloquinone focused diet,
meaning that the MK-7 supplementation was much more effective.
However, the compliance to the dietwasn’t good. VitaminD statuswas
decreased in-significantly during the MK-7-intervention and should
be investigated further.
Boiling broccoli decreases the potassium concentration and retains
phylloquinone concentrations. This could be of importance in dietary
guidance.
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SUPERIOR MESENTERIC ARTERY SYNDROME IMPROVED BY
ENTERAL NUTRITIONAL THERAPY: A RETROSPECTIVE STUDY IN A
SINGLE INSTITUTION
S.Wan1*, J. Yang1, X.Wang1. 1Research Institute of General Surgery, Jinling
Hospital, Medical School of Nanjing University, Nanjing, China
* Corresponding author.
Rationale: Background Superior mesenteric artery syndrome (SMAS)
is a relatively rare cause of chronic duodenal obstruction, owing to the
compression of the third portion of the duodenum. This retrospective
study aims to discuss the efficacy of enteral nutrition in nutritional
status and symptom improvement at a short-term follow-up for SMAS
patients.
Methods: We retrospectively analyzed the clinical data of patients
who are diagnosed with SMAS and treatedwith enteral nutrition from
September 2012 to January 2019.
Results: Twenty-six patients were included. The mean age was
24.96 ± 11.77 years; 16 of which were women, accounting for 61.5%.
Themean bodyweightwas 40.94 ± 10.16 kg, themeanweight loss was
11.73 ± 7.58 kg, and themean BMIwas 14.82 ± 2.52. Themean duration
of EN therapy was 10.10 ± 4.66 months. Two types of enteral nutrition
routes were used in these patients, including 14 cases of percutaneous
endoscopic gastrostomy with jejunal extension tube (PEG-J) and 12
cases of nasal jejunum tube (NJ). The serum level of hemoglobin,
albumin, pre-albumin, transferrin, RBP and IGF-1 increased signifi-
cantly (p < 0.05) after enteral nutrition therapy, and BMI and body
weight also notably increased. Through a median follow-up of 24
months (9–44) after EN therapy, the mean symptom score remarkably
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decreased from 24.28 ± 9.57 to 8.06 ± 8.29 (p < 0.0001). The clinical
outcomes based on the patients’ satisfaction with the treatment
showed that 65% of patients’ symptomswere resolved (13/20) and 15%
of patients’ symptoms were improved (3/20). A total of 16 complica-
tions occurred, including tube blockage (5/16), peristomal wound
infections (5/16), peristomal leakage (5/16), granulomas (5/16), and
nasopharyngeal pain (5/16).
Conclusions: Enteral nutrition therapy was proved to be an effective
and safe treatment option for SMAS patients. Moreover, even if it
cannot completely improve symptoms, it can improve the nutritional
status for subsequent treatment.
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ACCUTE EFFECTS OF DIET IN OLDER ADULTS WITH A RISK
PHENOTYPE FOR NEURODEGENERATIVE DISEASES USING
NEUROFILAMENT LIGHT: A PROOF OF CONCEPT
S. Becks1*, Y. Schönknecht1, J. Göpfert2, R. Fimmers3, P. Stehle1,
M.-C. Simon1, S. Egert1,4. 1Department of Nutrition and Food Sciences,
University of Bonn, Bonn, 2Natural and Medical Sciences Institute at the
University of Tuebingen, Tuebingen, 3Institute of Medical Biometry,
University Hospital Bonn, Bonn, 4Institute of Nutritional Medicine,
University Hohenheim, Hohenheim, Germany
* Corresponding author.
Rationale: Neurofilament light (NfL) is a scaffolding protein that is
exclusively expressed in neurons and released into the cerebrospinal
fluid and at lower concentrations into the bloodstream upon
neurodegeneration. The aim was to investigate the effects of meals
representing two different dietary patterns on neuronal response by
analyzing the neuroaxonal injury marker NfL in serum.
Methods: In a randomized crossover trial, each participant consumed
two iso-energetic (4300 kJ) meals, a Western diet high carbohydrate
and a Mediterranean diet meal (rich in oleic acid, n-3-fatty acids,
dietary fiber and antioxidants). Blood sampleswere collected at fasting
and 1.0, 2.0, 4.0 h postprandially. Serum NfL concentrations were
analyzed in 44 participants (25 male; range 60–80 y) with metabolic
syndrome traits using an ultrasensitive single molecule array method
(Simoa, Quanterix). Statistical analyses included correlation analyzes
and linear mixed models with age and baseline concentration as
covariates.
Results: Postprandial serum NfL concentrations decreased to a
minimum NfL level after 2 h (−13.5%, −14.6% respectively, P < 0.001)
independent of meal composition. Furthermore baseline serum NfL
concentrations (15.9 ± 6.0 pg/ml) were positively correlated with age
(mean age 69 ± 5 years; r = 0.57, P < 0.001) and no gender specific
differences were found in baseline concentrations or postprandial
responses.
Conclusions: Preliminary results showed a postprandial effect on
serum NfL concentrations independent of meal composition. As
expected the elevated baseline analyte levels observed in older
participants were correlated with age, which might be related to
neuronal degeneration. This assumption needs to be confirmed in
further studies.
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COMORBID ANXIETY AND DEPRESSION IN INTESTINAL FAILURE
AND COLORECTAL PATIENTS
S.C.A. White1*, F. Bergin2, F. Downie2, T. Rassam2. 1Colorectal Surgery,
2Newcastle Upon Tyne Hospitals, Newcastle Upon Tyne, United Kingdom
* Corresponding author.
Rationale: Significant comorbid anxiety and depression amongst
Intestinal Failure (IF) patients have often been observed by our team,
but we had never formally assessed this. Input from Health
Psychology/ Liaison Psychiatry services is not currently routine for IF
patients at our hospital. We therefore conducted a service review to
identify the level of unmet need.
Methods: We asked patients with Type 2 IF (defined as requiring
parenteral nutrition for at least 28 days1) to complete a Hospital
Anxiety and Depression Scale (HADS). We also extended this to
Colorectal patients not requiring parenteral nutrition for any length of
time.
The HADS is a well-validated tool used to identify cases of
anxiety disorders and depression and assess symptom severity.2 It is
a self-rating questionnaire, which generates a sub-score for both
anxiety and depression and classifies a score of 0–7 as normal, 8–10 as
a ‘borderline case’ and 11–21 as a ‘case’.
Results: The mean anxiety and depression scores for IF patients were
9.8 and 9.1, compared with 6.5 and 5.8 for Colorectal patients. This
represents a statistically significant difference in symptomatology
scoring between the groups (p = 0.0192 and p = 0.0051 respectively).
Both groups scored higher than the reported UK population averages
of 5–6 for anxiety and 3 for depression.3
There were 11 cases and 6 borderline cases of anxiety disorders in the
IF group (28 patients), versus 7 cases and 6 borderline cases amongst
the Colorectal group (30 patients). For depression, there were 11 cases
and 3 borderline cases amongst the IF group, versus 6 cases and 5
borderline cases amongst the Colorectal group.
11 of the 18 IF patients with abnormal scores had never accessed any
kind of professional mental health support.
Conclusions: These results confirm that anxiety and depression are a
particular problem amongst IF patients, although it should be noted
that a substantial number of Colorectal patients were also classified as
anxious or depressed. We are changing our practice to offer better
psychological support.
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INTRAVENOUS LIPID EMULSIONS AND LIVER FUNCTION IN ADULT
CHRONIC INTESTINAL FAILUREPATIENTS: POST-HOCRESULTS FROM
A RANDOMIZED CLINICAL TRIAL
S. Klek1*, K. Szczepanek1, L. Scislo2, E. Walewska2, M. Pietka1,
M. Pisarska3, M. Pedziwiatr3. 1Stanley Dudrick’s Memorial Hospital,
Skawina, 2Institute of Nursing and Midwifery, 32nd Department of
General Surgery, Jagiellonian University Medical College, Krakow, Poland
* Corresponding author.
Rationale: Intravenous lipid emulsion (ILE) is an essential component
of parenteral nutrition (PN), but also one of the key risk factors for
development of intestinal failure associated liver disease (IFALD). The
direct comparison of ILE during long-term PN has only been
performed once and for the time period of 12 months. The aim of
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the study was to analyse the influence of ILEs on liver function during
PN administered for more than two years.
Methods: A randomized, controlled clinical trial was performed at the
Intestinal Failure Center in Skawina, Poland. Fifty-one patients (30 F,
21 M, mean age 53.9 years) enrolled to home parenteral nutrition
(HPN) due to stable chronic intestinal failure (CIF), were randomized to
receive one the following ILEs for 12 months and then continued
observation for next 4 years: medium/long-chain triglycerides (MCT/
LCT), olive oil/LCT (OO/LCT) and a mix of LCT/MCT/OO/fish oil (SMOF).
Liver function was assessed clinically and with biochemical para-
meters (total bilirubin, SGOT, SGTP, GGPT, alkaline phosphatase) every
6 months.
Results: 41 of 51 patients finished 5-year study period. The most
common reason for intestinal failure (IF) was short bowel due to
mesenteric ischaemia, followed by Crohn’s disease, surgical complica-
tions and radiation enteritis. No signs of essential fatty acids deficiency
were diagnosed. All three ILEs demonstrated comparable influence on
liver in all study periods regarding bilirubin concentration (study
entry: OO/LCT: 18.0 (11.6–33.7), MCT/LCT 9.4 (5.9–16.0), SMOF 9.4
(7.6–12.3); study termination: 15.1 ± 5.5, 12.2 ± 8.7 and 11.1 ± 9.7,
respectively, p < 0.05) as well as GGTP, SGOT, SGPT and alkaline
phosphatase.
Conclusions: All ILEs of second and third generation can be used in
long term parenteral nutrition without increasing the risk of
complications.
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RARE COMPLICATIONS OF HOME PARENTERAL NUTRITION (HPN)
S. Klek1*, K. Szczepanek1, M. Pietka1, E. Walewska2, L. Scislo2,
M. Sumlet1, M. Kupiec1. 1Stanley Dudrick’s Memorial Hospital,
Skawina, 2Institute of Nursing and Midwifery, Krakow, Poland
* Corresponding author.
Rationale: Long term complications of home parenteral nutrition
(HPN) can be divided according to their incidence into relatively
frequent, such as central line catheter related bloodstream infection
(CR-BSI) and rare, such as intestinal failure related liver disease
(IFALD). Both of those may be life-threatening and can significantly
deteriorate the quality of life. The aim of the study was to analyze to
incidence of rare complications and their impact on clinical course.
Methods: A retrospective analysis of 582 patients (310 F, 272 M, mean
age 56.7) receiving HPN between December 1999 and December 2018
at the Intestinal Failure center in Skawina. All patients received
complex home care including wide-ranging medical supervision and
home PN delivery. All patients or their caregivers were trained at
hospital settings for at least 10 days before the onset of HPN.
Results: During analyzed period CRBSI’s ratio reached 0.42 episode/
1000 CVC days. Rare complications were observed in 24 patients
(4.1%). Themost frequentwas upper venous system thrombosis (n = 7),
followed by renal failure (n = 3), mechanical damage of central venous
catheter (n = 3), endocarditis (n = 3), metabolic bone disease with
pathologic fractures (n = 2), IFALD (n = 2), intracerebral abscess (n = 1),
respiratory failure (n = 1), severe pancreatitis (n = 1), fungal retinitis
(n = 1). 7 of 24 (29.1%) patients with rare complications died.
Conclusions: The reduction of the incidence of frequent HPN
complications can be achieved by the thorough training. In those
long term patients more attention must be paid, however, also to rare
complications, which may deteriorate not only the quality of life, but
also result in death.
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TITLE: EFFECTOF INDIVIDUALIZED DIETARYCOUNSELING IMPROVE
HYPERPHOSPHATEMIA AMONG HEMODIALYSIS PATIENTS
S.A. Khalil1*. 1Nutrition Services, King Faisal Specialist Hospital and
Research Centre Jeddah, Kingdom of Saudi Arabia, Jeddah, Saudi Arabia
* Corresponding author.
Rationale: Hyperphosphatemia is a significant health problem in end
stage renal disease (ESRD) patients on hemodialysis (HD). It can lead to
cardiovascular, bone and other disorders as well as to secondary
hyperparathyroidism and is also associated with increased prevalence
of mortality in HD patients. The aim of present study was to evaluate
effect of nutrition counseling and dietetic intervention on hyperpho-
sphatemia management.
Methods: The study was organized big dialysis centers in Khartoum
during 6 months. ESRD patients (n = 145) on regular HD (two-three
times weekly), dialyzed for at least 3 months were included to the
study. They were divided into test group (n = 83) and control group
(n = 62). The test group received nutritional counseling and consumed
individualized diets (restricted in phosphate according to National
Kidney Foundation) for a period of 6 months. The control group
consumed usual diets. Serum phosphorus levels were measured at
baseline and 2, 4 and 6 months after start of the study.
Results: Serum phosphorus levels decreased significantly from
5.6 mg/dL to at baseline 4.8, 4.2 and 3.8 mg/dL 2, 4 and 6 months
after the onset of study in the test group. In control group the decrease
was mild and insignificant (5.0, 5.0, 4.7 and 4.3 mg/dL, at baseline, 2, 4
and 6 months). Significant difference between groups were apparent
in month 4 and 6 (p < 0.05).
Conclusions: The study demonstrated that effective nutritional
counseling was effective in the control and improvement of serum
phosphorus level among HD patients. Therefore, nutritional counsel-
ing by qualified dietitians should bemandatory in renal units as part of
the medical therapy management to reduce the incidence of
hyperphosphatemia in HD.
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THE USE OF THE INDIRECT CALORIMETER TO ESTIMATE BASAL
ENERGY REQUIREMENT IN A WEIGHT MANAGEMENT PROGRAM
FOR OSA PATIENTS: A PILOT STUDY IN HONG KONG.
T.H.Y. Ting1*, C.Y. Wong1, C.W. Chen2, K.L. Choo2. 1Dietetics Deaprtment,
2Department of Medicine, North District Hospital, Hong Kong, China
* Corresponding author.
Rationale: Fifty-eight percentagemoderate to severe obstructive sleep
apnea (OSA) in adults are obese. Studies have proven that OSA patients
are more prone to develop cardiovascular and metabolic diseases.
Lifestyle modification program is recommended for all overweight
OSA adults to improve airway patency. This review investigated the
effectiveness of a weight management program using an indirect
calorimeter to estimate the basal energy requirement for OSA adults in
a Hong Kong acute hospital.
Methods: Seventeen obese OSA patients (BMI≥ 30 kg/m2) with mean
age of 49 year-old (SD±9.9 years) were recruited to attend an intensive
weightmanagement program from Jan to Dec 2018. Patientswere seen
by a dietitian monthly. Indirect calorimeter was used in the first
assessment to accurately measure their basal energy expenditure
(BEE). Bioelectrical impedance analyzer was used to collect the body
weight, body fat percentage (Fat %), and fat free mass (FFM). Mean
weight of the intervention group was compared with the historical
control group (n = 17), Fat %, FFM, and waist circumference (WC) were
compared before and post intervention (the third intervention).
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Results: The weight lost is significantly higher in the intervention
group (IG). The baseline and post-test mean weight of the IG are
107.0 ± 26 kg and 105.0 ± 24.9 kg respectively (p < 0.01). Whereas the
baseline and post-test mean weight of the control group are 93.2 ±
19.4 kg and 93.6 ± 19.2 kg respectively (p = 0.48). Fat % in the IG is
significantly lowered at the post-intervention (baseline 41.8 ± 10.8%,
post-test 40.7 ± 11.5%, p < 0.01). The FFM is significantly correlated
with the BEE of the OSA patients in this pilot (p = 0.038, r = 0.48).
Conclusions:Using an indirect calorimeter can accuratelyestimate the
basal energy expenditure for designing an effective diet plan for OSA
patients. Lifestyle modification that can increase FFM may have a
positive effect on the BEE of the OSA patients. A longitudinal study is
recommended to investigate the sustainability of similar lifestyle
modification program for OSA adults.
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THE EFFECTS A OF 12 WEEKS GROUP DIABETES EDUCATION
PROGRAM ON FASTING PLASMA GLUCOSE FOR LAO PATIENTS
WITH TYPE 2 DIABETES
U. Bahne1*, V. Vongvandy2, J.R. Andersen1. 1Department of Nutrition,
Exercise and Sports, University of Copenhagen, Copenhagen, Denmark,
2Center of Diabetes, Mahosot Hospital, Vientiane, Lao People's Democratic
Republic
* Corresponding author.
Rationale: The number of diabetics in the Laotian population is
sharply rising. Therefore, there is an increased need for innovative
thinking and effective treatment of diabetes. In Laos, diabetes schools
have not previously been developed and implemented as part of the
treatment of diabetes. The aim of the study was to implement a
12-week diabetes school for adults with type 2 diabetes and examine
the effect on plasma glucose (FPG), weight change, body mass index
(BMI), waist to hip ratio (WHR), blood pressure, lipid profile, HbA1c
and the quality of life as well as the patient’s own perception of their
disease
Methods:One hundred patientswith type 2 diabetes (≥18 years) were
randomized, 50 to the intervention group with participation in the 3-
day diabetes school: nutritional advices, physical activity and under-
standing of disease and knowledge and management of diabetic late
complications. 50 patients in the control group did not attend the
diabetics school. The study was an unblinded. Quality of life (EQ-5D)
and the patient’s own perception of their disease are evaluated using
semi-structured interviews by the staff.
Results: Twelve weeks of diabetic school reduces FPG significantly
(intervention: −21.0 mg/dl±88.8 mg/dl (SD) control: +18.6 mg/dl
±48.8 mg/dl (SD), (P = 0.02). BMI was also significantly reduced in
intervention group (intervention: −0.3681 kg/m²±0.62 kg/m² (SD),
control: +0.1042 kg/m²±0.90 kg/m² (SD), (P = 0.05). There is no effect of
the intervention on HbA1c, blood pressure, WHR or lipid profile.
The two semi-structured focus group interviews showed, that many of
the patients do not understand the consequences of their type 2
diabetes, and do not worry about the late complications before these
are a reality. Dietary treatment and physical activity is not an
integrated part of diabetes treatment in Laos, so this is unknown for
both patients and for large numbers of health professionals.
Conclusions: The 12-week diabetes school reduces FPG and BMI.
Disease insight is generally compromised in the Laotian population
with type 2 diabetes, so education such as the diabetes-schoolmust be
considered relevant to patients as well as health professionals.
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SEPTIC, THROMBOTIC AND MECHANICAL COMPLICATIONS IN
CENTRAL VENOUS CATHETERS OF NON ONCOLOGIC PATIENTS IN
HOME PARENTERAL NUTRITION FOR CHRONIC INTESTINAL
FAILURE. A RETROSPECTIVE OBSERVATION STUDY
U. Aimasso1*, E.C. Capello1, M. Fadda1, F.D. Merlo1, A. De Francesco1,
B. Mussa2. 1Medicine, Clinical Nutrition, 2Surgery, Citta della Salute e
della Scienza, Turin, Italy
* Corresponding author.
Rationale: Home parenteral nutrition is a life saving therapy for
patients with chronic intestinal failure (IF). Central venous accesses
(CVC) are essential devices for parenteral nutrition administration.
Unfortunately the use of these devices can lead to catheter related
blood stream infections (cbrsi), thrombosis CVC-related, or mechan-
ical complications that are associated with morbidity and mortality
rates. The aim of the authors was to evaluate the rates of CVC-related
complications in IF patients compared to international literature with
a focus on Peripherally Inserted Central Catheter (PICC).
Methods: we retrospectively collected data on 144 patients regularly
followed in our department from 10/1/2008 to 12/31/2015. For each
patient we reported mechanical, thrombotic and infectious complica-
tions CVC-related.
Results:
Central venous catheters
(CVC) Features
N(%)
Total number 304
Type of CVC
Totally implanted
Partially implanted
Hohn
Picc
Others
Not Known
25 (8%)
83 (27%)
126 (41%)
64 (21%)
2 (0.66%)
4 (1.3%)
CVC-Site
jugular int. Right/left
Subclavian Right/left
Brachial Right/left
Basilica Right/left
Not known
94 (31%)/62 (20%)
53 (17%)/27 (9%)
16 (5%)/16 (5%)
13 (4%)/7 (2%)
16 (5%)
Infusion frequency
7/7
<7/7
Not known
181 (60%),102 (7%)
117 (38%)
2 (2%)
Conclusions: Total adverse events rate was 0,92/1000 catheter days.
Thrombosis’ incidence was 0,08/1000 catheter days, sepsis’ 0,34/1000
catheter days andmechanical complications’ 0,48 /1000 catheter days.
Cox regression showed that the presence of PICC increases thrombosis’
risk 3,6 times and mechanical complications’ risk 3,0 times compared
to the others types of CVC; plus, an infusion rate 7/7 is related to an
icreased risk of crbsi.
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EFFECTS OF A HIGH-PROTEIN DIET ON GLYCEMIC CONTROL AND
INSULIN RESISTANCE IN TYPE 2 DIABETES PATIENTS: A SYSTEMATIC
REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED
TRIALS
W. Chen1*, Z. Yu1. 1Department of Clinical Nutrition, Peking Union
Medical College Hospital, Beijing, China
* Corresponding author.
Rationale: Obesity is a well-known risk factor of type 2 diabetes
mellitus (T2DM), and it is commonly accompanied by T2DM. Recently
some studies indicated that a high-protein diet was effective for
weight loss, and therefore we hypothesized that a high-protein diet
could help control blood glucose andmitigate insulin resistance (IR) by
weight management in T2DM patients, which are key feathers of
T2DM. The study aimed to systematically review the effects of a high-
protein diet on glycemic control and IR in T2DM patients.
Methods: We searched four electronic databases until May 1st 2018
and included all randomized clinical trials comparing a high-protein
diet with other diets. Two reviewers independently identified the
trials for inclusion and independently extracted data. Either a fixed- or
a random-effects model was used to combine the changes in each
outcome from baseline to the end of the intervention. The meta-
analysis was performed with RevMan 5.3 software.
Results: Twelve articles (thirteen studies) including 1138 T2DM
patients met our inclusion criteria. Glycemic control was not
significantly different between the high-protein diet group and
control group, with the changes in fasting plasma glucose (FPG)
(−0.13 (95% CI (−0.46, 0.19), p = 0.43)mmol/L) andHbA1c% (−0.05 (95%
CI (−0.18, 0.08, p = 0.92))) from baseline to the end of intervention.
However, the difference in IR between the two groups was statistically
significant. Most changes in lipids profileswere favorable. The changes
in HDL, LDL, TC, and TG were +0.03 (95% CI (−0.04,0.11), p = 0.35)
mmol/L, −0.10 (95% CI (−0.18, −0.02), p = 0.02) mmol/L, −0.21 (95% CI
(-0.31, −0.12), p < 0.01) mmol/L and −0.19 (95% CI (−0.33, −0.05),
p < 0.1) mmol/L, respectively. The result of HOMA-IR was −0.31 (95% CI
(−0.44, −0.18), p < 0.01). Additionally, the difference in safety in terms
of SCr (0.86 (95% CI (−1.92, 3.65), p = 0.54)) and eGFR (1.10 (95% CI
(−1.34, 3.55), p = 0.38)) was not significant.
Conclusions: This review showed that a high-protein diet does not
significantly improve glycemic control but can lower the levels of LDL,
TC, TG and HOMA-IR in T2DMpatients. In addition, a high-protein diet
had no significant influence on safety. Further studies are needed to
clarify the effects of a high-protein diet on glycemic control and IR in
T2DM patients.
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EFFECT OF HOME ENTERAL NUTRITION IN MALNOURISHED
PATIENTS WITH INTESTINAL FAILURE/INTESTINAL INSUFFICIENCY
X. Gao1*, L. Zhang1, Y. Zhang1, H. Liu2, S. Liu1, D. Zhou2, X. Wang1.
1Research Institute of General Surgery, Jinling Hospital, Medical School of
Nanjing University, 2Research Institute of General Surgery, Jinling
Hospital, Southern Medical University, Guangzhou, China, 305 East
Zhongshan Road, Nanjing, Jiangsu Province, China
* Corresponding author.
Rationale: Weight loss is frequent in malnourished patients
with intestinal failure/ intestinal insufficiency and poor nutritional
status is a contributing factor to the reduced quality of life. Enteral
nutrition is safe and effective in malnourished patients with chronic
intestinal failure/intestinal insufficiency. Prospective study aimed at
investigating the effects of home enteral nutrition in these patients are
lacking. The aim of this study was to assess the nutritional status,
quality of life, mortality and other clinical outcomes of home enteral
nutrition in malnourished patients with intestinal failure/intestinal
insufficiency.
Methods: The prospective observational study was carried out on
166 malnourished patients with intestinal failure/intestinal insuffi-
ciency in Jinling hospital from January 2016 to October 2018. All
patients were supported with six months home enteral nutrition after
discharge. Outcome measures included nutritional status,quality of
life,mortality,enteral feeding gastrointestinal complications and other
clinical outcome have been evaluated at 1,3 and 6 months after
discharge.
Results: One hundred and sixty-six patients were continued home
enteral nutrition. The patient’s body weight and nutritional status
could be maintained and significantly increased during home enteral
nutrition (p < 0.05). Quality of life is also significantly improved during
HEN (p < 0.05). There was no difference between the incidence rates
of tube and gastrointestinal complications in hospital and out of
hospital (p > 0.05) and the advanced age,diseases,low BMI and poor
nutritional status were identified as high risk factors for poor clinical
outcome.
Conclusions: HEN is a simple and feasible treatment to support
malnourished patients with intestinal failure/intestinal insufficiency
and improve quality of life and nutritional status.
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APPLICATION OF N-3 FATTY ACID DETECTION AND INTERVENTION
IN INFLAMMATORY AND ATHEROSCLEROSIS
Y. Liu1*, X. Zhang1, Y. Zhang1, Q. Xu1. 1Nutrition Department, People
Liberation Army General Hospital of China, BEIJING, BEIJING, China
* Corresponding author.
Rationale: Chronic metabolic diseases are closely related to the
inflammatory response of human body, and many studies have
reported that w-3 fatty acids can prevent the development of
chronic metabolic diseases through anti-inflammatory mechanisms.
Methods: The author studied w-3 fatty acids improved LPS-induced
systemic inflammatory response in mice as a visiting scholar at
Harvard Medical School, and found that w-3 fatty acids could reduce
the body’s inflammatory response by inhibiting TLR4 pathway, and
increase the body weight of mice, modify the nutritional status as well
as the systemic inflammation.
Results: Subsequently, we conducted experiments of intervene in
apoE−/−mice and RAW264.7 macrophages with w-3 fatty acids
intervention supported by the National Natural Science Foundation
of China (NSFC), through siRNA silencing and plasmid transfection, we
proved that w-3 fatty acids could inhibit the inflammatory reaction
and prevent the formation of atherosclerosis. TLR4molecular pathway
may be one of the possible mechanisms. At present, tandem mass
spectrometry were used in our laboratoryfor clinical blood fatty acid
detection, we tested the blood fatty acid in initial 102 patients with
metabolic syndrome, and in all the cases, n-6/n-3 ratio increased.
Conclusions: Therefore, systematically studying the relationship
between fatty acid ratio and changes in cardiovascular disease and
metabolism in a large population, not only help to establish the normal
range of fatty acids concentration for Chinese population, and also
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provide an important scientific basis for early cardiovascularmetabolic
diseases prediction, prevention and intervention.
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EFFECT OF MODERATE- AND HIGH-INTENSITY ACUTE AEROBIC
EXERCISE ON FOOD REWARD AND APPETITE IN
METHAMPHETAMINE INDIVIDUALS
Y. Zhou1*, L.C. Zhou1. 1Shanghai University of Sport, shanghai, China
* Corresponding author.
Rationale: Advances in neuroscience identified drug addiction as a
chronic brain disease,which is associatedwith overestimation of drug-
related rewards and underestimation of ‘natural’, non-drug-related
rewards. Methamphetamine (MA) is the second largest illegal drug
abuse in theworld and studies have shown that acute aerobic exercise
can reduce abusers’ sensitivity to MA-related craving. The aim of this
study was to determine the effects of acute aerobic exercise on reward
values of food and subjective feelings of appetite in MA abusers.
Methods: Forty-four men, who met the DSM-IV criteria for MA
dependence, with BMI of 24.8 ± 3.1 kg/m2 and age of 30.8 ± 4.7 years,
were randomly assigned to two training groups: moderate-(n = 22)
and high-(n = 22) group. Each group finished resting control or
exercise condition for 35 minutes, 1 wk apart, in a counterbalanced
order, with the moderate (65%∼75% HRmax) and high (75%∼85%
HRmax) intensity separately. Food reward values for visual food cues
assessed by the Leeds Food Preference Questionnaire and subjective
feelings of appetiteweremeasured aftermoderate- and high-intensity
aerobic exercise, or resting control session.
Results: Greater implicit wanting for sweet vs. savoury taste foods was
noted following exercise compared to the control session, and this was
independent of intensity (high: P = 0.011; moderate: P = 0.047).
Furthermore, the implicit wanting for savoury taste foods was higher
following high intensity exercise compared to the control session
(P = 0.004). High intensity exercise also significantly increases the
subjective feelingof hunger (P = 0.014). Therefore, acute aerobic exercise,
independent of intensity, increases the relative preference and implicit
wanting for savouryrelative to sweet taste foods.Additionally, significant
effects were founded on the implicit for savoury taste foods and
subjective feeling of hunger following acute aerobic high-intensity
exercise, but not in moderate-exercise and control sessions.
Conclusions: Acute aerobic exercise, especially high-intensity exer-
cise, can increase food reward and appetite in MA-dependent
individuals.
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NUTRITIONAL STATUS OF HEMODIALYSIS OUTPATIENTS WITH
OSTEOSARCOPENIC OBESITY
Y. Kitajima1*, S. Urabe2, S. Haga2, T. Hyodo2. 1Tokyo Healthcare
University, Tokyo, 2Eijin Clinic, Hiratsuka, Japan
* Corresponding author.
Rationale: Osteosarcopenic obesity has been reported to increase the
risk of fracture of elderly people, dysfunction including daily living
activities, and risk of infection. In this study, we investigated the
situation of Osteosarcopenic obesity of maintenance hemodialysis
outpatients.
Methods: The subjects were 102 patients (74 males, 28 females,
average age 69.4 ± 13.1 years old). The bone density (distal ⅓ of the
radial bone), abdominal girth, grip strength, circumference of the
lower leg (CC) were measured to evaluate bone mass, obesity (visceral
fat accumulation) and sarcopenia. Furthermore, GNRI (Geriatric
Nutritional Risk Index) of each evaluation group was compared.
Results: In the subjects, the bonemasswas 26.5% or less of YAM70% or
less, 45.1% of visceral fat accumulation (abdominal circumferencemale
85 cm or more, female 90 cm or more) and 26.5% corresponding to
sarcopenia. 3.0% of those who correspond to all three items. In
addition, GNRI was 90.2 ± 6.3 for YAM 70% or less, and 82.9 ± 6.6 for
sarcopenia.
Conclusions: As for Osteosarcopenic obesity of hemodialysis patients,
it was considered necessary to further study the relationship with
nutrition assenment index.
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N-3 PUFA-ENRICHED SEMI-VEGETARIAN DIET LOWERS LDL-
CHOLESTEROL AND URIC ACID LEVELS IN PATIENTS WITH
FAMILIAL HYPERCHOLESTEROLEMIA
Z. Kochan1*, K. Mironiuk2, A. Mickiewicz3, A. Janczy1, R.T. Smolenski4,
M. Gruchala3, J. Karbowska4. 1Department of Nutritional Biochemistry,
Medical University of Gdansk, Gdansk, 2Department of Commodity
Science and Quality Management, Gdynia Maritime University, Gdynia,
31st Department of Cardiology, 4Department of Biochemistry, Medical
University of Gdansk, Gdansk, Poland
* Corresponding author.
Rationale: Familial hypercholesterolemia (FH) is an inherited disorder
caused mainly by mutations in the gene for the LDL receptor and
characterized by high blood levels of LDL-cholesterol (LDL-C) convey-
ing an increased risk of coronary heart disease (CHD). The efficacy of
pharmacological lipid-lowering therapies, such as statin therapy, may
be compromised by poor compliance and/or diet rich in refined
carbohydrates or saturated fatty acids. Since n− 3 polyunsaturated
fatty acids (PUFA) may protect against CHD, we aimed to evaluate the
effect of semi-vegetarian diet enriched in walnuts and oily fish as
sources of n− 3 PUFA on blood levels of LDL-C and uric acid (UA), the
end product of purine catabolism that promotes atherosclerosis and
arterial hypertension, in FH patients.
Methods: The experimental diet was individually prescribed for 19
unrelated patients with established FH (11 of them treated with
statins: rosuvastatin, n = 9, and atorvastatin, n = 2) based on estimated
energy requirement and reported intake during the baseline. Serum
LDL-C and UA levels were measured at baseline and after 11–16 weeks
of dietary intervention. The datawere analysed using the paired t-test
and the Wilcoxon matched-pairs test.
Results: At the end of the dietary intervention, FH patients showed a
reduction in both LDL-C and UA serum levels: LDL-C decreased by
11.7% (p = 0.0435), and UA by 7.4% (p = 0.0488); while their BMI and
WHR did not change during the study (mean BMI: 24.8 vs. 24.1 kg/m2,
mean WHR: 0.89 vs. 0.87 at baseline and after the intervention,
respectively).
Conclusions: Adherence to n-3 PUFA-enriched semi-vegetarian diet
significantly lowers LDL-C and UA levels in the blood. Cardiovascular
risk in FH patients can therefore be further reduced by appropriate
dietary management, complementing pharmacological therapy.
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EVALUATION OF RELATIONSHIP BETWEEN VISCERAL ADIPOSITY
INDEX (VAI) AND BLOOD LIPIDS IN MULTIPLE SCLEROSIS (MS)
PATIENTS
Z. Uzdil1*, S. Kaya1, P. Sökülmez Kaya1, M. Terzi2. 1Faculty of Health
Sciences, Department of Nutrition and Dietetics, 2Faculty of Medicine,
Department of Neurology, Ondokuz Mayıs University, Samsun, Turkey
* Corresponding author.
Rationale: VAI is a marker of dysfunction for visceral fat tissue and
associated with cardiovascular risk. Weight control is recommended
for prevention of disease-related comorbidities in MS. There are not
enough studies in literature that evaluated VAI inMS. Aim of this study
was to determine effect of VAI on blood lipids in MS.
Methods: 29 male (25.9%) and 83 female (74.1%) relapsing remitting
MS patients, diagnosed according to Mc Donald criteriawere included
study. VAI was calculated by following formula]:
Males: VAI = (WC/[39.68 + (1.88 × BMI)]) × (TG/1.03) × (1.31/HDL)
Females: VAI = (WC/[36.58 + (1.89 × BMI)]) × (TG/0.81) × (1.52/HDL)
ExpandedDisability Status Scale (EDSS) and biochemistry results were
obtained from patient follow-up system. The relationship between VAI
and blood lipids was analyzed with Spearman correlation.
Results:Mean disease duration was 6.8+0.6 years and EDSS score was
0–6 points. 50.9% of themnormal, 25.9% of themoverweight and 23.2%
of them obese. As VAI value increased Low Density Lipoprotein (LDL),
total cholesterol and triglyceride increase, High Density Lipoprotein
(HDL) decrease. As VAI increased HDL decrease in male and LDL
increase in female. As Body Mass Index (BMI) increase, VAI increase in
all patients except male. VAI value of obese is higher among all patient
and spesific for female. The duration of MS and EDSS score were not
correlated with VIA.
Variables
Blood lipids VAI (n = 112)
LDL 0.235*
HDL −0.178
Total cholesterol 0.249**
Triglycerides 0.302**
BMI 0.371**
Correlation is significant *p < 0.05;**p < 0.01
Conclusions: In MS patients, VAI is associated with increased blood
lipids and can use assessing the risk of cardiovascular disease.
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LOW BODY MASS INDEX PREDICTS SHORT- AND LONG-TERM
CLINICAL OUTCOMES IN ASIAN CLINICAL PATIENTS
Z. Xue1*, J. Yu1, T. Higashikuchi2, C. Compher3. 1General Surgery, Peking
Union Medical College Hospital, Chinese Academy of Medical Sciences,
Beijing, China, 2School of Medicine, Fujita Health University, Toyoake,
Japan, 3University of Pennsylvania, Philadelphia, United States
* Corresponding author.
Rationale: Studies on malnutrition suggest low body mass index may
be associated with poor clinical outcomes. We aimed to investigate
published data to identify whether low BMI could predict short- and
long-term clinical outcomes in Asian hospitalized patients.
Methods: A search in the PubMed database including terms ‘body
mass index’ or ‘BMI’ or ‘malnutrition’ or ‘undernutrition’ AND ‘Asia’ or
‘Asian’ AND/OR ‘outcome’ or ‘complication’ or ‘mortality’ or ‘survival’
or ‘ICU’ for publications in English in the past 10 years was conducted.
Papers with data and clinical outcomes from Asian hospitalized
patients with BMI <18.5 kg/m2 or lower and sample size >50 were
included. Forest plots were constructed to determine the odds of in-
hospital complications, hospital mortality, ICU mortality and 5-year
survival in patients with BMI<18.5 kg/m2 versus BMI ≥18.5 kg/m2.
Results: Thirty-one studies were included, 16 of which analyzed the
association between low BMI and clinical outcomes. The prevalence of
BMI <18.5 kg/m2 varied from 2.7% to 48.0% in different disease settings
and varied Asian countries. Patients with BMI <18.5 kg/m2 had higher
overall complications (OR 1.99; 95% CI, 1.65–2.40), higher hospital
mortality (non-ICU patients, OR 2.48; 95% CI, 2.42–2.55; ICU patients,
OR 2.31; 95% CI, 2.25–2.38), and higher ICUmortality (OR 1.92; 95% CI,
1.84–2.01). Survival over 5 years was lower in the low BMI group (OR
0.30; 95% CI, 0.23–0.40).
Conclusions: Low BMImay predict worse short-term and longer-term
outcomes in Asian hospitalized patients.
References
1. Zheng W,McLerran DF, Rolland B, et al. Association between body-
mass index and risk of death in more than 1 million Asians. N Engl J
Med. 2011;364(8):719–29.
2. Lim SL, Ong KC, Chan YH, et al.Malnutrition and its impact on cost
of hospitalization, length of stay, readmission and 3‐year mortality.
Clin Nutr. 2012;31(3):345–350.
3. Compher C, Higashiguchi T, Yu J, et al. Does low body mass index
predict the hospital mortality of adult Western or Asian patients?
JPEN J Parenter Enteral Nutr. 2018;42:467–472.
4. Compher C, Chittams J, Sammarco T, et al. Greater Nutrient Intake
Is Associated With Lower Mortality in Western and Eastern
Critically Ill Patients With Low BMI: A Multicenter, Multinational
Observational Study. JPEN J Parenter Enteral Nutr, 2019;43(1):63–69.
Disclosure of Interest: None declared.
Nutritional assessment II
MON-PO476
NUTRITIONAL STATUS ASSESSMENT AS A SURROGATE TO CLINICAL
OUTCOME PREDICTION IN CARDIAC SURGERY PATIENTS
M. Panagidi1, G. Tsaousi1, P. Papakostas1, G. Stavrou1, V. Grosomanidis1,
G. Tagarakis1, K. Kotzampassi1*. 1AHEPA Hospital, Aristotle University of
Thessaloniki, Thessaloniki, Greece
* Corresponding author.
Rationale: Malnutrition has been identified as major determinant of
adverse clinical outcome following cardiac surgery. Our aim was to
investigatewhether the bioelectrical impedance analysis (BIA) indices,
namely phase angle (PhA), fat mass (FM), fat-free mass (FFM) and
tissue edema could serve as predictors of clinical outcome in cardiac
surgery patients.
Methods: Prospective, cohort study enrolling 194 consecutive adult
cardiac surgical patients (NCT03644030). Demographic, anthropo-
metric and clinical data were collected. Before elective surgery each
participant was subjected to BIA, for FM, FFM, intracellular, extracel-
lular and total body water [ICW, ECW, TBW] and PhA calculation. The
assessment was repeated on POD7. Patients with an early (<7 days)
adverse outcome were excluded from final analysis. Prolonged
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hospital length of stay (LOS) (≥14 days) constituted the outcome of
interest. Statistical analysis was performed by Mann-Whiney test,
stepwise logistic regression analysis and ROC curve analysis.
Results: Of the total cohort, 179 patients with a hospital LOS ≥7days
were finally assessed. Nutritional status deteriorated significantly on
POD7 (p < 0.01). Postoperative total body weight, BMI, hand grip
strength, arm perimeter, ECW (%), FFM (kg), (p < 0.01, for all) and PhA
(p < 0.001) were significantly impaired in patients with prolonged
hospital stay. Among them, PhA (OR, 4.41; 95%CI, 1.72–11.3; p = 0.002)
and FFM (OR,1.08; 95%CI, 1.01–1.15; p = 0.016) were identified as the
most reliable prognostic estimates of hospital-LOS ≥14 d. Both indices
presented a satisfactory discriminatory performance (AUC-PhA, 0.81;
95%CI, 0.74–0.87; p < 0.001; cut-off <3.4, and AUC-FFM, 0.76; 95%CI,
0.68–0.82; p < 0.001; cut-off <56.6 kg), in regards to hospital stay.
Mortality rate upon hospital discharge was 6.1% (n = 11).
Conclusions: Among the various BIA-derived indices which can serve
as accurate indicators of poor nutritional status identification, low
postoperative PhA and FFM values confer enhanced predictive ability
of prolonged hospitalization in cardiac surgery setting.
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APPLICATION OF GLIM CRITERIA FOLLOWING INITIAL SCREENING
TO IDENTIFY AND CATEGORIZE PATIENTS WITH RESPECT TO
NUTRITIONAL STATUS: AN INDIAN MULTI-CENTRE PILOT PROJECT
K. Deshpande Shukla1*, A. Dabhi2. 1Sevashram Hospital, Bharuch, 2Food
science and Nutrition Department, School of Lifesciences Gujarat
University, Ahmadabad, Ahmadabad, India
* Corresponding author.
Rationale: The purpose of this study is to apply GLIM criteria to
identify the prevalence, severity and aetiology of malnutrition in
hospitalised patients and identify the characteristics associated with
it.
Methods: This cross sectional, observational study included patients
≥18 years admitted in two hospitals. All patients were screenedwithin
24 hours of admission andmore than 2/3rd patients found at risk were
further assessed for presence of Phenotypic and Etiologic criteria
Results: Patients varied from young adults to elderly with 55% males
and 45% females. Prevalence ofmoderate and severemalnutritionwas
22% and 33% respectively. The proportion of acutemalnutritionwith
inflammation, chronic malnutrition with minimal/no inflamma-
tion, chronic malnutrition with inflammation and starvation was
63%, 22%, 11%, 4% respectively. Prevalence of chronic diseases was
57.7%. Major infections, acute stroke and pancreatitis were most
frequent causes of hospitalization. Almost all patients complained loss
of appetite irrespective of severity and aetiology of malnutrition
(p = 0.33). More than half of patients consumed ≤ 50% EER and
experienced unintentional weight loss. Only two –fifth patients
consumed normal diet before hospitalisation. There was statistically
significant difference between the mean current weight (p < 0.0001),
BMI (p < 0.0001) and calf circumference (p < 0.05) among the `at risk,
moderately and severely malnourished patients.
Conclusions: Prevalence of Disease RelatedMalnutritionwas 53%with
acute disease relatedmalnutrition havingmaximumprevalence. GLIM
is a flexible model offering many alternative parameters to classify
malnutrition according to severity and aetiology and can be readily
used in set-ups with minimum available resources.
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ASSESSING THE NUTRITIONAL STATUS AND MACRONUTRIENT
INTAKE OF PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
(SLE) AT OUT-PATIENT DEPARTMENT, RHEUMATOLOGY
DEPARTMENT, YANGON SPECIALITY HOSPITAL, YANGON,
MYANMAR
K.S. Yu Mon1*. 1Internal Medicine, Pun Hlaing Siloam Hospitals, Yangon,
Myanmar
* Corresponding author.
Rationale: Patients with systemic lupus erythematosus (SLE) suffer
from nutritional changes due to disease process or treatment. The
nutritional status may vary from malnourishment to overweight. The
dietary intake of the SLE patients is reduced due to low appetite, GI
symptoms and dietary changes.
Methods: Cross-sectional descriptive study design was used. The
study period was from October, 2017 to February, 2018. A sample of 53
participants was collected. To assess the nutritional status, BMI and
SGA were used. To assess the macronutrients intake, 24 hour food
recall was used.
Results:Mean age of SLE patients is 31 ± 10 years. In the current study,
a high prevalence of malnutrition was found. The nutritional status
was assessed by Body Mass Index (BMI) and Subjective Global
Assessment (SGA). Mean BMI is 20.5 ± 4 kg/m2. 45.3% of malnourish-
ment (undernutrition, overweight and obesity) was detected by using
BMI. According to SGA, 57% of malnutrition was detected. Therefore,
BMI alone is not enough to assess the nutritional status in such
patients because these patients are prone to oedema and disease
activity can also affect the nutritional status.
Macronutrient intake was assessed by 24 Hour Food Recall was
collected for 2 non-consecutive days. Mean energy intake was
877 ± 190 kcal per day while the TEE was 1866 ± 224 kcal per day.
Whether the patients have good or bad nutritional status, their dietary
intake was lower than the recommended range in patients with SLE.
Carbohydrate intake of the patients was between the acceptable range
of 45–65%. Protein intake was near the lower limit of the range. Fat
intakewas found out to be nearly upper limit of the distribution range.
In this study, Patients with SLE who consume less than or equal to
877 kcal per day have normal and underweight BMI scores. It was
significant with P value 0.004. 60.9% of patients were consuming >33
grams of protein per day and they had SGA grade A. It was also
significant with the P value of 0.005.
Conclusions: Hence, it is proved that the assessment of nutritional
status should be an integral part of patient care, as the imbalance
between adequate metabolism and immunity leads to malnutrition.
Also, BMI alone cannot reflect the nutritional status of the patients
with SLE. So, using BMI together with SGA will be more beneficial in
such high risk patients. Malnutrition is more prone in patients with
SLE and early detection of malnutrition will impact disease outcome
and treatment. Thus, interventions aimed at promoting adequate
nutritional status and food intake may contribute to reduction of
comorbidities and improved quality of life in these patients.
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EVALUATION OF SARCOPENIA THROUGH THE PSOAS INDEX IN
PATIENTS SUBMITTED TO DIGESTIVE TRACT SURGERY AT HOSPITAL
DO SERVIDOR PÚBLICO ESTADUAL DE SÃO PAULO, BRAZIL
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Rationale: Sarcopenia is directly related to the worst prognosis in
hospitalized patients. For its early diagnosis the evaluation of the psoas
using the CT scan proved to be an effective method.
Methods: A retrospective cross-sectional observational study was
performedwith patients undergoing gastrointestinal tract surgery at a
state public hospital in São Paulo, Brazil, where the presence of
sarcopenia was evaluated. From the analysis of transversal computed
tomography images, the tissues around the third lumbar vertebrawere
differentiated and separated based on the specific density of each; the
area of the psoas muscle was then calculated by the measurements of
its greatest transverse and longitudinal diameters. Through the
predictive equations developed by Mourtzakis and colleagues (2008)
the coefficient was calculated in order to predict patients’musclemass
and to identify those sarcopenic. Cut-off points for sarcopenia are
<385 mm2 for women and <545 for men.
Results: The sample for the composition of this study was 52 patients,
with a mean age of 61.3 years (± 12.89), being excluded 4 patients that
were not quantified the coefficients. Of which 52.08% were considered
sarcopenic.
Conclusions: The method proved to be effective for the diagnosis of
sarcopenia, allowing the definition of the most appropriate thera-
peutic plan to be performed.
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CORRELATION BETWEEN BODY SEGMENTS AND HEIGHT AMONGST
ADULTS IN A SOUTH AFRICAN HOSPITAL POPULATION
L. Van Den Berg1*, H.E. Erasmus1, C.M. Walsh1. 1Nutrition and Dietetics,
University of The Free State, Bloemfontein, South Africa
* Corresponding author.
Rationale:Accurate heightmeasurements is an important component
of nutritional assessment. Stunting is reported to affect the growth of
long bones in the lower body more than in the upper body and this
may impact on the accuracy of height predictive equations based on
body segments, when applied in populations with high levels of
stunting, such as in South Africa.
Methods: A descriptive cross-sectional study was performed on 141
participants (20–50 yrs) who could stand up straight and unassisted
for accurate height measurement, and who were recruited from the
three public hospitals in Bloemfontein by convenience sampling. In
addition to reference height, ulna length, knee height, tibia length,
fibula length and foot length were measured. Spearman correlation
coefficient was calculated and multiple regression analysis performed
to assess which body segment is most closely associated with actual
height.
Results: The participants were 61.7% male, with a median age of 38.8
years (IQR 10.1 yrs) and median height 169.3 cm for males and
158.4 cm for females. All body measurements segment were statistic-
ally significantly correlatedwith reference height. Knee height showed
the strongest associationwith reference height in bothmales (R2 0.77)
and females (R2 0.86), followed by tibia and fibula length. Foot length
and ulna length showed theweakest correlationwith reference height
in males and females respectively. Multiple regression analysis found
knee height to be best associated with reference height, whilst foot
length and ulna length showed theweakest associationwith reference
height.
Conclusions: In a South African population of hospitalised patients,
lower body segments were more closely associated with reference
height, than upper body segment. This may reflect the proportionally
greater effects of stunting on lower body long bone growth. Therefore,
in populations with high levels of stunting, equations to predict actual
height, may be more accurate if based on lower body segments.
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MON-PO481
COMBINED VOLUME-VISCOSITY SWALLOW TEST AND
VIDEOFLUOROSCOPY IN THE DIAGNOSIS OF OROPHARYNGEAL
DYSPHAGIA TO IMPROVE NUTRITIONAL ASSESSMENT
L. Visiedo Rodas1*, L. Rey fernandez1, S. Cano dominguez2, A. Roman
Casares3, J. Costa4, B. Tortajada Goitia1, J. Abiles Osinaga1. 1Farmacia y
Nutricion, Hospital Costa del Sol, Marbella, 2Servicio de Farmacia,
Hospital Virgen de las Nieves, Granada, 3Rehabilitacion, 4Radiologia,
Hospital Costa del Sol, Marbella, Spain
* Corresponding author.
Rationale: Determine the efficacy of volume-viscosity swallow test
(V-VST) and videofluoroscopy (VF) to detect risk of oropharyngeal
dysphagia (OD) and evaluate the nutritional assessment
Methods: For this prospective study 44 patients (age average 62 ± 12)
in Dysphagia Unit since November of 2015 were included.
V-VST and VF were used to evaluate the deglutition mechanism.
Statistical analysis of the data was performed using the Statistical
Package SPSS v15.0.
Results: The main causes of dysphagia were 27% stroke, 22% cognitive
impairment (senility or presbyphagia), 9% psychomotor retardation
and 7% amyotrophic lateral sclerosis
A total of 44 V-VSTwere performed. Dysphagiawas detected in 80%, of
wich 11% presented a impaired safety (cough and voice changes were
the most frequent symptom) and 31% presented impaired efficacy
(piecemeal deglutition). The remaining 58% of the patients presented
alterations in both.
In VF, dysphagiawas detected in 70%, where 68% presented alterations
in safety and efficacy (liquids penetrations to laryngeal vestibule) and
efficacy (piecemeal deglutition and weak bolus propulsión).
Regarding to nutritional approach, adapted diet was prescribed to 43%,
enteral nutrition by nasogastric and gastrostomy tube feeding was
performed on 11%. Thickeners were prescribed in 30%.
Conclusions: An early and effective diagnosis of OD improves the
patient’s quality of life, and minimise the complications associated
with swallowing disorders. V-VST and VF are low-cost screening
methods and easy to apply. However, VF offers a higher sensitivity and
specificity to personalized the nutrititional assessment.
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CHANGES IN BODY COMPOSITION AFTER 1 MONTH INTAKE OF
HALAL MEAT
L.M. Luengo1*, S. Gómez Vera2, I. Bejarano3, C. Carrasco Romero3,
A.B. Rodríguez Moratinos3. 1Biomedical Sciences, Faculty of Medicine,
University of Extremadura, 2Laboratory, University Hospital of Badajoz,
3Animal Phisiology, Faculty of Sciences, University of Extremadura,
Badajoz, Spain
* Corresponding author.
Rationale:Muslim population is increasing in our country and several
meat industries are using Halal ritual, which may change microorgan-
ism and transformation of muscle into meat. This is why we studied
meat changes and human body composition in healthy volunteers
before and after 1 month eating Halal meat and no other kind of meat.
Methods: 20 healthy adult volunteers (10 women) participated in the
study. They changed their previous meat intake for 0.5 kg lamb and
0.5 kg calf Halal meat weekly (given by researchers) for 1 month,
without any other change in their food habits. Meat was analysed by
pHmetry, gravimetry (water), Kjeldahl method (proteins), Floch
method, methylation and gas chromatography (lipids). Body compos-
ition was measures by bioimpedance (Tanita, Innerscan V, BC-601).
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Data were processed with Microsoft Excel® and analysed with SPSS®,
by one-factor ANOVA.
Results: Lamb Halal meat had more pH, humidity, lipids and proteins
than no Halal lamb meat; calf Halal meat had a lower pH and fat
content than no Halal calf meat (p < 0.05).
Every item regarding body composition improved (statistically no
significant) despite caloric intakewas higher (Table 1).Weight losswas
higher among women; fat mass loss, visceral fat loss, increase in
caloric intake, metabolic age loss and increase in muscle, water and
bone mass was higher among men (Table 1).
Weight
(kg)
% fat Muscle
mass
(kg)
Bone
mass
(kg)
BMI DCI
(kcal)
Metab
age
%
total
water
Visceral
fat level
WOMEN −0,61 −1,23 0,79 0,01 −0,23 13,1 −0,9 0,9 −0,1
MEN −0,22 −2,3 1,53 0,07 −0,09 183,1 −5,6 2,24 −0,6
ALL −0,415 −1,765 1,16 0,04 −0,16 98,1 −3,25 1,57 −0,35
These surprising results despite the study was short, may indicate
precocious desirable effects of intake of Halal meat. Nevertheless, part
of this result may be due to assay effect, which we cannot evaluate
because basal situation was the control of the intervention. As caloric
intake was higher, the only confusion factor could be more physical
activity.
Conclusions: Halal meat intake does not cause deleterious effects in
body composition y it seems to improve such body composition
despite a mildly higher caloric intake.
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MON-PO483
MODIFIED NUTRITION RISK IN CRITICALLY ILL (MNUTRIC) VS
MALNUTRITION UNIVERSAL SCREENING (MUST) TOOL: DETECTING
MALNUTRITION, SARCOPENIA AND MORTALITY
A. Kasti1, F. Solakis1, K. Katsas1, A. Skoufi1, N. Mainas1, M. Nikolaki1,
A. Tsochatzis2, N. Kelekis2, A. Armaganidis3, M. Theodorakopoulou3*.
1Department of Nutrition and Dietetics, 22nd Department of Radiology,
32nd ICU Department, University Hospital Attikon Athens Greece, Athens,
Greece
* Corresponding author.
Rationale:
Catabolic state of critical illness in associationwith inadequate nutrition
will lead to malnutrition. Thereby early and accurate detection of
malnourished patients is important. Various screening tools are used to
detect malnourished hospitalized patients but not all are validated for
the critically ill. Theobjective of this study is to compare themNutric and
MUST in assessing nutritional risk in the critically ill. Computed
tomography was also used to detect sarcopenia. Correlation of
malnutrition, sarcopenia and 1-year mortality was also investigated
Methods:A single-center retrospective cohort study in a 19 bedmixed
ICU of a tertiary care hospital. 248 patients, aged 62 ± 18, 57% males,
that stayed in the ICU > 48 hrs were analysed. The mNutric and the
MUST scores were calculated for all patients. mNutric scores ≥5 and
MUSTscores≥2were considered as high nutritional risk. Demographic
data, BMI, Outcome and abdominal CT scan were analysed. Outcome
was available in 179 patients. Computed tomography (CT) scans (slice
at the level of the 3rd lumbar vertebra) was used to identify sarcopenia.
Cut off point for determining sarcopenia by CT was Skeletal Muscle
Index- SMI 55 cm²/m² for men and 39 cm²/m² for women.
Results: 54% of the sample was at high nutritional risk according to
mNutricwhile 14% according toMUST. Estimated overall mortalitywas
33% (25%mNutric≥ 5, 6%MUST≥ 2). Malnourished patients according
to mNutric had 2.7 times higher mortality risk (Table 1). Only 21% of
the patients had abdominal CTs but 37% of them had substantial
edema (mean SMI = 43 ± 9.9 in men and 35 ± 7.7 cm²/m² in women)
rendering the CT scan invalid of predicting sarcopenia. In the
remaining 63% SMI was significantly lower in men (p < 0.001)
compared to cut-offs.
Table 1
Logistic regression [dependent variable mortality, independent variable
mNutric (Model 1) and Must (Model 2)], corrected for age, BMI, sex.
Variable Odds
Ratio
p 95% CI
Model 1 mNutric 2.7 0.02 1.2–6
Age (per decade) 1.4 0.02 1.1–1.8
BMI (kg/m2) 1 0.36 0.9–1.03
Sex 0.6 0.12 0.3–1.2
Model 2 Must 1.4 0.48 0.5–3.7
Age (per decade) 1.6 <0.001 1.3–2.1
BMI (kg/m2) 1 0.5 0.9–1.1
Sex 0.7 0.25 0.3–1.3
Conclusions: More than half of the patients were malnourished
according to mNutric, while higher scores indicate increased mortality
risk.MUSTseems to underestimatemalnutrition in ICU. Lower scores on
SMImaybeassociatedwithmortality,butpresenceofedemalead tobias.
References
1. Hameed F., Harris. S. Comparison of NUTRIC score and MUST score
for assessment of critically ill patients for early advanced nutrition
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MON-PO484
PHASE ANGLE AND NUTRITIONAL STATUS PARAMETERS IN
PATIENTS WITH HEAD AND NECK CANCER AT RISK AND NOT AT
RISKOF DYSPHAGIA: PRELIMINARY RESULTS
M. Milewska1*, M. Dąbrowska-Bender1, B. Jamróz2, E. Grochowska1,
T. Czernicki3, J. Chmielewska-Walczak2, K. Niemczyk2, D. Szostak-
Węgierek1. 1Department of Clinical Dietetics, 2Department of
Otolaryngology, 3Department of Neurosurgery, MEDICAL UNIVERSITY OF
WARSAW, Warsaw, Poland
* Corresponding author.
Rationale: Low value of phase angle have been found to be negative
prognostic factor for survival in different types of cancer. The aim of
the study was to investigate correlation between PA and nutritional
status patients with head and neck cancer (HNC) at risk and not at risk
of dysphagia.
Methods: The sample comprised 52 patients (32 males and 20
females), mean age 56 ± 13.4 years, consecutively admitted to
Otolaryngology Ward (March 2017-May 2018). Exclusion criteria
were: chemio-or radiotherapy, spread of cancer, chronic liver and
kidney diseases, epilepsy, metallic prosthesis, pacemaker or implan-
table defibrillators, lack of informed consent. Phase angle, PA (at
50 kHz) and body composition components (at 5, 50, 100 and
200 kHz) were obtained with BioScan Touch i8 (Maltron Int., UK).
Screening for malnutrition and dysphagia was performed with NRS
2002 and EAT-10, respectively. Patients were devided into 2 groups:
Group 1 (at risk of dysphagia) and Group 2 (not at risk of dysphagia).
Statistical analysis was performed with Statistica 13.1PL. The protocol
of the studywas approved by theMedical University Ethics Committee
Results: Overall, 61.8% of patients were identified at risk of dysphagia.
Accordingly to diagnostic criteria for malnutrition (ESPEN 2015)
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32,35% had a FFMI and unintentional weight loss below proposed cut
off values. Weight loss was significantly higher in patient at risk of
dysphagia (5.1 ± 5.8% vs. 1.2 ± 1.8%, p < 0.0086). The differences
between phase angle (cellular biomarker) were not significant
between analyzed groups (7.7 ± 1.1˚ Group 1 vs.7.8 ± 1° Group 2). PA
was negatively correlatedwith EAT-10 andNRS 2002 results (r =−0.49,
p < 0.0073 and r =−0.37, p < 0.0292, respectively). Moderate positive
correlation was found between PA and FFMI (r = 0.559, p < 0.00059),
however differences between FFMI in analyzed groups were not
significant.
Conclusions: Phase angle was within the range values in all HNC
patients, howeverwas lower inpatientswith low FFMI aswell as at risk
of dysphagia. Further investigation in a larger population is required.
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ASSESSMENT OF THE PHYSICAL DEVELOPMENT OF CHILDREN
AFTER OESOPHAGEAL RECONSTRUCTION – 10 YEARS FOLLOW-UP
M. Szymczak1, M. Łyszkowska1*, D. Broniszczak-Czyszek1,
A. Kamiński2, P. Kaliciński1. 1Department of Paediatric Surgery and
Organ Transplantation, The Children’s Memorial Health Institute,
2Department of Paediatric Surgery and Urology, The Children’s Hospital
of Medical University, Warsaw, Poland
* Corresponding author.
Rationale: The most common indication for oesophageal reconstruc-
tion in children is long-gap oesophageal atresia or complications after
chemical burns. The aim of the study was to assess the physical
development reflecting the nutritional status of children after
oesophageal reconstruction (OR).
Methods: 25 children after OR with jejunal or colon conduit were
included in the retrospective study. At the moment of operation they
were in age of 9months to 15 years. The assessment of their nutritional
status basing on body weight and body height was performed before
and at least 5 years after OR. Patients were classified into two groups
regarding the reason of OR: group I – congenital atresia, group II –
acquired stenosis of oesophagus. All patients before reconstruction
were on enteral nutrition via gastrostomy. During at least 5 years of
postoperative follow-up theywere fed orally with a diet appropriate to
their age.
Results: An improvement in the body mass of patients in both groups
was found, to a lesser extent an improvement in growth, especially in
the group II (Table 1).
Group I Group II
<3 and 3–25
percentile
25–75 and
>75
percentile
<3 and 3–25
percentile
25–75 and
>75
percentile
Body
weight
Body
height
Body
weight
Body
height
Body
weight
Body
height
Body
weight
Body
height
Before
reconstruction
[% of patients]
85% 80% 15% 20% 90% 70% 10% 30%
At least 5 years
after
reconstruction
[% of patients]
70% 40% 30% 60% 55% 77% 45% 23%
Conclusions: The patients after OR require permanent nutritional
care. Despite of restoring of oesophageal continuity and physiological
way of eating, their physical development of some of them is not
satisfactory.
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THE 10-POINT VERBAL AND VISUAL ANALOGUE SCALES FAIL TO
ASSESS DIETARY INTAKES AND MALNUTRITION IN ELDERLY
HOSPITALIZED IN ACUTE GERIATRICS UNIT
M. Bedbeder1, S. Boukhris2, C. Lahaye3, A. Gross3, A. Raynaud-Simon3,
M.J. Sanchez3*. 1Geriatry, APHP – Beaujon Hospital, Clichy, 2Geriatry, Rive
De Seine Hospital, Courbevoie, 3Geriatry, APHP – Bichat Hospital, Paris,
France
* Corresponding author.
Rationale: Low energy (EI) and protein (PI) intakes during hospital
stay contribute toworsening nutritional status and are associatedwith
increased mortality in elderly. The use of 10-point verbal (AVeS) and
visual (AViS) analogue scales allows a quick assessment of EI and
malnutrition but is not validated in elderly hospitalized in Acute
Geriatrics Unit (AGU).
Methods: We consecutively recruited 155 patients hospitalized in
the AGU of three French hospitals. Malnutrition was diagnosed using
BMI, weight loss, short form of Mini Nutritional Assessment, or
hypoalbuminemia (if Protein-C-Reactive <15 mg/l). One interviewer
performedAVeS and AViS.Mean daily EI and PI were calculated from3-
day dietary records. Cognitive status was evaluated using the Mini
Mental State Examination (MMSE).
Results: Among 155 patients (70% female, mean age 86 years), 60%
were malnourished. The mean daily EI and PI were 1366 kcal (22 kcal/
kg/day) and 55 g (0.89 g/kg/day) respectively. Only 17% of them
achieved the recommendation for EI and PI. AVeS was not correlated
with EI (ρ = 0,161 P = 0,05) and PI (ρ = 0,138 P = 0,09) whereas AViS was
poorly correlated with EI (ρ = 0.212 P = 0.009) and PI (ρ = 0.194
P = 0.02). Correlations were not ameliorated in the patients with
better cognitive functions (MMSE ≥24, N = 69). Sensitivity, specificity,
positive and negative prospective values for assessing malnutrition
were respectively 0.41, 0.58, 0.59 and 0.40 using AVeS <7 and 0.51, 0.56,
0.63 and 0.43 using AViS ≤0.5 portion.
Conclusions: In contrast to younger adults, AVeS and AViS were poorly
correlated with dietary intakes and had low diagnostic performance
for assessing malnutrition in elderly hospitalized in AGU. Regarding
the high prevalence of malnutrition and the low EI and PI for the vast
majority of patients, food supplementation could be systematically
proposed.
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IMPACT IN NUTRITIONAL STATUS AND DIET PROGRESSION OF A
NUTRITIONAL CONSULTATION AFTER STOMA CONSTRUCTION
M.M. Santa Maria1*, J.J.A. Villafranca1, L.R. Fernández1, L.V. Rodas1,
P.U. Navarro2, B.T. Goitia1, J. Abiles1. 1Pharmacy and Nutrition
Department, Hospital Costa del Sol, Marbella, 2Pharmacology
Department, University of Granada, Granada, Spain
* Corresponding author.
Rationale: In ostomized patients the oral diet reintroduction should
be performed progressively. In addition, malnutrition is a long-
termcomplication. Our objective is to evaluate the impact of a
nutritional consultation at dischargein these patiens.
Methods: A prospective study was performed. At discharge, the
patient has two appointment with dieticians for assessment and
diagnosis, a review of diet progression and nutritional treatment. The
patient’s weight was recorded and nutritional profile was requested
(albumin, prealbumin) at 7–10 days (visit1) and a month later (visit2).
Statistical analysis was performed.
Results: 77 patients were recruited, 65.7 ± 12.5 years, 74% men, 54.5%
colostomies. Nutritional diagnosis at Visit1 was 37.1% good nutritional
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status, 16.1% nutritional risk, 19.4% mild malnutrition*, 22.6% moder-
ate* and 4.8% severe*; At Visit2 was 62.9% good nutritional status,
24.2% nutritional risk and 6.4% mild malnutrition*, 4.8% moderate*,
1.6% severe* (*All protein-calorie). Weight’s difference between Visit1
and Visit2 was +1.1 ± 3.7 kg (p = 0.001). The mean nutritional
parameters measured between Visit1 and Visit2 were respectively:
Albumin 3,6 g/dL and 4,1 g/dL (+0.5 ± 0.4, p = 0.002), PreAlbumin
21.3 mg/dL and 26,4 mg/dL (+8.1 ± 7.1, p = 0.003). At Visit1 5.2% of the
patients tolerated soft diet, 50.6% complete, 2.6% astringent and 35.1%
low-residues; 42.9% required oral supplementation (mean extra
800 kcal/patient). At Visit2 71.2% tolerated complete diet requiring
supplementation 33.8% (mean extra 600 kcal/patient)
Conclusions: The nutritional consultation for ostomized patients has
allowed us to achieve a good nutritional status or maintain the
nutritional status in most patients with a correct transition of the diet
and an optimization in the use of oral supplements.
Disclosure of Interest: None declared.
MON-PO488
EVALUATIONOFQUALITYOF LIFE AFTERNUTRITIONCONSULTATION
IN OSTOMIZED PATIENTS
M.M. Santa Maria1*, J.J.A. Villafranca1, L.V. Rodas1, L.R. Fernandez1,
P.U. Navarro2, B.T. Goitia1, J. Abiles1. 1Pharmacy and Nutrition
Department, Hospital Costa del Sol, 2Pharmacology Department,
University of Granada, Marbella, Spain
* Corresponding author.
Rationale: Ostomized patients must face situations that can heavily
affect their quality of life. The goal of the study is evaluate this quality
of life after the implementation of a nutritional consultation at surgery
discharge.
Methods: A prospective study was performed. At discharge, the
patient’s weight was recorded and an analytical study was requested.
At 7–10 days (visit1) and a month later (visit2), the patient visits
nutritionist consultation for assessment and diagnosis, diet progres-
sion review and output stoma control education. In both visits, quality
of life was evaluated using the Montreux questionnaire, validated in
ostomized patients, which assesses the quality of life, including items
on self-sufficiency and well-being. Descriptive statistical analysis was
performed.
Results: 50 patients were recruited, 74% men, 67.19 ± 12.85 years, 62%
colostomies, 38% ileostomies. 74% of cases associated with an
oncological process, where 78% of patients did not receive chemo-
therapy in the 1st and/or 2nd visit. Education level: 37% primary
education, 39.1% secondary education, 10.9% university studies, 13%
without studies. Employment status: 10.6% unemployment, 21.3%
work, 53.2% retirement, 8.5% work leave, 6.4% family/home Care.
Nutritional diagnosis at Visit 1 was 38% good nutritional status, 6%
severe protein-calorie malnutrition. At visit 2 was 65.9% good
nutritional status, 2.4% severe protein-calorie malnutrition. The score
in Quality of life index increased between visits from 57.62 ± 14.15 to
63.29 ± 16.43 (p = 0.034) and the Physical well-being from
53.03 ± 19.56 to 61.14 ± 16.96 (p = 0.011).
Conclusions: It shows an improvement in the quality of life measured
in our patients after the nutritional intervention, as well as a
significant improvement in the physical well-being.
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GLIM IN PRACTICE: SENSIBILITY AND PROGNOSTIC VALUE FOR THE
DIAGNOSIS OF MALNUTRITION OF GASTROINTESTINAL SURGICAL
PATIENTS
J.R. Henrique1, C.N. Rodrigues1, Á.R.S. Ferreira1, M.I.T.D. Correia2*.
1Federal University of Minas Gerais, Belo Horizonte, Brazil, 2Department
of Surgery, Federal University of Minas Gerais, Belo Horizonte, Brazil
* Corresponding author.
Rationale: TheGlobal Leadership Initiative onMalnutrition (GLIM) is a
tool that aims to provide the nutritional status diagnosis based on
objective criteria different clinical contexts.
Methods: Patients with gastrointestinal diseases admitted in the
hospital for elective operations were evaluated within the first 24
hours of hospitalization. The patients were classified according to the
Subjective Global Assessment (reference method), the handgrip
strength and the GLIM. Muscle mass was evaluated by mid-arm
muscle (MAM), fat-free mass index (FFMI) by bioimpedance and calf
circumference (CC). Thus, the combination of each phenotypic factor
with 1 etiologic resulted in 10 GLIM models: G1: %weight loss
+decreased food intake (DFI); G2: Body Mass Index (BMI)+DFI;
G3: MAM+DFI; G4: FFMI+DFI; G5: CC+DFI; G6: %weight loss
+Inflammation (IN); G7: BMI+IN; G8: MAM+IN; G9: FFMI+IN; G10:
CC+IN. Postoperative complications (POC) and length of stay (LOS)
were assessed. The area under the curve (AUC) was calculated and a
p < 0.05 was considered statically significant.
Results: Therewere evaluated 118 patients, mean age 56,6 ± 14,9 years
old with 55.1% being female. Most of the patients underwent colonic
resections (36.4%), 33.9% esophageal, gastric and duodenal operations,
12.7% had liver and biliary tract procedures and others (17%).
Complications were seen in 20.6%, and 3.4% died. According to SGA,
51.7% of patients were undernourished. Low handgrip strength was
seen in 70.7%. Using the GLIM G1 model 34.7% were malnourished,
G2–18.6%, G3–11.0%, G4–19.6%, G5–28.0%, G6–44.9%, G7–21.2%, G8–
12.7%, G9-29.9% and G10-37.3%. The best models according to the AUC
was the G6 (AUC = 0.85), G1 (AUC = 0.80) and G5 (AUC = 0.75)
(p < 0,05). The median length of hospital stay was 7 days (minimum
2 days; maximum 114 days). There were no differences (p > 0.05)
between nutritional status in regards to POC and LOS independently of
the used assessment tool.
Conclusions: The GLIM models that presented the best sensibility for
malnutrition diagnoses were G6 and G1.
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BIOELECTRICAL IMPEDANCE ANALYSIS DEVICES: ARE THEIR RAW
MEASUREMENTS INTERCHANGEABLE?
M.-C. Gonzalez1*, on behalf of COCONUT, ALL Bia, S.P. Orlandi2, on
behalf of COCONUT, ALL Bia, F.B. Del Vecchio3, on behalf of ALL Bia,
L.M. Galliano3, N.R. Cardozo3, B.N.M.D. Silva2, A.C.C.A.D. Rocha3,
J.T. Aguiar Neto3, on behalf of COCONUT Study Group in Body
Composition and Nutrition; ALL Bia. 1Post-Graduate Program in
Health and Behavior, Catholic University of Pelotas, 2Nutrition College,
3Physical Education College, Federal University of Pelotas, Pelotas, Brazil
* Corresponding author.
Rationale: One of the most frequently used bioelectrical impedance
analysis (BIA) equations for skeletalmusclemass estimation (Jenssen’s
equation) and the new BIA equation for fat-freemass (FFM) estimation
for the Brazilian population were both developed using RJL devices,
however, it is unknownwhether the rawmeasurements [resistance (R)
and reactance (Xc)] from different BIA devices are interchangeable and
could be applied in these equations. The objectives of this study are: to
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compare these raw measurements from five different BIA devices;
compare FFM estimated from the Brazilian equation developed for RJL
(FFMRJL) when R and XC were measured by other devices; and
generated conversion equations for R and Xc from other devices,
having RJL measurements as reference.
Methods:We compared R and Xc from four different BIA devices in a
sample of 200 healthy subjects in a random order of tests, and each
device was compared to RJL values. After excluding outliers, the
agreement between each pair of devices was assessed using Bland-
Altman (BA) plots, and also precision, accuracy, and concordance
correlation coefficient (CCC). Linear regression analysis was used to
generate conversion equations for R and Xc from each device on
corresponding RRJLand XCRJL (reference values),respectively for each
sex. We also assessed the agreement between FFMRJLand FFM
estimations using the raw values derived from each device and after
proposed conversions.
Results: Differences among R-values varied from 3.28 to 6.27 ohms,
and precision, accuracy, and CCC were high (0.997–0.999). Differences
among Xc-values were higher than for R values (from 3.43 to
15.80 ohms) and results for precision, accuracy, and CCC varied from
0.242 to 0.989. Compared to FFMRJL,FFM was underestimated using all
the four devices, ranging from 0.91 to 3.01 kg, and 0.38 to 1.53 kg for
men and women, respectively. After R and Xc conversions, FFM
estimations from all devices were very similar compared to FFMRJL,
except one device for men.
Conclusions: There were variations in raw measurements across BIA
devices, which were more pronounced for Xc values. This resulted in
an underestimation of FFMRJL. R and Xc conversion equations
attenuated the underestimation and they should be used when a
non-RJL device is used for BIA measurements and applied in a RJL
equation.
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FIVE YEARS OF THE FIRST INTERDISCIPLINARY SPECIALIZED CLINIC
DEDIVATED TO TRACHEOSTOMY PATIENTS IN AUSTRIA
M.-M. Wetzinger Msc1*. 1Department of Dietetics and Nutrition, State
Hospital, University Teaching Hospital, Feldkirch, Austria
* Corresponding author.
Rationale: Patients with a tracheostomy have complex requirements
especially the nutrition situation is often unsatisfactory. In order to
improve this an interdisciplinary (ENT specialist, speech therapist,
certified nurse, dietitian) specialized clinic dedicated to tracheos-
tomy patients was established.
Methods: In the period fromNovember 2012 until December 2018 144
patients (111 men, 31 women, 2 children) were supervised by a
dietician. For this a dietary tracheostomy assessment was developed,
which also served for documentation and follow-up purposes. It
includes the screening tool NRS-2002 recommended by ESPEN after
Kondrup J. et al. [1], parameters of nutritional and medical status,
information about the type of food intake, nutrition-related problems,
diagnoses, and treatment status.
Results: At first assessment the mean body weight was 69.32 kg (R:
22–119.45) corresponding to a BMI of 24.62 (R: 12.9–50.7). According
to the results of the nutritional screening using NRS-2002 73
persons (50.69%) were at nutritional risk (NRS-2002 score≥ 3
Points) at their first presentation in the clinic.
The main content of dietetic advice and diet therapy were the
assessment of caloric intake, adaptation of enteral nutrition, energy
fortification by using natural foods, consistency adjustment, protein
enrichment using conventional foods, use of oral nutritional supple-
ments and initiating tube feeding.
71 patients (49.31%) received clinical nutrition (43 [30%] PEG/PEJ, 23
[16%] were fed with nasogastric tube and 2 [1%] with central venous
catheter), followed by 60 persons (41.67%) who took food orally and 13
patients (9.03%) who supplemented their oral nutrition with (par-)
enteral nutrition.
In the subgroup (≥assessment surveyed three times, 45 p.) the
following outlook emerges: The body weight (MW: 66.84 →
68.23 kg) and the BMI (MW: 23.61 → 24.09) increased slightly. The
NRS 2002 score shows a positive redistribution (NRS 0–2 [20 → 27]:
NRS 3–7 [25 → 18]) of the nutritional risk.
Conclusions: The involvement of the Department of Dietetics and
Nutrition optimizes the nutritional care for inpatients and is adapted
to the individual requirements of prescription of oral nutritional
supplements and enteral nutrition for outpatients.
Reference
1. Kondrup J. et al., Clinical Nutrition 2003; 22: 415–421.
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URINARY EXAMINATIONS FOR ESTIMATION OF FAT FREE MASS IN
PATIENTS WITH INTESTINAL FAILURE?
M. Køhler1*, S.S. Olesen2,3, H.H. Rasmussen1,3. 1Center for Nutrition and
Bowel Disease, 2Center for Pancreatic Diseases, Aalborg University
Hospital, 3Department of Clinical Medicine, Aalborg University, Aalborg,
Denmark
* Corresponding author.
Rationale: Altered body composition is a well-known complication in
patients with intestinal failure (IF) due to malnutrition and malab-
sorption. Measurement of body composition is not always available
nor affordable. However, urinary urea nitrogen and creatinine are
measured at low cost in most laboratories. Thus, our aim was to
examine the association between fat free mass and calculations based
on urinary urea nitrogen and creatinine excretion.
Methods: A cross-sectional study with patients stratified according to
the use of oral nutrition (ON) or home parenteral nutrition (HPN). We
recorded age, gender, body mass index (BMI), fat free mass by
bioelectrical impedance analysis (FFM-BIA), 24 h urinary urea nitro-
gen (UUN) and creatinine. We calculated creatinine height index (CHI
%) and FFM as 23.3 × u-creatinine (g/d) + 21.2 (FFM-calc) (Welle 1996).1
Statistics: T-test, Chi-square test, Pearson correlation and Bland-
Altman plot. Significance level: p < 0.05.
Results: In total 277 patients were included in the study (age 59 ± 15 Y,
male 44%, BMI 22.1 ± 4.3 kg/m2). The two groups were comparable
according to age andgender, butHPNpatient hadhigherUUNand lower
BMI, u-creatinine, CHI %, and FFM. The FFM-BIA correlated to CHI %
(r = 0.223, p < 0.001), UUN (r = 0.242, p < 0.001) and FFM-calc (r = 0.657,
p < 0.001). The correlation between FFM-BIA and FFM-calc was not
related to the use of HPN (r = 0.38, p = 0.67), thus, the two groups were
combined in a Bland-Altman plot showing limits of agreement: −12.2–
17.9 kg and an intra class correlation coefficient of: 0.66.
Conclusions: In lack of equipment to measure the fat free mass we
found that Welles equation for calculating fat free mass, is more
suitable than creatinine height index or urine urea nitrogen alone.
However, the equation is not precise and needs to be adjusted and
validated in patients with intestinal failure.
Reference
1. Welle S et al. Am J Clin Nutr 1996;63:151–6.
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SPORT NUTRITION KNOWLEDGE, BEHAVIORS AND SLEEP HABITS IN
PORTUGUESE HIGH-PERFORMANCE CANOEISTS
M.-R.G. Silva1,2,3*, T. Paiva4. 1Scientific Commission of the Gymnastics
Federation of Portugal, Lisbon, 2Research Centre for Anthropology and
Health, University of Coimbra, Coimbra, 3Faculty of Health Sciences of
University Fernando Pessoa, Oporto, 4CENC, Sleep Medicine Center,
Lisbon, Portugal
* Corresponding author.
Rationale: Along with training regime, adequate food intake and
appropriate sleep patterns are crucial for athletic success. This study
aims to evaluate sport nutrition knowledge, behaviors and sleep habits
among high-performance canoeists.
Methods: 46 Portuguese canoeists (28.3 ± 8.6 yrs old, 87%male and
13%female) participating in the 2015 National Cup of Canoeing were
included. A self-administered questionnaire was applied to collect the
following data: socio-demographic, anthropometric, training, sport
nutrition knowledge (Walsh et., 2011), behaviors and sleep habits. This
study was approved by the Ethical Committee of the University
Fernando Pessoa and written informed consent was obtained from all
participants. Descriptive linear regression analysis and Pearson
correlation coefficients were performed using SPSS. The significance
level was 5%.
Results: Participants (73.8 ± 3.4 kg;1.75 ± 1.12 m;23.6 ± 3.4 kg/m2)
trained a mean of 16.8 ± 8.2 h/week and slept significantly less on
weekdays (6.4 ± 2.3 h) than on weekends (10.0 ± 2.3 h, P < 0.001). The
average number of nutritional knowledge questions answered
correctly was 10.3 ± 1.9, giving a mean nutritional knowledge score
of 64.7%;no differences were observed between genders (P > 0.05).
Questions on carbohydrates were answered more accurately (63.8%),
with those on proteins and fat being answeredmost poorly (29.8% and
2.1%,respectively). Although most athletes were aware of hydration
(75.8%), they considered beer (27.7%) less caloric than Coca-Cola
(17.0%). Most participants were not aware that they should eat
immediately after training/match to start refuelling (76.6%). Vitamin
and mineral supplements were reportedly used by 61.2%. There was a
high consumption of fruits and vegetables (91.5%) and 96.4% ate
breakfast daily;4.3% reported not having a healthy diet and consuming
alcohol (12.8%).
Conclusions: Athletes would benefit from sport nutrition education
and sleep monitoring that enhance health and sport performance.
Reference
1. Walsh M.; Cartwright L.; Corish C.; Sugrue S.;Wood-Martin R. The
body composition, nutritional knowledge, attitudes, behaviors, and
future education needs of senior schoolboy rugby players in Ireland.
Int. J. Sport Nutr. Exerc. Metab. 2011, 21, 365.
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THE USE OF NUTRITIONAL SUPPLEMENTS, SOURCES OF
INFORMATION AND REASONS FOR THEIR USAGE AMONG
PORTUGUESE ATHLETES OF BOTH GENDERS
M.-R.G. Silva1,2,3*, H.-H. Silva4. 1Faculty of Health Sciences of University
Fernando Pessoa, Oporto, 2Research Centre for Anthropology and Health,
University of Coimbra, Coimbra, 3Scientific Commission of the Gymnastics
Federation of Portugal, 4Ministry of Education, Lisbon, Portugal
* Corresponding author.
Rationale: The use of nutritional supplements has been increasing
widely; however, many athletes are not well informed about their
effects. This study aimed to evaluate the consumption of nutritional
supplements in a group of athletes, determining sources of informa-
tion, as well as, reasons for their use in different sports.
Methods: Eighty-nine athletes (26,95 ± 5,9 years old) from 3 different
sports, namely crossfit (n = 23), football (n = 22) and volleyball (n = 21)
were interviewed and evaluated in order to collect information on
anthropometric data, training volume and behavior associated with
the use of nutritional supplements. Also the athletes’ nutritional
knowledge about supplementation was assessed. Weight, height and
waist and hip circumferences (WC and HC, respectively) were
measured according to international guidelines. Body mass index
was calculated. This study was approved by the Ethical Committee of
the University Fernando Pessoa and written informed consent was
obtained from all participants. Descriptive linear regression analysis
and Pearson correlation coefficients were performed using SPSS
version 25. The significance level was 5%.
Results: Participants trained an average of 5.2 ± 1.3 times/week with a
duration 1.9 ± 0.7 h/week. Female (n = 30) athletes’ BMI was 23.02 ±
2.46 kg/m2 and males’ (n = 59) was 24.28 ± 1.80 kg/m2. Surprisingly,
no significant differences were observed between gender (P > 0.05).
Many athletes consumed supplements during sports season (65.4%).
Although 31.6% reported the nutritionist or the physician (11.8%) as the
main sources of information about nutritional supplements, most
athletes (65.1%) reported not having sufficient knowledge about the
use and the risks of nutritional supplements. The two main reasons for
using nutritional supplements were: to improve athletic performance
(65.3%) and to accelerate recoveryaftera trainingorcompetition (29.4%).
Conclusions: Nutritional education among athletes and coaches is
crucial for a healthy training regime and a successful athletic
performance.
Disclosure of Interest: None declared.
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INNOVATIVE TECHNOLOGIES FOR IMAGE CAPTURE FOOD INTAKE
ASSESSMENT: A TOOL FOR CLINICAL AND EPIDEMIOLOGICAL
RESEARCH?
M.-F. Vaillant1*, L. Albaladejo2, P. Gillois2, J.-L. Bosson2. 1Laboratory of
Fundamental and Applied Bioenergetics, 2TIMC-IMAG UMR CNRS5525,
Universite Grenoble Alpes, Grenoble, France
* Corresponding author.
Rationale: The reference method for assessing nutrient intakes is the
traditional food survey, which faces a problem of quantification and
under-reporting. The use of innovative technologies is becoming a
solution for nutritional assessment.We conducted a systematic review
of articles published between 2007 and April 2019 on nutritional
intake assessment tools using image capture on smartphones. We
aimed to assess their reliability in epidemiological studies too.
Methods: Identification on Pubmed of articles in English on the
following inclusion criteria: studies on populations of all ages and
ethnic groups, with/without pathology, using photos to evaluate food
intake. Studies analysing the influence of photography on dietary
behaviour, technologies not using image capture, protocols using an
image catalogue were excluded.
Main criterion of the study: Image capture of dishes by photo
Secondary criterion: Comparison between the reference method and
new technology of the results obtained on qualitative and quantitative
estimations of dishes.
Results: 565 articles were identified by keywords, 70 by title and
abstract, 18 finally included:
• 3 studies focused on the automatic acquisition of images and
estimation of quantities. This procedure only requires the user to
take a picture. The application will automatically estimate the
volume and recognize the food by image processing algorithms,
facilitated by a fiduciary marker. A nutritional analysis can also be
performed by software with coding systems
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• 15 studies used image capture alone followed by analysis by a
nutrition professional. The user had to take pictures of his meals or
snacks before and after consumption. Hewas also asked to describe
the food, quantities, brands, cooking methods in writing or orally.
The specialist had to evaluate and analyse energy intakes.
Studies used heterogeneous protocols. The reliability of the caloric
estimation by image capture was compared to the gold standard
(double-labelledwater test) and conventionalmethods. The results for
image capture were closer to the gold standard, better than with
conventional methods.
Conclusions: Image capture methods are still uncommon in research
and clinical practice. The most commonly method in epidemiology is
to use a single image capture analysed by a trained dietician. The
published studies do not sufficiently compare technological perform-
ance with standard methods for estimating nutrient intake. To be
useful in epidemiological and clinical research, these tools need to be
improved, in particular to correct underestimated fats or added sugars.
References
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HEPATOBILIARY COMPLICATIONS OF TOTAL PARENTERAL
NUTRITION MANAGEMENT WITH TAURINE ENRICHED AMINOACID
SOLUTIONS.
M. Achaques Rodriguez1*, M. Moreno García1, N. Ibañez Heras1,
T. Molina García1. 1Pharmacy, Hospital Universitario de Getafe, Getafe,
Spain
* Corresponding author.
Rationale: Hepatobiliary complications of total parenteral nutrition
(TPN) appear in up to 90% of patients receiving TPN. Certain
hepatoprotector effect has been associated with taurine enriched
solutions. The aim of this study is to describe the variations on hepatic
parameters like gamma glutamil transferase (GGT), alkaline phos-
phatase (ALP) or bilirubin (Br).
Methods: Observational, retrospective and longitudinal study was
performed. Patients who have received TPN with taurine supplemen-
tation for almost 3 days from January 2016 to December 2017 were
included. Demographic and laboratory data were collected from
hospital electronic records. Laboratory data collected were GGT (also
in days 3, 7, 10 and 14), ALP, Br, lactate dehydrogenase (LDH) and
transaminases (AST and ALT)at the beginning and at the end of TPN
administration. We also collected data about reductions in lipid and
infusion times (cyclic TPN).Median values of GGT, AST, ALT, LDH, Br and
ALP were compared. Excel® was used to perform statistical analysis.
Results: A total of 60 patients were included, 68.3% males with a
median age of 69 years (IQR: 56–75). Mean TPN duration was 9 days
(IQR: 4–17). Lipid reductions were observed in a 95% of patients and a
75% of patients had cyclic TPN
Respecting to GGT variation from initial values we observed increases
of 10.7% at day 3, 32.1% at day 7, 31.8% at day 10 and 15.7% at day 14.
Comparing initial and final values we observed a variation of −0.2%.
Increases in ALT (7.8%), LDH (4.2%), ALP (22.6%), AST (15.9%) values
were observed and also a decrease on Br value (−7.8%) when
comparing initial and final values.
Conclusions: In our study population, the use of taurine enriched
solutions in TPN did not seem to have a beneficial effect on
hepatobiliary complications associated with TPN. We have not
observed analytic improvement in any of laboratory data analysed,
with the exception of Br.
Disclosure of Interest: None declared.
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HANDGRIP STRENGTH AMONG HEALTHY AMBULATORY ADULT
FILIPINOS
M.K.V. Woolbright1*, L.O. Llido1. 1Clinical Nutrition Services, St. Luke’s
Medical Center, Quezon City, Philippines
* Corresponding author.
Rationale: Nutritional assessment is usually obtained using the mass
index (BMI) representing physical size (weight/height2). However,
nutritional assessment may be better assessed using functional lean
body mass by handgrip strength. No handgrip strength values are
available to assess healthy ambulatory adult Filipinos.
Handgrip strengths of normal ambulatory adult Filipinos were
measured using a handgrip dynamometer. The values were used to
calculate the mean and standard deviation for male and female in
different age groups.
Methods: This is a cross sectional prospective study assessing the
handgrip strength of healthy ambulatory adult Filipinos participating
in two clinical gatherings. 911 ambulatory adult Filipinos consisting of
318 males and 593 females were tested for handgrip strength using
Camry handgrip dynamometers. Each participant performed three
strongest 5-second grips using their dominant hand. Their height and
weight were measured using a weighing scale with stadiometer.
Participants with an injury, previous surgery or stroke on their
dominant hand were excluded. Data were grouped according to sex
and age groups. Each set of data was then computed to represent
values showing ±2 standard deviations.
Results: Healthy ambulatory adult Filipinos showed a mean handgrip
strength of 28.7 with males = 38 and females = 23.7. The handgrip
values within 2 standard deviations of healthy ambulatory adult
Filipino males were: ages 18–29 = 14.3–62.7; ages 30–44 = 13.2–64.6;
ages 45–59 = 15.1–60.9; and ages ³60 = 14.2–38.0; while for females
were: ages 18–29 = 12.0–36.2; ages 30–44 = 12.8–36.8; ages 45–
59 = 5.4–38.8; and ages ³60 = 7.5–41.9.
Conclusions: Mean handgrip strength values and standard deviation
values were higher for males and lower for females. The study
recommends association of handgrip strength values amongmale and
female populations as well as in correlation to BMI.
Reference
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PHASE ANGLE AS A MARKER OF MICROVASCULAR DAMAGE IN
SYSTEMIC SCLEROSIS
A. Gigante1, M.L. Gasperini1, A. Iacolare1, A. Molfino1, L. Proietti1,
D. Margiotta2, L. Navarini2, A. Afeltra2, E. Rosato1, M. Muscaritoli1*.
1Department of translational and precisionmedicine, Sapienza University
of Rome, 2Department of Medicine, Unit of Allergology, Immunology,
Rheumatology, Campus Bio-Medico University of Rome, rome, Italy
* Corresponding author.
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Rationale: Systemic Sclerosis (SSc) is a connective tissue disease
characterized by microvascular damage and impaired angiogenesis.
The integrity of endothelial cell is important to its physiological
function such as production of mediators of angiogenesis.
Bioimpedentiometry (BIA)-derived Phase Angle (PhA) has been
proposed as a marker of cell membrane integrity. The aim of the
study was to assess whether PhA is altered in patients with SSc and
whether its values correlatewith VEGF levels and digitalmicrovascular
damage.
Methods: SSc patients underwent to BIA evaluation and VEGF
determination. Disease activity index (DAI) and nailfold videocapil-
laroscopy (NVC) were performed. For statistical analysis, Kruskal–
Wallis or Student’s test for continuous variables, Chi-square or Fisher’s
exact test for categorical variables and multiple regression analysis to
evaluate correlation between continuous variables, were used.
Results: Fifty-five SSc patientswere enrolled (46 females;mean age 53
±14 years). Median VEGF value was significanty higher in SSc patients
than in healthy controls [224 (95–435) vs 110 (65–217), p = 0.035].
Median PhA value was significantly lower in SSc patients than in
healthy controls [4.6 (2.5–6.7) vs 5.8 (5.7–6.5), p < 0.0001]. VEGF and
PhA positively and significantly correlated (p = 0.009, r = 0.1, beta
coefficient = 1.48) in SSc patients, while A negative correlation
between VEGF and DAI (p = 0.048, r = -0.05, beta coefficient = 0.48)
was found. PhAwas significantly (p = 0.006) lower in SSc patients with
late pattern [4.2 (2.5–5.3)] than SSc patients with other patterns. PhA
was significantly (p < 0,0001) lower in SSc patients with digital ulcers
(DUs) [4.2 (2.5–5.3)] than in patients without DUs [3.80 (2.50–5) vs
4.75 (2.80–7.3)].
Conclusions: VEGF levels in combination with PhA, NVC and DUs
history could be useful to estimate cellular and microvascular damage
in SSc patients.
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FAT FREE MASS IS REDUCED IN FEMALE SYSTEMIC SCLEROSIS
PATIENTS AND CORRELATES WITH DISEASE VARIABLES
E. Rosato1, A. Gigante1, M.L. Gasperini1, A. Iacolare1, A. Molfino1,
L. Proietti1, M. Muscaritoli1*. 1Department of translational and precision
medicine, Sapienza University of Rome, Rome, Italy
* Corresponding author.
Rationale: Changes in nutritional status and body composition are
frequently reported in Systemic Sclerosis (SSc) although their
prevalence depends on the methods of assessment used. The aim of
the study was to assess prevalence of sarcopenia in SSc patients and to
evaluate possible correlations with activity and severity disease.
Methods: Adults patients with diagnosis of SSc admitted to our
Scleroderma Unit were included in the study. Clinical status, disease
activity index (DAI), disease severity scale (DSS), modified Rodnan skin
score (mRSS), anthropometric data and bioelectrical impedance
analysis-assessed (Inbody 770; USA) fat free mass index (FFMI) were
recorded upon enrollment. For statistical analysis, Kruskal–Wallis or
Student’s test for continuous variables, Chi-square or Fisher’s exact test
for categorical variables and multiple regression analysis to evaluate
correlation between continuous variables, were used.
Results: Eighty-six female SSc patients were enrolled (mean age 55
±14 years, BMI 24.3 ± 4.1 kg/m2). Mean values of mRSS and disease
durationwere 11 ± 7 and 11.7 ± 8 years. Mean FFMI was 16.7 ± 2 kg/m2.
Patients were stratified according to FFMI: ≥15 kg/m2 (n = 68) and
FFMI <15 kg/m2 (n = 18). In groupwith reduced FFMI themedian value
of disease duration [12(10–18) vs 9 (8–11), p < 0.01], mRSS [18 (10–22)
vs 6 (6–8), p < 0.01] and DSS [7 (2–4) vs 3 (2–4), p < 0.001] were
significantly higher than in SSc with normal FFMI. Age was not
different between the two FFMI groups. In multiple regression
analysis, a negative correlation was observed between FFMI and
disease duration (p < 0.05, r = -0.37, beta coefficient −0.23), when
adjusting for age.
Conclusions: FFMI is reduced in female SSc patients with long disease
duration and high score of skin fibrosis. In addition, patients with
reduced FFMI show a negative correlation with DSS.
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NUTRITIONAL STATUS OF 24,534 CANCER PATIENTS WITH OR
WITHOUT DIABETES MELLITUS—RESULTS FROM INSCOC STUDY
M. Cong1*, H. Shi2. 1Department of Integrative Oncology, National Cancer
Center/National Clinical Research Center for Cancer/Cancer Hospital,
2Department of Gastrointestinal Surgery/Clinical Nutrition, Beijing
Shijitan Hospital, Capital Medical University, Beijing, China
* Corresponding author.
Rationale: The study aimed to characterize the nutritional status of
cancer patients with diabetes as compared with those without
diabetes, using diverse methods of nutritional assessment.
Methods: 24,534 patients with cancer were prospectively enrolled
from 72 hospitals in China. A series of parameters were investigated to
provide global estimation of nutritional status. Patients were sub-
divided into diabetes mellitus (DM) and non-DM groups and inter-
group comparison was made using Chi-square test and t-test.
Results: The incidence of diabetes was 7.0% in thewhole population. In
comparison with non-DM group, DM group had greater body weight
(63.12 kg vs. 59.83 kg, p < 0.001), similar level of fat-freemass (46.27 vs.
45.63, p = 0.177) yet lower handgrip (23.61 N vs. 24.81 N, p < 0.001). DM
group exhibited markedly decreased level of pre-albumin (99.22 mg/L
vs. 113.30 mg/L, p < 0.001) and albumin (38.64 g/L vs. 39.28 g/L, p =
0.022) and higher level of C-reactive protein (23.52 mg/L vs.18.60 mg/L,
p = 0.001). Notably, increased PG-SGA (6.43 vs. 5.93, p < 0.001) and
NRS2002 score (1.77 vs. 1.66, p = 0.006), as well as decreased Karnofsky
score (82.60 vs. 85.74, p < 0.001) were observed in the DM group.
Conclusions: Cancer patients with diabetes had bigger body mass yet
lower physical strength and poorer performance status, accompanied
by decrease in the level of (pre)albumin and elevated CRP. Tailored
nutrition intervention is necessary for this subpopulation considering
its unique pattern of nutritional status.
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HIGH PREVALENCE OF VITAMIN B12 DEFICIENCY BEFORE AND
EARLY AFTER GASTRECTOMY IN PATIENTS WITH GASTRIC CANCER
M. Ao1*, M. Awane2, Y. Asao3, T. Miyawaki1, K. Tanaka4. 1Food and
Nutrition, Kyoto Women’s University, 2Surgery, Rakuwa-kai Otowa
Hospital, Kyoto, 3Surgery, Hirakata-Kosai Hospital, Hirakata, 4Nutrition,
Kobe Gakuin University, Kobe, Japan
* Corresponding author.
Rationale: Gastric acid and intrinsic factor from stomach are required
for vitamin B12 (B12) absorption, and B12 deficiency is known to occur
after gastrectomy (GTx), but several years later because of large
amount of hepatic B12 storage. However, it may occur much earlier,
since most gastric cancer occurs in patients (pts) with atrophic
gastritis and B12 malabsorption may exit before surgery. In this paper,
we have tested this hypothesis.
Methods: Subjects were 23 and 50 pts before and after GTx,
respectively. They were evaluated for their blood B12, folate,
homocysteine levels, parameters of anemia, and nutrients intake
using a questionnaire. Informed consent was obtained.
Results: B12 concentration was decreased in both groups, and
significantly lower in pts after GTx (median; 201.5 pmol/L) than
those before GTx (median; 253.1 pmol/L) (p = 0.044). Prevalence of
B12 deficiency (lower than 220 pmol/L) was 35% and 63% in pts before
and after GTx, respectively, and the time from GTx to deficiency was
within twoyears in 29% of pts after GTx. In pts after GTx, blood B12 and
homocysteine concentrations were significantly negatively correlated
(r = -0.541, p = 0.046). Also, serumB12 and ferritin concentrationswere
lower inptswith anemia than in thosewithout it (p = 0.003, p = 0.061),
suggesting the coexistence of these nutrients deficiency.
Conclusions: B12 deficiency occurs in pts before and early after GTx.
Malabsorption of B12 and iron both occur after GTx, and they often
coincide. Although mean corpuscular volume (MCV) is increased and
decreased in the formerand latter, respectively, itmay not be altered in
their co-existence due to counteraction. B12 deficiency is likely to be
overlooked since B12 is not routinely measured. In conclusion, B12
deficiency is prevalent in gastric cancer pts before and early after GTx,
and more attention should be paid on B12 status.
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SEVENTY-FIVE-GRAM ORAL GLUCOSE TOLERANCE TEST USING A
FLASH GLUCOSE MONITORING SYSTEM
M. Akamine1*, H. Nishikawa2, Y. Fukunaga2, M. Ida2, Y. Saito2,
T. Taniguchi2, H. Sato3, T. Miyawaki1,2. 1Food and Nutrition, Kyoto
Women’s University, 2Health Administration Center, Rakuwakai Toji-
Minami Hospital, 3Infection Control, Rakuwakai Otowa Hospital, Kyoto,
Japan
* Corresponding author.
Rationale: A flash glucose monitoring (FGM) system, which continu-
ally measures glucose concentrations in interstitial fluid, has made it
possible to conveniently detect glycemic variations. The purpose of
this study was to compare venous plasma glucose (PG) levels with
interstitial glucose levels measured using the FGM (FGM-IG) system
during an oral glucose tolerance test (OGTT) in men and women.
Methods: Fifty-two healthy volunteers (25men and 27women;mean
age, 48.6 years) were recruited in annual health checkups. The
FreeStyle Libre Pro® sensor was inserted on the back of each upper
arm between 11:00 a.m. and 1:00 p.m. on the first day, and PG and
serum insulin levels were measured during 75-g OGTTs (at 0, 60, and
120minutes) on the second day after an overnight fast. A total of 75 PG
levels for men and 81 PG levels for women were paired with FGM-IG
levels simultaneously. We also measured height, body weight, waist
circumference (WC), and glycated hemoglobin (HbA1c) levels and
calculated body mass index (BMI) and homeostatic model assessment
insulin resistance (HOMA-IR). The relationships among PG, FGM-IG,
and these relative parameters were investigated. Informed consent
was obtained from each subject.
Results: There were significant and strong correlations between PG
and FGM-IG for men (r = 0.863, P < 0.001) and women (r = 0.759,
P < 0.001). Consensus error grid analysis indicated that all FGM-IG
levels were within Zones A (no effect on clinical action) and B (altered
clinical action – little or no effect on clinical outcome). The mean
absolute differences (MADs) were 15.1 mg/dL and 13.9 mg/dL for men
and women, respectively. The mean absolute relative differences
(MARDs) were 12.2% and 13.3% for men and women, respectively. The
MAD and MARD were not affected by factors such as age, BMI, WC,
HbA1c level, or HOMA-IR. Based on PG, 15 and 20 subjects were
diagnosed with normal glucose tolerance, 9 and 7 had impaired
glucose tolerance, and 1 and 0 had diabetes mellitus among men and
women, respectively. Based on FGM-IG, over 90% of subjects displayed
the same diagnosis based on PG.
Conclusions: FGM-IG reflected PG, and it was suggested that FGMwas
useful in the 75-g OGTT. Further studies are needed to clarify factors
affecting interstitial glucose levels.
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NUTRITIONAL RISK ATADMISSION ACCORDING TO HOSPITALWARD
AND ITS RELATION WITH MORTALITY: ANALYSIS OF 67,210 CASES
E.A. Rosas-Gonzalez1, M.P. Bejarano-Rosales2*, K. Alvarez-Altamirano2,
V. Fuchs-Tarlovsky2. 1Instituto Politécnico Nacional, 2Clinical Nutrition,
Hospital General de Mexico ‘Dr Eduardo Liceaga’, Mexico City, Mexico
* Corresponding author.
Rationale: The aim of this studywas to assess the association between
nutritional risk at hospital admission according to theward where the
patients were hospitalized and its relation with mortality.
Methods: An ambispective longitudinal and comparative study was
conducted in patients consecutively admitted at all the wards of the
Hospital General de México in a two year period. Nutritional Risk
Screening tool (NRS-2002)was appliedwithin 24–48 hours of hospital
admission. Nutritional risk prevalence, relative risk andmortalitywere
calculated for each ward. Chi-square test was performed to compare
relative risk in different wards and we calculate mortality rate in each
ward per year.
Results: Prevalence of nutritional risk was 18.87% in the screened
population (n = 67, 210 patients) at hospital admission. Patients
hospitalized with diseases related to the nephrology ward had the
highest nutritional risk 86.1% (RR 4.8); followed by the geriatric 74.5%
(RR 4.1), oncology 55.6% (RR3.7) neurology and neurosurgery ward
53.7% (RR 2.9). Infectiology ward was the one with the highest
mortality rate (98.5 per 1,000 people) during the two year period,
followed by neurology, neurosurgery (39.47) and oncology (34.76)
compared with all wards.
Conclusions: Nutritional risk prevalence at hospital admission had a
strong relationship with the ward where the patient will be admitted
to. Patientswith high nutritional risk had a significant associationwith
mortality according to the hospital ward of admission. Been a patient
with diseases related to the nephrology, geriatric and oncology wards
have the highest risk of malnutrition associated with mortality rate.
Therefore, nutritional monitoring and trained personnel are required
in those areas. Further research should explore the use of nutrition
screening and intervention before, during, and after hospitalization at
each ward to ensure an appropriate nutrition intervention.
Disclosure of Interest: None declared.
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MON-PO504
PHYSICIANS’ ATTITUDES TOWARDS MEDICATION RELATED
NUTRITION DISORDERS
N. Yalcin1*, B. Kelleci-Cakir1, A. Ekincioglu1, K. Demirkan1, M. Gulhan-
Halil2, O. Abbasoglu3. 1Department of Clinical Pharmacy, 2Division of
Geriatrics, 3Department of General Surgery, Hacettepe University, Ankara,
Turkey
* Corresponding author.
Rationale:Medications that affected the intake, digestion, absorption,
storage, metabolism and elimination of nutrients can cause medica-
tion related nutrition disorders (1). The aim of this study was to
evaluate the attitudes of physicians against medications that may
cause malnutrition, insufficient nutrition, sarcopenia, weight loss, and
micronutrient disorders.
Methods: A questionnaire consisting of 14 questions was applied to
the physicians attending to the ‘Medication Related Nutrition
Disorders’ titled seminar within the scope of Adult Nutrition
Support Unit Curriculum in 15th January 2019 by obtaining written
consent on the basis of voluntariness. We used the 3-point Likert scale
(Agree, Indecisive, Disagree) before and after the training.
Results: A total of 30 physicians with a median age of 34 years (23–59
years) and 19 (63.3%) women participated in the survey. While 24
(80.0%) of the physicians are specialists, 6 (20.0%) of them are
assistants and the median of period of service in profession is 13
years (range: 1–36 years). The distribution of the services of physicians
were as follows; intensive care unit (n = 11, 36.7%), pediatric
gastroenterology (n = 9, 30.0%), geriatrics (n = 7, 23.3%) and general
surgery (n = 3, 10.0%). It was the question that ‘Medications that cause
no taste or metallic/bitter taste affect the nutritional status of the
patients’ has been the most common answer to the ‘Disagree’ (6.67%).
It was the questions that ‘Vitamin B12 plasma levels should be
monitored in patients prescribing metformin’ and ‘Vitamin D plasma
levels should bemonitored inpatients prescribing phenytoin’ has been
the most common answer to the ‘Indecisive’ (23.33% and 23.33%
respectively). There was a statistically significant change in the
response to both questions after the training (p: 0.011 and p: 0.008
respectively).
Conclusions: Although the awareness of physicians about medication
related nutrition disorders is generally high, it has been observed that
the training contributed to improve the knowledge level. There is a
need for studies evaluating reflection to the physicians’ clinical
practices of this theoretical attitude.
Reference
1. Felípez L & Sentongo TA (2009). Drug-induced nutrient
deficiencies. Pediatric Clinics, 56(5), 1211–1224.
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NUTRITIONAL ASSESSMENT OF A POPULATION IN TURKANA,
KENYA: A PILOT STUDY.
N.M. Perez-Ferre1*, C. Hernández Pérez2, C. Marcuello1, L. Herraiz1,
M.A. Rubio1, A.L. Calle1, P. Matía1, on behalf of ‘Surgery in Turkana’.
1Endocrinology and Nutrition, 2General Surgery, Hospital Clinico San
Carlos, Madrid, Spain
* Corresponding author.
Rationale: The Spanish project ‘Surgery in Turkana’works since 2004
improving health status of Turkana population in the North of Kenya.
The objective of this study was to perform a nutritional assessment on
the population attended at Lodwar District Hospital during the
Surgical Campaign of February 2018.
Methods: Observational cases-series study. Ethical Committee of
HCSC approved the study. Demographic and clinical data were
collected: gender, age, location (rural/town), Turkana region, educa-
tional level, acute/chronic illness, comorbidities, weight loss.
Anthropometric data: weight, height, middle upper arm circumfer-
ence, tricipital skin fold, grade of edema, fat and muscle loss (physical
exam), muscular strength (dynamometer). Body composition data by
bioimpedance (BIA Akern101). Estimated coverage of caloric
requirements. Diagnosis of malnutrition: body mass index (BMI)
and ASPEN criteria in adults (>17 years-old).
Results: 218 patients were evaluated (48.2% males, 52.8% females).
Median age 33.5 years-old [17–48]. 80% from rural areas. Data about
weight loss remain unknown in most of the patients. Significant
differences were found between rural and urban population regarding
all the anthropometric data and most of the body composition data.
Using ASPEN criteria, 85.2% of males and 82.2% of females from rural
area were diagnosed of malnutrition vs 28.6% in males and 22.7% in
females from urban area. 65% of males and 64% of females from rural
area had BMI<18.5 vs 28.6% in males and 9.1% in females from urban
area.
Conclusions: High prevalence of malnutrition was detected in
Turkana population. However, diagnostic criteria for malnutrition in
hospitals of undeveloped countries are not well stablished. Studies are
required to find the most accurate criteria adapted to these scope.
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GLOBAL LEADERSHIP INITIATIVE ON MALNUTRITION (GLIM)
CRITERIA FOR DIAGNOSIS OF DISEASE RELATED MALNUTRITION
IN A HOSPITAL FROM THE AFRICAN CONTINENT. A CALL TO ACTION
N.M. Pérez-Ferre1,1*, C. Hernández Pérez2, C. Marcuello1, L. Herraiz1,
M.A. Rubio1, A.L. Calle1, P. Matía1, on behalf of ‘Surgery in Turkana’.
1Endocrinology and Nutrition, 2General Surgery, Hospital Clinico San
Carlos, Madrid, Spain
* Corresponding author.
Rationale: The objective of this study was to describe the prevalence
of malnutrition with the GLIM criteria in a sample of population at
Lodwar District Hospital (Turkana, Kenya) and to analyse the diagnosis
agreement using two cut-off points for BMI and three strategies to
measure muscle mass (MM).
Rural Urban
n(%) Men
(n = 54)
Female
(n = 73)
Men
(n = 14)
Female
(n = 22)
Glim1 (BMI <18.5 kg/m2
and FFMI <15/17 kg/m2)
n = 38
24 (63.2)
n = 50
38 (76)
n = 5
3 (60)
n = 9
3 (33.3)
Glim2 (BMI <20 kg/m2 and
FFMI <15/17 kg/m2
n = 44
30 (68.2)
n = 57
45 (78.9)
n = 9
5 (55.6)
n = 9
3 (33.3)
Glim3 (BMI <18.5 kg/m2
and low clinical muscle
mass)
n = 46
29 (63.0)
n = 61
42 (68.9)
n = 12
3 (25.0)
n = 20
0 (0.0)
Glim4 (BMI <20 kg/m2 and
low clinical muscle
mass)
n = 46
30 (65.2)
n = 61
44 (72.1)
n = 12
5 (41.7)
n = 20
0 (0.0)
Glim5 (BMI <18.5 kg/m2
and low hand grip
strength)
n = 46
31 (67.4)
n = 61
43 (70.5)
n = 12
5 (41.7)
n = 20
4 (20.0)
Glim6 (BMI <20 kg/m2 and
low hand grip strength)
n = 46
32 (69.6)
n = 61
46 (75.4)
n = 12
6 (50.0)
n = 20
4 (20.0)
Methods: Two levels of BMI (<18.5/<20.0 kg/m2) and 3 tools of MM
measure (FFMI <15 for female, <17 form male -Akern® bioimpedance-,
clinical evaluation and hand grip strength <16 kg for female, <27 kg for
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male -JAMAR® dynamometer-) were used to define malnutrition
phenotypic GLIM criteria.Weight evolutionwas unknown. Six diagnosis
approaches were tested with the combinations of those criteria.
Results: Total sample 163 (rural M/F: 54/73; urban M/F: 14/22). The
malnutrition prevalence is shown in the table.
The value of kappa for agreement was: GLIM 1–3/1–5/3–5: 0.897/
0.894/0.845; GLIM2-4/2-6/4-6/: 0.937/0.952/0.889.
Conclusions: GLIM criteria could be used for the diagnosis of
malnutrition in hospitals from the African continent, taking into
account special considerations.
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DIFFERENCES IN BODY COMPOSITION PARAMETERS ESTIMATED BY
BIOELECTRICAL IMPENDENCE DEVICE BETWEEN THE AFFECTED
AND UNAFFECTED SIDE OF THE BODY IN STROKE PATIENTS
N. Majdič1*, R. Špeh2, N. Puzic ́ Ravnjak1. 1University Rehabilitation
Institute, Republic of Slovenia – SOČA, Ljubljana, Slovenia, 2Casa di cura
pineta del Carso, Trieste, Italy
* Corresponding author.
Rationale: In everyday clinical practice and some literature,1 the body
composition parameters estimated by a bioelectrical impedance
device on the unaffected side of the body in stroke patients seems to
be better (lean body mass is usually a bit higher) than parameters on
the affected side. The aimof the studywas to prove that the selection of
the side is important, as measurements on the unaffected side can
underestimate the actual state.
Methods: Bioelectrical impedance analysis on both sides of the body
was performed in 46 stroke patients who were admitted to the
University Rehabilitation Institute, Republic of Slovenia and the
Institute Auxologico Italiano between October 2013 and May 2014.
Differences in body composition parameters on the affected and
unaffected sides were tested using independent t-test. When
comparing the two sides, the following criteria were taken into
account: the time interval between the stroke and the admission to the
rehabilitation institute, the spasticity of the affected side, oedema and
dysphagia.
Results: Therewas no statistically significant difference in estimate fat
free (mean difference 0,4; p-value 0,3516) and lean body mass (mean
difference 0,337; p-value 0,3581) between the affected and the
unaffected side. On the contrary, there was a statistically significant
difference in the phase angle (mean difference 1,1; p-value <0,001).
More than half of the patients (59%) had spasticity and 37% had
oedema on the affected side. The mean time interval between the
stroke and the admission to the rehabilitation institute was 294 days
(SD: 487,4; 3–2567 days).
Conclusions: Since the phase angle is one of the most reliable
indicators of the nutritional state of the body,2 and since the study has
shown that the values on the affected side are significantly lower, we
have decided to perform bioelectrical impedance analysis in stroke
patients on the affected side of the body (if possible). This way, we try
to avoid underestimation and misinterpretation of the results and
consequently inappropriate use of different clinical interventions to
prevent malnutrition.
References
1. Celik B, Ones K, Ince N. Body composition after stroke. Int J Rehabil
Res 2008; 31: 93–96.
2. Ha L, Hauge T, Iversen PO. Body composition in older acute stroke
patients after treatment with individualized, nutritional supple-
mentation while in hospital. BMC Geriatr 2010; 10: 75.
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ANALYSIS OF OUTCOMES OF THE NRS 2002 QUESTIONNAIRE IN
PATIENTS HOSPITALIZED ON NEPHROLOGY WARDS
P. Borek1,2*. 1Department of Oncology and Radhioterapy, Medical
University of Gdańsk, 2Department of Physiotherapy and Health
Sciences, Higher School of Health, Gdańsk, Poland
* Corresponding author.
Rationale: Malnutrition is a common problem among hospitalized
patients, there is a need for rapid and effective identification of
patients at risk of malnutrition in order to introduce the appropriate
prevention and /or nutritional intervention. One of the tools is quick
and easy to performa questionnaire NRS-2002 (Nutritional Risk Scale).
Methods: The aim of the study was to test the effectiveness of
NRS-2002 in the assessment of malnutrition patients hospitalized
in nephrology. The objective was to also an attempt to clinical
characteristics of the malnourished patients and assessment the
relationshipbetweennutritional statusandsometimeshospitalization.
Results: The analysis included 292 patients (K = 135 M= 157), median
age was 60 (IQR = 17) years. The average BMI was equal to 24.6
(IQR = 7.4). The median of duration of hospitalization 9 (IQR = 8) days.
Among the respondents in 119 patients (40%) had malnutrition (NRS
≥ 3). Group of undernourished peoplewas characterized bya statically
significant lower BMI (23.4, IQR = 6,4 vs 25.6, IQR = 6 = 7,3 p = 0.0000),
a more advanced age (73, IQR = 20 vs 54, IQR = 22 years; p = 0.0000),
lower serumalbumin (26, IQR = 9 vs 32.5, IQR = 7.3 g/l, p = 0.0000), and
almost twice longer duration of hospitalization (13, IQR = 14 vs 7,
IQR = 5 days, p = 0.0000)). Inmultiple regression analysis, the presence
of malnutrition assessed the scale of the NRS-2002 proved to be
an independent predictor of the duration of hospital stay (b = 11.2,
p <0.001).
Conclusions: The questionnaire NRS-2002 is a simple and useful tool
to determine malnutrition. Results of the analysis indicate a high
prevalence of malnutrition among patients hospitalized in nephrol-
ogy, as well as on the impact of this complication on the length of
hospitalization. Identification of malnourished patients with NRS-
2002 will allow the implementation of appropriate nutrition inter-
vention helping to improve outcomes in hospitalized patients.
References
1. Elia M., and Stratton R. J. 2000Howmuch undernutrition is there in
hospitals? Br J Nutr 84(3):257–9.
2. Fang S., et al. 2013 A multicentre assessment of malnutrition,
nutritional risk, and application of nutritional support among
hospitalized patients in Guangzhou hospitals. Asia Pac J Clin Nutr 22
(1):54–9.
3. Tangvik R. J., et al. 2015 Nutritional risk profile in a university
hospital population. Clin Nutr 34(4):705–11.
4. White J. V., et al. 2012 Consensus statement of the Academy of
Nutrition and Dietetics/American Society for Parenteral and Enteral
Nutrition: characteristics recommended for the identification and
documentation of adult malnutrition (undernutrition). J Acad Nutr
Diet 112(5):730–8.
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THE UNDER-NUTRITION RISK IN HOSPITALIZED MALAYSIAN
CHILDREN: USE OF 3-MINUTE NUTRITION SCREENING-PAEDIATRIC
(PAEDIATRIC 3-MINNS)
P.S. Yeo1,2*, C.C.M. Boey3, H. Abdul Majid1. 1Department of Social and
Preventive Medicine, Faculty of Medicine, University of Malaya, 2Malaysia
Ministry of Health, 3Department of Paediatrics, Faculty of Medicine,
University of Malaya, Kuala Lumpur, Malaysia
* Corresponding author.
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Rationale: In Malaysia, implementation of any nutrition screening
tools was not a routine pediatric clinical practice. There was also
limited information on under-nutrition proportion among hospita-
lised children in Malaysia. The study aimed to evaluate the under-
nutrition rate of children who admitted to the paediatrics wards of a
tertiary teaching hospital, a tertiary general hospital and a district
hospital using the validated Paediatric 3-MinNS.
Methods: This cross-sectional study with 284 patients aged 2–12
years was conducted in the paediatrics wards of Kuala Lumpur
Hospital Paediatrics Institute (KLHPI), University Malaya Medical
Centre (UMMC), and Hospital Sultanah Nora Ismail (HSNI), Batu
Pahat, Johor. Convenience sampling of paediatric patients who
admitted within 24–72 hours was recruited. All staff nurses at these
centres were given the trainings on using Paediatric 3-MinNS as the
nutrition screening tool. Social-demographic, anthropometric and
clinical datawas recorded. All statistical analyses were donewith SPSS
software, version 20.0, appropriate statistical tests were been carried
out to determine the relationship between the variables.
Results: The Paediatric 3-MinNS performed by the staff nurses
identified 25.4% of participants as being at high under-nutrition risk.
The highest proportion of participants with high under-nutrition risk
was found at HSNI (33%), followed by KLHPI (26.4%), and UMMC (15%).
When referred to the WHO criteria, 5.4% of the participants with high
under-nutrition risk assessed by the Paediatric 3-MinNS had severe
acute malnutrition, 9.7% had severe chronic malnutrition, and 11.1%
were severe thinness according to the BMI-for-age. There were 32.9%
participants with high risk score had the length of hospital stay more
than 5 days.
Conclusions: Findings of this study supported the use of Paediatric 3-
MinNS as the nutrition screening tool for hospitalised children in
Malaysia. It is recommended that all hospitals adopt the policy to
screen paediatric patients on admission for under-nutrition risk.
Disclosure of Interest: P. S. Yeo Grant/Research Support from:
Postgraduate Research Fund (PG075–2015A), C. C. M. Boey Grant/
Research Support from: Postgraduate Research Fund (PG075-2015A),
H. Abdul Majid Grant/Research Support from: Postgraduate Research
Fund (PG075-2015A).
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ENERGYAND PROTEIN INTAKE AFTER LIVER TRANSPLANTATION – A
COMPARISON OF TWO NUTRITIONAL PROTOCOLS
P. Nordstedt1*, C. Lindqvist2, G. Nowak3. 1Department of Transplantation
Surgery, Karolinska University Hospital, 2Function Area Clinical Nutrition,
Karolinska University Hospital, Department of Medicine, Karolinska
Insitutet, 3Department of Transplantation Surgery, Karolinska University
Hospital, Stockholm, Sweden
* Corresponding author.
Rationale: Individual adjustment of nutrition based on monitoring of
energy and protein intake in patients undergoing liver transplantation
(LTx) is important to promote enhaced recovery and to reduce
postoperative complications. The aim of this study was to evaluate
two nutritional protocols and its effect on protein intake during the
first seven days after Ltx.
Methods: Between September 2017–December 2018, adults patient
undergoing LTx in our center, where daily monitored for total energy
and protein intake during the first week after LTx. Patients with at least
3 days monitoring were included in the study. Protocol A (pA) was
based on enteral nutrition (EN) provided from postoperative day 1–4;
protocol B (pB) involved a faster rate and higher volume of EN and
additional high protein oral nutritional supplements (ONS). Besides
nutritional pA or pB, patients consumed food according to individual
tolerance. Mann-Whitney, t-test and chi-square test was used for
statistical analysis.
Results: Seventy patients were included in the study. During the first
postoperativeweek, patients with pB had a higher protein intake (95 g
vs 77 g) and covered a higher proportion of estimated protein needs
(80% vs 70%)
Table 1
Protein and energy intake.
Factor All (n = 70) A
(n = 34)
B
(n = 36)
p-
value
Energy intake kcal/d,
mean (SD)
1901 (438) 1795 (440) 1995 (426) 0.062
Intake in % of estimated
energy needs/d, mean
(SD)
84 (19) 80 (17) 88 (20) 0.088
Covering > 70% of energy
needs, n (%)
53 (76%) 24 (73%) 29 (81%) 0.441
Protein intake gram/d,
median (IQR)
81 (33) 77 (19) 95 (35) <0.01
Intake in % of estimated
protein needs, median
(IQR)
78 (22) 70 (27) 80 (30) <0.05
Covering > 70% of protein
needs, n (%)
45 (64%) 17 (50%) 28 (78%) <0.02
Conclusions: A nutritional protocol including higher rate of EN and
high protein ONS (pB) resulted in a higher protein intake early after
LTx. Effect of higher protein intake on post LTx complications will be
studied.
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A NEW EQUATION USING KNEE HEIGHT TO PREDICT OVERALL
HEIGHTAMONG OLDER PEOPLE IN SUB-SAHARAN AFRICA.
R. Mas1, B. Marin2,3,4, C. Mizéhoun-Adissoda5,6, S. Pilleron3,4,
M. Guerchet3,4, D. Houinato3,4,5, P. Mbelesso7, B. Ndamba-
Bandzouzi3,4,8, P.M. Preux2,3,4, J.C. Desport1,3,4, P. Fayemendy1,3,4,
P. Jésus1,3,4*. 1Nutrition Unit, 2Center of Epidemiology, Biostatistics and
Research Methodology, University Hospital of Limoges, 3INSERM, U1094,
Tropical Neuroepidemiology, School of Medicine of Limoges, 4UMR_S
1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and
Tropical Neurology, CNRS FR 3503 GEIST, University of Limoges, Limoges,
France, 5Laboratory of Non-communicable and Neurologic Diseases
Epidemiology (LEMACEN), 6School of Nutrition and Dietetic, Faculty of
Health Science, University of Abomey-Calavi, Cotonou, Benin, 7Neurology
Department, Amitié Hospital, Bangui, Central African Republic,
8Neurology Department, University Hospital of Brazzaville, Brazzaville,
Congo
* Corresponding author.
Rationale: Predictive formula for height using knee height (pHt) are
useful among people aged over 60 years who cannot get upright.
However, they were developed in caucasians and African-Americans
but not for older native Africans. With the increase of nutritional
epidemiologic studies in African older people it is therefore important
to have avalidated formula for this population.We therefore aimedi) to
propose a new validated formula in older people in sub-Saharan
Africa, ii) tostudy the nutritional status according to the body mass
index (BMI) with measured height (mHt) and pHt.
Methods:mHt and pHt were measured in a population of peopleover
65 years old from the Republic of Congo (ROC), Central African
Republic (CAR) and Benin. A new formulawas created for older people
of ROC and CAR after randomization in a derivation sample (n = 877)
and assessed for accuracy in a validation sample (n = 877). We also
tested this new formula in older people of Benin. The percentages of
accurate predictions (±5 cm) were compared between mHt and pHt
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with the new formula and Chumlea’s formulas for the American black
population (CBP). Chi2 and Mann-Whitney test was also used.
Results: We included 880 older people in ROC, 874 in CARand 220 in
Benin. There was no significant difference between characteristics of
the derivation sample and the validation sample. The new formula
significantly increases accuracy (71.3%) and decreases overestimation
(14.7%) compared to CBP (65.3%, p = 0.008 and 25.9%, p < 0.0001,
respectively) in validation sample. In Benin, the new formula gave the
same accuracy than CPB (81.8% vs.83.3%; p = 0.71), however it
decreased overestimation (4.6% vs.11.8%; p = 0.005). Moreover, there
was no significant difference in BMI calculated with the mHt and the
pHtwith our new formula, and the nutritional status based on BMI did
not differ.
Conclusions: The formula that we propose more accurately estimates
height in older native Africans. Moreover, this formula overestimates
less the height of older people. It could be useful for future
epidemiological studies but also in clinical practice.
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MON-PO512
MALNUTRITION KNOWLEDGE, ATTITUDES, AND PRACTICES IN
DUTCH HOSPITAL PROFESSIONALS FROM A REGIONAL DUTCH
HOSPITAL
P. Dewansingh1,2*, A. Hendrickx1,3, T. Boschma2, J.H. Strijbos4, C.P. van
der Schans1,5,6, H. Jager-Wittenaar1,7. 1Research Group Healthy Ageing,
Allied Health Care and Nursing, Hanze University of Applied Sciences,
Groningen, 2Nutrition and Dietetics, 3Physical Therapy, 4Department of
Lung Diseases, Hospital Nij Smellinghe, Drachten, 5Department of
Rehabilitation Medicine, 6Department of Health Psychology Research,
7Department of Maxillofacial Surgery, University of Groningen, University
Medical Center Groningen, Groningen, Netherlands
* Corresponding author.
Rationale: Prevention and treatment of malnutrition requires
adequate knowledge of (mal)nutrition among healthcare profes-
sionals involved in the nutrition care process. In this study, we
aimed to assess the level of nutrition knowledge, attitudes, and
practices in hospital healthcare professionals.
Methods: The Nutrition knowledge, attitudes, and practices as
perceived by the healthcare professionals (i.e., physicians, nurses,
dietitians, speech therapists, and physical therapists) were assessed,
using the validatedMalnutrition (M) Knowledge (K), Attitudes (A), and
Practices (P) (M-KAP) questionnaire. Participants were asked to score
1–5 points per KA statement, and 1–4 points per P statement. Total
M-KAP score was calculated by adding the KA scores to the P scores.
Maximum scores for KA and P were 100 and 28, respectively.
Results: 39 professionals (24% response rate, 32 nurses, 6 physical
therapists, and 1 speech therapist) completed the M-KAP question-
naire, of which 92% was female, 73% was aged ≥40 years, 59% worked
at the surgery department, 36% at the lung disease and cardiology
department. Mean total scores were 75.3 ± 5.5 for KA, 18.3 ± 3.3 for P,
and 93.6 ± 7.7 for total KAP. In total, 87% at least somewhat agreed that
malnutrition is a high priority at the hospital, 79% stated to have an
important role in promoting food intake, 21% somewhat disagreed
with the statement that all patients should be screened at hospital
admission, and 41% stated to somewhat agree to needing more
training to better support the nutrition needs of the patients. More
than half of the participants did not encourage patient’s family to bring
food from home (51%). Moreover, 51% stated to often/always visit and
check a patient during their meal time to see howwell they are eating.
Only 10% stated to often provide the patient or family with nutrition
education materials.
Conclusions:Hospital staff finds nutrition support important, but also
addresses the need formore training to better support nutrition needs
of their patients.
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MON-PO4513
PREDICTIVE VALUE OF GLIM CRITERIA FOR DIAGNOSING
MALNUTRITION ON HOSPITAL LENGTH OF STAY IN SELECTED
CLINICAL POPULATIONS
P. Dewansingh1,2*, T. Boschma2, A. Hendrickx1,3, W.P. Krijnen1,4, C.P. van
der Schans1,5,6,7, H. Jager-Wittenaar1,8. 1Research Group Healthy Ageing,
Allied Health Care and Nursing, Hanze University of Applied Sciences,
Groningen, 2Nutrition and Dietetics, 3Physical Therapy, Nij Smellinghe
Hospital, Drachten, 4Faculty of Mathematics and Natural Sciences,
University of Groningen, 5Faculty of Medical Sciences, 6Department of
Rehabilitation Medicine, 7Department of Health Psychology Research,
University Medical Center Groningen, 8Department of Maxillofacial
Surgery, University of Groningen, University Medical Center Groningen,
Groningen, Netherlands
* Corresponding author.
Rationale: We aimed to assess the predictive value of the Global
Leadership Initiative on Malnutrition (GLIM) criteria on length of
hospital stay (LOS).
Methods: Data were collected in patients from the surgery, urology,
lung disease, and cardiology wards of a Dutch hospital, <72 h after
hospital admission. MalnutritionGLIM was assessed by using the
Patient-Generated Subjective Global Assessment and bioelectrical
impedance analysis, and was defined as having ≥1 phenotypic
criterion: weight loss (WL), low body mass index (BMI), or reduced
muscle mass (MM), and ≥1 etiologic criterion: reduced food intake/
assimilation (RI) or inflammation/disease burden (IF). Difference in
LOS betweenmalnourished and well-nourished patients was assessed
with the Mann-Whitney U test. Predictive value of the GLIM criteria
was determined with generalized linear regression, correcting for the
confounders age, gender, diagnosis, and Charlson comorbidity index.
The GLIM criterion ‘low BMI’ was not corrected for age, since this
criterion already includes specific age ranges.
Results: In total, 455 patients were included (65 ± 15 years, 55%male),
of which 47% were categorized as having malnutritionGLIM (Table 1).
While significantly predicting LOS in the univariate analysis (1.1 d
longer LOS, p = 0.033), malnutritionGLIM did not significantly predict
LOS after correction for possible confounders. However, specific
combinations, i.e., WL+RI (Δ1.1 d), WL+IF (Δ1.3 d), and BMI+IF
(Δ1.6 d) significantly predicted LOS.
Table 1
Presence of GLIM criteria and difference in length of stay.
GLIM criteria Yes
N (%)
ΔLOS
days
p-value* ΔLOS
days
p-
value**
p-
value***
GLIM 212 (47%) 1.2 p = 0.033 1.1 p = 0.064
WL 54 (13%) 1.2 p = 0.095 1.2 p = 0.070
BMI 23 (5%) 1.5 p = 0.010 1.6 p = 0.002
MM 218 (48%) 1.2 p = 0.018 1.1 p = 0.219
RI 66 (15%) 1.2 p = 0.069 1.2 p = 0.109
IF 345 (76%) 1.2 p = 0.032 1.1 p = 0.129
WL+RI 18 (4%) 1.6 p = 0.007 1.6 p = 0.010
WL+IF 45 (11%) 1.3 p = 0.042 1.3 p = 0.022
BMI+RI 4 (1%) 1.2 p = 0.553 1.4 p = 0.340
BMI+IF 21 (5%) 1.5 p = 0.023 1.6 p = 0.006
MM+RI 40 (9%) 1.2 p = 0.111 1.1 p = 0.270
MM+IF 187 (41%) 1.2 p = 0.008 1.1 p = 0.082
LOS = length of stay, WL =weight loss, BMI = body mass index.
MM = reducedmuscle mass, RI = reduced intake/assimilation, IF = inflammation.
*Univariate model.
**Corrected for age, gender, diagnosis, co-morbidity.
***Corrected for gender, diagnosis, co-morbidity.
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Conclusions: In selected clinical populations, the predictive value of
variants of GLIM criteria for LOS is most significant for the less
prevalent weight loss and reduced intake combination, but not
significant for the highly prevalent reduced muscle mass with any
etiologic criteria combination. Further insight inpredictive value of the
GLIM criteria in other populations is needed.
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Rationale: The Dutch hospital Nij Smellinghe is implementing the
Patient-Generated Subjective Global Assessment Short Form (PG-SGA
SF) for nutritional screening. Insight is needed in how implementation
of this instrument affects the number of referrals to the various
professionals involved in the nutritional care process, and their
treatment plans. We aimed to evaluate the progress of the interdis-
ciplinary malnutrition prevention and treatment strategy to imple-
ment the PG-SGA SF and subsequent start of tailored interventions in
Nij Smellinghe within the STREAM (Strategy to proactively screen,
assess, prevent, and treat malnutrition) implementation study.
Methods: The implementation strategy was developed in co-creation
with the hospital staff, using the Knowledge-to-Action process.
Patients from the wards lung disease, cardiology, surgery, and
urology completed the PG-SGA SF <24 h after admission. Patients
completed the boxes on weight history, food intake, nutrition impact
symptoms (NIS), and activities/function. Dietitian referral results from
≥2 points on weight loss and/or food intake. Physiotherapist referral
was set at ≥2 points on activities/function. Patients reporting ≥1 of the
NIS nausea, constipation, mouth sores, pain, vomiting, diarrhea, dry
mouth, fatigue, or ‘other NIS’ were referred to the nurse. Patients
reporting ‘problems swallowing’were referred to the speech therapist.
Results: Between November 2018-March 2019, 788 of 1162 admitted
patients (68%) were screened with PG-SGA SF. Of the screened
patients, 29%were referred to the dietitian, 30% to the physiotherapist,
5% to the speech therapist, and/or 32% to the nurse. The dietitian
started treatment in 31%, but did not treat 51% of the PG-SGA SF-based
referred patients, and had already started treatment in 18%. The
physiotherapists started treatment in 32%, but did not treat 33%, and
had already started treatment in 35%. Main reasons for both
professional groups for not starting treatment were: patient already
discharged (n = 32; 27%), no time tovisit the patient (due to extrawork
load) (n = 43; 36%). The speech therapist started treatment in 72% of
the PG-SGA SF-based referred patients, but did not so in 28% due to
unconfirmed swallowing problems. Nurses started treatment in 25% of
the referred patients, but did not so in 58% (reasonsmostly unknown),
and had already started treatment of NIS in 17%.
Conclusions: Thus far, the STREAM implementation study resulted in
an acceptable screening rate. To improve the implementation progress,
the low cut off scores for referral to the various professionals will be
further evaluated and may require revision.
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ANTHROPOMETRIC INDICATORS AND BODY COMPOSITION IN
CHILDREN WITH CEREBRAL PALSY
R. Rakhmaeva1, A. Kamalova1*. 1Kazan State Medical University, Kazan,
Russian Federation
* Corresponding author.
Rationale: Children with cerebral palsy (CP) are at high risk for the
development of nutritional status disorders. Problems associated with
feeding, the characteristic ofmuscle tone and GMFCS level have a great
influence on the nutritional status of a child with CP. Timely diagnosis
and correction this disorders can help increase the rehabilitation
potential and quality of life of this children.
Methods: Our study included 43 children (22 girls and 21 boys) aged
2–17 years with spastic form of CP. Height, weight, and BMI were
assessed using programWHOAnthro andWHOAnthroPlus. The body
composition was measured using the bioelectric impedance (BIA).
Results: 12 children (28%) has GMFCS-I, 10 (23%) children has GMFCS-
II, 3 chilren has GMFCS-III (7%), 15 children has GMFCS-IV (35%) and 3
children has GMFCS-V (7%). According to the results of anthropometry
we revealed 20 underweight children (10/7/3 patients accordingly 1–
2–3rd degree of the undernutrition) and 5 overweight children.
According to data of BIA 12/20 underweight children (60%) has a
decrease of active cell mass (ACM): 7/10-4/7-1/3 children with mild,
moderate and severe undernutrition accordingly. Fat mass percent
(FM%) in underweight childrenwith CP wasmultidirectional and in all
children with overweight FM% was increased. Mean phase angle (PA)
value was 5.59 ± 1.06. Value <5.4 was in 13/43 children (30%): in 40%
children with mild undernutrition and 57% children with moderate
undernutrition. In 10/13 children a low value of PAwas combinedwith
a decrease in ACM. Despite normal anthropometric parameters we
revealed altered body composition for example, isolated change of FM
%, reduction in ACM or musculoskeletal mass and imbalance of lean
and fat mass in 14 children.
Conclusions: Diagnosis and correction of nutritional disorders in
children with CP presents new opportunities for providing compre-
hensive rehabilitation. Analysis of body composition allows to identify
target groups for individual nutritional correction in children with CP.
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MALNUTRITION RISK ASSESSMENT OF INPATIENTS WITH
INFLAMMATORY BOWEL DISEASE
R. Dudkowiak1*, K. Neubauer1, E. Poniewierka2. 1Dietetics Division,
Department of Gastroenterology and Hepatology, 2Department of
Gastroenterology and Hepatology, Wroclaw Medicaluniversity, Poland,
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* Corresponding author.
Rationale: Disorders of digestion and intestinal absorption associated
with disease activity and location of lesions, fear of eating and using
irrational diets significantly increase the risk of undernutrition and the
need for nutritional support in inflammatory bowel disease (IBD)
patients.
Methods: 51 patients with Crohn’s disease (CD; 24 women, 27 men)
and 46 patients with ulcerative colitis (UC; 23 women, 23 men) were
evaluated of nutritional status at the time of admission to the
gastroenterology ward. According to NRS 2002 score points patients
were divided into currently without risk (<3 points) and at risk (≥3
points) of undernutrition.
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Results: The risk of malnutrition occurred in 19 patients with CD
(37.3%) and 19 patient with UC (41.3%). Analysis of the exact number of
points obtained in the NRS 2002 showed that patients without
indications for nutritional intervention in themajority had a score of 0,
and among those requiring nutritional support greatest number of
points (5 points) received 11 of the 38 patients. The result of ≥3 points
was a consequence of the numberof points obtained in the component
responsible for the deterioration of nutritional status. There was no
statistical significance of the incidence of undernutrition among
patients in both groups (p = 0.683) even after taking account of sex.
The risk of malnutrition significantly prevailed inwomenwith CD (13)
which was not observed in relation to the gender of patients with UC
(10 women, 10 men). The risk of malnutrition showed a significant
association between disease activity: CD with CDAI (p = 0.00034) and
UC with Mayo (p = 0.00001). The average total score assessing disease
activity was significantly higher in patients at risk of malnutrition
(p <0.000001): CDAI (240.50 ± 83.21) and MAYO (7.1 ± 1.9).
Conclusions: Disease activity both in CD and UC patients significantly
increases the risk ofmalnutrition and the need for nutritional support.
Malnutrition risk assessment should be an important component of
therapy and treatment for IBD patients.
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RELATIONSHIP BETWEEN HANDGRIP STRENGTH AND
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Rationale:Hand Grip strength (HGS) is widely used in clinical practice
to assess the impact of a variety of disorders on hand function.
However, the relationship between HGS and both anthropometric and
bioimpedance variables has not been studied in obese patients. The
aim of this study is to evaluate this association in adult women with
overweight and obesity (BMI> 25 kg/m ²)
Methods:One hundred and six adult women (age range 18–65 y) (age
37.3 ± 13.4 yrs, weight 95.9 ± 20.7 kg, height 160,8 ± 5,6 cm, BMI 37.1
± 7.2 kg/m²) participated in the study.
Grip strength for both arms was measured with a handgrip
dynamometer and bioimpedance analysis was performed at 50 kHz
(DS Medica) in all subjects.
Themean HGSwas the average value of three handgripmeasurements
of the dominant hand.
The following variables were considered for the associationwithmean
HGS:
1) general characteristics: age, height, weight, BMI;
2) BIA measures: bioimpedance index (height² /resistance = BI index)
and PhA (whole body, arm and leg).
Statistical analysis was performed using linear correlation and
multiple regression analysis (SPSS vers. 18.0).
Results: Mean HGS was 23.3 ± 4.65 kg, whole body phase angle was
6.12 ± 0.76 degrees, arm phase angle 4.41 ± 0.73 and leg phase angle
was 7.50 ± 1.1 degrees.
According to ESPEN definition on sarcopenia, we found that 24
patients (22.6%) had mean HGS < 20 kg.
HGS was significantly correlated (linear correlation) with height
(r = .404, p = 0.000), age (r = -0.311, p = 0.001), weight (r = .228, p =
0.019) and among the general characteristic, and BI index (r = .240,
p = 0.013) and arm phase angle (r = .199,p = 0.040) among Bia
measures. When we performed the multiple regression analysis for
general characteristics, height and age (r = .454, SE = 4.18 kg) were the
more correlated parameters with HGS; when BIA measures are
considered, only IB was included (r = .240, SE = 4.53 kg).
When both general characteristic and BIA measures are considered in
the multiple regression analysis, we found that height and arm phase
angle were the most correlated parameters (r = .468, SE = 4.14 kg).
Conclusions: Our preliminary findings show that height and arm
phase angle seem the most correlated parameter with HGS in adult
obese women.
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Rationale: Both phase angle (PA) and handgrip strenght (HGS) are
considered as markers of nutritional status: phase angle decreases in
different forms of malnutrition and it’s also a predictor of survival, in
several pathological conditions; HGS, being a useful functional
capacity test for evaluating muscle strength in the general population,
is a diagnostic tool for assessing malnutrition, overall nutritional risk
and mortality. Aim of this study was to evaluate the association
between PA and HGS in a sample of young women.
Methods: 476 females, age range 18–40 years, with BMI between 10
and 25 kg/m2 consecutively undergoing a routine clinical nutritional
councelling at the Clinical Nutrition Outpatient Unit, from 2015 to
2018 were included in this study. Grip strength for the right and left
armswasmeasuredwith a handgrip dynamometer and bioimpedance
analysis was performed at 50 kHz (DS Medica) in all subjects.
Themean HGSwas the average value of three handgripmeasurements
of the dominant hand.
Patient group were split into: BMI subgroup 1 <16 kg/m2, n.114 (age
22.5 ± 5.3 y, weight 37.2 ± 4.5 kg, BMI 14.5 ± 1.2 kg/m2); BMI subgroup
2 = 16.0–18.5 kg/m2, n.171 (age 21.3 ± 5.5 y, weight 44.6 ± 3.7 kg, BMI
17.2 ± 0.7 kg/m2); BMI subgroup 3 = 18.5–25 kg/m2n.191 (age
22.8 ± 5.4 y, weight 54.8 ± 5.9 kg, BMI 21.0 ± 1.6 kg/m2).
Results: both PA andmeanHGS increased significantlywith increasing
BMI until group 3 (group1 :5.2 ± 0.9, group2 5.7 ± 0.7, group 3 6.3 ± 0.7
degrees; group1: 18.4 ± 4.6, group2 20.6 ± 4.8, group 3 23.3 ± 5.3 kg).
When we performed the linear correlation between PA and HGS, we
found a significantly decreasing correlation with increasing BMI
(group 1: r 0,417, p = 0,00; group 2 r = 0.324, p = 0.000; group 3
r = 0,308 p = 0.000).
Conclusions: Our preliminary findings shows that HGS and phase
angle seems strongly associated with BMI groups in Italian young
females in particular they are significantly correlated in underweight
patients (Group 1 and 2). So they should be considered as goodmarker
of nutritional status.
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CAN LIBRE PRO MONITOR POSTPRANDIAL HYPERGLYCEMIA AND
DUMPING SYNDROME IN SEVERELY HANDICAPPED CHILDREN AND
ADOLESCENTS WITH GASTROSTOMY?
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Rationale: Postprandial hyperglycemia/dumping syndrome owing to
enteral nutrient absorption after gastrostomy (GS) is easier controlled
by changing patients to blender meal consumption. However, this
varies with cases. We monitor glucose levels by continuous glucose
monitoring (CGM) systems. FreeStyle Libre Pro (FSL-Pro), which does
not need calibrations, was released, and here, we determined its
applicability in monitoring.
Methods: Fifteen patients with GS aged 7–20 years (male:female =
8:7) were recruited. FSL-Pro was installed for 14 days. In one case, the
actual measured values were compared with monitored values. We
also compared data tendencies with those from the same patients
using the MiniMed CGM-Gold (MiniMed) system in 2012.
Results: One of 15 patients was not measured for unknown reasons.
Two patients had hypoglycemia ≤50 mg/dL except during meals, but
no symptoms were observed. The correlation coefficient of the
measured and actual values was 0.82, and the coefficient of
determination was 0.68. The error was 27%±17.9%, and there was a
large difference of 1.91%±2.16% on MiniMed. The 113 measurements
were 19 times (16.8%) lower than the measured values.
Conclusions: FSL-Pro has lower invasivenesswithout calibrations, and
the sensor needle is half as short as 5 mm than that ofMiniMed and for
1/50 of the cost for the device. However, the error occurrence of the
sensor is very high. Therewas also a 27% difference between actual and
measured data. As per the manual, the average of their relative
difference is as high as 11.4%, possibly owing to the difference in
function asmonitoring long-termmedian levels using FSL-Pro and live
glucose levels to decide on insulin pumping with calibrations 4 times/
day using MiniMed. FSL-Pro may not be suitable for monitoring
postprandial hyperglycemia/dumping syndrome.
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Rationale: The aim of this study was to evaluate the energy
expenditure, hormone levels and nutritional status of the patients at
the first, second and third months after laparoscopic sleeve gastrec-
tomy (LSG).
Methods: This research performed on 20 female patients who had
laparoscopic sleeve gastrectomy operation in the medical faculty of
Erciyes University. Before the surgery, information about the demo-
graphic andhealth status of the individualswas obtainedwith the help
of a questionnaire form. Body analysis and anthropometric measure-
ment of these patient were performed. Mifflin-St Jeor equation is used
for estimation of resting metabolic rate, physical activity level (PAL) of
patients indicated with usage of the 24-hour physical activity record.
The biochemical data of the patients recorded retrospectively from
patient files. The SimplifiedNutritional Appetite Questionnaire (SNAQ)
form was used to determine the appetite score of the individuals.
Three-day food consumption record of these patients analyzed by
BeBiS program. Plasma total ghrelin levels were performed by
immunoenzymatic (ELISA) method using commercial ELISA kit.
These process repeated after the surgery following months of first,
second and third. Post-surgical complications were also evaluated in
postoperative term. The SPSS 25.0 used for analysis of the data.
Results: Bodyweight, BMI, body fat percentage and amount, body lean
tissue mass, total body water, waist, hip and neck circumference
measurements of the patients decreased in the postoperative term
(p < 0,05). While the resting metabolic rate (DMH) of the patients
decreased; physical activity level (PAL) and total energy expenditure
(TEH) increased during the follow-up period (p < 0,05). The fasting
blood glucose level decreased in the monitoring term and this
decreasing is correlated with the percentage of weight loss (r = -
0,472; p < 0,05). The level of serum triglyceride, AST, ALT decreased
despite to serum albumin, vitamin B12, magnesium, potassium,
calcium and phosphorus increased in the postoperative term (p <
0,05). Serum TSH levels decreased in the first and secondmonths after
surgery (p < 0,05), there was an increase in the postoperative third
month, but this difference was not significant (p > 0,05). Plasma
ghrelin hormone decreased during follow-up and there was a
significant and negative correlation between plasma ghrelin levels
and total protein and animal protein intake (r = -0.569; p <0.05). The
patients’ appetite score decreased in the first postoperative month (p
<0.05) and the increase after the first month was not significant
(p > 0.05). Total of energy, dietary fiber, carbohydrate and micronu-
trient intake decreased in the postoperative term (p < 0,05). Even
protein and fat intake decreased with diet, the percentage of protein
and fat energy increased (p < 0,05). At the first postoperative month,
30% of the patients reported nausea, 10% vomiting, 15% diarrhea, 70%
constipation and 75% fatigue. At the third postoperative month, 30% of
the patients reported nausea, 15% vomiting, 10% diarrhea, 45%
constipation and 70% hair loss.
Conclusions: There were positive changes in anthropometric mea-
surements, biochemical parameters and activity levels of patients,
however energy,macro andmicronutrient intakes decreased after LSG.
In this study, only correlation detected between ghrelin and protein
intake. It was thought that the decrease in ghrelin level may be
effective on weight loss by increasing protein intake. Besides; at
postoperative period patients may have some complications that had
to be checked for a long-term.
Table (abstract: MON-PO520):
Periods
Preop
± SS
Postop 1. Month
± SS
Postop 2. Month
± SS
Postop 3. Month
± SS
p
BMI (kg/m2) 46,95 ± 5,74a 42,21 ± 6,05b 40,47 ± 5,83c 38,80 ± 5,84d 0,000*
Physical activity level 1,50 ± 0,26a 1,66 ± 0,32b 1,84 ± 0,31b 1,82 ± 0,20b 0,000*
Fasting blood glucose (mg/dL) 118,10 ± 31,33a 103,00 ± 21,40a,b 96,40 ± 15,13b 97,35 ± 10,95b 0,001*
Ghrelin (pg/mL) 1123,66 ± 660,01a 546,09 ± 253,31b 382,28 ± 121,03c 259,93 ± 96,27d 0,000*
TSH (μIU/mL) 2,07 ± 0,74a 1,41 ± 0,75b 1,34 ± 0,69b 1,36 ± 0,77b 0,000*
Energy intake (kkal) 1415,84 ± 455,33a 584,67 ± 209,12b 636,79 ± 183,52b 666,60 ± 178,98b 0,000*
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BODY COMPOSITION USING L3 LEVEL CT IMAGING AND SURGICAL
OUTCOME IN INFLAMMATORY BOWEL DISEASE
S. Bamba1*, M. Sasaki1, A. Andoh2. 1Division of Clinical Nutrition,
2Division of Gastroenterology, Shiga University of Medical Science, Otsu,
Japan
* Corresponding author.
Rationale: Inflammatory bowel disease is known to present protein
energy malnutrition from malabsorption and protein leakage caused
by chronic inflammation of the intestinal tract, resulting in decreased
body muscle mass and fat mass. We examined the frequency of
sarcopenia and the relationship between the body composition and
prognostic factors in hospitalized patients with inflammatory bowel
disease (IBD).
Methods: We enrolled 187 patients with IBD who have admitted to
our hospital since 2010. We retrospectively measured L3 level skeletal
muscle area, psoas muscle area, subcutaneous and visceral fat area
from CT at hospitalization. Clinical data at hospital admission and the
follow-ups were extracted from the electronic medical record, and the
relation was examined. OsiriX was used to analyze CT images.
Results: The subjects were 99 patients with Crohn’s disease and 88
cases with ulcerative colitis. The ratio of male to female was 126: 61.
The median age was 34 years (including 33 cases over 50 years old).
Using the criteria of the Japan Society of Hepatology, the proportion of
patients with low skeletal muscle index was 27.2% for Crohn’s disease
and 43.2% for ulcerative colitis. Cox proportional hazards regression
analysis examined the relationship between each parameter and
intestinal resection using multivariate analysis and found that male,
Crohn’s disease (>ulcerative colitis), decreased psoas muscle index,
increased visceral fat/subcutaneous fat area ratio were significant
factors associated with intestinal resection.
Conclusions: Decrease in muscle mass in hospitalized patients was
more common in patients with ulcerative colitis compared to Crohn’s
disease. However, the decrease in muscle mass was significantly
associated with intestinal resection in Crohn’s disease, but not in
ulcerative colitis. Furthermore, our results suggest that visceral fat,
which is known as a source of tumor necrosis factor-alpha and other
adipokines, may modify the pathophysiology of Crohn’s disease.
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SARCOPENIA IN PATIENTS WITH SUPRACRICOID LARYNGECTOMY
S. Eyigör1*, D. Durusoy2, B. Sezgin2, V.E. Şahin2, B. Soylu3, K. Öztürk2.
1Department of Physical Medicine and Rehabilitation, 2Department of
Otolaryngology, Ege University School of Medicine, Iżmir, 3Clinical
Nutrition Nursing, Acibadem Mobil Home Care, Izmir, Turkey
* Corresponding author.
Rationale: Sarcopenia can be defined as a combination of low skeletal
muscle mass and decreased muscle function and can be used as a
significant prognostic factor on overall survival in patients with head
and neck cancer (1,2). The aim of the study is investigate of the
frequency of the sarcopenia in patients with supracricoid
laryngectomy
Methods: The data of 31 patients who underwent
supracricoid laryngectomy between the years of 2009–2018 in Ege
University Medical Faculty Otorhinolaryngology Department were
retrospectively reviewed., SARC-F questionnaire, isometric handrip
strengthmeasure (JAMAR), Bioelectrical Impedance Analysis and 4 mt
walking test were applied to all patients. EuropeanWorking Group on
Sarcopenia in Older People (EWGSOP2) criterias were used for
classification.
Results: 31 patients (4 female, 27 malewith the mean age 66.5 ± 9.55)
were included in the study. According to SARC-F questionnaire 1
patient (%3) had sarcopenia. When measured isometric handgrip
strength with Jamar hydraulic dynamometer propable sarcopenia
determined in 19 patients (% 62) according to EWSGOP2 criterias.
According to Bioelectrical Impedance Analyze, sarcopenia was
detected in 4 patients (%12) sarcopenia according to EWSGOP2
criterias. According to 4 mt walking test severe sarcopenia was
detected in 11 patients (% 35) according to EWSGOP2 criterias.
Conclusions: Sarcopenia is a risk factor for physical disability,
decreased quality of life (1) EWSGOP2 criterias can be used for the
diagnosis (2). Recent studies have shown that sarcopenia can be used
as a prognostic factor for overall survive in head and neck cancer
patients (1,2). In patients with supracricoid laryngectomy, low food
intake poses a risk for sarcopenia because of impaired swallowing
functions (1). Also presence of cancer, increased catabolic pathways
associated with age and larengeal cancer, increased inflammation
associated with cancer further increase this risk (1,2). Sarcopenia may
be prognosticly helpful among patients with supracricoid laryngect-
omy (1).
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RELATIȮN BETWEEN ORAL HEALTH AND NUTRIṪIȮNAL STATUS
S. Akin1*, S. Kesim2, T.Y. Manav2, E. Deniz Şafak2, A. Ozturk2,
M. Mazıcıoglu2, F. Fırat Özer2. 1Geriatrics, 2Erciyes University, Kayseri,
Turkey
* Corresponding author.
Rationale:Oral health problems relatedwith tooth loss or periodontal
diseases are fundamental health problems which may have a high
impact on nutrition, primarily in the elderly. Aim of this study was to
determine the association between oral health and nutritional status
in the community-dwelling Turkish elderly.
Methods: Nutritional status was assessed by the Mini Nutritional
Assessment (MNA). In oral examination decayed, use of dental
prostheses, number of natural teeth, use of toothpaste and tooth
brushing frequency were noted. Oral health-related quality of life and
periodontal status were assessed by the Oral Health Impact Profile
(OHIP-14) questionnaire and the Community Periodontal Index (CPI),
respectively.
Results: A total of 476 elderly subjects were included in this study. The
mean age and standard deviation (SD) were 71.8 (5.6) years (52.3%
were female). The well nourished frequency rate was 52.1%. The
remaining 44.2% of elderly subjects were determined to be at risk of
malnutrition (MNR) and 3.7% had malnutrition (MN). 37.4% of the
subjects were edentulous. Using toothpaste and brushing teeth rate
was about 50%. MN/MNR was higher in non-toothpaste users (59.4%)
than non tooth brushers (53.1%). In univariate analyses, demographi-
cal characteristics (gender, educational levels, and income), cognitive
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impairment, depression, oral health indicators (use of toothpaste,
tooth-brushing and oral health-related quality of life) were tested. In
multivariate analysis depressive mood (OR 2.54 95% CI 1.59–4.06), use
of toothpaste (OR 0.58 95% CI 0.38–0.88) and higher OHIP scores (OR
1.03 95% CI 1.01–1.06) were detected as independent determinants of
poor nutritional status in elderly.
Conclusions: Depressive mood, use of toothpaste and OHIP are
detected as significant parameters to assess the relationship
between oral health and nutritional status in the community-dwelling
Turkish elderly.
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CHANGES IN NUTRITIONAL ENERGY AND SUBSTRATE INTAKE IN
PREGNANT CZECH WOMEN IN THE LAST DECADE.
S. Najpaverova1,2*, M. Kovarik1,2, M. Kacerovsky3, Z. Zadak1,
M. Hronek1,2. 1Department of Research and Development, University
Hospital, 2Faculty of Pharmacy, Charles University, 3Department of
Obstetric and Gynekology, University Hospital, Hradec Králové, Czech
Republic
* Corresponding author.
Rationale: Malnutrition of the maternal organism during pregnancy
may result in disease of the child in later life. The aim of the study was
to evaluate the changes in the intake of nutritional energy and
substrates (NESI) in Czech pregnant women over the last 10 years and
determine the accuracy of the predictive equations for PNES.1
Methods: Thirty-five Czech pregnant women 29 ± 2,79 years old were
attended in the pilot study. NESI in the individual trimesters of
pregnancy obtained fromweekly nutritional records was evaluated by
the computer program NutriDan, and compared with values from the
predictive equations for PNES.1
Results: Over 10 years, PNES (according to the predictive equations)
increased in respect of protein in the 1st trimester of pregnancy by
9,58% (p = 0.02), and decreased in respect of carbohydrate intake in all
trimesters by 10,06% (p = 0.04), 14,60%. (p = 0.0002), and 12.71%
(p = 0.00003) respectively.
Conclusions: There were no differences in NESI on each day of week
over the period despite expectation. The predictive equations for PNES
can be used during pregnancy even after 10 years, except for protein
intake in the 1st trimester and carbohydrate intake throughout
pregnancy. A new equation for PNES will be derived from the results
for clinical practice. The study was supported by GA UK č. 1306218, SVV/
2017/260417, MH CZ –DRO (UHHK, 00179906) a PROGRES Q42
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IMPLEMENTATION OF STRATEGIES TOAMELIORATE TREATMENT OF
MALNOURISHED PATIENTS IN A MAXIMUM-CARE HOSPITAL –
EVALUATION OF QUANTITY AND QUALITY OF THE NUTRITIONAL
RISK SCREENING
S. Nau1*, C. Gottschild2, K. Günsel3, J. Köllner2, C. Schliep4,
H. Messmann1, S.K. Gölder1. 1III. Med. Klinik, 2Nutrition Support Team,
3University Hospital Augsburg, Augsburg, Germany, 4Medical Controlling,
University Hospital Augsburg, Augsburg, Germany
* Corresponding author.
Rationale: Treatment of disease-related malnutrition is a topic with
pronounced medical and economic consequences. In 2012, the
nutrition support team (NST) at the Augsburg Hospital introduced
strategies for better detection and treatment ofmalnourished patients.
We monitored the development of revenues and evaluated both
quantity and quality of the established screening method.
Methods: The Nutritional Risk Screening 2002 (NRS)was integrated in
the clinic information system and is now performed computer-based
as well as the assessment, recommendations, and reports of the NST. A
treatment algorithmwas created:with a NRS score = 3 patients receive
oral nutritional supplements by the respective ward, with a score >3
the NST is involved for further assessment and treatment. The number
of detected patients as measured by the respective entries in
the German DRG-system was evaluated as well as the possible
impact on revenues. A newly created evaluation tool was used to
assess the hospital- wide screening rate. The data of all wards, except
for the intensive care units, were included. To check the quality of the
screening, we retrospectively investigated the medical reports and
patients charts.
Results: The table shows the number of patients that were detected as
malnourished and represented in the DRG-system in the years 2012–
2018.
Coded
Cases
With
additonal
revenues
Additional
Revenues
(€)
Additional
Revenues/
Coded
Case (€)
2012 217 12% 59.025 272
2013 804 10% 108.023 134
2014 1893 6% 206.015 109
2015 2637 7% 376.600 143
2016 3325 5% 345.140 104
2017 3524 4% 320.777 91
2018 2886 4% 252.623 88
We observed a steady growth in the number of coded cases, except in
2018. The percentage of cases that triggered additional revenues
declined every year, reflecting the annual corrections in the DRG-
system.
At the appointed date we counted 1277 in-patients, 1012 of which
(79%) underwent the NRS. 110 patients had a score of 3 points, 116 a
score >3, corresponding to 22% of the in-patients. Of these only 23%
received nutritional support according to the algorithm or the
recommendations of the NST.We checked the quality of 449 screening
sheets. 158 (35%) proved to be erroneous, 21 patients at risk were not
detected. The most frequent mistakes were height (30%), body weight
(11%), and severity of disease (15%). 268 screenings (60%) were
incomplete because of unknown body weight loss.
Conclusions: Our data show that we were successful in establishing
the awareness for malnutrition and the screening process. Our efforts
were compensated by additional revenues. But our data also reveal
that in clinical routine the screening and treatment of malnourished
patients need to be improved. Repeated training and better
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documentation of height and body weight is required.
Interdisciplinary communication and interface management should
be intensified.
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DIALYSIS MALNUTRITION SCORE AS SIMPLE NUTRITION
ASSESSMENT AND ITS CORRELATION WITH ANTHROPOMETRY AND
BIOCHEMICAL PARAMETERS IN HEMODIALYSIS PATIENTS IN
UNIVERSITAS GADJAH MADA HOSPITALYOGYAKARTA-INDONESIA
S. Susetyowati1*. 1Nutrition and Health, Faculty of Medicine, Public
Health, and Nursing UGM, Yogyakarta, Indonesia
* Corresponding author.
Rationale: : Malnutrition is important problems in hemodialysis
patients due to side effect of the therapy. Dialysis malnutrition score
(DMS) is the newest reliable and valid method to evaluate malnutri-
tion in these patients. We aim to assess malnutrition using DMS and
investigate its correlation with objective nutrition assessment
parameters.
Methods: This cross-sectional study was conducted on January 2019
and involved 71 hemodialysis patients in Universitas Gadjah Mada
Hospital. Participants were assessed using Dialysis Malnutrition Score
(DMS), anthropometry parameter (body mass index/BMI, mid upper
arm circumference/MUAC, and body composition measurement) and
biochemical assessment (albumin and total iron binding capacity/
TIBC).
Results: Prevalence of malnutrition based on DMS was 33.8%, while
only 5.6% of participants had hipoalbumin. It was found that skeletal
muscle had significant negative correlation with DMS (r = -0.240 and
p = 0.037). The BMI, MUAC and percent body fat were positive
correlated significantly with DMS (r = 0.395, 0.267 and 0.272,
respectively, while p = 0.002, 0.021 and 0.019, respectively). Albumin
and TIBC had no significant positive correlation with DMS.
Conclusions: The lower skeletal muscle and the higher BMI, MUAC
and percent body fat, the higher risk of malnutrition. Combined
anthropometry-biochemical parameters with DMS is necessary for
assessing malnutrition in hemodialysis patients.
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VALIDITY COMPARISON: NUTRITION SCREENING TOOLS AGAINST
PATIENT GENERATED-SUBJECTIVE GLOBAL ASSESSMENT FOR
ONCOLOGY PATIENTS IN DR. SARDJITO GENERAL HOSPITAL
S. Susetyowati1*. 1Nutrition and Health, Faculty of Medicine, Public
Health, and Nursing, UGM, Yogyakarta, Indonesia
* Corresponding author.
Rationale: Nutrition screening tools are necessary to predict malnu-
trition and affect to nutrition intervention. We aim to investigate the
validity of nutrition screening tools for oncology patients.
Methods: This cross-sectional study was conducted on August 2018
and involved 175 oncology patients in Dr. Sardjito General Hospital.
Malnutrition risk of participants were screened using Nutrition Risk
Screening (NRS) 2002, Nutric-Score, Simple Nutrition Screening Tool
(SNST), the Royal Marsden Nutrition Screening Tool (RMNST) and
Malnutrition Screening Tool (MST). We assessed malnutrition status
using Patient Generated-Subjective Global Assessment (PG-SGA) as a
gold standard.
Results: Prevalence of malnutrition risk were 48.0% (NRS 2002), 11.4%
(Nutric-Score), 58.9% (SNST), 84.6 (RMNST), 49.1% (MST). As 68.6% of
participants were at malnutrition based on PG-SGA. Sensitivity were
obtained 63.33% (NRS 2002), 16.67% (Nutric-Score), 81.67% (SNST),
97.50% (RMNST), 64.17% (MST). Specificity were found 85.45% (NRS
2002), 100.0% (Nutric-Score), 90.90% (SNST), 43.64% (RMNST), 83.64%
(MST). Positive predictive value were revealed 90.47% (NRS 2002),
100.0% (Nutric-Score), 95.14% (SNST), 79.05% (RMNST), 89.53% (MST).
Negative predictive value were found 51.65% (NRS 2002), 35.48%
(Nutric-Score), 69.44% (SNST), 88.89% (RMNST), 51.69 (MST). Area
under curve (AUC) were obtained 0.744 (NRS 2002), 0.583 (Nutric-
Score), 0.863 (SNST), 0.706 (RMNST), 0.739 (MST).
Conclusions: The SNST and RMNST had excellent sensitivity for
identifying patients who were at risk of malnutrition, while for
identifying patients who were not at risk of malnutrition only RMNST
which had poor specificity. Based on the AUC, SNST had the best
accuracy for sceening in oncology inpatients setting.
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DISORDERS OF NUTRITIONAL STATUS IN PATIENTS QUALIFIED FOR
SURGERY DUE TO HIP OSTEOARTHRITIS
S. Małgorzewicz1*, M. Potrykus1, K. Boniecka1, S. Czaja-Stolc1,
D. Maciejczyk1, M. Juchum1, E. Wernio1, P. Łuczkiewicz2, A.J. Dardzińska1.
1Clinical Nutrition, 2II Clinic of Orthopaedics and Kinetic Organ
Traumatology, Medical University of Gdańsk, Gdansk, Poland
* Corresponding author.
Rationale: The recent studies suggests that high dietary protein levels
may be beneficial in reducing bone loss and hip fracture risk inpatients
with hip osteoarthritis. In turn, in patients undergoing surgery, the
abnormal nutritional status may affect the complications after the
procedure.
The aim of the study was a comprehensive assessment of the
nutritional status of patients qualified for surgery due to osteoarthritis
of the hip.
Methods: 52 people (24 K, 28 M) aged 67.5 ± 9.2 years underwent hip
arthroplasty in the Orthopedic Clinic of GUMed. Nutritional status was
assessed according to MNA. Body composition (BIA) and hand grip
strength were examined. In addition, a 24-hour nutritional interview
was collected and analysed.
Results: The low protein intake was found in 44.4% of subjects, low
calcium intake in 84.4%; the Ca/P ratio in diet was 0.53 (recommended
1–1.5). The mean supply of vitamin D with diet was 2.5 ± 2.2 μg
(AI = 15 μg). There were no significant differences between the group
of patients with postoperative complications and without complica-
tions. The length of hospitalisation significantly correlated with the
ECM/BCM malnutrition index (r = 0.35, p < 0.05).
Conclusions: In the study group, there were evident nutritional
disorders in the form of excessive body mass with the simultaneous
risk of malnutrition and low intake of protein, calcium, and vitamin D
in the diet.
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PERFORMANCE OF NUTRITIONAL ASSISTANCE CARE LEVELS IN
PREDICTING PROLONGED HOSPITAL STAY, INFECTION AND
HOSPITAL MORTALITY
T. Aloy Dos Santos1*, V.C. Luft2,3, A.M.K. Jochims3, G.C. Souza2,3,
Z.D.A. Santos2,3, J.C.D. Almeida1,2,3. 1Programa de Pós-Graduação em
Ciências Médicas: Endocrinologia, 2Departamento de Nutrição,
Universidade Federal do Rio Grande do Sul, 3Serviço de Nutrição,
Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
* Corresponding author.
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Rationale: Different methods have been proposed for nutritional
screening and assessment of inpatients, and integrated approaches are
encouraged for patient care. This retrospective cohort study aimed to
evaluate the performance of nutritional assistance care (NAC) levels
determined in a tertiary public hospital to predict prolonged hospital
stay, infection and mortality of inpatients.
Methods: A one-year period of secondary data from patients (adults
and elderly) admitted to clinical and surgery units in Hospital de
Clinicas de Porto Alegre (Brazil) was obtained. Only the first evaluation
of each patient was considered, and patient data (demographic,
clinical, anthropometric and nutritional risk factors) were obtained
from the electronic medical records via query requests. After
nutritional assessment, NAC was determined according to each
patient’s age, BMI, and the number of nutritional risks in four levels.
Results: In the present study, 5,114 patients were included and were
60 ± 17 years old and 50.6% male. 59.5% of patients were admitted in
the surgical unit, 26% of patients experienced prolonged hospital stays,
16.1% of patients had hospital infections, and 2.7% of patients died.
Patients was classified into NAC levels: NAC1 = 1.9%, NAC2 = 59.0%,
NAC3 = 16.0% and NAC4 = 23.2%. The survival curve shows that the
probability of mortality increases with NAC (Cox analysis; p < 0.001).
Furthermore, a positive association with death was observed in
patients with NAC3 (PR = 6.95; 95% CI 3.56–13.56) or NAC4
(PR = 12.67; 95% CI 6.79–23.67). The AUC ROC (mortality as outcome)
was 0.79 (95% CI 0.76–0.83) for NAC3 or above. Positive associations
between infection or prolonged hospital stay with NAC3 or NAC4were
also observed.
Conclusions: In this study, inpatients classified as at least NAC3 had a
higher risk of mortality, infection and prolonged hospital stay.
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IN FASTING, BMI, ACTIVITY OF DAILY LIVING AND IMMUNITY ARE
NOT DETERIORATED EVEN WHEN RAPID TURNOVER PROTEINS
DECREASE, HOWEVER, THEREAFTER, DETERIORATED WITH A
REDUCTION OF SERUM ALBUMIN
T. Shimizu1*, T. Namikawa2, K. Banba2, Y. Tamamura3, A. Takezawa4,
T. Nishikimi5. 1Department of Cerebrovascular Diseases, Wakakusa-
Tatsuma Rehabilitation Hospital, Daito, 2Department of Rehabilitation,
Suita Tokushuen, Geriatric Health Services Facility, Suita, 3Department of
Rehabilitation, 4Department of nutrition, 5Department of Medicine,
Wakakusa-Tatsuma Rehabilitation Hospital, Daito, Japan
* Corresponding author.
Rationale: In elderly people, body mass index (BMI), activity of daily
living (ADL) and immunity are important factors to live their healthy
life. In order to keep these factors better, nutrition may play an
important role. Serum proteins are considered an essential nutritional
factors, then the association of serum proteins and BMI, ADL and
immunity was investigated.
Methods: Eighty-five elderly people (18 males, 67 females, 84 ± 9
years) admitted to a geriatric health services facility for more than
three months and in a stable state were subjected. Their ADL was
evaluated by Barthel Index (BI), and immunity was assessed by CD4+ T
cell counts (CD4). The association of BMI, BI and CD4 with serum
proteins was investigated. Albumin, transferrin (TRF), transthyretin
(TTR) and retinol binding proteins (RBP) are analyzed as serum
proteins. Albumin is a static index of nutrition, meanwhile TRF, TTR
and RBP, called rapid turnover proteins, are dynamic indexes of
nutrition. The biological half-life times of these serum proteins are
different each other.
Results: The correlation coefficient of BMIwith albuminwas r = 0.2259
(p = 0.038), but thatwith TRFwas r = -0.01021,with TTR, r = 0.0375 and
with RBP, r = -0.0774 respectively. Rapid turnover proteins are not
statistically correlated with BMI. The correlation coefficient of BI with
albumin was r = 0.4100 (p = 9.73 × 10–5), but that with TRF was
r = 0.0909, with TTR r = -0.0196, and with RBP, r = -0.0966. Rapid
turnover proteins are not statistically correlated with BI either. The
correlation coefficient of CD4 with albumin was r = 0.26 (p = 0.0134)
but that with TRF was r = 0.090, with TTR, r = -0.0196 and with RBP,
r = 0.0196. Rapid turnover proteins are not correlated with CD4 either.
BMI, BI and CD4 were associated with albumin, but with rapid
turnover proteins.
Conclusions: In this study, BMI, ADL and immunity were associated
with serum albumin. However, they are not associated with TRF, TTR,
RBP. The half-life of albumin is 21 days, that of TRF, 7days, that of TTR, 3
days and that of RBP, 0.5 day, respectively. In the process of fasting, RBP,
TTR, TRF and albumin decrease in that order according to their
biological half-life time. BMI, ADL and immunity might not be
deteriorated soon after fasting, even when RBP, TTR and TRF
somehow decrease, but thereafter, finally when albumin is reduced,
BMI, ADL and immunity might be deteriorated. In ancient times when
our ancestors could not eat adequately yet, they tried to move around
to get foods while their BMI, ADL and immunity were still maintained,
and eventually they could survive.
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EVALUATION OF THE APPLICABILITY AND FEASIBILITY OF GLIM
CRITERIA TO DIAGNOSE MALNUTRITION IN CLINICAL PRACTICE
V. Ijmker-Hemink1*, S. Heerschop1, G. Wanten2, M. van den Berg1.
1Gastroenterology and Hepatology – Intestinal Failure and Dietetics,
2Gastroenterology and Hepatology, RADBOUDUMC, Nijmegen,
Netherlands
* Corresponding author.
Rationale: The Global Leadership Initiative on Malnutrition (GLIM)
comprising representatives of four clinical nutrition societies reached
a new global consensus for diagnosingmalnutrition. We evaluated the
applicability and feasibility of these new GLIM criteria in clinical
practice. Furthermore, we assessed whether malnutrition was asso-
ciated with length of hospital stay according to the GLIM diagnostic
criteria.
Methods: This study concerned a post hoc analysis of a prospective
cohort study including hospital patients (n = 624) from our depart-
ments of Gastroenterology, Gynecology, Urology, and Orthopedics.
First, patients were screened using the MUST score. Patients scoring
MUST≥ 1were included in the diagnostic assessment according to the
GLIM criteria.
Results: Overall 624 patients, with a mean age of 60 ± 16 years (47%
male) were included. In total, 153 patients (25%) were screened as at
risk by the MUST score and the majority of patients scored positive on
unintentional weight loss (82%). Based on GLIM criteria, 132 patients
(21%) were classified as malnourished compared to 172 (28%)
according to the PG-SGA. In >90% of the cases the items unintentional
weight loss (phenotypic criteria) and disease burden (etiologic
criteria) lead to the diagnosis of malnutrition. Reduced muscle mass
in absence of unintentional weight loss and low BMI were not
observed. Also, malnutrition was not associated with length of stay.
Conclusions: Our findings raise questions about the relevance of
including reduced muscle mass as a criterion since reduced muscle
mass was overdue to diagnose malnutrition in our population. Also,
assessment of muscle mass is not always feasible in the clinical and/or
research setting. Future studies should bolster the GLIM criteria in
other populations and clinical settings.
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THE OPTIMAL ESTIMATE FOR RESTING METABOLIC RATE IN MALE
BODYBUILDERS
W. Vissers1,2*, M. Jager1, S. Leij-Halfwerk1. 1Nutrition and Dietetics,
University of Arnhem and Nijmegen, Nijmegen, 2Vintage Genetics,
Oosterhout, Netherlands
* Corresponding author.
Rationale: Increased fat free mass is expected to increase the resting
metabolic rate (RMR) of bodybuilders. However, it is currently
unknown how to accurately predict the RMR of bodybuilders.
Therefore, the aim of this study is to determine whether an increase
in fat free mass correlates with an increased RMR in bodybuilders and
to determine the best accurate formula to predict the RMR in male
bodybuilders.
Methods: After an overnight fast height (m), weight (kg) and fat free
mass index (FFMI) in kg/m2 were measured in male bodybuilders.
RMR was measured by indirect calorimetry (RMRm) and compared to
11 predictive equations for RMR (RMRp). Predictive equations were
includedwhenbased on fat freemass. Accuracyof RMRpwas evaluated
as percentage of subjects predicted within ±10% of RMRm. Root mean
squared error (RMSE) and mean absolute difference (bias) between
RMRp and RMRm were calculated. Relationship between FFMI and
RMRm was determined using Pearson’s correlation.
Results: Twenty male bodybuilders (age: 25.5 yr, weight: 91.7 kg, BMI
25.1 kg/m2, FFMI 24.2 kg/m2) were selected and signed informed
consent. FFMI was positively correlated with RMRm (Pearson r = 0,71,
p < 0,01). Most accurate equations were the Cunningham, Johnstone
and Katch-McCardle with 70%, 65% and 60% accurate predictions,
respectively. Bias of these equations was −2,4, −8,5 and −9,5% and
RMSE was 284, 354 and 371 kcal/day, respectively.
Conclusions: This study shows that an increased FFMI positively
correlates with the RMR of bodybuilders. The Cunningham formula is
the preferred equation for estimating the RMR of male bodybuilders.
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CORRELATIONBETWEENHANDGRIP STRENGTHANDMUSCLEMASS
IN INTEGRATED INPATIENT ROOM OF CIPTO MANGUNKUSUMO
HOSPITAL, INDONESIA
W. Sinaga1*, F.Witjaksono1, N.R.M.Manikam1, F. Nurwidya1,W. Lestari1,
L.I. Octovia1, S. Sonia1, Y. Wulandari1, W.I. Wardhani1, K. Sutanto1.
1Department of Nutrition, Cipto Mangunkusumo Hospital, Faculty of
Medicine Universitas Indonesia, Jakarta, Indonesia
* Corresponding author.
Rationale: Muscle mass is one of body composition elements1 while
handgrip is commonly used as a functional capacity indicator.2 The
aim of this study was to analyze correlation between handgrip
strength and muscle mass in integrated inpatient room of Cipto
Mangunkusumo Hospital, Indonesia.
Methods: This study was a cross sectional study with consecutive
sampling, as a part of malnutrition research in integrated inpatient
room of Cipto Mangunkusumo Hospital, Indonesia. This study was
conducted from October to December 2018. Inclusion criteria were
patients admitted to integrated inpatient room and aged ≥18 year.
Patientwhowas unable to do themeasurementwas excluded from the
study. Handgrip strength was measured by using Jamar handgrip
dynamometer and skeletal mass was measured by SECAmedical Body
Composition Analyzer (mBCA) 525.
Results: There were 185 subjects, consist of 90 men and 95 women
in this study. The subjects had mean age 46.6+13.2 years, mean
handgrip strength 16.5 ± 9.3 kg and mean skeletal mass 17.1 ± 7 kg.
Kolmogorov-Smirnov test resulted normal distribution data with p
value > 0,05. Pearson Correlation show r 0.281; p <0.001 between
handgrip strength and muscle mass.
Conclusions: The correlation between handgrip strength and muscle
mass in integrated inpatient room of Cipto Mangunkusumo Hospital,
Indonesia was significantly positive. The conclusion of this study was
the lower handgrip, the less muscle mass. Results of this study can be
used as a basis for further research about body composition and
functional capacity in hospital.
References
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CLINICAL IMPACT OF PREOPERATIVE SERUM CHOLINESTERASE IN
GASTRIC CANCER
Y. Hirono1*, K. Katayama2, T. Naruse3, T. Goi3. 1Cancer Care Promotion
Center, University of Fukui Hospital, 2Cancer Care Promotion Center,
Unversity of Fukui Hospital, 3Department of Surgery I, University of Fukui,
Yoshidagun, Japan
* Corresponding author.
Rationale: The preoperative nutritional and immunological statuses
have been reported to be associated not only with postoperative
complications, but also with prognoses of patients with gastroentero-
logical malignancies. We have been reported the impact of the
preoperative Onodera’s prognostic nutritional index (PNI) and con-
trolling nutritional status on both short-term and long-term outcomes
in gastric cancer patients. The aim of this study was to investigate the
value of the preoperative serum cholinesterase (ChE) levels on the
short-term and long-term outcomes in gastric cancer.
Methods: We reviewed the medical records of 330 patients with
gastric cancer who underwent gastrectomy at our hospital from 2004
to 2010. Serum cholinesterase level was used as preoperative
nutritional index. Patients were divided into normal ChE group and
decreased ChE group. Postoperative complications were classified by
Clavien-Dindo classification. Overall survival curves were calculated
by Kaplan-Meier methods. The outcomes from different groups of
patients were compared by log-rank test.
Results: The mean preoperative ChE level was 262.8. Preoperative ChE
had a significant correlation with preoperative PNI. Preoperative ChE
was not associated with postoperative complications. Patients with
decreased preoperative serum ChE had significant poor prognoses
thanpatientswith normal ChE levels in gastric cancer. The decreases of
preoperative serum ChE levels were related to deaths by cancer in
stage II-IV gastric cancer and deaths by other disease in stage I gastric
cancer.
Conclusions: This study suggested that preoperative cholinesterase is
a simple nutritional index and one of the predictors of the survival in
gastric cancer.
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NUTRITIONAL STATUS ASSESSMENT OF ELDERLY PATIENTS IN
NURSING HOME USING BIOIMPEDANCE SPECTROSCOPY
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Rationale: Phase angle (PA), which is one of the bioimpedance
spectroscopy (BIS) indices, has been studied to have a significant role
in evaluating nutritional status and predicting clinical outcomes in
critically-ill patients. We investigated the association between PA and
nutritional status assessment in elderly patients living in nursing
homes.
Methods: Residents who are living in nine nursing homes in relation
to Myongji hospital included in this study. PA was measured twice
every 6 months using BIS and demographic and anthropometric data
were collected. We divided the patients into two groups according to
themedian PAvalues (High PA >3.65̊; Low PA ≤3.65̊). In addition to the
comparison between the two groups, and multivariate regression
analysis were performed to verify the association between PA and
nutritional markers.
Results: A total of 213 nursing home residents were enrolled in this
study. Mean age was 82.1 years old, female was 163 (76.5%). High PA
group showed higher bodymass index (high PA, 22.4 ± 3.6 kg/m2; low
PA,19.2 ± 3.4 kg/m2, P < 0.001) andmini nutritional assessment (MNA)
score (high PA, 10.2 ± 1.8; low PA, 8.1 ± 2.0, P < 0.001). In addition,
anthropometric data such as mid-arm circumference, hand grip
strength, and skin fold thickness were significantly higher in high PA
group. When analyzing parameters of the BIS according to PA group,
high PA group showed lower over-hydration and higher lean tissue
index. However, fat tissue index was not different between the two PA
groups. The same results were reproduced in the second BIS results. In
multivariate regression analysis, PAwas significant factor for associat-
ing with MNA score after adjusting sex, age, and body mass index.
(β = 0.135, P < 0.001).
Conclusions: This study suggests that PA reflects nutritional status in
the elderly who are living in nursing homes using noninvasive BIS
technique.
Disclosure of Interest: None declared.
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EVALUATION OF DIARRHEA USING A STOOL CHART AND THE
VALIDITY OF THE CHART
Y. Ishikawa1*, M. Koganezaki2, M. Shimada3, T. Yoshinuma4,
C. Yamahisa4, H. Yamada5, H. Noda5, T. Yamagou2, M. Kinoshita6,
T. Hoshikawa7. 1Department of Nutrition, Public Fussa Hospital,
2Department of Nursing, 3Department of pharmacy, 4Department of
Clinical Laboratory, 5Department of Rehabilitation, 6Department of
Nutrition, 7Department of Surgery, Public Fussa Hospital, Fussa, Japan
* Corresponding author.
Rationale: Conducting appropriate evaluations and monitoring of
diarrhea is important in tube feeding management. In this study, we
reviewed and examined the stool chart to evaluate its validity for tube
feeding administration.
Methods:Wemodified the King’s stool chart (KSC) byWhelan et al. to
better suit the patients of the hospital the authors belong to, and
evaluated this Modified King’s stool chart (MKSC). In the intervention
with a nutrition support team (NST) we performed nutrition
management using tube feeding to 47 patients, and conducted a
retrospective study with the MKSC values for a total of 312 days. Using
all of the MKSC values, we divided the patients into 2 groups: with or
without diarrhea risk factors (use of antibiotics, presence of hypoal-
buminemia (25 g/L <) and Clostridium difficile (CD)), and compared
the groups by t-test. Based on the mean MKSC value we divided the
patients into four groups: A (MKSC values: 0–4), B (5 to 9), C (10–14),
and D (≥15). Next, the odds ratios for discontinuation of tube feeding
due to absence of probability of improvement in stool forms were
calculated for each group. To determine cut-off values for MKSC we
performed a Receiver Operating Characteristic analysis using signs of
improvement in stool forms (possible or not possible to continue tube
feeding) as the objective variable and the highest MKSC value as the
explanatory variable.
Results: Therewas a significant difference in themeanMKSC values of
diarrhea. Comparing the groups with and without risk factors for
diarrhea (CD: p = 0.005, with or without antibiotics: p = 0.039, and
hypoalbuminemia (25 g/L <: p = 0.0002), the odds ratio of the group C
was double that of B, and the Dwas 9.3 times higher than B. As a result
of the Receiver Operating Characteristic analysis, we obtained the
following values: 0.75 for the area under the curve (AUC), 15 points for
the cutoff value, 1.0 for the sensitivity, 0.575 for the specificity,
p = 0.038, and R2 = 0.11. It was suggested that patients who reached 15
points even if only once, the stool form did not improve with a
probability of 73%, allowing the discontinuation of tube feeding.
Considering these results, we evaluated the details of the chart.
Conclusions: The findings suggest that the newly created chart is
useful to evaluate the validity of tube feeding during the administra-
tion as well as to evaluate diarrhea.
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REFERENCE OF MALNUTRITION PREVALENCE DIAGNOSED
ACCORDING TO GLOBAL LEADERSHIP INITIATIVE ON
MALNUTRITION CRITERIA IN THE ELDERLY REQUIRING CARE IN
JAPAN
Y. Oe1*, S. Kohyama1, K. Maeda2. 1Nutrition Management Division,
Sompo Care Foods Co., LTD., Tokyo, 2Palliative Care Center, Aichi Medical
University, Aichi, Japan
* Corresponding author.
Rationale: Most of elderly who requires nursing care has chronic
disease, it diminished intake, there has been a great increase in the fall
risk through decrease of skeletal muscle by less momentum, and
increasing risk of malnutrition. Andmalnutrition known for adversely
affect elderly’s prognosis about infect by decreased immunity and
delayed healing of disease. In 2018, the Global Leadership Initiative on
Malnutrition (GLIM) released new criteria for diagnosing and grading
malnutrition. However, there are few studies on the reliability and
relevance of the GLIM standards in elderly people in Asia. Therefore,
the present study aimed to investigate the prevalence of GLIM-defined
malnutrition in elderly Japanese facilities to identify severe malnutri-
tion according to GLIM criteria.
Methods: The subjects were 1,327 people aged 67–107 (average
88.3 ± 5.9 years) who live in nursing homes, and screened under the
GLIM criteria using the Malnutrition Universal Screening Tool (MUST)
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to identify undernutrition risk persons, and then Under-diagnostic
assessment of thosewho are at risk of undernutrition should be judged
whether they fall under the phenotype andetiology, and thosewho fall
undereither thephenotypeoretiologymaybe thosewhoareunder the
threat of undernutrition and who fall under both the phenotype and
etiology I was diagnosed with malnutrition. Finally, the severity of
those whowere diagnosed with malnutrition was determined.
Results: As a result of testing using GLIM criteria, 608 out of 1,327
people at risk formalnutrition (46%). Of the 608 patients, 205 (15.4% of
the total) corresponded to the phenotype only, 6 (0.5% of the total)
corresponded to the etiologic type only, and 392 were typified by the
phenotypic and etiologic type (29.5% of the total). As a result of
judging severity of 392 persons who corresponded to the phenotype
and etiologic type, the moderatewas 159 (12.0% of thewhole) and the
severe was 233 (17.6% of the whole).
Conclusions: Based on the above results, the prevalence of malnutri-
tion diagnosed on the basis of GLIM in elderly people requiring
longevity in Japan was approximately 30%.
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CROSS CULTURAL ADAPTATION AND VALIDATION OF THE ‘PATIENT-
GENERATED SUBJECTIVE GLOBAL ASSESSMENT (PG-SGA)’ FOR
NUTRITIONAL STATUS ASSESSMENT OF CANCER PATIENTS IN IRAN
Z. Ghoreishi1,2*, J. Shahabbasi3, H. Jager-Wittenaar4, F. Ottery4,5,
M. Asghari Jafarabadi6, R. Dolatkhah7, S. Dastgiri3. 1Nutrition Research
Center, Tabriz University of Medical Sciences, 2Clinical Nutrition, Faculty
of Nutrition and Food Sciences, Tabriz University of Medical Sciences,
3Tabriz Health Services Management Research Center, Department of
Community and FamilyMedicine, Faculty ofMedicine, Tabriz University of
Medical Sciences, Tabriz, Iran, Islamic Republic of, 4Research Group
Healthy Ageing, Hanze University of Applied Sciences, Groningen,
Netherlands, 5Oncology Care Consultants, Ottery & Associates LLC,
Greater Chicago Area, Greater Chicago, Illinois, United States, 6Traffic
and Accident Research Center, Tabriz University of Medical Sciences,
7Hematology and Oncology Research Center, Tabriz University of Medical
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Rationale: Patients with cancer are at high risk of malnutrition. This
may result in a remarkable reduction in the quality of life and poor
prognosis. The Patient-Generated Subjective Global Assessment (PG-
SGA) is a standard tool for assessment of the nutritional status of
cancer patients in both research and clinical settings which enables
screening, assessing, and following up nutritional status, of the cancer
patients. The aim of this study was cross culturally adaption and
validation of PG-SGA in Persian for using in Iranian patients.
Methods: The guidelines of International Society for
Pharmacoeconomics and Outcomes Research (ISPOR) was used for
the cross cultural adaption of PG-SGA. The measures for content, face
and construct validity using exploratory factor analysis were investi-
gated. Tool relevancy for data analysis was calculated by intra class
correlation coefficient and internal consistency using Cronbach’s
Alpha coefficient.
Results: The accessibility rate of PG-SGA was 100%, and content
validity in terms of its ease of understanding, difficulty, and relevancy
were found 0.94, 0.84 and 0.92, respectively. The face validity was
100%. The reliability of the tool using test-retest was calculated 0.84.
An internal consistency of 0.60 was obtained using Cronbach’s Alpha,
and a value of more than 0.60 for structural validity was achieved
(p < 0.001).
Conclusions: The Persian version of PG-SGA can be easily understood.
It can be used for assessing and surveilling the nutritional status of the
patients with cancer in Iran.
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EXPLORING THE ASSOCIATION BETWEEN ARTERIAL DYSFUNCTION
AND SKELETAL MUSCLEMASS AND FUNCTION IN HEALTHYADULTS:
A SYSTEMATIC REVIEW
J.C. Lieblein-Boff1*, S. Dvoretskiy2,3, S.L. Pereira1, S. Jonnalagadda1.
1ABBOTT, Columbus, OH, 2ABBOTT, 3University of Illinois, Urbana-
Champaign, IL, United States
* Corresponding author.
Rationale: The prevalence of arterial dysfunction increases with age,
especially in older adults, a population also prone to sarcopenia. This
systematic review explores the association between arterial dysfunc-
tion and skeletal muscle mass and function in healthy adults.
Methods: EMBASE and MEDLINE were searched for original articles
between January 2009 andMarch 2019. Evidence from cross-sectional
and randomized controlled studies was included. All relevant articles
were assessed for predefined criteria regarding study outcome,
population, and design. Out of 1246 studies, 19 studies were included.
The primary assessments of skeletal muscle health were muscle mass
and strength. Arterial health was assessed by arterial stiffness (pulse
wave velocity, augmentation index) and carotid intima-media
thickness.
Results: All 19 studies demonstrated a significant association between
arterial dysfunction and skeletal muscle health. Of the 8 studies that
examined muscular strength and macrovascular blood flow, all
reported a significant negative association between strength and
arterial stiffness. All 7 studies measuring muscle mass reported a
significant negative correlation between muscle mass and arterial
stiffness. The remaining 4 studies examined muscular function and
demonstrated a significant negative association between muscular
function and arterial stiffness.
Conclusions:Multiple studies have revealed an association between
arterial health and skeletal muscle impairment in healthy adults,
which warrants further investigation. The review highlights het-
erogeneity in methods to assess arterial health. This study also
points to the importance of screening for muscle impairment in
patients with arterial dysfunction and initiating early nutrition and
exercise intervention to prevent progression to sarcopenia in this
population.
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EXPLORING THE IMPACT OF DEMOGRAPHICS ON DECREASED BONE
AND JOINTHEALTH INAGINGPOPULATIONS: A SYSTEMATIC REVIEW
J.C. Lieblein-Boff1*, K. Chiu2,3. 1ABBOTT, Columbus, OH, 2ABBOTT,
3University of Illinois, Urbana-Champaign, IL, United States
* Corresponding author.
Rationale: The global population over age 60 is expected to double by
2050making age-related decreases in bone and joint health a growing
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concern. A systematic review was conducted to address the impact of
age, gender, and ethnicities on bone and joint-related health concerns.
Methods: PubMed and ProQuest were used to identify peer-reviewed,
original articles from 2009 to 2019 on search terms related to bone and
joint health as well asmental and physical function parameters. Of 311
studies screened, 190 studies were included based on age, population,
study design, and health conditions.
Results: Of the 190 studies across global populations, 141 showed that
Quality of life (QoL) or health-related QoL andmobilitywere decreased
with age-related decline in bones and joints. Thirty-three studies
stratified data by gender and reported that QoL and mobility were
worse in aging females with bone and joint conditions compared to
their male counterparts. The associations between gender differences
and mental and social health measures were not definitive; however
15 studies showed thatmental and social health declinewith bone and
joint health issues. Two studies analyzed bone mineral density (BMD)
changes across ethnic groups in aging women. While BMD declined
across all groups, this decline in BMD was most prominent in Asian
women.
Conclusions: Age-related declines in bone and joint health were
associated with mental and functional concerns, including declined
QoL or health-related QoL, low mobility, and poor physical function.
Age-related changes in function may affect women to a greater degree
than men; however, gender did not clearly contribute to worse scores
in mental and social health. There may be differences across
ethnicities, but this has not been widely characterized.
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THE IMPORTANCE OF PARENTERAL NUTRITION COMPOSITION IN
THE CONSERVATIVE TREATMENT OF ABDOMINAL CATASTROPHE
J. Víšek1*, K. Hasplova1, M. Lasticova1, V. Adamkova1, J. Manak1,
L. Sobotka1, V. Blaha1. 1Department of Gerontology and Metabolism,
University Hospital and Medical Faculty in Hradec Kralove, Charles
University in Prague, Hradec Kralove, Czech Republic
* Corresponding author.
Rationale: Parenteral nutrition (PN) plays a crucial role in the
treatment of patients with abdominal catastrophe (AC) with intestinal
fistulae. Optimizing the composition of PN can lead to an improvement
in the success of the conservative healing of these patients. Our aim
was to evaluate the effect of PN on the success of conservative
treatment of AC.
Methods: A total of 114 patients treated in our center in 2015–2018
were enrolled in the study. The composition of PN in the main
macronutrients was analyzed retrospectively and compared with the
success of 6-week conservative treatment of AC. Comparison of results
was performed by unpaired T test.
Results: All patients were provided with appropriate nutritional
support based on recent recommendations. Of 114 patients, spontan-
eous closurewas achieved in a total of 18 patients (15.8%). In the group
of conservatively healed patients the composition of PN: energy was
1832 ± 337 kcal/day (26.2 ± 4.8/kg of body weight), amino acids
110 ± 32 g/day (1.6 ± 0.5/kg of body weight), glucose 278 ± 88 g/day
(4 ± 1.3/kg of body weight), fat 31 ± 22 g/day (0.4.2 ± 0.3/kg of body
weight). In the group of conservatively unhealed patients, the
composition of PN: energy was 1645 ± 459kcal/day (23.5 ± 6.6/kg of
bodyweight), amino acids 102 ± 30 g/day (1.5 ± 0.4/kg of bodyweight),
glucose 254 ± 92 g/day (3.6 ± 1.3/kg of body weight), fat 20 ± 22 g/day
(0.3 ± 0.3/kg of body weight).
Overall morality was 4.4%. The composition of PN was not statistically
different between the two groups.
Conclusions: There was no difference in the composition of PN
between the group of conservatively healed and unhealed patients
with AC. Thus, the success of conservative treatment was probably due
to factors other than the difference in PN composition and will be the
focus of our other analyzes.
Supported by grants AZV CR No. 17–28882A, 17-29241A.
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MALNUTRITION PREVALENCE AND BURDEN AMONG COMMUNITY-
DWELLING OLDER SPANISH ADULTS
L. Rodríguez-Mañas1*, B. Rodriguez-Sánchez2, J.A. Carnicero-Carreño1,
S. Sulo3, D. Lanctin3, J. Partridge3, S. Pereira3, R. Rueda4. 1Hospital
Universitario de Getafe, Getafe, 2Universidad de Castilla-La Mancha,
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Rationale: Up to 30% of community-dwelling older adults across the
globe are at-risk of malnutrition but little is known about the burden
of malnutrition among this population. We assessed malnutrition risk
prevalence and its impact on health outcomes and healthcare
utilization in a population-based cohort of Spanish older adults.
Methods: Data from 1,660 older (range = 66–98 years) community-
dwelling adults participating in the Toledo Study on Healthy Ageing
waves 2 (year 2011–2013) and 3 (year 2015) were analyzed.
Nutritional risk criteria included either body mass index (BMI) = 20–
25 kg/m2 or unintentional weight loss (≥4.5 kg in the last year), and/or
low hand grip strength (<30.4 kg for men or 19.8 kg for women).
Malnutrition status criteria included BMI<20 kg/m2 and presence of
any of the other criteria. Six participants were classified as malnour-
ished; therefore, a single group was created including both at-risk and
malnourished participants.
Results: Malnutrition risk prevalence was 32.6%. Older (OR = 1.029–
1.069), functionally-dependent (OR = 1.747–2.572), and depressed
(OR = 1.087–1.101) participants and those being admitted to hospital
(OR = 1.297–1.470) were more likely to be at-risk/malnourished.
Furthermore, females (OR = 0.311–0.685) and participants with
greater shoulder strength (OR = 0.916–0.958), lean mass (OR = 0.926–
0.989), and whole-body fat (OR = 0.884–0.914) were less likely to be
at-risk/malnourished. At-risk/malnourished participants had longer
hospital stays (5.53 vs. 2.98 days, p < 0.01) and higher hospitalization
costs (€2,189 vs. €1,692, p < 0.01) compared to well-nourished
counterparts.
Conclusions: Malnutrition risk affects over 30% of Spanish commu-
nity-dwelling older adults and has negative consequences on their
health and economic outcomes. These results highlight the import-
ance of introducing effective community-based nutrition screening
and interventions to reduce malnutrition risk in community-dwelling
older adults.
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DISEASE AND FOOD INTAKE WITHIN LAST WEEK ARE
CONTRIBUTING FACTORS TO MALNUTRITION, THE RESULTS OF
NUTRITIONDAY 2018 IN CHINA
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Rationale: We aimed to analyze the data of worldwide nutritionDay
2018 from 10 large comprehensive hospitals in China and to elaborate
the comprehensive situation of nutritional characteristics, nutritional
support treatment programs and malnutrition risk factors of inpa-
tients in China.
Methods: NutritionDay’s standardized questionnaires were adopted,
and we recruited inpatients in 10 hospitals on November 15, 2018. We
collected information on patients’ disease information, history of food
intake, weight change, and nutritional support, etc. Malnutrition was
objectively defined as a BMI <18.5 kg/m2 or unintentional weight loss
>5% in the last 3 months.
Results: A total of 930 patients from 10 hospitals participated in the
survey (M 538 VS F 389, 57.8% VS 41.8%;Mean SD age 507.114.9 years).
Among the 267 cases ofmalnutrition andmalnutrition risk, 53.18% did
nutritional support, and 127 cases did not do nutritional support,
accounting for 46.82%. 142 (53.18%) patientsof malnutrition and
malnutrition risk received nutritional support: PN 54(20.3%), EN 88
(33%). Among the patients without malnutrition, 167 received
nutritional support, accounting for 25.23%. Through multivariate
analysis, it was found that the occurrence of malnutrition in
hospitalized patients was not related to age, gender, but was related
to the change of food intake within last week and the type of disease.
Conclusions: Chinese hospital staff is generally lack of knowledge and
awareness of malnutrition. Disease and food intake within last week
are the contributing factors to malnutrition.
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ARE WE EATING ENOUGH FRUITS AN VEGETABLES IN LATIN
AMERICA?: RESULTS FROM ELANS STUDY
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4Universidad de Costa Rica, San José, Costa Rica, 5Instituto de
Investigación Nutricional, Lima, Peru, 6Universidad Central de
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* Corresponding author.
Rationale: It has been recognized that fruit and vegetable intake (FVI)
are important to prevent chronic diseases (1–2). The world health
organization (WHO) recommended a minimum of five servings or
400 g per day (3).
The aim of this study is to determine the intake of fruits and vegetables
by sex, age and socioeconomic level in eight Latin-American (LA)
countries that participated of the ELANS study.
Methods: Data from the ELANS study, conducted in eight LA countries
(Argentina, Brazil, Colombia, Costa Rica, Chile, Ecuador, Perú and
Venezuela) was analyzed using descriptive statistics by age group, sex
and socioeconomic level (SEL). The ELANS study interviewed 9218
subjects (4409 males and 4809 females) of the main cities in each
country. The FVI was collected using two 24 hours dietary recall of
nonconsecutive days by trained personal, following the multiple pass
methodology. During the recall the personal used portion models and
photos to determine the size portion in hose whole measures, later,
those portions were translate into grams by dietitians trained to do so.
Results: Themean FVI in the eight countrieswas 200 g/day (males 202
and females 198), being the highest in Ecuador (282 g/day) and the
lowest in Colombia (161 g/day). The FVI is highest in males than
females in 5 of the 8 countries (Colombia, Costa Rica, Chile, Ecuador
and Venezuela).
The FVI increaseswith age, ranging fron 176 g/day (CI 90.4–61.6) at 15–
19 years of age to 226 g/day (CI 133–319) at 50–65 years of age. despite
this increase, 70.99% of the later group did not reached the
recommendations on any of the two days compared with 80.95% of
the 15–19 y group (p < 0.001).
As expected, the intake was lower inthe low SEL 180 g/day (CI 98.8–
261.2) and higher in the high SEL 224 g/day (CI 128–320).
Finally, it is important to highlight that only 4.2% of the populationmet
the recommendations in both days and 19.13% did it at least one day.
The data presented in this analysis only take into account the subjects
that after analysis were considered as plausibles (people who did not
sub or overestimate his/her intake)
Conclusions: The findings reinforce the low intake of fruits and
vegetables by the Latin. American population, since 95.8% did not
reach the WHO’s recommendations in both days. In addition, this low
intake is independent of sex, age or SEL.
It is important to reevaluate the programs and policies to encourage
FVI to mitigate future health issues associated with inadequate FVI.
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L-CARNITINE ORAL SUPPLEMENTATION IN CHILDREN WITH
INTESTINAL FAILURE RECEIVING LONG TERM PARENTERAL
NUTRITION
M. Greczan1*, K. Olszewska1, D. Rokicki1, J.B. Książyk1. 1Department of
Pediatrics, Nutrition and Metabolic Diseases, Children’s Memorial Health
Institute, Warsaw, Poland
* Corresponding author.
Rationale: Carnitine is essential for long-chain fatty acids transport,
and carnitine deficiency may contribute for intestinal failure asso-
ciated liver disease. The aim of our study was to investigate the
influence of oral carnitine supplementation 30 mg/kg in children
receiving long-term parenteral nutrition on liver function.
Methods:We included 44 randomly selected patients (0.12–16.9 years
old; median 5.9 years)). Serum ALT, AST, GGTP, bilirubin, albumin, ALP,
FFA, acylcarnitine profile and INR at the start point and after at least 6
months of L-carnitine oral supplementation in a day dose of 30 mg/kg
were analysed using Wilcoxone matched-pairs test.
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Results: Forty patients (90%) had serum carnitine concentration below
normal level at a start point. Median free and total carnitine serum
concentration increased after supplementation: 19.2 vs. 26; p < 0,001
and 31.45 vs. 40.75; p < 0,001respectively. Median acylcarnitines
concentrations significantly increased. Decrease of median INR 1.23
vs. 1.17; p < 0,005 and median GGTP 29 vs. 20 p < 0,007 and median
ALP 324 vs. 262.5, p < 0,002 were observed. No significant changes
were observed with respect to alanine aminotransferase, aspartate
transaminase, bilirubin, albumin and free fatty acids.
Conclusions: The majority of our patients had carnitine deficiency.
Oral supplementation of L-carnitine increased serum free and total
carnitine concentration, increased long-chain acylcarnitines concen-
trations, and improved some liver function tests. We conclude that L-
carnitine oral supplementation in patients on long term parenteral
nutrition is effective and have a positive impact on liver function.
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PREVALENCE AND DETERMINANTS OF EATING DISORDERS AMONG
HIGH SCHOOL ADOLESCENT FEMALES IN GHARBIA GOVERNORATE,
EGYPT
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Department, Faculty of Medicine Tanta University, Tanta, Egypt
* Corresponding author.
Rationale: Eating disorders are serious illnesses, particularly among
adolescent girls with an excessive concern about body weight and
shape,that requires screening for prompt interventions.
Methods: A cross-sectional study conducted during two academic
years 2016–2018, included 800 high school adolescent females,
recruited from two school in Tanta City and one rural school in
Gharbia Governorate, Egypt. An interview questionnaires was used to
collect the following data: sociodemographic characteristics and
anthropometric profile using BMI for age percentile. The Eating
Attitude Test (EAT-26) was used to assess the attitudes, behavior and
traits associated with eating disorders. Body image satisfaction was
measured using the 34-item Body Shape Questionnaire (BSQ-34).
Descriptive statistics, chi-square and logistic regression were per-
formed for data analysis.
Results: According to EAT-26 test. the prevalence of positive screening
of eating disorders was 35.5% (n = 284). Logistic regression analysis
unveiled that the signficant independent predictors of eating
disorders were low educational level of parents (OR: 1.6 for fathers,
3.5 formothers),workermothers (OR:6.6), increased bodyweight (OR:
2.5) for overweight/obese, and body shape dissatisfaction (OR: 4.9).
Factor analysis of EAT-26 revealed that,three factors (preoccupation
with thinness, perceived social pressure to gain weight, and food
preoccupation) recorded the highest scores.
Table 1, demonstrated that overweight/obese adolescents dissatisfied
with their body shape, significantly had higher score for EAT-26 scale
(p = 008,p < 0.0001),It also shows that all subscales of EAT-26 except
social pressure to gain weight were significantly higher among
adolescents who are dissatisfied with their body shape (p <0.0001).
Conclusions: Disordered eating attitudes and behaviors are prevalent
among adolescent females at high schools. Periodic screening and
specific management strategies targeting adolescents to correct the
corporeal image misconceptions,unhealthy weight management and
control eating behavior disorders are required.
Disclosure of Interest: None declared.
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DESCRIPTIVE STUDY OF NUTRITIONAL STATUS IN PATIENTS WITH
ESOPHAGEAL CANCER. ACCORDING TO THE NEW GLIM CRITERIA
O. Abdel-Lah1*, E.D. Alonso2, E. Sanchez1, C. Ruiz Gorjón3,
L. Hernandez-Cosido4, F.C. Parreño4, L. Muñoz-Belvis5. 1Surgery,
2Surgery, Complejo Asistencial Universitario de Salamanca, Salamanca,
3Antención Primaria SACYL, Zamora, 4Surgery, Complejo Asistencial
Universitario de Salamanca, 5Surgery, Complejo Asistencia Universitario
de Salamanca, Salamanca, Spain
* Corresponding author.
Rationale: The prevalence of malnutrition in these patients is
currently unknown; it is estimated to be 78.9%. Aim: know the
nutritional status of patients diagnosed with esophageal cancer in our
environment at the time of admission according to the new GLIM
criteria (1).
Methods: The informationwas collected prospectively of all admitted
patients diagnosed with malignant esophageal pathology from
January 2016 to December 2018. Urgent and scheduled admissions
were included. A complete nutritional assessment was carried out:
anthropometry (current weight, usual weight in the last 3 months and
height), malnutrition risk screening was carried out through MUST
andNRS2002 test and nutritional diagnosiswasmade according to the
GLIM criteria. Also albumin, prealbumin and c-reactive protein.
Results: 44 patients, 86,4% were males, with a mean age of 64.5 ± 11.7
years, the median hospital stay was 16.5 ± 13.5 days and 72.7% were
scheduled. Adenocarcinoma or carcinoma: 40 91%, GIST: 3 6.7% TNE: 1
2.3%, 86.4% were operated 38/44.
The nutritional screening withMUSTand NRS2002 showed a high risk
of malnutrition of 86.4% and 77% respectively. Following the GLIM
Table 1 (abstract: MON-PO546): Eat-26 and its comprising subscales in relation to BMI and body shape satisfaction between studied adolescent females.
Eat-26: psychometric
subscale
Preoccupation
with thinness
Dieting Social pressure
to gain weight
Bulimia Food
preoccupation
Overall
Eat-26
score
BMI
- Underweight
- Normal weight
Overweight/obese
5.008 ± 2.7
5.32 ± 3.75
6.9 ± 3.6
3.18 ± 3.6
2.13 ± 2.4
2.5 ± 2.6
5.16 ±3.37
4.77± 6.06
1.78 ±1.9
0.8 ± 1.7
1.93 ± 2.7
2.3 ± 2.4
2.2 ±2.4
3.06 ±2.5
5.2± 3.8
15.3 4 ± 12
18.28 ±11.8
19.1 ±10.5
Test of significance 11.24a 6.2a 141.9b 53.02b 56.5a 4.81a
p-value 0.0001* 0.002* <0.0001* <0.0001* <0.0001* 008*
Perceived body shape
- Satisfied
- Dissatisfied
0.14 ±5.7
7.19± 3.4
2.18± 2.9
3.31± 3.2
4.75± 5.8
2.9 ±3.7
0.91 ± 1.94
2.72 ±2.7
2.53± 2.5
4.62± 3.5
14.53 ±10.8
20.86 ± 9.5
Test of significance 3.86a 3.35a 31.6b 90.193b 40.7a 8.75a
p-value <0.0001* <0.0001* <0.0001* <0.0001* <0.0001* <0.0001*
aF ANOVA test.
bKruskal Wallis Test.
*Significance.
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criteria, 75% were malnourished and 36.4% had severe malnutrition.
The rest of the results are shown in the Table 1. Separated according to
the stage of disease. The majority of the patients 61.4% had an
advanced stage. 54.6% received neoadjuvant treatment and 20.5%
patients had a stage IV of them 66.7% entered urgently and 89% met
criteria of malnutrition; 5 (55.5%) were operated to place a nutritional
access route and 2 metastasis stents.
GLOBAL INITIAL
STAGE
ADVANCED
STAGE
STAGE
IV
% Average LOSS
WEIGHT
9 7,5 8 14,5
NRS 2002 34(77,2%) 5 21 8
MUST 39(86,4%) 6 25 8
GLIM 33(75%) 4 50% 19 70,4% 8 89%
Moderate 17 (38,6%) 1 11 2
Severe 16 (36,4%) 3 8 6
N 44 8 27 9
% 100 18,2 61,4 20,5
IQ 38 8 26 5
% 86,3 100 96,2 55,5
Conclusions: The incidence of malnutrition according to the new
GLIM criteria in patients with esophageal malignant pathology is 75%
in 36.4% the malnutrition is severe, even half of the patients with
initial stages are malnourished.
Reference
1. Cederholm T, Jensen GL, Correia MITD, et al. GLIMWorking Group.
GLIM criteria for the diagnosis of malnutrition – A consensus report
from the globalclinical nutrition community. Clin Nutr. 2019 Feb;38
(1):1–9.
Disclosure of Interest: None declared.
MON-PO548
INCIDENCE AND GRADE OF MALNUTRITION ON PATIENTS WITH
GASTRIC CANCER
O. Abdel-Lah1*, E.D. Alonso1, S. Alonso1, C. Ruiz Gorjón2, I. Jimenez1,
S. Carrero1, F.C. Parreño1, L. Muñoz-Belvis3. 1Surgery, Complejo
Asistencial Universitario de Salamanca, Salamanca, 2Antención
Primaria SACYL, Zamora, 3Surgery, Complejo Asistencia Universitario de
Salamanca, Salamanca, Spain
* Corresponding author.
Rationale: Despite the great incidence of malnutrition in hospitalized
patients, only recently has been reached a consensus for the
evaluation, diagnosis and classification of nutritional status. Aim:
know the incidence and grade of malnutrition on patients with gastric
cancer in our environment at the time of admission according to the
new GLIM criteria.
Methods: The informationwas collected prospectively of all admitted
patients diagnosed with gastric cancer from July 2016 to December
2018. On admission, during the first 24 h, nutritional risk screening
was performed with validated test and height and weight were
collected (current and six month ago). According with the new GLIM
criteria, these patients were classified according to their nutritional
status. Once the risk ofmalnutrition is considered, we can establish the
diagnosis when there is an etiological factor (in this case, every
patients have the disease/inflammation factor) and a phenotypic
criterion (weight loss >5% in the last 6 months, BMI < 20 in younger
than 70 years-old or <22 in elder than 70 years-old, or loss muscle
mass). According to the presence and severity of the phenotypic
factors, malnutrition is classified as moderate or severe. The
descriptive statistic was carried out with SPSS 24.
Results: We evaluated a sample of 101 patients (65 men and 36
women) aged between 44 and 88 years old (mean 71,84 years-old).
The median of hospital length stay was 10 days. 96% of the patients
were operated. According to ESPEN recommendations, some of the
validated malnutrition screening methods were performed upon
admission; malnutrition risk is presented in 64,94% of the cases (63/
101). 54,27% met diagnostic criteria for malnutrition. 20,83% (20
patients) presented moderate malnutrition and 29,16% (28 patients)
presented severe malnutrition.
Conclusions: More than a Half of patients (54,3%) diagnosed with
gastric cancer presented criteria for malnutrition upon admission.
Almost in the 30% the malnutrition is severe.
Reference
1. Cederholm T, Jensen GL, Correia MITD, et al. GLIMWorking Group.
GLIM criteria for the diagnosis of malnutrition – A consensus
report from the globalclinical nutrition community. Clin Nutr. 2019
Feb;38(1):1–9.
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#INSTADIET – CAN SOCIAL MEDIA BE A RELIABLE SOURCE OF
INFORMATION ON NUTRITION AND DIETETICS
P. Kabata1*, D. Winniczuk-Kabata2, P.M. Kabata3, K. Połom4,
J. Jasḱiewicz4. 1Department of Surgical Oncology, Medical Univerisity of
Gdańsk, 2Department of Anesthesiology and Intensive Care, Medical
University of Gdańsk, 3Pomeranian Centre of Toxicology, 4Department of
Surgical Oncology, Medical University of Gdańsk, Gdańsk, Poland
* Corresponding author.
Rationale: Social media are growing, worldwide platforms for
unlimited exchange of various content. Thanks to their accessibility
and short form they can be used as an easy, wide-range communi-
cation and information tool for companies, scientific communities,
patient advocacy organizations as well as special interest groups. The
aim of this study was to see whether Instagram® profiles can be a
reliable source of information and knowledge about nutrition and
dietetics.
Methods: Random identification of nutrition-related posts was
performed using built-in website search engine. Posts were searched
by 5 popular hashtags, 250 newest posts of each. Advertisement posts
were discarded. Each eligible post was then categorized (dietetics,
fitness, motivation, other) and assessed with regards to quality of
nutrition information provided (grades 0–3; 0 – very low, 3 – good
quality), popularity (number of followers, likes and comments) and
engagement measures (like, comment and engagement ratio).
Results:A total of 1190 posts were reviewed.Most of these, 63,8%were
categorized as ‘dietetic’. ‘Fitness’, ‘motivation’ and ‘other’ categories
stood for 8,2%, 4,8% and 23,2% respectively. The overall quality of the
content in terms of nutritional knowledge was very low (median
n = 0), also when divided into categories. Dietetic posts were the most
liked (mean n = 116 likes per post) and of highest quality, however
those motivational and fitness raised biggest engagement (33% and
22% respectively) and number of followers (n = 4356 and n = 3451
respectively).
Conclusions: Random post search cannot be treated as valuable
source of nutrition information. Dedicated search of high-quality
professional profiles is preferred to obtain quality information.
Disclosure of Interest: None declared.
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SCREENING OF EATING DISORDERS USING THE SCOFF-FAMONG 964
ACTIVE WORKERS AND STUDENTS
M. Arnal1, P. Fayemendy1,2,3, B. Morin1, M. Perrier4, M. Gravelat5,
M. Gérard6, C. Le Flahec7, V. Sabourdy7, S. Depoux8, M. Szopinski9,
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University of Limoges, 3INSERM, U1094, Tropical Neuroepidemiology,
School of Medicine of Limoges, 4Interprofessional Association for
Occupational Health 87, 5Inter-company medical service of the health
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Mutual Social Agricultural, 7Legrand Society Autonomous Medical
Department, 8Department of Occupational Medicine, Hospital of Esquirol,
9Department of Occupational Health of the AMCOBTP, 10University
Medicine Department, University of Limoges, 11Specialized Center of
Obesity of Limousin, University Hospital of Limoges, Limoges, France
* Corresponding author.
Rationale: Eating disorders (ED) including anorexia nervosa (AM),
bulimia nervosa (BN), binge eating disorder (BED) and night-eating
syndrome (NES) are severe psychiatric and nutritional disorders. ED
screening can be realizedwith the SCOFF-F. The aim of our workwas i)
to detect ED using SCOFF-F among students and active workers in the
French county of Haute-Vienne ii) to research factors associatedwith a
positive SCOFF-F.
Methods: This prospective study was conducted during 5 months in
6 departments of Occupational Medicine and a Department of
University Medicine. Using an anonymous self-questionnaire of the
declarative data concerning the age, the body mass index (BMI), the
presence of ED, the physical activities were collected. The SCOFF-Fwas
also realized (positive if 2 positive responses on 5). Statistical analysis
included Student’s t-tests, Chi2, and logistic regression.
Results: 964 people with a mean age of 34.3 ± 12.6 years old were
included. Mean BMI was 24.4 ± 4.6 kg/m², with 4.7% undernourished
and 12.2% obese. 26.7% of people were students. People reported AM,
BN, BES, andNES in 2.5%, 4.0%, 3.6%, and 2.8% of cases, respectively. The
SCOFF-F was positive in 13.7% of the cases, and more frequently in the
students (46.9% vs 23.6%, p <0.0001). In multivariate analysis, lower
age, women, higher BMI, high-level sport activity, quality of life
impaired by disorders, and reported ED were positively associated
with positive SCOFF-F (OR = 1.03, p = 0.01, OR = 2.17, p = 0.009,
OR = 1.09, p = 0.002, OR = 3.00, p = 0.002, OR = 5.3, p <0.0001 and
OR = 4.20, p <0.0001 respectively). For reported TCA positive SCOFF-F
was more specifically associated with BN and NES (OR = 4.6, p = 0.001
and OR = 5.64, p = 0.002 respectively).
Conclusions: Our study provides the first data on the screening of ED
in adults in the county of Haute-Vienne. The SCOFF-F screened 14% of
ED, which is consistent with the literature. In our population, it seems
more specifically positive in case of BN and NES reported by the
people. Even if we did not find an association according to the socio-
professional status, the students remain at risk of ED which is easy to
screen in University Medicine with the SCOFF-F.
Disclosure of Interest: None declared.
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CHARACTERISTICS OF HOSPITALIZED ADULT PATIENTS USING
ORAL NUTRITION SUPPORT AT A TERTIARY REFERRAL CENTER IN
MEXICO CITY
P.M. Martínez-Matsumoto1, L. Castillo-Martínez2, A.L. Reyes-
Ramírez2*, J. Tello-Santillán2, A.E. Serralde Zúñiga2. 1Clinical Nutrition
Service, INCMNSZ, México, 2Clinical Nutrition Service, INCMNSZ, Mexico
* Corresponding author.
Rationale: Hospitalized patients usually reduce food intake due to
sickness, thus the use of oral nutritional supplementation (ONS) can be
useful to prevent malnutrition associated with adverse outcomes.
Therefore, the aim was to describe the clinical and nutritional
characteristics of hospitalized patients with ONS at a tertiary referral
centre in Mexico City (INCMNSZ).
Methods: The study was conducted in hospitalized adult patients at
the INCMNSZ in April 2018. NRS-2002 was performed during the first
24 h of hospitalization, and medical nutrition therapy was prescribed
for those who needed it. The patients with ONS were followed for 4
days in which anthropometric and dietary measurements were
performed: weight, body mass index (BMI), handgrip strength, 24 h
dietary recall, the adherence to the prescription and tolerance.
Quantitative continuous variables were expressed as mean ±SD.
Categorical variables were summarized using frequencies and per-
centages. Paired t-test was used to compare related samples (day 0 vs
4) and Chi-square test for categorical variables. P value less than 0.05
was considered statistically significant.
Results: A total of 293 patients were eligible and the main diagnosis
was cancer (31%), half of the total population had nutritional risk and
only 10.2% had ONS. The ones with ONS 70% were females, were
56 ± 22 years old, BMI 21.3 ± 4.5 kg/m2, and 83% had nutritional risk.
Therewas a statistically significant increase in the energy (73% vs 90%)
and protein (77% vs 94%) intake, and 60% of patients were reached in
the estimated energy requirements (66% vs 90%). Standard enteral
formulas were used in 57% of the patients, 73% consumed >50% of the
ONS prescribed, and only 3% reported nausea.
Conclusions: In hospitalized adult patients who do not meet their
requirements with the diet, the ONS is a good option to increase the
energy and protein with good acceptance and tolerance.
Disclosure of Interest: None declared.
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S. Arslan1*, S. Kadayıfçılar2, F.G. Samur3. 1Nutrition and Dietetics,
Kastamonu University, Kastamonu, 2Department of Ophthalmology,
3Nutrition and Dietetics, Hacettepe University, Ankara, Turkey
* Corresponding author.
Rationale: Age-related macular degeneration (AMD) is one of the
main socioeconomical health issues worldwide. AMD has a multifac-
torial etiology with a variety of risk factors. Smoking is the most
important modifiable risk factor for AMD development and progres-
sion. The association between smoking and AMD has been consist-
ently demonstrated in many epidemiological studies carried out
within different populations in the last decades confirming previous
clinical impressions.
Methods: Total 200 (100 studygroup,100 control group), >50 years old
participants in Hacettepe University are attended to the study.
Demographic data were assessed by a standardized interviewer-
assisted questionaire with the method of face-to-face interview.
The socio-demographic features of individuals (gender, age, occupa-
tion, educational status, health conditions), use of cigarettes and drugs
was questioned. The individuals under 50 years old, who had special
nutrition conditions, cardiovascular diseases and eye surgery history
were not included in the study.
Results: When the individuals in the case group were analyzed in
terms of smoking, it was found that 54.0% of themwere smokers, and
46.0% of them never smoked. In the control group, it was found that
24.0% of individuals were smokers, and 76.0% of them never smoked.
There was a statistically significant difference between these two
groups in terms of smoking and the smoking rate in the case groupwas
found to be higher than the control group (p < 0.001). The mean
duration of smoking was 30.6 ± 14.6 years in the case group and
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29.3 ± 12.3 years in the control group and no statistically significant
difference was found between the two groups (p > 0.05). Also in a
multivariate analysis, smoking (odds ratio (OR): 6.59, = 0.021) was
identified as risk factors for developing AMD.
Conclusions: Consequently, in our study, as has been previously
studies, smoking by itself promotes development of AMD. However,
patients are not frequently aware of the significant role played by
cigarette smoking in blindness associatedwith AMD. Sometimes, even
physicians forget about advising patients of the relevance to quit
smoking. Quitting smoking reduces the risk of AMD. Countries should
show health warnings on cigarette packets related to this issue
(‘SMOKING CAUSES BLINDNESS’).
Disclosure of Interest: None declared.
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HOME ARTIFICIAL NUTRITION (HAN) IN A SOUTHERN ITALY LOCAL
HEALTH CARE UNIT (LHCU).
V. Amato1*, G. Prestieri1, V. Zurlo1. 1Home Artificial Nutrition Unit,
Department of Territorial Actvities and Social-Health Integration, Local
Health Care Unit ‘Napoli 3 Sud’, Torre del Greco, Naples, Italy
* Corresponding author.
Rationale: HAN prescription is a safe and steadily increasing practice
for non-hospitalized patients who needs nutritional support. Aim of
the study was to evaluate patients characteristic and prescriptions in
2018 at HAN Unit of LHCU ‘Napoli 3 Sud’, Naples, Italy.
Methods: Retrospective evaluation of data collected from 3695 HAN
patients (M = 1509, F = 2186) registered from January 1st to 31
December 2018. In addition to Home Parenteral Nutrition (HPN),
Home Enteral Nutrition (HEN) and Home Intra-Venous Fluids (HIVF),
Oral Nutritional Supplements (ONS) prescriptions has been included.
Results: The majority (96%) of HAN patients were adults (>18 years),
with the highest percentage aged over 70 years (75.5%). ONS
represented 65.2% of HAN prescriptions, mostly for swallowing
disorders and disease-related malnutrition (data not shown). The
prevalence of parenteral support (HPN+HIVF; 548) was 14.8%,
prescribed mainly to cancer patients (62.6%). Patients on HEN were
409 (11.1%) and 76.5% had neurological disease; Percutaneous
Endoscopy Gastrostomy (PEG) was the prevalent route of feeding
(52.9%) then nasogastric tube (44.5%); less commonwas jejunostomy
(2.6%). Patients on mixed HAN (HPN/HIVF + HEN/ONS) were 300
(8.1%). The largest diagnostic category for HAN patients was
neurological disease (2308, 62.5%); vascular disorders and brain
injuries contributing for 55% and degenerative disorders 33.5%.
About 26% of HAN patients were oncological: 374 had Gastro-
Intestinal (GI) cancer (38%); lung (15.6%) and head-neck cancer
(8.3%) followed. Benign GI diseases, including IBDs and GI surgery,
accounting for 5% of HAN prescriptions.
Conclusions: Elderly patients represented the largest HANpopulation.
Main HAN prescription in 2018 was ONS. Use of parenteral support as
‘palliative care’ could probably explain high HPN and HIVF prescrip-
tions [1].
Reference
1. Pironi et al. Development of home artificial nutrition in Italy over a
seven year period: 2005–2012. BMC Nutrition (2017) 3:6.
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INVESTIGATION ON THE CONSTRUCTION AND MANAGEMENT OF
NUTRITION DEPARTMENT IN TERTIARY HOSPITALS IN FUJIAN
PROVINCE OF CHINA
Y. Mu1*, F. Lin1, X. Lv2, C. Xu2, Y. Dai3. 1Department of Clinical nutrition,
2Fujian Provincial Hospital, Fuzhou, China, 3Department of Oncology,
Fujian Provincial Hospital, Fuzhou, China
* Corresponding author.
Rationale: China issued the National Nutrition Plan (2017–2030) in
2017, which identifies clinical nutrition as one of six major actions,
emphasizing the importance of clinical nutrition in achieving the goal
of healthy China. With the increasing demand for nutritional therapy
in clinical practice, there are higher requirements for the hardware,
allocation and staffing of clinical nutrition department. Therefore, it is
the necessary to understand the current situation and problems for
improving the nutrition status and health condition.
Methods: A cluster sampling method was used to investigate the
current situation and main problems of the construction and
management of clinical nutrition department in tertiary hospitals in
Fujian Province by questionnaires inmedical institutions fromOctober
to November in 2018.
Results: Total 46 tertiary hospitals were participated in the ques-
tionnaires. There were differences in the management attribution of
clinical nutrition departments, belonging to clinical department,
medical technology department and back office, respectively, with
non-standard names of departments. The nutrition professionals and
facilities were insufficient. The clinical diagnosis and treatment of
nutrition were not fully developed, with less than 50% hospitals
carrying out nutrition ward-rounds, outpatient clinics, medical
records, and nutrition risk screening, etc. Less than 15% of hospitals
has carryied out nutrition-related teaching and research.
Conclusions: The construction and management of clinical nutrition
department is inadequate in tertiary hospitals in Fujian Province.
Hospital managers should attach more importance to it by improving
the equipment and staffing and strengthening the quality control to
promote the development of clinical nutrition work.
Disclosure of Interest: Y. Mu Grant/Research Support from: Key
Projects of Training Young Backbone Talents in Health System of Fujian
Province, F. Lin: None declared, X. Lv: None declared, C. Xu: None
declared, Y. Dai: None declared.
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MEDITERRANEAN DIET ADHERENCE SCORE AS INDICATOR FOR
PREDIABETES IN TAIWAN
Y.C. Hou1,2*, I.-S. Tzeng3, C.-Y. Kuo4. 1School of nutrition and Health
Sciences, Taipei medical university, Taipei, 2Department of nutrition,
3Department of research, Taipei Tzuchi Hospital, Buddhist Tzu chiMedical
Foundation., New Taipei City, 4Wu zing street, TMU, Taipei, Taiwan,
Province of China
* Corresponding author.
Rationale: TheMediterranean diet has long been considered a healthy
eating pattern that decreases the risks of chronic diseases such type 2
diabetes. Prediabetes is the high-risk state for diabetes where the
patients can revert to being healthy via life style changes or
interventions.
Methods: This study analyzes Mediterranean diet adherence scores of
prediabetes patients in order to see if the 14-item questionnaire can be
used as an indicator for hyperglycemia. A total of 119 prediabetes
patients in Taiwan enrolled in this study.
Results:We found significance in gender, cholesterols, sugar, and DHA
in terms of the adherence score. No significance was found in glucose
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and HbA1c levels compared with adherence scores. Upon closer
analysis, most single pointers except for legumes and butter/cream/
margarine have no significant effect.
Conclusions: From our results we conclude that the Mediterranean
diet adherence score is not an effective indicator in the context of low
Mediterranean diet adherence score. Partial adherence to the
Mediterranean diet provides little benefit compared to the full benefits
shown in literature.
References
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THE INVENTION OF TONGUE COVER TO REDUCE DISCOMFORT
DURING INTAKE OF ORAL NUTRITIONAL SUPPLEMENTS
H. Fukuda1*, A. Yamashita2, H. Ishikawa3, N. Nagata3, M. Niihara4.
1Division of Neurology, 2Division of Nutrition, 3Department of Pharmacy,
4Division of Esophageal Surgery, Shizuoka Cancer Center Hospital,
Nagaizumi-cho, Sunto-gun, Shizuoka, Japan
* Corresponding author.
Rationale: Oral nutrition supplementations are provided to patients
who have inadequate or unable to take nutrition. However, there are
many cases where patients refuse to take because of the fact that the
supplements are not delicious. Nutrient manufacturers have added
various flavors such as fruits and soups, but the situation is not
satisfactory. Our object is to provide a tongue cover that can reduce
unpleasant feeling upon intake.
Methods:We tried to make a thin film that cover the whole tongue to
reduce taste feeling. We looked for edible materials for safe in use.
Results: The tongue cover is composed of two films. An upper film
covers the upper surface of the tongue and a lower film does the tip
portion of the tongue. We used gelatin, glycerin and others that can
melt a few minutes after they are attached to the tongue, and easily
break when ingested. In addition, it is safe to swallow the cover during
use or after use as it is edible.
Conclusions: The tongue cover can facilitate long-term nutrient
intake. In addition, it is possible to reduce pain and discomfort at the
time of medication in patients suffering from pain due to glossitis and
stomatitis, and also to reduce discomfort at the time of intake due to
bitterness of the mouth. The tongue cover made of edible materials
seemed to be useful in clinical practice.
Disclosure of Interest: None declared.
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FIRST RESULTS ON RADIOLOGIC PERCUTANEOUS GASTROSTOMY AT
OUR CENTER
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I. Rebollo Pérez1*. 1Endocrinología y nutrición, Hospital Juan Ramon
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* Corresponding author.
Rationale: In recent years radiologic percutáneous gastrostomy (RPG)
is increasing due to the shorter procedure, simplicity, low cost and low
morbility. In 2016, members of Nutrition and Interventional Radiology
Units at our Hospital agreed to routinely introduce RPG in clinical
management of patients at risk of malnutrition.
Methods:Descriptive study of GPR performed at our Center from 2016
to 2018. We recorded the following variables: gender, age, procedure
date, cancellations and its cause, indications, length of hospital stay,
enteral nutrition start and complications.
Results: We received 33 requests for RPG, 23 of which were finally
performed: 2 (8,7%) in 2016, 5 (21,7%) in 2017 and 16 (69,6%) in 2018.
Causes of cancellations were: patient decease in 2 (20%) cases, loss of
eligibility criteria in 4 (40%) and other reasons in 4 (40%). In 91,7% of
the cases were the first radiological gastrostomy, and in 8,3% were
feeding tube replacement. Mean age of the patients was 62 years (SD
7,58) and 73,9% were men. Main indication (52,1%) was dysphagia
(neurological in 39,1% and organic in 13%), followed by prophylactic
RPG (43,5%). Median of stay length in Hospital was 1 day (range 1–21).
We iniciated enteral diet in the 12 hours after RPG in 5% of the
patients; between 12–24 hours in 20% and beyond 24 hours in 75%.
There were major complications in 2 cases (8,7%): 1 gastrostomy tube
malposition, with instilled nutrition into peritoneal cavity and 1
gastric bleeding that required transfusión. And 13% of minor
complications during the first 6 months.
Table 1 (abstract: MON-PO555): Multivariable-adjusted odds ratios (OR, 95% confidence intervals) for AC and HbA1C according to the fulfilment of each item included
in the 14-point screener of adherence to the Mediterranean diet.
14-point screener of adherence to the
Mediterranean diet
% positive at
recruitment
AC HbA1C
OR (95%CI) p OR (95%CI) p
1. Use of olive oil as main culinary lipid 3.36% 0.46 (0.04–5.18) .526 536525941.01 (0.00 – NA) .999
2. Olive oil >4 tablespoons 0.84% 446424639.79 (0.00 – NA) 1.000 707623346.94 (0.00 – NA) 1.000
3. Vegetables ≧2 servings/d 13.45% 2.18 (0.24–19.59) .485 1.04 (0.31–3.50) .955
4. Fruits ≧3 servings/d 11.76% 1.29 (0.14–11.54) .819 1.03 (0.25–4.16) .970
5. Red/processed meats <1/d 80.67% 1.45 (0.35–6.01) .613 1.79 (0.66–4.89) .254
6. Butter. cream. margarine <1/d 94.96% 0.00 (0.00 – NA) .999 5.86 (0.98–34.94) .052
7. Soda drinks <1/d 76.47% 0.67 (0.13–3.39) .629 1.04 (0.38–2.83) .943
8. Wine glasses ≧7/wk 3.36% 119295180.26 (0.00 – NA) .999 0.22 (0.03–1.75) .152
9. Legumes ≧3/wk 2.52% 0.06 (0.00–0.76) .030 1.03 (0.08–13.87) .980
10. Fish/seafood ≧3/wk 2.52% 251062931.25 (0.00 – NA) .999 1.11 (0.09–14.35) .938
11. Commercial sweets and
confectionery ≦2/wk
69.75% 1.18 (0.32–4.37) .810 0.74 (0.28–1.95) .536
12. Tree nuts ≧3/wk 3.36% 203202786.91 (0.00 – NA) .999 1.13 (0.11–11.60) .919
13. Poultry more than red meats 30.25% 0.46 (0.04–5.18) .526 536525941.01 (0.00 – NA) .999
14. Use of sofrito sauce ≧2/wk 9.24% 446424639.79 (0.00 – NA) 1.000 707623346.94 (0.00 – NA) 1.000
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Conclusions: RPG in our Center has experienced exponential growth
in the last 3 years.
Dysphagia is still main indication, butwe have a relevant percentage of
prophylactic stenting.
We should begin enteral nutrition before 24 hours after RPG if posible.
Disclosure of Interest: None declared.
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COST-BENEFIT ANALYSIS OF USING AUTOMATIC COMPOUNDING
DEVICES IN TPN PREPARATION IN TAIWAN
J.-H. Wang1*, Y.-C. Lin1, I.-H. Tsai1, C.-Y. Lin1, H.-L. Tsao1, Y.-L. Wang1.
1Department of Pharmacy, Kaohsiung Medical University Hospital,
Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China
* Corresponding author.
Rationale: Total parenteral nutrition (TPN) formulations are paren-
teral nutrition tailored to patients’ nutritional needs. Before the
introduction of fully automatic compounding devices (ACD), TPN was
prepared withmanual dispensary. The automata have been able to cut
down time and improve patient safety; however, the tubing cost and
residual drug are much higher compared to manual dispensing. In
order to understand the cost and economic benefit of switching to
ACD, further analytical study was conducted.
Methods: Cost comparison between manual modulation using
conventional method and ACD modulation (Baxtar, EM2400).
Additional effectiveness of the different modulations used is also
considered in this analysis.
Results: The National Health Insurance in Taiwan reimburses NT$365
per TPN bag. The daily pipeline cost is about NT $5,000 and cost for the
residual drug is about NT $790. To balance these cost, 15 bags have to
be allocated. Cost analysis shows the expenditure of using ACD is about
NT $379,601 per month. Profit-wise, ACD is 1.4 times higher than
manual modulation (about NT $59,510 per month). The introduction
of automatic modulation increases the number of TPN prepared by
about 40%. Accounting for no additional increase in manpower, extra
preparations in eye drops and pediatric TPN can be achieved, which
in turn improve institutional efficiency and increase surplus. The
expenditure of pediatric TPN is about NT $24,941 per month. Because
of the manpower saved, we can prepare about additional 50 bottles of
eye drops in one hour.
Conclusions: Compared with the human errors that can be generated
by manual modulation, the ACD safer, more economically beneficial,
manpower savings, more profitable and most importantly adds extra
values to the institution. In the future, these additional benefits can
provide more opportunities to design more nutritional formulas for
different ethnic groups to meet the requirements of clinicians and to
provide safe and effective PN treatment to patients.
Disclosure of Interest: None declared.
MON-PO559
BACTERIAL CONTAMINATION DURING CONTINUOUS
ADMINISTRATION OF A STERILE LIQUID ENTERAL NUTRITION
FORMULA IN A STERILE SEALED BAG: A PROSPECTIVE
INTERVENTIONAL STUDY.
J. Hatakeyama1*, H. Baba2, Y. Sakai3, S. Aso4. 1Emergency and Critical
Care Medicine, 2Surgery, 3Clinical Laboratory, Yokohama City Minato Red
Cross Hospital, 3-12-1 Shin-yamashita, Naka-ku, Yokohama, Kanagawa,
231-8682, 4Clinical Epidemiology and Health Economics School of Public
Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo,
113-0033, Japan
* Corresponding author.
Rationale: The European Society for Clinical Nutrition and
Metabolism has not yet provided any suggestions concerning bacterial
contamination during the administration of enteral nutrition (EN)
formulavia a feeding tube. On the other hand, the American Society for
Parenteral and Enteral Nutrition states that EN formula should be used
within 8 hours. However, in our experiment, there was no evidence of
bacterial contamination during continuous administration of EN in a
sterile sealed bag even up to 24 hours. We attempted to clarify the
actual degree of bacterial contamination of EN formula during daily
use in critically ill patients.
Methods: A single-institution, prospective study. Patients who were
over twenty years old and received 24-hour continuous EN in a sterile
sealed bagbetween December 2016 and July 2018 at the intensive care
unit were enrolled in the study. A 3-ml sample of the EN formula was
collected for bacterial culture every four hours from the sterile bag that
hungon the side of the patients’ beds. Culture disheswere incubated at
35°C for 48 hours prior to evaluation. The primary endpoint of the
study was detection of bacterial colonies and the secondary endpoints
were the presence of gastroenteritis, the stool score as defined by
King’s stool chart, and the volume of fluids draining via the nasogastric
tube over a period of 24 hours.
Results: A total of 630 specimens were collected for culture from a
total of 30 patients. No bacterial colonies were detected. None of the
patients developed gastroenteritis, the stool score on King’s stool chart
was 0, and the gastric aspirate volume was 0 ml.
Conclusions: Therewas no bacterial contamination during continuous
administration of a sterile liquid EN formula in a sterile sealed bag for
up to 24 hours at a clinical site. Thus, a 24-hour hang time of the EN
formula can be allowed for patients receiving continuous EN in the
intensive care unit. Amulticenter trial is necessary to confirm our data.
Disclosure of Interest: None declared.
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STERILITY TESTING OF TOTAL PARENTERAL NUTRITION SOLUTIONS
L. López-Vinardell1*, N. Garin1, L. Gras-Martín1, J. Cardenete1,
E. Rodríguez-Murphy1, D. Cardona1, J.T. De Pourcq1, P. Riera1.
1Pharmacy Department, Hospital de la Santa Creu i Sant Pau,
Barcelona, Spain
* Corresponding author.
Rationale: Total parenteral nutrition (TPN) is a high-risk factor for
bloodstream infections (BSI), as its high nutrient content provides a
suitable culture media for microorganisms. The manufacturing of
individualised TPN solutions implies further technical manipulation
compared to 3-chamber bags, thereby increasing the risk of contam-
ination. Thus, it is essential to ensure aseptic conditions during the
preparation process to guarantee the sterility of these admixtures and
prevent potential BSI. The aim of this studywas to assess the sterility of
individualized TPNs compounded in horizontal laminar flow hoods
following GMPs in the Pharmacy Department of a University Hospital.
Methods: Sterility of TPNs was assessed by means of a validated 0.45-
μm membrane filtration method (1). A randomised sample of 50 mL
was taken every 45 bags according to the cumulative sum control
charts and, after its filtration, the membrane was transferred to a
blood-agar medium. An additional 20 mL samplewas taken to be used
as a control in case of a positive result.
Results: Between 2012 and 2018, 47,975 bags were prepared. Among
them, 1,071 were randomised for testing. The results of the agar blood
cultures are detailed below.
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Bags tested (year) Agar blood cultures results
129 (2012) All negative
144 (2013) One TPNwas reported to be contaminated
with coagulase-negative Staphylococci.
The control sample was negative.
147 (2014) One TPNwas reported to be contaminated
with Pseudomonas fluorescens. The
control sample was negative.
188 (2015) All negative
161 (2016) All negative
159 (2017) All negative
143 (2018) All negative
Bacterial growth was observed only on two filters (0.2% of the
samples), but the negative results of the subsequent controls indicated
accidental contamination during the filtration process and/or the
manipulation of the samples.
Conclusions: Our study demonstrates the sterility of the TPNs
prepared in the Pharmacy Department. The lack of contamination
reveals that the QualityManagement System for our Production Unit is
effective.
Reference
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Microbiological quality control study of ‘all-in-one’ total parenteral
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MON-PO561
STANDARDIZED COMMERCIAL PARENTERAL NUTRITION WITH
EXTRA NITROGEN FORMULATIONS PRESCRIPTION IN A TERTIARY
HOSPITAL
L. Vilaró1, A. Siles1, A. Vilariño1, M. Ardèvol1, L. Bordejé2*. 1Pharmacy
Department, 2Critical Patients Unit, Hospital Germans Trias i Pujol,
Badalona, Spain
* Corresponding author.
Rationale: Clinical nutrition guidelines recently increased protein
requirements for parenteral nutrition (PN). Therefore, the first
standardized commercial parenteral nutrition (SPN) formulations do
not reach the nutritional needs for some patients. The new extra
nitrogen SPN (ENSPN) were commercialized to fulfil them. The goal of
this study is to analyse the extra protein addition to SPN before and
after the inclusion of ENSPN in a Hospital Drug Formulary and its
impact in the amount of timeneeded for the preparationprocess in the
Pharmacy Department.
Methods: Descriptive, retrospective study in a tertiary hospital.
Patients admitted from March 2018 to March 2019 who needed PN
were included and divided in two groups: before the inclusion of
ENSPN in the Hospital Drug Formulary (from March 2018 to October
2018) and after the inclusion (from November 2018 to March 2019).
Demographic and clinical variableswere registered. Datawas collected
from medical records and analysed with STATA®14.
Results: A total of 424 patients were included, 261 before the
implementation of ENSPN (first group) and 163 after the implemen-
tation (second group). There was no statistical difference regarding
neither gender nor age between both groups. Parenteral nutritionwas
administered an average of 13.8 days (95%CI 10.9–16.8) in the first
group and 10.8 days (95%CI9.5–12.1) in the second (p = 0.1304). A total
of 3519 PN were prepared during the first period and 1866 during the
second. The addition of external proteins was needed in 38.2% (1344/
3519) before the inclusion of ENSPN, and only in 16.8% (313/1866)
after, which represents a 21.4% reduction (p = 0.000). Critical Patients
Unit (24.6%), Oncology and Haematology Unit (22.3%) and
Resuscitation Unit (20.1%) were who most prescribed ENSPN. If we
estimate an average of 6 minutes for each extra protein addition to
SPN, and taking into account a 21.4% reduction of it after the inclusion
of ENSPN, the PN preparation timewas decreased an average of 2.23 h
per week.
Conclusions: The use of ENSPN allows reducing extra protein addition
to SPN. These new formulations are helpful to fulfil protein require-
ments in patients on which traditional SPN do not adjust properly.
Moreover, ENSPN permits a significant reduction in PN preparation
time with direct consequences in the use of resources.
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MON-PO562
REDUCTION IN HEALTH CARE UTILIZATION WITH TRANSITION TO
PEPTIDE BASED DIET IN INTOLERANT HOME ENTERAL NUTRITION
PATIENTS
M.S. Mundi1*, S. Velapati1, A. Kuchkuntla1, R.T. Hurt2. 1Division of
Endocrinology, 2Division of General Internal Medicine, Mayo Clinic,
Rochester, United States
* Corresponding author.
Rationale: Since introduction of percutaneous endoscopic gastros-
tomy in the 1980’s, the prevalence of enteral nutrition support has
increased significantly. Despite these increases, many patients are
unable to tolerate standard polymeric formula (SPF) resulting in
significant health care resource utilization. Peptide based diets (PBD)
have emerged as a viable option in SPF intolerant patients, however
data in Home Enteral Nutrition (HEN) is lacking.
Methods: Retrospective review of our prospectively maintained HEN
database was conducted to assess tolerance, efficacy, and impact on
health care utilization in patients on PBD.
Table 1
Results for HEN patients intolerant to SPF.
Characteristic (n = 43) On
standard
polymeric
Feed
On
Peptide
Based
feed
P-value
Nausea/vomiting n(%) 17 (40%) 10 (23%) 0.021
Diarrhea 20 (47%) 10 (23%) 0.0023
Abdominal pain/Cramping 10 (23%) 2 (5%) 0.0114
Abdominal distention 4 (9%) 1 (2%) 0.1797
Average number of patient-
initiated phone calls
1.8 ± 1.65 1.1 ± 1.0 0.0051
Average number of visits to ER 0.3 ± 0.6 0.09 ± 0.3 0.0273
Average number of provider
visits
1.3 ± 1.3 0.3 ± 0.5 ≤0.0001
Results: From January 1st, 2016 to May 1st, 2018, 98 patients were
placed on PBD with 55 patients being started directly and 43 patients
being transitioned from SPF. In patients transitioned to PBD, symptoms
of nausea/vomiting, diarrhea, abdominal pain, and distention
improved significantly. Health care utilization also declined signifi-
cantly including mean number of phone calls (1.8 ± 1.65 to 1.1 ± 1.0, p-
value 0.005), mean number of emergency room visits (0.3 ± 0.6 to
0.09 ± 0.3, p-value 0.03), and mean number of provider visits (1.3 ± 1.3
to 0.3 ± 0.5, p-value<0.0001).
Conclusions: Overall, PBD was well tolerated and resulted in a
significant improvement in symptoms of gastrointestinal distress
and health care utilization in patients intolerant to SPF.
Disclosure of Interest:M.Mundi Grant/Research Support from:Nestle
and Fresenius Kabi, S. Velapati: None declared, A. Kuchkuntla: None
declared, R. Hurt: None declared.
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MON-PO563
RESULTS OF THE IMPLEMENTATION OF A VIRTUAL NUTRITIONAL
CONSULTATION IN HUELVA’S POPULATION.
L. Florencio Ojeda1, M. Lainez López1, M. Martín López1, M.I. Rebollo
Pérez1*. 1Endocrinología y Nutrición, Hospital Juan Ramon Jimenez,
Huelva, Spain
* Corresponding author.
Rationale: Descriptive analysis of the implementation of a nutritional
teleconsultation as a communication tool between Primary Care (PC)
and Clinical Nutrition and Dietetics Unit (CNDU) for the care of the
population at risk with neurological pathology.
Methods: Descriptive and retrospective analysis. Data are collected
from all patients who have been cited in nutritional teleconsultation
from November 2017 to March 2019, the data collected from these
patients and the treatment established are analyzed.
Results: Total of 181 patients, with an average age of 83,2 years, 23,8%
are men and 76,2% are women. The main diagnosis of the most of the
derivative patients are vascular dementia (37,5%) and Alzheimer’s
disease (32,5%). Average MNA 11,4 points (malnourished). Brachial
circumference average 23,6 cm. Knee-heel distance average 45,3 cm.
Mean height calculated 154,8 cm. Mean weight calculated 50,2 kg.
Average BMI 20,8 kg/m². Average albumin 3,4 g/dL. About nutritional
diagnosis, 17,22% presented SGA-A, 67,22% SGA-B and 15,56% SGA-C.
As established treatment, in 5% of the cases we advise dietary
recommendations, in 11,1% nutritional recommendations with adap-
tated diet, in 69,4% were prescribed ONS and in 14,5% of the cases
enteral nutrition. It was necessary to request a new appointment to
provide new data in 13,25% of cases.
Conclusions: The creation of virtual communication tools between PC
and CDNU for the care of the population at risk with neurological
pathology increases the detection of malnutrition and the introduc-
tion of nutritional treatment for these patients.
The introduction of a nutritional teleconsultation for the care of these
patients achieves the accessibility of the patient and the family to the
nutritional treatment in an agile and effective way.
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MON-PO564
IMPACT OF COMPUTER CALCULATION PROGRAM FOR
INDIVIDUALIZED PARENTERAL NUTRITION OF EXTREMELY LOW
BIRTH WEIGHT (ELBW) INFANTS ON SELECTED CLINICAL
PARAMETERS
M. Chojecka1*. 1Neonatology, Ginekologiczno-Połoz ̇niczy Szpital
Kliniczny Uniwersytetu Medycznego im. Karola Marcinkowskiego w
Poznaniu, Poznań, Poland
Rationale: Nutrition supply in the first weeks of life of preterm
neonates is an essential part of medical care conditioning extrauterine
growth and development. Quality of nutrition impacts significantly
efficacy of treatment in critically ill neonates and recovery after
surgery. Thesis of the study is that using computer software to apply
TPN in ELBW newborns can improve growth, decrease morbidity and
increase guidelines compliance.
Methods: Retrospective medical records analysis of 94 extremely low
birth weight preterm infants admitted to NICU within 2 first days of
life, born over a one-year period before (2013) and after (2016)
introducing computer software for appling parenteral nutrition.
Composition of PN at 1st, 3rd and 7th day of life was obtained.
Growth was assessed based on difference in weight, head circumfer-
ence and body length percentile on Fenton charts at two points of
time.
Results: Mann-Whitney test showed that more energy, fluids,
proteins, lipids and carbohydrates were administered at all time
points in computer-calculated group. In this group, lower NEC and
conjugated hyperbilirubinemia morbidity at the level of statistical
tendency were observed. Considering ESPEN/ESPGHAN Guidelines on
paediatric parenteral nutrition (2005) there was no difference in
compliance. However when compared with detailed recommenda-
tions by D.H. Adamkin (2008) there was a difference in lipid
administration adequacy. At all time points computer-calculated
group received appropriate amount of lipids and conventionally
administered PN group didn’t. In the computer-calculated group
duration of PN was shorter (average 30,81 vs. 25,25 days).
Conclusions: Calculating PN via computer software increased admin-
istration of nutrients, shortened duration of PN and possibly lowered
morbidity.
References
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USE OF PFAT5 TO EVALUATE ADMIXTURE COMPATIBILITY
M. Klang1*. 1Research Pharmacy, Memorial Sloan-Kettering Cancer
Center, New York, United States
* Corresponding author.
Rationale: Lipid emulsions are susceptible to instability when co-
infused with concomitant medications and electrolytes. The optimal
assay has been proposed as measurement of the PFAT5. The PFAT5 is
defined by USP Chapter 729 as the percentage of fat residing in
globules larger than 5 μm as measured by light obscuration. The lipid
would be considered unstable if that value would exceed.0.05%. This
preliminary study was undertaken to evaluate the use of PFAT5
technology in evaluating co-administered electrolytes.
Methods: A light-obscuration particle sizer HIAC 9703+was calibrated
for particles 1.8 to 50 μm. This study evaluated Intralipid® and
SMOFlipid® for compatibility with Normal Saline and Magnesium
Sulfate Solutions. Fat emulsion samples were transferred from
manufacturer’s containers into B Braun, Excel® plastic containers.
One ml samples were removed from each mixture and evaluated
initially and after 24 hours of exposure. Each sample was diluted with
particle-freewater (PFW) at 1:200 dilution. All tests were conducted in
triplicate and reported as mean. The particle sizer system was rinsed
with PFW three times and verified for system suitability according to
USP 788 test between each sample.
Results: Each of the samples showed a slight increase in the PFAT5
after 24 hours in the polyolefin containers. It was expected than
baseline would remain the same and that the addition of electrolytes
would follow a pattern similar as the pattern shown in aggregation
number theory, where high valence cationswill have higher disruptive
effects. The change was most pronounced in the SMOFlipid samples
containing magnesium, but not with Intralipid mixed in an identical
process.
0 24 Change
SMOF 0.011 0.017 1.499206
S+NS 0.013 0.016 1.255363
S+Mg 0.019 0.047 2.462739
Intralipid 0.018 0.020 1.121033
I + NS 0.018 0.024 1.334504
I + Mg 0.018 0.022 1.195849
Conclusions: This preliminary studywas undertaken to determine the
feasibility of using light obscuration derived PFAT5 model as a tool in
evaluating lipid compatibility. The lipid market is complex and there
exists few studies that use validatedmeans to determine the impact of
co-infused medications. Future studies will evaluate a wide range of
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medications and electrolytes, to ensure the safety of concomitant
delivery.
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EVALUATION OF THE AMOUNT OF RESIDUAL LIPID EMULSION IN
CHAMBERS OF FLUSHED TOTALLY IMPLANTABLE VENOUS ACCESS
DEVICES USING FLUORESCENCE IMAGING
N. Okamura1*, T. Yamato1, I. Yamaoka2. 1Information Center for Infusion
Therapy and Product, 2Medical Foods Research Institute, Otsuka
Pharmaceutical Factory, INC., Naruto/Muya, Japan
* Corresponding author.
Rationale: Flushing of totally implantable venous access devices is
essential for the prevention of occlusion, which occasionally occurs
during lipid emulsion dosing1)2). In this study, we succeeded in
visualizing and quantifying the behavior of the lipid emulsion in
totally implantable venous access devices after flushing, and we
identified an effective flushing speed and flushing method.
Methods: A quantitative fluorescence imaging technique was used to
evaluate the amount of residual lipid emulsion in port chambers.
Chambers were filled with lipid emulsion containing indocyanine
green and then flushed with 5 to 70 mL of normal saline to compare
the residual amounts between intensities as visualized by quantitative
fluorescence imaging and the turbidity of the solution recovered from
the chambers. Chambers were flushed at various speeds (15–60 mL/
min),with a time interval of 1 or 3 s between boluses, andwith varying
directions of flow.
Results: The residual amounts determined by fluorescence imaging
did not differ from those calculated from the turbidity of the recovered
solution. A lipid emulsion residue that cannot be visually confirmed in
the port chamber was seenwith fluorescence imaging. The slower the
flushing speed, the more lipid emulsion that remained. When the
flushing speed was 40 mL/min or more, 99.98% or more of the lipid
emulsion was discharged by flushing with 20 mL of normal saline.
Compared with continuous flushing, pulsatile flushing with either
time interval did not decrease the residual amount. The areas well
cleaned after flushing were oriented to the bevel-opening direction,
but when the flushing speed was high, the entire area was uniformly
cleaned. The residual amounts determined by fluorescence imaging
did not differ from those calculated from the turbidity of the recovered
solution. A lipid emulsion residuewhich can’t be visually confirmed in
the port chamber was revealed by using fluorescence imaging. The
slower the flushing speed, the more lipid emulsion that remained.
When the flushing speeds was 40 mL or more, the lipid emulsion of
99.98% or more was discharged by flushing with 20 mL of normal
saline. Compared with continuous flushing, pulsatile flushing with
either time interval did not decrease the residual amounts. The areas
well cleansed after flushing were oriented to the bevel-opening
direction, but when the flushing speed was high, entire area was
cleaned uniformaly.
Conclusions: Imaging with indocyanine green enables the visualiza-
tion and quantitative determination of residual lipid emulsion in
chambers after flushing. These findings suggest that, to reduce the
residual amount of lipid emulsion in a chamber, fast and energetic
flushing continuously, as opposed to pulsatile flushing, is of para-
mount importance.
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THE EFFECT OF ENTERAL NUTRITION ON PATIENTS’ QUALITY OF
LIFE (QOL): A SYSTEMATIC REVIEW
O. Ojo1*, E. M. Keaveney2, X.-H. Wang3, P. Feng3. 1Faculty of Education
and Health, University of Greenwich, London, United Kingdom, 2Rockfield
Medical Devices, Galway, Ireland, 3The School of Nursing, Soochow
University, Suzhou, China
* Corresponding author.
Rationale: Although enteral nutrition has been shown to promote
nutritional status, improve wound healing, and enhance patients’
quality of life (QoL), evidence of tube and feed complications and
reduced QoL has also been reported. The aim of this systematic review
is to evaluate the effect of enteral nutrition on patients’ QoL, which is
particularly relevant as the prevalence of patients on enteral feeding is
increasing.
Methods: Three databases (EMBASE, Pubmed and PsycINFO) were
searched for relevant articles based on Population, Intervention,
Comparator, Outcomes (PICO) framework. The review was in line
with PRISMA guidelines and involved the use of synonyms and
medical subject headings. Search terms were combined using Boolean
operators (AND/OR) and only eligible articles meeting the inclusion
criteria were selected for the review.
Results: Fourteen articles which met the criteriawere included. Three
distinct themes emerged (the effect of early versus late enteral tube
feeding on QoL; the QoL of patients on gastrostomy versus standard
care, and the effect of enteral nutrition on QoL). Overall, nine studies
reported improvement in the QoL of patients on enteral nutrition,
while five studies demonstrated either no significant difference or
reduction in QoL. Some factors which may have influenced these
outcomes are differences in types of gastrostomy tubes; enteral
feeding methods (including time patients spent connected to enteral
feed/pump), and patients’ medical conditions, as well as the generic
and/or type of QoL measuring instrument used.
Conclusions: The majority of reviewed studies suggest that enteral
nutrition is effective in improving patients’ QoL. The use of enteral
nutrition specific QoL measuring instruments is recommended for
future research and improved management strategies including use of
mobile enteral feeding pumps should further enhance patients’ QoL.
Disclosure of Interest: O. Ojo Grant/Research Support from: This
researchwas supported from funding obtained fromRockfieldMedical
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SELECTIVE IN VITRO ACTIVITY OF A MICROBIOTA ACCESSIBLE
CARBOHYDRATES ON KEY BACTERIA FROM GUT MICROBIOME
S. Vidal1*, Y. Miao1, P. Steenhout1, Y. Adesokan1. 1Gnubiotics Science SA,
Epalinges, Switzerland
* Corresponding author.
Rationale: Human Milk Oligosaccharides (HMOs) are unconjugated
complex carbohydrates abundant in human milk. HMOs selectively
serve as a source of energy for desired bacteria in the infant gut
modulating mucosal barrier function and promoting immunological
responses. We have developed an oligosaccharides based formulation
containing up to 130 Microbiota Accessible Carbohydrates (MACs)
mimicking the natural diversity and complexity of HMOs. Our aimwas
to investigate the ability of key bacteria from the gut to use the
formulation GMX in vitro.
Methods: Bifidobacterium bifidum ATCC 11863, B. animalis subsp. lactis
DSMZ 10140, B. breve ATCC 15700, Lactobacillus acidophilus ATCC
13651, Akkermansia muciniphila ATCC BAA835 and Bacteroides
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thetaiotaomicron ATCC 29148 were cultivated in liquid minimal
medium (MM) supplemented with glucose, MM supplemented with
the formulation GMX and MM without supplementation. Cultures
were performed in 96-well plates in triplicate in anaerobiosis at 37°C
and bacterial growth was measured by optical density (OD) at 600 nm
after 24 h, 48 h, 72 h and 96 h.
Results: All the tested strains were able to grow better in MM with
GMX in comparisonwith MMwithout supplementation. In B. bifidum,
the maximum growth was reached after 96 h (OD = 0.704). However,
in B. animalis, B. breve and L. acidophilus it was reached after 24 h
(OD = 0.315, OD = 0.607 and OD = 0.713, respectively). The bacterial
species exhibiting more growth after 24 h were A. muciniphila
(OD = 1.292) and B. thetaiotaomicron (OD = 1.11).
Conclusions:MAC formulation GMXwith a structural diversity similar
to HMOs has the capacity to stimulate important components of the
gut microbiota in vitro. Our MAC formulation could have the potential
to serve as a source of energy and nutrients for desired intestinal
bacteria helping to restore a healthy microbiota in patients with
dysbiosis.
Disclosure of Interest: None declared.
MON-PO569
WHAT AND HOW MANY PATIENTS ARE MONITORED BY THE UMCG
NUTRITIONAL SUPPORT TEAM FOR INTESTINAL FAILURE AND
TRANSPLANTATION BECAUSE OF INITIALLY SHORT-TERM TOTAL
PARENTERAL NUTRITION (TPN) AT HOME, ADMINISTERED BY A
GROWING NUMBER OF PICC’S?
S. Tabak1*, J. Barentsen1, W.Westerhuis1, G. Dijkstra1. 1Gastroenterology
and Hepatology, UMCG, Groningen, Netherlands
* Corresponding author.
Rationale: The Nutrition Support Team UMCG (consisting of dieti-
cians, registered nurses, nurse practitioners and gastroenterologists)
coordinates and monitors (since 2009) an increasing number of adult
patients with initially short-term Total Parenteral Nutrition (TPN) at
home for several indications. These are for instance fistulas and short
bowel but also regards patients with intestinal failure awaiting ITx (as
the UMCG is the only intestinal transplant center in the Netherlands)
and therefore depend on long-term TPN. The administering by PICC
instead of CVC is increasing in (initially) short-term TPN, whereas
numbers of complications were not objectified yet.
Methods: In this retrospective overview we present numbers of a
variable and growing group of adult patients, over the last two years,
by exploring our electronical registration system.
Results: The number of patients with short term Home Parenteral
Nutrition increased from 22 per year in 2017 to 41 per year in 2018,
whilst the number of long term patients was 7 (in both years).
Indications for TPN can be roughly divided into four groups, in which
incidence accidentally differs per year, namely; fistulas (27% in 2017
and 34% in 2018), (functional) short bowel (23% in 2017 and 12% in
2018), poor enteral access (for example gastroparesis, stenosis
esophagus and ileus) occurred with 9% of the patients in 2017 and
29% of the patients in 2018, and other (for example hyperemesis, chyle
leakage and cancer), 36% (2017) versus 24%. On average, patients were
administered short term TPN during 18.3 weeks in 2017 and 19.0
weeks in 2018. Overall, the TPNwas administered bya PICC in 21 out of
22 patients in 2017 and 39 out of 41 patients in 2018. Regarding
complications, in 2017 PICC’s had to be replaced five times (24%)
because of infection or mechanical complications, which increased in
2018 to 62%. However, most patients did not need a replacement, 86%
in 2017 and 61% in 2018. Patientswith fistulas hadmost problemswith
catheter because of infection.
Conclusions: The multidisciplinary coordination and monitoring by
the Nutrition Support Team of a case-mix of patients with mostly
short-termTPNat home, is increasing. Using a PICC instead of a CVC for
administering TPN might decrease complications, however more
research is needed.
Disclosure of Interest: None declared.
MON-PO570
ACCURACY OF THE CONEX AS A NEW METHOD TO ESTIMATE
NASOGASTRIC TUBE INSERTION LENGTH TO IMPROVE PATIENT
SAFETY: A PROSPECTIVE OBSERVATIONAL TRIAL
T. Torsy1*, R. Saman2, K. Boeykens2, I. Duysburgh2, D. Beeckman3.
1Odisee University College, 2AZ Nikolaas, Sint-Niklaas, 3Ghent University,
Ghent, Belgium
* Corresponding author.
Rationale:Misplacement of a nasogastric (NG) tube compromises safe
administration of nutrients and increases the risk of pulmonary
aspiration. Despite being commonly used, the nose-earlobe-xiphoid
(NEX) distance is inadequate in predicting the required NG tube
length[1] and is even not evidence-based. A recently RCT[2] demon-
strated that in >20% of all patients NEX distance underestimated NG
insertion length. Primary aim was to test an alternative approach, the
‘correction of the NEX’ (CoNEX) method, in predicting correct tip
positioning: (NEX*0.38696)+30.37+6 cm. Secondary aim was to
investigate the likelihood to successfully obtain gastric aspirate.
Methods: A 7-month prospective trial was conducted in a Belgian
general hospital. NG tubes were inserted/repositioned by a CNS
according to a standardized protocol. Tip positioning was verified by 2
radiologists using chest X-ray. Adult patients needing a tube were
included (N = 218). Correct tip positioning was defined as >3 cm under
the lower esophageal sphincter (LES).
Results: Predicting the required NG tube length using the CoNEX
method resulted in the tip of the NG tube situated >3 cm under the LES
in all patients. The depth of the tube tip in the stomach was not a
determining factor for a possible upward loop of the tube inside the
stomach.Within 2 hours after placement/reposition, it was possible to
successfully obtain gastric aspirate in 77.9% of all tubes.
Conclusions: Of all known methods to determine an adequate NG
tube insertion length, the CoNEX method seems to be the most
accurate method for correct gastric tip positioning (>3 cm under LES).
Also, the success of obtaining gastric aspirate is at least equal to that of
other methods.
References
1. Taylor SJ, Allan K, McWilliam H, Toher D. The ‘NEX’ guideline is
incorrect. Br J Nurs 2014;23:641–644.
2. Torsy T, Saman R, Boeykens K, Duysburgh I, Van Damme N,
Beeckman D. Comparison of Two Methods for Estimating the Tip
Position of a Nasogastric Feeding Tube: A Randomized Controlled
Trial. Nutr Clin Pract 2018;33:843–850.
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MON-PO571
FROM COMPOUND TO ‘READY TO USE’- PARENTERAL NUTRITION
BAGS USE IN A TERTIARY MEDICAL CENTER: AN OBSERVATIONAL
STUDY
Z. Baras1*, M. Theilla2, P. Singer3. 1General Pharmacy, Rabin Medical
Center, Beilinson Hospital, Petach Tikva, 2Nursing Department, Steyer
School of Health Professions, Sackler School of Medicine, Tel Aviv
University, Tel Aviv, 3Department of General Intensive Care and Institute
for Nutrition Research, RabinMedical Center, BeilinsonHospital, Affiliated
to the Sackler School of Medicine, Tel Aviv University, Petah Tikva, Israel
* Corresponding author.
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Rationale: Providing compounded PN bags has been preferred for
many years but a restriction in pharmacist manpower induced a re-
evaluation of the distribution of parenteral nutrition (PN) bags
according to requirement. In addition, these bags had a limited
expiry date, and may not be applicable in case of patient’s change in
condition. Moreover, compounded PN bags are 50%>80% more
expensive than the equivalent industrial ones. The access to more
‘ready to use’ industrial formulas covering most of the needs of a
tertiary hospital induced a change in strategy. This study follows the
use of compound vs ‘ready to use’ bags during the period of transition.
Methods: All the PN bags ordered by the Medical Nutrition Therapy
team were noted from 2012 to 2018 for type of PN: peripheral or
central use, compound bags purchased by the pharmacy, use of
different types of ready to use bags including small volume and
electrolyte free bags. The pharmacy was asked to comply with special
orders including addition of specific electrolytes to the electrolyte free
solutions, use of partial volumes, omission of compartment such as
lipids. Number of bags per year were compared using unpaired T test.
Table
Personalized vs Ready-to-Use.
Year Compounded Ready
to use
EF
2012 288 0
2013 586 0
2014 14 325
2015 2 520
2016 0 279
2017 0 425
2018 0 562
Results: Personalized compounded bags were ordered 288 times in
2012, 586 times in 2013 and 14 times in 2014, reaching only 2 orders in
2015. Electrolyte free PN were ordered 55 in 2012, 37 in 2013, but 325
in 2014 and 520 in 2016 and 279 in 2016, 425 in 2017 and 562 times in
2018. Electrolyte modifications were performed according to patient’s
needs in 90% of the electrolyte free bags in the Internal Medicine
wards, 79% surgical units, 75% oncology and 46% ICU. Omega 3 lipid
(Omegaven) supplementation decreased from 468 to 136 times in
2013 and 0 in 2016. Glutamine decreased from164 in 2013 to 0 in 2014.
Ready to use omega 3 enriched formulas increased from 3% in 2012 to
47% in 2018 (p < 0.05), in relation to all the PN distributed. Patient
receiving PN increased from 334/year to 395/ year in 2018. Mean
duration of treatment remained stable ranging between 11.2 and 14.2
days during this period.
Conclusions: Transition between compounding and ‘ready to use’
PN bags is feasible within a year when using electrolyte free ready to
use bags. An increase in omega-3 fatty acid enriched formulas due to
new approved indications was observed together with a decrease in
prescription of Omegaven.
Disclosure of Interest: None declared.
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COMPARISON OF IMPACT OF TWO BARIATRIC SURGERIES ON RISK
FACTORS FOR CARDIOVASCULAR DISEASES
M. Stankiewicz1, S.Malgorzewicz1,M. Pieszko1*, L. Kaska2,M. Proczko2,
J. Bigda2, P.W. Ludian1. 1Department of Clinical Nutrition, 2Department of
General, Endocrine and Transplant Surgery, Medical University of Gdańsk,
Gdańsk, Poland
* Corresponding author.
Rationale: Obesity is an epidemic of the 21st century. Diseases
associated with obesity increase both mortality rate among the
patients with morbid obesity and socioeconomic costs for the whole
society (treatment, annuity, long term sick leave). Obesity concerns
both young and adult parts of society. Treatment based on diet and
physical activity is not efficient in case of morbid obesity
Methods: This research was about to compare the impact of two types
bariatric procedures, Sleeve Gastrectomy (SG) and Gastric Bypass (GB),
on parameters that may reduce cardiovascular risk. Test results before
surgery and 3, 6, 12 months after surgery were taken into account.
Changes in glycosylated hemoglobin, fasting glucose and insulin, total
cholesterol, LDL cholesterol andHDL cholesterolwere compared. Apart
from biochemical changes, changes in weight composition were
analyzed, such as fat-free and fat body mass and water content in
the body. The study group consisted of 39 people, including 23 people
after laparoscopic SG and 16 people after laparoscopic GB.
Results: After 12 months, the patients lost on average 29.0% of their
initial body weight after SG and 30.1% after GB. There was also a
decrease in fat body mass, lean body mass and muscle mass in both
groups. The differences were statistically significant in such para-
meters as HbA1C, fasting glucose, LDL cholesterol, HDL cholesterol and
insulin after SG surgery. After GB statistically significant changes were
observed in HbA1c, fasting glucose, total cholesterol and LDL
cholesterol.
Conclusions: Bariatric surgery is an effective treatment for obesity.
After 12 months of surgery, most of the metabolic parameters in both
groups were improved. SG and GB treatments reduce the cardiovas-
cular risk one year after surgery, however more research is needed to
assess the long-term benefits of bariatric surgery.
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THE ROLE OF FTO GENOTYPE IN THE ASSOCIATION BETWEEN FTO
GENE EXPRESSION AND ANTHROPOMETRIC MEASURES IN OBESE
AND OVERWEIGHT ADOLESCENT BOYS.
S. Doaei1, M. Gholamalizadeh2*. 1Research Center of Health and
Environment, 1Research Center of Health and Environment, Guilan
University of Medical Sciences, Rasht, Iran, Rasht, 2Cancer Research
Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.,
Tehran, Iran, Islamic Republic of
* Corresponding author.
Rationale: The role of FTO genotype in the effect of FTO gene
expression level on change in body mass index and body composition
has not been studied. This study aimed to investigate the role of FTO
genotype in the association between change in the expression level of
the FTO genewith changes in anthropometric measurements in obese
and overweight adolescent boys
Methods: Eighty-four boys aged 12–16 years participated in this
longitudinal study. A bioimpedance analyzer (BIA) was used to
estimate percentage of body fat (%body fat) and percentage of skeletal
muscle (%skeletal muscle). The FTO gene expression level in peripheral
bloodmononuclear cells (PBMCs)was assessed using quantitative Real
Time PCR (qPCR). The DNA samples were genotyped for the FTO gene
polymorphisms by DNA sequencing. All measurements were per-
formed at baseline and after intervention
Results: A significant association was observed between the level of
gene expression and %skeletal muscle. The gene expression fold
changewas significantly associatedwith change in %skeletal muscle in
AAor AG genotype carriers (β = 0.34, p = .02). No significant association
was detected between the change in FTO gene expressionwith change
in anthropometric indices in GG genotype carriers.
Conclusions: A significant associationwas observed between the level
of gene expression and %skeletal muscle. The gene expression fold
changewas significantly associatedwith change in %skeletal muscle in
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AAor AG genotype carriers (β = 0.34, p = .02). No significant association
was detected between the change in FTO gene expressionwith change
in anthropometric indices in GG genotype carriers.
Disclosure of Interest: None declared.
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12-WEEK KETOGENIC DIET IN OBESE
N. Mohorko1*, M. Černelič-Bizjak1, T. Poklar-vatovec1, G. Grom1,
S. Kenig1, A. Petelin1, Z. Jenko-Pražnikar1. 1University of Primorska,
Faculty of Health Sciences, Izola, Slovenia
* Corresponding author.
Rationale: Ketogenic diet (KD) is widely promoted in public but has
little attention inmedical circleswhere a lot of scepticism is present on
its behalf with fear of causing ketoacidosis and dyslipidaemia.
However, in ketosis physiologic milieu differs from the one in
carbohydrate-rich diet. To avoid miscommunication based on unsci-
entific beliefs, evaluation of patients’ strategies for losing weight is
extremely important. Our aim was to evaluate the impact of 12-week
KD (12KD) on physiological and psychological parameters of obese
adults.
Methods: 35 sedentary obese participants (BMI: 36.1 ± 5.6 kg/m2;
37 ± 7 years) completed 12KD. Eating behaviour, body mass and body
composition, resting metabolic rate, aerobic and anaerobic capabil-
ities, fasting biochemical and endocrine parameters and cognitive
functions were measured at baseline and at the end of weeks 1, 2, 4, 8
and 12.
Results: We observed decreased appetite, spontaneous lowering of
energy intake, significant loss of body mass, decreased emotional and
external eating, improved physical performance and increased body
image satisfaction. Transiently, a significant drop in glucose and
significant increases in LDL-cholesterol, CRP, and BDNF were observed
in the first twoweeks; then, all listed parameters returned to baseline.
On the other hand, a significant reduction in insulin and leptin levels,
and a significant increase in adiponectin and NPY were detected
throughout the duration of 12KD. Changes in body mass, glucose,
insulin, leptin and NPY significantly negatively correlated with
changes in beta-hydroxybutyrate. Therewere no signs of ketoacidosis.
Conclusions: 12KD proved beneficial on body mass loss, physical
performance, cognitive function, eating behaviour and metabolic
profile. Due to omission of large amounts of food groups, micronu-
trient intake should be further evaluated.
Disclosure of Interest: N. Mohorko: None declared, M. Černelič-
Bizjak: None declared, T. Poklar-vatovec: None declared, G. Grom
Other: LCHF coach – no access to analysis nor interpretation of results,
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MON-PO575
PREVALENCE AND DETERMINANTS OF DEPRESSION AND
PSYCHIATRIC DISORDERS AMONG THAI OBESE PATIENTS
K. Patee1, W. Saengphatrachai1, P. Pariwatcharakul1, P. Pramyothin1*.
1Mahidol University, Bangkok, Thailand
* Corresponding author.
Rationale: People living with obesity (PwO) have higher risk of
chronic physical and mental illness such as depression, stress, and
anxiety. Depression is reported to be associatedwith poor outcomes of
obesity treatment. This study was carried out to investigate the
prevalence and determinants of depression in Thai PwO.
Methods: This cross-sectional study enrolled PwO (BMI>23 kg/m2)
from an outpatient clinic at an academic medical center in Bangkok,
Thailand from 2016 to 2018. Obesity treatments included bariatric
surgery and non-surgical treatment. Psychiatric disorder and depres-
sion was assessed by the Thai General Health Questionnaire-12 (Thai
GHQ-12 with score ≥2 indicated possible psychiatric problems), and
the Patient Health Questionnaire-9 (PHQ-9 with score ≥10 indicates
possible depression). All subjects underwent a standardized clinical
evaluation with questionnaires and a psychiatric referral when
needed.
Results: Among 227 patients (aged 44 ± 13.9, 64.8% female, BMI
36.8 ± 8.1) enrolled, the prevalence of depressive symptoms was 17.2%
(95% CI 0.13–0.24) as defined by PHQ-9 (higher than normal Thai
population 2.7%) and 29.7% (95% CI 0.24–0.37) when defined by Thai
GHQ-12 screening tools. Seventy-nine (34.6%) patients screened
positive for either depression or psychiatric problems, and 27 (11.9%)
screened positive with both tests. Two patients had severe depressive
symptoms requiring psychiatrist referral. Thai GHQ-12 and PHQ-9
scores did not differ significantly in terms of BMI, age, sex, education,
marital status, comorbidity diseases, Edmonton Obesity Staging
System (EOSS) stage and bariatric surgery (p > 0.05).
Conclusions: Compared with previous studies, we showed that the
prevalence of depressive symptoms and mental health problems in
PwO was higher than the normal Thai population. No significant
predictors for depression or psychiatric disorder was identified in this
population.
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RS9930506 FTOGENE POLYMORPHISMANDOBESITY RISK: AMETA-
ANALYSIS
S. Doaei1*, M. Gholamalizadeh2. 1Research Center of Health and
Environment, Guilan University of Medical Sciences, Rasht, Iran, Rasht,
2Cancer Research Center (CRC), Shahid Beheshti University of Medical
Sciences, Tehran, Iran., Tehran, Iran, Islamic Republic of
* Corresponding author.
Rationale: Obesity is related to variations in the fat mass and an
obesity associated gene (FTO); however, as the number of reports in
different populations increases, there is a need to determine more
precisely the effect sizes in each population group. This meta-analysis
aimed to investigate the association of the rs9930506 FTO gene
polymorphism and obesity.
Methods: We searched PubMed, MEDLINE, and Web of Science, to
identify studies investigating the associations between the rs9930506
polymorphism and obesity risk. We pooled adjusted odds ratios (OR)
as overall and in continent subgroup. Summary ORs were estimated
using a random effects model.
Results: We identified 8 eligible case-control studies, investigating
3337 obesity cases and 3159 healthy controls. Considering the
dominant model of inheritance, there was an association between
the polymorphism and obesity (OR 1.34 [1.03–1.74]). The association
remained significant in European subgroup (OR 1.68 [1.2–2.36]), but
not in Asian subgroup. We also found a significant association when
the model of inheritance was recessive (OR 2.47; 95% CI 1.56–3.91).
Conclusions: This study suggested that the carrier of rs9930506
polymorphism of FTO are at higher risk for obesity. Individual studies
with large sample size are needed to further evaluate the associations
between the FTO gene polymorphisms and obesity risk in various
ethnic populations
Disclosure of Interest: None declared.
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THE BODY COMPOSITION CHANGE OF OBESE TETRAPLEGIC
PATIENTS AFTER SHORT-TERM REHABILITATION
S. Im1*, J.C. Shin1, E.Y. Han2, K.H. Cho3, M.C. Ha1. 1Department and
Rearch Institute of Rehabilitation Medicine, Yonsei Rehabilitation
Hospital, Seoul, 2Department of Rehabilitation, Jeju National University
Hospital, Jeju, 3Department of Rehabilitation, Kumi CHA Hospital, Kumi,
Korea, Republic of
* Corresponding author.
Rationale: The prevalence of obesity among spinal cord injury (SCI)
individuals has been reported to be very high as 40–66% across studies
and it is related with incresing risks of disorders of carbohydrate
metabolism and coronary artery disease. Therefore, this study aims to
reveal the change of body composition in the obese tetraplegic
patients following short-term rehabilitation treatment.
Methods: The medical charts of SCI patients who were admitted to
tertiary university hospital for rehabilitation treatment from 2016 to
2017 were reviewed. Only the patients with A and B by ASIA
Impairment Scale and with available records of initial and follow-up
body weight and body composition analysis by bioelectrical imped-
ance were included.
In our institution, short-term rehabilitation consists of appropriate
nutritional support, physical therapy including passive or active
exercise, respiratory muscle training, and neuromuscular electrical
stimulation lasting 6–8 weeks.
Obesity was defined as body mass index (BMI)≥ 22 kg/m2 or body fat
mass > 25% for male and > 35% for female.
The prevalence of obesity and body composition change in obese
patients after short-term rehabilitation were analyzed.
Results: Total 36 tetraplegia patients were included. The average age
was 44.0 years old, the majority of participants were male (97.2%) and
ASIA A (68.4%). Twenty-three patients (63.9%) were classified as obese
in accordance with aforementioned definition of obesity (Table 1).
After short-term rehabilitation, absolute fat mass (kg), fat percentage
and fat mass index (kg/m2) were significantly reduced (p < 0.05). On
the other hand, body weight and BMI tended to decrease. Absolute
skeletal muscle mass (kg) and skeletal muscle percentage tended to
increase (Table 2).
Conclusions: The percentage of obesity was consistently high in
tetraplegic patients. Through short-term rehabilitation, obesity can be
managed effectively without any loss of skeletal muscle mass, even in
the tetraplegic patient with ASAI A and B, who have severe disability in
theirmotor function. These results imply thatmodifiable obesity in SCI
patients need to be identified depending on their metabolic demand
in relation to physical condition and intensity of rehabilitation therapy
for proper management. Further studies with more patients with
various features of SCI (level, severity and chronicity) are necessary in
order to establish effective management of obesity in SCI patients.
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THE BODY COMPOSITION CHANGE OF OBESE TETRAPLEGIC
PATIENTS AFTER SHORT-TERM REHABILITATION
S. Im1*, J.C. Shin1, E.Y. Han2, K.H. Cho3, M.C. Ha1. 1Department and
Research Institute of Rehabilitation Medicine, Yonsei Rehabilitation
Hospital, Seoul, 2Department of Rehabilitation Medicine, Jeju National
University Hospital, Jeju, 3Department of Rehabilitation Medicine, Kumi
CHA Hospital, Kumi, Korea, Republic of
* Corresponding author.
Rationale: The prevalence of obesity among SCI individuals has been
reported to be very high as 40–66% across studies and the obesity is
relatedwith increasing risks of carbohydratemetabolism disorder and
coronaryartery disease. Therefore, this studyaims to reveal the change
of body composition in the obese tetraplegic patients following short-
term rehabilitation treatment.
Methods: The medical charts of SCI patients who were admitted to
tertiary university hospital for rehabilitation treatment from 2016
to 2017 were reviewed. Only the patients with A and B by ASIA
Impairment Scale and with available records of initial and follow-up
body weight and body composition analysis by bioelectrical imped-
ance were included.
In our institution, short-term rehabilitation consists of appropriate
nutritional support, physical therapy including passive or active
exercise, respiratory muscle training, and neuromuscular electrical
stimulation lasting 6–8 weeks.
Obesity was defined as body mass index (BMI)≥ 22 kg/m2 or body fat
mass > 25% for male and > 35% for female.
The prevalence of obesity and body composition change in obese
patients after short-term rehabilitation were analyzed.
Results: Total 36 tetraplegia patients were included. The average age
was 44.0 years old, the majority of participants were male (97.2%) and
ASIA A (68.4%). Twenty-three patients (63.9%) were classified as obese
in accordance with aforementioned definition of obesity (Table 1).
After short-term rehabilitation, absolute fat mass (kg), fat percentage
and fat mass index (kg/m2) were significantly reduced (p < 0.05). On
the other hand, body weight and BMI tended to decrease. Absolute
skeletal muscle mass (kg) and skeletal muscle percentage tended to
increase (Table 2).
Conclusions: The percentage of obesity was consistently high in
tetraplegic patients. Through short-term rehabilitation, obesity can be
managed effectively without any loss of skeletal muscle mass, even in
the tetraplegic patient with ASAI A and B, who have severe disability in
theirmotor function. These results imply thatmodifiable obesity in SCI
patients need to be identified depending on their metabolic demand
in relation to physical condition and intensity of rehabilitation therapy
for proper management. Further studies with more patients with
various features of SCI (level, severity and chronicity) are necessary in
order to establish effective management of obesity in SCI patients.
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ASSOCIATION OF OBESITY AND AGE-RELATED MACULAR
DEGENERATION IN TURKISH POPULATION
S. Arslan1*, S. Kadayıfçılar2, F.G. Samur3. 1Nutrition and Dietetics,
Kastamonu University, Kastamonu, 2Department of Ophthalmology,
3Nutrition and Dietetics, Hacettepe University, Ankara, Turkey
* Corresponding author.
Rationale: The aim of this study was to establish the prevalence and
association of age-related macular degeneration (AMD) and obesity
which was not studied in Turkish population over 50 years of age.
Methods: A total of 200 (100 study group, 100 control group) patients
with gradable fundus photography were included. All patients
underwent detailed ophthalmic examination and AMD was graded
with retinal photographs. Grading of AMD was done according to the
International ARM Epidemiological Study Group and staged based on
grading in worse eye. The association of AMD severity and obesity
(based on body mass index, waist-hip ratio, waist circumference) was
assessed. The main outcome variable was an association between the
presence and severity of AMD with different grades of obesity.
Results:When individuals were evaluated according to BMI averages;
BMI average of case group was found to be significantly high,
compared with control group (p < 0.001). When waist circumference
averages of control group were analyzed, they were found to be
significantly high between the men, compared with case group
(p < 0.05).Whenwaist/hip circumference ratewas analyzed; therewas
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no statistically significant difference between the groups (p > 0.05).
While the mean BMI was 30.4 ± 4.9 in women and 27.8 ± 2.9 in men in
case group, it was found to be 29.1 ± 4.8 in women and 26.9 ± 3.3 in
men in control group. There was statistically significant difference in
terms of BMI means between control and case groups (p < 0.05).
Conclusions:We found direct assosication between BMI and presence
of AMD in Turkish population. No direct association was noted
between the presence or severity of AMD and waist/hip rate. Further
studies are necessary in order to conclude a causal association AMD
development and abdominal obesity.
Disclosure of Interest: None declared.
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DO INTENSIVE PREOPERATIVE AND POSTOPERATIVE BEHAVIOURAL
INTERVENTIONS IMPACTONHEALTH-RELATEDBARIATRIC SURGERY
OUTCOMES? A SYSTEMATIC REVIEW
S. Marshall1*, H. Mackay2, G. Rich3, E. Isenring1. 1Bond University
Nutrition and Dietetics Research Group, Faculty of Health Sciences and
Medicine, Bond University, Robina, 2Nutrition and Dietetics, Mater
Misericordiae Limited, Brisbane, 3Gastroenterology, Bariatrics Australia,
Sydney, Australia
* Corresponding author.
Rationale: Although pre- and postoperative support by a multidiscip-
linary team (MDT) is recommended as best practice, it is unknown if
intensive behavioural interventions improve outcomes beyond stand-
ard MDT support. This systematic review aimed to evaluate the effect
that intensive pre- and postoperative behavioural interventions have
on health-related outcomes post-surgery in adult bariatric surgery
patients.
Methods: Six databases were searched for intervention studies in any
language up until July 2018. Study quality was assessed using the
Cochrane Risk of Bias tool.
Results: 6,871 records were screened, identifying 17 eligible publica-
tions (n = 10 trials; n = 1,169 participants in total) which mostly had
low to unclear risk of bias. Intensive behavioural interventions
addressed lifestyle (n = 4 trials), physical activity (n = 3 trials), or
cognitive behavioural therapy (n = 3 trial); which were delivered as
preoperative interventions (n = 3 trials), postoperative interventions
(n = 2 trials), or pre- and postoperative intervention (n = 5 trials).
Intensive interventions varied from weekly to quarterly in frequency,
with a duration from 6-weeks to 24-months. No trial which concluded
intervention delivery before 6-months post-surgery reported any
effect compared with control (n = 6 trials). All six trials which
commenced or continued MDT delivery 6-months post-surgery
reported significant improvements in weight and/or fat loss (n = 4
trials) and depression (n = 1 trial) compared with control.
Conclusions: For the best outcomes and most efficacious use of
resources, intensive multidisciplinary behavioural interventions may
be of the greatest value if they commence 6-months postoperatively;
with standard multidisciplinary support provided pre- and early
postoperatively.
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FIBER CONSUMPTION AND TIME POST SURGERY MAY PREDICT
WEIGHT REGAIN AMONG WOMEN IN THE LATE POSTOPERATIVE
PERIOD OF Y-EN-ROUX GASTRIC BYPASS
M.F. Reichmann1, S. Todeschini2*, N. Setter2, R.M. Vilela1,
R. Radominski1, A.C. Campos1. 1Universidade Federal do Paraná,
2universidade Federal do Parana, Curitiba, Brazil
* Corresponding author.
Rationale: Bariatric Surgery is a successfull treatment against obesity.
Y-en-Roux gastric bypass (YRGB) provides great weight loss, but over
the years, a common weight regain has been noticed among these
patients. Thereby, the aim of this study is find out what could be
impacting onweight regain amongwomen in the late postoperative of
YRGB.
Methods: In the period of March to September 2017, the whole
population (n = 340) of two out-patient departments of the Complexo
Hospital de Clínicas of the Universidade Federal do Paraná was
considered following inclusion criteria. The analyses carried out
were: hospital records, 24 h food record, 3-days food record,
anthropometric evaluation and physical activity questionnaire. A
multiple linear regression was used to predict weight regain, based
on fiber intake (FI), time post surgery (TS) and Physical activity (PA)
with the GraphPad Prism® software with a 95% significance level.
Results: 57 participants were the final sample, with a mean age of 47
years. Most of the participants were obese with a mean weight regain
percentage of 19%. Participants`weight regain percentage decrease
48,62% for each gram per kiloweight of fiber intake, and increase 2,15%
for each time post surgery (p = 0,0252 and p = 0,0016).
Conclusions: Fiber intake and time post surgey directly impact on
weight regain amongwomen in the late postoperative period of YRGB.
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EFFECT OF HIGH INTENSITY PRACTICE ON THE BODY COMPOSITION
TO HIGH-CARBOHYDRATE DIET IN JAPANESE SUMOWRESTLING
T. Sato1*, M. Nakajima1, Y. Takeishi2. 1Jissen Women’s University, Tokyo,
2Kyushu Institute of Information Science, Fukuoka, Japan
* Corresponding author.
Rationale: The obese observations suggest that the efficiency of
metabolism changes in response to the level of nutrition such as to
provide a long-term control of energy balance that is additional to any
control of energy intake. Furthermore, there are largely advantageous
to increase the bodyweight by eating high-carbohydrate diet in Sumo.
However, there were not enough data between obese and body
composition in Japanese Sumo wrestling. The purpose of this study
was to investigate of the body compositionwith high intensity practice
in Sumo students.
Methods: Twenty five top level male Sumo wrestling player as
volunteer who belong to college Sumo association in Japan (mean
±SD; age:21.04 ± 0.98; height 174.0 ± 0.06 cm; weight 116.52 ± 24.28
kg; BMI 38.31 ± 7.45 kg/m2) participated in this study. They are well
known to eat rice cooking quite much more, high-carbohydrate diet
traditionally. It was performed examination of body composition. The
body composition was measured using the impedance with multi
frequency and reactance (Physion MD, Japan). After collecting the
impedance data, it was calculated muscle mass, individual part of
muscle mass and body water mass.
Results: It was assume were no subject normal range in BMI. Almost
subject were over 35 of BMI, obese conditions. However, there were
more muscle mass than body fat (Table 1).
Table 1
Result of Body Composition.
N = 25 Average S.D
BMI 38.3 6.7
% Mucle Mass 37.3 4.9
% Fat Mass 28.0 6.0
% Lean Fat Mass 72.9 6.3
Conclusions: Consequently, high carbo loading is used by Sumo
wrestling on a daily basis due to competition properties for more gain
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in weight. Therefore, the judgment result of BMI is showed over obese
class II according to Japanese setting data. However, all subjects were
within the reference values in both groups in cholesterol (Nakajima,
et al, 2018). This study would suggest that BMI was not mean obesity
conditions, it was necessary measurement body composition, espe-
cially recorded muscle mass and lean fat mass.
Reference
1. Nakajima Mizuki, Sato Takeshi, Takeishi Yousuke, 2018, Effect of
daily short term and high intensity training to the metabolic
function in college sport student, Integrative food, Nutrition and
Metabolism, Vol5(3), pp. 1–4.
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ANALYSIS OF RELATIONSHIP BETWEEN BLOOD EXAMINATION AND
BODY COMPOSITION IN OVER 35 OF BMI
Y. Takeishi1*, M. Nakajima2, T. Sato2. 1Kyushu Institute of Information
Science, Fukuoka, 2Jissen Women’s University, Tokyo, Japan
* Corresponding author.
Rationale: In the long term, exercise trainingmay result in an increase
of muscle mass, the largest component of fat-free mass of the body.
Generically, there is a greater thermic response when Japanese Sumo
wrestling students are to wish more weight for their competition
ability due to regular basis of overfeeding. Furthermore, there are
largely advantageous to increase the body weight by eating high-
carbohydrate diet in Sumo. However, there were not enough data
between obese and body composition in Sumowrestling. The purpose
of this study was to investigate relationship between the body
composition with high intensity practice in Sumo and blood test.
Methods: 25 top level male Sumo wrestling player as volunteer
participated in this study. It was performed examination of body
composition. The body composition was measured using the imped-
ance with multi frequency and reactance. After collecting the
impedance data, it was calculated % of muscle mass, fat mass and
lean body fat. Moreover, it was collected the blood examination. All
measurement itemswere calculated correlation coefficient each other.
Results: Table 1.
Table 1
Correlation coefficient of typical measurement items.
ALT
(GPT)
(IU/L)
γ-
GTP
(IU/L)
Total
Protein
(g/dL)
CHOL
(mg/
dL)
Glycoalbumin
(%)
Muscle
Mass
(%)
Fat
Mass
(%)
Lean
body
mass
(%)
ALT (GPT) (IU/L) 0.50 0.56 0.17 0.11 −0.25 0.24 −0.35
γ-GTP (IU/L) 0.50 0.28 0.15 −0.07 −0.31 0.25 −0.25
Total Protein
(g/dL)
0.56 0.28 0.46 −0.03 −0.23 0.32 −0.21
CHOL (mg/dL) 0.17 0.15 0.46 −0.24 −0.43 0.42 −0.14
Glycoalbumin
(%)
0.11 −0.07 −0.03 −0.24 0.37 −0.33 0.10
Muscle Mass (%) −0.25 −0.31 −0.23 −0.43 0.37 −0.80 0.43
Fat Mass (%) 0.24 0.25 0.32 0.42 −0.33 −0.80 −0.66
Lean body
mass (%)
−0.35 −0.25 −0.21 −0.14 0.10 0.43 −0.66
Conclusions:We performed anthropometric and RMRmeasurements
on college Sumo students. The level of obesity was assessed using BMI
and %Fat as reference indices. All of the Sumo wrestlers were
categorized as obese using the conventional WHO criteria based on
the BMI. Due to their heavy lean body mass, Sumo wrestlers can be
misclassified as obese in both body composition (Ozeki) and blood test
(Nakajima).
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LONG-TERM OUTCOME OF LAPAROSCOPIC SLEEVE GASTRECTOMY
FOR CHINESE SUPER OBESE PATIENTS
Z. Li1*, W. Kang1, J. Yu1, Z. Ma1. 1Department of General Surgery, Peking
Union Medical College Hospital, Chinese Academy of Medical Sciences
and Peking Union Medical College, Beijing, China
* Corresponding author.
Rationale: Laparoscopic sleeve gastrectomy (LSG) is an effective
stand-alone bariatric procedure with favorable results on weight loss
and comorbidity resolution. However, data concerning the long-term
efficacy of LSG in the treatment of super obesity (SO, body mass index
[BMI]≥5 0) remain scarce. We aimed to evaluate the effectiveness and
safety of LSG onweight loss and obesity-associated co-morbidities for
Chinese SO patients.
Methods: Using the Bariatric Outcomes Longitudinal Database of
Peking Union Medical College Hospital from August 2012 to August
2015, a total of 115 obese patients (70 females) underwent LSG by a
single surgeonwere enrolled. Patientswere followed up after 1, 3, 6,12,
18, and 24 months and yearly thereafter. Medium-term outcome
measures were: excess weight loss (%EWL), co-morbidities improve-
ment, and complications.
Results: 38 SO patients (33.0%) met the inclusion criteria, comprising
22 men (BMI 53.5 ± 5.7 kg/m2) and 16 women (BMI 52.2 ± 5.3 kg/m2).
The common co-morbidities were liver function damage (53.3%),
dyslipidemia (52.0%), Obstructive sleep apnea (45.3%), type 2 diabetes
(38.7%), arterial hypertension (37.3%). The rate of co-morbidities
improvement was 75.0%, 58.3%, 83.3%, 75.0% and 58.3% at 3 years after
surgery, and there were no differences in co-morbidity resolution
status between SO and nonsuper-obese patients. The mean yearly %
EWL to postoperative year 3 was 56.4% (year 1), 60.6% (year 2), 58.1%
(year 3), respectively, which all were significantly lower than in the 77
nonsuper-obese patients, 76.6% (year 1), 75.9% (year 2), 74.7% (year 3).
The proportion of patients having successful weight loss was 57.9%
(n = 22) postoperative year 1 according the definition of %EWL > 50%,
lower than 81.7% in the nonsuper-obesity. Early severe complications
(Clavien-Dindo classification > II) occurred in 2.6% of patients and no
difference from the averagewas found. There were 2 reoperations due
toweight again and no deaths. Eleven of 38 patients experienced new-
onset gastroesophageal reflux, which could be relieved by acid
suppressants.
Conclusions: Conclusions LSG is effective in co-morbidities improve-
ment and is safe for Chinese SO patients, while weight loss outcomes
were less favorable, and further research is required.
Disclosure of Interest: None declared.
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ASSOCIATIONS OF CARDIOVASCULAR AND ALL-CAUSE MORTALITY
WITH METABOLIC SYNDROME IN HEMODIALYSIS PATIENTS
Z.M. Dimitrijevic1*, A. Jovanovic1, T. Vrecic1, J. Randjelovic1,
M. Cvetkovic1, B. Mitic1. 1Nephrology Clinic, Clinical Center, NIS, Serbia
* Corresponding author.
Rationale: Metabolic syndrome (MetS) is a clustering of risk factors,
such as abdominal obesity, insulin resistance, dyslipidemia and
hypertension that together increase the risk of cardiovascular diseases.
Chronic hemodialysis (HD) patients have multiple comorbidities and
many metabolic disorders, causing a frequent occurrence of metabolic
syndrome in this population. Besides, metabolic syndrome itself
increases the risk of cardiovascular diseases. The goal of this studywas
to assess the prevalence ofMetS inHDpatients and its associationwith
all-cause and cardiovascular disease (CVD) mortality.
Methods: A total of 138 HD patients were included in the prospective
analysis. We analyzed demographic, anthropometric and biochemical
data. Outcome measures were all-cause and CVDmortality during the
three years follow-up.
Results:MetSwas diagnosed in 57,24% of enrolled patients. During the
36 months of follow-up, 33 patients died. MetS patients showed a
significantly higher mortality rate than non-MetS (30,4%vs.16,36%;
p < 0,001). The association of the different MetS components with all-
cause mortality reached significance when minimally three compo-
nents were present [1,81(95%CI = 1,21–2,33)], with a grouped increase
in effect size for subjects with four or five MetS components. Subjects
with MetS exhibited nearly twice as high risk for all-cause [HR = 1,90
(95%CI) = 1,25–2,83] and CV [HR = 1,99 (95%CI) = 1,42–2,97] mortality
compared with those without MetS after adjustment for age, gender,
and cardiovascular disease.
Conclusions: Our study demonstrated that MetS is widespread in HD
patients. The focus must be on an active screening approach and
treatment of cardiometabolic risk factors aiming to reduce mortality.
Disclosure of Interest: None declared.
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GASTRIC RESIDUAL VOLUME TO GUIDE ENTERAL FEEDING IN UK
PICUS AND NEONATAL UNITS
L.N. Tume1*, F.V. Valla2, J. Dorling3, C. Gale4, N. Pathan5, B. Arch6,
L. Latten7, I. Andrzejewska8, K. Woolfall9, A. Beissel10, E. Deja11,
L. Roper12, H. Ecclestone6. 1Faculty of Health & Applied Sciences,
University of West of England, Bristol, United Kingdom, 2PICU, Hôpital
Femme Mère Enfant, Lyon, France, 3Division of Neonatal-Perinatal
Medicine, Dalhousie University and IWK Health Centre, Halifax, Canada,
4NICU, Chelsea & Westiminister Hospital, London, 5PICU, Addenbrooke’s
Hospital, Cambridge, 6Clinical Trials Unit, University of Liverpool,
7Department Dietetics, AlderHey Children’s Hospital, Liverpool, 8NICU,
Chelsea &Westminister Hospital, London, 9Department of Health Services
Research, University of Liverpool, Liverpool, United Kingdom, 10NICU,
Hôpital Femme Mère Enfant, Lyon, France, 11Department of Health
Services Research, University of Liverpool, 12Department of Health
Services Research, Universiity of Liverpool, Liverpool, United Kingdom
* Corresponding author.
Rationale: To describe practices around gastric residual volume (GRV)
monitoring to guide feeding in UK neonatal (NNUs) and pediatric
intensive care units PICUs).
Methods: Cross-sectional e-survey of a triad of nurse, doctor and
dietician in all UK pediatric intensive care units and Neonatal units
between July – September 2018.
Results: 24/27 (89%) PICUs and 95/183 (52%) NNUs completed the
survey. 96% PICUs and 85% NNUs hadwritten guidance around enteral
feeding. Guidelines were sent by 19/24 (79%) PICUs and 28/95 (29%) of
NNUs.
For PICU continuous feeding was more frequent (15/24 62%) than
bolus (9/24 37%) via the gastric route as their primary feedingmethod.
All but one PICU routinely measured GRV, regardless of the method of
feeding. Eighteen units had an agreed definition of feed tolerance, and
all these included GRV. GRV thresholds for feed tolerance were either
volume based (ml/kg body weight) (11/21 52%) or a percentage of the
volume of feed administered (6/21 29%). Yet only a third of units
provided guidance about the technique of GRV measurement. For
NNUs almost all (94.7% 90/95) fed by bolus feed. NNUs reported
variable frequencyof GRVmeasurement frombefore every feed (20/90
22%) to only when clinically indicated (27/90 30%) and guidelines
showed most this was most commonly (10/28 35% 4–6 hourly. Some
NNUs stated they did not measure this routinely, or use GRV alone to
stop feeds. When GRV was used the amount considered ‘significant’
varied, but was usually expressed as a percentage of the feed
previously given. Decision-making around GRV was made predomin-
antly by the bedside nurse (62%) or the nurse in charge (29%).
Conclusions: Both UK PICUs and NNUs commonly use GRV to guide
enteral feeding, and determine feeding tolerance, this was more
prevalence in PICUs. This knowledge of baseline practice will assist us
in detrmining whether a trial of no routine GRV measurement is
possible in the UK. Qualitative work will now explore parent and
healthcare professional views’ around this practice and acceptability
and feasibility of a future trial.
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EVALUATION OF THE LEVEL OF NUTRITIONAL NEOPHOBIA IN
CHILDREN AGED 6–9
M. Pieszko1*, M. Gdulska1, M. Stankiewicz1, S. Małgorzewicz1. 1Medical
University of Gdańsk, Gdańsk, Poland
* Corresponding author.
Rationale: Nutritional neophobia is a general aversion to eating new
or unknown food. The occurrence of selective food is especially
common in children, and its consequence, in addition to insufficient
variation in food intake, are nutrient deficiencies.
Methods: The study involved 201 children, including 97 girls and 104
boys. The study population was divided into two age groups 6–7 years
and 8–9 years. Children’s Neophobia Scale (CFNS) questionnaire was
used. The scale was modified by adjusting the form to the age of the
population studied. The formof answers to the questionswas the child’s
reaction, which was marked on the 5-point scale depicting facial
expression. In CFNS, the response range was from 8 to 40 points. The
higher the number of points obtained, the higher the level of nutritional
neophobia. The results were developed using the Statistics version 24.
Results: Based on the obtained results, it was shown that the average
number of points obtained by the respondents was 22,33 ± 6,02. It was
observed that the highest percentage of examined children (70%) was
characterized byaverage,while 13% low level of nutritional neophobia.
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Analysis of the results on gender differences showed that boys scored
more (23,60 ± 6,35) in neophobia than girls (20,98 ± 5,36). The
difference was statistically significant (p = 0,002). It was checked
whether the level of neophobia is different in age groups. It was found
that children aged 6–7 are more often characterized by a neophobic
attitude than older children, it was not a statistically significant
difference.
Conclusions: In the study group, it was observed that the majority of
children showed an average level of nutritional neophobia. A relation-
ship between gender and neophobiawas observed. The boys achieved a
significantly higher level of neophobia. There were no statistically
significant differences between the age groups in neophobia.
Disclosure of Interest: None declared.
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CUTOFF POINTS OF ANTHROPOMETRIC AND IMPEDANCEMETRIC
PARAMETERS IN 10 TO 16 YEARS OLD GIRLS WITH METABOLIC
SYNDROME
M.M.A. Abulmeaty1*, on behalf of Research Group 1439–78,
R. Muhanna1, N. Almadani1, on behalf of KSU Research Group no
1439-78. 1Clinical Nutrition Program, Community Health Sciences, King
Saud University, Riyadh, Saudi Arabia
* Corresponding author.
Rationale: Children are at great risk of developing metabolic
syndrome (MetS) due to their unhealthy lifestyle, however, cutoff
points of the common anthropometric and impedancemetric para-
meters are still not sharply defined in 10-to16 years age group.
Methods:Across-sectional study, inwhich170childrenwere recruited
through frequent visits to schools in the western, central and eastern
regions inRiyadh city betweenAugust andDecember 2017. Theparents
signedawritten consent. ChildrenwithMetSwere identified according
to IDF criteria of MetS.1 Body weight (Wt), height (Ht) were measured
andbodymass index (BMI)was calculated (Wtkg/Ht
2
m).Waist (WC), hip
(HC) and mid arm (MAC) circumferences were taken, and skinfold
thickness at 4 sites (biceps, triceps, subscapular and abdominal) was
measured by a caliper, then they were used to calculate the percent
body fat by the Slaughter equation2 (PBF_S). Themid-armmuscle area
(MAMA) was also calculated according to Soler-Cataluña.3 Tanita BC-
418was used to determine the percentage of body fat (PBF_B), fatmass
index (FMI), fat-free mass index (FFMI), and total body water (TBW).
ROC curves were used to determine cutoff values.
Results: Table 1.
Table 1
Cutoff values of the studied parameters with their sensitivity and specificity.
Measures Sensitivity Specificity Cutoff point
BMI (kg/m2) 79% 80.4% 26.88
WC (cm) 87.5% 72.5% 81.5
HC (cm) 75% 72.5% 100.0
PBF_S (%) 62.5% 43.1% 29.94
MAMA (cm2) 75% 60.8% 25.99
PBF_B (%) 79.2% 60.8% 34.65
FMI 83.3% 60.8% 8.84
FFMI 79.2% 72.5% 16.59
TBW 70.8% 56.9% 29.25
Conclusions: Anthropometric and impedancemetric parameters were
defined in our population of this age/gender group. the values could
help in the diagnosis of MetS in this population.
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FOOD HABITS, ANTHROPOMETRIC PROFILE AND PHYSICAL (IN)
ACTIVITY IN PORTUGUESE CHILDREN
M.-R. G. Silva1,2,3*, H.-H. Silva4. 1Scientific Commission of the Gymnastics
Federation of Portugal, Lisbon, 2Research Centre for Anthropology and
Health, University of Coimbra, Coimbra, 3Faculty of Health Sciences,
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Rationale: Unhealthy food habits and physical inactivity are obeso-
genic factors that contribute to pediatric obesity. This study aims to
evaluate food and fluids intake, anthropometric profile and level of
physical activity of Portuguese children.
Methods: 223 children aged from 4 to 6 years old were included. A
questionnaire was applied to participants’ parents using a food semi-
quantitative questionnaire. Socio-demographic, clinical data and
physical activity habits were assessed. Weight, height and waist
circumference (WC) were measured according to international guide-
lines. Bodymass index was calculated. This study was approved by the
Ethical Committee of the University Fernando Pessoa and written
informed consent was obtained from all participants. Descriptive
linear regression analysis and Pearson correlation coefficients were
performed using SPSS version 25. The significance level was 5%.
Results:Most participants (52.4%) had 5 dailymeals. Milk (86%), bread
(67%), cereals (52%) and yogurt (43%) were the most consumed foods.
Soap was consumed once a da (33%). Water consumption was
significantly below the recommended (P < 0.05) and meat was far
more consumed than fish (P < 0.01). The majority of participants (76%)
reported a daily intake of 2–3 pieces of fruit and 24% consumed only 1
piece. However, 58% of the participants ate candies 2–6 times a week,
23% never ate vegetables and only 19% consumed 2–3 pieces once a
day. The favorite foods were pasta (52%) and fruit (48%); the least
preferred were vegetables (43%) and fish (14%); 39% of the children
being below the z-score for BMI, 29% presented a normal BMI, 19%
were overweight and 14% were already obese. WC varied between 46
and 62.5 cm and; 33% practiced physical exercise once aweek.Walking
(42.9%) and swimming(19.0%) were the main physical activities.
Conclusions: Precocious interventions are crucial in preventing
pediatric obesity, as well as, a varied diet and an active lifestyle.
Disclosure of Interest: None declared.
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OPERATIONAL DIAGNOSTIC ASSESSMENT OF MALNUTRITION OF
THE STRONGKIDS TOOL IN HOSPITALIZED PEDIATRIC PATIENTS
O.L. Pinzon-Espitia1,2*, J. Echeverry-Raad2, L.C. Sánchez-
Giraldo3, J.T. Mappe-Rojas3. 1Nutrición, Hospital Universitario Mayor –
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Nutrición y Dietética, Universidad Nacional de Colombia, Bogotá D.C,
Colombia
* Corresponding author.
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Rationale: The objective of this research was to validate the
STRONGkids tool by diagnosing the operational performance of
malnutrition in a highly complex health service provider specialized
in children.
Methods: Descriptive cross-sectional study, in which 300 pediatric
patients were selected consecutively over 5 weeks in October and
November 2018. Approval by the Ethics Committee of the Faculty of
Medicine of the National University of Colombia and the Research
Ethics Committee of the Fundación Hospital Pediátrico laMisericordia.
Inclusion criteriawere: Greater than 1month and less than or equal to
17 years 11 months, who have informed consent authorized by their
parents or guardians. Exclusion criteria: patientswithout admission to
hospitalization or surgery, who could not have anthropometry
performed, whowere in critical care, in resuscitation, burned patients,
patients with cerebral motor insufficiency, patients with Down’s
Syndrome or any other pathology affecting growth.
Results: Malnutrition prevalence of 3.6%. The STRONGkids tool
showed a high sensitivity and specificity (>80%) to identify malnutri-
tion according to the Weight/Size (W/A) indicator in children under 5
years old and the BMI/A indicator in patients over 5 years old, when
only the high risk level given by the questionnaire is considered in
comparison with the nutritional classification by anthropometry. A
moderate positive correlation was observed in the W/A and BMI/A
indicators with a Spearman correlation coefficient of 0.46 and 0.57 for
each indicator and according to themoderate Kappa coefficient for the
same indicators between the anthropometric classification and the
high risk classification of the questionnaire. Kappa: −0.125, EE 0.0261,
CI (95%) −0.1673 −0.0651.
Conclusions: The STRONGkids tool presents a high sensitivity and
specificity as a diagnostic criterion of malnutrition in hospitalized
patients with ‘high risk’ classification in comparison with the
anthropometric classification according to Colombian regulations.
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QUALITATIVE ANALYSIS OF SPECIFIC TRAINING NEEDS IN
PAEDIATRIC NUTRITIONAL ASSESSMENT IN CHILDREN AT
NUTRITIONAL RISK (UNDER AND OVERWEIGHT); PROCESS TO
DEVELOPING A CARE PATHWAY.
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Rationale: Recent evidence suggests that current paediatric
nutritional screening tools are unsuitable for routine use in clinical
practice [1], with none designed to identify those who are overweight
or obese [2]. In order to develop effective care pathways and screening
methods for the assessment of acutely unwell children to identify and
manage those with nutritional deficits (including overweight), we
need to better understand attitudes, behaviours, barriers and learning
needs of staff whose role includes identifying nutrition risk.
Methods: Interviews of nurses, dietitians and doctors involved in
paediatric clinical assessment were conducted in a children’s hospital.
Each interviewwas opened with the question ‘You are informed that a
child you are about to see has an abnormal BMI (underweight/
overweight) what do you then think and do?’. Interviews were
transcribed and qualitative analysis, including framework method-
ology and thematic analysis were used to identify attitudes, beha-
viours, barriers and facilitators to nutritional assessment and further
management.
Results: Qualitative analysis revealed a common thought process for
initially assessing a child’s nutritional state if identified to have an
abnormal body mass index, from presentation through to referral to a
dietitian/nutrition team. It also demonstrated that the process and
level of intervention was influenced by two key factors; a) the
perceived impact of the presenting complaint on the nutritional status,
including the potential negative implications onmental health, and b)
the potential impact on communication and relationships built with
patients and their families. Therewas general agreement that children
who are underweight are assessed differently to those who are
overweight, due to a greater concern of an underlying organic
pathology for thosewho are underweight. Barriers identified included
the severity of the acute presentation, time limits for thorough
assessment and meaningful conversations with patients and families.
Additional analysis identified absence of knowledge on how to
manage both underweight and overweight patients including simple
dietary advice for families, and a scarcity of knowledge and
information for staff regarding additional resources available for
children and families.
Conclusions: Assessment for nutritional risk, during an acute
admission is influenced by multiple factors. Understanding staff
members perceptions, current practices and training needs will
enable the development of care pathway (s), incorporating improved
knowledge, a focus on nutritional assessment and a clear nutrition
management pathway.
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MANAGEMENT AND SCREENING OF CHILDHOOD OBESITY:
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University of Limoges, 4INSERM, U1094, Tropical Neuroepidemiology,
School of Medicine of Limoges, 5Nutrition Unit, University Hospital of
Limoges, Limoges, 6Department of Pediatrics, 7Specialized center of
obesity of Aquitaine Nord, 8Network for the Prevention and
Management of Pediatric Obesity, University Hospital of Bordeaux,
Bordeaux, France
* Corresponding author.
Rationale: Obesity in children is a public health problem (3.5–4% in
France). In relation to the difficulties encountered by healthcare
professionals, the Networks for the Prevention and Management of
Pediatric Obesity (RéPPOP) are major actors in this care. The French
region Limousin does not have a RéPPOP. The purpose of our workwas
to understand and evaluate the needs and practices of General
Practitioners (GPs) and Liberal Pediatricians in our region.
Methods: A questionnairewith socio-demographic data of physicians,
their practices concerning the screening andmanagement of pediatric
obesity, as well as their difficulties and suggestions for improvement,
was sent bymail to all GPs (n = 777) and Liberal Pediatricians (n = 18) of
Limousin in April 2016. A reminder by mail was also realized.
Statistical analysis included Student t tests, ANOVA and Chi2.
Results: Two hundred and thirty-eight questionnaires were included
in the analysis (230 for GPs and 8 for Pediatricians). The GPs reported
23.2 ± 18.1% of children under 16 years old in their patient population.
GPs reported an average of 3.5%±4.8% of obese children in their patient
population, while the Pediatrics reported 4.7%±3.7%. 22% of GPs
reported having realized an additional training on childhood obesity in
the last 5 years. The GPs systematically calculated the bodymass index
in 39.3% of the cases, reported it on the curves of corpulence in 31.8% of
the cases and traced the curves in 26.6% of the cases. Physicians trained
in obesity performed these 3 steps significantly more frequently than
untrained physicians (p = 0.005, p = 0.03, p = 0.05, respectively). Their
main difficulties were family motivation (80.7%), socio-economic
difficulties (51.2%) and frequent failures (45.6%). Suggestions to
improve obesity care in children were the reimbursement of dietary
consultations (63.0%), the creation of a RéPPOP (53.5%) and a request
for training (29.1%). Physicians were unhappy with their care with a
score of 3.9 ± 1.6 on 10 points for GPs and 5.1 ± 1.9 for Pediatricians.
Thirty GPs (13%) were interested in a training conducted in Limousin
by the RéPOPP.
Conclusions: Although not exhaustive, our survey focused the
practices, difficulties and expectations of the GPs and Pediatricians
of Limousin for childhood obesity. Following this survey, a trainingwas
conducted by the RéPOPP to the GPs of Limousin.
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NUTRITION STATUS OF CHILDREN WITH CEREBRAL PALSY:
USEFULNESS OF NEW US CEREBRAL PALSY GROWTH CHART
S. Mallawaarachchi1*, R. Jayatissa2, J. Jagoda3, G.J. Tennakoon4,
P.K. Mallawaarachchi1. 1Ministry of Health Sri Lanka, Post Graduate
Institute of Medicine, University of Colombo., 2Ministry of Health Sri
Lanka, Medical Research Institute Colombo, 3Ministry of Health Sri Lanka,
Lady Ridgeway hospital for children Colombo, 4Ministry of Health Sri
Lanka, Sri Jayawardhanapura General Hospital, Kotte, Colombo, Sri Lanka
* Corresponding author.
Rationale: Nutritional status is a key factor affecting the quality of life
in a child with Cerebral Palsy (CP). Early identification and manage-
ment of malnutrition in CP children is important for long term care.
To assess the nutritional status of childrenwith CPwith newCP growth
chart in US compared with WHO growth chart to identify the most
useful tool.
Methods: A cross sectional study was conducted in 104 children with
cerebral palsy attending a rehabilitation clinic in a tertiary care
hospital in Colombo, Sri Lanka. Interviewer administered question-
naires was administered to mother or immediate care giver to collect
relevant information and 24-hour diet recall data. The level of Gross
Motor Function Classification System (GMFCS) was used and the level
of GMFCS was categorized into five; walks independently without
limitations; walks independently with limitations; walks independ-
ently using a hand-held mobility device; self-mobility with limita-
tions, may use poweredmobility and no head control with transported
in a manual wheelchair. Weight and height/length was measured and
plotted in both weight-for-height for children under 5 years and BMI-
for-Age for children above 5 years usingWHO growth charts and US CP
charts according to the level of GMFCS.
Results: Malnutrition by GMFCS of the study population was 1.0%,
5.8%, 8.7%, 4.8%, and 22.3% in level 1, 2, 3, 4 and 5 respectively. Overall
malnutrition in the study populationwas 53.9% usingWHO charts and
43% using CP growth charts (kappa = 0.76). 24-hour dietary recall
revealed 33.7% and 63.5% of them had low protein and calorie intake
respectively
Conclusions: High level of malnutrition was observed in CP children
with applying both WHO and US growth charts and had good
agreement. It is useful to detect malnutrition with the level of GMFCS
for targeted interventions.
Disclosure of Interest: None declared.
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TO STUDY THE IMPACT OF COMPLIMENTARY FEEDING PRACTICES
ON NUTRITIONAL STATUS AND SPEECH OF 12 TO 36 MONTH OLD
CHILDREN :OBSERVATIONAL STUDY IN NORTHERN INDIA
S. Arora1*. 1Pediatrics, Pushpanjali Hospital, Gurgaon, India
* Corresponding author.
Rationale: To assess the impact of infant and young child feeding
practices on nutritional status of 12 to 36 month old children. To study
the speech development of 12–36 months of children and its
association with infant feeding practices in well nourished children.
Methods: 40 children in the age group of 12–36 months who visited
opd in the months of january and february 2019 were taken as study
subject. Mothers of children who were willing to participate in the
study were interviewed on predesigned questionnaire which had
questions pertaining to age of the child, sex, caste, religion,
birthweight of child, mothers age, mothers education, fathers
education, nuclear or joint family, timing of start of breastfeeding,
type of feeding- exclusive breast feeding, formula feeding, cows milk
or mixed feeding, till what age they continued breast feeding, time of
start of complimentary feeding, were they given diverse food items,
time of change of texture of food from pureed to lumpy food and then
family food, frequency of complimentary food per day, duration of
screen time per day and is there any history of speech delay in family.
Weight for age,height for age, weight for height,(on WHO charts) and
speech development of the child were recorded using Language
Evaluation Scale Trivandrum. Pearson Chi square test/Fischer Exact
test was applied to test the variables with nominal/categorical data. P-
value less than 0.05 was taken as significant at 95%confidence levels.
Results: Mean age of the children- 23.3 months. Breastfeeding<6
hours after birth-32.5%. Exclusive breastfeeding-62.5%. Malnourished
children was significantly associated with maternal education (p
0.001), time of start of breast feeding (p 0.044) food diversity (p 0.003)
and food frequency (p < 0.001). Children with speech delay was
significantly associated with change of texture of food (p 0.017).
Conclusions: Poor maternal education, delay in the time of start of
breastfeeding (after 6 hours),inadequate food diversity score (<4) and
inappropriate food frequency of complimentary feeding leads to
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malnutrition and delay in the change of texture of food (from pureed
to lumps) lead to speech delay.
Disclosure of Interest: None declared.
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DIETARY HABITS AND NNTRITIONAL STATUS IN PATIENTS WITH
DUCHENNE MUSCULAR DYSTROPHY
S. Małgorzewicz1*, E. Wernio1, K. Śledzińska2, E. Wasilewska3,
A. Szlagatys-Sidorkiewicz4, J. Wierzba5. 1Clinical Nutrition,
2Department of General Nursing, 3Department of Allergology,
4Department of Pediatrics, Gastroenterology, Hepatology and Nutrition,
5Department of Pediatrics, Hematology and Oncology, Medical University
of Gdańsk, Gdansk, Poland
* Corresponding author.
Rationale: Duchenne muscular dystrophy is a neuromuscular disease
with several nutritional disturbances – from underweight to obesity.
Methods:70 boyswithDMDwere enrolled to the studywithmean age
10.13 ± 4.25 years. Weight and height were measured, BMI calculated
and appropriate z scores were computed from Polish Growth Charts.
Dietary habits were assessed based on Food Frequency Questionnaire
and 24-hours Dietary Recall.
Results: In anthropometric measurements was found only significant
difference in height z- score among age groups (p < 0.05), it decreased
with age (r = -0.442; p < 0.001). In the group aged 9–12.99 years old
50% of boys were overweight or obese. Patients on steroid therapy had
significantly lower height (p = 0.03). The most common mistakes in
the diet were: excess of consumed sweets, snacks, low intake of
vegetables and fruits in relation to the recommendations. The patients’
diet was characterized by a high glycemic index. The observed
abnormalities in dietary intake correlated with the age of patients.
Conclusions: It is important to assess nutritional status in patients
with DMD to quickly recognize any abnormalities and to introduce
appropriate management to minimize the risk of any possible
complications of malnutrition.
Disclosure of Interest: None declared.
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COMPARISON OF DIFFERENT METHODS OF REVEALING BODY
WEIGHT DEFICIT IN CHILDREN WITH CEREBRAL PALSY.
O. Titova1, N. Taran1*, T. Strokova1. 1Federal Research Centre of Nutrition
and Biotechnology, Moscow, Russian Federation, Moscow, Russian
Federation
* Corresponding author.
Rationale: To estimate the frequencyof bodyweight deficit in children
with cerebral palsy (CP) according to WHO criteria and specific grow
percentile charts.
Methods: 81 children with СP at the age 2–16 years were examined.
Children were divided to 5 groups according to class of motor activity
(GMFCS): I – 5 children (6.2%); II – 4 (4.9%); III – 10 (12.4%); IV – 27
(33.3%); V – 35 children (43.2%). All children conducted anthropom-
etry. The data were evaluated using WHO criteria and specific grow
percentile charts. The body composition (bioimpedance analysis, BIA)
was assessed in 45 (55.6%) children.
Results: According to the WHO criteria in group I body weight deficit
was determined in 4 (80%), in II – in 4 (100%), in III – in 7 (70%), in IV –
in 23 (85%) and in V – in 34 (97%) children. Severe weight deficit was
revealed in group I – in 1 (20%) child, in II – in 3 (75%) children, in III – 3
(30%) children, in IV – in 12 (44%) children, in V – in 28 (80%) children.
According to specific percentile tables, body weight deficit was
observed in 4 (80%); 4 (100%); 6 (60%); 17 (63%) and 27 (77.1%)
children in these groups, respectively. Severe weight deficit was
identified in group I in 1 (20%) child, in II – in 2 (50%) children, III – 1
(10%) child, IV – in 8 (30%) children, V in 16 (45.7%) children. The
underweight by BIAwas detected in 2 (67%) children in group I,1 (25%)
children in II, 2 (50%) children in III, 8 (67%) children in IV, and in 19
(86,4%) children in V group. Severe deficit wasn’t identified in I, II and
III groups, in group IV it was revealed in 4 (33,3%) children, in V – in 10
(45.45%) children.
Conclusions: Based on the results of BIA it can be concluded that using
these methods to assess the physical development of children with is
comparable only in patients with mild motor disorders (I-III class
GMFCS).
Disclosure of Interest: None declared.
Perioperative care II
MON-PO597
THE EFFECT OF A PERIOPERATIVE MULTINUTRIENT SUPPLEMENT
ON COLLAGEN SYNTHESIS DURING EARLY HERNIA REPAIR: A
RANDOMISED CLINICAL PILOT STUDY
M. Kjær1*, A.K.S. Frederiksen1, N.I. Nissen2, N. Willumsen2, G. van
Hall3,4, L.N. Jørgensen1, J.R. Andersen5, M.S. Ågren1,6. 1Digestive Disease
Center, Bispebjerg Hospital, University of Copenhagen, Copenhagen,
2Nordic Bioscience A/S, Herlev, 3Department of Biomedical Sciences,
University of Copenhagen, 4Clinical Metabolomics Core Facility,
Department of Clinical Biochemistry, Rigshospitalet, 5Department of
Nutrition, Exercise and Sports, University of Copenhagen, 6Copenhagen
Wound Healing Center, Bispebjerg Hospital, University of Copenhagen,
Copenhagen, Denmark
* Corresponding author.
Rationale: The inguinal hernia disease is associated with an
imbalanced collagenmetabolism including attenuated type V collagen
synthesis. The aim of the present studywas to normalise this distorted
collagen equilibrium by supplying a combination of nutrients
necessary for collagen synthesis to patients undergoing inguinal
hernia repair.
Methods: Twenty-one male patients scheduled for Lichtenstein
inguinal hernia repair were randomized to an enriched nutritional
supplementation (ENS-protein) group receiving 55 mg zinc, 1250 mg
vitamin C, 14 g arginine and 14 g glutamine daily (n = 10) or to a
control group (n = 11). Both groups received 1.5 g/kg of high-quality
protein daily for 28 days. In addition, experimental epidermal wounds
were created from raised suction blisters. Biomarkers of type I (CICP),
type III (PRO-C3) and type V (PRO-C5) collagen synthesis were
measured by enzyme-linked immunosorbent assays together with
zinc and free amino acids in serum collected at baseline (day -14), day
0 before surgeryand onpostoperative day 1 (day 1).Wound fluids from
surgical drain were analysed for CICP, PRO-C3 and PRO-C5 on
postoperative days 1 and 2.
Results: Fourteen days of ENS-protein raised the serum zinc level
(p = 0.002) but reduced (p = 0.022) total amino acid levels preopera-
tively. Postoperatively, serum PRO-C5 decreased (p = 0.046) in the
protein group but not in the patients receiving ENS-protein, who also
had higher (p = 0.041) PRO-C5 levels than the protein group on day
1. CICPwound fluid levels increased from day 1 to day 2 in both groups
andwere higher on day 2 in the ENS-protein group compared with the
protein group (P = 0.029). PRO-C3 increased (p = 0.028) from day 1–
day 2 in the ENS-protein group, but not in the protein group. One
patient in the ENS-protein group developed wound infection and
subsequent hernia recurrence. In the protein group, two patients
developed wound infections and hernia recurred in three other
patients within the 1-year follow-up period. The epidermal wounds
healed uneventfully in both groups.
S280 Abstracts / Clinical Nutrition 38 (2019) S59–S296
Conclusions: Supplementation with zinc, vitamin C, arginine and
glutamine maintained type V collagen synthesis systemically follow-
ing inguinal hernia repair and increased type I collagen synthesis
locally.
References: The research was funded by Medtrition Inc, Lancaster,
Pennsylvania, USA
Supplements were kindly supplied by Pharma Nord A/S and DAVA
Foods A/S, and wound dressings by Mölnlycke Health Care
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THE APPLICABILITY OF INDIRECT CALORIMETRY, BIOELECTRICAL
IMPEDANCE ANALYSIS AND SELECTED BIOCHEMICAL PARAMETERS
IN THE ERAS PROTOCOL IN PATIENTS UNDERGOING LIVER TUMOR
RESECTION
M. Andrzejewska1*, M. Ławiński1, M.K. Skroński1, A. Ukleja2,
P. Nyckowski1, M. Słodkowski1, M. Theilla3, P. Singer3. 1Department of
General, Gastroenterological and Oncological Surgery, 2Department of
Clinical Dietetics, Medical University of Warsaw, Warsaw, Poland,
3Department of General Intensive Care and Institute for Nutrition
Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
* Corresponding author.
Rationale: Analysis of changes in resting metabolic rate (RMR), body
composition and biochemical indicators may improve the Enhanced
Recovery After Surgery (ERAS) protocol and are relatively easy to
implement in perioperative care for liver surgery. A characteristic
parameter obtained due to the bioelectrical impedance is the phase
angle (PA), which reduced value indicates lower cell mass andworsens
the prognosis.
Methods: Observational study in 131 patients (68 women and 63
men) was conducted. All of themwere treated by surgical resection of
tumor within the liver. The majority of cases had metastatic changes
(80,15%). Data was collected the day before surgery and in day 7 after
surgery. T-test, Wilcoxon signed-rank test, multiple regression and
Friedman’s test were used to compare the 2 days.
Results:Average RMRbefore surgerywas 1284.3 kcal ±183.1 inwomen
and 1676.7 kcal ±256.2 in men. No significant change was observed at
Day 7. Day 7 lab results found an increase in GGT, ALTand CRP (96.92 U/
L, 73.40 U/L and 47.83 mg/L respectively) (p < 0.05). Statistically
significant differences (p < 0.05) in body composition parameters
were found, mainly in intracellular water, musclemass, body cell mass
and fat mass. Average PA value was lower by 0.74°.
Conclusions: Despite a decrease in muscle mass and fat mass, no
significant difference was found in resting energy expenditure
between pre and post-operative period. Phase angle was decreased.
The monitoring of these parameters may be included in the ERAS
protocol.
Disclosure of Interest: None declared.
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BENEFICIAL EFFECTS OF THE SHORT-TERM EARLY ENTERAL
NUTRITION IMMEDIATELY AFTER GASTRECTOMY FOR GASTRIC
CANCER: A PROPENSITY SCORE MATCHING ANALYSIS
M. Otani1*, K. Hasegawa1, T. Shonaka1, M. Gochi1, M. Miyamoto1,
C. Tani1, N. Matsuno1, H. Furukawa1, Y. Sumi1. 1Department of Surgery,
Asahikawa Medical University, Asahikawa City, Japan
* Corresponding author.
Rationale: It is well-known that nutritional status of the patients with
gastric cancer who undergo gastrectomy deteriorates after surgery.
Most patients will suffer from weight loss during one month after
gastrectomy, especially first one week. Therefore, we conducted a
study to evaluate whether the early short-term (4 days) nutritional
support with enteral feeding immediately after gastrectomy can
improve the nutritional status of the patients, compared to the
conventional early oral feeding.
Methods: The medical records of 446 patients between January 2007
and July 2018, were analyzed retrospectively. Patients were divided
into two groups: the enteral nutrition (EN) group (N = 311) and the oral
nutrition (ON) group (N = 135). In the EN group, a nasojejunal feeding
tube (5 French) was inserted intraoperatively, and immediately after
surgery elemental formulae (Elental®: EA Pharma Co., Tokyo, Japan)
were administered through theNJ tube initiallyat 300 kcal over first 24
hours then increased 300 kcal every 24 hours in a stepwise fashion by
1200 kcal on the final day (day 4). The EN group was also given the
same conventional ON feeding given to the control (ON group), during
the above period.Weight loss, nutritional index, morbidity, and length
of hospital stay after surgery were compared between two groups.
Propensity score matching was performed in order to adjust for any
baseline differences, using the STATA module of ‘PSMATCH2’. This
study was approved by the Asahikawa Medical University Research
Ethics Committee (No.18142).
Results:Hundred and six matched pairs were created with propensity
score matching. The patients in the EN groupmaintained preoperative
body weight 7 days after gastrectomy (median: 97.0%, interquartile
range: 95.3 98.7 vs median: 95.6%, interquartile range: 94.2 97.0,
P < 0.001), and higher levels of transthyretin (median: 16.2 mg/dL,
interquartile range: 12.4 19.2 vs median: 12.7 mg/dL, interquartile
range: 10.4 16.0, P < 0.001), compared to the ON group. No significant
difference was found between two groups in the lengths of hospital
stay after surgery (P = 0.08) and the morbidity after surgery such as
postoperative pneumonia (P = 0.28) and surgical site infection (P = 1.0).
Conclusions: Short-term EN immediately after gastrectomy could
improve the nutritional status of the patients with gastric cancer in
maintaining both body weight and the level of transthyretin in the
early period after surgery.
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INDIRECT CALORIMETRY IN ONCOLOGICAL SURGERY LIVER
PATIENTS – COMPARISON OF RESTING ENERGY EXPENDITURE
WITH PREDICTION EQUATIONS
M. Ławiński1*, M.K. Skroński1, A. Ukleja2, M. Andrzejewska1,
P. Nyckowski1, M. Słodkowski1, M. Theilla3, P. Singer3. 1Department of
General, Gastroenterological and Oncological Surgery, 2Department of
Clinical Dietetics, Medical University of Warsaw, Warsaw, Poland,
3Department of General Intensive Care and Institute for Nutrition
Research, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel
* Corresponding author.
Rationale: Indirect calorimetry (IC) is the recommended tool to assess
resting energy expenditure (REE) in patients. Mathematical equations
based on anthropometry (body mass, height, age and sex) are usually
calculated if IC is not available. These equations have been integrated
in devices measuring bioelectrical impedance (BIA). The goal of this
studywas to evaluate the accuracyof these equations in comparison to
IC in a specific population; the patients undergoing liver resection.
Methods: 104 patients (48 M, 56 F, age 60.8 ± 10.1 years) with
metastatic changes in the liver, qualified for surgical treatment such as
hemihepatectomies (n = 39), focal resections (n = 36) and segmentec-
tomies (n = 29) were performed. The measurements were performed
before elective surgery and at day 7 postoperative. The data obtained
were compared with the Harris-Benedict and Mifflin formulas. T-test,
Wilcoxon test and Blandt-Altman differences analysis, were used
depending on the data distribution.
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Results: REE was 1469,75 kcal in mean while mean result for Harris-
Benedict equation was 1556,865 kcal and for Mifflin was 1431,74 kcal.
REE determined by IC was higher on average by 399 kcal in men
(p < 0.0001). At day 7, RMR did not change significantly (M: −22 kcal,
F: +5 kcal). After hemihepatectomies, REE decreased by 79,55 kcal and
after segmentectomies and focal sections increased by 23,04 and
47,50 kcal respectively. The highest correlation level was obtained for
the use of the Mifflin formula before surgery (R = 0.85, Av diff. =
+43.77; Limit of agreement (LoA): −271 to +358), and Harris-Benedict
after surgery (R = 0.85, Av diff. =−36.36; LoA: −344 to +271).
Calculation derived from BIA method showed the lowest agreement
with IC measurement (R = 0.76, Av diff. = +36.75, LoA: −417 to +344).
Conclusions: The procedure of partial resection of the liver does not
have a significant impact on resting energy expenditure. If IC is not
available, Mifflin equation before and Harris Benedict after surgery
should be preferred. Currently, there is no ideal predictive equation for
REE evaluation in liver oncological surgery.
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TOTAL PARENTERAL NUTRITION EFFECTS AMONG PATIENTS
WITH PANCREATIC CANCER UNDERGOING
PANCREATICODUODENECTOMY
D. Karagiannis1, P. Katralis2*, S. Kakavas3, Z. Bouloubasi1, A. Almperti1,
D. Constantinou2, A. Baschali1, Z. Mastora3, G. Stylianidis2. 1Clinical
Nutrition and Dietetics, 2Second Department of Surgery, 3First
Department of Critical Care Medicine and Pulmonary Services, Medical
School of Athens University, Evangelismos District General Hospital of
Athens, Athens, Greece
* Corresponding author.
Rationale: Pancreatic cancer is one of the most common malignant
disorders of the digestive system, and pancreaticoduodenectomy (PD)
is the standard intervention for the curative therapy of pancreatic
cancer. Postoperative nutrition support including total parenteral
nutrition (TPN), have been proven to be effective in improving the
clinical outcomes, although there is no direct comparison available
between different types of parenteral nutrition shortages. The purpose
of this study was to determine the effects of intravenous lipid
emulsions (IVE) on clinical outcomes in pancreatic cancer patients
who underwent pancreaticoduodenectomy.
Methods: A randomized, controlled clinical trial was conducted by a
single center in Greece, Athens. Data including patients’ character-
istics, laboratory results, and postoperative complications were
recorded on specific forms during the perioperative period in a
series of 82 patients aged 41–81 years, between November 2016 and
January 2019. The post-operative feeding route was proposed by the
Nutrition Support Team and patients were monitored until their
discharge from the hospital. Patients receiving parenteral nutrition for
at least 5 days were randomized to receive one the following: an Olive
oil/Long Chain Triglycerides (OO/LCT) or LCT/MCT/OO/fish oil contain-
ing IVE groups. Clinical evaluation and biochemical tests were
performed at enrolment and after hospital discharge. Potential
associations between parenteral nutrition and length of hospital stay
were analyzed using generalized linear models adjusting for age, BMI,
serum albumin levels, caloric intake and total bilirubin.
Results: Overall, out of the 82 patients, 40 (48.2%) were fed through
TPN during the first 5 post-operative days: 18 via LCT/MCT/OO/fish oil
and the rest (n = 22) via olive oil/LCT IVE. The multivariable-adjusted
relative risk (95% CI) for increased hospital stay (>12 days) was 1.22
(1.05–1.38) in the group receiving olive oil/LCT compared to those
receiving LCT/MCT/OO/fish oil. No significant differences between
groups were observed regarding surgical complications involving bile
leakage, pancreatic fistula, intraperitoneal bleeding, gastrointestinal
bleeding or wound infection (all P > 0.05).
Conclusions: LCT/MCT/OO/fish oil intravenous lipid emulsion may be
more effective than olive oil/LCT in reducing hospital stay among
patients with pancreatic cancer undergoing pancreaticoduodenect-
omy but more studies in the field are needed.
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HIGH-FAT ENTERAL NUTRITION ALLEVIATES POSTOPERATIVE ILEUS
IN RATS VIA INHIBITING ROS/JNK PATHWAY
S. Tan1*, G. Wu1, Y. Jiang1, Q. Meng1, Q. Xi1, Q. Zhuang1, Y. Han1.
1Department of General Surgery/Shanghai Clinical Nutrition Research
Center, Zhongshan Hospital, Fudan University, Shanghai, China
* Corresponding author.
Rationale: Postoperative ileus (POI) is a common but major compli-
cation after surgery characterized by delayed gastrointestinal motility
recovery, adversely affecting postoperative outcomes. Previous studies
including ours have shown that intestinal inflammationwas themajor
cause of POI and high-fat enteral nutrition could reduce intestinal
inflammation and alleviate POI. However, the mechanism remains
unknown. It is suggested that activation of ROS/JNK pathway is
involved in various inflammation induced diseases. This study was
therefore to investigate the role of ROS/JNK pathway in a rat model of
POI, and the effect of high-fat enteral nutrition.
Methods: POI was induced by peritoneal air exposure for 3 hours in
rats. Intestinal segmentswere collected at several time points to assess
inflammatory mediators and ROS/JNK pathway in sham-operated rats,
POI rats and POI rats fed a high-fat or control nutrition. Intestinal
motility was measured 24 hours after surgery by charcoal transport
assay.
Results: Peritoneal air exposure resulted in a significant increase of
inflammatory mediators such as tumor necrosis factor (TNF)-α,
interleukin (IL)-1β and myeloperoxidase activity, and reduction of
intestinal motility compared to sham-operated group (P < 0.05).
Inhibition of ROS/JNK pathway through an ROS scavenger and JNK
inhibitor prevented peritoneal air exposure inducing POI (P < 0.05).
Furthermore, administration of high-fat enteral nutrition significantly
alleviated POI, reduced intestinal inflammatory mediators and
inhibited ROS/JNK pathway compared to rats treated with control
nutrition (P < 0.05).
Conclusions:High-fat enteral nutrition could alleviate POI induced by
peritoneal air exposure, and the underlying mechanism may be via
inhibiting ROS/JNK pathway.
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BODY COMPOSITION INFLUENCES MAJOR POST-OPERATIVE
COMPLICATIONS, 90-DAY AND OVERALL SURVIVAL IN PANCREATIC
SURGERY PATIENTS.
S. Velho1*, M.P. Santos2, C. Cunha3, L. Agostinho4, R. Cruz4, F. Costa5,
M. Garcia3, P. Oliveira3, R. Maio3, V.E. Baracos6, M. Cravo2. 1Dietetics and
Nutrition, 2Gastroenterology, 3Surgery, 4Radiology, Hospital Beatriz
Ângelo, Loures, 5Oncology, Hospital da Luz, Lisboa, Portugal, 6Oncology,
University of Alberta, Alberta, Canada
* Corresponding author.
Rationale: Pancreatic surgery still carries a high morbidity and
mortality even in dedicated centers. The aim of this study was to
evaluate the influence of patients’ body composition on postoperative
complications and survival of pancreatic surgery.
Methods: Retrospective study in patients undergoing pancreatic
surgery between March 2012 and December 2017. Demographic,
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clinical data and postoperative complications classified according to
Clavien-Dindo were recorded. Body composition was assessed using
routine diagnostic or staging Computed Tomography (CT). Multiple
Cox proportional hazards models were adjusted.
Results: Ninety patients were included, 55% male, mean age of
68 ± 10.9 years. Of those, 92% underwent total pancreatectomy or
pancreaticoduodenectomy, 7% distal pancreatectomy and 1% multi-
visceral resection; 84% had malignant disease. The incidence of major
complicationswas 28% and 90-daymortalitywas 9%. Visceral Fat Area/
Skeletal Muscle Area (VFA:SMA) ratio was associated with increased
risk of complications (OR = 2.24, 95%CI = 1.14–4.87, p = 0.02) and 90-
day survival (HR = 2.13, 95%CI = 1.13–4.01, p = 0.014). On simple
analysis lower overall survival was observed in patients aged ≥70
years (p = 0.0009), with postoperative complications ≥IIIb (p = 0.01),
with increase of VFA:SMA (p = 0.007) and decrease inmuscle radiation
attenuation (p = 1.6 × 10−5). In an overall survival model adjusted for
age, disease malignancy, postoperative complications and body
composition parameters, muscle radiation attenuation remained
significantly associated with survival (HR:0.92; IC95%:0.8–0.9; p =
0.004). Amodelwhich included only body composition variables had a
discrimination ability (C-statistic 0.76) superior to a model which
comprised conventional clinical variables (C-statistic 0.68).
Conclusions: Body composition is a major determinant of post-
operative complications and survival in pancreatic surgery patients.
Disclosure of Interest: None declared.
MON-PO604
EARLY CLOSURE OF THE PROTECTIVE ILEOSTOMY AFTER RECTAL
RESECTION DOES NOT DETERIORATE THE FUNCTION OF
GASTROINTESTINAL TRACT
S. Klek1*, M. Pisarska2, T. Cegielny3, R. Choruz4, J. Salowka4,
P. Szybinski4, M. Pedziwiatr5. 1General and Cancer Surgery, Stanley
Dudrick’s Memorial Hospital, Skawina, 22nd Department of General
Surgery, Jagiellonian University Medical College, Krakow, 3General and
Cancer Sugery, 4Stanley Dudrick’s Memorial Hospital, Skawina,
5Jagiellonian University Medical College, Krakow, Poland
* Corresponding author.
Rationale: Early closure of the protective loop ileostomy (PLI) is a new
technique used to deal with PLI which is performed to reduce
anastomotic leak rate after the resection of rectum. The aim of the
study was to analyze whether PLI enables early oral feeding according
to ERAS protocol and does not deteriorate the GI function.
Methods:A randomized clinical trial was performed betweenOctober,
the 1st 2016 and December, the 31st, 2017. 58 adult patients (24 F, 34M,
mean age 55.7 and 56.2) operated on for rectal carcinoma according to
ERAS protocol with PLI, were randomly assigned into late (L) or early
(E) closure group (14 days after discharge). Gastrointestinal function
and complications’ rate were analyzed.
Results: There were no significant differences between groups
regarding neither the length of surgery (83.2 ± 15.9 vs 87.1 ± 21.7 min,
in E and L, respectively), intraoperative blood loss (15.2± 7.5 vs 17.3±
11.1 ml, respectively), median hospital stay (p > 0.05). The time to start
oral diet with liquid product was (2.2 [1.5–3.5] hours after surgery).
Intermittent nausea was observed in 2 (3.4%), vomiting resulting in
withholding oral diet in 2 (3.4%). Mean time to pass flatus was 1.9 days
(range 1.0–3.5), stool 2.9 (1.0–5.5) (p > 0.05)
Conclusions: Early closure of PLI is a safe and effective therapeutic
approach, improving the recovery. It does not deteriorate the GI
function. It should be implemented as a part of ERAS protocol for rectal
cancer patients.
Disclosure of Interest: S. Klek Speakers Bureau of: Baxter, Braun,
Fresenius, Nutricia, Nestle, Shire, VIpharm,M. Pisarska: None declared,
T. Cegielny: None declared, R. Choruz: None declared, J. Salowka: None
declared, P. Szybinski: None declared, M. Pedziwiatr: None declared.
MON-PO605
THE OPTIMAL PERIOPERATIVE NUTRITION SUPPORT IN
GASTROINTESTINAL SURGERY: A SYSTEMATIC REVIEW AND META-
ANALYSIS
T.Wuensch1*, A. Müller1, J. Quint1, M. Biebl1, J. Pratschke1, F. Aigner1, on
behalf of The Workgroup for Perioperative Care. 1Department of
Surgery, Campus Charité Mitte and Campus Virchow-Klinikum,
Charité – Universitätsmedizin Berlin, Berlin, Germany
* Corresponding author.
Rationale: Perioperative nutrition support is an integral pillar of
Enhanced Recovery After Surgery (ERAS) protocols for major abdom-
inal surgery, as it plays a pivotal role for postoperative recovery. Yet,
patients undergoing surgery of the gastrointestinal (GI) tract might
require tailored nutritional treatment due to the surgical remodelling
of the intestinal tract. Therefore, we undertook a systematic meta-
analysis of the most popular nutrition support strategies for GI tract
surgery and evaluated their specific effects on length of hospital stay
(LoS) and postoperative complication rates.
Methods: A systematic search of the MEDLINE, EMBASE and
COCHRANE databases for randomized controlled trials (RCTs) was
conducted to identify studies with perioperative nutritional interven-
tions on GI tract surgery patients. Relevant datawas collected in a SPSS
table and analysed using the R software.
Results: Data was extracted from 70 RCTs containing 6128 patients.
The most frequent nutritional interventions were: early oral feeding
after surgery, immunonutrition, preoperative carbohydrate loading,
amino acid supplementation or fatty acid supplementation. The
strongest effects on LoS reduction were observed by early oral
feeding (MD = -1.67; 95% CI, −2.25 to −1.09), that also reduces
complication rates (RR = 0.75; 95% CI, 0.58 to 0.89). Supplementation
with amino acids or immunonutrition (containing n-3 fatty acids,
arginine and RNA) lead also to significantly lower LoS. Preoperative
carboloading reduces the LoS (MD−7.33 days, 95% CI−14 to −1.11), but
does not influence complication rates. Further subgroup analysis were
conducted showing distinct effects of nutritional interventions on
upper or lower GI tract patients.
Conclusions: The optimal perioperative nutrition support should
include high quality nutrients, like essential amino acids and n-3 fatty
acids. Furthermore, timing matters to achieve the maximal beneficial
effects. However, asminimal requirement, patients should be fed early
after surgery to avoid detrimental catabolic fasting conditions.
Disclosure of Interest: None declared.
MON-PO606
AN INTENSIFIED PERIOPERATIVE NUTRITION SUPPORT
EFFECTIVELY REDUCES PERIOPERATIVE FASTING PERIODS AND
IMPROVES NUTRIENT SUPPLY
T. Wuensch1*, J. Quint1, J. Wizenty1, M. Biebl1, J. Pratschke1, F. Aigner1,
on behalf of TheWorkgroup for PerioperativeMedicine. 1Department of
Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité –
Universitätsmedizin Berlin, Berlin, Germany
* Corresponding author.
Rationale: Prolonged perioperative fasting periods (as stated in the
ESPEN guidelines on ‘Clinical nutrition in surgery’) should be avoided
to create an optimal metabolic environment for postoperative
recovery. However, in clinical practice, adhering to the recommenda-
tions is often hampered, as the importance of nutrition of surgical
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patients is underestimated and human resources of professional
trained staff are limited.
Methods:We investigated the exact perioperative fasting periods and
daily nutrient intakes of patients (n = 49) undergoing elective GI tract
surgery under ‘standard of care’ conditions and when a structured
professional perioperative nutritional support was provided.
Results: Perioperative fasting periods showed high variations, ranging
from 24.0 h to 183.0 h (median: 71.0 h), with significant differences
between pre- and postoperative fasting periods in patients with upper
or lower GI tract malignancies, respectively. The prolonged fasting
periods were accompanied by a mean cumulative energy deficit of
9075 ± 2168 kcal (mean±SD) from the day before surgery until the
postoperative day 4. By a structured, individualized perioperative
nutritional support, both, fasting periods (median: 42.5 h, range:
23.0–80 h) and cumulative energy deficits were reduced (mean±SD:
6635 ± 3098 kcal).
Conclusions: Perioperative fasting periods and nutrient supply can be
improved by an intensified perioperative nutrition support delivered
by a professional trained nutritionist. Apparently simplemeasures like
pre-admission nutritional counselling, daily check-ups, nutritional
support and providing the acceptedmeals (liquid, soft or solid diet) are
highly effective in achieving the recommended ‘avoidance of long
periods of preoperative fasting’ and to reduce energy deficits to
counteract deteriorating metabolic stress states.
Disclosure of Interest: None declared.
MON-PO607
RELATIONSHIP BETWEEN NUTRITIONAL ASSESSMENT AND
DETERIORATION OF ACTIVITIES OF DAILY LIVING IN PATIENTS
WITH LUNG CANCER
Y. Ueta1*, K. Miyakoshi2, H. Sugimura3. 1Department of Nutrition,
2Department of Rehabilitation Medicine, 3Department of Thoracic
Surgery, Kameda General Hospital, Kamogawa, Chiba, Japan
* Corresponding author.
Rationale: Activities of daily living (ADL) tends to deteriorate in
patients with lung cancer after surgery. Malnutrition can be a cause of
ADL deterioration. To minimize the effects, nutritional screening and
nutritional therapy is required. In this study, we report the relationship
between preoperative nutritional screening and postoperative ADL.
Methods: The subjects were hospitalized patients with lung cancer
who underwent lung resection from January 2013 to December 2017.
The participants were divided in two groups by ADL change: ADL
declining group and non-declining group. We evaluated their ADL by
Functional IndependenceMeasure Japanese edition version 3 (FIM) on
admission and at discharge. Predictive factors consideredwere age, the
Mini Nutrition Assessment-Short Form (MNA-SF), and the serum
albumin level (Alb). These values were collected from our medical
records, retrospectively. Multivariate analysis was done to collect
significant predictive factors using logistic regression analysis. To
complete these statistical analyses, we used the software package
SPSS15.0 Japanese edition, considering P < 0.05 as statistically
significant.
Results: The subjects were 570 patients (365 male, 205 female). The
mean age was 68.0 ± 9.01; mean MNA-SF was 10.9 ± 1.60; and mean
Alb was 4.12± 0.405 g/dL; while the FIM at admission was 122 ± 13.4;
and the FIM at discharge was 122 ± 14.3. In the logistic regression
analysis, MNA-SF was demonstrated as significant factor to predict
ADL deterioration (OR = 0.832, 95% CI: 0.728–0.951).
Conclusions: MNA-SF was the significant predictive factor of ADL
deterioration. Nutritional status should be taken into consideration in
order to provide an effective treatment plan.
Disclosure of Interest: None declared.
MON-PO608
PHAGOCYTIC ACTIVITY OF BLOOD PLATELETS IN VARIOUS MODELS
OF PREOPERATIVEORAL IMMUNONUTRITION IN INVASIVEGASTRIC
CANCER PATIENTS.
Z.K. Kamocki1*, A. Jurczuk1, J. Matowicka-Karna2. 12 Department of
General and Gastroenterological SurgeryMedical, 2Department of Clinical
Laboratory Diagnostics, Medical Unversity of Bialystok, Bialystok, Poland
* Corresponding author.
Rationale: The role of platelets in host defense in patients with gastric
cancer is unknown. The aim was to determine phagocytic activity of
thrombocytes in invasive gastric cancer patients depends of various
models of oral preoperative oral immunonutrition.
Methods: The study involved invasive gastric cancer patients prepared
to surgery. They were fed a natural hospital diet. In addition, each
patient received a three-chamber nutritional bag with a capacity of
1206 ml. Patients were randomly divided into two immunonutrition
groups. Group I was received an oral glutamine (Resource Glutamine)
2× 5 g per day. Group II a solution of arginine, ω− 3 fatty acids and
nucleotides (IMPACT) in the amount of 8.6 g arginine, 2.37 g of ω− 3
fatty acids, and 0.86 g of nucleotides daily. A total count of platelets,
percentage of phagocytic thrombocytes and phagocytic index was
measured twice – before and 12 days after surgery.
Results: Fifty-two patients was enrolled to the study. Twenty-four
patients loss above 10% their bodyweight, on average 14%. The average
duration was from 7 to 24 days, on average 12 days. In both group a
significant improvement in platelets count and percentage of
phagocytic thrombocytes was observed (p < 0,05). Phagocytic index
raised only in group with oral glutamine supplementation (p < 0,05).
Conclusions: Both glutamine-based and arginine-based oral immu-
nonutrition improved blood platelets count and percentage of
phagocytic thrombocytes. Glutamine-based immunonutrition
increased phagocytic index. Arginine-based immunonutrition pro-
tected against fall of phagocytic index.
Disclosure of Interest: None declared.
MON-PO609
LYMPHOCYTE SUBPOPULATIONS IN A MODEL OF PRE-OPERATIVE
ORAL AND PARENTERAL GLUTAMINE-BASED IMMUNONUTRITION
IN PATIENTS WITH INVASIVE GASTRIC CANCER.
Z.K. Kamocki1*, A. Jurczuk1, J. Osada2. 12 Department of General and
Gastroenterological Surgery, 2Department of Haematological Diagnostics,
Medical University of Bialystok, Bialystok, Poland
* Corresponding author.
Rationale: Immune system in gastric cancer patients is impaired. The
aim was to access the total content of lymphocytes and their
subpopulations in patients with gastric cancer during preoperative
glutamine-based immunonutrition depends on its route of supply.
Methods: The study involved patients with invasive gastric cancer
prepared to surgery. They were fed a natural hospital diet. In addition,
each patient received a peripheral three-chamber nutritional bag with
a capacity of 1206 ml. They were randomly divided into 2 groups.
Group I received an oral glutamine (Resource Glutamine) 2 × 5 g daily.
Group II were given an intravenous solution of glutamine (Dipeptiven)
100 ml with 0,2 g/ml medicinal product. Levels of total content of
lymphocytes and their subpopulations (CD3+,CD4+.CD8+,CD!9+,NK
cells) was measured twice – before and after immunonutrition.
Results: Forty-six patients were enrolled into the study. Eighteen
patients lost above 10% body weight, on average 14.8%. The average
duration of immunonutrition was from 7 to 18 days–on average 13
days. Total content of lymphocytes and their subpopulations were
significantly reduced in both groups in comparisonwith control group
before immunonutrition. In patients with oral glutamine
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supplementation a statistically significant decline of total content of
lymphocytes was noticed (p < 0,05). There were no more relevant
changes in lymphocyte subpopulations. In Group with intravenous
glutamine administration no significant changes was observed.
Conclusions: Immunonutrition based on intravenous glutamine
prevented lymphocyte and their subpopulations from decrease but
did not improve their content. 10 g oral glutamine could not protect
total lymphocyte content.
Disclosure of Interest: None declared.
Critical care II
MON-PO610
INDICATORS OF OPTIMAL NUTRITION SUPPORT IN INTENSIVE CARE
UNIT CAN BE IMPROVED BY A MULTIFACETED INTERVENTION:
IMPLEMENTATION OF A DEFINED PROTOCOL AND
MULTIDISCIPLINARY ROUNDS
K. Ouaijan1*, G. Juvelekian1, N. Ghattas1, L. Mattar2. 1Intensive Care Unit,
Saint George Hosptal University Medical Center, 2Natural Sciences,
Lebanese American University of Beirut, Beirut, Lebanon
* Corresponding author.
Rationale: Implication of nutrition support dieticians in daily patient
rounds, staff meetings and multidisciplinary discussions can prove
efficient in prompting better enteral nutrition delivery, helping in
optimizing patient outcomes. The objectives of our study is to evaluate
the impact of this simple intervention on the enteral nutrition delivery
rates in a closed intensive care unit.
Methods: Clinical and nutrition data were collected for all adult
critically ill patients admitted to the ICU at Saint George University
Medical center Lebanon for more than 48 hours and who are eligible
for EN during two periods of time: T1 and T2.
T1 is the observational period and extended from March 2016 to June
2016. T2 is the intervention period that extended from March 2017 to
December 2017. During T2, protocols for nutrition support were
established and multidisciplinary rounds were held, with implication
of a nutrition support dietician in daily rounds, staffmeetings, and case
discussions.
Nutrition risk is determined using the Nutrition Risk Screening NRS 4.
The other measured outcomes were initiation of enteral feeding with
24 hours, reaching enteral nutrition target within 72 hours andwithin
7 days, and finally initiation of trophic feeding when indicated.
Potential barriers to reach EN target are listed. Descriptive statistics are
performed and chi-square test was used to compare frequencies
between the two time periods.
Results: One hundred seventeen patients were included in the study,
50 patients and 67 patients in T1 and T2 periods respectively. 76% of
patients are at high risk of malnutrition using the NRS score, 84% in T1
and 70% in T2.
Fifty percent of the patients (n = 25) started enteral feeding within 24
hours in T1 as compared to an improved rate of 63% (n = 42) in T2
(x2 = 1.459, p = 0.154).
Enteral nutrition target of≥ 70% of prescribed caloric needs reached
within 72 hours in hemodynamically stable patients was 28% in T1 as
compared to 36% in T2 (x2 = 7.999, p = 0.245). The difference in
reaching EN target within 1 week was statistically significant
between T1 (60%, n = 30) and T2 (79%, n = 53) (x2 = 5.096, p = 0.039).
The most common barriers in T1 were the slow progress in infusion
rate (47%) and stopping feeding due to diarrhea (28%) due to absence
of awell-designed protocol that was targeted in the intervention in T2.
Initiation of trophic feeding when indicated in hemodynamically
unstable patients improved between the two time periods increasing
from 28.5% in T1 to 92% in T2. This difference was statistically
significant (x2 = 5.698, p = 0.029).
The mean LOS was 17 days, however a decreased trend of 3 days was
observed between T1 (18.62 days) and T2 (15.85 days) (p = 0.347).
Outcome T1 T2
Number of patients 50 67
Enteral feeding started
within 24 h
25 (50%) 42 (63%)
Enteral feeding target
reached within 72 hours
14 (28%) 24 (35.8%)
Enteral feeding target
reached within 1 week
30 (60%) 53 (79.1%)
Number pf patients eligible
for trophic feeding
7 12
Trophic feeding initiated 2 (28.5%) 10 (92%)
Conclusions: The implementation of awell-designed protocol and the
presence of the ICU dietitian have successfully improved nutrition
management by providing early and better delivery of enteral
nutrition. This optimal nutrition support was reflected in a trend
towards a reduction in length of stay.
Disclosure of Interest: None declared.
MON-PO611
VITAMIN D STATUS AND INFLAMMATORY BIO-MARKERS IN
CRITICALLY ILL PATIENTS WITH SEPSIS
L.S. Alnasrallah1*, M.M.A. Abulmeaty2, A.M. Almajwal2, Y. Arabi3,
H. Aldorzih3, K. Maghrabi4, N. Salahulddin4, A. Al Harthy5, A. Mady5,
N. Eldib5, N.M. Al-Daghri6, M. Khattak6. 1ICU Nutrition, King Saud
Medical City, 2Clinical Nutrition Program, Community Health Sciences,
King Saud University, 3Intensive Care, King Abdulaziz Medical City,
National Guard Health Affairs, 4Intensive Care, King Faisal Specialist
Hospital and Research Center, 5Intensive Care, King Saud Medical City,
6Chair for Biomarkers of Chronic Diseases, Biochemistry, King Saud
University, Riyadh, Saudi Arabia
* Corresponding author.
Rationale: To assess the status of vitamin D and the common
inflammatory mediators in critically ill (ICU) patients with sepsis
versus matched controls.
Methods: A total of 47 ICU patients (22 with sepsis and 25 controls)
were included in a case-control, multicenter, prospective, observa-
tional study between Januaryand August 2018. The study conducted in
ICU units of King SaudMedical City, King Abdulaziz Medical City of the
National Guard Health Affairs and King Faisal specialist hospital and
research center. Patients with newly diagnosed sepsis according to
Singer, et al, (2016)1 consensus (within 48 hours) were defined as
cases. Patients were followed for one week, 3 blood samples were
taken (D0, D3, and D7) to measure 25-hydroxyvitamin D (25OHVD)
and inflammatory markers (tumor necrosis factor alpha [TNF α],
Granulocyte – colony-stimulating factor [G-CSF], Monocyte chemo-
attractant protein-1 [MCP-1], Interleukin [IL]-6, IL-8, and IL-10). the
SOFA and APACHE scores were used to assess the study participants.
The ethical approval was taken from the ethical committee in each
hospital. The ROC curves used to test the predictors and to define the
cutoff points of the best sensitivity and specificity.
Results: The prevalence of vitamin-D deficiency (25-OHVit
D≤ 25 nmol/l) was 68.2% in sepsis and 56% in controls. At D7, 25-
OHVit D was significantly low in the sepsis group vs control group
(12.62 ± 8.49 vs 32.95 ± 22.02 nmol/l, P < 0.05). Also, IL-10 was signifi-
cantly higher in the sepsis group through the period of the study
(P < 0.05). other inflammatory parameters showed insignificant
changes between both groups at any day. Moreover, insignificant
changes were detected in both 25-OHVit D or IL-10 level before and
after the study period (P > 0.05). In sepsis group, SOFA score correlated
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with TNF α (r = 0.36, P < 0.05) and IL-10 (r = 0.37, P < 0.05). however,
therewere none significant negative correlations between 25-OHVit D
and APACHE II or SOFA scores. Based on ROC curves, the best predictors
were TNF-α and IL-10 (AUC; 0.756 & 0. 737, respectively) (Table 1)
Table 1
The cutoff values of the studied parameters.
Parameter AUC Cutoff value Sensitivity Specificity
25-OHVit D .426 23.54 nmol/l 54.5% 47.4%
G-CSF .440 262.24 pg/ml 54.5% 36.8%
IL-6 .670 43.92 pg/ml 72.7% 68.4%
IL-8 .665 59.15 pg/ml 63.6% 57.9%
MCP-1 .560 2117.83 pg/ml 63.6% 47.4%
TNF-α .756 35.98 pg/ml 72.7% 78.9%
IL-10 .737 24.30 pg/ml 63.6% 73.7%
Conclusions: In the population studied, patients with sepsis have low
serum concentrations of 25-OHVit D and IL-10. However, IL-10 rather
than other parameters could predict sepsis with a cutoff point
24.30 pg/ml. More studies are needed to confirm the use of IL-10 as
a prognostic test.
References
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MON-PO612
A RANDOMIZED CONTROLLED TRIAL ON THE EFFECTS OF
INTERMITTENT GRAVITY DRIP VERSUS BOLUS ENTERAL FEEDING
ON THE INCIDENCE OF HOSPITAL-ACQUIRED PNEUMONIA AMONG
INTENSIVE CARE PATIENTS
M.F.B. Gajo1*, R.A.G. Sy2, C.R. Cipriano2. 1Department of Internal
Medicine, 2Ospital ng Makati, Makati City, Philippines
* Corresponding author.
Rationale: Hospital acquired pneumonia is a frequent complication
of patients on enteral feeding. Bolus feeding is currently practice in
our institution however its aspiration risk is not yet established.
Intermittent gravity feeding iswidely used however its effectiveness in
preventing pneumonia is not yet proven. Trials have shown conflicting
results on which feeding method has a lower risk for pneumonia.
Methods: We performed a randomized study to examine the
effectiveness of intermittent gravity drip feeding as a strategy in
reducing the incidence of pneumonia. We included patients requiring
nasogastric feeding within 24 hours from admission. We randomly
assigned patients using fish-bowl technique to either 1. Intermittent
gravity drip feeding 2. Bolus feeding. The primary outcome was
development of hospital acquired pneumonia. The secondary outcome
was length of hospital stay and mortality.
Results: 106 were randomized into intermittent group and 104 into
the bolus group. The baseline characteristicswere similar at the start of
the study. The primaryoutcome occurred in 55 of 104 patients (53%) in
bolus group and 21 of 106 patients (20%) in the intermittent group
(RR = 0.37). Mortality occurred in 42 of 104 patients (41%) in bolus
group and 26 of 106 patients (25%) in the intermittent group
(RR = 0.60). The average hospital stay for the bolus group was 17 ± 11
days compared to intermittent group with 13 ± 10 days.
Conclusions: 106 were randomized into intermittent group and 104
into the bolus group. The baseline characteristics were similar at the
start of the study. The primary outcome occurred in 55 of 104 patients
(53%) in bolus group and 21 of 106 patients (20%) in the intermittent
group (RR = 0.37). Mortality occurred in 42 of 104 patients (41%) in
bolus group and 26 of 106 patients (25%) in the intermittent group
(RR = 0.60). The average hospital stay for the bolus group was 17 ± 11
days compared to intermittent group with 13 ± 10 days.
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MON-PO613
COMPARISON OF NUTRITIONAL RISK AND MALNUTRITION
CRITERIA IN CRITICALLY ILL PATIENTS
M. Ilinskiy1*. 1General ICU, Hospital Research Institute of Emergency
Medicine Named after N.V. Sklifosovsky, Moscow, Russian Federation
* Corresponding author.
Rationale: Nutritional status is important factor associated with
outcomes (complications, length of hospital stay, mortality) in
intensive care unit (ICU) patients. Recently has been proposed criteria
to determine the group of patients for effective medical nutrition
therapy, but there is discrepancy in the selection of these criteria
among ESPEN and ASPEN communities [1, 2].
Methods: The prospective observational study included n = 213 ICU
patients admitted from September to December 2018 (trauma n = 119,
neurologic n = 41, others n = 53). The disease severity, organ dysfunc-
tion, nutritional risk and diagnosis of malnutrition were evaluated
during 24 hours by APACHE II, SOFA, NRS, NUTRIC and GLIM criteria,
respectively. Cox regression analyses used to identify risk of mortality.
Results: According to NRS (≥3 points) the adequate medical nutrition
therapymay improve outcomes in 82% (n = 174) of critically ill patients
and the main risk factor was severity of disease (APACHE II > 10) – 99%
(n = 172). NRS (p = 0.001, HR 1.590) and NUTRIC (p = 0.000, HR 1.625)
scores were risk factors of hospital mortality. However, the level of
high nutritional risk (≥5 points NRS or NUTRIC), as described by
ASPEN authors, verifies in our subpopulation different groups of
patients: NRS n = 21 and NUTRIC n = 54, that included only six patients
with NRS≥ 5 points. The GLIM’s criteria of malnutrition met n = 41
patients (severe malnutrition n = 20, that included n = 15 with NRS≥ 5
and n = 7 patients with NUTRIC≥ 5).
Conclusions: Thus, various mathematical models, nutritional risks/
status criteria and disease severity assessments identifies different
groups of patient. Considering remarkable experience of Global
Leadership Initiative on Malnutrition, perhaps, in the future, it will
be possible to combine already existing or formulate new nutritional
risk criteria in order to standardize themwith malnutrition diagnostic
factors.
References
1. PubMed ID: 26773077.
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MON-PO614
DO OUR NEW STANDARDISED PARENTERAL NUTRITION (PN) BAGS
MEET PROTEIN REQUIREMENTS BETTER ON OUR INTENSIVE CARE
UNIT (ICU)?
M. Barne1*. 1Department Nutrition and Dietetics, Addenbrookes Hospital,
Cambridge, United Kingdom
* Corresponding author.
Rationale: ESPEN Critical care guidelines (2018)1 recommend 1.3 g
protein/kg actual body weight, aiming to meet >80% energy & protein
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requirements by day 3 on critical care. Protein intake ≥1.2 g/kg have
been linked with positive outcomes on ICU.2,3 Following an audit in
2016, protein provision was found to be suboptimal in ICU patient on
PN; a higher protein bag was introduced & a subsequent re-audit to
review change of practice. The ICU is amixedmedical & surgical unit in
large tertiary hospital.
Methods:All patients considered for PNunder the ICUdietitians over a
6 month period were included. Hospital records were retrospectively
analysed to compare the prescribed regime vs. estimated require-
ments. If patients were having a graduated build-up of PN, the target
regime was used. Chi squared was used for statistical analysis.
Audit standard:100% of patients receive 80–110% of their estimated
protein requirements
Results: Of the 107 new PN prescription, 67% of patients had a PN
regime that met between 80 and 110% of their protein requirements,
87% had a regime that met ≥80% of requirements (up from 25%
patients in 2016). Only 43% met ≥100% of requirements.
26% patientswere obese, these patientswere significantly less likely to
meet protein requirements than patients with a BMI <30 (29% vs 8%,
p < 0.01), 60% of patients on ≥10 ml/hr propofol did not meet
requirements vs 8.2% of those on <10 ml/hr propofol (p < 0.01).
Conclusions: Protein provision has significantly improved with the
change to higher protein bags, however 23% patients received <80% of
their protein requirements. Over a short period the impact may be
small, but patients requiring extended periods on PN could acquire a
significant protein deficit which may impact their survival and
recovery from a critical care stay. As a result of the audit we will be
exploring ways to supplement protein further.
References
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DETERMINANTOF DYSGLYCEMIA ANDGLUCOSE VARIABILITY IN ICU
LONG-STAYER PATIENTS
M.M. Berger1*, M.V. Viana1, G.E. Bagnoud1, A. Martinez1, O. Pantet1,
P. Eckert1. 1Service de Médecine Intensive Adulte, Centre Hospitalier
Universitaire VD CHUV, Lausanne, Switzerland
* Corresponding author.
Rationale: The intensive care (ICU) patient population has evolved
towards and increasing numberof very long ICU stays. Long-stayers are
defined as requiring more than 1 weeks of mechanical ventilation and
of ICU therapy. In an attempt to better coordinate their treatment and
reduce their length of stay, the service instituted a dedicated program
for patients staying more than 2 weeks. There is a lack of information
about their blood glucose profile and insulin needs over time. The
study aimed at investigating the factors associatedwith Hypoglycemia
(<4.1 mmol/l) or Hyperglycemia (>10 mmol/l) during the different
phases of their ICU stay.
Methods: Retrospective analysis of 150 consecutive patients admitted
to the long-stayer program of themultidisciplinary ICU. Data extracted
from the computerized system: age, weight, SAPS2 score, blood GLU
and lactate, daily glucose intakes, 24 hr insulin needs to achieve
glucose (Glu) targets 6–8 mmol/l. Separate analysis of the 5 first days,
and 6–30 days, and of days with dysglycemia. Data as mean±SD,
median [IQR 25–75], univariate analysis.
Results: The patients’ characteristics were: age 62 [52–71] years,
SAPSII score 51[39–66]. Early HyperGlu was associated with higher
severity (54.6 ± 17.4 vs. 52.1 ± 16.1 p = 0.040) and lactate (1.83[1.3–2.9]
vs 1.37[1.05–1.94]mmol/L, p < 0.001), but not with Glu intake, and
resulted in higher Insulin (34[11–76] vs16[0–38]UI/h, p < 0.001)
needs; late HyperGlu was observed in younger (62.6 ± 14.5 vs
63.8 ± 14.3; p = 0.013), heavier patients (BMI 27.6 ± 6.2 vs 25.3 ± 4.9
kg/m2; p < 0.001), and resulted in higher insulin (53[25–96] vs 4[0–32]
UI/h p < 0.001)needs. Early HypoGlu was observed in younger
(57.9 ± 16.6 vs 63.3 ± 13.9 years p = 0.013) and leaner patients (BMI
24 ± 6.3 vs 26.2 ± 5.5 kg/m2; p < 0.001), and late HypoGlu, in younger
patients (58.8 ± 19.2 vs 63 ± 14.2 years p = 0.003) with low Glu intake
(159.5[111.5–211.3] vs 199[156–245] g/day p < 0.001).
Conclusions: While hyperGlu was observed across the ICU stay, the
variables associated with Hypo- and HyperGlu differed over time. Late
HypoGlu was associated with low Glu intake, which was not observed
during the early period; leaner younger patientswere at highest risk of
HypoGlu, while modestly overweight elder patients were most
exposed to HyperGlu.
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THE SIGNIFICANCE OF THE CONUT SCORE FOR MEASUREMENT IN
TRAUMA PATIENTS
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T. Mawatari1,2, Y. Nomura1,2, A. Sugita1,2, A. Sakurai1,2, K. Kinoshita1.
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Rationale: The relationship between nutrition status of severe trauma
patients and their severity and outcome have been still clearly
unknown. The aim of study is to assess its relationship and how
should we detect their nutrition risk using by the Injury Severity
Score (ISS).
Methods: In this observational study, data were collected from injury
patients admitted to our ICU needing seven or more days of
hospitalization. We assessed nutritional condition using the
Controlling Nutritional Status (CONUT) score. The patients were
organized into two groups: (1) CONUT-low (CONUT-L) patients had
CONUTscores of four or less points on the seventh hospital day and (2)
CONUT-high (CONUT-H) patients had CONUT scores of five or more
points. We tested the correlation between length of stay in the ICU
(and hospitalization) and CONUT score, and we tested the correlation
between ISS on admission and the CONUT score.
Results:A sample of 21 patientswas analysed (eight CONUT-L patients
and thirteen CONUT-H patients). On the seventh hospital day,
transthyretin was significantly different between two groups (p =
0.01). Length of stay in the ICU (median days: 8.0 v.13.0, p = 0.016) and
length of hospitalization (median days: 24.0 v. 40.0, p = 0.039) were
significantly different. CONUT score on the seventh hospital day was
related to the ISS on admission (γ = 0.59, p = 0.005). The ISS on
admission was significantly different between the groups (median:
11.0 v. 25.0, p = 0.003). The area under the receiver-operating-
characteristics (ROC) curve when ISS was used to differentiate the
CONUT-L from the CONUT-H patients was 0.87, and the ISS value of 21
had the highest combined sensitivity and specificity.
Conclusions: The CONUT score provided knowledge about prognosis
for injury patients. The patients with scores higher than an ISS value of
21 might need a particularly careful assessment of their nutritional
conditions.
Disclosure of Interest: None declared.
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INCIDENCE OF GASTROINTESTINAL SYSTEM INTOLERANCE,
HYPERNATREMIA AND HYPERGLYCEMIA IN CRITICALLY ILL
PATIENTS: FIRST SEVEN DAILY MONITORING RESULTS AFTER
ENTERAL NUTRITION
N.T. Özer1*, N. Savas ̧2, S. Onuk2, H. Sipahioğlu2, G. Günes ̧ Şahin1,
S. Şahin1, M. Sungur3, K. Gündoğan2. 1Division of Clinical Nutrition,
Erciyes University Health Sciences Institute, 2Department of Medicine,
Division of Medical Intensive Care, Erciyes University, School of Medicine,
3Department of Medicine, Division of Medical Intensive Care, Erciyes
University Health Sciences Institute, Kayseri, Turkey
* Corresponding author.
Rationale:Gastrointestinal (GIS) intolerance, electrolyte disturbances,
hyperglycemia due to EN may develop frequently in critically ill
patients. We aimed to determine the incidence of GIS intolerance,
hypernatremia and hyperglycemia in the acute period.
Methods: The study was conducted prospectively in Intensive Care
Unit (ICU). Patients who are above 18 years old was received EN more
than 48 hours (h) in the first 72 h of ICU admission. Symptoms of GIS
intolerance were accepted as constipation, diarrhea, aspiration and
high gastric residual volume (GRV). We evaluated as high gastric
residual volume (GRV>150 mL), hypernatremia (Na>145 mmol/L) and
hyperglycemia (Blood glucose > 140 mg/dL).
Results: We enrolled 122 patients. The mean age was 59 ± 19 years.
The most common reasons for ICU admission were respiratory failure
(34%) and neurological diseases (20%). The mean SOFA score and
NUTRIC score of the patients was respectively 9 ± 3, 5 ± 2. A rate of
37.7% of the patients had diabetes mellitus and blood glucose levels
were optimized by applying insulin protocol to these patients. A total
of patients, 74% were received nasoduodenal nutrition and 16% of the
patients received nasogastric nutrition. At baseline,meanNavalue and
blood glucose value was respectively 142.6 ± 6.51 mmol/L, 138.2 ±
57.67 mg/dL in patients. GIS intolerance symptoms due to EN and
patients number are listed in Table 1. It was observed that
hyperglycemia in 105 patients (86%) and hypernatremia in 77 patients
(63%).
Table 1
Frequency and number of patients with symptoms of GIS intolerance due to EN.
Symptoms of
GIS intolerance
Patient (%) Frequency (times)
Constipation 81 (66) 226
Diarrhea 56 (46) 117
High GRV 31 (25) 62
Conclusions: The most common symptoms of GIS intolerance were
determined that constipation and diarrhea in patients who were
received EN in ICU. Hyperglycemia and hypernatremiawere also found
to be high rate in the patients.
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FACTORS AFFECTING THE CANDIDEMIA IN PARENTERALLY FED
PATIENTS
N. Surmelioglu1*, N. Yalcin2, B. Kelleci2, K. Demirkan2, M. Gunduz3.
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Rationale: The incidence of candidemia has increased in recent years
and it is an important cause of mortality andmorbidity in hospitals. In
order to reduce the risk of candidemia, empirical treatment should be
initiated in high-risk patients group. To identify high-risk patients
group usually clinical risk factors are used. Important risk factors for
the candidemia have been identified and indicated in the ‘Candida
Score’ and ‘Predictive Rules’. Parenteral nutrition (PN) is one of these
important factors.
The aimof this studywas to evaluate the risk factors other than the risk
factors indicated in the Candida Score thatmayaffect the development
of candidemia in non-neutropenic adult patients who received PN
treatment.
Methods: Patients who were admitted to a university hospital
between 1st of January and 31st of December 2018, over 18 years
old, non-neutropenic, who don’t received chemotherapy during PN
treatment, who were applied Candida growth screening tests before
and after PN treatment and who has negative Candida growth
screening test result before PN treatment were included in the study.
Patients with and without Candida growth after PN treatment were
compared in terms of demographic characteristics, days of hospital-
ization, duration of PN treatment, leukocyte, platelet, empiric
antifungal administration and other drugs. Statistical analysis was
performed using SPSS V.23 program.
Results: Total of 75 patients included in the study. From the total of
patients, 31 were female, and the mean±standard deviation of agewas
60,84 ± 17,083 and in 28 of them, Candida growth detected after PN
treatment. The number of days in the hospital (p = 0.023) and the
duration of PN treatment (p = 0.001) were found to be statistically
related to Candida growth. The mean day of Candida growth duration
was found 13,21 ± 5,84 days in patients with Candida growth. In the
binary logistic regression analysis to determine the effect of the drugs
used on the growth of candida it was found that carbapenem (Odds
ratio 15.82 and 95% confidence interval 1.85–134.93, p = 0.012),
tigecycline (Odds ratio 38.32 and 95% confidence interval 1.38–
1062.08, p = 0.031) and empirical antifungals (Odds ratio 0.014 and
95% confidence interval 0.001–0.27, p = 0.005) were found to be
effective variables.
Conclusions: In conclusion, it should be kept in mind that the use of
broad-spectrum antibiotics, especially carbapenem, and tigecycline,
may also present a risk for the development of candidemia in
patients receiving PN treatment, as well as the known risk factors
such as long duration of hospital stays and empirical antifungal agent
usage.
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CORRELATION OF GENDER AND BODY PARAMETERS WITH
OBJECTIVE MEASURES OF MUSCLE STRENGTH AND FATIGUE
O. Vysata1*, A.M. Bhorkar2, M. Valis2, Z. Zadak3. 1Department of
Neurology, Charles University Faculty of Medicine and University
Hospital, Sokolska 581, Hradec Kralove, 2Department of Neurology,
Charles University Faculty of Medicine and University Hospital,
Sokolska 581, Hradec Kralove, 3Centrum for Science and Research,
Charles University Faculty of Medicine and University Hospital,
Sokolska 581, Hradec Kralove, Hradec Kralove, Czech Republic
* Corresponding author.
Rationale: Intensive care patients can lose 20% of their muscle
mass in just 10 days. It can contribute to long-term disability. In
these patients, it is difficult to measure muscle strength and fatigue
with current methods due to lack of cooperation. In this pilot study
we are testing the dependence of objective maximum muscle
strength and fatigue on sex, weight, height, calf circumference and
degree of training.
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Methods: Muscle strength of the tibialis anterior muscle was
measured by increasing electric current intensity stimulation in the
motor point of the muscle. Muscle fatigue was measured by 16 series
of repetitive high frequency stimulations with 70% of maximum
intensity used for muscle strehgthmeasurement. The air pressurewas
measured in the cuff located on the instep of the foot fixed in a solid
plunger. Twomeasurementswere performed on 14 healthy volunteers
over a 2 weeks. Association betweenmeasured values and sex, weight,
height, calf circumference and degree of training was measured by the
Pearson product-moment correlation coefficient.
Results: Significant association was found between muscle strength
and calf circumference (Pearson’s correlation coefficient = 0.68, p =
0.02). Other associations were non-significant.
Conclusions: The proposed method measures the force of the muscle
fibers in a cylindrical volume defined by the size and distance of
stimulation electrodes. Since a larger calf volume means a greater
column height of the muscle fibers between the electrodes, this
parameter is positively correlated with the maximummeasured force.
On the other hand, other parameters do not affect the strength of a
defined volume of healthy muscle fibers.
Supported by MH CZ – DRO (UHHK, 00179906)- by the grant projects
of the Ministry of Health of the Czech Republic (FN HK 00179906) and
of the Charles University in Prague, Czech Republic (PROGRESQ40) the
project: PERSONMED – Center for the Development of Personalized
Medicine in Age-Related Diseases, Reg. Nr. CZ.02.1.01/0.0/0.0/17_048/
0007441, co-financed by ERDF and state budget of the Czech Republic.
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OR TO BREATHE: ENERGY AND PROTEIN INTAKE IN CRITICALLY ILL
PATIENTS WITH RESPIRATORY FAILURE TREATED BY HIGH FLOW
NASAL CANNULA (HFNC) OXYGENATION.
O. Zerbib1*, S. Rattanachaiwong2, N. Palti3, I. Kagan1, P. Singer1.
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Research, Rabin Medical Center, Tel Aviv, Israel, 2Division of Clinical
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Rationale:HFNCoxygenation ismore frequently used in the ICU. Since
this treatment can be given for many days and may impair nutritional
intake, we planned to evaluate the energy and protein intake of
patients receiving this therapy.
Methods: Patients requiring HFNC oxygenation after extubation
or to prevent intubation were included consecutively in 2018.
Demographics, route of nutrition (oral, enteral and/or parenteral),
calories and protein prescribed and administered, complications were
noted at the day of observation and until discharge. Statistical analysis
used Chi square or KruskalWallis H test. Values are in mean and range
or ±SD.
Results: Forty two HFNC therapies were applied in 40 patients, 2.5
days after admission in mean. HFNC was 51.5 hours (21- = 103.5). Age
was 51 ± 19, BMIwas 25.4 kg/m2, 60%weremale, APACHE II was 19 ± 6,
SOFA 6.8 ± 2.9. 62.5% were post extubation and 37.5% to defer
intubation. 21 patients treated with tube feeding (TF) received 365
(247–1193) kcal/d and 18.5 (13.9–33.3) g/d protein, while those with
oral feeding (OF) (n = 13) received higher (p < 0.04) calories: 621 (459–
850) kcal/d and 22 (20–45) g/d protein. Parenteral nutrition alone
(3 pts) or with TF (3 pts) did not provide more than 500 kcal/d (244–
1193). When PN was administered with TF, it provided only 306 (50–
504) kcal/d. Two patients did not receive any nutrition. TF patients
stayed longer (p < 0.03) (14 days, 8–20) than OF group (4 days, 2–10
range) only). Patients with no nutrition stayed the shorter (5.5 days, 4–
7). Thirteen patients required intubation (8 from TF) and 2 died (1 on
TF and 1 on TF and PN). LOS in the ICU was 8 (5–17) days
Conclusions: OF is more efficient to reach calorie and protein target
when compared to TF in patients receiving HFNC oxygenation.
However, both are underfeeding these patients and energy require-
ment remains to be determined.
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VALIDITYOF PREDICTIVE EQUATIONS FOR ESTIMATION OF RESTING
ENERGY EXPENDITURE AMONG MECHANICALLY VENTILATED
CRITICALLY ILL PATIENTS AT DIFFERENT PHASES OF CRITICAL
ILLNESS
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Rationale: Several predictive equations (PEs) have been developed for
estimation of resting energy expenditure (REE) but no validity study
has been done among mechanically ventilated critically ill patients in
Southeast Asian population. This study is aimed at determining the
validity of eight PEs for prediction of REE among critically ill adult
Malaysian patients during acute phase (≤5 days), late phase (6–10
days) and chronic phase (>10 days) in intensive care unit (ICU).
Methods: This was a prospective observational study conducted in a
mixed ICU of University of Malaya Medical Centre, Malaysia from
December 2016 to December 2018. REE was measured among 302
patients (acute phase), 180 patients (late phase) and 91 patients
(chronic phase) by using Indirect Calorimetry (IC). Comparisons were
made with eight commonly used predictive equations (with a total of
21 sub-equations): Harris Benedict (HBE) basic (1919) & variants
(1999), Mifflin St Jeor (MSJ) (1990), Swinamer (1990), Penn State
equations (PSU; 4 variants), American College of Chest Physicians
(ACCP) (1997), Brandi (1999), Faisy (2003) and European Society for
Clinical Nutrition and Metabolism (ESPEN) (2006) to estimate the
energy requirement of the patients. Degree of agreement for REE
estimated by eight PEs (REE-PE) was validated against REE measured
by IC (REE-IC) using intraclass correlation coefficient (ICC) and the
Bland-Altman test. The accuracy is defined as REE-PE values differing
within ±10% range compared to REE-IC.
Results: Mean REE-IC for all critically ill patients was 1762 ± 447 kcal
(acute phase), 1884 ± 508 kcal (late phase) and 1856 ± 445 kcal
(chronic phase). In the acute phase, both Penn State equations [PSU
(HBE) 2003a] and [PSU (m) 2003b] showed the highest agreement
with REE-IC (ICC 0.655, 95% CI 0.585–0.715) and (ICC 0.655, 95% CI
0.557–0.731) respectively, p < 0.001. For late phase, Brandi (1999)
equation showed highest agreement with REE-IC (ICC 0.701, 95%CI
0.615–0.770; p < 0.001). During chronic phase, Faisy (2003) equation
showed the highest agreement with REE-IC (ICC 0.745, 95%CI 0.614–
0.831; p < 0.001). Based on the Bland-Altman test, good agreement
was also observed between these REE-PE and REE-IC which char-
acterized bya narrow interval. Percentage of accuracy for these REE-PE
were approximately 40%. The equations that consistently showed good
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agreement (ICC 0.6–0.8) for all of the three phases were Brandi (1999),
Faisy (2003), Swinamer (1990) andHarris Benedict (1919) × 1.25. None
of the REE-PE had excellent agreement (ICC > 0.8).
Conclusions: PEs tend to over or underestimate the energy require-
ment of critically ill patients. This occurs at different phases of critical
illness. The usage of IC is important for patient care. When IC is not
available, a PE that is developed from the relevant population should
be used.
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L-CITRULLINE REDUCES AMMONIUM ACETATE INDUCED
HYPERAMMONEMIA IN MICE
P. Girard1*, M.-C. Coppé1, P. Cloarec1, M. Verleye1. 1Pharmacologie,
BIOCODEX, Compiègne, France
* Corresponding author.
Rationale: Urea cycle disorders disrupt the conversion of toxic
ammonia into urea inducing hyperammonemia that affect the
central nervous system (Summar and Mew, 2018). Our goal is to
evaluate the beneficial effect of the urea cycle intermediate L-citrulline
(LC, Biocodex-Gentilly-France) in the ammoniumacetate (AA) induced
hyperammonemia model in mice.
Methods: For this purpose, two studies were performed in male CD1
mice according to themethod of O’Connor et al. (1984): a lethal dose of
AA (12 mmol/kg) was administered to assess the impact of LC on the
neurological score and on the percentage of death, and a non-lethal
dose of AA (8 mmol/kg) to evaluate its impact on the blood ammonia
level. Behaviour was assessed according to Stephens and Levy (1994).
Data are expressed asmeans±SEM, and statistical analysis are based on
ANOVA. ED50 (dose inducing an effect in 50% of animals) was
determined according to Tallarida s’ method (2001).
Results: Intraperitoneal administration of 12 mmol/kg AA rapidly
produces behavioural troubles and death occurs in 90–100% of mice.
LC intravenous administration (2 mmol/kg) significantly reduces the
neurological score and the percentage of death (8%). Oral administra-
tion of LC (4 mmol/kg) also significantly decreases the neurological
score and the percentage of death (25%). Concerning protection from
death, LC ED50s values are of 0.79 ± 0.16 and 0.98 ± 0.10 mmol/kg by
intravenous or oral route, respectively. LC intravenous or oral
administration significantly reduces hyperammonemia by 52 and
62% respectively.
Conclusions: These results show that intravenous or oral administra-
tion of L-citrulline effectively reduce both death frequency and
neurological troubles induced by a lethal dose of ammonium acetate
and decrease blood hyperammonemia induced bya non-lethal dose of
AA inmice. L-citrulline confirms to be an efficient compound to reduce
clinical manifestation of hyperammonemia in this animal model.
References
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ASSESSMENT OF FEEDING INTOLERANCE DEFINITIONS IN THE
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Rationale: Intolerance, or presumed intolerance, to enteral nutrition is
one of themain factors for not reaching target caloric goals in critically
ill children. Feeding intolerance (FI) is inconsistently defined in current
literature. Our aim was to evaluate the association between FI and
clinical outcomes using different definitions of FI and to determine the
most predictive definition.
Methods: Prospectively collected data obtained in the PEPaNIC RCT
study of patients with an admission of ≥4 days and complete GI
assessment were used. Clinical endpoints were newacquired infection
and PICU mortality. Assessment of FI definitions were performed by
adding the presence of FI in multiple regression models including
baseline variables, severity of illness, centre and early PN randomiza-
tion on admission day 4. The FI definitions analysed were: 1) large
gastric residual volume (GRV) (defined as ≥5 ml/kg/day); 2) Percent of
enteral intake compared to resting energy expenditure (REE); 3)
Presence of one or multiple GI symptoms (GRV, vomiting, diarrhoea
and abdominal distention); 4) Combination of GI symptoms and
percentage of enteral intake to REE. The considered enteral intake
thresholds were set arbitrarily based on the literature, or derived from
ROC analysis.
Results: In total, 431 patients were included with a median age of 0.9
years [IQR 0.1–6.0], PRISM score of 9 [IQR 5–15] and PICU length of stay
of 9 days [IQR 5–16]. New infection occurred in 122 (28%) patients and
22 (5%) died during PICU admission. The FI definition that was most
predictive for new infectionwas defined as having enteral intake≤ 35%
of REE (p = 0.004; OR 2.07 (95%CI1.27–3.38)). No significant associa-
tions were found between PICU mortality and the different FI
definitions.
Conclusions: On day 4 of admission, feeding intolerance defined as
enteral intake ≤ 35% of REE was most associated with the primary
outcome measure new infection. This definition might provide a
stepping stone for future research.
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HYPERGLYCEMIA AND MODIFIED NUTRIC SCORE IN CRITICAL
PATIENTS HOSPITALIZED IN AN INTENSIVE CARE UNIT
L.A.P. Souza1, L.F.M. Oliveira1, R.L. Ferretti1*. 1University of Taubate,
Taubaté, Brazil
* Corresponding author.
Rationale: Hyperglycemia is common in hospitalized patients,
especially thosewho are critically ill. The NUTRIC score is a nutritional
risk assessment tool for critically ill patients. Themain objective of this
study was to verify the association between hyperglycemia and
modified NUTRIC score in critical patients hospitalized in an Intensive
Care Unit at a hospital in the city of Taubaté/SP
Methods: A cross-sectional study with secondary data of critical
patients in an Intensive Care Unit, from August 2017 to June 2018,
contemplating male and female patients aged 18 years or older. The
variables of interest are age, sex, clinical diagnosis, APACHE II, SOFA,
number of comorbidities, length of hospital stay before admission to
the ICU, and type of nutritional therapy to evaluate the NUTRIC score,
which was considered high (>5 points) and low (0–4 points).
Hyperglycemia was considered when blood glucose was higher than
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180 mg/dL. For data evaluation, we performed descriptive statistics,
chi-square of independence and relative risk analysis (odds ratio) with
95% confidence interval. The level of statistical significance considered
was p <0.05.
Results:A total of 30 patientswere selected, of which 70%were female
(n = 21). The mean agewas 68.57 years±16.34, and the mean glycemia
was 192,37 ± 64,36 mg/dL. The prevalence of hyperglycemia was 67%.
And prevalence of high nutritional risk was in 70% of the patients. It
was verified that there is an association between hyperglycemia and
NUTRIC score. There was an association between hyperglycemia and
NUTRIC score (p <0.001). Patients with hyperglycemia presented a
100% risk for the high nutritional risk by the NUTRIC score [OR = 1.0
(0.698–1.644)]
Conclusions: It is concluded that there is an association between
hyperglycemia and adapted NUTRIC score in critically ill patients. The
majority of the patients presented hyperglycemia (67%) and high
nutritional risk according to the NUTRIC score (70%).
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Rationale: Purpose of this audit is to improve patient care by
identifying the number of patients who received prescribed continu-
ous tube feeding in ICUs of the NHSL.
Recent ICU guideline of ESPEN (European society of clinical nutrition
and metabolism) recommended continuous feeding rather than bolus
enteral feeding for ICU patients and ASPEN (American society of
enteral and parenteral association) guideline also recommended
continuous tube feeding for patientswith intolerance to bolus feeding.
Methods: Convenience sample of 50 patients who were prescribed
continuous feeding, selected from ICUs. Measure of level of perform-
ance in ICUs are taken as, at least 80% of the expected ideal standard
(100%) due to limited resources
Results: In this audit 33 patients from 50 had been given continuous
feeding in the ICUs. Percentage of the continuous feeding is 66%.
Reasons for not having continuous feeding are non-availability of
feeding pumps and bags (20%), lack of knowledge regarding operation
of the feeding pumps (6%), lack of knowledge regarding importance of
the continuous feeding for feeding intolerant patients (4%)and lack of
care providers in the ICUs (4%).
Achievement of prescribed energy delivery is 74% in this sample.
Performance of continuous feeding is well below the standard
expectation (80%) and did not meet the standard. Achievement of
prescribed energy delivery also did not meet expectations.
Main reasons for these results are lack of feeding pumps and feeding
bags, shortage of staff, lack of knowledge regarding operation of
pumps and importance of continuous feeding
Conclusions: Continuous feeding practices in NHSL did not meet
expectations. Steps should be taken to increase feeding pumps, bags
and training of ICUs care providers.
Re-audit is mandatory for evaluate the impact on feeding practices by
these measures
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RESTRICTION TO DELAY RENAL REPLACEMENT THERAPY IN SEPTIC
PATIENTS WITH ACUTE RENAL FAILURE IN THAMMASAT
UNIVERSITY HOSPITAL, PRELIMINARY ANALYSIS.
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Medicine, 2Epidemiology, Thammasat University, Bangkok, Thailand
* Corresponding author.
Rationale: Currently, there is no consensus on amount of protein
intake among acute kidney injury (AKI) with septic patients that not
receiving renal replacement therapy (RRT). Protein from food can
enhance urea production,whichmay cause uremia resulting in dialysis
need. This research investigated the effect of limiting protein intake
and its effect on delaying dialysis.
Methods: The study design was non-blinded randomized controlled
trial in septic patientswith AKI. Patientswas enrolled based on inclusion
criteria that were 1. acute kidney injury stage 2 according to KDIGO
definition 2. sepsis patients with any source 3. received enteral feeding
or parenteral nutrition 4. not have contraindication for nutritional
support and exclusion criteria that were 1. refused treatment before RRT
2. improved AKI or death within 48 hours 3. initiated RRT within 48
hours. The enrolled patients were randomized into a study group with
low protein, 0.9–1.0 gm/kg/day, and control group, receiving protein
1.2–1.5 gm/kg/day. Both groups received the same amount of energy at
20–25 kcal/kg/d. The collected datawere baseline characteristic, time to
dialysis, time to death 30 daysmortality, hospital acquired infection, rate
of catheter related blood stream infection and BUN/Cr each day until AKI
resolved or dialysis initiation.
Results: A total of 32 patients underwent randomization. 7 patients
were excluded by exclusion criteria. Mean age in low protein group and
normal protein group were 75.3 ± 18.7, 75.7 ± 18.5 years old (p = 0.96).
Actual weight were 58.7 ± 14.6, 59.5 ± 11.6 kg (p = 0.88). Ideal body
weight were 53.9 ± 5.5,51.7 ± 4.1 kg (p = 0.28). baseline GFR were
77.8 ± 20, 68.5 ± 18.2 ml/min/1.73m2 (p = 0.23). The Kaplan–Meier
estimates of time to indication for dialysis did not differ significantly
(P = 0.966), time to event of starting dialysis did not differ significantly
(P = 0.995) and time to death did not differ significantly (P = 0.659)
between two groups. There were no significant difference between the
normalprotein and lowproteindiet groupon30-daymortality (38.5%vs
50%, P 0.561), rate of hospital acquired infection (61.5% vs 75%, P 0.673),
and catheter related blood stream infection (0% vs 16.7%, P 0.22).
Conclusions: In this preliminary report, there was no significant
difference in time to dialysis between two groups. As a result, limited
protein intake may not increase benefit of delay RRT in sepsis patients.
However, this trial had limitation due to low number of study
population.
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PROBLEMS IN REACHING TARGET CALORIES IN INTENSIVE CARE
UNIT: PROSPECTIVE, SINGLE CENTER, FIRST SEVEN DAYS FOLLOW-
UP RESULTS AFTER ENTERAL NUTRI˙TI˙ON
S. Onuk1, N.T. Özer2, N. Savas ̧1, S. Şahin2*, G. Günes ̧ Şahin2,
H. Sipahioğlu1, M. Sungur1, K. Gündoğan1. 1Department of Medicine,
Division of Medical Intensive Care, Erciyes University, School of Medicine,
2Division of Clinical Nutrition, Erciyes University Health Sciences Institute,
Kayseri, Turkey
* Corresponding author.
Rationale: Enteral nutrition reduces morbidity and mortality in
critically ill patients. It has got some problems reaching the target
calories. The aimof this studywas to determine these problems during
enteral nutrition in acute period with critically illness.
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Methods: This study was performed prospectivly in Intensive Care
Unit (ICU). The study was carried out in the first 72 hours after
admission. The patients were 18 years and older whowere fed enteral
for 48 hours.
Results: In this study 122 patients were included. The mean age was
59 ± 19 years. The most common of reason for ICU admission were
respiratory failure (34%) and neurological diseases (20%). The mean
APACHE II score was 22 ± 7. Mean NUTRIC score was 5 ± 2. Nutrition
route of patients were 74% by nasoduodenal and 16% by nasogastric
route. The target caloric requirement of the patients was 1805 ± 308
kcal/day. Patients received calories were 900 ± 374, 1368 ± 637,
1432 ± 645 and 1420 ± 603 kcal/day on 1, 4, 6 and 7 days respectively.
Enteral nutrition was interrupted 323 times during ICU. The most
common causes and durations are shown in Table 1.
Table 1
Reasons and duration of enteral nutrition interruption.
Causes of most interruptions
(range)
Frequency
(times)
Duration
(h)
Radiological operations 80 3(1–43)
Problems with feeding tube 45 25(1–111)
Hemodynamic instability 31 22(2–116)
Perioperative prosedures 31 6(1–30)
Conclusions: As a result of this study, malnutrition risk was found to
be high in patients with intensive care unit followed by enteral
nutrition. The calculated target calorieswere reached at amaximumof
79.3% on the sixth day. The biggest obstacle to achieving target calories
was found as a daily radiological procedure.
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FASTING IS ASSOCIATED WITH LOWER IN-HOSPITAL SURVIVAL IN
ELDERLY CRITICALLY ILL PATIENTS
S.H. Loss1*, M.V. Viana1, P.D.V. Teichmann2, L.A. Gross2, L.F. Sperb2,
B.O. Lisboa2, V.L. Costa2, T.P. Paula2, L.V. Viana2. 1ICU, HCPA, 2Nutrology,
UFRGS, Porto Alegre, Brazil
* Corresponding author.
Rationale: Elderly patients (>65 years) have an increased nutritional
risk. During critical care stay fasting is prescribed due to various
reasons. We hypothesized that in elderly critically patients fasting
would have a deleterious effect
Methods: This is a retrospective cohort that evaluated fasting in the
first 7 days of ICU admission. We excluded patients that stayed less
than 24 hours. Patients were divided into two groups: fasting group
defined as prescription of no nutritional support for at least 24 hours
and the fed group defined as having a prescription of any type of
nutrition support. We performed a cox regressionmodel analysis with
in-hospital mortality as the outcome variable
Results: The hospital mortality of the 540 included patients was 54.1%
after 21 [13–38] days of follow-up (age 74.01 ± 6.83 years, male 281
(52%), SAPS3 67.1± 13.89, BMI 27.03 ± 6.05) The fasting group hadmore
surgical patients (32% vs.10.8% p < 0.001), higher SAPS3 (70.31 ± 13.44
vs 65.98 p < 0.002) and mortality (68.5% vs 49.1% p < 0.001) compared
to the fed group. There was no difference between fasting and fed
group regarding admission age, sex and BMI. In a multivariate cox
regression analysis (HR,95%) fasting was independently associated
with mortality (fasting 1.61[1.20–2.16]; SAPS3 1.02[1.01–1.03];
Surgical admission 0.74[0.49–1.12]
Conclusions: In elderly critically patients fasting was a predictor for
in-hospital mortality
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INDICATIONS FOR PERCUTANEOUS ENDOSCOPIC GASTROSTOMY IN
PATIENTS WITH ACUTE CEREBRAL INFARCTION
Y. Ogawa1*, A. Naganuma1, M. Inagawa1, M. Kimura1, M. Kanai1,
T. Yoshida1, T. Kaneda1, A. Morohoshi1, C. Shimoda1, K. Sakamoto1,
M. Manome1, K. Noguchi1, T. Tanaka1, T. Ogawa1, H. Ishihara1. 1Akasaki
General Medical Center National Hospital Organization, Takasaki-shi
Gunnma-ken, Japan
* Corresponding author.
Rationale: Early enteral feeding is recommended in patients with
acute cerebral infarction (ACI), who cannot take food orally.
Percutaneous endoscopic gastrostomy (PEG) is recommended if
enteral nutrition is needed for ³1 month. However, many patients in
our hospital are discharged with nasogastric tubes instead of
undergoing PEG, as dysphagia often improves within a few weeks.
We retrospectively assessed the characteristics of patients with ACI in
whom dysphagia was found by videoendoscopic examination of
swallowing (VE) at admission, and PEG indicated at discharge.
Methods: We studied 274 patients with ACI who underwent VE on
hospital admission during the 3 years from April 2016 and had a Food
Intake Level Scale (FILS) score of ≤7, excluding those with mild
dysphagia. Patientswith an FILS score≤3 at dischargewere considered
to have severe dysphagia and PEG was indicated (Group A, n = 71),
whereas thosewith an FILS score at discharge of≥4were considered to
have mild dysphagia (Group B, n = 203). Age, sex, body mass index
(BMI), serum albumin level and FILS score at admission, amount of
nutrition administered on the 3rd and 7th day of hospitalization, and
infarction site (supra- or infratentorial) were assessed. Factors
contributing to group A pathology were identified by logistic
regression analysis using EZR software, by dividing the observational
items into binary variables.
Results: The mean hospitalization length in group Awas 32 days. Five
patients underwent PEG. In group B, the recovery from dysphagia to an
FILS score ≥4 required up to 15 days. Multivariate analysis identified
FILS score≤3 at admission (p < 0.0001), BMI≤22 (p = 0.04), and serum
albumin level ≤3.0 g/dL at admission (p < 0.001) as the contributing
factors to group A pathology.
Conclusions: PEGmay be considered in patients with ACI meeting the
following criteria at admission: FILS score ≤3, BMI ≤22, or serum
albumin ≤3.0 g/dL.
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EFFECTIVENESS AND SAFETY OF SELENIUM SUPPLEMENTATION
FOR TYPE 2 DIABETESMELLITUS INADULTS: A SYSTEMATIC REVIEW
OF RANDOMISED CONTROLLED TRIALS
A. Stróżyk1*, Z. Osica2, J.D. Przybylak2, M. Kołodziej1, B.
M. Zalewski1, B. Mrozikiewicz-Rakowska3, H. Szajewska1.
1Department of Paediatrics, 2Medical University of Warsaw, Warsaw,
Poland, 3Department of Diabetology and Internal Diseases, Medical
University of Warsaw, Warsaw, Poland
* Corresponding author.
Rationale: Although selenium (Se) is an essential micronutrient and
antioxidant, its role in the management of type 2 diabetes mellitus
(T2DM) remains unclear. We systematically assessed the effectiveness
and safety of Se supplementation in adults with T2DM.
Methods:MEDLINE, EMBASE, and the Cochrane Librarywere searched
up to April 2018 for randomised controlled trials (RCTs), evaluating the
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effectiveness of Se against a comparator on DM-related outcomes. The
methods were specified in advance and documented in a protocol
published in PROSPERO with registration number CRD42017078657.
Results: Four RCTs (241 participants) were included. In individual
RCTs, Se administration significantly reduced fasting insulin levels
(mean difference (MD), −3.6 μIU/mL; 95% CI, −6.36 to −0.84; MD,
−5.8 μIU/mL; 95% CI, −9.23 to−2.37), HOMA-IR (MD,−1; 95% CI, −1.79
to −0.21; MD, −1.6; 95% CI, −2.58 to −0.62), and HOMA-B (MD, −13.6;
95% CI,−23.4 to−3.8;MD,−22.6; 95%Cl,−36.39 to−8.81). No effects of
Sewere noted onmost of the other outcomes of interest. The impact on
HDL was ambiguous. None of the RCTs assessed the mortality,
diabetes-related complications, non-HDL, blood pressure, and
health-related quality of life. The impact on HDL and fasting plasma
glucose (FPG) was ambiguous. Only one adverse event (nausea) was
reported as a reason for discontinuing the intervention, however,
among the studies, the reporting was not accurate. Furthermore, only
one RCT reported increase in FPG level in Se group (MD = 36.38 mg/dl;
95% CI = 15.39 to 57.37).
Conclusions: Currently, there is no evidence to support the effective-
ness of Se supplementation in T2DM population. Due to the increased
risk of adverse effects in patients with T2DM supplemented with Se,
safety should be carefully assessed in further, well-designed RCTs.
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EFFECT OF VITAMIN D SUPPLEMENTATION IN PEOPLE WITH
CHRONIC OBSTRUCTIVE PULMONARY DISEASE: A SYSTEMATIC
REVIEW.
A.V.O. Moreira1*, J.B.P. Mendes1, J.M. Sacramento1, A.A. Camelier1,
F. W. R. Camelier1. 1Bahia State University, Salvador, Brazil
* Corresponding author.
Rationale: The epithelial lining and pulmonary immune cells can
produce vitamin D, increasing the synthesis of antimicrobial peptides,
regulation of the inflammatory response, remodeling of the airways
and improvement of respiratory muscle function. Nevertheless,
evidences indicate that people with Chronic Obstructive Pulmonary
Disease (COPD) exhibit low serum vitamin D levels. The aim of this
review was to systematize knowledge to investigate the potential role
for vitamin D supplementation in people with COPD.
Methods: The review protocol was registered in the International
Prospective Register of Systematic Reviews through trial registration
number CRD42018105156. Web of Science, Scopus, EMBASE and
Medlinewere searched. Studies were eligible for inclusion if theywere
randomized clinical trials that applied oral supplementation of
cholecalciferol, evaluated serum levels by 25 (OH)D, studies published
in English, Portuguese or Spanish; and excluded studies with
individuals with others associated respiratory conditions.
Results:Of the 63.583 records identified,10were eligible for inclusion.
The intervention period into the studies ranged from six weeks to 12
months; the interventions ranged from 800 IU to 300.000 IU. All were
efficient at elevating serum levels of 25 (OH)D >50 nmol/L. The
statistical increase in predicted FEV1% (p = 0.001), decrease in the
frequency of exacerbations (p = 0.021; p = 0.042; p = 0.001; p = 0.001)
and improvement in functional capacity (p = 0.001) was observed.
Conclusions: The present review suggest a potential role for vitamin D
supplementation in reducing the frequency of exacerbations, improv-
ing lung function and physical performance in people with COPD.
Nevertheless, the studies exhibit many heterogeneities and conflicting
results.
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THE PREVALENCE, CONTRIBUTING FACTORS AND SIDE EFFECTS OF
CAFFEINE CONSUMPTIONAMONG LEBANESEUNIVERSITYMEDICAL
AND PHARMACY STUDENTS.
S. Hlais1, R. Francis1, S. Jneid1, A. Aoun2*. 1Saint Joseph University, Beirut,
2Notre Dame University – Louaize, Zouk Mosbeh, Lebanon
* Corresponding author.
Rationale: Caffeine is the most widely consumed psychoactive
substance. Unlike many other psychoactive substances, it is legal and
unregulated in all parts of the world. More than 90% of the adult
population consume it on daily basis.
Methods: The objective of the study was to evaluate the prevalence of
caffeine consumption in Lebanese University students, as well as the
socio-demographic, lifestyle and health characteristics associatedwith
this consumption. The study also aimed to explore students’ knowl-
edge about the caffeine content of different beverages and to evaluate
the side effects of excessive caffeine consumption. A cross sectional
online self- administered questionnaire was sent in October and
December 2018 to medicine and pharmacy students at the Saint-
Joseph University, Beirut, Lebanon. The chi-square statistical test was
used. Bivariate analysis was conducted with the consumption of
caffeine as the dependent variable.
Results: The total numberof respondentswas 251with a response rate
of 40.3%.Mean agewas 21 years with a range between 17 and 28 years.
Overall students’ knowledge of the caffeine content of different
beverages and products was generally very good. The prevalence of
caffeine consumption among participants was 95.6% with a 95%
confidence interval of (93.1% – 98.2%); 75.3% noticed an increase in
consumption after entry to university. No significant association was
found between caffeine consumption and the consumption of tobacco,
alcohol and vitamins. Reported caffeine consumption increased
especially during exam periods. The beneficial effects described by
the majority of consumers were improved attention, concentration
and alertness. 24.6% of students stated being a highly dependent; Only
50% of students reported no withdrawal symptoms when caffeine is
stopped for more than 24–48 hours. Adverse effects of caffeine
consumption such as palpitations, tremors, insomnia and pollakiuria
were reported by 18% to 24% of students. Our bivariate analysis showed
that 21 years was the threshold age at which the average caffeine
consumption increases (p-value = 0.01) as well as the perceived risk of
caffeine dependence (p-value = 0.005).
Conclusions: Future physicians and pharmacist specialists play a
major role of counseling in public health. Monitoring of their
knowledge and their personal consumption of caffeine is of great
importance.
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PLASMA LEVELS OF VITAMINS AND TRACE ELEMENTS ARE LOW IN
PATIENTS WITH CONTINUOUS VENO-VENOUS HEMOFILTRATION
THERAPY AND IV DOUBLE VITAMIN AND TRIPLE TRACE ELEMENT
SUPPLEMENTATION IS SAFE. RESULTS FROM THE MECCIAS TRIAL.
E. De Waele1*, J. Jonckheer1, R. Jacobs1, J. Demol1, K. Lanckmans2,
M.L. Malbrain1, H.D. Spapen1. 1ICU, 2Hematology and Clinical Chemistry,
UZ Brussel, Brussels, Belgium
* Corresponding author.
Rationale: Continuous veno-venous hemofiltration (CVVH) removes
non-selective molecules such as vitamins and trace-elements.
Nutritional therapy needs to be adapted to those losses. Double
clinical available doses of vitamins and triple trace-elements could
intervenewith plasma levels. The aimwas tomonitor plasma levels for
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safety while administering high IV doses combined with parenteral
nutrition for 24 hours during CVVH.
Methods: Ten ventilated critically ill adult patients on CVVH were
treated with parenteral nutrition (1070 kcal, 56 g protein) enriched
with double dose of commerciallyavailable IV vitamins and triple dose
of trace elements for 24 hours. Plasma levels of 8 vitamins and 5 trace-
elements were monitored by samples before administration of this
‘CVVH survival solution’, after 30minutes and 24hours. Comparison to
limits of normal was done.
Results:
Low Plasma status High Plasma Levels Normal Plasma Levels
Vit C Vit B12 Vit B1 Vit B9 Vit AVit E
Vit D Vit B6 Mangane Chrome
Copper Zinc Selenium
Trace-elements remained stable at every time point. Vitamin C was
undetectable low in all patients and did not improvewith 375 mg/24 h
supplementation. Vitamin D was below threshold in all patients but
did not decrease with 600 IU D3. Most plasma levels remained stable.
Conclusions: Supplementation of commercially available double
doses of vitamins and triple dose of trace- elements to compensate
for losses and practice in line with recommendations for nutritional
therapy adaptation during CVVH is insufficient to correct hypovita-
minosis C and D but safe and stabilizing for most vitamins and all trace
elements.
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HOW RISKY OF INTRAVENOUS IRON ADMINISTRATION? (ANALYSIS
OF IRON DEPOSITION BY 157 PATHOLOGICAL LIVER TISSUES)
H. Akatsu1*, Y. Kawade1, K. Arakawa1, Y. Masaki1, H. Tanaka1,
T. Kanematsu1, Y. Hashizume2, K. Tsuneyama3, T. Manabe4,
T. Ohohara1, M. Maruyama5, on behalf of Fukushimura NST team.
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Tokushima, 4Department of Hygiene and Public Health, Teikyo University
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Rationale: Vitamins and minerals are routinely administered under
total parenteral nutrition (TPN). The fine adjustment of the iron agent
is difficult because existing blendedmineral preparation is used. In the
case of long-term, it is unclear if the recommended iron content is
indeed appropriate.
Methods: The liver tissues from 187 anatomical cases for 15 years was
stained with Berlin Blue, and was evaluated in five stages from 0 to V
by three or more observers. Comparisons weremade between the two
groups with and without iron staining and among the three groups
with grade 1, 2 and 3 ≦ with iron staining.
Also postmortem blood was punctured from the subclavian vein
before autopsy and collected, centrifuged within 3 hours, stored at
−80C, and then measured unsaturated serum iron, serum iron,
albumin, prealbumin, hepcidin, and IL6 concentrations.
Results: Iron accumulation was significantly higher in the 1) male
(p = 0.005), 2) surgery history (p = 0.044), 3) central vein administra-
tion history (p <0.001). In addition, the iron staining group was
significantly longer than the non-iron group on the days of lifelong
iron administration (p = 0.038). In serum analysis, unsaturated serum
iron was significantly higher in the group without iron staining, and
ferritin and serum ironwere significantly higher in the groupwith iron
positive staining. No statistically significant difference was observed
between the two groups for another serum data.
Conclusions: The recommended iron dose in Japan is slightly higher
than in Europe and the United States. In actual long-term TPN
administration, there were only cases where no iron administration
was performed. In this study, iron deposition in the liver was
examined, and it was suggested that chronic intravenous iron
administration may cause tissue deposition.
It is necessary to keep in mind that there is a possibility of tissue
deposition if long-term administration of iron preparations extends to
long-term administration even if it is the recommended daily dose.
Disclosure of Interest: None declared.
MON-PO635
CONTRIBUTIONOF LEBANESE COMPOSITEDISHES TOANTIOXIDANT
INTAKES IN LEBANON
M.A. Itani1*, L. Nasreddine1, I. Toufeili1. 1American University of Beirut,
Beirut, Lebanon
* Corresponding author.
Rationale: The Lebanese diet is comprised predominantly of a group
of cooked vegetable-based composite dishes along with fresh fruits
and vegetables and processed cereals chiefly in the form of bread. This
diet is considered as a variant of the typical Mediterranean Diet which
is actively promoted for its positive health effects. No data exist on the
polyphenol fractions and antioxidant capacities (AC) of composite
dishes consumed in Lebanon. In this work, Lebanese composite dishes
were analyzed for their polyphenolic fractions contents and their
contribution to the dietary antioxidant intake.
Methods: Thirty-two Lebanese composite dishes were prepared
according to procedures commonly followed in the Middle East. The
extractable polyphenols (EPP) were quantified by the Folin-Ciocalteu
procedure on the aqueous-organic extracts, and the non-extractable
proanthocyanidins (NEPA), in the residues after extraction, were
measured colorimetrically. The antioxidant capacities (AC) of the
dishes were assessed by the trolox equivalent antioxidant capacity
(TEAC) and the ferric reducing ability of plasma (FRAP) assays.
Results: Results showed that the NEPA contents (15.2–2103.3 mg/
100 g fresh weight) were higher than those of EPP (10.9–455.8 mg/
100 g fresh weight) in most dishes. Stuffed vegetables with vegetable-
based dishes contributed most to the dietary antioxidant intake at an
average of 59.2%; bread contributed 13.8%, legume-based dishes
10.75%, wheat-based dishes 8.8% and rice-based dishes 7.4% of
antioxidant intakes.
Conclusions: Although studies focus chiefly on the EPP contents of
dietary commodities, our study has shown that he NEPA fraction
contributes significantly to the total antioxidant intake. The generated
data will have a pivotal role in assessing the antioxidant quality of
Lebanese, and related Mediterranean, diets and in identifying dietary
items with high AC for improving the dietary antioxidant intakes of
populations.
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SERUM VITAMIN B12 LEVELS IN PATIENTS WITH FAMILIAL
HYPERCHOLESTEROLEMIA
N. Szupryczyńska1*, A. Wojda1, M. Pajkowski2, K. Chlebus2,
M. Gruchała2, Z. Kochan1. 1Department of Nutritional Biochemistry,
21st Department of Cardiology, Medical University of Gdańsk, Gdańsk,
Poland
* Corresponding author.
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Rationale: There are significant gaps in the current knowledge about
diet and the vitamin status in patients with familial hypercholester-
olemia (FH). One of diet advices for patients with FH is to encourage
consumption of plant products which are not a good source of vitamin
B12. This vitamin is involved in the metabolism of homocysteine – one
of the risk factors of cardiovascular diseases. The aim of the study was
to evaluate if there is a deficiency of vitamin B12 among FH patients.
Methods: The study included 44 adult patients, bothmen andwomen,
with familial hypercholesterolemia, whowere patients of The National
Centre for FH at University Clinical Hospital, Medical University of
Gdańsk. The control group consisted of 44 sex-, BMI-, and age-
matched healthy volunteers. Vitamin B12 levels in serum were
determined using active-B12 (holotranscobalamin) enzyme-immuno-
assay (EIA). To assess differences in dietary intake of themost common
food groups between FH patients and the control group, a Food
Frequency Questionnaire with 6 answers (FFQ-6) was used. Statistical
analysis of the results was made with the R Statistical Software.
Results: There were no statistically significant differences in vitamin
B12 serum levels – median (Q1-Q3) in FH = 69.2 (52.3–87.7); control
= 70.1 (51.8–82.1) pmol/l. However, differences in intakes of some food
sources of vitamin B12 – poultry, redmeat, sausages, cheese, and eggs –
were statistically significant (p < 0.05) between both groups.
Conclusions: Accurate assessment of dietary intake of vitamins
involved in homocysteine metabolism, such as vitamin B12, and
detailed evaluation of vitamin status in patients with FH in order to
determine all dietary factors that affect homocysteine levels can have
major benefits for their health.
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DIETARY INTERVENTION FOR SYSTEMIC METAL ALLERGY PATIENTS
ON CLINICAL SYMPTOM AND URINARY METAL EXCRETION.
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Rationale: Patientswith eczemawith systemicmetal allergy including
chromium (Cr), nickel (Ni), cobalt (Co), tin (Sn), should be paid
attention on symptomatic exacerbation by the excessive metal intake
in food. However, difficulty in dietary intervention for metal allergy
has been reported. Our purpose was to evaluate the effectiveness of
dietary intervention for metal allergy by registered dietitian.
Methods: Thirty two patients with cutaneous symptom diagnosed as
metal allergy were assigned randomly to dietary intervention by
registered dietitian (DI, n = 21) or control groups (C, n = 11). Dietary
intervention using Food Frequency Questionnaire Based on Food
Group (FFQg) with Trace Mineral Food Composition Table was
performed and evaluated one month later. Dermatologists treated
skin lesions of patients of both two groups equally during the
intervention. Skin symptoms with Severity Scoring of Atopic
Dermatitis (SCORAD) and Visual analogue scale (VAS) of itching,
routine blood tests and urinary metal excretion evaluated using ICP
mass spectrometry were analyzed.
Results: Both groups showed excessive 10% energy intake before
intervention andDI group improved to appropriate value. After dietary
intervention, DI group decreased Ni and Co intake (p < 0.01), but C
group decreased Ni intake (p < 0.05). DI group improved SCORAD total
score including particularly a range of the eczema, an oozing,
excoriation, drying (p < 0.01–0.05), and erythema. In contrast,
improvement of skin symptom was not observed in C group.
Analysis of urinary excretion demonstrated positive correlation
among blood thymus and activation-regulated chemokine (TARC)
density, the blood numberof eosinophils and urinary Cr excretion in Cr
allergy patients, and serum CRP level and urinary Ni or Sn in Ni or Sn
allergy patients respectively (p < 0.01–0.05, r = 0.505–0.817).
Conclusions:Dietary intervention by registered dietitianwas effective
to improve skin symptom via the reduction of metal intake.
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SERUM 25-HYDROXYVITAMIN D LEVELS AMONG REGIONS IN
MONGOLIA
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Rationale: Owing to a low availability and lack of dietary habit of
vitamin D-rich foods including fish and mushrooms, most of
Mongolian are said to have risk of vitamin D deficiency. Another
factor is that solar radiation is too small to induce cutaneous synthesis
of pre-vitamin D in winter because Mongolia is located in a high
latitude and highland. In fact, the prevalence of rickets is very high in
Mongolia. The aim of this study is to determine the spatial status of
vitamin D in Mongolia.
Methods: This study was conducted as one of the cross-sectional
surveys in National Cancer Cohort Study in Mongolia. Serum 25-
hydroxyvitaminD, 25 (OH)D: themost abundant vitaminDmetabolite
in the circulation, was determined from 541 healthy subjects (10–64
years) living in 6 Mongolian provinces and capital, Ulaanbaatar. Blood
sampleswere collected from September toDecember, 2016. Univariate
analyses were conducted to describe the characteristics of partici-
pants, examine variable distributions. The mean serum 25 (OH)D
concentrations were calculated for subgroup of the study population
according to the sampling scheme of sex, generation, and region.
Results:Mean serum 25 (OH)D concentrations (± standard deviation)
was 16.6 (±7.0) ng/mL (recommendation value, ≥30.0 ng/mL), and
70.1% of subjects was ‘deficient’ (<20 ng/ml) and 24.2% was ‘insuffi-
cient’ (20≤, <30 ng/mL). The levels of 25 (OH)D were significantly
lower for female (14.9 ± 5.9 ng/mL) than male (19.5 ± 7.8 ng/mL,
p < 0.001) although there is no differentiation by age (r = -0.013,
p = 0.755). Subjects of Ulaanbaatar had the lowest levels of 25 (OH)D
(7.9 ± 2.6 ng/ml) of all provinces and therewere significant differences
even if seasonality sampling blood was considered. The levels of 25
(OH)D were relatively high in provinces on southern Mongolia.
Conclusions: Our results show that Mongolian had extremely low
vitamin D levels, particularly in Ulaanbaatar. This is probably partly
because of the impact of air pollution rather than dietary habit or solar
radiation: Ulaanbaatar is the most air pollution affected area in
Mongolia and annual mean of PM2.5, which reduces ultraviolet-B
radiation for the synthesis of pre-vitamin D, are 6–10 times higher
than the safety level. A comprehensive policy including dietary
modification, supplement with vitamin D consumption, and the
remedy for air pollution is required.
Disclosure of Interest: None declared.
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MANAGEMENT OF IRON SUPPLEMENTATION IN PATIENTS WITH
INFLAMMATORY BOWEL DISEASE-A PRACTICAL APPROACH
Z. Sundov1*, A. Sundov2. 1Gastroenterology, Clinical Hospital Split,
2General Practitioner, Community Health Center Split, Split, Croatia
* Corresponding author.
Rationale: Inflammatory bowel disease (IBD), such as Crohn’s disease
(CD) and ulcerative colitis (UC) are chronic, relapsing, inflammatory
disorders of gastrointestinal tract with increasing global incidence and
prevalence. Among broad spectrum of extra intestinal complications
encountered in IBD patients, anaemia is the most common. The most
prevalent type of anaemia in these patients is iron deficiency anaemia
(IDA), secondary to chronic blood loss and impaired iron absorption
due to tissue damage. Several studies have shown that IBD patients
receiving intravenous iron incurred lower total health care cost
compared to patients receiving oral iron. For several decades,
medical treatments for IBD were limited to amino salicylates,
thiopurines and steroids, which do not change disease course. With
increased understanding of immunopathology of IBD, novel, targeted
therapies have unlocked new era of IBD treatment and allowed us to
reach new therapeutic goal such as mucosal healing.
Methods: We hypothesized that biological therapy will reduce the
need for intravenous iron supplementation in IBD patients with IDA.
Study was conducted during in time January 01, to December 31, 2018
in Department of Gastroenterology, University hospital Split, Croatia
and included all IBD patients currently treated in our department.
Results: Out of total of 321 IBD patients, 110 (34.3%) were receiving
biological therapy. Out of 211 (65.7%) patients who are not receiving
biological therapy, 78 (37%) were receiving intravenous iron, while
only 10 out of 110 (9.1%) who are receiving biological therapy were
receiving intravenous iron.
Conclusions: Biological therapy reduces the need for intravenous iron
supplementation in patients with IBD, most likely by achieving
significantly higher degree of mucosal healing and subsequent
increase in iron absorption.
Disclosure of Interest: None declared.
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OMEGA-3 FATTY-ACID ENRICHED PARENTERAL NUTRITION
REGIMENS IN HOSPITALIZED PATIENTS IN EU5 COUNTRIES: A
PHARMACOECONOMIC ANALYSIS
L. Pradelli1*, K. Mayer2, S. Klek3, A. J. Omar Alsaleh4, M. Rosenthal5,
A. R. Heller6, M. Muscaritoli7. 1Adres, Torino, Italy; 2University Giessen,
Giessen, Germany; 3Stanley Dudrick’s Memorial Hospital, Skawina,
Poland; 4Via Vittorio Alfieri, 17, AdRes, Torino, Italy; 5Division of Trauma
and Acute Care Surgery, University of Florida College of Medicine, Miami,
United States; 6Anaesthesiology and Intensive Care Medicine, University
of Augsburg, Augsburg, Germany; 7Translational and Precision Medicine,
Sapienza University of Rome, Rome, Italy
* Corresponding author.
Rationale: The aim of this study is to perform a cost-consequence
analysis of the use of omega-3 (ω-3) fatty-acid enriched parenteral
nutrition (PN) in the EU5 countries, from the hospital perspective.
Methods: A cost-consequence analysis was performed using a
probabilistic discrete event simulation model with country-specific
inputs derived from published sources. The relative ω-3 supplemen-
tation effect estimates were from our recent meta-analysis [1]. The
model estimates and compares costs and clinical impact associated
with ω-3 fatty-acid enriched PN vs. PN containing standard lipid
emulsions (without omega-3 fatty acids; std–PN). Data captured were
cost of PN, cost of infection, cost of hospital length of stay and total cost
per patient; clinical eventswere infections avoided and hospital length
of stay. Inputs uncertainty is evaluated via both deterministic (DSA)
and probabilistic (PSA) sensitivity analyses.
Results: Avoided infections and shortened length of stay due to ω-3
fatty-acid enriched PN, as compared with std-PN, in the EU5s have an
expected impact on total costs per patient as shown inTable 1. Both the
PSA and DSA analyses confirmed the robustness of the outputs of the
model to all tested changes in the inputs.
Table 1
Results
Impact of ω-3 PN on total cost/patient
compared to std-PN (Mean ± SD)
UK −2,528 ± 942 £ (−2,853 ± 1,063 €)
Germany −2,228 ± 1,389 €
Italy −1,766 ± 1,275 €
France −2,244 ± 848 €
Spain −1,782 ± 1,307 €
Conclusion:ω-3 fatty-acid enriched PN is likelya dominant alternative
to std-PN from the point of view of a hospital in any of the EU5
countries as it is associated with significantly improved patient
outcomes and cost savings.
Reference
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hospitalized patients: systematic review with meta-analysis and
trial sequential analysis. JPEN 2019 (Accepted).
Disclosure of Interest: L. Pradelli Grant/Research Support from:
Fresenius Kabi, K. Mayer Consultant for: Fresenius Kabi, S. Klek
Consultant for: Fresenius Kabi, A. J. Omar Alsaleh: None declared,
M. Rosenthal Consultant for: Fresenius Kabi, A. Heller Consultant for:
Fresenius Kabi, M. Muscaritoli Consultant for: Fresenius Kabi.
SUN-LB641
SURVEY OF SARCOPENIA IN OUTPATIENTS WITH TYPE 2 DIABETES
A. Ishikawa1*, N. Mori2, K. Maeda2. 1Department of Internal medicine,
Nomura Clinic, Nagoya; 2Palliative Care Center, Aichi Medical University,
Nagakute, Japan
* Corresponding author.
Rationale: Prevalence of sarcopenia is consideredhigh amongpatients
with type 2 diabetes, but there are few reports. We investigated the
prevalence of sarcopenia in outpatients with type 2 diabetes.
Methods: Subjects comprised 551 outpatients with type 2 diabetes
(males 355, aged range 20 to 88, mean 63.7 yrs old, mean BMI
26.1 kg/m2, mean HbA1c 7.4%), baselinemeasurements were taken for
muscle mass using the bioelectrical impedance analysis method
(InBody720), grip strength and gait speed. Sarcopeniawas determined
using Asian Working Group for Sarcopeniadiagnostic criteria. The
relationshipbetweendiabetes indexanddiabetesdrugswasexamined.
Results: Seventy-one cases (mean, age 74.7 yrs old BMI 21.6 kg/m2)
(prevalence 12.9%) were judged as sarcopeni, and of 298 cases aged
over 65 yrs old 67 were judged as having sarcopenia. Sarcopenia and
obesity complicationswere found in 2.0% of patients aged 20 to 88, and
3.35% aged ≥65 yrs old, sarcopenia and obesity complications were
more frequently observed in the elderly. HbA1c did not significantly
differ by presence or absence of sarcopenia. Associations with diabetic
drugs were: biguanide 47.8%, insulin 20.6% in the sarcopenia-free
group, and26.8%biguanide in thesarcopeniagroup, Insulin38.0% in the
group with obesity, 45.5% biguanide in the group with obesity, Insulin
54.5% and insulin usage rate associationwith biguanide (P = 0.004) and
insulin (p = 0.02) was high, sarcopenia-free and judged groups.
Conclusion: The prevalence of sarcopenia in outpatients with type 2
diabetes was 12.9%, and 22.5% among patients aged ≥65 yrs old. It is
considered that risk of sarcopenia is increased in patients ≥65 yrs old,
including lean patients, high BMI, and insulin users.
Reference
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BENEFICIAL EFFECT OF OLIVE OIL BASED PARENTERAL NUTRITION
COMPARED TO FISH OIL IN CRITICALLY ILL PATIENTS
E. Pardo1*, T. Lescot1,2, P. Massanet3, N. Lapidus2,4, V. Fraipont5,
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Clinical Nutrition 38 (2019) S297–S322
Contents lists available at ScienceDirect
Clinical Nutrition
journal homepage: ht tp: / /www.elsevier .com/locate/clnu
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* Corresponding author.
Rationale: Parenteral nutrition (PN) is essential forcritically ill patients
to ensure a proper caloric and protidic support when enteral route is
contraindicatedor insufficient. Lipid emulsion constitute almost half of
the non-protein caloric intake in PNandmay have an intrinsic effect on
systemic inflammatory response. Previous data has shown the
probable superiority of fish oil (FO) and olive oil (OO) based lipid
emulsion onpatient outcome, compared to soy-bean, in the ICU setting
[1], however a controversy persists. Our objective was to compare FO
and OO in critically ill patients receiving parenteral nutrition.
Methods: Data was extracted from the FRANS database, an inter-
national prospective observational studyassessingnutritional prescrip-
tion in the ICU conducted in 26 ICUs in France and Belgium between
February and August 2015 on 1210 patients. For the present sub-study,
patient receiving exclusive or supplemental OO or FO based PN at a
minimal amount of 10 kcal/kg per day of prescription were selected.
Were excluded patients receiving multiple type of PN. Multivariate
logistic regression with propensity score analysis was carried out.
Results: Three hundred forty-six patients met inclusion criteria (234
FO and 112 OO group).Median agewas 64 [51, 75], BMIwas 25 [22, 29],
admission SOFA score was 8 [5, 11] and 87% were mechanically
ventilated. Patients received a median intake of 20.84 kcal/kg [16.1,
25.4] and 0.81 g/kg [0.61, 1.04] of protein per day. The amount of
calories and protein did not differ between groups. OO based PN was
significantly associated with better day-28 survival compared to FO
(OR 0.44, IC95 0.23–0.87) containing PN in a multivariate model
adjusted on admission SOFA and admission diagnosis. No difference
was found regarding days of mechanical ventilation, ICU mortality or
length of stay in the ICU.
Conclusion: In our cohort, OO based PN administration in critically ill
patients was associated with improved survival compared to FO.
Randomized controlled trials are needed to confirm our results.
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CAN USE OF DIETARY FIBER SHORTEN ICU STAY AND REDUCE
MORTALITY IN ICU SETTINGS?: A SYSTEMIC REVIEW AND META-
ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
N. Lin1*, G.-J. Yang1, H.-M. Lang1, H.-Y. Sun1, Y. Wen1, Y.-M. Li1, F.-X. Li1,
R. Meier2, L.-J. Tang1. 1The General Hospital of Western Theater
Command, Chengdu, China; 2Arztpraxis MagenDarm Basel, CH-4051
Basel, Switzerland
* Corresponding author.
Rationale:We plan to explore the possible effect of dietary fiber (DF)
on reducing mortality or shorten ICU stay in patients with severe
diseases.
Methods: PubMed, CNKI and Cochrane databases were searched until
March 1st, 2019. The searching subject terms in heads, abstracts or
main texts included dietary fiber (DF), prebiotics, synbiotics, intensive
care medicine, intensive care unit, clinical trial. Reference papers of
studies or reviews were also retrieved and screened according to the
inclusion and exclusion criteria. Two independent researchers
selected randomized controlled trials reporting the DF type, dose,
duration and mortality rate and length of stay in ICU and/or hospital.
Data analysis was performed using RevMan 5.3 software.
Results: Ten studies involving 671 participants were included; Dietary
fiber significantly reduced mortality compared with control [Odds
Ratio 95% CI, 0.68 (0.47, 0.98), Z = 2.09, P = 0.04, fixed effect model].
However, DF cannot shorten ICU stay when comparedwith the control
arm [SMD 95% CI, −0.14 (−0.38, 0.10), Z = 1.16, P = 0.24, random effect
model]. For subgroup analysis, dietary fiber and synbiotics were tested
separately. Dietary fiber alone, either as part of EN formula or
supplementation, could significantly reduce mortality than the
control. Especially in Asian ICU settings, DF plays an essential role in
changing the outcome.
Conclusion: Dietary fiber could reduce mortality rather than shorten
ICU stay. Sensitive analysis revealed that dietary fiber alone can exert
the effect especially in Asian ICU patients.
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NUTRITIONALRISKASSESSMENT IN CRITICALLY ILL PATIENTSUSING
NUTRITION RISK IN CRITICALLY ILL (NUTRIC) SCORE
R. Kalavathy1*, Sumaya Ahmed Al Araj1, Nazneen Zara1, Yousuf Altair1,
Khadra Omer1. 1Clinical Nutrition, Ibrahim Bin Hamad Obaidallah
Hospital, RAS AL KHAIMAH, UAE, Ras Al Khaimah, United Arab Emirates
* Corresponding author.
Rationale:We aim to assess the nutritional risk in critically ill patients
using NUTRIC score – an Intensive Care Unit (ICU) specific nutrition
risk assessment tool at Ibrahim Bin Hammad Obaidullah Hospital
(IBHOH), Ras Al Khaimah (RAK), United Arab Emirates (UAE).
Methods: A prospective observational study was conducted in the ICU
at IBHOH for 8months (June 2017 to January 2018). Institutional ethics
committee approval was obtained. Adult patients (>18 years) who
were admitted in the ICU and stayed for more than 24 hours were
included in the study. To identify the patients at nutritional risk we
used modified NUTRIC score (m- NUTRIC score – without IL-6 values)
and patients having a NUTRIC sore of 0–4 were classified to have low
malnutrition risk and those having a score between 5–9 were
associated with worse clinical outcomes. SPSS 24 software was used
and the difference in the mean of the variables was tested using Z test,
which follows normal distribution. All other variables which are not
following normal distribution, median test and Chi square test were
performed.
Results: Data of 50 patients was analyzed. A total of 84% patients had
a high NUTRIC score (>5) and 16% had a low NUTRIC score (<4). The
length of ICU stay had a median of 9 days for patients with high
NUTRIC score and 5 for those with low NUTRIC score, which indicates
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higher the NUTRIC score, the length of stay in ICU also increases. The
mortality rate in our studywas 26% and out of these patients 92.3% had
a high NUTRIC score and the remaining 7.7% had a low NUTRIC score
which clearly indicates higher the NUTRIC score, higher the mortality
rate.
Conclusion: We observed high NUTRIC score is associated with
increased mortality and ICU length of stay and these patients are most
likely to benefit from aggressive nutrition therapy.
Reference
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PARENTERAL NUTRITION IN SURGICAL ICU: REFEEDING
HYPOPHOSPHATEMIAOR REFEEDING SYNDROME?
A. Yaroshetskiy1*, V. Konanykhin1, S. Stepanova1, N. Resepov2. 1Pirogov
Russian National Research Medical University; 2Vorokhobov municipal
hospital #67, Moscow, Russian Federation
* Corresponding author.
Rationale: Hypophosphatemia is a hallmark of refeeding syndrome,
but it has no specific clinical manifestations and is often subclinical
[1–2]. Since there are many causes of hypophosphatemia, it is unclear
howoftenhypophosphatemia is caused by the resumption of nutrition
and how this affects the outcome.
Methods: We included patients (n = 75) after abdominal surgery on
total parenteral nutrition (TPN) with short-term relative contra-
indications to early enteral nutrition. We excluded pregnant patients,
patients with shock, hyperglycemia more than 20 mmol/l, ketosis,
acute renal or/and hepatic failure. We did not provide any additional
phosphate replacement. We assessed nutritional risk and refeeding
syndrome risk by NRS 2002 and NICE scales. We measured phosphate
levels before TPNand after 24 h of TPN.We assessed organ dysfunction
and its connectionwith phosphate levels before and after 24 h of TPN.
Results: 57,4% patients had elevated nutritional and refeeding
syndrome risk (NRS 2002 >=3 and more than 2 NICE minor criteria).
Before the refeeding, 28 patients (38.9%) had hypophosphatemia
(serum phosphate <0.82 mmol/l), and 2 patients (2.7%) had severe
hypophosphatemia (<0.32 mmol/l). 24 hours after the resumption of
nutrition hypophosphatemia had 49 patients(68.1%), and 6 patients –
severe hypophosphatemia (8.3%). After 24 h of TPN serum phosphate
level significantly decreased in all patients from 0.90 (0.61–1.15) to
0.62 (0.50–0.84) mmol/l, p < 0.001. Patients who developed delirium
(n = 15) had significantly lower baseline phosphate levels (0.73 (0.52–
0.93) vs 0.92 (0.74–1.17) mmol/l, p = 0.019). All patients onmechanical
ventilation (n = 17) had lower but nonsignificant phosphorus level 0.79
(0.61–0.97) vs 0.93(0.67–1.15) mmol/l (p = 0.242). Patients receiving
catecholamines (n = 9) had lower but nonsignificant phosphorus level
0.77(0.60–1.01) vs 0.92(0.67–1.14) mmol/l (p = 0.315).
Conclusion: Hypophosphatemia is common in surgical ICU, and
refeeding can lead to a significant reduction in serum phosphate
levels. Baseline hypophosphatemia can be a predictor of delirium.
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PHASE ANGLE (PA) AND MORTALITY IN CRITICALLY ILL ELDERLY
PATIENTS AT 28 DAYS AND 60 DAYS
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Rationale: Recent studies have shown an association of low phase
angle (PA) andmortality during Intensive Care Unit (ICU) stayand after
hospital discharge. The objective of this study were to verify PA
prognostic value onmortality and also its correlationwith severity and
function scales in a sample of elderly ICU patients.
Methods: Patients older than≥60 years, undermechanical ventilation
≥ 48 h, length of stay≥ 3 days, hemodynamically stable were studied.
PAwas measured by a single frequency bioelectrical impedance (BIA)
at the 1st day after stability (PA1). Severity (APACHE II, SOFA, SAPS III)
and functional scales (Barthel Index) were assessed in the first 24
hours. Mortality after 28 (D28M) and 60 days (D60M), and overall
hospital mortality (OHM) were assessed.
Results: A sample of 68 elderly patients were enrolled (mean age
80.2 ± 9.1 years, 56.5% female). Sepsis was present in 33 patients
(47.8%). The median (interquartile range) of severity and functional
scores were 18 (15;22) for Apache II, 5 (4;7) for SOFA, 65 (62;74) for
SAPS3 = 67,58 (1,68), and 85 (50;100) for Barthel. Median PA1 was 3.5
(3.0;4.1) and D28M, D60M, and OHM were 35,9%, 44,8%, and 46,6%,
respectively. There was no significant correlation between PA1 and
Apache II, SOFA, and Saps III scores, but there was a low significant
correlation between PA1 and Barthel score (r = 0,39, p = 0,001).Median
PA1were significantly lower in patientswhowere dead at D28, D60, or
during hospitalization. The area under ROC curve assessing D28M,
D60M, and OHM prediction by PA1 was 0.71, 0.77, and 0.80,
respectively. We found a cutoff of 3.29°, with a sensitivity of 74% and
specificity of 81% to predict OHM.
Conclusion: In the elderly ICU patients PA1 dońt showany correlation
with severity scores, but a lowcorrelationwith Barthel score. Survivors
patients presented a significantly higher PA1 and PA1≥ 3.29° could be
used as a survival marker in this population.
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PYROGLUTAMIC ACIDOSIS BY GLUTATHIONE REGENERATION
BLOCKAGE IN CRITICAL PATIENTS
Y. Gamarra1, J. Molina-López2, L. Herrera-Quintana1, H. Vázquez-
Lorente1, J. Castaño-Pérez3, F. Santiago3, E. Planells1*. 1PHYSIOLOGY,
Universidad de Granada, Spain, Granada; 2actividad física, University of
Huelva, Huelva; 3Intensive Care Unit, Hospital Virgen de las Nieves,
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* Corresponding author.
Rationale: To evaluate oxidative stress from glutathione depletion in
critically ill patients with septic shock.
Methods: Prospective analytical studyof 42 critically ill patientswith a
septic shock whowere monitored from admission (initial) to 3 days of
stay (final) in the intensive care unit (ICU). Data collected included
PyroGlu and glutamic acid (Glu) using liquid chromatography/mass
spectrometry, and glutathione peroxidase (GPX) activity with a
colorimetric assay.
Results: In patients with septic shock, serum and urine PyroGlu levels
were higher, erythrocyte GPX activity/gr Hb was lower, and urine Glu
levels were lower compared to reference values, for both initial and
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final values. Initial serum Glu levels were also lower. Serum PyroGlu
levels had a correlation with both initial and final serum Glu levels.
Urine Glu/mg creatinine correlated with APACHE II (p = 0.03).
Conclusion: Septic patients have higher levels of PyroGlu, lower levels
of Glu, and lower erythrocyte GPX activity, suggesting that these
biomarkers could be used as an indicator of glutathione depletion,
being related to severity parameters. This study can guide future
studies on the importance of monitoring the levels of pyroglutamic
acidosis in critical patients with septic shock in order to preserve the
oxidative status and its evolution during the stay in the ICU.
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USE A HIGH-PROTEIN TUBE FEEDING IN CRITICALLY ILL PATIENTS:
THE RESULTS OF A MULTICENTER STUDY
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Rationale: Our observations suggest that most patients the protein
less than 0.4 g/kg BWusing standard tube feeding. The purpose of this
study is to show that in critically ill patients tube enteral feeding with
an increased protein content the median time to normalization of
nitrogen balance is less than inpatients recei-ving standard nutritional
support.
Methods: Multicenter randomized clinical trial. 28 patients in the
group of the studied product Nutrisone Advanced Protisone (1), and 32
patients in standard nutritional support group (2). inclusion critera:
1. pts admitted in ICU due to SIRS, sepsis (SOFA 2 points or more), after
major GI surgery, or complications after surgical interventions
2. Initiation of tube feeding in the first 24 hours after admission to
the ICU. All patients had to receive EN at the rate of 20–25 kcal/kg/day,
protein – 1.2 g/kg/day.
Results: A statistically significant increase in nitrogen balance relative
to baseline was observed only in the group 1 on Day 3 (the median
increase was 10 g/day in the group 1, (p = 0.006) vs 3.4 g/day in group
2). The amount of enterally administered protein was statistically
significantly higher in the group 1 on Day 3 (p = 0.032) compared to
the group 2. The volume of input and absorbed EN, as well as the
amount of energy introduced, did not significantly differ between the
groups. The percentage of patients providing daily protein require-
ments relative to the calculated one was significantly higher in the
group 1, compared to the group2, on Day 3 (96.2% compared to 55.9%,
median, p = 0.042). We also noted a decrease in the LoS the ICU (25
versus 29 days) and the duration of mechanical ventilation (23 versus
29 days), infection (pneumonia in 8 versus 12 patients), and bedsores
(0 versus 5 patients). There were no intolerance of EN in both group.
Conclusion: Enteral feeding with high protein resulted in higher
protein intake and positive nitrogen balance than an isocaloric EN
without an increase in energy intake. This formulae is in according to
nutritional guidelines and is suitable as a first-line nutritional
treatment for critically ill patients.
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Changi General Hospital; 7SingHealth Polyclinics, Singapore, Singapore
* Corresponding author.
Rationale: Aging is associated with suboptimal nutritional status and
has been linked to adverse health outcomes. The objective of this
cross-sectional study was to describe nutritional biomarkers status in
community-dwelling older people with a Malnutrition Universal
Screening Tool (MUST) score of 0 in Singapore.
Methods: A total of 400 (183 males and 217 females) community-
dwelling older people aged ≥65 years took part in this study. Ten
biomarkers associated with nutritional status were analyzed, using
serum for pre-albumin, albumin, total protein, creatinine, 25-hydroxy
vitamin D, vitamin B12, zinc, corrected calcium, ferritin, and using
whole blood for hemoglobin.
Results: Participants were robust; 98% had a Charlson Comorbidity
score of 0. Over 90% of participants had normal level of each of the
following biomarkers: pre-albumin, albumin, total protein, creatinine,
corrected calcium, and vitamin B12. Almost three quarters (73%) of
participants had normal ferritin level and 27% had high ferritin level.
Similarly, 81% had normal hemoglobin level and 16% had high
hemoglobin level. Prevalence of vitamin D insufficiency was 38.5%
(20–<30 μg/L) and a further 13.5% had vitamin D deficiency (<20 μg/L).
Overall, 10% had zinc deficiency (<724 μg/L) based on fasting level. The
levels of corrected calcium and vitamin B12 were higher in females
than in males (both P≤ 0.007). The levels of pre-albumin, albumin,
creatinine, serum ferritin, 25-hydroxy vitamin D, and hemoglobin
were higher in males than in females (all P≤ 0.023).
Conclusion: The high prevalence of suboptimal vitamin D and zinc
status in independently ambulant community-dwelling older people
with a MUST score of 0 is concerning and deserves urgent attention.
These findings highlight the need for early detection of nutritional
insufficiencies in older people and the development of targeted
preventive public health nutrition strategies.
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IN COMMUNITY-DWELLING OLDER PEOPLE IN SINGAPORE
S. L. Tey1*, S. T. H. Chew2, C.H.How3,M. Yalawar4, G. Baggs5,W. L. Chow6,
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* Corresponding author.
Rationale: There is limited evidence onprevalence of lowmusclemass
in community-dwelling older people with normal nutritional status
and factors associated with low muscle mass has not been well
characterized in this population group.
Methods: This cross-sectional study was designed to examine the
prevalence of low appendicular skeletal muscle mass index (ASMI;
appendicular skeletal muscle mass/height2) in community-dwelling
older people with normal nutritional status (Malnutrition Universal
Screening Tool score = 0) in Singapore and to determine factors
associated with low ASMI. Bioelectrical impedance analysis was used
to determine ASMI. LowASMIwas defined as <7.0 kg/m2 formales and
<5.7 kg/m2 for females (Asian Working Group for Sarcopenia, 2014).
Results: 400 older people (183males and 217 females) aged ≥65 years
completed the study. Overall prevalence of low ASMI was 20.6%, in
which females were more affected than males (24.9% vs. 15.5%;
P = 0.021). In the multiple logistic regression model, age (OR = 1.13;
P < 0.001), BMI (OR = 0.55; P < 0.001) and calf circumference
(OR = 0.80; P < 0.001) were associated with low ASMI in the total
cohort. Bonemass was associatedwith lower odds of having low ASMI
in gender-specific models (both P≤ 0.008). After adjusting for
covariates, every 10 years increase in age was associated with a 3.4-
fold (95% CI: 1.8, 6.2) higher odds of having low ASMI.
Conclusion: One in five community-dwelling older people with
normal nutritional status had low ASMI. Every 10 years increase in
agewas associatedwith a 3.4-fold greater prevalence of lowASMI. BMI,
calf circumference and bone mass were associated with lower odds of
having low ASMI. These findings could be used to identify older adults
who are at riskof lowASMI anddevise effective public health strategies
to delay the progression to sarcopenia in this population group.
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PREVALENCE OF SARCOPENIA IN COMMUNITY-DWELLING OLDER
ADULTS IN IRELAND: COMPARISON OF EWGSOP1 AND EWGSOP2
DEFINITIONS
C. H. Murphy1*, A. M. Mcmorrow1, E. M. Flanagan1, H. Cummins2,
S. N. Mccarthy2, M. J. Mcgowan3, S. Rafferty4, B. Egan5, G. De Vito1,
C. A. Corish1, H. M. Roche1. 1University College Dublin; 2Teagasc Food
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Rationale: In 2010, the European Working Group on Sarcopenia in
Older People (EWGSOP) published a definition for the identification of
individuals with sarcopenia (EWGSOP1)1. In 2018, this definition was
updated based on the newest evidence (EWGSOP2)2, with the focus
now on low muscle strength rather than low muscle quantity as the
key characteristic of sarcopenia. The aim of this study was to identify
the prevalence of sarcopenia among community-dwelling older adults
in Ireland for the first time and to assess agreement between the
EWGSOP1 and EWGSOP2 definitions.
Methods: In a cross-sectional analysis, 490 community-dwelling
adults (age 78 ± 8 y, body mass index 27.6 ± 5.1 kg/m2) were assessed.
Skeletal muscle mass was estimated using bioelectrical impedance
analysis, muscle strength was measured via handgrip dynamometry
and physical performance via the Short Physical Performance Battery.
Sarcopenia was defined according to both the original criteria
(EWGSOP1) and the updated criteria (EWGSOP2).
Results: Using the EWGSOP1 definition, the prevalence of sarcopenia
was 7.1% (2.6% sarcopenia, 4.5% severe sarcopenia) and 3.6% were
classified as pre-sarcopenic (lowmuscle mass without a decrement in
strength or physical performance). Using the EWGSOP2 definition, the
prevalence of sarcopenia was 5.5% (1.6% sarcopenia, 3.9% severe
sarcopenia) and 23.4% were classified as having low strength but
without a decrement in muscle mass. Five of the participants who
were classified as sarcopenic (2 sarcopenia, 3 severe sarcopenia) by
EWGSOP1 were classified as normal using EWGSOP2.
Conclusion: The prevalence of sarcopenia in community-dwelling
older adults in Ireland is in line with the prevalence reported in other
European countries using the EWGSOP1 definition. We report a
slightly lower prevalence using the EWGSOP2 definition compared to
the EWGSOP1 definition.
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Rationale: Essential amino acid tryptophan is a potent endogenous
free radical scavenger and antioxidant. Accumulated evidence indi-
cates that amino acids, particularly tryptophan, exert a protective
effect against a variety of organ inflammation and injury. However,
there are few scientific reports about themechanisms involved in anti-
inflammatory action of tryptophan on organ damage, including liver.
Pro-inflammatory cytokine interleukin (IL)-1β stimulates the induc-
tion of inducible nitric oxide synthase (iNOS) expression and nitric
oxide production in primary rat cultured hepatocytes, and the
prevention of iNOS expression and nitric oxide production is
considered to be an indicator of liver protection. This study aimed to
examine whether tryptophan influences the induction of iNOS gene
expression and the mechanisms involved.
Methods: Hepatocytes were isolated from rats (male Wistar, 200–
250 g) by collagenase perfusion and low centrifugation, and cultured.
Tryptophan was added into primary cultures of rat hepatocytes
stimulated by IL-1β. The iNOS induction, nitric oxide production and
its signaling pathway were analyzed.
Results: IL-1β induced iNOS gene expression, which was followed by
iNOS expression and nitric oxide production. Tryptophan inhibited the
expression of iNOS mRNA and protein, and decreased the production
of nitric oxide. Tryptophan blocked two essential signaling pathways,
the activation of nuclear factor (NF)-κB and upregulation of type I IL-
1receptor (IL-1RI); Tryptophan had no effects on the degradation of
IκB, but inhibited NF-κB activation, its nuclear translocation from
cytoplasm and DNA binding. Tryptophan also inhibited the phosphor-
ylation of Akt, down stream kinase of phosphatidylinositol 3-kinase,
which was followed by the reduction of IL-1RI protein expression.
Conclusion: Results indicate that tryptophan can prevent nitric oxide
production by the suppression of iNOS gene, in part through the
inhibitions of NF-κB activation and IL-1RI upregulation, in inflamed
hepatocytes.
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OMEPRAZOLE INHIBITS A PRODUCTION OF PROINFLAMMATORY
BIOMARKER NITRIC OXIDE IN INTERLEUKIN-1? STIMULATED
HEPATOCYTES
M. Kotsuka1*, R. Nakatake1,2, Y. Hashimoto1, M. Hatta1, T. Yoshida1,
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Rationale: Proton pump inhibitors (PPIs) are proven to possess other
therapeutic potentials apart of acid anti-secretory actions. We found
that lansoprazole (PPIs) inhibited the induction of inducible nitric
oxide synthase (iNOS) gene expression in cultured hepatocytes and
prolonged the survival in a ratmodel of liver injury (Nakatake et al.Dig
Dis Sci 2019 in press). However, there is little evidence that another PPI
omeprazole affects inflammatory mediators, such as NO and TNF-α,
and has a liver-protective effect. This study aimed to investigate liver
protective effects of omeprazole byexamining iNOS induction in IL-1β-
stimulated hepatocytes.
Methods: Hepatocytes were isolated from rats (male Wistar, 200–
250 g) by collagenase perfusion and cultured. Cells were treated with
IL-1β in the presence or absence of omeprazole. iNOS induction and its
signaling pathway were analyzed.
Results: In IL-1β stimulated cells, omeprazole decreased expression
levels of iNOS mRNA and protein, resulting in the inhibition of NO
production. Omeprazole inhibited the activation of NF-κB (its
translocation from the cytoplasm to nucleus and DNA binding).
Omeprazole further blocked the type I IL-1 receptor upregulation
(another essential signaling pathway for iNOS induction) through
phosphatidylinositol 3-kinase/Akt. Transfection experiments revealed
that omeprazole reduced iNOS mRNA levels at both promoter
transactivation (mRNA synthesis) and mRNA stabilization steps.
Conclusion: Omeprazole affects one of proinflammatory mediator
induction, such as iNOS in hepatocytes. Omeprazole may play an
important regulatory role in the host response during liver injury and
have therapeutic potential for organ injuries, including the liver.
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A SYSTEMATIC REVIEW OF DIETARY INTAKE CHANGE IN PEOPLE
WHO LIVE WITH AND BEYOND CANCER
A. A. Aldossari1*, M. Hann1, J. Sremanakova1, A. M. Sowerbutts1,
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Rationale: People who live with and beyond cancer are thought to be
highly motivated to change their dietary intake. However, it has not
been documented what specific dietary changes people make after a
cancer diagnosis. In this systematic review, we summarized the
evidence on changes in dietary intake and supplement usage.
Methods: A systematic search of the electronic database was
conducted by using medical subject headings (MeSH) and text
words related to cancer and dietary change. Title and abstracts were
screened and full texts were identified through online software and
data were extracted. Quality of studies was assessed using the Joanna
Briggs Institute Critical Appraisal Checklist.
Results:We identified 43 studies with 238,140 participants diagnosed
with breast, colorectal and other types of cancer, age range 18–75
years. 30 studies assessed dietary changes over time with a mean 3.6
(SD 3.4) years follow up. Out of these 30 studies, an increase in fibre,
fruit and vegetable and whole grain intake was showed in 3 (10%), 2
(6.6%) and 3 (10%) studies, respectively, while 4 (13.3%) studies found a
decrease in red meat. Out of 20 studies assessing supplement use, 6
(30%) studies reported supplement use before and after cancer
diagnosis and 3 (15%) studies found an increase in supplement use
after diagnosis. Out of 8 studies comparing dietary intake between
cancer survivors and healthy people, 3 studies showed that cancer
survivors increased fruit and vegetable consumption compared to
non-cancer controls.
Conclusion: We conclude that there is evidence that people after
cancer were motivated to change their diet without any intervention
in a small number of studies. However, the majority of evidence
showed no changes indicating that a cancer diagnosis alone is
insufficient to motivate people to change to a heathier eating
pattern, suggesting most people after cancer would potentially
benefit from a supportive dietary intervention.
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NEOADJUVANT CHEMOTHERAPY FOR OESOPHAGEAL CANCER
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Rationale: CT-based cutoff values for determining low skeletal muscle
volume in cancer patients have been derived by optimal stratification,
and are sex and BMI-specific. The aim of the present study was to
investigate the age and sex-specific differences in skeletal muscle,
visceral (VAT) and subcutaneous adipose tissue (SAT) in patients
suitable for suitable resection of oesophageal cancer.
Methods: This was a retrospective, observational, single-centre study.
Medical records of patients who underwent neoadjuvant chemother-
apy followed byoesophagectomywere reviewed. Cross-sectional areas
at the third lumbar vertebrae on routine staging and post-chemo-
therapy CT scans were measured, and skeletal muscle, visceral and
subcutaneous adipose tissue indexed for height. Intra-muscular fat
cross-sectional area (CSA) was also recorded. The associations
between age, sex, skeletal muscle and adipose measurements were
examined.
Results: 71 patients were included (56 males and 15 females).
Significant differences in body composition at diagnosis were seen
between males and females, and those above and below 60 years of
age. Males had a higher baseline muscle and visceral adipose tissue
mass (p = 0.0123 and p = 0.016) whereas females had higher levels of
subcutaneous fat (p = 0.017). All patients were found to lose muscle
volume during chemotherapy, but there was no difference between
rates ofwasting byage or sex. However, older patients had significantly
more total fat loss and females lost significantlymore subcutaneous fat
during chemotherapy (p = 0.024 and p = 0.05 respectively).
Conclusion: Rates of adipose wasting appear to be age-specific and
sexually dimorphic in oesophageal cancer. Further studies are required
to define alterations in different adipose depots during cancer
progression and their prognostic value.
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EXPERIENCES OF ENTERAL NUTRITION IN PATIENTS WITH HEAD
AND NECK CANCER UNDERGOING RADICAL RADIOTHERAPY: A
QUALITATIVE APPROACH
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Rationale: Patients with head and neck cancer (HNC) undergoing
radical radiotherapy (RT) frequently experience impaired nutritional
and functional status. This requires enteral nutrition (EN) via either
prophylactic gastrostomy (G) or reactive nasogastric (NG) tube.
Limited qualitative data exists regarding the patient experience. The
studyaimed to gain an understanding of the patient’s experience of EN
to enable future recommendations for services that best meet and
address patient needs.
Methods: Face to face interviews were conducted with 29 patients,
diagnosed with oropharnygeal cancer who required EN, whilst
undergoing radical RT. Interviews were digitally recorded, transcribed
verbatim and thematically analysed.
Results: 20 male and 9 female participants were interviewed, age
range 41–81 years (mean 62 years). 18 participants had G tube placed
prophylactic and 11 had a reactive NG tube. Patients who had G tube
reported confidence issues, health care professional’s (HCP’s) attitude
and lack of support when commencing EN. Conversely, those fed via
NG tube felt fully competent and supported on commencement but
reported an awareness of the tube in situ and reported fear of
misplacement. All participants reported that EN had become a routine
and they identified the importance of it in their survival. However,
although those with NG were reticent due to body image issues, both
groups reported they felt too unwell for social interactions.
Conclusion: This study did not demonstrate a clear preference for
either G or NG tube. An overarching premisewas that patient choice is
fundamental. HCPs need to acknowledge and support this. Policies and
procedures should be designed and implemented which reflect true
patient centred care.
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HANDGRIP STRENGTH SIGNIFICANTLY IMPROVED AFTER 3-MONTH
PHYSICAL AND NUTRITIONAL THERAPY IN ADVANCED CANCER
PATIENTS
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Rationale: Malnutrition in cancer patients is a complex problem and
requires a multimodal approach. The following analysis investigated
physical performance and body composition of patients participating
in a multimodal trial.
Methods: Advanced cancer patients participated in a 12-week
randomized controlled trial including training sessions, nutrition
counselling and a leucine-rich supplement. Patients in the control
group received usual care. Physical performance was measured using
the short physical performance battery (SPPB, primary endpoint),
handgrip strength, timed up-and-go and 60-seconds sit-to-stand test.
Body composition was measured using bioelectrical impedance
analysis.
Results: A total of 52 patients were randomized to the intervention
(n = 27) or control group (n = 25). The 23 women and 29 men with an
average age of 63.1 ± 10.3 years had a BMI of 25.4 ± 4.7 kg/m2 at study
inclusion. Patients in the intervention group had a SPPB of 10.9 ± 1.4 at
baseline and 11.3 ± 0.9 at three months. Patients in the control group
had a SPPB of 10.3 ± 2.0 at baseline and 10.1 ± 2.9 at three months. The
difference between the groups was not significant (p = 0.128). In
contrast, handgrip strength improved significantly from 35.8 ± 9.8 kg
at baseline to 37.6 ± 10.0 kg at three months in the intervention group
compared to 35.7 ± 8.8 kg at baseline to 34.0 ± 10.1 kg at three months
in the control group (p < 0.001). Further tests for physical performance
as well as body composition did not change significantly between the
groups after three months.
Conclusion: The present trial showed a significant improvement of
handgrip strength through the implementation of a multimodal
therapy in advanced cancer patients. However, no improvements in
S303Abstracts / Clinical Nutrition 38 (2019) S297–S322
further physical performance tests, especially in the primary endpoint
SPPB as well as the body composition were seen.
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HOME ENTERAL NUTRITION AFTER MINIMALLY INVASIVE
ESOPHAGECTOMY CAN IMPROVE QUALITY OF LIFE AND REDUCE
THE RISKOF MALNUTRITION
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Rationale: The potential benefits of home enteral nutrition (HEN) and
the effects of HEN on quality of life (QOL) after esophagectomy remain
unclear. The aim was to investigate the effect of 3 months HEN on
health relatedQOL and nutritional status of esophageal cancer patients
who were preoperatively malnourished.
Methods: 142 malnourished (PG-SGA stage B or C) patients with
esophageal cancer were assigned to receive Ivor Lewis minimally
invasive esophagectomy (MIE group) with laparoscopic jejunal
feeding tube placement or open esophagectomy (OE group) with
nasojejunal feeding tube placement. After discharge, patients in the
MIE group received HEN with 500–1000 kcal/d for 3 months, while
the OE group patients did not receive HEN, as nasojejunal feeding
tubes had been removed. QLQ-C30 and PG-SGA questionnaires were
used to evaluate the QOL and the risk of malnutrition.
Results: 67 patients were enrolled in the MIE group and 75 patients
were enrolled in the OE group. Symptoms related to fatigue, nausea,
vomiting, pain, and appetite loss were significantly decreased in the
patients treated with 3 months HEN. Similarly, patients treated with
3 months HEN had a lower risk of malnutrition than patients did
not receive HEN (PG-SGA score, 5.7 vs 7.9, p < 0.01). More patients in
the MIE group (received 3 months HEN) were able to complete
postoperative chemoradiotherapy than patients in the OE group
(p < 0.01).
Conclusion: MIE and subsequent treatment with 3 months HEN can
improve the QOL and reduce the risk of malnutrition in preoperatively
malnourished patients.
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SETTINGS: SIGNALS FROM THE INTERNATIONAL NUTRITION AUDIT
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Rationale: Providing nutrition for patients with head and neck (HN)
and esophageal (E) cancers (CA) is challenging due to the complex
nature of their prolonged disease trajectory. Despite their risk for
developing CA-associated malnutrition and cachexia, little is known
about how well nutrition is being delivered to this population.
Methods: In a multicenter prospective audit, adult pts with curative
HN or E CA were enrolled from 11 international cancer care settings.
Details on the timing of assessment, nutrition needs, swallowing
ability, type and route of nutrition and percentage target calories and
protein received were collected over six months by the dietitian/
nutritionist. Descriptive analyses usingmeans, standard deviation and
percentages are used.
Results: Between 2016 and 2018, 170 pts (121 HN and 49 E CA)
were enrolled. Pts had an average age of 63 yrs, Body Mass Index of
26.7 and majority were assessed by a nutrition expert before radio/
chemotherapy or within one month of diagnoses. At baseline, 47%
had swallowing problems and average nutrition prescription was
29.7 kcal/kg/day, 1.53 g/kg/day protein. Over 6 months, 86% received
an oral diet, of these 84% also received oral nutrition supplements.
Enteral nutrition (EN) was received by 54% pts for an average of 62.7
days per pt for reactive (58%) vs. proactive (42%) reasons with the
gastric route being preferred to jejunal (66% vs. 34%). A total of 45% pts
received oral plus EN for an average of 54 days while <1% received PN
(alone or combined with EN and oral). Average percentage target
calories and protein received from oral were 53% and 47%; EN 90% and
88%; PN 80% and 90% (n = 1).
Conclusion: Current nutrition practices across international CA care
settings suggest that there is room for improvement in the delivery of
nutrition based on the targets of prescribed nutrition received.
Funding: This study is partially funded by Fresenius Kabi Deutschland
GmbH and Baxter.
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IMPACT OF BODY MASS INDEX AMONGST PATIENTS WITH GASTRIC
CARCINOMA:A MULTICENTERAL STUDY
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Rationale: Gastric cancer (GC) remains a common cancer in Turkey.
There is increasing evidence of an association between obesityand risk
of GC. Body mass index has been suggested to correlate with
clinicopathologic factors in GC and increase the risk of death. We
define clinical and pathological variables of GC. We aimed to analyze
the impact of BMI on clinical predictive markers in Turkish GC pts in
this registry.
Methods: GC patients registered in twomedical oncology clinics were
included in the analysis. Patients were stratified according to BMI:
<18.5 (underweight), 18.5–25 (normal weight), 25.1–30 (overweight),
and >30 (obese). Surgical outcomes and clinicopathologic factors were
analyzed using Pearsons correlation, spearman correlation and chi-
square test when appropriate.
Results: 691 patients were examined. 67.9%(n = 469) were male;
median age (range) was 62 (23–92). Disease was localized at antrum
(47.7%), gastroesophagial junction (31.4%) and other. Median BMI
(range) was 23 (12–44). Of these, 53 (7.7%) with <18.5, 394 (57%) 18.5–
25, 181(26.2%) 25.1–30, and 63(8.9%) >30 (obese). There was a weak
positive correlation between age and BMI (p = 0.0001). Low BMI was
associated with a lower number of metastatic lymph nodes (P = NS),
high number of examined total lymph node count (p = 0.0001,
r:−0.08) and operability (p = 0.001). However, tumor location, size,
pathologic stage, metastatic site, histopathology, obstruction, perfor-
ation were not significantly associated with BMI. Additionaly, the use
of neoadjuvant chemoradiotherapy or adjuvant chemotherapy/radio-
therapy was not associated with BMI. Increased BMI was associated
with the use of neoadjuvant chemotherapy (p = 0.011).
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Conclusion: BMI does not have any impact on the clinicopathologic
features of GC, but rather an indication of physical fitness. LowBMIwas
associated with operability and higher number of examined lymph
node count. But therewas no associationwith tumor localisation, size,
pathologic stage and metastasis.
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A THIRD LEVEL HOSPITAL’s EXPERIENCE
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Rationale: Head and neck cancer (HNC) is a heterogeneous group of
tumors with high risk of malnutrition. The early establishment of a
proper nutritional support is essential to improve nutritional status
and clinical outcomes.
Methods: This is a retrospective observational study. All HNC patients
from the committee were included from December 2017 to December
2018 (N = 145). Patients who were not evaluated by our department
were excluded from the study (n = 57). Nutritional markers such as
anthropometrical and biochemical datawas analyzed before and after
the surgery.
Results: 88 patients were evaluated. Age at diagnosis: 62.97 ± 11.78
years old; 79.5% ♂. Charlson comorbidity index: 3.95 ± 1.88 points.
53.4% of patients were evaluated before the surgery, 44.3% were
evaluated during the hospitalization and only 62.5% were reevaluated
after the surgery. 35.2% of our patients met criteria of malnutrition
(percentage of weight loss > 10% in the last 6 months or >5% in the last
3 months; BMI <18.5 kg/m2 or albumin <3 g/dl): n = 8 mild, n = 13
moderate, n = 10 severe. 59.1% (n = 52) received any kind of nutritional
support during the follow up. Thirty six patients (40.9%) needed a
feeding tube meanwhile only two patients (2.27%) needed parenteral
nutrition during hospitalization. We found differences between
patients that received nutritional assessment and those who did not,
regarding initial weight (73.86 vs 66.39 kg; p = 0.025); % of weight loss
(3.62 vs 8.91%; p = 0.004), initial albumin (4.28 vs 3.90 g/dl p = 0.019)
and final vitamin D levels (17.58 us 30.69 ng/dl; p = 0.019). We did not
find differences with regard to surgery complications (p = 0.147),
readmission during the first year (p = 0.466), need of second surgery
(p = 0.432), recurrences (p = 0.280) or exitus (p = 0.264).
Conclusion: HNC patients are at high risk of malnutrition. In spite of
planning a proper perioperative nutritional support, we do not get as
good results as we expected. This could be explained by only
malnourished patients and therefore, those with the poorest progno-
sis, are evaluated and treated by our department.
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NUTRITIONAL STATUS AND ANTHROPOMETRICAL MEASUREMENTS
IN CANCER PATIENTS REFERRED FOR INPATIENT PARENTERAL
NUTRITION: PRELIMINARY ANALYSES FROM A UK TERTIARY
REFERRAL CENTRE
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Rationale: Malnutrition in cancer patients is common and when
enteral nutrition cannot meet requirements, patients may start
parenteral nutrition (PN). In practice malnutrition is often assessed
via conventional measures with limited use of other anthropometrics.
We examined a variety of nutritional and anthropometric measures in
cancer patients referred for PN.
Methods: Of 85 (non)cancer patients referred for inpatient PN, 28
patients with active cancer were included (inclusion criteria: >18 yrs,
capacity to consent, started on PN at University College London
Hospital-UCLH) between Jan-May 2019. Medical and anthropometric
data, Karnofsky- and WHO-Performance Status (KPS, WPS), and
nutritional risk (using UCLH Screening Tool-NST and Subjective
Global Assessment PG-SGA), were recorded.
Results: 28 patients (median age: 59yrs (range: 21–83) and 55.2%
female) with primary malignancies of mainly gastrointestinal (n = 14/
28) and hematological (n = 10/28) origin. Baseline prognostic scores
weremodest:WPS: 2 (1–4), KPS: 60 (40–80), & GPS 1 (0–2). Therewas
high risk of malnutrition on both nutrition screening tools (UCLH-NST
score 8; PG-SGA: 11). Patients had a normal weight and BMI (56 kg:
35.1–102.2); BMI 20.7 kg/m2: 12.4–33.4), however, significant weight
loss in past 0–6 months 22.5% (−0.45–85.7). However, hand grip
strength was below reference values: left 38.6 kg (13.6–93.7), right
38.9 kg (13.3–85.9), lower triceps skinfold 9 mm (3.8–31.6), borderline
mid-upper arm circumference 25.3 cm (16.7–32.1), and MAMC
21.1 cm (15.1–28.8).
Conclusion: Baseline weight and BMI were normal; however, hand
grip strength and triceps skinfold were below normal. Our findings
suggest that additional nutrition measures provide more information
regarding body composition and muscle function in cancer patients.
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1Department of Infectious Disease and Hepatology, Wroclaw Medical
Univercity, Wrocław; 2Department of Infectious Disease and Hepatology,
Wroclaw Medical Univercity, Wroclaw, Poland
* Corresponding author.
Rationale:Malnutrition is considered to be a common, but frequently
underdiagnosed condition in patients with hepatocellular carcinoma
(HCC). Poor nutritional status has been shawn to have negative
influence on survival in HCC patients. There is no commonly accepted
gold standard for the diagnosis of malnutrition in these patients but
low BIA-derived PhA (≤5,18°) is an independent factor of poor
prognosis in HCC patients.
Methods: We have enrolled 20 patients with HCC out of total 243
patients with liver cirrhosis of different etiologies (chronic hepatitis B
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and C, alcoholic liver disease, non-alcoholic steatohepatitis, primary
biliary cholangitis) hospitalized in our department in 2018. 25% (5
patients) were female, 75% (15 patients) were male. 25% (5 patients)
fulfilled criteria of BCLC A category, 40% (8 patients) – BCBL B category
and 35% (7 patients) – BCLC C category. For the nutritional status body
mass index (BMI), serum albumin concentration, white blood cells
count (WBC) and BIA-derived PhA were evaluated. Test T and Chi2
were performer.
Results: We have enrolled 20 patients with HCC out of total 243
patients with liver cirrhosis of different etiologies (chronic hepatitis B
and C, alcoholic liver disease, non-alcoholic steatohepatitis, primary
biliary cholangitis) hospitalized in our department in 2018. 25% (5
patients) were female, 75% (15 patients) were male. 25% (5 patients)
fulfilled criteria of BCLC A category, 40% (8 patients) – BCBL B category
and 35% (7 patients) – BCLC C category. For the nutritional status body
mass index (BMI), serum albumin concentration, white blood cells
count (WBC) and BIA-derived PhA were evaluated. Test T and Chi2
were performer.
Conclusion: In our study good nutritional status was observed only in
patients of BCLC A category. This may be a proof that poor prognosis of
BCLC B and BCLC C stages results not only from the tumour stage, liver
function and patient’s performance but also from malnutrition that
progresses in the course of the disease.
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Rationale: Patients with esophageal (E) and head & neck (HN) cancers
(CA) are at high risk for malnutrition. Identification of nutrition risk is
essential to guide nutrition care. The Patient Generated-Subjective
Global Assessment (PG-SGA) is a validated nutrition risk screen for
oncology. We report changes in the PG-SGA over the course of
treatment in patients with E and HN CA.
Methods: A multicenter prospective audit of adult patients undergo-
ing curative treatment for HN or E CA. Enrolled patients were from 11
cancer centers in Canada, Netherlands, Italy, Australia and United
States. Dietitians/nutritionists administered the PG-SGA over the
course of treatment: baseline (admission to cancer center), at 2, 4
and 6 months. PG-SGA scores ≥9 indicate a critical need for nutrition
intervention/symptom control. Descriptive statistics are presented.
Results: From Aug 2016-March 2018, 170 patients were enrolled. At
baseline, mean PG-SGA scores were 10 ± 6; patients lost a mean of
2.4 kg (3.5%) in the previous 6 months and had high prevalence of
nutrition impact symptoms (NIS): problems swallowing (36%), pain
(31%), no appetite (22%), and fatigue (21%). At 2months, PG-SGA scores
increased from baseline to 13 ± 7 (P < 0.001), declining to 9 ± 5 at 4 and
6 months (P > 0.05 from baseline). Weight loss accelerated at 2 and 4
months with losses of 4.3 kg (P = 0.03) and 2.4 kg (P = 0.002),
respectively, but stabilized by 6 months. NIS significantly increased
(P < 0.001) at 2 months, with some decline by months 4–6 (P > 0.05
from baseline); NIS taste/smell alterations, dry mouth, and problems
swallowing remained prevalent at month 6.
Conclusion: These results highlight the need for continuous nutrition
risk assessment and tailored nutrition interventions throughout the
treatment trajectory of patients with HN and E CA.
Funding: This study is partially funded by Fresenius Kabi Deutschland
GmbH and Baxter.
Reference
International Nutrition Audit in FORegut TuMors (INFORM)
ClinicalTrials.gov Identifier: NCT0282948
Disclosure of Interest: A. Laviano: None declared, L. Martin: None
declared, R. Dhaliwal Other: Nestle, Baxter, L. Gramlich Grant/Research
Support from: Fresenius-Kabi, Nutricia, Baxter.
SUN-LB665
STABILITY OF THE NEUROMUSCULAR JUNCTION IN CANCER
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Rationale: Cancer cachexia is a major cause of patient morbidity and
mortality, with no efficacious treatment or generally-accepted
management strategy. Despite sharing pathophysiological features
with a number of other neuromuscular wasting conditions, the
mechanisms underlying cachexia remain poorly understood. Studies
using animal models have suggested that pathological targeting of the
neuromuscular junction (NMJ) may play a key role in the pathogenesis
of cachexia, but this has yet to be investigated in human patients.
Methods: High-resolution morphological analyses were undertaken
on NMJs in samples of rectus abdominis muscle obtained from
patients undergoing surgery for upper GI cancer compared with
control cases. Cancer patients included those with both cachexia
(according to the consensus definition) and weight stable disease
(n = 6 per group).
Results: Therewere six patients analysed per group providing a total of
240 NMJ’s. Patients in the cachectic group had a mean weight loss of
10.1% ± 2.41% and a mean SMI of 37.32 ± 1.79. Despite a significant
degree of muscle fibre atrophy noted in patients with cachexia
compared to weight stable cancer and control patients, NMJ
morphology was fully conserved, with no significant differences
observed in any of the twenty-one pre- and post-synaptic parameters
measured (including axon diameter, nerve terminal area, nerve
terminal complexity and percentage overlap between pre- and post-
synaptic structures).
Conclusion: NMJs remain structurally intact and conserved during
cancer and cachexia, suggesting that denervation of skeletal muscle is
not a major driver of pathogenesis. The absence of NMJ pathology in
human cancer is in contrast to observations noted in animal models,
and supports the hypothesis that intrinsic changes within skeletal
muscle, independent of any changes in motor neurons, represent the
primary locus of pathology in cachexia.
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DO LONGITUDINAL EPIGENETICS CHANGES AFTER A 6-WEEKS OF
HYPOCALORIC DIETARY INTERVENTION CAN MODULATE CANCER
PATHWAYS?
C. F. Nicoletti1*, C. Cortes-Oliveira1, N. Y. Noronha1, M. A. Pinhel1,
A. Jacome2, J. S. Marchini1, A. B. Crujeiras3, C. B. Nonino1. 1Faculty of
Medicine of Ribeirao Preto, University of São Paulo, Ribeirão Preto, Brazil;
2Universidad La Coruña, La Coruña; 3Universidad de Santiago de
Compostela, Santiago de Compostela, Spain
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Rationale: Evidence has shown that weight loss-interventions could
dynamically and reversibly modulate DNA methylation levels. This
study investigated: 1. the role of a hypocaloric dietary intervention on
global and promoter-specific DNA methylation; 2. possible changes in
genes related to cancer pathways.
Methods: For this, 11 obese (36.9 ± 10.3 y, 58.5 ± 10.5 kg/m2) and 24
normal-weight (36.9 ± 11.8y, 22.5 ± 1.6 kg/m2) women were enrolled.
Anthropometric evaluation and blood collection were performed
before and after a 6-weeks of a hypocaloric diet (1,200 kcal/day). DNA
methylation was analyzed in DNA extracted from peripheral leuko-
cytes using Infinium Human Methylation 450 BeadChip assay. This
array contains 485,577 probes, which cover 21,231 (99%) RefSeq genes.
All genome-wide DNAmethylation datawas analyzed by parametric t
test. CpG sites with a false discovery rate <5%, raw p values <0.01 and
methylation change >10% were considered significant. Gene ontology
analysis was performed using WEBGestalt.
Results: There was a weight reduction of 5.6%. Analysis showed that
505 genes were differently methylated between obese and normal
weight women and changed with the intervention. After diet, 264
genes remained different from control group, while 241 become
similar to normal weight individuals (AKT3, RHOQ, HIP1R and INPP5A,
which were from PI3 kinase, pyruvate metabolism, TCA cycle, and p53
pathway by glucose deprivation). On another hand, important genes
such as CTNNA1, CTNNA2, WNT5B, FYN, PRKCA, PRKCZ and PCDHGB1
from cadherin, Wnt pathway and angiogenesis signaling were always
different from control group. As our mainly results, we observed that
1. dietary intervention was able to modify (hypermethylate) cancer-
related genes; 2. these pathways was always less methylated when
comparing to control group, even after diet.
Conclusion: In conclusion, 6-weeks of hypocaloric dietary interven-
tion can promote epigenetic changes of cancer-related pathways;
however, it is not enough to became equal normal weight women.
Reference
SAMBLAS M.; MANSEGO M.L.; ZULET M.A.; MILAGRO F.I.; MARTINEZ
J.A. An integrated transcriptomic and epigenomic analysis identifies
CD44 gene as a potential biomarker for weight loss within an
energy-restricted program. Eur J Nutr. 2018.
Disclosure of Interest: None declared.
SUN-LB667
EFFECTS OF METABOLIC SYNDROME AND ITS COMPONENTS ON
ARTERIAL STIFFNESS IN ASYMPTOMATIC KOREAN POPULATION
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Rationale:Metabolic syndrome (MS) is known a risk factor for cardio-
and cerebro-vascular disease. Arterial stiffness (AS) is an early marker
of systemic atherosclerosis. Cardio-ankle vascular index (CAVI)
represents the stiffness of the whole artery, is easy to measure,
independent of blood pressure (BP), and has better reproducibility
than brachial-ankle pulse wave velocity. The relationship between AS
and presence of MS, in addition to age and sex as confounders were
investigated to identify the characteristics of CAVI.
Methods: A cross-sectional study was conducted for 2251 health
check-up subjects (1599 males and 652 females), aged 21–81 years,
who had undergone anthropometric measurement, metabolic blood
work, and CAVI, simultaneously. The classification of MS followed the
revised National Cholesterol Education Program criteria. Multiple
logistic regression analysis was performed to analyze the association.
A predefined CAVI cutoff value of 8 was used for analysis, based on
previous studies demonstrated that CAVI≥ 8 was associated with
significant coronary stenosis or calcification in asymptomatic subjects
and is the optimal cutoff for predicting carotid arteriosclerosis.
Results:
MS was present in 1118 subjects (49.7%). Significant association
between CAVI≥ 8 and MS (OR 1.53, 95% CI 1.25–1.87, p < 0.001) was
recognized after adjusting age and sex. Only high BP (OR 1.88, 95% CI
1.49–2.37, p < 0.001) of 5 metabolic components showed significant
association with CAVI≥ 8 after adjusting age, sex, smoking, alcohol
drinking, and exercise.
Conclusion: Presence ofMS, as well as age, associatedwith AS. Among
5 components of MS, high BP has significant association with AS.
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INVOLVED WITH INFLAMMATORY PATHWAYS IN WOMEN WITH
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Rationale: DNA methylation is an important epigenetic marker in the
determination of biological processes and diseases in humans,
including obesity.
Methods: This is a longitudinal intervention study, which 11 women
(35.7 ± 5.1 years) with grade III obesity were submitted to a
hypocaloric dietary intervention (1200 kcal/day) for 6 weeks.
Anthropometric data [weight, BMI], body composition [fat free mass
(FFM) and fat mass (FM)] and peripheral blood for methylation
analysis were collected before and after intervention. Genome-wide
methylation analysis was conducted using the Infinium
HumanMethylation450 BeadChip. For statistical analysis, Shapiro-
Wilk, Wilcoxon and Mann-Whitney test were used (p < 0.05). We
Table (abstract: SUN-LB667).
Variables metabolic
syndrome
age sex (male) High Blood
Pressure
High Fasting
Glucose
High
Triglyceride
Low HDL-
cholesterol
Abdominal
obesity
Odds ratio (95% Confidence
Interval)
1.53 (1.25–1.87) 1.16 (1.14–1.18) 1.42 (1.13–1.78) 1.88 (1.50–2.37) 1.56 (0.34–7.15) 1.29 (0.89–1.63) 1.13 (0.85–1.49) 0.84 (0.69–1.04)
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applied a threshold for the significant CpG sites based on Δβ with a
minimum value of 10% and a p-value less than 0.01.
Results: A significant weight loss of 9.2 ± 3.6 kg (5.6%, p < 0.003) was
observed after 6weeks of dietary intervention, in addition to reduction
in BMI (59.8 ± 11.0 to 56.3 ± 9.7 kg/m2 p < 0.003), FFM (66.2 ± 9.0 to
63.7 ± 7.7 kg; p < 0.006) and FM (91.9 ± 24.5 to 85.1 ± 22.1 kg; p <
0.003). The evaluation of the genes related to inflammation showed
changes in methylation levels at 20 CpG sites, 9 of which were
hypomethylation (TNF, IL1A, IL6R, HGF, CCL2, CCL28, RIPK1, RIPK2,
TRAF2) and 11 hypermethylated (IL6, IL10RB, CCL23, CCL24, CCL28,
SQSTM1/MGAT4B, RIPK2, NR2C2, NFKB2) after dietary intervention.
Conclusion:Hypocaloric dietary intervention for sixweeks can reduce
weight, BMI and fat mass and is able to change the DNA methylation
profile of genes related to inflammation in obese women.
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Rationale: Changes in body composition following energy restriction
are highly variable between individuals, but whether compensatory
adaptations in biological or behavioural components of total daily
energy expenditure (TEE) underlie this variability remains unclear.
Therefore, this study examined whether changes in TEE and its
components were associated with the rate of weight loss (WL) in
women following dietary energy restriction.
Methods: 46 women with overweight and obesity
(BMI = 29.1 ± 2.4 kg/m2) were randomised to continuous (25% energy
restriction) or intermittent energy restriction (ad libitum day alter-
natedwith 75% energy restriction day) until≥5%WLor up to 12weeks.
At baseline and post-intervention, body composition (air displace-
ment plethysmography), resting metabolic rate (RMR; indirect
calorimetry) and 7-day free-living TEE and physical activity (PA;
accelerometry) were measured. Rate of WL was defined as percentage
of WL divided by days to final measures. Analyses were conducted
with dietary groups combined as no pre-post intervention differences
in PA or body composition existed.
Results: 35 women reached a WL of 6.0 ± 1.6% in 65 ± 17 days. There
were no associations between changes in RMR and rate of WL
(r =−0.084; p = 0.629). Changes in TEE (r = 0.501; p = 0.002), total PA
(r = 572; p < 0.0001) and MVPA (r = 0.574; p < 0.0001) were positively
associated with rate of WL, while changes in sedentary time were
negatively associated with rate of WL (r = 0.552; p = 0.001).
Conclusion: These data suggest that compensatory responses in
behavioural rather than biological components of TEE may influence
the rate of WL during energy restriction. Changes in PA and sedentary
behaviour in response toWLwere highly variable between individuals
and may in part help account for the heterogeneity seen in dietary-
induced WL.
Trial registration: NCT03447600.
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BRANCHED-CHAIN AMINO ACID AND BRANCHED-CHAIN KETOACID
INGESTION INCREASE MUSCLE PROTEIN SYNTHESIS RATES IN VIVO
IN OLDER ADULTS
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J. M. Senden1, J. van Kranenburg1, A. P. Gijsen1, W. K. H. W. Wodzig2,
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Rationale: Limited data are currently available on the effects of
branched-chain amino acids (BCAA) and branched-chain ketoacids
(BCKA) ingestion on postprandial muscle protein synthesis rates. This
study compared the impact of ingesting 6 g BCAA, 6 g BCKA, and 30 g
milk protein (MILK) on myofibrillar protein synthesis rates in older
males.
Methods: In a parallel design, forty-five older males (age: 71 ± 1 y,
BMI: 25.4 ± 0.8 kg/m2) were randomly assigned to ingest 6 g BCAA, 6 g
BCKA, or 30 g MILK. Basal, early (0–2 h) and late (2–5 h) postprandial
myofibrillar protein synthesis rates were assessed by primed continu-
ous L-[ring-13C6]phenylalanine infusions with the collection of blood
samples and muscle biopsies. Data were analyzed using repeated-
measures and one-way ANOVA. Data represent means ± SEM.
Results: Ingestion of MILK, BCAA and BCKA significantly increased
early myofibrillar protein synthesis rates (0–2 h) above basal rates
(from 0.020 ± 0.002%/h to 0.042 ± 0.004%/h, 0.022 ± 0.002%/h to
0.044 ± 0.004%/h and 0.023 ± 0.003%/h to 0.044 ± 0.004%/h, respect-
ively; P < 0.001), with no differences between groups (P > 0.05).
Myofibrillar protein synthesis rates during the late postprandial phase
(2–5 h) remained elevated in MILK (0.039 ± 0.004%/h; P < 0.001), but
returned to baseline values following BCAA and BCKA ingestion
(0.024 ± 0.005%/h and 0.024 ± 0.005%/h, respectively; P > 0.05).
Conclusion: Ingestion of 6 g BCAA, 6 g BCKA, and 30 g MILK increases
myofibrillar protein synthesis rates during the early postprandial
phase (0–2 h) in vivo in healthy older males. The postprandial increase
following the ingestion of 6 g BCAA and BCKA is short-lived, with
higher myofibrillar protein synthesis rates only being maintained
following the ingestion of an equivalent amount of intact milk protein.
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SUN-LB671
COAGULATION AND DIGESTION CHARACTERISTICS OF MILK
PROTEIN MIXTURES
S. Verlaan1,2*, M. H. Schoemaker1, M. van den Belt3, H. van Dijck1,
J. Schloesser3, A. Kardinaal3. 1Frieslandcampina, Wageningen;
2Amsterdam UMC, Amsterdam; 3NIZO, Ede, Netherlands
* Corresponding author.
Rationale: Malnourished older adults need high levels of essential
amino acids (EAA), including leucine, to stimulate muscle protein
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synthesis, but their intake is limited. Oral nutritional supplements can
support the protein intake of malnourished people by providing fast-
digestible, high-quality proteins. Therefore we aimed to evaluate
mixtures of milk proteins on coagulation and digestion.
Methods: Coagulation characteristics of milk proteins andmixtures in
different ratios were studied in an in vitro stomach digestion model. A
mixture (RESANATM, R; casein:whey protein and hydrolysate in 2:1
ratio) was selected for comparison in a randomized, controlled, cross-
over trial (ClinicalTrials.gov Identifier: NCT03547362). Post-prandial
serum (E)AA profiles were evaluated in 12 healthy older adults (mean
age 71.3 ± 4.6 years, 50%male)who consumed 20 g of either casein (C),
whey (W), or selected protein mixture (R). The data were statistically
analyzed using mixed models, pair-wise compared, and expressed as
means ± SEM.
Results: In vitro gastric coagulation was shown for casein-rich
mixtures, but not for R protein mixture that consisted of two-thirds
of casein. Consumption of C, W, and R proteins resulted in different
serum AA profiles (all p < 0.001) in healthy older participants.
Maximum concentrations of total AA and EAA were significantly
higher for W and R vs. C (all p < 0.001). Maximum leucine
concentration was significantly higher for W vs. R vs. C (408 ± 19 vs.
304 ± 13 vs 216 ± 12 μmol/L; all p < 0.001).
Conclusion: The limited gastric coagulation of the R protein mixture
may have contributed to the fast and high rise in post-prandial serum
AA levels, followed by a sustained delivery. This essential amino acid
digestion profile, including leucine, might help malnourished older
adults to preserve their muscle mass.
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BUDGET IMPACT ANALYSIS OF A HOSPITAL-BASED NUTRITION
PROGRAM FOR MALNOURISHED COLOMBIAN PATIENTS
G. Buitrago1*, J. Vargas2, S. Sulo3, J. Partridge4, M. Guevara2, G. Gomez5,
J. D. Misas5. 1Universidad Nacional de Colombia, Bogota, Colombia;
2EconoPharma Consulting, Mexico City, Mexico; 3Abbott Nutrition, Abbott
Park; 4Abbott Nutrition, Columbus, United States; 5Abbott Nutrition,
Bogota, Colombia
* Corresponding author.
Rationale:Malnutrition affects up to 50% of Colombian inpatientswho
experience poor health and economic outcomes. Although the
optimization of nutrition care through comprehensive nutrition
programs for malnourished patients is associated with improved
outcomes and cost savings, little is known about the economic
advantage of implementing similar programs in Colombian hospitals.
We estimated the financial advantages of adopting a comprehensive
hospital-based nutrition program for malnourished Colombian
patients from a third-party payer perspective.
Methods: Budget impact analysis was mainly informed using data
from Giraldo et al. (2015) and other secondary data sources. The
outcomes of interests included length of stay, 30-day readmissions,
and complications (infectious/non-infectious). A Markov model was
developed where patients were assigned to receive nutrition support
within 24–48 hours post-hospital admission or continue without
nutrition support. The model was set at 60-days time-horizon with a
daily cycle length. All event probabilities were estimated assuming a
Poisson-like behavior.
Results: Average total costs over 60-days were $3,626 for patients
without nutrition support vs $2,328 for patients with nutrition
support; thus, representing a savings of $1,298 (35.8% decrease) per
patient. Differences in costs between the groups were: $2,600 vs
$1,538 for hospital-associated costs; $850 vs $640 for readmissions;
and $170 vs $91 for malnutrition-related complications, respectively.
Total costs savings for Colombia is estimated to be $1.09 billion.
Conclusion: Hospital-based nutrition programs can improve the
health outcomes and reduce healthcare costs of malnourished
hospitalized patients, whilst helping hospitals in Colombia with
healthcare resource management to provide optimal quality of
nutrition care to their patients at a reduced overall cost. These results
provide a rationale for implementation of comprehensive nutrition
programs for the malnourished hospitalized Colombian population.
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DIETARY HABITS OF DALMATIAN TYPE 2 DIABETES PATIENTS
D. Bucan Nenadic1, J. Radic1,2*, I. Novak2. 1University Hospital Centre,
Split, Croatia; 2School of Medicine, University of Split, Split, Croatia
* Corresponding author.
Rationale: Previous studies emphasize the importance of good dietary
practices in management of diabetes mainly by reducing the body
weight as a strong relationship between obesity and the upsurge of
diabetes is reported. The objective of the present study was to observe
the dietary patterns and food frequencies as well as regular exercise,
prevalence of overweight or obesity and correlation of body mass
index (BMI) with body mass composition parameters in Dalmatian
diabetic patients attending the Nephrology Outpatient Clinic.
Methods: 114 diabetic patients 66 (57.9%) men and 48 (42.1%) women
were included. Study was an interviewer administered questionnaire
based cross-sectional study. Food frequency questionnaire (FFQ) has
been used to assess diet in diabetic patients. Also, for each patient data
about age, gender, bodyweight and heightwere collected and BMIwas
calculated. Tanita MC780 Multi Frequency segmental body compos-
ition analyser was used to measure content of body fat, muscle mass
and visceral fat each study subject.
Results: Of the study population 54 (47.4%) patients were educated
about diabetic diet but just 8 (7%) complained with diet, 23 (20.2%)
don’t remember when they measured body weight last time and 59
(51.8%) don’t have regular physical activity. Of the study population 9
(7.9%) patients consume one meal /day, 91(79.8) consume 2–4 meal/
day while 14 (12.3%) consumemore than four meal/day. Furthermore,
85 (74.6%) patents are adding salt in meals, 26 (23%) patients
consumed cured meat products and 98 (86%) consumed bread every
day. Also, 79 (69%) patients consumed fruit while 60 (53%) consumed
vegetables and 56 (49%) drink milk every day. From the study
population, 100 (87.7%) of the patients were either overweight or
obese. Those patients with BMI≥ 25 had significantly higher percent-
age of fat tissue content (29 (22–36) vs.17.3 (12.9–25.8), p < 0.001) and
lower percentage of muscle mass content (68 (60–74) vs. 78.5 (70.6–
82.8), p < 0.001).
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Conclusion: Results revealed the importance of educating patients
with type 2 diabetes on dietary changes and more importantly the
involvement in regular physical activity.
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DRACOCEPHALUM MOLDAVICA L. SEED EXTRACTS MODULATE
INFLAMMATION AND OXIDATIVE STRESS IN HUMAN SKIN CELLS
E. Song1*, J. Choi1, H. Gwon1, S.-G. Choi2, J. Chun3, Y. H. Chang1,
J. Hwang1. 1Food and nutrition, Myongji University, Yongin; 2Food Science
and Technology, Gyeongsang National University, Jinju; 3Food Science and
Technology, Suncheon National University, Suncheon, Republic of, Korea
* Corresponding author.
Rationale: This study was conducted to investigate its phytosterol
contents and antioxidant activity of aqueous (AE) and ethanolic
extracts (EE) and supercritical CO2 extracted oil (SC-oil) of
Dracocephalum moldavica L. (DM) seed.
Methods: Total polyphenol content and total flavonoid content was
performed to analyze anti-oxidant capacity of DM seed extracts. For
the fatty acid contents in DM seed extracts, GC-FID was used after
saponification. Total phytosterols for campesterol, stigmasterol, β-
sitosterol + fucosterol, and Δ5-avenasterol were analyzed using GC-FID
analysis Human dermal fibroblast and HaCaT cell were used to
determine mRNA expression of HAS and Hyaluronidase after sample
treatment.
Results: Compared to AE and SC-oil, EE showed the highest content of
total phytosterols (EE, 963.74; AE, 296.91; SC-oil, 611.30 mg/100 g) in
descending order of β-sitosterol + fucosterol, stigmasterol, Δ5-avenas-
terol and campesterol. In terms of antioxidant activity, EE had the
highest radical scavenging capacities of ABTS and DPPH. In lipox-
ygenase inhibition assay, AE and EE showed similar inhibition capacity
compared to nordihydroguaiaretic acid (NDGA) and SC-oil inhibited
more than NDGA. These results indicate that EE and SC-oil showed
anti-oxidant and anti-inflammatory activities due to the highest levels
of total phytosterols compared to aqueous extract. In human dermal
fibroblasts and HaCaT cell lines, UVB decreased hyaluronic acid (HA)
concentration via hyaluronic acid synthase 2 inhibition and hyalur-
onidase 1 induction, which was recovered by SC-oil in dose-
dependently manner. SC-oil may protect photoaging by regulating
HA concentration at molecular levels in UVB-irradiated human cells.
Conclusion: In conclusion, DM may be potentially applied in the area
of anti-aging and atopy cosmetics due to its anti-oxidant and anti-
inflammatory effects.
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DRACOCEPHLAUM MOLDAVICA L. SEED EXTRACTS AMELIORATE
PHOTO-AGING ANDWOUND HEALING IN HACAT CELL AND 3D SKIN
MODEL
E. Song1*, J. Hwang1, J. Choi1, H. Gwon1, J. Chun2, S.-G. Choi3,
Y. H. Chang1. 1Food and nutrition, Myongji University, Yongin; 2Food
Science and Technology, Suncheon National University, Suncheon; 3Food
Science and Technology, Gyeongsang National University, JInju, Republic
of, Korea
* Corresponding author.
Rationale: Dracocephalum moldavica L. (DM) has been used for
cardiovascular disease and dermatitis due to antioxidant and antiviral
activities. However, few studies on DM and its extracts have been
reported. This study was conducted to investigate its wound healing
and skin extracellular matrix (ECM) effects in HaCaT cell.
Methods: To determine wound healing effect of DM seed extracts,
wound healing assay was conducted. After 80–90% of confluece with
HaCaT cell in 24 well plate, each well scratched using 200 μL tip and
treated sample. The wound clousure was observed after 24 hours. The
3D skinmodel which comprise epidermis and dermiswas used for the
test. Each model was punched using 40 mm of biopunch and after 48
hours of sample treatment, the layers was observed.
Results: The wound healing assay was conducted with extracts-
aqueous extract (AE), ethanolic extract (EE), and Superfluid critical
extract (SC-oil). SC-oil-treated HaCaT cell showed cell closure in dose-
dependent manner, whereas AE and EE showed more effective in
lower concentrations. However, 0.125 mg/mL, the highest does, of EE
showed the highest recovery rate. In 3D culture model, EGF recovered
from the wound to 2,468 μm. While 3D model treated with AE and EE
had no recovery, 3D model treated with SC-oil at 1% and 4% recovered
from the wound to 94.6 and to 38.29 μm, respectively. SC-oil
significantly decreased UVB-induced mRNA level of MMP-1 and AE
and EE significantly decreased those levels in dose-dependent
manner. SC-oil and AE tended to decrease elastase-1mRNA expression
in UVB-treated HaCaT cell.
Conclusion: In conclusion, DM may be potentially applied in the area
of cosmetics against photo-aging due to its wound healing and skin
ECM protective effects.
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ECONOMIC EVALUATION OF INDIVIDUALIZED NUTRITIONAL
SUPPORT IN MEDICAL INPATIENTS: SECONDARY ANALYSIS OF THE
EFFORT TRIAL
P. Schuetz1*, S. Sulo2, S. Walzer3, L. Vollmer3, Z. Stanga1, F. Gomes4,
R. Rueda5, J. Partridge6. 1Kantonsspital Aarau, Aarau, Switzerland;
2Abbott Nutrition, Abbott Park, United States; 3MArS Market Access &
Pricing Strategy GmbH, Weil am Rhein, Germany; 4University of Basel,
Basel, Switzerland; 5Abbott Nutrition, Granada, Spain; 6Abbott Nutrition,
Columbus, United States
* Corresponding author.
Rationale: Existing guidelines support the importance of nutritional
interventions for medical inpatients at malnutrition risk to alleviate
the burden malnutrition has on their outcomes. While recent studies
reported positive effects of nutritional support on health outcomes,
limited evidence exists on whether in-hospital nutritional support
also results in economic advantages. We report the results of the
economic evaluation of the EFFORT trial.
Methods: 2,028 medical inpatients at nutritional risk were randomly
assigned to receive individualized nutritional support to reach protein
and energy goals (intervention group; n = 1,015) or standard hospital
food (control group; n = 1,013). To calculate the economic impact, a
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Markov model was developed with relevant health states. Costs were
estimated for days in normal hospital ward and Intensive Care Unit
(ICU), hospital-associated complications, and nutritional support.
Results: In-hospital nutritional intervention cost alone was CHF90
per-patient, while the total nutritional support cost after including
dietitian consultation time was CHF283,85. In the base-case analysis,
30-day costs averaged CHF29,263 per-patient in the intervention
group versus CHF29,477 in the control group; resulting in per-patient
cost savings of CHF214 when accounting for nutritional intervention
cost only. Per-patient cost savings was CHF19,56 when accounting for
total nutritional support cost. The costs savingsweremainly due to ICU
length of stay (0,19 vs. 0,23 days) and complication (2,11 vs. 2,44)
reductions.
Conclusion: In-hospital nutritional support for medical inpatients is
associated with a cost reduction of up to CHF214 per-patient treated
due to reducing the risk for ICU admissions and hospital-associated
complications. These findings support the positive clinical and
economic benefits for at-risk medical inpatients resulting from
comprehensive nutrition programs including malnutrition screening,
consultation, and nutritional support. Policies and practices support-
ing optimization of nutrition care for medical inpatients are critical.
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EFFECTS OF AU-1803 ON CHOLIC ACID INDUCED-INTESTINAL
DAMAGE AND LIVER WEIGHT GAIN IN MICE
T. Koda1*, J. Takanari2, H. Imai1. 1Tokyo Healthcare University, Tokyo;
2Aminoup Co. Ltd., Sapporo, Japan
* Corresponding author.
Rationale: Cholic acid (CA) is sterol compounds that is synthesized
from cholesterol in the liver and secreted into the duodenm as the
main compound of bile. During transit to the large intestine, CA
undergo modifications to the steroid nucleus by somemembers of the
gut microbiota, yielding deoxy-cholic acid (DCA). DCA have been
reported to causes inflammatory bowel lesion and liver damage1).
Previously we reported that AU1803 treatment suppressed extrinsic
CA-derived bowel lesion in mice2). In this study, we examined how
AU1803 treatment suppressed CA-derived bowel lesion and liver
weight gain in mice.
Methods:Male ICR mice were acclimated on a control diet for 7 days
and then divided randomly into 6 groups. Each group was fed one of 3
diets for 7 days: control diet (control group and CA group), a diet
supplemented with 0.3% w/w AU1803 (LAU group and LAU + CA
group) and 0.6% w/w AU1803 (HAU group and HAU + CA group).
Control group, LAU group and HAU group were fed the same diet for
next 28 days. The other groupswere fed a diet supplemented 1.2%w/w
CA for next 28 days, respectively. Body weight and food intake were
measured during the experimental period. The colon and liverweights
were measured and used in histological assay.
Results: Themean bodyweight gain of CA groupwas smaller than that
of the other groups during experiment. The ratios of colonweight and
length of mice in CA group were significantly greater than the ratio of
colon weight and length in CA-untreated mice. Compared with the
ratio of colon weight and length in CA group and that of LAU + CA and
HAU + CA groups, AU tended to suppress the increase of ratio in colon
weight and length. The mean liver weights of mice in CA treated
groups were greater than that of mice in CA-untreated group. There
were no significant differences in means of liver weight between CA
group and LAU of HAU + CA group.
Conclusion:Adiet supplementedwith AUmay suppress DCA-induced
inflammatory bowel disease but not liver toxicity in mice.
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IMPACT OF PROGNOSTIC NUTRITIONAL INDEX ON OUTCOMES IN
PATIENTS WITH MYCOBACTERIUM AVIUM COMPLEX LUNG DISEASE
S. Moon1*, Y.-A. Kang1. 1Division of Pulmonary and Critical Care
Medicine, Department of Internal Medicine, Yonsei University College of
Medicine, Seoul, Republic of, Korea
* Corresponding author.
Rationale: Malnutrition is associated with immune dysfunction and
inflammatory processes. It also affects the quality of life andmorbidity
of patients with pulmonary disease. This study aimed to evaluate
whether Onodera’s prognostic nutritional index (PNI) is associated
with mortality and sputum culture conversion in Mycobacterium
avium complex lung disease (MAC-LD) patients.
Methods: 471 patients diagnosed with MAC-LD between May 2005
and September 2017 were examined. The PNI score was calculated at
the time of diagnosis: PNI = 10 × serum albumin (g/dL) + 0.005 × total
lymphocyte count (/mm3). Patientswere divided into themalnutrition
and non-malnutrition groups according to the cut-off PNI score of 45.
The cut-off PNI score was determined based on studies by Pinato et al.
Multiple logistic regression models and multivariate Cox proportional
hazards models were used to estimate the odds ratio (OR) for sputum
culture conversion and the relationship between clinical parameters
and mortality, respectively.
Results: In the logistic regression model, when age, gender, smoking
status, radiographic type, AFB test result, treatment duration, and
malnutrition were included, malnutrition (OR: 2.533, 95% confidence
interval [CI]: 1.059–6.057, P = 0.037) was significantly related to
culture conversion failure. Cox proportional hazard analysis demon-
strated that malnutrition (hazard ratio: 3.711; 95% CI: 2.095–6.574;
P < 0.001), lower BMI, fibrocavitary or unclassifiable radiologic find-
ings, history of cancer, and history of diabetes were significant risk
factors for all-cause mortality.
Conclusion: Malnutrition is an independent predictor for failure of
sputum culture conversion and all-cause mortality in patients with
MAC-LD. It is important to stress the importance of nutritional
assessment for patients with MAC-LD.
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MINI NUTRITIONAL ASSESSMENT SHORT FORM AND KIHON
CHECKLIST ARE SIMPLE AND USEFUL SCREENING FOR CARDIAC
CACHEXIA IN OUTPATIENTS WITH HEART FAILURE
N. Suzuki1*, K. Kida2, S. Doi3, Y. Nakayama1, M. Kasahara1, K. Okuyama1,
K. Mizukoshi1, K. Ashikaga3, H. Matsuda1, K. Mizuno1, T. Harada3,
Y. J. Akashi3. 1Division of Cardiology, Department of Internal Medicine,
St. Marianna University School of Medicine Yokohama City Seibu
Hospital, Yokohama; 2Department of Pharmacology; 3Division of
Cardiology, Department of Internal Medicine, St. Marianna University
School of Medicine, Kawasaki, Japan
* Corresponding author.
Rationale: Cardiac cachexia is a poor prognosis and diagnosis is
important. However, diagnosis of cardiac cachexia for outpatients is
not sufficiently performed because it may be time-consuming. We
investigated screening methods useful for the diagnosis of cardiac
cachexia in the clinical setting.
Methods: Totally 118 outpatientswith CHFagedover 65 years oldwere
enrolled. The criteria for evaluating cachexia by Evans were used.
Nutritional status was assessed by the Mini Nutritional Assessment
Short Form (MNA®-SF) and frailty was assessed by the ‘Kihon
checklist’. We compared and evaluated these assessments and the
diagnosis of cachexia.
Results: The mean age was 76.0 ± 7.4 years old and left ventricular
ejection fractionwas 43.6 ± 17.2%. Of the study patients, 54.7% patients
were male, 20.7% patients had ischemic heart failure, 45.9% patients
had MNA®-SF score ≤11, and 14.4% patients had cardiac cachexia. The
1year event-free survival rates were cardiac cachexia group 64.7% and
non-cardiac cachexia group 88.5% (Log-rank, p < 0.01). The multivari-
ate logistic regression analysis suggested that MNA®-SF score {odds
ratio (OR), 0.51; 95% confidence interval (CI), 0.36–0.66; p < 0.01} and
Kihon checklist score (OR, 1.35; 95% CI, 1.19–1.59; p < 0.01) might be
independent predictors for cardiac cachexia in heart failure patients.
Conclusion: Evaluation by MNA®-SF and Kihon checklist score was
simply performed by questions, which were useful for diagnosing
cachexia.
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NUTRITIONAL STATUS IN ADULTS WITH CYSTIC FIBROSIS AND
PANCREATIC INSUFFICIENCY
N. Sripalan1*, I. E. Moen2, P. L. Finstad3, H. K. Brekke1, M. Ekornes4,
S. Gharagozlian5. 1Department of Nutrition, University of Oslo;
2Norwegian Resource Centre for Cystic Fibrosis, Oslo University
Hospital; 3Pulmonary dep, CF unit, Instutition Oslo University Hospital,
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Gjettum/Drammen; 5Section of Clinical Nutrition, Oslo University
Hospital, Oslo, Norway
* Corresponding author.
Rationale: Cystic fibrosis (CF) with pancreatic insufficiency (PI) need
pancreatic enzyme and vitamin supplements to prevent malnutrition
due to malabsorption of macro- and micronutrients. Few studies have
been evaluating nutritional status inpatientswith CFand PI. The aimof
the study was to assess nutritional status in adult CF with PI.
Methods: A cross-sectional pilot study, was carried out in adult
patients at the Department of Pulmonary Medicine at Oslo University
Hospital (OUH) from August to December 2018. Patients with liver
disease were excluded. Nutritional status was assessed by anthropo-
metric measurements (including weight, height, body mass index
(BMI)), handgrip strength (HGS) and body composition analysis using
dual energy X-ray absorptiometry (DXA). Spirometry and biochemical
measurements were also measured. A 24 hours diet recall, in three
separate days, was used to assess the participants’ dietary intake.
Results: 34 participants were included. Mean BMI was 24.0 kg/m2
for all the subjects, where 61.5% of female subjects had BMI below
22 kg/m2 and 42.9% of the male subjects had BMI below 23 kg/m2.
11.1% (3/27) of the subjects had osteopenia. A significant but moderate
correlation (r = 0.51; p = 0.008) of body mineral density (BMD) with
handgrip strength (HGS) was found. There were significant but
moderate correlations of lean body mass (LBM) with BMD (r = 0.62;
p < 0.001), lean body mass index (LBMI) with HGS (r = 0.67; p < 0.001),
and LBMI with FEV1% (r = 0.39; p = 0.04). 32% (8/25), 4.2% (1/24) and
12.5% (3/24) of the subjects, respectively, had deficiency in vitamin
(vit) D, A and E. 3.4% (1/29) of the subjects were iron anemia deficient.
Median (IQR) intake of energy was 82 (65.2–104.8) % EAR (estimated
average requirements), min-max (43.2–178.3) compared to recom-
mendations specific for CF which is 120–150% of EAR.
Conclusion: A high prevalence of subjects with low intake of energy
was found. Fat-soluble vitamins status was not optimal, despite using
vitamin supplementation and pancreatic enzymes. BMD and LBM
seem to correlate with peripheral muscle strength and lung function.
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PREVENTION OF NUTRITIONAL DEFICIENCIES IN CHRONIC
HEPATITIS C PATIENTS- NEW VIRUS REMOVAL TREATMENT-
Y. Fueda1*, H. Kotera2, A. Matsumori3. 1Department of Medical
Engineering, Morinomiya University of Medical Sciences, Osaka;
2Department of Medical Engineering, Himeji Dokkyo University, Himeji;
3Asian Pacific Society of Cardiology, Kyoto, Japan
* Corresponding author.
Rationale: The number of hepatitis C virus (HCV) infection patients
exist about 200 million people in the world. Chronic hepatitis C
patients with advanced fibrosis may develop nutritional deficiencies
and muscle weakness. The virus removal has shown nutrition
improvement and the suppression of bone fractures [1]. Currently,
the effective virus removal treatment is only interferon combination
therapy. The purpose of this study was development of new virus
removal treatment. We suggested the filter which specifically
absorbed HCV and examine of HCV removal rate.
Methods: We separated the mononuclear leukocyte layer from the
HCV infection blood of three cooperators, and immunostained them
using the monoclonal HCV antibody. In addition, we examined the
filter material which specifically absorbed HCV using 14 HCV infection
patients. We tried appearance coating of hydroxypropyl cellulose
(HPC), which was hydrophilic polymer, and cellulose acetate (CA) in
syndiotactic polystyrene (SPS) resin. SPS resin which is the material of
leukocyte removal filter used as blood transfusion filter disturbs
removal of leukocyte ingredient [2]. The filters of fiber diameter were
1.8 μmand 3.5 μm.We performed perfusion of blood to each filter, and
measured the blood count before and after the experiment.
Results: Firstly, HCV positive cells were confirmed with three cases.
Mononuclear leukocyte might phagocytose HCV antigen. Secondly,
the removal efficiency of blood cells with SPS-HPC of 3.5 μm were
higher than other filters. Finally, the removal rates of HCV in thewhole
blood, plasma and the mononuclear leukocytes significantly
decreased 59.2%, 57.0% and 77.2%, respectively.
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Conclusion: The mononuclear cells which infected HCV might be
carried to other organs as well as liver. We confirmed that most HCV
virus and mononuclear cell with HCV were absorbed by SPS-HPC. We
suggested that the SPS-HPC prevent from nutritional deficiencies as a
result of suppressing the development of chronic hepatitis.
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PROTEINANDENERGY INTAKEDURINGHEMODIALYSIS TREATMENT
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M. G. A. van den Berg1*. 1Department of Gastroenterology and
Hepatology-Dietetics; 2Department of Nephrology; 3Radboud Institute
for Health Sciences, Scientific Centre for Quality of Healthcare, Radboud
University Medical Centre, Nijmegen, Netherlands
* Corresponding author.
Rationale: Eating during hemodialysis (HD) improves nutritional
status, clinical outcomes, quality of life and reduces mortality. There is
controversy in providing food during HD, because this could lead to
symptomatic hypotensive events (SHE’s) [1]. Radboud University
Medical Centre introduced a new food service (NFS) to the dialysis
department, which contains several small protein-rich foods and
adheres to the Dutch dietary HD guidelines. Objectives were to
investigate whether NFS improves protein and energy intake during
HD, compared to the old food service (OFS) and evaluate the numberof
SHE’s between food services in HD patients.
Methods: A prospective cohort design was used with 25 HD
outpatients (mean HD duration 4 hours). Intake and SHE were
measured three days within one week during OFS and three days six
months later during NFS. SHE was defined as a systolic drop
>20 mmHg between two blood pressure measurements and 1)
temporary or permanent fluid removal stop or 2) nausea or 3)
dizziness. Intake differences between food services was analysed with
linear mixed models and corrected for fluid removal.
Results: Protein and energy intake over the three measurements
within each food servicewas fairly constant.Mean ± SDprotein intakes
for OFS and NFS were 26 ± 11 and 31 ± 13 grams, energy intakes were
603 ± 218 and 724 ± 244 kcal. For fluid removal adjusted differences
between OFS and NFSwere significant, in favour of NFS (protein: β 3.2,
95%CI 0.2–6.1; energy: β 105.8, 95%CI 46.4–165.2). No increase in SHE’s
occurred at NFS (2 SHE’s at OFS vs. 1 SHE at NFS).
Conclusion: NFS resulted in an increased protein and energy intake,
while no increase in SHE was observed.
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REAL-WORLD EVIDENCE OF CLINICAL CHARACTERISTICS AND
TOLERANCE OUTCOMES AMONG ADULT POST-ACUTE CARE
PATIENTS RECEIVING PEPTIDE-BASED DIETS IN THE US
C. Lowen1,2*, C. Lavallee3, P. Seelam3, S. Balakrishnan3, A. Henrikson1,
B. Kesting4, K. Araujo Torres1. 1Medical Affairs, Nestle Health Science,
Bridgewater, New Jersey; 2Medicine/Gastroenterology, University of
Louisville, Louisville, KY; 3DRG, Burlington, MA; 4Market Access, Nestle
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* Corresponding author.
Rationale: Enteral tube feeding (ETF) is a medical nutrition therapy
used to help meet nutritional requirements in patients who have
inadequate volitional intake. Inadequate delivery of ETF may be
secondary to enteral formula intolerance, leading to malassimilation
of nutrients. Our aim is to assess the real-world tolerance of enteral
peptide-based diets (PBDs) in adults outside of the hospital in a post-
acute care setting.
Methods: Medical claims data were obtained from the Decision
Resources Group Real World Evidence Data Repository US database.
The cohort of adult patients (>18 years old) included patients receiving
PBDs through ETF for any condition after hospital discharge between
Q1-2013 and Q4-2017. Patients were observed up to 1-year post-
initiation of PBDs after hospital discharge. Univariate descriptive
statistics, including means, standard deviations, and proportions were
calculated for study variables.
Results: Mean age of the 2,256 included patients was 53.1 (SD 18.1)
years and 47.8% were female. The most commonly observed
underlying conditions were relative to the digestive system, endocrine
nutritional and metabolic diseases, and diseases of the respiratory
system. Use of PBDs is associated with a reduction in nausea and
vomiting, 26.3% vs 15.1% (p < 0.001); diarrhea, 25.4% vs 16.9%
(p < 0.001); constipation 28.5% vs 18.9% (p < 0.001); abdominal
distension, 12.8% vs 7.3% (p < 0.001); and gastric residual, 8.1% vs
4.2% (p < 0.001); ≥2 adverse tolerance events, 28.6% vs 16.2% (p <
0.001). No significant change in weight, BMI, or HbA1c was observed.
In the 30 days post initiation of PBDs, 46.2% of patients had >1
inpatient visit (mean 3.6, SD 4.1). In the same period, 99.8% of patients
had >1 outpatient visit recorded (mean 5.0 SD 3.4).
Conclusion: This study shows that enteral feedingwith PBDs leads to a
significant improvement in gastrointestinal tolerance events.
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THE EFFECT OF TWO IN-HOSPITAL MEAL SERVICES ON PROTEIN
AND ENERGY INTAKE IN ELDERLY
M.H.W. vanVeghel1, I. A.M. DeGroot2*,M.Manders1, I. A.M. Gisbertz3.
1HAN University of Applied Sciences, Nijmegen; 2Dietetics;
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Rationale: All hospitalized elderly patients have higher protein needs,
regardless of their former nutritional status. The aim of this study was
to investigate the effect of two new in-hospital meal services in
Bernhoven on protein (and energy) intake of elderly.
Methods: Patients of the current meal service (A) (n = 32) received an
energy and protein enriched diet only when they were at risk for
malnutrition. During the secondmeal service (B) (n = 36), ALL patients
received one oral nutritional supplement extra (400 kcal, 20 g
protein). During the third meal service (C) (n = 35), ALL patients
were offered an protein and energy enriched diet. Protein and energy
intake were calculated by having write down as accurately as possible
what has been eaten and drunk on the fourth recording day. Protein
and energy requirementswere calculated by using formulas. Both new
meal services (B and C)were compared to the currentmeal service (A).
Results: As can be seen in Table 1, meal service C significantly
improved protein intake in % of requirements, compared to the current
meal service (A). Usingmeal service C, significantly more patients met
100% of their protein requirement (46% vs 19%, p < 0.05) compared to
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meal service A. Using meal service B this differencewas also observed
(33% vs 19%, p = 0.174), altough not significantly different.
Table 1
Protein and energy intake in percentage of calculated requirements
Meal service A B C
Protein, % of requirements* 64(52–95) 87(69–107) 98(76–114)a
Energy, % of requirements* 86 ± 31 93 ± 29 96 ± 22
*Mean ± SD for metric variables and median and (IQR) for non-metric variables
aStatistically significant difference P < 0,05.
Conclusion: We have shown to improve protein intake in our elderly
patients, by adjusting our standard meal service. Use of one additional
oral nutritional supplement a day showed a trend towards higher
protein intake, but was not significant.
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TRANSITION BETWEEN NUTRITION CATEGORIES IN HEMODIALYSIS
PATIENTS, 1 YEAR FOLLOW UP STUDY
S. Blumberg1*, Z. Barnea2, R. Cernes2, A. Katkov2, A. Levi3, A. Biro2,
Z. Katzir2, L. Feldman2. 1Nephrology Institute and Depatrment of Clinical
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Rationale:We have previously characterized four nutritional categor-
ies in hemodialysis (HD) patients, by themethod of ICNDS (Integrative
Clinical Nutrition Dialysis Score) and slope of three subsequent
monthly scores. Four categories emerged as predictors of survival.
This study aims to explore transition between nutrition categories
from HD initiation up to 12 months.
Table 1
Transition between nutrition categories from HD initiation up to 12 months
follow up.
Categories following 1 year HD, percent patients
Category
1
Category
2
Category
3
Category
4
Mortality
Categories at HD
initiation,
percent
patients
(N = 226)
Category 1
(N = 81)
39.5 22.2 8.6 2.5 27.2
Category 2
(N = 79)
34.1 24.1 2.5 1.3 38
Category 3
(N = 52)
23.1 25 9.6 0 42.3
Category 4
(N = 14)
28.6 21.4 14.3 0 35.7
Methods: In 226 HD patients initiated dialysis, nutrition status was
monthly evaluated by ICNDS, a method based on seven parameters
(albumin, creatinine, urea, cholesterol, Kt/V, CRP, post dialysis weight
change). We calculated slope of first three subsequent monthly scores
of each patient at HD commencement and 12 months later. Patients
were divided into four categories: Category 1: score >= 75 slope >= 0;
Category 2: score >= 75 slope < 0; Category 3: score < 75 slope > 0;
category 4: score < 75 slope < 0. We have explored transition between
nutrition categories following 1 year in HD.
Results: Majority of patients evaluated at HD commencement as
category 1 remained in the same category following 12 months in
dialysis. Patients at category 1 at HD commencement had reduced
mortality risk compared to other categories. Probability to improve
nutrition status of patients evaluated as category 2,3 and 4 at initiation
of HD was higher than probability to stay at the same category.
Conclusion:Although nutrition status at HD commencement is amain
prognostic factor, transition between nutrition categories following
first year in HD might improve survival as well as nutrition status.
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AUKONLINE SURVEY TOASSESS THE USE OFAMULTIDISCIPLINARY
TOOL TO AID MANAGEMENT OF GASTROINTESTINAL SYMPTOMS IN
ENTERALLY FED PATIENTS WITH NEUROLOGICAL CONDITIONS
S. Saduera1*. 1Medical Affairs Dietitian, Nestlé Health Science, Gatwick,
United Kingdom
* Corresponding author.
Rationale: There is currently no consensus definition of “enteral
feeding intolerance”.1,2 Clinical manifestations may include: nausea,
vomiting or regurgitation, diarrhoea, abdominal pain, abdominal
distension, high gastric residual volumes1–3. To help guide clinical
practice, a working group of specialist dietitians and a consultant
neuro-gastroenterologist met with the aim of developing a pragmatic
guidance tool.
Methods: During March and April 2019, an online survey was sent to;
Neurosciences Group (NSG) and the Parenteral and Enteral Nutrition
Group (PENG) of the British Dietetic Association (BDA). The purpose
was to understand; (a) What has been the current uptake of the tool
amongst dietitians (b) To gather insights on the potential use of the
tool amongst dietitians and other Health Care Professionals (HCP’s).
Results: The survey was completed by 65 members, 68% had seen the
tool, 32% had not. Since it’s launch 36% have used the tool and 20%
using it on amonthly basis. Areas in the toolmost useful were; nausea/
vomiting (71%), abdominal pain/bloating (65%), constipation (62%),
diarrhoea (56%), reflux (44%), epigastric pain (35%) and early satiety
(29%). Reasons for this were; “these were common symptoms
experienced by patients”, “difficultly determining the cause of these
symptoms” and “allowing dietitians to consider alternative routes
beforemaking changes”. Ninetyone percent felt the tool can be used in
acute and community settings. The majority were extremely likely or
likely to use the tool. Sixty eight percent believe it can improve quality
of life for patients. Between 85–91% would recommend the tool to
other HCP’s and use at their next visit. Members believe the tool could
be used by; dietitians with limited experience in neurological
conditions (88%), student dietitians (88%), specialist neurology
nurses (70%), GPs (65%), junior doctors/registrars (62%), gastroenter-
ology nurses (53%), neurologists (53%), gastroenterologists (50%) and
ward nurses (47%).
Conclusion: The response to the tool has been very positive, described
as fantastic, user-friendly and practical. Next steps include additional
data collection in its use in clinical practice.
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BOTH MALNUTRITION AND FRAILTY, AND MALNUTRITION AND
SARCOPENIA OVERLAP SUBSTANTIALLY IN HOSPITALIZED OLDER
ADULTS: A SYSTEMATIC REVIEWAND META-ANALYSIS
G. Ligthart-Melis1, Y. Luiking1*, A. Kakourou1, S. Elemans1,
T. Cederholm2, A. Maier3, M. De van der Schueren4. 1Danone Nutricia
Research, Utrecht, Netherlands; 2Uppsala University Hospital, Uppsala,
Sweden; 3University of Melbourne, Melbourne, Australia; 4VU University
Medical Center, Amsterdam, Netherlands
* Corresponding author.
Rationale: A previous meta-analysis revealed a prevalence of 19%
frailty and 2.3% malnutrition in community-dwelling older adults (1).
Of those with malnutrition, 68% were also frail, whereas only 8.4% of
frail older people were also malnourished. A new meta-analysis in
hospitalised older adults examining the overlap in prevalence of (risk
of) malnutrition and (pre-)frailty, and the overlap in prevalence of
(risk of) malnutrition and sarcopenia has been undertaken.
Preliminary data are presented.
Methods: A systematic literature search resulted in a selection of 29
papers on (risk of) malnutrition and frailty and 20 papers on (risk of)
malnutrition and sarcopenia. Available data were used to report the
overall and overlapping prevalence of (risk of) malnutrition and (pre-)
frailty, and prevalence of (risk of) malnutrition and sarcopenia. The
association between (risk of) malnutrition and (pre-)frailty or
sarcopenia was determined with Odds ratios.
Results: Pooled data revealed that 67% [95% CI: 59, 74%] of older,
hospitalized adults were (at risk of being) malnourished, 82% [95% CI:
75, 90%] were (pre-)frail and 37% [95% CI: 26, 48%] had sarcopenia.
Furthermore, a high overlapping prevalence and concomitant Odds
Ratio was observed for (risk of) malnutrition and (pre-)frailty (50%;
OR: 5.24 [95% CI: 3.58, 7.67]) and for (risk of) malnutrition and
sarcopenia (42%; 4.06 [95% CI: 2.16, 6.80]). Also, 89% and 55% of those
with (risk of) malnutrition were frail or sarcopenic, respectively, and
61% of the frail and 89% of thosewith sarcopeniawere (at risk of being)
malnourished.
Conclusion: The prevalence and overlap of (risk of) malnutrition and
(pre-)frailty or sarcopenia in hospitalized older adults was observed to
be substantial, indicating that most older adults suffer from two and
perhaps even three of these geriatric syndromes. This supports the
importance of screening for these syndromes before or at hospital
admission to guide intervention and nutritional support.
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NECK CIRCUMFERENCE IS INDEPENDENTLY ASSOCIATED WITH
OBESITY IN FEMALE EMIRATI STUDENTS
D. Papandreou1*, Z. Taha1, M. Abboud2. 1Department of Health, Zayed
University, Abu Dhabi; 2Department of Health, Zayed University, Dubai,
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* Corresponding author.
Rationale: Neck circumference is a new tool that has been linked to
obesity. However, no studies in UAE have been conducted yet. The
purpose of this study was to measure the obesity levels in a college
population and to correlate themwith NC and other anthropometrical
indexes.
Methods: Three hundred and fifty-five female students aged 18–24
were conveniently selected to participate in the study.
Anthropometrical indexes were obtained from all subjects after 12-h
fasting. NC was measured with a regular plastic tape to the nearest
0.5 mm. Statistical significance was considered for P < 0.05.
Results: Eighty-five out of 355 female college students (23.9%) were
overweight (OW) and obese (OB). The OW/OB group had significantly
important higher levels (p < 0.001) of waist Circumference (WC), Free
fatty mass (FFM) and neck circumference (NC), P < 0.021 compared to
the normal group. In Pearson Correlation, NC (r = 0.881),WC (r = 0.712)
and BF (r = 0.732) were significantly (P < 0.001) strongly positively
correlatedwith obesity. Inmultiple regression analysis, NC (Beta: 2.12;
0.85,2.32) and WC (Beta: 1.21; 077, 1.98) were significantly (P < 0.001)
independently associated with obesity.
Conclusion: Neck circumference is a new tool that may be used safely
to measure neck fatness levels. In addition, NC was found to be
independently associated with obesity levels in Emirati college
students. More extended studies including data from all Emirates are
necessary for the development of cut off references and the possible
associations with CV risk factors that may lead to health problems for
obese people later in their life.
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PREVALENCE OF HOSPITAL MALNUTRITION AND DURATION OF
HOSPITALIZATION IN A SECOND LEVEL HOSPITAL
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Coalla1, S. González Martínez1, L. Díaz Naya1, A. Arias Magadan4,
G. Gutiérrez Buey1. 1Endocrinology and Nutrition, Hospital Universitario
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Rationale: Hospital malnutrition is associated with greater risk of
morbidity and mortality. The aim of the study was to determine the
prevalence of nutritional risk in patients hospitalised in a second level
hospital in Spain.
Methods: Cross-sectional, observational study in a period of 5
consecutive days, assessing the prevalence of malnutrition at patient
admission using Malnutrition Universal Screening Tool (MUST).
Exclusion criteria were patients <18 years old, pregnancy and ICU.
For statistical analysis SPSS v20 was used
Results: 111 patients were included, 53.8% males, mean age 67.1 years
(SD 18). 51.4% were >70 years. Mean BMI 27.07 Kg/m2 (SD 5.1). Using
MUST the prevalence of malnutrition was 28.8% (13.5% medium risk
and 15.5% high risk). Mean duration of hospitalization were greater in
patients at high risk (9 days, 95% confidence interval (CI) 4.3–13.7),
than in low and medium risk patients (5.9 days, 95% CI 4.7–7.2),
p < 0.009. 25.3% of patients at high risk died during the 30 days
posthospitalization, comparing to 10% of patients in the other groups
(p < 0.001). Only 1.8% af all (2 patients) received a nutritional support
at admission.
Conclusion: This study shows that hospital malnutrition is a prevalent
condition in hospitalized patients that is associated with longer
hospital stays and double risk of death. Nutritional support strategies
are needed at admission.
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OUTPATIENTS
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Rationale: Disease-related malnutrition (DRM) in hospitalized
patients is known to have significant negative impact on clinical
outcomes.Meanwhile, DRM in gastroenterologyoutpatients is vaguely
investigated. The aim of this study was to investigate the prevalence of
unintentional weight loss (UWL) and reduced food intake (RFI) as
contributors for the risk of DRM in outpatients.
Methods: All outpatients visiting the department of Gastroenterology,
Aalborg University Hospital, Denmark, for any reason, during one
week in September 2018 were invited to participate. Data regarding
UWL within the past three months, RFI the past week, nutritional
impact symptoms (NIS) and demographics were collected in this
questionnaire-based cross-sectional study. Descriptive analysis, chi-
squared test and multiple logistic regression analysis were used for
statistics.
Results:Out of 348 eligible patients, 346were included;medical clinic
(n = 170) and surgical clinic (n = 176). UWL occurred in 26%, mean
weight loss 7.1 kg (SD 5.2) and 24% had RFI. A significant increased risk
of UWL was identified in patients with BMI <18.5 kg/m2 (OR 6.1, CI:
2.0–18.7, p = 0.003). NIS were more frequent in the medical clinic. The
main self-reported reasons for NIS affecting UWLwere lack of appetite
(15% vs. 12%), pain (14% vs. 8%) and nausea (12% vs. 3%).
Conclusion: One in four outpatients experienced UWL and/or RFI as
contributors to the risk of DRM, which may have a significant negative
impact on clinical outcome. Follow-up studies are needed for further
investigation of UWL and RFI as contributing factors for DRM, the
impact on clinical outcome and of nutritional intervention in
outpatients.
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ADULT HOSPITALIZED PATIENTS IN MEXICO CITY
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Rationale: Malnutrition poses a significant burden on patients’
nutrition, clinical and health outcomes and results in increased costs
as a result of higher healthcare use. We assessed malnutrition risk
prevalence and characteristics of hospitalized adults receiving care at a
tertiary hospital in Mexico City.
Methods: Malnutrition risk was assessed by the nutriologist in non-
critical areas during the first 24 hours of admission using NRS-2002.
Main characteristics included age, gender, body mass index (BMI),
weight changes during hospital stay, food intake, nutrition support.
Length of hospital stay, and healthcare use 30-days post hospital dis-
chargewere also recorded. Results are reported for qualifying patients
had complete data per questionnaires required by nutritionDay 2015.
Results: A total of 146 patients were included, malnutrition risk was
61%. Patients were 52 y, predominantly male (59%), and underweight
(BMI = 24.6 ± 5.9). Of the total patients, 70.5% reported weight loss,
with 28.8% of the patients losing >8 kg; main reasons for decreased
food intake were inability to eat due to medical tests, loss of appetite,
and other. In terms of nutrition support, 39% of the patients were on
therapeutic diet, 34.9% of regular diet, 8.22% on oral nutritional
supplements, and the remaining patients on parenteral or enteral
nutrition. The average length of stay was 11 [range:2–92] and 79.5% of
the patients were successfully discharged home independently. Over
6% of the patients died, while less than 1% of the patients were
readmission 30-days post hospital discharge.
Conclusion: Malnutrition risk was higher among patients 52 years
with low BMI, thus leading to longer hospital stay. The results
emphasize the need for systematic nutrition screening and treatment
protocols to ensure hospitalized patients can experience improved
nutrition and health outcomes.
Reference
Mogensen KM, Malone A, Becker P, et al. AND/ASPEN Consensus
Malnutrition Characteristics: Usability and Association With
Outcomes. Nutri Clini Pract 2019; 1–9.
Disclosure of Interest: None declared.
MON-LB692
DIET QUALITY IN LATE MIDLIFE IS ASSOCIATED WITH FASTER
WALKING SPEED IN LATER LIFE IN WOMEN, BUT NOT MEN:
FINDINGS FROM A BRITISH BIRTH COHORT
T. G. Tektonidis1,2*, P. Esser1, S. Coe1,2, J. Maddock3, S. Buchanan4,
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Rationale:Healthy diet has been linked to better physical functioning
while ageing, but evidence on the prospective relationship of overall
diet quality in late midlife and walking speed in later life is limited.
Research on potential sex differences in this relationship is scarce.
Methods: This study investigated the association between overall diet
quality, as assessed by the Healthy Eating Index-2015 at age 60–64 y,
and measures of walking speed seven years later, among men and
women from the Insight 46, a neuroscience sub-study of the Medical
Research Council National Survey of Health and Development. Diet
was assessed at age 60–64 y using five-day food diaries, from which
total HEI-2015 was calculated. At age 69–71 y, walking speed was
estimated during a four 10-meter walk at self-selected pace, using an
inertial measurement unit. Multivariable linear regression models
with sex as modifier, controlling for age, follow-up, lifestyle, health
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and social variables and physical performance were used. The final
sample was 164 women and 167 men (n = 331).
Results: On average, women had higher HEI-2015 scores at age 60–
64 y and slower walking speed than men at age 69–71 y. A 10 point
increase in HEI-2015 was associated with faster walking speed seven
years later among women (B:.024, 95% CI:.006,.043), but not men. The
association remained significant in the multivariable model (B:.021,
95% CI:.003,.040).
Conclusion: Inwomen in late midlife, but not men, higher diet quality
is associated with better physical capability in later life.
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MANAGEMENT OF HYPONATREMIA IN PATIENTS WITH TOTAL
ENTERAL TUBE FEEDING (TEN), ARE WE DOING IT RIGHT?
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Rationale: The appropiate treatment of non-severe hyponatremia
according to the clinical guidelines should be fluid restriction-FR-(<1
liter) in euvolemic patients, furosemide in hypervolemic and isotonic
saline (IS) in hypovolemic. The aim of this study was to know the
current management of hyponatremia in patients with TEN.
Methods: An observacional, prospective study during 24 months. The
study was designed in non-critically hyponatremic patients receiving
TEN and presenting hyponatremia. Data collected included sex, age,
clinical volemia, type of treatment (FR, furosemide, IS) and serum
sodium levels before and 72 hours after started treatment. Total
volume of fluid (TEN and addition non-TEN iv fluids) were also
included before and during hyponatremia treatment.
Results: 29 patients were included, 58,9% males, age 76 (IR 68–84)
years. 3,4% were hypovolemic, 89,6% were euvolemic and 6,9% were
hypervolemic. All of them received treatment and was appropiate
treatment in 100% hypovolemic, 65,3% euvolemic and 50% hypervo-
lemic patients. Eunatremia (Serum sodium >135 mmol/L) was reached
by 48,3%: 50% of hypervolemic and 54,1% of euvolemic patients;
eunatremia was not reached in hypovolemic patients. We found
eunatremia in 64,3% patients with adequate treatment and in 35,7%
without adequate treatment (p = 0.555). In euvolemic patients total
volume during hyponatremia management was 1800 (IR 1600–2200)
mL: 1200 (IR 1000–1332)mL of TEN and 800 (IR 600–800)mL of non-
TEN iv.
Conclusion: Eunatremia was more frequent in patients with appro-
priate treatment. However, in euvolemic patientswith hyponatremia it
is difficult to establish the appropriate treatment. In these patients, the
fluid restriction to less than 1 liter is not possible.
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Rationale: In a previous study conducted in Spain (PREDyCES 2009)
the prevalence of malnutrition was 23.7%. The main objective of the
SeDREno studywas to check the prevalence of hospitalmalnutrition at
admission, according to GLIM criteria, ten years later.
Methods: the study was conducted in 5 communities of the north of
Spain, in a period of 5–7 days (SeDREno: DRE north week). Cross-
sectional, observational, multicentre study in routine clinical practice,
which assessed the prevalence of hospital malnutrition at patient
admission using GLIM criteria.
Results: 2185 patients, 54.8% males, mean aged 67.1 ± 17 years (50.2%
were ≥70 years), mean BMI 26.9 ± 5.6 kg/m2. Malnutrition was
observed in 29.7% of patients according to GLIM criteria (12.5%
severe and 17.2% moderate). In patients ≥70 years malnutrition was
observed in 34.8% (14.7% severe and 20.1% moderate)(p < 0.001).
Multivariate analysis revealed that age, gender, weight, BMI and
polymedicationwere the main factors associated with the presence of
malnutrition (p < 0.001). It was observed a significantly greater
nutritional risk for women with respect to men (p = 0.048), and
those admitted as emergencies and to medical department (p <
0.001). Clinical conditions significantly associated at admissionwith a
higher prevalence of malnutrition were dysphagia (47.6% p < 0.001),
cognitive impairment (43.4% p < 0.001),cancer (39.1% p < 0.001),
digestive pathology (37.7% p < 0.001),diabetes (34.8% p < 0.004) and
cardiovascular disease (33.4% p < 0.004). Malnutrition was associated
with an increase in length of hospital stay and death (p < 0.001).
Conclusion: In SeDREno study, almost one in three patients are
malnourished. In patients admitted, with acute or chronic pathology, it
is only necessary to detect a phenotypic criterion to meet GLIM
criteria. In patients ≥70 years, the presumption of malnutrition must
be admitted to implementing early detection and treatmentmeasures.
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Rationale: There are many reaserch comparing different methods of
enteral nutrition in patients on Intensive Care Units. However there is
no enough data about nutrition in patients after sudden cardiac arrest.
The aim of this studywas to compare twomethods of enteral nutrition
intermittent and continuous in terms tolerance in patients after
cardiac arrest.
Methods: Retrospective analysis of medical records for 40 patients
Intensive Care Unit in 2017–2019. 20 patients were analyzed in each
specific method of nutrition. They were fed at least 5 days of industrial
diet and dosing through the nasogastric tube. In the case of the
continuousmethod, patients were infused continuously for 20 hours a
day. If the intermittent method is used up to 5 bolus for 2 hours with a
6-hour night break. Tolerances of both forms were analyzed.
Results: The characteristics of the two groups were similar. Enteral
nutritionwas implemented on average 44 ± 21.9 hours. There were no
differences in the level of biochemical parameters and glycemia
between these groups. Vomiting occurred in almost 35% of patients,
with no differences between the groups. The analysis showed a
significant decrease in diarrhea in patients after the intermittent
method compared with continuous administration (OR 0.167, 95% CI
[0.03–0.0], p = 0.029).
Conclusion: In patients after sudden cardiac arrest, the method of
intermittent enteral nutrition appears to be better tolerated than the
continuousmethod by reducing diarrhea. Therewere no differences in
other aspects, such as infection, decubitus ulcers, biochemical or
glycemic tests.
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Rationale:Gutmicrobial colonization in early life runs in parallel with
immune system maturation and plays a role in intestinal physiology
and regulation. Aging on the other hand leads to alterations in gut
microbial diversity, immunity and metabolism resulting in an
increased susceptibility to infections and disease. Studies indicate
that nutrition, including pre-, pro- and synbiotics, plays an important
role in development and maintenance of a balanced gut environment.
Methods: The present study describes an extensive “Gut Health
Discovery Platform (GHDP)” studying 3 main factors contributing to
gut health: (1.) The microbiome, including assays on anaerobic
culturing, 16s sequencing, shotgun metagenomic and metabolite
analysis, (2.) The intestinal epithelial cells, including assays on anti-
adhesion, barrier integrity, barrier enforcement and chemokine/
cytokine profiling, (3.) The immune cells, including assays on
immune responsiveness and cytokine profiling. The effects of a
range of new oligosaccharides (OS) were studied in a part of the
GHDP followed by integrative analysis.
Results: In the microcolon model, using infant faces as inoculum,
specific OS inhibited, stimulated or were ineffective in modulating
Bifidobacteria growth. Intestinal cell assays showed a differential
capability for each of the tested OS in inhibiting E. coli adhesion and E.
coli induced intestinal barrier disruption.
Conclusion: Extensive in vitro screening will contribute to the
knowledge and selection of present and newmicrobiomemodulators.
The present study shows that OS can be grouped based on different
readouts, allowing to focus on a specific group, or the selection of a
representative member from each group. Based on this knowledge the
most suitable components can be identified and taken into clinical
trials in the relevant target population or in healthy volunteer
challenge models.
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Rationale: Consumption of probiotics can modulate the microbiota of
breast milk and this, in turn, influences the health and growth of the
newborn.
Methods: 625 mothers-child pairs participated in a randomized,
double blind, and controlled study. Women were divided into 2
groups: Probiotic group that consumed 1 capsule/day of L.fermentum
Lc40 3 × 109cfu; Control group received 1 capsule/day with maltodex-
trin. 16 weeks lasted the intervention. The microbiota of the breast
milk and childreńs feces was analyzed. The growth and health of the
babies were controlled throughout the intervention period.
Results: 16 weeks intervention was completed by 291 mother-child
pairs. A significant correlation was detect between breast milk load of
Lactobacillus, Staphylococcus and Streptococcus with the load of
Lactobacillus, Staphylococcus, Bacteroides and E. coli in the children’s
feces (p < 0.05) due to the modulation produced by the probiotic.
Respect health parameters, it was observed that infantile colic was
significantly more probable in children whose mother had higher
levels of anaerobes in the milk (p = 0.044), and a higher incidence of
respiratory infections was correlated with the burden of staphylococci
in breast milk and the feces of babies. In adition, the interventionwith
L.fermentum Lc40 reduced the effect of Staphylococcus on the health
of children (p < 0.05). Finally, it was found that babies of women with
higher Lactobacillus values in breast milk had higher weight z-scores,
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and E. coli load in children’s feces was related to z scores of greater
weight and height (p < 0.05).
Conclusion: The microbiota of breast milk affects infant colonization
and, consequently, in parameters of growth and health of babies. The
modulation of themicrobiota of breastmilkwith probiotics can induce
a healthier growth of babies.
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Rationale: Preterm infants are likely to have growth failure from both
nutrition and non-nutrition factors. The research aimed to investigate
the factors affecting the growth of preterm infants who received
parenteral nutrition.
Methods: The study was a retrospective cohort collecting data from
January 2012 to July 2016. The relationships were determined by
multiple regression means between those factors and indices of the
growth includingweight increase rate, weight at age 36weeks, time to
regain birth weight and growth failure.
Results: A 80 preterm infants included into this study with mean
gestational age of 32 weeks, mean birth weight of 1468 grams and
mean weight at aged 36 weeks of 1876.38 grams. The association
between the infants’ growth indices and factors were shown. Time to
have full enteral feeding (r = 0.33, 95% CI: 0.01–0.48) was associated
significantly with weight increase rate at 36 weeks old, the birth
weight [r =−0.53, 95% CI: (−445.04) – (−216.70)] was associated with
weight at age 36 weeks, the initial timing of parenteral nutrition (PN)
[r =−0.24, 95% CI: (−4.10) – (−0.40)], the average protein amount in
parenteral nutrition (r = 0.39, 95% CI: 0.55–3.43), the initial protein
amount in parenteral nutrition [r =−0.46, 95% CI: (−3.19) – (−1.00)]
was associated with time to regain birth weight. Birth weight
(OR = 15.90, 95% CI: 1.54–164.14) was associated with growth failure
at age 36 weeks.
Conclusion: The most obvious nutrition factor facilitating growth of
preterm infants who had received parenteral nutritionwas the higher
protein initiation amount in PN feeding.
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Rationale: Blenderised foods being given to children requiring tube
feeding is increasing. Current position statements do not recommend
this (1) as it may increase the risk of tube occlusion and nutritional
inadequacies(2,3).
Methods: A tube feed formula has been developed to address safety
and nutritional inadequancies. Study design followed the UK Advisory
Committee on Borderline Substances (ACBS) criteria to support
submission for prescription usage in the National Health Service
(NHS). All participants (n = 19) were tube fed, recruited from NHS
settings and under the care of a dietitian/doctor. All participants were
given the new formula for 7 days, Isosource Junior Mix,Nestlé Health
Science. Demographic, medical datawas obtained and gastrointestinal
(GI) tolerance recorded. Stool type was measured using the Bristol
Stool Chart.
Results: Participants (1–14 years) had a range of medical conditions;
global developmental delay, epilepsy, cerebral palsy and Down’s
syndrome; 16/19 completed the 7-day trial and average daily
formula intake was 730mls (480–1400 ml) for those completing. A
number of participants reported positive changes in stool consistency;
becoming firmer and decreasing in frequency. One child saw improved
mood, eye contact and concentration. Resolution of reflux and gradual
decrease in retching were observed in 2 participants. One child
experienced bloating and flatulence; they were previously on a tube
feed without fibre which may have caused symptoms. There were no
weight changes during the study.
Conclusion: The new tube feed was well tolerated by majority of
participants, with a decrease in GI symptoms and beneficial changes in
stool type.
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SARCOPENIC OBESITY ON PATIENTS AWAITING LIVER
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Rationale: Evidence suggests that sarcopenia is associated with poor
clinical outcomes and overall survival in the general surgical
population. However, the significance of sarcopenia in the liver
transplantation (LT) population remains unclear.
The purpose of this study is to investigate the impact of low skeletal
muscle mass, muscle quality and sarcopenic obesity on patients
awaiting LT.
Methods: We retrospectively analyzed patients who underwent LT at
our center, between January 2013 and January 2018. Body composi-
tion parameters including skeletal muscle mass index (SMI), intra-
muscular adipose tissue content (IMAC), visceral fat area (VFA) were
evaluated by preoperative plain computed tomography imaging at
the level of the third lumbar vertebra (L3) and also clinical and
biochemical parameterswere taken. This study defined sarcopenia as a
low SMI (male < 52.4 cm2/m2; female < 38.5 cm2/m2) and obesity a
VFA >100 cm2. The percentage of muscle fat infiltration (% MFI) was
calculated using the following formula: % MFI = IMAC (cm2) [ IMAC
(cm2) +MME (cm2)] × 100. Logistic regressions and Kaplan-Meier
analysis was performed.
Results: The study included 94 patients (76 men) with a mean age
of 60,14(DS 8,57), 72 (76,6%) had sarcopenia and 52 (55,3%) had
sarcopenic obesity. Multivariate analysis identified PCR (p 0,04), low
SMI (p 0,048) and Creatinine (p 0,035) as independent risk factors for
death after LT. There was a negative correlation between PCR and SMI
(p = 0,01).
Conclusion: Sarcopenia and sarcopenic obesity were highly prevalent
in liver transplantation patients. PCR and creatinine were both good
predictors of mortality in this population. High SMI is an excellent
predictor for survival in this group of patients.
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NUTRITIONAL AND FUNCTIONAL CHARACTERISTICS OF ELDERLY
ONCOLOGY PATIENTS UNDERGOING MAJOR ABDOMINAL SURGERY
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Rationale: To describe the functional and nutritional characteristics of
onco-geriatric patientswho are candidates for elective gastrointestinal
surgery and to identify factors associated with malnutrition before
surgery.
Methods: Cross-sectional analysis of prospectively maintained data-
base of patients age 65 years and older who were candidates for
elective gastrointestinal surgery for cancer between the years 2018–
2019. Patients underwent Geriatric Assessment (GA) in our outpatient
clinic by multidisciplinary team including geriatric MD, nurse and
dietitian. Preoperative data collected included patient’s demographics
and anthropometrics. Nutritional status was evaluated using the Mini
Nutritional Assessment or Subjective Global Assessment. Functional
parameters including: Time Up and Go test result, grip strength and
frailty score (using Rockwood frailty scale) were collected. variablels
described using frequencies and percentages. The Chi square test was
used to examine associations between malnutrition before surgery
and demographics, nutritional and functional parameters.
Results: 75 patients undergo GA in our clinic. The mean age was
78.70 ± 7 years and mean BMI was 26.26 ± 5.22 kg/m². 43.5% patients
(n = 30) were in the normal BMI range for age, 26.1% patients (n = 18)
were underweight, 8.7% (n = 6) were overweight and 21.7% (n = 15)
were obese. 23% (n = 16) lostmore than 10% of their Usual BodyWeight
in the last 6months and 23% (n = 16) lost between 5–10% of their UBW.
22.6% (n = 14) of the patient were diagnosed as malnourished and
37.1% (n = 23) were at risk for malnutrition. 8.8% of the patients (n = 6)
were diagnosed as frail and 31% (n = 21) were diagnosed as pre-frail.
67.2% of the patients (n = 43) had grip strength in the criterion for
frailty (by gender and BMI). 61.4% of the patients (n = 43)were at risk of
falling according to TUG test. Factors associated with malnutrition
before surgery were: frailty score≥ 4 (p = 0.008), weight loss≥ 5%
(p < 0.001) and cancer type (p = 0.021).
Conclusion: Nutritional and functional assessment, as part of
preoperative GA, identified high rates of impaired nutritional status,
functional decline and frailty. These factors can influence the surgical
treatment decision and improve before surgery by prehabilitation.
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Rationale: The randomized, controlled trials of obesity interventions
find remarkable heterogeneity of responses among adult patients—
whether the intervention pertains to lifestyle (dietary, physical
activity), or is a pharmacological or surgical intervention. Indeed,
most RCTs for obesity interventions include a mixture of patients that,
despite meeting the inclusion criteria for the study, vary remarkably
when it comes to the medical history of their disease, their associated
comorbidities, and many other factors (including lifestyle and
environmental factors) that may drive the heterogeneous responses
to the same intervention. Only stratification-driven analysis should
allow to decipher the obesity heterogeneity.
Methods: A group of European obesity researchers convened in 2018
to create a plan for helping shape future studies by identifying the
minimal set of variables that should be included in trials of different
kinds of obesity interventions (whatever the type and the endpoints of
the intervention). Of course, besides this minimal core set, RCTs or
other trials may collect data on additional variables, depending on the
specific area of focus.
Results: This initiative, called @OBEDIS and funded by the JPI HDHL,
was createdwith the aim of giving the research communitya blueprint
for designing future RCTs to allow the sharing andmerging of datasets,
and to enable meaningful subgroup analyses. To achieve this, the
@OBEDIS experts surveyed the scientific literature, shared their expert
opinions on a recommendedminimal core set of variables to include in
all future trials of adult obesity interventions, and sought to reach
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consensus on both these variables and the related assessment
methods.
Conclusion: The @OBEDIS results pave the way to new generation of
relevant obese phenotype definitions, and open the door to new
innovative patient stratification, driving a paradigm shift in the future
obesity treatment, going from “one-size-fits-all” to precision
medicine.
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Şentürk, M., S251 (MON-PO520)
Seok, M., S178 (MON-PO326)
Seol, E., S178 (MON-PO326)
Sergeeva, A., S62 (SUN-PO011)
Serlie, M., S20 (OR41)
Serlie, M.J., S11 (OR19)
Serralde Zúñiga, A. E., S316 (MON-LB691)
Serrano-Oliver, A., S133 (SUN-PO199)
Serrano Valles, C., S317 (MON-LB693)
Serrano-Valles, C., S123 (SUN-PO171)
Servant, R.E., S49 (PT08.1)
Sestili, P., S176 (SUN-PO317)
Setter, N., S274 (MON-PO581)
Severine, A.N., S64 (SUN-PO017), S64 (SUN-PO018), S141 (SUN-PO221)
Sevillano, M., S125 (SUN-PO177)
Seyssel, K., S19 (OR39)
Sezen, C.B., S90 (SUN-PO085)
Sezgin, B., S252 (MON-PO522)
Sgantzos, M., S146 (SUN-PO235)
Shahabbasi, J., S258 (MON-PO538)
Shams, N.A., S221 (MON-PO441)
Shao, C., S39 (PT03.04)
Sharkey, L., S206 (MON-PO399), S206 (MON-PO400)
Shaw, C., S200 (MON-PO383)
Shen, G., S304 (SUN-LB658)
Shen, J., S42 (PT04.5)
Shen’, N. P., S300 (SUN-LB648)
Shen, Y., S39 (PT03.04)
Shergill-Bonner, R., S319 (MON-LB699)
Shestopalov, A., S62 (SUN-PO012)
Sheveleva, P., S196 (MON-PO373)
Shibanov, L., S119 (SUN-PO161)
Shibasaki, E., S156 (SUN-PO265)
Shi, H., S243 (MON-PO500)
Shih, Y.-L., S90 (SUN-PO086), S95 (SUN-PO099), S210 (MON-PO409)
Shih, Y.L., S96 (SUN-PO100), S102 (SUN-PO115)
Shikany, J.M.S.M., S37 (PT02.6)
Shi, L., S158 (SUN-PO268)
Shimada, A., S1 (CN02)
Shimada, M., S81 (SUN-PO062), S257 (MON-PO536)
Shimizu, H., S205 (MON-PO398), S212 (MON-PO416)
Shimizu, T., S156 (SUN-PO265), S186 (MON-PO346),
S255 (MON-PO530)
Shimoda, C., S292 (MON-PO629)
Shimonov, M., S113 (SUN-PO145), S119 (SUN-PO161),
S119 (SUN-PO162)
Shimony, T., S22 (OR46)
Shin, C.S., S33 (PT01.1)
Shin, J.C., S273 (MON-PO577), S273 (MON-PO578)
Shinohara, M., S60 (SUN-PO005)
Shintani, H., S61 (SUN-PO009)
Shintani, T., S61 (SUN-PO009)
Shin, Y.C., S173 (SUN-PO308)
Shirai, H., S8 (OR11)
Shonaka, T., S281 (MON-PO599)
Shukla, K. Deshpande, S235 (MON-PO477)
Sibilska, M., S26 (OR57)
Sicchieri, J.M.F., S97 (SUN-PO104), S98 (SUN-PO105)
Sideris, K., S131 (SUN-PO195)
Siebenrock, T., S175 (SUN-PO315)
S347Abstracts / Clinical Nutrition 38 (2019) S323–S354
Sifontes, M.A., S194 (MON-PO367)
Siles, A., S267 (MON-PO561)
Silva, B.N.M.D., S239 (MON-PO490)
Silva-Fernández, J.M., S162 (SUN-PO279)
Silva, F.M., S65 (SUN-PO020), S135 (SUN-PO204), S142 (SUN-PO223),
S143 (SUN-PO227), S144 (SUN-PO228)
Silva Froján, C., S86 (SUN-PO075)
Silva, G.T.D., S81 (SUN-PO060)
Silva, H.-H., S241 (MON-PO494), S277 (MON-PO589)
Silva, L.D., S187 (MON-PO349)
Silva, L.K., S141 (SUN-PO221), S142 (SUN-PO222)
Silva, M., S69 (SUN-PO033)
Silva, M.-R. G., S277 (MON-PO589)
Silva, M.-R.G., S241 (MON-PO493), S241 (MON-PO494)
Silva, R., S74 (SUN-PO044)
Silva, S., S92 (SUN-PO089)
Simapaisan, P., S68 (SUN-PO031)
simats oriol, G., S136 (SUN-PO207)
Simmaco, M., S85 (SUN-PO071), S105 (SUN-PO123)
Simon, J., S18 (OR38)
Simon, K., S305 (SUN-LB663)
Simon, M.-C., S229 (MON-PO460)
Simonsick, E.M., S2 (CN05)
Sinaga, W., S256 (MON-PO533)
Sinai, T., S22 (OR46)
Singer, P., S2 (CN03), S4 (GM02), S219 (MON-PO433),
S270 (MON-PO571), S281 (MON-PO598),
S281 (MON-PO600), S289 (MON-PO620)
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